Citrus Sinensis ID: 021982

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300----
Protein Sequence
MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL
Secondary Structure (PSIPRED)
cccccHHHHccccccccEEEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHHHcccccccEEEEEEEEcccccccccEEEEEEEccHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEEcccccccccccccccccccEEEEEccccHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccccccccccccccccccccccccccccHHHHcccccHHHHHHHHHcccccccccccHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEEEEEEEccccccEEEEEEcccccEEEEEEEccEccccEccHHHHHHHHHHccccccccEEEEEEEEccccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHccccccccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHHcHHHHHcccccc
Coil and Loop (DISEMBL)
MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKtrlheddegvppttlREVSILRMlsrdphvvrlmdvkqgqnkegrTVLYLVFEYMDTDLKKYIRSFRqtgenipvntVKSLMYQLCKGvafchghgilhrdlkphnllmdrkTMTLKIADLGLARAFTLPIKKYTHEILTLWyrapevllgsthysTAVDMWSVACIFAELVTktalfpgdsELQQLLHIFRllgtpnekvwpgvsslmnwheypqwnpqslatavpnldkDGLDLLEQMLQydpskrisakkamehpyfddldktrl
Flexible Loop (DISEMBL)
mvmdafeklekvgegtygkvyrarekatgkivalkktrlheddegvppttlrevsiLRMLSRDPHVvrlmdvkqgqnkegrtvLYLVFEYMDTDLKKYIRSFrqtgenipvNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPskrisakkamehpyfddldktrl
Low Complexity Region (SEG)
MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL
Disordered region (IsUnstruct)
**************GTYGKVYRAREKATGKIVALKKT************TLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLE******************************
Disordered Region (DISOPRED)
*VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQ*G*NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT**
Disordered Region (DISEMBL)
MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF********
Disordered Region (DISPRO)
*VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	304	2.2.26 [Sep-21-2011]
Q8LG64	315	Cyclin-dependent kinase B	yes	no	0.996	0.961	0.861	1e-158
Q38775	312	Cell division control pro	N/A	no	0.996	0.971	0.854	1e-157
Q8LF80	313	Cyclin-dependent kinase B	no	no	0.980	0.952	0.852	1e-155
Q0J4I1	326	Cyclin-dependent kinase B	yes	no	0.986	0.920	0.8	1e-145
Q8L4P8	303	Cyclin-dependent kinase B	no	no	0.986	0.990	0.681	1e-126
Q38774	305	Cell division control pro	N/A	no	0.990	0.986	0.673	1e-119
P25859	309	Cyclin-dependent kinase B	no	no	0.993	0.977	0.647	1e-118
Q2V419	311	Cyclin-dependent kinase B	no	no	0.993	0.971	0.643	1e-118
P29618	294	Cyclin-dependent kinase A	no	no	0.953	0.986	0.568	1e-99
P23111	294	Cell division control pro	N/A	no	0.953	0.986	0.561	5e-99

>sp|Q8LG64|CKB22_ARATH Cyclin-dependent kinase B2-2 OS=Arabidopsis thaliana GN=CDKB2-2 PE=1 SV=2

 Score =  556 bits (1432), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 262/304 (86%), Positives = 285/304 (93%), Gaps = 1/304 (0%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            M+AFEKLEKVGEGTYGKVYRAREKATG IVALKKTRLHED+EGVPPTTLRE+SILRML+
Sbjct: 12  AMEAFEKLEKVGEGTYGKVYRAREKATGMIVALKKTRLHEDEEGVPPTTLREISILRMLA 71

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPH+VRLMDVKQG NKEG+TVLYLVFEY+DTDLKK+IRSFRQ G+NIP NTVK LMYQL
Sbjct: 72  RDPHIVRLMDVKQGINKEGKTVLYLVFEYVDTDLKKFIRSFRQAGQNIPQNTVKCLMYQL 131

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKG+AFCHGHG+LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP+KKYTHEILTLWYRA
Sbjct: 132 CKGMAFCHGHGVLHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPMKKYTHEILTLWYRA 191

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYST VDMWSV CIFAELVTK A+F GDSELQQLL IFRLLGTPNE+VWPGV
Sbjct: 192 PEVLLGATHYSTGVDMWSVGCIFAELVTKQAIFAGDSELQQLLRIFRLLGTPNEEVWPGV 251

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL-D 300
           S L +WHEYPQW P SL+TAVPNLD+ GLDLL +ML+Y+P+KRISAKKAMEHPYFDDL D
Sbjct: 252 SKLKDWHEYPQWKPLSLSTAVPNLDEAGLDLLSKMLEYEPAKRISAKKAMEHPYFDDLPD 311

Query: 301 KTRL 304
           K+ L
Sbjct: 312 KSSL 315

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|Q38775|CDC2D_ANTMA Cell division control protein 2 homolog D OS=Antirrhinum majus GN=CDC2D PE=2 SV=1

 Score =  554 bits (1427), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 259/303 (85%), Positives = 285/303 (94%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            MDAF KLEKVGEGTYGKVYRA EK+TGKIVALKKTRLHED+EGVPPTTLREVS+LRMLS
Sbjct: 10  AMDAFVKLEKVGEGTYGKVYRAMEKSTGKIVALKKTRLHEDEEGVPPTTLREVSLLRMLS 69

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPHVVRL+DVKQGQNKEG+TVLYLVFEYMDTDLKKYIRSF+QTGE+I    VKSLMYQL
Sbjct: 70  RDPHVVRLLDVKQGQNKEGKTVLYLVFEYMDTDLKKYIRSFKQTGESIAPMNVKSLMYQL 129

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHG+LHRDLKPHNLLMDRKTM LKIADLGLARA+TLPIKKYTHEILTLWYRA
Sbjct: 130 CKGVAFCHGHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAYTLPIKKYTHEILTLWYRA 189

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYS AVDMWSVACIFAELVT+ ALFPGDSELQQLLHIFRLLGTPNE++WPGV
Sbjct: 190 PEVLLGATHYSPAVDMWSVACIFAELVTQKALFPGDSELQQLLHIFRLLGTPNEEIWPGV 249

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+L++WHEYPQW  Q +++AVP LD+ GL+LL +ML Y+PS+RISAKKAMEHPYFD+LDK
Sbjct: 250 STLVDWHEYPQWTAQPISSAVPGLDEKGLNLLSEMLHYEPSRRISAKKAMEHPYFDELDK 309

Query: 302 TRL 304
           + L
Sbjct: 310 SGL 312

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q8LF80|CKB21_ARATH Cyclin-dependent kinase B2-1 OS=Arabidopsis thaliana GN=CDKB2-1 PE=1 SV=2

 Score =  548 bits (1412), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 254/298 (85%), Positives = 279/298 (93%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED+EGVP TTLRE+SILRML+
Sbjct: 10  AMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDEEGVPSTTLREISILRMLA 69

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPHVVRLMDVKQG +KEG+TVLYLVFEYMDTD+KK+IRSFR TG+NIP  T+KSLMYQL
Sbjct: 70  RDPHVVRLMDVKQGLSKEGKTVLYLVFEYMDTDVKKFIRSFRSTGKNIPTQTIKSLMYQL 129

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKG+AFCHGHGILHRDLKPHNLLMD KTM LKIADLGLARAFTLP+KKYTHEILTLWYRA
Sbjct: 130 CKGMAFCHGHGILHRDLKPHNLLMDPKTMRLKIADLGLARAFTLPMKKYTHEILTLWYRA 189

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYSTAVDMWSV CIFAELVT  A+F GDSELQQLLHIF+L GTPNE++WPGV
Sbjct: 190 PEVLLGATHYSTAVDMWSVGCIFAELVTNQAIFQGDSELQQLLHIFKLFGTPNEEMWPGV 249

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           S+L NWHEYPQW P +L++AVPNLD+ G+DLL +MLQY+P+KRISAK AMEHPYFDDL
Sbjct: 250 STLKNWHEYPQWKPSTLSSAVPNLDEAGVDLLSKMLQYEPAKRISAKMAMEHPYFDDL 307

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q0J4I1|CKB21_ORYSJ Cyclin-dependent kinase B2-1 OS=Oryza sativa subsp. japonica GN=CDKB2-1 PE=1 SV=1

 Score =  513 bits (1322), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 240/300 (80%), Positives = 269/300 (89%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            MD +EKLEKVGEGTYGKVY+AREKATG+IVALKKTRL EDDEGVPPT LREVS+LRMLS
Sbjct: 24  AMDLYEKLEKVGEGTYGKVYKAREKATGRIVALKKTRLPEDDEGVPPTALREVSLLRMLS 83

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +D HVVRL+D+KQGQNKEG+T+LYLVFEYMDTDLKK+IR+ RQ  + IPV TVK LMYQL
Sbjct: 84  QDSHVVRLLDLKQGQNKEGQTILYLVFEYMDTDLKKFIRAHRQNLQKIPVPTVKILMYQL 143

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHG G+LHRDLKPHNLLMDRKTM LKIADLGL+R+FT+P+KKYTHEILTLWYRA
Sbjct: 144 CKGVAFCHGRGVLHRDLKPHNLLMDRKTMALKIADLGLSRSFTVPLKKYTHEILTLWYRA 203

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+ HYST VD+WSV CIFAEL T   LF GDSE+QQLLHIF+LLGTPNE+VWPGV
Sbjct: 204 PEVLLGAAHYSTPVDIWSVGCIFAELATNQPLFAGDSEVQQLLHIFKLLGTPNEQVWPGV 263

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S L NWHEYPQWNP  ++  V  LD D LDLLE+MLQY+PSKRISAKKAMEHPYF+D++K
Sbjct: 264 SKLPNWHEYPQWNPSKVSDLVHGLDADALDLLEKMLQYEPSKRISAKKAMEHPYFNDVNK 323

Forms a complex with CYCB2-1 or CYCB2-2 that activates CDK kinase in tobacco BY2 cells during G2/M (mitosis) phases. May be involved in the regulation of the cell cycle at the G2/M transition.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q8L4P8|CKB11_ORYSJ Cyclin-dependent kinase B1-1 OS=Oryza sativa subsp. japonica GN=CDKB1-1 PE=2 SV=1

 Score =  450 bits (1157), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 208/305 (68%), Positives = 258/305 (84%), Gaps = 5/305 (1%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +EKLEKVGEGTYGKVY+A+++ATG++VALKKTRL  D+EG+PPT LRE+SILR+LS+
Sbjct: 1   MEKYEKLEKVGEGTYGKVYKAQDRATGQLVALKKTRLEMDEEGIPPTALREISILRLLSQ 60

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMY 119
             +VVRL+ V+Q   K G+ VLYLVFE++DTDLKK++ ++R+ G N   +P N +KS +Y
Sbjct: 61  SLYVVRLLSVEQA-TKNGKPVLYLVFEFLDTDLKKFVDAYRK-GPNPRPLPTNVIKSFLY 118

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           QLCKGVA CHGHG+LHRDLKP NLL+D++   LKIADLGL RAFT+P+K YTHEI+TLWY
Sbjct: 119 QLCKGVAHCHGHGVLHRDLKPQNLLVDKEKGILKIADLGLGRAFTVPMKSYTHEIVTLWY 178

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           RAPEVLLGSTHYST VD+WSV CIFAE+V + ALFPGDSELQQLLHIFRLLGTP E+ WP
Sbjct: 179 RAPEVLLGSTHYSTGVDIWSVGCIFAEMVRRQALFPGDSELQQLLHIFRLLGTPTEEQWP 238

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           GV+ L +WHE+PQW PQ L   VP+L+ +G+DLL +MLQY+P+ RISAK AMEHPYFD L
Sbjct: 239 GVTDLRDWHEFPQWKPQILERQVPSLEPEGVDLLSKMLQYNPANRISAKAAMEHPYFDSL 298

Query: 300 DKTRL 304
           DK++ 
Sbjct: 299 DKSQF 303

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q38774|CDC2C_ANTMA Cell division control protein 2 homolog C OS=Antirrhinum majus GN=CDC2C PE=2 SV=1

 Score =  428 bits (1101), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 206/306 (67%), Positives = 252/306 (82%), Gaps = 5/306 (1%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +EKLEKVGEGTYGKVY+A EK+TG++VALKKTRL  D+EGVPPT LREVS+L+MLS+
Sbjct: 1   MEKYEKLEKVGEGTYGKVYKALEKSTGQVVALKKTRLEMDEEGVPPTALREVSLLQMLSQ 60

Query: 63  DPHVVRLMDVKQ-GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLM 118
             +VVRL+ V+     K G+ +LYLVFEY+DTDLKK+I S R+ G N   +P   ++S +
Sbjct: 61  SLYVVRLLSVEHVDCAKNGKPLLYLVFEYLDTDLKKFIDSHRK-GPNPRPLPPQQIQSFL 119

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +QLCKGV+ CH HG+LHRDLKP NLL+D+    LKIADLGLARAFT+P+K YTHEI+TL 
Sbjct: 120 FQLCKGVSHCHAHGVLHRDLKPQNLLLDKDKGVLKIADLGLARAFTVPLKSYTHEIVTLS 179

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YRAPEVLLGS+HYSTAVDM SV CIFAE+V + ALFPGDSE QQLLHIFRLLGTP+++ W
Sbjct: 180 YRAPEVLLGSSHYSTAVDMSSVGCIFAEMVRRQALFPGDSEFQQLLHIFRLLGTPSDEQW 239

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
           PGVSSL +WH YPQW PQ+ A AVP+L  DGLDLL + L+YDP+ RISAK A++HPYFD 
Sbjct: 240 PGVSSLRDWHVYPQWEPQNSAPAVPSLGPDGLDLLTKTLKYDPADRISAKAALDHPYFDT 299

Query: 299 LDKTRL 304
           LDK++ 
Sbjct: 300 LDKSQF 305

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P25859|CKB11_ARATH Cyclin-dependent kinase B1-1 OS=Arabidopsis thaliana GN=CDKB1-1 PE=1 SV=2

 Score =  424 bits (1089), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 200/309 (64%), Positives = 248/309 (80%), Gaps = 7/309 (2%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +EKLEKVGEGTYGKVY+A EK TGK+VALKKTRL  D+EG+PPT LRE+S+L+MLS 
Sbjct: 1   MEKYEKLEKVGEGTYGKVYKAMEKGTGKLVALKKTRLEMDEEGIPPTALREISLLQMLST 60

Query: 63  DPHVVRLMDVKQ-----GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VK 115
             +VVRL+ V+       +++  ++ LYLVFEY+DTDLKK+I S+R+     P+    ++
Sbjct: 61  SIYVVRLLCVEHVHQPSTKSQSTKSNLYLVFEYLDTDLKKFIDSYRKGPNPKPLEPFLIQ 120

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            LM+QLCKGVA CH HG+LHRDLKP NLL+ +    LKIADLGL RAFT+P+K YTHEI+
Sbjct: 121 KLMFQLCKGVAHCHSHGVLHRDLKPQNLLLVKDKELLKIADLGLGRAFTVPLKSYTHEIV 180

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           TLWYRAPEVLLGSTHYST VDMWSV CIFAE+V + ALFPGDSE QQLLHIFRLLGTP E
Sbjct: 181 TLWYRAPEVLLGSTHYSTGVDMWSVGCIFAEMVRRQALFPGDSEFQQLLHIFRLLGTPTE 240

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           + WPGVS+L +WH YP+W PQ L  AVP+L   G+DLL +ML+Y+P++RISAK A++HPY
Sbjct: 241 QQWPGVSTLRDWHVYPKWEPQDLTLAVPSLSPQGVDLLTKMLKYNPAERISAKTALDHPY 300

Query: 296 FDDLDKTRL 304
           FD LDK++ 
Sbjct: 301 FDSLDKSQF 309

May control G2/M (mitosis) phase progression. Plays a role in regulating seedling growth in darkness via regulation of hypocotyl cell elongation and cotyledon cell development. Plays a role in stomatal development. Required to suppress endoreduplication.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q2V419|CKB12_ARATH Cyclin-dependent kinase B1-2 OS=Arabidopsis thaliana GN=CDKB1-2 PE=1 SV=2

 Score =  423 bits (1088), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 200/311 (64%), Positives = 248/311 (79%), Gaps = 9/311 (2%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +EKLEKVGEGTYGKVY+A EK TGK+VALKKTRL  D+EG+PPT LRE+S+L+MLS+
Sbjct: 1   MEKYEKLEKVGEGTYGKVYKAMEKTTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSQ 60

Query: 63  DPHVVRLMDVKQGQNKEGRTV-------LYLVFEYMDTDLKKYIRSFRQTGENIPVNT-- 113
             ++VRL+ V+     +  TV       LYLVFEY+DTDLKK+I S R+     P+    
Sbjct: 61  SIYIVRLLCVEHVIQSKDSTVSHSPKSNLYLVFEYLDTDLKKFIDSHRKGSNPRPLEASL 120

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 173
           V+  M+QL KGVA CH HG+LHRDLKP NLL+D+    LKIADLGL+RAFT+P+K YTHE
Sbjct: 121 VQRFMFQLFKGVAHCHSHGVLHRDLKPQNLLLDKDKGILKIADLGLSRAFTVPLKAYTHE 180

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           I+TLWYRAPEVLLGSTHYSTAVD+WSV CIFAE++ + ALFPGDSE QQLLHIFRLLGTP
Sbjct: 181 IVTLWYRAPEVLLGSTHYSTAVDIWSVGCIFAEMIRRQALFPGDSEFQQLLHIFRLLGTP 240

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            E+ WPGV +L +WH YP+W PQ L+ AVP+L  +G+DLL QML+Y+P++RISAK A++H
Sbjct: 241 TEQQWPGVMALRDWHVYPKWEPQDLSRAVPSLSPEGIDLLTQMLKYNPAERISAKAALDH 300

Query: 294 PYFDDLDKTRL 304
           PYFD LDK++ 
Sbjct: 301 PYFDSLDKSQF 311

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29618|CDKA1_ORYSJ Cyclin-dependent kinase A-1 OS=Oryza sativa subsp. japonica GN=CDKA-1 PE=1 SV=1

 Score =  363 bits (931), Expect = 1e-99,   Method: Compositional matrix adjust.
 Identities = 170/299 (56%), Positives = 228/299 (76%), Gaps = 9/299 (3%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +EK EK+GEGTYG VYRAR+K T + +ALKK RL ++DEGVP T +RE+S+L+ +  
Sbjct: 1   MEQYEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHH 60

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++VRL DV   + +     +YLVFEY+D DLKK++ S  +  +N     +KS +YQ+ 
Sbjct: 61  G-NIVRLHDVIHSEKR-----IYLVFEYLDLDLKKFMDSCPEFAKN--PTLIKSYLYQIL 112

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +GVA+CH H +LHRDLKP NLL+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAP
Sbjct: 113 RGVAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLGS  YST VDMWSV CIFAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGVS
Sbjct: 173 EILLGSRQYSTPVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVS 232

Query: 243 SLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
           SL ++   +P+W  Q LAT VP LD  GLDLL +ML+Y+P+KRI+A++A+EH YF DL+
Sbjct: 233 SLPDYKSAFPKWQAQDLATIVPTLDPAGLDLLSKMLRYEPNKRITARQALEHEYFKDLE 291

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P23111|CDC2_MAIZE Cell division control protein 2 homolog OS=Zea mays GN=CDC2 PE=2 SV=1

 Score =  360 bits (925), Expect = 5e-99,   Method: Compositional matrix adjust.
 Identities = 168/299 (56%), Positives = 229/299 (76%), Gaps = 9/299 (3%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +EK+EK+GEGTYG VY+A +KAT + +ALKK RL ++DEGVP T +RE+S+L+ ++ 
Sbjct: 1   MEQYEKVEKIGEGTYGVVYKALDKATNETIALKKIRLEQEDEGVPSTAIREISLLKEMNH 60

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++VRL DV   + +     +YLVFEY+D DLKK++ S  +  +N     +KS +YQ+ 
Sbjct: 61  G-NIVRLHDVVHSEKR-----IYLVFEYLDLDLKKFMDSCPEFAKN--PTLIKSYLYQIL 112

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            GVA+CH H +LHRDLKP NLL+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAP
Sbjct: 113 HGVAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG+  YST VD+WSV CIFAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGVS
Sbjct: 173 EILLGARQYSTPVDVWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEQSWPGVS 232

Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
            L ++   +P+W  Q LAT VPNLD  GLDLL +ML+Y+PSKRI+A++A+EH YF DL+
Sbjct: 233 CLPDFKTAFPRWQAQDLATVVPNLDPAGLDLLSKMLRYEPSKRITARQALEHEYFKDLE 291

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	304
255539342	313	CDK, putative [Ricinus communis] gi|2235	0.996	0.968	0.930	1e-168
449455643	312	PREDICTED: cyclin-dependent kinase B2-2-	0.996	0.971	0.914	1e-165
32187089	306	cyclin-dependent kinase [Populus tremula	0.996	0.990	0.907	1e-165
224086116	306	predicted protein [Populus trichocarpa]	0.996	0.990	0.910	1e-164
210148100	306	cyclin-dependent kinase B [Populus tomen	0.996	0.990	0.904	1e-164
344221929	307	cyclin-dependent kinase [Camellia sinens	0.996	0.986	0.900	1e-164
319439587	302	cyclin dependent kinase B2 [Cucurbita ma	0.993	1.0	0.910	1e-163
1806146	316	cdc2MsF [Medicago sativa]	0.990	0.952	0.906	1e-162
388514733	312	unknown [Lotus japonicus]	0.996	0.971	0.907	1e-162
357441091	316	Cyclin-dependent kinase [Medicago trunca	0.990	0.952	0.906	1e-162

>gi|255539342|ref|XP_002510736.1| CDK, putative [Ricinus communis] gi|223551437|gb|EEF52923.1| CDK, putative [Ricinus communis]

 Score =  598 bits (1541), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 282/303 (93%), Positives = 295/303 (97%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           VM+AFEKLEKVGEGTYGKVYRARE+ATGKIVALKKTRLHEDDEGVPPTTLRE+SILRMLS
Sbjct: 11  VMEAFEKLEKVGEGTYGKVYRARERATGKIVALKKTRLHEDDEGVPPTTLREISILRMLS 70

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPHVVRLMDVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIPV +VKSLMYQL
Sbjct: 71  RDPHVVRLMDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPVKSVKSLMYQL 130

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHGILHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYRA
Sbjct: 131 CKGVAFCHGHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRA 190

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLGSTHYSTAVDMWSV CIFAELVTK ALFPGDSELQQLLHIFRLLGTPNEK+WPGV
Sbjct: 191 PEVLLGSTHYSTAVDMWSVGCIFAELVTKQALFPGDSELQQLLHIFRLLGTPNEKLWPGV 250

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S L+NWHEYPQW+PQSL++AVPNLDKDGLDLL QMLQY+PSKRISAKKAMEHPYFDDL+K
Sbjct: 251 SKLVNWHEYPQWSPQSLSSAVPNLDKDGLDLLAQMLQYEPSKRISAKKAMEHPYFDDLNK 310

Query: 302 TRL 304
             L
Sbjct: 311 AIL 313

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449455643|ref|XP_004145561.1| PREDICTED: cyclin-dependent kinase B2-2-like [Cucumis sativus] gi|449531219|ref|XP_004172585.1| PREDICTED: cyclin-dependent kinase B2-2-like [Cucumis sativus]

 Score =  586 bits (1510), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 277/303 (91%), Positives = 290/303 (95%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            M+AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED+EGVPPTTLREVSILRMLS
Sbjct: 10  AMEAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDEEGVPPTTLREVSILRMLS 69

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPH+VRLMDVKQGQNKEG+TVLYLVFEYMDTDLKK+I+SFR TGENIPVNTVKSLMYQL
Sbjct: 70  RDPHIVRLMDVKQGQNKEGKTVLYLVFEYMDTDLKKFIKSFRHTGENIPVNTVKSLMYQL 129

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHGILHRDLKPHNLLMDRKTM LKIADLGLARAFT+PIKKYTHEILTLWYRA
Sbjct: 130 CKGVAFCHGHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTVPIKKYTHEILTLWYRA 189

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYSTAVDMWSVACIFAEL TK  LFPGDSELQQLLHIFRLLGTPNEKVWPGV
Sbjct: 190 PEVLLGATHYSTAVDMWSVACIFAELATKQPLFPGDSELQQLLHIFRLLGTPNEKVWPGV 249

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S LMNWHEYPQWNPQSL+TAVPNLD  GLDLL +ML+Y+PS RISAKKAMEHPYFDDL+K
Sbjct: 250 SKLMNWHEYPQWNPQSLSTAVPNLDDKGLDLLSKMLKYEPSMRISAKKAMEHPYFDDLNK 309

Query: 302 TRL 304
             L
Sbjct: 310 EYL 312

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|32187089|gb|AAP73784.1| cyclin-dependent kinase [Populus tremula x Populus tremuloides]

 Score =  585 bits (1509), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 275/303 (90%), Positives = 290/303 (95%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            MD FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS
Sbjct: 4   AMDLFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 63

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPH+VRL+DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIP+  VKSLMYQL
Sbjct: 64  RDPHIVRLLDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPIKNVKSLMYQL 123

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHG+LHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYR+
Sbjct: 124 CKGVAFCHGHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRS 183

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYSTAVD+WSV CIFAEL TK ALFPGDSELQQLLHIFRLLGTPNE++WPGV
Sbjct: 184 PEVLLGATHYSTAVDVWSVGCIFAELATKQALFPGDSELQQLLHIFRLLGTPNEEMWPGV 243

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+LMNWHEYPQW PQSL++AV NLDKDGLDLL QMLQYDPSKRISAKKAMEHPYFDDL+K
Sbjct: 244 SNLMNWHEYPQWKPQSLSSAVTNLDKDGLDLLSQMLQYDPSKRISAKKAMEHPYFDDLEK 303

Query: 302 TRL 304
             L
Sbjct: 304 DHL 306

Source: Populus tremula x Populus tremuloides

Species: Populus tremula x Populus tremuloides

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224086116|ref|XP_002307822.1| predicted protein [Populus trichocarpa] gi|222857271|gb|EEE94818.1| predicted protein [Populus trichocarpa]

 Score =  585 bits (1507), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 276/303 (91%), Positives = 290/303 (95%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            MD FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS
Sbjct: 4   AMDLFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 63

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPH+VRL+DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIPV TVKSLMYQL
Sbjct: 64  RDPHIVRLLDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPVKTVKSLMYQL 123

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHG+LHRDLKPHNLLMDRKT  LKIADLGLARAFTLPIKKYTHEILTLWYR+
Sbjct: 124 CKGVAFCHGHGVLHRDLKPHNLLMDRKTTMLKIADLGLARAFTLPIKKYTHEILTLWYRS 183

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+T YSTAVD+WSV CIFAEL TK ALFPGDSELQQLLHIFRLLGTPNE++WPGV
Sbjct: 184 PEVLLGATRYSTAVDVWSVGCIFAELATKQALFPGDSELQQLLHIFRLLGTPNEEMWPGV 243

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+LMNWHEYPQW PQSL++AV NLDKDGLDLL QMLQYDPSKRISAKKAMEHPYFDDL+K
Sbjct: 244 SNLMNWHEYPQWKPQSLSSAVTNLDKDGLDLLSQMLQYDPSKRISAKKAMEHPYFDDLEK 303

Query: 302 TRL 304
            RL
Sbjct: 304 DRL 306

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|210148100|gb|ACJ09092.1| cyclin-dependent kinase B [Populus tomentosa]

 Score =  584 bits (1506), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 274/303 (90%), Positives = 291/303 (96%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            MD FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS
Sbjct: 4   AMDLFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 63

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPH+VRL+DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTGENIP+ TVKSLMYQL
Sbjct: 64  RDPHIVRLLDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGENIPIKTVKSLMYQL 123

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHG+LHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYR+
Sbjct: 124 CKGVAFCHGHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRS 183

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYSTAVD+WSV CIFAEL TK ALFPGDSELQQLLHIFRLLGTPNE++WPGV
Sbjct: 184 PEVLLGATHYSTAVDVWSVGCIFAELATKQALFPGDSELQQLLHIFRLLGTPNEEMWPGV 243

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+LMNWHEYPQW PQSL++AV NLD+DGL+LL QMLQYDPSKRISAKKAMEHPYFDDL+K
Sbjct: 244 SNLMNWHEYPQWKPQSLSSAVTNLDEDGLNLLSQMLQYDPSKRISAKKAMEHPYFDDLEK 303

Query: 302 TRL 304
             L
Sbjct: 304 DHL 306

Source: Populus tomentosa

Species: Populus tomentosa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|344221929|gb|AEN02468.1| cyclin-dependent kinase [Camellia sinensis]

 Score =  582 bits (1501), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 273/303 (90%), Positives = 289/303 (95%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            M+AFEKLEKVGEGTYGKVYRARE+ATGKIVALKKTRLHEDDEGVPPTTLRE+S+LRMLS
Sbjct: 5   AMEAFEKLEKVGEGTYGKVYRARERATGKIVALKKTRLHEDDEGVPPTTLREISLLRMLS 64

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPHVVRLMDVKQGQNKEG+TVLYLVFEYMDTDLKK+IR+FRQTGENIP  TVK LMYQL
Sbjct: 65  RDPHVVRLMDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRTFRQTGENIPNKTVKCLMYQL 124

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHG+LHRDLKPHNLLMDRKTM LKIADLGLARAF LPIKKYTHEILTLWYRA
Sbjct: 125 CKGVAFCHGHGVLHRDLKPHNLLMDRKTMMLKIADLGLARAFVLPIKKYTHEILTLWYRA 184

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYSTAVDMWSV CIFAEL+TK ALFPGDSELQQLLHIFRLLGTPNE+VWPGV
Sbjct: 185 PEVLLGATHYSTAVDMWSVGCIFAELITKQALFPGDSELQQLLHIFRLLGTPNEQVWPGV 244

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S LMNWHEYPQWNPQ L++AVPNLD+DG DLL +MLQY+PSKRISAKKAMEHPYFDDLDK
Sbjct: 245 SKLMNWHEYPQWNPQKLSSAVPNLDEDGQDLLLKMLQYEPSKRISAKKAMEHPYFDDLDK 304

Query: 302 TRL 304
             L
Sbjct: 305 AYL 307

Source: Camellia sinensis

Species: Camellia sinensis

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|319439587|emb|CBJ18167.1| cyclin dependent kinase B2 [Cucurbita maxima]

 Score =  580 bits (1494), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 275/302 (91%), Positives = 288/302 (95%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED+EGVPPTTLREVSILRMLSR
Sbjct: 1   MEAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDEEGVPPTTLREVSILRMLSR 60

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           DPH+VRLMDVKQGQNKEG+TVLYLVFEYMDTDLKK+I+SFR TGE+IPVNTVKSLMYQLC
Sbjct: 61  DPHIVRLMDVKQGQNKEGKTVLYLVFEYMDTDLKKFIKSFRHTGESIPVNTVKSLMYQLC 120

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           KGVAFCHGHGILHRDLKPHNLLMDRKTM LKIADLGLARAFTLPIKKYTHEILTLWYRAP
Sbjct: 121 KGVAFCHGHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTLPIKKYTHEILTLWYRAP 180

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EVLLG+THYSTAVDMWSV CIFAEL TK ALFPGD ELQQLLHIFRLLGTPNEKVWPGVS
Sbjct: 181 EVLLGATHYSTAVDMWSVGCIFAELATKQALFPGDFELQQLLHIFRLLGTPNEKVWPGVS 240

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 302
            LMNW EYPQWNPQSL+TAVPNLD   LDLL QML+Y+PSKRISAK+AMEHPYFDDL+K 
Sbjct: 241 KLMNWPEYPQWNPQSLSTAVPNLDDKALDLLAQMLKYEPSKRISAKRAMEHPYFDDLNKA 300

Query: 303 RL 304
            L
Sbjct: 301 YL 302

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1806146|emb|CAA65982.1| cdc2MsF [Medicago sativa]

 Score =  578 bits (1490), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 273/301 (90%), Positives = 288/301 (95%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD
Sbjct: 16  EAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 75

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           PHVVRL+DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTG+NIP  T+K LMYQLCK
Sbjct: 76  PHVVRLLDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGQNIPPPTIKGLMYQLCK 135

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           GVAFCHGHGILHRDLKPHNLLMDRKTM LKIADLGLARAFT+P+KKYTHEILTLWYRAPE
Sbjct: 136 GVAFCHGHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTVPLKKYTHEILTLWYRAPE 195

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           VLLG+THYS AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE VWPGVS 
Sbjct: 196 VLLGATHYSMAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEDVWPGVSK 255

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 303
           LMNWHEYPQW PQSL+ AVP L++ G+DLL QMLQY+PSKR+SAKKAMEHPYFDDLDKT 
Sbjct: 256 LMNWHEYPQWGPQSLSKAVPGLEEAGVDLLSQMLQYEPSKRLSAKKAMEHPYFDDLDKTH 315

Query: 304 L 304
           L
Sbjct: 316 L 316

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388514733|gb|AFK45428.1| unknown [Lotus japonicus]

 Score =  578 bits (1490), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 275/303 (90%), Positives = 290/303 (95%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V +AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED+EGVPPTTLREVSILRMLS
Sbjct: 10  VKEAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDEEGVPPTTLREVSILRMLS 69

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           RDPHVVRLMDVKQGQ+KEG+TVLYLVFEYMDTDLKK+IR+FRQTG+N+P  TVKSLMYQL
Sbjct: 70  RDPHVVRLMDVKQGQSKEGKTVLYLVFEYMDTDLKKFIRTFRQTGQNVPPKTVKSLMYQL 129

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           CKGVAFCHGHGILHRDLKPHNLLMDRKT  LKIADLGLARAFT+PIKKYTHEILTLWYRA
Sbjct: 130 CKGVAFCHGHGILHRDLKPHNLLMDRKTNMLKIADLGLARAFTVPIKKYTHEILTLWYRA 189

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVLLG+THYS AVDMWSVACIFAELVTK ALFPGDSELQQLLHIFRLLGTPNE+VWPGV
Sbjct: 190 PEVLLGATHYSMAVDMWSVACIFAELVTKQALFPGDSELQQLLHIFRLLGTPNEEVWPGV 249

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S LMNWHEYPQWNPQSL+TAVPNLD+ GLDLL +ML Y+PSKRISAKKAMEH YFDDLDK
Sbjct: 250 SKLMNWHEYPQWNPQSLSTAVPNLDELGLDLLSEMLHYEPSKRISAKKAMEHCYFDDLDK 309

Query: 302 TRL 304
           T L
Sbjct: 310 TYL 312

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357441091|ref|XP_003590823.1| Cyclin-dependent kinase [Medicago truncatula] gi|355479871|gb|AES61074.1| Cyclin-dependent kinase [Medicago truncatula]

 Score =  578 bits (1489), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 273/301 (90%), Positives = 288/301 (95%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD
Sbjct: 16  EAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 75

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           PHVVRL+DVKQGQNKEG+TVLYLVFEYMDTDLKK+IRSFRQTG+NIP  T+K LMYQLCK
Sbjct: 76  PHVVRLLDVKQGQNKEGKTVLYLVFEYMDTDLKKFIRSFRQTGQNIPPPTIKGLMYQLCK 135

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           GVAFCHGHGILHRDLKPHNLLMDRKTM LKIADLGLARAFT+P+KKYTHEILTLWYRAPE
Sbjct: 136 GVAFCHGHGILHRDLKPHNLLMDRKTMMLKIADLGLARAFTVPLKKYTHEILTLWYRAPE 195

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           VLLG+THYS AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE VWPGVS 
Sbjct: 196 VLLGATHYSMAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEDVWPGVSK 255

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 303
           LMNWHEYPQW PQSL+ AVP L++ G+DLL QMLQY+PSKR+SAKKAMEHPYFDDLDKT 
Sbjct: 256 LMNWHEYPQWGPQSLSKAVPGLEETGVDLLSQMLQYEPSKRLSAKKAMEHPYFDDLDKTY 315

Query: 304 L 304
           L
Sbjct: 316 L 316

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	304
TAIR|locus:2037410	315	CDKB2;2 "cyclin-dependent kina	0.993	0.958	0.864	5.9e-144
TAIR|locus:2011761	313	CDKB2;1 "cyclin-dependent kina	0.993	0.964	0.844	2.6e-141
TAIR|locus:2080290	309	CDKB1;1 "cyclin-dependent kina	0.990	0.974	0.659	1.1e-108
TAIR|locus:2064087	311	CDKB1;2 "cyclin-dependent kina	0.986	0.964	0.646	4.9e-108
UNIPROTKB|P29618	294	CDKA-1 "Cyclin-dependent kinas	0.953	0.986	0.571	1.9e-92
UNIPROTKB|P35567	302	cdk1-a "Cyclin-dependent kinas	0.967	0.973	0.564	9.3e-91
TAIR|locus:2099478	294	CDC2 "cell division control 2"	0.950	0.982	0.546	1.5e-90
UNIPROTKB|P24941	298	CDK2 "Cyclin-dependent kinase	0.953	0.973	0.563	1.9e-90
UNIPROTKB|F1SPH6	298	CDK2 "Uncharacterized protein"	0.953	0.973	0.56	2.5e-90
UNIPROTKB|E2QW70	298	CDK2 "Uncharacterized protein"	0.953	0.973	0.56	3.1e-90

TAIR|locus:2037410 CDKB2;2 "cyclin-dependent kinase B2;2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1407 (500.3 bits), Expect = 5.9e-144, P = 5.9e-144
 Identities = 262/303 (86%), Positives = 285/303 (94%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             M+AFEKLEKVGEGTYGKVYRAREKATG IVALKKTRLHED+EGVPPTTLRE+SILRML+R
Sbjct:    13 MEAFEKLEKVGEGTYGKVYRAREKATGMIVALKKTRLHEDEEGVPPTTLREISILRMLAR 72

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             DPH+VRLMDVKQG NKEG+TVLYLVFEY+DTDLKK+IRSFRQ G+NIP NTVK LMYQLC
Sbjct:    73 DPHIVRLMDVKQGINKEGKTVLYLVFEYVDTDLKKFIRSFRQAGQNIPQNTVKCLMYQLC 132

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             KG+AFCHGHG+LHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP+KKYTHEILTLWYRAP
Sbjct:   133 KGMAFCHGHGVLHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPMKKYTHEILTLWYRAP 192

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             EVLLG+THYST VDMWSV CIFAELVTK A+F GDSELQQLL IFRLLGTPNE+VWPGVS
Sbjct:   193 EVLLGATHYSTGVDMWSVGCIFAELVTKQAIFAGDSELQQLLRIFRLLGTPNEEVWPGVS 252

Query:   243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL-DK 301
              L +WHEYPQW P SL+TAVPNLD+ GLDLL +ML+Y+P+KRISAKKAMEHPYFDDL DK
Sbjct:   253 KLKDWHEYPQWKPLSLSTAVPNLDEAGLDLLSKMLEYEPAKRISAKKAMEHPYFDDLPDK 312

Query:   302 TRL 304
             + L
Sbjct:   313 SSL 315

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=TAS

GO:0007346 "regulation of mitotic cell cycle" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009755 "hormone-mediated signaling pathway" evidence=IEP;IMP

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA;IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000280 "nuclear division" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0051225 "spindle assembly" evidence=RCA

TAIR|locus:2011761 CDKB2;1 "cyclin-dependent kinase B2;1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1382 (491.5 bits), Expect = 2.6e-141, P = 2.6e-141
 Identities = 256/303 (84%), Positives = 283/303 (93%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED+EGVP TTLRE+SILRML+R
Sbjct:    11 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDEEGVPSTTLREISILRMLAR 70

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             DPHVVRLMDVKQG +KEG+TVLYLVFEYMDTD+KK+IRSFR TG+NIP  T+KSLMYQLC
Sbjct:    71 DPHVVRLMDVKQGLSKEGKTVLYLVFEYMDTDVKKFIRSFRSTGKNIPTQTIKSLMYQLC 130

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             KG+AFCHGHGILHRDLKPHNLLMD KTM LKIADLGLARAFTLP+KKYTHEILTLWYRAP
Sbjct:   131 KGMAFCHGHGILHRDLKPHNLLMDPKTMRLKIADLGLARAFTLPMKKYTHEILTLWYRAP 190

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             EVLLG+THYSTAVDMWSV CIFAELVT  A+F GDSELQQLLHIF+L GTPNE++WPGVS
Sbjct:   191 EVLLGATHYSTAVDMWSVGCIFAELVTNQAIFQGDSELQQLLHIFKLFGTPNEEMWPGVS 250

Query:   243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL-DK 301
             +L NWHEYPQW P +L++AVPNLD+ G+DLL +MLQY+P+KRISAK AMEHPYFDDL +K
Sbjct:   251 TLKNWHEYPQWKPSTLSSAVPNLDEAGVDLLSKMLQYEPAKRISAKMAMEHPYFDDLPEK 310

Query:   302 TRL 304
             + L
Sbjct:   311 SSL 313

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=TAS

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0009755 "hormone-mediated signaling pathway" evidence=IEP;IMP

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA;IMP

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000280 "nuclear division" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0010583 "response to cyclopentenone" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0051225 "spindle assembly" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2080290 CDKB1;1 "cyclin-dependent kinase B1;1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1074 (383.1 bits), Expect = 1.1e-108, P = 1.1e-108
 Identities = 203/308 (65%), Positives = 246/308 (79%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             M+ +EKLEKVGEGTYGKVY+A EK TGK+VALKKTRL  D+EG+PPT LRE+S+L+MLS 
Sbjct:     1 MEKYEKLEKVGEGTYGKVYKAMEKGTGKLVALKKTRLEMDEEGIPPTALREISLLQMLST 60

Query:    63 DPHVVRLMDVK---QGQNKEGRTV--LYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VK 115
               +VVRL+ V+   Q   K   T   LYLVFEY+DTDLKK+I S+R+     P+    ++
Sbjct:    61 SIYVVRLLCVEHVHQPSTKSQSTKSNLYLVFEYLDTDLKKFIDSYRKGPNPKPLEPFLIQ 120

Query:   116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
              LM+QLCKGVA CH HG+LHRDLKP NLL+ +    LKIADLGL RAFT+P+K YTHEI+
Sbjct:   121 KLMFQLCKGVAHCHSHGVLHRDLKPQNLLLVKDKELLKIADLGLGRAFTVPLKSYTHEIV 180

Query:   176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
             TLWYRAPEVLLGSTHYST VDMWSV CIFAE+V + ALFPGDSE QQLLHIFRLLGTP E
Sbjct:   181 TLWYRAPEVLLGSTHYSTGVDMWSVGCIFAEMVRRQALFPGDSEFQQLLHIFRLLGTPTE 240

Query:   236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
             + WPGVS+L +WH YP+W PQ L  AVP+L   G+DLL +ML+Y+P++RISAK A++HPY
Sbjct:   241 QQWPGVSTLRDWHVYPKWEPQDLTLAVPSLSPQGVDLLTKMLKYNPAERISAKTALDHPY 300

Query:   296 FDDLDKTR 303
             FD LDK++
Sbjct:   301 FDSLDKSQ 308

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0048825 "cotyledon development" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0010376 "stomatal complex formation" evidence=IEP;TAS

GO:0042023 "DNA endoreduplication" evidence=TAS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2064087 CDKB1;2 "cyclin-dependent kinase B1;2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
 Identities = 201/311 (64%), Positives = 253/311 (81%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             M+ +EKLEKVGEGTYGKVY+A EK TGK+VALKKTRL  D+EG+PPT LRE+S+L+MLS+
Sbjct:     1 MEKYEKLEKVGEGTYGKVYKAMEKTTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSQ 60

Query:    63 DPHVVRLMDVKQG-QNKEG------RTVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVN 112
               ++VRL+ V+   Q+K+       ++ LYLVFEY+DTDLKK+I S R+ G N   +  +
Sbjct:    61 SIYIVRLLCVEHVIQSKDSTVSHSPKSNLYLVFEYLDTDLKKFIDSHRK-GSNPRPLEAS 119

Query:   113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH 172
              V+  M+QL KGVA CH HG+LHRDLKP NLL+D+    LKIADLGL+RAFT+P+K YTH
Sbjct:   120 LVQRFMFQLFKGVAHCHSHGVLHRDLKPQNLLLDKDKGILKIADLGLSRAFTVPLKAYTH 179

Query:   173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
             EI+TLWYRAPEVLLGSTHYSTAVD+WSV CIFAE++ + ALFPGDSE QQLLHIFRLLGT
Sbjct:   180 EIVTLWYRAPEVLLGSTHYSTAVDIWSVGCIFAEMIRRQALFPGDSEFQQLLHIFRLLGT 239

Query:   233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
             P E+ WPGV +L +WH YP+W PQ L+ AVP+L  +G+DLL QML+Y+P++RISAK A++
Sbjct:   240 PTEQQWPGVMALRDWHVYPKWEPQDLSRAVPSLSPEGIDLLTQMLKYNPAERISAKAALD 299

Query:   293 HPYFDDLDKTR 303
             HPYFD LDK++
Sbjct:   300 HPYFDSLDKSQ 310

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051726 "regulation of cell cycle" evidence=TAS

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0030332 "cyclin binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|P29618 CDKA-1 "Cyclin-dependent kinase A-1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 921 (329.3 bits), Expect = 1.9e-92, P = 1.9e-92
 Identities = 171/299 (57%), Positives = 229/299 (76%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             M+ +EK EK+GEGTYG VYRAR+K T + +ALKK RL ++DEGVP T +RE+S+L+ +  
Sbjct:     1 MEQYEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHH 60

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
               ++VRL DV   + +     +YLVFEY+D DLKK++ S  +  +N P   +KS +YQ+ 
Sbjct:    61 G-NIVRLHDVIHSEKR-----IYLVFEYLDLDLKKFMDSCPEFAKN-PT-LIKSYLYQIL 112

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             +GVA+CH H +LHRDLKP NLL+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAP
Sbjct:   113 RGVAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             E+LLGS  YST VDMWSV CIFAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGVS
Sbjct:   173 EILLGSRQYSTPVDMWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRVLGTPNEQSWPGVS 232

Query:   243 SLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
             SL ++   +P+W  Q LAT VP LD  GLDLL +ML+Y+P+KRI+A++A+EH YF DL+
Sbjct:   233 SLPDYKSAFPKWQAQDLATIVPTLDPAGLDLLSKMLRYEPNKRITARQALEHEYFKDLE 291

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|P35567 cdk1-a "Cyclin-dependent kinase 1-A" [Xenopus laevis (taxid:8355)]

 Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
 Identities = 171/303 (56%), Positives = 226/303 (74%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             MD + K+EK+GEGTYG VY+ R KATG++VA+KK RL  ++EGVP T +RE+S+L+ L  
Sbjct:     1 MDEYTKIEKIGEGTYGVVYKGRHKATGQVVAMKKIRLENEEEGVPSTAIREISLLKELQH 60

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
              P++V L+DV    ++     LYL+FE++  DLKKY+ S   +G+ I    VKS +YQ+ 
Sbjct:    61 -PNIVCLLDVLMQDSR-----LYLIFEFLSMDLKKYLDSI-PSGQYIDTMLVKSYLYQIL 113

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             +G+ FCH   +LHRDLKP NLL+D K + +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct:   114 QGIVFCHSRRVLHRDLKPQNLLIDSKGV-IKLADFGLARAFGIPVRVYTHEVVTLWYRAP 172

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             EVLLGS  YST VD+WS+  IFAE+ TK  LF GDSE+ QL  IFR LGTPN +VWP V 
Sbjct:   173 EVLLGSVRYSTPVDVWSIGTIFAEIATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVE 232

Query:   243 SLMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
             SL ++ + +P+W   SL+  V N+DKDGLDLL +ML YDP+KRISA+KA+ HPYFDDLDK
Sbjct:   233 SLQDYKNSFPKWKGGSLSANVKNIDKDGLDLLAKMLIYDPAKRISARKALLHPYFDDLDK 292

Query:   302 TRL 304
             + L
Sbjct:   293 SSL 295

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2099478 CDC2 "cell division control 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 903 (322.9 bits), Expect = 1.5e-90, P = 1.5e-90
 Identities = 163/298 (54%), Positives = 227/298 (76%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             MD +EK+EK+GEGTYG VY+AR+K T + +ALKK RL ++DEGVP T +RE+S+L+ +  
Sbjct:     1 MDQYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
               ++V+L DV   + +     LYLVFEY+D DLKK++ S     +++  + +K+ +YQ+ 
Sbjct:    61 S-NIVKLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSTPDFSKDL--HMIKTYLYQIL 112

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             +G+A+CH H +LHRDLKP NLL+DR+T +LK+AD GLARAF +P++ +THE++TLWYRAP
Sbjct:   113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             E+LLGS HYST VD+WSV CIFAE++++  LFPGDSE+ QL  IFR++GTP E  W GV+
Sbjct:   173 EILLGSHHYSTPVDIWSVGCIFAEMISQKPLFPGDSEIDQLFKIFRIMGTPYEDTWRGVT 232

Query:   243 SLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
             SL ++   +P+W P  L T VPNLD DG+DLL +ML  DP+KRI+A+ A+EH YF DL
Sbjct:   233 SLPDYKSAFPKWKPTDLETFVPNLDPDGVDLLSKMLLMDPTKRINARAALEHEYFKDL 290

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0042023 "DNA endoreduplication" evidence=RCA;IMP

GO:0009555 "pollen development" evidence=IMP

GO:0008284 "positive regulation of cell proliferation" evidence=IMP

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0040020 "regulation of meiosis" evidence=IMP

GO:0048229 "gametophyte development" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0010048 "vernalization response" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=IGI

GO:0000910 "cytokinesis" evidence=IMP

GO:0009409 "response to cold" evidence=IEP

GO:0009574 "preprophase band" evidence=TAS

GO:0010005 "cortical microtubule, transverse to long axis" evidence=IDA

UNIPROTKB|P24941 CDK2 "Cyclin-dependent kinase 2" [Homo sapiens (taxid:9606)]

 Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
 Identities = 169/300 (56%), Positives = 229/300 (76%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct:     1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
              P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct:    61 -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct:   113 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct:   172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query:   243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
             S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct:   232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

GO:0005524 "ATP binding" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0035173 "histone kinase activity" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0007126 "meiosis" evidence=TAS

GO:0051298 "centrosome duplication" evidence=TAS

GO:0006260 "DNA replication" evidence=TAS

GO:0060968 "regulation of gene silencing" evidence=IDA

GO:0031571 "mitotic G1 DNA damage checkpoint" evidence=TAS

GO:0071732 "cellular response to nitric oxide" evidence=TAS

GO:0005813 "centrosome" evidence=TAS

GO:0015030 "Cajal body" evidence=IDA

GO:0005768 "endosome" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=NAS

GO:0030332 "cyclin binding" evidence=IDA

GO:0000075 "cell cycle checkpoint" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0000084 "S phase of mitotic cell cycle" evidence=TAS

GO:0000085 "G2 phase of mitotic cell cycle" evidence=TAS

GO:0000216 "M/G1 transition of mitotic cell cycle" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0031145 "anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process" evidence=TAS

GO:0051439 "regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=IEP

GO:0016572 "histone phosphorylation" evidence=IDA

UNIPROTKB|F1SPH6 CDK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 901 (322.2 bits), Expect = 2.5e-90, P = 2.5e-90
 Identities = 168/300 (56%), Positives = 230/300 (76%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             M+ F+K+EK+GEGTYG VY+A+ K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct:     1 MENFQKVEKIGEGTYGVVYKAKNKVTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
              P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct:    61 -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             +G+AFCH H +LHRDLKP NLL++ +  ++K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct:   113 QGLAFCHSHRVLHRDLKPQNLLINAEG-SIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct:   172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query:   243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
             S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct:   232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

GO:0060968 "regulation of gene silencing" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0015030 "Cajal body" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2QW70 CDK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
 Identities = 168/300 (56%), Positives = 229/300 (76%)

Query:     3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             M+ F+K+EK+GEGTYG VY+A+ K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct:     1 MENFQKVEKIGEGTYGVVYKAKNKVTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query:    63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
              P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct:    61 -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112

Query:   123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct:   113 QGLAFCHSHRVLHRDLKPQNLLINAEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

Query:   183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
             E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct:   172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query:   243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
             S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct:   232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

GO:0060968 "regulation of gene silencing" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0015030 "Cajal body" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q63699	CDK2_RAT	2, ., 7, ., 1, 1, ., 2, 2	0.5566	0.9539	0.9731	yes	no
P43063	CDK1_CANAL	2, ., 7, ., 1, 1, ., 2, 2	0.5460	0.9342	0.8958	N/A	no
Q8LF80	CKB21_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.8523	0.9802	0.9520	no	no
Q41639	CDC2_VIGAC	2, ., 7, ., 1, 1, ., 2, 3	0.5536	0.9506	0.9829	N/A	no
Q8LG64	CKB22_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.8618	0.9967	0.9619	yes	no
O55076	CDK2_CRIGR	2, ., 7, ., 1, 1, ., 2, 2	0.56	0.9539	0.9731	yes	no
Q00646	CDK1_EMENI	2, ., 7, ., 1, 1, ., 2, 3	0.5064	0.9473	0.8916	yes	no
Q05006	CDC22_MEDSA	2, ., 7, ., 1, 1, ., 2, 2	0.5268	0.9506	0.9829	N/A	no
P23572	CDK1_DROME	2, ., 7, ., 1, 1, ., 2, 3	0.5101	0.9440	0.9663	yes	no
P54119	CDK1_AJECA	2, ., 7, ., 1, 1, ., 2, 3	0.5015	0.9473	0.8888	N/A	no
P35567	CDK1A_XENLA	2, ., 7, ., 1, 1, ., 2, 3	0.5643	0.9671	0.9735	N/A	no
P04551	CDK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.5165	0.9572	0.9797	yes	no
Q9DGA2	CDK1_ORYJA	2, ., 7, ., 1, 1, ., 2, 3	0.5643	0.9671	0.9702	N/A	no
P51958	CDK1_CARAU	2, ., 7, ., 1, 1, ., 2, 3	0.5676	0.9671	0.9735	N/A	no
P24033	CDK1B_XENLA	2, ., 7, ., 1, 1, ., 2, 3	0.5643	0.9671	0.9735	N/A	no
P23111	CDC2_MAIZE	2, ., 7, ., 1, 1, ., 2, 3	0.5618	0.9539	0.9863	N/A	no
P24923	CDC21_MEDSA	2, ., 7, ., 1, 1, ., 2, 3	0.5442	0.9375	0.9793	N/A	no
Q38772	CDC2A_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5469	0.9506	0.9829	N/A	no
Q38773	CDC2B_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.5543	0.9078	0.9857	N/A	no
Q38774	CDC2C_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.6732	0.9901	0.9868	N/A	no
Q0J4I1	CKB21_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.8	0.9868	0.9202	yes	no
Q38775	CDC2D_ANTMA	2, ., 7, ., 1, 1, ., 2, 3	0.8547	0.9967	0.9711	N/A	no
Q9DG98	CDK1_ORYLU	2, ., 7, ., 1, 1, ., 2, 3	0.5643	0.9671	0.9702	N/A	no
Q9W739	CDK1_RANDY	2, ., 7, ., 1, 1, ., 2, 3	0.5511	0.9671	0.9735	N/A	no
P24941	CDK2_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.5633	0.9539	0.9731	yes	no
P34112	CDK1_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.5581	0.9440	0.9695	yes	no
P52389	CDC2_VIGUN	2, ., 7, ., 1, 1, ., 2, 3	0.5503	0.9506	0.9829	N/A	no
P23437	CDK2_XENLA	2, ., 7, ., 1, 1, ., 2, 2	0.5466	0.9539	0.9764	N/A	no
Q9DGD3	CDK1_ORYLA	2, ., 7, ., 1, 1, ., 2, 3	0.5643	0.9671	0.9702	N/A	no
Q9DGA5	CDK1_ORYCU	2, ., 7, ., 1, 1, ., 2, 3	0.5610	0.9671	0.9702	N/A	no
Q5E9Y0	CDK2_BOVIN	2, ., 7, ., 1, 1, ., 2, 2	0.56	0.9539	0.9731	yes	no
P93101	CDC2_CHERU	2, ., 7, ., 1, 1, ., 2, 3	0.5503	0.9506	0.9829	N/A	no
P43450	CDK2_CARAU	2, ., 7, ., 1, 1, ., 2, 2	0.5570	0.9473	0.9664	N/A	no
P48963	CDK2_MESAU	2, ., 7, ., 1, 1, ., 2, 2	0.56	0.9539	0.9731	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.994
3rd Layer	2.7.11.23	0.994
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	304
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.0
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-169
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-160
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-143
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-140
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-140
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-125
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-123
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-122
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-122
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-120
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-120
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-117
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-110
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-106
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-102
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-96
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-96
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-95
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-94
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-94
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-92
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-92
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-89
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-89
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-86
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-85
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-85
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-85
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-83
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-82
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-80
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-78
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-78
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-76
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-74
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-72
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-71
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-69
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-69
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-65
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-62
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-61
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-59
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-56
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-56
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-56
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-55
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-55
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-53
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-51
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-50
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-50
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-50
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-49
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-43
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-42
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-41
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-39
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-38
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-36
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-36
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-35
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-33
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-31
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-30
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-29
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-26
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-22
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-22
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-21
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-17
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-16
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-13
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.001
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.004

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  507 bits (1306), Expect = 0.0
 Identities = 202/295 (68%), Positives = 247/295 (83%), Gaps = 1/295 (0%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           DA+EKLEK+GEGTYGKVY+AR+K TGK+VALKKTRL  D+EG+PPT LRE+S+L+MLS  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLC 122
            ++VRL+DV+  + K G+  LYLVFEY+D+DLKK++ S  R  G  +P  T+KS MYQL 
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           KGVA CH HG++HRDLKP NLL+D++   LKIADLGL RAF++P+K YTHEI+TLWYRAP
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EVLLGSTHYST VD+WSV CIFAE+  K  LFPGDSELQQLLHIF+LLGTP E+VWPGVS
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            L +WHE+PQW PQ L+ AVP+L  +GLDLL++ML+YDP+KRISAK A+ HPYFD
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  469 bits (1209), Expect = e-169
 Identities = 168/292 (57%), Positives = 224/292 (76%), Gaps = 11/292 (3%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EKLEK+GEGTYG VY+AR+K TG+IVALKK RL  ++EG+P T LRE+S+L+ L   P+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PN 59

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +V+L+DV   + K     LYLVFEY D DLKKY+         +  N +KS+MYQL +G+
Sbjct: 60  IVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPG---PLSPNLIKSIMYQLLRGL 111

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
           A+CH H ILHRDLKP N+L++R    LK+AD GLARAF +P++ YTHE++TLWYRAPE+L
Sbjct: 112 AYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           LGS HYSTAVD+WSV CIFAE++T   LFPGDSE+ QL  IF++LGTP E+ WPGV+ L 
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230

Query: 246 NW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           ++   +P++ P+ L   +P LD +G+DLL +MLQY+P+KRISAK+A++HPYF
Sbjct: 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  448 bits (1154), Expect = e-160
 Identities = 176/292 (60%), Positives = 228/292 (78%), Gaps = 10/292 (3%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++K+EK+GEGTYG VY+AR+K TG+IVALKK RL  +DEGVP T +RE+S+L+ L   P+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPN 59

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +VRL+DV   +NK     LYLVFE++D DLKKY+ S   TG + P+  +KS +YQL +G+
Sbjct: 60  IVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSYLYQLLQGI 112

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
           A+CH H +LHRDLKP NLL+DR    LK+AD GLARAF +P++ YTHE++TLWYRAPE+L
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           LGS  YST VD+WS+ CIFAE+V +  LFPGDSE+ QL  IFR LGTP+E VWPGV+SL 
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231

Query: 246 NWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           ++   +P+W  Q L+  VPNLD+DGLDLL +ML YDP+KRISAK A++HPYF
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  404 bits (1040), Expect = e-143
 Identities = 167/292 (57%), Positives = 224/292 (76%), Gaps = 10/292 (3%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+  P+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +V+L+DV   +NK     LYLVFE++  DLKK++ +   +G  IP+  +KS ++QL +G+
Sbjct: 61  IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSG--IPLPLIKSYLFQLLQGL 113

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
           AFCH H +LHRDLKP NLL++     +K+AD GLARAF +P++ YTHE++TLWYRAPE+L
Sbjct: 114 AFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           LG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+SL 
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 246 NWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           ++   +P+W  Q  +  VP LD+DG DLL QML YDP+KRISAK A+ HP+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  398 bits (1023), Expect = e-140
 Identities = 166/298 (55%), Positives = 228/298 (76%), Gaps = 9/298 (3%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           MD +EK+EK+GEGTYG VY+AR++ T + +ALKK RL ++DEGVP T +RE+S+L+ +  
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++VRL DV   + +     LYLVFEY+D DLKK++ S     +N  +  +K+ +YQ+ 
Sbjct: 61  G-NIVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRL--IKTYLYQIL 112

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+A+CH H +LHRDLKP NLL+DR+T  LK+AD GLARAF +P++ +THE++TLWYRAP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLGS HYST VD+WSV CIFAE+V +  LFPGDSE+ +L  IFR+LGTPNE+ WPGV+
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232

Query: 243 SLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           SL ++   +P+W P+ LAT VP L+  G+DLL +ML+ DPSKRI+A+ A+EH YF DL
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Length = 294

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  397 bits (1022), Expect = e-140
 Identities = 166/292 (56%), Positives = 220/292 (75%), Gaps = 9/292 (3%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + K+EK+GEGTYG VY+ R K TG+IVA+KK RL  ++EGVP T +RE+S+L+ L + P+
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +V L DV   +++     LYL+FE++  DLKKY+ S  + G+ +    VKS +YQ+ +G+
Sbjct: 61  IVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGI 114

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            FCH   +LHRDLKP NLL+D K   +K+AD GLARAF +P++ YTHE++TLWYRAPEVL
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           LGS  YST VD+WS+  IFAE+ TK  LF GDSE+ QL  IFR+LGTP E VWPGV+SL 
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 246 NW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           ++ + +P+W   SL +AV NLD+DGLDLLE+ML YDP+KRISAKKA+ HPYF
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  357 bits (918), Expect = e-125
 Identities = 155/293 (52%), Positives = 202/293 (68%), Gaps = 12/293 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EKLEK+GEGTYG V++A+ + T +IVALK+ RL +DDEGVP + LRE+ +L+ L +  +
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +VRL DV     K     L LVFEY D DLKKY  S    G+ I    VKS M+QL KG+
Sbjct: 61  IVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCN--GD-IDPEIVKSFMFQLLKGL 112

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
           AFCH H +LHRDLKP NLL++ K   LK+AD GLARAF +P++ Y+ E++TLWYR P+VL
Sbjct: 113 AFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171

Query: 186 LGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
            G+  YST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WPGVS L
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231

Query: 245 MNWHEYPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            ++  YP +    SL   VP L+  G DLL+ +L  +P +RISA++A++HPYF
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  354 bits (912), Expect = e-123
 Identities = 138/298 (46%), Positives = 195/298 (65%), Gaps = 21/298 (7%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL---HEDDEGVPPTTLREVSILRMLSR 62
           +EK +K+GEGTY  VY+AR+K TG+IVA+KK +L    E  +G+  T LRE+ +L+ L +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60

Query: 63  DPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT---VKSLM 118
            P+++ L+DV     N      + LVFE+M+TDL+K I+          V T   +KS M
Sbjct: 61  HPNIIGLLDVFGHKSN------INLVFEFMETDLEKVIKD------KSIVLTPADIKSYM 108

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
               +G+ + H + ILHRDLKP+NLL+      LK+AD GLAR+F  P +K TH+++T W
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRW 167

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YRAPE+L G+ HY   VDMWSV CIFAEL+ +    PGDS++ QL  IF  LGTP E+ W
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           PGV+SL ++ E+  + P  L    P    D LDLL+++L  +P+KRI+A++A+EHPYF
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  351 bits (902), Expect = e-122
 Identities = 140/293 (47%), Positives = 196/293 (66%), Gaps = 8/293 (2%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR--D 63
           +E+L ++GEG YG VY+AR+  TG+ VALKK R+   +EG+P +TLRE+++L+ L     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++VRL+DV  G   +    L LVFE++D DL  Y+    + G  +P  T+K LM QL +
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLR 118

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           GV F H H I+HRDLKP N+L+      +KIAD GLAR ++  +   T  ++TLWYRAPE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPE 176

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           VLL S+ Y+T VDMWSV CIFAEL  +  LF G SE  QL  IF ++G P+E+ WP   S
Sbjct: 177 VLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           L     +P + P+S  + VP + ++GLDLL++ML ++P KRISA +A++HPYF
Sbjct: 236 L-PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  351 bits (902), Expect = e-122
 Identities = 150/301 (49%), Positives = 203/301 (67%), Gaps = 20/301 (6%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +EKL ++ EGTYG VYRAR+K TG+IVALKK ++ ++ EG P T+LRE++IL +  + 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINIL-LKLQH 63

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQ---TGENIPVNTVKSLMYQ 120
           P++V + +V  G N +    +Y+V EY++ DLK  + + +Q     E      VK LM Q
Sbjct: 64  PNIVTVKEVVVGSNLDK---IYMVMEYVEHDLKSLMETMKQPFLQSE------VKCLMLQ 114

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L  GVA  H + ILHRDLK  NLL++ + + LKI D GLAR +  P+K YT  ++TLWYR
Sbjct: 115 LLSGVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+LLG+  YSTA+DMWSV CIFAEL+TK  LFPG SE+ QL  IF+LLGTP EK+WPG
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233

Query: 241 VSSL-----MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
            S L       + +YP    +    A  +L  +G DLL ++L YDP+KRISA+ A++HPY
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Query: 296 F 296
           F
Sbjct: 293 F 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  346 bits (891), Expect = e-120
 Identities = 130/295 (44%), Positives = 187/295 (63%), Gaps = 12/295 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EK+ ++GEGTYG+VY+AR K TG++VALKK R+  + EG P T +RE+ +L+ L R P+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPN 59

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +VRL ++      +G+  +Y+VFEYMD DL   + S          + +K  M QL +G+
Sbjct: 60  IVRLKEIVTS---KGKGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGL 113

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAPEV 184
            + H +GILHRD+K  N+L++   + LK+AD GLAR +T      YT+ ++TLWYR PE+
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           LLG+T Y   VDMWSV CI AEL     +F G +EL+QL  IF L G+P ++ WPGVS L
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232

Query: 245 MNWHEY--PQWNPQSLATAVPNL-DKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             +      +   + L     +L D   LDLL+++L  DP KRISA +A++H YF
Sbjct: 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  345 bits (887), Expect = e-120
 Identities = 155/293 (52%), Positives = 206/293 (70%), Gaps = 12/293 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++KL K+GEGTYG VY+AR+K TG+IVA+KK +L  + EG+P T LRE+ +L+ L   P+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +++L+DV + +       LYLVFE+MDTDL K I+  RQ G  +P + +KS +YQL +G+
Sbjct: 60  IIKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKD-RQRG--LPESLIKSYLYQLLQGL 111

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
           AFCH HGILHRDLKP NLL++     LK+AD GLAR+F  P++ YTH ++T WYRAPE+L
Sbjct: 112 AFCHSHGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           LG   YST VD+WSV CIFAEL+++  LFPG SE+ QL  IFR LGTP+ +VWP  +SL 
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 246 --NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                 +P+     L    PN     LDLL QML YDP KRI+A++A+ HPYF
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  339 bits (870), Expect = e-117
 Identities = 149/292 (51%), Positives = 207/292 (70%), Gaps = 10/292 (3%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F++LEK+GEGTY  VY+ R + TG+IVALK+  L + +EG P T +RE+S+++ L +  +
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIREISLMKEL-KHEN 59

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +VRL DV   +NK     L LVFEYMD DLKKY+ +    G  +  NTVKS  YQL KG+
Sbjct: 60  IVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGI 113

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
           AFCH + +LHRDLKP NLL++++   LK+AD GLARAF +P+  +++E++TLWYRAP+VL
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           LGS  YST++D+WSV CI AE++T   LFPG +   QLL IFR++GTP E  WPG+S L 
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232

Query: 246 NWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +   +P++ PQ L    P+ D  G+DLL ++LQ +P  RISA  A++HP+F
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  321 bits (824), Expect = e-110
 Identities = 142/299 (47%), Positives = 205/299 (68%), Gaps = 16/299 (5%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++KL+K+GEG+Y  VY+ R K TG++VALK+ RL E +EG P T +RE S+L+ L +
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIREASLLKDL-K 61

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L D+        +  L LVFEY+DTDLK+Y+      G  + ++ V+  ++QL 
Sbjct: 62  HANIVTLHDIIHT-----KKTLTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLL 113

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+A+CH   +LHRDLKP NLL+  +   LK+AD GLARA ++P K Y++E++TLWYR P
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPP 172

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKVWPGV 241
           +VLLGST YST++DMW V CIF E+ T   LFPG ++++ QL  IFR+LGTP E+ WPGV
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232

Query: 242 SSLMNW--HEYPQWNPQSLATAVPNLDK--DGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           SS   +  + +P + P+ L    P LD+   G +L  + LQY+P KRISA +AM+HPYF
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  310 bits (796), Expect = e-106
 Identities = 131/294 (44%), Positives = 193/294 (65%), Gaps = 13/294 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++ L ++GEG +G V++A+++ TG+ VALKK  L   + G+P   LRE+  L+   + P+
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPY 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VV+L+DV       G +   LV EYM +DL + +R   +    +P   VKS M  L KGV
Sbjct: 61  VVKLLDV----FPHG-SGFVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGV 112

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-YTHEILTLWYRAPEV 184
           A+ H +GI+HRDLKP NLL+      LKIAD GLAR F+    + Y+H++ T WYRAPE+
Sbjct: 113 AYMHANGIMHRDLKPANLLISA-DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           L G+  Y   VD+W+V CIFAEL+  + LFPG+++++QL  +FR LGTPNE+ WPG++SL
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231

Query: 245 MNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            ++++  +P+  P  L    P+   + LDLL+ +L YDPSKR+SA +A+ HPYF
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  300 bits (771), Expect = e-102
 Identities = 136/293 (46%), Positives = 191/293 (65%), Gaps = 10/293 (3%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FEKL ++GEGTYG VYRAR+  +G+IVALKK R+  + +G+P ++LRE+++L  L R P+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPN 67

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +V L +V  G++ +    ++LV EY + DL   + +          + VK LM QL +G+
Sbjct: 68  IVELKEVVVGKHLDS---IFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGL 121

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            + H + I+HRDLK  NLL+  K   LKIAD GLAR + LP K  T +++TLWYRAPE+L
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           LG T Y+TA+DMW+V CI AEL+    L PG SE++QL  I +LLGTPNE +WPG S L 
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240

Query: 246 NWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
              ++  P+    +L    P L + GL LL  +L YDP KR +A++A+E  YF
Sbjct: 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  285 bits (730), Expect = 3e-96
 Identities = 140/296 (47%), Positives = 197/296 (66%), Gaps = 13/296 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ + KL+K+GEGTY  V++ R K T  +VALK+ RL E +EG P T +REVS+L+ L +
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKNL-K 61

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L D+   +       L LVFEY+D+DLK+Y+ +    G  + ++ VK  M+QL 
Sbjct: 62  HANIVTLHDIIHTER-----CLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLL 113

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+++CH   ILHRDLKP NLL++ K   LK+AD GLARA ++P K Y++E++TLWYR P
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VLLGST YST +DMW V CI  E+ T   +FPG +  ++L  IFRLLGTP E+ WPG++
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232

Query: 243 SLMNWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           S   +  Y  PQ+  Q L    P LD DG+DLL  +L Y+   RISA+ A+ H YF
Sbjct: 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  284 bits (729), Expect = 7e-96
 Identities = 141/299 (47%), Positives = 201/299 (67%), Gaps = 13/299 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ + KL+K+GEGTY  VY+ R K T  +VALK+ RL E +EG P T +REVS+L+ L +
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDL-K 62

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L D+   +       L LVFEY+D DLK+Y+      G +I ++ VK  ++QL 
Sbjct: 63  HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLL 114

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+ +CH   +LHRDLKP NLL++ +   LK+AD GLARA ++P K Y++E++TLWYR P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           ++LLGST YST +DMW V CIF E+ T   LFPG +  +QL  IFR+LGTP E+ WPG+ 
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233

Query: 243 SLMNW--HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           S   +  + YP++    L    P LD DG +LL ++LQ++  KRISA++AM+HPYF  L
Sbjct: 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  285 bits (731), Expect = 1e-95
 Identities = 116/303 (38%), Positives = 174/303 (57%), Gaps = 18/303 (5%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L+ +G G YG V  A +K TG+ VA+KK     DD       LRE+ +LR L R  +
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCK 123
           ++ L+D+ +  + E    +Y+V E M+TDL K I+S        P+    ++  +YQ+ +
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFLYQILR 114

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYR 180
           G+ + H   ++HRDLKP N+L++     LKI D GLAR       +    T  ++T WYR
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+LL S+ Y+ A+D+WSV CIFAEL+T+  LFPG   + QL  I  +LGTP+E+    
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 241 VSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           ++S      Y    P+   + L+   P    + +DLLE+ML +DP KRI+A +A+ HPY 
Sbjct: 234 ITS-EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 297 DDL 299
             L
Sbjct: 293 AQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  280 bits (720), Expect = 1e-94
 Identities = 124/295 (42%), Positives = 186/295 (63%), Gaps = 16/295 (5%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRD 63
           ++ ++++G+GT+G VY AR K TG++VA+K  K + +  +E      LREV  LR L+  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEEC---MNLREVKSLRKLNEH 57

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L +V + +N E    LY VFEYM+ +L + ++   + G+    + ++S++YQ+ +
Sbjct: 58  PNIVKLKEVFR-ENDE----LYFVFEYMEGNLYQLMKD--RKGKPFSESVIRSIIYQILQ 110

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+A  H HG  HRDLKP NLL+      +KIAD GLAR        YT  + T WYRAPE
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLARE-IRSRPPYTDYVSTRWYRAPE 168

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           +LL ST YS+ VD+W++ CI AEL T   LFPG SE+ QL  I  +LGTP ++ WP    
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228

Query: 244 LMNWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           L +   +  PQ+ P SL   +PN   + +DL++ ML++DP KR +A +A++HPYF
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  279 bits (716), Expect = 9e-94
 Identities = 143/299 (47%), Positives = 200/299 (66%), Gaps = 13/299 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ + KLEK+GEGTY  V++ R K T  +VALK+ RL E +EG P T +REVS+L+ L +
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKDL-K 62

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L D+           L LVFEY+D DLK+Y+      G  + ++ VK  +YQ+ 
Sbjct: 63  HANIVTLHDIVHTDKS-----LTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQIL 114

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+A+CH   +LHRDLKP NLL++ +   LK+AD GLARA ++P K Y++E++TLWYR P
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 173

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VLLGS+ YST +DMW V CIF E+ +   LFPG +   +L  IFRLLGTP E+ WPG+S
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233

Query: 243 SLMNWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           S   +  Y  P++ PQ L    P LD +G++LL + LQY+  KRISA++AM+H YF  L
Sbjct: 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  273 bits (701), Expect = 4e-92
 Identities = 104/292 (35%), Positives = 161/292 (55%), Gaps = 39/292 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E LEK+GEG++GKVY AR+K TGK+VA+K  +  +  +      LRE+ IL+ L + P+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKL-KHPN 58

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VRL DV + ++K     LYLV EY +  DL   ++   +    +  +  +  + Q+   
Sbjct: 59  IVRLYDVFEDEDK-----LYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSA 109

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + + H  GI+HRDLKP N+L+D     +K+AD GLAR    P +K T  + T  Y APEV
Sbjct: 110 LEYLHSKGIVHRDLKPENILLDED-GHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEV 167

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           LLG   Y  AVD+WS+  I  EL+T    FPGD +L +   +F+ +G P     P     
Sbjct: 168 LLG-KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLE---LFKKIGKPKPPFPP----- 218

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                              ++  +  DL+ ++L  DP KR++A++A++HP+F
Sbjct: 219 ----------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  274 bits (704), Expect = 7e-92
 Identities = 132/314 (42%), Positives = 189/314 (60%), Gaps = 35/314 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L K+GEGT+G+VY+AR+  TG++VALKK  +H + +G P T LRE+ IL+ L + P+
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPN 68

Query: 66  VVRLMD---VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTG--ENIPVN----TVKS 116
           VV L+D    +  ++K  R  +Y+V  YMD DL         +G  EN  V      +K 
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL---------SGLLENPSVKLTESQIKC 119

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK-------- 168
            M QL +G+ + H + ILHRD+K  N+L+D +   LKIAD GLAR +  P          
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 169 ---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
              KYT+ ++T WYR PE+LLG   Y+TAVD+W + C+FAE+ T+  +  G S++ QL  
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238

Query: 226 IFRLLGTPNEKVWPGVSSL---MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
           IF+L GTP E+ WPG  SL      H +  + P++L      L  +GLDLL ++L  DP 
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEERFGKLGPEGLDLLSKLLSLDPY 297

Query: 283 KRISAKKAMEHPYF 296
           KR++A  A+EHPYF
Sbjct: 298 KRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  268 bits (687), Expect = 3e-89
 Identities = 125/320 (39%), Positives = 184/320 (57%), Gaps = 34/320 (10%)

Query: 6   FEKLEKVGEGTYGKVYRAREKA--TGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSR 62
           +E    +G GTYG+VY+A+ K    GK  A+KK +   E   G+  +  RE+++LR L  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQT-GENIPVNTVKSLMYQL 121
             +VV L++V        ++V YL+F+Y + DL + I+  RQ    +IP + VKSL++Q+
Sbjct: 62  -ENVVSLVEVFL--EHADKSV-YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 122 CKGVAFCHGHGILHRDLKPHN-LLMDRKTM--TLKIADLGLARAFTLPIKKYTHE---IL 175
             GV + H + +LHRDLKP N L+M        +KI DLGLAR F  P+K        ++
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHI 226
           T+WYRAPE+LLG+ HY+ A+D+W++ CIFAEL+T   +F G              QL  I
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237

Query: 227 FRLLGTPNEKVWPGVSSLMNWHEYPQ-------WNPQSLAT---AVPNLDKDGLDLLEQM 276
           F +LGTP EK WP +  +  +    +        +  SLA         D  G DLL ++
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSN-SLAKWMEKHKKPDSQGFDLLRKL 296

Query: 277 LQYDPSKRISAKKAMEHPYF 296
           L+YDP+KRI+A++A+EHPYF
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  265 bits (679), Expect = 9e-89
 Identities = 109/292 (37%), Positives = 160/292 (54%), Gaps = 33/292 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L K+G G++G VY+A+ K TGKIVA+K  +   +      T  RE+ ILR LS  P+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH-PN 59

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VRL+D       E +  LYLV EY +  DL  Y+      G  +  +  K +  Q+ +G
Sbjct: 60  IVRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRG 110

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + + H +GI+HRDLKP N+L+D +   +KIAD GLA+         T  + T WY APEV
Sbjct: 111 LEYLHSNGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV 169

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           LLG   Y   VD+WS+  I  EL+T    F G++ L QL  I R+LG P E         
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE--------- 220

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
               + P+W+  S         ++  DL+++ L  DPSKR +A++ ++HP+F
Sbjct: 221 ---FDEPKWSSGS---------EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  261 bits (669), Expect = 3e-86
 Identities = 125/312 (40%), Positives = 178/312 (57%), Gaps = 39/312 (12%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHE------------DDEGVPPTTLREVSILRM 59
           +GEGTYGKV +A +  TGKIVA+KK ++ E               G+  TTLRE+ I+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYI-RSFRQTGENIPVNTVKSLM 118
           +    +++ L+DV    +      + LV + M +DLKK + R  R T        VK ++
Sbjct: 77  IKH-ENIMGLVDVYVEGD-----FINLVMDIMASDLKKVVDRKIRLTESQ-----VKCIL 125

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI----------- 167
            Q+  G+   H    +HRDL P N+ ++ K +  KIAD GLAR +  P            
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI-CKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 168 ---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 224
              ++ T +++TLWYRAPE+L+G+  Y  AVDMWSV CIFAEL+T   LFPG++E+ QL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 284
            IF LLGTPNE  WP    L  + E+    P+ L T  PN   D +DLL+ +L+ +P +R
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304

Query: 285 ISAKKAMEHPYF 296
           ISAK+A++H YF
Sbjct: 305 ISAKEALKHEYF 316

Length = 335

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  258 bits (660), Expect = 1e-85
 Identities = 126/293 (43%), Positives = 186/293 (63%), Gaps = 8/293 (2%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR--D 63
           +E + ++G G YG VY+AR+  +G  VALK  R+  +++G+P +T+REV++L+ L     
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++VRLMDV      +  T + LVFE++D DL+ Y+      G  +P  T+K LM Q  +
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLR 119

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ F H + I+HRDLKP N+L+      +K+AD GLAR ++  +   T  ++TLWYRAPE
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMA-LTPVVVTLWYRAPE 177

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           VLL ST Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  WP   +
Sbjct: 178 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           L     +    P+ + + VP +++ G  LL +ML ++P KRISA +A++HP+F
Sbjct: 237 LPR-GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  257 bits (658), Expect = 4e-85
 Identities = 125/307 (40%), Positives = 179/307 (58%), Gaps = 21/307 (6%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
             +D F+ + ++GEGTYG+VY+AR+K TG++VALKK RL  + EG P T +RE+ ILR L
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 61  SRDPHVVRLMDV---KQG--QNKEGRTVLYLVFEYMDTDLKKYIRS----FRQTGENIPV 111
               ++V L ++   KQ     K+ +   YLVFEYMD DL   + S    F +       
Sbjct: 64  -NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE------- 115

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-Y 170
           + +KS M QL +G+ +CH    LHRD+K  N+L++ K   +K+AD GLAR +     + Y
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPY 174

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           T++++TLWYR PE+LLG   Y  A+D+WS  CI  EL TK  +F  + EL QL  I RL 
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234

Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNP--QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
           G+P   VWP V  L  ++         + L      +    LDLL+ ML  DPSKR +A+
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 289 KAMEHPY 295
           +A+  P+
Sbjct: 295 EALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  256 bits (655), Expect = 8e-85
 Identities = 119/302 (39%), Positives = 175/302 (57%), Gaps = 23/302 (7%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +E L  VGEG YG V + R KATG+IVA+KK +  EDDE V  T LREV +LR L R 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RH 59

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            ++V L +  +   ++GR  LYLVFEY++  L + + +    G  +P + V+S ++QL +
Sbjct: 60  ENIVNLKEAFR---RKGR--LYLVFEYVERTLLELLEASP-GG--LPPDAVRSYIWQLLQ 111

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL-PIKKYTHEILTLWYRAP 182
            +A+CH H I+HRD+KP N+L+   +  LK+ D G ARA    P    T  + T WYRAP
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+L+G T+Y   VD+W++ CI AEL+    LFPGDS++ QL  I + LG     + P   
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG----PLPPSHQ 226

Query: 243 SLMNWHEY-------PQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
            L + +             P+SL    P  +    LD L+  L+ DP +R++  + ++HP
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286

Query: 295 YF 296
           YF
Sbjct: 287 YF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  254 bits (652), Expect = 1e-83
 Identities = 117/309 (37%), Positives = 183/309 (59%), Gaps = 37/309 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKT----RLHEDDEGVPPTTLREVSILRMLS 61
           +E L+K+G+G YG V++A ++ T ++VALKK     R   D +     T RE+  L+ L 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ----RTFREIMFLQELG 64

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENI--PVNTVKSLMY 119
             P++V+L++V + +N +    +YLVFEYM+TDL   IR+      NI   V+  + +MY
Sbjct: 65  DHPNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRA------NILEDVH-KRYIMY 114

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTH 172
           QL K + + H   ++HRDLKP N+L++     +K+AD GLAR+ +        P+   T 
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPV--LTD 171

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
            + T WYRAPE+LLGST Y+  VDMWSV CI  E++    LFPG S L QL  I  ++G 
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 233 PNEK-----VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
           P+ +       P  +++++    P    + L   +P    D LDLL+++L ++P+KR++A
Sbjct: 232 PSAEDIESIKSPFAATMLD--SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289

Query: 288 KKAMEHPYF 296
           ++A+EHPY 
Sbjct: 290 EEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  250 bits (640), Expect = 3e-82
 Identities = 116/311 (37%), Positives = 175/311 (56%), Gaps = 30/311 (9%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
             +EKL K+G+GT+G+V++AR K T +IVALKK  +  + EG P T LRE+ IL++L + 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KH 70

Query: 64  PHVVRLMDV----KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
            +VV L+++        N+  +   YLVFE+ + DL   + S +     +    +K +M 
Sbjct: 71  ENVVNLIEICRTKATPYNRY-KGSFYLVFEFCEHDLAGLL-SNKNVKFTLSE--IKKVMK 126

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEIL 175
            L  G+ + H + ILHRD+K  N+L+  K   LK+AD GLARAF+L       +YT+ ++
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           TLWYR PE+LLG   Y   +DMW   CI AE+ T++ +  G++E  QL  I +L G+   
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245

Query: 236 KVWPGVSSLMNWHEYPQWN----PQSLATAVP------NLDKDGLDLLEQMLQYDPSKRI 285
           +VWPGV       +   +     PQ     V         D   LDL++++L  DP+KRI
Sbjct: 246 EVWPGVD------KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299

Query: 286 SAKKAMEHPYF 296
            A  A+ H +F
Sbjct: 300 DADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  243 bits (623), Expect = 5e-80
 Identities = 122/293 (41%), Positives = 173/293 (59%), Gaps = 19/293 (6%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVV 67
           L K+GEGT+ +V +A+ + TGK  A+K  + H    E V    LRE+  LR LS  P+++
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV--NNLREIQALRRLSPHPNIL 61

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           RL++V     K GR  L LVFE MD +L + I+  ++    +P   VKS MYQL K +  
Sbjct: 62  RLIEVLF-DRKTGR--LALVFELMDMNLYELIKGRKRP---LPEKRVKSYMYQLLKSLDH 115

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAPEVL 185
            H +GI HRD+KP N+L+      LK+AD G  R      P   YT  I T WYRAPE L
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPP---YTEYISTRWYRAPECL 170

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV--SS 243
           L   +Y   +D+W+V C+F E+++   LFPG +EL Q+  I  +LGTP+ +V      S 
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            MN++ +P      L   +PN   +GLDLL+++L YDP +RI+AK+A+ HPYF
Sbjct: 231 HMNYN-FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  239 bits (612), Expect = 3e-78
 Identities = 127/294 (43%), Positives = 189/294 (64%), Gaps = 9/294 (3%)

Query: 6   FEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--R 62
           +E + ++GEG YGKV++AR+ K  G+ VALK+ R+   +EG+P +T+REV++LR L    
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+VVRL DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL 
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLL 120

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+ F H H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAP 178

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EVLL S+ Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +L     +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF
Sbjct: 238 ALPR-QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  239 bits (611), Expect = 4e-78
 Identities = 139/301 (46%), Positives = 192/301 (63%), Gaps = 16/301 (5%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D++EKLEK+GEG+Y  VY+ + K  GK+VALK  RL E+ EG P T +RE S+L+ L + 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGL-KH 62

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            ++V L D+        +  L LVFEY+ TDL +Y+   +  G   P N VK  ++QL +
Sbjct: 63  ANIVLLHDIIHT-----KETLTLVFEYVHTDLCQYMD--KHPGGLHPEN-VKLFLFQLLR 114

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+++ H   ILHRDLKP NLL+   T  LK+AD GLARA ++P   Y++E++TLWYR P+
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKVWPGVS 242
           VLLGST YST +DMW V CIF E++   A FPG  ++Q QL  IF +LGTPNE  WPGV 
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233

Query: 243 SLMNW--HEYPQWNPQSLATAVPNLD--KDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
           SL ++    +  ++P++L  A   L       DL  ++LQ  P  R+SA+ A+ H YF D
Sbjct: 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Query: 299 L 299
           L
Sbjct: 294 L 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  233 bits (596), Expect = 6e-76
 Identities = 130/299 (43%), Positives = 181/299 (60%), Gaps = 20/299 (6%)

Query: 5   AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           ++  LEK+GEG+Y  VY+   +  G++VALK   + + +EGVP T +RE S+L+ L +  
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIREASLLKGL-KHA 63

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++V L D+        +  L  VFEYM TDL +Y+   +  G   P N V+  M+QL +G
Sbjct: 64  NIVLLHDIIHT-----KETLTFVFEYMHTDLAQYM--IQHPGGLHPYN-VRLFMFQLLRG 115

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +A+ HG  ILHRDLKP NLL+      LK+AD GLARA ++P + Y+ E++TLWYR P+V
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNEKVWPGVSS 243
           LLG+T YS+A+D+W   CIF E++     FPG S+  +QL  I+ +LG P E  WPGVS 
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234

Query: 244 LMNWHEYPQW----NPQSLATAVPNLDK--DGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           L N+   P+W     PQ L      L +     DL  QML   P  RISA+ A+ HPYF
Sbjct: 235 LPNYK--PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  231 bits (591), Expect = 2e-74
 Identities = 107/302 (35%), Positives = 172/302 (56%), Gaps = 14/302 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V   ++ +E +G G YG V  A +  +GK VA+KK     D   +   TLRE+ ILR   
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF- 61

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +  +++ + D+ +    + + V Y+V + M++DL   I S  Q         ++  +YQL
Sbjct: 62  KHDNIIAIRDILRPPGADFKDV-YVVMDLMESDLHHIIHS-DQPLTE---EHIRYFLYQL 116

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-TLPIKK---YTHEILTL 177
            +G+ + H   ++HRDLKP NLL++ +   L+I D G+AR   + P +     T  + T 
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           WYRAPE+LL    Y+TA+DMWSV CIFAE++ +  LFPG + + QL  I  +LG+P+E+V
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235

Query: 238 WPGVSS--LMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
              + S  +  + +  P+  P   +   P    + LDLL QMLQ+DP +RI+ ++A++HP
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295

Query: 295 YF 296
           + 
Sbjct: 296 FL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  223 bits (569), Expect = 7e-72
 Identities = 113/305 (37%), Positives = 178/305 (58%), Gaps = 31/305 (10%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +EKL K+GEG+YG V++ R + TG+IVA+KK    EDD  +    LRE+ +L+ L + 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KH 59

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           P++V L++V + + K     L+LVFEY D     +L+K  R        +P + +K +++
Sbjct: 60  PNLVNLIEVFRRKRK-----LHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIW 107

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           Q  + V FCH H  +HRD+KP N+L+  K   +K+ D G AR  T P   YT  + T WY
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWY 166

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           RAPE+L+G T Y   VD+W++ C+FAEL+T   L+PG S++ QL  I + LG     + P
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIP 222

Query: 240 GVSSLMNWHEY--------PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
               + + +++        P+   + L +  PN+    L  L+  LQ DP++R+S ++ +
Sbjct: 223 RHQQIFSTNQFFKGLSIPEPE-TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281

Query: 292 EHPYF 296
           EHPYF
Sbjct: 282 EHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  222 bits (569), Expect = 3e-71
 Identities = 110/301 (36%), Positives = 164/301 (54%), Gaps = 24/301 (7%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT----TLREVSILRMLS 61
           ++ L  +GEG YG V  A  K TG  VA+KK    E       T    TLRE+ ILR   
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-----QTFCQRTLREIKILRRFK 61

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            + +++ ++D+ +  + E    +Y+V E M+TDL K I++   + ++I     +  +YQ+
Sbjct: 62  HE-NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI-----QYFLYQI 115

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEILTLW 178
            +G+ + H   +LHRDLKP NLL++     LKI D GLAR            T  + T W
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YRAPE++L S  Y+ A+D+WSV CI AE+++   LFPG   L QL  I  +LGTP+++  
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234

Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
             + S +    Y    P           PN D   LDLL++ML ++P KRI+ ++A+ HP
Sbjct: 235 NCIIS-LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293

Query: 295 Y 295
           Y
Sbjct: 294 Y 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  219 bits (559), Expect = 1e-69
 Identities = 119/297 (40%), Positives = 169/297 (56%), Gaps = 21/297 (7%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G YG V  A+   T + VA+KK     D+      TLRE+ +LR L  + +V+ + D
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE-NVIAIKD 71

Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 131
           +    ++E    +Y+V+E MDTDL + IRS  QT  +   +  +  +YQL +G+ + H  
Sbjct: 72  IMPPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSD---DHCQYFLYQLLRGLKYIHSA 127

Query: 132 GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 191
            +LHRDLKP NLL++     LKI D GLAR  +      T  ++T WYRAPE+LL  + Y
Sbjct: 128 NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186

Query: 192 STAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP---------NEKVWPGVS 242
           +TA+D+WSV CIFAEL+ +  LFPG   + QL  I  LLG+P         NEK    + 
Sbjct: 187 TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR 246

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           SL      P    QS A   P+ +   +DLLE+ML +DPSKRI+ ++A+ HPY   L
Sbjct: 247 SL------PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  214 bits (548), Expect = 9e-69
 Identities = 111/298 (37%), Positives = 169/298 (56%), Gaps = 21/298 (7%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L  VGEG+YG V + + K TG+IVA+KK    EDD+ V    +RE+ +L+ L R  +
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHEN 61

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V L++V + + +     LYLVFE++D     DL+KY          +  + V+  ++Q+
Sbjct: 62  LVNLIEVFRRKKR-----LYLVFEFVDHTVLDDLEKY-------PNGLDESRVRKYLFQI 109

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            +G+ FCH H I+HRD+KP N+L+ +  +  K+ D G AR    P + YT  + T WYRA
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVSQSGVV-KLCDFGFARTLAAPGEVYTDYVATRWYRA 168

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT--PNEKVWP 239
           PE+L+G T Y  AVD+W+V C+  E++T   LFPGDS++ QL HI + LG   P  +   
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228

Query: 240 GVSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             + L      P+    + L    P L    LDL +Q L+ DP  R S+ + + H +F
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  206 bits (527), Expect = 9e-65
 Identities = 109/299 (36%), Positives = 163/299 (54%), Gaps = 14/299 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V D ++ L  VG G YG+V  A +  TG+ VA+KK             T RE+ +L+ + 
Sbjct: 13  VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM- 71

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +V+ L+DV     + E    +YLV   M  DL   ++  + + ++I     + L+YQ
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI-----QFLVYQ 126

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H  GI+HRDLKP N+ ++ +   LKI D GLAR       + T  + T WYR
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR---HTDDEMTGYVATRWYR 182

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I  L+GTP+E++   
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242

Query: 241 VSS--LMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +SS    N+ +  PQ   +         +   +DLLE+ML  DP KRI+A +A+ HPY 
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  194 bits (496), Expect = 8e-62
 Identities = 88/284 (30%), Positives = 130/284 (45%), Gaps = 70/284 (24%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +GEG +G VY AR+K TGK VA+K  +  ED   +    LRE+ IL+ L   P++V+L  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK-EDSSSLLEELLREIEILKKL-NHPNIVKLYG 58

Query: 72  VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           V + +N      LYLV EY +   LK  ++        +  + +  ++ Q+ +G+ + H 
Sbjct: 59  VFEDEN-----HLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHS 110

Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
           +GI+HRDLKP N+L+D     +K+AD GL++  T         + T  Y APEVLLG  +
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170

Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           YS   D+WS+  I  EL           EL+ L                           
Sbjct: 171 YSEKSDIWSLGVILYEL----------PELKDL--------------------------- 193

Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                                 + +MLQ DP KR SAK+ +EH 
Sbjct: 194 ----------------------IRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  196 bits (501), Expect = 5e-61
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 21/302 (6%)

Query: 6   FEKLEKVGEGTYGKVYRAREKAT--GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +E ++++G+G YG V  AR   T   + VA+KK       + +    LRE+ +LR     
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 64  PHVVRLMD---VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            ++  L D   V  G   E    LYL  E M+ DL + IRS +   +       +S +YQ
Sbjct: 62  KNITCLYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLTDA----HFQSFIYQ 113

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK----YTHEILT 176
           +  G+ + H   +LHRDLKP NLL++     LKI D GLAR F+    +     T  + T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            WYRAPE++L    Y+ A+D+WSV CI AEL+ +  +F G   + QL  I ++LGTP+E+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232

Query: 237 VWPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
               + S          P    +   +  PN +   LDLLE++L +DP+KRIS ++A+EH
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292

Query: 294 PY 295
           PY
Sbjct: 293 PY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  193 bits (492), Expect = 3e-59
 Identities = 115/300 (38%), Positives = 163/300 (54%), Gaps = 18/300 (6%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRL 69
           +G G +G V+   +   GK VALKK      +        RE   L+ML   +  +V+  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE---LKMLCFFKHDNVLSA 64

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
           +D+ Q  + +    +Y+V E M +DL K I S     + +  + VK  +YQ+ +G+ + H
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLH 120

Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-THEILTLWYRAPEVLLGS 188
             GILHRD+KP NLL++   + LKI D GLAR       K+ T E++T +YRAPE+L+GS
Sbjct: 121 SAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
            HY++AVD+WSV CIFAEL+ +  LF   S +QQL  I  LLGTP+ +           H
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239

Query: 249 EY--PQWNP--QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 304
               P   P    L T       + + LL +ML +DP KRISA  A+ HPY   LD+ RL
Sbjct: 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY---LDEGRL 296

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  184 bits (467), Expect = 1e-56
 Identities = 117/302 (38%), Positives = 171/302 (56%), Gaps = 24/302 (7%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + FE L  VGEG YG V + R K T +IVA+KK +  E++E V  TTLRE+ +LR L ++
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
                ++++K+   + G+  LYLVFEY++   K  +    +    +P   V+S +YQL K
Sbjct: 61  ----NIVELKEAFRRRGK--LYLVFEYVE---KNMLELLEEMPNGVPPEKVRSYIYQLIK 111

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAP 182
            + +CH + I+HRD+KP NLL+    + LK+ D G AR  +      YT  + T WYR+P
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT-PNEKVW--- 238
           E+LLG+  Y  AVDMWSV CI  EL     LFPG+SE+ QL  I ++LG  P E++    
Sbjct: 171 ELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229

Query: 239 --PGVSSLMNWHEYPQWN-PQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
             P    L     +P  N PQSL       L    LDL++ +L+ +P+ R   ++ + HP
Sbjct: 230 SNPRFHGL----RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Query: 295 YF 296
            F
Sbjct: 286 AF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  184 bits (470), Expect = 2e-56
 Identities = 99/313 (31%), Positives = 157/313 (50%), Gaps = 38/313 (12%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +G G+ G V+ A +    K VA+KK  L   D       LRE+ I+R L  D +
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL--TDPQSVKHALREIKIIRRLDHD-N 63

Query: 66  VVRLMDV---KQGQNKEGRT------VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           +V++ +V         E          +Y+V EYM+TDL   +         +     + 
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-----LSEEHARL 118

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--- 173
            MYQL +G+ + H   +LHRDLKP N+ ++ + + LKI D GLAR        Y+H+   
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD---PHYSHKGYL 175

Query: 174 ---ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
              ++T WYR+P +LL   +Y+ A+DMW+  CIFAE++T   LF G  EL+Q+  I   +
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235

Query: 231 GTPNEK-------VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK 283
               E+       V P           P+   + L   +P ++ + LD LEQ+L ++P  
Sbjct: 236 PVVREEDRNELLNVIPSFVRNDGG--EPR---RPLRDLLPGVNPEALDFLEQILTFNPMD 290

Query: 284 RISAKKAMEHPYF 296
           R++A++A+ HPY 
Sbjct: 291 RLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  184 bits (469), Expect = 3e-56
 Identities = 114/312 (36%), Positives = 173/312 (55%), Gaps = 31/312 (9%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRMLSRD 63
           ++  E +G+G+YG V  A +  TG+ VA+KK  +++  E V   T  LRE+ +LR+L R 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKK--INDVFEHVSDATRILREIKLLRLL-RH 58

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P +V +  +    ++     +Y+VFE M++DL + I++     +++     +  +YQL +
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLR 114

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AF--TLPIKKYTHEILTLWYR 180
            + + H   + HRDLKP N+L +     LKI D GLAR AF  T     +T  + T WYR
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 181 APEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP----- 233
           APE L GS  + Y+ A+D+WS+ CIFAE++T   LFPG + + QL  I  LLGTP     
Sbjct: 174 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 234 ----NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
               NEK    +SS+       +  P   +   PN D   L LLE++L +DP  R +A++
Sbjct: 233 SRVRNEKARRYLSSMR------KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286

Query: 290 AMEHPYFDDLDK 301
           A+  PYF  L K
Sbjct: 287 ALADPYFKGLAK 298

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  183 bits (465), Expect = 1e-55
 Identities = 109/299 (36%), Positives = 160/299 (53%), Gaps = 17/299 (5%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L++VG G YG V  A +K TG+ VA+KK       E       RE+++L+ +  + +
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-N 75

Query: 66  VVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           V+ L+DV       +     YLV  YM TDL+K +      G  +  + V+ L+YQ+  G
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCG 129

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + + H  GI+HRDLKP NL ++     LKI D GLAR     +  Y   ++T WYRAPEV
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADAEMTGY---VVTRWYRAPEV 185

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +L   HY+  VD+WSV CI AE++T   LF G   L QL  I ++ G P  +    +   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED- 244

Query: 245 MNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
                Y    P++  +  +T  P      +DLLE+ML+ D  KR++A +A+EHPYFD  
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  181 bits (462), Expect = 3e-55
 Identities = 103/293 (35%), Positives = 155/293 (52%), Gaps = 17/293 (5%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L+ VG G +G V  AR++ TG+ VA+KK         +   T RE+ +L+ L R  +
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ L D+           +Y V E + TDL + + S       +    ++  +YQ+ +G+
Sbjct: 71  IISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-----LEKQFIQYFLYQILRGL 121

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            + H  G++HRDLKP N+L++ +   LKI D GLAR   +   + T  + T +YRAPE++
Sbjct: 122 KYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGLAR---IQDPQMTGYVSTRYYRAPEIM 177

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS-- 243
           L    Y   VD+WS  CIFAE++    LFPG   + Q   I  LLGTP + V   + S  
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237

Query: 244 -LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
            L      P+  P   +    N D   +DLLE+ML +DP KRISA +A+ HPY
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  178 bits (453), Expect = 8e-54
 Identities = 107/305 (35%), Positives = 169/305 (55%), Gaps = 14/305 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V D +  L++VG G YG V  A ++ TG  VA+KK       E       RE+ +L+ + 
Sbjct: 13  VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV     + +     YLV  +M TDL K ++      E +  + ++ L+YQ
Sbjct: 73  HE-NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQ 126

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + KG+ + H  GI+HRDLKP NL ++     LKI D GLAR     +  Y   ++T WYR
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTDSEMTGY---VVTRWYR 182

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+L   HY+  VD+WSV CI AE++T   LF G   L QL+ I ++ GTP+++    
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242

Query: 241 VSS--LMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           + S    N+  + P++  +   + +PN +   +++LE+ML  D   RI+A +A+ HPYF+
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302

Query: 298 DLDKT 302
           +    
Sbjct: 303 EFHDP 307

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  178 bits (452), Expect = 2e-53
 Identities = 86/308 (27%), Positives = 139/308 (45%), Gaps = 34/308 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-HEDDEGVPPTTLREVSILRMLSRDP 64
           +  L K+GEG++G+VY AR++   K+VALK      E         LRE+ IL  L+  P
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++V+L D  Q +       LYLV EY+D   L+  ++   + G  +  +    ++ Q+  
Sbjct: 59  NIVKLYDFFQDEGS-----LYLVMEYVDGGSLEDLLKKIGRKG-PLSESEALFILAQILS 112

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------TL 177
            + + H  GI+HRD+KP N+L+DR    +K+ D GLA+    P    +   L      T 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 178 WYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVLLG +  + S++ D+WS+     EL+T    F G+                 +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL-------K 225

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
            +    +  +     P             + K   DLL+++L  DP  R+S+   + H  
Sbjct: 226 IILELPTPSLASPLSPSNP--------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Query: 296 FDDLDKTR 303
              L    
Sbjct: 278 LAHLKLKE 285

Length = 384

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  174 bits (441), Expect = 4e-51
 Identities = 99/292 (33%), Positives = 164/292 (56%), Gaps = 12/292 (4%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G++G VY A    T + VA+KK  L +     P    RE+ I++ L+   +++ L D
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKV-LQD-----PQYKNRELLIMKNLNH-INIIFLKD 126

Query: 72  ---VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
               +  +  E    L +V E++   + KY++ + +    +P+  VK   YQLC+ +A+ 
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H   I HRDLKP NLL+D  T TLK+ D G A+   L  ++    I + +YRAPE++LG+
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSYICSRFYRAPELMLGA 245

Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
           T+Y+T +D+WS+ CI AE++    +F G S + QL+ I ++LGTP E     ++      
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 249 EYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           ++P   P+ L    P     D ++ + Q L+Y+P KR++  +A+  P+FDDL
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357

Length = 440

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  168 bits (427), Expect = 3e-50
 Identities = 111/321 (34%), Positives = 171/321 (53%), Gaps = 46/321 (14%)

Query: 11  KVGEGTYGKVYRAREK--ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           KVG GTYG VY+A+ K     K  ALK+     +  G+  +  RE+++LR L + P+V+ 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLREL-KHPNVIA 62

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNTVKSLMYQLCK 123
           L  V    +      ++L+F+Y + DL   I+  R +  N     +P + VKSL+YQ+  
Sbjct: 63  LQKVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 124 GVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIKKYTH---EILTL 177
           G+ + H + +LHRDLKP N+L+     +   +KIAD+G AR F  P+K        ++T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHIFR 228
           WYRAPE+LLG+ HY+ A+D+W++ CIFAEL+T   +F    E           QL  IF 
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239

Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNL-------------DKDGLDLLEQ 275
           ++G P +K W  +  +    EYP        T   N              D     LL++
Sbjct: 240 VMGFPADKDWEDIRKM---PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296

Query: 276 MLQYDPSKRISAKKAMEHPYF 296
           +L  DP+KRI++++A++ PYF
Sbjct: 297 LLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  167 bits (425), Expect = 5e-50
 Identities = 112/318 (35%), Positives = 170/318 (53%), Gaps = 40/318 (12%)

Query: 11  KVGEGTYGKVYRAREK--ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           KVG GTYG VY+A+ K     +  ALK+     +  G+  +  RE+++LR L + P+V+ 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLREL-KHPNVIS 62

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNTVKSLMYQLCK 123
           L  V           ++L+F+Y + DL   I+  R +  N     +P   VKSL+YQ+  
Sbjct: 63  LQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 124 GVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIKKYTH---EILTL 177
           G+ + H + +LHRDLKP N+L+     +   +KIAD+G AR F  P+K        ++T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHIFR 228
           WYRAPE+LLG+ HY+ A+D+W++ CIFAEL+T   +F    E           QL  IF 
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239

Query: 229 LLGTPNEKVW------PGVSSLMNWHEYPQWNPQSLATAVPNL----DKDGLDLLEQMLQ 278
           ++G P +K W      P  S+LM       +   SL   +       D     LL+++L 
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299

Query: 279 YDPSKRISAKKAMEHPYF 296
            DP KRI++++AM+ PYF
Sbjct: 300 MDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  168 bits (427), Expect = 5e-50
 Identities = 108/299 (36%), Positives = 158/299 (52%), Gaps = 14/299 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 15  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM- 73

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +  +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 128

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 184

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244

Query: 241 VSS--LMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +SS    N+     Q    + A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  166 bits (421), Expect = 3e-49
 Identities = 106/299 (35%), Positives = 157/299 (52%), Gaps = 14/299 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +    + VA+KK             T RE+ +L+ + 
Sbjct: 13  VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK 72

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV     + E    +YLV   M  DL   ++  + + E++     + L+YQ
Sbjct: 73  HE-NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV-----QFLIYQ 126

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L +G+ + H  GI+HRDLKP N+ ++     L+I D GLAR     +  Y   + T WYR
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADDEMTGY---VATRWYR 182

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+   ALFPG+  + QL  I  ++GTP+ +V   
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242

Query: 241 VSS---LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +SS          P    Q L       +   +DLLE+ML  D  KRISA +A+ HPYF
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  147 bits (374), Expect = 7e-43
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 42/296 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + E +G G++G VY A +K TG+++A+K   L  D E       RE+ IL  L   P+
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-PN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +VR    ++    E +  L +  EY+   +     + S  +    +P   ++    Q+ +
Sbjct: 61  IVRYYGSER---DEEKNTLNIFLEYVSGGS-----LSSLLKKFGKLPEPVIRKYTRQILE 112

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-TLPIKKYTHEIL-TLWYRA 181
           G+A+ H +GI+HRD+K  N+L+D     +K+AD G A+    +   + T  +  T ++ A
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           PEV+ G   Y  A D+WS+ C   E+ T K       + +  L  I      P       
Sbjct: 172 PEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP------- 223

Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                   E P+            L ++  D L + L+ DP KR +A + ++HP+ 
Sbjct: 224 --------EIPEH-----------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  145 bits (369), Expect = 4e-42
 Identities = 77/294 (26%), Positives = 138/294 (46%), Gaps = 40/294 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E ++++G+G++GKVY  R K+ GK+  LK+  L    E      L EV IL+ L   P+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++  +  + + K     L +V EY D  DL + I+  ++ G+  P   +     QLC  
Sbjct: 61  IIKYYESFEEKGK-----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLWYRAP 182
           + + H   ILHRD+KP N+ +      +K+ D G+++    T+ + K    + T +Y +P
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYLSP 172

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+      Y+   D+WS+ C+  EL T    F G++ L +L    ++L      +    S
Sbjct: 173 ELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGEN-LLEL--ALKILKGQYPPIPSQYS 228

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           S +                         +L+  +LQ DP +R S  + ++ P+ 
Sbjct: 229 SELR------------------------NLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  146 bits (371), Expect = 2e-41
 Identities = 106/327 (32%), Positives = 159/327 (48%), Gaps = 50/327 (15%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +  TG+ VA+KK      +        RE+ +L  L 
Sbjct: 14  VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL-VLMKLV 72

Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+       ++    +  L+YQ
Sbjct: 73  NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQ 126

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR----AFTLPIKKYTHEILT 176
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR    +F +     T  ++T
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMM-----TPYVVT 180

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE- 235
            +YRAPEV+LG   Y   VD+WSV CI  E++  T LFPG   + Q   I   LGTP++ 
Sbjct: 181 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239

Query: 236 ---KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-----------------DLLEQ 275
              ++ P V +      Y +  P+    +   L  D L                 DLL +
Sbjct: 240 FMSRLQPTVRN------YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK 293

Query: 276 MLQYDPSKRISAKKAMEHPY----FDD 298
           ML  DP KRIS   A++HPY    +D 
Sbjct: 294 MLVIDPEKRISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  139 bits (352), Expect = 1e-39
 Identities = 83/299 (27%), Positives = 137/299 (45%), Gaps = 51/299 (17%)

Query: 15  GTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVK 73
           G YG+V+ A++K+TG I A+K  +  +   +      L E  IL   ++ P+VV+L    
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDIL-SQAQSPYVVKLYYSF 62

Query: 74  QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG 132
           QG+       LYLV EY+   DL   + +      ++  +  +  + ++   + + H +G
Sbjct: 63  QGKKN-----LYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG 113

Query: 133 ILHRDLKPHNLLMDRKTMTLKIADLGLARA-------FTLPIKKYTHEIL-TLWYRAPEV 184
           I+HRDLKP N+L+D     LK+ D GL++             +K    I+ T  Y APEV
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +LG  H S  VD WS+ CI  E +     F G++  +   +I              ++  
Sbjct: 173 ILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--------------LNGK 217

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA---MEHPYFDDLD 300
           + W E               +  + +DL+ ++L  DP KR+ AK       HP+F  +D
Sbjct: 218 IEWPED------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  137 bits (347), Expect = 4e-38
 Identities = 101/313 (32%), Positives = 151/313 (48%), Gaps = 33/313 (10%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  +++L+ +G G  G V  A +   G  VA+KK      ++       RE+ +L+ ++
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78

Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I         +    +  L+YQ
Sbjct: 79  HK-NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM------ELDHERMSYLLYQ 131

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTACTNFM-MTPYVVTRYYR 189

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP------- 233
           APEV+LG   Y   VD+WSV CI  ELV  + +F G   + Q   +   LGTP       
Sbjct: 190 APEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248

Query: 234 ----------NEKVWPGVSSLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
                     N   +PG+S    + E +P W   S +           DLL +ML  DP 
Sbjct: 249 LQPTVRNYVENRPQYPGIS----FEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304

Query: 283 KRISAKKAMEHPY 295
           KRIS  +A+ HPY
Sbjct: 305 KRISVDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  136 bits (343), Expect = 1e-37
 Identities = 101/311 (32%), Positives = 157/311 (50%), Gaps = 25/311 (8%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 75  HK-NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 127

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 185

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP----NEK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 186 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 287 AKKAMEHPYFD 297
             +A++HPY +
Sbjct: 305 VDEALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  131 bits (331), Expect = 2e-36
 Identities = 78/319 (24%), Positives = 130/319 (40%), Gaps = 69/319 (21%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSR 62
           F+  + +GEG++  V  A+EK T K  A+K   K +L +  E        E  +L  L+ 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNG 60

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P +++L    Q +       LY V EY  + +L +YIR +     ++     +    ++
Sbjct: 61  HPGIIKLYYTFQDEEN-----LYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEI 111

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--------TLPIKKYTHE 173
              + + H  GI+HRDLKP N+L+D+  M +KI D G A+                    
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 174 IL------------TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            +            T  Y +PE LL       + D+W++ CI  +++T    F G +E  
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229

Query: 222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDP 281
               I +L                  + +P           PN   D  DL+E++L  DP
Sbjct: 230 TFQKILKLE-----------------YSFP-----------PNFPPDAKDLIEKLLVLDP 261

Query: 282 SKRISAKKAME----HPYF 296
             R+   +  +    HP+F
Sbjct: 262 QDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  132 bits (334), Expect = 4e-36
 Identities = 96/313 (30%), Positives = 154/313 (49%), Gaps = 29/313 (9%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81

Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 134

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP----NEK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309

Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 6e-36
 Identities = 81/292 (27%), Positives = 130/292 (44%), Gaps = 49/292 (16%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV   R+K TGK+ A+K   K ++ +  E     TL E +IL      P +V+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE--VEHTLTERNILS-RINHPFIVK 57

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L    Q + K     LYLV EY    +L  ++    +          +    ++   + +
Sbjct: 58  LHYAFQTEEK-----LYLVLEYAPGGELFSHLSKEGR----FSEERARFYAAEIVLALEY 108

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
            H  GI++RDLKP N+L+D     +K+ D GLA+  +    +      T  Y APEVLLG
Sbjct: 109 LHSLGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167

Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
              Y  AVD WS+  +  E++T    F  +   +    I+       + +          
Sbjct: 168 KG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEK--ILKDPL---------- 210

Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYF 296
             +P             L  +  DL+  +LQ DP+KR+ +  A E   HP+F
Sbjct: 211 -RFP-----------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 2e-35
 Identities = 78/289 (26%), Positives = 141/289 (48%), Gaps = 42/289 (14%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           + +G G +G VY+     TG  VA+K+  L +  E    + ++E+ +L+ L   P++V+ 
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-PNIVKY 64

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
           +   +  +      LY++ EY +   L++ I+ F    E++    V   +YQ+ +G+A+ 
Sbjct: 65  IGSIETSDS-----LYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYL 115

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLG 187
           H  G++HRD+K  N+L   K   +K+AD G+A      + K    ++ T ++ APEV+  
Sbjct: 116 HEQGVIHRDIKAANILTT-KDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEM 173

Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
           S   STA D+WS+ C   EL+T     P   +L  +  +FR++   +  +  G+S  +  
Sbjct: 174 SGA-STASDIWSLGCTVIELLTGN---PPYYDLNPMAALFRIVQDDHPPLPEGISPEL-- 227

Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                  D L Q  Q DP+ R +AK+ ++HP+ 
Sbjct: 228 ----------------------KDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  126 bits (319), Expect = 7e-35
 Identities = 80/296 (27%), Positives = 139/296 (46%), Gaps = 42/296 (14%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++  K+G GT+GKVY A    TG+++A+K+ R+ ++D         E+ +L +L   P++
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNL 61

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           V+   V+  + K     +Y+  EY        +    + G  +  + ++    QL +G+A
Sbjct: 62  VKYYGVEVHREK-----VYIFMEYCS---GGTLEELLEHGRILDEHVIRVYTLQLLEGLA 113

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLG----LARAFTLPIKKYTHEILTLWYRAP 182
           + H HGI+HRD+KP N+ +D   + +K+ D G    L    T   ++      T  Y AP
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Query: 183 EVLLGST--HYSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWP 239
           EV+ G     +  A D+WS+ C+  E+ T    +   D+E Q + H+             
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV------------- 219

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                      P   P SL      L  +G D L++ L+ DP KR +A + ++HP+
Sbjct: 220 ------GAGHKPPI-PDSL-----QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (311), Expect = 1e-33
 Identities = 81/293 (27%), Positives = 141/293 (48%), Gaps = 44/293 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE LEK+G+G +G+VY+AR K TGK VA+K  +L   ++      + E+ IL+   + P+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK--KEKIINEIQILKKC-KHPN 58

Query: 66  VVRLMD--VKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           +V+     +K+ +       L++V E+     LK  ++S  QT   +  + +  +  +L 
Sbjct: 59  IVKYYGSYLKKDE-------LWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELL 108

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           KG+ + H +GI+HRD+K  N+L+      +K+ D GL+   +   K     + T ++ AP
Sbjct: 109 KGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLS-DTKARNTMVGTPYWMAP 166

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EV+ G   Y    D+WS+     EL       P  SE    L   + L        PG+ 
Sbjct: 167 EVING-KPYDYKADIWSLGITAIELAEGK---PPYSE----LPPMKALFKIATNGPPGLR 218

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           +   W +  +                  D L++ LQ +P KR +A++ ++HP+
Sbjct: 219 NPEKWSDEFK------------------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  123 bits (311), Expect = 1e-33
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 18/225 (8%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E LE +G+G++G V + R K+ GKI+  K+       E      + EV+ILR L + P+
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPN 60

Query: 66  VVRLMD---VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +VR  D    +  Q       LY+V EY +  DL + I+  ++  + I    +  ++ QL
Sbjct: 61  IVRYYDRIIDRSNQ------TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 122 CKGVAFCH-----GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
              +  CH     G+ +LHRDLKP N+ +D     +K+ D GLA+            + T
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            +Y +PE L   + Y    D+WS+ C+  EL   +  F   ++LQ
Sbjct: 174 PYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 1e-31
 Identities = 83/298 (27%), Positives = 137/298 (45%), Gaps = 46/298 (15%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR-EVSILRMLSRDPHVV 67
           L+ + +G +G VY A++++TG   A+K  +  +       T ++ E +I+ +    P+V 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           +L    Q ++      LYLV EY++  D    I    +T   +P +  K  + ++  GV 
Sbjct: 61  KLYYSFQSKDY-----LYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVE 111

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
             H  GI+HRD+KP NLL+D +T  LK+ D GL+R      KK+   + T  Y APE +L
Sbjct: 112 DLHQRGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN-KKF---VGTPDYLAPETIL 166

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV-SSLM 245
           G        D WS+ C+  E +     F                 TP + V+  + S  +
Sbjct: 167 GVGD-DKMSDWWSLGCVIFEFLFGYPPFHA--------------ETP-DAVFDNILSRRI 210

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 300
           NW E                  + +DL+ ++L  DP+KR+ A    E   HP+F  ++
Sbjct: 211 NWPEE----------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  116 bits (292), Expect = 6e-31
 Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 40/291 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F+ L+K+G+G+YG VY+ +  +  +  ALK+  L    +      + E+ IL  ++  P+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++   +     NK     L +V EY    DL K I   ++  + IP   +  +  QL +G
Sbjct: 61  IISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +   H   ILHRDLK  N+L+    + +KI DLG+++     + K   +I T  Y APEV
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDL-VKIGDLGISKVLKKNMAKT--QIGTPHYMAPEV 172

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
             G   YS   D+WS+ C+  E+ T    F   S +Q L            KV  G    
Sbjct: 173 WKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDL----------RYKVQRG---- 216

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHP 294
               +YP          +P +    L + +  MLQ  P  R +  K +  P
Sbjct: 217 ----KYP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  114 bits (288), Expect = 2e-30
 Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 10/217 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLS 61
           +  F+  +K+G+G +  VY+A     G++VALKK ++ E  D       L+E+ +L+ L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             P+V++ +      N+     L +V E  D  DL + I+ F++    IP  T+     Q
Sbjct: 61  H-PNVIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           LC  +   H   I+HRD+KP N+ +   T  +K+ DLGL R F+         + T +Y 
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD 217
           +PE +     Y+   D+WS+ C+  E+    + F GD
Sbjct: 174 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 7e-30
 Identities = 90/305 (29%), Positives = 140/305 (45%), Gaps = 45/305 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSR 62
           F+ L +VG+G YG+V+ A++K TG+IVALK   K+ L + +E      L E  IL   ++
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDIL-TTTK 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
              +V+L+   Q         LYL  EY+   D     R+       +  +  +  M ++
Sbjct: 60  SEWLVKLLYAFQDDEY-----LYLAMEYVPGGDF----RTLLNNLGVLSEDHARFYMAEM 110

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYR 180
            + V   H  G +HRDLKP N L+D  +  +K+ D GL++        Y + ++ +  Y 
Sbjct: 111 FEAVDALHELGYIHRDLKPENFLIDA-SGHIKLTDFGLSKGIV----TYANSVVGSPDYM 165

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEVL G   Y   VD WS+ C+  E +     F G               TPNE  W  
Sbjct: 166 APEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------------TPNE-TW-- 207

Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK-AMEHPYFDDL 299
             +L  W E  Q           NL  +  DL+ +++  DPS+R  + +    HP+F ++
Sbjct: 208 -ENLKYWKETLQR--PVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEV 263

Query: 300 DKTRL 304
           D   L
Sbjct: 264 DWNEL 268

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  113 bits (285), Expect = 8e-30
 Identities = 86/297 (28%), Positives = 133/297 (44%), Gaps = 50/297 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            E+++ +G+G+ G VY+ R K TGKI ALKK  +  D+E      LRE+  LR     P+
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLR-SCESPY 60

Query: 66  VVRLMDV--KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           VV+      K+G+       + +V EYMD      +    +    IP   +  +  Q+ K
Sbjct: 61  VVKCYGAFYKEGE-------ISIVLEYMD---GGSLADLLKKVGKIPEPVLAYIARQILK 110

Query: 124 GVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           G+ + H    I+HRD+KP NLL++ K   +KIAD G+++     + +    + T+ Y +P
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E + G   YS A D+WS+     E       FP           F   G P+   +    
Sbjct: 170 ERIQGE-SYSYAADIWSLGLTLLECA--LGKFP-----------FLPPGQPS---FF--- 209

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGL-----DLLEQMLQYDPSKRISAKKAMEHP 294
            LM                 P+L  +       D +   LQ DP KR SA + ++HP
Sbjct: 210 ELMQ---------AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  112 bits (283), Expect = 2e-29
 Identities = 80/297 (26%), Positives = 138/297 (46%), Gaps = 50/297 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++ LEK+GEG  G+VY+A ++ATGK VA+KK RL + ++ +    + E+ I++   + P+
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL---IINEILIMKD-CKHPN 76

Query: 66  VVRLMD--VKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +V   D  +           L++V EYMD    TD+        Q    +    +  +  
Sbjct: 77  IVDYYDSYLVGD-------ELWVVMEYMDGGSLTDI------ITQNFVRMNEPQIAYVCR 123

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++ +G+ + H   ++HRD+K  N+L+  K  ++K+AD G A   T    K    + T ++
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYW 182

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV+     Y   VD+WS+  +  E+      +  +  L+ L  I    G P  K   
Sbjct: 183 MAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI-TTKGIPPLK--- 237

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                         NP+           +  D L + L  DP KR SA++ ++HP+ 
Sbjct: 238 --------------NPEK-------WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 2e-28
 Identities = 75/296 (25%), Positives = 132/296 (44%), Gaps = 51/296 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F  LE +G+G++G+VY+A +K T ++VA+K   L E ++ +     +E+  L    R P+
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQC-RSPY 60

Query: 66  VVRLMD--VKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           + +     +K        + L+++ EY       DL K  +        +    +  ++ 
Sbjct: 61  ITKYYGSFLK-------GSKLWIIMEYCGGGSCLDLLKPGK--------LDETYIAFILR 105

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++  G+ + H  G +HRD+K  N+L+  +   +K+AD G++   T  + K    + T ++
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFW 164

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV+  S  Y    D+WS+     EL        G+  L  L H  R+L         
Sbjct: 165 MAPEVIKQSG-YDEKADIWSLGITAIELAK------GEPPLSDL-HPMRVL--------- 207

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                      P+ NP SL        K   D +   L  DP +R SAK+ ++H +
Sbjct: 208 --------FLIPKNNPPSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (269), Expect = 2e-27
 Identities = 84/295 (28%), Positives = 127/295 (43%), Gaps = 37/295 (12%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D  E L ++G G  G V +   + TGKI+A+K  RL E +E +    LRE+ IL      
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRL-EINEAIQKQILRELDIL-HKCNS 58

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++V                + +  EYMD   L K ++  +     IP   +  +   + 
Sbjct: 59  PYIVGFYGAFYNNGD-----ISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVL 110

Query: 123 KGVAFCH-GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           KG+ + H  H I+HRD+KP N+L++ +   +K+ D G++      + K    + T  Y A
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK--TFVGTSSYMA 167

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE + G   YS   D+WS+     EL T    FP   E      IF LL           
Sbjct: 168 PERIQG-NDYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFELL----------- 213

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             ++N  E P   P            D  D +   L  DP +R S K+ +EHP+ 
Sbjct: 214 QYIVN--EPPPRLPSG------KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  106 bits (268), Expect = 2e-27
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 42/211 (19%)

Query: 7   EKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
              +K+GEG +G+VY+ +           VA+K  +    ++ +    LRE  I+R L  
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE-EFLREARIMRKL-D 59

Query: 63  DPHVVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY 119
            P+VV+L+ V  ++         LY+V EYM+  DL  Y+R   +    + ++ + S   
Sbjct: 60  HPNVVKLLGVCTEEEP-------LYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFAL 109

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIK 168
           Q+ +G+ +      +HRDL   N L+  + + +KI+D GL+R              LPI+
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                    W  APE L     +++  D+WS
Sbjct: 169 ---------WM-APESLK-EGKFTSKSDVWS 188

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  106 bits (266), Expect = 3e-27
 Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 62/302 (20%)

Query: 8   KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---EGVPPTTLREVSILRMLSRDP 64
           K E +G G++G VY       G   A+K+  L +D    +       +E+++L  L + P
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHP 62

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           ++V+ +    G  +E    LY+  E      +   LKKY  SF +         ++    
Sbjct: 63  NIVQYL----GTEREEDN-LYIFLELVPGGSLAKLLKKY-GSFPEP-------VIRLYTR 109

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEI 174
           Q+  G+ + H    +HRD+K  N+L+D   + +K+AD G+A+     +F    K      
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDTNGV-VKLADFGMAKQVVEFSFAKSFKG----- 163

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            + ++ APEV+     Y  A D+WS+ C   E+ T     P  S+L+ +  +F++     
Sbjct: 164 -SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK---PPWSQLEGVAAVFKI---GR 216

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            K  P                      +P+ L  +  D + + LQ DPS R +A + +EH
Sbjct: 217 SKELP---------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255

Query: 294 PY 295
           P+
Sbjct: 256 PF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 4e-27
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 42/222 (18%)

Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +K+GEG +G+VY+ +   +      VA+K  +    +E      L+E  +++ L   P+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERK-DFLKEARVMKKL-GHPNV 58

Query: 67  VRLMDV-KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQT-----GENIPVNTVKSLMY 119
           VRL+ V  + +       LYLV EYM+  DL  Y+R  R          + +  + S   
Sbjct: 59  VRLLGVCTEEEP------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR------------AFTLPI 167
           Q+ KG+ +      +HRDL   N L+    + +KI+D GL+R               LPI
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171

Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           +         W  APE L     +++  D+WS   +  E+ T
Sbjct: 172 R---------WM-APESLKDGI-FTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  105 bits (265), Expect = 5e-27
 Identities = 81/298 (27%), Positives = 142/298 (47%), Gaps = 49/298 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + F+ LEK+GEG+YG VY+A  K TG++VA+K   + ED + +    ++E+SIL+     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI----IKEISILKQ-CDS 57

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           P++V+               L++V EY      +D+ K I +   T E I       ++Y
Sbjct: 58  PYIVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIMK-ITNKTLTEEEIAA-----ILY 106

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           Q  KG+ + H +  +HRD+K  N+L++ +    K+AD G++   T  + K    I T ++
Sbjct: 107 QTLKGLEYLHSNKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV+    + + A D+WS+     E+       P  S++  +  IF +          
Sbjct: 166 MAPEVIQEIGYNNKA-DIWSLGITAIEMAE---GKPPYSDIHPMRAIFMI---------- 211

Query: 240 GVSSLMNWHEYPQWNPQSLATAVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                      P   P +L+   P     +  D +++ L  DP +R SA + ++HP+ 
Sbjct: 212 -----------PNKPPPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  104 bits (262), Expect = 2e-26
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 47/215 (21%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRL---HEDDEGVPPTTLREVSILR 58
            E  +K+GEG +G+VY+   K  G+     VA+K  +     E+ E      L E SI++
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMK 56

Query: 59  MLSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
            LS  P++VRL+ V  QG+       LY+V EYM   DL  ++R   + GE + +  +  
Sbjct: 57  KLSH-PNIVRLLGVCTQGEP------LYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQ 106

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------ 164
           +  Q+ KG+ +      +HRDL   N L+    + +KI+D GL+R               
Sbjct: 107 MALQIAKGMEYLESKNFVHRDLAARNCLVTEN-LVVKISDFGLSRDIYEDDYYRKRGGGK 165

Query: 165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           LPIK         W  APE L     +++  D+WS
Sbjct: 166 LPIK---------WM-APESLKDG-KFTSKSDVWS 189

Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 3e-26
 Identities = 78/304 (25%), Positives = 137/304 (45%), Gaps = 47/304 (15%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
             FE +E +GEGTYGKVY+AR K TG++VA+K   + ED+E        E +ILR  S  
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYSNH 62

Query: 64  PHVVRLMDVKQGQNKEGRTV-LYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLM 118
           P++         +N  G    L+LV E       TDL   ++  R+ G+ +    +  ++
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL---VKGLRKKGKRLKEEWIAYIL 119

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +  +G+A+ H + ++HRD+K  N+L+  K   +K+ D G++      + +    I T +
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 179 YRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGD---SELQQLLHIFRLLG 231
           + APEV+         Y    D+WS+       +T   L  G     ++  +  +F++  
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLG------ITAIELADGKPPLCDMHPMRALFKIPR 232

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
            P     P + S  NW +                     D + + L  +  +R   ++ +
Sbjct: 233 NPP----PTLKSPENWSKKFN------------------DFISECLIKNYEQRPFMEELL 270

Query: 292 EHPY 295
           EHP+
Sbjct: 271 EHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  103 bits (258), Expect = 5e-26
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 47/214 (21%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKI----VALKKTRLHEDDEGVPPTT---LREVSILRM 59
              +K+GEG +G+VY+   K  G      VA+K  +    ++         LRE  I+R 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ----QIEEFLREARIMRK 57

Query: 60  LSRDPHVVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           L   P++V+L+ V  ++         L +V EYM   DL  Y+R  R   + + ++ + S
Sbjct: 58  L-DHPNIVKLLGVCTEEEP-------LMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLS 107

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------L 165
              Q+ +G+ +      +HRDL   N L+      +KI+D GL+R              L
Sbjct: 108 FALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           PI+         W  APE L     +++  D+WS
Sbjct: 167 PIR---------WM-APESLK-EGKFTSKSDVWS 189

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  102 bits (257), Expect = 7e-26
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 48/298 (16%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +G G +G+V   + K+  +  ALK   + H  + G       E  IL      P +V+L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL-EECNHPFIVKLY 59

Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF-- 127
              + +       +Y++ EY    +L   +R      +    +   +  Y  C  +AF  
Sbjct: 60  RTFKDKKY-----IYMLMEYCLGGELWTILR------DRGLFDEYTARFYIACVVLAFEY 108

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
            H  GI++RDLKP NLL+D     +K+ D G A+      K +T    T  Y APE++L 
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILN 166

Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
              Y  +VD WS+  +  EL+T    F  D E    + I+  +   N K           
Sbjct: 167 K-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGK----------- 212

Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 300
            E+P             +DK   DL++Q+L+ +P +R+       K   +H +F+  D
Sbjct: 213 LEFPN-----------YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (252), Expect = 3e-25
 Identities = 76/293 (25%), Positives = 134/293 (45%), Gaps = 44/293 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE L K+G+G++G V++   KA  ++ A+K+  L + +       + E  +L  L    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSY 60

Query: 66  VVRLMD--VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           ++R  +  + +G+       L +V EY +  DL K ++   Q G  +P + V     Q+ 
Sbjct: 61  IIRYYESFLDKGK-------LNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQIL 111

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRA 181
            G+A  H   ILHRD+K  NL +D     +KI DLG+A+  +     + + I+ T +Y +
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLS 169

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE L     Y+   D+W++  +  E  T    F  +++   +L I R        V+P V
Sbjct: 170 PE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-------GVFPPV 221

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           S + +         Q LA            L++Q L  D  +R    + + +P
Sbjct: 222 SQMYS---------QQLA-----------QLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 98.2 bits (245), Expect = 4e-24
 Identities = 78/297 (26%), Positives = 123/297 (41%), Gaps = 46/297 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDP 64
           FE L  +G+G +GKV   +++ T K+ A+K     +  E G     L E  IL+ L   P
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            +V L       + +    +YLV + +   DL+ ++    +  E      VK  + ++  
Sbjct: 61  FLVNLW-----YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----QVKFWICEIVL 111

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + + H  GI+HRD+KP N+L+D +   + I D  +A   T P    T    T  Y APE
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVT-PDTLTTSTSGTPGYMAPE 169

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL--QQLLHIFRLLGTPNEKVWPGV 241
           VL     YS AVD WS+     E +     + G S     Q+        T +       
Sbjct: 170 VLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYPAT- 224

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS--AKKAMEHPYF 296
                      W+             + +D + ++L+ DP KR+    K    HPYF
Sbjct: 225 -----------WS------------TEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 97.7 bits (243), Expect = 6e-24
 Identities = 74/292 (25%), Positives = 129/292 (44%), Gaps = 37/292 (12%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E ++K+GEG++GK+Y A+ K+  +   +K+  L +        + +EV +L  + + P+
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +V      Q   +     L++V EY D  DL K I   RQ G     + + S   Q+  G
Sbjct: 61  IVTFFASFQENGR-----LFIVMEYCDGGDLMKRIN--RQRGVLFSEDQILSWFVQISLG 113

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +   H   ILHRD+K  N+ + +  M  K+ D G+AR     ++     + T +Y +PE+
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
              +  Y+   D+WS+ C+  EL T    F G++  Q +L I +                
Sbjct: 174 -CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ---------------- 216

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                         A   PN  +D   L+ Q+ +  P  R S    ++ P+ 
Sbjct: 217 -----------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.7 bits (238), Expect = 3e-23
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 38/290 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EK+  VG G +G V+  R KA  K+V +K+  + +  +        E  +L++LS  P+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++   +     N      L +V EY     L +YI+  ++    +  +T+     Q+   
Sbjct: 61  IIEYYE-----NFLEDKALMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLA 113

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +   H   ILHRDLK  N+L+D+  M +KI D G+++  +   K YT  + T  Y +PE+
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPEL 172

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
             G   Y+   D+W++ C+  EL +    F   +    +L I    GT            
Sbjct: 173 CEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GT------------ 217

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   + P S          D   L+  ML  DPSKR    + M  P
Sbjct: 218 --------FAPIS-----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.9 bits (236), Expect = 6e-23
 Identities = 72/299 (24%), Positives = 138/299 (46%), Gaps = 41/299 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL----HEDDEGVPPTTLREVSILRMLS 61
           + K +++G G +   Y+AR+  TG ++A+K+         + E V     +E+ ++  L+
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             PH++R++      +     V ++    +   L KY  +F+   E + +N  +    QL
Sbjct: 62  H-PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFK---EAVIINYTE----QL 112

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK---KYTHEIL-TL 177
            +G+++ H + I+HRD+K  NLL+D     L+IAD G A           ++  ++L T+
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            + APEVL G   Y  + D+WSV C+  E+ T    +  +     L  IF+ + +     
Sbjct: 173 AFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-IASATTA- 229

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P +             P+ L+  +        D+  + L+  P  R  +++ ++HP F
Sbjct: 230 -PSI-------------PEHLSPGLR-------DVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 94.7 bits (235), Expect = 1e-22
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 10/214 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDP 64
           F+  +K+G G + +VYRA      K VALKK ++ E  D       ++E+ +L+ L+  P
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-P 62

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +V++ +D     N+     L +V E  D  DL + I+ F++    IP  TV     QLC 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            V   H   ++HRD+KP N+ +   T  +K+ DLGL R F+         + T +Y +PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD 217
             +    Y+   D+WS+ C+  E+    + F GD
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 88/346 (25%), Positives = 135/346 (39%), Gaps = 95/346 (27%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRML 60
           D FE ++ +G G +G+V+  R+K TG++ A+K   K+ + +          R        
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK----------RNQIAHVRA 50

Query: 61  SRD-------PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKY-IRSFRQTGENIPV 111
            RD       P +V+L    Q +       LYLV EYM   DL    IR      +  P 
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEH-----LYLVMEYMPGGDLMNLLIRK-----DVFPE 100

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA----------- 160
            T +  + +L   +   H  G +HRD+KP N+L+D     +K+AD GL            
Sbjct: 101 ETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREY 159

Query: 161 --------------RAFTLPIKKYTH----EILTLWYRAPEVLLGSTHYSTAVDMWSVAC 202
                                K+        + T  Y APEVL G T Y    D WS+  
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGV 218

Query: 203 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE---YPQWNPQSLA 259
           I  E++     F  D+          L  T         + ++NW E   +P   P S  
Sbjct: 219 ILYEMLYGFPPFYSDT----------LQET--------YNKIINWKESLRFPPDPPVS-- 258

Query: 260 TAVPNLDKDGLDLLEQMLQYDPSKRI-SAKKAMEHPYFDDLDKTRL 304
                   + +DL+ ++L  DP  R+ S ++   HP+F  +D   L
Sbjct: 259 -------PEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENL 296

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 93.2 bits (231), Expect = 3e-22
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 10/214 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDP 64
           F   +K+G G + +VYRA     G  VALKK ++ +  D       ++E+ +L+ L+  P
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-P 62

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +V++        N+     L +V E  D  DL + I+ F++    IP  TV     QLC 
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            +   H   ++HRD+KP N+ +   T  +K+ DLGL R F+         + T +Y +PE
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD 217
             +    Y+   D+WS+ C+  E+    + F GD
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 94.1 bits (234), Expect = 3e-22
 Identities = 83/300 (27%), Positives = 139/300 (46%), Gaps = 50/300 (16%)

Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV  A  K T +   I ALKK  + EDD+     T+ E  +L +    P +  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD--VECTMVERRVLALAWEHPFLTH 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q +       L+ V EY++  DL  +I+S  +  E       ++  Y  ++  G+
Sbjct: 61  LFCTFQTKEH-----LFFVMEYLNGGDLMFHIQSSGRFDEA------RARFYAAEIICGL 109

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            F H  GI++RDLK  N+L+D+    +KIAD G+ +       K +    T  Y APE+L
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
            G   Y+ +VD WS   +  E++   + F G+ E  +L          N++         
Sbjct: 169 KGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSIL-----NDRPH------- 214

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFDDLDKTRL 304
               +P+W           + K+  D L ++ + DP+KR+     + +HP+F  +D  RL
Sbjct: 215 ----FPRW-----------ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 93.3 bits (232), Expect = 3e-22
 Identities = 85/320 (26%), Positives = 132/320 (41%), Gaps = 85/320 (26%)

Query: 8   KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           K E +G+GTYG+VY A    TG+++A+K+  L       P T               H  
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVEL-------PAT-----------IAGRHDS 46

Query: 68  RLMDVKQGQNKEGRT---------VLYLVFEYMDTDLKKYI---------RSFRQTGENI 109
           R  D+ +    E  T         V YL FE  +  L  ++            R  G   
Sbjct: 47  RQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE 106

Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK 169
               V+    Q+ +G+A+ H  GILHRDLK  NLL+D      KI+D G        I K
Sbjct: 107 E-QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFG--------ISK 156

Query: 170 YTHEIL----------TLWYRAPEVL-LGSTHYSTAVDMWSVACIFAELVTKTALFPGD- 217
            + +I           ++++ APEV+   S  YS  VD+WS+ C+  E      +F G  
Sbjct: 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE------MFAGRR 210

Query: 218 --SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQ 275
             S+ + +  +F+L    N++  P +             P  +     NL    LD L  
Sbjct: 211 PWSDEEAIAAMFKLG---NKRSAPPI-------------PPDV---SMNLSPVALDFLNA 251

Query: 276 MLQYDPSKRISAKKAMEHPY 295
               +P  R +A++ ++HP+
Sbjct: 252 CFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 93.5 bits (232), Expect = 6e-22
 Identities = 87/298 (29%), Positives = 143/298 (47%), Gaps = 46/298 (15%)

Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV+ A  K T +   I ALKK  +  DD+     T+ E  +L +    P +  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLTH 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L    Q   KE    L+ V EY++  DL  +I+S  +   ++P  T  +   ++  G+ F
Sbjct: 61  LYCTFQ--TKEN---LFFVMEYLNGGDLMFHIQSCHKF--DLPRATFYAA--EIICGLQF 111

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
            H  GI++RDLK  N+L+D     +KIAD G+ +   L   K      T  Y APE+LLG
Sbjct: 112 LHSKGIVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
              Y+T+VD WS   +  E++   + F G  E ++L    R                M+ 
Sbjct: 171 QK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIR----------------MDN 212

Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFDDLDKTRL 304
             YP+W           L ++  D+L ++   +P +R+  K  + +HP+F ++D + L
Sbjct: 213 PCYPRW-----------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSAL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 9e-22
 Identities = 75/302 (24%), Positives = 142/302 (47%), Gaps = 61/302 (20%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRL---HEDDEGVPPTTL----REVSILRMLSRDP 64
           +G G++G VY     ++G+++A+K+  L       +    + L    RE+++L+ L    
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-E 66

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-----DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           ++V+ +      +      L +  EY+        L  Y  +F +T        V++ + 
Sbjct: 67  NIVQYLGSSLDADH-----LNIFLEYVPGGSVAALLNNY-GAFEET-------LVRNFVR 113

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR---AFTLPIKKYTHEIL- 175
           Q+ KG+ + H  GI+HRD+K  N+L+D K   +KI+D G+++   A +L  K        
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 176 --TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             ++++ APEV +  T Y+   D+WS+ C+  E++T    FP   +  QL  IF++    
Sbjct: 173 QGSVFWMAPEV-VKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI---- 224

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            E   P + S                    N+  + +D LE+  + D +KR +A + ++H
Sbjct: 225 GENASPEIPS--------------------NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264

Query: 294 PY 295
           P+
Sbjct: 265 PF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 91.4 bits (227), Expect = 1e-21
 Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 38/290 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  +  +G+G +G+    R      +V  K+  L    E      L E+ IL +L   P+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++   +     +      L +  EY +   L   I   RQ G+      V   ++Q+   
Sbjct: 61  IIAYYN-----HFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSA 113

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V++ H  GILHRD+K  N+ + +  + +K+ D G+++            + T +Y +PE+
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
             G   Y+   D+W++ C+  EL+T    F   + L  ++ I +   TP   V+   SS 
Sbjct: 173 CQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSE 228

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +                        + L+  +LQ DP KR +A + ++ P
Sbjct: 229 L------------------------ISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.1 bits (227), Expect = 2e-21
 Identities = 89/315 (28%), Positives = 133/315 (42%), Gaps = 72/315 (22%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-------EGVPPTTLREVSI 56
           D FE ++ +G G++G+V   R K +GK  ALK   L +         E V    L E  I
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALK--ILSKAKIVKLKQVEHV----LNEKRI 54

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK 115
           L+ + R P +V L     G  ++    LYLV EY+   +L  ++R         P    +
Sbjct: 55  LQSI-RHPFLVNL----YGSFQDDSN-LYLVMEYVPGGELFSHLRKSG----RFPEPVAR 104

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKY 170
               Q+   + + H   I++RDLKP NLL+D     +KI D G A     R +TL     
Sbjct: 105 FYAAQVVLALEYLHSLDIVYRDLKPENLLLDS-DGYIKITDFGFAKRVKGRTYTLC---G 160

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           T E     Y APE++L S  Y  AVD W++  +  E++     F  D+ +Q    I+   
Sbjct: 161 TPE-----YLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEK- 209

Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
                KV            +P +              D  DL+  +LQ D +KR+   K 
Sbjct: 210 -ILEGKV-----------RFPSF-----------FSPDAKDLIRNLLQVDLTKRLGNLKN 246

Query: 291 -----MEHPYFDDLD 300
                  HP+F  +D
Sbjct: 247 GVNDIKNHPWFAGID 261

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 90.5 bits (225), Expect = 5e-21
 Identities = 81/304 (26%), Positives = 137/304 (45%), Gaps = 54/304 (17%)

Query: 12  VGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV  A  K T ++ A   LKK  + +DD+     T+ E  +L +  + P + +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLTQ 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC--KGV 125
           L    Q +++     L+ V EY++  DL  +I+   +  E       ++  Y      G+
Sbjct: 61  LHSCFQTKDR-----LFFVMEYVNGGDLMFHIQRSGRFDEP------RARFYAAEIVLGL 109

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            F H  GI++RDLK  N+L+D +   +KIAD G+ +   L     +    T  Y APE+L
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
                Y  AVD W++  +  E++   + F GD E  +L           ++V        
Sbjct: 169 SY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL-----EDEV-------- 213

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-----HPYFDDLD 300
               YP+W           L K+   +L+  L  +P KR+      E     HP+F ++D
Sbjct: 214 ---RYPRW-----------LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259

Query: 301 KTRL 304
             +L
Sbjct: 260 WDKL 263

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 89.8 bits (223), Expect = 6e-21
 Identities = 82/311 (26%), Positives = 135/311 (43%), Gaps = 55/311 (17%)

Query: 6   FEKLEKVGEGTYGKVYRARE---KATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           FE L  +G G YGKV+  R+      GK+ A   LKK  + +  +     T  E  +L  
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAK-TAEHTRTERQVLEA 60

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTV 114
           + R P +V L    Q   K     L+L+ +Y++     T L  Y R      E+   + V
Sbjct: 61  VRRCPFLVTLHYAFQTDTK-----LHLILDYVNGGELFTHL--YQR------EHFTESEV 107

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           +  + ++   +   H  GI++RD+K  N+L+D     + + D GL++ F    ++  +  
Sbjct: 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAEEEERAYSF 166

Query: 175 L-TLWYRAPEVLL-GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
             T+ Y APEV+  GS  +  AVD WS+  +  EL+T  + F  D E      I R +  
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK 226

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
                            +P             +  +  D ++++L+ DP KR+ A  A E
Sbjct: 227 SKPP-------------FP-----------KTMSAEARDFIQKLLEKDPKKRLGANGADE 262

Query: 293 ---HPYFDDLD 300
              HP+F  +D
Sbjct: 263 IKNHPFFQGID 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 89.6 bits (222), Expect = 1e-20
 Identities = 80/300 (26%), Positives = 141/300 (47%), Gaps = 50/300 (16%)

Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV  A  K  G+   + ALKK  +  DD+     T+ E  +L +   +P +  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD--VECTMVEKRVLALAWENPFLTH 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q +       L+ V E+++  DL  +I+      +    +  ++  Y  ++  G+
Sbjct: 61  LYCTFQTKEH-----LFFVMEFLNGGDLMFHIQ------DKGRFDLYRATFYAAEIVCGL 109

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            F H  GI++RDLK  N+++DR    +KIAD G+ +       + +    T  Y APE+L
Sbjct: 110 QFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
            G   Y+ +VD WS   +  E++   + F GD E  +L    R + TP+           
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIR-VDTPH----------- 214

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-HPYFDDLDKTRL 304
               YP+W           + K+  D+LE++ + DP++R+     +  HP+F  ++ T L
Sbjct: 215 ----YPRW-----------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTAL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 2e-20
 Identities = 64/295 (21%), Positives = 122/295 (41%), Gaps = 51/295 (17%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILR----MLS--RDPH 65
           +G+G +G+VY   +  TG+ +A+K+     D     P T +EV+ L     +L   +   
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS----PETKKEVNALECEIQLLKNLQHER 65

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +V+     +         L +  EYM    +K  ++++    E +     +    Q+ +G
Sbjct: 66  IVQYYGCLRDDET-----LSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEG 116

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR---AFTLPIKKYTHEILTLWYRA 181
           V + H + I+HRD+K  N+L D     +K+ D G ++                 T ++ +
Sbjct: 117 VEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+ G  +   A D+WSV C   E++T+    P  +E + +  IF++   P     P  
Sbjct: 176 PEVISGEGYGRKA-DVWSVGCTVVEMLTEK---PPWAEFEAMAAIFKIATQPTNPQLP-- 229

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                 ++  D  + L +    +  KR SA++ + H + 
Sbjct: 230 ---------------------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 2e-20
 Identities = 78/303 (25%), Positives = 123/303 (40%), Gaps = 46/303 (15%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E +E +G G    VY A      + VA+K+  L +    V     +EV  +   +  
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNH- 58

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT----DLKKYIRSFRQTGENIPVNTVKSLMY 119
           P+VV+           G   L+LV  Y+      D+ K         E I    +K ++ 
Sbjct: 59  PNVVKY----YTSFVVGD-ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL- 112

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEIL 175
              KG+ + H +G +HRD+K  N+L+     ++KIAD G++ +         K     + 
Sbjct: 113 ---KGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVG 168

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T  + APEV+     Y    D+WS      EL T  A                    P  
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA--------------------PYS 208

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPN--LDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           K +P +  LM      Q +P SL T        K    ++   LQ DPSKR +A++ ++H
Sbjct: 209 K-YPPMKVLML---TLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264

Query: 294 PYF 296
            +F
Sbjct: 265 KFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.3 bits (219), Expect = 2e-20
 Identities = 90/304 (29%), Positives = 129/304 (42%), Gaps = 50/304 (16%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G +G+V   + KATGK+ A K   K RL +         L E  IL  +S    +V 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVS-SRFIVS 57

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L         E +  L LV   M+  DLK +I +  + G        +++ Y  Q+  G+
Sbjct: 58  L-----AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA----RAIFYAAQIICGL 108

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
              H   I++RDLKP N+L+D     ++I+DLGLA       KK      T  Y APEVL
Sbjct: 109 EHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVL 166

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
            G   Y  +VD +++ C   E++   + F    E  +   + R                 
Sbjct: 167 QGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV---------- 215

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLD 300
              EYP                   DL E +LQ DP KR+     SA +  EHP F DL+
Sbjct: 216 ---EYPDKFSPEAK-----------DLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Query: 301 KTRL 304
             RL
Sbjct: 262 WRRL 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 4e-20
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 13/206 (6%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILR--MLSRD 63
           +++LE +G G YG VYR +   TG++VALK   L   D+ V     REV++L     S+ 
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-REVALLSQLRQSQP 61

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++ +      G   +G   L+++ EY +      +R+  + G  I    +  ++ ++  
Sbjct: 62  PNITKYY----GSYLKG-PRLWIIMEYAEGG---SVRTLMKAGP-IAEKYISVIIREVLV 112

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + + H  G++HRD+K  N+L+   T  +K+ D G+A        K +  + T ++ APE
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTN-TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT 209
           V+    +Y T  D+WS+     E+ T
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 87.6 bits (217), Expect = 5e-20
 Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 52/304 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D  E L+++G+G YG VY+   + TG  +A+K+ RL E DE      + E+ IL   +  
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHK-AVS 58

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V   D       EG   +Y+  EYMD      + +     E IP + ++ + Y + K
Sbjct: 59  PYIV---DFYGAFFIEG--AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVK 113

Query: 124 GVAFC-HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           G+ F    H I+HRD+KP N+L++     +K+ D G++      + K    I    Y AP
Sbjct: 114 GLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTN--IGCQSYMAP 170

Query: 183 EVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGD------SELQQLLHIFRLLG 231
           E +          Y+   D+WS+     E+      +P +      ++L  ++      G
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-----G 225

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
            P     P +                          D  D + + L   P++R +  + +
Sbjct: 226 DP-----PTLP--------------------SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Query: 292 EHPY 295
           EHP+
Sbjct: 261 EHPW 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 49/296 (16%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           E++ ++G G  G VY+   + TG++ ALK    + +D  V     RE+ ILR ++  P+V
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-VRRQICREIEILRDVNH-PNV 134

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT---VKSLMYQLCK 123
           V+  D+    N E    + ++ E+MD            + E   +     +  +  Q+  
Sbjct: 135 VKCHDMFD-HNGE----IQVLLEFMD----------GGSLEGTHIADEQFLADVARQILS 179

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+A+ H   I+HRD+KP NLL++     +KIAD G++R     +      + T+ Y +PE
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPE 238

Query: 184 VL---LGSTHYS-TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            +   L    Y   A D+WS+               G S L+  L  F   G   +  W 
Sbjct: 239 RINTDLNHGAYDGYAGDIWSL---------------GVSILEFYLGRFP-FGVGRQGDW- 281

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
             +SLM      Q  P++ ATA           +   LQ +P+KR SA + ++HP+
Sbjct: 282 --ASLMCAICMSQ-PPEAPATASREFR----HFISCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 6e-20
 Identities = 81/301 (26%), Positives = 137/301 (45%), Gaps = 50/301 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +E ++++G GTYG VY+AR+ ATG++VA+K  +L   D+       +E+S+L+   R 
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--FEIIQQEISMLKE-CRH 59

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           P++V        ++K     L++V EY       D+      ++ T   +    +  +  
Sbjct: 60  PNIVAYFGSYLRRDK-----LWIVMEYCGGGSLQDI------YQVTRGPLSELQIAYVCR 108

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           +  KG+A+ H  G +HRD+K  N+L+      +K+AD G++   T  I K    I T ++
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYW 167

Query: 180 RAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQL---LHIFRLLGTPN 234
            APEV        Y    D+W++     EL          +ELQ     LH  R L    
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIEL----------AELQPPMFDLHPMRAL---- 213

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                    L++   +P   P  L            D +++ L  DP KR +A K ++HP
Sbjct: 214 --------FLISKSNFP---PPKL-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Query: 295 Y 295
           +
Sbjct: 262 F 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.8 bits (215), Expect = 7e-20
 Identities = 62/249 (24%), Positives = 117/249 (46%), Gaps = 28/249 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATG-KIVALKKTRLH---------EDDEGVPPTTLREVS 55
           +  LE +G G +G VY+ R+K  G  ++ALK+  +H         E D+ +    + EV+
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVT 60

Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTV 114
           I++   R P++VR        ++     LY+V + ++   L ++  S ++  +      +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115

Query: 115 KSLMYQLCKGVAFCHGHG-ILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIKKY 170
            ++  Q+   + + H    I+HRDL P+N+++   D+ T+T    D GLA+    P  K 
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT----DFGLAKQKQ-PESKL 170

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           T  + T+ Y  PE+ + +  Y    D+W+  CI  ++ T    F   + L     I   +
Sbjct: 171 TSVVGTILYSCPEI-VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229

Query: 231 GTP-NEKVW 238
             P  E ++
Sbjct: 230 YEPLPEGMY 238

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 85.0 bits (210), Expect = 2e-19
 Identities = 77/287 (26%), Positives = 121/287 (42%), Gaps = 34/287 (11%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +++G+G++G VY  ++K       LK  +     E  P  T++     ++LS+  H    
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI- 64

Query: 70  MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
             VK   +   R    ++ EY    DL   +   + TG+ +  N V     QL  GV + 
Sbjct: 65  --VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H   ILHRDLK  N+ +  K   LKI D G++R         T    T +Y +PE  L  
Sbjct: 123 HQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA-LKH 179

Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
             Y +  D+WS+ CI  E+      F G + L  +L I          V     SL    
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI----------VEGPTPSL---- 225

Query: 249 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
             P+   + L +           +++ ML  DPS R SA + + +P+
Sbjct: 226 --PETYSRQLNS-----------IMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-19
 Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 42/303 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + ++G+G +GKVY+A+ K TG   A K  ++  ++E      + E+ IL    + 
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE--LEDFMVEIDILSEC-KH 61

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V L +    +NK     L+++ E+ D      I    + G   P   ++ +  Q+ +
Sbjct: 62  PNIVGLYEAYFYENK-----LWILIEFCDGGALDSIMLELERGLTEP--QIRYVCRQMLE 114

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + F H H ++HRDLK  N+L+      +K+AD G++      ++K    I T ++ APE
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173

Query: 184 VLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           V+   T     Y    D+WS+     EL       P   EL  +  + ++L +       
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQME---PPHHELNPMRVLLKILKSE------ 224

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNL-DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
                          P +L    P+       D L+  L  DP  R +A + ++HP+  D
Sbjct: 225 ---------------PPTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Query: 299 LDK 301
              
Sbjct: 268 QSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.1 bits (211), Expect = 4e-19
 Identities = 79/287 (27%), Positives = 122/287 (42%), Gaps = 41/287 (14%)

Query: 8   KLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
            ++++GEG +GKV   R       TG+ VA+K    H  +E       RE+ ILR L  +
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDHE 66

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            ++V+   V +     G   L L+ EY+ +  L+ Y++  R   + I +  +     Q+C
Sbjct: 67  -NIVKYKGVCEKP---GGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQIC 119

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLW 178
           KG+ +      +HRDL   N+L++     +KI+D GLA+        Y      E    W
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT----------KTALFPGDSELQ-QLLHIF 227
           Y APE L  S   S A D+WS      EL T          +     G ++ Q  +  + 
Sbjct: 179 Y-APECLRTSKFSS-ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 228 RLLGTPNEKVWP------GVSSLMN--WHEYPQWNPQSLATAVPNLD 266
            LL    E++         V  LM   W   PQ  P S A  +  +D
Sbjct: 237 ELL-KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP-SFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 84.3 bits (208), Expect = 4e-19
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 12/214 (5%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  VGEG++G+    +   + +  A+K+ RL +    V     R+ ++L    + P+
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSRKEAVLLAKMKHPN 59

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +V        ++ E    LY+V EY D  DL + I+   Q G+  P +T+     Q+C G
Sbjct: 60  IVAFK-----ESFEADGHLYIVMEYCDGGDLMQKIK--LQRGKLFPEDTILQWFVQMCLG 112

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V   H   +LHRD+K  N+ + +    +K+ D G AR  T P       + T +Y  PE+
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
              +  Y+   D+WS+ CI  EL T    F  +S
Sbjct: 172 -WENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 85.3 bits (211), Expect = 5e-19
 Identities = 86/310 (27%), Positives = 131/310 (42%), Gaps = 66/310 (21%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-----DDEGVPPTTLREVSILRML 60
           FE  E +G G++G+V  A+ K TG+  A+K  +  E       + V     +E SIL  L
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHV----AQEKSILMEL 75

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           S  P +V +M   Q +N+     +Y + E+ +  +L  ++R         P +  K    
Sbjct: 76  SH-PFIVNMMCSFQDENR-----VYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHA 125

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW- 178
           +L     + H   I++RDLKP NLL+D K   +K+ D G A       KK      TL  
Sbjct: 126 ELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFA-------KKVPDRTFTLCG 177

Query: 179 ---YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
              Y APEV+    H   AVD W++  +  E +     F  D+        FR+     E
Sbjct: 178 TPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIY----E 225

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK-----A 290
           K+  G        ++P W            D    DL++ +LQ D +KR+   K      
Sbjct: 226 KILAGRL------KFPNW-----------FDGRARDLVKGLLQTDHTKRLGTLKGGVADV 268

Query: 291 MEHPYFDDLD 300
             HPYF   +
Sbjct: 269 KNHPYFHGAN 278

Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.7 bits (207), Expect = 7e-19
 Identities = 60/224 (26%), Positives = 110/224 (49%), Gaps = 11/224 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + K++K+GEG++GK    + K  GK   +K+  + +        + +EV++L  + + P+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +V+       ++ E    LY+V +Y +  DL K I +  Q G   P + +     Q+C  
Sbjct: 61  IVQYQ-----ESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLA 113

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +   H   ILHRD+K  N+ +  K  T+K+ D G+AR     ++     I T +Y +PE+
Sbjct: 114 LKHVHDRKILHRDIKSQNIFL-TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
              +  Y+   D+W++ C+  E+ T    F   +    +L I R
Sbjct: 173 -CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 1e-18
 Identities = 75/314 (23%), Positives = 137/314 (43%), Gaps = 70/314 (22%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-----DDEGVPPTTLREVSILR 58
           D  E+++ VG GT+G+V+  R++ +    ALK   + E      ++ V      E  +L+
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH----NEKRVLK 56

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSL 117
            +S  P ++RL   +  Q       LY++ EY+   +L  Y+R+  +       +    L
Sbjct: 57  EVSH-PFIIRLFWTEHDQRF-----LYMLMEYVPGGELFSYLRNSGR------FSNSTGL 104

Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   I++RDLKP N+L+D++   +K+ D G A       KK      
Sbjct: 105 FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFGFA-------KKLRDRTW 156

Query: 176 TLW----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           TL     Y APEV + S  ++ AVD W++  +  E++     F  D        I+    
Sbjct: 157 TLCGTPEYLAPEV-IQSKGHNKAVDWWALGILIYEMLVGYPPFFDD----NPFGIY---- 207

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK-- 289
              EK+   ++  + +       P+ L            DL++++L  D ++R+   K  
Sbjct: 208 ---EKI---LAGKLEF-------PRHLDLYAK-------DLIKKLLVVDRTRRLGNMKNG 247

Query: 290 ---AMEHPYFDDLD 300
                 H +F  +D
Sbjct: 248 ADDVKNHRWFKSVD 261

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 83.6 bits (207), Expect = 1e-18
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 66/313 (21%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +   +L ++GEG  G V + R K TG I ALK      + + +    LRE+ I +     
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILRELEINKSCK-S 58

Query: 64  PHVVR----LMDVKQGQNKEGRTVLYLVFEYM-----DTDLKKYIRSFRQTGENIPVNTV 114
           P++V+     +D            + +  EY      D+  KK  +   + GE +     
Sbjct: 59  PYIVKYYGAFLDESSSS-------IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIA 111

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG--------LARAFTLP 166
           +S++    KG+++ H   I+HRD+KP N+L+ RK   +K+ D G        LA  FT  
Sbjct: 112 ESVL----KGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSLAGTFT-- 164

Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ----Q 222
                    T +Y APE + G   YS   D+WS+     E+      FP + E      +
Sbjct: 165 --------GTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE 215

Query: 223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
           LL     +  P  K  PG    + W E  +                  D ++Q L+ DP+
Sbjct: 216 LLSYIVNMPNPELKDEPGNG--IKWSEEFK------------------DFIKQCLEKDPT 255

Query: 283 KRISAKKAMEHPY 295
           +R +    +EHP+
Sbjct: 256 RRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 47/295 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            +   K+GEG+ G V  A +K+TG+ VA+KK  L +           EV I+R     P+
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQH-PN 77

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V +       ++     L++V E+++    TD+   +   R   E I      ++   +
Sbjct: 78  IVEMYSSYLVGDE-----LWVVMEFLEGGALTDI---VTHTRMNEEQI-----ATVCLAV 124

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            K ++F H  G++HRD+K  ++L+      +K++D G     +  + +    + T ++ A
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV +    Y T VD+WS+  +  E+V     +  +  LQ +  I R    P  K    V
Sbjct: 184 PEV-ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLKNLHKV 241

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           S  +                           L++ML  DP++R +A + + HP+ 
Sbjct: 242 SPRL------------------------RSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 24/232 (10%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F    K+G G +G+V+    K   + VA+K   L  DD        +EV  L+ L R  H
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVR-VAIKI--LKSDDLLKQQDFQKEVQALKRL-RHKH 63

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++ L  V       G  V Y++ E M+   L  ++RS    G+ +PV ++  +  Q+ +G
Sbjct: 64  LISLFAV----CSVGEPV-YIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEG 116

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRA 181
           +A+      +HRDL   N+L+       K+AD GLAR     +  Y     +I   W  A
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDV--YLSSDKKIPYKW-TA 172

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRL 229
           PE       +ST  D+WS   +  E+ T   + +PG +      Q+   +R+
Sbjct: 173 PEA-ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM 223

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 81/308 (26%), Positives = 136/308 (44%), Gaps = 57/308 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLS- 61
           F  L  +G G +GKV  A  K TG+   I ALKK  +   DE    + + E  I    + 
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58

Query: 62  -RDPHVVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
            R P +V L    Q ++      +  V EY    DL  +I +   +         +++ Y
Sbjct: 59  ERHPFLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDVFS-------EPRAVFY 106

Query: 120 QLCK--GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
             C   G+ + H + I++RDLK  NLL+D +   +KIAD GL +       + +    T 
Sbjct: 107 AACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTP 165

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            + APEVL   T Y+ AVD W +  +  E++   + FPGD E +    I       N++V
Sbjct: 166 EFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV------NDEV 218

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAME 292
                       YP+            L ++ + ++ ++L+ +P +R+      A+   +
Sbjct: 219 -----------RYPR-----------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256

Query: 293 HPYFDDLD 300
            P+F D++
Sbjct: 257 QPFFRDIN 264

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 82.9 bits (204), Expect = 1e-17
 Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 32/248 (12%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ +E ++K+G G +G+V+  + K T +    K        E      + EV+++R L +
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-K 70

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             ++VR +D  +  NK  +  LY++ E+ D  DL + I+   +    I  + +  +  QL
Sbjct: 71  HKNIVRYID--RFLNKANQK-LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 122 CKGVAFCH-------GHGILHRDLKPHNLLMDRKTMTL----------------KIADLG 158
              +A+CH       G  +LHRDLKP N+ +      +                KI D G
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 159 LARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPG 216
           L++   + I+   H  + T +Y +PE+LL  T  Y    DMW++ CI  EL +    F  
Sbjct: 188 LSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 217 DSELQQLL 224
            +   QL+
Sbjct: 246 ANNFSQLI 253

Length = 1021

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 68/237 (28%), Positives = 117/237 (49%), Gaps = 26/237 (10%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSR 62
           D +E +E +G+GTYGKV++   K  G   A+K    +H+ DE +      E +IL+ LS 
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA----EYNILKALSD 73

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLM 118
            P+VV+   +   ++ +    L+LV E  +    TDL   ++ F + GE +    +  ++
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL---VKGFLKRGERMEEPIIAYIL 130

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           ++   G+   H +  +HRD+K +N+L+  +   +K+ D G++   T    +    + T +
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 179 YRAPEVL-----LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           + APEV+     L ST Y    D+WS+       +T   L  GD  L   LH  R L
Sbjct: 190 WMAPEVIACEQQLDST-YDARCDVWSLG------ITAIELGDGDPPLAD-LHPMRAL 238

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 79.8 bits (196), Expect = 3e-17
 Identities = 70/295 (23%), Positives = 137/295 (46%), Gaps = 47/295 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+K+  L +  +      + E+ ++R  +++P+
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRE-NKNPN 77

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+         T   +    + ++  + 
Sbjct: 78  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV--------VTETCMDEGQIAAVCREC 124

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 125 LQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E+V     +  ++ L+  L++    GTP  +     
Sbjct: 184 PEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQ----- 236

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L+ D  +R SAK+ ++HP+ 
Sbjct: 237 ------------NPERLSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 78.9 bits (194), Expect = 4e-17
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 37/288 (12%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +  VG+G+YG+V   R +  GK   +KK  L            +E  +L  L + P++V 
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVA 63

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
             +  +G++     +LY+V  + +  DL  Y +   Q G+ +P N V     Q+   + +
Sbjct: 64  YRESWEGED----GLLYIVMGFCEGGDL--YHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
            H   ILHRDLK  N+ + R T  +K+ DLG+AR         +  I T +Y +PE L  
Sbjct: 118 LHEKHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFS 175

Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
           +  Y+   D+W++ C   E+ T    F    ++  L  ++R++    E   P +      
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSL--VYRII----EGKLPPMPK---- 224

Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                           +   +  +L+  ML   P KR S K  +  PY
Sbjct: 225 ----------------DYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 79.4 bits (196), Expect = 5e-17
 Identities = 88/329 (26%), Positives = 135/329 (41%), Gaps = 77/329 (23%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR--------EVSIL 57
           FE ++ +  G YG VY  R K T +  A+KK              LR        E  IL
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-------LILRNQIQQVFVERDIL 55

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNT 113
              + +P VV +       + E +  L +V EY++      L K I +       +PV+ 
Sbjct: 56  TF-AENPFVVSMF-----CSFETKRHLCMVMEYVEGGDCATLLKNIGA-------LPVDM 102

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP------- 166
            +    +    + + H +GI+HRDLKP NLL+      +K+ D GL++   +        
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYE 161

Query: 167 --IKKYTHEIL------TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             I+K T E L      T  Y APEV+L    Y   VD W++  I  E +     F GD 
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGD- 219

Query: 219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 278
                        TP E     +S  + W E  +        A+P    D  DL+ ++L+
Sbjct: 220 -------------TPEELFGQVISDDIEWPEGDE--------ALPA---DAQDLISRLLR 255

Query: 279 YDPSKRI---SAKKAMEHPYFDDLDKTRL 304
            +P +R+    A +  +H +F  LD   L
Sbjct: 256 QNPLERLGTGGAFEVKQHRFFLGLDWNGL 284

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 79/305 (25%), Positives = 141/305 (46%), Gaps = 55/305 (18%)

Query: 12  VGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV  AR K +G++ A   LKK  + +DD+     T+ E  IL +    P + +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD--VECTMTEKRILSLARNHPFLTQ 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q  ++     L+ V E+++  DL  +I+  R+  E       ++  Y  ++   +
Sbjct: 61  LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEITSAL 109

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            F H  GI++RDLK  N+L+D +    K+AD G+ +      K  +    T  Y APE+ 
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI- 167

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           L    Y  +VD W++  +  E++   A F  ++E      I       N++V        
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------NDEV-------- 213

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDL 299
               YP W           L +D +D+L+  +  +P+ R+ +      +  + HP+F +L
Sbjct: 214 ---VYPTW-----------LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259

Query: 300 DKTRL 304
           D  +L
Sbjct: 260 DWEKL 264

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 79/318 (24%), Positives = 135/318 (42%), Gaps = 52/318 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  ++ +  G+ G+V+ A +      V LK         G   TTL E  +L+ ++  P 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNH-PS 118

Query: 66  VVRLMDVKQGQNKEGRTVLY-----LVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLM 118
           V+R+ D          T++      +V  +  +DL  Y+  RS       +P++    + 
Sbjct: 119 VIRMKD----------TLVSGAITCMVLPHYSSDLYTYLTKRSRP-----LPIDQALIIE 163

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            Q+ +G+ + H   I+HRD+K  N+ ++     + I DLG A+ F +    +     T+ 
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQ-FPVVAPAFLGLAGTVE 221

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPGDSELQ--------QLLHIFR 228
             APEV L    Y++  D+WS   +  E++    T      S  +         LL I  
Sbjct: 222 TNAPEV-LARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280

Query: 229 LLGTPNEKV--WPGVSSLMNWHEYPQWNPQSLATAVP-----NLDKDGLDLLEQMLQYDP 281
            L    E+    PG   +  + EY     Q   T  P     NL  DG  L+ +ML +D 
Sbjct: 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPY-TRYPCFQRVNLPIDGEFLVHKMLTFDA 339

Query: 282 SKRISAKKAMEHPYFDDL 299
           + R SA++ + +P F  L
Sbjct: 340 AMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 86/312 (27%), Positives = 140/312 (44%), Gaps = 56/312 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKA---TGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           FE L+ +G G YGKV+  R+     TGK+ A   L+K  L +  + V  T   E ++L  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-TERNVLEH 60

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVNTV 114
           + + P +V L    Q + K     L+L+ +Y     M T L  Y R      +N   + V
Sbjct: 61  VRQSPFLVTLHYAFQTEAK-----LHLILDYVSGGEMFTHL--YQR------DNFSEDEV 107

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           +    ++   +   H  GI++RD+K  N+L+D +   + + D GL++ F    K+ T+  
Sbjct: 108 RFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSF 166

Query: 175 L-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T+ Y APE++ G   +  AVD WS+  +  EL+T  + F  + E      + R +   
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--- 223

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAK 288
             K  P   S                     +  +  DLL ++L+ DP KR+      A 
Sbjct: 224 -LKCDPPFPSF--------------------IGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262

Query: 289 KAMEHPYFDDLD 300
           +  EHP+F  LD
Sbjct: 263 EIKEHPFFKGLD 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 27/225 (12%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKI-----VALKKTRLHEDDEGVPPTT-LREV 54
           +  +    + ++G+G++G VY    K   K      VA+K   ++E+         L E 
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT--VNENASMRERIEFLNEA 60

Query: 55  SILRMLSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN 112
           S+++  +   HVVRL+ V   GQ         +V E M   DLK Y+RS R   EN P  
Sbjct: 61  SVMKEFN-CHHVVRLLGVVSTGQPT------LVVMELMAKGDLKSYLRSRRPEAENNPGL 113

Query: 113 TVKSL--MY----QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--T 164
              +L        ++  G+A+      +HRDL   N ++    +T+KI D G+ R    T
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVKIGDFGMTRDIYET 172

Query: 165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              +K    +L + + APE L     ++T  D+WS   +  E+ T
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 77.6 bits (191), Expect = 2e-16
 Identities = 80/309 (25%), Positives = 137/309 (44%), Gaps = 62/309 (20%)

Query: 12  VGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV  A  K T ++ A   LKK  + +DD+     T+ E  IL + ++ P +  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD--VDCTMTEKRILALAAKHPFLTA 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q +++     L+ V EY++  DL   I+  R+  E       +S  Y  ++   +
Sbjct: 61  LHCCFQTKDR-----LFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAAEVTLAL 109

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            F H HG+++RDLK  N+L+D +    K+AD G+ +   L     T    T  Y APE+ 
Sbjct: 110 MFLHRHGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI- 167

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFRLLGTPNEKVWPGVS 242
           L    Y  +VD W++  +  E++     F  D+E    + +LH   L             
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL------------- 214

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-------KKAMEHPY 295
                  YP W           L K+ + +L+  +  +P+KR+             +HP+
Sbjct: 215 -------YPVW-----------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256

Query: 296 FDDLDKTRL 304
           F ++D   L
Sbjct: 257 FKEIDWVLL 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.4 bits (190), Expect = 2e-16
 Identities = 70/309 (22%), Positives = 133/309 (43%), Gaps = 50/309 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +E + ++G+G +GKVY+A+ K TG + A K      ++E      + E+ IL   +  
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNH- 68

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVNTVKSLM 118
           P++V+L+       K     L+++ E+     +D  + +  R   +         ++ + 
Sbjct: 69  PYIVKLLGAFYWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVIC 116

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            Q+ + + + H   I+HRDLK  N+L+      +K+AD G++      +++    I T +
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 179 YRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
           + APEV++  T     Y    D+WS+     E+     + P   EL  +    R+L    
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPM----RVLLKIA 228

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +   P +S    W    ++                 D L+  L   P  R SA + +EHP
Sbjct: 229 KSEPPTLSQPSKWS--MEFR----------------DFLKTALDKHPETRPSAAQLLEHP 270

Query: 295 YFDDLDKTR 303
           +   +   R
Sbjct: 271 FVSSVTSNR 279

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 77.0 bits (189), Expect = 3e-16
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 44/294 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + F KLEK+G+G++G+V++  +  T K+VA+K   L E ++ +     +E+++L      
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCD-S 61

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN--TVKSLMYQL 121
           P+V +         K     L+++ EY+         S     E  P++   + +++ ++
Sbjct: 62  PYVTKYYGSYLKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREI 110

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            KG+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    + T ++ A
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+  S  Y +  D+WS+     EL       P  SEL  +  +F +            
Sbjct: 170 PEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSELHPMKVLFLI------------ 213

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                    P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H +
Sbjct: 214 ---------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 77.2 bits (190), Expect = 4e-16
 Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 63/315 (20%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
             F+    VG G +G+V   REKATG I A+K  +          +   E   +  +S  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTVKSLM 118
           P + +L    Q ++      LYLV EY       + L +Y   F +       +  +  +
Sbjct: 61  PWIPQLQYAFQDKDN-----LYLVMEYQPGGDLLSLLNRYEDQFDE-------DMAQFYL 108

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--------LPIKKY 170
            +L   +   H  G +HRD+KP N+L+DR T  +K+AD G A   T        LP+   
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDR-TGHIKLADFGSAARLTANKMVNSKLPVG-- 165

Query: 171 THEILTLWYRAPEVLL-----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
                T  Y APEVL      G   Y    D WS+  I  E++   + F   +  +    
Sbjct: 166 -----TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-- 218

Query: 226 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI 285
                           +++MN+  + ++         P +  D LDL++ +L     +R+
Sbjct: 219 ----------------NNIMNFQRFLKF------PEDPKVSSDFLDLIQSLLC-GQKERL 255

Query: 286 SAKKAMEHPYFDDLD 300
             +    HP+F  +D
Sbjct: 256 GYEGLCCHPFFSKID 270

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.7 bits (188), Expect = 4e-16
 Identities = 70/295 (23%), Positives = 137/295 (46%), Gaps = 47/295 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G V+ A + ATG+ VA+K+  L +  +      + E+ +++ L ++P+
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KELIINEILVMKEL-KNPN 77

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+         T   +    + ++  + 
Sbjct: 78  IVNFLDSFLVGDE-----LFVVMEYLAGGSLTDV--------VTETCMDEAQIAAVCREC 124

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 125 LQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E+V     +  ++ L+  L++    GTP  +     
Sbjct: 184 PEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQ----- 236

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L+ D  KR SAK+ ++HP+ 
Sbjct: 237 ------------NPEKLSPIFR-------DFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.7 bits (188), Expect = 5e-16
 Identities = 68/295 (23%), Positives = 135/295 (45%), Gaps = 47/295 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R  +++P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRE-NKNPN 78

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+         T   +    + ++  + 
Sbjct: 79  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV--------VTETCMDEGQIAAVCREC 125

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP  +     
Sbjct: 185 PEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ----- 237

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L  D  KR SAK+ ++H + 
Sbjct: 238 ------------NPEKLSAIFR-------DFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 41/292 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            E   K+GEG+ G V  AREK +G+ VA+K   L +           EV I+R       
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNV 80

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           V        G+       L+++ E++    L   +   R   E I     +S++  LC  
Sbjct: 81  VEMYKSYLVGEE------LWVLMEFLQGGALTDIVSQTRLNEEQI-ATVCESVLQALC-- 131

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
             + H  G++HRD+K  ++L+      +K++D G     +  + K    + T ++ APEV
Sbjct: 132 --YLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 188

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +   T Y T VD+WS+  +  E+V     +  DS +Q +    RL  +P  K       L
Sbjct: 189 I-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPPPK-------L 237

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            N H+             P L     D LE+ML  +P +R +A++ ++HP+ 
Sbjct: 238 KNAHK-----------ISPVLR----DFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.5 bits (188), Expect = 5e-16
 Identities = 72/292 (24%), Positives = 132/292 (45%), Gaps = 41/292 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML-SRDP 64
           + + EK+G+G  G VY A + ATG+ VA+K+  L +     P   L    IL M  ++ P
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKHP 76

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++V  +D     ++     L++V EY+       + +     E      + ++  +  + 
Sbjct: 77  NIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRECLQA 127

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ APEV
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +     Y   VD+WS+  +  E+V     +  ++ L+  L++    GTP  +        
Sbjct: 187 VT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQ-------- 236

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                    NP+ L+           D L + L+ D  KR SAK+ ++HP+ 
Sbjct: 237 ---------NPEKLSAIFR-------DFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 76.1 bits (187), Expect = 6e-16
 Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 47/299 (15%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +G+G++GKV + R++ T +I ALK  R  H         TL E ++L  ++  P +V L 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGVAFC 128
              Q   K     LYLV  +++         F         +  ++  Y  +L   +   
Sbjct: 60  FSFQSPEK-----LYLVLAFINGG-----ELFHHLQREGRFDLSRARFYTAELLCALENL 109

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H   +++RDLKP N+L+D     + + D GL +       K      T  Y APE+LLG 
Sbjct: 110 HKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168

Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
             Y+ AVD W++  +  E++T    F  D  + ++    ++L  P    +P         
Sbjct: 169 G-YTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYR--KILQEP--LRFPD-------- 214

Query: 249 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLDKTRL 304
                            D+D  DLL  +L  DP++R+    A E   HP+F  L   +L
Sbjct: 215 ---------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKL 258

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (188), Expect = 7e-16
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 47/298 (15%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+GT+G+VY+ R+K T +I A+K   K  +    E       R + +  +L   P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L    Q       + LYLV +YM   +L  ++    Q       +  K  + +L   +  
Sbjct: 61  LKFSFQTD-----SDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAELVLALEH 111

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLL 186
            H + I++RDLKP N+L+D  T  + + D GL++A  L   K T+    T  Y APEVLL
Sbjct: 112 LHKYDIVYRDLKPENILLD-ATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
               Y+  VD WS+  +  E+    + F  + + QQ+   +R +     +    V S   
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQM---YRNIAFGKVRFPKNVLSD-- 223

Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM----EHPYFDDLD 300
                                +G   ++ +L  +P  R+ A +      EHP+F D+D
Sbjct: 224 ---------------------EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 17/236 (7%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSR 62
           D +E +E +G+GTYGKVY+   K  G + A+K      D DE +      E +IL+ L  
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA----EYNILQSLPN 77

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P+VV+   +    +K     L+LV E  +   + + ++     G+ +    +  ++Y  
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
             G+   H + I+HRD+K +N+L+  +   +K+ D G++   T    +    + T ++ A
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196

Query: 182 PEVLLGSTHYSTA----VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           PEV+     Y  +     D+WS+       +T   L  GD  L  +  +  L   P
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLG------ITAIELGDGDPPLFDMHPVKTLFKIP 246

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 78/312 (25%), Positives = 129/312 (41%), Gaps = 54/312 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSR 62
           F     +G+G +G+V   + +ATGK+ A K   K R+ +         L E  IL  ++ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVN- 58

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY-- 119
              VV L         E +  L LV   M+  DLK +I +    G     +  +++ Y  
Sbjct: 59  SRFVVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAA 109

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--LPIKKYTHEILTL 177
           ++  G+   H   I++RDLKP N+L+D     ++I+DLGLA        I+     + T+
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRG---RVGTV 165

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEV + +  Y+ + D W + C+  E++       G S  +Q            EKV
Sbjct: 166 GYMAPEV-VKNERYTFSPDWWGLGCLIYEMIE------GKSPFRQR----------KEKV 208

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAME 292
                      E  +   +          +    +  Q+L  DP  R+      A++   
Sbjct: 209 --------KREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260

Query: 293 HPYFDDLDKTRL 304
           HP+F   +  RL
Sbjct: 261 HPFFRTANFKRL 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.8 bits (178), Expect = 7e-15
 Identities = 71/296 (23%), Positives = 138/296 (46%), Gaps = 52/296 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KLE++G+G++G+V++  +  T ++VA+K   L E ++ +     +E+++L      P+
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCD-SPY 63

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKY--IRSFRQTGENIPVNTVKSLMY 119
           V +      G   +G T L+++ EY+      DL +      F+          + +++ 
Sbjct: 64  VTKYY----GSYLKG-TKLWIIMEYLGGGSALDLLRAGPFDEFQ----------IATMLK 108

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++ KG+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    + T ++
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV+  S  Y +  D+WS+     EL       P +S++  +  +F +          
Sbjct: 168 MAPEVIQQSA-YDSKADIWSLGITAIELAKGE---PPNSDMHPMRVLFLI---------- 213

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                      P+ NP +L        K   + ++  L  DPS R +AK+ ++H +
Sbjct: 214 -----------PKNNPPTL---TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.8 bits (178), Expect = 7e-15
 Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 28/239 (11%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSIL----RMLSRDPHVV 67
           +G+G +G+VY   +  TG+ +A+K+ +   +     P T +EV+ L    ++L    H  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPES----PETSKEVNALECEIQLLKNLLHE- 64

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++             L +  E+M    +K  ++S+    EN+     +    Q+ +GV+
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------LPIKKYTHEILTLWYR 180
           + H + I+HRD+K  N+L D     +K+ D G ++           +K  T    T ++ 
Sbjct: 121 YLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTG---TPYWM 176

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           +PEV+ G   Y    D+WSV C   E++T+    P  +E + +  IF++   P   V P
Sbjct: 177 SPEVISGEG-YGRKADIWSVGCTVVEMLTEK---PPWAEFEAMAAIFKIATQPTNPVLP 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.9 bits (179), Expect = 7e-15
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 29/214 (13%)

Query: 9   LEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           ++++G+G +G V    Y   +  TG++VA+KK  L            RE+ IL+ L  D 
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK--LQHSTAEHLRDFEREIEILKSLQHD- 65

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L LV EY+    L+ Y++  R+      ++  K L+Y  Q+
Sbjct: 66  NIVKYKGVCYSA---GRRNLRLVMEYLPYGSLRDYLQKHRER-----LDHRKLLLYASQI 117

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YT----HEIL 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K  Y      E  
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTK--VLPQDKEYYKVREPGESP 174

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 175 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.3 bits (180), Expect = 8e-15
 Identities = 80/310 (25%), Positives = 138/310 (44%), Gaps = 54/310 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           F  L  +G+G++GKV  A  K T ++ A   LKK  + +DD+     T+ E  +L +  +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD--VECTMVEKRVLALPGK 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY-- 119
            P + +L    Q  ++     LY V EY++  DL  +I+   +  E   V       Y  
Sbjct: 60  PPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGKFKEPHAV------FYAA 108

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++  G+ F H  GI++RDLK  N+++D +   +KIAD G+ +      K       T  Y
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDY 167

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APE++     Y  +VD W+   +  E++     F G+ E  +L                
Sbjct: 168 IAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELF--------------- 210

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHP 294
              S+M   E+    P+SL+       K+ + + + +L   P+KR+       +   EH 
Sbjct: 211 --QSIM---EHNVSYPKSLS-------KEAVSICKGLLTKHPAKRLGCGPTGERDIREHA 258

Query: 295 YFDDLDKTRL 304
           +F  +D  +L
Sbjct: 259 FFRRIDWEKL 268

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.7 bits (178), Expect = 9e-15
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 18/211 (8%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE +E VG GTYG+VY+ R   TG++ A+K   + ED+E        E+++L+  S   +
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSHHRN 74

Query: 66  VVRLMDVKQGQNKEGR-TVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +         ++  G    L+LV E+      TDL K  +     G  +  + +  +  +
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-----GNALKEDWIAYICRE 129

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+A  H H ++HRD+K  N+L+  +   +K+ D G++      + +    I T ++ 
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 181 APEVLLGSTH----YSTAVDMWSVACIFAEL 207
           APEV+    +    Y    D+WS+     E+
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 76/312 (24%), Positives = 136/312 (43%), Gaps = 55/312 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKA---TGKIVALKKTRLHEDDEGVPPT--TLREVSILRML 60
           FE L+ +G G YGKV+  R+ +   +GK+ A+K  +     +    T  T  E  +L  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTVK 115
            + P +V L    Q   K     L+L+ +Y++     T L +  R F++         V+
Sbjct: 62  RQSPFLVTLHYAFQTDTK-----LHLILDYINGGELFTHLSQRER-FKE-------QEVQ 108

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               ++   +   H  GI++RD+K  N+L+D     + + D GL++ F     +  +   
Sbjct: 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFC 167

Query: 176 -TLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
            T+ Y AP+++ G    +  AVD WS+  +  EL+T  + F  D E      I R +   
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--- 224

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAK 288
                     L +   YPQ            +     D+++++L  DP KR+      A 
Sbjct: 225 ----------LKSEPPYPQ-----------EMSALAKDIIQRLLMKDPKKRLGCGPSDAD 263

Query: 289 KAMEHPYFDDLD 300
           +  +HP+F  ++
Sbjct: 264 EIKKHPFFQKIN 275

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 75/296 (25%), Positives = 134/296 (45%), Gaps = 32/296 (10%)

Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            +++  +GEG +GKV    Y      TG+ VA+K  +  E          +E+ ILR L 
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLY 64

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            +     ++  K    ++G   + L+ E++ +  LK+Y+    +    I +        Q
Sbjct: 65  HE----NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQ 117

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILT 176
           +CKG+ +      +HRDL   N+L++ +   +KI D GL +A     + YT     +   
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            WY APE L+ S  Y  A D+WS      EL+T       DSE   +    +++G  + +
Sbjct: 177 FWY-APECLIQSKFY-IASDVWSFGVTLYELLTYC-----DSESSPMTLFLKMIGPTHGQ 229

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
           +   V+ L+   E  +  P+      PN  ++   L+ +  ++ PSKR + +  +E
Sbjct: 230 M--TVTRLVRVLEEGKRLPRP-----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 47/290 (16%)

Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A EK TGK VA+KK  L +           EV I+R    +  V    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYN 86

Query: 71  DVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
               G        L++V E+++    TD+  + R   +    + ++ +++L Y       
Sbjct: 87  SYLVGDE------LWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSY------- 133

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
             H  G++HRD+K  ++L+      +K++D G     +  + K    + T ++ APEV +
Sbjct: 134 -LHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV-I 190

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
               Y T VD+WS+  +  E++     +  +  LQ +  I   L  P  K    VSS++ 
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLR 249

Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                     L+ ML  +PS+R +A++ ++HP+ 
Sbjct: 250 ------------------------GFLDLMLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 71.3 bits (174), Expect = 2e-14
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE +E VG GTYG+VY+ R   TG++ A+K   +  D+E       +E+++L+  S   +
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64

Query: 66  VVRLMDVKQGQNKEGR-TVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +         +N  G    L+LV E+      TDL K  +     G  +    +  +  +
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICRE 119

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G++  H H ++HRD+K  N+L+  +   +K+ D G++      + +    I T ++ 
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 181 APEVLLGSTH----YSTAVDMWSVACIFAEL 207
           APEV+    +    Y    D+WS+     E+
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 27/243 (11%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR---EVSILRMLSRDPHVVR 68
           +G G +G+VY   +  TG+ +A+K+     D +           E+ +L+ L  D  V  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 69  LMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
              ++  + K+    L +  EYM    +K  ++++    EN+     +    Q+ +GV++
Sbjct: 70  YGCLRDPEEKK----LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------LPIKKYTHEILTLWYRA 181
            H + I+HRD+K  N+L D     +K+ D G ++           IK  T    T ++ +
Sbjct: 122 LHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTG---TPYWMS 177

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP-G 240
           PEV+ G   Y    D+WSVAC   E++T+    P  +E + +  IF++   P + + P G
Sbjct: 178 PEVISGEG-YGRKADVWSVACTVVEMLTEK---PPWAEYEAMAAIFKIATQPTKPMLPDG 233

Query: 241 VSS 243
           VS 
Sbjct: 234 VSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 22/214 (10%)

Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            +K+  +GEG +GKV    Y      TG++VA+K  +  E  +       +E++IL+ L 
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLY 64

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + ++V+    K   +++G   L L+ EY+    L+ Y+         + +  +     Q
Sbjct: 65  HE-NIVKY---KGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQ 115

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILT 176
           +C+G+A+ H    +HRDL   N+L+D   + +KI D GLA+A     + Y      +   
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
            WY A E  L    +S A D+WS      EL+T 
Sbjct: 175 FWY-AVEC-LKENKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.7 bits (173), Expect = 4e-14
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKK---TRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G +G+V   + K TGK+ A KK    RL +  +      L E  IL  ++  P +V 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVN-SPFIVN 57

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L         E +T L LV   M+  DLK +I +  + G  + +  V     Q+  G+  
Sbjct: 58  L-----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILH 110

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI-KKYTHEILTLWYRAPEVLL 186
            H   I++RD+KP N+L+D +    +++DLGL  A  L   K  T    T  Y APE+L 
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQG-NCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEILK 167

Query: 187 GSTHYSTAVDMWSVACIFAELV 208
               YS  VD +++ C   E+V
Sbjct: 168 EEP-YSYPVDWFAMGCSIYEMV 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.1 bits (171), Expect = 6e-14
 Identities = 72/294 (24%), Positives = 135/294 (45%), Gaps = 48/294 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KLE++G+G++G+VY+  +  T ++VA+K   L E ++ +     +E+++L      P+
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCD-SPY 63

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           + R      G   +G T L+++ EY+      DL K           +    + +++ ++
Sbjct: 64  ITRYY----GSYLKG-TKLWIIMEYLGGGSALDLLK--------PGPLEETYIATILREI 110

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            KG+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    + T ++ A
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+  S  Y    D+WS+     EL       P +S+L  +  +F +            
Sbjct: 170 PEVIKQSA-YDFKADIWSLGITAIELAKGE---PPNSDLHPMRVLFLI------------ 213

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                    P+ +P +L        K   + +E  L  DP  R +AK+ ++H +
Sbjct: 214 ---------PKNSPPTLEG---QYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.0 bits (171), Expect = 8e-14
 Identities = 79/306 (25%), Positives = 131/306 (42%), Gaps = 62/306 (20%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRD--PHV 66
           +G G +G+VY  R+  TGK+ A+K   K R+    +      L E  +L ++S    P +
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFI 59

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V +       +K     L  + + M+  DL  ++       E      ++    ++  G+
Sbjct: 60  VCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEA----EMRFYAAEIILGL 110

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAPEV 184
              H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  + T  Y APEV
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFS---KKKPHASVGTHGYMAPEV 166

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL-----LHIFRLLGTPNEKVWP 239
           L     Y ++ D +S+ C+  +L+       G S  +Q        I R+  T   +  P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQHKTKDKHEIDRMTLTMAVE-LP 219

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHP 294
              S                        +   LLE +LQ D ++R+      A++  EHP
Sbjct: 220 DSFS-----------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256

Query: 295 YFDDLD 300
           +F  LD
Sbjct: 257 FFRSLD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 27/229 (11%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           + L ++G G +G V +   K +G I+A+K+ R    DE      L ++ ++   S  P++
Sbjct: 7   KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRS-TVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKK-YIRSFRQTGENIP--------VNTVKSL 117
           V+         +EG    ++  E MD  L K Y   +      IP        V TVK+L
Sbjct: 66  VKFYGA---LFREG--DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
            Y             I+HRD+KP N+L+DR    +K+ D G++      I K T +    
Sbjct: 121 NY-------LKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVDSIAK-TRDAGCR 171

Query: 178 WYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPG-DSELQQL 223
            Y APE +  S    Y    D+WS+     E+ T    +P  +S   QL
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 70.2 bits (172), Expect = 9e-14
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 69/306 (22%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKK--------TRLHEDDEGVPPTTLREVSIL 57
           F  L ++G G++G VY AR+  T ++VA+KK            +D        ++EV  L
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-------IIKEVRFL 69

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM---DTDLKKYIRSFRQTGENIPVNTV 114
           + L R P+ +   + K    +E     +LV EY     +D+ +  +   Q  E      +
Sbjct: 70  QQL-RHPNTI---EYKGCYLRE--HTAWLVMEYCLGSASDILEVHKKPLQEVE------I 117

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
            ++ +   +G+A+ H H  +HRD+K  N+L+     T+K+AD G A +   P   +   +
Sbjct: 118 AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSA-SLVSPANSF---V 172

Query: 175 LTLWYRAPEVLLG--STHYSTAVDMWS--VACI-FAELVTKTALFPGDSELQQLLHIFRL 229
            T ++ APEV+L      Y   VD+WS  + CI  AE   K  LF  ++ +  L HI + 
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE--RKPPLFNMNA-MSALYHIAQ- 228

Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
               N+   P +SS  +W +Y                    + ++  LQ  P  R S+++
Sbjct: 229 ----NDS--PTLSS-NDWSDY------------------FRNFVDSCLQKIPQDRPSSEE 263

Query: 290 AMEHPY 295
            ++H +
Sbjct: 264 LLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.5 bits (170), Expect = 9e-14
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 45/270 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV--PPTTLREVSILRMLS 61
           +  + ++K+G G +G+V+        K VA+K  +     +G   P   L E ++++ L 
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLK-----QGSMSPEAFLAEANLMKQL- 58

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           + P +VRL  V        +  +Y++ EYM+   L  ++++    G  + +N +  +  Q
Sbjct: 59  QHPRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQ 110

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-----------TLPIKK 169
           + +G+AF      +HRDL+  N+L+  +T+  KIAD GLAR               PIK 
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIK- 168

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFR 228
                    + APE +   T ++   D+WS   +  E+VT   + +PG +  + + ++ R
Sbjct: 169 ---------WTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218

Query: 229 LLGTPNEKVWPG-VSSLMN--WHEYPQWNP 255
               P     P  +  LM   W E P+  P
Sbjct: 219 GYRMPRPDNCPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.7 bits (170), Expect = 9e-14
 Identities = 86/312 (27%), Positives = 140/312 (44%), Gaps = 54/312 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL-RMLS 61
           F +   +G+G +G+V   + +ATGK+ A   L+K R+ +         L E  IL ++ S
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNS 59

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY- 119
           R   VV L         E +  L LV   M+  DLK +I    + G        +++ Y 
Sbjct: 60  R--FVVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYA 108

Query: 120 -QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTL 177
            ++C G+   H   I++RDLKP N+L+D     ++I+DLGL  A  +P  +     + T+
Sbjct: 109 AEICCGLEDLHQERIVYRDLKPENILLDDHGH-IRISDLGL--AVHVPEGQTIKGRVGTV 165

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEV + +  Y+ + D W++ C+  E++       G S  QQ     R      E+V
Sbjct: 166 GYMAPEV-VKNERYTFSPDWWALGCLLYEMIA------GQSPFQQ-----RKKKIKREEV 213

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAME 292
              V  +    EY +               D   L + +L  DP +R+      A++  E
Sbjct: 214 ERLVKEVQ--EEYSE-----------KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260

Query: 293 HPYFDDLDKTRL 304
           HP F  ++  RL
Sbjct: 261 HPLFKQINFKRL 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +G G+Y KV   R K   +I A+K  K  L  DDE +      E  +    S +P +V L
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQ-TEKHVFEQASSNPFLVGL 61

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
               Q  ++     L+LV EY++  DL  +++  R+    +P    +    ++C  + F 
Sbjct: 62  HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRK----LPEEHARFYAAEICIALNFL 112

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H  GI++RDLK  N+L+D     +K+ D G+ +    P    +    T  Y APE+L G 
Sbjct: 113 HERGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
             Y  +VD W++  +  E++   + F
Sbjct: 172 -EYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 46/214 (21%)

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 173
           ++++M Q+   +   H  GI+HRD+KP N++    + + KI DLG A    + I     E
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE 316

Query: 174 -ILTLWYRAPEVLLGSTHYSTA---------------------VDMWSVACIFAELVTKT 211
            +L   Y APE  + ST   +A                      D++S   IF ++    
Sbjct: 317 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA--- 373

Query: 212 ALFPG---DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY--PQWNPQSLATAVPNLD 266
             FP    DS L Q           N ++      L+ W +   P+ +P  L      LD
Sbjct: 374 --FPNLRSDSNLIQF----------NRQLKRNDYDLVAWRKLVEPRASPD-LRRGFEVLD 420

Query: 267 KD---GLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            D   G +LL+ M+++   +RISAK A+ HPYFD
Sbjct: 421 LDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 26/242 (10%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILR---MLSRDPHVVR 68
           +G+G +G+VY   +  TG+ +A K+ +   +     P T +EVS L     L ++    R
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPES----PETSKEVSALECEIQLLKNLQHER 65

Query: 69  LMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           ++             L +  EYM    +K  ++++    E++     +    Q+ +G+++
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------LPIKKYTHEILTLWYRA 181
            H + I+HRD+K  N+L D     +K+ D G ++           I+  T    T ++ +
Sbjct: 122 LHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTG---TPYWMS 177

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+ G   Y    D+WS+ C   E++T+    P  +E + +  IF++   P     P  
Sbjct: 178 PEVISGEG-YGRKADVWSLGCTVVEMLTEK---PPWAEYEAMAAIFKIATQPTNPQLPSH 233

Query: 242 SS 243
            S
Sbjct: 234 IS 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 81/338 (23%), Positives = 132/338 (39%), Gaps = 83/338 (24%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRML 60
             F+K++ +G+G  G+V+  R K TGK+ ALK   K  + + ++     T +E  IL   
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILA-T 57

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
              P +  L    Q +     T L LV +Y    +L + ++  RQ G+ +     +    
Sbjct: 58  LDHPFLPTLYASFQTE-----TYLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAA 110

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMTLKIADLGLAR 161
           ++   + + H  GI++RDLKP N+L+                         K    G  R
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 162 AFTLPIKKY---------------THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE 206
           +    I                  T E     Y APEV+ G  H  +AVD W++  +  E
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEE-----YIAPEVISGDGH-GSAVDWWTLGILLYE 224

Query: 207 LVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLD 266
           ++  T  F G +  +   +I  L                    +P   P S         
Sbjct: 225 MLYGTTPFKGSNRDETFSNI--LKKEVT---------------FPGSPPVS--------- 258

Query: 267 KDGLDLLEQMLQYDPSKRI-SAKKAME---HPYFDDLD 300
               DL+ ++L  DPSKR+ S + A E   HP+F  ++
Sbjct: 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 76/311 (24%), Positives = 133/311 (42%), Gaps = 52/311 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           F     +G+G +G+V   + +ATGK+ A   L+K R+ +         L E  IL  ++ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--EAMALNEKRILEKVNS 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY-- 119
              VV L         E +  L LV   M+  DLK +I +    G     +  +++ Y  
Sbjct: 60  R-FVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FDEQRAIFYAA 109

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLW 178
           +LC G+       I++RDLKP N+L+D +   ++I+DLGL  A  +P  +     + T+ 
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGH-IRISDLGL--AVQIPEGETVRGRVGTVG 166

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV + +  Y+ + D W + C+  E++       G S  ++            E+V 
Sbjct: 167 YMAPEV-INNEKYTFSPDWWGLGCLIYEMIQ------GQSPFRKR----------KERV- 208

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEH 293
                     E  +   +          +D   +   +L  +P +R+      A    +H
Sbjct: 209 -------KREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261

Query: 294 PYFDDLDKTRL 304
           P F +++  RL
Sbjct: 262 PIFKNINFKRL 272

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 70/292 (23%), Positives = 128/292 (43%), Gaps = 37/292 (12%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE ++++G GTYG VY+AR   TG++ A+K  +L   + G     +++  I+    +  +
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHSN 67

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +V        ++K     L++  E+      + I  +  TG  +  + +  +  +  +G+
Sbjct: 68  IVAYFGSYLRRDK-----LWICMEFCGGGSLQDI--YHVTGP-LSESQIAYVSRETLQGL 119

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            + H  G +HRD+K  N+L+      +K+AD G++   T  I K    I T ++ APEV 
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178

Query: 186 LGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
                  Y+   D+W+V     EL     L P   +L  +  +F  L T +    P +  
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL---AELQPPMFDLHPMRALF--LMTKSNFQPPKLKD 233

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
            M W                         ++  L  +P KR +A+K ++HP+
Sbjct: 234 KMKW------------------SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.2 bits (167), Expect = 3e-13
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 51/304 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D  E +E++G G YG V + R   TG I+A+K+ R   + +      L ++ I       
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDC 59

Query: 64  PHVVRLMDV--KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           P+ V       ++G        +++  E MDT L K+ +     G  IP + +  +   +
Sbjct: 60  PYTVTFYGALFREGD-------VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSI 112

Query: 122 CKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
            K + + H    ++HRD+KP N+L++R    +K+ D G++      + K T +     Y 
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAK-TIDAGCKPYM 170

Query: 181 APEVLLGST---HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           APE +        Y    D+WS+     EL T    FP D                    
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYD-------------------- 208

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-----DLLEQMLQYDPSKRISAKKAME 292
                   +W    Q   Q +    P L  +       D + + L+ +  +R +  + ++
Sbjct: 209 --------SWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260

Query: 293 HPYF 296
           HP+F
Sbjct: 261 HPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 28  TGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL 86
           TG  VA+K  R    ++E       RE ++   L   P++V L+D   G+   G   L+ 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLD--SGEAPPGL--LFA 56

Query: 87  VFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD 146
           VFEY+     + +R        +P      LM Q+   +A  H  GI+HRDLKP N+++ 
Sbjct: 57  VFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113

Query: 147 RKTMT--LKIADLGL------ARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDM 197
           +  +    K+ D G+       R   +     T E+L T  Y APE L G    +   D+
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDL 172

Query: 198 WSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           ++   IF E +T   +  G S + ++L  ++ L 
Sbjct: 173 YAWGLIFLECLTGQRVVQGAS-VAEIL--YQQLS 203

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 67/262 (25%), Positives = 121/262 (46%), Gaps = 37/262 (14%)

Query: 9   LEKVGEGTYGKVYRAREKATGKI-VALKKTR---LHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G G +G V+  + +  GKI VA+K  R   + EDD       + E  ++  LS  P
Sbjct: 9   LKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDD------FIEEAKVMMKLSH-P 59

Query: 65  HVVRLMDV--KQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
           ++V+L  V  KQ         +++V EYM    L  Y+R  +          +  +   +
Sbjct: 60  NLVQLYGVCTKQRP-------IFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDV 109

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
           C+ + +   +G +HRDL   N L+  +   +K++D GLAR + L   +YT    T +   
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLAR-YVLD-DQYTSSQGTKFPVK 166

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKV 237
           +  PEV    + +S+  D+WS   +  E+ ++  + +   S  + +  +         K+
Sbjct: 167 WAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL 225

Query: 238 WP-GVSSLMN--WHEYPQWNPQ 256
            P  V ++M   WHE P+  P 
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPA 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 67.6 bits (165), Expect = 4e-13
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 45/262 (17%)

Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 68

Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 69  GVCTREPP-----FYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE 121

Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 122 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 170

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI----FRLLGTP 233
           + APE L  +  +S   D+W+   +  E+ T   + +PG  +L Q+  +    +R+    
Sbjct: 171 WTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRMERPE 228

Query: 234 NEKVWPGVSSLMNWHEYPQWNP 255
                P V  LM      QWNP
Sbjct: 229 G--CPPKVYELM--RACWQWNP 246

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 76/317 (23%), Positives = 124/317 (39%), Gaps = 65/317 (20%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +  E L ++G GT G+VY+ R K TG ++A+K+ R   + E      L ++ ++ + S D
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVV-LKSHD 72

Query: 64  -PHVVRLM-------DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQ-TGENI----P 110
            P++V+         DV             +  E M T L K ++  +    E+I     
Sbjct: 73  CPYIVKCYGYFITDSDVF------------ICMELMSTCLDKLLKRIQGPIPEDILGKMT 120

Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 170
           V  VK+L Y   K       HG++HRD+KP N+L+D     +K+ D G++    +  K  
Sbjct: 121 VAIVKALHYLKEK-------HGVIHRDVKPSNILLDASG-NVKLCDFGIS-GRLVDSKAK 171

Query: 171 THEILTLWYRAPEVLLGSTH---YSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHI 226
           T       Y APE +        Y    D+WS+     EL T    +    +E + L  I
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231

Query: 227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                                    Q  P SL         D    ++  L  D  KR  
Sbjct: 232 L------------------------QEEPPSLPPNE-GFSPDFCSFVDLCLTKDHRKRPK 266

Query: 287 AKKAMEHPYFDDLDKTR 303
            ++ ++HP+    +   
Sbjct: 267 YRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 11  KVGEGTYGKVYRA--REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           ++G G +G V +   + K + K VA+K  +   +D  +    LRE ++++ L  +P++VR
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVR 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           ++ + + ++        LV E  +   L K++    Q  +++    +  L++Q+  G+ +
Sbjct: 61  MIGICEAES------WMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKY 110

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEV 184
                 +HRDL   N+L+  +    KI+D GL++A       Y   TH    + + APE 
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 185 LLGSTHYSTAVDMWSVACIFAE 206
            +    +S+  D+WS   +  E
Sbjct: 170 -MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPH 65
           E++G G +G+V+  R +A    VA+K  R     E +PP      L+E  IL+  S  P+
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCR-----ETLPPDLKAKFLQEARILKQYSH-PN 54

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VRL+ V   +       +Y+V E +   D   ++R+    G  + V  +  ++     G
Sbjct: 55  IVRLIGVCTQKQP-----IYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAG 106

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRA 181
           + +      +HRDL   N L+  K   LKI+D G++R     +   T    +I   W  A
Sbjct: 107 MEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQIPVKW-TA 164

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAE 206
           PE  L    YS+  D+WS   +  E
Sbjct: 165 PEA-LNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 82/301 (27%), Positives = 129/301 (42%), Gaps = 57/301 (18%)

Query: 12  VGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+GT+GKV   REKATGK  A   LKK  +   DE     TL E  +L+  +R P +  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE--VAHTLTESRVLQN-TRHPFLTA 59

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q  ++     L  V EY +  +L  ++   R   E+      ++  Y  ++   +
Sbjct: 60  LKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSAL 108

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            + H   +++RDLK  NL++D K   +KI D GL +              T  Y APEV 
Sbjct: 109 GYLHSCDVVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV- 166

Query: 186 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           L    Y  AVD W +  +  E++  +   +  D E      +F L+             L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELI-------------L 208

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 299
           M    +P+            L  +   LL  +L+ DP +R+      AK+ MEH +F  +
Sbjct: 209 MEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257

Query: 300 D 300
           +
Sbjct: 258 N 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 86/345 (24%), Positives = 133/345 (38%), Gaps = 90/345 (26%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR-EVSILRMLSR 62
           D FE ++ +G G +G+V   ++K TG I A+KK R  E  E      +R E  IL   + 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL-AEAD 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKY-IRSFRQTGENIPVNTVKS 116
           +P VV+L    Q +N      LYL+ EY     M T L K    +  +T         + 
Sbjct: 60  NPWVVKLYYSFQDENY-----LYLIMEYLPGGDMMTLLMKKDTFTEEET---------RF 105

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-----TLPIKKYT 171
            + +    +   H  G +HRD+KP NLL+D K   +K++D GL         T   +  +
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILS 164

Query: 172 H-----------------EILTLW----------------YRAPEVLLGSTHYSTAVDMW 198
           H                      W                Y APEV L  T Y+   D W
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWW 223

Query: 199 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSL 258
           S+  I  E++     F  D+  +    I                  +NW E  Q+ P  +
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQETYRKI------------------INWKETLQF-PDEV 264

Query: 259 ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HPYFDDLD 300
                 L  +  DL++++   +  +R+      E   HP+F  +D
Sbjct: 265 -----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.0 bits (163), Expect = 9e-13
 Identities = 66/302 (21%), Positives = 133/302 (44%), Gaps = 52/302 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +E + ++G+G +GKVY+A+ K TG + A K      ++E      + E+ IL      
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH- 61

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVNTVKSLM 118
           P++V+L+D    +N      L+++ E+     +D  + +  R   +         ++ + 
Sbjct: 62  PNIVKLLDAFYYENN-----LWILIEFCAGGAVDAVMLELERPLTEP-------QIRVVC 109

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            Q  + + + H + I+HRDLK  N+L       +K+AD G++   T  I++    I T +
Sbjct: 110 KQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPY 168

Query: 179 YRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT-P 233
           + APEV++  T     Y    D+WS+     E+     + P   EL  +  + ++  + P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEP 225

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P            +W+             +  D L++ L+ +   R +  + ++H
Sbjct: 226 PTLAQPS-----------RWSS------------EFKDFLKKCLEKNVDARWTTTQLLQH 262

Query: 294 PY 295
           P+
Sbjct: 263 PF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +G G+Y KV   R K T +I A+K  K  L  DDE +      E  +    S  P +V L
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQ-TEKHVFEQASNHPFLVGL 61

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
               Q +++     L+ V EY++  DL  +++  R+    +P    +    ++   + + 
Sbjct: 62  HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYL 112

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H  GI++RDLK  N+L+D +   +K+ D G+ +    P    +    T  Y APE+L G 
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
             Y  +VD W++  +  E++   + F
Sbjct: 172 D-YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 78/310 (25%), Positives = 142/310 (45%), Gaps = 54/310 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           F  L  +G+G++GKV  A  K T ++ A   LKK  + +DD+     T+ E  +L +  +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD--VECTMVEKRVLALQDK 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY-- 119
            P + +L    Q  ++     LY V EY++  DL  +I+   +  E       +++ Y  
Sbjct: 60  PPFLTQLHSCFQTVDR-----LYFVMEYVNGGDLMYHIQQVGKFKEP------QAVFYAA 108

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++  G+ F H  GI++RDLK  N+++D +   +KIAD G+ +   +          T  Y
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDY 167

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APE+ +    Y  +VD W+   +  E++     F G+ E +    +F+           
Sbjct: 168 IAPEI-IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQ----------- 211

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHP 294
              S+M   E+    P+SL+       K+ + + + ++   PSKR+       +   EH 
Sbjct: 212 ---SIM---EHNVSYPKSLS-------KEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258

Query: 295 YFDDLDKTRL 304
           +F  +D  +L
Sbjct: 259 FFRRIDWDKL 268

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 23/197 (11%)

Query: 11  KVGEGTYG----KVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++G G +G     VY+ R+K     VA+K  + +E+++ V    +RE  I+  L  +P++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQID--VAIKVLK-NENEKSVRDEMMREAEIMHQLD-NPYI 57

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VR++ V + +       L LV E      L K++   +   + I V+ V  LM+Q+  G+
Sbjct: 58  VRMIGVCEAEA------LMLVMEMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGM 108

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
            +  G   +HRDL   N+L+  +    KI+D GL++A       Y       W   + AP
Sbjct: 109 KYLEGKNFVHRDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 183 EVLLGSTHYSTAVDMWS 199
           E +     +S+  D+WS
Sbjct: 168 ECIN-FRKFSSRSDVWS 183

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G+GTYG VY AR+ +T   +A+K+    +     P   L E   L    +  ++V+ + 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP---LHEEIALHSYLKHRNIVQYL- 71

Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 131
              G + E       + +     L   +RS +         T+     Q+ +G+ + H +
Sbjct: 72  ---GSDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLHDN 127

Query: 132 GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVL-LGST 189
            I+HRD+K  N+L++  +  +KI+D G ++     I   T     TL Y APEV+  G  
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 190 HYSTAVDMWSVACIFAELVT 209
            Y    D+WS+ C   E+ T
Sbjct: 187 GYGAPADIWSLGCTIVEMAT 206

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 83/306 (27%), Positives = 140/306 (45%), Gaps = 65/306 (21%)

Query: 9   LEKVGEGTYGKVYRAR---EKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           L+ +G+G YGKV++ R      TGKI A   LKK  +  + +    T   E +IL  + +
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK-AERNILEAV-K 58

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-----TDLKKYIRSFRQTGENIPV-NTVKS 116
            P +V L+   Q   K     LYL+ EY+        L++         E I + +T   
Sbjct: 59  HPFIVDLIYAFQTGGK-----LYLILEYLSGGELFMHLER---------EGIFMEDTACF 104

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL- 175
            + ++   +   H  GI++RDLKP N+L+D +   +K+ D GL +  ++     TH    
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGH-VKLTDFGLCKE-SIHEGTVTHTFCG 162

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T+ Y APE+L+ S H   AVD WS+  +  +++T    F  ++  + +           +
Sbjct: 163 TIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-----------D 210

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKA 290
           K+  G  +L      P           P L  +  DLL+++L+ +PS R+      A + 
Sbjct: 211 KILKGKLNL------P-----------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253

Query: 291 MEHPYF 296
             HP+F
Sbjct: 254 QSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 16/223 (7%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M  + +E ++ +G G +G+V   R K+T K+ A+K     E  +        E   +   
Sbjct: 40  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +  P VV+L    Q         LY+V EYM   DL   + ++     ++P    +    
Sbjct: 100 ANSPWVVQLFYAFQDDR-----YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTA 149

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLW 178
           ++   +   H  G +HRD+KP N+L+D K+  LK+AD G         + +    + T  
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 179 YRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           Y +PEVL    G  +Y    D WSV     E++     F  DS
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)

Query: 12  VGEGTYGKVYRAREKAT----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +G G +G+V+ A+ K      G+ + L K      DE +     RE+ + R LS   +VV
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVV 71

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENI---PVNTVK--SLMYQL 121
           RL+    G  +E     Y++ EY D  DLK+++R+ +   E +   P++T +  +L  Q+
Sbjct: 72  RLL----GLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLPIKKYTHEILTLWYR 180
             G+        +HRDL   N L+      +K++ L L++  +     K  + ++ L + 
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTAL 213
           APE +     +ST  D+WS   +  E+ T+  L
Sbjct: 186 APEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 17/218 (7%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           F  L  +G+G++GKV  A  K T ++ A   LKK  + +DD+     T+ E  +L +  +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD--VECTMVEKRVLALSGK 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P + +L    Q  ++     LY V EY++  DL   I+   +  E   V        ++
Sbjct: 60  PPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAA----EI 110

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
             G+ F H  GI++RDLK  N+++D +   +KIAD G+ +              T  Y A
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIA 169

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 219
           PE+ +    Y  +VD W+   +  E++   A F G+ E
Sbjct: 170 PEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 3e-12
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 29/214 (13%)

Query: 8   KLEKV-GEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTT----LREVSILRM 59
            +EKV G G +G+V R R K  GK    VA+K  +      G         L E SI+  
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK-----AGSSDKQRLDFLTEASIMGQ 61

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
               P+++RL    +G   + R V+ ++ EYM+   L K++R     G+      V  ++
Sbjct: 62  FDH-PNIIRL----EGVVTKSRPVM-IITEYMENGSLDKFLR--ENDGKFTVGQLVG-ML 112

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH---EIL 175
             +  G+ +      +HRDL   N+L++   +  K++D GL+R        YT    +I 
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             W  APE  +    +++A D+WS   +  E+++
Sbjct: 172 IRW-TAPEA-IAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 23/221 (10%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           F +   +G+G +G+V   + +ATGK+ A   L+K R+ +         L E  IL  ++ 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG--ESMALNEKQILEKVNS 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY-- 119
              VV L         E +  L LV   M+  DLK +I +    G        ++L Y  
Sbjct: 60  Q-FVVNL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEERALFYAA 109

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLW 178
           ++  G+   H    ++RDLKP N+L+D     ++I+DLGL  A  +P  +     + T+ 
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGH-IRISDLGL--AVKIPEGESIRGRVGTVG 166

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 219
           Y APEV L +  Y+ + D W + C+  E++   + F G  E
Sbjct: 167 YMAPEV-LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.5 bits (159), Expect = 3e-12
 Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 57/301 (18%)

Query: 12  VGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+GT+GKV   REKA+GK  A   LKK  +   DE     TL E  +L+  +R P +  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE--VAHTLTESRVLKN-TRHPFLTS 59

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q +++     L  V EY++  +L  ++   R   E+      ++  Y  ++   +
Sbjct: 60  LKYSFQTKDR-----LCFVMEYVNGGELFFHLSRERVFSED------RTRFYGAEIVSAL 108

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            + H   I++RDLK  NL++D K   +KI D GL +              T  Y APEV 
Sbjct: 109 DYLHSGKIVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV- 166

Query: 186 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           L    Y  AVD W +  +  E++  +   +  D E      +F L+             L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-------------L 208

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 299
           M   ++P+            L  D   LL  +L  DP+KR+      AK+ M H +F  +
Sbjct: 209 MEDIKFPR-----------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257

Query: 300 D 300
           +
Sbjct: 258 N 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.1 bits (158), Expect = 4e-12
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E +++VG GTYG VY+AR   TG++ A+K  +L   D+     +L +  I  +      
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD----FSLIQQEIFMVKECKHC 66

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN--TVKSLMYQLCK 123
            +    V    +   R  L++  EY      + I  +  TG   P++   +  +  +  +
Sbjct: 67  NI----VAYFGSYLSREKLWICMEYCGGGSLQDI--YHVTG---PLSELQIAYVCRETLQ 117

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+A+ H  G +HRD+K  N+L+      +K+AD G+A   T  I K    I T ++ APE
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176

Query: 184 VLLGSTH--YSTAVDMWSVACIFAEL 207
           V     +  Y+   D+W+V     EL
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 71/325 (21%), Positives = 130/325 (40%), Gaps = 53/325 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEKL ++G G  G V +   + +G I+A K   L E    +    +RE+ +L      
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHE-CNS 58

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++V          +     + +  E+MD   L + ++   +    IP N +  +   + 
Sbjct: 59  PYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVL 109

Query: 123 KGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLG--------LARAFTLPIKKYTHE 173
           +G+ +    H I+HRD+KP N+L++ +   +K+ D G        +A +F          
Sbjct: 110 RGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMANSF---------- 158

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           + T  Y +PE L G THY+   D+WS+     E+       P     ++L  +F      
Sbjct: 159 VGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMF----GR 212

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLA----------TAVPNLDKDGL-----DLLEQMLQ 278
                    S      +P  +P+ +A             P L          D +++ L+
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLK 272

Query: 279 YDPSKRISAKKAMEHPYFDDLDKTR 303
            +P +R   K+  +HP+    +   
Sbjct: 273 KNPKERADLKELTKHPFIKRAELEE 297

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 80/313 (25%), Positives = 134/313 (42%), Gaps = 65/313 (20%)

Query: 9   LEKVGEGTYGKVYRARE---KATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           L+ +G+G++GKV+  R+      G++ A   LKK  L   D      T  E  IL  ++ 
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDR---VRTKMERDILAEVNH 57

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTVKSL 117
            P +V+L    Q + K     LYL+ +++      T L K +     T E+     VK  
Sbjct: 58  -PFIVKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMF---TEED-----VKFY 103

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK      T+
Sbjct: 104 LAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEK 236
            Y APEV+    H + + D WS   +  E++T +  F G    + +  I +  LG P   
Sbjct: 163 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ-- 219

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAM 291
                                       L  +   LL  + + +P+ R+ A     ++  
Sbjct: 220 ---------------------------FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIK 252

Query: 292 EHPYFDDLDKTRL 304
            HP+F  +D  +L
Sbjct: 253 RHPFFSTIDWNKL 265

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 53/303 (17%)

Query: 12  VGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G +G+V   + +ATGK+ A   L K RL +  +G     + +  + ++ SR   +V 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSR--FIVS 57

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q      +T L LV   M+  DL+ +I +  +  EN      ++  Y  Q+  G+
Sbjct: 58  LAYAFQT-----KTDLCLVMTIMNGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGL 110

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
              H   I++RDLKP N+L+D     ++I+DLGLA        K      T  + APE+L
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
            G   Y  +VD +++     E++   A  P           FR  G   EKV        
Sbjct: 170 QGE-EYDFSVDYFALGVTLYEMI--AARGP-----------FRARG---EKV-------- 204

Query: 246 NWHEYPQWNPQSLATAVPNLDK---DGLDLLEQMLQYDPSKRISAK-----KAMEHPYFD 297
              E  +   + L  +V   DK         E +L  DP KR+  +         HP F 
Sbjct: 205 ---ENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261

Query: 298 DLD 300
           DL+
Sbjct: 262 DLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 5e-12
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 41/205 (20%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +    +G+G +G V     +  G+ VA+K  +   DD       L E S++  L R P++
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTL-RHPNL 62

Query: 67  VRLMDVK-QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM---YQL 121
           V+L+ V  QG        LY+V EYM    L  Y+RS         V T+   +     +
Sbjct: 63  VQLLGVVLQGNP------LYIVTEYMAKGSLVDYLRS-----RGRAVITLAQQLGFALDV 111

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEI 174
           C+G+ +      +HRDL   N+L+    +  K++D GLA+  +       LP+K      
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVA-KVSDFGLAKEASQGQDSGKLPVK------ 164

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWS 199
               + APE L     +ST  D+WS
Sbjct: 165 ----WTAPEALREKK-FSTKSDVWS 184

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 16/223 (7%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M  + ++ ++ +G G +G+V   R K++ K+ A+K     E  +        E   +   
Sbjct: 40  MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +  P VV+L    Q         LY+V EYM   DL   + ++     ++P    K    
Sbjct: 100 ANSPWVVQLFCAFQDDKY-----LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTA 149

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-TLPIKKYTHEILTLW 178
           ++   +   H  G++HRD+KP N+L+D K   LK+AD G         + +    + T  
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208

Query: 179 YRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           Y +PEVL    G  +Y    D WSV     E++     F  DS
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.7 bits (157), Expect = 6e-12
 Identities = 66/290 (22%), Positives = 128/290 (44%), Gaps = 47/290 (16%)

Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A  K++GK+VA+KK  L +           EV I+R    + +VV + 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE-NVVEMY 83

Query: 71  DVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           +     ++     L++V E+++    TD+  + R   +    + +  +K+L        +
Sbjct: 84  NSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKAL--------S 130

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
             H  G++HRD+K  ++L+      +K++D G     +  + +    + T ++ APE L+
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LI 188

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
               Y   VD+WS+  +  E+V     +  +  L+ +  I   L  P  K    VS  + 
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKNLHKVSPSLK 247

Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                     L+++L  DP++R +A + ++HP+ 
Sbjct: 248 ------------------------GFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 6e-12
 Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 36/261 (13%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPH 65
           EK+G+G +G VY+   K   + VA+K  R        PP      L+E  IL+     P+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTE-VAVKTCR--STL---PPDLKRKFLQEAEILKQYDH-PN 53

Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +V+L+ V  Q Q       +Y+V E +    L  ++   R+    + V  +  +      
Sbjct: 54  IVKLIGVCVQKQP------IYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAA 104

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLW 178
           G+ +      +HRDL   N L+    + LKI+D G++R      +T+       +I   W
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSREEEGGIYTVSDG--LKQIPIKW 161

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKV 237
             APE  L    Y++  D+WS   +  E  +     +PG S  Q    I      P  ++
Sbjct: 162 -TAPEA-LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQL 219

Query: 238 WP-GVSSLMN--WHEYPQWNP 255
            P  +  LM   W   P+  P
Sbjct: 220 CPEEIYRLMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 64.3 bits (156), Expect = 8e-12
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 25/228 (10%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKK-----TRLHEDDEGVPPTTLREVSILRML 60
           F  L ++G G++G VY A    T ++VA+KK      + +E  + +    ++EV  L+ L
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI----IKEVKFLQQL 78

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + P+ +   + K    KE     +LV EY        +   ++  + +    + ++ + 
Sbjct: 79  -KHPNTI---EYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEV---EIAAITHG 129

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
             +G+A+ H H ++HRD+K  N+L+      +K+AD G A   + P   +   + T ++ 
Sbjct: 130 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASKSS-PANSF---VGTPYWM 184

Query: 181 APEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
           APEV+L      Y   VD+WS+     EL  +       + +  L HI
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 16/238 (6%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G I+A K   L E    +    +RE+ +L   +  
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 62

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 123 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 171

Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           E L G THYS   D+WS+     E+ + +  + P D++  +L+    + G P E    
Sbjct: 172 ERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 63.5 bits (155), Expect = 9e-12
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 40/216 (18%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV--PPTTLREVSILRMLSRDPHV 66
             K+G G +G+V+      T K VA+K  +      G   P   L+E  I++ L R   +
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK-VAVKTLK-----PGTMSPEAFLQEAQIMKKL-RHDKL 63

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L  V   +       +Y+V EYM    L  +++S    G+ + +  +  +  Q+ +G+
Sbjct: 64  VQLYAVCSEEEP-----IYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGM 116

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-----------TLPIKKYTHEI 174
           A+      +HRDL   N+L+  + +  KIAD GLAR               PIK      
Sbjct: 117 AYLESRNYIHRDLAARNILVG-ENLVCKIADFGLARLIEDDEYTAREGAKFPIK------ 169

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
              W  APE       ++   D+WS   +  E+VT 
Sbjct: 170 ---W-TAPEAANYGR-FTIKSDVWSFGILLTEIVTY 200

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 43/288 (14%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
            + +GEG +G+V +A             VA+K  +    ++ +    + E+ +++M+ + 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKH 75

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGE----NIPVN-----T 113
            +++ L+ V   +       LY+V EY    +L+ ++R+ R  GE    + P       T
Sbjct: 76  KNIINLLGVCTQEGP-----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 114 VKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IK 168
            K L+   YQ+ +G+ F      +HRDL   N+L+    + +KIAD GLAR        +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV-MKIADFGLARDIHHIDYYR 189

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS--ELQQLL- 224
           K T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL 
Sbjct: 190 KTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248

Query: 225 ---HIFRLLGTPNEKVWPGVSSLMN--WHEYPQWNPQSLATAVPNLDK 267
               + +      E     +  LM   WHE P   P +    V +LD+
Sbjct: 249 EGYRMEKPQNCTQE-----LYHLMRDCWHEVPSQRP-TFKQLVEDLDR 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 94/339 (27%), Positives = 140/339 (41%), Gaps = 78/339 (23%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSI-LRMLSRDP 64
           F+ L  +GEGT+GKV  A ++   +  A+K  R       VP  T R+  I ++ + +  
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR------NVPKYT-RDAKIEIQFMEK-- 181

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENI--------PVN--TV 114
             VR  D         R  L  +  Y   +         + G  +        P +   +
Sbjct: 182 --VRQADP------ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHL 233

Query: 115 KSLMYQLCKGVAFCHGHG---ILHRDLKPHNLLMDRKTMTL---------------KIAD 156
             +++Q   GVA  + H    ++H DLKP N+LM+     +               +I D
Sbjct: 234 AQIIFQT--GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 157 LGLA---RAFTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTA 212
           LG     R     I    H      YR+PEV+LG    YST  DMWS+ CI  EL T   
Sbjct: 292 LGGCCDERHSRTAIVSTRH------YRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKL 343

Query: 213 LFPGDSELQQLLHIFRLLGT-PNEKVWPG------VSSLMN--WHEYPQWNPQSLAT--- 260
           L+     L+ L  + + LG  P+E  W G         L N      P  +P+ LA    
Sbjct: 344 LYDTHDNLEHLHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR 401

Query: 261 --AVPNLDKDGL--DLLEQMLQYDPSKRISAKKAMEHPY 295
              V  + +D L  DL+  +L YD  KR++A++   HPY
Sbjct: 402 ARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 73/311 (23%), Positives = 116/311 (37%), Gaps = 76/311 (24%)

Query: 10  EKVGEGTYGKVYRA--REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
             +GEG +G VY+         KI    KT  +     V    L+E  I+R     PH+V
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIV 70

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTDLKKY--IRSFRQTG-ENIPVNTVKSLMYQLCKG 124
           +L+ V           +++V E     L     +RS+ Q    ++ + ++    YQL   
Sbjct: 71  KLIGVITENP------VWIVME-----LAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHE 173
           +A+      +HRD+   N+L+      +K+ D GL+R              LPIK     
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLPIK----- 173

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
               W  APE  +    +++A D+W       E+     L  G    Q         G  
Sbjct: 174 ----WM-APES-INFRRFTSASDVWMFGVCMWEI-----LMLGVKPFQ---------GVK 213

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N  V   +  + N    P   P +    + +       L+ +   YDPSKR         
Sbjct: 214 NNDV---IGRIENGERLPM--PPNCPPTLYS-------LMTKCWAYDPSKR--------- 252

Query: 294 PYFDDLDKTRL 304
           P F +L K +L
Sbjct: 253 PRFTEL-KAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 81/317 (25%), Positives = 127/317 (40%), Gaps = 51/317 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F  LE    G  G  +   +  T + V +K         G    T  E  ILR ++  P 
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINH-PS 144

Query: 66  VVRLMDVKQGQNKEGRTVLY-----LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +++L            T  Y     L+     TDL  Y+ + R    NI +  + ++   
Sbjct: 145 IIQLKG----------TFTYNKFTCLILPRYKTDLYCYLAAKR----NIAICDILAIERS 190

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLW 178
           + + + + H + I+HRD+K  N+ ++     + + D G A  F + I   KY     T+ 
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFG-AACFPVDINANKYYGWAGTIA 248

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG-------DSELQQLLHIFRLL 230
             APE LL    Y  AVD+WS   +  E+ T   +LF         DS+ Q  L I R  
Sbjct: 249 TNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307

Query: 231 GTPNEKVWPGVSSLMNWH--------EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
             PNE      ++L   +          P   P  L T +  L  D   L+ +ML +D  
Sbjct: 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP--LWTNLYELPIDLEYLICKMLAFDAH 365

Query: 283 KRISAKKAMEHPYFDDL 299
            R SA+  ++   F D+
Sbjct: 366 HRPSAEALLDFAAFQDI 382

Length = 391

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 42/294 (14%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
            E +G G  G VY+A    T +I+A+K   L    E +    + E+ IL      P+++ 
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCD-SPYIIG 63

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
                  +N+     + +  E+MD   L  Y +        IP + +  +   + KG+ +
Sbjct: 64  FYGAFFVENR-----ISICTEFMDGGSLDVYRK--------IPEHVLGRIAVAVVKGLTY 110

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
                ILHRD+KP N+L++ +   +K+ D G++      I K T+ + T  Y APE + G
Sbjct: 111 LWSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNSIAK-TY-VGTNAYMAPERISG 167

Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
              Y    D+WS+   F EL      +P   + Q  L   +LL                 
Sbjct: 168 E-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-------------V 213

Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY---FDD 298
            E P   P      V    +  +  + Q ++  P +R + +  M+HP+   ++D
Sbjct: 214 DEDPPVLP------VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 33/233 (14%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLH-EDDEGVPPTTLREVSILRMLS 61
           M  ++ +  +G+G  G+VY A +    + VALKK R    ++  +    LRE  I   L 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQT-------GENIPVNTV 114
             P +V +  +      +G  V Y +       LK  ++S  Q         E   V   
Sbjct: 61  H-PGIVPVYSICS----DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA----------FT 164
            S+ +++C  + + H  G+LHRDLKP N+L+      + I D G A              
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLLDID 174

Query: 165 LPIKKYTHEILTLW--------YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           +  +   +  +T+         Y APE LLG    S + D++++  I  +++T
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 17/224 (7%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP-PTTLREVSILRMLSRDP 64
           F  L ++G G++G VY AR+    ++VA+KK               ++EV  L+ L R P
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 75

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           + ++       ++       +LV EY        +   ++  + +    + ++ +   +G
Sbjct: 76  NTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAVTHGALQG 127

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +A+ H H ++HRD+K  N+L+    + +K+ D G A +   P   +   + T ++ APEV
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA-SIMAPANXF---VGTPYWMAPEV 182

Query: 185 LLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
           +L      Y   VD+WS+     EL  +       + +  L HI
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 17/224 (7%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP-PTTLREVSILRMLSRDP 64
           F  L ++G G++G VY AR+  T ++VA+KK               ++EV  L+ + + P
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHP 85

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           + +        ++       +LV EY        +   ++  + +    + ++ +   +G
Sbjct: 86  NSIEYKGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAITHGALQG 137

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +A+ H H ++HRD+K  N+L+      +K+AD G A +   P   +   + T ++ APEV
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSA-SIASPANSF---VGTPYWMAPEV 192

Query: 185 LLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
           +L      Y   VD+WS+     EL  +       + +  L HI
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILR---MLSR 62
           F  ++ +  G +GKVY  R+K   K+ A+K  +     + +    + +V   R    LS+
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK---KADMINKNMVHQVQAERDALALSK 62

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P +V L    Q  N      +YLV EY+   D+K  +  +    E + V  +  +   L
Sbjct: 63  SPFIVHLYYSLQSANN-----VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 117

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR 161
                + H HGI+HRDLKP N+L+  +   +K+ D GL++
Sbjct: 118 ----DYLHRHGIIHRDLKPDNMLISNEGH-IKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 58/308 (18%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++GKV  A+ KA GK  A+K   K  + +  E      + E ++L    + P +V 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ--KHIMAERNVLLKNVKHPFLVG 60

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q  +K     LY V +Y++  +L  +++  R   E       ++  Y  ++   +
Sbjct: 61  LHYSFQTADK-----LYFVLDYVNGGELFFHLQRERSFPE------PRARFYAAEIASAL 109

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            + H   I++RDLKP N+L+D +   + + D GL +      K  +    T  Y APEVL
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
                Y   VD W +  +  E++     F      +   +I                   
Sbjct: 169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN----------------- 210

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME----HPYF----- 296
                    P  L    PN+      LLE +LQ D +KR+ AK        H +F     
Sbjct: 211 --------KPLRLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259

Query: 297 DDLDKTRL 304
           DDL   ++
Sbjct: 260 DDLVNKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 83/301 (27%), Positives = 136/301 (45%), Gaps = 52/301 (17%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRD--PHV 66
           +G G +G+VY  R+  TGK+ A+K   K R+ +  +G     L E  +L ++S    P +
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQG-ETLALNERIMLSLVSTGDCPFI 59

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V +       +K     L  + + M+  DL  ++       E      ++    ++  G+
Sbjct: 60  VCMTYAFHTPDK-----LCFILDLMNGGDLHYHLSQHGVFSEK----EMRFYATEIILGL 110

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILTLWYRAPEV 184
              H   +++RDLKP N+L+D      +I+DLGLA  F+   KK  H  + T  Y APEV
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFS---KKKPHASVGTHGYMAPEV 166

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           L   T Y ++ D +S+ C+  +L+       G S        FR   T ++     ++  
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLR------GHSP-------FRQHKTKDKHEIDRMTLT 213

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 299
           +N  E P        +  P L      LLE +LQ D SKR+      A++  EH +F  +
Sbjct: 214 VNV-ELPD-------SFSPELKS----LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261

Query: 300 D 300
           D
Sbjct: 262 D 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 54/235 (22%)

Query: 10  EKVGEGTYGKVYRAREKATGK--------------IVALKKTRLHEDDEGVPPTTLREVS 55
           EK+GEG +G+V+    +   +              +VA+K  R  +  +      L+E+ 
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKTARNDFLKEIK 69

Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKY-----IRSFRQTGENI 109
           I+  L ++P+++RL+ V    +      L ++ EYM+  DL ++     I S      NI
Sbjct: 70  IMSRL-KNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 110 PVNTVKSLMY---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--- 163
           P  ++ +L+Y   Q+  G+ +      +HRDL   N L+     T+KIAD G++R     
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN-HYTIKIADFGMSRNLYSG 182

Query: 164 ---------TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                     LPI+         W     +LLG   ++TA D+W+      E+ T
Sbjct: 183 DYYRIQGRAVLPIR---------WMAWESILLGK--FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.0 bits (150), Expect = 4e-11
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 71

Query: 67  VRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL--MYQL- 121
           VRL+ V  QGQ         ++ E M   DLK Y+RS R   EN PV    SL  M Q+ 
Sbjct: 72  VRLLGVVSQGQPT------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125

Query: 122 ---CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
                G+A+ + +  +HRDL   N  M  +  T+KI D G+ R    T   +K    +L 
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARN-CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + +PE L     ++T  D+WS   +  E+ T
Sbjct: 185 VRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 20/220 (9%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE++ ++G G  G V + + K +G I+A K   L E    +    +RE+ +L   +  
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 62

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++V          +     + +  E+MD   L + ++  ++    IP   +  +   + 
Sbjct: 63  PYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVL 113

Query: 123 KGVAFC-HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYR 180
           +G+A+    H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y 
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYM 169

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSE 219
           +PE L G THYS   D+WS+     EL + +  + P D++
Sbjct: 170 SPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 15/206 (7%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +G G+Y KV     K T +I A+K  K  L  DDE +      E  +    S  P +V L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQ-TEKHVFETASNHPFLVGL 61

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
               Q +++     L+ V E++   DL  +++  R+    +P    +    ++   + F 
Sbjct: 62  HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLALNFL 112

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H  GI++RDLK  N+L+D +   +K+ D G+ +    P    +    T  Y APE+L G 
Sbjct: 113 HERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
             Y  +VD W++  +  E++   + F
Sbjct: 172 -DYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 6e-11
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 36/223 (16%)

Query: 12  VGEGTYGKVY----------RAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +GEG +G+V           + +E  T  +  LK     +D   +    + E+ +++M+ 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 78

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------EN 108
           +  +++ L+    G   +    LY++ EY    +L++Y+R+ R  G            E 
Sbjct: 79  KHKNIINLL----GACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 109 IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-- 166
           +    + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR       
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDVNNIDY 192

Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            KK T+  L + + APE L     Y+   D+WS   +  E+ T
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 49/285 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSIL 57
           + A   LE++GEG +GKVY+       E+ +   VA+K   L E+ E       R+ + L
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT--LKENAEPKVQQEFRQEAEL 61

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYI------------RSFRQ 104
               + P++V L+ V     KE  T   ++FEY+   DL +++                 
Sbjct: 62  MSDLQHPNIVCLLGV---CTKEQPTC--MLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 105 TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT 164
              ++  +    +  Q+  G+ +   H  +HRDL   N L+    +T+KI+D GL+R   
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-LTVKISDFGLSRDI- 174

Query: 165 LPIKKYTHE--------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP- 215
                Y+ +        +L + +  PE +L    ++T  D+WS   +  E+ +   L P 
Sbjct: 175 -----YSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFS-YGLQPY 227

Query: 216 ---GDSELQQLLHIFRLLGTPNEKVWPGVSSLMN--WHEYPQWNP 255
               + E+ +++   +LL  P E     V +LM   W+E P   P
Sbjct: 228 YGFSNQEVIEMIRSRQLLPCP-EDCPARVYALMIECWNEIPARRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 24/231 (10%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           ++ + ++K+G G +G+V+        K VA+K  +        P + L E  I++ L  D
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLK---PGTMSPESFLEEAQIMKKLRHD 61

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGE--NIPVNTVKSLMYQL 121
             +V+L  V           +Y+V EYM    K  +  F + GE   + +  +  +  Q+
Sbjct: 62  -KLVQLYAVVS------EEPIYIVTEYMS---KGSLLDFLKDGEGRALKLPNLVDMAAQV 111

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLW 178
             G+A+      +HRDL+  N+L+    +  KIAD GLAR   +   +YT        + 
Sbjct: 112 AAGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLAR--LIEDNEYTARQGAKFPIK 168

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFR 228
           + APE  L    ++   D+WS   +  ELVTK  + +PG +  + L  + R
Sbjct: 169 WTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 34/301 (11%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +  E +  +G G  G V + +   TG ++A KK         V    LRE+ I+    R 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHE-CRS 62

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V        +N      + +  E+MD       R +++ G  IPV  +  +   + +
Sbjct: 63  PYIVSFYGAFLNENN-----ICMCMEFMDCG--SLDRIYKKGGP-IPVEILGKIAVAVVE 114

Query: 124 GVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           G+ + +  H I+HRD+KP N+L++ +   +K+ D G++      I      + T  Y +P
Sbjct: 115 GLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIADTF--VGTSTYMSP 171

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E + G   Y+   D+WS+     EL      FP                  +     G  
Sbjct: 172 ERIQGG-KYTVKSDVWSLGISIIELALGK--FPFAF---------------SNIDDDGQD 213

Query: 243 SLMNWHEYPQWNPQSLATAVPNLD--KDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
             M   +  Q   Q     +P+ D  +D  D ++  L  DP++R + ++    P F    
Sbjct: 214 DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273

Query: 301 K 301
           +
Sbjct: 274 R 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 78/308 (25%), Positives = 133/308 (43%), Gaps = 49/308 (15%)

Query: 12  VGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTL-REVSILRMLSRDPH 65
           +GEG +G+V  A      +    K V +    L +D      + L  E+ +++M+ +  +
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK--------- 115
           ++ L+    G   +    LY++ EY    +L++Y+R+ R  G +   +T K         
Sbjct: 80  IINLL----GACTQDGP-LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 116 ---SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKY 170
              S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV-MKIADFGLARDVHNIDYYKKT 193

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL 229
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG      +  +F+L
Sbjct: 194 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELFKL 248

Query: 230 LGTPNEKVWPGVSS-----LMN--WHEYPQWNPQSLATAVPNLDK--------DGLDLLE 274
           L   +    P   +     +M   WH  P   P +    V +LD+        + LDL  
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRP-TFKQLVEDLDRVLTVTSTDEYLDLSV 307

Query: 275 QMLQYDPS 282
              QY P 
Sbjct: 308 PFEQYSPG 315

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 72/261 (27%), Positives = 113/261 (43%), Gaps = 33/261 (12%)

Query: 10  EKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDP 64
           +++G G +G V    Y   +      VA+K   L ++         LRE S++  L   P
Sbjct: 1   KELGHGNFGSVVKGVYL-MKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDH-P 56

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            +VRL+ V +G+       L LV E      L KY++  R     IPV+ +K L +Q+  
Sbjct: 57  CIVRLIGVCKGEP------LMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAM 106

Query: 124 GVAFCHGHGILHRDLKPHN-LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---Y 179
           G+A+      +HRDL   N LL++R     KI+D G++RA       Y       W   +
Sbjct: 107 GMAYLESKHFVHRDLAARNVLLVNRHQA--KISDFGMSRALGAGSDYYRATTAGRWPLKW 164

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD---SELQQLLHIFRLLGTPNEK 236
            APE +     +S+  D+WS      E  +  A   G+   +E+  +L     L  P E 
Sbjct: 165 YAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE- 222

Query: 237 VWPGVSSLMN--WHEYPQWNP 255
               + S+M   W   P+  P
Sbjct: 223 CPQEIYSIMLSCWKYRPEDRP 243

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 55/236 (23%)

Query: 10  EKVGEGTYGKVYRAREKATGK----------------IVALKKTRLHEDDEGVPPTTLRE 53
           EK+GEG +G+V+    +   K                +VA+K  R  + ++      L+E
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDANKNARNDFLKE 69

Query: 54  VSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGE----- 107
           + I+  L +DP+++RL+ V    +      L ++ EYM+  DL +++             
Sbjct: 70  IKIMSRL-KDPNIIRLLAVCITSDP-----LCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 108 --NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-- 163
              I  +T+  +  Q+  G+ +      +HRDL   N L+  K  T+KIAD G++R    
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG-KNYTIKIADFGMSRNLYS 182

Query: 164 ----------TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                      LPI+         W     +LLG   ++TA D+W+      E++T
Sbjct: 183 GDYYRIQGRAVLPIR---------WMSWESILLGK--FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 20/232 (8%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L K+G G +G+V+      T   VA+K  +    D   P   L E  I++ L R P +++
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMD---PKDFLAEAQIMKKL-RHPKLIQ 65

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L  V   +       +Y+V E M    L +Y++     G  + +  +  +  Q+  G+A+
Sbjct: 66  LYAVCTLEEP-----IYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAY 118

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI-LTLWYRAPEVLL 186
                 +HRDL   N+L+  +    K+AD GLAR     I +        + + APE  L
Sbjct: 119 LEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 234
               +S   D+WS   +  E+VT   + +PG +    LQQ+   +R+   P 
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG 228

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 31/219 (14%)

Query: 9   LEKVGEGTYGKVYR--AREKATGKI---VALK----KTRLHEDDEGVPPTTLREVSILRM 59
           L ++G+G++G VY   AR+   G+    VA+K       L E  E      L E S+++ 
Sbjct: 11  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-----FLNEASVMKG 65

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGEN---IPVNTVK 115
            +   HVVRL+ V      +G+  L +V E M   DLK Y+RS R   EN    P  T++
Sbjct: 66  FTCH-HVVRLLGVVS----KGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119

Query: 116 SLMY---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKY 170
            ++    ++  G+A+ +    +HRDL   N  M     T+KI D G+ R    T   +K 
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARN-CMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              +L + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 81/366 (22%), Positives = 124/366 (33%), Gaps = 131/366 (35%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILR------- 58
           F K++ +G G +G+V   R+  T  + A+K              TLR+  +L        
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMK--------------TLRKADVLMRNQAAHV 48

Query: 59  MLSRD-------PHVVRLMDVKQGQNKEGRTVLYLVFEY------MDTDLKKYIRSFRQT 105
              RD         VV+L      Q+K+    LY V +Y      M   ++  I      
Sbjct: 49  KAERDILAEADNEWVVKLY--YSFQDKDN---LYFVMDYIPGGDMMSLLIRLGI------ 97

Query: 106 GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL 165
                 +  +  + +L   +   H  G +HRD+KP N+L+DR    +K+ D GL   F  
Sbjct: 98  ---FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGF-- 151

Query: 166 PIKKYTH----------------EILTLW------------------------------- 178
              ++TH                E    W                               
Sbjct: 152 ---RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTP 208

Query: 179 -YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVLL  T Y+   D WSV  I  E++     F  D              TP E  
Sbjct: 209 NYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQ 253

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME---HP 294
                 ++NW        Q+       L ++  DL+ ++       R+    A E   HP
Sbjct: 254 L----KVINWETTLHIPSQA------KLSREASDLILRLCC-GAEDRLGKNGADEIKAHP 302

Query: 295 YFDDLD 300
           +F  +D
Sbjct: 303 FFKGID 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 58.8 bits (142), Expect = 4e-10
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 27/214 (12%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSILRML 60
                ++++G G +G V+        K VA+K  R   + E+D       + E  ++  L
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEED------FIEEAQVMMKL 56

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMY 119
           S  P +V+L  V        R+ + LVFE+M+   L  Y+R+ R         T+  +  
Sbjct: 57  SH-PKLVQLYGVCTE-----RSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCL 107

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW- 178
            +C+G+A+     ++HRDL   N L+    + +K++D G+ R F L   +YT    T + 
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQV-VKVSDFGMTR-FVLD-DQYTSSTGTKFP 164

Query: 179 --YRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
             + +PEV   S  YS+  D+WS   +  E+ ++
Sbjct: 165 VKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 78/304 (25%), Positives = 138/304 (45%), Gaps = 42/304 (13%)

Query: 12  VGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +GEG +G+V RA      K        VA+K  + +  D+ +    + E+ +++++ +  
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA-DLISEMELMKLIGKHK 78

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK-------- 115
           +++ L+ V     +EG   LY++ EY    +L++++R+ R  G +   +  K        
Sbjct: 79  NIINLLGV---CTQEGP--LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 116 ----SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK 169
               S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV-MKIADFGLARGVHDIDYYKK 192

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLHI 226
            ++  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL  
Sbjct: 193 TSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251

Query: 227 FRLLGTPNEKVWPGVSSLMN--WHEYPQWNP------QSLATAVPNLDKDGLDLLEQMLQ 278
              +  P+      +  LM   WH  P   P      ++L   +  + ++ LDL     Q
Sbjct: 252 GHRMDKPSNCTHE-LYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQ 310

Query: 279 YDPS 282
           Y PS
Sbjct: 311 YSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 58.5 bits (141), Expect = 5e-10
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 67

Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 68  AVVSEEP------IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 120 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 177 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 57/301 (18%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L+  +R P +  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQN-TRHPFLTA 59

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q  ++     L  V EY +  +L  ++   R   E       ++  Y  ++   +
Sbjct: 60  LKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIVSAL 108

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            + H   +++RD+K  NL++D K   +KI D GL +              T  Y APEV 
Sbjct: 109 EYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV- 166

Query: 186 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           L    Y  AVD W +  +  E++  +   +  D E      +F L+             L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI-------------L 208

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDL 299
           M    +P+            L  +   LL  +L+ DP +R+      AK+ MEH +F  +
Sbjct: 209 MEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257

Query: 300 D 300
           +
Sbjct: 258 N 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 47/288 (16%)

Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 82

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +
Sbjct: 83  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--I 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 196

Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI 226
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG      +  +
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEEL 251

Query: 227 FRLLGTPNEKVWPGVSS-----LMN--WHEYPQWNPQSLATAVPNLDK 267
           F+LL   +    P   +     +M   WH  P   P +    V +LD+
Sbjct: 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.4 bits (141), Expect = 6e-10
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 49/232 (21%)

Query: 12  VGEGTYGKVYRA-----REKATGKIVALKKTRLHEDDEGVPPTTLR----EVSILRMLSR 62
           +GEG +GKV +A     + +A    VA+K  +     E    + LR    E ++L+ ++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-----ENASSSELRDLLSEFNLLKQVNH 62

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTG--------------- 106
            PHV++L              L L+ EY     L+ ++R  R+ G               
Sbjct: 63  -PHVIKLYGACSQDGP-----LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 107 -----ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLA 160
                  + +  + S  +Q+ +G+ +     ++HRDL   N+L+ + + M  KI+D GL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKM--KISDFGLS 174

Query: 161 RAF---TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           R        +K+    I   W  A E L     Y+T  D+WS   +  E+VT
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 58.3 bits (142), Expect = 7e-10
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 30/194 (15%)

Query: 104 QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF 163
           +    +    VK ++ QL + +   H H I+H D+K  N+L DR    + + D GL +  
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160

Query: 164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL 223
             P     ++  TL Y +PE + G  +Y  + D W+V  +  EL+T    F  D      
Sbjct: 161 GTP---SCYD-GTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKED------ 209

Query: 224 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK 283
                     +E++   + SL    +  Q         + N+ K+  D ++ ML+Y+ + 
Sbjct: 210 ---------EDEEL--DLESL---LKRQQKKL----PFIKNVSKNANDFVQSMLKYNINY 251

Query: 284 R-ISAKKAMEHPYF 296
           R  +  + ++HP+ 
Sbjct: 252 RLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 49/278 (17%)

Query: 8   KLEKV-GEGTYGKVYRAR---EKATGKIVALKKTRL----HEDDEGVPPTTLREVSILRM 59
           KL K+ GEG +G V   +   +  +   VA+K  +L    + + E      L E + ++ 
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF----LSEAACMKD 57

Query: 60  LSRDPHVVRLMDVK-QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG--ENIPVNTVK 115
               P+V++L+ V  +  + +      ++  +M   DL  ++   R  G  E +P+ T+ 
Sbjct: 58  FDH-PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR------------AF 163
             M  +  G+ +      +HRDL   N  M R+ MT+ +AD GL++              
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARN-CMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPG--DSEL 220
            +P+K    E L     A  V      Y++  D+W+      E+ T+    +PG  + E+
Sbjct: 176 KMPVKWIAIESL-----ADRV------YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224

Query: 221 QQLL-HIFRLLGTPN--EKVWPGVSSLMNWHEYPQWNP 255
              L H  RL    +  ++++  + S   W   P+  P
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYSC--WRADPKDRP 260

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 67/254 (26%), Positives = 112/254 (44%), Gaps = 27/254 (10%)

Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T K VA+K  +       +P   L+E  I++ L  D  V    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTK-VAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN--IPVNTVKSLMYQLCKGVAFC 128
            V +         +Y+V E+M    K  +  F + G+   + +  +  +  Q+  G+A+ 
Sbjct: 69  VVSE-------EPIYIVTEFMG---KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEVL 185
                +HRDL+  N+L+    +  KIAD GLAR   +   +YT        + + APE  
Sbjct: 119 ERMNYIHRDLRAANILVG-DNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWP-GVSS 243
           L    ++   D+WS   +  ELVTK  + +PG    + L  + R    P  +  P  +  
Sbjct: 176 L-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234

Query: 244 LMN--WHEYPQWNP 255
           LM   W + P   P
Sbjct: 235 LMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +G+G++GKV  A+ K+ G   A+K    KT L + ++      + E ++L    + P +V
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQN---HIMAERNVLLKNLKHPFLV 59

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYI---RSFRQTGENIPVNTVKSLMYQLCK 123
            L    Q   K     LY V +Y++  +L  ++   R F +         V S       
Sbjct: 60  GLHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVAS------- 107

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + + H   I++RDLKP N+L+D +   + + D GL +    P +  +    T  Y APE
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166

Query: 184 VLLGSTHYSTAVDMWSVACIFAELV 208
           VL     Y   VD W +  +  E++
Sbjct: 167 VLRKEP-YDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)

Query: 11  KVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++GEG +GKV+ A       +    +VA+K   L E  E       RE  +L +L    H
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTVLQHQ-H 68

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRS------FRQTGENIPVN--TVKS 116
           +VR      G   EGR  L +VFEYM   DL +++RS          GE++     T+  
Sbjct: 69  IVRFY----GVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123

Query: 117 LMY---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYT 171
           ++    Q+  G+ +      +HRDL   N L+ +  + +KI D G++R    T   +   
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGG 182

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             +L + +  PE +L    ++T  D+WS   +  E+ T
Sbjct: 183 RTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M  + F+ ++ +G G +G+V   R K++ ++ A+K   L + +        R  S     
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK--LLSKFE-----MIKRSDSAFFWE 92

Query: 61  SRD-------PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVN 112
            RD         +V+L    Q         LY+V EYM   DL   + ++     +IP  
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDK-----YLYMVMEYMPGGDLVNLMSNY-----DIPEK 142

Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-RAFTLPIKKYT 171
             +    ++   +   H  G +HRD+KP N+L+D K+  LK+AD G   +     + +  
Sbjct: 143 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCD 201

Query: 172 HEILTLWYRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             + T  Y +PEVL    G  +Y    D WSV     E++     F  DS
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 10  EKVGEGTYGKVYRAR--EKATGKI-VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
             +G+G +G VY     +    KI  A+K      D E V    L+E  I++  S  P+V
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFS-HPNV 58

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM---YQLCK 123
           + L+ +      EG  ++ L +     DL+ +IRS      + P  TVK L+    Q+ K
Sbjct: 59  LSLLGICL--PSEGSPLVVLPY-MKHGDLRNFIRS----ETHNP--TVKDLIGFGLQVAK 109

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----LPIKKYTHEILTLWY 179
           G+ +      +HRDL   N ++D ++ T+K+AD GLAR         +  +T   L + +
Sbjct: 110 GMEYLASKKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
            A E L     ++T  D+WS   +  EL+T+ A
Sbjct: 169 MALESLQTQK-FTTKSDVWSFGVLLWELMTRGA 200

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 63/243 (25%)

Query: 10  EKVGEGTYGKVYRAR----------------EKATGKIVALKKTRLHEDDEGVPPTTLRE 53
           EK+GEG +G+V+                    K    +VA+K  R  + ++      L+E
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-PDANKNARNDFLKE 69

Query: 54  VSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFR---QTGEN- 108
           V IL  L  DP+++RL+ V   ++      L ++ EYM+  DL +++ S     +     
Sbjct: 70  VKILSRLK-DPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEENGN 123

Query: 109 --------IPVNTVKSLMY---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL 157
                   +P  +  SL++   Q+  G+ +      +HRDL   N L+  + +T+KIAD 
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIKIADF 182

Query: 158 GLARAF------------TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFA 205
           G++R               LPI+         W     +L+G   ++TA D+W+      
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIR---------WMAWECILMGK--FTTASDVWAFGVTLW 231

Query: 206 ELV 208
           E++
Sbjct: 232 EIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 65/262 (24%), Positives = 117/262 (44%), Gaps = 39/262 (14%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++++G G +G V+  + +A  K VA+K      + E+D       + E  ++  LS  P 
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED------FIEEAKVMMKLSH-PK 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +V+L  V   Q       LY+V E+M+   L  Y+R   Q    +  + + S+   +C+G
Sbjct: 61  LVQLYGVCTQQKP-----LYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEG 112

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRA 181
           + +   +  +HRDL   N L+   T  +K++D G+ R + L   +YT        + +  
Sbjct: 113 MEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTR-YVLD-DEYTSSSGAKFPVKWSP 169

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPG 240
           PEV   S  YS+  D+WS   +  E+ T+  + F   S  +    +  ++        P 
Sbjct: 170 PEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE----VVEMISRGFRLYRPK 224

Query: 241 VSS-------LMNWHEYPQWNP 255
           ++S          WHE P+  P
Sbjct: 225 LASMTVYEVMYSCWHEKPEGRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 12/150 (8%)

Query: 84  LYLVFEY-MDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCKGVAFCHGHGILHRDLKP 140
           L L+ EY    DL K I+  ++  E++P     V  L YQ+   +   H   ++HRDLK 
Sbjct: 140 LLLIMEYGSGGDLNKQIK--QRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197

Query: 141 HNLLMDRKTMTLKIADLGLARAFT--LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW 198
            N+ +   T  +K+ D G ++ ++  + +   +    T +Y APE L     YS   DMW
Sbjct: 198 ANIFL-MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMW 255

Query: 199 SVACIFAELVTKTALFPGDSE---LQQLLH 225
           S+  I  EL+T    F G S+   +QQ+L+
Sbjct: 256 SLGVILYELLTLHRPFKGPSQREIMQQVLY 285

Length = 478

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 39/249 (15%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT-----LREVSILR 58
           ++ + ++K+G G +G+V+      + K VA+K  +        P T      L E ++++
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLK--------PGTMSVQAFLEEANLMK 56

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSL 117
            L  D  +VRL  V   +       +Y++ EYM    L  +++S    G  + +  +   
Sbjct: 57  TLQHD-KLVRLYAVVTKEEP-----IYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDF 108

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---I 174
             Q+ +G+A+      +HRDL+  N+L+    M  KIAD GLAR   +   +YT      
Sbjct: 109 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLMC-KIADFGLAR--VIEDNEYTAREGAK 165

Query: 175 LTLWYRAPEVL-LGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE------LQQLLHI 226
             + + APE +  GS  ++   D+WS   +  E+VT   + +PG S       LQ+   +
Sbjct: 166 FPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223

Query: 227 FRLLGTPNE 235
            R+   P+E
Sbjct: 224 PRMENCPDE 232

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 55.3 bits (133), Expect = 6e-09
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 9   LEKVGEGTYG--KVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           L+++G G +G  K  + R +    I  +K+  + ED+       + E  ++  LS    +
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMMKLSH-EKL 61

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L  V   Q       +Y+V EYM    L  Y+R     G+    + +  +   +C+G+
Sbjct: 62  VQLYGVCTKQRP-----IYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGM 113

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
           A+      +HRDL   N L+D +   +K++D GL+R + L   +YT  + + +   +  P
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSR-YVLD-DEYTSSVGSKFPVRWSPP 170

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVT 209
           EVLL S  +S+  D+W+   +  E+ +
Sbjct: 171 EVLLYSK-FSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 23/167 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRML 60
           + F  ++ +G+G +G+V   ++K TGKI A+K   K+ + + D+      L  V   R +
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ------LAHVKAERDV 54

Query: 61  ---SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKS 116
              S  P VV L    Q         LYL+ E++   DL   +  +    E++     + 
Sbjct: 55  LAESDSPWVVSLYYSFQDAQ-----YLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRF 105

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF 163
            M +    +   H  G +HRD+KP N+L+DR    +K++D GL+  F
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 51/231 (22%)

Query: 9   LEKVGEGTYGKVYRAR--------EKATGKIVALKKT---RLHEDDEGVPPTTLREVSIL 57
             ++GEG +GKV+           +K    +  LK+T      +D E       RE  +L
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-------REAELL 62

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRS-------FRQTGENI 109
                + ++V+      G   EG     +VFEYM+  DL K++RS        +     +
Sbjct: 63  TNFQHE-NIVKFY----GVCTEGDP-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116

Query: 110 PVNTVKSLMY---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 166
              T+  L+    Q+  G+ +      +HRDL   N L+    + +KI D G++R     
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-LVVKIGDFGMSRDV--- 172

Query: 167 IKKYT--------HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              YT        H +L + +  PE ++    ++T  D+WS   +  E+ T
Sbjct: 173 ---YTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 55.3 bits (133), Expect = 7e-09
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 24/215 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR----EVSILRMLS 61
           + K E +G+G YG VY       G+++A+K+  L   +             EV +L+ L 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL- 59

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +  ++V+ +      N      + +  E++    +   +  F    E +     K    Q
Sbjct: 60  KHVNIVQYLGTCLDDN-----TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK----Q 110

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EIL---- 175
           +  GVA+ H + ++HRD+K +N+++      +K+ D G AR         TH  +L    
Sbjct: 111 ILDGVAYLHNNCVVHRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169

Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            T ++ APEV +  + Y    D+WS+ C   E+ T
Sbjct: 170 GTPYWMAPEV-INESGYGRKSDIWSIGCTVFEMAT 203

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 53/226 (23%), Positives = 100/226 (44%), Gaps = 37/226 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRA---REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           D     + + EGT+G+++      EK   +     KT      E      L+E  +L  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIP--VNT--VK 115
           S   +++ ++ V      E     ++++ YM+  +LK +++  R    N P  ++T  + 
Sbjct: 66  SH-QNILPILHV----CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------ 163
            +  Q+  G+++ H  G++H+D+   N ++D + + +KI D  L+R              
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNE 179

Query: 164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             P+K         W  A E L+    YS+A D+WS   +  EL+T
Sbjct: 180 NRPVK---------WM-ALESLVNK-EYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.1 bits (133), Expect = 7e-09
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 19/197 (9%)

Query: 10  EKVGEGTYGKVYRAREKA-TGKI--VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +K+G+G++G V R       GK+  VA+K  +  +    +    L+E +I+  L    ++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSL-DHENL 58

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENI-PVNTVKSLMYQLCKGV 125
           +RL  V           L +V E     L   +   R+       ++T+     Q+  G+
Sbjct: 59  IRLYGVVLTHP------LMMVTEL--APLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRAP 182
            +      +HRDL   N+L+      +KI D GL RA       Y    H  +   + AP
Sbjct: 111 RYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 183 EVLLGSTHYSTAVDMWS 199
           E L   T +S A D+W 
Sbjct: 170 ESLRTRT-FSHASDVWM 185

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 75/307 (24%), Positives = 124/307 (40%), Gaps = 56/307 (18%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +G+G++GKV  AR KA  K  A+K    K  L + +E      + E ++L    + P +V
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE---KHIMSERNVLLKNVKHPFLV 59

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L    Q  +K     LY V +Y++  +L  +++  R   E       +    ++   + 
Sbjct: 60  GLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALG 110

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
           + H   I++RDLKP N+L+D +   + + D GL +         +    T  Y APEV L
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEV-L 168

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
               Y   VD W +  +  E++     F   +  +   +I                    
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------------------ 210

Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK----KAMEHPYF-----D 297
                   P  L    PN+      LLE +LQ D +KR+ AK    +   H +F     D
Sbjct: 211 -------KPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260

Query: 298 DLDKTRL 304
           DL   ++
Sbjct: 261 DLINKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 64/237 (27%), Positives = 112/237 (47%), Gaps = 38/237 (16%)

Query: 8   KLEK-VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT-----LREVSILRMLS 61
           KLEK +G G +G+V+ A      K VA+K  +        P +      L E ++++ L 
Sbjct: 9   KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMK--------PGSMSVEAFLAEANVMKTLQ 59

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            D  +V+L  V        +  +Y++ E+M    L  +++S    G   P+  +     Q
Sbjct: 60  HD-KLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQ 110

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTL 177
           + +G+AF      +HRDL+  N+L+   ++  KIAD GLAR   +   +YT        +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLAR--VIEDNEYTAREGAKFPI 167

Query: 178 WYRAPEVL-LGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRL 229
            + APE +  GS  ++   D+WS   +  E+VT   + +PG S    ++ L   +R+
Sbjct: 168 KWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 222

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.9 bits (134), Expect = 8e-09
 Identities = 45/190 (23%), Positives = 83/190 (43%), Gaps = 10/190 (5%)

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE- 173
           +++M QL   V + H   ++HRD+K  N+ ++     + + D G A  F    + + +  
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGW 328

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD---SELQQLLHIFRLL 230
           + T+   +PE+L G   Y    D+WS   I  ++++      GD      +QLL I   L
Sbjct: 329 VGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Query: 231 GTPNEKVWPGVSSLMNWHEYPQWN--PQSLATAVPN--LDKDGLDLLEQMLQYDPSKRIS 286
              +E+       L ++ +  + +    S+   + N  L  D    L +ML +D   R  
Sbjct: 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG 447

Query: 287 AKKAMEHPYF 296
           A + +  P F
Sbjct: 448 AAELLALPLF 457

Length = 501

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.9 bits (132), Expect = 9e-09
 Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 36/268 (13%)

Query: 12  VGEGTYGKVYRAREK-----ATGKI-VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +G G +G+VY           +G I VA+K  R    D+      L+E  ++   +  P+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNH-PN 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM---YQL 121
           +V+L+ V      +     Y++ E M+  DL  Y+R  R      P+ T+K L+     +
Sbjct: 61  IVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTM----TLKIADLGLARAFTLP--IKKYTHEIL 175
            KG  +      +HRDL   N L+  K       +KI D GLAR        +K    +L
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIF---RLLG 231
            + + APE LL    ++T  D+WS   +  E++T     +P  +  + L H+    RL  
Sbjct: 176 PVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234

Query: 232 TPN--EKVWPGVSSLMN--WHEYPQWNP 255
             N  +K++     LM   W + P   P
Sbjct: 235 PENCPDKIY----QLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 63/240 (26%)

Query: 10  EKVGEGTYGKVY-------------------RAREKATGKIVALKKTRLHEDDEGVPPTT 50
           EK+GEG +G+V+                    A       +VA+K  R    D       
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPV---LVAVKVLRPDASDNARE-DF 66

Query: 51  LREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENI 109
           L+EV IL  LS DP++ RL+ V           L ++ EYM+  DL ++++       + 
Sbjct: 67  LKEVKILSRLS-DPNIARLLGVCTVDP-----PLCMIMEYMENGDLNQFLQK-HVAETSG 119

Query: 110 PVNTVKS-----LMY---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR 161
                KS     L+Y   Q+  G+ +      +HRDL   N L+ +   T+KIAD G++R
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN-YTIKIADFGMSR 178

Query: 162 -AFT-----------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             ++           LPI+         W     VLLG   ++T  D+W+      E++T
Sbjct: 179 NLYSSDYYRVQGRAPLPIR---------WMAWESVLLGK--FTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 23/200 (11%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           E +GEG +G V +   + TG+ VA+K  +     +      L E +++  L    ++VRL
Sbjct: 12  EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAF----LEETAVMTKL-HHKNLVRL 64

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL--CKGVAF 127
           + V           LY+V E M    K  + +F +T     V+ ++ L + L   +G+ +
Sbjct: 65  LGVILHNG------LYIVMELMS---KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
                ++HRDL   N+L+    +  K++D GLAR  +       +  L + + APE  L 
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVA-KVSDFGLARVGS---MGVDNSKLPVKWTAPEA-LK 170

Query: 188 STHYSTAVDMWSVACIFAEL 207
              +S+  D+WS   +  E+
Sbjct: 171 HKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 36/219 (16%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRL--------HEDDEGVPPTTLREVSILRMLSRD 63
           +GEG +G+V +AR K  G  +     R+        H D  G       E+ +L  L   
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-------ELEVLCKLGHH 67

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFR------------QTGENIP 110
           P+++ L+        E R  LYL  EY    +L  ++R  R             T   + 
Sbjct: 68  PNIINLLGA-----CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 170
              +      + +G+ +      +HRDL   N+L+  +    KIAD GL+R   + +KK 
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKT 181

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              +   W       L  + Y+T  D+WS   +  E+V+
Sbjct: 182 MGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 34/219 (15%)

Query: 12  VGEGTYGKVYRAR---EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G +G V  A+   E  + + VA+K  +            LRE + ++     P+V++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH-PNVIK 65

Query: 69  LMDVKQGQNKEGRTVLYLV-FEYMD-TDLKKYIRSFRQTGE---NIPVNTVKSLMYQLCK 123
           L+ V      +GR  + +V   +M   DL  ++   R  GE    +P+ T+   M  +  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR------------AFTLPIKKYT 171
           G+ +      +HRDL   N +++ + MT+ +AD GL++            A  LP+K   
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
            E            L    Y+T  D+W+      E++T+
Sbjct: 184 LES-----------LADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 75/316 (23%), Positives = 130/316 (41%), Gaps = 59/316 (18%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREK-------ATGKIVALKKTRLHEDDEGVPPTTLRE 53
           M  + F  +  +G G++G+V  A  K       A  +    K  +  + D         E
Sbjct: 27  MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH-----VFSE 81

Query: 54  VSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT 113
             IL  +   P  V L     G  K+  + LYLV E++   +     +F +  +  P + 
Sbjct: 82  RKILNYI-NHPFCVNL----YGSFKD-ESYLYLVLEFV---IGGEFFTFLRRNKRFPNDV 132

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 173
                 Q+     +     I++RDLKP NLL+D+    +K+ D G A+   +  + YT  
Sbjct: 133 GCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAK--VVDTRTYTL- 188

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  Y APE+LL   H   A D W++     E++     F  +  L  L++        
Sbjct: 189 CGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPL--LIY-------- 237

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAK 288
            +K+  G+        +P++           LD +   L++++L +D +KR       A+
Sbjct: 238 -QKILEGIIY------FPKF-----------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQ 279

Query: 289 KAMEHPYFDDLDKTRL 304
              EHP+F ++D   L
Sbjct: 280 NVKEHPWFGNIDWVSL 295

Length = 340

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 67/273 (24%), Positives = 127/273 (46%), Gaps = 35/273 (12%)

Query: 9   LEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +E++GE  +GKVY+     T      + VA+K   L +  EG      +  +++R   + 
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKT--LKDKAEGPLREEFKHEAMMRSRLQH 67

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYI--RS-FRQTGENIPVNTVKS--- 116
           P++V L+ V   +       L ++F Y   +DL +++  RS     G      TVKS   
Sbjct: 68  PNIVCLLGVVTKEQP-----LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 117 ------LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IK 168
                 ++ Q+  G+ F   H ++H+DL   N+L+  K + +KI+DLGL R        K
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK-LNVKISDLGLFREVYAADYYK 181

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDSELQQLL 224
              + +L + + +PE ++    +S   D+WS   +  E+ +   L P     + ++ +++
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFS-YGLQPYCGYSNQDVIEMI 239

Query: 225 HIFRLLGTPNE-KVWPGVSSLMNWHEYPQWNPQ 256
              ++L  P++   W     L  W+E+P   P+
Sbjct: 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATG-KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           FE +  +GEG +G+V RA  K  G K+ A  K       E        E+ +L  L   P
Sbjct: 6   FEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR------------QTGENIPV 111
           +++ L+        E R  LY+  EY    +L  ++R  R             T   +  
Sbjct: 64  NIINLLGA-----CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 171
             +      +  G+ +      +HRDL   N+L+  + +  KIAD GL+R   + +KK  
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTM 177

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             +   W  A E L  S  Y+T  D+WS   +  E+V+
Sbjct: 178 GRLPVRWM-AIESLNYSV-YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 22/212 (10%)

Query: 12  VGEGTYGKVYRAREKATG-KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG +G+V +AR K  G ++ A  K       +        E+ +L  L   P+++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR------------QTGENIPVNTVKSL 117
                   E R  LYL  EY    +L  ++R  R             T   +    +   
Sbjct: 63  GA-----CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
              + +G+ +      +HRDL   N+L+  +    KIAD GL+R   + +KK    +   
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           W       L  + Y+T  D+WS   +  E+V+
Sbjct: 177 WMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 25/215 (11%)

Query: 11  KVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++GEG +GKV+ A          KI+   KT L +  +       RE  +L  L  + H+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKT-LKDASDNARKDFHREAELLTNLQHE-HI 69

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIR-----SFRQTGENIPVNTVKSLMY- 119
           V+      G   EG   L +VFEYM   DL K++R     +      N P    +S M  
Sbjct: 70  VKFY----GVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEI 174
              Q+  G+ +      +HRDL   N L+  + + +KI D G++R    T   +   H +
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           L + +  PE ++    ++T  D+WS+  +  E+ T
Sbjct: 184 LPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 44/271 (16%)

Query: 11  KVGEGTYGKVYRA--------REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++GEG +GKV+ A        ++K    + ALK   L    +       RE  +L  L  
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNLQH 66

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSF------------RQTGENI 109
           + H+V+   V    +      L +VFEYM   DL K++R+             RQ    +
Sbjct: 67  E-HIVKFYGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
            ++ +  +  Q+  G+ +      +HRDL   N L+    + +KI D G++R    T   
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYY 179

Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFP-GDSELQQLL 224
           +   H +L + +  PE ++    ++T  D+WS   I  E+ T  K   F   ++E+ + +
Sbjct: 180 RVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238

Query: 225 HIFRLLGTPNEKVWPG-VSSLM--NWHEYPQ 252
              R+L  P  +V P  V  +M   W   PQ
Sbjct: 239 TQGRVLERP--RVCPKEVYDIMLGCWQREPQ 267

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 58/298 (19%)

Query: 12  VGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+GT+GKV   +EKATG+  A   LKK  +   DE     TL E  +L+  SR P +  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQN-SRHPFLTA 59

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QLCKGV 125
           L    Q  ++     L  V EY +  +L  ++   R   E+      ++  Y  ++   +
Sbjct: 60  LKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSAL 108

Query: 126 AFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
            + H    +++RDLK  NL++D K   +KI D GL +              T  Y APEV
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167

Query: 185 LLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
            L    Y  AVD W +  +  E++  +   +  D E      +F L+             
Sbjct: 168 -LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI------------- 208

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 296
           LM    +P+            L  +   LL  +L+ DP +R+      AK+ M+H +F
Sbjct: 209 LMEEIRFPR-----------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 51/302 (16%)

Query: 12  VGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +G+G++GKV  A+ K  GK  A+K    K  L+  ++      + E ++L    + P +V
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ---KHIMAERNVLLKNVKHPFLV 59

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L    Q   K     LY V ++++  +L  +++  R    + P    +    ++   + 
Sbjct: 60  GLHYSFQTTEK-----LYFVLDFVNGGELFFHLQRER----SFPEPRARFYAAEIASALG 110

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
           + H   I++RDLKP N+L+D +   + + D GL +         T    T  Y APEV+ 
Sbjct: 111 YLHSINIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR 169

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
               Y   VD W +  +  E++     F      +   +I          + PG  SL  
Sbjct: 170 KQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH----KPLVLRPGA-SLTA 223

Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK----KAMEHPYFDDLDKT 302
           W                        +LE++L+ D  +R+ AK    +  EHP+F+ L  T
Sbjct: 224 W-----------------------SILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT 260

Query: 303 RL 304
            L
Sbjct: 261 DL 262

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 24/216 (11%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAR---EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM 59
               EK++ +G G +G VY+     E    KI    K    E         L E  +  M
Sbjct: 6   ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV--M 63

Query: 60  LSRD-PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            S D PHVVRL+ +           + L+ + M   L   +   R   +NI    + +  
Sbjct: 64  ASVDHPHVVRLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWC 115

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL-KIADLGLARAFTLPIKKYTHE--IL 175
            Q+ KG+++     ++HRDL   N+L+  KT    KI D GLA+   +  K+Y  E   +
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 176 TLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVT 209
            + + A E +L    TH S   D+WS      EL+T
Sbjct: 174 PIKWMALESILHRIYTHKS---DVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 70/306 (22%), Positives = 128/306 (41%), Gaps = 42/306 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE L+ +G G +G+V   + K TG++ A+K     E  +       RE   + +    
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +  L    Q +N      LYLV +Y +  DL   +  F    + +P +  +  + ++ 
Sbjct: 61  RWITNLHYAFQDENN-----LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMV 112

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG-LARAFTLPIKKYTHEILTLWYRA 181
             +   H  G +HRD+KP N+L+D+    +++AD G   R       +    + T  Y +
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 182 PEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           PE+L     G   Y    D WS+     E++     F  +S ++    I           
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI----------- 220

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHP 294
                  MN  E+ Q+ P      V ++ ++  DL+ +++   P  R+     +   +HP
Sbjct: 221 -------MNHKEHFQFPPD-----VTDVSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHP 267

Query: 295 YFDDLD 300
           +F+ +D
Sbjct: 268 FFEGID 273

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 84/343 (24%), Positives = 130/343 (37%), Gaps = 89/343 (25%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE L+ +G G +G+V   ++K TG I A+K  R  +  E      +R    + + +  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEY------MDTDLKKYIRSFRQTGENIPVNTVKSL 117
             VV++    Q +       LYL+ E+      M   +KK   S   T   I    +   
Sbjct: 61  AWVVKMFYSFQDKRN-----LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL--- 112

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-----TLPIKKYTH 172
                  +   H  G +HRD+KP NLL+D K   +K++D GL         T   +  TH
Sbjct: 113 ------AIDAIHQLGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTH 165

Query: 173 E------------------------------ILTLWYRAPEVLLGSTHYSTAVDMWSVAC 202
                                          + T  Y APEV +  T Y+   D WS+  
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGV 224

Query: 203 IFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV 262
           I  E++     F  +              TP E        +MNW E   + P+     V
Sbjct: 225 IMYEMLIGYPPFCSE--------------TPQET----YRKVMNWKETLVFPPE-----V 261

Query: 263 PNLDKDGLDLLEQMLQY--DPSKRISAKKAME---HPYFDDLD 300
           P + +   DL+   L++  D   RI +    E   HP+F+ +D
Sbjct: 262 P-ISEKAKDLI---LRFCTDSENRIGSNGVEEIKSHPFFEGVD 300

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 48/221 (21%)

Query: 12  VGEGTYGKVYRA------REKATGKI-VALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A      +  A  K+ V + K   H  +       + E+ I+  L    
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER---EALMSELKIMSHLGNHE 99

Query: 65  HVVRLMD--VKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           ++V L+      G        + ++ EY    DL  ++R  R++   + +  + S  YQ+
Sbjct: 100 NIVNLLGACTIGGP-------ILVITEYCCYGDLLNFLRRKRES--FLTLEDLLSFSYQV 150

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-------------AFTLPIK 168
            KG+AF      +HRDL   N+L+    +  KI D GLAR             A  LP+K
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLLTHGKIV-KICDFGLARDIMNDSNYVVKGNAR-LPVK 208

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                     + APE +     Y+   D+WS   +  E+ +
Sbjct: 209 ----------WMAPESIFNCV-YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 65/281 (23%), Positives = 129/281 (45%), Gaps = 39/281 (13%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATG----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           + A   +E++GE  +GK+Y+      G    ++VA+K  +   + +       +E S++ 
Sbjct: 4   LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ-QEASLMA 62

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN----- 112
            L   P++V L+ V   +       + ++FEY++  DL +++   R    ++  +     
Sbjct: 63  ELHH-PNIVCLLGVVTQEQP-----VCMLFEYLNQGDLHEFL-IMRSPHSDVGCSSDEDG 115

Query: 113 TVKS---------LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF 163
           TVKS         +  Q+  G+ +   H  +H+DL   N+L+  + + +KI+DLGL+R  
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ-LHVKISDLGLSREI 174

Query: 164 TLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GD 217
                 +     +L + +  PE ++    +S+  D+WS   +  E+ +   L P     +
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFS-FGLQPYYGFSN 232

Query: 218 SELQQLLHIFRLLGTPNEKVWPGVSSLMN--WHEYPQWNPQ 256
            E+ +++   +LL    E   P + SLM   W E P   P+
Sbjct: 233 QEVIEMVRKRQLLPCS-EDCPPRMYSLMTECWQEGPSRRPR 272

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 59/261 (22%), Positives = 104/261 (39%), Gaps = 33/261 (12%)

Query: 52  REVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPV 111
           RE+ IL+ +S    ++ L+   + ++      + +V      DL  Y+         +P+
Sbjct: 135 REIDILKTISHRA-IINLIHAYRWKS-----TVCMVMPKYKCDLFTYV----DRSGPLPL 184

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 171
               ++  +L + +A+ HG GI+HRD+K  N+ +D     + + D G A          T
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHP--DT 241

Query: 172 HEIL----TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG---DSELQQLL 224
            +      TL   +PE LL    Y    D+WS   +  E+  K     G    S   QL 
Sbjct: 242 PQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR 300

Query: 225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWN---------PQSLATAVPNLDKDGLDLLEQ 275
            I R +   +   +P   S      + Q+          P  +     ++D +   L+ +
Sbjct: 301 SIIRCMQV-HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEY--LIAK 357

Query: 276 MLQYDPSKRISAKKAMEHPYF 296
           ML +D   R SA+  +  P F
Sbjct: 358 MLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 32/177 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F K++ +G G +G+V  AR+  T  + A+K              TLR+  +L + ++  H
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMK--------------TLRKKDVL-LRNQVAH 47

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENI---------PVNTVKS 116
           V    D+    + E   V+ L + + D D   ++  +   G+ +         P +  + 
Sbjct: 48  VKAERDILAEADNE--WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARF 105

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 173
            + +L   V   H  G +HRD+KP N+L+DR    +K+ D GL   F     ++TH+
Sbjct: 106 YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGF-----RWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)

Query: 8   KLEKV-GEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           K+EKV G G +G+V   R K  GK    VA+K  +    ++      L E SI+      
Sbjct: 7   KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDH- 64

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P+++ L    +G   + + V+ +V EYM+   L  ++R  +  G+   +  V  ++  + 
Sbjct: 65  PNIIHL----EGVVTKSKPVM-IVTEYMENGSLDAFLR--KHDGQFTVIQLV-GMLRGIA 116

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTH---EILTLW 178
            G+ +    G +HRDL   N+L++   +  K++D GL+R     P   YT    +I   W
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             APE  +    +++A D+WS   +  E+++
Sbjct: 176 -TAPEA-IAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 53/231 (22%)

Query: 12  VGEGTYGKVYRAREKATG-------KIVALK------KTRLHEDDEGVPPTTLREVSILR 58
           +G+G +G+V++AR  A G        +VA+K         +  D +       RE ++  
Sbjct: 13  IGQGAFGRVFQAR--APGLLPYEPFTMVAVKMLKEEASADMQADFQ-------REAAL-- 61

Query: 59  MLSRD-PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRS--------------- 101
           M   D P++V+L+    G    G+  + L+FEYM   DL +++R                
Sbjct: 62  MAEFDHPNIVKLL----GVCAVGKP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 102 -FRQTGENIPVNTVKSLMY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
             +     +P++  + L    Q+  G+A+      +HRDL   N L+  + M +KIAD G
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFG 175

Query: 159 LARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL 207
           L+R        K   ++ + + +  PE +     Y+T  D+W+   +  E+
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATG---KI-VALKKTRLHEDDEGVPPTTLREV--SILRM 59
           F+K++ +G G +G VY+      G   KI VA+K+ R     E   P   +E+      M
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAYVM 63

Query: 60  LSRD-PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSL 117
            S D PHV RL+ +         + + L+ + M    L  Y+R   +  +NI    + + 
Sbjct: 64  ASVDNPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNW 114

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--IL 175
             Q+ KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   +
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            + + A E +L    Y+   D+WS      EL+T
Sbjct: 174 PIKWMALESILHRI-YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 65/299 (21%), Positives = 123/299 (41%), Gaps = 56/299 (18%)

Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV---------SILR---- 58
           +G G  G V  A+  + G+  A+K   +    E        EV         SI++    
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
              +DP           +N E   ++ LV +Y +  DL++ I+S  +T      +    L
Sbjct: 100 FAKKDP-----------RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLL 148

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-- 175
             Q+   V   H   ++HRD+K  N+L+    + +K+ D G ++ +   +          
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-VKLGDFGFSKMYAATVSDDVGRTFCG 207

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T +Y APE+      YS   DM+S+  +  EL+T    F G++ +++++H          
Sbjct: 208 TPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMH---------- 255

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           K   G           +++P       P++  +  +++  +L  DP +R S+ K +  P
Sbjct: 256 KTLAG-----------RYDPLP-----PSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 49.2 bits (117), Expect = 6e-07
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 33/215 (15%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           + M   + L+ +G+G +G V     +  G  VA+K  +    ++      L E S++  L
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQL 56

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
            R  ++V+L+ V      E +  LY+V EYM    L  Y+RS  ++   +  + +     
Sbjct: 57  -RHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSL 109

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTH 172
            +C+ + +   +  +HRDL   N+L+    +  K++D GL +  +       LP+K    
Sbjct: 110 DVCEAMEYLEANNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK---- 164

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL 207
                 + APE L     +ST  D+WS   +  E+
Sbjct: 165 ------WTAPEALR-EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 49.7 bits (118), Expect = 8e-07
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 16/216 (7%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE L+ +G G +G+V   + K   K+ A+K     E  +       RE   + +   +  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +  L    Q +N      LYLV +Y +  DL   +  F    + +P +  +  + ++   
Sbjct: 63  ITTLHYAFQDENN-----LYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIA 114

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG-LARAFTLPIKKYTHEILTLWYRAPE 183
           +   H    +HRD+KP N+LMD     +++AD G   +       + +  + T  Y +PE
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173

Query: 184 VLL----GSTHYSTAVDMWSVA-CIFAELVTKTALF 214
           +L     G   Y    D WS+  C++  L  +T  +
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 28/193 (14%)

Query: 49  TTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN 108
           +++ E  +LR LS  P V+ L+DV+      G T L  V     +DL  Y+ +  +    
Sbjct: 206 SSVHEARLLRRLSH-PAVLALLDVRV---VGGLTCL--VLPKYRSDLYTYLGARLR---- 255

Query: 109 IPVNT--VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA----RA 162
            P+    V ++  QL   + + HG GI+HRD+K  N+L++     + + D G A     +
Sbjct: 256 -PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGS 313

Query: 163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA-LF--PGDSE 219
           ++ P   +     T+   APEVL G   Y+ +VD+WS   +  E    TA LF      E
Sbjct: 314 WSTPF--HYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370

Query: 220 LQ----QLLHIFR 228
            +    Q+L I R
Sbjct: 371 RRPYDAQILRIIR 383

Length = 461

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 49.3 bits (117), Expect = 8e-07
 Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 37/267 (13%)

Query: 12  VGEGTYGKVYRAREKATGKI--VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +GEG +G V   +      I  VA+K  ++           L E   ++     P+V+RL
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH-PNVMRL 65

Query: 70  MDV-KQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGV 125
           + V  Q    EG     ++  +M   DL  ++   R     + +P   +   M  +  G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA------------RAFTLPIKKYTHE 173
            +      +HRDL   N +++ + M + +AD GL+            R   +P+K    E
Sbjct: 126 EYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG--DSELQQLLHIFRLL 230
            L     A  V      Y+T  D+WS      E+ T+    +PG  +SE+   L     L
Sbjct: 185 SL-----ADRV------YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233

Query: 231 GTPNEKVWPGVSSLMN--WHEYPQWNP 255
             P + +  G+ SLM+  W   P+  P
Sbjct: 234 KQPPDCL-DGLYSLMSSCWLLNPKDRP 259

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)

Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G G +G+V+R   K  G+    VA+K  +     E      L E SI+   S   +++R
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHH-NIIR 70

Query: 69  LMDVKQGQNKEGRTVLY----LVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           L         EG    +    ++ EYM+   L KY+R     GE      V  ++  +  
Sbjct: 71  L---------EGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLV-GMLRGIAA 118

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTH---EILTLWY 179
           G+ +      +HRDL   N+L++   +  K++D GL+R     P   YT    +I   W 
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW- 176

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            APE  +    +++A D+WS   +  E+++
Sbjct: 177 TAPEA-IAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 67/307 (21%), Positives = 117/307 (38%), Gaps = 54/307 (17%)

Query: 20  VYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE 79
           V+ A+ K T  +VA+KK  L    +       +E+   R L + P+++  +      ++ 
Sbjct: 16  VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSE- 73

Query: 80  GRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILH 135
               LY+V   M      DL K    F    E +P   +  ++  +   + + H  G +H
Sbjct: 74  ----LYVVSPLMAYGSCEDLLK--THFP---EGLPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 136 RDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYT-------HEILTLWYRAPEVLL 186
           R +K  ++L+  D K +   ++ L  + +     K+           +  L + +PEVL 
Sbjct: 125 RSVKASHILLSGDGKVV---LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 187 GSTH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
            +   Y+   D++SV     EL      F  D    Q+L          EKV   V  L+
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQML---------LEKVRGTVPCLL 231

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLD----------------LLEQMLQYDPSKRISAKK 289
           +   YP +      +   N   +  D                 +E  LQ DP  R SA +
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291

Query: 290 AMEHPYF 296
            + H +F
Sbjct: 292 LLNHSFF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.0 bits (111), Expect = 7e-06
 Identities = 24/71 (33%), Positives = 42/71 (59%), Gaps = 6/71 (8%)

Query: 95  LKKYIRSFRQTGENIP-----VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT 149
           L++++ + ++  +N+P     +N +K +M Q+  G+   H  GI+HRD+KP NLL+    
Sbjct: 287 LEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346

Query: 150 MTLKIADLGLA 160
             +KI D G A
Sbjct: 347 Q-VKIIDFGAA 356

Length = 507

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.6 bits (110), Expect = 8e-06
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 7/114 (6%)

Query: 107 ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 166
           E +    + S  YQ+ +G+ F      +HRDL   N+L+ +  + +KI D GLAR   + 
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI-VKICDFGLARDI-MH 289

Query: 167 IKKYTHE---ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
              Y  +    L + + APE +  +  Y+T  D+WS   +  E+ +     +PG
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 26/217 (11%)

Query: 5   AFEKLEKV-GEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRML 60
           +  K+E+V G G +G+V R R K  GK    VA+K  +    ++      L E SI+   
Sbjct: 4   SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQF 62

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMY 119
              P+++ L    +G   + R V+ ++ E+M+      + SF RQ      V  +  ++ 
Sbjct: 63  DH-PNIIHL----EGVVTKSRPVM-IITEFMENGA---LDSFLRQNDGQFTVIQLVGMLR 113

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEI- 174
            +  G+ +      +HRDL   N+L++   +  K++D GL+R      + P   YT  + 
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDP--TYTSSLG 170

Query: 175 --LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             + + + APE  +    +++A D+WS   +  E+++
Sbjct: 171 GKIPIRWTAPEA-IAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 78/353 (22%), Positives = 123/353 (34%), Gaps = 101/353 (28%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F K++ +G G +G+V  A +  T  + A+K              TLR+  +L   ++  H
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMK--------------TLRKKDVLNR-NQVAH 47

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTG---------ENIPVNTVKS 116
           V    D+    + E    LY  F+  D D   ++  +   G         E  P    + 
Sbjct: 48  VKAERDILAEADNEWVVKLYYSFQ--DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF 105

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP---------- 166
            + +L   +   H  G +HRD+KP N+L+D     +K+ D GL   F             
Sbjct: 106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGS 164

Query: 167 -IKKYTHEILTLW------------------------------------YRAPEVLLGST 189
            I++ + E   LW                                    Y APEVLL   
Sbjct: 165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RK 223

Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y+   D WSV  I  E++     F              L  TP E        ++NW  
Sbjct: 224 GYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQL----KVINWEN 265

Query: 250 YPQWNPQSLATAVPNLDKDGLDLLEQML--QYDPSKRISAKKAMEHPYFDDLD 300
                PQ        L  + +DL+ ++     +   R  A     HP+F ++D
Sbjct: 266 TLHIPPQV------KLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.6 bits (108), Expect = 9e-06
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 53/222 (23%)

Query: 84  LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN 142
           ++LV ++ +   L  +I  F     NIP   VK    ++   +   H  GI+ RDL P+N
Sbjct: 60  VFLVLQHAEGGKLWSHISKFL----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115

Query: 143 LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVAC 202
           +L+D +   +++                  E +   Y APEV  G +  + A D WS+  
Sbjct: 116 ILLDDRGH-IQLTYFSRWSEVE---DSCDGEAVENMYCAPEV-GGISEETEACDWWSLGA 170

Query: 203 IFAELVTKTALF---PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA 259
           I  EL+T   L    P        L+I                        P+W      
Sbjct: 171 ILFELLTGKTLVECHPSGINTHTTLNI------------------------PEW------ 200

Query: 260 TAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYF 296
                + ++   LL+Q+LQ++P++R+ A     +    HP+F
Sbjct: 201 -----VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 16/218 (7%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE ++ +G G +G+V   + K T +I A+K     E  +       RE   + +    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +  L    Q +N      LYLV + Y+  DL   +  F    + +P +  +  + ++ 
Sbjct: 61  QWITTLHYAFQDENY-----LYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMV 112

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG-LARAFTLPIKKYTHEILTLWYRA 181
             +   H    +HRD+KP N+L+D     +++AD G   +       + +  + T  Y +
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171

Query: 182 PEVLL----GSTHYSTAVDMWSVA-CIFAELVTKTALF 214
           PE+L     G   Y    D WS+  C++  L  +T  +
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 6   FEKLEKVGEGTYGKVYRA---REKATGKI-VALKKTRLHEDDEGVPPTTLREVS--ILRM 59
             KL+ +G G +G V++     E  + KI VA+K     +D  G    T +E++  +L M
Sbjct: 9   LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI---QDRSG--RQTFQEITDHMLAM 63

Query: 60  LSRD-PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            S D  ++VRL+ +  G +      L LV +     L   +   RQ  +++    + +  
Sbjct: 64  GSLDHAYIVRLLGICPGAS------LQLVTQLSP--LGSLLDHVRQHRDSLDPQRLLNWC 115

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-EILT- 176
            Q+ KG+ +   H ++HR+L   N+L+ +    ++IAD G+A       KKY + E  T 
Sbjct: 116 VQIAKGMYYLEEHRMVHRNLAARNILL-KSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174

Query: 177 -LWYRAPEVLLGS-THYSTAVDMWSVACIFAELVT 209
             W     +L G  TH S   D+WS      E+++
Sbjct: 175 IKWMALESILFGRYTHQS---DVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 175
           +Q+ KG+ F      +HRDL   N+L+    + +KI D GLAR  +  P  ++K     L
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGDAR-L 243

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 231
            L + APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 244 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302

Query: 232 TPNEKVWPGVSSLMN-WHEYPQWNP 255
            P+        ++++ WH  P   P
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRP 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 67/289 (23%), Positives = 111/289 (38%), Gaps = 69/289 (23%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE L+ +G G +G+V   ++K TG + A+K  R  +  E        +V  +R   RD  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK------EQVGHIRA-ERDIL 55

Query: 66  VV--RLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           V    L  VK   + + +  LYL+ E++       + +     + +     +  + +   
Sbjct: 56  VEADSLWVVKMFYSFQDKLNLYLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAETVL 112

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--------------TLPIKK 169
            +   H  G +HRD+KP NLL+D K   +K++D GL                  +LP   
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLP-SD 170

Query: 170 YTHEILT------LWYR----------------APEVLLGSTHYSTAVDMWSVACIFAEL 207
           +T + +        W R                APEV +  T Y+   D WS+  I  E+
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEM 229

Query: 208 VTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ 256
           +     F  +              TP E        +MNW E   + P+
Sbjct: 230 LIGYPPFCSE--------------TPQET----YKKVMNWKETLIFPPE 260

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 28/125 (22%)

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----------- 164
           S  YQ+ KG++F      +HRDL   N+L+    +T KI D GLAR              
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIRNDSNYVVKGNA 276

Query: 165 -LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSE 219
            LP+K          + APE +     Y+   D+WS   +  E+ +  ++ +PG   DS+
Sbjct: 277 RLPVK----------WMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325

Query: 220 LQQLL 224
             +++
Sbjct: 326 FYKMI 330

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 31/158 (19%)

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------ 163
           S  +Q+ +G+ F      +HRDL   N+L+    + +KI D GLAR              
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGDA 235

Query: 164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSE 219
            LP+K          + APE +     Y+T  D+WS   +  E+ +  A  +PG   D E
Sbjct: 236 RLPLK----------WMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284

Query: 220 LQQLLHIFRLLGTPNEKVWPGVSSLM--NWHEYPQWNP 255
             + L     +  P E   P + S+M   WH  P+  P
Sbjct: 285 FCRRLKEGTRMRAP-EYATPEIYSIMLDCWHNNPEDRP 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 13/146 (8%)

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEIL 175
           +Q+ +G+ F      +HRDL   N+L+    + +KI D GLAR  +  P  ++K +   L
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGSAR-L 238

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 231
            L + APE +     Y+T  D+WS   +  E+ +  A  +PG   + E  Q L     + 
Sbjct: 239 PLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297

Query: 232 TPNEKVWPGVSSLM--NWHEYPQWNP 255
            P E   P +  +M   W   P+  P
Sbjct: 298 AP-ENATPEIYRIMLACWQGDPKERP 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 42.7 bits (100), Expect = 9e-05
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 27/205 (13%)

Query: 10  EKVGEGTYGKVYRA--REKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRD 63
           E +G+G +G+V++   ++K     VA+K  +     E +P       L E  IL+     
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTP---VAVKTCK-----EDLPQELKIKFLSEARILKQYDH- 51

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+ V        R  +Y+V E +      ++   R+  + +    +         
Sbjct: 52  PNIVKLIGVCTQ-----RQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAA 104

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT--HEILTLWYRA 181
           G+A+      +HRDL   N L+    + LKI+D G++R     I   +   +I   W  A
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSRQEDDGIYSSSGLKQIPIKW-TA 162

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAE 206
           PE  L    YS+  D+WS   +  E
Sbjct: 163 PEA-LNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 39/218 (17%)

Query: 4   DAFEKLEKVGEGTYGKVY----RAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM 59
           D+   L  +G G +G+VY    R R+    ++    KT      E      L E  I+  
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
                ++VRL+ V        R   +++ E M   DLK ++R  R   E     T+K L+
Sbjct: 66  F-NHQNIVRLIGVSFE-----RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119

Query: 119 YQLC---KGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAF---------- 163
           +      KG  +   +  +HRD+   N L+  K      KIAD G+AR            
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179

Query: 164 --TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
              LPIK          +  PE  L    +++  D+WS
Sbjct: 180 RAMLPIK----------WMPPEAFLDGI-FTSKTDVWS 206

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 6/94 (6%)

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP---IKKYTHEIL 175
           YQ+  G+ F      +HRDL   N+L+    + +KI D GLAR        I K +   L
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKL-VKICDFGLARDIMRDSNYISKGS-TFL 303

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            L + APE +  +  Y+T  D+WS   +  E+ T
Sbjct: 304 PLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 65/313 (20%), Positives = 123/313 (39%), Gaps = 53/313 (16%)

Query: 20  VYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK 78
           VY AR   TG +V ++ T L    +E +    L+   +L    R P+++    V      
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEEHL--KALQNEVVLSHFFRHPNIMTSWTVFTTG-- 71

Query: 79  EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRD 137
              + L+++  +M        ++++   G +  +  + ++++   +G+ + H +G +HR+
Sbjct: 72  ---SWLWVISPFMAYGSANSLLKTYFPEGMSEAL--IGNILFGALRGLNYLHQNGYIHRN 126

Query: 138 LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL---------TLWYRAPEVLLGS 188
           +K  ++L+    +   ++  GL+  ++L       +++          L + +PE+L   
Sbjct: 127 IKASHILISGDGL---VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183

Query: 189 TH-YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            + Y+   D++SV     EL T    F      Q LL   +L G P     P   +    
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ--KLKGPPY---SPLDITTFPC 238

Query: 248 HEYPQWNPQS-----------------------LATAVP-NLDKDGLDLLEQMLQYDPSK 283
            E    N QS                       L T           +L+E  LQ DP K
Sbjct: 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298

Query: 284 RISAKKAMEHPYF 296
           R SA   + H +F
Sbjct: 299 RPSASSLLSHAFF 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 22/212 (10%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK-KTRLHEDDEGVPPTTLREVSILRMLSRD- 63
            ++++ +G G +G VY+      G+ V +    ++  +  G           L M S D 
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           PH+VRL+ V           + LV + M    L  Y+   +   +NI    + +   Q+ 
Sbjct: 69  PHLVRLLGVCLS------PTIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIA 119

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLAR      K+Y  +   + + + 
Sbjct: 120 KGMMYLEERRLVHRDLAARNVLV-KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 181 APEVLLGSTHY---STAVDMWSVACIFAELVT 209
           A E +    HY   +   D+WS      EL+T
Sbjct: 179 ALECI----HYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 14/165 (8%)

Query: 75  GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI 133
           GQ  E    L LVFEY +  DLK Y+   +    N  +  ++ +  ++  GV   H H  
Sbjct: 62  GQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120

Query: 134 LHRDLKPHNLLMDRKTMTLKIAD--LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH- 190
           LH DL   N  +    +T+K+ D  +G +R     I+    + + L + APE L+G  H 
Sbjct: 121 LHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE-LVGEFHG 178

Query: 191 ------YSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFR 228
                  +   ++W++     EL    A  +   S+ + L H+ +
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 48/224 (21%)

Query: 10  EKVGEGTYGKVYRAREKATG-----------KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           +++G G +GKV    E  +G           ++ A  + ++   +E  P  +L+  ++L+
Sbjct: 1   KEIGNGWFGKVILG-EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIP-VNTVKS 116
            L +   V               T   LV E+    DLK Y+RS R+     P   T++ 
Sbjct: 60  CLGQCTEV---------------TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR 104

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA------FTLPIKKY 170
           +  ++  G+   H +  +H DL   N L+    +T+KI D GL+        +  P + +
Sbjct: 105 MACEIALGLLHLHKNNFIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKEDYYVTPDQLW 163

Query: 171 THEILTLWYRAPEVLLGSTHYSTAV-------DMWSVACIFAEL 207
               + L + APE L+   H +  V       ++WS+     EL
Sbjct: 164 ----VPLRWIAPE-LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 30/216 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATG---KI-VALKKTRLHEDDEGVPPTTLREV---SILR 58
            +K++ +G G +G VY+      G   KI VA+K  R     E   P   +E+   + + 
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-----ENTSPKANKEILDEAYVM 63

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSL 117
                P+V RL+ +         + + LV + M    L  Y+R  +   + I    + + 
Sbjct: 64  AGVGSPYVCRLLGICL------TSTVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNW 114

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--IL 175
             Q+ KG+++     ++HRDL   N+L+      +KI D GLAR   +   +Y  +   +
Sbjct: 115 CVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKV 173

Query: 176 TLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVT 209
            + + A E +L    TH S   D+WS      EL+T
Sbjct: 174 PIKWMALESILHRRFTHQS---DVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 35/123 (28%), Positives = 50/123 (40%), Gaps = 28/123 (22%)

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV- 237
           Y APE+LLG  H   AVD W++     E +T    F  ++  Q   +I       N  + 
Sbjct: 546 YLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL------NRDIP 598

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           WP         E    N Q+   A+           E +L  DP+KR   K+  +HP F 
Sbjct: 599 WP------EGEEKLSVNAQN---AI-----------EILLTMDPTKRAGLKELKQHPLFH 638

Query: 298 DLD 300
            +D
Sbjct: 639 GVD 641

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	304
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
smart00090	237	RIO RIO-like kinase.	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.71
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG1243	690	consensus Protein kinase [General function predict	99.62
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.5
COG4248	637	Uncharacterized protein with protein kinase and he	99.44
KOG3087	229	consensus Serine/threonine protein kinase [General	99.44
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.32
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
PRK09902	216	hypothetical protein; Provisional	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.09
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.96
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.9
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.59
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.57
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.39
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.33
KOG2270	520	consensus Serine/threonine protein kinase involved	98.32
PF01636	239	APH: Phosphotransferase enzyme family This family	98.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.17
PLN02876	822	acyl-CoA dehydrogenase	98.16
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.01
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.97
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.83
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.81
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.81
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.75
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.57
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.55
PRK05231	319	homoserine kinase; Provisional	97.53
PLN02236	344	choline kinase	97.47
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.41
PRK12396	409	5-methylribose kinase; Reviewed	97.34
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.17
PTZ00384	383	choline kinase; Provisional	97.15
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.94
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.9
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.87
PLN02756	418	S-methyl-5-thioribose kinase	96.41
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.35
PRK10593	297	hypothetical protein; Provisional	96.32
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.2
PTZ00296	442	choline kinase; Provisional	95.24
PRK11768	325	serine/threonine protein kinase; Provisional	95.19
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.81
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.63
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.28
PRK10271	188	thiK thiamine kinase; Provisional	93.98
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.59
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.93

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.6e-58  Score=354.64  Aligned_cols=288  Identities=49%  Similarity=0.871  Sum_probs=270.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|...+.||+|.||.||++++..+|+.||||+++.....+.......+|++.|+.+ +|+||+.++++|.+...    
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~----   75 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSN----   75 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCc----
Confidence            4689999999999999999999999999999999998877777778889999999999 99999999999998888    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +.+|+||+..+|...++.   ....++..++..++.+++.|++|+|++.|+||||||.|+|++.+| .+||+|||+++.
T Consensus        76 -l~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~  150 (318)
T KOG0659|consen   76 -LSLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARF  150 (318)
T ss_pred             -eEEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhc
Confidence             999999999999998876   345799999999999999999999999999999999999999888 999999999999


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...+........-|-+|+|||.+.+...|+...|+||.|||+.||+-|.+.|.+.++.+++..+++.++.|.+..|+.+.
T Consensus       151 f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  151 FGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             cCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            98887777776779999999999999889999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ...++..+...+.......++..++++.+|+.+||..||.+|+|+.|.|+|+||+..+
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            9999988888888888888999999999999999999999999999999999999764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-58  Score=384.03  Aligned_cols=289  Identities=40%  Similarity=0.753  Sum_probs=253.3

Q ss_pred             CchhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            1 MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         1 ~i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .+|++|.++++||.|.||.||+++.+.++..||||.++.....-. ...-.+|+..|++++.||||+++.+++.+.+.  
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~--   83 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR--   83 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCc--
Confidence            368999999999999999999999999999999998875432211 12334799999999669999999999988773  


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++||||++.+|.+.++.+   +.++++..+..++.||++||+|+|++|++|||+||+|||+.+.. .+||+|||+|
T Consensus        84 --~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLA  157 (538)
T KOG0661|consen   84 --ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLA  157 (538)
T ss_pred             --eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccc
Confidence              29999999999999999985   56899999999999999999999999999999999999999665 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      +.+... .-.+.+..|-+|+|||+++....|+.+.|+||+|||++|+.+-++.|.+.++.+++.+++..++.|....|+.
T Consensus       158 Rev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  158 REVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            887654 3445667799999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC--cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMN--WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ......  ...+++.....+....++.++++.+||.+||.+||.+||||.|.|+||||+.-
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            433222  23455556666777788899999999999999999999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-57  Score=371.63  Aligned_cols=263  Identities=30%  Similarity=0.460  Sum_probs=222.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-----CCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .+.|.+.+.||+|+||.|-+|..+.+++.||||++........     ......+|+++|+++ +||+|+++++++...+
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPD  249 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCC
Confidence            4678999999999999999999999999999999987543322     223456899999999 9999999999999988


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKI  154 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl  154 (304)
                      .     .|+||||++| .|.+.+...    ..+.++....++.|++.|+.|||++||+||||||+|||+..+  ...+||
T Consensus       250 s-----~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  250 S-----SYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             c-----eEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence            8     8999999996 999988663    458888899999999999999999999999999999999755  258999


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhCCC--CCCCchhHHHHHHHHHHHhhccccCCCCchHH-HHHHHHHHhC
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLLG  231 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~  231 (304)
                      +|||+|...+.. ..+...+|||.|.|||++.+..  .+..+.|+|||||+||.+++|.+||.+..... ....+.+.-.
T Consensus       321 tDFGlAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y  399 (475)
T KOG0615|consen  321 TDFGLAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY  399 (475)
T ss_pred             cccchhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence            999999887744 5677789999999999997543  24568899999999999999999998876655 5555544333


Q ss_pred             CCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......|                        ..+|++..+||.+||..||+.|||++|+|+||||+.++
T Consensus       400 ~f~p~~w------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  400 AFGPLQW------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cccChhh------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            3332233                        26889999999999999999999999999999999876

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.3e-57  Score=354.85  Aligned_cols=287  Identities=40%  Similarity=0.720  Sum_probs=253.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      |+.|+.+.++|.|+||+||+++++.+|+-||||++.-+..+....+...+|+.+|+++ +|+|++.++++|.....    
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrk----   75 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRK----   75 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcce----
Confidence            7899999999999999999999999999999999988888787888899999999999 99999999999998777    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +++|||||+.++.+.++...+   ..+.+.+..++.|++.|+.|+|+++++||||||+|||++.++ .+||+|||+|+.
T Consensus        76 -lhLVFE~~dhTvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~  150 (396)
T KOG0593|consen   76 -LHLVFEYCDHTVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFART  150 (396)
T ss_pred             -eEEEeeecchHHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHh
Confidence             999999999999888887533   588999999999999999999999999999999999999888 999999999998


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...+....+....|-+|+|||.+.+..+|+...||||+||++.||++|.+.|.+.++.+++..+...++....+-..-+.
T Consensus       151 L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  151 LSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             hcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            88777777788889999999999998889999999999999999999999999999999999999998876654322222


Q ss_pred             c---cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          243 S---LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       243 ~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .   +....-........+...++.+++-+.+|+++||..||.+|++-+|++.||+|+.+
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            2   11112222334445666788999999999999999999999999999999999654

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-54  Score=350.95  Aligned_cols=297  Identities=59%  Similarity=1.051  Sum_probs=269.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCC-eeeeeceeccccc-CC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH-VVRLMDVKQGQNK-EG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~~-~~   80 (304)
                      +..|..+++||.|+||+||+|+.+.+|+.||+|+++.+...+.......+|+.+++.+ +|+| |+.+.+++..... ++
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence            4579999999999999999999999999999999998877666777889999999999 9999 9999999887662 33


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++|||+.+.+|..++.........++...++.++.||+.||+|||+++|+||||||.||+++.++ .+||+|||++
T Consensus        89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchH
Confidence            344899999999999999998765434577789999999999999999999999999999999999877 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....-+....+....|.+|+|||++.+...++...||||+|||++||+++...|...++.++...++..++.|.+..|+.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            98777777788889999999999999998899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc-cCCCCC-CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMNWH-EYPQWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .....++. .+..+. ...+....+..+++..+++.+||+.+|.+|.|+...|+||||..++.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            99998887 555555 66777788888899999999999999999999999999999998853

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-55  Score=376.83  Aligned_cols=254  Identities=27%  Similarity=0.464  Sum_probs=228.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +|...+.||.|||+.+|.+++..+|..||+|++.+.. .......++.+|+++.+++ +||||++++++|++...     
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~n-----   92 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNN-----   92 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCc-----
Confidence            5999999999999999999999999999999998743 2334567888999999999 99999999999999998     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +|+|.|.|.. +|..+++.    ..++++.+++.++.||+.||.|||+.+|+|||||..|+|++++- +|||+|||+|+.
T Consensus        93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~  167 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQ  167 (592)
T ss_pred             eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeee
Confidence            9999999985 77777763    35799999999999999999999999999999999999999666 999999999999


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      +..+.......+|||.|.|||++.... .+..+||||+||+||.|+.|++||...+-.+.+.++...-..          
T Consensus       168 le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~----------  236 (592)
T KOG0575|consen  168 LEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS----------  236 (592)
T ss_pred             ecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc----------
Confidence            998878888889999999999998766 699999999999999999999999999998988888653211          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                        .+..+|.++++||..||+.||.+|||+++||.|+||+.
T Consensus       237 ------------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  237 ------------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             ------------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence                              12268999999999999999999999999999999943

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-55  Score=348.81  Aligned_cols=290  Identities=48%  Similarity=0.866  Sum_probs=262.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|+.+..|++|.||.||.++++.++.-||+|.++.....+.......+|+++|.++ +||||+.+.++....+.+.  
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~--  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDK--  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccce--
Confidence            3689999999999999999999999999999999998887777777889999999999 8999999999987665433  


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +|+||||+..+|...+.+..   .++...++..+..|++.|++|||.+.|+||||||+|+|++..| .+||+|||+|+.
T Consensus       152 -iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~  226 (419)
T KOG0663|consen  152 -IYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLARE  226 (419)
T ss_pred             -eeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhh
Confidence             89999999999999998754   5899999999999999999999999999999999999999888 999999999999


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ++.+...++...-|.+|+|||.+++...+++..|+||+|||+.||+++.+.|.+.+..+++.++++.++.|.+..|+++.
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            99988888888889999999999999889999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCcc--cCCCCCCCcccccCCC--CChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWH--EYPQWNPQSLATAVPN--LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~--~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......  .+...+..++...++.  +++...+|++.+|..||.+|.||+|.|.|+||.+.+
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            876553  4444444455444444  559999999999999999999999999999999854

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-54  Score=360.07  Aligned_cols=287  Identities=46%  Similarity=0.827  Sum_probs=251.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|+.+++||+|.||.||++++..+|+.||+|+++.+........-..+|+.+|++| +||||+++.++..+....   
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~---  191 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSG---  191 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCc---
Confidence            3679999999999999999999999999999999999887777788888999999999 999999999998876211   


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+|+||||++-+|..++.+   ..-.+++.++..++.|++.||+|+|++|++|||||..|||+|.+| .+||+|||++++
T Consensus       192 siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~  267 (560)
T KOG0600|consen  192 SIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARF  267 (560)
T ss_pred             eEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceee
Confidence            1899999999998887764   234699999999999999999999999999999999999999888 999999999997


Q ss_pred             cccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          163 FTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       163 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      +..... ..+...-|.+|+|||.+++...|+...|+||.||||.||++|++.|...++.+++..+++..+.|.+..|+ .
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~  346 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-V  346 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-c
Confidence            765443 36666779999999999999999999999999999999999999999999999999999999999999998 3


Q ss_pred             cccCCcccCC-CCC-CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          242 SSLMNWHEYP-QWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       242 ~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ........+. ... ...+...+..++....+|+..||..||.+|.||.+.|+|+||..
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            3333322222 222 22355567899999999999999999999999999999999944

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-55  Score=352.26  Aligned_cols=258  Identities=29%  Similarity=0.475  Sum_probs=221.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++.+.+..||+|..|+||+++++.++.-+|+|++.. ..+....+++.+|+++++.+ .||+|+.+++.|.....    
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~----  151 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE----  151 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc----
Confidence            3577889999999999999999999999999999943 33444567889999999999 99999999999998773    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...++||||+| +|.+.+...    +.+++..+..++.++++||.|||+ .+|+||||||+|||++..| .|||+|||.+
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS  226 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVS  226 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEecccccc
Confidence            18999999996 999888764    569999999999999999999995 8999999999999999888 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC-----chHHHHHHHHHHhCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD-----SELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~-----~~~~~~~~~~~~~~~~~~  235 (304)
                      ......  ......||..|||||.+.+.. |+.++||||||++++|+.+|+.||...     ...+.+..++....+   
T Consensus       227 ~~lvnS--~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP---  300 (364)
T KOG0581|consen  227 GILVNS--IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP---  300 (364)
T ss_pred             HHhhhh--hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC---
Confidence            877655  456678899999999999887 899999999999999999999999875     344444444432111   


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCC-CCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                              ..+. .+|+++++||..||++||.+|||+.|+++|||+++...
T Consensus       301 ------------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  301 ------------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             ------------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence                                    1111 38999999999999999999999999999999997654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-54  Score=349.37  Aligned_cols=263  Identities=30%  Similarity=0.498  Sum_probs=231.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.|++++.||.|+||+|+.++.+++++.||+|++++....+ ........|.++|..+ +||.|++++-.|++...   
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~k---   99 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEK---   99 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCe---
Confidence            367999999999999999999999999999999998764322 2456778899999998 99999999999999988   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +|+|+||+.| .|...|+.    ...++++.+..++..|+.||.|||++||+||||||+|||+|.+| +++|+|||++
T Consensus       100 --LylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~  172 (357)
T KOG0598|consen  100 --LYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLC  172 (357)
T ss_pred             --EEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccc
Confidence              9999999997 99888865    35699999999999999999999999999999999999999888 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...-.........+||+.|||||++.+.. ++..+|.||||+++|+|++|..||...+......++.+.-..        
T Consensus       173 k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~--------  243 (357)
T KOG0598|consen  173 KEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP--------  243 (357)
T ss_pred             hhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC--------
Confidence            86554444555579999999999999886 899999999999999999999999999999988888764311        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC----CHHHHhcCCCccccccccC
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI----SAKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~eil~~~~~~~~~~~~~  304 (304)
                                         .....++.+++++++++|+.||++|.    ++.+|-+||||..++++++
T Consensus       244 -------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  244 -------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence                               11224889999999999999999996    7999999999999998753

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-54  Score=347.40  Aligned_cols=293  Identities=39%  Similarity=0.667  Sum_probs=259.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +...|..++.||.|++|.|..+.++.+|..||||++...-......++..+|+..|+.+ +|+||+.+.+++.....+..
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccccccc
Confidence            34567778999999999999999999999999999987666677788999999999999 89999999999988555566


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..+|+|+|+++.+|.+.+++    +..++++.+..++.|++.||+|+|+.+++||||||.|++++.+. .+||+|||+++
T Consensus        99 ~DvYiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR  173 (359)
T KOG0660|consen   99 NDVYLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLAR  173 (359)
T ss_pred             ceeEEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEecccccee
Confidence            66999999999999998876    23499999999999999999999999999999999999999888 89999999998


Q ss_pred             ecccC--CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .....  ...++...-|-+|+|||.+.+...++...||||+||||.||++|+..|.+.+...++..+...++.+.+....
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            77542  2334556669999999999988889999999999999999999999999999999999999999999887766


Q ss_pred             cccccC---CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          240 GVSSLM---NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       240 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ...+..   -..+.+..++..+...+++.++.+.+|+.+||..||.+|+|++|.|.||||+...
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            665332   2346777788889999999999999999999999999999999999999998763

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.1e-52  Score=346.91  Aligned_cols=283  Identities=49%  Similarity=0.928  Sum_probs=235.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++.+.||.|+||.||++.++.++..+++|.++..... .....+.+|+.+++.+ +||||+++++++.....    
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~----   77 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNL-KHANIVTLHDIIHTERC----   77 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCe----
Confidence            46899999999999999999999999999999998754322 2334667899999999 99999999999887665    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .+++|||+.++|.+++...   ...+++..+..++.||+.||.+||++|++|+||||+||+++.++ .+||+|||++..
T Consensus        78 -~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~  152 (288)
T cd07871          78 -LTLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARA  152 (288)
T ss_pred             -EEEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceee
Confidence             8999999999998887652   23578899999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....+.+....|+...
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         153 KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             ccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            55443444455678999999998776668999999999999999999999999988888888888888888877776654


Q ss_pred             ccCCcccC--CCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ....+...  +...........+.++.++.+||.+||+.||.+|||++|+++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            43332211  1222222233445788999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=352.67  Aligned_cols=261  Identities=30%  Similarity=0.472  Sum_probs=230.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|.+++.||.|+|++|++|+++.+++.||||++.+.- ..+...+.+..|..+|.+|++||.|++++-.|+++..    
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s----  148 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES----  148 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc----
Confidence            57999999999999999999999999999999876542 2233445677899999999999999999999999988    


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +|+|+||+. |+|.+++...    +.+++...+.++.+|+.||+|||++||+||||||+|||+|+++ +++|+|||.+.
T Consensus       149 -LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK  222 (604)
T KOG0592|consen  149 -LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAK  222 (604)
T ss_pred             -eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccc
Confidence             999999998 5999999875    5699999999999999999999999999999999999999888 99999999998


Q ss_pred             ecccCCCc-----------c--ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHH
Q 021982          162 AFTLPIKK-----------Y--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       162 ~~~~~~~~-----------~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  228 (304)
                      .++.....           .  ....||..|.+||++..+. .++.+|+|+||||+|.|+.|.+||...++.-.+.++..
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            77432111           1  3467899999999888776 89999999999999999999999999999999999887


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                      .-...                            .+++++.+.+||+++|-.||+.|+|+.||.+||||..++++-
T Consensus       302 l~y~f----------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  302 LDYEF----------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             hcccC----------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            53332                            237889999999999999999999999999999999999864

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-53  Score=341.94  Aligned_cols=289  Identities=38%  Similarity=0.690  Sum_probs=252.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .|...+.+|+|+||.||.+....++..+|||.+..+..-      -..|+++++.+ +||||++++-+|.........+.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHH
Confidence            477789999999999999999999999999988765432      23799999999 99999999999887665534456


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      .+||||++.+|.+.++.....+..++...+.-+..||.+||.|||+.||+||||||.|+|+|.+.+.+||+|||.|....
T Consensus        98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            78999999999999998777778899999999999999999999999999999999999999998899999999998887


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      .+... .....|-.|+|||.+.+...|+.+.||||.||++.||+-|++.|.+.+..+++..+++.++.|+..+...+.-.
T Consensus       178 ~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  178 KGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             cCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            66444 55667899999999999999999999999999999999999999999999999999999999998776655544


Q ss_pred             CCcccCCCCCCCcccc-cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          245 MNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       245 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .....+++.....+.. .....++++.+|+.++|..+|.+|.++.|++.||||.++..
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            4444555555555544 66789999999999999999999999999999999998743

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-51  Score=349.19  Aligned_cols=259  Identities=32%  Similarity=0.491  Sum_probs=223.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC---CCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .+.|.+.+.||+|+||+|+.+.+..++..+++|++......   ......+.+|+.+++++..||||+++++++..... 
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~-   94 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK-   94 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe-
Confidence            46899999999999999999999999999999976654211   23455666899999999449999999999998888 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          +++||||+.| .|.+++..    ..++++.++..+++|+++|++|+|+.||+||||||+||+++.+..++||+|||
T Consensus        95 ----~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   95 ----IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             ----EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence                9999999996 99999876    35789999999999999999999999999999999999999882499999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ++.............+|++.|+|||++.+.. +.+.++||||+|++||.|++|..||.+.+.......+.+....     
T Consensus       167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~-----  241 (370)
T KOG0583|consen  167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK-----  241 (370)
T ss_pred             cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc-----
Confidence            9987744445667789999999999999877 6789999999999999999999999998777777765442111     


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCC-ChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNL-DKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                          +   ...+ |.++++|+++||..||.+|+|+.+|+.||||+.
T Consensus       242 --------------------~---p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 --------------------I---PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --------------------C---CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                1   1134 899999999999999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-53  Score=328.28  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=220.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .+|+++++||.|.||+||++.+..+|..++.|.+.....+........+|+++|++| +||||++++++...++.   ..
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~---ev   94 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDN---EV   94 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccc---hh
Confidence            469999999999999999999999999999999987666666677888999999999 99999999985333222   12


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh--cC--ccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG--HG--ILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~--~~--i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      +.++||+|+ |+|.+.++.++.....+++..+|.++.|++.||..+|+  .+  +.|+||||.||+++.+| .|||+|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence            789999999 59999999999999999999999999999999999999  44  99999999999999888 99999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      +++..........+..|||.||+||.+.+++ ++.+|||||+||++|||+..+.||...+-.+...++.+.-.++..   
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p---  249 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP---  249 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---
Confidence            9998888777777889999999999999887 899999999999999999999999998666666666553211111   


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                                             ...+|.++..+|..|+.+||..||+.
T Consensus       250 -----------------------~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  250 -----------------------DEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             -----------------------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence                                   02678999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-51  Score=333.79  Aligned_cols=262  Identities=31%  Similarity=0.527  Sum_probs=224.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ..+|.+.+.||+|+||+||+++++.++..++||.+....-.......+..|+.+|+.+ +||||+.++++.+..+.    
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~----   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDF----   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCe----
Confidence            4679999999999999999999999999999999886643444455678899999999 99999999999998887    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--C---CeEEEee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--T---MTLKIAD  156 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~---~~vkl~d  156 (304)
                       +++|||||+| +|.+++...    +.+++..+..++.||+.||++||+++|+|+||||.|||++..  +   ..+||+|
T Consensus        84 -i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   84 -IYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             -EEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence             9999999995 999999874    469999999999999999999999999999999999999754  2   4799999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ||+++..... ......+|+|.|||||++.... |+.++|+||+|+++|+|++|..||...+..+....+.+.-      
T Consensus       159 FGfAR~L~~~-~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~------  230 (429)
T KOG0595|consen  159 FGFARFLQPG-SMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN------  230 (429)
T ss_pred             cchhhhCCch-hHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc------
Confidence            9999988754 4556678999999999998766 8999999999999999999999999999888777443311      


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                         .........+++...+++...++.+|.+|.+..+-+.|+++..-..
T Consensus       231 -------------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  231 -------------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             -------------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence                               1111222256777889999999999999999999999999876543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.7e-50  Score=337.01  Aligned_cols=287  Identities=44%  Similarity=0.808  Sum_probs=227.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEcc-CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~   80 (304)
                      ++|++++.||+|+||.||++.+.. ++..+++|.+..............+|+.+++.+.  +||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 4678999988765544444455667777777663  6999999999886544333


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...++++||+++++|.+++...  ....+++.+++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            3448999999999999988763  234589999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+....+.+....|++
T Consensus       158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             EeccCC-cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            765543 2333456789999999987765 78999999999999999999999999988888888888777666555544


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ....... .+.......+....+.+++.+.+++.+||+.||++|||+.|+|+||||
T Consensus       236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccch-hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            3221111 111112222333445788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.4e-50  Score=339.16  Aligned_cols=287  Identities=46%  Similarity=0.829  Sum_probs=226.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++.++..+++|++...... .......+|+.+++.+ +||||+++++++.....    
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~----   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGL-KHANIVLLHDIIHTKET----   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCe----
Confidence            46899999999999999999999989999999998754322 2234567899999999 99999999999887765    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++||||+.+++.+++...   ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+||+|||++..
T Consensus        78 -~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  152 (303)
T cd07869          78 -LTLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARA  152 (303)
T ss_pred             -EEEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCccee
Confidence             8999999999998887652   34689999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch-HHHHHHHHHHhCCCCCCCCccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ............+++.|+|||++.+...++.++||||||+++|+|++|..||....+ .+....+....+.+....|+..
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence            544433444556789999999987766688999999999999999999999987544 4555556655555555555443


Q ss_pred             cccCCcc--cCCCCCCCccccc--CCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWH--EYPQWNPQSLATA--VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~--~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .......  ......+..+...  ....++++.+|+.+||+.||.+|||+.|+++||||++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            3221110  0000011111111  113567899999999999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-51  Score=320.56  Aligned_cols=258  Identities=28%  Similarity=0.455  Sum_probs=228.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|+.++-||.|+||.|.+++.+.+|..||+|++..+.. ...+.....+|..+|+.+ .||.++++.+.+.+...   
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~---  118 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSN---  118 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCe---
Confidence            4689999999999999999999999999999999876542 222345667899999999 89999999999999888   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||.+| .|..++..    ..++++..++.++.+|+.||+|||+.+|++|||||+|||+|.+| .+||+|||++
T Consensus       119 --lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFA  191 (355)
T KOG0616|consen  119 --LYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFA  191 (355)
T ss_pred             --EEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccce
Confidence              9999999996 89999866    35699999999999999999999999999999999999999888 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..+...   .-..+|||.|+|||.+.... ++.++|.||||+++|||+.|..||...+....+.+++..-..        
T Consensus       192 K~v~~r---T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--------  259 (355)
T KOG0616|consen  192 KRVSGR---TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--------  259 (355)
T ss_pred             EEecCc---EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--------
Confidence            876643   34568899999999998877 899999999999999999999999999998888888864322        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                          .++.+++++++||+++|+.|-.+|.     ..++|.+||||+.+++.+
T Consensus       260 --------------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  260 --------------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             --------------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence                                2236899999999999999999994     788999999999998765

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.2e-51  Score=346.15  Aligned_cols=256  Identities=30%  Similarity=0.523  Sum_probs=233.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      |++|.+.+.||+|.||.||+++.+.+.+.|++|.+.+..+.+...+.+.+|+.+++.+ +||||+.++++|+...+    
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~----   75 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAH----   75 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccce----
Confidence            6899999999999999999999999999999999998888887888899999999999 99999999999999888    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +++|.||+-|+|..++..    ++.++++.+..++.+++.||.|||+++|.|+|+||.||+++..+ .+|++|||+++.
T Consensus        76 -~~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   76 -LWVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARA  149 (808)
T ss_pred             -EEEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhh
Confidence             999999999999999865    56799999999999999999999999999999999999999777 999999999999


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      +..+....+..-|||.|||||+..+.. ++..+|+|||||++||+++|++||-..+..+....+...-..          
T Consensus       150 m~~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~----------  218 (808)
T KOG0597|consen  150 MSTNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK----------  218 (808)
T ss_pred             cccCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----------
Confidence            988888888888999999999988766 899999999999999999999999887777666666542111          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                        .+.++|..+.+|+.++|..||.+|.|..+++.|||.+.
T Consensus       219 ------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  219 ------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             ------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence                              12278999999999999999999999999999999875

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6e-50  Score=339.25  Aligned_cols=288  Identities=49%  Similarity=0.935  Sum_probs=236.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++.+.||+|+||.||++.++.++..+++|.+...... .....+.+|+++++++ +||||+++++++.....    
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----   78 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKS----   78 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCe----
Confidence            57899999999999999999999999999999998754332 2334567899999999 99999999999887766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .+++|||+.+++.+.+...   ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        79 -~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  153 (309)
T cd07872          79 -LTLVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARA  153 (309)
T ss_pred             -EEEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcccccee
Confidence             8999999999988887653   23578899999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+.+..+.+....|+...
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            55444444445668899999998776668999999999999999999999999988888888888888877776665544


Q ss_pred             ccCCcc--cCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          243 SLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       243 ~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ......  ..+...........+.++.++.+||.+||+.||.+|||+.|+++||||..+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            332211  11222222223344578999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.7e-50  Score=353.89  Aligned_cols=290  Identities=33%  Similarity=0.597  Sum_probs=228.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---CC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---EG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~   80 (304)
                      ++|++++.||+|+||.||++.+..++..+++|.+....      ....+|+.+++.+ +||||+++++++.....   ..
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhc-CCCCCcceeeeEeecccccCCC
Confidence            56999999999999999999999999999999875321      2345799999999 99999999998754332   22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ..+++++|||+++++.+++.........+++..++.++.||+.||.|||+.|++||||||+||+++.++..+||+|||++
T Consensus       139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            33577999999999998888766666789999999999999999999999999999999999999977657999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....... ......+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+...++.+....+..
T Consensus       219 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        219 KNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             hhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            7654432 223446789999999988766689999999999999999999999999888888888887776654432221


Q ss_pred             ccccCCcccCCCCCCCccc-ccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLA-TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .........++......+. ......+.++.+||.+||+.||.+|||+.|+++||||.++..
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            1110000111111111111 123357889999999999999999999999999999987643

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.1e-50  Score=337.41  Aligned_cols=265  Identities=30%  Similarity=0.501  Sum_probs=226.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+|+.+.+|..+|+|+++++.- ...+...+..|-++|... .+|.+++++-.|++...   
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~---  215 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEY---  215 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCe---
Confidence            3689999999999999999999999999999999987652 333456778899999996 99999999999999988   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +|+||||++| ++..+|..    ...+++++++.++.+++.|++.+|+.|++|+||||+|+|||..| ++||+|||++
T Consensus       216 --LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs  288 (550)
T KOG0605|consen  216 --LYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLS  288 (550)
T ss_pred             --eEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeecccccc
Confidence              9999999996 88888765    36799999999999999999999999999999999999999888 9999999998


Q ss_pred             eeccc---------------------C--CC------c------------------cccccccccCCChhhhhCCCCCCC
Q 021982          161 RAFTL---------------------P--IK------K------------------YTHEILTLWYRAPEVLLGSTHYST  193 (304)
Q Consensus       161 ~~~~~---------------------~--~~------~------------------~~~~~~~~~~~~PE~~~~~~~~~~  193 (304)
                      .....                     +  ..      .                  .....|||.|+|||++.+.. ++.
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~  367 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGK  367 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCc
Confidence            53311                     0  00      0                  01236799999999999988 899


Q ss_pred             chhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHH
Q 021982          194 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLL  273 (304)
Q Consensus       194 ~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  273 (304)
                      ..|.||||||||||+.|-+||...+..+...++.+.-......                        ....+++++.+||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------------------~~~~~s~eA~DLI  423 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------------------------EEVDLSDEAKDLI  423 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------------------CcCcccHHHHHHH
Confidence            9999999999999999999999999999999888753221110                        0114679999999


Q ss_pred             HHhhcCCCCCCC---CHHHHhcCCCccccccccC
Q 021982          274 EQMLQYDPSKRI---SAKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       274 ~~~l~~dp~~Rp---s~~eil~~~~~~~~~~~~~  304 (304)
                      .+||. ||.+|.   +++||..||||+.++++.|
T Consensus       424 ~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  424 TRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             HHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence            99999 999999   5999999999999999865

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-50  Score=330.20  Aligned_cols=261  Identities=29%  Similarity=0.504  Sum_probs=211.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .+|...+.||+|+||.||++.+..+|...++|.+.......  ...+.+|+.+|.++ +||||+++++.......   ..
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~---~~   90 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRL-NHPNIVQYYGSSSSREN---DE   90 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhC-CCCCEEeeCCccccccC---ee
Confidence            35889999999999999999999989999999887663222  56688999999999 79999999997443332   34


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +.++|||+.| +|.+++...  .+ .+++..++.+..|++.||+|||++|++||||||+|||++..++.+||+|||.+..
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            8999999986 999999873  22 6999999999999999999999999999999999999998434999999999876


Q ss_pred             ccc---CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC-chHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTL---PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ...   .........||+.|+|||++.+.....+++|||||||++.||+||..||... ...+....+..   .      
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~------  238 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---E------  238 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---c------
Confidence            663   2223445678999999999986432446999999999999999999999874 22222222211   1      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                       ...+..+..+|+++++||.+|+..||.+||||+++|+|||....
T Consensus       239 -----------------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  239 -----------------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             -----------------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                             11223344799999999999999999999999999999999763

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-50  Score=343.25  Aligned_cols=291  Identities=35%  Similarity=0.611  Sum_probs=225.8

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|+||.||++.++.++..+++|.+............+.+|+.+++.+ +||||+++++++...........
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence            58999999999999999999999999999998875433333345678899999999 99999999998876554444458


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +++|||++++|.+.+..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus        80 ~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          80 YVVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            99999999999888764    24589999999999999999999999999999999999999777 89999999987543


Q ss_pred             cCC---CccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          165 LPI---KKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       165 ~~~---~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...   .......+++.|+|||++.+. ..++.++||||||+++|+|++|..||...+.......+....+.+....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221   112334678999999998652 3478999999999999999999999988777666665555555443322221


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ......   ................+.+++.+.+++.+||+.||.+|||++|+++||||+.+..
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            111100   0001111112233344578899999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-50  Score=344.70  Aligned_cols=256  Identities=32%  Similarity=0.543  Sum_probs=231.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeec-CCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLH-EDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      =|++++-||.|+.|.|-+|++..+|+..|||++... .-.+.....+..|+-+++.+ .|||++.++++++....     
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~-----   86 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQH-----   86 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCce-----
Confidence            388999999999999999999999999999999875 44555677889999999999 99999999999998887     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +|+|.||+.| .|++++..    .+++++.+..+++.||+.|+.|+|..+|+|+|+||+|+|+|..+ ++||+|||+|..
T Consensus        87 lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsL  161 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASL  161 (786)
T ss_pred             EEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeec
Confidence            9999999985 99999866    36899999999999999999999999999999999999999888 799999999976


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      .. +.......+|+|.|++||+..+.++.+.++||||.|+|||.|+||..||++.+-...+.++.+..-.          
T Consensus       162 e~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~----------  230 (786)
T KOG0588|consen  162 EV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE----------  230 (786)
T ss_pred             cc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc----------
Confidence            44 4467778899999999999999999999999999999999999999999999888888887764222          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                        .+..+|.++++||++||.+||..|+|.+||+.|||+....
T Consensus       231 ------------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  231 ------------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             ------------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence                              2247999999999999999999999999999999998764

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6e-49  Score=329.97  Aligned_cols=286  Identities=44%  Similarity=0.813  Sum_probs=228.0

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccCCce
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +|++++.||+|++|.||++.++.+++.+++|.+..............+|+.+++.+.  +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588999999999999999999999999999998765444433445567777776653  699999999998765544445


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ..++++|++.+++.+++....  ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCcccc
Confidence            589999999999988887632  34589999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      .... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+....+.+....|+...
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         158 YSCQ-MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccCc-ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            5432 2223345688999999997765 8999999999999999999999999888888888887777666555444322


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .... ...............+.++..+.++|.+||+.||.+|||+.|++.||||
T Consensus       236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPR-GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccc-cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1111 1111222233344456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7e-49  Score=330.70  Aligned_cols=294  Identities=68%  Similarity=1.200  Sum_probs=243.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.+.+|||++++++++.....++...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999999999999999887655444455677889999999966799999999987766545555


Q ss_pred             EEEEEeccCCCHHHHHHHhccC-CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++|||+++++.+++...... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++..++|+|||.+..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            7999999999999988764432 357899999999999999999999999999999999999997345999999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+......++......+....|+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            54443333344567889999998766557899999999999999999999999888888888888777777666666555


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      ....................+.++..+.++|.+||..||.+|||+.|++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            5544444444444444555567899999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-51  Score=312.54  Aligned_cols=262  Identities=30%  Similarity=0.431  Sum_probs=229.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .-++|.+.+.||+|.|+.|+.+.+..+|+.+++|++....-....-..+.+|+.+.+.| .||||+++.+....+..   
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~---   84 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF---   84 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccce---
Confidence            35789999999999999999999999999999998876554444567888999999999 99999999998877776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~dfg  158 (304)
                        .++|||++.| .|..-+..+    .-+++..+...++||+.||.|+|.+||+|+|+||+|+++.+.  +.-+||+|||
T Consensus        85 --~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   85 --HYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             --eEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccc
Confidence              8999999997 776666553    347888899999999999999999999999999999999643  3579999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .+..++ +........|+|.|++||++...+ ++..+|||+.|++||-++.|..||-+.+....++.+.+.-.....+.|
T Consensus       159 vAi~l~-~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w  236 (355)
T KOG0033|consen  159 LAIEVN-DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW  236 (355)
T ss_pred             eEEEeC-CccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence            999888 556667778999999999998877 899999999999999999999999998888888888876544444444


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      +                        ++++++++|+++||..||.+|+|+.|.|+|||..+-
T Consensus       237 ~------------------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  237 D------------------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             C------------------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            3                        899999999999999999999999999999999763

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-49  Score=332.55  Aligned_cols=282  Identities=39%  Similarity=0.686  Sum_probs=221.0

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||+++++.++..+++|.+............+.+|+.+++.+ +||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGK-----   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCE-----
Confidence            479999999999999999999999999999999886655455556778899999999 99999999999887665     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .++||||+.+++.+.+...   ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||.+...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccc
Confidence            8999999998766655432   34689999999999999999999999999999999999999777 8999999999765


Q ss_pred             ccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          164 TLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       164 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+....+......+....
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            43322 223346789999999998766 7999999999999999999999999877766665555544443322221111


Q ss_pred             ccCCcccCC----CCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEYP----QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .....+...    .............+|.++.+||.+||+.||.+|||++|+++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            111111000    001111122234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.3e-49  Score=331.83  Aligned_cols=287  Identities=48%  Similarity=0.930  Sum_probs=235.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||.|++|.||++.++.++..+++|.+...... .....+.+|+.+++.+ +||||+++++++.....    
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~----   78 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKS----   78 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhc-CCCCcceEEEEEecCCe----
Confidence            46899999999999999999999989999999988754322 2234567899999999 99999999999987766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++++||+.++|.+++...   ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        79 -~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~  153 (301)
T cd07873          79 -LTLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARA  153 (301)
T ss_pred             -EEEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhc
Confidence             8999999999998887653   34688999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+...+..+....|+...
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            54443334445568899999998876668899999999999999999999999888888888888877777776665543


Q ss_pred             ccCCcc--cCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ....+.  ..............+.+++++.+||.+||+.||.+|||+.|+++||||..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            222211  1112222223334457899999999999999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.4e-49  Score=329.29  Aligned_cols=284  Identities=58%  Similarity=1.066  Sum_probs=232.7

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++++.||+|++|.||++.++.++..+++|.+............+.+|+.+++++ +|||++++++++.....     .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESR-----L   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCe-----E
Confidence            48899999999999999999998999999999876554444556778899999999 89999999999987666     8


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++||||+.+++.+++..... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        75 ~~v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          75 YLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEEecCCCCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            99999999999888876433 35689999999999999999999999999999999999999777 89999999987665


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      ..........+++.|+|||.+.+...++.++|+||||+++|+|++|..||................+.+....|+.....
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            44444444566889999999877665789999999999999999999999988877777777666666655555544433


Q ss_pred             CCcccC-CCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          245 MNWHEY-PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       245 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .++... ..+...........+++++.++|++||+.||.+|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            322211 1112222333445689999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=337.54  Aligned_cols=256  Identities=28%  Similarity=0.508  Sum_probs=223.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..|....++|+|+.|.||.+....+++.|+||.+......  ...-+.+|+.+++.. +|+||+.+++.|...+.     
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~de-----  344 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDL-HHPNIVNFLDSYLVGDE-----  344 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhc-cchHHHHHHHHhcccce-----
Confidence            5688999999999999999999999999999998765432  345678999999999 99999999999988766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||++| +|.+.+..     ..+++.++..++..+++||+|||.+||+|+|||.+|||+..++ .+||+|||++..
T Consensus       345 LWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaq  418 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQ  418 (550)
T ss_pred             eEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeec
Confidence            9999999996 88888776     3589999999999999999999999999999999999999888 899999999998


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      +.........-.|||.|||||+..... |+++.||||||++.+||+-|.+||-..+...-+..+... +.+.-       
T Consensus       419 i~~~~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l-------  489 (550)
T KOG0578|consen  419 ISEEQSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL-------  489 (550)
T ss_pred             cccccCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc-------
Confidence            887777777889999999999998877 899999999999999999999999876665555444332 22211       


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                       .....+|+.+++|+.+||..|+.+|+||.|||+||||+..
T Consensus       490 -----------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  490 -----------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             -----------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                             1223799999999999999999999999999999999654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.7e-49  Score=329.02  Aligned_cols=282  Identities=54%  Similarity=0.984  Sum_probs=230.6

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|++|.||++.++.+|..+++|.+............+.+|+.+++.+ +|||++++++++.+...     .
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~-----~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKK-----L   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCc-----e
Confidence            58899999999999999999999999999999876655544556777899999999 99999999999987766     8


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++++||+++++.+++...   ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        75 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            999999999988877652   34689999999999999999999999999999999999999777 89999999987665


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccC-CCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ..........+++.|+|||.+.+...++.++||||||+++|+|++|..|+ ...+.......+.+.++.+....|+....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            54444445566889999999887665789999999999999999998885 45555666666766666665555555444


Q ss_pred             cCCcccCCCCCCC-cccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQ-SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ............. .+....+.+++++.++|.+||+.||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            3333322222211 2234456789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=325.93  Aligned_cols=270  Identities=24%  Similarity=0.357  Sum_probs=226.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|++...||.|..++||.++....+..|+||.+........ ...+.+|++.++.+ +||||++++..|.....    
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~----   98 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLI-DHPNIVTYHCSFVVDSE----   98 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhc-CCCCcceEEEEEEecce----
Confidence            3679999999999999999999999999999999988776665 78899999999999 99999999999998887    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||.++.+ ++.+.++.....+  +.+..+..++++++.||.|||++|.+|||||+.|||++.+| .|+|+|||.+.
T Consensus        99 -LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa  174 (516)
T KOG0582|consen   99 -LWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSA  174 (516)
T ss_pred             -eEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeee
Confidence             9999999995 9999999966644  99999999999999999999999999999999999999888 99999999986


Q ss_pred             ecccCCCcc----ccccccccCCChhhh-hCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPIKKY----THEILTLWYRAPEVL-LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~~~~----~~~~~~~~~~~PE~~-~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      .+.......    ....|+++|+|||++ .....|+.++||||||++..|+.+|..||....+.+.+-...+.-.+... 
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-  253 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-  253 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-
Confidence            664432222    344789999999994 45555999999999999999999999999988876665544433211111 


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                       -                ..........++..++.+|..||..||.+|||+.++|+|+||+...
T Consensus       254 -t----------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  254 -T----------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             -c----------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence             0                0011112235777999999999999999999999999999999863

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-49  Score=341.42  Aligned_cols=263  Identities=28%  Similarity=0.446  Sum_probs=230.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||.|+||+|+++..+.++..||||++++... ..+.....+.|..++...++||.++.++.+|+...+   
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~---  443 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH---  443 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe---
Confidence            4679999999999999999999999999999999987642 334456778899999999889999999999999998   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        +++||||+.|..  +..  .+....+++..+..++..++.||.|||++||+|||||.+|||+|.+| .+||+|||+++
T Consensus       444 --l~fvmey~~Ggd--m~~--~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcK  516 (694)
T KOG0694|consen  444 --LFFVMEYVAGGD--LMH--HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCK  516 (694)
T ss_pred             --EEEEEEecCCCc--EEE--EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEeccccccc
Confidence              999999999843  221  24446799999999999999999999999999999999999999999 99999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ..-......+..+|||.|+|||++.+.. |+...|.||||++||+||.|..||...+..+....+...            
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------  583 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------  583 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence            6544445667789999999999999887 899999999999999999999999999999999888752            


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccccC
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~~  304 (304)
                                      ...++..+|.+..++++++|..+|++|..     +++|..||||+.++++.|
T Consensus       584 ----------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L  635 (694)
T KOG0694|consen  584 ----------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL  635 (694)
T ss_pred             ----------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence                            11223368999999999999999999995     589999999999998764

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.5e-49  Score=328.44  Aligned_cols=265  Identities=26%  Similarity=0.402  Sum_probs=214.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .|+..+.||+|+||.||++.+..++..+++|.+...... ......+.+|+.+++.+ +|++++++.+.+.....     
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~-----   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDA-----   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCe-----
Confidence            378889999999999999999999999999988754322 12234567899999999 99999999999887766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.+ +|...+...  ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~  151 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEE
Confidence            8999999986 887776542  234689999999999999999999999999999999999999777 899999999976


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...........+........        
T Consensus       152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  221 (285)
T cd05631         152 IPEGE-TVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--------  221 (285)
T ss_pred             cCCCC-eecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------
Confidence            54322 223446789999999998765 79999999999999999999999987654333333322221111        


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccccC
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~~  304 (304)
                                      ......+++++.+|+++||+.||.+|||     ++++++||||..++++++
T Consensus       222 ----------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~  272 (285)
T cd05631         222 ----------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL  272 (285)
T ss_pred             ----------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence                            1112357899999999999999999997     899999999999987753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=286.44  Aligned_cols=288  Identities=51%  Similarity=0.970  Sum_probs=266.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      |.+|.-.++||+|.+|+||+++++.++.-+++|-++.+..++.......+|+-+++.+ +|.||+++++....+..    
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkk----   75 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKK----   75 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCce----
Confidence            4678999999999999999999999999999999999999998999999999999999 99999999999888777    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +-+|+|+|...|..++.+.   .+.++.+.+..++.|++.+|.++|+.++.|+|+||.|.+++.+| .+|++|||+++.
T Consensus        76 -ltlvfe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglara  150 (292)
T KOG0662|consen   76 -LTLVFEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARA  150 (292)
T ss_pred             -eEEeHHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhh
Confidence             8999999999999998874   35789999999999999999999999999999999999999888 999999999998


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc-cccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .+-+....+.+.-|.+|.||.++.+..-++...|+||-||++.|+... .+.|...+..++..+++..++.+.+..|+.+
T Consensus       151 fgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             cCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            888877777778899999999999988899999999999999999975 5557888889999999999999999999999


Q ss_pred             cccCCcccCCCCCCC-cccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQWNPQ-SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ....++.-.+.++.. ++.+..+.+...-+++++++|.-+|.+|+++++.++||+|.+..
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            999998888877554 68888999999999999999999999999999999999999753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.2e-49  Score=339.94  Aligned_cols=282  Identities=34%  Similarity=0.596  Sum_probs=228.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC-----CCeeeeeceeccccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD-----PHVVRLMDVKQGQNK   78 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h-----~~i~~~~~~~~~~~~   78 (304)
                      -+|.+++.||+|+||.|-+|.+..++..||||++++..   ....+...|+.+|..+++|     -|+++++++|..-++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            47999999999999999999999999999999998643   3345677899999999534     389999999999988


Q ss_pred             CCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC-CCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~-~~~vkl~df  157 (304)
                           +|+|+|.++.+|.++++...-  ..++...++.++.||+.||..||+.||+||||||+|||+..- ...|||+||
T Consensus       263 -----lciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  263 -----LCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             -----eeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence                 999999999999999998544  569999999999999999999999999999999999999643 258999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |++++.....-   ...=+-.|+|||++++.. ++.+.||||||||+.||++|.+.|.+.+..++++.++..++.|+...
T Consensus       336 GSSc~~~q~vy---tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  336 GSSCFESQRVY---TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             ccccccCCcce---eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99988765433   334477899999999988 89999999999999999999999999999999999999999876543


Q ss_pred             CccccccCCc-------------ccCC-------------------CC--CCCcccccCC-CCChhhHHHHHHhhcCCCC
Q 021982          238 WPGVSSLMNW-------------HEYP-------------------QW--NPQSLATAVP-NLDKDGLDLLEQMLQYDPS  282 (304)
Q Consensus       238 ~~~~~~~~~~-------------~~~~-------------------~~--~~~~~~~~~~-~~~~~l~~li~~~l~~dp~  282 (304)
                      +....+...+             ++..                   ..  ....+....+ .-...+.+||.+||.+||.
T Consensus       412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~  491 (586)
T KOG0667|consen  412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA  491 (586)
T ss_pred             HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence            2221111111             1100                   00  0111111222 2234568999999999999


Q ss_pred             CCCCHHHHhcCCCcccc
Q 021982          283 KRISAKKAMEHPYFDDL  299 (304)
Q Consensus       283 ~Rps~~eil~~~~~~~~  299 (304)
                      +|+|+.|.|+||||...
T Consensus       492 ~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  492 ERITPAQALNHPFLTGT  508 (586)
T ss_pred             hcCCHHHHhcCcccccc
Confidence            99999999999999854

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-49  Score=330.72  Aligned_cols=256  Identities=26%  Similarity=0.404  Sum_probs=214.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.++.+++.+++|.+..... .......+.+|+.+++.+ +||||+++++++.+...    
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~----   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRF----   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCe----
Confidence            479999999999999999999999999999999875432 122345677899999999 99999999998887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...    ..+++..+..++.|++.||++||++|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~  149 (291)
T cd05612          76 -LYMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAK  149 (291)
T ss_pred             -EEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcch
Confidence             8999999985 898888652    4689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ......   ....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.....          
T Consensus       150 ~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----------  215 (291)
T cd05612         150 KLRDRT---WTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL----------  215 (291)
T ss_pred             hccCCc---ccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----------
Confidence            654322   2345789999999987766 78999999999999999999999988877666655543210          


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                        .....+++.+.+||++||+.||.+||+     ++++++||||..+++.
T Consensus       216 ------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         216 ------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             ------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                              011246889999999999999999995     9999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-49  Score=308.59  Aligned_cols=262  Identities=32%  Similarity=0.495  Sum_probs=228.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC--C----chhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV--P----PTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~--~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      .+.|.-.+.||.|..++|-.+.++.++..+++|++.........  .    ..-..|+.+|+++..||+|+.+.+.++..
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            35688899999999999999999999999999988765432221  1    23356899999999999999999999988


Q ss_pred             ccCCceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           77 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      ..     +++|+|.+. |.|.+++.+-    -.+++.+...+++|+..|++|||..+|||+||||+|||++.+. +++|+
T Consensus        96 sF-----~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~is  165 (411)
T KOG0599|consen   96 AF-----VFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKIS  165 (411)
T ss_pred             ch-----hhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEe
Confidence            77     899999998 6999999874    3489999999999999999999999999999999999999665 99999


Q ss_pred             eccceeecccCCCccccccccccCCChhhhhC-----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHh
Q 021982          156 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  230 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  230 (304)
                      |||+++....+ ......+|||+|+|||.+..     .+.|+...|+|++|+|||.++.|.+||-.......+..+....
T Consensus       166 DFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  166 DFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             ccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            99999988766 56677899999999999863     4458999999999999999999999998888888888888766


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .......|.                        ++|...++||.+||++||.+|.|++|.|.||||..+
T Consensus       245 yqF~speWa------------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  245 YQFRSPEWA------------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             cccCCcchh------------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            665555554                        688899999999999999999999999999999655

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.1e-48  Score=333.92  Aligned_cols=287  Identities=33%  Similarity=0.561  Sum_probs=221.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||.||++.+..++..+++|.+............+.+|+.+++.+ +||||+++++++..... ..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence            46889999999999999999999999999999999876544444456777899999999 99999999999875442 22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....+++|||+++++.+.+..      .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCc
Confidence            234799999999988777642      478899999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+...++.+.......
T Consensus       171 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         171 RTACTN-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccccC-ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            654332 2233456789999999997765 78999999999999999999999998877776666666555443321111


Q ss_pred             cccc--------CCc-----c-cCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSL--------MNW-----H-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~--------~~~-----~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ....        ...     . .+..+............++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            1000        000     0 00011111111222345788999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-49  Score=334.86  Aligned_cols=257  Identities=28%  Similarity=0.413  Sum_probs=215.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +++|++.+.||+|+||.||++.++.+++.+++|++..... .......+.+|+.+++++ +||||+++++.+.....   
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~---   92 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENR---   92 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCE---
Confidence            4789999999999999999999999999999999875432 222345678899999999 99999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.| +|.+.+...    ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus        93 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         93 --VYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             --EEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence              8999999986 888888652    4688999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .......   ....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+.....         
T Consensus       166 ~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------  232 (329)
T PTZ00263        166 KKVPDRT---FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---------  232 (329)
T ss_pred             eEcCCCc---ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc---------
Confidence            7654332   2346789999999998766 78999999999999999999999988776655554432100         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                         .....++..+.+||.+||+.||.+||+     ++++++||||++.++.
T Consensus       233 -------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        233 -------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                               011247789999999999999999997     7999999999986543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=323.80  Aligned_cols=260  Identities=28%  Similarity=0.481  Sum_probs=216.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-------CC-----CchhHHHHHHHHHccCCCCeeeee
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-------GV-----PPTTLREVSILRMLSRDPHVVRLM   70 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~-----~~~~~~e~~~l~~l~~h~~i~~~~   70 (304)
                      .++|++.+.||+|.||.|-++++..+++.||||++.......       ..     .....+|+.+++++ .||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence            578999999999999999999999999999999987643211       11     13678899999999 999999999


Q ss_pred             ceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCC-CChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC
Q 021982           71 DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGEN-IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK  148 (304)
Q Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~  148 (304)
                      ++.-+...+   .+|+|+|||+. .+.+.     ....+ +++.+++.++.+++.||+|||.+||+||||||.|+|++.+
T Consensus       175 EvLDDP~s~---~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  175 EVLDDPESD---KLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EeecCcccC---ceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence            997765543   38999999984 43322     33345 9999999999999999999999999999999999999988


Q ss_pred             CCeEEEeeccceeecccC-----CCccccccccccCCChhhhhC---CCCCCCchhHHHHHHHHHHHhhccccCCCCchH
Q 021982          149 TMTLKIADLGLARAFTLP-----IKKYTHEILTLWYRAPEVLLG---STHYSTAVDMWSVACIFAELVTKTALFPGDSEL  220 (304)
Q Consensus       149 ~~~vkl~dfg~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  220 (304)
                      + .|||+|||.+.....+     ........|||-|+|||.+.+   ....+.+.||||+|++||.|+.|+.||......
T Consensus       247 g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  247 G-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             C-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            7 9999999999765222     223445688999999999987   334678999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      +.+.++.+.--..                          ...+.+..++++||.+||++||.+|.++.+|..|||...
T Consensus       326 ~l~~KIvn~pL~f--------------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  326 ELFDKIVNDPLEF--------------------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHhcCcccC--------------------------CCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            9998887632111                          112257889999999999999999999999999999865

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-48  Score=316.20  Aligned_cols=264  Identities=26%  Similarity=0.393  Sum_probs=225.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.|++++.||.|.-|+||+++.++++..+|+|++.+..- ......+...|.+||.++ +||.++.++..++.+..   
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~---  151 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKY---  151 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccce---
Confidence            3679999999999999999999999999999999987542 244456788899999999 99999999999999887   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++||||.| +|....+.  +.+..++++.+..++..++.||+|||..||++|||||+||||..+| +++|+||.++
T Consensus       152 --~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS  226 (459)
T KOG0610|consen  152 --SCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLS  226 (459)
T ss_pred             --eEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeecccc
Confidence              9999999997 88777766  6667899999999999999999999999999999999999999888 9999999987


Q ss_pred             eecccC---------------------------------CC-----------------------ccccccccccCCChhh
Q 021982          161 RAFTLP---------------------------------IK-----------------------KYTHEILTLWYRAPEV  184 (304)
Q Consensus       161 ~~~~~~---------------------------------~~-----------------------~~~~~~~~~~~~~PE~  184 (304)
                      ......                                 ..                       ......||-.|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            443110                                 00                       0112245788999999


Q ss_pred             hhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCC
Q 021982          185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  264 (304)
Q Consensus       185 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (304)
                      +.+.. -+.+.|.|+||+++|||+.|..||+..++.+.+.++...-...+.                          .+.
T Consensus       307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~--------------------------~~~  359 (459)
T KOG0610|consen  307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE--------------------------EPE  359 (459)
T ss_pred             eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC--------------------------CCc
Confidence            99887 599999999999999999999999999999999888763221111                          126


Q ss_pred             CChhhHHHHHHhhcCCCCCCCC----HHHHhcCCCccccccc
Q 021982          265 LDKDGLDLLEQMLQYDPSKRIS----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       265 ~~~~l~~li~~~l~~dp~~Rps----~~eil~~~~~~~~~~~  302 (304)
                      ++..+++||+++|.+||.+|..    |+||.+||||+.+++.
T Consensus       360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence            7799999999999999999998    9999999999999986

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.5e-48  Score=323.48  Aligned_cols=283  Identities=59%  Similarity=1.089  Sum_probs=232.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|+.++.||.|++|.||++.+..++..+++|.+............+.+|+++++++ +||||+++++++.+...     .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-----~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENK-----L   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCc-----E
Confidence            48899999999999999999998999999998876554444456788999999999 99999999999887665     8


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +++|||+.++|.+++...  ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        75 ~~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            999999998988888653  235689999999999999999999999999999999999999777 89999999987655


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      ..........+++.|+|||.+.+....+.++|+||||+++|+|+||..||...+............+.+....|+.....
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            44333344456788999998876655688999999999999999999999988888888888877777766555543332


Q ss_pred             CCcc-cCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          245 MNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       245 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ..+. .+..+.........+.+++++.++|.+||+.||.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            2211 222223333444456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-48  Score=333.81  Aligned_cols=289  Identities=37%  Similarity=0.615  Sum_probs=226.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||.||++.+..++..+++|.+............+.+|+.+++.+ +||||+++++++..... ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccc
Confidence            56899999999999999999999999999999998875433333345567899999999 99999999998864432 22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++++++++++|.+.+..     ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus        92 ~~~~~~~~~~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccc
Confidence            234789999998898887653     4689999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+.......
T Consensus       166 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         166 RQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             eecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            765432   23446789999999998765689999999999999999999999988877777766666555443322221


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......   ...........+.......++.+.+||.+||..||.+|||+.|+++||||....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            111000   001111122223333446778899999999999999999999999999998763

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-48  Score=333.08  Aligned_cols=253  Identities=27%  Similarity=0.384  Sum_probs=209.3

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|++..... .......+.+|+.+++.+ +||||+++++++.....     .++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~-----~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDR-----LCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCE-----EEEEE
Confidence            468999999999999999999999999875422 222234567899999999 99999999999887776     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|.+.+..    ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++.......
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          75 EYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            99986 88887764    24689999999999999999999999999999999999999777 89999999987543333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+....                 
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----------------  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-----------------  211 (323)
T ss_pred             CcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            3344456899999999987765 7999999999999999999999998776655444433210                 


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                 ......+++++.+||++||+.||.+||     ++.++++||||..++++
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         212 -----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                       011235789999999999999999999     89999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-47  Score=321.68  Aligned_cols=291  Identities=57%  Similarity=1.058  Sum_probs=236.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++.+.||.|++|.||++.++.++..+++|.+............+.+|+++++++ +|||++++++++.....    
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   75 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKR----   75 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCe----
Confidence            4689999999999999999999998999999998876554444456778899999999 99999999999987766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++||||+++++.+.+...  ....+++..++.++.||+.||++||++|++|+||+|+||+++.++..+||+|||++..
T Consensus        76 -~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 -LYLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             -EEEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence             8999999998888887652  2234688889999999999999999999999999999999996665899999999976


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+...++.++|+||||+++|+|+||..||...+..+....+....+.+....|.+..
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT  232 (294)
T ss_pred             cCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence            54443333444567899999998776557899999999999999999999999888777777777777776666665443


Q ss_pred             ccCCcccC-CCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          243 SLMNWHEY-PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       243 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ...++... +.+.........+.+++++.+++.+||+.||.+||++.++++||||.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            33332111 111222233345678999999999999999999999999999999998764

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.9e-48  Score=332.73  Aligned_cols=287  Identities=32%  Similarity=0.540  Sum_probs=224.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++.+.||+|+||.||++.+..+++.+++|++............+.+|+.+++.+ +||||+++++++..... ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence            46889999999999999999999999999999999876544444456778899999999 99999999998765432 22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++||||+.+++.+.+..      .+++..+..++.|++.||.+||++|++|+||||+||+++.++ .++|+|||++
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a  173 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA  173 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCc
Confidence            234799999999998887743      478899999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...++.+....+..
T Consensus       174 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         174 RTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             cccCCC-CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            765433 2233446789999999998765 79999999999999999999999998888888777777666554332221


Q ss_pred             ccccC--------Cccc------CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLM--------NWHE------YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~--------~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      .....        ....      ................+..+.+||.+||+.||.+|||+.|+|+||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            11100        0000      0000001111122234578899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=326.16  Aligned_cols=262  Identities=32%  Similarity=0.529  Sum_probs=229.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.+.|.+.+.||+|.||.||.++++.+|..+++|.+.+..... .....+.+|+++|+++..||||+.+.+.+++...  
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~--  110 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS--  110 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe--
Confidence            3467999999999999999999999999999999998654322 2346788999999999559999999999999887  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC---CeEEEee
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIAD  156 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~---~~vkl~d  156 (304)
                         +++|||++.| .|.+.+...     .+++..+..++.|++.|++|||+.|++|+|+||+|+|+....   ..++++|
T Consensus       111 ---~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  111 ---VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             ---EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence               9999999996 999999875     399999999999999999999999999999999999997543   3799999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ||++..... .......+||+.|+|||++.... ++...||||+|+++|.|++|..||...+.......+...-......
T Consensus       183 FGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~  260 (382)
T KOG0032|consen  183 FGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE  260 (382)
T ss_pred             CCCceEccC-CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC
Confidence            999998877 56778889999999999988766 8999999999999999999999999999888777666543333333


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .|                        +.++..+.++|++||..||..|+|+.++|+|||++..
T Consensus       261 ~w------------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  261 PW------------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             Cc------------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            33                        3789999999999999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=322.56  Aligned_cols=254  Identities=29%  Similarity=0.403  Sum_probs=214.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcE-EEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKI-VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~-~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +...+.+.+|+|+||+||++.++  |.. +++|.+.....+......+.+|+.++.++ +||||++++|.+.....    
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~----  113 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG----  113 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC----
Confidence            45667788999999999999987  455 99999887665544467899999999999 99999999999998872    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC-ccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      .+++||||+.+ +|.+++...  ....+++..++.++.+|+.|++|||+++ |+|+||||+|||++.+..++||+|||++
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            18999999985 999998764  4568999999999999999999999999 9999999999999976559999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +.........+...||+.|||||++.+. ..++.++||||||+++|||+||..||......+....+......+      
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------  265 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------  265 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence            8776544455557889999999999853 448999999999999999999999999998866555555332221      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          .....+++.+.+++.+||..||.+||++.+|+.
T Consensus       266 --------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 --------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                112248899999999999999999999999875

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.6e-47  Score=322.30  Aligned_cols=289  Identities=47%  Similarity=0.833  Sum_probs=235.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||.|++|.||++.++.++..+++|.+..............+|+.+++++ +|+|++++++++.....   .
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~---~   81 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHL---D   81 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCC---C
Confidence            4689999999999999999999999999999999876554444445567899999999 99999999999875432   1


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ..++++||+.++|.+++...   ...+++.++..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence            27999999999988888653   25689999999999999999999999999999999999999777 899999999987


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....|+...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            65543333444457889999998776657899999999999999999999999999888888888888777766665544


Q ss_pred             ccCCcccCC--CCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          243 SLMNWHEYP--QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       243 ~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .........  ......+.......++.+.++|.+||+.||.+|||+.+++.||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            332211111  111112233344578999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-47  Score=331.61  Aligned_cols=288  Identities=32%  Similarity=0.542  Sum_probs=222.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||.||++.+..++..+++|.+............+.+|+.+++.+ +||||+++++++..... +.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence            46889999999999999999999998999999998875544444456777899999999 99999999998865432 22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....+++|||+++++.+.+..      .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCccc
Confidence            234799999999988877653      488999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+........++.+....+..
T Consensus       167 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         167 RTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccCCCc-cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            765433 2233456789999999987765 78999999999999999999999998887777766666655543322111


Q ss_pred             cccc--------CCcc--c----CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSL--------MNWH--E----YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~--------~~~~--~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ....        ..+.  .    ..+.............+..+.+||.+||+.||.+|||+.|+++||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            1000        0000  0    00000011111223456788999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.6e-48  Score=334.32  Aligned_cols=289  Identities=38%  Similarity=0.589  Sum_probs=226.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|+||.||++.+..+++.+++|.+............+.+|+.+++.+ +||||+++++++...........
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence            47889999999999999999998999999998865433333345778899999999 99999999999987664344458


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++++||+.++|.+.+..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus        80 ~lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          80 YVVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            99999999988887754    35689999999999999999999999999999999999999777 99999999997654


Q ss_pred             cCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          165 LPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       165 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ... .......+++.|+|||.+.+...++.++|||||||++|+|++|..||...+..+....+....+.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322 2233345688999999998766689999999999999999999999999888888887777666554332211100


Q ss_pred             cC-Ccc-cCCCCC--CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          244 LM-NWH-EYPQWN--PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       244 ~~-~~~-~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .. ... ......  ...........++++.+||.+||+.||.+|||+.|+++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            00 000 000000  001112234568899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.1e-47  Score=321.16  Aligned_cols=286  Identities=47%  Similarity=0.862  Sum_probs=235.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC---CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +|++.+.||+|++|.||++.+..++..+++|.+......   ......+..|+++++.+ +|+|++++++++.....   
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~---   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSN---   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCE---
Confidence            588899999999999999999988999999998765433   22334567899999999 89999999999988655   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .++||||+.++|.+++....   ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 --~~lv~e~~~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          77 --INLVFEFMETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             --EEEEEcccCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence              89999999779998886521   3689999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||.+.+...++.++|+||||+++++|++|..||...+..+....+...+..+....++..
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            76654444444455788999999876655789999999999999999998888887777777777777666666555554


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ....+...................+..+.++|.+||+.||.+|||+.|++.||||.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence            44444433333334444445567889999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-48  Score=317.83  Aligned_cols=255  Identities=29%  Similarity=0.489  Sum_probs=227.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +..+|++.+.||.|.||+|-++.+...|+.|+||.++++. ++++....+.+|+.++..| +||||+.++++|+..+.  
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdK--  127 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDK--  127 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCce--
Confidence            4578999999999999999999999999999999998765 4556677899999999999 99999999999998877  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++||||.++ .|.+++..+    ..+++.+...+++||++|+.|+|+++++|+|||.+|||+|.++ ++||+|||+
T Consensus       128 ---IvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGL  199 (668)
T KOG0611|consen  128 ---IVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGL  199 (668)
T ss_pred             ---EEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccch
Confidence               9999999985 999999875    4599999999999999999999999999999999999999877 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +..+... ......+|+|.|.+||...+.++-++..|.||||++||.|+.|..||+..+..-....+.+....       
T Consensus       200 SNly~~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------  271 (668)
T KOG0611|consen  200 SNLYADK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------  271 (668)
T ss_pred             hhhhccc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-------
Confidence            9766544 55677899999999999999988899999999999999999999999999988777766553211       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                            .+.-+.++.-||++||-++|.+|.|+++|-+|=|++
T Consensus       272 ----------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  272 ----------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ----------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                  124567888999999999999999999999998864

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-48  Score=334.56  Aligned_cols=262  Identities=29%  Similarity=0.486  Sum_probs=217.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.+..+++.+++|++..... .......+..|+.++..+ +||||+++++.+.+...    
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~----   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEH----   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCe----
Confidence            579999999999999999999999999999999875432 223345677899999999 99999999999887776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++...    ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~  149 (350)
T cd05573          76 -LYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCK  149 (350)
T ss_pred             -EEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCc
Confidence             8999999975 998888763    5689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCC-----------------------------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccc
Q 021982          162 AFTLPI-----------------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA  212 (304)
Q Consensus       162 ~~~~~~-----------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~  212 (304)
                      ......                             .......|++.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCC
Confidence            655433                             2233456799999999998775 8999999999999999999999


Q ss_pred             cCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-HHHHh
Q 021982          213 LFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-AKKAM  291 (304)
Q Consensus       213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~eil  291 (304)
                      ||...+.......+........                        ......+++++.++|.+||. ||.+||+ +++++
T Consensus       229 Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         229 PFYSDTLQETYNKIINWKESLR------------------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCCHHHHHHHHhccCCccc------------------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            9998886665555543111100                        00111378999999999998 9999999 99999


Q ss_pred             cCCCccccccc
Q 021982          292 EHPYFDDLDKT  302 (304)
Q Consensus       292 ~~~~~~~~~~~  302 (304)
                      +||||+++++.
T Consensus       284 ~hp~~~~~~~~  294 (350)
T cd05573         284 SHPFFKGIDWE  294 (350)
T ss_pred             cCCCcCCCCHH
Confidence            99999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-47  Score=318.57  Aligned_cols=260  Identities=26%  Similarity=0.352  Sum_probs=208.9

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      ||+|+||+||++.++.+++.+++|.+...... ......+..|+.+++.+ +||||+++.+.+.....     .+++|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~-----~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTD-----LCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCe-----EEEEEeC
Confidence            79999999999999999999999998754322 11234566799999999 99999999998887665     8999999


Q ss_pred             cCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc
Q 021982           91 MDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK  169 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~  169 (304)
                      +.| +|...+.........+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            986 88877765444456789999999999999999999999999999999999999776 8999999999766554433


Q ss_pred             cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCccc
Q 021982          170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE  249 (304)
Q Consensus       170 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (304)
                      .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...................                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            34456789999999998765 7899999999999999999999997654332222222211110                


Q ss_pred             CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          250 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                              .......++..+.+++.+||+.||.+||     +++++++||||+.++++.
T Consensus       217 --------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         217 --------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             --------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence                    0011235889999999999999999999     889999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.5e-47  Score=317.40  Aligned_cols=286  Identities=52%  Similarity=0.918  Sum_probs=229.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.++.++..+++|.++...........+.+|+++++++ +||||+++++++.....   .
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~---~   79 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNL---D   79 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCC---C
Confidence            5789999999999999999999998999999999986655544445667899999999 89999999998876521   1


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ..++++||+.++|.+.+....   ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        80 ~~~lv~e~~~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~  155 (293)
T cd07843          80 KIYMVMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLARE  155 (293)
T ss_pred             cEEEEehhcCcCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceee
Confidence            289999999999988876532   3689999999999999999999999999999999999999777 899999999987


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+....+.++|+||||+++|+|++|..||......+....+....+.+....|+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            66543444445568889999998776657899999999999999999999999888888888877777766655554433


Q ss_pred             ccCCcccCC--CCCCCcccccCCC--CChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEYP--QWNPQSLATAVPN--LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~~--~~~~~~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .........  ...........+.  +++.+.++|++||+.||++|||+.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            222211110  0011111222333  58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.4e-48  Score=330.04  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=214.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC-cEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG-KIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++.+.||+|+||.||++.++.++ ..+++|.+..... .......+..|+.+++.+ +||||+++++++.....  
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~--  105 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESY--  105 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCE--
Confidence            468999999999999999999876554 6799998865432 222345677899999999 99999999999988766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .+++|||+.| +|.+++...    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||+
T Consensus       106 ---~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~  177 (340)
T PTZ00426        106 ---LYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGF  177 (340)
T ss_pred             ---EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCC
Confidence               8999999975 898888652    4689999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +......   .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+.....        
T Consensus       178 a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------  245 (340)
T PTZ00426        178 AKVVDTR---TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------  245 (340)
T ss_pred             CeecCCC---cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------
Confidence            9765432   23346789999999998765 78999999999999999999999998877666555543211        


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                          .....+++.+.++|++||+.||.+|+     |++++++||||.++++.
T Consensus       246 --------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        246 --------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                11235788999999999999999995     89999999999988654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-47  Score=328.76  Aligned_cols=264  Identities=28%  Similarity=0.457  Sum_probs=216.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.+..++..+++|++..... .......+..|+.++..+ +||||+++++++.....    
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~----   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEY----   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCE----
Confidence            479999999999999999999999999999999875432 122345677899999999 89999999999987776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.| +|.+++..    ...+++..+..++.|++.||.+||+.|++|+||||+||+++.++ .+||+|||++.
T Consensus        76 -~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~  149 (333)
T cd05600          76 -LYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSK  149 (333)
T ss_pred             -EEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCc
Confidence             8999999986 99988865    24689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ....   ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+...........    
T Consensus       150 ~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----  221 (333)
T cd05600         150 GIVT---YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV----  221 (333)
T ss_pred             cccc---ccCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC----
Confidence            5443   223446789999999998775 89999999999999999999999988776665555443211110000    


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                      .......+++++.++|.+||+.+|.+|||+.++++||||.+.+..
T Consensus       222 ----------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         222 ----------------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             ----------------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence                            000013578999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-47  Score=325.08  Aligned_cols=250  Identities=28%  Similarity=0.448  Sum_probs=207.0

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      ||+|+||.||++.+..++..+++|.+.... ........+..|+.+++.+ +||||+++++++.....     .+++|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEK-----LYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCe-----EEEEEcC
Confidence            799999999999999999999999987532 1222345667899999999 99999999999887766     8999999


Q ss_pred             cCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc
Q 021982           91 MDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK  169 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~  169 (304)
                      +.+ +|.+++..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          75 INGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            986 88888865    24689999999999999999999999999999999999999777 8999999998754333333


Q ss_pred             cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCccc
Q 021982          170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE  249 (304)
Q Consensus       170 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (304)
                      .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....                   
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-------------------  209 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-------------------  209 (312)
T ss_pred             cccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-------------------
Confidence            34456799999999998765 7999999999999999999999998877665554443210                   


Q ss_pred             CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC---CHHHHhcCCCcccccc
Q 021982          250 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~~~~  301 (304)
                               ......+++.+.++|.+||+.||.+||   ++.++++||||.+.++
T Consensus       210 ---------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         210 ---------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence                     011235789999999999999999997   5899999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-47  Score=325.80  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=209.2

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||+++++.+++.+++|++..... ..........|..++..+.+||||+++++++.....     .++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-----~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR-----LFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE-----EEEEE
Confidence            468999999999999999999999999875421 222334566788888877689999999999887766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.| +|.+.+..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNG  150 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCC
Confidence            99986 88877754    24689999999999999999999999999999999999999777 89999999987543333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.....                
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------------  213 (320)
T cd05590         151 KTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------  213 (320)
T ss_pred             CcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence            3344456799999999987665 78999999999999999999999998877666655543110                


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH------HHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~eil~~~~~~~~~~~  302 (304)
                                  .....++.++.++|++||+.||.+||++      +++++||||..++++
T Consensus       214 ------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         214 ------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             ------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence                        0112478899999999999999999998      999999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-48  Score=324.48  Aligned_cols=261  Identities=28%  Similarity=0.463  Sum_probs=236.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+++|.+++.+|.|+||.+++++++.++..+++|++......+........|+.+++++ .||||+.+.+.|...+.   
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~---   77 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQ---   77 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCc---
Confidence            47899999999999999999999999999999999998876666666888999999998 99999999999887664   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                       .++|+|+||+| ++.+.+...+  +..++++.++.|+.|++.|+.|||+++|+|+|||+.||++++++ .|+|+|||++
T Consensus        78 -~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGla  153 (426)
T KOG0589|consen   78 -LLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLA  153 (426)
T ss_pred             -eEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhh
Confidence             27999999997 9999998854  57899999999999999999999999999999999999999888 7899999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...+..........|||.|++||.+.+.+ ++.++|||||||++|||++-+.+|...+-.....++++....+..     
T Consensus       154 K~l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp-----  227 (426)
T KOG0589|consen  154 KILNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP-----  227 (426)
T ss_pred             hhcCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-----
Confidence            99888776777789999999999998877 899999999999999999999999999999999998876544433     


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                            ...+.+++.+|..||..+|..||++.++|.+|.+..
T Consensus       228 ----------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  228 ----------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ----------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                                  368899999999999999999999999999987653

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-47  Score=326.19  Aligned_cols=259  Identities=26%  Similarity=0.416  Sum_probs=212.4

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +|++++.||+|+||.||++.++.+++.+++|++..... .......+..|..++..+..|++|+.+++++...+.     
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-----   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE-----
Confidence            58899999999999999999999999999999875432 222334567788888888445678889888887665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||+.| +|.+.+...    ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~  150 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKE  150 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCccee
Confidence            8999999985 888887652    4588999999999999999999999999999999999999777 899999999865


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+.....           
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----------  218 (324)
T cd05587         151 NIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----------  218 (324)
T ss_pred             cCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            433333334456799999999998766 78999999999999999999999988777666655543110           


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-----HHHhcCCCccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKT  302 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~eil~~~~~~~~~~~  302 (304)
                                       .....++.++.+++.+||..||.+|++.     +++++||||..+++.
T Consensus       219 -----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         219 -----------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                             1112578899999999999999999986     899999999987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-47  Score=331.14  Aligned_cols=279  Identities=24%  Similarity=0.319  Sum_probs=212.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+..+++.+++|...        ...+.+|+++++++ +||||+++++++.....    
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~----  157 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAI-NHPSIIQLKGTFTYNKF----  157 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCe----
Confidence            357999999999999999999999999999999643        23467899999999 99999999999887665    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++++|++.++|..++...    ..+++..++.++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++..
T Consensus       158 -~~lv~e~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~  231 (391)
T PHA03212        158 -TCLILPRYKTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACF  231 (391)
T ss_pred             -eEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCcccc
Confidence             8999999999988887652    4588999999999999999999999999999999999999777 899999999865


Q ss_pred             cccC-CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC-------chHHHHHHHHHHhCCCC
Q 021982          163 FTLP-IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD-------SELQQLLHIFRLLGTPN  234 (304)
Q Consensus       163 ~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~-------~~~~~~~~~~~~~~~~~  234 (304)
                      .... ........|++.|+|||++.+.. ++.++||||||+++|+|++|..||...       ........+....+.++
T Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        232 PVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             cccccccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence            3321 12233456799999999987765 799999999999999999999886432       22344455555544433


Q ss_pred             CCCCcccccc-CC-c---ccCCCCCCCc--ccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          235 EKVWPGVSSL-MN-W---HEYPQWNPQS--LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       235 ~~~~~~~~~~-~~-~---~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .......... .. +   .......+..  .......++.++.+||.+||+.||.+|||+.|+|+||||.+++.
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence            2211000000 00 0   0000000000  00111246778999999999999999999999999999998754

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-47  Score=326.39  Aligned_cols=255  Identities=27%  Similarity=0.411  Sum_probs=208.8

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHH---HHccCCCCeeeeeceecccccCCc
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSIL---RMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l---~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |++++.||+|++|.||++.++.++..+++|.+..... .......+..|+.++   +.+ +||||+++++++.....   
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~---   76 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDH---   76 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCE---
Confidence            6789999999999999999999999999999875431 122234555565554   445 79999999999987776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|...+..     ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus        77 --~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          77 --VCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             --EEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence              8999999986 77766543     4689999999999999999999999999999999999999877 9999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+.....         
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---------  218 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV---------  218 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            65433333334456799999999987765 78999999999999999999999998877666555443210         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~  301 (304)
                                         .....++..+.++|.+||+.||.+||     ++.++++||||++++.
T Consensus       219 -------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         219 -------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                               11235789999999999999999999     7999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.4e-47  Score=324.79  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=210.4

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|++..... .......+..|..++..+.+||+|+++++++.....     .++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~-----~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR-----LFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe-----EEEEE
Confidence            469999999999999999999999999875432 222334566788888877689999999999988776     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|...+..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNG  150 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCC
Confidence            99986 88877754    24689999999999999999999999999999999999999777 89999999987544333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.....                
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~----------------  213 (321)
T cd05591         151 VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV----------------  213 (321)
T ss_pred             ccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            3344456799999999987765 79999999999999999999999998887776665543210                


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-------CHHHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-------SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------s~~eil~~~~~~~~~~~  302 (304)
                                  .....++.++.++|.+||+.||.+||       ++.++++||||..++++
T Consensus       214 ------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         214 ------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             ------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence                        01124788999999999999999999       99999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-47  Score=325.62  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=208.2

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|++..... .......+..|+.+++.+ +||||+++++.+.....     .++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~-----~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDR-----LCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCE-----EEEEE
Confidence            468999999999999999999999999875422 222334566799999999 99999999999887766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus        75 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          75 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            99986 88777754    24689999999999999999999999999999999999999777 89999999986543333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....                
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~----------------  212 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------  212 (323)
T ss_pred             CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence            3334456799999999987765 79999999999999999999999987776655544432100                


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~  301 (304)
                                  .....+++++.++|.+||+.||.+||     ++.++++||||...++
T Consensus       213 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         213 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                        11235789999999999999999998     9999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-46  Score=315.96  Aligned_cols=283  Identities=46%  Similarity=0.854  Sum_probs=232.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|++|.||++.+..++..+++|++............+.+|+.+++++ +|||++++++++.....     .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~-----~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSG-----F   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCe-----e
Confidence            58899999999999999999998899999999887654444556788999999999 89999999999887665     8


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++|+||++++|.+.+....   .++++.+++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        75 ~~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            9999999669998886532   5689999999999999999999999999999999999999776 89999999987665


Q ss_pred             cCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          165 LPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       165 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      .... ......++..|+|||.+.+....+.++||||||+++++|++|..||...........+...++.+....|+....
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4321 233446688999999987766578999999999999999999888988888777777777777666655555443


Q ss_pred             cCCccc--CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          244 LMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       244 ~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      ..++..  ........+....+..+.++.++|.+||+.||.+|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            333211  111122223445567889999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-47  Score=325.56  Aligned_cols=253  Identities=28%  Similarity=0.389  Sum_probs=208.1

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|++..... .......+.+|+.+++.+ +||||+++.+.+.....     .++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~-----~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDR-----LCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCE-----EEEEE
Confidence            468999999999999999999999999875422 222345667899999999 99999999999887776     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|...+..    ...+++.++..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++.......
T Consensus        75 Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          75 EYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            99986 88777754    24689999999999999999999999999999999999999777 89999999986543333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....                 
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-----------------  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-----------------  211 (328)
T ss_pred             cccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-----------------
Confidence            3334456799999999987765 7999999999999999999999998776655444332110                 


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                 ......+++++.++|++||..||.+|+     ++.++++||||...+++
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         212 -----------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             -----------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                       011236789999999999999999997     89999999999887543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-46  Score=314.18  Aligned_cols=282  Identities=61%  Similarity=1.130  Sum_probs=230.0

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |++.+.||.|++|.||++.++.+|..+++|.+............+.+|+++++.+ +|||++++++++.....     .+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~-----~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENK-----LY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCe-----EE
Confidence            6788999999999999999998999999999876654444455678899999999 89999999999887765     89


Q ss_pred             EEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           86 LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      +++||++++|.+++.....  ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        75 iv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFLDLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEEeccCcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            9999998899988876332  4689999999999999999999999999999999999999866 999999999876544


Q ss_pred             CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      .........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+......+....|+......
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            43333444557889999988766557889999999999999999999999888877777777776666655554433322


Q ss_pred             Cccc-CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          246 NWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       246 ~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      +... .............+.++.++.++|.+||+.||.+|||++|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            2211 11222223334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.7e-47  Score=328.86  Aligned_cols=263  Identities=22%  Similarity=0.370  Sum_probs=211.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||+||++.++.+++.+++|++..... .......+..|+.++..+ +||+|+++++.+.+...    
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~----   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLN----   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCe----
Confidence            579999999999999999999999999999999875321 222335677899999999 99999999999988776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++..    ...+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~  149 (363)
T cd05628          76 -LYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCT  149 (363)
T ss_pred             -EEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCcc
Confidence             8999999986 88888865    25689999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCC-----------------------------------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHH
Q 021982          162 AFTLPIK-----------------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE  206 (304)
Q Consensus       162 ~~~~~~~-----------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~  206 (304)
                      .......                                   ......||+.|+|||++.+.. ++.++|||||||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~e  228 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYE  228 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHH
Confidence            5432110                                   012346799999999998765 7899999999999999


Q ss_pred             HhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCC---C
Q 021982          207 LVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS---K  283 (304)
Q Consensus       207 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~  283 (304)
                      |++|..||...+..+....+........                       +. ....+++++.++|.+|+. +|.   .
T Consensus       229 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------~p-~~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         229 MLIGYPPFCSETPQETYKKVMNWKETLI-----------------------FP-PEVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHcCcCccc-----------------------CC-CcCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            9999999988777666665543211000                       00 011478899999999776 444   4


Q ss_pred             CCCHHHHhcCCCcccccccc
Q 021982          284 RISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       284 Rps~~eil~~~~~~~~~~~~  303 (304)
                      ||+++||++||||+.++++.
T Consensus       284 r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         284 APGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCHHHHhCCCCCCCCCHHH
Confidence            68999999999999887653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.8e-47  Score=323.23  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=213.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +|++++.||+|+||.||++.+..++..+++|++..... ..........|..++..+..|++++++.+++...+.     
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR-----   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE-----
Confidence            48899999999999999999999999999999875432 122233455677778777678999999999887766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++||||+.+ +|.+.+...    ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~  150 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCcee
Confidence            8999999985 888877552    4589999999999999999999999999999999999999777 899999999875


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+.....           
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----------  218 (323)
T cd05616         151 NMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----------  218 (323)
T ss_pred             cCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            443333334456799999999998766 79999999999999999999999988777666555543211           


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-----HHHhcCCCccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKT  302 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~eil~~~~~~~~~~~  302 (304)
                                       .....++.++.+++.+||+.||.+|++.     .++++||||..++++
T Consensus       219 -----------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         219 -----------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                             1112578999999999999999999984     899999999988754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-47  Score=330.07  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=213.4

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++++..++..+++|++..... .......+.+|+.+++.+ +||||+++++++.+...    
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~----   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENY----   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCe----
Confidence            479999999999999999999999999999999875432 222334567899999999 89999999999988776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++..    ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~  149 (364)
T cd05599          76 -LYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCT  149 (364)
T ss_pred             -EEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccce
Confidence             8999999976 88888765    24689999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCC--------------------------------------ccccccccccCCChhhhhCCCCCCCchhHHHHHHH
Q 021982          162 AFTLPIK--------------------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI  203 (304)
Q Consensus       162 ~~~~~~~--------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~i  203 (304)
                      .......                                      ......||+.|+|||++.+.. ++.++|||||||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~i  228 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVI  228 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhH
Confidence            5432110                                      011235799999999987765 7999999999999


Q ss_pred             HHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC
Q 021982          204 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK  283 (304)
Q Consensus       204 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  283 (304)
                      +|+|++|..||...+..+....+........                       . .....+++++.+||.+||. +|.+
T Consensus       229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------~-~~~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQ-----------------------F-PDEVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHHhhcCCCCCCCCCHHHHHHHHHcCCCccC-----------------------C-CCCCCCCHHHHHHHHHHcc-CHhh
Confidence            9999999999998877665555443110000                       0 0011578999999999997 9999


Q ss_pred             CCC---HHHHhcCCCccccccc
Q 021982          284 RIS---AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       284 Rps---~~eil~~~~~~~~~~~  302 (304)
                      |++   +.++++||||+..+++
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCHH
Confidence            998   9999999999987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.7e-47  Score=320.53  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=206.6

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.+..++..|++|+++.... ..........|..++....+||||+++++++.....     .++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-----~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH-----LFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-----EEEEE
Confidence            468999999999999999999999999875432 122233445566677665589999999999887665     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.| +|...+..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGE  150 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCC
Confidence            99975 88887765    24689999999999999999999999999999999999999777 89999999987654333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....                 
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-----------------  212 (316)
T cd05592         151 GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-----------------  212 (316)
T ss_pred             CccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            3344456799999999988766 7899999999999999999999998877766555443211                 


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-HHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-KKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~eil~~~~~~~~~~~  302 (304)
                                 ......++.++.++|.+||+.||.+||++ .++++||||..++++
T Consensus       213 -----------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05592         213 -----------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWE  257 (316)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence                       01112578899999999999999999986 489999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-45  Score=310.03  Aligned_cols=283  Identities=38%  Similarity=0.726  Sum_probs=218.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||++.++.+++.+++|.+............+.+|+++++.+ +|||++++++++.....     
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~-----   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRK-----   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCE-----
Confidence            579999999999999999999998899999998876544433445677899999999 99999999999987765     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .+++|||+++++.+.+..   ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceec
Confidence            899999999855444432   234689999999999999999999999999999999999999777 8999999999876


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC---CCcc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK---VWPG  240 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~  240 (304)
                      ...........++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+..........   .+..
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            5543333344567889999998775557899999999999999999999998877766666555544432221   1100


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ......................+.++..+.+|+.+||+.||.+|||+.|++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00000000000001111222345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1e-46  Score=320.06  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=206.1

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|.+..... ..........|..++....+||+|+++++++...+.     .++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH-----LFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE-----EEEEE
Confidence            469999999999999999999999999875432 122234556677777765589999999999987766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.| +|..++..    ...+++.++..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGD  150 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCC
Confidence            99986 88887755    24689999999999999999999999999999999999999777 89999999986543333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....                 
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-----------------  212 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-----------------  212 (316)
T ss_pred             CceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence            3334456799999999998766 7999999999999999999999998777665554443210                 


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-HHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-KKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~eil~~~~~~~~~~~  302 (304)
                                 ......++.++.++|.+||+.||.+||++ +++++||||+.+++.
T Consensus       213 -----------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         213 -----------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence                       00112478899999999999999999998 589999999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2e-47  Score=326.73  Aligned_cols=264  Identities=28%  Similarity=0.414  Sum_probs=215.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|.+.+.||+|+||.||++.++.++..+++|.+..... .......+.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~----   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDN----   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCe----
Confidence            479999999999999999999999999999999886432 222345677888999998 99999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++...   ...+++..+..++.|++.||++||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~  150 (330)
T cd05601          76 -LYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAA  150 (330)
T ss_pred             -EEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCe
Confidence             8999999975 998888653   24689999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCCc-cccccccccCCChhhhhC-----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          162 AFTLPIKK-YTHEILTLWYRAPEVLLG-----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       162 ~~~~~~~~-~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ........ .....+++.|+|||++..     ...++.++||||||+++|+|++|..||...+.......+.......  
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--  228 (330)
T cd05601         151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL--  228 (330)
T ss_pred             ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--
Confidence            66443222 223457899999999863     3347889999999999999999999998877766665554321000  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                       .+                     ...+.+++++.+||.+||+ ||.+|||++++++||||+++++.
T Consensus       229 -~~---------------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         229 -KF---------------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             -CC---------------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence             00                     0112578999999999998 99999999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=315.02  Aligned_cols=264  Identities=26%  Similarity=0.383  Sum_probs=213.6

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .|++.+.||+|+||.||++.+..++..+++|++...... ......+.+|+.+++.+ +||||+++++.+.....     
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDA-----   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCe-----
Confidence            488899999999999999999989999999998754322 22234456799999999 99999999999887765     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++|||+.| +|.+.+...  ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            8999999985 887777542  234689999999999999999999999999999999999999776 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......+++.|+|||++.+.. ++.++|+||+|+++|+|++|..||...........+...+....        
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  221 (285)
T cd05605         152 IPEGE-TIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--------  221 (285)
T ss_pred             cCCCC-ccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------
Confidence            54332 223346789999999987665 78999999999999999999999987665444333333221111        


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                      ......++..+.+||.+||..||.+||     +++++++||||.+.++++
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR  271 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence                            011225788999999999999999999     999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.8e-47  Score=320.58  Aligned_cols=253  Identities=27%  Similarity=0.429  Sum_probs=208.2

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||+||++.++.++..+++|.++.... ..........|..++..+.+||||+++++++.....     .++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~-----~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR-----LFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-----EEEEE
Confidence            469999999999999999999999999885431 222344566788888888689999999999887766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.| +|...+..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGG  150 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCC
Confidence            99986 88877754    24689999999999999999999999999999999999999777 89999999986533332


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.....                
T Consensus       151 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----------------  213 (318)
T cd05570         151 VTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----------------  213 (318)
T ss_pred             CcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            3333446789999999998766 78999999999999999999999987776555544432100                


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-----HHHhcCCCcccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDK  301 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~eil~~~~~~~~~~  301 (304)
                                  .....++..+.+||++||..||.+|||+     .++++||||+..++
T Consensus       214 ------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         214 ------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             ------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                        0112578899999999999999999999     99999999998765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-46  Score=312.35  Aligned_cols=283  Identities=50%  Similarity=0.948  Sum_probs=222.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.++.++..+++|.+...... .....+.+|+++++.+ +|+||+++++++.....    
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~----   77 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDL-KHANIVTLHDIIHTKKT----   77 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhC-CCcceeeEEEEEecCCe----
Confidence            57899999999999999999999988999999998754322 2234566899999999 99999999999887765    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++||||+.++|.+++...   ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        78 -~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~  152 (291)
T cd07844          78 -LTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARA  152 (291)
T ss_pred             -EEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccc
Confidence             8999999999998887653   23689999999999999999999999999999999999999777 899999999865


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc-hHHHHHHHHHHhCCCCCCCCccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ............++..|+|||.+.+...++.++||||+|+++|+|++|..||.... ..+....+....+.+....|+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         153 KSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             cCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            43332222333457889999998765557899999999999999999999997665 45555556666666555555444


Q ss_pred             cccCCcccC--CCCCCCcccccCCCCC--hhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          242 SSLMNWHEY--PQWNPQSLATAVPNLD--KDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       242 ~~~~~~~~~--~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .........  ............+.++  .++.+++.+||+.||.+|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            332222111  1111122222333455  888999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.4e-46  Score=311.97  Aligned_cols=283  Identities=52%  Similarity=0.978  Sum_probs=230.0

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++++.||.|++|.||++.++.++..+++|.+...... .....+.+|+.+++.+ +|||++++++++...+.     .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-----~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKEL-KHENIVRLHDVIHTENK-----L   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCc-----E
Confidence            588999999999999999999999999999998765432 2335667899999999 99999999999988776     8


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++++||+.+++.+++..... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        74 ~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~  151 (284)
T cd07836          74 MLVFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFG  151 (284)
T ss_pred             EEEEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhc
Confidence            99999999999888865432 34689999999999999999999999999999999999999776 89999999987655


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      ..........+++.|++||.+.+...++.++|+||||+++|+|++|..||...+..+....+......+....|......
T Consensus       152 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             CCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence            44333344456888999999877655789999999999999999999999988888777777777666666555544433


Q ss_pred             CCcccC-CCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          245 MNWHEY-PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       245 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ..+... ............+.++..+.+++.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            222211 1111122233345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-46  Score=325.14  Aligned_cols=262  Identities=25%  Similarity=0.392  Sum_probs=213.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.++.++..+++|.+..... .......+.+|+.+++.+ +||||+++++++.+...   
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~---  117 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKY---  117 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCE---
Confidence            4679999999999999999999999999999999875321 222234566899999999 99999999999887776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++..     ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+||+|||.+
T Consensus       118 --~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~  189 (370)
T cd05596         118 --LYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (370)
T ss_pred             --EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccce
Confidence              8999999975 89888764     3588999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCC---CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGST---HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~---~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ........ ......|++.|+|||++.+..   .++.++|+|||||++|+|++|..||...+.......+.......   
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---  266 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL---  266 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC---
Confidence            76543321 223456799999999986532   37889999999999999999999999887766655554321100   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~  300 (304)
                      .++                     ....+|.++.+||.+||+.+|.+  |+|++++++||||+..+
T Consensus       267 ~~~---------------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         267 TFP---------------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             CCC---------------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            000                     11257899999999999999987  99999999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-47  Score=316.59  Aligned_cols=259  Identities=32%  Similarity=0.568  Sum_probs=210.3

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |++++.||+|+||+||++.+..++..+++|.+...............|+.+++++ +||||+++++++.....     .+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~-----~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNY-----LY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSE-----EE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccccc-----cc
Confidence            7889999999999999999999999999999986654433333344589999999 99999999999988666     89


Q ss_pred             EEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           86 LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++||++.+ +|.+++..    ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        75 ~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             ccccccccccccccccc----cccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccc
Confidence            99999998 99999983    25689999999999999999999999999999999999999666 99999999997654


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      ..........+++.|+|||++......+.++|+||||+++++|++|..||...........+............      
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  223 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------  223 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc------
Confidence            44445556677899999999883445899999999999999999999999987433333333332211100000      


Q ss_pred             CCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                     ......+..+.++|.+||+.||++|||+.++++||||
T Consensus       224 ---------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  224 ---------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             ---------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ---------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                           0001223789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.7e-46  Score=318.14  Aligned_cols=285  Identities=22%  Similarity=0.337  Sum_probs=213.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|++|.||++.+..++..+++|.+..... ......+.+|+++++.+ +||||+++++++.....   
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~---   77 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGE---   77 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCE---
Confidence            35789999999999999999999999999999998875422 22235678899999999 99999999999887765   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                        .+++|||+.+ +|.+++...    ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  150 (331)
T cd06649          78 --ISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGV  150 (331)
T ss_pred             --EEEEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcc
Confidence              8999999986 898888652    4589999999999999999999986 699999999999999777 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +......  ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+...........+.
T Consensus       151 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         151 SGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             ccccccc--ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence            8655332  223346789999999988765 8999999999999999999999998766544332211110000000000


Q ss_pred             ccccc-------CCcccCCCCC------------CCc-ccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSL-------MNWHEYPQWN------------PQS-LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~-------~~~~~~~~~~------------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .....       ...+......            ... .......+++++.+||.+||..||++|||+.++++||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence            00000       0000000000            000 000112478899999999999999999999999999999876


Q ss_pred             cc
Q 021982          300 DK  301 (304)
Q Consensus       300 ~~  301 (304)
                      ..
T Consensus       308 ~~  309 (331)
T cd06649         308 EV  309 (331)
T ss_pred             cc
Confidence            44

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2e-46  Score=318.19  Aligned_cols=254  Identities=28%  Similarity=0.442  Sum_probs=206.8

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|.+..... ..........|..++....+||||+++++++.....     ++++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~-----~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN-----LFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE-----EEEEE
Confidence            468999999999999999999999999876431 122234455677777765599999999999887766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.| +|.+.+..    ...+++.++..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGD  150 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCC
Confidence            99985 88888865    24688999999999999999999999999999999999999777 89999999986543332


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+....                 
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-----------------  212 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-----------------  212 (316)
T ss_pred             CceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence            3333456789999999987765 7999999999999999999999998877665554443210                 


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHH-HHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK-KAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-eil~~~~~~~~~~~  302 (304)
                                 ......++.++.++|.+||+.||.+||++. ++++||||..++++
T Consensus       213 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         213 -----------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                       001124778999999999999999999996 99999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-46  Score=320.49  Aligned_cols=294  Identities=39%  Similarity=0.660  Sum_probs=230.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|.+.+.||.|++|+||++.+..++..+++|.+............+..|+.+++.+ +|+||+++++++........
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheeccccccc
Confidence            56789999999999999999999999999999998875433333445677899999999 99999999998876544333


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...++++||++++|.+++..    ..++++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~  156 (337)
T cd07858          82 NDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLAR  156 (337)
T ss_pred             CcEEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCcccc
Confidence            34799999999998888764    24689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            65443333334456889999999876555899999999999999999999999887776666666666555444332111


Q ss_pred             ccc--CCc-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSL--MNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ...  ..+ ...............+.+++++.++|++||+.||.+|||++++++||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            110  000 001111112222334578999999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.5e-46  Score=315.02  Aligned_cols=280  Identities=37%  Similarity=0.677  Sum_probs=209.0

Q ss_pred             hhhcccccceEEEEEEEc--cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREK--ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      .++||+|+||.||++.++  .++..+++|.+....    ......+|+.+++.+ +||||+++++.+.....   ...++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~---~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLREL-KHPNVISLQKVFLSHAD---RKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhc-CCCCCcceeeeEecCCC---cEEEE
Confidence            568999999999999975  356789999876432    234567899999999 99999999998864332   23789


Q ss_pred             EEeccCCCHHHHHHHhcc-----CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC---CCCeEEEeecc
Q 021982           87 VFEYMDTDLKKYIRSFRQ-----TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KTMTLKIADLG  158 (304)
Q Consensus        87 v~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~---~~~~vkl~dfg  158 (304)
                      ++||+++++.+++.....     ....+++..+..++.|++.||.|||++|++|+||||+||+++.   ....+||+|||
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          78 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            999999999888764321     1235889999999999999999999999999999999999942   22489999999


Q ss_pred             ceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---------HHHHHHH
Q 021982          159 LARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHI  226 (304)
Q Consensus       159 ~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---------~~~~~~~  226 (304)
                      ++........   ......+++.|+|||++.+...++.++||||+||++|+|++|..||.....         ......+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            9976654322   223456689999999998766689999999999999999999999964332         3455566


Q ss_pred             HHHhCCCCCCCCccccccCCcccCC----------CCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYP----------QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ....+.+....|.............          ..............+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            6666665555444432221110000          000001111122456678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-47  Score=290.87  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=227.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||.|.||.||.++.+.++.-+++|++.+++- ......++.+|+++-..| +||||++++++|.+...   
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~r---   96 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKR---   96 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccce---
Confidence            4689999999999999999999999999999999877652 333456788999999999 99999999999999988   


Q ss_pred             eEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .|+++||.. |++...|..  +....+++...+.++.|++.||.|+|.++++||||||+|+|++..+ .+|++|||.+
T Consensus        97 --iyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGws  171 (281)
T KOG0580|consen   97 --IYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWS  171 (281)
T ss_pred             --eEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCce
Confidence              999999998 599999886  4456799999999999999999999999999999999999999888 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....  .......+||..|.|||+..+.. .+...|+|++|++.||++.|..||......+.+.++.+.-.         
T Consensus       172 V~~p--~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~---------  239 (281)
T KOG0580|consen  172 VHAP--SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL---------  239 (281)
T ss_pred             eecC--CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc---------
Confidence            7654  45556678999999999888877 79999999999999999999999999998888888765311         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         ..+..++.++.++|.+||..+|.+|.+..|++.|||..+.
T Consensus       240 -------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  240 -------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                               1124799999999999999999999999999999998753

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.1e-47  Score=322.90  Aligned_cols=263  Identities=28%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             hhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCC--CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHED--DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +|++++.||+|+||.||++++.   .++..+++|++.....  ..........|+.+++.+.+||+|+++++++..... 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~-   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK-   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE-
Confidence            4889999999999999999874   4678899999875322  222334567899999999679999999999887766 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++|||+.+ +|.+++..    ...+++.++..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||
T Consensus        80 ----~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG  150 (332)
T cd05614          80 ----LHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFG  150 (332)
T ss_pred             ----EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCc
Confidence                8999999986 88888765    24689999999999999999999999999999999999999777 89999999


Q ss_pred             ceeecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          159 LARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ++....... .......|++.|+|||++.+...++.++||||||+++|+|++|..||...........+...+...    
T Consensus       151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----  226 (332)
T cd05614         151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC----  226 (332)
T ss_pred             CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC----
Confidence            987543322 222234679999999999876557899999999999999999999996433221111111111000    


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~  301 (304)
                                          .......+++.+.+++.+||+.||.+||     +++++++||||++.+.
T Consensus       227 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         227 --------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                0011235788999999999999999999     8889999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.8e-46  Score=320.29  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|+++.... .......+..|..+++.+.+||||+++++++.....     .+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~-----~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR-----LFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE-----EEEEE
Confidence            468999999999999999999999999875432 222334567888999888789999999999987776     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.| +|..++..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCC
Confidence            99986 88877754    24699999999999999999999999999999999999999777 89999999986432222


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch--------HHHHHHHHHHhCCCCCCCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--------LQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||.....        .+........          
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------  219 (329)
T cd05588         151 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE----------  219 (329)
T ss_pred             CccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc----------
Confidence            3334456799999999998765 78999999999999999999999963211        1111111110          


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC------HHHHhcCCCcccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS------AKKAMEHPYFDDLDK  301 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~eil~~~~~~~~~~  301 (304)
                                       ........++..+.++|++||+.||.+|+|      ++++++||||.++++
T Consensus       220 -----------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         220 -----------------KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                             001122357889999999999999999997      789999999998755

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-47  Score=328.70  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=209.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.++.++..+++|++..... .......+..|+.+++.+ +||||+++++++.+...    
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~----   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQY----   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCe----
Confidence            579999999999999999999999999999998865421 222345677899999999 99999999999987776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++...    ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||+++
T Consensus        76 -~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~  149 (377)
T cd05629          76 -LYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLST  149 (377)
T ss_pred             -eEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeeccccc
Confidence             8999999975 898888652    4689999999999999999999999999999999999999777 89999999985


Q ss_pred             ecccCC-------------C----------------------------------ccccccccccCCChhhhhCCCCCCCc
Q 021982          162 AFTLPI-------------K----------------------------------KYTHEILTLWYRAPEVLLGSTHYSTA  194 (304)
Q Consensus       162 ~~~~~~-------------~----------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~  194 (304)
                      ......             .                                  ......|++.|+|||++.+.. ++.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~  228 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQE  228 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCc
Confidence            321100             0                                  000235789999999987765 7999


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHH
Q 021982          195 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLE  274 (304)
Q Consensus       195 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  274 (304)
                      +|||||||++|+|++|..||...+..+....+.......   .++                     ....++.++.+||.
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p---------------------~~~~~s~~~~dli~  284 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL---YFP---------------------DDIHLSVEAEDLIR  284 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc---CCC---------------------CCCCCCHHHHHHHH
Confidence            999999999999999999998877666555444311000   000                     01147889999999


Q ss_pred             HhhcCCCCCC---CCHHHHhcCCCccccccc
Q 021982          275 QMLQYDPSKR---ISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       275 ~~l~~dp~~R---ps~~eil~~~~~~~~~~~  302 (304)
                      +||. +|.+|   +|+.++++||||..++.+
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9998 66665   599999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.5e-47  Score=300.01  Aligned_cols=291  Identities=42%  Similarity=0.761  Sum_probs=241.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCc----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      ..|+.+..||+|.+|.||++..++++.    .++||.++.+..........-+|+..++.+ +|||++.+..++...+. 
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~-  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDK-  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCc-
Confidence            579999999999999999997655443    689999988777767777888999999999 99999999999887422 


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccC-CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC---CeEEEe
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIA  155 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~---~~vkl~  155 (304)
                         .+++++||..-+|.+.+...+.. ...++...+..++.||+.|+.|||++-+.|+||||.||++..++   +.|||+
T Consensus       102 ---~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  102 ---KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             ---eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence               38999999999999998765432 24688999999999999999999999999999999999998772   399999


Q ss_pred             eccceeecccCCCcccc---ccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCC---------CchHHHH
Q 021982          156 DLGLARAFTLPIKKYTH---EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG---------DSELQQL  223 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~---------~~~~~~~  223 (304)
                      |+|+++.+..+-..+..   -.-|.+|+|||.+++..+++.+.|||++|||+.||+|..+.|..         +-..++.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999988765443322   23389999999999999999999999999999999999888864         3346788


Q ss_pred             HHHHHHhCCCCCCCCccccccCCcccC------CCCCCCccccc---CCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          224 LHIFRLLGTPNEKVWPGVSSLMNWHEY------PQWNPQSLATA---VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                      .+++..++.|....|+.+.+...+...      ..+.+-++...   ...-++...+|+.+||+.||.+|.|+++.++|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            899999999999999999888776211      12222222222   234566689999999999999999999999999


Q ss_pred             Ccccc
Q 021982          295 YFDDL  299 (304)
Q Consensus       295 ~~~~~  299 (304)
                      ||.+-
T Consensus       339 yF~~d  343 (438)
T KOG0666|consen  339 YFTED  343 (438)
T ss_pred             ccccC
Confidence            99864

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-47  Score=322.83  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=209.0

Q ss_pred             hhhcccccceEEEEEEE---ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            9 LEKVGEGTYGKVYRARE---KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      ++.||+|+||.||++.+   +.++..+++|++...............|+++++++ +||||+++++.+.....     .+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-----~~   74 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGK-----LY   74 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCE-----EE
Confidence            36799999999999986   35678999999876543333344567799999999 99999999999887766     89


Q ss_pred             EEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           86 LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +||||+.+ +|.+++..    ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus        75 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~  149 (318)
T cd05582          75 LILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESI  149 (318)
T ss_pred             EEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccC
Confidence            99999985 88888754    24689999999999999999999999999999999999999777 89999999987654


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      ..........|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.....             
T Consensus       150 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-------------  215 (318)
T cd05582         150 DHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-------------  215 (318)
T ss_pred             CCCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            4433334456789999999987765 78999999999999999999999988776665555432110             


Q ss_pred             CCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                     .....+++.+.++|++||+.||.+|||     ++++++||||..+++.
T Consensus       216 ---------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         216 ---------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence                           112257899999999999999999999     7889999999887543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-46  Score=322.45  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=204.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|+.++.||+|+||.||++.+..+++.|++|++.... .......+.+|+.+++.+ +|+||+++++++.....    
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----  146 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGE----  146 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCe----
Confidence            467999999999999999999999999999999986432 222335677899999999 99999999999887766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       ++++|||+.+ +|.+.        ....+..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       147 -~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~  216 (353)
T PLN00034        147 -IQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSR  216 (353)
T ss_pred             -EEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccce
Confidence             8999999987 65432        2356778889999999999999999999999999999999777 89999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      .............|+..|+|||.+..    ....+.++|||||||++|+|++|+.||......+...........     
T Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----  291 (353)
T PLN00034        217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-----  291 (353)
T ss_pred             ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-----
Confidence            76544333344567999999998743    223457899999999999999999999744332222211111100     


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         ........++.++.+||.+||+.||.+|||+.|+++||||...
T Consensus       292 -------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        292 -------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             -------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                               0011123578899999999999999999999999999999885

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-46  Score=318.97  Aligned_cols=253  Identities=29%  Similarity=0.466  Sum_probs=207.2

Q ss_pred             hhhcccccceEEEEEEEc---cCCcEEEEEEeeecCC--CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            9 LEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHED--DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++.||+|+||.||++++.   .+++.+++|++.....  .......+..|+.+++.+ +||||+++++.+.....     
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~-----   74 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGK-----   74 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCe-----
Confidence            368999999999999874   4678899999875421  222234567899999999 99999999999987766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++|||+.| +|.+.+..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  149 (323)
T cd05584          75 LYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKE  149 (323)
T ss_pred             EEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCee
Confidence            8999999986 88888765    24688899999999999999999999999999999999999777 999999999865


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+.....           
T Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-----------  217 (323)
T cd05584         150 SIHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-----------  217 (323)
T ss_pred             cccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            433333333456799999999987765 78999999999999999999999988776665555443110           


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~  301 (304)
                                       ...+.+++.+.++|.+||+.||.+||     +++++++||||.....
T Consensus       218 -----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         218 -----------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                             11235788999999999999999999     8999999999987643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-46  Score=326.15  Aligned_cols=262  Identities=26%  Similarity=0.412  Sum_probs=208.8

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .|++++.||+|+||+||++.++.++..+++|++..... .......+..|+.+++.+ +||||+++++.+.+...     
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~-----   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDN-----   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCE-----
Confidence            68899999999999999999999999999999875432 222345677899999999 99999999999987766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++||||+.| +|.+++...    ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++..
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            8999999976 888887652    4588999999999999999999999999999999999999777 899999998753


Q ss_pred             cccCCC-----------------------------------------------ccccccccccCCChhhhhCCCCCCCch
Q 021982          163 FTLPIK-----------------------------------------------KYTHEILTLWYRAPEVLLGSTHYSTAV  195 (304)
Q Consensus       163 ~~~~~~-----------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~  195 (304)
                      ......                                               ......|++.|+|||.+.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCcc
Confidence            211000                                               011235789999999987765 78999


Q ss_pred             hHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHH
Q 021982          196 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQ  275 (304)
Q Consensus       196 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  275 (304)
                      |||||||++|+|++|..||...+..+....+.......                        .......+++++.+||.+
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------~~~~~~~~s~~~~dli~~  285 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL------------------------HIPPQVKLSPEAVDLITK  285 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc------------------------CCCCCCCCCHHHHHHHHH
Confidence            99999999999999999998877655544443211000                        000112578999999999


Q ss_pred             hh--cCCCCCCCCHHHHhcCCCccccccc
Q 021982          276 ML--QYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       276 ~l--~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      |+  ..+|..|+++.++++||||..+++.
T Consensus       286 ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         286 LCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HccCcccccCCCCHHHHhcCcccCCCChh
Confidence            65  4555569999999999999987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-46  Score=320.63  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=204.7

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHH-HHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVS-ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||+||++.++.+++.+++|++..... .......+..|.. +++.+ +||||+++++.+.....     .+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~-----~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADK-----LYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCE-----EEEE
Confidence            468999999999999999999999999875432 1112233444444 45667 99999999999887665     8999


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.| +|..++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus        75 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          75 LDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             EcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            999986 88887754    34689999999999999999999999999999999999999777 8999999998654333


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      ........|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            33334456799999999987765 7999999999999999999999998877666555543311                


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH----HHHhcCCCccccccc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKT  302 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~~~~~~~  302 (304)
                                  ....+.++..+.++|.+||+.||.+||++    .++++||||..+++.
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         213 ------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence                        01123578999999999999999999988    699999999887643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-45  Score=314.65  Aligned_cols=288  Identities=42%  Similarity=0.727  Sum_probs=233.0

Q ss_pred             chhhhhh-hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC------------CCchhHHHHHHHHHccCCCCeee
Q 021982            2 VMDAFEK-LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG------------VPPTTLREVSILRMLSRDPHVVR   68 (304)
Q Consensus         2 i~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~h~~i~~   68 (304)
                      +.++|.. .+.||+|++|.||++.++.++..+++|++........            ....+.+|+++++.+ +||||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceee
Confidence            4567875 4679999999999999998999999998875432221            112467899999999 9999999


Q ss_pred             eeceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC
Q 021982           69 LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK  148 (304)
Q Consensus        69 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~  148 (304)
                      +++++.....     .+++||++.|+|.+++..    ...+++..+..++.|++.||++||+.|++|+||+|+||+++.+
T Consensus        85 ~~~~~~~~~~-----~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         85 LVDVYVEGDF-----INLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK  155 (335)
T ss_pred             eeEEEecCCc-----EEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC
Confidence            9999887766     899999999999888864    2458999999999999999999999999999999999999977


Q ss_pred             CCeEEEeeccceeeccc--------------CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccC
Q 021982          149 TMTLKIADLGLARAFTL--------------PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF  214 (304)
Q Consensus       149 ~~~vkl~dfg~~~~~~~--------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~  214 (304)
                      + .++|+|||.+.....              .........+++.|+|||.+.+...++.++|+||||+++|+|++|..||
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        156 G-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             C-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            7 899999999876541              1122223345788999999877665789999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          215 PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                      ...+..+....+....+.+....|+...............+.......+..+.++.++|.+||+.||.+|||++|++.||
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        235 PGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             CCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            99888888888888777776665655444333333333333444445567889999999999999999999999999999


Q ss_pred             Cccccc
Q 021982          295 YFDDLD  300 (304)
Q Consensus       295 ~~~~~~  300 (304)
                      ||..-.
T Consensus       315 ~~~~~~  320 (335)
T PTZ00024        315 YFKSDP  320 (335)
T ss_pred             ccCCCC
Confidence            998753

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.1e-47  Score=321.83  Aligned_cols=252  Identities=26%  Similarity=0.368  Sum_probs=206.6

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.+..++..+++|++..... .......+..|+.+++.+ +||||+++.+.+.....     .++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~-----~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDR-----LCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCE-----EEEEE
Confidence            468999999999999999999999999875432 222234566788899998 99999999999887766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      ||+.+ +|...+..    ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++ .+||+|||++......
T Consensus        75 E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          75 EYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCC
Confidence            99986 88777654    2468999999999999999999997 7999999999999999777 8999999998654333


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      ........|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+.....               
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~---------------  213 (325)
T cd05594         150 GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------------  213 (325)
T ss_pred             CcccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence            33334456799999999987765 79999999999999999999999987766555444332100               


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~  301 (304)
                                   .....+++++.++|.+||+.||.+|+     ++.++++||||..+..
T Consensus       214 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         214 -------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             -------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence                         01225789999999999999999997     9999999999997643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.2e-46  Score=317.97  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=212.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +|+..+.||+|+||.||++.++.++..|++|++..... ..........|..++..+.+|++++++.+++...+.     
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-----   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR-----   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE-----
Confidence            47788999999999999999999999999999875422 222334566788888888667888899998887766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++||||+.| +|.+++...    ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~  150 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccc
Confidence            8999999985 888877542    4689999999999999999999999999999999999999777 899999999865


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.....           
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----------  218 (323)
T cd05615         151 HMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----------  218 (323)
T ss_pred             cCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            433322333445789999999987765 78999999999999999999999988776665555543210           


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                       .....++.++.+++.+||+.||.+|++     .+++++||||..+++.
T Consensus       219 -----------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         219 -----------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             -----------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence                             011257889999999999999999997     5799999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.1e-46  Score=321.73  Aligned_cols=262  Identities=25%  Similarity=0.408  Sum_probs=211.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.++.++..+++|++..... .......+.+|+.+++.+ +||||+++++.+.....   
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~---  117 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKY---  117 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCE---
Confidence            4689999999999999999999999999999999865322 222234567889999998 99999999999987776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++..     ..+++.++..++.||+.||++||++|++|+||||+||+++.++ .+||+|||++
T Consensus       118 --~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a  189 (370)
T cd05621         118 --LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTC  189 (370)
T ss_pred             --EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccc
Confidence              8999999985 89888864     3578999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCC---CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGST---HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~---~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ........ ......|++.|+|||++.+..   .++.++|+||||+++|+|++|..||...+.......+.......   
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---  266 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL---  266 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc---
Confidence            76643222 223456899999999997542   36889999999999999999999998887766665554321110   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~  300 (304)
                      .++                     ....++..+.+++.+||+.++.+  |+|+.|+++||||+...
T Consensus       267 ~~p---------------------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         267 NFP---------------------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             CCC---------------------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            000                     01247899999999999865543  89999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-46  Score=313.60  Aligned_cols=248  Identities=27%  Similarity=0.436  Sum_probs=212.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.+++++.||+|.||.||.+.++. ...+++|.++..   ......+.+|+++++.| +|++|+++++++..+..     
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~p-----  275 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEP-----  275 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhC-cccCeEEEEEEEecCCc-----
Confidence            568899999999999999999975 346999988754   22346788999999999 99999999999998776     


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++|||||+. |+|.++|..  ..+..+...+++.++.|||+|++||++++++||||-..||||+.+. .+||+|||+++.
T Consensus       276 iyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~  352 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARL  352 (468)
T ss_pred             eEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccccc
Confidence            899999998 799999988  4557799999999999999999999999999999999999999777 999999999985


Q ss_pred             cccCCCcc-ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...+.... ...-....|.|||.+..+. ++.+|||||||++||||+| |+.|+...+..+....+.+..+-+.      
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~------  425 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR------  425 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC------
Confidence            54332221 2222267799999998777 8999999999999999999 8999999999999998877554433      


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           +..+|+++.+++..||..+|++|||++.+..
T Consensus       426 ---------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  426 ---------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             ---------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                                 3479999999999999999999999997654

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.5e-46  Score=318.45  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=202.3

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.++.++..+++|++..... .......+..|+.++.++.+||||+++++++.....     .++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-----~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-----LFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE-----EEEEE
Confidence            469999999999999999999999999876432 222334566788888877689999999999888766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|..++..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCC
Confidence            99986 88777654    24689999999999999999999999999999999999999777 89999999986533322


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch--------HHHHHHHHHHhCCCCCCCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--------LQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||.....        .........   .       
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~---~-------  219 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---E-------  219 (329)
T ss_pred             CccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh---c-------
Confidence            3334456799999999998765 78999999999999999999999953211        111111111   0       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC------HHHHhcCCCcccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS------AKKAMEHPYFDDLDK  301 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~eil~~~~~~~~~~  301 (304)
                                       ........++..+.++|.+||+.||.+|||      +.++++||||..+++
T Consensus       220 -----------------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         220 -----------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                             001122357889999999999999999998      579999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-45  Score=307.52  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=203.7

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      ||+|+||.||++.++.++..+++|.+...... .........|+++++.+ +||||+++.+.+.....     .+++|||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~-----~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTH-----LCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCe-----EEEEEec
Confidence            79999999999999999999999988653322 11223455689999999 99999999999887665     8999999


Q ss_pred             cCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc
Q 021982           91 MDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK  169 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~  169 (304)
                      +.| +|.+.+...  ....+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus        75 ~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~-~  150 (277)
T cd05607          75 MNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGK-T  150 (277)
T ss_pred             CCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCc-e
Confidence            986 888777542  234588999999999999999999999999999999999999777 89999999987654432 2


Q ss_pred             cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCccc
Q 021982          170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE  249 (304)
Q Consensus       170 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (304)
                      .....+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...........+.......                
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  213 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED----------------  213 (277)
T ss_pred             eeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------
Confidence            23346788999999998776 8999999999999999999999997654322222222211100                


Q ss_pred             CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH----HHHhcCCCcccccccc
Q 021982          250 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKTR  303 (304)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~~~~~~~~  303 (304)
                             ........+++++.+++.+||+.||.+||++    ++++.||||+.+++.+
T Consensus       214 -------~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         214 -------EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             -------ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence                   0000112578899999999999999999999    6788999999887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-47  Score=289.60  Aligned_cols=263  Identities=25%  Similarity=0.413  Sum_probs=214.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||.|||+-||+++.-.++..|++|.+..+.  .......++|++..+.+ +|||+++++++...+..++..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence            368999999999999999999999999999999988766  33457888999999999 999999999998888777888


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ..|++++|+. |+|.+.+......+..+++.+++.++.++++||++||+..  ++|+||||.||++.+++ .+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccC
Confidence            8999999998 6999999999888889999999999999999999999998  99999999999999766 999999999


Q ss_pred             eeecccCC---------CccccccccccCCChhhhhCCC--CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHH
Q 021982          160 ARAFTLPI---------KKYTHEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       160 ~~~~~~~~---------~~~~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  228 (304)
                      ++...-..         +......+|..|+|||.+.-..  ..+.++|||||||+||.||.|..||.....  .      
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~------  247 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--Q------  247 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--c------
Confidence            87653211         1122335589999999996433  378999999999999999999999874321  0      


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                        +.   +.          .-......-+++... -+|+.+.++|+.||++||.+||++.+++++
T Consensus       248 --Gg---Sl----------aLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  248 --GG---SL----------ALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             --CC---eE----------EEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence              00   00          000000111122222 388999999999999999999999999874

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.7e-46  Score=330.85  Aligned_cols=267  Identities=21%  Similarity=0.315  Sum_probs=219.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC---
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE---   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~---   79 (304)
                      .++|++.+.||+|+||+||++.+..++..+++|.+............+.+|+..+..+ +|+|++++.+.+......   
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcc
Confidence            4689999999999999999999999999999999876654444455677899999998 999999998877644321   


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      ....++++|||+.+ +|.+.+........++++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFG  188 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFG  188 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecc
Confidence            12246899999985 99999987666667899999999999999999999999999999999999999777 89999999


Q ss_pred             ceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ++.......  .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....      
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~------  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR------  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC------
Confidence            987654321  1223346799999999998765 8999999999999999999999998877655554443211      


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                           .....+.+++++.+++.+||+.||.+|||+.++++|||++..
T Consensus       262 ---------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 ---------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                 111223688999999999999999999999999999998754

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=306.45  Aligned_cols=281  Identities=60%  Similarity=1.119  Sum_probs=234.0

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |+..+.||+|++|.||.+.+..++..+++|.+............+..|+.+++.+ +|+|++++++++.....     .+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~-----~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERK-----LY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCc-----eE
Confidence            6778899999999999999999999999999887654444556778899999999 89999999999887765     89


Q ss_pred             EEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           86 LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      +++|+++++|.+++....   ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        75 ~v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            999999999999987632   3689999999999999999999999999999999999999776 899999999877655


Q ss_pred             CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      .........++..|+|||.+.+....+.++|+||||++++++++|..||...+..+....+....+.+....|+......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            44344444557889999998776558999999999999999999999999988888888888877777766665554443


Q ss_pred             Cc-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          246 NW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       246 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .+ ...............+.++..+.++|++||..||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            11 1222222333334456678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-45  Score=316.83  Aligned_cols=291  Identities=37%  Similarity=0.661  Sum_probs=224.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|++|.||++.+..++..|++|.+.... .......+.+|+.+++.+ +||||+++++++........
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhC-CCCCcCchhheeeccccccc
Confidence            5678999999999999999999999999999999886422 222345677899999999 89999999998776554444


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...++++|++.+++.+.+..     .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~  154 (336)
T cd07849          81 NDVYIVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLAR  154 (336)
T ss_pred             ceEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECccccee
Confidence            45799999999988877654     4689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          162 AFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       162 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .......   ......+++.|+|||.+.+...++.++||||||+++|+|++|..||...+.......+...++.+....+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            6543221   1123456888999998876555899999999999999999999999887766666666555554433222


Q ss_pred             ccccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          239 PGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       239 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ........   ....+......+....+..++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            11111000   001111111222233456789999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.1e-45  Score=301.09  Aligned_cols=256  Identities=27%  Similarity=0.464  Sum_probs=210.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||.|++|.||++.++.++..+++|.+............+..|+++++++ +|+|++++.+.+.....    ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~----~~   75 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDG----LL   75 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCC----EE
Confidence            48999999999999999999998899999999876544444455678899999999 99999999987654332    27


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++|++.+ +|.+++...  ...++++.+++.++.+++.|+.+||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            899999985 898888763  235689999999999999999999999999999999999999777 8999999999776


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||++.+.. ++.++|+||||++++++++|..||...+.......+.....            
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            54434444456788999999987765 78999999999999999999999987665444333322110            


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                     ......+++.+.+++.+||+.||.+|||+.+++.||||
T Consensus       220 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 ---------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ---------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                           11123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.5e-46  Score=325.01  Aligned_cols=261  Identities=27%  Similarity=0.445  Sum_probs=209.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+|++++.||+|+||.||++++..++..+++|++..... .......+.+|+.+++.+ +||||+++++.+.+...    
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~----   75 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDN----   75 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCE----
Confidence            368999999999999999999999999999999875421 222345677899999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+.+...    ..+++..+..++.||+.||+|||++||+|+||||+|||++.++ .++|+|||++.
T Consensus        76 -~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~  149 (382)
T cd05625          76 -LYFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCT  149 (382)
T ss_pred             -EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCc
Confidence             8999999986 888887652    4688999999999999999999999999999999999999777 89999999874


Q ss_pred             ecccCC-----------------------------------------------CccccccccccCCChhhhhCCCCCCCc
Q 021982          162 AFTLPI-----------------------------------------------KKYTHEILTLWYRAPEVLLGSTHYSTA  194 (304)
Q Consensus       162 ~~~~~~-----------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~  194 (304)
                      ......                                               .......|++.|+|||++.+.. ++.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~  228 (382)
T cd05625         150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQL  228 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCe
Confidence            321000                                               0001235789999999998766 7899


Q ss_pred             hhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHH
Q 021982          195 VDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLE  274 (304)
Q Consensus       195 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  274 (304)
                      +|||||||++|+|++|..||...+..+....+........                        ......+++++.++|.
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~s~~~~~li~  284 (382)
T cd05625         229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH------------------------IPPQAKLSPEASDLII  284 (382)
T ss_pred             eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC------------------------CCCcccCCHHHHHHHH
Confidence            9999999999999999999988776655554443111100                        0011257899999999


Q ss_pred             HhhcCCCCCCCC---HHHHhcCCCcccccc
Q 021982          275 QMLQYDPSKRIS---AKKAMEHPYFDDLDK  301 (304)
Q Consensus       275 ~~l~~dp~~Rps---~~eil~~~~~~~~~~  301 (304)
                      +|+ .||.+|++   ++++++||||+.++.
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            976 59999997   999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-46  Score=325.63  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=209.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +.|++++.||+|+||.||+++++.+++.+++|++..... .......+.+|+.+++.+ +||||+++++.+.+.+.    
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~----   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDN----   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCE----
Confidence            469999999999999999999999999999999865321 222345677899999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||||+.| +|.+++..    ...+++..+..++.||+.||+|||+.||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~  149 (376)
T cd05598          76 -LYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCT  149 (376)
T ss_pred             -EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCc
Confidence             8999999975 89888865    24588999999999999999999999999999999999999777 89999999874


Q ss_pred             ecccC-------------------------------------------CCccccccccccCCChhhhhCCCCCCCchhHH
Q 021982          162 AFTLP-------------------------------------------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMW  198 (304)
Q Consensus       162 ~~~~~-------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~  198 (304)
                      .....                                           ........|++.|+|||++.+.. ++.++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw  228 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWW  228 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeee
Confidence            32100                                           00011235789999999987766 79999999


Q ss_pred             HHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhc
Q 021982          199 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ  278 (304)
Q Consensus       199 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  278 (304)
                      ||||++|+|++|..||...+..+....+.......                        .......+++++.++|.+|+ 
T Consensus       229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------------~~~~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTL------------------------HIPSQAKLSREASDLILRLC-  283 (376)
T ss_pred             eccceeeehhhCCCCCCCCCHHHHHHHHhccCccc------------------------cCCCCCCCCHHHHHHHHHHh-
Confidence            99999999999999998877665554443211000                        00011257899999999977 


Q ss_pred             CCCCCCC---CHHHHhcCCCcccccc
Q 021982          279 YDPSKRI---SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       279 ~dp~~Rp---s~~eil~~~~~~~~~~  301 (304)
                      .+|.+|+   |+.++++||||+.++.
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            5999999   9999999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.2e-46  Score=322.77  Aligned_cols=262  Identities=25%  Similarity=0.426  Sum_probs=212.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.++.++..+++|++.... ........+..|..++..+ +||+|+++++.+.+...    
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~----   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRN----   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCE----
Confidence            47899999999999999999999999999999987532 2233345677899999999 99999999999987776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++..    ...+++..+..++.|++.||++||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~  149 (360)
T cd05627          76 -LYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCT  149 (360)
T ss_pred             -EEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCc
Confidence             8999999986 88888865    24689999999999999999999999999999999999999777 99999999976


Q ss_pred             ecccCCC-----------------------------------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHH
Q 021982          162 AFTLPIK-----------------------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE  206 (304)
Q Consensus       162 ~~~~~~~-----------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~  206 (304)
                      .......                                   ......|++.|+|||++.+.. ++.++|+|||||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilye  228 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYE  228 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeee
Confidence            4421100                                   011236789999999988766 7899999999999999


Q ss_pred             HhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-
Q 021982          207 LVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-  285 (304)
Q Consensus       207 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-  285 (304)
                      |++|..||...+.......+.......   .+                     .....+++++.++|.+|+ .||.+|+ 
T Consensus       229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~---~~---------------------p~~~~~s~~~~~li~~l~-~~p~~R~~  283 (360)
T cd05627         229 MLIGYPPFCSETPQETYRKVMNWKETL---VF---------------------PPEVPISEKAKDLILRFC-TDSENRIG  283 (360)
T ss_pred             cccCCCCCCCCCHHHHHHHHHcCCCce---ec---------------------CCCCCCCHHHHHHHHHhc-cChhhcCC
Confidence            999999998877766655554311000   00                     001137889999999977 4999998 


Q ss_pred             --CHHHHhcCCCccccccc
Q 021982          286 --SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       286 --s~~eil~~~~~~~~~~~  302 (304)
                        +++++++||||..++++
T Consensus       284 ~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCHHHHhcCCCCCCCCHH
Confidence              58999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-45  Score=306.48  Aligned_cols=281  Identities=54%  Similarity=0.994  Sum_probs=229.3

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |++.+.||+|++|.||++.++.++..+++|.+............+..|+++++++ +|+|++++++++.....     .+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGD-----LY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCC-----EE
Confidence            6788999999999999999998899999998876554434456778899999999 89999999999887766     89


Q ss_pred             EEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           86 LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      +++||+.+++.+.+...   ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        75 ~v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            99999999988887652   24789999999999999999999999999999999999999776 899999999977665


Q ss_pred             CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      .........++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+....+.+....+.......
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            44333344567889999998876458999999999999999999999998888877777777766666555554443321


Q ss_pred             Cc--ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          246 NW--HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       246 ~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ..  ...............+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11  1112222222333445789999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.8e-45  Score=315.11  Aligned_cols=293  Identities=35%  Similarity=0.670  Sum_probs=230.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|.+.+.||+|++|.||++.++.++..+++|.+............+.+|+.+++.+ +||||+++.+++..... ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~   80 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGA-DF   80 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCC-CC
Confidence            45789999999999999999999999999999999876544444556777899999999 89999999998775442 22


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...++++||+.++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~  155 (334)
T cd07855          81 KDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMAR  155 (334)
T ss_pred             ceEEEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccce
Confidence            34799999999888777643    34589999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCc----cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ........    .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            65432211    12345688899999987655589999999999999999999999988877777777777666665444


Q ss_pred             CccccccCCc---ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          238 WPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       238 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      +.........   ..........+....+..+.++.++|.+||+.||.+|||+.+++.||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence            3322211100   011111122223344678999999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-45  Score=314.53  Aligned_cols=266  Identities=23%  Similarity=0.397  Sum_probs=212.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.+..+++.+++|++.... ........+.+|..++..+ +|+||+++++++.....    
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~----   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENN----   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCe----
Confidence            57999999999999999999999999999999987532 1222334577888999998 99999999999987776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++...   ...+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~  150 (331)
T cd05597          76 -LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCL  150 (331)
T ss_pred             -EEEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCcee
Confidence             8999999975 998888652   34689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCC-ccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPIK-KYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~~-~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ....... ......|++.|+|||++..    ...++.++|||||||++|+|++|..||...+..+....+.....     
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-----  225 (331)
T cd05597         151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----  225 (331)
T ss_pred             ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            6543322 2223457999999999863    23368899999999999999999999988776665555432110     


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~~~  302 (304)
                                        ...+......++..+.++|++||..++++  |+++.++++||||...++.
T Consensus       226 ------------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         226 ------------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             ------------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence                              00111122358899999999999765444  8899999999999887543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-45  Score=314.32  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=204.4

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|+||.||++.+..++..+++|++..... .......+..|..++.++.+||+|+.+++++.....     .++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-----LFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-----EEEEE
Confidence            469999999999999999999999999875432 222334567888888888789999999999887766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.| +|...+..    ...+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCC
Confidence            99986 88777754    24689999999999999999999999999999999999999777 89999999987543333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc------hHHHHHHHHHHhCCCCCCCCccc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||....      ..+........  .         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~---------  218 (327)
T cd05617         151 DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K---------  218 (327)
T ss_pred             CceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C---------
Confidence            3334456799999999987765 7999999999999999999999996422      11111111110  0         


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC------HHHHhcCCCccccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS------AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~eil~~~~~~~~~~~  302 (304)
                                      .......++..+.+++.+||+.||.+|++      ++++++||||+.++++
T Consensus       219 ----------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         219 ----------------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                            00112357889999999999999999998      5799999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-44  Score=301.04  Aligned_cols=262  Identities=24%  Similarity=0.433  Sum_probs=210.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC-c
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG-R   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~-~   81 (304)
                      .+.|++.+.||.|++|.||++.+..++..+++|.+.....   ....+..|+.+++++.+|||++++++++......+ .
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4679999999999999999999999999999998875432   23467789999999867999999999987654322 2


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++|||+.+ +|.+++...  ....+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCc
Confidence            357899999986 898888763  234689999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCC----CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ..............+++.|+|||++.+.    ..++.++|+||||+++|+|++|..||...............   .   
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~---  232 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P---  232 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C---
Confidence            7654433333445678899999998632    23788999999999999999999999766544333322110   0   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                          ........++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       233 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 --------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             --------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                                0001112467899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-45  Score=310.49  Aligned_cols=287  Identities=42%  Similarity=0.794  Sum_probs=218.5

Q ss_pred             hhhhhhhcccccceEEEEEEEcc--CCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKA--TGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +|++.+.||+|++|.||++.++.  ++..+++|.+.... ..........+|+.+++.+ +||||+++++++.+...   
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHAD---   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCC---
Confidence            58899999999999999999988  78999999988643 2333446677899999999 99999999999987621   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCC-CCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC----CCCeEEEee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGE-NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR----KTMTLKIAD  156 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~----~~~~vkl~d  156 (304)
                      ...++|||++++++.+.+........ .+++..++.++.|++.||.|||+.+++|+||+|+||+++.    ++ .+||+|
T Consensus        77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          77 KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            13899999999998888866544333 7899999999999999999999999999999999999997    55 899999


Q ss_pred             ccceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH---------HHHH
Q 021982          157 LGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL---------QQLL  224 (304)
Q Consensus       157 fg~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---------~~~~  224 (304)
                      ||++........   ......+++.|+|||.+.+...++.++|+||||+++++|++|..||......         ....
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876543322   1223355788999999877665789999999999999999999999755432         3444


Q ss_pred             HHHHHhCCCCCCCCccccccCCcccC------CCCCCCcc---cccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNWHEY------PQWNPQSL---ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  295 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  295 (304)
                      .+...+..+....+........+...      ........   .......+..+.+++.+||+.||.+|||+.|+++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            55555554444333222222221110      00000011   1111267788999999999999999999999999999


Q ss_pred             c
Q 021982          296 F  296 (304)
Q Consensus       296 ~  296 (304)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.3e-45  Score=306.26  Aligned_cols=283  Identities=37%  Similarity=0.679  Sum_probs=218.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||++.++.+++.+++|.+............+.+|+++++.+ +||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKR-----   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCe-----
Confidence            579999999999999999999998899999998765444333455677899999999 99999999999987666     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .++++||+.+++.+.+..   ....+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeec
Confidence            899999999854443332   223589999999999999999999999999999999999999777 9999999998766


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........++..|+|||.+.+....+.++||||||+++|+|++|..||......+....+.................
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            55444444455688999999987765578899999999999999999999987777666666665544322111000000


Q ss_pred             c---CCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 L---MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .   ..................+.++..+.+++.+||+.||.+||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0   0000000001111222345788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.5e-45  Score=307.60  Aligned_cols=289  Identities=39%  Similarity=0.737  Sum_probs=221.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC---
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE---   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~---   79 (304)
                      .++|++.+.||+|++|.||++.++.++..+++|.+..............+|+++++++ +||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence            5789999999999999999999999999999998876544444444566899999999 999999999987765431   


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      .....++++||+.+++.+.+...   ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCC
Confidence            22346999999999888877542   23689999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCCc----cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      +.........    .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            8765432211    123345788999998877655788999999999999999999999888777666666665555444


Q ss_pred             CCCccccccCCcccC--CCCCCCcccc--cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          236 KVWPGVSSLMNWHEY--PQWNPQSLAT--AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ..++.......+...  ..........  .....+..+.++|.+||..||.+|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            444433221111110  0000000000  111246778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.8e-45  Score=307.94  Aligned_cols=289  Identities=43%  Similarity=0.806  Sum_probs=227.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC---
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE---   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~---   79 (304)
                      .++|++.+.||+|++|.||++.++.++..+++|.+..............+|+++++.+ +||||+++++++......   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence            4789999999999999999999999999999999876554443445667899999999 999999999987654432   


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ....+++++||+.+++...+..   ....+++.++..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            2234789999999988776654   234699999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCCc-----------cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHH
Q 021982          160 ARAFTLPIKK-----------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       160 ~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  228 (304)
                      +.........           .....+++.|+|||.+.+...++.++||||||+++|+|++|..||...+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8765432221           11224477899999987665578999999999999999999999998888888887777


Q ss_pred             HhCCCCCCCCccccccCCcccC--CCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEY--PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ..+.+....++...........  ....+.........++..+.++|.+||+.||.+|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            7666655555443332221110  0111112223345677889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.2e-45  Score=304.65  Aligned_cols=279  Identities=41%  Similarity=0.704  Sum_probs=215.2

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc--ccCCceE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ--NKEGRTV   83 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~~~~   83 (304)
                      |++++.||+|++|.||++.+..++..+++|.++........ ....+|+.+++++.+|+|++++++++.+.  ..     
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~-----   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGR-----   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCc-----
Confidence            67889999999999999999989999999988754333222 23457888898886699999999998866  33     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .++++||+.+++.+.+...   ...+++.+++.++.|++.||++||+.|++|+||+|+||+++. + .++|+|||.+...
T Consensus        75 ~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEeccccccc
Confidence            7999999999988887652   246899999999999999999999999999999999999997 5 9999999998765


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ..... .....+++.|+|||.+......+.++|+||||+++|+|++|..||...+..+.........+.+..........
T Consensus       150 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         150 YSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             ccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            43322 22345688999999876655578999999999999999999999988877766666655544443321110000


Q ss_pred             cC-CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LM-NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .. .....+...........+.++.++.++|.+||+.||.+|||++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00 000111111112223345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.9e-45  Score=316.01  Aligned_cols=287  Identities=33%  Similarity=0.578  Sum_probs=221.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|++|.||++.+..++..+++|.+............+.+|+.+++++ +|||++++++++..... +.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence            46789999999999999999999999999999998865433333445677899999999 99999999998875432 22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++|+||+.+++.+.+..      .++...+..++.|++.||++||+.|++|+||||+||+++.++ .++|+|||.+
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccc
Confidence            234799999999998887754      288999999999999999999999999999999999999877 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+...++.+.......
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         166 RTAGTSF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eeCCCCC-CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            7654432 223345688999999998766 79999999999999999999999998887777777776666654322211


Q ss_pred             ccccCCc----------ccCCCCC-----CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLMNW----------HEYPQWN-----PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~~~----------~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      .......          ..+....     ...........++.+.++|.+||+.||.+|||+.|+|.||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence            1100000          0000000     00000012245677899999999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.6e-45  Score=308.57  Aligned_cols=280  Identities=37%  Similarity=0.694  Sum_probs=208.4

Q ss_pred             hhhcccccceEEEEEEEcc--CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKA--TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      ...||+|+||.||++.++.  ++..+++|.+....    ....+.+|+.+++.+ +||||+++++++.....   ...++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~---~~~~l   77 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLREL-KHPNVIALQKVFLSHSD---RKVWL   77 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCC---CeEEE
Confidence            4689999999999999754  45789999876432    234577899999999 99999999998864322   23789


Q ss_pred             EEeccCCCHHHHHHHhcc-----CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC---CCCeEEEeecc
Q 021982           87 VFEYMDTDLKKYIRSFRQ-----TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KTMTLKIADLG  158 (304)
Q Consensus        87 v~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~---~~~~vkl~dfg  158 (304)
                      ++||+++++.+++.....     ....+++..++.++.|++.||.+||+.|++|+||||+||++..   ....++|+|||
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          78 LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            999999999888764321     1235888999999999999999999999999999999999942   22489999999


Q ss_pred             ceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---------HHHHHHH
Q 021982          159 LARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHI  226 (304)
Q Consensus       159 ~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---------~~~~~~~  226 (304)
                      ++........   ......+++.|+|||.+.+...++.++||||||+++|+|+||..||.....         ......+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            9976654322   223345688999999998766589999999999999999999999975432         3445556


Q ss_pred             HHHhCCCCCCCCccccccCCcccCC------CCCCC----cccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYP------QWNPQ----SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ...++.+....|........+....      .....    .........+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            6666666655554433222211110      00000    1111122456778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.6e-45  Score=299.86  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=213.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|.+.+.||+|++|.||++.++.++..+++|.+............+.+|+.+++.+ +|||++++++++.....     .
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGK-----L   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCE-----E
Confidence            47888999999999999999999999999999876544444456778899999999 99999999999887765     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+.+ +|.+++...  ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            999999975 999988763  235789999999999999999999999999999999999999777 8999999998776


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||++.+.. ++.++|+||||+++++|++|..||...+..+....+.....            
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------  218 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            55444344456788999999987766 78999999999999999999999988776554444332111            


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                     ......++..+.+++.+||+.+|.+||++.++++|||+
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 ---------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ---------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                           11111477899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.5e-45  Score=305.38  Aligned_cols=264  Identities=24%  Similarity=0.415  Sum_probs=211.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|++++.||+|++|.||++.+..++..+++|.+....  ......+..|+.+++.+ +|||++++++.+.....    
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   83 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGK----   83 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCe----
Confidence            467999999999999999999999999999999886432  22345677899999999 89999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ ++...+...   ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        84 -~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~  158 (292)
T cd06644          84 -LWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSA  158 (292)
T ss_pred             -EEEEEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccce
Confidence             8999999997 666665432   24689999999999999999999999999999999999999776 89999999886


Q ss_pred             ecccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      .............+++.|+|||.+.+    ...++.++|+||||+++|+|++|..||...+.......+.....+     
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  233 (292)
T cd06644         159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-----  233 (292)
T ss_pred             eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-----
Confidence            54433333334456889999998853    233678999999999999999999999776654433333211000     


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                                          .......++.++.++|.+||..||.+||+++++++||||..++..+
T Consensus       234 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         234 --------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             --------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence                                0011225778899999999999999999999999999999887654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-46  Score=318.91  Aligned_cols=253  Identities=29%  Similarity=0.409  Sum_probs=202.9

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccCCceEEEEEE
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      ||+|+||+||++.++.++..+++|++..... ..........|..++....  +||+|+++++.+.....     .+++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~-----~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD-----LYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe-----EEEEE
Confidence            7999999999999999999999999865321 1112233445666666553  79999999999888776     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|.+.+..    ...+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDN  150 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCC
Confidence            99986 88877754    34689999999999999999999999999999999999999777 89999999986543333


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .......|++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+......               
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------  215 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR---------------  215 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence            33344567999999999977655789999999999999999999999887766555444321000               


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC----CHHHHhcCCCcccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI----SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~eil~~~~~~~~~~  301 (304)
                                  .....+++++.++|++||+.||.+||    ++.++++||||.+.++
T Consensus       216 ------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         216 ------------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             ------------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence                        00114788999999999999999998    7999999999987653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.1e-45  Score=317.14  Aligned_cols=262  Identities=25%  Similarity=0.393  Sum_probs=210.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||++.++.++..+++|.+..... .......+.+|..+++.+ +||||+++++.+.....   
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~---  117 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRY---  117 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCE---
Confidence            4789999999999999999999999999999999865321 222234566788999998 99999999999887665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++..     ..+++..+..++.||+.||++||++|++|+||||+||+++.++ .+||+|||++
T Consensus       118 --~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a  189 (371)
T cd05622         118 --LYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (371)
T ss_pred             --EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCce
Confidence              8999999975 88888764     3578899999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCC---CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGST---HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~---~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ........ ......|++.|+|||++.+..   .++.++|||||||++|+|++|..||...+.......+........  
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--  267 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--  267 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc--
Confidence            76643221 223456799999999987542   378899999999999999999999998777666655543211100  


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~  300 (304)
                       +                     .....++..+.++|.+||..++.+  |++++++++||||++..
T Consensus       268 -~---------------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         268 -F---------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             -C---------------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence             0                     011258899999999999844433  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-45  Score=328.26  Aligned_cols=281  Identities=26%  Similarity=0.395  Sum_probs=208.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC------CCeeeeeceeccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD------PHVVRLMDVKQGQ   76 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h------~~i~~~~~~~~~~   76 (304)
                      .++|++++.||+|+||+||++.+..++..|+||+++....   .......|+++++.+ .|      .+++.+++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l-~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKV-RQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHH-hhcCcccCcceeeeEEEEEcC
Confidence            3679999999999999999999999999999999864321   122345577777666 43      4588888887654


Q ss_pred             ccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCC-----
Q 021982           77 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTM-----  150 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~-----  150 (304)
                      ..    ..+++|++++++|.+++...    ..+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.     
T Consensus       204 ~~----~~~iv~~~~g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        204 TG----HMCIVMPKYGPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             Cc----eEEEEEeccCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence            32    37899999998999888652    468999999999999999999998 59999999999999986542     


Q ss_pred             ----------eEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH
Q 021982          151 ----------TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL  220 (304)
Q Consensus       151 ----------~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  220 (304)
                                .+||+|||.+.....   ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+..
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                      499999998754322   233456799999999998776 899999999999999999999999988888


Q ss_pred             HHHHHHHHHhCCCCCCCCccccc-----cCC-cccC-CCCCCCccc-------ccCCCCChhhHHHHHHhhcCCCCCCCC
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSS-----LMN-WHEY-PQWNPQSLA-------TAVPNLDKDGLDLLEQMLQYDPSKRIS  286 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps  286 (304)
                      +....+...++..+.........     ... .... .......+.       ......++.+.+||.+||..||.+|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            77777777666543321111000     000 0000 000000000       000012466789999999999999999


Q ss_pred             HHHHhcCCCcccc
Q 021982          287 AKKAMEHPYFDDL  299 (304)
Q Consensus       287 ~~eil~~~~~~~~  299 (304)
                      ++|+|+||||.+.
T Consensus       432 a~e~L~Hp~~~~~  444 (467)
T PTZ00284        432 ARQMTTHPYVLKY  444 (467)
T ss_pred             HHHHhcCcccccc
Confidence            9999999999985

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-44  Score=303.55  Aligned_cols=282  Identities=44%  Similarity=0.788  Sum_probs=217.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||+|++|.||++.+..++..+++|.+..... ......+.+|+++++.+ +|+||+++.+++.....     
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~-----   77 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGL-KHANIVLLHDIIHTKET-----   77 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCe-----
Confidence            579999999999999999999998999999999875432 22334567899999999 99999999999887655     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .++++||+.+++.+++...   ...+++.++..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 ~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEecccccccc
Confidence            8999999998888776542   24578889999999999999999999999999999999999777 8999999998765


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch-HHHHHHHHHHhCCCCCCCCcccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...........+++.|+|||.+.+...++.++|+||||+++|+|++|..||..... .+........++.+....++...
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            44333334445688999999987655578899999999999999999999976543 35555555555555544444333


Q ss_pred             ccCCcccCC--CCCCCcccccCC--CCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEYP--QWNPQSLATAVP--NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~~--~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ...++....  ............  ..+..+.+++.+||..||.+|||+.|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            222211110  000111111111  236788999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.1e-45  Score=300.50  Aligned_cols=255  Identities=25%  Similarity=0.493  Sum_probs=212.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|++|.+|.+.+..+++.+++|.+............+.+|+.+++.+ +|||++++.+++.....     .
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGN-----L   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCe-----E
Confidence            58899999999999999999999999999999876544333445788899999999 99999999999887665     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+.+ +|.+.+...  ....+++.+++.++.|++.|+.+||++|++|+||+|+||+++.++ .++++|||.+...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            999999986 898888652  234578999999999999999999999999999999999999777 8999999999766


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||.+.+.. .+.++|+||||+++++|++|..||...+..+....+....             
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-------------  217 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-------------
Confidence            54433333345678899999987765 7899999999999999999999998776666555443211             


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                    .......++.++.++|.+||+.+|.+||++.++++||||
T Consensus       218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         218 --------------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             --------------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                          111123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-45  Score=313.32  Aligned_cols=292  Identities=39%  Similarity=0.686  Sum_probs=235.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.+ +|||++++.+++...........
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence            58999999999999999999998899999998876544344556788999999999 89999999999887763334448


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +++|||+.+++.+.+..    ..++++..++.++.|++.||.+||+.|++|+||+|.||+++.++ .++|+|||.+....
T Consensus        80 ~lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          80 YIVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            99999999888887754    23799999999999999999999999999999999999999776 99999999998765


Q ss_pred             cCC---CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          165 LPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       165 ~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ...   .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543   12334456888999999987745899999999999999999999999999888888887777666554433211


Q ss_pred             cc--cCCc-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          242 SS--LMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       242 ~~--~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      ..  ..++ ..........+....+.++..+.++|.+||+.||.+|||++++++||||+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            10  0011 0111122223444456789999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=313.10  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=219.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..|..+++||+|.||.||++.+..+++.+++|++......+ ....+.+|+.++.++ +++||.++++.+.....     
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~-~~~~it~yygsyl~g~~-----   85 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQC-DSPNITEYYGSYLKGTK-----   85 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhc-CcchHHhhhhheeeccc-----
Confidence            35888899999999999999999999999999998765443 356778899999999 99999999999998887     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++++|||+.| ++.+.++.    +..+++..+..+++.++.||.|||.++..|+|||+.||++..++ .|||+|||.+..
T Consensus        86 LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~q  160 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeee
Confidence            8999999996 88888865    34458999999999999999999999999999999999999886 999999999998


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............|||.|||||++.+.. |+.++||||||++.+||.+|.+|+....+...+..+-               
T Consensus       161 l~~~~~rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---------------  224 (467)
T KOG0201|consen  161 LTNTVKRRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---------------  224 (467)
T ss_pred             eechhhccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc---------------
Confidence            887766667789999999999999655 8999999999999999999999998876621111110               


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                  ....+.....+|+.+++||..||+.||+.||||.++|.|+|.+...
T Consensus       225 ------------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  225 ------------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             ------------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                        0111112226889999999999999999999999999999998854

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-45  Score=314.62  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHH-HHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVS-ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||.||+++++.++..+++|++...... ......+..|.. +++.+ +||||+++++++...+.     .+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~-----~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK-----LYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCe-----EEEE
Confidence            4699999999999999999999999998753211 111223333433 45667 99999999999887766     8999


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.| +|.+++..    ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus        75 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          75 LDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            999986 88887764    24588899999999999999999999999999999999999777 8999999998654333


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      ........|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            33334456799999999988765 7899999999999999999999998877766655544310                


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHH----HHhcCCCccccccc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK----KAMEHPYFDDLDKT  302 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~----eil~~~~~~~~~~~  302 (304)
                                  ....+.+++.+.++|.+||+.||.+||++.    ++++|+||..+++.
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         213 ------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             ------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence                        011236889999999999999999999876    89999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=302.19  Aligned_cols=259  Identities=26%  Similarity=0.433  Sum_probs=214.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||++.+..++..+++|.+..... ......+..|+++++.+ +|+|++++.+++.....     
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSK-----   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCe-----
Confidence            579999999999999999999999999999998875432 22334677899999999 89999999999887755     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++|++.+ +|.+++..     .++++..++.++.|++.|+.+||+.+++|+||+|+||+++.++ .++|+|||.+..
T Consensus        74 ~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~  147 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQ  147 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccccccee
Confidence            8999999986 88888765     2789999999999999999999999999999999999999877 899999999987


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.....+          
T Consensus       148 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------  216 (274)
T cd06609         148 LTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP----------  216 (274)
T ss_pred             ecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC----------
Confidence            765544444456688899999988766 899999999999999999999999876644333322211000          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                    ...  ...++.++.+++.+||..||.+|||++++++||||.+..++
T Consensus       217 --------------~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         217 --------------SLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             --------------CCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence                          000  01278899999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-45  Score=315.12  Aligned_cols=275  Identities=24%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .+|++++.||+|+||.||++.+..++..+++|+...        .....|+.+++++ +||||+++++++.....     
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----  131 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNV-NHPSVIRMKDTLVSGAI-----  131 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhC-CCCCCcChhheEEeCCe-----
Confidence            359999999999999999999998899999997432        2345799999999 99999999999987766     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .++++|++.++|.+++..   ...++++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||.+...
T Consensus       132 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  207 (357)
T PHA03209        132 TCMVLPHYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFP  207 (357)
T ss_pred             eEEEEEccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCcccccc
Confidence            899999999999888765   235789999999999999999999999999999999999999777 8999999998643


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccC-CCCch---------HHHHHHHHHHhCCC
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSE---------LQQLLHIFRLLGTP  233 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~-~~~~~---------~~~~~~~~~~~~~~  233 (304)
                      ... .......|++.|+|||++.+.. ++.++||||||+++|+|+++..|+ .....         ...+..+...++..
T Consensus       208 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~  285 (357)
T PHA03209        208 VVA-PAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH  285 (357)
T ss_pred             ccC-cccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence            322 2223446789999999988765 799999999999999999865554 32211         12233333333322


Q ss_pred             CCCCCccccc------cCCcccCCCCCCC-cccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          234 NEKVWPGVSS------LMNWHEYPQWNPQ-SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       234 ~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ... ++....      ...+......... ........++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       286 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        286 PEE-FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             hhh-cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            211 110000      0000000000000 0001123577888999999999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.8e-45  Score=310.68  Aligned_cols=284  Identities=23%  Similarity=0.367  Sum_probs=210.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++.+.||.|+||.||++.+..++..+++|.+..... ......+.+|+++++.+ +||||+++++++.....   
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~---   77 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGE---   77 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCE---
Confidence            46789999999999999999999999999999998765422 22234678899999999 89999999999987765   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                        .+++|||+.+ +|.+++...    ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~  150 (333)
T cd06650          78 --ISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGV  150 (333)
T ss_pred             --EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCc
Confidence              8999999975 999988652    4588999999999999999999975 799999999999999777 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhC-CCCCCCC
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG-TPNEKVW  238 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  238 (304)
                      +......  ......+++.|+|||++.+.. ++.++|+|||||++|+|++|..||................. .......
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (333)
T cd06650         151 SGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET  227 (333)
T ss_pred             chhhhhh--ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence            8654332  122345688999999987765 78999999999999999999999987655333221111000 0000000


Q ss_pred             -ccccccCC-cccC-C-CC------------CCCccc-ccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          239 -PGVSSLMN-WHEY-P-QW------------NPQSLA-TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       239 -~~~~~~~~-~~~~-~-~~------------~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                       +....... .... + ..            ...... .....++.++.+||.+||+.||.+|||+.|++.||||+...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence             00000000 0000 0 00            000000 00123678899999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4e-45  Score=306.17  Aligned_cols=263  Identities=27%  Similarity=0.414  Sum_probs=209.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-CCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .|+..+.||+|+||.||++.+..+++.+++|.+........ ....+..|+.+++++ +|++++.+.+.+...+.     
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~-----   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDA-----   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCE-----
Confidence            36788899999999999999999999999998875432221 223456799999999 99999999999887665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++|||+.| +|.+.+....  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVH  151 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceee
Confidence            8999999985 8888875532  24689999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......+++.|+|||++.+.. ++.++|+||+|+++|+|++|..||....................        
T Consensus       152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------  221 (285)
T cd05630         152 VPEGQ-TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--------  221 (285)
T ss_pred             cCCCc-cccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------
Confidence            54332 223346789999999987765 79999999999999999999999986543221111111100000        


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                      ......+++++.+|+.+||+.||.+|||     ++|+++||||..++..
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         222 ----------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             ----------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                            0112357889999999999999999999     9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=302.67  Aligned_cols=260  Identities=26%  Similarity=0.442  Sum_probs=211.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||.|++|.||++.+..++..+++|.+....  ......+..|+.+++++ +|||++++++.+.....     
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----   76 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENK-----   76 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCe-----
Confidence            68999999999999999999998889999999886432  22234677899999999 89999999999887665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++|||+++ +|.+++...   ..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~  152 (280)
T cd06611          77 LWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAK  152 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchh
Confidence            8999999987 887777652   24689999999999999999999999999999999999999777 899999998866


Q ss_pred             cccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ............+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...+.......+......      
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  226 (280)
T cd06611         153 NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP------  226 (280)
T ss_pred             hcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC------
Confidence            5443333344456889999998853    233678999999999999999999999877655544433221000      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                         .......++.++.++|.+||+.||.+|||+.++++||||.+..
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         227 -------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             -------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                               0001125788999999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.8e-44  Score=302.87  Aligned_cols=290  Identities=42%  Similarity=0.765  Sum_probs=228.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---   78 (304)
                      ..++|++.+.||.|++|.||++.++.++..+++|.+............+.+|+++++.+ +|||++++++++.....   
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhh
Confidence            35789999999999999999999998899999999876554444445677899999999 99999999999876551   


Q ss_pred             --CCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           79 --EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        79 --~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                        +....+++++||+++++...+...   ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|
T Consensus        84 ~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCc
Confidence              111248999999999888777542   34689999999999999999999999999999999999999776 999999


Q ss_pred             ccceeecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          157 LGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       157 fg~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ||.+........ ......++..|+|||.+.+....+.++||||||+++++|++|..||...+..+....+....+.+..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999876544321 1122344778999998876555789999999999999999999999988888888877777666665


Q ss_pred             CCCccccccCCcccCC--CCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          236 KVWPGVSSLMNWHEYP--QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ..|+.......+....  .............++..+.+++.+||+.||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            5555443322221111  111111222334578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.9e-45  Score=311.62  Aligned_cols=290  Identities=31%  Similarity=0.585  Sum_probs=219.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +..+|++.+.||.|++|.||++.+..++..+++|.+.....  .....+.+|+++++.+ +|||++++++.+........
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccc
Confidence            45789999999999999999999999999999998865433  3345677899999999 99999999988765432211


Q ss_pred             ---------eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeE
Q 021982           82 ---------TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        82 ---------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~v  152 (304)
                               ...++++||++++|.+.+..     ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++..+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                     24789999999988877753     4689999999999999999999999999999999999998766689


Q ss_pred             EEeeccceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHH
Q 021982          153 KIADLGLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  229 (304)
                      +++|||.+.........   .....++..|+|||.+.+...++.++||||||+++|+|++|..||......+........
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999998765432111   122345778999998876555889999999999999999999999887776665555543


Q ss_pred             hCCCCCCCCccccccCC--cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          230 LGTPNEKVWPGVSSLMN--WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .................  ................+.++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            32222111111100000  00001111122223345788999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-44  Score=303.01  Aligned_cols=266  Identities=24%  Similarity=0.384  Sum_probs=212.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|.+.+.||+|++|.||++.+..++..+++|.+....   .....+..|+.+++++.+|||++++++++...+.....
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            467999999999999999999999999999999876432   12345667889999887899999999998765433333


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..++++||+.+ +|.+++.........+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~  176 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSA  176 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccch
Confidence            47999999986 99888876555566789999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCC----CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGST----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      .............++..|+|||.+....    .++.++|+||||+++|+|++|..||...........+......   . 
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~---~-  252 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP---T-  252 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC---C-
Confidence            6544333333445688899999886432    2578999999999999999999999877665544433221000   0 


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                           .......+..+.++|.+||+.||.+|||+.++++||||+
T Consensus       253 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 ---------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                 001124567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5e-45  Score=325.37  Aligned_cols=258  Identities=22%  Similarity=0.310  Sum_probs=213.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccC-CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKAT-GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .|.+.+.||+|++|.||.+.+..+ +..+++|.+....  ......+..|+.+++.+ +||||+++++++...+.     
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~-----  139 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDK-----  139 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCE-----
Confidence            489999999999999999998777 6778888664332  22234567799999999 99999999999988776     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++||||+.| +|.+.+........++++.++..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++..
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~  218 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQ  218 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCcee
Confidence            8999999975 99998876555566899999999999999999999999999999999999999777 899999999986


Q ss_pred             cccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......  ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+......        
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------  289 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--------  289 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence            543321  123345799999999987765 799999999999999999999999887766655554331110        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         .....++.++.++|.+||..||.+|||+.+++.|+|++.+
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                               1112578899999999999999999999999999998754

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.1e-45  Score=304.15  Aligned_cols=265  Identities=23%  Similarity=0.403  Sum_probs=208.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||+|+||.||++.++.++..+++|.+........ ...+..|...+.+..+|||++++++++.....     
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~-----   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGD-----   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-----
Confidence            478999999999999999999999999999998875432222 23444555553333399999999999887666     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++|||++|+|.+++.........+++..++.++.|++.||.+||++ +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~  153 (283)
T cd06617          75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGY  153 (283)
T ss_pred             EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccc
Confidence            899999999999999887665567899999999999999999999997 999999999999999777 899999999875


Q ss_pred             cccCCCccccccccccCCChhhhhCC---CCCCCchhHHHHHHHHHHHhhccccCCCCch-HHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGS---THYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  238 (304)
                      ..... ......++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||..... .+...........   .  
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~--  227 (283)
T cd06617         154 LVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP---Q--  227 (283)
T ss_pred             ccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC---C--
Confidence            53321 12223567889999988652   3368899999999999999999999975332 2222222211000   0  


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                           .....+|.++.++|.+||..||.+|||+.++++||||.....+
T Consensus       228 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         228 ---------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             ---------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence                                 0011478899999999999999999999999999999987655

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=300.10  Aligned_cols=265  Identities=26%  Similarity=0.449  Sum_probs=213.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~   81 (304)
                      .++|++.+.||+|++|.||++.++.++..+++|.+.....   ....+.+|+.+++++..|+||+++++++..... ...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4789999999999999999999988889999998875432   235677899999998679999999999876553 333


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++|||+.+ +|.+++.........+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~  160 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVS  160 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence            457999999996 88888877554456899999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCC----CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ..............+++.|+|||.+...    ..++.++||||||+++|+|++|..||...........+....   .. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-  236 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP-  236 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC-
Confidence            7655443334445678899999988542    336788999999999999999999997655443333322110   00 


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                           ........+..+.++|.+||..||.+|||+.++++|||+
T Consensus       237 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 ---------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ---------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                 000112367889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-44  Score=308.06  Aligned_cols=285  Identities=20%  Similarity=0.264  Sum_probs=208.3

Q ss_pred             hhhhhcccc--cceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            7 EKLEKVGEG--TYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         7 ~~~~~lg~g--~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      ++++.||+|  ++++||++.++.++..+++|.+............+.+|+.+++.+ +||||+++++++...+.     .
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~-----~   74 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNE-----L   74 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCE-----E
Confidence            357889999  678999999999999999999876544444445677899999999 99999999999988776     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++|+||+.+ ++.+++....  ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++++||+.....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~  151 (327)
T cd08227          75 WVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSM  151 (327)
T ss_pred             EEEEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcc
Confidence            999999985 8888886532  24589999999999999999999999999999999999999777 8999999865433


Q ss_pred             ccCCCc-------cccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCC-
Q 021982          164 TLPIKK-------YTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN-  234 (304)
Q Consensus       164 ~~~~~~-------~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-  234 (304)
                      ......       .....++..|+|||++.+. ..++.++||||||+++|+|++|..||.................+.. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence            211110       1112346779999998764 3478999999999999999999999987655443333222111000 


Q ss_pred             -------CCCC---ccccccCCccc-------CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          235 -------EKVW---PGVSSLMNWHE-------YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       235 -------~~~~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                             +...   ...........       ...............+++.+.+||.+||+.||.+|||++|+++||||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                   0000   00000000000       000001111222345778999999999999999999999999999998


Q ss_pred             ccc
Q 021982          298 DLD  300 (304)
Q Consensus       298 ~~~  300 (304)
                      ++.
T Consensus       312 ~~~  314 (327)
T cd08227         312 QIK  314 (327)
T ss_pred             hcc
Confidence            864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-45  Score=312.75  Aligned_cols=253  Identities=24%  Similarity=0.367  Sum_probs=202.2

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHH-HHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVS-ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||.||++++..++..+++|.+..... .......+..|.. +++.+ +||||+++++.+...+.     .++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~-----~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEK-----LYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCE-----EEEE
Confidence            468999999999999999999999999875321 1112233444444 56777 99999999999887766     8999


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.| +|...+..    ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus        75 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          75 LDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             EcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            999986 88777654    34688999999999999999999999999999999999999877 8999999998653333


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      ........|++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP----------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            23333456789999999987665 7899999999999999999999998877655555443210                


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH----HHHhcCCCccccccc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKT  302 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~~~~~~~  302 (304)
                                  ....+..+..+.++|.+||+.||.+||++    .++++|+||..+++.
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         213 ------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence                        11123577889999999999999999976    499999999877543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.5e-45  Score=312.92  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=203.0

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHH-HHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVS-ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||.||++.++.++..+++|++..... .......+..|.. +++.+ +||||+++++.+...+.     .+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~-----~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEK-----LYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCE-----EEEE
Confidence            468999999999999999999999999875422 1112233444544 45666 99999999999887766     8999


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.| +|...+..    ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus        75 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          75 LDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             EcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            999986 88777754    34689999999999999999999999999999999999999777 8999999998654333


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      ........|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~----------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP----------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            33334456799999999987765 7899999999999999999999998877666555443210                


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH----HHHhcCCCcccccc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDK  301 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~~~~~~  301 (304)
                                  ....+..+..+.++|++||+.||.+||++    .++++||||+.+++
T Consensus       213 ------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 ------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             ------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                        01123578899999999999999999977    59999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=307.70  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=214.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++.+.||+|++|.||++.+..++..+++|.+....... .....+..|+++++.+ +||||+++++.+.....    
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~----   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETY----   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCE----
Confidence            47899999999999999999999889999999987643221 2345678899999999 89999999999877665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.| +|.+++...  ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||.+.
T Consensus        76 -~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~  151 (316)
T cd05574          76 -LCLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSK  151 (316)
T ss_pred             -EEEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhh
Confidence             8999999986 998888652  335789999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCCc-----------------------------cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccc
Q 021982          162 AFTLPIKK-----------------------------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA  212 (304)
Q Consensus       162 ~~~~~~~~-----------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~  212 (304)
                      ........                             .....|+..|+|||.+.+.. ++.++||||||+++|+|++|..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCC
Confidence            54322110                             11224577899999987765 7899999999999999999999


Q ss_pred             cCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC----HH
Q 021982          213 LFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS----AK  288 (304)
Q Consensus       213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~  288 (304)
                      ||...+.......+......     +                     .....++..+.++|.+||..||.+|||    ++
T Consensus       231 pf~~~~~~~~~~~~~~~~~~-----~---------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         231 PFKGSNRDETFSNILKKEVT-----F---------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCCchHHHHHHHhcCCcc-----C---------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            99887766555444321000     0                     001137899999999999999999999    99


Q ss_pred             HHhcCCCcccccccc
Q 021982          289 KAMEHPYFDDLDKTR  303 (304)
Q Consensus       289 eil~~~~~~~~~~~~  303 (304)
                      ++++||||+..++..
T Consensus       285 ~ll~~~~~~~~~~~~  299 (316)
T cd05574         285 EIKQHPFFRGVNWAL  299 (316)
T ss_pred             HHHcCchhhcCChhh
Confidence            999999999987654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-44  Score=297.42  Aligned_cols=255  Identities=22%  Similarity=0.412  Sum_probs=209.0

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC---CCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE---GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.|.+.+.||+|++|.||.+.+..++..+++|.+.......   .....+.+|+.+++++ +||||+++++++.....  
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~--   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDET--   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCe--
Confidence            57999999999999999999999889999999887543222   1234677899999999 99999999999987765  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++++|++.+ +|.+.+...    ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.
T Consensus        79 ---~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~  150 (263)
T cd06625          79 ---LSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGA  150 (263)
T ss_pred             ---EEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccc
Confidence               8999999986 888888653    4588999999999999999999999999999999999999776 899999999


Q ss_pred             eeecccCCCcc---ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +..........   ....++..|+|||.+.+.. .+.++||||||+++|+|++|..||...+............      
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------  223 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------  223 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC------
Confidence            87654321111   2334578899999988766 7899999999999999999999998766554443322110      


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                          ........++..+.++|.+||..||.+|||+.++++||||
T Consensus       224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                0111223578899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-44  Score=303.56  Aligned_cols=258  Identities=25%  Similarity=0.441  Sum_probs=211.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ..+|++++.||+|++|.||++.+..++..+++|.+......  ....+.+|+.+++.+ +|||++++++.+.....    
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~----   91 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMREN-KNPNIVNYLDSYLVGDE----   91 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCE----
Confidence            46899999999999999999999989999999988754332  235677899999998 99999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++..     ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        92 -~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~  164 (296)
T cd06654          92 -LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCA  164 (296)
T ss_pred             -EEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccch
Confidence             8999999986 89888754     3578999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||.+.+.. .+.++|+||||+++|+|++|..||................ .+        
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~--------  234 (296)
T cd06654         165 QITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP--------  234 (296)
T ss_pred             hccccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CC--------
Confidence            6544333333446788999999887655 7899999999999999999999998766543332221100 00        


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                      .......++..+.+++.+||..||.+|||+.++++||||...+
T Consensus       235 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         235 ----------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                            0011235778899999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.4e-45  Score=312.27  Aligned_cols=266  Identities=23%  Similarity=0.372  Sum_probs=212.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||+++++.++..+++|.+.... ........+.+|..++..+ +|++|+++++.+.+...    
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~----   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENN----   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCE----
Confidence            57999999999999999999999999999999886422 1222234467788888888 99999999999887766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++...   ...+++..+..++.||+.||.+||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~  150 (332)
T cd05623          76 -LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCL  150 (332)
T ss_pred             -EEEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchhe
Confidence             8999999975 999988653   23689999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCC-ccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPIK-KYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~~-~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ....... ......|++.|+|||++.+    ...++.++||||||+++|+|++|..||...+..+....+......    
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----  226 (332)
T cd05623         151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER----  226 (332)
T ss_pred             ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc----
Confidence            5433222 2233467999999999863    334788999999999999999999999888776666655432100    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~~~  302 (304)
                                         .........+++++.+|+++||..++.+  |++++++++||||..++++
T Consensus       227 -------------------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         227 -------------------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             -------------------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence                               0111122357899999999999765444  7899999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-45  Score=317.72  Aligned_cols=281  Identities=22%  Similarity=0.341  Sum_probs=212.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc--CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA--TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ..+|.+++.||.|++|.||++....  ++..+++|.+...       ....+|+.+++.+ +||||+++++.+.....  
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~--  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTI-SHRAIINLIHAYRWKST--  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhc-CCCCccceeeeEeeCCE--
Confidence            4579999999999999999997643  4567888876532       2345799999999 99999999999887665  


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                         .+++||++.+++.+++..    ...+++.+++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus       161 ---~~lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a  232 (392)
T PHA03207        161 ---VCMVMPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAA  232 (392)
T ss_pred             ---EEEEehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccc
Confidence               899999999999888843    35689999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc---hHHHHHHHHHHhCCCCC
Q 021982          161 RAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS---ELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       161 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~  235 (304)
                      ........  ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||....   ....+..+.+.++....
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            76543322  122346799999999987765 7899999999999999999999996543   34455555555543322


Q ss_pred             CCCccccccC---CcccCCCCCC--Ccccc--cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          236 KVWPGVSSLM---NWHEYPQWNP--QSLAT--AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       236 ~~~~~~~~~~---~~~~~~~~~~--~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                      . ++......   ..........  .....  ....++.++.++|.+||..||.+|||+.|+|.||||.+.+.+.
T Consensus       312 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        312 E-FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             c-cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence            1 11100000   0000000000  00000  0124677899999999999999999999999999999877654

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-44  Score=318.37  Aligned_cols=275  Identities=25%  Similarity=0.351  Sum_probs=206.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ...|.+.+.||+|+||.||++.+..++..+++|...        .....+|+++++++ +|+||+++++++.....    
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~----  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRL-SHPAVLALLDVRVVGGL----  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCE----
Confidence            347999999999999999999999999999999532        23456899999999 99999999999877665    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .+++||++.++|.+++...   ...+++.+++.++.|++.||.|||++||+|+||||+|||++.++ .++|+|||++..
T Consensus       235 -~~lv~e~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~  309 (461)
T PHA03211        235 -TCLVLPKYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACF  309 (461)
T ss_pred             -EEEEEEccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCcee
Confidence             8999999999998888652   23689999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc-------hHHHHHHHHHHhCCC
Q 021982          163 FTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-------ELQQLLHIFRLLGTP  233 (304)
Q Consensus       163 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-------~~~~~~~~~~~~~~~  233 (304)
                      .......  .....|++.|++||++.+.. ++.++|||||||++|+|++|..|+....       ....+..+.......
T Consensus       310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~  388 (461)
T PHA03211        310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH  388 (461)
T ss_pred             cccccccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence            5432211  12345799999999998766 7999999999999999999876653221       122333333332221


Q ss_pred             CCCCCcccccc---CCc------ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          234 NEKVWPGVSSL---MNW------HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       234 ~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ... ++.....   ..+      ..........+ .....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       389 ~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        389 VDE-FPQHAGSRLVSQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             ccc-CCCCcchHHHHHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            111 1110000   000      00000000011 112256778999999999999999999999999999974

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-44  Score=304.44  Aligned_cols=259  Identities=25%  Similarity=0.454  Sum_probs=210.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|++|.||++.+..++..+++|.+......  ....+.+|+.+++.+ +|+|++++++++.....    
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~----   90 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMREN-KNPNIVNYLDSYLVGDE----   90 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCE----
Confidence            47899999999999999999999889999999988754322  235677899999999 99999999999987665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++..     ..+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        91 -~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~  163 (297)
T cd06656          91 -LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCA  163 (297)
T ss_pred             -EEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccce
Confidence             8999999986 88888754     4578999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...+........... +.         
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~---------  232 (297)
T cd06656         164 QITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT---------  232 (297)
T ss_pred             EccCCccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CC---------
Confidence            6654433334446688999999887755 789999999999999999999999765442222111100 00         


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                     ........++..+.+++.+||..||.+|||+.++++||||.....
T Consensus       233 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         233 ---------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             ---------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                           000112357788999999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.7e-44  Score=300.01  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=209.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|++.+.||+|++|.||++.+..++..+++|.+....  ......+..|+.+++.+ +|||++++++.+.....     
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~-----   76 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENN-----   76 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCE-----
Confidence            45799999999999999999999889999999875432  22245677899999999 99999999999887665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.+ ++...+..   ...++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        77 ~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~  152 (282)
T cd06643          77 LWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAK  152 (282)
T ss_pred             EEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEcccccccc
Confidence            8999999986 66665543   234789999999999999999999999999999999999999777 899999999865


Q ss_pred             cccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ............+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...+.......+......      
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------  226 (282)
T cd06643         153 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP------  226 (282)
T ss_pred             ccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC------
Confidence            5433333334456889999998852    233678999999999999999999999877665554444332110      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                         .......++..+.++|.+||+.||.+|||++++++||||+....
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         227 -------------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             -------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence                               00111246789999999999999999999999999999987644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-44  Score=302.74  Aligned_cols=264  Identities=26%  Similarity=0.406  Sum_probs=213.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .|+..+.||+|+||+||++.+..+++.+++|.+....... .....+.+|+++++.+ +|++++.+.+.+...+.     
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~-----   74 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDA-----   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCE-----
Confidence            3677889999999999999999999999999886543221 1223466799999999 99999999998887766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.+ +|...+...  ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~  151 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVK  151 (285)
T ss_pred             EEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCccee
Confidence            8999999986 787777542  224689999999999999999999999999999999999999776 899999999866


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+.........       
T Consensus       152 ~~~~~-~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~-------  222 (285)
T cd05632         152 IPEGE-SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-------  222 (285)
T ss_pred             cCCCC-cccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------
Confidence            44322 223346789999999987765 789999999999999999999999877665544444332222111       


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCcccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~  303 (304)
                                       .....++.++.+|+.+||+.||.+|||     +.+++.|+||...+.++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         223 -----------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             -----------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence                             112357889999999999999999999     89999999999986654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=302.24  Aligned_cols=283  Identities=41%  Similarity=0.741  Sum_probs=219.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||++.++.++..+++|.+............+.+|+++++.+ +|+|++++++++...+.     
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGR-----   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCE-----
Confidence            479999999999999999999998899999998876555555567888999999999 89999999999987665     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .++++||+++++...+..   ....+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeeccccc
Confidence            899999999876655433   234589999999999999999999999999999999999999776 8999999998766


Q ss_pred             ccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          164 TLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       164 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......++..|+|||.+.+...++.++|+||||+++|+|++|..||......+.........+...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            55432 33344567889999999877458999999999999999999999998777666555555444433222111111


Q ss_pred             ccCCcc--cCCCC-CCCccc-ccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWH--EYPQW-NPQSLA-TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~--~~~~~-~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ......  ..... ...... .....++.++.+||++||..||.+|||+++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            100000  00000 001111 1223458999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-44  Score=296.08  Aligned_cols=253  Identities=27%  Similarity=0.495  Sum_probs=209.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||++.+..++..+++|.+.....    ...+.+|+.+++.+ +|||++++++++.....     
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~-----   72 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQC-DSPYIVKYYGSYFKNTD-----   72 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCc-----
Confidence            679999999999999999999998889999998865432    46788999999999 99999999999987765     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++|++++ +|.+++...   ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~  148 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQ  148 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchh
Confidence            8999999996 888887642   34689999999999999999999999999999999999999777 899999999877


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............++..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+...    ..       
T Consensus       149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~-------  216 (256)
T cd06612         149 LTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----PP-------  216 (256)
T ss_pred             cccCccccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----CC-------
Confidence            655433333445688999999987765 789999999999999999999999876554332221110    00       


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                    ........++.++.+++.+||+.||.+|||+.|++.||||
T Consensus       217 --------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         217 --------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             --------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                          0000122467889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-45  Score=312.43  Aligned_cols=289  Identities=37%  Similarity=0.650  Sum_probs=226.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.+ +|||++++.+++..... ..
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence            45789999999999999999999999999999998765433333345667899999999 99999999998765443 23


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++++|+++++|.+++..     .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        92 ~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccc
Confidence            334799999998899888764     4689999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....++..|+|||.+.+...++.++||||||+++|++++|..||...........+....+.+.+..+.+
T Consensus       166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         166 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             cccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            765433   23335578899999987655578999999999999999999999988887777776666655544433322


Q ss_pred             ccccCC--c-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN--W-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......  + .................++..+.++|.+||+.||.+|||+.+|++||||.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence            221100  0 00111111222333446789999999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-44  Score=298.17  Aligned_cols=259  Identities=29%  Similarity=0.504  Sum_probs=214.5

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|++|.||++.+..++..+++|.+............+..|+++++.+ +|||++++++++.....   ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~---~~~   76 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSN---QTL   76 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCC---CEE
Confidence            58899999999999999999999999999998876544444455677899999999 99999999997764322   127


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH-----hcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-----GHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-----~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      ++++||+.+ +|.+++........++++..++.++.|++.||.+||     +.+++|+||+|+||+++.++ .++|+|||
T Consensus        77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEeccc
Confidence            899999986 999999876666678999999999999999999999     89999999999999999776 99999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .+..............+++.|+|||.+.+.. .+.++|+||||+++++|++|..||...+..+....+...         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------  225 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---------  225 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence            9987665443234456789999999987765 789999999999999999999999887654443333221         


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                        .........+..+.+++.+||+.+|.+|||+.+|++|||+
T Consensus       226 ------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ------------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ------------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                              1111223578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.9e-44  Score=302.44  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=211.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+.....  .....+.+|+.+++.+ +|||++++++.+.....     
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----   90 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKEL-KNPNIVNFLDSFLVGDE-----   90 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhc-CCCceeeeeeeEecCce-----
Confidence            469999999999999999999999999999998865432  2345677899999999 99999999999887666     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.+ +|..++..     ..+++.++..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~  164 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQ  164 (296)
T ss_pred             EEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchh
Confidence            8999999986 88877754     3589999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...+.......+.... .+         
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~---------  233 (296)
T cd06655         165 ITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TP---------  233 (296)
T ss_pred             cccccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cc---------
Confidence            554433333445688999999887655 7899999999999999999999998876654443332210 00         


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                     .......+++.+.++|++||..||.+|||+.+++.||||+...
T Consensus       234 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         234 ---------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ---------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                           0011225788999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-44  Score=300.54  Aligned_cols=266  Identities=24%  Similarity=0.393  Sum_probs=209.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|++|.||++.+..++..+++|.+.....   ....+..|+.+++.+.+|||++++++++........
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            45789999999999999999999999999999998754221   124567788999998679999999998764433333


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++|||+.| +|.+++.........+++..++.++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||.+
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~  171 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVS  171 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCce
Confidence            348999999986 89888876555556789999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCC----CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ..............+++.|+|||.+...    ..++.++|+||||+++|+|++|..||................  ..  
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~--  247 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP--PP--  247 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC--CC--
Confidence            7665433333344678999999988532    236889999999999999999999997765433332211100  00  


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                           ........+..+.+++.+||+.||.+|||+.|+++|+||
T Consensus       248 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 ---------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ---------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                 000112357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-45  Score=334.90  Aligned_cols=266  Identities=25%  Similarity=0.462  Sum_probs=214.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||+||++.+..++..+++|.+............+..|+.+++.+ +||||+++++++.....   
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~---   86 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKAN---   86 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCC---
Confidence            45789999999999999999999999999999999876544444456778899999999 99999999998865432   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-------CccccCCCCCCeEEeCC-----
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-------GILHRDLKPHNLLMDRK-----  148 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-------~i~h~dl~~~Nil~~~~-----  148 (304)
                      ..+++||||+.+ +|.+++.........+++..++.++.||+.||.|||+.       +|+|+||||+|||++.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            137999999985 99999987655556799999999999999999999985       49999999999999642     


Q ss_pred             -----------CCeEEEeeccceeecccCCCccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCC
Q 021982          149 -----------TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPG  216 (304)
Q Consensus       149 -----------~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~  216 (304)
                                 ...+||+|||++....... ......+++.|+|||++.+. ..++.++|||||||+||+|++|..||..
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                       1248999999997654332 22334679999999998653 3478999999999999999999999987


Q ss_pred             CchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          217 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ..............  +                         .......+.++.+||..||+.+|.+|||+.|+|.|||+
T Consensus       246 ~~~~~qli~~lk~~--p-------------------------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        246 ANNFSQLISELKRG--P-------------------------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CCcHHHHHHHHhcC--C-------------------------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            66554443332211  0                         00112468899999999999999999999999999999


Q ss_pred             ccc
Q 021982          297 DDL  299 (304)
Q Consensus       297 ~~~  299 (304)
                      ..+
T Consensus       299 k~i  301 (1021)
T PTZ00266        299 KNV  301 (1021)
T ss_pred             hhc
Confidence            865

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-44  Score=308.51  Aligned_cols=291  Identities=38%  Similarity=0.698  Sum_probs=225.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++++.+||||+++++++.....   
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---
Confidence            56889999999999999999999998899999998865433333445677899999999789999999998765332   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...++|+||+.++|.+++..     ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~  155 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLAR  155 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchh
Confidence            12789999999998888764     2678889999999999999999999999999999999999777 99999999987


Q ss_pred             ecccCC-----CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPI-----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ......     .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+....+.+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            554322     122233568889999988776668899999999999999999999998887777766666655444332


Q ss_pred             CCccccccCCc---ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          237 VWPGVSSLMNW---HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       237 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .+.........   ...............+.++.++.++|.+||+.||.+|||+.++++||||....+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence            22211110000   000111122233444568999999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.3e-44  Score=295.35  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=212.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|+..+.||+|++|.||++.+..++..+++|.+............+.+|+.+++++ +|||++++++.+.....     .
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~-----~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKA-----L   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCE-----E
Confidence            58899999999999999999999999999999876554444556788899999999 99999999998876655     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++|++.+ +|.+++...  ....+++..+..++.+++.++++||++|++|+||+|+||+++.++..++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            999999986 999998763  23468999999999999999999999999999999999999876667899999999766


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ..... .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+....             
T Consensus       153 ~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08220         153 SSKSK-AYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-------------  217 (256)
T ss_pred             CCCcc-ccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-------------
Confidence            54322 22345688999999987655 7899999999999999999999998776655444433211             


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                    .......++..+.+++.+||+.||.+|||+.|+++||||
T Consensus       218 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 --------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                          011122578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.7e-44  Score=293.94  Aligned_cols=255  Identities=24%  Similarity=0.455  Sum_probs=215.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++++.||.|++|.||.+++..++..+++|.+............+.+|+++++++ +|+||+++++++.....     .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~-----~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNT-----L   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCe-----E
Confidence            58999999999999999999999999999999876554444556788999999999 99999999999988765     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      +++|||+.+ +|.+++....  ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            999999985 9999887632  35689999999999999999999999999999999999999777 8999999999776


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||.+.+.. .+.++|+||||+++++|++|..||......+....+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-------------  217 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            55443334456789999999987665 7889999999999999999999998776655555443210             


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                    .......++.++.+++.+||..||.+|||+.++++|||+
T Consensus       218 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 --------------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                          111113678899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=305.52  Aligned_cols=261  Identities=31%  Similarity=0.478  Sum_probs=233.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ..=|.+.+-||+|+|..|-++++--+|..|++|++.+..-+...-..+..|+.-++.. .||||++++++.-....    
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTK----   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTK----   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccce----
Confidence            3458999999999999999999999999999999998887777778899999999998 99999999988655444    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +|+|+|.-++ +|.+++...   ...+.++....++.||+.|+.|+|+.++||+||||+|+.+...-.-|||+|||++.
T Consensus        92 -lyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   92 -LYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             -EEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence             9999999986 999999763   35689999999999999999999999999999999999887665599999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .+.++ ......+|+.-|.|||.+++..+..++.||||||+|||.|+.|+.||...++.+.+.++..+....+       
T Consensus       168 kf~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP-------  239 (864)
T KOG4717|consen  168 KFQPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP-------  239 (864)
T ss_pred             cCCCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-------
Confidence            76655 5677789999999999999999888999999999999999999999999999999998887543322       


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                           ..+|.+.++||.+||..||.+|.|.++|.+++|++.++.
T Consensus       240 ---------------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  240 ---------------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             ---------------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                                 268899999999999999999999999999999998764

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-44  Score=298.21  Aligned_cols=285  Identities=49%  Similarity=0.888  Sum_probs=221.9

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccCCceE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      |++.+.||+|++|.||++.++.++..+++|.+............+.+|+.+++.+.  +|||++++++++......+...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67889999999999999999888999999998765444333445667777776663  5999999999988766544455


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .+++||++++++.+++....  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceec
Confidence            89999999999988886632  23689999999999999999999999999999999999999876 9999999998776


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ..... .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......+...++......+....|+....
T Consensus       158 ~~~~~-~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         158 SFEMA-LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             cCCcc-cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            44322 22334578899999987765 78999999999999999999999998888887777776555443322221110


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      . .................+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 L-PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             c-chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            0 000111111222233344677889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-45  Score=306.48  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=209.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..|+++++||+||.+.||++...+ ..-|++|.+.....+......+..|+..|..|..|.+|+++++|...+..     
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~-----  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY-----  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce-----
Confidence            469999999999999999998754 45577887777778888889999999999999999999999999888766     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      +|+|||+-+.+|..+|.....   ..+...+..+..||+.|+.+.|..||||.||||.|+++- .| .+||+|||.+..+
T Consensus       435 lYmvmE~Gd~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  435 LYMVMECGDIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIANAI  509 (677)
T ss_pred             EEEEeecccccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechhccc
Confidence            999999999999999987332   234348999999999999999999999999999999998 66 8999999999877


Q ss_pred             ccCCCc--cccccccccCCChhhhhCCC----------CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhC
Q 021982          164 TLPIKK--YTHEILTLWYRAPEVLLGST----------HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  231 (304)
Q Consensus       164 ~~~~~~--~~~~~~~~~~~~PE~~~~~~----------~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  231 (304)
                      ......  ....+||+.|||||.+....          ..++++||||||||||+|+.|+.||....+..  .++.. +.
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--aKl~a-I~  586 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--AKLHA-IT  586 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--HHHHh-hc
Confidence            655333  34568899999999995321          15789999999999999999999998655422  22222 22


Q ss_pred             CC-CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          232 TP-NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      .| .+-.++...                      -..++.++++.||..||++|||+.++|+|||+.-
T Consensus       587 ~P~~~Iefp~~~----------------------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  587 DPNHEIEFPDIP----------------------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CCCccccccCCC----------------------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            22 222222111                      1123899999999999999999999999999875

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.4e-44  Score=295.50  Aligned_cols=256  Identities=28%  Similarity=0.521  Sum_probs=212.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|.+.+.||+|++|.||++.++.++..+++|.+............+.+|+++++.+ +|+|++++++.+.....     .
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~-----~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGR-----L   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCe-----E
Confidence            58889999999999999999999999999999876543333455777899999999 99999999999887665     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+.+ +|.+++...  ....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++..++++|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            999999976 998888653  23457899999999999999999999999999999999999977657899999998766


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||.+.+.. ++.++|+||||+++++|++|..||...+............             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            54433333445788999999887665 7899999999999999999999998766555444332210             


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                    .....+.++.++.++|.+||..+|.+|||+.+++.||||
T Consensus       219 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 --------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                          111123577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.9e-45  Score=309.88  Aligned_cols=266  Identities=21%  Similarity=0.348  Sum_probs=211.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++.+.||+|+||.||+++++.+++.+++|.+..... .......+.+|..++..+ +|++|+.+.+++...+.    
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~----   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENY----   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCE----
Confidence            579999999999999999999999999999998865321 122234466788888888 99999999999987776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++...   ...+++..+..++.|++.||++||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~  150 (331)
T cd05624          76 -LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCL  150 (331)
T ss_pred             -EEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEecccee
Confidence             8999999975 898888653   24689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCc-cccccccccCCChhhhhCC----CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPIKK-YTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ........ .....|++.|+|||++.+.    ..++.++|+||||+++|+|++|..||...+..+....+......    
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----  226 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER----  226 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----
Confidence            65443221 2234679999999998752    23688999999999999999999999877766655544321100    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~~~  302 (304)
                                         ..+......+++++.+++.+||..++.+  |++++++++||||..++++
T Consensus       227 -------------------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         227 -------------------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             -------------------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence                               0111122357899999999999976654  5799999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-44  Score=302.56  Aligned_cols=256  Identities=30%  Similarity=0.452  Sum_probs=213.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++.+.||+|++|.||++.+..+++.+++|++..... .......+.+|+++++++ +||||+++++++.....    
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSN----   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCe----
Confidence            479999999999999999999999999999999875432 222345677899999999 89999999999887766    


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+. ++|.+++...    ..+++..+..++.|++.||.+||+.|++|+||+|.||+++.++ .++|+|||++.
T Consensus        76 -~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~  149 (290)
T cd05580          76 -LYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAK  149 (290)
T ss_pred             -EEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCcc
Confidence             899999995 5998888663    5689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .....   .....+++.|++||.+.+.. .+.++|+||||+++|+|++|..||...+.......+....           
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  214 (290)
T cd05580         150 RVKGR---TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-----------  214 (290)
T ss_pred             ccCCC---CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            65443   22335688999999887665 7899999999999999999999998777544444433210           


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                       ......++..+.++|.+||+.||.+|+     +++++++||||+.+++.
T Consensus       215 -----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 -----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             -----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                             011124688999999999999999999     99999999999988753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-44  Score=300.33  Aligned_cols=281  Identities=46%  Similarity=0.845  Sum_probs=224.1

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc--ccCCceE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ--NKEGRTV   83 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~~~~   83 (304)
                      |++++.||+|++|.||++.+..++..+++|.+............+.+|+.+++.+ +|||++++++++...  ..     
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~-----   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGS-----   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCc-----
Confidence            6788999999999999999998899999999987653334445677899999999 899999999998876  33     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      .++++||+++++.+++...   ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPY  150 (287)
T ss_pred             EEEEeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeec
Confidence            8999999999888877542   24789999999999999999999999999999999999999777 8999999999766


Q ss_pred             ccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          164 TLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       164 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......++..|+|||.+.+...++.++||||||+++|+|++|..||...+.......+......+....|+...
T Consensus       151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence            54321 12233457889999988765557899999999999999999999999888877777777776666655555443


Q ss_pred             ccCCcccCC--CCCCCcccccCCC-CChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEYP--QWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~~--~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .........  ......+...... ++..+.+++++||+.||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            321111110  0011111122233 48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-44  Score=308.26  Aligned_cols=289  Identities=37%  Similarity=0.651  Sum_probs=222.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC-C
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE-G   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-~   80 (304)
                      +.++|.+...||+|++|.||++.+..++..+++|.+............+.+|+.+++.+ +||||+++.+++...... .
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCC
Confidence            45789999999999999999999998899999998875443343445678899999999 999999999998755432 2


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++++|++..++.....      ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~  164 (342)
T cd07879          92 FQDFYLVMPYMQTDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLA  164 (342)
T ss_pred             CceEEEEecccccCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCC
Confidence            23368999999887766542      3689999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .....   ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.+.......
T Consensus       165 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         165 RHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             cCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            65432   223345678899999987755578999999999999999999999988776666666555444333222111


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ......   ...........+....+..+.++.+||.+||+.||.+|||+.+++.||||..+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            111000   0011111222333344568889999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-44  Score=308.25  Aligned_cols=289  Identities=37%  Similarity=0.668  Sum_probs=222.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|++|.||++.+..++..+++|.+............+.+|+.+++.+ +||||+++++++..... ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccc
Confidence            46789999999999999999999999999999998864333333344677899999999 99999999999875543 22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++++|++++++.+.+..     .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~  165 (343)
T cd07880          92 FHDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA  165 (343)
T ss_pred             cceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            334689999998888877653     4689999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .......   ....+++.|++||.+.+...++.++|+||||+++|++++|..||...+.......+.+............
T Consensus       166 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         166 RQTDSEM---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             cccccCc---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            7554322   2335578899999987755578999999999999999999999998877766666655443332221111


Q ss_pred             ccccCC--c-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN--W-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......  + ..........+....+.+++.+.++|.+||+.||.+|||+.+++.||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            110000  0 00011111122333457888999999999999999999999999999998763

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-43  Score=294.85  Aligned_cols=257  Identities=23%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.+..++..+++|.++.....  ....+.+|+.+++.+ +||||+++++.+.....    
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~----   80 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDK----   80 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCE----
Confidence            47899999999999999999999999999999998754322  234567799999999 99999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++++||+++ +|.+++...    ..+++.+++.++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        81 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~  154 (267)
T cd06645          81 -LWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSA  154 (267)
T ss_pred             -EEEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeee
Confidence             8999999986 888887642    4689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhh--CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .............+++.|+|||.+.  ....++.++|+||||+++|+|++|..||...............  .....   
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~~---  229 (267)
T cd06645         155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQPP---  229 (267)
T ss_pred             EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCCC---
Confidence            6654433334456789999999874  2333788999999999999999999998765443322221110  00000   


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  295 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  295 (304)
                                       .. .....++..+.++|.+||+.||.+|||+++|++|||
T Consensus       230 -----------------~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 -----------------KL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -----------------cc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                             00 011246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.8e-44  Score=304.26  Aligned_cols=286  Identities=36%  Similarity=0.633  Sum_probs=224.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||.|++|.||++.+..++..+++|.+............+..|+.+++.+ +|||++++.+++.....   
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~---   83 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLE---   83 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCC---
Confidence            46789999999999999999999999999999998865444444456777899999999 99999999998865332   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       ..++++|+++++|.+.+..     .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        84 -~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~  156 (328)
T cd07856          84 -DIYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLAR  156 (328)
T ss_pred             -cEEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCcccccc
Confidence             1789999998888877753     4688889999999999999999999999999999999999776 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .....   .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...........+.+.++.+.+......
T Consensus       157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            54322   223355788999998876555899999999999999999999999888776666666666665544333222


Q ss_pred             cccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .....   ................+.++..+.++|.+||+.+|.+|||+++++.||||+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            11100   0011111111222334568899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-44  Score=308.23  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=198.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+.     .++..|++|.+.... .......+.+|+.++..+.+||||+++++.+....
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            478999999999999999999752     334679999886432 22223567889999999978999999999876543


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc----------------------------------------------------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ----------------------------------------------------  104 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------  104 (304)
                      .    .++++|||+.+ +|.+++.....                                                    
T Consensus        85 ~----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          85 G----PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             C----ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            2    27899999985 99988865321                                                    


Q ss_pred             ------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc--ccccccc
Q 021982          105 ------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILT  176 (304)
Q Consensus       105 ------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~  176 (304)
                            ...++++.++..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.........  .....++
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence                  123578889999999999999999999999999999999999777 8999999999765332211  1222345


Q ss_pred             ccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCC
Q 021982          177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP  255 (304)
Q Consensus       177 ~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (304)
                      +.|+|||++.+.. ++.++||||||+++|+|++ |..||......+........-                         
T Consensus       240 ~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------------------------  293 (338)
T cd05102         240 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-------------------------  293 (338)
T ss_pred             ccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC-------------------------
Confidence            7899999987765 7999999999999999997 999998755433322222110                         


Q ss_pred             CcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          256 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                       .........++.+.+++.+||+.||.+|||+.++++
T Consensus       294 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         294 -TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             000112357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-43  Score=297.33  Aligned_cols=262  Identities=23%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~   81 (304)
                      .+.|++.+.||.|+||.||++.+..++..+++|.+.....   ....+..|+.+++.+.+|+|++++++++..... +..
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            3679999999999999999999999999999998765322   234667788889888779999999999864332 223


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++|||+.+ +|.+++....  ...+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~  168 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVS  168 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcch
Confidence            458999999986 8988887633  34588899999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ..............+++.|+|||.+..    ...++.++|+||||+++|+|++|..||...........+....      
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------  242 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP------  242 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC------
Confidence            755433333344567889999998853    2337889999999999999999999997665443333221110      


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                          ........++..+.++|.+||+.||.+|||+.||+.||||
T Consensus       243 --------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 --------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                0001112578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=298.32  Aligned_cols=285  Identities=29%  Similarity=0.509  Sum_probs=223.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC-C----Ceeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD-P----HVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~----~i~~~~~~~~~~   76 (304)
                      +.++|.++..||+|+||.|-.+.++.++..+++|+++.-.+-   .....-|++++.+++.+ |    .++.+.+||...
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY---reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY---REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH---hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            467999999999999999999999999999999998754322   34555688888888433 2    377787888877


Q ss_pred             ccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--------
Q 021982           77 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--------  148 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--------  148 (304)
                      ++     .++|+|.++-++.+++.+.  .-.+++...+..++.|++.++++||+.+++|.||||+||++...        
T Consensus       164 gh-----iCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  164 GH-----ICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             Cc-----eEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence            77     8999999999999999883  44689999999999999999999999999999999999999431        


Q ss_pred             -----------CCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC
Q 021982          149 -----------TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD  217 (304)
Q Consensus       149 -----------~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  217 (304)
                                 +..++++|||.++......   +....|-.|+|||++++-+ ++.+.||||+||||+|+.||...|..+
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccC
Confidence                       2369999999998766543   3445588899999999987 999999999999999999999999999


Q ss_pred             chHHHHHHHHHHhCCCCCCCCccccc-------cCCcccCCC--------CCCCccccc---CCCCChhhHHHHHHhhcC
Q 021982          218 SELQQLLHIFRLLGTPNEKVWPGVSS-------LMNWHEYPQ--------WNPQSLATA---VPNLDKDGLDLLEQMLQY  279 (304)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~--------~~~~~~~~~---~~~~~~~l~~li~~~l~~  279 (304)
                      ++.+.++++...+++.+..-..+...       -.+|-+...        .....+...   .......+.+||++||..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            99999999999988765432211100       001110000        001111111   112234589999999999


Q ss_pred             CCCCCCCHHHHhcCCCccccc
Q 021982          280 DPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       280 dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ||.+|+|+.|+|+||||..+.
T Consensus       393 DP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  393 DPARRITLREALSHPFFARLT  413 (415)
T ss_pred             CccccccHHHHhcCHHhhcCC
Confidence            999999999999999998764

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-43  Score=292.29  Aligned_cols=257  Identities=28%  Similarity=0.564  Sum_probs=217.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|++|.||++.+..++..+++|.+............+.+|+++++.+ +|||++++.+.+.....     .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~-----~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGK-----L   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCE-----E
Confidence            58899999999999999999998899999999876655445566788899999999 89999999999887755     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++|++.+ +|.+.+.........+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            999999986 99999887654457899999999999999999999999999999999999999766 8999999999776


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||.+.+.. .+.++|+||+|+++++|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            55443334456788999999887665 7899999999999999999999998777555444433211             


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                    .......++..+.+++.+||..+|.+|||+.++++||||
T Consensus       220 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 --------------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                          111122578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.5e-44  Score=299.70  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=204.0

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||+|++|.||++.+..++..+++|.+..... ......+.+|+++++++ +|||++++++.+...+.     
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKC-DSPYIIGFYGAFFVENR-----   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCE-----
Confidence            478999999999999999999999999999998865421 22234677899999999 99999999999988766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.+ ++..+        ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        74 ~~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~  144 (279)
T cd06619          74 ISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQ  144 (279)
T ss_pred             EEEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCccee
Confidence            8899999997 55332        2478889999999999999999999999999999999999877 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH---HHHHHHHhCCCCCCCCc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ---LLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~  239 (304)
                      ....  ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........   ..............   
T Consensus       145 ~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  218 (279)
T cd06619         145 LVNS--IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP---  218 (279)
T ss_pred             cccc--cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC---
Confidence            5432  223346688999999988765 79999999999999999999999965322110   01111111100000   


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                         .......++++.+++.+||+.||.+||+++++++||||...+.+
T Consensus       219 -------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         219 -------------------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence                               00112467889999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-43  Score=294.36  Aligned_cols=262  Identities=24%  Similarity=0.367  Sum_probs=212.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||.|++|+||++.+..++..+++|.+....... ....+.+|+..++.+ +|+|++++++.+.....     
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDE-----   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCE-----
Confidence            57999999999999999999998889999999886544333 456788899999999 99999999998877665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++|++.+ +|.+.+..... ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~  151 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSAS  151 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHH
Confidence            8999999986 88888865322 24689999999999999999999999999999999999999776 899999999876


Q ss_pred             cccCCCc----cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .......    .....++..|+|||.+......+.++|+||||+++++|++|..||...+............   ... +
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~-~  227 (267)
T cd06610         152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PPS-L  227 (267)
T ss_pred             hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---CCC-c
Confidence            5543222    1223468889999998876558999999999999999999999998776655444433211   000 0


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                        ........+++.+.+++.+||..||.+|||+.+++.||||
T Consensus       228 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         228 ------------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ------------------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                              0000123678999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-43  Score=294.37  Aligned_cols=257  Identities=24%  Similarity=0.374  Sum_probs=204.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.+..++..+++|++......  ....+.+|+.+++.+ +||||+++++.+.....    
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~----   80 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREK----   80 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCE----
Confidence            46799999999999999999999989999999988654322  234567899999999 99999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++++||+++ +|.+.+..    ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        81 -~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~  154 (267)
T cd06646          81 -LWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAA  154 (267)
T ss_pred             -EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccce
Confidence             8999999986 88887754    24689999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .............+++.|+|||.+..  ...++.++|+||+|+++|+|++|..||...........+......       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------  227 (267)
T cd06646         155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-------  227 (267)
T ss_pred             eecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC-------
Confidence            66544333334466889999998753  333678999999999999999999998655432222111110000       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  295 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  295 (304)
                                      .........++..+.++|++||+.||.+|||++++++|+|
T Consensus       228 ----------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         228 ----------------PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ----------------CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                            0000011246789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.3e-44  Score=299.47  Aligned_cols=258  Identities=24%  Similarity=0.439  Sum_probs=210.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|.....||+|++|.||++.+..++..+++|.+....  ......+.+|+..++.+ +|+|++++++.+...+.    
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~----   93 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDE----   93 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCe----
Confidence            466788899999999999999998889999999876432  22234677899999999 99999999999887666    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++..     ..+++.+++.++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus        94 -~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~  166 (292)
T cd06658          94 -LWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCA  166 (292)
T ss_pred             -EEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchh
Confidence             8999999987 77776643     3588999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.........      
T Consensus       167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  239 (292)
T cd06658         167 QVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK------  239 (292)
T ss_pred             hcccccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc------
Confidence            5544333333456788999999987655 789999999999999999999999877665544433322111000      


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                         ....++..+.+++.+||..||.+|||++++++||||....
T Consensus       240 -------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         240 -------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             -------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence                               0124678899999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=286.19  Aligned_cols=262  Identities=28%  Similarity=0.450  Sum_probs=220.3

Q ss_pred             chhhhhhh-hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKL-EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      |.++|.+. +.||-|-.|.|-.+.++.++..+++|++..+       .+.++|++..-+.+.||||+.++++|..... +
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~-~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQ-G  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc-C
Confidence            34566653 6799999999999999999999999998743       4667899998888899999999999987654 4


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeec
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADL  157 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~df  157 (304)
                      ..++.+|||.+.| .|+..+++  +....+++.++..+++||+.|+.|||+.+|.||||||+|+|....  +..+||+||
T Consensus       131 rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence            6679999999996 99999988  444679999999999999999999999999999999999999643  357999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch----HHHHHHHHHHhCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE----LQQLLHIFRLLGTP  233 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~  233 (304)
                      |++..... .......+.||.|.|||++.... +....|+||+|+++|-|+.|-+||-....    .....++.......
T Consensus       209 GFAK~t~~-~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  209 GFAKETQE-PGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccCC-CccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            99976554 34556667799999999887665 89999999999999999999999976543    23444454444445


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      +...|+                        .+|++.+++|+.+|..+|.+|.|++++++|||....
T Consensus       287 P~pEWs------------------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  287 PEPEWS------------------------CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             CChhHh------------------------HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            555554                        688999999999999999999999999999999765

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-43  Score=303.37  Aligned_cols=290  Identities=37%  Similarity=0.623  Sum_probs=223.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccC--CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKAT--GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +|++.+.||+|+||.||++.+..+  +..+++|.+............+.+|+.+++.+.+||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            588899999999999999999887  8899999887544333344567789999999967999999998754322 1222


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ..++++++++++|.+.+..    ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~  154 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARG  154 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCcee
Confidence            3789999999998888754    35689999999999999999999999999999999999999777 899999999976


Q ss_pred             cccCCC----ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ......    ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+...++.+....+
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            543221    1223456889999998877555899999999999999999999999988877777777776665544322


Q ss_pred             ccccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          239 PGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       239 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ........   ...........+....+..+..+.+++.+||+.||.+|||+.+++.||||.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            22111100   001111112223333456789999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.1e-44  Score=298.42  Aligned_cols=258  Identities=25%  Similarity=0.413  Sum_probs=209.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.+.|+..+.||+|++|.||++.+..++..+++|.+...... .....+.+|+.+++++ +|||++++++.+.....   
T Consensus         2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   76 (277)
T cd06642           2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTK---   76 (277)
T ss_pred             hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcC-CCCccHhhhcccccCCc---
Confidence            457899999999999999999999888999999987644322 2345678899999999 99999999999887665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++|+||+++ +|.+++..     .++++..+..++.|++.|+.+||++|++|+||+|+||+++.++ .++++|||++
T Consensus        77 --~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~  148 (277)
T cd06642          77 --LWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVA  148 (277)
T ss_pred             --eEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEcccccc
Confidence              8999999986 88777643     4689999999999999999999999999999999999999776 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...           
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-----------  216 (277)
T cd06642         149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-----------  216 (277)
T ss_pred             ccccCcchhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-----------
Confidence            76544332223345678899999987765 789999999999999999999998765443322211100           


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                      ........++..+.+++.+||+.+|.+|||+.++++||||....
T Consensus       217 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 ----------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ----------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                            00111124678899999999999999999999999999998653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-43  Score=296.82  Aligned_cols=269  Identities=23%  Similarity=0.383  Sum_probs=208.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|...+.||+|++|.||++.+..++..+++|.+...... .....+.+|+.++.++.+|+||+++++++..+..    
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~----   77 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD----   77 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc----
Confidence            36788999999999999999999999999999988754332 2234667899999998559999999999887665    


Q ss_pred             EEEEEEeccCCCHHHHHHHhc-cCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           83 VLYLVFEYMDTDLKKYIRSFR-QTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                       .+++||++.+++.++..... .....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++
T Consensus        78 -~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  155 (288)
T cd06616          78 -CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGIS  155 (288)
T ss_pred             -EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchh
Confidence             78999999987766554321 2235789999999999999999999975 999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ....... ......+++.|+|||.+.+.  ..++.++|+||||+++|+|++|..||.....  ....+..........  
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~--  230 (288)
T cd06616         156 GQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI--  230 (288)
T ss_pred             HHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc--
Confidence            6544322 11233567889999998766  3588999999999999999999999976542  111221111110000  


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                        ........++.++.+|+.+||+.||.+|||+++|+.||||.....
T Consensus       231 ------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         231 ------------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             ------------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                              000111357889999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=291.66  Aligned_cols=261  Identities=30%  Similarity=0.403  Sum_probs=225.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      -|++|..++.||.|.||+|-+++.+.+++.|+||++++.- ...+....-..|-.+|... +||.+..+.-.|+..+.  
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~dr--  242 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDR--  242 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCce--
Confidence            3789999999999999999999999999999999887542 2222344555688889998 99999999888888877  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         +++||||.+| .|.-.+..    ..-++++....+-..|+.||.|||+++||++|||.+|.++|++| ++||+|||+
T Consensus       243 ---lCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGL  314 (516)
T KOG0690|consen  243 ---LCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGL  314 (516)
T ss_pred             ---EEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeeccc
Confidence               9999999997 77666543    45699999999999999999999999999999999999999998 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...-.........+|||.|+|||++..+. ++.+.|.|.+|++||+|++|+.||...++.....-+...-         
T Consensus       315 CKE~I~~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed---------  384 (516)
T KOG0690|consen  315 CKEEIKYGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED---------  384 (516)
T ss_pred             chhcccccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh---------
Confidence            976666667778889999999999998877 8999999999999999999999999888877666554321         


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                         ...+.+++++++.|+.++|..||++|.     .+.||.+|+||..++++
T Consensus       385 -------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  385 -------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             -------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence                               112337999999999999999999998     68899999999999876

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-44  Score=305.86  Aligned_cols=288  Identities=37%  Similarity=0.607  Sum_probs=220.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|.+.+.||+|++|.||++.+..++..+++|++............+.+|+.+++++ +||||+++.+++..... ..
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccc
Confidence            46889999999999999999999988899999998865433332345677899999999 99999999998764432 12


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++++++++++|.+.+..     ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus        94 ~~~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~  167 (345)
T cd07877          94 FNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA  167 (345)
T ss_pred             cccEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccc
Confidence            223688999998898877653     3589999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .....   ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+......+....+..
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         168 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             ccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            65432   223345688899999987755578999999999999999999999987776666666655554443332222


Q ss_pred             ccccCC--c-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMN--W-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ......  + ..................++++.++|.+||+.||.+|||+.++++||||.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence            211100  0 0001111111222233578899999999999999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-43  Score=295.30  Aligned_cols=257  Identities=32%  Similarity=0.419  Sum_probs=205.7

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      ||+|+||+||++.++.++..+++|.+..... .......+..|+.+++.+ +|||++++++.+.....     .++++||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDD-----LCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCe-----EEEEEec
Confidence            6899999999999999999999998875432 222334556899999999 89999999999887665     8999999


Q ss_pred             cCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc
Q 021982           91 MDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK  169 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~  169 (304)
                      +.+ +|.+++....  ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus        75 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~-~~  150 (277)
T cd05577          75 MNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGG-KK  150 (277)
T ss_pred             CCCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccC-Cc
Confidence            986 8988887632  24689999999999999999999999999999999999999777 8999999988654432 22


Q ss_pred             cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCccc
Q 021982          170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE  249 (304)
Q Consensus       170 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (304)
                      .....++..|+|||.+.+.. ++.++|+||||+++++|++|..||...........+......                 
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  212 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----------------  212 (277)
T ss_pred             cccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------------
Confidence            23345678899999987766 889999999999999999999999766542222222211100                 


Q ss_pred             CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          250 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                             ........+++++.++|.+||+.||.+||     ++.++++||||.++++.+
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence                   01112235789999999999999999999     888899999999988754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-43  Score=292.77  Aligned_cols=253  Identities=25%  Similarity=0.517  Sum_probs=205.8

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-------CCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-------VPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      +|.+...||+|++|.||++.+..++..+++|.+........       ....+..|+.+++.+ +||||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence            47888999999999999999988899999998875433221       123567889999999 9999999999988776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      .     .++++||+.+ +|.+++...    .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|
T Consensus        80 ~-----~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          80 H-----LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             c-----cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecc
Confidence            6     8999999986 888888653    4688999999999999999999999999999999999999776 899999


Q ss_pred             ccceeecccCCC------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHh
Q 021982          157 LGLARAFTLPIK------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  230 (304)
Q Consensus       157 fg~~~~~~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  230 (304)
                      ||.+........      ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999876642211      111234678899999987665 7889999999999999999999998776554443322210


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                                 .......++..+.++|++||+.||.+||++.++++||||
T Consensus       229 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ---------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ---------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                       111123578899999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.3e-43  Score=294.45  Aligned_cols=258  Identities=25%  Similarity=0.421  Sum_probs=211.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ...|+..+.||.|++|.||++.+..++..+++|.+..... ......+.+|+.+++.+ .|||++++++.+.+...    
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   76 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTK----   76 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCE----
Confidence            4679999999999999999999998899999998875432 12245677899999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.| +|.+++..     .++++.++..++.|++.|+.+||+.+++|+||+|+||+++.++ .++++|||.+.
T Consensus        77 -~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~  149 (277)
T cd06640          77 -LWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAG  149 (277)
T ss_pred             -EEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccce
Confidence             8999999986 88888754     4688999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------  216 (277)
T cd06640         150 QLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN------------  216 (277)
T ss_pred             eccCCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC------------
Confidence            6544332333345678899999987665 789999999999999999999999866544333221110            


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                     ........++..+.+++.+||+.||.+||++.++++||||.+...
T Consensus       217 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         217 ---------------NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ---------------CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                           001112246788999999999999999999999999999988754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=292.17  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=210.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||.|++|.||++.+..++..+++|++......  ....+.+|+.+++.+ +|||++++++.+.....    
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~----   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDK----   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhC-CCCChhceEEEEEeCCE----
Confidence            36899999999999999999999888899999998765433  456788999999999 99999999999877665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       ++++|||+++ +|.+++...   ..++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        75 -~~l~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~  149 (262)
T cd06613          75 -LWIVMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSA  149 (262)
T ss_pred             -EEEEEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccch
Confidence             8999999997 888877652   24689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .............++..|+|||.+.+.  ...+.++|+||||+++|+|++|..||...+..............+.     
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  224 (262)
T cd06613         150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-----  224 (262)
T ss_pred             hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-----
Confidence            665443333444668889999988655  2378899999999999999999999987765544433322100000     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  295 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  295 (304)
                                        ........+.++.+++++||..||.+|||+.+++.|+|
T Consensus       225 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 ------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                              00011245678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-43  Score=293.73  Aligned_cols=259  Identities=24%  Similarity=0.461  Sum_probs=209.8

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccCCce
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .|+..+.||+|++|.||++.+..++..+++|.+..... ......+.+|+.+++.+.  .|||++++++++.....    
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~----   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR----   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE----
Confidence            58899999999999999999998999999998865322 223356778999999983  39999999999876655    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++..     .++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 -~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 -LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             -EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence             8999999986 88887754     3689999999999999999999999999999999999999776 99999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+...  .         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~---------  218 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--K---------  218 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--C---------
Confidence            77655444444567889999999876655789999999999999999999999766543322211100  0         


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                   ...+  ....++.++.+++.+||+.||.+||++.+++.||||++...
T Consensus       219 -------------~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         219 -------------PPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             -------------CCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence                         0000  00126789999999999999999999999999999988654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-43  Score=295.15  Aligned_cols=273  Identities=25%  Similarity=0.432  Sum_probs=210.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|+..+.||.|++|.||++.+..++..+++|.+...... .....+.+|+++++++ +||||+++++++.....   ..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~---~~   75 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSC-KSPYIVKYYGAFLDESS---SS   75 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCC---Ce
Confidence            4688999999999999999999988999999988754322 3345678899999999 99999999998865432   12


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++++|||+++ +|.+++.........+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~  154 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGE  154 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccc
Confidence            7899999986 99888876655566789999999999999999999999999999999999999777 899999999865


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch--HHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--LQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......  ....++..|++||.+.+.. ++.++|+||||+++|+|++|..||.....  ..... ....+........+ 
T Consensus       155 ~~~~~~--~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~-  229 (287)
T cd06621         155 LVNSLA--GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-LLSYIVNMPNPELK-  229 (287)
T ss_pred             cccccc--ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-HHHHHhcCCchhhc-
Confidence            443221  2234578899999887665 78999999999999999999999976522  00011 11111110000000 


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                                      .........++.+.+++.+||..||.+|||+.|++.||||++...++
T Consensus       230 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         230 ----------------DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             ----------------cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence                            00000012467889999999999999999999999999998876554

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=294.72  Aligned_cols=281  Identities=43%  Similarity=0.792  Sum_probs=222.3

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |++.+.||+|++|+||++.+..++..+++|.+....... ......+|+..++++.+|||++++++++.....     .+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~-----~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDE-----LY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc-----EE
Confidence            678899999999999999998889999999876443221 122345688899999339999999999988665     89


Q ss_pred             EEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           86 LVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      ++|||++|++.+.+....  ...+++..+..++.|++.+|.+||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        75 lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            999999889988887632  34689999999999999999999999999999999999999766 999999999876544


Q ss_pred             CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      .. ......++..|+|||.+.+...++.++|+||||+++++|++|..||......+....+...++.+....|.......
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         152 RP-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             CC-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence            32 22334567889999988766668999999999999999999999999988888888888777776665544332221


Q ss_pred             Cccc--CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          246 NWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       246 ~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      ....  .+...........+..+.++.++|++||+.||.+|||+.|++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            1111  11111112223334557889999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.6e-43  Score=295.96  Aligned_cols=257  Identities=24%  Similarity=0.438  Sum_probs=210.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..|.....||+|+||.||++.+..++..+++|.+.....  .....+.+|+.+++.+ +|||++++++.+.....     
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~-----   92 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEE-----   92 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCe-----
Confidence            457778899999999999999988899999998864332  2345677899999999 99999999999887766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.+ +|.+.+..     ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++..
T Consensus        93 ~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~  166 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQ  166 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhh
Confidence            8999999986 77776643     4589999999999999999999999999999999999999777 899999999865


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+.. ++.++|+||||+++++|++|..||......+....+...    ..       
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~-------  234 (297)
T cd06659         167 ISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PP-------  234 (297)
T ss_pred             cccccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----CC-------
Confidence            544433334456789999999987765 799999999999999999999999876655544333211    00       


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                    ........++.++.++|.+||+.||.+||++.++++||||.+..
T Consensus       235 --------------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         235 --------------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             --------------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence                          00111235778899999999999999999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-43  Score=295.29  Aligned_cols=262  Identities=26%  Similarity=0.464  Sum_probs=208.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||+|++|.||++.+..++..+++|.+.... .......+.+|+.+++++ +||||+++++.+...+.     
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~-----   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGA-----   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCe-----
Confidence            57999999999999999999999899999999886432 122235677899999999 99999999999887665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .++++||+.+ +|..++... .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~  151 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSG  151 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            8999999997 887777542 223478999999999999999999997 5999999999999999766 89999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhCCC-----CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      .....  ......+++.|+|||.+.+..     .++.++|+||||+++|+|++|..||...................   
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---  226 (286)
T cd06622         152 NLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD---  226 (286)
T ss_pred             cccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC---
Confidence            55332  122334678899999885432     25789999999999999999999997655443333222211111   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                           .....+.++.++.++|.+||..||.+||++.++++||||....
T Consensus       227 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         227 ---------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             ---------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence                                 1112235889999999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.9e-43  Score=291.65  Aligned_cols=257  Identities=31%  Similarity=0.520  Sum_probs=213.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||.|++|.||++.+..++..+++|.+...... .....+.+|+..+..+ +|+|++++.+++.....     
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----   73 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGE-----   73 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCe-----
Confidence            4789999999999999999999999999999988765432 3456788899999999 89999999999888765     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .++++||+.+ +|.+++...    .++++..++.++.|++.|+.+||+ .|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~  148 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISK  148 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccce
Confidence            8999999995 999888753    568999999999999999999999 9999999999999999777 89999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHHHHHhCCCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  238 (304)
                      .............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.....   .+....+...   .     
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~-----  219 (264)
T cd06623         149 VLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---P-----  219 (264)
T ss_pred             ecccCCCcccceeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---C-----
Confidence            7655444433445688999999887664 78999999999999999999999987742   2222222210   0     


Q ss_pred             ccccccCCcccCCCCCCCcccccCCC-CChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                         ....... ++..+.++|.+||..+|.+|||+.++++||||+.++
T Consensus       220 -------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 -------------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                               0111123 788999999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-43  Score=293.54  Aligned_cols=255  Identities=29%  Similarity=0.512  Sum_probs=207.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|+..+.||+|++|.||++.++.+++.+++|.+...... .....+.+|+++++++ +||||+++++.+.....     
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~-----   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKC-NSPYIVGFYGAFYNNGD-----   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHC-CCCchhhhheeeecCCE-----
Confidence            4789999999999999999999999999999988764332 3345677899999999 79999999999888765     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .++++|++.+ +|.+++....   .++++..+..++.|++.|+.+||+ .|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~  149 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSG  149 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccch
Confidence            8999999995 9988887632   578999999999999999999999 9999999999999999776 89999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc-----hHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-----ELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~  236 (304)
                      ........  ...++..|+|||.+.+.. ++.++|+||||+++++|++|..||....     ..+.......   .... 
T Consensus       150 ~~~~~~~~--~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-  222 (265)
T cd06605         150 QLVNSLAK--TFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPP-  222 (265)
T ss_pred             hhHHHHhh--cccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCC-
Confidence            55432211  145678899999987765 8999999999999999999999997652     1122211111   1000 


Q ss_pred             CCccccccCCcccCCCCCCCcccccCC-CCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                             .... .++..+.++|.+||..||.+|||+.+++.||||+..
T Consensus       223 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         223 -----------------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             -----------------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                                   0001 278889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-43  Score=292.44  Aligned_cols=259  Identities=25%  Similarity=0.477  Sum_probs=207.7

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC----CCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE----GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +|+..+.||+|++|.||++.+..++..+++|++.......    .....+..|+..++++ +|+|++++++++.+.+.  
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~--   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSH--   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCe--
Confidence            4888999999999999999999999999999887543211    1235678899999999 99999999999987776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++++||+.| +|.+++...    .++++..++.++.|++.||.+||++|++|+||+|+||+++.++..++|+|||.
T Consensus        78 ---~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          78 ---FNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             ---EEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence               8999999986 888888652    46889999999999999999999999999999999999987765799999999


Q ss_pred             eeecccCCCc----cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLPIKK----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      +.........    .....++..|+|||.+.+.. ++.++|+||||+++++|++|..||...........+.......  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--  227 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence            8766543221    12234578899999987655 7899999999999999999999997554332222222111000  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                           ........+++++.+++.+||..||.+|||+.++++||||+
T Consensus       228 ---------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 ---------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ---------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                 01112235788999999999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.8e-43  Score=289.04  Aligned_cols=252  Identities=27%  Similarity=0.463  Sum_probs=207.8

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||.|++|.||++.+..++..+++|.+...... .....+..|+.+++.+ +|+|++++.+.+.....     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGH-----L   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCE-----E
Confidence            588999999999999999999999999999998754322 2345677899999999 99999999999987766     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+.+ ++.+++...  ....+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++++|||.+...
T Consensus        74 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~  150 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLL  150 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceee
Confidence            999999985 888887652  335689999999999999999999999999999999999999777 8999999998766


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||++.+.. .+.++|+||||+++|+|++|..||...+.......+.....            
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  217 (255)
T cd08219         151 TSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY------------  217 (255)
T ss_pred             cccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC------------
Confidence            54433333456788999999987765 79999999999999999999999987765555444432111            


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                                     ......++..+.++|.+||+.||.+|||+.++++--
T Consensus       218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                           111225778899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.7e-43  Score=288.84  Aligned_cols=254  Identities=23%  Similarity=0.412  Sum_probs=203.8

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC----CCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +|++.+.||+|+||.||++.+. ++..+++|.+........    ....+.+|+++++.+ +|+||+++.+++.+...  
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~--   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNT--   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCe--
Confidence            5889999999999999999874 678899998875432211    124577899999999 99999999999987765  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++++||+.| +|.+++...    .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.
T Consensus        77 ---~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          77 ---ISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             ---EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchh
Confidence               8999999986 888888652    4588999999999999999999999999999999999999777 999999998


Q ss_pred             eeecccC------CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          160 ARAFTLP------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       160 ~~~~~~~------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      +......      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.....  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--  225 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--  225 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC--
Confidence            8654221      11122345688899999987765 78999999999999999999999987655443332222100  


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                             ........++.++.++|++||+.||.+||++.++++||||
T Consensus       226 -----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 -----------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -----------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                   0111223578899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.6e-43  Score=292.37  Aligned_cols=252  Identities=30%  Similarity=0.460  Sum_probs=208.6

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +|++.+.||.|++|.||++.+..++..+++|.+....... .....+.+|+++++++ +||||+++++.+.....     
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEEN-----   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCe-----
Confidence            5889999999999999999999889999999987543222 3456788899999999 99999999999887766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.| +|.+++...    .++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            8999999987 888888652    4789999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH--HHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL--QQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......  ........   .        
T Consensus       150 ~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~--------  216 (258)
T cd05578         150 VTPDT-LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T--------  216 (258)
T ss_pred             cCCCc-cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c--------
Confidence            54432 223345678899999987766 799999999999999999999999876642  22221111   0        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH--HHHhcCCCc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA--KKAMEHPYF  296 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~eil~~~~~  296 (304)
                                      .........+..+.++|.+||+.||.+||++  .|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0111223577999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=309.67  Aligned_cols=263  Identities=25%  Similarity=0.419  Sum_probs=217.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|.++..||.|+||.||++.++.++...+.|++....  ......+.-|+.+|..+ .||+|+++++.|..++.     
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~C-dHP~ivkLl~ayy~enk-----  103 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENK-----  103 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCc-----
Confidence            56899999999999999999999887777788776433  33467788899999999 89999999998888877     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++.|+|+|...+.+.-  ..+..++++++..++.|++.||.|||+++|+|+|||..|||+.-+| .++|+|||.+...
T Consensus       104 LwiliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn  180 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKN  180 (1187)
T ss_pred             eEEEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccc
Confidence            999999999855554433  2346899999999999999999999999999999999999999888 9999999998776


Q ss_pred             ccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...........|||.|||||+...    ..+|..++||||||++|.+|..+.+|-...+..-.+.++.+.-  |+.  . 
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PPT--L-  255 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PPT--L-  255 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CCc--c-
Confidence            666566677899999999999853    3448999999999999999999999987777766555554321  100  0 


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                        +  .+..-+..+.+++.+||..||..||++.+||.||||.+++-.
T Consensus       256 ------------------l--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  256 ------------------L--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             ------------------c--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence                              0  112455788999999999999999999999999999987543

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.1e-43  Score=295.73  Aligned_cols=280  Identities=22%  Similarity=0.381  Sum_probs=208.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++.+.||+|++|.||++.+..++..+++|.+..... ......+.+|+++++++ +||||+++++++.....     
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGE-----   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCE-----
Confidence            479999999999999999999999999999998764322 12234577899999999 99999999999987776     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .++++||+.+ +|.+++...    .++++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+.
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~  148 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG  148 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCcc
Confidence            8999999986 998888653    468999999999999999999997 5999999999999999777 89999999886


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCC-CCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN-EKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  240 (304)
                      ......  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.... ........... ......
T Consensus       149 ~~~~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         149 QLIDSM--ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             cccccc--cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcc
Confidence            543321  23345688999999987655 78999999999999999999999976553322 22221111100 000000


Q ss_pred             ccccCCcccCCC---------C-CCC-cccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMNWHEYPQ---------W-NPQ-SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~~~~~~~---------~-~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                       ...........         . ... ........++.++.+++.+||..||.+|||+.++++||||.+..
T Consensus       225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         225 -PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             -cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence             00000000000         0 000 00001123678899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-42  Score=286.37  Aligned_cols=254  Identities=26%  Similarity=0.471  Sum_probs=208.4

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC---CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +|+..+.||+|++|.||++.+..++..+++|.+......   ......+..|+.+++.+ +|+|++++++++.....   
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~---   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDN---   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCe---
Confidence            588899999999999999999888999999988764422   22345677899999999 99999999999887665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++++||+.+ +|.+++...    .++++..++.++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        77 --~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          77 --LYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             --EEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence              8999999986 888888652    4588999999999999999999999999999999999999777 9999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....... ......+++.|++||.+.....++.++|+||||+++|+|++|..||......+.........          
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------  218 (258)
T cd06632         150 KQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK----------  218 (258)
T ss_pred             eeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc----------
Confidence            7654432 22344568889999998665447899999999999999999999998776544443322210          


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                      ........+++.+.+++.+||+.+|.+|||+.+++.|||+
T Consensus       219 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 ----------------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ----------------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                            0111223578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-42  Score=291.26  Aligned_cols=260  Identities=28%  Similarity=0.489  Sum_probs=214.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|++...||+|++|.||++.+..++..+++|.+.....   ....+.+|+++++.+ +|+|++++++.+.....    
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~----   89 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDC-KHPNIVDYYDSYLVGDE----   89 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCE----
Confidence            4679999999999999999999998899999999875443   345677899999999 99999999999888765    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++++||+.+ +|.+++....   ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        90 -~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~  164 (286)
T cd06614          90 -LWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAA  164 (286)
T ss_pred             -EEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhh
Confidence             8999999995 9999988743   3789999999999999999999999999999999999999777 89999999886


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+.......        
T Consensus       165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  235 (286)
T cd06614         165 QLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--------  235 (286)
T ss_pred             hhccchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Confidence            5544333333344678899999887665 7899999999999999999999998776655444332210000        


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                       ......++..+.++|.+||+.+|.+|||+.+++.|+||.+.-+
T Consensus       236 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         236 -----------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             -----------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence                             0011237789999999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-42  Score=287.86  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      ||.|++|.||++.+..++..+++|++...... ......+.+|+.+++.+ +||||+++++.+.+...     .++++||
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKY-----IYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCc-----cEEEEec
Confidence            68999999999999988999999998754322 23345788899999999 99999999999887766     8999999


Q ss_pred             cCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc
Q 021982           91 MDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK  169 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~  169 (304)
                      +.+ +|.+++...    ..+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+....... .
T Consensus        75 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~-~  148 (262)
T cd05572          75 CLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQ-K  148 (262)
T ss_pred             CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccc-c
Confidence            975 998888652    3589999999999999999999999999999999999999777 89999999987665432 2


Q ss_pred             cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc--hHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS--ELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       170 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      .....+++.|++||.+.+.. ++.++|+||||+++|+|++|..||....  .......+....                 
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  210 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-----------------  210 (262)
T ss_pred             cccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC-----------------
Confidence            22345688999999987655 7899999999999999999999998766  333333322100                 


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                               .........++++.++|.+||+.||.+||+     +.|+++||||++.+++
T Consensus       211 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         211 ---------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence                     001111235789999999999999999999     9999999999988764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-42  Score=290.27  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=196.3

Q ss_pred             hcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC-CchhHHHHHHHHHc--cCCCCeeeeeceecccccCCceEEEEE
Q 021982           11 KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV-PPTTLREVSILRML--SRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l--~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      .||+|+||.||++.+..++..+++|.+......... .....++..+++.+  .+||+++.+++.+...+.     .++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK-----LCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe-----EEEE
Confidence            489999999999999989999999988754332221 12233343333332  278999999999887766     8999


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.+ +|.+++..    ...+++..+..++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~  150 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK  150 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc
Confidence            999986 88877754    24689999999999999999999999999999999999999777 8999999998654432


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH--HHHHHHHHhCCCCCCCCcccccc
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ--QLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      .  .....+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.......  .......   .            
T Consensus       151 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~------------  213 (279)
T cd05633         151 K--PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T------------  213 (279)
T ss_pred             C--ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---c------------
Confidence            2  2234578999999998755557899999999999999999999997543221  1111110   0            


Q ss_pred             CCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                  ........+++++.++|.+||..||.+||     |++++++||||+.++++.
T Consensus       214 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         214 ------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             ------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence                        00011235789999999999999999999     699999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=287.82  Aligned_cols=254  Identities=27%  Similarity=0.451  Sum_probs=200.8

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +.||+|++|.||++.+..+++.+++|.++..... .........|..++....+|+|++++++++...+.     .++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-----~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY-----LYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe-----EEEEE
Confidence            5799999999999999989999999988654321 11122334444444443489999999999987665     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|.+++...    .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....  
T Consensus        77 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~--  149 (260)
T cd05611          77 EYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE--  149 (260)
T ss_pred             eccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc--
Confidence            99986 898888652    4689999999999999999999999999999999999999777 899999998865433  


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                        .....+++.|++||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.......              
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  212 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW--------------  212 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC--------------
Confidence              22334678899999988766 7899999999999999999999998777655544433211000              


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC---CHHHHhcCCCccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~~~~~  302 (304)
                                .......++..+.+++.+||+.||.+||   +++|+++||||++++++
T Consensus       213 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         213 ----------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             ----------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence                      0011125789999999999999999999   45799999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.3e-42  Score=289.50  Aligned_cols=256  Identities=25%  Similarity=0.467  Sum_probs=208.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .|...+.||.|++|.||++.+..++..+++|.+.....  .....+.+|+.+++.+ +|||++++++++...+.     .
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~-----~   91 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDE-----L   91 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCe-----E
Confidence            56677899999999999999988899999998754322  2234577899999999 99999999999887665     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+.| +|.+++..     .++++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        92 ~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~  165 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQV  165 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhh
Confidence            999999976 88888765     4589999999999999999999999999999999999999777 9999999987655


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.......          
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~----------  234 (285)
T cd06648         166 SKEVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK----------  234 (285)
T ss_pred             ccCCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC----------
Confidence            44333333445788999999987665 7899999999999999999999998766555544433211000          


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                     ......++..+.+++.+||+.||.+|||+.++++||||++..
T Consensus       235 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         235 ---------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             ---------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence                           001124778999999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1e-42  Score=288.99  Aligned_cols=256  Identities=28%  Similarity=0.474  Sum_probs=206.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++.+.||+|++|.||++.++.++..+++|.+..... .......+.+|+.+++.+ +|||++++++++...+.    
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNE----   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCe----
Confidence            679999999999999999999998999999998765332 222334567899999999 99999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++++||+.+ +|.+++.........+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 -~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 -LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             -EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence             8999999996 89888876655556789999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH-HHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .............+++.|+|||.+.+.. .+.++|+||||+++|+|++|..||...... ............+.      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6654333333345688999999987765 789999999999999999999998654321 12222211111000      


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         ......+..+.+++.+||+.+|.+|||+.++++
T Consensus       228 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 -------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             -------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                               011246788999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-42  Score=287.10  Aligned_cols=257  Identities=20%  Similarity=0.412  Sum_probs=203.0

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC---CCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE---GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ..|++.+.||+|++|.||++.+..++..+++|.+.......   .....+.+|+.+++.+ +||||+++++++.....  
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~--   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAE--   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCC--
Confidence            46899999999999999999999999999999887543222   1234577899999999 99999999998765321  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                       ...++++||+.+ +|.+.+...    ..+++..++.++.|++.||++||+.+++|+||+|+||+++.++ .++|+|||+
T Consensus        79 -~~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~  152 (266)
T cd06651          79 -KTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGA  152 (266)
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCC
Confidence             127899999986 898888652    3588999999999999999999999999999999999999776 899999999


Q ss_pred             eeecccCC---CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +.......   .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||................   .  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~---~--  226 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP---T--  226 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC---C--
Confidence            86543321   1112234678899999987755 7899999999999999999999998765544443332110   0  


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                           .......+++.+.+++ +||..||.+|||++||++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                 0111124678888998 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-42  Score=294.24  Aligned_cols=261  Identities=27%  Similarity=0.434  Sum_probs=209.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|++|.||++.+..+++.+++|.+...... ......+.+|+++++.+ +||||+++++.+.....    
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~----   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRH----   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCE----
Confidence            4789999999999999999999999999999988754321 22335677899999999 99999999999877665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.| +|.+++...    .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++++|||.+.
T Consensus        76 -~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~  149 (305)
T cd05609          76 -LCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSK  149 (305)
T ss_pred             -EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCcc
Confidence             8999999986 888888652    4689999999999999999999999999999999999999777 89999999875


Q ss_pred             ecccCC---------------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHH
Q 021982          162 AFTLPI---------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI  226 (304)
Q Consensus       162 ~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~  226 (304)
                      ......               .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+.....
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~  228 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  228 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            321100               0011124577899999987765 799999999999999999999999877665544444


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC---HHHHhcCCCcccccc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS---AKKAMEHPYFDDLDK  301 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~~~~  301 (304)
                      ......                         .......++.++.++|.+||+.||.+||+   +.++++||||...+.
T Consensus       229 ~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         229 ISDDIE-------------------------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             HhcccC-------------------------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            331100                         00111257889999999999999999997   799999999977654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.7e-43  Score=294.27  Aligned_cols=258  Identities=26%  Similarity=0.468  Sum_probs=209.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|.+++.||+|++|.||++.+..++..+++|.+....  ......+.+|+.+++.+ +|||++++++.+.....    
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~----   90 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMREN-KHPNIVNYLDSYLVGDE----   90 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCc----
Confidence            368999999999999999999998888999999876432  22235677899999999 89999999999887766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++|+||+.+ +|.+++..     ..+++.++..++.|++.|+.+||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        91 -~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~  163 (293)
T cd06647          91 -LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCA  163 (293)
T ss_pred             -EEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCccee
Confidence             8999999986 88888754     3578899999999999999999999999999999999999776 89999999887


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|++||.+.... ++.++|+||||+++|++++|..||...+.......+... +.+        
T Consensus       164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~--------  233 (293)
T cd06647         164 QITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP--------  233 (293)
T ss_pred             cccccccccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCC--------
Confidence            6554433334445688899999987655 789999999999999999999999876553322211110 000        


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                     . ......++..+.++|++||..+|.+||++.+++.||||...+
T Consensus       234 ---------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         234 ---------------E-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ---------------C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                           0 001124678899999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.8e-42  Score=285.42  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=197.2

Q ss_pred             hhhhhhhhc--ccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            4 DAFEKLEKV--GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         4 ~~y~~~~~l--g~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.|.+.+.+  |+|+||.||++.++.++..+++|.+.......       .|......+.+|||++++++.+...+.   
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~---   83 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKG---   83 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCe---
Confidence            467777776  99999999999999999999999886432211       133333333379999999999988775   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++...    .++++.+++.++.|++.||.+||+.|++|+||+|+||+++.++..++|+|||.+
T Consensus        84 --~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 --HVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             --eEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence              8999999975 999988652    378999999999999999999999999999999999999977658999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH-HHHHHHHhCCCCCCCCc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-LLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  239 (304)
                      ......    ....++..|+|||++.+.. ++.++|+||||+++|+|++|..||........ ..........       
T Consensus       158 ~~~~~~----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  225 (267)
T PHA03390        158 KIIGTP----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------  225 (267)
T ss_pred             eecCCC----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-------
Confidence            765432    1235688999999997765 78999999999999999999999985543321 1222111100       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-HHHHhcCCCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-AKKAMEHPYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~eil~~~~~~~  298 (304)
                                        .....+.+++.+.++|.+||+.||.+||+ ++++++||||++
T Consensus       226 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 ------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ------------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                              11122368899999999999999999996 599999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=305.76  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=211.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++..+...||+|.||+||.++|.++   ||||++.......+..+.+.+|+.+++.- +|.||+-+.|++....    
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~----  461 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPP----  461 (678)
T ss_pred             CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCc----
Confidence            346788899999999999999999754   99999998887777889999999999998 9999999999998876    


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +.||+.||+| +|..++.-.   ...+...+++.|++|+++|+.|||.++|+|+|||..||++..++ .|||+|||++
T Consensus       462 --~AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGLa  535 (678)
T KOG0193|consen  462 --LAIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGLA  535 (678)
T ss_pred             --eeeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccce
Confidence              5899999999 898888642   35689999999999999999999999999999999999999776 9999999998


Q ss_pred             eeccc--CCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTL--PIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~--~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ..-..  +........|...|+|||++.-  ...+++.+||||||+++|||++|..||......+.+-++-+....    
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~----  611 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM----  611 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC----
Confidence            75432  3344555677899999999963  334899999999999999999999999955544444333222111    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         ........+.+.++++|+..||..++++||++.+||.
T Consensus       612 -------------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  612 -------------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -------------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                               1122223367789999999999999999999999987

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-43  Score=316.74  Aligned_cols=291  Identities=19%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc-EEEEEEeee---------------cCCCCCCCchhHHHHHHHHHccCCCCe
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK-IVALKKTRL---------------HEDDEGVPPTTLREVSILRMLSRDPHV   66 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-~~~iK~~~~---------------~~~~~~~~~~~~~e~~~l~~l~~h~~i   66 (304)
                      .++|++++.||+|+||+||++..+.... ..+.|.+..               ..........+.+|+.+++.+ +||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence            4689999999999999999987654322 122221100               001111223567899999999 99999


Q ss_pred             eeeeceecccccCCceEEEEEEeccCCCHHHHHHHhc-cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE
Q 021982           67 VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFR-QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM  145 (304)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~  145 (304)
                      +++++++.....     .+++++++.+++.+++.... .........++..++.||+.||.|||++||+|+||||+|||+
T Consensus       226 v~l~~~~~~~~~-----~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        226 LKIEEILRSEAN-----TYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             CcEeEEEEECCe-----eEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            999999988776     89999999998888775422 112234567788999999999999999999999999999999


Q ss_pred             eCCCCeEEEeeccceeecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc-CCCC--chHH
Q 021982          146 DRKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGD--SELQ  221 (304)
Q Consensus       146 ~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p-~~~~--~~~~  221 (304)
                      +.++ .+||+|||++........ ......|++.|+|||++.+.. ++.++|||||||++|+|++|..+ +...  ....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9777 899999999976654322 222346799999999998766 79999999999999999998764 4322  2334


Q ss_pred             HHHHHHHHhCCCCCCCCccc-cccCCcccCCC--CCCCcccc--cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          222 QLLHIFRLLGTPNEKVWPGV-SSLMNWHEYPQ--WNPQSLAT--AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .+..+...+...... ++.. ....++.....  .....+..  ....++.++.++|.+||+.||.+|||+.|+|+||||
T Consensus       379 ~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        379 QLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            444444443322211 1111 00000000000  00001111  112467788999999999999999999999999999


Q ss_pred             cccccc
Q 021982          297 DDLDKT  302 (304)
Q Consensus       297 ~~~~~~  302 (304)
                      +....+
T Consensus       458 ~~~~~~  463 (501)
T PHA03210        458 SAEEEE  463 (501)
T ss_pred             hcCCch
Confidence            886543

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3e-42  Score=285.94  Aligned_cols=258  Identities=22%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC---CCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG---VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +++|++.+.||+|++|.||.+.+..++..+++|.+........   ....+..|+.+++++ .||||+++++++.+... 
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-   78 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPME-   78 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCC-
Confidence            3679999999999999999999999999999998865432221   234667799999999 99999999998765432 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                        ..+++++||+.+ +|.+++...    ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||
T Consensus        79 --~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg  151 (265)
T cd06652          79 --RTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFG  151 (265)
T ss_pred             --ceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCc
Confidence              127899999986 898888652    3578899999999999999999999999999999999999776 89999999


Q ss_pred             ceeecccCC---CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          159 LARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       159 ~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      .+.......   .......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||..............   .+. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-  226 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT-  226 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC-
Confidence            987543211   1122335678899999987755 78999999999999999999999987655444433221   110 


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                            .......++..+.++|++|+. +|.+||+++++++|||+.
T Consensus       227 ----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                  011123567888999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-42  Score=286.13  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=212.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||.|++|.||++.++.++..+++|.+............+.+|+.+++.+ +|+||+++.+++.....     .
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNK-----L   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCE-----E
Confidence            58899999999999999999998999999999876544444445677899999999 89999999999887655     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+++ +|.+++.........+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            999999976 89998877655556789999999999999999999999999999999999999766 8999999998766


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...  ......+++.|+|||.+.+.. ++.++|+||||+++++|++|..||...+.......+...              
T Consensus       154 ~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------------  216 (256)
T cd08530         154 KKN--MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--------------  216 (256)
T ss_pred             ccC--CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence            544  222345688999999987665 788999999999999999999999887765443333211              


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                   ........++.++.+++.+||+.+|.+|||+.++++||++
T Consensus       217 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 -------------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -------------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                         1111122577889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.1e-42  Score=292.77  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=208.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|+..+.||+|++|.||++.+..++..+++|.+...... ......+.+|+.+++.+ +|||++++.+++.....   
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~---   89 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHT---   89 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCe---
Confidence            46799999999999999999999988999999988644322 22234677899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .++++||+.|++.+.+...   ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus        90 --~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~  163 (307)
T cd06607          90 --AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSAS  163 (307)
T ss_pred             --EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcce
Confidence              8999999999888877542   24689999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .....    ....+++.|+|||++.+  ...++.++||||||+++|+|++|..||...+.......+...  .+.     
T Consensus       164 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-----  232 (307)
T cd06607         164 LVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP-----  232 (307)
T ss_pred             ecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCC-----
Confidence            54432    22345788999998752  334788999999999999999999999876655543332211  000     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                         .......+..+.++|.+||+.||.+||++.+++.||||..-.
T Consensus       233 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         233 -------------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             -------------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                               000113677899999999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.4e-42  Score=286.28  Aligned_cols=257  Identities=29%  Similarity=0.544  Sum_probs=206.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|++.+.||+|++|.||++.+..++..+++|.++...........+..|+++++.+ +|+||+++++.......     .
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~-----~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREK-----V   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCE-----E
Confidence            68999999999999999999988899999999876654434566788999999999 99999999998776665     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+.+ +|.+++..    ...+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          75 YIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            999999986 88888765    24578899999999999999999999999999999999999766 8999999998766


Q ss_pred             ccCCCccc----cccccccCCChhhhhCCC--CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          164 TLPIKKYT----HEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       164 ~~~~~~~~----~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ........    ...+++.|+|||.+.+..  ..+.++||||||++++++++|..||............... ..  ...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~--~~~  226 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH--KPP  226 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC--CCC
Confidence            44322221    235578999999987543  2688999999999999999999999765432222111111 00  000


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .                     .....++..+.++|.+||+.||.+|||+.+++.|||+
T Consensus       227 ~---------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         227 I---------------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             C---------------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0                     0112458889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-42  Score=289.14  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=209.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+-|++++.||+|+||.||++.+..++..+++|.+..... ......+.+|+.+++++ +||||+++++.+.....    
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~----   76 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTK----   76 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCe----
Confidence            4568999999999999999999988899999998764332 22335677899999999 99999999999887766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++|+||+++ +|.+++..     .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++ .++++|||++.
T Consensus        77 -~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06641          77 -LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAG  149 (277)
T ss_pred             -EEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccce
Confidence             8999999986 88877753     4689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------  216 (277)
T cd06641         150 QLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN------------  216 (277)
T ss_pred             ecccchhhhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC------------
Confidence            6544332333345678899999887654 788999999999999999999999876554433332111            


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                     ........++.++.+++.+||+.||.+||++.++++||||.+.
T Consensus       217 ---------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         217 ---------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ---------------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                           0011122578899999999999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-42  Score=287.17  Aligned_cols=259  Identities=26%  Similarity=0.479  Sum_probs=205.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC--------CchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV--------PPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~--------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      +|.+.+.||+|++|.||++.+..++..+++|.+.........        ...+..|+.+++.+ +|||++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence            578899999999999999999888999999988653322111        23466789999999 999999999998776


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      ..     .++++||+.+ +|.+++...    .++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++++
T Consensus        81 ~~-----~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          81 EY-----LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             Cc-----eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEe
Confidence            65     8999999986 888888653    4689999999999999999999999999999999999999777 99999


Q ss_pred             eccceeecccCCC--ccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCC
Q 021982          156 DLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       156 dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      |||.+........  ......++..|+|||.+.... .++.++|+||||++++++++|..||..................
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA  230 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence            9999865432211  122334678899999987654 3789999999999999999999999766554433322211000


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .                      .......+.++..+.++|.+||..||.+|||++++++||||
T Consensus       231 ~----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 P----------------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             C----------------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            0                      00111223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.3e-42  Score=287.12  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             hhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      .....||+|+||.||++.+..++..+++|.+.....  .....+.+|+.+++.+ +|+||+++++++.....     .++
T Consensus        11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----~~l   82 (268)
T cd06624          11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGF-----FKI   82 (268)
T ss_pred             CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCE-----EEE
Confidence            344679999999999999988889999998764322  2235677899999999 99999999999887765     899


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCC--ChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENI--PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~--~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++||+.+ +|.+++....   .++  ++..+..++.|++.||.+||+.|++|+||+|+||+++.++..++|+|||.+...
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999986 9998886521   234  788889999999999999999999999999999999865558999999998765


Q ss_pred             ccCCCccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...........+++.|+|||.+.+.. .++.++|+||||+++|+|++|..||................            
T Consensus       160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~------------  227 (268)
T cd06624         160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF------------  227 (268)
T ss_pred             ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh------------
Confidence            44333333445688999999986543 37889999999999999999999997644322111111000            


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                   .........+++++.+++.+||+.+|.+|||+.+++.||||
T Consensus       228 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 -------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                         00111223577899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=297.07  Aligned_cols=267  Identities=28%  Similarity=0.421  Sum_probs=222.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++.|++-+.||.|+||.|+.+..+.+|+.|+.|.+.+.. +..........|..+|..+ +.+.|+.+--.|+..+.   
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~---  259 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDA---  259 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCc---
Confidence            456788889999999999999999999999999876543 2222334567899999999 88988888777777776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++|+..++| +|.=.+-+.  ...-+++..++.++.+|+.||++||+.+||+||+||+|||+|..| +++|+|+|++
T Consensus       260 --LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLA  334 (591)
T KOG0986|consen  260 --LCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLA  334 (591)
T ss_pred             --eEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceE
Confidence              9999999997 665444432  224699999999999999999999999999999999999999888 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      +.+..+... ....||.+|||||++.+.. |+...|.|||||++|+|+.|..||...........+-+.......+    
T Consensus       335 vei~~g~~~-~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e----  408 (591)
T KOG0986|consen  335 VEIPEGKPI-RGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE----  408 (591)
T ss_pred             EecCCCCcc-ccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh----
Confidence            988776443 4448999999999998877 9999999999999999999999999887766655554443332221    


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccccC
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~~  304 (304)
                                          ....+|++++++.+.+|+.||.+|.     +++++-+||||+++|+++|
T Consensus       409 --------------------y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  409 --------------------YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             --------------------cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence                                1237899999999999999999998     7889999999999999875

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-44  Score=315.88  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=206.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeec-eecccccCC-c
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD-VKQGQNKEG-R   81 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~-~~~~~~~~~-~   81 (304)
                      .++++.+.|.+|||+.||+|.+...+..||+|.+...  ++.......+|+++++.|.+|+|||.++| .......++ .
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            3578889999999999999999988789999987655  55557788899999999988999999999 444333333 3


Q ss_pred             eEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           82 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      -.++++||||. |+|.+++..+.+..  |++.++++|+.++++|+.+||...  |+|||||.+|||++.++ ..||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCccc
Confidence            45889999999 59999999876654  999999999999999999999997  99999999999999888 99999999


Q ss_pred             ceeecccCCCccc---------cccccccCCChhhhh--CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHH
Q 021982          159 LARAFTLPIKKYT---------HEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  227 (304)
Q Consensus       159 ~~~~~~~~~~~~~---------~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  227 (304)
                      .++-.-.......         ....|+.|++||++.  ++..+++|+|||+|||+||-|+..+.||........+....
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y  271 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY  271 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc
Confidence            9875433321110         112389999999985  33448999999999999999999999998774432221111


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                                   .+ ..++.++..+.+||+.||+.||.+||++.|++.+
T Consensus       272 -----------------------------~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  272 -----------------------------SF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -----------------------------cC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                                         01 1124788999999999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.2e-42  Score=289.44  Aligned_cols=256  Identities=22%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCC-----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      -.++|++++.||.|++|.||++.+...+     ..+++|.+.... .......+.+|+..++.+ +||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCC
Confidence            3578999999999999999999886555     568888876332 222234577899999999 999999999998876


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCC------------CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCe
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL  143 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Ni  143 (304)
                      ..     .+++|||+.+ +|.+++.......            ..+++.+++.++.|++.||.+||+.|++|+||||+||
T Consensus        81 ~~-----~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni  155 (283)
T cd05048          81 QP-----TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC  155 (283)
T ss_pred             Cc-----eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceE
Confidence            65     8999999985 9999987642211            4578899999999999999999999999999999999


Q ss_pred             EEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchH
Q 021982          144 LMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  220 (304)
Q Consensus       144 l~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~  220 (304)
                      +++.++ .++|+|||++.......  .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......
T Consensus       156 l~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         156 LVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             EEcCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999776 89999999987543321  1222334578899999887765 7999999999999999998 99999877665


Q ss_pred             HHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      +....+.....                           ......++.++.+|+.+||+.||.+||++.+|+++
T Consensus       234 ~~~~~i~~~~~---------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQL---------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCc---------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55444332111                           11123688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-44  Score=276.79  Aligned_cols=291  Identities=38%  Similarity=0.731  Sum_probs=241.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---C
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---E   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~   79 (304)
                      .+.|.-+.++|+|.||.||+++.+++++.|++|++..............+|+.+|..+ +|+|++.+++++.....   .
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence            4568889999999999999999999999999987776655555667788999999999 99999999998865432   2


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      .+..+++||++|..+|...+....   ..+++.++..++.++.+||.|+|+..|.|+|+|+.|+|+++++ .+||+|||+
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGl  170 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGL  170 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeecccc
Confidence            233589999999999988886532   3689999999999999999999999999999999999999888 999999999


Q ss_pred             eeecccCC----CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLPI----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ++......    ...+...-|.+|++||.+.+...++++.|+|+-||++.+|.|+.+-+...++..++.-+...++....
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            96543221    12223344899999999999988999999999999999999999999999999999999999999999


Q ss_pred             CCCccccccCCcccC--CCCCCCc---cccc--CCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          236 KVWPGVSSLMNWHEY--PQWNPQS---LATA--VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~--~~~~~~~---~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ..||...+..-+.+.  ...+.+.   +...  .-.-+++..+|+..+|..||.+|++++++++|.||.+
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            999988877665544  2112211   1111  1133567889999999999999999999999999965

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=283.73  Aligned_cols=253  Identities=29%  Similarity=0.534  Sum_probs=212.4

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|.+.+.||+|++|.+|++.+..++..+++|.+............+.+|+++++++ +|||++++.+++.....     .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDS-----L   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCE-----E
Confidence            58889999999999999999998899999999886654334456788999999999 99999999999877655     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++|++++ +|.+++...    .++++..++.++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        75 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            999999987 888887653    5689999999999999999999999999999999999999766 8999999999877


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........++..|++||...+.. .+.++|+||||+++++|++|..||...............              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            65544444456688999999887665 789999999999999999999999876644333332210              


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                   ........++..+.+++.+||..+|++|||+.+++.||||
T Consensus       215 -------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 -------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                         0111223578899999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.8e-42  Score=291.67  Aligned_cols=261  Identities=24%  Similarity=0.350  Sum_probs=200.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc----------------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCe
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA----------------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV   66 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   66 (304)
                      .++|++.+.||+|+||.||++.+..                ++..+++|.+.... .......+.+|+.+++++ +||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRL-KDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhc-CCCCe
Confidence            5789999999999999999998643                23468999876432 122234677899999999 99999


Q ss_pred             eeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccC---------------CCCCChHHHHHHHHHHHHHHHHHHh
Q 021982           67 VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT---------------GENIPVNTVKSLMYQLCKGVAFCHG  130 (304)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~Lh~  130 (304)
                      +++++++.....     .+++|||+.+ +|.+++......               ...+++..++.++.||+.||.+||+
T Consensus        82 v~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          82 IRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             eEEEEEEecCCc-----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999999987766     8999999985 999988653211               1246778899999999999999999


Q ss_pred             cCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHh
Q 021982          131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV  208 (304)
Q Consensus       131 ~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll  208 (304)
                      .|++|+||||+||+++.++ .+||+|||++........  ......++..|+|||++.+.. ++.++||||||+++|+|+
T Consensus       157 ~~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         157 LNFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             CCccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHH
Confidence            9999999999999999776 899999999875533211  112223467899999987765 899999999999999998


Q ss_pred             h--ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC
Q 021982          209 T--KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS  286 (304)
Q Consensus       209 ~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  286 (304)
                      +  +..||...+..+........+......                    ......+.++..+.+++.+||+.||.+|||
T Consensus       235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQ--------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             HccCCCCCCcCCHHHHHHHHHHHhhhcccc--------------------ccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence            7  567787766655554443322111110                    001112357889999999999999999999


Q ss_pred             HHHHhc
Q 021982          287 AKKAME  292 (304)
Q Consensus       287 ~~eil~  292 (304)
                      +.+|.+
T Consensus       295 ~~~i~~  300 (304)
T cd05096         295 FSDIHA  300 (304)
T ss_pred             HHHHHH
Confidence            999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-42  Score=286.90  Aligned_cols=252  Identities=31%  Similarity=0.570  Sum_probs=205.4

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      ||+|++|.||++.+..++..+++|.+..... .......+.+|+++++++ +|||++++++.+.....     .++++|+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~-----~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKN-----LYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcE-----EEEEEec
Confidence            6899999999999998899999998865432 223445777889999999 89999999998877665     8999999


Q ss_pred             cCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCC-
Q 021982           91 MDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK-  168 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~-  168 (304)
                      +.+ +|.+++...    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++........ 
T Consensus        75 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          75 LPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            986 898888653    3689999999999999999999999999999999999999877 899999999865433311 


Q ss_pred             -------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          169 -------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       169 -------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                             ......++..|++||...+.. .+.++|+||||++++++++|..||......+....+......     ++  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~--  221 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE-----WP--  221 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC-----CC--
Confidence                   223335578899999987766 789999999999999999999999877766555444321000     00  


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH---HHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA---KKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~eil~~~~~~~~~~  301 (304)
                                         ....++..+.+++.+||+.+|.+|||+   .++++||||+++++
T Consensus       222 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         222 -------------------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             -------------------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                               001258899999999999999999999   99999999998864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.5e-42  Score=283.49  Aligned_cols=257  Identities=28%  Similarity=0.528  Sum_probs=209.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|+..+.||+|++|.||++.+..++..+++|.+............+.+|+..++++ +||||+++++.+....   ....
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~---~~~~   76 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEE---KNTL   76 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCC---CCeE
Confidence            47888999999999999999998899999999876654444567788999999999 8999999999988762   1128


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++|++.+ +|.+++...    ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        77 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          77 NIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            999999965 898888763    2789999999999999999999999999999999999999766 8999999999876


Q ss_pred             ccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          164 TLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       164 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .....  ......++..|+|||.+.+.. .+.++|+||||+++++|++|..||..........  .....          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL--YKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH--Hhccc----------
Confidence            65433  133446688999999887766 7999999999999999999999998766222111  11100          


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                   ...........+..+.+++.+||+.||.+||++.+++.||||
T Consensus       219 -------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 -------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                         011111223568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.7e-42  Score=284.53  Aligned_cols=256  Identities=26%  Similarity=0.433  Sum_probs=206.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC---CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED---DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +|.+.+.||+|++|.||++.+...+..+++|..+....   ..........|+.+++.+ +|||++++++++.+...   
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDA---   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCc---
Confidence            58899999999999999999987766666666553222   222233556788999999 99999999999887765   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++++||+.+ +|.+.+.........+++.+++.++.|++.||.+||+.|++|+||+|+||+++ ++ .++|+|||.+
T Consensus        77 --~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~-~~~l~d~g~~  152 (260)
T cd08222          77 --FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NN-LLKIGDFGVS  152 (260)
T ss_pred             --eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cC-CEeecccCce
Confidence              8999999986 88888876555567899999999999999999999999999999999999998 44 6999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............+++.|+|||.+.+.. .+.++|+||||+++|+|++|..||................          
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~----------  221 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP----------  221 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC----------
Confidence            76654433334455688999999886655 6889999999999999999999997666554444332210          


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                       .......++.++.++|.+||+.||.+||++.++++||||
T Consensus       222 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 -----------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -----------------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                             111122577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4e-42  Score=284.47  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=206.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||.|++|.||++.++. +..+++|.+.....  .....+..|+.+++.+ +|||++++++++.....    
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~----   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEP----   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcC-CCcchhheeeeEecCCC----
Confidence            3679999999999999999999987 78899998765432  1245678899999999 99999999999887766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...  ....+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~  152 (261)
T cd05148          77 -VYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLAR  152 (261)
T ss_pred             -eEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchh
Confidence             8999999986 999998763  335689999999999999999999999999999999999999776 99999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .............++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+......        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (261)
T cd05148         153 LIKEDVYLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--------  223 (261)
T ss_pred             hcCCccccccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC--------
Confidence            6654433333334467899999887655 7899999999999999998 89999877665555544432111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         .....+++.+.+++.+||+.||.+|||+.++++
T Consensus       224 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 -------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                               112367889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.5e-42  Score=288.00  Aligned_cols=255  Identities=23%  Similarity=0.439  Sum_probs=207.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .|.....||+|++|.||++..+.++..+++|.+....  ......+.+|+.+++.+ +|+|++++++.+...+.     .
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----~   92 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDE-----L   92 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCE-----E
Confidence            3555678999999999999999899999999875322  22345677899999999 89999999999987766     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      +++|||+.+ +|.+++..     ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~  166 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceec
Confidence            999999987 77776543     3579999999999999999999999999999999999999777 8999999988665


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||......+....+........         
T Consensus       167 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  236 (292)
T cd06657         167 SKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL---------  236 (292)
T ss_pred             ccccccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc---------
Confidence            44333333445688999999887655 78999999999999999999999987666555444332211100         


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                      .....+++.+.+++.+||+.||.+||++.++++||||.+.
T Consensus       237 ----------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         237 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             ----------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence                            0112478899999999999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.5e-42  Score=289.92  Aligned_cols=254  Identities=29%  Similarity=0.517  Sum_probs=209.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|.+.+.||+|++|.||++.+..++..+++|++..+.. .......+..|.++++++.+||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~----   76 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN----   76 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce----
Confidence            579999999999999999999998999999998875332 222335677889999999339999999999887665    


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++||++. ++|.+++...    ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++++|||.+.
T Consensus        77 -~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 -LYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             -EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence             899999995 5999888763    3699999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCC--------------------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH
Q 021982          162 AFTLPIK--------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ  221 (304)
Q Consensus       162 ~~~~~~~--------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~  221 (304)
                      .......                    ......++..|+|||.+.+.. .+.++|+||||++++++++|..||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            6543321                    122234578899999887765 7899999999999999999999999887655


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH----HHHhcCCCc
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYF  296 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~  296 (304)
                      ..........                            .....+++.+.++|.+||+.||.+|||+    +++++||||
T Consensus       230 ~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKLEY----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhcCC----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            5544432110                            1112568899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-42  Score=285.91  Aligned_cols=260  Identities=24%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|++|+||++.+..++..+++|++..... ......+.+|+++++.+ +||||+++++.+.....    
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~----   77 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENN----   77 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCE----
Confidence            4789999999999999999999998899999998765422 23346778899999999 99999999999988765    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                       .++++||+.+ +|.+++..    ..++++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++ .++|+|||++
T Consensus        78 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~  151 (284)
T cd06620          78 -ICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVS  151 (284)
T ss_pred             -EEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcc
Confidence             8999999986 88777654    2468999999999999999999997 5899999999999999776 8999999988


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH-------HHHHHHHhCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-------LLHIFRLLGTP  233 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-------~~~~~~~~~~~  233 (304)
                      .......  .....++..|+|||++.+.. .+.++|+||||+++|++++|..||........       ...........
T Consensus       152 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd06620         152 GELINSI--ADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE  228 (284)
T ss_pred             cchhhhc--cCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence            6543221  12345688999999987664 78999999999999999999999986544210       01111111000


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ..                    ..+  ....++.++.+|+.+||+.||.+|||+.|+++|+||...
T Consensus       229 ~~--------------------~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 PP--------------------PRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             cC--------------------CCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            00                    000  001367889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.1e-42  Score=298.71  Aligned_cols=256  Identities=20%  Similarity=0.317  Sum_probs=199.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC-----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+...+     ..|++|.+...... .....+.+|+.+++.+.+|+||+++++.+....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            467999999999999999999864433     47999988644322 223467789999999878999999999988877


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc----------------------------------------------------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ----------------------------------------------------  104 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------  104 (304)
                      .     .+++|||+.+ +|.+++.....                                                    
T Consensus       116 ~-----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         116 P-----VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             C-----eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            6     8999999985 99988854321                                                    


Q ss_pred             --------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc-
Q 021982          105 --------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-  169 (304)
Q Consensus       105 --------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~-  169 (304)
                                    ...++++.+++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++......... 
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                          113578889999999999999999999999999999999999666 8999999998765433211 


Q ss_pred             -cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          170 -YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       170 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                       .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...................              
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~--------------  334 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM--------------  334 (374)
T ss_pred             eccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------
Confidence             11122356799999987665 8999999999999999997 999997765443333332211000              


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                  .....+++++.+++.+||+.||.+|||+.++++
T Consensus       335 ------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 ------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        011236789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.7e-42  Score=297.81  Aligned_cols=257  Identities=22%  Similarity=0.340  Sum_probs=199.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEE-----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRARE-----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+     ..++..+++|+++.... ......+.+|+.+++.+.+||||+++++++....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            35799999999999999999974     33456899998864322 2233567789999999978999999999998877


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc----------------------------------------------------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ----------------------------------------------------  104 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------  104 (304)
                      .     .+++|||+.+ +|.+++.....                                                    
T Consensus       113 ~-----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         113 P-----TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             c-----ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            6     8999999985 99888865321                                                    


Q ss_pred             -------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982          105 -------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus       105 -------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                                         ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                               112578889999999999999999999999999999999999666 899999999876543


Q ss_pred             CCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          166 PIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       166 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ....  .....++..|+|||++.+.. ++.++||||||+++|+|++ |..||...............-..          
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR----------  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------
Confidence            3221  11122356799999987765 7999999999999999998 88898765544333333221000          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                      .......+.++.+++.+||+.||++|||+.+|++.
T Consensus       336 ----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 ----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                            00112357889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.5e-42  Score=283.13  Aligned_cols=255  Identities=28%  Similarity=0.482  Sum_probs=206.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++.+.||+|++|.||++.+..++..+++|.++.... .......+.+|+.+++++ +|++++++++.+...+.    
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~----   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNE----   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCe----
Confidence            579999999999999999999998899999998875432 222356788899999999 99999999999987765    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++.........+++.+++.++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 -LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             -EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceee
Confidence             8999999986 99999887655566789999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH--HHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL--QQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~  239 (304)
                      .............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......  .....+.....        
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  225 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--------  225 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--------
Confidence            6544333333445688899999887665 789999999999999999999998654321  11111111000        


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                        .......++..+.++|.+||..+|.+|||+.+|++
T Consensus       226 ------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         226 ------------------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ------------------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                              00001257789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5e-42  Score=284.86  Aligned_cols=257  Identities=26%  Similarity=0.476  Sum_probs=204.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++.+.||+|++|.||++.++.++..+++|.+..... .......+.+|+.+++.+ +||||+++++++.....    
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~----   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNE----   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCe----
Confidence            689999999999999999999988899999998765332 222335677899999999 99999999999887666    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++++|++.+ +|.+++.........+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++++|||.+.
T Consensus        77 -~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 -LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             -EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence             8999999986 99998876555556789999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............++..|+|||.+.+.. .+.++|+||||+++|+|++|..||.......  ......+....   +   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~---~---  225 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCD---Y---  225 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhcCC---C---
Confidence            6554433333446688999999987765 7889999999999999999999986543221  11111111000   0   


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                      .......++..+.+++.+||..||.+|||+.+|++
T Consensus       226 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 ----------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ----------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                            00011247789999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8e-45  Score=286.47  Aligned_cols=257  Identities=23%  Similarity=0.417  Sum_probs=219.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +-|.++.+||.|+||.||++.++.+|..++||.+....    ....+.+|+.++.++ +.|++++++|.|-...+     
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sD-----  102 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSD-----  102 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHc-CCchhhhhhhhhccCCc-----
Confidence            45899999999999999999999999999999987643    457889999999999 99999999998877776     


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++|||||+ |+..+.+..+   ..+++++++..+++.-+.+|+|||...-+|+|||..|||++.+| ..||+|||.+-.
T Consensus       103 LWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQ  178 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQ  178 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccch
Confidence            999999999 6999988764   45899999999999999999999999999999999999999888 999999999988


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..........-.|||.|++||++..-. |..++||||||++..+|..|++||.+..+.--+-+    +...+...+.+  
T Consensus       179 LTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM----IPT~PPPTF~K--  251 (502)
T KOG0574|consen  179 LTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM----IPTKPPPTFKK--  251 (502)
T ss_pred             hhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEe----ccCCCCCCCCC--
Confidence            777666667778999999999998877 89999999999999999999999987654221111    11111111111  


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                         +..-|.++.++++.||-..|++|.|+.++++|||.++.+
T Consensus       252 -------------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  252 -------------------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             -------------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence                               113567889999999999999999999999999998764

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9e-42  Score=286.43  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=204.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|++|.||++..+.     .+..+++|.+...... .....+.+|+..++.+ +|||++++++++....
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCC
Confidence            5789999999999999999997642     2447899986533221 1223566789999999 8999999999987766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~  150 (304)
                      .     .+++|||+.+ +|.+++......      ....+...+..++.|++.||.|||++|++|+||||+||+++.++ 
T Consensus        83 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-  156 (288)
T cd05061          83 P-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-  156 (288)
T ss_pred             C-----cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-
Confidence            5     8999999985 999999764321      23456778899999999999999999999999999999999776 


Q ss_pred             eEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHH
Q 021982          151 TLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIF  227 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~  227 (304)
                      .++|+|||++.........  .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            8999999998754332111  11123356799999987665 7899999999999999998 788998766655444332


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc------CCCcccccc
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME------HPYFDDLDK  301 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~------~~~~~~~~~  301 (304)
                      ...                           ........++.+.+++.+||+.||.+|||+.++++      ||||..+++
T Consensus       236 ~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         236 DGG---------------------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             cCC---------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            110                           00011246789999999999999999999999987      999998874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-41  Score=288.65  Aligned_cols=259  Identities=22%  Similarity=0.371  Sum_probs=209.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.|...+.||+|++|.||++.+..++..+++|.+...... ......+.+|+.+++.+ +|||++++++++.+...   
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~---   95 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHT---   95 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE---
Confidence            45677788999999999999999989999999988754332 22234577899999999 99999999999888766   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .+++|||+.|++.+.+...   ..++++.++..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        96 --~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~  169 (313)
T cd06633          96 --AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSAS  169 (313)
T ss_pred             --EEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCc
Confidence              8999999999888877542   34689999999999999999999999999999999999999777 89999999885


Q ss_pred             ecccCCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ....    .....++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+.....+       
T Consensus       170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------  238 (313)
T cd06633         170 KSSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP-------  238 (313)
T ss_pred             ccCC----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------
Confidence            4322    223456888999999853  234788999999999999999999999877665555444321100       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                         ......++..+.+++.+||+.+|.+||++.+++.||||...+.
T Consensus       239 -------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         239 -------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             -------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence                               0011246678999999999999999999999999999987653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.1e-42  Score=283.00  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=202.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ..+|.+.+.||+|++|.||++.++.++..+++|.+....   .....+.+|++.++.+ +||||+++++++.....    
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   76 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP----   76 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCC----
Confidence            467899999999999999999999889999999876332   2235678899999999 99999999999887766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++....  ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 -~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~  152 (263)
T cd05052          77 -FYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR  152 (263)
T ss_pred             -cEEEEEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCcccc
Confidence             8999999975 8998886632  34689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccc-cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYT-HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .......... ....++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+......       
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------  224 (263)
T cd05052         153 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM-------  224 (263)
T ss_pred             ccccceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-------
Confidence            6544322111 112256799999887665 7899999999999999998 89999876655444443221110       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                          .....++.++.+++.+||+.||.+|||+.++++.
T Consensus       225 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         225 --------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence                                1123578999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-41  Score=278.99  Aligned_cols=252  Identities=28%  Similarity=0.506  Sum_probs=207.7

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .|.+.+.||+|++|.||++.+..++..+++|.+.....  .....+.+|+.+++.+ +|++++++++.+.....     .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----~   72 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDE-----L   72 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCe-----E
Confidence            47889999999999999999998899999999875443  2346788899999999 89999999999887765     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++++||+++ +|.+++....   ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  148 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQL  148 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeeccccccc
Confidence            999999995 8888876532   4689999999999999999999999999999999999999776 9999999998776


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ..... .....++..|+|||.+.+.. .+.++|+||||+++++|++|..||...+..............  .  .     
T Consensus       149 ~~~~~-~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~--~-----  217 (253)
T cd05122         149 SDTKA-RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP--G--L-----  217 (253)
T ss_pred             ccccc-ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC--C--c-----
Confidence            55432 33445688999999987765 789999999999999999999999877554444333221000  0  0     


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  295 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  295 (304)
                                      .....++..+.++|.+||+.||.+|||+.++++|||
T Consensus       218 ----------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 ----------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ----------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                            000124788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-41  Score=284.70  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|.+.+.||+|++|.||++.+..     ++..+++|.+...... .....+.+|+++++.+ +||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNF-QHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhc-CCCCchheeeEEecCC
Confidence            3679999999999999999998753     3567999987644322 1235778899999999 9999999999998876


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhc----------cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEe
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFR----------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD  146 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~  146 (304)
                      .     .+++|||+.+ +|.+++....          .....+++..+..++.|++.|+.+||++|++|+||+|+||+++
T Consensus        82 ~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~  156 (280)
T cd05049          82 P-----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG  156 (280)
T ss_pred             C-----eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence            6     8999999986 9999987642          2234578899999999999999999999999999999999999


Q ss_pred             CCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHH
Q 021982          147 RKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQL  223 (304)
Q Consensus       147 ~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~  223 (304)
                      .++ .++|+|||.+.......  .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+..
T Consensus       157 ~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~  234 (280)
T cd05049         157 YDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI  234 (280)
T ss_pred             CCC-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            777 99999999987543221  1112233467899999987766 7999999999999999998 99999877666554


Q ss_pred             HHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          224 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ..+....                           .......++..+.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         235 ECITQGR---------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHcCC---------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4433211                           11112257889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.8e-41  Score=287.10  Aligned_cols=257  Identities=23%  Similarity=0.386  Sum_probs=207.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.|...+.||.|++|.||++.++.++..+++|.+..... .......+.+|+++++.+ +|+|++++.+++.....   
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   89 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHT---   89 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCe---
Confidence            3568999999999999999999998899999998865322 222234567899999999 99999999999887665   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .++|+||+.|++.+.+...   ..++++.++..++.|++.|+.+||+.+++|+||+|+||+++.++ .++|+|||++.
T Consensus        90 --~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~  163 (308)
T cd06634          90 --AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSAS  163 (308)
T ss_pred             --eEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccce
Confidence              8999999999887776542   24689999999999999999999999999999999999999776 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .....    ....+++.|+|||.+.+  ....+.++||||||+++|+|++|..||...+..+....+......       
T Consensus       164 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------  232 (308)
T cd06634         164 IMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------  232 (308)
T ss_pred             eecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC-------
Confidence            65432    22356788999999853  233788999999999999999999998776554443333221100       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         ......++..+.++|.+||+.+|.+||++.+++.|||+...
T Consensus       233 -------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         233 -------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                               00112577889999999999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=276.17  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=215.8

Q ss_pred             hhh-hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            6 FEK-LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         6 y~~-~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      |++ .+.||+|+++.|-.+....++..|++|++.++...  ...+..+|++++.++..|+||+.++++|+++..     +
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH--sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~-----F  151 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH--SRSRVFREVETFYQCQGHKNILQLIEFFEDDTR-----F  151 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCch--HHHHHHHHHHHHHHhcCCccHHHHHHHhcccce-----E
Confidence            443 46799999999999999999999999999877433  356888999999999999999999999999888     9


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeecccee
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLAR  161 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg~~~  161 (304)
                      |+|||-+.| +|...+...    ..+++.++..+.++|+.||.+||.+||.|+|+||+|||-..-+  .-|||+||.+..
T Consensus       152 YLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             EEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence            999999986 888888774    4599999999999999999999999999999999999996443  359999998865


Q ss_pred             ecccC-------CCccccccccccCCChhhhh----CCCCCCCchhHHHHHHHHHHHhhccccCCCCc------------
Q 021982          162 AFTLP-------IKKYTHEILTLWYRAPEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDS------------  218 (304)
Q Consensus       162 ~~~~~-------~~~~~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~------------  218 (304)
                      .+...       ......+.|+..|||||+..    ....|..+.|.||||+|+|-|++|-+||....            
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            44221       22344567789999999873    34458999999999999999999999997533            


Q ss_pred             ---hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 021982          219 ---ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  295 (304)
Q Consensus       219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  295 (304)
                         ....+..+.......++++|-                        .+|.+.+++|+.+|-.|+.+|.++.++++|||
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWa------------------------hIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWA------------------------HISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhH------------------------HhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence               233445555544445555553                        68899999999999999999999999999999


Q ss_pred             cccccc
Q 021982          296 FDDLDK  301 (304)
Q Consensus       296 ~~~~~~  301 (304)
                      +.....
T Consensus       364 ~~~~~~  369 (463)
T KOG0607|consen  364 VQRCAP  369 (463)
T ss_pred             ccccch
Confidence            987643

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-41  Score=285.72  Aligned_cols=258  Identities=22%  Similarity=0.382  Sum_probs=209.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.|...+.||+|+||.||++.+..++..+++|.+...... ......+.+|+++++.+ +|||++++++++.....   
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~---   99 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHT---   99 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCe---
Confidence            35689999999999999999999988999999988754322 22334677899999999 99999999999887766   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .+++|||+.|++.+.+...   ..++++.++..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus       100 --~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~  173 (317)
T cd06635         100 --AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSAS  173 (317)
T ss_pred             --EEEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCcc
Confidence              8999999999888776542   34689999999999999999999999999999999999999777 89999999876


Q ss_pred             ecccCCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .....    ....+++.|+|||.+..  ....+.++|+||||+++|+|++|..||...........+.......      
T Consensus       174 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------  243 (317)
T cd06635         174 IASPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT------  243 (317)
T ss_pred             ccCCc----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC------
Confidence            44322    23356788999998752  2347889999999999999999999998766555544443321110      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                          ......++.+.+++.+||+.+|.+||++.++++|+|+....
T Consensus       244 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 --------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             --------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                                01124678899999999999999999999999999986643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.6e-42  Score=292.78  Aligned_cols=285  Identities=21%  Similarity=0.309  Sum_probs=204.6

Q ss_pred             hhhcccc--cceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982            9 LEKVGEG--TYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g--~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      ...||.|  ++|+||.+.+..+++.|++|.+............+.+|+.+++.+ +||||+++++++.....     .++
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~-----~~~   76 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSW-----LWV   76 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCc-----eEE
Confidence            4567777  889999999999999999999875543333345677888888888 99999999999988776     899


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      ++||+.+ ++.+++.....  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++++||+.+.....
T Consensus        77 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~  153 (328)
T cd08226          77 ISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVR  153 (328)
T ss_pred             EEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhc
Confidence            9999986 89888876432  3588999999999999999999999999999999999999777 899999976432211


Q ss_pred             CCCc-------cccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC--
Q 021982          166 PIKK-------YTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE--  235 (304)
Q Consensus       166 ~~~~-------~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--  235 (304)
                      ....       .....++..|++||++.+. ..++.++||||||+++|+|++|..||.....................  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence            1000       0011235669999998764 33789999999999999999999999877655444333221110000  


Q ss_pred             CCCcccccc-CC----------cccCC----CCCC--CcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          236 KVWPGVSSL-MN----------WHEYP----QWNP--QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       236 ~~~~~~~~~-~~----------~~~~~----~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ..++..... .+          .....    ....  .........+++.+.+|+++||+.||.+|||+.|+++||||..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence            000000000 00          00000    0000  0001112356788999999999999999999999999999998


Q ss_pred             cccc
Q 021982          299 LDKT  302 (304)
Q Consensus       299 ~~~~  302 (304)
                      +.++
T Consensus       314 ~~~~  317 (328)
T cd08226         314 VKEQ  317 (328)
T ss_pred             HHHh
Confidence            7554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=302.82  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=213.8

Q ss_pred             hcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           11 KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      .||.|.+|+||.++|..+....+||.+..  ++......+.+|+...+++ +|.||++++|.+...+.     +-+.||-
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf-----~kIFMEq  653 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGF-----FKIFMEQ  653 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCe-----EEEEeec
Confidence            58999999999999999999999998764  3444567788999999999 99999999999777665     8899999


Q ss_pred             cCC-CHHHHHHHhccCCCCC--ChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           91 MDT-DLKKYIRSFRQTGENI--PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~--~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ..| +|.+.+.+  .+ +|+  ++.++..+.+||++||.|||.+.|||+|||-+|+||+..++.+||+|||-++....-.
T Consensus       654 VPGGSLSsLLrs--kW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  654 VPGGSLSSLLRS--KW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             CCCCcHHHHHHh--cc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            986 99999887  33 356  7889999999999999999999999999999999999887799999999998877666


Q ss_pred             CccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          168 KKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      .......||..|||||++..+ ..|+.++|||||||++.||.||++||-.....+-..-....+                
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy----------------  794 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY----------------  794 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce----------------
Confidence            666677889999999999754 349999999999999999999999997665543322111111                


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                               +.-+..+..+|.+++++|.+|+.+||..||+|.++|.+||+..-+++
T Consensus       795 ---------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk  841 (1226)
T KOG4279|consen  795 ---------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK  841 (1226)
T ss_pred             ---------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence                     11122233678889999999999999999999999999999886443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.4e-42  Score=283.37  Aligned_cols=251  Identities=19%  Similarity=0.233  Sum_probs=198.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+.||+|+||.||++.++   ..+..+++|.+...... .....+.+|+.+++.+ +||||+++++++..... 
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNT-   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCC-
Confidence            467999999999999999999765   34567889988754222 2234677899999999 99999999999887665 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++||||+++ +|.+++...   ...+++..++.++.|++.||++||++|++|+||+|+||+++.++ .++++|||
T Consensus        81 ----~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg  152 (266)
T cd05064          81 ----MMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFR  152 (266)
T ss_pred             ----cEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCc
Confidence                8999999986 788777642   24689999999999999999999999999999999999999776 89999999


Q ss_pred             ceeecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      .+......... .....++..|+|||.+.+.. ++.++||||||+++|++++ |..||......+....+......    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----  227 (266)
T cd05064         153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL----  227 (266)
T ss_pred             ccccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----
Confidence            87543221111 11123356899999987765 8999999999999999775 99999877766655544322111    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                             .....++..+.+++.+||+.+|.+|||+++|++
T Consensus       228 -----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 -----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                   112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.4e-41  Score=282.37  Aligned_cols=254  Identities=26%  Similarity=0.375  Sum_probs=195.6

Q ss_pred             hcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC-CchhHHHH---HHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982           11 KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV-PPTTLREV---SILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~---~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      .||+|++|.||++.+..+++.+++|.+......... ......+.   ..++.. .||+++.+.+.+.....     .++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~-----~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK-----LSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCE-----EEE
Confidence            479999999999999988999999988754322211 11222333   334444 79999999999887766     899


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      |+||+.| +|..++..    ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++ .++|+|||++.....
T Consensus        75 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          75 ILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            9999986 78777653    24689999999999999999999999999999999999999777 899999999865433


Q ss_pred             CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       166 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      ..  .....++..|+|||.+.+...++.++|+||+|+++|+|++|..||..................             
T Consensus       150 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  214 (278)
T cd05606         150 KK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------------  214 (278)
T ss_pred             cC--CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-------------
Confidence            22  223467899999999876555789999999999999999999999766322111111000000             


Q ss_pred             CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                  .......++..+.+++.+||..||.+||     ++.++++||||++.++.
T Consensus       215 ------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         215 ------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence                        0011224688999999999999999999     99999999999988654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-41  Score=280.28  Aligned_cols=249  Identities=22%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|+++++||+|++|.||++.+.. +..+++|.+....   .....+.+|+.+++.+ +|+||+++++.+.....    
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   75 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT---MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEP----   75 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc---hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC----
Confidence            4789999999999999999998754 5668999865422   1245778899999999 99999999999887666    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++++|++.+ +|.+++...  ....+++..+..++.|++.||++||+.+++|+||+|+||+++.++ .++|+|||.+.
T Consensus        76 -~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~  151 (261)
T cd05072          76 -IYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLAR  151 (261)
T ss_pred             -cEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccce
Confidence             8999999975 999988763  335688899999999999999999999999999999999999777 89999999997


Q ss_pred             ecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......       
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------  223 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------  223 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            65432211 12223356799999887665 7889999999999999998 99999877666555544332111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          .....++.++.+++.+||+.||++|||++++++
T Consensus       224 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         224 --------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                111257889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.4e-41  Score=276.81  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|++|.||++.+. ++..+++|.+.....   ....+.+|+.+++++ +|++++++++++... .   
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~-~---   74 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKL-RHDKLVQLYAVVSEE-P---   74 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhc-CCCceEEEEeEECCC-C---
Confidence            5688999999999999999999876 456689998765332   234678899999999 999999999987542 2   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++...  ....+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        75 --~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~  149 (260)
T cd05070          75 --IYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLA  149 (260)
T ss_pred             --cEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceee
Confidence              6899999986 999888652  234689999999999999999999999999999999999999766 8999999999


Q ss_pred             eecccCCCcc-ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+......      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------  222 (260)
T cd05070         150 RLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM------  222 (260)
T ss_pred             eeccCcccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            7654332111 1223356799999887655 7899999999999999999 88999877666555544321111      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           ......+..+.+++.+||..||.+|||++++++
T Consensus       223 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 ---------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                 111257789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.4e-41  Score=286.42  Aligned_cols=283  Identities=20%  Similarity=0.244  Sum_probs=202.6

Q ss_pred             hhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      .+.+.+|.|  |.||.++...++..+++|++............+..|+.+++.+ +|+||+++++++.....     .++
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~-----~~~   76 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSE-----LYV   76 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCe-----EEE
Confidence            344444444  5566666677899999999886544444556888999999999 89999999999887766     899


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      +|||+.+ ++.+++....  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++++||+.+.....
T Consensus        77 ~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~  153 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIK  153 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecc
Confidence            9999985 8888887642  34588999999999999999999999999999999999999777 899999998865532


Q ss_pred             CCC-------ccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC-C-C
Q 021982          166 PIK-------KYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP-N-E  235 (304)
Q Consensus       166 ~~~-------~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~-~  235 (304)
                      ...       ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||................... . .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence            211       11222346789999998764 337889999999999999999999998766544333222111100 0 0


Q ss_pred             CCCccccccCCc----ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          236 KVWPGVSSLMNW----HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       236 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ..++........    .................++.++.+++.+||+.||.+|||+.++++||||+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            000000000000    00000000011112234567889999999999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-41  Score=290.77  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=198.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++++.||.|+||.||++.+..     +++.+++|++..... ......+..|+++++++.+|+||+++++++....
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4689999999999999999997543     346899998864322 2223456789999999878999999999876543


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC---------------------------------------------------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT---------------------------------------------------  105 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------  105 (304)
                      .    .+++++||+.+ +|.+++......                                                   
T Consensus        85 ~----~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          85 G----PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             C----CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            2    27899999986 898888643211                                                   


Q ss_pred             ------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc--cccccccc
Q 021982          106 ------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTL  177 (304)
Q Consensus       106 ------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~  177 (304)
                            ..++++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.........  .....++.
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCc
Confidence                  13688999999999999999999999999999999999999776 8999999999765432221  12223356


Q ss_pred             cCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCC
Q 021982          178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQ  256 (304)
Q Consensus       178 ~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (304)
                      .|+|||++.+.. ++.++|||||||++|+|++ |..||......+..........                         
T Consensus       240 ~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------------  293 (337)
T cd05054         240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-------------------------  293 (337)
T ss_pred             cccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-------------------------
Confidence            799999988766 8999999999999999998 9999976443333222221100                         


Q ss_pred             cccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          257 SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                       ........++++.+++.+||+.+|.+||++.|+++|
T Consensus       294 -~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         294 -RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             001112567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-41  Score=285.36  Aligned_cols=263  Identities=23%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.++.++..+++|.+....... ....+..|+.++....+||||+++++++.....    
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~----   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD----   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCe----
Confidence            467999999999999999999999889999999987543222 233455677666666479999999999987766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+++.+.+...   ..++++..+..++.|++.|+.|||+ .|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        89 -~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          89 -VFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             -EEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence             8999999988877776552   2378999999999999999999997 5999999999999999776 89999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhCC---CCCCCchhHHHHHHHHHHHhhccccCCCCch-HHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGS---THYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~  237 (304)
                      ....... .....+++.|+|||.+.+.   ..++.++|+||||+++|+|++|..||..... .+....+...   ... .
T Consensus       164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~-~  238 (296)
T cd06618         164 RLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EPP-S  238 (296)
T ss_pred             hccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CCC-C
Confidence            5543222 2233457889999998654   2368899999999999999999999976433 2222222211   000 0


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      +                     .....++.++.+|+.+||+.||.+|||+++++.||||.....
T Consensus       239 ~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         239 L---------------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             C---------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            0                     001146789999999999999999999999999999987644

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-42  Score=284.22  Aligned_cols=247  Identities=30%  Similarity=0.469  Sum_probs=195.2

Q ss_pred             hhhhcccccceEEEEEEEc----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            8 KLEKVGEGTYGKVYRAREK----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.+.||.|.||.||.|.++    ..+..|+||.+... ........+.+|++.++++ +||||+++++++.....     
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~-----   75 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEP-----   75 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSS-----
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccc-ccccccccccccccccc-----
Confidence            5678999999999999988    34567899988532 2222356888999999999 99999999999996655     


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++|+||+. |+|.+++...  ....+++.++..++.|++.||.|||+.+++|++|+++||+++.++ .+||+|||++..
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccc
Confidence            899999998 5999999884  345789999999999999999999999999999999999999777 999999999977


Q ss_pred             cccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          163 FTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       163 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .....  ...........|+|||.+.+.. ++.++||||||+++|||++ |..||...+..+....+......       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~-------  224 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL-------  224 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET-------
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-------
Confidence            63221  1122334577899999988776 7999999999999999999 68999888777766666432211       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          .....++..+.++|.+||+.||.+|||+.+|++
T Consensus       225 --------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  225 --------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                122357899999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-41  Score=282.63  Aligned_cols=256  Identities=24%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ..++|++.+.||+|++|.||++.+++     .+..+++|.+..... ......+.+|+.+++.+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC
Confidence            46889999999999999999998753     345789998753221 11234567899999999 999999999998766


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccC------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT  149 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~  149 (304)
                      ..     .+++|||+.+ +|.+++......      ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++
T Consensus        82 ~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          82 QP-----TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CC-----eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC
Confidence            65     8999999985 999988764321      13457788999999999999999999999999999999999777


Q ss_pred             CeEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHH
Q 021982          150 MTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  226 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~  226 (304)
                       .++|+|||++.........  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+
T Consensus       157 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         157 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             -CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             8999999998654322111  11223367899999987765 7999999999999999999 68899877665554433


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ....                           ........+..+.+++.+||+.||.+|||+.|++++
T Consensus       235 ~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         235 MEGG---------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HcCC---------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3210                           001112567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=294.10  Aligned_cols=254  Identities=28%  Similarity=0.445  Sum_probs=215.9

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      -+.||+|-||+||-++++.+|+.|+||++.+-.........+++|+++|..+ .||.|+.+--.++..+.     +++||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~er-----vFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPER-----VFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCce-----EEEEe
Confidence            3679999999999999999999999999987766666668899999999999 99999999988888777     99999


Q ss_pred             eccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeeccceeecccC
Q 021982           89 EYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLP  166 (304)
Q Consensus        89 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg~~~~~~~~  166 (304)
                      |-+.|+..+.+-+  +..+.+++.....++.||+.||+|||-++|+||||||+|||+...+  ..+||+|||++++++..
T Consensus       643 EKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  643 EKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            9999987777766  3346799999999999999999999999999999999999997544  58999999999998876


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH-HHHHHHHHHhCCCCCCCCccccccC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      ... ..-.|||-|+|||++.+.. +++.-|+||+|+|+|.-++|..||....+- +++++..  +.-|            
T Consensus       721 sFR-rsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa--FMyP------------  784 (888)
T KOG4236|consen  721 SFR-RSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA--FMYP------------  784 (888)
T ss_pred             hhh-hhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhccc--cccC------------
Confidence            433 3457899999999998877 899999999999999999999999866542 2222211  1111            


Q ss_pred             CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                   +....++++++.+||..+|++...+|.|.+..|+|||+++.
T Consensus       785 -------------p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  785 -------------PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             -------------CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                         11223789999999999999999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-41  Score=282.24  Aligned_cols=245  Identities=16%  Similarity=0.190  Sum_probs=195.5

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-CCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      ..++.|+++.||++..  +|+.+++|.+........ ....+.+|+.+++++ +||||+++++++.+... .....+++|
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~-~~~~~~lv~  101 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVD-DLPRLSLIL  101 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEeccc-CCCceEEEE
Confidence            5789999999999987  478999999876533221 135666999999999 99999999999876221 112378999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      ||+.+ +|.+++..    ...+++.....++.+++.|+.+||+ .+++|+||+|+||+++.++ .+||+|||++......
T Consensus       102 Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        102 EYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP  176 (283)
T ss_pred             EeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc
Confidence            99996 89998865    2468889999999999999999998 4999999999999999777 8999999998754432


Q ss_pred             CCccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      .   ....+++.|+|||.+.+. ..++.++||||||+++|+|++|..||...+..+....+......+            
T Consensus       177 ~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------  241 (283)
T PHA02988        177 P---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL------------  241 (283)
T ss_pred             c---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------------
Confidence            2   233568899999998752 348999999999999999999999999877666555543321110            


Q ss_pred             CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                    ......++++.+++.+||+.||.+|||++++++
T Consensus       242 --------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 --------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             --------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                          011257889999999999999999999999986

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-41  Score=277.93  Aligned_cols=248  Identities=29%  Similarity=0.468  Sum_probs=203.4

Q ss_pred             hhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982           10 EKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      +.||+|+||.||++.+...   +..+++|.+....... ....+.+|+..++.+ +|+|++++++++.....     .++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~-----~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEP-----LYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhc-CCCChheeeeeecCCCc-----eEE
Confidence            4689999999999999866   8889999887554333 456788899999999 79999999999887555     899


Q ss_pred             EEeccC-CCHHHHHHHhccC-----CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           87 VFEYMD-TDLKKYIRSFRQT-----GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        87 v~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      +|||+. ++|.+++......     ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~  152 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLS  152 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccc
Confidence            999996 5999998875322     46799999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          161 RAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       161 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      .......  .......+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+....       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------  224 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------  224 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            7665432  2223344578899999887764 8999999999999999999 599998886655555443210       


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                          .......+++++.+++.+||+.||.+|||+.+++++
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                111123568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-41  Score=282.42  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=199.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|.+.+.||+|+||.||++.+.     .++..+++|.+....  ......+.+|+.+++++ +|||++++++++....
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence            357999999999999999999853     234568888775432  22345678899999999 9999999999988766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc---------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ---------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR  147 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~  147 (304)
                      .     .++++||+.+ +|.+++.....         ....+++.+++.++.|++.||++||+.|++|+||||+||+++.
T Consensus        81 ~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~  155 (288)
T cd05093          81 P-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  155 (288)
T ss_pred             c-----cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            6     8999999985 99998875431         2235899999999999999999999999999999999999997


Q ss_pred             CCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHH
Q 021982          148 KTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  224 (304)
Q Consensus       148 ~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~  224 (304)
                      ++ .++|+|||.+........  ......+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+...
T Consensus       156 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~  233 (288)
T cd05093         156 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  233 (288)
T ss_pred             CC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            77 899999999875533211  112223467899999887655 7899999999999999998 899998776655444


Q ss_pred             HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .+....                           .......++.++.+++.+||+.||.+|||+.+++.
T Consensus       234 ~i~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         234 CITQGR---------------------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHcCC---------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            443211                           01112257789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-41  Score=276.26  Aligned_cols=248  Identities=21%  Similarity=0.310  Sum_probs=198.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .+|++.+.||+|++|.||++.++. +..+++|.+.....   ....+.+|+++++.+ +||||+++++++.....     
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----   73 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM---SEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRP-----   73 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC---CHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCc-----
Confidence            578999999999999999998864 56799998753322   224677899999999 99999999999877665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++|++.| +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~  149 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARY  149 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCccccee
Confidence            8999999976 898888652   23689999999999999999999999999999999999999777 899999999876


Q ss_pred             cccCCCcc-ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ........ ....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...+..+....+......        
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  220 (256)
T cd05059         150 VLDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL--------  220 (256)
T ss_pred             cccccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC--------
Confidence            54322111 1112245799999887765 7899999999999999999 89999877666555444322111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                         ......+.++.+++.+||..+|.+|||+.++++.
T Consensus       221 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         221 -------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                               1112478899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.3e-41  Score=311.34  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=199.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +++|++++.||+|+||.||++.+..+++.+++|.+...... ......+.+|+.+++.+ +|||++++++++.+.+.   
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~---   76 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDP---   76 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCE---
Confidence            57899999999999999999999999999999998754322 22234678899999999 99999999999887665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccC-------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEE
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQT-------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK  153 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vk  153 (304)
                        .+++|||+.| +|.+++......       ....+...++.++.||+.||.+||++|++||||||+||+++.++ .++
T Consensus        77 --lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vK  153 (932)
T PRK13184         77 --VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVV  153 (932)
T ss_pred             --EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEE
Confidence              8999999986 999988764322       13456677899999999999999999999999999999999777 899


Q ss_pred             EeeccceeecccCC------------------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCC
Q 021982          154 IADLGLARAFTLPI------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP  215 (304)
Q Consensus       154 l~dfg~~~~~~~~~------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  215 (304)
                      |+|||++.......                  .......|++.|+|||.+.+.. ++.++|||||||++|+|+||..||.
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            99999997652110                  0111235799999999987766 7999999999999999999999997


Q ss_pred             CCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHh
Q 021982          216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  291 (304)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  291 (304)
                      ..........  .....+.                       .......+++.+.+++.+||+.||.+||+..+.+
T Consensus       233 ~~~~~ki~~~--~~i~~P~-----------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        233 RKKGRKISYR--DVILSPI-----------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             Ccchhhhhhh--hhccChh-----------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            6443322111  0000000                       0001136788999999999999999998765544

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.2e-41  Score=277.26  Aligned_cols=249  Identities=24%  Similarity=0.429  Sum_probs=200.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..+.|++++.||+|+||.||++..+. +..+++|.+.....   ....+.+|+.+++++ +|+|++++++++... .   
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~---   74 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM---SPEAFLAEANLMKQL-QHPRLVRLYAVVTQE-P---   74 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC---cHHHHHHHHHHHHhc-CCcCeeeEEEEEccC-C---
Confidence            46789999999999999999998654 67799998764332   235678899999999 999999999986543 2   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++++|++.+ +|.+++...  ....+++.++..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        75 --~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~  149 (260)
T cd05067          75 --IYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLA  149 (260)
T ss_pred             --cEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcce
Confidence              7899999975 999888652  335689999999999999999999999999999999999999776 8999999998


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ........ ......++..|+|||.+.... ++.++|+||||+++|++++ |..||...+..+....+......+     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  223 (260)
T cd05067         150 RLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-----  223 (260)
T ss_pred             eecCCCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----
Confidence            76552221 112223457899999887665 7899999999999999999 999998777665555443221111     


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                            .....+.++.+++.+||+.||.+|||++++++
T Consensus       224 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         224 ----------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                  11246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.8e-41  Score=277.24  Aligned_cols=249  Identities=20%  Similarity=0.321  Sum_probs=199.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||.+.+.. +..+++|.+.....   ....+.+|+.+++++ +||||+++++++.....    
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   73 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRP----   73 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCC----
Confidence            4679999999999999999998764 44699998764322   234678899999999 89999999999877665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||+|.||+++.++ .++|+|||.+.
T Consensus        74 -~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~  148 (256)
T cd05113          74 -IYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSR  148 (256)
T ss_pred             -cEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccce
Confidence             7999999975 888888653   23689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+.......      
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------  221 (256)
T cd05113         149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY------  221 (256)
T ss_pred             ecCCCceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC------
Confidence            55432211 11223356799999987665 7899999999999999998 999998777655555443321110      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                           .....+..+.+++.+||+.||.+|||+.+|+.+
T Consensus       222 ---------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         222 ---------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                                 112467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=297.15  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=212.0

Q ss_pred             hhhhhcccccceEEEEEEEccCCcEEEEEEeeecC--CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +.-..||+|+|.+||+|.|..+|..|+.-.++...  .......++..|+.+|+.| +||||++++++|.+...   ...
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n---~~i  118 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDN---KTI  118 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCC---cee
Confidence            34578999999999999999999988876555443  2333447899999999999 99999999999987765   347


Q ss_pred             EEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           85 YLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .+|+|.+. |+|..|++.++.    .+...+..|++||+.||.|||++.  |+|+|||-+||||+++-+.|||+|+|+|+
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeeecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence            78999997 699999988644    788899999999999999999985  99999999999999887899999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH-HHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ........  .-.|||.|||||++..  .|+...||||||++|+||.|+..||..+.+. +.+.++...+.+.       
T Consensus       195 l~r~s~ak--svIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~-------  263 (632)
T KOG0584|consen  195 LLRKSHAK--SVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA-------  263 (632)
T ss_pred             Hhhccccc--eeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH-------
Confidence            87765443  3689999999999973  4899999999999999999999999987765 5555555433221       


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                      ++.   .--.+++++||.+||.. ...|||+.|+|.||||..-
T Consensus       264 ----------------sl~---kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  264 ----------------ALS---KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ----------------Hhh---ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                            111   12368999999999999 8899999999999999873

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=279.45  Aligned_cols=252  Identities=21%  Similarity=0.341  Sum_probs=200.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+.||+|+||.||++.++.+   ...+++|.+.... .......+..|+.+++.+ +||||+++++.+..... 
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRP-   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCc-
Confidence            46899999999999999999998654   3468889876432 222234677899999999 99999999999877665 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++||++.+ +|.+++...   ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||
T Consensus        80 ----~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg  151 (266)
T cd05033          80 ----VMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFG  151 (266)
T ss_pred             ----eEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccc
Confidence                8999999986 999888652   23689999999999999999999999999999999999999777 89999999


Q ss_pred             ceeecccCCCccc--cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          159 LARAFTLPIKKYT--HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       159 ~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ++...........  ...+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......+  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--  228 (266)
T cd05033         152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP--  228 (266)
T ss_pred             hhhcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            9987642211111  223357899999887665 7899999999999999998 999998776655444443211111  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               .....+..+.+++.+||+.||.+||++.+++++
T Consensus       229 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 -------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                     112577899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.1e-41  Score=276.66  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++. +..+++|.+.....   ....+.+|+.+++.+ +||||+++++++.....    
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   73 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM---SEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKP----   73 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc---cHHHHHHHHHHHHHC-CCCCceeEEEEEccCCC----
Confidence            3679999999999999999998764 45789997653322   235678899999999 99999999999887766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...   ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++++|||.+.
T Consensus        74 -~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~  148 (256)
T cd05114          74 -LYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTR  148 (256)
T ss_pred             -EEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCcc
Confidence             8999999985 888887642   23588999999999999999999999999999999999999776 89999999987


Q ss_pred             ecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+.......      
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~------  221 (256)
T cd05114         149 YVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY------  221 (256)
T ss_pred             ccCCCceeccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC------
Confidence            55332211 11223356799999987655 7899999999999999999 899998877666655554321110      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           .....+..+.+++.+||+.||.+|||++++++
T Consensus       222 ---------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         222 ---------------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ---------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                 11135678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=313.67  Aligned_cols=266  Identities=26%  Similarity=0.407  Sum_probs=225.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|.+++.||+|+||.|.+++++++++.||+|.+.+-... ......+.+|-.++.-. +.+=|+.+.-.|+++..   
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~---  149 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERY---  149 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccc---
Confidence            47899999999999999999999999999999988763221 22345677888888776 78889999999999998   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +|+||||+.| +|...+..+    .+++++.+..++..|+-||..+|+.|+|||||||+|||+|..| ++||+|||.+
T Consensus       150 --LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsC  222 (1317)
T KOG0612|consen  150 --LYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSC  222 (1317)
T ss_pred             --eEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhH
Confidence              9999999986 888888764    2699999999999999999999999999999999999999998 9999999999


Q ss_pred             eecc-cCCCccccccccccCCChhhhhC---C-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          161 RAFT-LPIKKYTHEILTLWYRAPEVLLG---S-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       161 ~~~~-~~~~~~~~~~~~~~~~~PE~~~~---~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ..++ .+.-......|||.|.|||++..   . ..|++..|.||+|+++|||+.|..||-..+-.+.+.+|.+....   
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~---  299 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES---  299 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh---
Confidence            8887 44455667899999999999963   2 44899999999999999999999999988888888888764100   


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC---HHHHhcCCCccccccccC
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS---AKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~~~~~~~  304 (304)
                                          -.++ ....+|.++++||++.++. |..|.+   ++++-+||||..++|+.|
T Consensus       300 --------------------l~FP-~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~i  349 (1317)
T KOG0612|consen  300 --------------------LSFP-DETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDNI  349 (1317)
T ss_pred             --------------------cCCC-cccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhhh
Confidence                                1111 1125899999999999984 677887   999999999999998754

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=294.90  Aligned_cols=255  Identities=24%  Similarity=0.406  Sum_probs=217.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +.|.-++.||.|+||.||.+++..+...|+||++..+.+.. ..+..+.+|+..|+++ .|||++.+.+||..+..    
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~T----  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHT----  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccch----
Confidence            35888999999999999999999999999999998776432 3456888999999999 99999999999998877    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++|||||-|+..+.+.-.+   .|+.+.++..+..+.+.||+|||+.+.+|+|||..|||+...+ .|||+|||.+..
T Consensus       101 -aWLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi  175 (948)
T KOG0577|consen  101 -AWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASI  175 (948)
T ss_pred             -HHHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhh
Confidence             89999999998888886543   5899999999999999999999999999999999999999777 999999999866


Q ss_pred             cccCCCccccccccccCCChhhhh--CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..+.    ....|||.||+||+++  ....|+-+.||||||++..++.-.++|+..-+...-+..+...-.+        
T Consensus       176 ~~PA----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP--------  243 (948)
T KOG0577|consen  176 MAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------  243 (948)
T ss_pred             cCch----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC--------
Confidence            5433    3457899999999996  3445899999999999999999999998888777766666543111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                        .-..+.-|..+.+|+..||+.=|.+|||++++|.|+|...
T Consensus       244 ------------------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  244 ------------------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             ------------------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence                              1112245678899999999999999999999999999754

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.5e-41  Score=280.98  Aligned_cols=255  Identities=22%  Similarity=0.335  Sum_probs=200.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-----CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      +..|++.+.||.|+||.||++.+..+     +..+++|++..... ......+.+|+.++..+ +||||+++++++....
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~   81 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCC
Confidence            46799999999999999999987543     46799998874332 11234567788899999 9999999999988776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhc------------cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL  144 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil  144 (304)
                      .     .++++||+.+ +|.+++....            .....+++..++.++.|++.||.+||+.|++|+||||+||+
T Consensus        82 ~-----~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil  156 (283)
T cd05091          82 P-----LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL  156 (283)
T ss_pred             c-----eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence            6     8999999985 8888875321            11235788899999999999999999999999999999999


Q ss_pred             EeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHH
Q 021982          145 MDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQ  221 (304)
Q Consensus       145 ~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~  221 (304)
                      ++.++ .+||+|||++.......  .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+
T Consensus       157 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  234 (283)
T cd05091         157 VFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  234 (283)
T ss_pred             ecCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99776 89999999986543221  1122233467899999987766 7899999999999999998 788888776665


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ....+......                           .....++.++.+++.+||+.||.+||++++|++.
T Consensus       235 ~~~~i~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         235 VIEMIRNRQVL---------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            55544332111                           1123578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-41  Score=275.39  Aligned_cols=245  Identities=31%  Similarity=0.482  Sum_probs=202.8

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      ||.|++|.||.+.+..++..+++|.+...... ......+..|+.+++.+ +|||++++++.+.....     .+++||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEK-----LYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCe-----eEEEEec
Confidence            68999999999999888999999988764322 22345778899999999 89999999999887766     8999999


Q ss_pred             cC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc
Q 021982           91 MD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK  169 (304)
Q Consensus        91 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~  169 (304)
                      +. ++|.+++...    ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        75 ~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          75 APGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            95 5998888653    3589999999999999999999999999999999999999777 8999999998776544333


Q ss_pred             cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCccc
Q 021982          170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE  249 (304)
Q Consensus       170 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (304)
                      .....++..|+|||...+.. .+.++|+||||+++|++++|..||...+.......+....                   
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------  209 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP-------------------  209 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-------------------
Confidence            44456688899999887665 7889999999999999999999998777644444333200                   


Q ss_pred             CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH---HHHhcCCCc
Q 021982          250 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA---KKAMEHPYF  296 (304)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~eil~~~~~  296 (304)
                               ......++..+.+++++||..||.+|||+   +++++||||
T Consensus       210 ---------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 ---------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                     01112457899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-41  Score=278.63  Aligned_cols=258  Identities=20%  Similarity=0.287  Sum_probs=201.4

Q ss_pred             hhhhhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCc
Q 021982            6 FEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGR   81 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~   81 (304)
                      |++++.||+|+||.||.+....+   +..+++|.+............+..|+..++.+ +|||++++++++..... ...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence            67889999999999999987643   36799998876544444445678899999999 99999999998765443 333


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhcc--CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQ--TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      ...++++||+.+ +|..++.....  ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCcc
Confidence            447899999985 88888755432  224689999999999999999999999999999999999999776 99999999


Q ss_pred             ceeecccCCCcc--ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          159 LARAFTLPIKKY--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       159 ~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      .+..........  .....+..|++||.+.+.. ++.++||||||+++|+|++ |..||......+....+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            987654332111  1122356799999886655 7999999999999999999 889998776655544433211     


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                            .......+++.+.+++.+||+.||.+|||+.+++.+
T Consensus       233 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 ----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  011123578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-41  Score=276.28  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=202.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+++|++.+.||+|++|.||++.++. +..+++|.+.....   ....+.+|+++++.+ +|+|++++++++.....   
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   75 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM---SPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEP---   75 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc---CHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCc---
Confidence            56899999999999999999999764 56789998764332   235788899999999 89999999999877665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++||++.+ +|.+++...  ....+++..+..++.+++.|+.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus        76 --~~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~  150 (261)
T cd05034          76 --IYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLA  150 (261)
T ss_pred             --eEEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccc
Confidence              8999999986 999888763  234689999999999999999999999999999999999999777 9999999998


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ........ .......+..|+|||.+.+.. .+.++|+||||++++++++ |..||...+.......+......+     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-----  224 (261)
T cd05034         151 RLIEDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-----  224 (261)
T ss_pred             eeccchhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            76543211 111222356799999887665 7899999999999999998 999998777666555543321111     


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                            .....+.++.+++.+||+.||.+||+++++++
T Consensus       225 ----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         225 ----------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                  11245789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.5e-41  Score=279.35  Aligned_cols=258  Identities=19%  Similarity=0.293  Sum_probs=198.6

Q ss_pred             hhhhhhcccccceEEEEEEEccCCc--EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCce
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGK--IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGRT   82 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~~   82 (304)
                      +.+.+.||+|++|.||++.+..++.  .+++|.++...........+..|+.+++.+ +||||+++++++..... ....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCC
Confidence            4578899999999999999877665  588998775543333456677899999999 99999999997654322 2223


Q ss_pred             EEEEEEeccCC-CHHHHHHHhc--cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ..++++||+.+ +|.+++....  .....+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||+
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCc
Confidence            47899999985 8888775432  2234588999999999999999999999999999999999999776 899999999


Q ss_pred             eeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +.........  .....+++.|++||.+.+.. ++.++|+||||+++|+|++ |..||...........+...-      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN------  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC------
Confidence            8765432211  11223467899999887765 7999999999999999999 789998766554444332210      


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                           .....+.++..+.++|.+||+.||.+|||+.+|++.
T Consensus       232 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 ---------------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                 001123577889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-42  Score=295.15  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=225.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..|.+.+.||+|.|++|.++.+..++..|+||.+.++.-+......+.+|+++++.+ +||||++++.+...+..     
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~-----  129 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEAT-----  129 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecce-----
Confidence            468999999999999999999999999999999988776666666788999999999 99999999999998887     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||+.+ .+.+++...    ....+......+.|+++|++|||+++|+|+|||++||+++.+- ++||+|||++..
T Consensus       130 lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~  204 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTF  204 (596)
T ss_pred             eEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeecccccee
Confidence            9999999986 899999874    3466688999999999999999999999999999999999766 899999999998


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      +..+ ......+|++.|.|||++.+..+.++..|+||+|+++|.|+.|..||++.+-.+...........          
T Consensus       205 ~~~~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r----------  273 (596)
T KOG0586|consen  205 FDYG-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR----------  273 (596)
T ss_pred             eccc-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec----------
Confidence            8854 56677899999999999999998999999999999999999999999988765554443322111          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                        ..--++-+..++|+++|-.+|.+|++.+++..|.|.....
T Consensus       274 ------------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  274 ------------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             ------------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence                              1124778899999999999999999999999999987653

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=280.42  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=201.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCC-----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      .+++|++.+.||+|++|.||++.++...     ..+++|.+...... .....+.+|+.+++.+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEF-NCHHVVRLLGVVSTG   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC
Confidence            4688999999999999999999886433     78999987543211 1234567899999999 999999999998877


Q ss_pred             ccCCceEEEEEEeccC-CCHHHHHHHhccC------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC
Q 021982           77 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQT------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT  149 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~  149 (304)
                      ..     .+++|||+. ++|.+++......      ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus        82 ~~-----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~  156 (277)
T cd05032          82 QP-----TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CC-----cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC
Confidence            65     899999997 4999998764321      23478889999999999999999999999999999999999877


Q ss_pred             CeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHH
Q 021982          150 MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  226 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~  226 (304)
                       .++|+|||++........  ......++..|+|||.+.+.. .+.++||||||+++|++++ |..||...+..+....+
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         157 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             -CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence             899999999875533211  122234467899999987665 7999999999999999998 89999876665544433


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ...                           .........+..+.+++.+||+.+|++|||+.++++
T Consensus       235 ~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         235 IDG---------------------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             hcC---------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            211                           001112246889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.3e-41  Score=275.95  Aligned_cols=244  Identities=25%  Similarity=0.412  Sum_probs=192.9

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEe
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE   89 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   89 (304)
                      +.||+|++|.||++.++.++..+++|.+.... .......+.+|+++++.+ +||||+++++++.....     .++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQP-----IYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCC-----eEEEEe
Confidence            46999999999999999889999999875332 222335678899999999 99999999999887766     899999


Q ss_pred             ccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCC
Q 021982           90 YMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK  168 (304)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~  168 (304)
                      |+.+ +|.+++..   ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        74 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          74 LVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVY  149 (252)
T ss_pred             eccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccc
Confidence            9986 88888754   234689999999999999999999999999999999999999777 899999999865432211


Q ss_pred             cc--ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          169 KY--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       169 ~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      ..  .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......             
T Consensus       150 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-------------  215 (252)
T cd05084         150 ASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-------------  215 (252)
T ss_pred             cccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-------------
Confidence            11  1112245699999887665 7899999999999999998 88888766654443333221110             


Q ss_pred             CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                    ......+..+.+++.+||+.||.+|||+.++++
T Consensus       216 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 --------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             --------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          111246789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7e-41  Score=276.49  Aligned_cols=242  Identities=22%  Similarity=0.347  Sum_probs=193.0

Q ss_pred             hcccccceEEEEEEE--ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           11 KVGEGTYGKVYRARE--KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      .||+|+||.||++.+  ..++..+++|++............+..|+.+++.+ +||||+++++++....      .+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~lv~   74 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEAES------WMLVM   74 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCC------cEEEE
Confidence            689999999999965  45677899998875544433455778899999999 9999999999875432      68999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|.+++...    ..+++..+..++.|++.||++||++|++|+||+|.||+++.++ .++|+|||.+.......
T Consensus        75 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          75 ELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            99985 888888642    4689999999999999999999999999999999999999776 89999999987654432


Q ss_pred             Cc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          168 KK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       168 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ..   .....+++.|+|||.+.... ++.++|+||||+++|+|++ |..||......+....+.....            
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~------------  216 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER------------  216 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            21   11222357899999886554 7899999999999999998 9999987766555444432110            


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                     ......+++++.++|.+||+.||.+||++++|..
T Consensus       217 ---------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 ---------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                           1112358899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=276.03  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=200.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.+.. +..+++|.+.....   ....+.+|+.+++++ +|||++++++++.....    
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEP----   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHC-CCCCccceeEEEecCCC----
Confidence            4789999999999999999998764 46799998764322   245678899999999 89999999999887766    


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++||++. ++|.+++....  ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus        76 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~  151 (261)
T cd05068          76 -IYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLAR  151 (261)
T ss_pred             -eeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEE
Confidence             899999995 59999887632  35689999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ........ ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......       
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------  223 (261)
T cd05068         152 VIKEDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------  223 (261)
T ss_pred             EccCCcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            76532211 11112245799999887655 7999999999999999999 99999877665555444321110       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          ......+..+.+++.+||+.||.+||++.++++
T Consensus       224 --------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 --------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             --------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                111257789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-40  Score=275.99  Aligned_cols=248  Identities=24%  Similarity=0.395  Sum_probs=197.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.++||+|++|.||++.+..+ ..+++|.+.....   ....+..|+++++.+ +||||+++++.+... .    
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~-~----   74 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE-P----   74 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhC-CCCCcceEEEEECCC-C----
Confidence            57899999999999999999988765 4589998864322   234678899999999 899999999876432 2    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...  ....+++..++.++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||.+.
T Consensus        75 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~  150 (262)
T cd05071          75 -IYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLAR  150 (262)
T ss_pred             -cEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCcee
Confidence             6899999986 999988752  234678999999999999999999999999999999999999777 89999999997


Q ss_pred             ecccCCCcc-ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ......... ....++..|+|||...+.. ++.++|+||||+++|+|++ |..||......+....+......       
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------  222 (262)
T cd05071         151 LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------  222 (262)
T ss_pred             eccccccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-------
Confidence            654432211 1233466799999887665 7999999999999999999 88888877665544433221100       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          .....++..+.+++.+|++.||.+|||+.++++
T Consensus       223 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 --------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             --------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                011257889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.7e-41  Score=286.27  Aligned_cols=251  Identities=23%  Similarity=0.348  Sum_probs=196.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ..+|++.+.||+|+||.||++.+..++.    .+++|.+.... .......+.+|+.+++.+ +||||+++++++.... 
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~~-   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCCC-
Confidence            3579999999999999999999865554    38888876332 122335677899999999 9999999999987643 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .+++++++.+ +|.+++...   ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++ .+||+||
T Consensus        83 -----~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~Df  153 (316)
T cd05108          83 -----VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDF  153 (316)
T ss_pred             -----ceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccc
Confidence                 5788999874 898888753   23578899999999999999999999999999999999999776 8999999


Q ss_pred             cceeecccCCCccc--cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKKYT--HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |++...........  ....+..|++||.+.+.. ++.++||||||+++|+|++ |..||......+..........   
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---  229 (316)
T cd05108         154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---  229 (316)
T ss_pred             cccccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC---
Confidence            99987654322211  122356799999987765 7999999999999999998 9999987655443322211100   


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                              ....+.++.++.+++.+||..||.+|||+.+++.+
T Consensus       230 ------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 ------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    01112467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=266.16  Aligned_cols=261  Identities=25%  Similarity=0.432  Sum_probs=211.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++.+.+..||+|..|.||+++.+.+|...++|+++.....+ ..+++...+.+......+|.|++++|+|.....     
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-----  165 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-----  165 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----
Confidence            46778899999999999999999999999999998665443 345666677776666579999999999998877     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++.||.++.-+...+...   ..++++..+..+...+++||.||.+ +|++|+|+||+|||+|..| ++|++|||.+-.
T Consensus       166 V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGr  241 (391)
T KOG0983|consen  166 VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccce
Confidence            8899999986554444432   2479999999999999999999985 5899999999999999888 999999999977


Q ss_pred             cccCCCccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCc-hHHHHHHHHHHhCCCCCCCCc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +... ...+...|-+.||+||.+...  ..|.-++||||||++++||.||..||...+ +.+.+.++.+... |.     
T Consensus       242 lvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~-----  314 (391)
T KOG0983|consen  242 LVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PL-----  314 (391)
T ss_pred             eecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CC-----
Confidence            6554 233445678889999998643  448889999999999999999999998864 4566666655221 11     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                        +.. -.++|+.+.+|+..||+.|+.+||.-.++|+|||.....
T Consensus       315 ------------------L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  315 ------------------LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             ------------------CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                              111 114899999999999999999999999999999887654

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.1e-41  Score=283.17  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=201.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC-----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|++|.||++.+....     ..+++|.+..... ......+.+|+++++.+.+|+||+++++++....
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            468999999999999999999876433     6788898764322 1223457789999999878999999999988766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhc------------cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL  144 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil  144 (304)
                      .     .+++|||+.+ +|.+++....            .....+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        90 ~-----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          90 P-----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             C-----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            6     8999999975 9999887532            23456889999999999999999999999999999999999


Q ss_pred             EeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHH
Q 021982          145 MDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQ  221 (304)
Q Consensus       145 ~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~  221 (304)
                      ++.++ .++|+|||.+........  ......++..|+|||.+.+.. ++.++||||||+++|++++ |..||......+
T Consensus       165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99777 999999999876543211  111222356799999887655 7899999999999999997 899988766555


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ....+......                           ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYRM---------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            44433221100                           1112567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.6e-41  Score=281.47  Aligned_cols=255  Identities=21%  Similarity=0.379  Sum_probs=199.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      +++|++.+.||+|+||.||++.+.    .++..+++|.+..... ......+.+|+.+++.+ +||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~   81 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence            467899999999999999999853    3456789998764322 22234677899999999 99999999999887766


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhcc-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeE
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQ-------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL  144 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil  144 (304)
                           .+++|||+.+ +|.+++.....             ....+++.++..++.|++.||+|||++|++|+||+|+||+
T Consensus        82 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil  156 (283)
T cd05090          82 -----VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL  156 (283)
T ss_pred             -----eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence                 8999999985 89888854221             1234788899999999999999999999999999999999


Q ss_pred             EeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHH
Q 021982          145 MDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQ  221 (304)
Q Consensus       145 ~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~  221 (304)
                      ++.++ .++|+|||++.......  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......
T Consensus       157 i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         157 IGEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             EcCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99776 89999999997653321  1122233456799999987665 7999999999999999998 888987766544


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ....+....                           .......+++.+.+++.+||+.||.+||++.+|+++
T Consensus       235 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         235 VIEMVRKRQ---------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHcCC---------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            444332211                           001122578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.1e-41  Score=279.09  Aligned_cols=256  Identities=21%  Similarity=0.337  Sum_probs=200.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|.+.+.||+|++|.||++.+..     ++..+++|.+...... .....+..|+.+++.+ +|+||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKF-NHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCC
Confidence            4679999999999999999999976     6678888977543221 1224577899999999 9999999999887766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC---CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--Ce
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT---GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MT  151 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~  151 (304)
                      .     .+++|||+.| +|.+++......   ...+++..+..++.||+.||++||+.+++|+||+|+||+++.++  ..
T Consensus        83 ~-----~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          83 P-----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             C-----cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence            5     7899999975 999988764321   23588999999999999999999999999999999999998553  36


Q ss_pred             EEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHH
Q 021982          152 LKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       152 vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~  228 (304)
                      ++|+|||.+........  .......+..|+|||++.+.. ++.++||||||+++|+|++ |..||...+.......+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~  236 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG  236 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999876532211  111222246799999997766 8999999999999999997 9999987766554433322


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ...                           ......++..+.+++.+||+.||.+|||+.++++|
T Consensus       237 ~~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         237 GGR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            100                           01123578899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.7e-41  Score=283.99  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=197.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcE--EEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKI--VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++.+.||+|+||.||+|.++.++..  +++|.+... ........+.+|+.++.++.+||||+++++++.....  
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~--   82 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--   82 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC--
Confidence            36799999999999999999998777654  455554421 1122234667799999998789999999999887766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR  147 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~  147 (304)
                         .++++||+.+ +|.+++.....            ....+++.+++.++.|++.|+++||+.|++|+||||+||+++.
T Consensus        83 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~  159 (303)
T cd05088          83 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  159 (303)
T ss_pred             ---ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence               8999999975 99998865421            1235789999999999999999999999999999999999997


Q ss_pred             CCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHH
Q 021982          148 KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  226 (304)
Q Consensus       148 ~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~  226 (304)
                      ++ .++|+|||++........ ......+..|+|||.+.+.. ++.++||||||+++|+|+| |..||...+..+.....
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         160 NY-VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             CC-cEEeCccccCcccchhhh-cccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            77 899999999853322111 11122356799999887655 7899999999999999998 99999766655444332


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ....                           .......+++++.+++.+||+.+|.+|||+++++.+
T Consensus       237 ~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         237 PQGY---------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             hcCC---------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1100                           000112467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-40  Score=290.39  Aligned_cols=255  Identities=22%  Similarity=0.351  Sum_probs=197.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccC-----CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKAT-----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ++|++++.||+|+||.||++.+...     +..+++|.+..... ......+..|+++++.+..||||+++++++.....
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            5788999999999999999987433     34689998864322 22235678899999999559999999999987766


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhcc-----------------------------------------------------
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQ-----------------------------------------------------  104 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  104 (304)
                           .++||||+.+ +|.+++.....                                                     
T Consensus       116 -----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         116 -----IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             -----eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence                 8999999985 99888865321                                                     


Q ss_pred             ---------------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE
Q 021982          105 ---------------------------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM  145 (304)
Q Consensus       105 ---------------------------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~  145 (304)
                                                             ....+++..+..++.|++.||.|||+.+++|+||||+||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                   01347888899999999999999999999999999999999


Q ss_pred             eCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHH
Q 021982          146 DRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQ  222 (304)
Q Consensus       146 ~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~  222 (304)
                      +.++ .++|+|||++........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||........
T Consensus       271 ~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         271 AQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             eCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            9776 899999999876543222  112233467899999987765 7999999999999999997 8999876544333


Q ss_pred             HHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .......-.                          .......++.++.+++.+||+.||.+|||+.+|.+
T Consensus       349 ~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         349 FYNKIKSGY--------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHhcCC--------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            322222100                          00111257889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.7e-41  Score=282.77  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=197.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCc--EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGK--IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++|++.+.||.|+||.||++..+.++.  .+++|.++... .......+..|+.++.++.+||||+++++++.....   
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~---   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY---   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc---
Confidence            689999999999999999999877664  46777665321 112234677899999998779999999999887665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK  148 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~  148 (304)
                        .++++||+.+ +|.+++.....            ....+++..++.++.|++.||++||+.|++|+||||+||+++.+
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 --LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             --ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence              8999999975 99999865321            11358889999999999999999999999999999999999976


Q ss_pred             CCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHH
Q 021982          149 TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIF  227 (304)
Q Consensus       149 ~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~  227 (304)
                      + .++|+|||++......... .....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+......
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~  232 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKK-TMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP  232 (297)
T ss_pred             C-eEEECCcCCCccccceecc-CCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence            6 8999999998543221111 1112245799999887665 7899999999999999997 999998776655444432


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .....                           .....++.++.+|+.+||+.||.+|||++++++.
T Consensus       233 ~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         233 QGYRM---------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21110                           1112578899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.7e-41  Score=280.47  Aligned_cols=263  Identities=26%  Similarity=0.422  Sum_probs=206.2

Q ss_pred             hhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCC--CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHED--DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .|++.+.||.|++|.||.+.+.   .+|..+++|.+.....  .......+..|+++++.+.+|++|+++++.+..... 
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~-   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK-   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe-
Confidence            4788999999999999999874   3678899998875332  222234567899999999779999999999887665 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++++||+.+ +|.+++...    .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||
T Consensus        80 ----~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg  150 (290)
T cd05613          80 ----LHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFG  150 (290)
T ss_pred             ----EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCc
Confidence                8999999996 898888652    4688999999999999999999999999999999999999777 89999999


Q ss_pred             ceeecccCC-CccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPI-KKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      .+....... .......++..|++||.+.+.. ..+.++|+||||+++|+|++|..||...........+........  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--  228 (290)
T cd05613         151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--  228 (290)
T ss_pred             cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--
Confidence            987654321 1122345688899999987532 367899999999999999999999975433222222222111100  


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDK  301 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~  301 (304)
                                            ......++..+.+++++||+.||.+||     ++++++.||||..+++
T Consensus       229 ----------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         229 ----------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                                  001124778899999999999999997     8999999999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=273.81  Aligned_cols=256  Identities=23%  Similarity=0.439  Sum_probs=204.0

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC---CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED---DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ++|++.+.||+|++|.||++.+..++..+++|.+.....   .......+.+|+.+++++ +|+||+++++++.+...  
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~--   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEE--   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCC--
Confidence            579999999999999999999999999999998754321   122334677899999999 99999999998765432  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                       ..+++++||+.+ +|.+++...    .++++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        79 -~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~  152 (264)
T cd06653          79 -KKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGA  152 (264)
T ss_pred             -CEEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcccc
Confidence             127899999986 888887652    3588999999999999999999999999999999999999776 899999999


Q ss_pred             eeecccCC---CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +.......   .......++..|+|||.+.+.. .+.++|+||||++++++++|..||..............   .+.. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-  227 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK-  227 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC-
Confidence            87653321   1112335688899999987765 78999999999999999999999987655544433321   1111 


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                            ......+++.+.+++.+||. +|..|||+.++++|||.
T Consensus       228 ----------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 ----------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                  11223688899999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-40  Score=279.49  Aligned_cols=261  Identities=24%  Similarity=0.388  Sum_probs=202.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC----------------cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCe
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG----------------KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV   66 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----------------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   66 (304)
                      .++|++++.||+|+||.||++.+...+                ..+++|.+...... .....+.+|+++++++ +|||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRL-SDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhc-CCCCE
Confidence            578999999999999999999876543                45788887644322 2345677899999999 99999


Q ss_pred             eeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhcc-------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC
Q 021982           67 VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ-------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL  138 (304)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl  138 (304)
                      +++++++.....     .++++|++.+ +|.+++.....       ....+++..++.++.|++.||.+||+.|++|+||
T Consensus        82 ~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl  156 (296)
T cd05051          82 ARLLGVCTVDPP-----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL  156 (296)
T ss_pred             eEEEEEEecCCC-----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence            999999887765     8999999985 89998876431       1236899999999999999999999999999999


Q ss_pred             CCCCeEEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh--ccccC
Q 021982          139 KPHNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALF  214 (304)
Q Consensus       139 ~~~Nil~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~--g~~p~  214 (304)
                      ||+||+++.++ .++|+|||.+.......  .......+++.|+|||.+.+.. ++.++||||||+++|+|++  |..||
T Consensus       157 kp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         157 ATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             chhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCC
Confidence            99999999776 99999999987543321  1112233467899999987755 7999999999999999998  67788


Q ss_pred             CCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          215 PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ......+........+......                    ......+.++.++.+++.+||+.||.+|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         235 EHLTDQQVIENAGHFFRDDGRQ--------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCcChHHHHHHHHhcccccccc--------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            7766655554443321111000                    001112356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.7e-40  Score=272.58  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=197.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.+..+ ..+++|.+....   .....+.+|+.+++.+ +|||++++++++... .    
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~----   74 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKL-RHDKLVPLYAVVSEE-P----   74 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC-C----
Confidence            47899999999999999999988665 458889765432   2235677899999999 999999999887532 2    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...  ....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        75 -~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~  150 (260)
T cd05069          75 -IYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLAR  150 (260)
T ss_pred             -cEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccce
Confidence             6899999986 999988762  234578999999999999999999999999999999999999777 89999999997


Q ss_pred             ecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ........ .....++..|+|||...+.. .+.++|+||||+++|+|++ |..||......+....+......       
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------  222 (260)
T cd05069         151 LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-------  222 (260)
T ss_pred             EccCCcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            65433211 11223467799999887655 7999999999999999999 89999877665555444321111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          ......+..+.+++++||..||.+||+++++++
T Consensus       223 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 --------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             --------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                011257789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=272.51  Aligned_cols=245  Identities=25%  Similarity=0.413  Sum_probs=200.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++...  ++.+++|.+.....   ....+.+|+.+++.+ +|+|++++++++.....    
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~----   74 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNP----   74 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCC----
Confidence            467999999999999999999875  78899998875432   346788899999999 89999999999887655    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++||++.+ +|.+++....  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        75 -~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~  150 (256)
T cd05039          75 -LYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAK  150 (256)
T ss_pred             -eEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccc
Confidence             8999999985 9999887632  23689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .......   ....+..|+|||.+.... ++.++|+||||++++++++ |..||......+....+......        
T Consensus       151 ~~~~~~~---~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  218 (256)
T cd05039         151 EASQGQD---SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM--------  218 (256)
T ss_pred             ccccccc---cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence            6533222   223356799999887655 7889999999999999997 99999877655544433221100        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         .....+++.+.++|.+||..+|.+|||+.+++.
T Consensus       219 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         219 -------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                               011246889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-40  Score=273.05  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=192.5

Q ss_pred             hhcccccceEEEEEEEccCC---cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATG---KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      +.||+|++|.||++.+...+   ..+++|.+...... .....+..|+++++.+ +|||++++++++... .     .++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~-----~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQL-DHPCIVRLIGVCKGE-P-----LML   72 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcCC-c-----eEE
Confidence            47999999999999876554   68999988754432 2345677899999999 999999999987543 2     689


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      +|||+.+ +|.+++...    ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        73 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~  147 (257)
T cd05060          73 VMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGA  147 (257)
T ss_pred             EEEeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeec
Confidence            9999975 999988753    3689999999999999999999999999999999999999777 899999999876644


Q ss_pred             CCCccc---cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          166 PIKKYT---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       166 ~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ......   ...++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+.....          
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------  216 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER----------  216 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc----------
Confidence            332221   112245799999887665 8999999999999999998 9999987766544443322110          


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                       ......++..+.+++.+||+.||.+|||+.++++
T Consensus       217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             0112357789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=290.17  Aligned_cols=244  Identities=30%  Similarity=0.495  Sum_probs=201.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|.+...+|.|+|+.|-.+.+..+++.+++|++.....      ...+|+.++....+||||+++.+.+.+...     
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~-----  390 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE-----  390 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCce-----
Confidence            578899999999999999999999999999999876522      233567677777799999999999999888     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEe-CCCCeEEEeecccee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLAR  161 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~-~~~~~vkl~dfg~~~  161 (304)
                      .++|||.+.| .+.+.+..     .+....++..|+.+|+.|+.+||++|++||||||+|||++ ..+ +++|+|||.+.
T Consensus       391 ~~~v~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~  464 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWS  464 (612)
T ss_pred             eeeeehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhh
Confidence            9999999997 55555544     2333377788999999999999999999999999999995 555 89999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .....   ....+-|..|.|||++.... ++.+.|+||||++||+|++|..||........   +...++.+...     
T Consensus       465 ~~~~~---~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~~s-----  532 (612)
T KOG0603|consen  465 ELERS---CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPKFS-----  532 (612)
T ss_pred             hCchh---hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCccc-----
Confidence            66554   33445588999999998665 89999999999999999999999988777622   22222222111     


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                           ..+|..+++||++||++||.+||++.+++.||||.
T Consensus       533 ---------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  533 ---------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             ---------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence                                 26999999999999999999999999999999993

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.3e-40  Score=278.60  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=199.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ..++|.+.+.||.|+||.||++.+.     .++..+++|.+..... ......+.+|+.+++++.+||||+++++++...
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            3578999999999999999999763     2345788888764321 222346778999999997799999999998877


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      +.     .+++|||+.+ +|.+++....  ...+++.++..++.|++.||.|||+++++|+||+|+||+++.++ .++++
T Consensus       112 ~~-----~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~  183 (302)
T cd05055         112 GP-----ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKIC  183 (302)
T ss_pred             Cc-----eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEEC
Confidence            66     8999999985 9998886522  23489999999999999999999999999999999999999666 89999


Q ss_pred             eccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCC
Q 021982          156 DLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       156 dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      |||.+........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+...........
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~  262 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR  262 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence            9999875543221  111223467899999987766 7899999999999999998 99998776654444333221000


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                                .......++.+.+++.+||+.+|.+|||+.++++
T Consensus       263 --------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 --------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                      0011246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-40  Score=281.23  Aligned_cols=256  Identities=24%  Similarity=0.387  Sum_probs=198.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .++|.+.+.||+|+||.||++.+...       ...+++|.+..... ......+..|+.+++.+.+|||++++++++..
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            46899999999999999999987432       24588888764322 22234677899999999789999999999887


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      ...     .+++|||+.+ +|.+++.....            ....+++.+++.++.|++.||++||+.|++|+||+|+|
T Consensus        96 ~~~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  170 (307)
T cd05098          96 DGP-----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN  170 (307)
T ss_pred             CCc-----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence            766     8999999985 99999976432            12358889999999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .++|+|||.+.........  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.....
T Consensus       171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999777 8999999998655332111  11122346899999887765 7899999999999999998 8888876554


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .+....+....                           .......++.++.+++.+||..+|.+|||+.+++++
T Consensus       249 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 EELFKLLKEGH---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHcCC---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            44333322110                           001122578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.4e-40  Score=278.03  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=195.6

Q ss_pred             hhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +|++.+.||+|+||.||++.+..     ....+++|.+..... ......+..|+++++.+ +||||+++++.+..... 
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP-   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC-
Confidence            47899999999999999998753     224577777653322 11234677899999999 99999999999887666 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhcc--------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQ--------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL  138 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl  138 (304)
                          .++++||+.+ +|.+++.....                    ...++++..++.++.|++.||.+||+.|++|+||
T Consensus        78 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di  153 (290)
T cd05045          78 ----LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL  153 (290)
T ss_pred             ----cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence                7999999985 99988865321                    1235788999999999999999999999999999


Q ss_pred             CCCCeEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCC
Q 021982          139 KPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFP  215 (304)
Q Consensus       139 ~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~  215 (304)
                      +|+||+++.++ .++|+|||++........  ......++..|+|||.+.+.. ++.++||||||+++++|++ |..||.
T Consensus       154 kp~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         154 AARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             hhheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            99999999766 899999999865432211  112223356899999887665 7999999999999999998 999997


Q ss_pred             CCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .................                           .....++.++.+++.+||+.||.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         232 GIAPERLFNLLKTGYRM---------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCHHHHHHHHhCCCCC---------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            76655444332211100                           011257789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.7e-40  Score=270.90  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=196.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++.+.||+|++|.||++...  +..+++|.+....    ....+.+|+.+++++ +|++++++++++.....    
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~----   73 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKG----   73 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCC----
Confidence            578999999999999999999765  6778999875322    234678899999999 99999999997654322    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..++++||+.+ +|.+++...  ....+++..++.++.|++.||++||++|++|+||+|+||+++.++ .++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~  150 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTK  150 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccce
Confidence            17899999985 999988763  234588999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.+...         
T Consensus       151 ~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  217 (256)
T cd05082         151 EASSTQ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---------  217 (256)
T ss_pred             eccccC---CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            543322   1223356799999887665 7899999999999999997 9999987665554444332110         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                        ......+++.+.+++.+||+.||.+|||+.++++
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 ------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                              0112357899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.8e-40  Score=276.18  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=195.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++.+.||+|++|+||++.+..++.    .|++|.+..... ......+.+|+.++..+ +||||+++++++.... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~-   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGV-GSPYVCRLLGICLTST-   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCCC-
Confidence            4679999999999999999999876665    378888764322 22234667888999998 9999999999887543 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .+++++++.+ +|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+||
T Consensus        83 -----~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~df  153 (279)
T cd05109          83 -----VQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDF  153 (279)
T ss_pred             -----cEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCC
Confidence                 5789999984 888887642   24689999999999999999999999999999999999998766 8999999


Q ss_pred             cceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |++.........  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.... .  
T Consensus       154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--  229 (279)
T cd05109         154 GLARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-R--  229 (279)
T ss_pred             CceeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-c--
Confidence            999766533221  11223367899999987665 7899999999999999998 889987765544333222110 0  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                              .......+.++.+++.+||+.||.+||++.++++
T Consensus       230 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         230 ------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    0111257789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-41  Score=300.40  Aligned_cols=251  Identities=26%  Similarity=0.428  Sum_probs=210.8

Q ss_pred             hhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +-+..+.||.|+||+||+++-.+     ....|+||.++... +.+...+|++|+.++..+ +||||++++|++...+. 
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P-  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDP-  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCe-
Confidence            45678999999999999997643     23568999886433 333567999999999999 99999999999999888 


Q ss_pred             CceEEEEEEeccC-CCHHHHHHHhccCC----------CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC
Q 021982           80 GRTVLYLVFEYMD-TDLKKYIRSFRQTG----------ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK  148 (304)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~  148 (304)
                          +++||||+. |+|.++|.......          .+++..+.+.++.||+.|+.||-++.+||+||-.+|.||..+
T Consensus       564 ----~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  564 ----LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             ----eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence                999999998 79999997755322          248889999999999999999999999999999999999955


Q ss_pred             CCeEEEeeccceeeccc-CCCcc-ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHH
Q 021982          149 TMTLKIADLGLARAFTL-PIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLH  225 (304)
Q Consensus       149 ~~~vkl~dfg~~~~~~~-~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~  225 (304)
                      - .|||+|||+++.+-. +.-+. ....-..+|||||.+.-+. ++.+|||||+|++|||+++ |.-||...++.+.++.
T Consensus       640 l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  640 L-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             e-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            5 999999999986532 22222 2334478999999999887 8999999999999999998 8999999999998888


Q ss_pred             HHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHh
Q 021982          226 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  291 (304)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  291 (304)
                      +.+.                           .+-..+.++|.++.+|+.+||+..|.+|||+.||=
T Consensus       718 i~~g---------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  718 IRAG---------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHcC---------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            7652                           23344558999999999999999999999999974

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.3e-40  Score=272.57  Aligned_cols=255  Identities=24%  Similarity=0.440  Sum_probs=204.6

Q ss_pred             hhhhhhhcccccceEEEEEEEcc-CCcEEEEEEeeecCCC--------CCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDD--------EGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .|++.+.||+|++|.||++.+.. .+..+++|.+......        ......+..|+.++....+|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 6778999987653321        11223455677777653499999999999887


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEE
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLK  153 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vk  153 (304)
                      ...     .+++|||+.+ +|.+++.........+++..++.++.|++.+|.+||+ .|++|+||+|.||+++.++ .++
T Consensus        81 ~~~-----~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          81 NDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             CCe-----EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence            766     8999999986 9999887765556679999999999999999999996 7899999999999999777 899


Q ss_pred             EeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |+|||.+....... ......++..|++||.+.+.. ++.++|+||||+++|+|++|..||...........+......+
T Consensus       155 l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (269)
T cd08528         155 ITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP  232 (269)
T ss_pred             Eecccceeeccccc-ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence            99999997655443 334556788999999998765 7999999999999999999999998776665554443321111


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .                          .....++.+.+++.+||+.||.+||++.|+..+
T Consensus       233 ~--------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 L--------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             C--------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            0                          011467899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=278.10  Aligned_cols=260  Identities=22%  Similarity=0.358  Sum_probs=198.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccC--------------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeee
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKAT--------------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL   69 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~--------------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   69 (304)
                      ++|++.+.||+|+||.||.+.+...              ...+++|.+.... .......+.+|+++++++ +|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l-~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRL-KNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence            5899999999999999999987543              2348888876432 222234677899999999 99999999


Q ss_pred             eceecccccCCceEEEEEEeccCC-CHHHHHHHhcc--------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 021982           70 MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ--------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP  140 (304)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~  140 (304)
                      ++++.....     .+++|||+.+ +|.+++.....        ....+++..++.++.|++.||.|||+.|++|+||+|
T Consensus        83 ~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp  157 (295)
T cd05097          83 LGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT  157 (295)
T ss_pred             EEEEcCCCc-----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence            999987666     8999999986 99888865321        112468889999999999999999999999999999


Q ss_pred             CCeEEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh--ccccCCC
Q 021982          141 HNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPG  216 (304)
Q Consensus       141 ~Nil~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~--g~~p~~~  216 (304)
                      +||+++.++ .++|+|||++.......  .......+++.|+|||.+.+.. ++.++|+||||+++++|++  |..||..
T Consensus       158 ~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         158 RNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999766 89999999986543221  1112223367899999987766 7999999999999999998  6778877


Q ss_pred             CchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          217 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .+..+...............                    ......+..++.+.+++.+||+.||.+|||+++|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGRQ--------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cChHHHHHHHHHhhhhcccc--------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            66655544443322111110                    011122357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.3e-41  Score=258.43  Aligned_cols=282  Identities=28%  Similarity=0.607  Sum_probs=222.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++++|+|.++.||.+.+..++..++||+++.-.     .+.+.+|+.+|+.|..+|||++++++..+.....  
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt--  109 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT--  109 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC--
Confidence            368999999999999999999998899999999987543     3578899999999988999999999988765432  


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       ..+++|+.+. +....-       ..++...+...+.+++.||.|+|+.||+|+|+||.|+++|.....++|+|+|++.
T Consensus       110 -paLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  110 -PSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             -chhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence             5799999997 444433       2488889999999999999999999999999999999999887799999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccC-CCCchHHHHHHHHHHhCCCCCC----
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTPNEK----  236 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~----  236 (304)
                      ++..+. .......+-.|--||.+..-..+...-|+|||||+|..|+..+.|| .+.++.+++.++.+.++...-.    
T Consensus       182 FYHp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  182 FYHPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             hcCCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            876553 3333344667889999988777899999999999999999998886 5677888888888877753211    


Q ss_pred             -----CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 -----VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                           .-+++......++...|..-.-+....-.++++.+|+.++|..|..+|+|+.|.+.||||..+.
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                 1112222111122111111111222234679999999999999999999999999999998764

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3e-40  Score=277.58  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=198.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .+|.+.+.||+|++|.||.+.+..     ++..+++|.+.....  .....+.+|+.+++++ +||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNL-QHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCc
Confidence            568899999999999999998643     344577777653221  1224677899999999 99999999999887666


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM  145 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~  145 (304)
                           .+++|||+.+ +|.+++.....            ....+++..++.++.||+.|+++||++|++|+||+|+||++
T Consensus        82 -----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~  156 (291)
T cd05094          82 -----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV  156 (291)
T ss_pred             -----eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence                 8999999975 99999876321            12347899999999999999999999999999999999999


Q ss_pred             eCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHH
Q 021982          146 DRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQ  222 (304)
Q Consensus       146 ~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~  222 (304)
                      +.++ .++|+|||++........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+.
T Consensus       157 ~~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  234 (291)
T cd05094         157 GANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV  234 (291)
T ss_pred             ccCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9777 999999999875543211  122234467899999887765 7899999999999999999 9999877766554


Q ss_pred             HHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ...+....                           ........+..+.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         235 IECITQGR---------------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHhCCC---------------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            44332110                           00111246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=287.93  Aligned_cols=240  Identities=23%  Similarity=0.343  Sum_probs=202.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +....++-||+|+.|.||.++.+  +..|+||+++.         .-..+++-|+.| +||||+.+.|+|.....     
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkL-kH~NII~FkGVCtqsPc-----  186 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKL-KHPNIITFKGVCTQSPC-----  186 (904)
T ss_pred             HHhhhhhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhc-cCcceeeEeeeecCCce-----
Confidence            44556788999999999999876  77899998762         223578889999 99999999999998877     


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++||||||. |-|...|+.    +.+++...+..|..+|+.|+.|||.+.|+|+|||.-||||..++ .|||+|||-++.
T Consensus       187 yCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e  261 (904)
T KOG4721|consen  187 YCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKE  261 (904)
T ss_pred             eEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHh
Confidence            899999998 689998876    46799999999999999999999999999999999999999887 999999999977


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      .... .......||..|||||++.+.+ .+.+.||||||++||||+||..||.+.+....+..+-.              
T Consensus       262 ~~~~-STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--------------  325 (904)
T KOG4721|consen  262 LSDK-STKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--------------  325 (904)
T ss_pred             hhhh-hhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccC--------------
Confidence            6655 4555668999999999998877 89999999999999999999999998765433322111              


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                  +..--..+.++++.+.=||+.||+-.|..|||+.+||.|
T Consensus       326 ------------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  326 ------------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ------------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence                        111112344788999999999999999999999999998

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.1e-40  Score=275.26  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=198.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++...     .++..+++|.+....  ......+.+|+++++.+ +|+||+++.+++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence            467999999999999999999753     235578888765332  22235678899999999 9999999999988766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC-----------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT-----------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM  145 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~  145 (304)
                      .     .++++||+.+ +|.+++......           ...+++..+..++.|++.|++|||+.|++|+||+|+||++
T Consensus        81 ~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~  155 (280)
T cd05092          81 P-----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV  155 (280)
T ss_pred             c-----eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence            5     8999999985 999988754221           1357889999999999999999999999999999999999


Q ss_pred             eCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHH
Q 021982          146 DRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQ  222 (304)
Q Consensus       146 ~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~  222 (304)
                      +.++ .++|+|||++........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+.
T Consensus       156 ~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  233 (280)
T cd05092         156 GQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA  233 (280)
T ss_pred             cCCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence            9766 899999999875432211  112223367899999887765 7999999999999999998 8999977766555


Q ss_pred             HHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ...+.....                           ......+++.+.+++.+||+.||.+||++.+|+.
T Consensus       234 ~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         234 IECITQGRE---------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHcCcc---------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            444332110                           0111257889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.3e-40  Score=273.97  Aligned_cols=251  Identities=22%  Similarity=0.334  Sum_probs=198.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+.||+|+||.||++.++.++.   .+++|.+..... ......+.+|+.+++++ +||||+++++++...+. 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKP-   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCc-
Confidence            4689999999999999999998864443   688888764322 22235678899999999 99999999999876665 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++|||+.+ +|.+++...   ...+++.++..++.|++.|+.+||++|++|+||+|+||+++.++ .++++|||
T Consensus        80 ----~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg  151 (267)
T cd05066          80 ----VMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFG  151 (267)
T ss_pred             ----cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCC
Confidence                8999999986 898888652   24689999999999999999999999999999999999999776 89999999


Q ss_pred             ceeecccCCCccc---cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          159 LARAFTLPIKKYT---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       159 ~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      .+...........   ...++..|++||.+.+.. ++.++|+||||+++|++++ |..||......+....+......  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~--  228 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL--  228 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC--
Confidence            9876644322111   112246799999987665 7999999999999999886 99999877655444433321110  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               .....+++.+.+++.+||+.+|.+|||+.++++
T Consensus       229 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 -------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                     011246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-40  Score=281.82  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=200.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccC-------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKAT-------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   74 (304)
                      ...+|++++.||+|+||.||++.+...       +..+++|.+.... .......+.+|+++++++.+||||+++++++.
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            346799999999999999999986432       2357888776432 22234567789999999977999999999988


Q ss_pred             ccccCCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCC
Q 021982           75 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH  141 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~  141 (304)
                      ....     .++++||+.+ +|.+++.....            ....++..++..++.|++.||.|||++|++|+||+|+
T Consensus        89 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          89 QDGP-----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             cCCc-----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            7765     8999999985 99999876421            1235778889999999999999999999999999999


Q ss_pred             CeEEeCCCCeEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCc
Q 021982          142 NLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS  218 (304)
Q Consensus       142 Nil~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~  218 (304)
                      ||+++.++ .++|+|||++.........  .....++..|+|||++.+.. ++.++||||||+++|+|++ |..||...+
T Consensus       164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         164 NVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             eEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999777 8999999998765432211  11122346799999987765 7899999999999999998 888887766


Q ss_pred             hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..+....+......                           ......+..+.+++.+||+.+|.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         242 VEELFKLLKEGHRM---------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            55544443321100                           0112567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-40  Score=270.33  Aligned_cols=242  Identities=24%  Similarity=0.339  Sum_probs=190.3

Q ss_pred             hcccccceEEEEEEEc--cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           11 KVGEGTYGKVYRAREK--ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      .||+|+||.||++.++  ..+..+++|...... .......+.+|+.+++++ +||||+++++++... .     .+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~-~-----~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEAE-A-----LMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcCC-C-----eEEEE
Confidence            4899999999999775  345568899876442 222335677899999999 999999999987543 2     78999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ||+.+ +|.+++...   ...+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.+.......
T Consensus        74 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          74 EMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADD  149 (257)
T ss_pred             EeCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCc
Confidence            99985 888887642   34689999999999999999999999999999999999999776 89999999987544332


Q ss_pred             Cc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          168 KK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       168 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ..   .....+++.|+|||.+.... ++.++|+||||+++|++++ |..||......+....+.....            
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  216 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR------------  216 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC------------
Confidence            21   11122256899999887655 7899999999999999996 9999988776655444432110            


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                     .......++++.+++.+||..||++||++.+|.+
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           1112357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.9e-40  Score=278.68  Aligned_cols=255  Identities=23%  Similarity=0.393  Sum_probs=198.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .++|.+.+.||+|++|.||++.+..       ....+++|.+..... ......+..|+.+++++..||||+++++++..
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3679999999999999999998632       234688888764322 22234577899999999679999999999887


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      ...     .++++||+.+ +|.+++.....            ....+++.++..++.|++.||.|||+.|++|+||||+|
T Consensus        90 ~~~-----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          90 EGP-----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             CCc-----eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            665     8999999985 99999976432            12458889999999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .++|+|||.+.........  .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.....
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999777 8999999999755432111  11122346799999987755 7899999999999999999 8889977665


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .+....+....                           .......++.++.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 EELFKLLREGH---------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcCC---------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            55444332210                           00112256789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.2e-40  Score=276.83  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=197.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc----------------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCe
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA----------------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV   66 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~----------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   66 (304)
                      .++|++.+.||+|+||.||++.+..                ++..+++|.+.... .......+.+|+++++.+ +|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l-~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRL-KDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCc
Confidence            4689999999999999999986542                23467888876432 222235677899999999 99999


Q ss_pred             eeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCC-------CCCChHHHHHHHHHHHHHHHHHHhcCccccCC
Q 021982           67 VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG-------ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL  138 (304)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl  138 (304)
                      +++++++.....     .+++|||+.+ +|.+++.......       ..+++.++..++.|++.||++||+.|++|+||
T Consensus        82 ~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl  156 (296)
T cd05095          82 IRLLAVCITSDP-----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL  156 (296)
T ss_pred             ceEEEEEecCCc-----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence            999999887766     8999999985 9998887643221       24677889999999999999999999999999


Q ss_pred             CCCCeEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh--ccccC
Q 021982          139 KPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALF  214 (304)
Q Consensus       139 ~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~--g~~p~  214 (304)
                      ||+||+++.++ .++|+|||++........  ......+++.|++||...+.. ++.++|+||||+++|+|++  |..||
T Consensus       157 kp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         157 ATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             ChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            99999999766 899999999875433211  111223356799999887665 8999999999999999998  77888


Q ss_pred             CCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          215 PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ...+..+........+.....                    .........+++.+.+++.+||+.||.+|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         235 SQLSDEQVIENTGEFFRDQGR--------------------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cccChHHHHHHHHHHHhhccc--------------------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            776655544433222111000                    0000112246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-40  Score=277.86  Aligned_cols=256  Identities=24%  Similarity=0.390  Sum_probs=200.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .++|++.+.||+|+||.||++.+..       .+..+++|...... .......+.+|+.+++.+.+||||+++++.+..
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            5689999999999999999997531       23468888776432 222345678899999998789999999999887


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhccC------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      ...     .+++|||+.+ +|.+++......            ...++..++..++.|++.||.|||++|++|+||||+|
T Consensus        93 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          93 DGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             CCc-----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            765     8999999985 999998764321            2357888899999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .++|+|||.+.........  .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+.
T Consensus       168 ili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         168 VLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999777 8999999999766432211  11223356799999987765 7899999999999999998 7888877665


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .+....+.....                           ......++..+.+++.+||..+|.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGHR---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            554443322100                           00112578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.7e-40  Score=282.42  Aligned_cols=258  Identities=23%  Similarity=0.365  Sum_probs=196.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||.|+||.||++.+.     .+++.+++|.++.... ......+.+|+.++..+.+||||+++++++....
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            368999999999999999999853     4567899998864322 2223467789999999977899999999876543


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC---------------------------------------------------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT---------------------------------------------------  105 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------  105 (304)
                      .    ..+++|||+.+ +|.+++......                                                   
T Consensus        85 ~----~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          85 G----PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             C----ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            2    27899999986 999888653210                                                   


Q ss_pred             ------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCC--ccc
Q 021982          106 ------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYT  171 (304)
Q Consensus       106 ------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~--~~~  171 (304)
                                  ...+++..+..++.|++.||.|||+.|++|+||||.||+++.++ .++|+|||++........  ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcC
Confidence                        12467888899999999999999999999999999999999777 999999999876533221  111


Q ss_pred             cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccC
Q 021982          172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY  250 (304)
Q Consensus       172 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (304)
                      ...+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||...............-..                  
T Consensus       240 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  300 (343)
T cd05103         240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------  300 (343)
T ss_pred             CCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC------------------
Confidence            223356799999987665 7999999999999999997 89998765433322222211000                  


Q ss_pred             CCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                              .......++++.+++.+||+.||.+|||+.+|++|
T Consensus       301 --------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 --------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    00111356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.5e-40  Score=269.96  Aligned_cols=245  Identities=25%  Similarity=0.333  Sum_probs=195.9

Q ss_pred             hhcccccceEEEEEEEcc-CCc--EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982           10 EKVGEGTYGKVYRAREKA-TGK--IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~-~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      +.||+|++|.||++.+.. ++.  .+++|.+...... .....+..|+..++++ +||||+++++.+.. ..     .++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~-----~~~   72 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HP-----LMM   72 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-Ce-----EEE
Confidence            468999999999999865 333  5889988765433 3456778899999999 99999999999877 33     899


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      ++||+.+ +|.+.+.....  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        73 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~  149 (257)
T cd05040          73 VTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQ  149 (257)
T ss_pred             EEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEeccccccccccc
Confidence            9999975 99999876432  4689999999999999999999999999999999999999877 999999999876644


Q ss_pred             CCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          166 PIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       166 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ....   .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+......         
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------  219 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER---------  219 (257)
T ss_pred             cccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc---------
Confidence            2211   11233467899999887665 7899999999999999998 99999877666655544321100         


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                       .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       220 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                             0011246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-39  Score=283.29  Aligned_cols=257  Identities=20%  Similarity=0.327  Sum_probs=199.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|.+.+.||+|+||.||++++..     .+..+++|++...... .....+.+|+.++.++..||||+++++.+....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            4678999999999999999998643     3467999998754322 223467789999999944999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc----------------------------------------------------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ----------------------------------------------------  104 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------  104 (304)
                      .     .++|+||+.+ +|.+++.....                                                    
T Consensus       115 ~-----~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         115 P-----IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             C-----cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            5     8999999985 99998865321                                                    


Q ss_pred             ------------------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982          105 ------------------------------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus       105 ------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                                                                ....+++..++.++.|++.||.|||+.+++|+||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                      11246777889999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .++|+|||++........  ......+++.|++||.+.+.. ++.++|+||||+++|+|++ |..||.....
T Consensus       270 iLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         270 VLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            9999766 999999999875432211  112234567899999987665 7899999999999999998 8899976655


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .+........-.                          .......++.++.+++.+||..||.+||++.+|++.
T Consensus       348 ~~~~~~~~~~~~--------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         348 NEQFYNAIKRGY--------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             hHHHHHHHHcCC--------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444333322100                          001122468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.8e-40  Score=274.77  Aligned_cols=266  Identities=22%  Similarity=0.316  Sum_probs=195.2

Q ss_pred             hhhh-hhhhhcccccceEEEEEEE----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAF-EKLEKVGEGTYGKVYRARE----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y-~~~~~lg~g~~g~v~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++| ++++.||+|+||+||.+..    ..++..+++|.+..... ......+.+|+++++.+ +|||++++++++....
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   79 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG   79 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            5677 9999999999999988653    34677899998865422 12335677899999999 9999999999876533


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      .   ...+++|||+.+ +|.+++..     ..+++.+++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|
T Consensus        80 ~---~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~d  150 (283)
T cd05080          80 G---KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGD  150 (283)
T ss_pred             C---ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEee
Confidence            2   227899999986 88888865     3589999999999999999999999999999999999999776 899999


Q ss_pred             ccceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          157 LGLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       157 fg~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      ||++.........   .....++..|+|||.+.+.. ++.++||||||+++|+|++|..|+.......  ......... 
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~-  226 (283)
T cd05080         151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQG-  226 (283)
T ss_pred             cccccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhccccc-
Confidence            9998765433221   11123356799999887665 7899999999999999999999986544221  111100000 


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                       ........      +..  ...........++..+.+++.+||+.||++|||++++++
T Consensus       227 -~~~~~~~~------~~~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         227 -QMTVVRLI------ELL--ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             -ccchhhhh------hhh--hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             00000000      000  000011123467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.8e-40  Score=275.04  Aligned_cols=254  Identities=22%  Similarity=0.373  Sum_probs=199.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+..     ++..+++|.+..... ......+.+|+.+++.+ +|||++++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEF-DHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCC
Confidence            4689999999999999999998753     567899998764322 12234677899999999 9999999999988776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL  138 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl  138 (304)
                      .     .++++||+.+ +|.+++.....                  ....+++..++.++.|++.||.+||++|++|+||
T Consensus        82 ~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl  156 (288)
T cd05050          82 P-----MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL  156 (288)
T ss_pred             c-----cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            5     8999999985 99999875321                  1134788899999999999999999999999999


Q ss_pred             CCCCeEEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCC
Q 021982          139 KPHNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFP  215 (304)
Q Consensus       139 ~~~Nil~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~  215 (304)
                      +|.||+++.++ .++|+|||.+.......  ........+..|+|||.+.+.. ++.++||||||+++|+|++ |..||.
T Consensus       157 ~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         157 ATRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             cHhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999777 89999999987543221  1112223356799999887665 8999999999999999997 888887


Q ss_pred             CCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .....+....+...                           ........++.++.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         235 GMAHEEVIYYVRDG---------------------------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCHHHHHHHHhcC---------------------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            66655544433211                           000112257789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-39  Score=272.56  Aligned_cols=250  Identities=20%  Similarity=0.263  Sum_probs=191.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcE----EEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKI----VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||.|+||+||++.+..++..    +++|.+.... .......+..++..+..+ +||||+++++++.... 
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~~~-   82 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSL-DHAYIVRLLGICPGAS-   82 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcC-CCCCcceEEEEECCCc-
Confidence            46799999999999999999998776663    6666654221 112234566677788888 9999999999875432 


Q ss_pred             CCceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++++|++. |+|.+++...   ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+||
T Consensus        83 -----~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Df  153 (279)
T cd05111          83 -----LQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADF  153 (279)
T ss_pred             -----cEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCC
Confidence                 578899987 5999988652   24689999999999999999999999999999999999999766 8999999


Q ss_pred             cceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |.+........  ......++..|++||.+.+.. ++.++||||||+++|++++ |..||...........+.... .  
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~--  229 (279)
T cd05111         154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-R--  229 (279)
T ss_pred             ccceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-c--
Confidence            99976533221  112233467899999987665 7999999999999999998 999997765443322221110 0  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                              .......+.++.+++.+|+..||.+|||+.|+++
T Consensus       230 ------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         230 ------------------------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                    0011135678899999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.5e-40  Score=276.77  Aligned_cols=264  Identities=28%  Similarity=0.438  Sum_probs=203.5

Q ss_pred             hhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCC--CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHED--DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +|++.+.||.|++|.||++.+.   .++..+++|++.....  .......+..|+.++.++.+||+++++++.+..... 
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~-   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK-   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE-
Confidence            4788999999999999999864   3567899998874322  122334667899999999779999999999877665 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++||||+.+ +|.+++..    ...+++..+..++.|++.+|.+||+.|++|+||+|.||+++.++ .++|+|||
T Consensus        80 ----~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg  150 (288)
T cd05583          80 ----LHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFG  150 (288)
T ss_pred             ----EEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECc
Confidence                8999999986 88887754    24688999999999999999999999999999999999999776 89999999


Q ss_pred             ceeecccCCC-ccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPIK-KYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ++........ ......++..|++||.+.+.. ..+.++|+||||+++|+|++|..||...........+.......   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---  227 (288)
T cd05583         151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS---  227 (288)
T ss_pred             cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc---
Confidence            9865433221 112235688999999986543 26789999999999999999999996543221111111111000   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC---HHHHhcCCCccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS---AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~~~~~  302 (304)
                                           .......++..+.+++.+||+.||.+|||   +.++++||||+.+++.
T Consensus       228 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         228 ---------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             ---------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                                 00112357889999999999999999998   5678999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.1e-40  Score=274.23  Aligned_cols=260  Identities=20%  Similarity=0.310  Sum_probs=201.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++.+.||+|+||.||++.+..    ++..+++|.+... ........+.+|+.+++.+ +|||++++++++.....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCC
Confidence            4789999999999999999999876    2467888877532 2222345677899999999 99999999998765422


Q ss_pred             CCceEEEEEEeccC-CCHHHHHHHhccCC----CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEE
Q 021982           79 EGRTVLYLVFEYMD-TDLKKYIRSFRQTG----ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK  153 (304)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vk  153 (304)
                          ..+++++++. ++|.+++.......    ..+++.+++.++.|++.||.|||+.+++|+||+|+||+++.++ .++
T Consensus        83 ----~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~k  157 (280)
T cd05043          83 ----PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVK  157 (280)
T ss_pred             ----CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEE
Confidence                1689999997 59999987654322    5689999999999999999999999999999999999999776 999


Q ss_pred             EeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHh
Q 021982          154 IADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLL  230 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~  230 (304)
                      |+|||++..+......  .....++..|+|||.+.+.. ++.++||||||+++|++++ |..||...+..+....+....
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  236 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY  236 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence            9999998754322111  11123356799999987665 7999999999999999999 999998776555433322211


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ..                           .....+++++.+++.+||..||++|||+.++++  .|.++
T Consensus       237 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~--~l~~~  276 (280)
T cd05043         237 RL---------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ--CLTDF  276 (280)
T ss_pred             CC---------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence            00                           011246789999999999999999999999986  44443

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=268.33  Aligned_cols=243  Identities=26%  Similarity=0.403  Sum_probs=193.8

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEe
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE   89 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   89 (304)
                      +.||.|++|.||++.+.. ++.+++|.+...... .....+..|+++++.+ +|+||+++++++.....     .++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQP-----IYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCC-----eEEEEE
Confidence            469999999999999887 889999987754332 2345678899999999 99999999999887776     899999


Q ss_pred             ccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCC
Q 021982           90 YMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK  168 (304)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~  168 (304)
                      ++.+ +|.+++...   ...+++..+..++.+++.+|.+||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        73 ~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          73 LVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIY  148 (251)
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcc
Confidence            9975 888887652   23678999999999999999999999999999999999999777 899999999875542211


Q ss_pred             ccc--cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccC
Q 021982          169 KYT--HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM  245 (304)
Q Consensus       169 ~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (304)
                      ...  ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......             
T Consensus       149 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~-------------  214 (251)
T cd05041         149 TVSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-------------  214 (251)
T ss_pred             eeccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC-------------
Confidence            111  112245699999887665 7999999999999999999 78888777654444433221100             


Q ss_pred             CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                    .....++.++.+++.+||..+|.+|||+.|+++
T Consensus       215 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 --------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             --------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                          011246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-39  Score=269.92  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=198.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|+..+.||+|++|.||++.++.++.   .+++|.+..... ......+..|+.+++.+ +|||++++.+++..... 
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKP-   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCC-
Confidence            4679999999999999999999876554   688887754321 12234677899999999 99999999999987766 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++|||+++ +|.+++..   ....+++.++..++.|++.|+.+||+.|++|+||+|+||+++.++ .++++|||
T Consensus        81 ----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg  152 (268)
T cd05063          81 ----AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFG  152 (268)
T ss_pred             ----cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCc
Confidence                8999999986 88888764   224689999999999999999999999999999999999999766 89999999


Q ss_pred             ceeecccCCCccc---cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          159 LARAFTLPIKKYT---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       159 ~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      .+...........   ....++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+......+ 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~-  230 (268)
T cd05063         153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP-  230 (268)
T ss_pred             cceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-
Confidence            9876543222111   112245799999987665 7899999999999999997 999997766655444443211111 


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                                ....++.++.+++.+||+.||.+||++.++++
T Consensus       231 --------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 --------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             --------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                      01146788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.9e-39  Score=268.31  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=198.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+++|++.+.||+|++|.||++.+.. +..+++|.+....   .....+.+|+.+++.+ +|+||+++.+.+.. ..   
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~---   74 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS---MSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EP---   74 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh---hHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CC---
Confidence            46889999999999999999998654 4568899776432   1235677899999999 89999999999876 33   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++...  ....+++.++..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        75 --~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~  149 (260)
T cd05073          75 --IYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLA  149 (260)
T ss_pred             --eEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcce
Confidence              7899999975 999998763  335678889999999999999999999999999999999999777 9999999998


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ........ ......++..|+|||.+.... ++.++|+||||+++|++++ |..||...+.......+.....       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------  221 (260)
T cd05073         150 RVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-------  221 (260)
T ss_pred             eeccCCCcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-------
Confidence            76543221 112223456799999987655 7899999999999999998 8999987665554443322110       


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          .......+.++.+++.+||+.||.+||++.++++
T Consensus       222 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 --------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             --------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                0111357789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.4e-40  Score=301.43  Aligned_cols=263  Identities=29%  Similarity=0.461  Sum_probs=200.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc----
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK----   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~----   78 (304)
                      ..+|+.++.||+||||.||+++++-+|+.||||++.... .+.....+.+|+..+.++ +|||+++++..|.....    
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccc
Confidence            357999999999999999999999999999999998776 556677888999999999 99999998874321110    


Q ss_pred             --------------------------------------------------------------------------------
Q 021982           79 --------------------------------------------------------------------------------   78 (304)
Q Consensus        79 --------------------------------------------------------------------------------   78 (304)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------C--C-------ceEEEEEEeccCCCHHHHHHHhccCCCCC-ChHHHHHHHHHHHHHHHH
Q 021982           79 ---------------------E--G-------RTVLYLVFEYMDTDLKKYIRSFRQTGENI-PVNTVKSLMYQLCKGVAF  127 (304)
Q Consensus        79 ---------------------~--~-------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~-~~~~~~~~~~~i~~~l~~  127 (304)
                                           +  .       ...+||-||||..++...+-....   .. ..+..|+++++|+.||.|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHH
Confidence                                 0  0       145788899999755444433211   11 578899999999999999


Q ss_pred             HHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc------------------cCCCccccccccccCCChhhhhCCC
Q 021982          128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------------LPIKKYTHEILTLWYRAPEVLLGST  189 (304)
Q Consensus       128 Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~------------------~~~~~~~~~~~~~~~~~PE~~~~~~  189 (304)
                      +|++|++||||||.||+++.++ .|||+|||+++...                  .+....+...||..|.|||++.+..
T Consensus       713 IH~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  713 IHDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHhCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999777 99999999998721                  1122345667899999999998766


Q ss_pred             --CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCCh
Q 021982          190 --HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK  267 (304)
Q Consensus       190 --~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (304)
                        .++.+.|+||||++|+||+.   ||.   .......+...++...-..                   . ....-.--+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~---TsMERa~iL~~LR~g~iP~-------------------~-~~f~~~~~~  845 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFG---TSMERASILTNLRKGSIPE-------------------P-ADFFDPEHP  845 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCC---chHHHHHHHHhcccCCCCC-------------------C-cccccccch
Confidence              59999999999999999983   443   3333444444443211100                   0 011113335


Q ss_pred             hhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          268 DGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       268 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      .-..+|++||+.||++||||.|+|++.||-
T Consensus       846 ~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  846 EEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            567899999999999999999999999986

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-39  Score=267.84  Aligned_cols=243  Identities=25%  Similarity=0.396  Sum_probs=196.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||.+..  ++..+++|.++...    ....+.+|+.+++.+ +|||++++.+++....     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~-----   72 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKL-HHKNLVRLLGVILHNG-----   72 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCCC-----
Confidence            57899999999999999999864  57789999876432    235678899999999 9999999999986543     


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...  ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        73 -~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~  148 (254)
T cd05083          73 -LYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLAR  148 (254)
T ss_pred             -cEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccce
Confidence             6899999985 999998763  234688999999999999999999999999999999999999777 89999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+......        
T Consensus       149 ~~~~~~---~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------  216 (254)
T cd05083         149 VGSMGV---DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------  216 (254)
T ss_pred             eccccC---CCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------
Confidence            543321   1222356799999887655 7899999999999999997 99999877665544433221100        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         .....+++.+.+++.+||+.+|.+||++.+++.
T Consensus       217 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         217 -------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                               011257889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.4e-40  Score=271.54  Aligned_cols=251  Identities=22%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .+.|++.+.||+|++|.||++.++.++.   .+++|.+.... .......+..|+.+++.+ +||||+++.+++..... 
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~-   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRP-   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCc-
Confidence            5679999999999999999999876654   58999876432 222345778899999999 99999999999887666 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++++||+.+ +|.+++...   ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||
T Consensus        80 ----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg  151 (269)
T cd05065          80 ----VMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFG  151 (269)
T ss_pred             ----eEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCc
Confidence                8999999986 888887652   24689999999999999999999999999999999999999766 89999999


Q ss_pred             ceeecccCCCc--ccccc---ccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCC
Q 021982          159 LARAFTLPIKK--YTHEI---LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       159 ~~~~~~~~~~~--~~~~~---~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      .+.........  .....   .+..|+|||.+.+.. ++.++||||||+++|++++ |..||...+..+....+......
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~  230 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL  230 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            98655432211  11111   135799999987665 7999999999999999886 99999877665544443221110


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      +                           ....++..+.+++.+||..+|.+||++.++++
T Consensus       231 ~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 P---------------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             C---------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0                           11257788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.6e-39  Score=267.05  Aligned_cols=249  Identities=27%  Similarity=0.439  Sum_probs=200.1

Q ss_pred             hhhhhhcccccceEEEEEEEccCC----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATG----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +++.+.||.|+||.||.+.+...+    ..+++|.+...... .....+..|+..++.+ +|+|++++++++.....   
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~---   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEP---   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCe---
Confidence            357889999999999999998766    88999988644322 1356788899999999 99999999999888765   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++||++.+ +|.+++.....  ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus        76 --~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~  150 (258)
T smart00219       76 --LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLS  150 (258)
T ss_pred             --eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCc
Confidence              8999999986 89888876322  2289999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCCccc-cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIKKYT-HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ........... ...+++.|+|||.+.+.. .+.++|+||||+++++|++ |..||...+.......+.....       
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------  222 (258)
T smart00219      151 RDLYDDDYYKKKGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------  222 (258)
T ss_pred             eecccccccccccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------
Confidence            76654322111 123568899999885544 7999999999999999998 7888877666555554432111       


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          .......+.++.+++.+||+.||.+|||+.++++
T Consensus       223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 --------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                1112247889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=269.81  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=190.0

Q ss_pred             hhcccccceEEEEEEEccCCc--EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATGK--IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|++|.||++.++.++.  .+++|.+.... .......+..|++++.++.+||||+++++++.....     .+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-----~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-----LYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC-----ceEE
Confidence            368999999999999987765  35777665321 222234677899999999789999999999887665     7999


Q ss_pred             EeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEE
Q 021982           88 FEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI  154 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl  154 (304)
                      |||+.+ +|.+++.....            ....+++.++..++.|++.|+++||+.|++|+||||+||+++.++ .+++
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl  153 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKI  153 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEE
Confidence            999975 99999876331            123578999999999999999999999999999999999999777 9999


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCC
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      +|||++......... .....+..|+|||++.... ++.++|+||||+++|+|++ |..||...+..+....+....   
T Consensus       154 ~dfgl~~~~~~~~~~-~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---  228 (270)
T cd05047         154 ADFGLSRGQEVYVKK-TMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---  228 (270)
T ss_pred             CCCCCccccchhhhc-cCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---
Confidence            999998532221111 1122256799999887655 7999999999999999997 999997665544433322110   


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                              .......++.++.+++.+||..||.+|||+.+++.
T Consensus       229 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 ------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                    00011246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=270.45  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++.+.||+|+||.||++.++.++.    .+++|....... ......+.+|+.+++++ +|||++++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-Cc
Confidence            5689999999999999999999876554    577887654332 22335677899999999 99999999999876 22


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++++||+.+ +|.+++...   ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+||
T Consensus        83 -----~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~df  153 (279)
T cd05057          83 -----VQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDF  153 (279)
T ss_pred             -----eEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCC
Confidence                 7899999975 998888652   23589999999999999999999999999999999999999777 8999999


Q ss_pred             cceeecccCCCccc--cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKKYT--HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |.+...........  ...++..|+|||.+.... ++.++|+||||+++|++++ |..||......+....+......  
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--  230 (279)
T cd05057         154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL--  230 (279)
T ss_pred             cccccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC--
Confidence            99976653322211  122256799999887655 7899999999999999998 99999887665544444321100  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               ......+..+.+++.+||..||.+|||+.++++
T Consensus       231 -------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 -------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                     111246678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-39  Score=269.76  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=199.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-----CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|+.++.||+|+||.||+++.+.+     ...+++|.+.... .......+..|+.+++++ +|+|++++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence            36799999999999999999997543     3568888765322 222345678899999999 9999999999988766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCC-----CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCe
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTG-----ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT  151 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~  151 (304)
                      .     .+++|||+.+ +|.+++.......     ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .
T Consensus        82 ~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~  155 (275)
T cd05046          82 P-----HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-E  155 (275)
T ss_pred             c-----ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-c
Confidence            5     8999999985 9999987644221     2689999999999999999999999999999999999999877 8


Q ss_pred             EEEeeccceeecccC-CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHH
Q 021982          152 LKIADLGLARAFTLP-IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       152 vkl~dfg~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~  229 (304)
                      ++++|||++...... ........++..|+|||.+.+.. .+.++||||||+++|+|++ |..||...............
T Consensus       156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~  234 (275)
T cd05046         156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG  234 (275)
T ss_pred             EEEcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence            999999998643221 11222334467799999887665 7899999999999999998 78898766554433332211


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ...     +                     .....++..+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~~~-----~---------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 KLE-----L---------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CcC-----C---------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            000     0                     0112578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.1e-39  Score=265.14  Aligned_cols=248  Identities=21%  Similarity=0.360  Sum_probs=197.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .+|++.+.||+|++|.||++.+.. +..+++|.+.....   ....+.+|+++++.+ +||+++++++++.....     
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----   73 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM---SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSP-----   73 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC---CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCc-----
Confidence            578899999999999999998764 66799998764322   234678899999999 99999999999877665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++++||+.+ +|.+++...   ..++++..++.++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~  149 (256)
T cd05112          74 ICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRF  149 (256)
T ss_pred             eEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceee
Confidence            8999999986 888777542   24578999999999999999999999999999999999999666 899999999875


Q ss_pred             cccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....... ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......        
T Consensus       150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------  220 (256)
T cd05112         150 VLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL--------  220 (256)
T ss_pred             cccCcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC--------
Confidence            5432111 11222356899999887655 7899999999999999998 89999877665544443221100        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                         ......+..+.+++.+||+.+|.+|||+.++++.
T Consensus       221 -------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         221 -------------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                               0011357889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=300.67  Aligned_cols=252  Identities=24%  Similarity=0.419  Sum_probs=208.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCc-----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .-++...||+|+||.||.+.......     .|++|.++... +......+.+|..+++.+ +||||++++|++.+... 
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~-  769 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGP-  769 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCC-
Confidence            45677889999999999998765433     38888876543 233456888999999999 99999999999998666 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccC---CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQT---GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                          .++++|||.| +|+.+|++.+..   ...++...++.++.+|++|++||+++++||+||..+|+|++... .|||+
T Consensus       770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEc
Confidence                7999999985 999999885322   35689999999999999999999999999999999999999886 99999


Q ss_pred             eccceeec-ccCCCccccc-cccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCC
Q 021982          156 DLGLARAF-TLPIKKYTHE-ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       156 dfg~~~~~-~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      |||+|+.+ +......... .-...|||||.+.... ++.++||||||+++||++| |..||...++.+....+...-  
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            99999843 3332222222 3357899999999865 8999999999999999999 789999999988887665531  


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               .-..++.+++.+.+++..||+.+|++||++..|++
T Consensus       922 -------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 -------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                     22233479999999999999999999999999987

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.1e-39  Score=268.53  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=198.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|.+.+.||+|++|.||++.+...   ...+++|....... ......+.+|+.+++.+ +|||++++++++.+..  
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~--   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQF-DHPHIVKLIGVITENP--   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhC-CCCchhceeEEEcCCC--
Confidence            46789999999999999999987543   34688887764332 22335678899999999 9999999999887533  


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++|||+.+ +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||
T Consensus        81 ----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g  152 (270)
T cd05056          81 ----VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFG  152 (270)
T ss_pred             ----cEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCc
Confidence                5799999985 899988652   23589999999999999999999999999999999999999777 89999999


Q ss_pred             ceeecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ++......... .....+++.|+|||.+.... ++.++||||||+++|++++ |..||...+..+....+......    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----  227 (270)
T cd05056         153 LSRYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL----  227 (270)
T ss_pred             eeeecccccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC----
Confidence            98765433211 11222346799999886655 7899999999999999986 99999887776655444321100    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                             .....++..+.+++.+|+..+|.+|||+.+++.
T Consensus       228 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         228 -----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   112357889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=310.05  Aligned_cols=256  Identities=28%  Similarity=0.466  Sum_probs=215.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|+-..++|.|.||.||.+.+..+|...++|.+..+.......+...+|..++..+ +|||+++++|+-.+...     +
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRek-----v 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREK-----V 1309 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHH-----H
Confidence            46667899999999999999999999999999998877777788899999999999 99999999999887776     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      +|.||||.| +|.+.++..    .-.++.-...+..|++.|+.|||+.||||+||||.||+++.+| .+|++|||.+..+
T Consensus      1310 ~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEe
Confidence            999999996 888888662    3467777788999999999999999999999999999999888 9999999999988


Q ss_pred             ccCCCcc----ccccccccCCChhhhhCCC--CCCCchhHHHHHHHHHHHhhccccCCCCchH-HHHHHHHHHhCCCCCC
Q 021982          164 TLPIKKY----THEILTLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRLLGTPNEK  236 (304)
Q Consensus       164 ~~~~~~~----~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~  236 (304)
                      .......    ....||+.|||||++.+..  .-..+.|||||||++.||+||+.||...++. .....+-...      
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh------ 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH------ 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC------
Confidence            7654333    3457899999999997643  2567899999999999999999999876543 3333333221      


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                           -++.+..+|.+.++||..||..||++|.++.||++|.|=+.
T Consensus      1459 ---------------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1459 ---------------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             ---------------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                                 11222358899999999999999999999999999998664

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-39  Score=267.05  Aligned_cols=240  Identities=19%  Similarity=0.264  Sum_probs=182.6

Q ss_pred             hhcccccceEEEEEEEccC------------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982           10 EKVGEGTYGKVYRAREKAT------------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~------------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      +.||.|++|.||++.....            ...+++|.+....  ......+.+++.+++.+ +||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQV-SHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            4689999999999985322            2357778765432  22344677888999999 9999999999988766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM------  150 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~------  150 (304)
                      .     .+++|||+++ +|..++..   ...++++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.      
T Consensus        78 ~-----~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          78 E-----NIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             C-----CEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCc
Confidence            5     7899999996 66666543   2346899999999999999999999999999999999999986541      


Q ss_pred             eEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHh-hccccCCCCchHHHHHHHHHH
Q 021982          151 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll-~g~~p~~~~~~~~~~~~~~~~  229 (304)
                      .++++|||.+......    ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||......+........
T Consensus       150 ~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  225 (262)
T cd05077         150 FIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ  225 (262)
T ss_pred             eeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC
Confidence            3899999988654322    22345778999998875555899999999999999998 588887765443322111100


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .                             ......+.++.+||.+||+.||.+||++.+|+++
T Consensus       226 ~-----------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 C-----------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             c-----------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            0                             0011345788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.1e-39  Score=263.03  Aligned_cols=243  Identities=22%  Similarity=0.393  Sum_probs=190.9

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEe
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE   89 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   89 (304)
                      +.||+|++|.||++... ++..+++|.+..... ......+.+|+++++.+ +||||+++++++.....     .+++||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQP-----IYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCc-----cEEEEE
Confidence            36899999999999865 577899998764321 11223567899999999 99999999999887665     899999


Q ss_pred             ccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCC
Q 021982           90 YMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK  168 (304)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~  168 (304)
                      |+.+ +|.+++...   ...+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus        73 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          73 LVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             CCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceecccccc
Confidence            9985 888877542   23578999999999999999999999999999999999999776 899999999865433221


Q ss_pred             cc-ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          169 KY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       169 ~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      .. ....+++.|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+.....               
T Consensus       149 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---------------  212 (250)
T cd05085         149 SSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---------------  212 (250)
T ss_pred             ccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence            11 1122356799999887655 7899999999999999998 9999987665544443322110               


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                  ......++..+.+++.+||+.+|.+|||+.++++
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         213 ------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                        0112257889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=282.87  Aligned_cols=251  Identities=25%  Similarity=0.427  Sum_probs=207.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCc---E-EEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGK---I-VALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~---~-~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ++-.+.+.||+|+||.||++..+..+.   . ||+|..+.+. ........+.+|+.+++.+ +||||++++|+......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCc
Confidence            445667999999999999998765422   3 8899887532 4455667899999999999 99999999999988887


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           +++|||+|.| +|.++|+....   .++..+...++.+.+.||+|||+++++||||-.+|+|++.++ .+||+||
T Consensus       236 -----l~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDF  306 (474)
T KOG0194|consen  236 -----LMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDF  306 (474)
T ss_pred             -----cEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCcc
Confidence                 9999999996 99999987432   589999999999999999999999999999999999999766 7899999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHH-HhCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFR-LLGTPNE  235 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~-~~~~~~~  235 (304)
                      |+++............--..+|+|||.+.... ++.++||||+|+++||+++ |..||......+....+.. ..+.+  
T Consensus       307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~--  383 (474)
T KOG0194|consen  307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP--  383 (474)
T ss_pred             ccccCCcceeeccccccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC--
Confidence            99865431111111112257899999998875 8999999999999999999 7889999999988888844 22222  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               .....+.++..++.+|+..||+.|||+.++.+
T Consensus       384 -------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  384 -------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             -------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                                     22257788999999999999999999999876

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.3e-39  Score=266.53  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=192.8

Q ss_pred             hhcccccceEEEEEEEccCC------cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982           10 EKVGEGTYGKVYRAREKATG------KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.||+|++|.||++.++...      ..+++|.+..... ......+.+|+++++.+ +||||+++++++.....     
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----   73 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEP-----   73 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCC-----
Confidence            36899999999999876433      5788897754321 22345778899999999 99999999999887665     


Q ss_pred             EEEEEeccCC-CHHHHHHHhcc---CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC----CeEEEe
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQ---TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----MTLKIA  155 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~----~~vkl~  155 (304)
                      .+++|||+.+ +|.+++.....   ....+++.++..++.|++.||.|||+.+++|+||+|+||+++.++    ..++++
T Consensus        74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEEC
Confidence            8999999985 99999875332   224578899999999999999999999999999999999998644    369999


Q ss_pred             eccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCC
Q 021982          156 DLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       156 dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      |||++.......  .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+....  
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--  230 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG--  230 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC--
Confidence            999986543221  1111223467899999987765 7999999999999999998 999998766655443332110  


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               .......+++.+.+++.+||..+|.+||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                     00112357889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.7e-39  Score=265.44  Aligned_cols=252  Identities=22%  Similarity=0.306  Sum_probs=188.1

Q ss_pred             hhcccccceEEEEEEEcc--CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKA--TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||.||++....  ....+++|.+.... .......+.+|+..++.+ +||||+++++.+.....     .+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~-----~~lv   73 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIP-----YLLV   73 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCc-----eEEE
Confidence            469999999999997543  23467777665332 122234567899999999 99999999999887766     8999


Q ss_pred             EeccCC-CHHHHHHHhccC-CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           88 FEYMDT-DLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      |||+.+ +|.+++...... ....++..+..++.||+.|++|||++|++|+||||+||+++.++ .++|+|||.+.....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~  152 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYP  152 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEecccccccccc
Confidence            999985 999998764322 23346788899999999999999999999999999999999777 899999999864322


Q ss_pred             CC--CccccccccccCCChhhhhC------CCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          166 PI--KKYTHEILTLWYRAPEVLLG------STHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       166 ~~--~~~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ..  .......+++.|+|||++..      ...++.++||||||+++|+|++ |..||....+.+.............. 
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-  231 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP-  231 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC-
Confidence            11  11122334677999998753      2336889999999999999999 78898877766555444332111100 


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           .......++..+.+++..|+ .||.+|||+++|++
T Consensus       232 ---------------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         232 ---------------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ---------------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                 01112357788899999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-38  Score=264.55  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=187.9

Q ss_pred             hhcccccceEEEEEEEcc--CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKA--TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||.||++....  ++..+++|.+....... ....+.+|+.+++++ +||||+++++++.+...     .+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-----~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-EQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTP-----YLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-HHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCC-----cEEE
Confidence            468999999999998653  34578889876543221 223677899999999 99999999999887665     7999


Q ss_pred             EeccCC-CHHHHHHHhccC-CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           88 FEYMDT-DLKKYIRSFRQT-GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      |||+.+ +|.+++...... ....++..+..++.|++.|+.|||+.|++|+||||+||+++.++ .++|+|||.+.....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~  152 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYK  152 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccC
Confidence            999985 999988764322 23456778889999999999999999999999999999999776 899999999864332


Q ss_pred             CCCc--cccccccccCCChhhhhCCC------CCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          166 PIKK--YTHEILTLWYRAPEVLLGST------HYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       166 ~~~~--~~~~~~~~~~~~PE~~~~~~------~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ....  .....+++.|+|||++.+..      .++.++|+||||+++|+|++ |..||......+.............. 
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  231 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP-  231 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC-
Confidence            2111  11234467899999886421      25789999999999999996 99999877665543332221111000 


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           ........++.+.+++.+|+ .+|.+|||+++|+.
T Consensus       232 ---------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         232 ---------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ---------------------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                                 00111246678899999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.2e-39  Score=267.97  Aligned_cols=265  Identities=23%  Similarity=0.411  Sum_probs=193.4

Q ss_pred             hhhhhhhcccccceEEEEEEE----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            5 AFEKLEKVGEGTYGKVYRARE----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      -|++++.||+|++|.||.+..    ..++..+++|.+..... ......+.+|+++++.+ .|||++++.+++.....  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~--   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG--   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC--
Confidence            479999999999999999974    34677899998764422 22345678899999999 99999999998876421  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                       ...+++|||+.| +|.+++...   ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        81 -~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~  155 (284)
T cd05079          81 -NGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGL  155 (284)
T ss_pred             -CceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcc
Confidence             127899999975 898888642   23589999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +.........   .....++..|+|||.+.+.. ++.++||||||+++|+|+++..|........     ....++....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~~-----~~~~~~~~~~  229 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLF-----LKMIGPTHGQ  229 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccchh-----hhhccccccc
Confidence            8765433211   11233466799999887665 7899999999999999999876643321100     0000000000


Q ss_pred             CC-ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VW-PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .. .......        ...........++..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         230 MTVTRLVRVL--------EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             ccHHHHHHHH--------HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            00 0000000        000011122367899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=277.30  Aligned_cols=260  Identities=25%  Similarity=0.347  Sum_probs=192.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|.-...||+|+||.||++.-..+ ..++||.+.......  ..++..|+.++.++ +|||+++++|||.+...    .
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~----~  146 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRL-RHPNLVKLLGYCLEGGE----H  146 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcC-CCcCcccEEEEEecCCc----e
Confidence            4567778999999999999987654 889999766544332  45699999999999 89999999999997762    1


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC---ccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG---ILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~---i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      .++|+||+. |+|.+.+......  +++|.....|+.++|+||+|||...   |+|+|||+.|||+|.+- +.||+|||+
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGL  223 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGL  223 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccC
Confidence            799999998 6999998763222  8899999999999999999999853   99999999999999554 999999999


Q ss_pred             eeecccCCCccccc-cccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc--hHHHHHHHH-HHhCCCCC
Q 021982          160 ARAFTLPIKKYTHE-ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS--ELQQLLHIF-RLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~~~~~~~-~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~--~~~~~~~~~-~~~~~~~~  235 (304)
                      +............. .||.+|++||....+. .+.++||||||++|+|++||+.|.+...  .......+. ......  
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--  300 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--  300 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--
Confidence            95443311222222 7899999999887754 8999999999999999999998877532  111122211 111110  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCC-----hhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLD-----KDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                       ...         +   .....+..  ...+     ..+..+..+|++.+|..||++.|++.
T Consensus       301 -~~~---------e---iiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 -KLR---------E---IVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -chh---------h---eeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence             000         0   00000000  0112     23567889999999999999999764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-39  Score=296.66  Aligned_cols=148  Identities=28%  Similarity=0.545  Sum_probs=128.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +++|++++.||+|+||.||++.+..++..|++|++..... .......+..|+.+++.+ +||||+++++.+.....   
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~---   78 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANN---   78 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCE---
Confidence            5789999999999999999999999999999999875432 122235677888999998 99999999998877666   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++...    ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++ .++|+|||++
T Consensus        79 --~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls  151 (669)
T cd05610          79 --VYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLS  151 (669)
T ss_pred             --EEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCC
Confidence              8999999975 999888652    4588999999999999999999999999999999999999777 8999999987


Q ss_pred             e
Q 021982          161 R  161 (304)
Q Consensus       161 ~  161 (304)
                      .
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.2e-39  Score=262.04  Aligned_cols=228  Identities=26%  Similarity=0.364  Sum_probs=181.9

Q ss_pred             ccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCC-
Q 021982           15 GTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-   93 (304)
Q Consensus        15 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-   93 (304)
                      |.+|.||++.++.+++.+++|.+.....       ...+...+... .||||+++++++.....     .+++|||+.| 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~-~~~~i~~~~~~~~~~~~-----~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPH-CVPNMVCLHKYIVSEDS-----VFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhc-CCCceeehhhheecCCe-----EEEEEecCCCC
Confidence            8899999999999999999999875431       22344444455 79999999999887765     8999999986 


Q ss_pred             CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCccccc
Q 021982           94 DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE  173 (304)
Q Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~  173 (304)
                      +|.+++...    .++++..+..++.|++.||.+||+.|++|+||||+||+++.++ .++++|||.+.......   ...
T Consensus        71 ~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~~---~~~  142 (237)
T cd05576          71 KLWSHISKF----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDSC---DGE  142 (237)
T ss_pred             CHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhcccccc---ccC
Confidence            898888653    3589999999999999999999999999999999999999877 89999999876554322   223


Q ss_pred             cccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCC
Q 021982          174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQW  253 (304)
Q Consensus       174 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (304)
                      .++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|+........         .                     
T Consensus       143 ~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------~---------------------  191 (237)
T cd05576         143 AVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGIN---------T---------------------  191 (237)
T ss_pred             CcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------c---------------------
Confidence            3467799999886655 78999999999999999999987653321100         0                     


Q ss_pred             CCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-----HHHhcCCCc
Q 021982          254 NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYF  296 (304)
Q Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~eil~~~~~  296 (304)
                        .........+++.+.++|.+||+.||.+|||+     +++++||||
T Consensus       192 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         192 --HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             --ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence              00001123578899999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-38  Score=267.13  Aligned_cols=267  Identities=24%  Similarity=0.369  Sum_probs=192.9

Q ss_pred             hhhhhhhhcccccceEEEEEEE----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            4 DAFEKLEKVGEGTYGKVYRARE----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      ++|++++.||+|+||.||.+..    ..++..+++|.+....  ......+.+|+++++.+ +|||++++.+++..... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR-   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC-
Confidence            5789999999999999999973    4567889999876432  22235677899999999 99999999997654322 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                        ...++++||+.+ +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||
T Consensus        80 --~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg  153 (284)
T cd05081          80 --RNLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFG  153 (284)
T ss_pred             --CceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCc
Confidence              127899999975 999988642   23588999999999999999999999999999999999999777 89999999


Q ss_pred             ceeecccCCCcc---ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          159 LARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       159 ~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ++..........   ....++..|+|||.+.+.. ++.++|+||||+++++|++|..|+....... ...+... .. ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~-~~-~~  229 (284)
T cd05081         154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGND-KQ-GQ  229 (284)
T ss_pred             ccccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccc-cc-cc
Confidence            987654332211   1112244599999987665 7899999999999999999987765433211 0000000 00 00


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ..........        ...........++..+.+++.+||+.+|.+|||+.+|+.
T Consensus       230 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         230 MIVYHLIELL--------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cchHHHHHHH--------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0000000000        000011122467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=262.49  Aligned_cols=285  Identities=34%  Similarity=0.549  Sum_probs=232.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +..+|.-++.+|.|+- .|-.+.|.-.++++++|+...........++..+|...+..+ +|+||++++.++.-... +.
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence            3468999999999998 888888988999999998877666666778888999999999 99999999999875442 23


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+|+|||+++.+|.+.+..      .++-+.+..++.|++.|+++||+.||.||||||+||++..+. .+||.|||++
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~a  165 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVILM------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLA  165 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhh
Confidence            344899999999999888763      578889999999999999999999999999999999999888 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...+.. -.++....+-.|.+||++.+.. +....||||+||++.+|++|+..|...+.-++..++...++.+..++..+
T Consensus       166 r~e~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccCcc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            865554 4667777789999999999887 89999999999999999999999999999999999999999987765443


Q ss_pred             cccc-CCccc-------------CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          241 VSSL-MNWHE-------------YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       241 ~~~~-~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      +... .++..             +++..-.......+.-+..+++++.+||-.||++|.|++++|+||+++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            3211 11110             111111111111122335578999999999999999999999999997

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=270.00  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=224.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+|..+..||.|+||+|-++..+++...|+||+++++- ..++....-+.|..+|....+-|.++++..+|+.-+.    
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR----  424 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR----  424 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh----
Confidence            35788899999999999999999999999999888653 2223344555678888877678899999999999888    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +|+||||++| +|--.++..    +.+.+..+..++..|+-||-+||++||+++|||.+||+++.+| ++||+|||++.
T Consensus       425 -LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcK  498 (683)
T KOG0696|consen  425 -LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  498 (683)
T ss_pred             -eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeeccccc
Confidence             9999999997 776666553    5689999999999999999999999999999999999999998 99999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .--.+.......+|||.|+|||.+.-++ |+...|.||+|++||||+.|++||+..+..+..+.+.......        
T Consensus       499 Eni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy--------  569 (683)
T KOG0696|consen  499 ENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY--------  569 (683)
T ss_pred             ccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC--------
Confidence            5544445556678999999999888776 8999999999999999999999999999999998887643322        


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccccC
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~~  304 (304)
                                          +..+|.++.+++...|...|.+|..     -.+|-.||||..+++++|
T Consensus       570 --------------------PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  570 --------------------PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             --------------------cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence                                2368999999999999999999984     468999999999998874

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-39  Score=267.75  Aligned_cols=240  Identities=19%  Similarity=0.286  Sum_probs=184.2

Q ss_pred             hhcccccceEEEEEEEccCCc-------EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982           10 EKVGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~-------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +.||+|+||.||++.++..+.       .+++|.+....  ......+.+|..+++.+ +|||++++++++.....    
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~----   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDE----   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCC----
Confidence            469999999999998865443       37777664322  22234667888999999 99999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCe-------EEE
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT-------LKI  154 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~-------vkl  154 (304)
                       .+++|||+.+ +|.+++...   ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++..       +++
T Consensus        74 -~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          74 -SIMVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             -cEEEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence             7899999986 888887652   2358899999999999999999999999999999999999876522       799


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcc-ccCCCCchHHHHHHHHHHhCCC
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT-ALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      +|||.+......    ....++..|+|||++.+...++.++|+||||+++|+|++|. .|+...+...... .....   
T Consensus       150 ~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~---  221 (258)
T cd05078         150 SDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDR---  221 (258)
T ss_pred             cccccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHcc---
Confidence            999988644322    12345778999999987555789999999999999999995 5555544433222 11100   


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               .......+.++.+++.+||+.||.+|||+++|++.
T Consensus       222 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         222 -------------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -------------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                     00112355789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=268.01  Aligned_cols=261  Identities=15%  Similarity=0.205  Sum_probs=186.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCC---------chhHHHHHHHHHccCCCCeeee
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVP---------PTTLREVSILRMLSRDPHVVRL   69 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~h~~i~~~   69 (304)
                      ..++|++.+.||+|+||.||++.+..+   +..+++|............         .....+...+..+ .|++++.+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~   88 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKY   88 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcE
Confidence            357899999999999999999998876   5666777543322111000         0111222334455 79999999


Q ss_pred             eceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC
Q 021982           70 MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT  149 (304)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~  149 (304)
                      +++....... ....+++++++..++.+.+...    ...++..+..++.|++.||.+||+.+++||||||+||+++.++
T Consensus        89 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         89 YGCGSFKRCR-MYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EEeeeEecCC-ceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence            9876544321 1235788888887777766542    2357888999999999999999999999999999999999776


Q ss_pred             CeEEEeeccceeecccCC-------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH
Q 021982          150 MTLKIADLGLARAFTLPI-------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ  222 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~  222 (304)
                       .++|+|||++.......       .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||........
T Consensus       164 -~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        164 -RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             -cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence             89999999987653221       1112235799999999988766 79999999999999999999999987643222


Q ss_pred             HHHHH--HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          223 LLHIF--RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       223 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .....  ........                      .....+..+..+.+++..|++.+|.+||+.++|++
T Consensus       242 ~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        242 LIHAAKCDFIKRLHE----------------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhHHHHHHHhhh----------------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11111  11000000                      00012356788999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-38  Score=265.28  Aligned_cols=257  Identities=21%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             hhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc-
Q 021982            6 FEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR-   81 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~-   81 (304)
                      |++.+.||+|++|.||++.+.   .++..+++|.+............+.+|+++++.+ +|||++++++++......+. 
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence            678899999999999999864   3467899998876544443445677899999999 99999999998876544332 


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhcc--CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQ--TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      ...+++++|+.+ ++.+++.....  ....++...++.++.|++.||+|||+.|++|+||+|+||+++.++ .++++|||
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECccc
Confidence            235788899875 88777654322  123578899999999999999999999999999999999999666 89999999


Q ss_pred             ceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          159 LARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       159 ~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      .+.........  .....+++.|++||.+.+.. .+.++||||||+++|+|++ |..||...+..+....+.....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR----  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc----
Confidence            98765432211  11223356799999887665 7899999999999999999 8888876665444333322100    


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                             ....+..+..+.+++.+||+.+|.+|||+.+++.
T Consensus       234 -----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         234 -----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   0011256789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-38  Score=269.41  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=192.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|+..+.||+|++|.||++.+..++.    .+++|.+..... ......+.+|+.+++.+ +||||+++++++.... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~-   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASM-DHPHLVRLLGVCLSPT-   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCCC-
Confidence            3578999999999999999999876665    467776653221 11123567889999999 9999999999886543 


Q ss_pred             CCceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++++|++. |+|.+++...   ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+||
T Consensus        83 -----~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Df  153 (303)
T cd05110          83 -----IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDF  153 (303)
T ss_pred             -----ceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccc
Confidence                 468899998 5888887652   23588999999999999999999999999999999999998766 8999999


Q ss_pred             cceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |++.........  .....++..|++||.+.+.. ++.++||||||+++|+|++ |..||......+... ........ 
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~-  230 (303)
T cd05110         154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERL-  230 (303)
T ss_pred             cccccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCC-
Confidence            999765433221  11223366899999887655 7999999999999999997 899997665433222 22210000 


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               ...+..+..+.+++.+|+..||.+||++.++++.
T Consensus       231 -------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 -------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     0112467789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-38  Score=263.05  Aligned_cols=245  Identities=23%  Similarity=0.326  Sum_probs=183.7

Q ss_pred             hhcccccceEEEEEEEcc---CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEE
Q 021982           10 EKVGEGTYGKVYRAREKA---TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      +.||+|+||.||++.+..   .+..+++|.+.... .......+..|+.+++.+ +|||++++++++...+.    ..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~----~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEG----SPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCC----CcEE
Confidence            468999999999998643   34568889764321 112234667889999999 99999999997653322    1689


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      ++||+.+ +|.+++...   ....++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++.....
T Consensus        75 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~  150 (262)
T cd05058          75 VLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYD  150 (262)
T ss_pred             EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccC
Confidence            9999985 998888652   23457778889999999999999999999999999999999776 899999999875432


Q ss_pred             CC----CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc-cccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          166 PI----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       166 ~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..    .......+++.|+|||.+.+.. ++.++||||||+++|+|++| ..||...+..+....+......        
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~--------  221 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL--------  221 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence            11    1111223467899999887665 78999999999999999995 5566655544433333221000        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         .....+++.+.+++.+||..+|.+||++.++++
T Consensus       222 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 -------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             -------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                               001246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=271.17  Aligned_cols=267  Identities=25%  Similarity=0.416  Sum_probs=213.3

Q ss_pred             CchhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-----CCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            1 MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-----GVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         1 ~i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .|.++|.+++.||.|+|+.||++.+-.-++.+++|+-.....+.     ...+...+|..+.+.| .||.|+++++++.-
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSL  538 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeee
Confidence            36789999999999999999999998888999999876554332     2334667899999999 99999999999986


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc--CccccCCCCCCeEEeCCC--C
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--GILHRDLKPHNLLMDRKT--M  150 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--~i~h~dl~~~Nil~~~~~--~  150 (304)
                      ..+.    ++-|+|||.| +|.=+|+..    ..+++.++..++-||++||.||.+.  .|+|.||||.|||+-..+  .
T Consensus       539 Dtds----FCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  539 DTDS----FCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             cccc----ceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence            5553    8999999999 666666653    4589999999999999999999987  599999999999996432  5


Q ss_pred             eEEEeeccceeecccCCC-------ccccccccccCCChhhhhC---CCCCCCchhHHHHHHHHHHHhhccccCCCCchH
Q 021982          151 TLKIADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLG---STHYSTAVDMWSVACIFAELVTKTALFPGDSEL  220 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  220 (304)
                      .+||+|||++.++.....       ..+...||.+|+|||.|.-   .+..+.+.||||+|+|+|.++.|+.||......
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            899999999998865432       2345678999999999953   344899999999999999999999999877654


Q ss_pred             HHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      +.+-.-...+ ...+..                    + ...|.+++++.+||++||+.--+.|....++-.||+|..
T Consensus       691 QdILqeNTIl-kAtEVq--------------------F-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  691 QDILQENTIL-KATEVQ--------------------F-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHHhhhchh-cceecc--------------------C-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            4332221111 111111                    1 122468999999999999999999999999999999853

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-38  Score=264.97  Aligned_cols=239  Identities=19%  Similarity=0.275  Sum_probs=181.9

Q ss_pred             hcccccceEEEEEEEccC------------------------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCe
Q 021982           11 KVGEGTYGKVYRAREKAT------------------------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV   66 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~------------------------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   66 (304)
                      +||+|+||.||++....+                        ...+++|.+.....  .....+.+++.+++.+ +||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l-~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQV-SHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcC-CCCCe
Confidence            699999999999875321                        23477777653321  2234567788899998 99999


Q ss_pred             eeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE
Q 021982           67 VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM  145 (304)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~  145 (304)
                      +++++++.....     .++||||+.+ +|..++..   ....+++.++..++.|++.||+|||++|++|+||||+||++
T Consensus        79 v~~~~~~~~~~~-----~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill  150 (274)
T cd05076          79 AFVHGVCVRGSE-----NIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL  150 (274)
T ss_pred             eeEEEEEEeCCc-----eEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEE
Confidence            999999887766     7999999996 77776653   23468899999999999999999999999999999999999


Q ss_pred             eCCC------CeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHh-hccccCCCCc
Q 021982          146 DRKT------MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDS  218 (304)
Q Consensus       146 ~~~~------~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll-~g~~p~~~~~  218 (304)
                      +..+      ..++++|||.+......    ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||....
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            7543      24899999987543221    12245778999998876555899999999999999985 6899987765


Q ss_pred             hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..+......... .                            .....++.+.++|.+||+.+|.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         227 PSEKERFYEKKH-R----------------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             hHHHHHHHHhcc-C----------------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            544322111100 0                            001245678999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-38  Score=261.35  Aligned_cols=237  Identities=19%  Similarity=0.299  Sum_probs=183.6

Q ss_pred             hhcccccceEEEEEEEccCC----------cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982           10 EKVGEGTYGKVYRAREKATG----------KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~----------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +.||+|+||.||++.+..++          ..+++|.+......   ...+.+|+.+++.+ +||||+++++++.. .. 
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~-   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQL-SHKHLVKLYGVCVR-DE-   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcC-CCcchhheeeEEec-CC-
Confidence            46899999999999998766          24666765533221   46778899999999 99999999998877 43 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC------eE
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM------TL  152 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~------~v  152 (304)
                          .++++||+.+ +|.+++....   ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.      .+
T Consensus        75 ----~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          75 ----NIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             ----cEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeE
Confidence                6899999986 8888887632   26889999999999999999999999999999999999986542      59


Q ss_pred             EEeeccceeecccCCCccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHh
Q 021982          153 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLL  230 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~  230 (304)
                      +|+|||++......    ....++..|+|||.+.+. ..++.++|+||||+++|+|++ |..||...+........... 
T Consensus       148 kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-  222 (259)
T cd05037         148 KLSDPGIPITVLSR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-  222 (259)
T ss_pred             EeCCCCcccccccc----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-
Confidence            99999998765431    122346779999998766 348999999999999999999 57777666533222211100 


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                         ..                         ........+.+++.+||..+|.+|||+.++++
T Consensus       223 ---~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 ---HR-------------------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---CC-------------------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence               00                         00012278899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-38  Score=265.19  Aligned_cols=256  Identities=26%  Similarity=0.422  Sum_probs=195.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEc----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREK----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +.|++.+.||+|++|.||++...    .++..+++|.+...... .....+.+|+++++.+ .||||+++++++..... 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~-   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG-   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC-
Confidence            56899999999999999999864    34778999988754332 2345788999999999 99999999998766321 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                        ...+++|||+.+ +|.+++....   ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||
T Consensus        81 --~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg  154 (284)
T cd05038          81 --RSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFG  154 (284)
T ss_pred             --CceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccc
Confidence              127899999975 9999886532   2589999999999999999999999999999999999999776 89999999


Q ss_pred             ceeecccCCCcc---ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH-----------HH
Q 021982          159 LARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-----------LL  224 (304)
Q Consensus       159 ~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----------~~  224 (304)
                      .+..........   ....++..|++||.+.+.. .+.++|+||||+++++|++|..|+........           ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            997665322211   1123355699999887665 78999999999999999999999865432210           11


Q ss_pred             HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .+...+...                       ........++.++.+++.+||+.+|.+|||+.|+++
T Consensus       234 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         234 RLLELLKEG-----------------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHcC-----------------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            111110000                       000111246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.7e-38  Score=260.24  Aligned_cols=252  Identities=20%  Similarity=0.306  Sum_probs=187.3

Q ss_pred             hhcccccceEEEEEEEccCC--cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKATG--KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||.||++....++  ..+++|.+..... ......+.+|+..++.+ +|||++++++.+.....     .+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~-----~~lv   73 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIP-----YLLV   73 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCc-----cEEE
Confidence            46999999999999754332  3455665543322 12245778888999999 99999999999887665     8999


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.+ +|.+++..........++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKE  152 (268)
T ss_pred             EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcc
Confidence            999985 99999876444344567788899999999999999999999999999999999777 8999999987532211


Q ss_pred             --CCccccccccccCCChhhhhCC------CCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          167 --IKKYTHEILTLWYRAPEVLLGS------THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       167 --~~~~~~~~~~~~~~~PE~~~~~------~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                        ........++..|+|||++...      ...+.++||||||+++|+|++ |..||...+..+....+........   
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---  229 (268)
T cd05086         153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL---  229 (268)
T ss_pred             hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc---
Confidence              1112233557889999987531      225789999999999999997 4678877766665555443211100   


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         ........+++.+.+++..|+ .+|.+|||+.+|++
T Consensus       230 -------------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 -------------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -------------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                               001112247788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=265.73  Aligned_cols=287  Identities=31%  Similarity=0.515  Sum_probs=211.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC-------CCeeeeeceeccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD-------PHVVRLMDVKQGQ   76 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h-------~~i~~~~~~~~~~   76 (304)
                      .+|.+.++||.|.|++||++.|..+.+.||+|+.+...   ........|+.+|+++..+       .+|+++++.|...
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            58999999999999999999999999999999887432   2234567899999988543       3699999999988


Q ss_pred             ccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCC-----
Q 021982           77 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTM-----  150 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~-----  150 (304)
                      ..++.. +++|+|+++.+|+.++.....  ..++...+.+|++||+.||.|||+ .||+|.||||+|||+.....     
T Consensus       155 GpNG~H-VCMVfEvLGdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  155 GPNGQH-VCMVFEVLGDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             CCCCcE-EEEEehhhhhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence            877776 799999999999999988544  458899999999999999999995 59999999999999943100     


Q ss_pred             --------------------------------------------------------------------------------
Q 021982          151 --------------------------------------------------------------------------------  150 (304)
Q Consensus       151 --------------------------------------------------------------------------------  150 (304)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 021982          151 --------------------------------------------------------------------------------  150 (304)
Q Consensus       151 --------------------------------------------------------------------------------  150 (304)
                                                                                                      
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                            


Q ss_pred             eEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc------hHHHHH
Q 021982          151 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLL  224 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~------~~~~~~  224 (304)
                      +|||+|||-++-...   .++...-|-.|++||++.+.. |+..+||||++|+.|||.||...|...+      +.+.++
T Consensus       392 ~vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  392 RVKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             eEEEeeccchhhhhh---hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            022222222211110   001111156699999999987 8999999999999999999999997543      567788


Q ss_pred             HHHHHhCCCCCCCCccccccCCc----------ccCCCCCCCcccccCCCCC----hhhHHHHHHhhcCCCCCCCCHHHH
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNW----------HEYPQWNPQSLATAVPNLD----KDGLDLLEQMLQYDPSKRISAKKA  290 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ei  290 (304)
                      .++..++..+.+....-..+.++          +....|.-..+-....+.|    .++.+|+.-||+.+|.+||||.+.
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            88888877665443322222222          1222221111111111333    457799999999999999999999


Q ss_pred             hcCCCccccc
Q 021982          291 MEHPYFDDLD  300 (304)
Q Consensus       291 l~~~~~~~~~  300 (304)
                      |+|||+..+.
T Consensus       548 l~hPwLn~~~  557 (590)
T KOG1290|consen  548 LKHPWLNPVA  557 (590)
T ss_pred             hcCccccCCC
Confidence            9999999653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=275.82  Aligned_cols=262  Identities=24%  Similarity=0.387  Sum_probs=227.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++++.+.-||-|+||.|-++.-+....-+++|++++.. .+..+...+..|-+++..+ ..|.|++++..|.++..    
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~ky----  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKY----  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchh----
Confidence            45678889999999999999887666568888877543 3444556778899999999 89999999999999998    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +|++||.|-| .+...+..    .+.+.......++.+++.|++|||++||+++||||+|.+++.+| -+||.|||++.
T Consensus       495 -vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAK  568 (732)
T KOG0614|consen  495 -VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAK  568 (732)
T ss_pred             -hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHH
Confidence             9999999975 88888865    36699999999999999999999999999999999999999888 89999999999


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .++.+.... ..+|||.|.|||.+++.. .....|.||||+++|||++|.+||...++...+..+.+.+...        
T Consensus       569 ki~~g~KTw-TFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------  638 (732)
T KOG0614|consen  569 KIGSGRKTW-TFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------  638 (732)
T ss_pred             HhccCCcee-eecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------
Confidence            998876554 458999999999999887 5899999999999999999999999999999988887754221        


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccccC
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~~  304 (304)
                                        ..+..++....+||+++...+|.+|..     +.+|-.|.||..+++++|
T Consensus       639 ------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  639 ------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             ------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence                              122357888999999999999999995     899999999999999865

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=259.83  Aligned_cols=286  Identities=35%  Similarity=0.589  Sum_probs=227.0

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      --+.||.|+||.||.+.|..+|+.+++|++.+-...-...+++.+|+.++..+ +|.|++..+++.+-...+-...+|++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34679999999999999999999999999887555555567888999999999 99999999998876655444447788


Q ss_pred             EeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC-
Q 021982           88 FEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-  166 (304)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~-  166 (304)
                      +|.+..+|-..+.+    ..+++.+.+.-++.||+.||+|||+.||.|+||||.|.+++.+. .+||+|||+++..... 
T Consensus       136 TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  136 TELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhh
Confidence            88888777666654    46799999999999999999999999999999999999999777 9999999999876543 


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      ...++.+.-|..|++||.+.+..+++.+.||||+|||+.|++..+..|.-.+.-+++..+...++.+..+...-.-.+..
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            34456667789999999999999999999999999999999999999999999999999999999886542211100111


Q ss_pred             cccCCCCCCC-cccccCC-----CCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          247 WHEYPQWNPQ-SLATAVP-----NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       247 ~~~~~~~~~~-~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .+-.+.-.+. +.+....     .-..+...++..||.+||.+|.+.++.+.|+++.+.
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            1111111111 1111111     122345678899999999999999999999998765

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=271.48  Aligned_cols=249  Identities=24%  Similarity=0.436  Sum_probs=205.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccC----CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKAT----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +...+.++||.|-||.||++....-    +-.|+||+-+.+...++ ...+..|..+++.+ +||||++++|++.+..  
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnf-dHphIikLIGv~~e~P--  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNF-DHPHIIKLIGVCVEQP--  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhC-CCcchhheeeeeeccc--
Confidence            4456788999999999999986432    23588888776544433 67889999999999 9999999999998876  


Q ss_pred             CceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++|||.+. |.|..+++..+   ..++...+.-++.||+.||.|||+.++|||||-..||||.... -|||+|||
T Consensus       465 ----~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFG  536 (974)
T KOG4257|consen  465 ----MWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFG  536 (974)
T ss_pred             ----eeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccc
Confidence                799999998 79999998643   4689999999999999999999999999999999999999666 89999999


Q ss_pred             ceeecccCCCcc-ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPIKKY-THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +++.+....-.. +...-..-|+|||.+.-.. ++.++|||+||+.+||+++ |..||.+..+.+.+..+.+        
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--------  607 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--------  607 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC--------
Confidence            998775542222 2222257799999886555 7999999999999999886 8999998887776655543        


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         +.....++++++.+..|+.+||..||.+||.+.+|..
T Consensus       608 -------------------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  608 -------------------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             -------------------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence                               3444556789999999999999999999999988754

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=276.56  Aligned_cols=211  Identities=29%  Similarity=0.447  Sum_probs=178.7

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCceEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGRTVL   84 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~~~~   84 (304)
                      |..-+.||.|+||.||.++++.+|+.+|||+++... ...-.....+|+++++++ +|+|||++.++-..... ...+..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccc
Confidence            456688999999999999999999999999988644 222345677899999999 79999999998665541 112346


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC---CeEEEeeccce
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLA  160 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~---~~vkl~dfg~~  160 (304)
                      .++||||.| +|...+.+. .+...+++.+++.++.+++.||+|||++||+||||||.||++....   ...||+|||.|
T Consensus        93 vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             eEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            899999986 999988764 4456799999999999999999999999999999999999995332   46899999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL  220 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  220 (304)
                      +....+. .+.+..||+.|++||++..+..++...|.||||+++|++.||..||......
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            8877764 7778899999999999987666999999999999999999999999765544

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-37  Score=281.04  Aligned_cols=284  Identities=24%  Similarity=0.289  Sum_probs=176.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC----CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|.+.+.||+|+||.||++.+..+    +..+++|.+......     ... ....++.. .+.++...+..+.....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~-~~e~l~~~-~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIW-MNERVRRA-CPNSCADFVYGFLEPVS  203 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHH-HHHHHHhh-chhhHHHHHHhhhcccc
Confidence            46899999999999999999999888    889999986532111     111 11112222 22233332222221111


Q ss_pred             -CCceEEEEEEeccCC-CHHHHHHHhccC----------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 021982           79 -EGRTVLYLVFEYMDT-DLKKYIRSFRQT----------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP  140 (304)
Q Consensus        79 -~~~~~~~lv~e~~~~-~l~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~  140 (304)
                       ......++++||+++ +|.+++......                ........+..++.|++.||.|||+.||+|+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence             122238999999986 888887642100                00112345678999999999999999999999999


Q ss_pred             CCeEEeCCCCeEEEeeccceeecccCCC-ccccccccccCCChhhhhCCCC---------------------CCCchhHH
Q 021982          141 HNLLMDRKTMTLKIADLGLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTH---------------------YSTAVDMW  198 (304)
Q Consensus       141 ~Nil~~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~---------------------~~~~~Di~  198 (304)
                      +|||++.++..+||+|||++........ ......+++.|+|||.+.....                     ++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999996545899999999976543221 2233466899999997743221                     23456999


Q ss_pred             HHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhc
Q 021982          199 SVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ  278 (304)
Q Consensus       199 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  278 (304)
                      ||||+||+|+++..|+.  +................ ..|....   ... ...... .........+....+||.+||+
T Consensus       364 SlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~-~~~~~~~---~~~-~~~~~~-~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDL-VAWRKLV---EPR-ASPDLR-RGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcH-HHHHHhh---ccc-cchhhh-hhhhhccccchHHHHHHHHHcc
Confidence            99999999998765533  22223322222211100 0000000   000 000000 0000011223456799999999


Q ss_pred             CCCCCCCCHHHHhcCCCcccccc
Q 021982          279 YDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       279 ~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .||.+|||+.|+|+||||.....
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999999987543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1e-36  Score=248.95  Aligned_cols=243  Identities=39%  Similarity=0.657  Sum_probs=196.4

Q ss_pred             cceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCC-C
Q 021982           16 TYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-D   94 (304)
Q Consensus        16 ~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~   94 (304)
                      ++|.||++.+..++..+++|.+........ ...+.+|+..++++ +|++++++.+++.....     .++++|++++ +
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~-----~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKL-KHPNIVRLYDVFEDEDK-----LYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCE-----EEEEEeCCCCCC
Confidence            589999999998899999999875443321 46888999999999 99999999999887655     8999999998 9


Q ss_pred             HHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCcccccc
Q 021982           95 LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI  174 (304)
Q Consensus        95 l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~  174 (304)
                      |.+++...    ..++...++.++.+++.++.+||+.+++|+||+|.||+++.++ .++++|||.+....... ......
T Consensus        74 L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~-~~~~~~  147 (244)
T smart00220       74 LFDLLKKR----GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGG-LLTTFV  147 (244)
T ss_pred             HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeecccc-cccccc
Confidence            99888663    2288999999999999999999999999999999999999776 99999999998765542 333445


Q ss_pred             ccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCC
Q 021982          175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWN  254 (304)
Q Consensus       175 ~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (304)
                      ++..|+|||.+.+.. .+.++|+||||++++++++|..||...................                     
T Consensus       148 ~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---------------------  205 (244)
T smart00220      148 GTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP---------------------  205 (244)
T ss_pred             CCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC---------------------
Confidence            688899999887655 7889999999999999999999998743333333222211000                     


Q ss_pred             CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          255 PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                         .......++.++.+++.+||..||.+||++.++++||||
T Consensus       206 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      206 ---FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               000011277899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=252.00  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=217.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|+++..||+|++++|-.++.+++.+-|++|++++.- .++......+.|..+..+.++||.++.+..+|+.+..   
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr---  325 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR---  325 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce---
Confidence            357999999999999999999999999999999988653 2333456777899999999999999999999999887   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++|.||.+| +|.=.++.    ...++++.+..+...|+.||.|||+.||+++|||.+|+++|..+ ++||+|+|.+
T Consensus       326 --lffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmc  398 (593)
T KOG0695|consen  326 --LFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMC  398 (593)
T ss_pred             --EEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchh
Confidence              9999999997 65433433    34699999999999999999999999999999999999999888 9999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC-------chHHHHHHHHHHhCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD-------SELQQLLHIFRLLGTP  233 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~-------~~~~~~~~~~~~~~~~  233 (304)
                      ..--.+....+..+|||.|.|||.+.+.. ++...|.|+||++|++|+.|+.||+..       +..+.+-.++-..   
T Consensus       399 ke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek---  474 (593)
T KOG0695|consen  399 KEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK---  474 (593)
T ss_pred             hcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh---
Confidence            76555556667789999999999988877 899999999999999999999999632       1222222222111   


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC------CHHHHhcCCCcccccccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI------SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~eil~~~~~~~~~~~~  303 (304)
                                              ....+..+|..+..+++.-|++||++|.      .+.++..|+||..++++-
T Consensus       475 ------------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  475 ------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             ------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence                                    1112235777788999999999999997      688999999999998764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=249.73  Aligned_cols=266  Identities=23%  Similarity=0.360  Sum_probs=208.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +..+-+..||.|+||+|++-.++.+|+..|+|.++.... +...+++..|.+....-++.|+|++++|..-.++.     
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----  137 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----  137 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----
Confidence            456778899999999999999999999999999986543 22335666777766666699999999999888887     


Q ss_pred             EEEEEeccCCCHHHHHHHh-ccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           84 LYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .++.||.++-++..+-+.. ......+++..+..+....+.||.||.+ ..|+|+|+||+|||+++.| .|||+|||.+-
T Consensus       138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcG  216 (361)
T KOG1006|consen  138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICG  216 (361)
T ss_pred             eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchH
Confidence            8999999997764432221 1233568999999999999999999985 4899999999999999888 99999999986


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCC-CCCchhHHHHHHHHHHHhhccccCCCCch-HHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... ..+...|-..|+|||.+..... +.-+||+||||++|+|+.||..|+..++. .+++..+...  .++.-..+
T Consensus       217 qLv~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g--dpp~l~~~  293 (361)
T KOG1006|consen  217 QLVDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG--DPPILLFD  293 (361)
T ss_pred             hHHHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC--CCCeecCc
Confidence            554432 2334456677999999976544 88999999999999999999999987765 3455444432  11110000


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                          ..--+++..+..+|.-||.+|-+.||...+++.+||+...
T Consensus       294 --------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  294 --------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             --------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence                                0012578899999999999999999999999999998754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=278.95  Aligned_cols=254  Identities=30%  Similarity=0.409  Sum_probs=197.3

Q ss_pred             hhhhhhcccccceE-EEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            6 FEKLEKVGEGTYGK-VYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         6 y~~~~~lg~g~~g~-v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      |.-.+.+|.|+.|+ ||.+...  ++.||||.+....     ...+.+|++.|+....||||+++++...+...     .
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF-----~  578 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQF-----L  578 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCce-----E
Confidence            34457788999877 7999765  7799999776332     23567899999999999999999988666655     9


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC---CC-CeEEEeeccce
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KT-MTLKIADLGLA  160 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~---~~-~~vkl~dfg~~  160 (304)
                      ||+.|.|..+|.++++.-............+.+..|++.||++||+.+||||||||.||||..   ++ ..++|+|||++
T Consensus       579 YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  579 YIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             EEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            999999999999999873111111222456889999999999999999999999999999986   23 68999999999


Q ss_pred             eecccCCCcc---ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc-cccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      .....+....   ....||.+|+|||++.+.. -+.+.|||||||++|+.++| ..||.+....+  .++...       
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~-------  728 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTG-------  728 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcC-------
Confidence            9987665443   4467799999999998776 57799999999999999997 99998765433  222211       


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                        ...+....+..+.++.+||.+|+++||..||+|.++|.||||=+.
T Consensus       729 ------------------~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  729 ------------------NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             ------------------ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                              111111112222378899999999999999999999999998553

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=263.79  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=212.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +...++++||+|-||.|.+++-.. +..||+|+++...... ....+.+|+++|.+| +||||+.+.+.|...+.     
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqL-khPNIveLvGVC~~DeP-----  609 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKN-ARNDFLKEIKILSRL-KHPNIVELLGVCVQDDP-----  609 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchh-HHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCc-----
Confidence            456789999999999999998654 6889999988654333 357899999999999 99999999999998887     


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++++||+. |+|.+++.....  +.+.......++.||++|++||.+.++|||||.+.|+|++.+. ++||+|||.++.
T Consensus       610 icmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~  686 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRN  686 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccc
Confidence            899999998 699999987422  2246677788999999999999999999999999999999776 999999999975


Q ss_pred             cccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh--ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT--KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ...+.  .......-..+|+|||.+..++ .+.++|+|+||+++||+++  ...||...++.+..++....+....... 
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~-  764 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV-  764 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce-
Confidence            53322  2222334478999999999887 7999999999999999876  5789999998888888777655543332 


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         ....++-++..+.+++.+|+..|..+|||++++-.
T Consensus       765 -------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  765 -------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                               23334568899999999999999999999999854

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=272.35  Aligned_cols=265  Identities=24%  Similarity=0.439  Sum_probs=224.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|.+...+|.|.+|.||+++++.+++..++|+.......   ...+..|.++++.+..|||++.+++++......+...
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            3578889999999999999999999999999987655433   3567789999999999999999999998777777777


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++|||+|+| +..+.++...  +..+.|+.+..+++.++.||.+||++.++|+|+|-.|||++.++ .|||+|||.+..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeee
Confidence            9999999996 9999999977  67899999999999999999999999999999999999999888 999999999998


Q ss_pred             cccCCCccccccccccCCChhhhhCCCC----CCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~----~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .+..........|||.|||||++.....    ++.++|+||||++..||--|.+|+-+..+.-.   ++...+.|+.+.-
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRNPPPkLk  249 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNPPPKLK  249 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hccCCCCCCcccc
Confidence            8887777777899999999999965332    67899999999999999999999887665332   2333333322210


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                            ....-+..+.++|..||..|-.+||+..++|.|||..+.
T Consensus       250 ----------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  250 ----------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ----------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                                  011345678899999999999999999999999999854

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=264.04  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=209.4

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      ..+.++||.|-||.||.+.|+.....+++|+++-+.   -....+.+|+.+++.+ +|||+++++++|..+..     +|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpP-----FY  339 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPP-----FY  339 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCC-----eE
Confidence            345689999999999999999988899999887433   2357899999999999 99999999999999988     99


Q ss_pred             EEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           86 LVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ||+||+- |+|+++|....+  ..++...++.++.||++|++||.+++++|+||-..|.||..+. .||++|||+++.+.
T Consensus       340 IiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhhhc
Confidence            9999987 799999998655  5688889999999999999999999999999999999999776 99999999999887


Q ss_pred             cCCCccc-cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          165 LPIKKYT-HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       165 ~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      .+..... ..--..-|.+||.+.-+. ++-++|||+||++|||+.| |-.||...+-.+.+.-+.+.++-.         
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~---------  486 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD---------  486 (1157)
T ss_pred             CCceecccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc---------
Confidence            6532211 111156799999887666 7899999999999999998 788999888777777665543322         


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                        ...++++.+.+|++.||++.|..||++.||-+
T Consensus       487 ------------------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  487 ------------------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             ------------------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence                              23389999999999999999999999998743

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=275.13  Aligned_cols=248  Identities=21%  Similarity=0.347  Sum_probs=215.8

Q ss_pred             hhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      .+.+.||.|.||.|+.++-+..++   .|+||+++.- ..+.+...|..|+.|+-++ +||||+++.|+......     
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~P-----  704 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKP-----  704 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCce-----
Confidence            467889999999999999876654   5899998753 3344567899999999999 99999999999998887     


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++|++||+. |+|..+|..   ++..++.-++..|++.|+.|++||-+-|+|||||-..||||+.+- .+|++|||+++.
T Consensus       705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRv  780 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRV  780 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceee
Confidence            999999997 699999986   345699999999999999999999999999999999999999555 999999999997


Q ss_pred             cccCCCccccccc---cccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIKKYTHEIL---TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~~~~~~~~---~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ...++.......|   ..+|.|||.+.-.. .+.++||||+|++|||.|+ |..||=+.++.+.+..+...++-|+..  
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm--  857 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM--  857 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC--
Confidence            7665533333333   58999999998776 7999999999999999776 999999999999999999887777665  


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               .++..+.+|+..||++|-.+||.+.||+++
T Consensus       858 -------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  858 -------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             -------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                     588999999999999999999999999874

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=265.41  Aligned_cols=254  Identities=26%  Similarity=0.350  Sum_probs=210.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccC-Cc--EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKAT-GK--IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~-~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ++..+.++||+|+||.|+.+.|... |+  .|+||.++...... ....+..|++++.++ .|+|+++++|+..+..   
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L-~H~hliRLyGvVl~qp---  184 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKL-QHPHLIRLYGVVLDQP---  184 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhc-cCcceeEEeeeeccch---
Confidence            4578899999999999999998653 33  58899887554332 678899999999999 9999999999988744   


Q ss_pred             ceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         +.+|||.+. |+|.+.|..  .....+....+..++.||+.|+.||.+++++|+||-..|+++.... .|||+|||+
T Consensus       185 ---~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGL  258 (1039)
T KOG0199|consen  185 ---AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGL  258 (1039)
T ss_pred             ---hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccc
Confidence               689999999 599999988  3446789999999999999999999999999999999999999766 999999999


Q ss_pred             eeecccCCCcccc--cc-ccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLPIKKYTH--EI-LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~~~~~~--~~-~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      .+..+.+......  .. -..-|+|||.+.... ++.++|+|++|+++|||+| |..||......+.+..+-.       
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~-------  330 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA-------  330 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc-------
Confidence            9877655333211  11 156799999988777 7999999999999999998 6899999998887776642       


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                          +..-...+.++.++.+++..||..+|..|||+..|.+.-++
T Consensus       331 --------------------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  331 --------------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             --------------------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence                                22223334689999999999999999999999999765443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.5e-37  Score=261.10  Aligned_cols=285  Identities=32%  Similarity=0.538  Sum_probs=223.2

Q ss_pred             CchhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccC-----CCCeeeeeceecc
Q 021982            1 MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-----DPHVVRLMDVKQG   75 (304)
Q Consensus         1 ~i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~~i~~~~~~~~~   75 (304)
                      +|-++|.+....|.|-|++|..|.++..|..||||++.+....   .+.=..|+++|+.|+.     --|++.++..|..
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3567899999999999999999999999999999999865422   2344579999999943     2378888888888


Q ss_pred             cccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           76 QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      .++     +|+|||.+.-+|.+.|+.+..+ -.+....+..++.|+.-||..|.+.|++|+||||+||||+.....+|||
T Consensus       506 knH-----LClVFE~LslNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  506 KNH-----LCLVFEPLSLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             cce-----eEEEehhhhchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence            888     9999999999999999987554 4578889999999999999999999999999999999999887899999


Q ss_pred             eccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          156 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      |||.|.....+  ..+++.-+-.|.|||.+++-. |....|+||+||+|||+.||...|.+.++.+++.-.+...+..+.
T Consensus       580 DfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  580 DFGSASFASEN--EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             cCccccccccc--cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            99999776553  334445577799999999987 899999999999999999999999999988877766666555443


Q ss_pred             CCCccccccCCcc----------cCCCCCC-------------Ccccc---cCCCCC-------hhhHHHHHHhhcCCCC
Q 021982          236 KVWPGVSSLMNWH----------EYPQWNP-------------QSLAT---AVPNLD-------KDGLDLLEQMLQYDPS  282 (304)
Q Consensus       236 ~~~~~~~~~~~~~----------~~~~~~~-------------~~~~~---~~~~~~-------~~l~~li~~~l~~dp~  282 (304)
                      +.. .-+.+.+.|          +......             ..+..   ..+.++       ..+++|+..||..||.
T Consensus       657 Kml-RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  657 KML-RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHh-hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence            211 011111111          0000000             01111   011233       3478999999999999


Q ss_pred             CCCCHHHHhcCCCccc
Q 021982          283 KRISAKKAMEHPYFDD  298 (304)
Q Consensus       283 ~Rps~~eil~~~~~~~  298 (304)
                      +|.|..|.|.||||..
T Consensus       736 KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  736 KRITVNQALKHPFITE  751 (752)
T ss_pred             hcCCHHHHhcCCcccC
Confidence            9999999999999974

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.9e-36  Score=248.79  Aligned_cols=282  Identities=28%  Similarity=0.511  Sum_probs=214.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEcc---CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKA---TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      |.+.|++++++|.|.|++||++.+..   ....+++|.+...+.    ..++..|++.|..+..+.||+++.+++...+.
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            56789999999999999999999876   677899998875443    35688999999999999999999999998888


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           ..+|+||+.. ...++..+       ++..++..+++.++.||+++|++||+|+||||.|++.+.....-.|+||
T Consensus       110 -----v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  110 -----VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             -----eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEec
Confidence                 8999999996 66666544       7899999999999999999999999999999999999988889999999


Q ss_pred             cceeecccC--------------------------------------------CCccccccccccCCChhhhhCCCCCCC
Q 021982          158 GLARAFTLP--------------------------------------------IKKYTHEILTLWYRAPEVLLGSTHYST  193 (304)
Q Consensus       158 g~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~  193 (304)
                      |++......                                            ........||++|+|||++..-+.-++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            998622100                                            000112256899999999998777899


Q ss_pred             chhHHHHHHHHHHHhhccccCCCC-chHHHHHHHHHHhCCC--------CCC--CCcccccc-------CCcccCC-CCC
Q 021982          194 AVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFRLLGTP--------NEK--VWPGVSSL-------MNWHEYP-QWN  254 (304)
Q Consensus       194 ~~Di~slG~il~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~-------~~~~~~~-~~~  254 (304)
                      +.||||.|+|++.++++..||... ++.+.+..+...++..        ...  .|.. ++.       .++.... ...
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k-sn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK-SNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc-ccccccHHHHhchhccChhhc
Confidence            999999999999999999998543 3334444444444321        112  2221 110       0011110 000


Q ss_pred             C------CcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          255 P------QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       255 ~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .      -.........+..+.+|+.+||..||.+|.|+++.|.||||.+.+
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            0      011112234556889999999999999999999999999999764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-37  Score=262.56  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=208.0

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      -|..++.||-|+||+|.++....+...|++|++++... ...+......|-.||... ..+=+++++-.|++.+.     
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdn-----  703 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDN-----  703 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCc-----
Confidence            47788999999999999999999999999999876432 233445667788999998 89999999999999888     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +|+||||+.| ++-.+|-.    -+-+.++.+..++..+.+|+++.|+-|++|+||||+|||||.+| ++||+|||+++-
T Consensus       704 LYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTG  778 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  778 (1034)
T ss_pred             eEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeecccccc
Confidence            9999999986 77666644    24578888899999999999999999999999999999999998 999999999864


Q ss_pred             cc---------cCC----Cc-----------------------------cccccccccCCChhhhhCCCCCCCchhHHHH
Q 021982          163 FT---------LPI----KK-----------------------------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSV  200 (304)
Q Consensus       163 ~~---------~~~----~~-----------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl  200 (304)
                      ..         .+.    ..                             .....||+.|++||++.... ++.-.|.||.
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~  857 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSV  857 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHh
Confidence            41         000    00                             01225689999999998877 7999999999


Q ss_pred             HHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCC
Q 021982          201 ACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD  280 (304)
Q Consensus       201 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  280 (304)
                      |+|||+|+.|+.||-..+..+...++.+.                  ..+.      ....--++|.+..+||.++.. +
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~nw------------------~~~l------~~~~~~~ls~e~~~li~kLc~-s  912 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVINW------------------RNFL------HIPYQGNLSKEALDLIQKLCC-S  912 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeeeh------------------hhcc------ccccccccCHHHHHHHHHHhc-C
Confidence            99999999999999888776554444321                  1111      111223789999999987554 4


Q ss_pred             CCCCC---CHHHHhcCCCcccccccc
Q 021982          281 PSKRI---SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       281 p~~Rp---s~~eil~~~~~~~~~~~~  303 (304)
                      ++.|.   .++||..||||+.+++..
T Consensus       913 ad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  913 ADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             hhhhhcccchhhhhcCccccccchHh
Confidence            66676   678899999999998754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.3e-35  Score=258.17  Aligned_cols=279  Identities=19%  Similarity=0.321  Sum_probs=183.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc----------------cCCcEEEEEEeeecCCC------------CCCCchhHHHH
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK----------------ATGKIVALKKTRLHEDD------------EGVPPTTLREV   54 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~----------------~~~~~~~iK~~~~~~~~------------~~~~~~~~~e~   54 (304)
                      .++|++.++||+|+||+||++...                ..++.|++|.+......            .........|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            468999999999999999998642                23467999987643211            11122333466


Q ss_pred             HHHHHccCCCC-----eeeeeceecccccCC---ceEEEEEEeccCC-CHHHHHHHhcc--------------------C
Q 021982           55 SILRMLSRDPH-----VVRLMDVKQGQNKEG---RTVLYLVFEYMDT-DLKKYIRSFRQ--------------------T  105 (304)
Q Consensus        55 ~~l~~l~~h~~-----i~~~~~~~~~~~~~~---~~~~~lv~e~~~~-~l~~~l~~~~~--------------------~  105 (304)
                      .++.++ +|.+     ++.+++++.....++   ....++|+||+++ +|.+++.....                    .
T Consensus       224 ~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777 4443     356677765432211   1237899999986 88888764211                    0


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCcc-ccccccccCCChhh
Q 021982          106 GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-THEILTLWYRAPEV  184 (304)
Q Consensus       106 ~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~-~~~~~~~~~~~PE~  184 (304)
                      ...+++..+..++.|++.+|.|||+.+++|+||||+||+++.++ .++|+|||++.......... ....+++.|++||.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence            12346678899999999999999999999999999999999777 89999999986554322111 12233789999998


Q ss_pred             hhCCCC---------------------CCCchhHHHHHHHHHHHhhccc-cCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          185 LLGSTH---------------------YSTAVDMWSVACIFAELVTKTA-LFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       185 ~~~~~~---------------------~~~~~Di~slG~il~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      +.....                     .....|+||+||++++|++|.. |+...............   . ...|....
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~---~-~~~~r~~~  457 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN---D-LNRWRMYK  457 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc---h-HHHHHhhc
Confidence            854221                     1234799999999999999875 66533221111000000   0 00000000


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCC---CCCCCHHHHhcCCCccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDP---SKRISAKKAMEHPYFDD  298 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~eil~~~~~~~  298 (304)
                      .          ....+. .....++...+|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       458 ~----------~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        458 G----------QKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             c----------cCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            0          000011 133578899999999999866   68999999999999964

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=278.72  Aligned_cols=252  Identities=17%  Similarity=0.307  Sum_probs=181.4

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.+.....||+|+||.||++.+..++..+++|.+....      .....|++.++++ +||||+++++++.+...     
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~-----  757 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN------SIPSSEIADMGKL-QHPNIVKLIGLCRSEKG-----  757 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc------cccHHHHHHHhhC-CCCCcceEEEEEEcCCC-----
Confidence            45666778999999999999998889999999876322      1223568899999 99999999999987766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH---hcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH---GHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh---~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      .++||||+.+ +|.+++..       +++.++..++.|++.|++|||   +.+++|+||||+||+++.++ ..++. ++.
T Consensus       758 ~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~  828 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSL  828 (968)
T ss_pred             CEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-ecc
Confidence            7999999985 99988853       789999999999999999999   66999999999999999666 55554 554


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch-HHHHHHHHHHhCCC-CCCC
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTP-NEKV  237 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~  237 (304)
                      .......    ....+++.|+|||++.+.. ++.++||||||+++|||+||+.||..... ........+..... ....
T Consensus       829 ~~~~~~~----~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (968)
T PLN00113        829 PGLLCTD----TKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM  903 (968)
T ss_pred             ccccccC----CCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence            4322111    1225678999999987665 89999999999999999999999854221 11111111111000 0000


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      +.         +. . .... .........++.+++.+||+.||.+|||+.|+++.
T Consensus       904 ~~---------~~-~-~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        904 WI---------DP-S-IRGD-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ee---------Cc-c-ccCC-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00         00 0 0000 00001122356789999999999999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=257.21  Aligned_cols=254  Identities=24%  Similarity=0.407  Sum_probs=201.0

Q ss_pred             hhhhhhhhcccccceEEEEEEEcc-------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKA-------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ++..+.+.||+|+||.|+++.-..       ....+++|..+..... .....+..|+++++.+..|+|++.+++.+...
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344667799999999999997431       1346888987755444 56778899999999999999999999999885


Q ss_pred             ccCCceEEEEEEeccC-CCHHHHHHHhc---cCC---------CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCe
Q 021982           77 NKEGRTVLYLVFEYMD-TDLKKYIRSFR---QTG---------ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL  143 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Ni  143 (304)
                      ..     .+++.||+. |+|.+++...+   ...         ..++...++.++.||+.|++||.+.+++||||-.+||
T Consensus       375 ~~-----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  375 GP-----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             Cc-----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence            54     899999998 69999998865   111         1388999999999999999999999999999999999


Q ss_pred             EEeCCCCeEEEeeccceeecccCCCcc-cccc--ccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCc-
Q 021982          144 LMDRKTMTLKIADLGLARAFTLPIKKY-THEI--LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS-  218 (304)
Q Consensus       144 l~~~~~~~vkl~dfg~~~~~~~~~~~~-~~~~--~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~-  218 (304)
                      |+..+. .+||+|||+++......... ....  -...|||||.+.... ++.++||||+|++||||+| |..||.... 
T Consensus       450 Li~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  450 LITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             EecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999776 99999999998543321111 1111  245699999998854 8999999999999999998 788888755 


Q ss_pred             hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ..+....+..                           +.....+..+++++.++++.||+.+|.+||++.++.+
T Consensus       528 ~~~l~~~l~~---------------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  528 TEELLEFLKE---------------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHHhc---------------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            3333332222                           2222333468999999999999999999999999876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=214.19  Aligned_cols=217  Identities=26%  Similarity=0.447  Sum_probs=182.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +...-+..||+|++|.|-+.++..+|...++|-+...-.. ...++...++++..+...+|.++.++|-+..+..     
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----  119 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----  119 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----
Confidence            3456678999999999999999999999999987754332 2345666788888777799999999998888877     


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++.||.+..+|..+-.+....+..+++..+-+++..++.||.+||++ .++|||+||+|||++.+| .||++|||.+-.
T Consensus       120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~  198 (282)
T KOG0984|consen  120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGY  198 (282)
T ss_pred             EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEccccccee
Confidence            999999999999998888888889999999999999999999999976 899999999999999998 999999999977


Q ss_pred             cccCCCccccccccccCCChhhhhC---CCCCCCchhHHHHHHHHHHHhhccccCCCC-chHHHHHHHHH
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLG---STHYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFR  228 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~il~~ll~g~~p~~~~-~~~~~~~~~~~  228 (304)
                      ....... +...|-..|+|||.+..   +..|+-++||||||+++.||.+++.||... ++.+++..+..
T Consensus       199 L~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  199 LVDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             ehhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            6554332 33456677999999853   335889999999999999999999999765 45666666654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=234.20  Aligned_cols=248  Identities=22%  Similarity=0.333  Sum_probs=186.0

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc-CCCCeeeeeceecccccCCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..++.+.+|+|.||.||++.-.  ++.||||+++...     ...+..|.++.+... .|+||+++++.-...... ...
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~e  282 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RME  282 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccc
Confidence            3567899999999999999654  6899999998543     345667777776543 899999999987665533 445


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc---------CccccCCCCCCeEEeCCCCeEE
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---------GILHRDLKPHNLLMDRKTMTLK  153 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---------~i~h~dl~~~Nil~~~~~~~vk  153 (304)
                      +++|++|.. |+|.++|+.     ..+++....+++..+++||+|||+.         .|+|||||..||||..|. +..
T Consensus       283 ywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-Tcc  356 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCC  356 (534)
T ss_pred             eeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEE
Confidence            899999997 799999987     5789999999999999999999974         499999999999999777 999


Q ss_pred             EeeccceeecccC--CCccccccccccCCChhhhhCCCCCC-----CchhHHHHHHHHHHHhhccccCC--C--------
Q 021982          154 IADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYS-----TAVDMWSVACIFAELVTKTALFP--G--------  216 (304)
Q Consensus       154 l~dfg~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~-----~~~Di~slG~il~~ll~g~~p~~--~--------  216 (304)
                      |+|||++..+...  ........||.+|||||++.+.-.+.     .+.||||+|.+||||++....+.  .        
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            9999999877543  22334478899999999998754444     46899999999999998544331  0        


Q ss_pred             -------CchHHHHHHHHHHh-CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHH
Q 021982          217 -------DSELQQLLHIFRLL-GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK  288 (304)
Q Consensus       217 -------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (304)
                             ++-.+....+.... ++.....|..+                      .--..+.+.+..||+.||+.|.|+.
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----------------------~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----------------------AGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----------------------ccHHHHHHHHHHHcCCchhhhhhhH
Confidence                   11122222222211 11111122111                      1234578999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=244.11  Aligned_cols=199  Identities=27%  Similarity=0.385  Sum_probs=175.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC------CCCCchhHHHHHHHHHcc--CCCCeeeeeceeccc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD------EGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQ   76 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~   76 (304)
                      .|..++.||.|+||.|++|.++.+...|+||.+.+....      +......-.|+++|..+.  .|+||++++++|++.
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            589999999999999999999999899999988765421      223345667999999993  399999999999999


Q ss_pred             ccCCceEEEEEEeccC-C-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEE
Q 021982           77 NKEGRTVLYLVFEYMD-T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI  154 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl  154 (304)
                      +.     ++++||..+ | +|+++++-    ...+++.+...+++|++.|+++||++||+|||||-+|+.++.+| -+||
T Consensus       642 d~-----yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~kl  711 (772)
T KOG1152|consen  642 DY-----YYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKL  711 (772)
T ss_pred             Ce-----eEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEE
Confidence            88     999999998 5 89999976    34599999999999999999999999999999999999999888 8999


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCC
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP  215 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  215 (304)
                      +|||.+.....++  +....||..|.|||++.+..+.+...|||+||++||.++....||-
T Consensus       712 idfgsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999997766653  3456789999999999999999999999999999999999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=251.19  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=213.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|.+++.+|+|.+|.||+++++.++...++|.++....+.  ...+..|+-+++.+ +||||+.+++.+.....     
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc-~h~nivay~gsylr~dk-----   86 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDK-----   86 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecC-CCcChHHHHhhhhhhcC-----
Confidence            67999999999999999999999999999999998765443  45667899999999 99999999999988777     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++++||||+| +|.+.    ..-..++++.++..+.+..+++++|||++|=+|||||-.||+++..+ .||+.|||.+-.
T Consensus        87 lwicMEycgggslQdi----y~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaq  161 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDI----YHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQ  161 (829)
T ss_pred             cEEEEEecCCCcccce----eeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhh
Confidence            8999999997 66553    24457899999999999999999999999999999999999999787 999999999988


Q ss_pred             cccCCCccccccccccCCChhhhh--CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHH-HHhCCCCCCCCc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF-RLLGTPNEKVWP  239 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  239 (304)
                      ++.-..+.....|++.|++||+-.  ....+....|+|++|++..|+--.+.|..+.........+. ..++++..++-.
T Consensus       162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~  241 (829)
T KOG0576|consen  162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT  241 (829)
T ss_pred             hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence            887777777889999999999873  23338899999999999999988888865544433333222 223333222111


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                              .-++.+.+|++.+|..+|++|||++.+|+|||...
T Consensus       242 ------------------------kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  242 ------------------------KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ------------------------cchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                                    34567889999999999999999999999999764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=7.3e-32  Score=215.35  Aligned_cols=213  Identities=40%  Similarity=0.668  Sum_probs=180.8

Q ss_pred             cccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEecc
Q 021982           12 VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM   91 (304)
Q Consensus        12 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~   91 (304)
                      ||+|.+|.||++.+..++..+++|.+....... ....+.+|+..++.+ .|++++++++++.....     .++++|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~-----~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKL-NHPNIVKLYGVFEDENH-----LYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCe-----EEEEEecC
Confidence            689999999999998889999999987544321 245788999999999 89999999999887654     89999999


Q ss_pred             CC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC-CCCeEEEeeccceeecccCCCc
Q 021982           92 DT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-KTMTLKIADLGLARAFTLPIKK  169 (304)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~-~~~~vkl~dfg~~~~~~~~~~~  169 (304)
                      .| +|.+++....   ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++ .++|+|||.+.........
T Consensus        74 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (215)
T cd00180          74 EGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSL  149 (215)
T ss_pred             CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcch
Confidence            94 9998887532   36899999999999999999999999999999999999997 55 8999999999766554322


Q ss_pred             cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCccc
Q 021982          170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE  249 (304)
Q Consensus       170 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (304)
                      .....+...|++||.+......+.++|+|++|++++++                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            33445688899999887763478999999999999999                                          


Q ss_pred             CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          250 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                                       ..+.+++.+|++.||.+||++.++++++
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             2445799999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=244.51  Aligned_cols=247  Identities=24%  Similarity=0.315  Sum_probs=201.8

Q ss_pred             hhhhhhcccccceEEEEEEEccCC----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATG----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+-.+.||+|+||+||++.+--.+    -+|+||++..... ......+.+|+-++.++ +|||++++++++....    
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~----  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASL-DHPNLLRLLGVCMLST----  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcC-CCchHHHHhhhcccch----
Confidence            556789999999999999985434    3678887764332 22356888999999999 9999999999998776    


Q ss_pred             eEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +.+|++|+. |+|.++++..   ..++.....+.|..||++|++|||.+++|||||-.+|+||..-+ .||+.|||++
T Consensus       772 --~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla  845 (1177)
T KOG1025|consen  772 --LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLA  845 (1177)
T ss_pred             --HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchh
Confidence              579999998 5999999874   34788999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCCccccccc--cccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          161 RAFTLPIKKYTHEIL--TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~--~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ..............+  .+-|++-|.+.... ++.++||||+|+++||+|| |..|+......+.-..+...        
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------  916 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------  916 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc--------
Confidence            877665554444333  56688888877666 8999999999999999998 88898887766654443321        


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         ..-..++..+-++..++.+||-.|+..||+++++..
T Consensus       917 -------------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  917 -------------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -------------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                               122334578999999999999999999999998754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-32  Score=225.21  Aligned_cols=193  Identities=28%  Similarity=0.429  Sum_probs=155.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHH--HHccCCCCeeeeeceecccccC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSIL--RMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l--~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      |..+-++.+.+|+|.||.||.+.++  |..||||++....     .....+|.+++  ..+ +|+||+.+++.-...+ +
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmL-RHENILgFIaaD~~~~-g  279 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-----ERSWFRETEIYQTVML-RHENILGFIAADNKDN-G  279 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccc-----hhhhhhHHHHHHHHHh-ccchhhhhhhccccCC-C
Confidence            3456778899999999999999887  7889999986322     12334555554  455 9999999998755444 3


Q ss_pred             CceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc--------CccccCCCCCCeEEeCCCC
Q 021982           80 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------GILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------~i~h~dl~~~Nil~~~~~~  150 (304)
                      .-..+++|++|.. |||.++|..     ..++.+..+.++..+++||++||..        .|.|||||..||||.+++ 
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-  353 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-  353 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-
Confidence            3456999999998 799999976     5789999999999999999999974        399999999999999888 


Q ss_pred             eEEEeeccceeecccCCC----ccccccccccCCChhhhhCCCC-----CCCchhHHHHHHHHHHHhh
Q 021982          151 TLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVT  209 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~il~~ll~  209 (304)
                      ..-|+|+|++........    ......||.+|||||++...-.     --..+||||||.++||+.-
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            999999999987765432    2345678999999999975432     1246899999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=214.46  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=190.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeece-ecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDV-KQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~-~~~~~~~~   80 (304)
                      +.+.|.+.+.||.|.||.+-+++++.++..+++|.+....   .....+.+|..---.|+.|.||+..++. |+..+.  
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~--   96 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA--   96 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce--
Confidence            4688999999999999999999999999999999877443   2345677777655556679999988876 444443  


Q ss_pred             ceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC-CCCeEEEeecc
Q 021982           81 RTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-KTMTLKIADLG  158 (304)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~-~~~~vkl~dfg  158 (304)
                         +++++||+. |+|..-+..     ..+-+.....++.|+++|+.|||++++||||||.+||||.. +..+|||+|||
T Consensus        97 ---YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   97 ---YVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             ---EEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecc
Confidence               789999998 687766543     45788899999999999999999999999999999999953 44699999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCC----CCCCCchhHHHHHHHHHHHhhccccCCCCch-HHHHHHHHHHhCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHIFRLLGTP  233 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~  233 (304)
                      ..+..+.-......   ...|.+||.+...    -...+.+|+|+||+++|+++||..||..... ...+....+..+..
T Consensus       169 ~t~k~g~tV~~~~~---~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  169 LTRKVGTTVKYLEY---VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             cccccCceehhhhh---hcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence            99776654333222   4568999988532    2256789999999999999999999974322 23344444443332


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS  286 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  286 (304)
                      ..                     ..+..+.-+++.+..+.++-|.++|+.|--
T Consensus       246 ~~---------------------~~P~~F~~fs~~a~r~Fkk~lt~~~~drck  277 (378)
T KOG1345|consen  246 NP---------------------ALPKKFNPFSEKALRLFKKSLTPRFKDRCK  277 (378)
T ss_pred             Cc---------------------cCchhhcccCHHHHHHHHHhcCCcccccch
Confidence            21                     233344568999999999999999999943

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=217.29  Aligned_cols=255  Identities=18%  Similarity=0.253  Sum_probs=200.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-----CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++++....+-+|.||.||.+.++.-     .+.+.+|+++... .+-+...+..|.-.+..+ .|||++.+.++...+.
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcC-cCCCccceeEEEeecc
Confidence            35677888899999999999976532     2346677776433 333445666777778887 8999999999876543


Q ss_pred             cCCceEEEEEEeccC-CCHHHHHHHhccCC----CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeE
Q 021982           78 KEGRTVLYLVFEYMD-TDLKKYIRSFRQTG----ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~v  152 (304)
                      .    ..++++.+.+ |+|..++...+...    ..++..++..++.|++.|++|||+.|++|.||-..|.+++.. ..|
T Consensus       361 ~----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqV  435 (563)
T KOG1024|consen  361 A----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQV  435 (563)
T ss_pred             C----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeE
Confidence            3    2678888888 69999998554222    357778899999999999999999999999999999999955 599


Q ss_pred             EEeeccceeecccCCC-ccc-cccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHH
Q 021982          153 KIADLGLARAFTLPIK-KYT-HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~-~~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~  229 (304)
                      ||+|=.+++..-+... ..+ .+.....||+||.+.+.. ++.++|+||||++||||+| |+.|+...++.+....+...
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            9999999876533211 111 123367899999998877 8999999999999999998 89999999988877665442


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                                 ..-..+-++|++++.++..||..+|++||+++|+..
T Consensus       515 ---------------------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 ---------------------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ---------------------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                                       222333489999999999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.2e-31  Score=251.18  Aligned_cols=205  Identities=17%  Similarity=0.242  Sum_probs=145.6

Q ss_pred             CC-CCeeeeeceecccccCC--ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC
Q 021982           62 RD-PHVVRLMDVKQGQNKEG--RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL  138 (304)
Q Consensus        62 ~h-~~i~~~~~~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl  138 (304)
                      +| +||..+++++.....++  ...++.++|+++++|.+++..   ....+++.+++.++.||+.||.|||++||+||||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            44 57777777764333222  234788899999999999864   2346999999999999999999999999999999


Q ss_pred             CCCCeEEeCCC------------------CeEEEeeccceeecccCC----------------CccccccccccCCChhh
Q 021982          139 KPHNLLMDRKT------------------MTLKIADLGLARAFTLPI----------------KKYTHEILTLWYRAPEV  184 (304)
Q Consensus       139 ~~~Nil~~~~~------------------~~vkl~dfg~~~~~~~~~----------------~~~~~~~~~~~~~~PE~  184 (304)
                      ||+|||++..+                  ..+|++|||++.......                .......+++.|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996433                  245666666654321100                00011346888999999


Q ss_pred             hhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCC
Q 021982          185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  264 (304)
Q Consensus       185 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (304)
                      +.+.. ++.++|||||||+||||++|..|+.....  ....+.....+ ..                          ...
T Consensus       187 ~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~-~~--------------------------~~~  236 (793)
T PLN00181        187 DNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLP-PQ--------------------------ILL  236 (793)
T ss_pred             hccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcC-hh--------------------------hhh
Confidence            88766 79999999999999999998877653221  11111111100 00                          001


Q ss_pred             CChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          265 LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       265 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ..+...+++.+||++||.+|||+.|+++||||.+.
T Consensus       237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            23456789999999999999999999999999764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.4e-29  Score=204.43  Aligned_cols=210  Identities=36%  Similarity=0.578  Sum_probs=172.2

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |.+.+.||+|++|.||++.+..++..+++|.+...... .....+.+|++.++.+ +|+|++++++.+.....     .+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~-----~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEP-----LY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCc-----eE
Confidence            56788999999999999999988899999998765433 2356788899999999 99999999999877655     89


Q ss_pred             EEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           86 LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +++|++.+ +|.+++.....   .+++..+..++.+++.++.+||+.+++|+|++|.||+++.++ .++|+|||.+....
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            99999998 99998876322   178999999999999999999999999999999999999776 99999999987765


Q ss_pred             cCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCC-CchH-HHHHHH
Q 021982          165 LPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG-DSEL-QQLLHI  226 (304)
Q Consensus       165 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~-~~~~-~~~~~~  226 (304)
                      ... .......++..|++||.+.+....+.++|+|+||+++++|++|..||.. .... .....+
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~  214 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW  214 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence            442 1223345578899999884333477899999999999999999999976 3443 333333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.5e-29  Score=196.83  Aligned_cols=169  Identities=17%  Similarity=0.212  Sum_probs=128.4

Q ss_pred             CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCcccc
Q 021982           93 TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH  172 (304)
Q Consensus        93 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~  172 (304)
                      |+|.+++...   ..++++.+++.++.|++.||.|||+.+      ||+||+++.++ .+++  ||.+.......     
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc-----
Confidence            5788888653   346999999999999999999999998      99999999776 8888  99987654432     


Q ss_pred             ccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH-HHHHHHHHHhCCCCCCCCccccccCCcccCC
Q 021982          173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP  251 (304)
Q Consensus       173 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (304)
                      ..+++.|+|||++.+.. ++.++||||||+++|+|++|..||...... .....+...........              
T Consensus        64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------  128 (176)
T smart00750       64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD--------------  128 (176)
T ss_pred             CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc--------------
Confidence            25689999999998766 789999999999999999999999765443 22333322211110000              


Q ss_pred             CCCCCcccccCCCCCh--hhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          252 QWNPQSLATAVPNLDK--DGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       252 ~~~~~~~~~~~~~~~~--~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                             ......++.  ++.+++.+||+.||.+|||+.|+++|+|+..-.
T Consensus       129 -------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      129 -------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             -------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence                   000112333  689999999999999999999999999987543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-26  Score=196.01  Aligned_cols=255  Identities=21%  Similarity=0.231  Sum_probs=190.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCC-cEEEEEEeeecCCCCCCCchhHHHHHHHHHcc---CCCCeeeeeceec-ccccC
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATG-KIVALKKTRLHEDDEGVPPTTLREVSILRMLS---RDPHVVRLMDVKQ-GQNKE   79 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~h~~i~~~~~~~~-~~~~~   79 (304)
                      +|++.+.||+|+||.||.+.+..++ ..+++|.-........  ..+..|..++..+.   ..++++.+++... .... 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~-   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF-   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce-
Confidence            7999999999999999999988765 5677887655432221  26677888888885   2468999998874 4433 


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC----CeEEEe
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----MTLKIA  155 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~----~~vkl~  155 (304)
                          -++||+.++.+|.+......  ...++..++..++.|++.+|+++|+.|++||||||.|+++...+    ..+.|.
T Consensus        96 ----~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   96 ----NFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             ----eEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence                78999999999999876644  46799999999999999999999999999999999999998653    479999


Q ss_pred             eccceeecc---cC------CCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHH
Q 021982          156 DLGLARAFT---LP------IKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH  225 (304)
Q Consensus       156 dfg~~~~~~---~~------~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~  225 (304)
                      |||+++...   ..      ... .....||.+|+|+.++.+.. .+++.|+||+++++.+++.|..||...........
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~  248 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK  248 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHH
Confidence            999998322   11      111 22345899999999998887 79999999999999999999999977664433333


Q ss_pred             HHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          226 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ...........                       ......+..+..+...+-+.+...+|....+..
T Consensus       249 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  249 FEKDPRKLLTD-----------------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             HHHHhhhhccc-----------------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            32221111000                       011234456667777666677778887665543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.1e-29  Score=225.72  Aligned_cols=265  Identities=25%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             hhhhhcccccceEEEEEEEccCCcEEEEEEeeec----CCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLH----EDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .....+|.|++|.++.+........+..|.++..    .........+..|+-+-..+ +|||++..+....+...    
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDG----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhccc----
Confidence            3567789999998888877666665666654421    11111112245566667777 99999888888777665    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       ..-.||||.++|..++...    ..+...++..+++|++.|++|+|+.|+.|+|+|++|+++..++ .+||+|||.+..
T Consensus       396 -~~~~mE~~~~Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 -ILQSMEYCPYDLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             -chhhhhcccHHHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCccee
Confidence             4445999999888888762    4688899999999999999999999999999999999999888 999999999876


Q ss_pred             cccCCC----ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ...+..    ......|+..|+|||++.+..+..+..||||.|+++..|.+|+.||......+....-...  ....   
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--~~~~---  544 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--SDQR---  544 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc--cccc---
Confidence            654433    2445677899999999999887788899999999999999999999876654332100000  0000   


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                    ............++.+.+.+|.+||++||.+|.|+++|++++||+++..
T Consensus       545 --------------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  545 --------------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             --------------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                          0001111223367788899999999999999999999999999998753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-27  Score=180.68  Aligned_cols=214  Identities=22%  Similarity=0.324  Sum_probs=177.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +...|+++++||+|+||.+|.+....+|..||||.-+.    ......+.-|..+.+.+..-..|+.+..+......   
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~----~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y---   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS----KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY---   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc----cCCCcchhHHHHHHHHhccCCCCchhhhhcccccc---
Confidence            56789999999999999999999999999999997543    23345777899999999666778777777666655   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeeccc
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~dfg~  159 (304)
                        -++|||.++.+|.+.+.-..+   .++..+++-++.|++.-++|+|..+++|+||||+|+|..-+  ...+.++|||+
T Consensus        86 --nvlVMdLLGPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   86 --NVLVMDLLGPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             --ceeeeeccCccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence              689999999999998876543   68999999999999999999999999999999999999533  35899999999


Q ss_pred             eeeccc-------CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHH
Q 021982          160 ARAFTL-------PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       160 ~~~~~~-------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  228 (304)
                      +..+..       +........||.+|.|--...+.. .+.+.|+-|+|++|.++.-|..||.+.......++..+
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence            987643       233445567899999998887766 58999999999999999999999998766554444433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-25  Score=179.54  Aligned_cols=206  Identities=20%  Similarity=0.312  Sum_probs=176.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.-.|+++++||.|.||+++.+.+--++..||||.-+    ..+...++..|....+.|...+.|+.++-+.+....   
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP----rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~---   98 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP----RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY---   98 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecc----ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccch---
Confidence            4457999999999999999999999999999999543    234467889999999999899999999877776666   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC----CeEEEeec
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----MTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~----~~vkl~df  157 (304)
                        -.+|+|.++.+|.+.++...   ..++..+++.++.|++.-++++|++.++++||||+|+||..-+    ..+-++||
T Consensus        99 --NiLVidLLGPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   99 --NILVIDLLGPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             --hhhhhhhhCcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence              57999999999999998753   4799999999999999999999999999999999999996432    47999999


Q ss_pred             cceeecccC-------CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH
Q 021982          158 GLARAFTLP-------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL  220 (304)
Q Consensus       158 g~~~~~~~~-------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  220 (304)
                      |++..+..+       .+......||.+||+--..++.+ -+++.|+-|||=++++.+-|..||......
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            999877543       23344567899999999998887 699999999999999999999999875543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4e-26  Score=178.62  Aligned_cols=246  Identities=20%  Similarity=0.297  Sum_probs=193.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++...+..+|.....|..|+++++  |..++.|++............+.+|.-.|+-+ .||||+++++.+.....    
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppn----  261 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPN----  261 (448)
T ss_pred             hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCC----
Confidence            345677889999999999999987  56788898887777777778899999999999 99999999999988877    


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCC-CeEEEeecc
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKT-MTLKIADLG  158 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~-~~vkl~dfg  158 (304)
                       +.++..|+. |+|...+..  +.+--.+..++.+++.+++.+++|||+..  +.--.|+...+++|.+- .++-++|--
T Consensus       262 -lv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  262 -LVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             -ceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence             899999998 699998876  33334677889999999999999999974  44446889999999654 233344544


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCC--CCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ++...       .....+|-|++||.+...+.  .-..+|+|||++++||+.|...||.+.++.+--.++.-        
T Consensus       339 fsfqe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial--------  403 (448)
T KOG0195|consen  339 FSFQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--------  403 (448)
T ss_pred             eeeec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--------
Confidence            43221       11233788999999976543  45689999999999999999999999888765544421        


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHh
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  291 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  291 (304)
                                        .+.....+|+++..+..|+.-|++.||.+||.++.|+
T Consensus       404 ------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 ------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                              2233345568999999999999999999999998765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.9e-23  Score=178.34  Aligned_cols=264  Identities=33%  Similarity=0.545  Sum_probs=200.8

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-CCchhHHHHHHHHHccCCC-CeeeeeceecccccCCceE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-VPPTTLREVSILRMLSRDP-HVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~~~~~~~   83 (304)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+........ ....+.+|+.++..+ .|+ +++++.+.+.....     
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~-----   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGS-----   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCE-----
Confidence            678889999999999999987   6688888876654443 466788899999999 666 79999999855544     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++++++.+ ++.+.+...... ..++......++.|++.++.++|+.+++|+|+||+||+++..+..++++|||.+..
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            7899999997 777555543221 36899999999999999999999999999999999999997764699999999875


Q ss_pred             cccCCC------ccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHHHHHhC
Q 021982          163 FTLPIK------KYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFRLLG  231 (304)
Q Consensus       163 ~~~~~~------~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~  231 (304)
                      ......      ......++..|++||.+.+.  ...+...|+|++|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            544332      24566779999999999874  4589999999999999999999999877764   233333322221


Q ss_pred             CC-CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          232 TP-NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      .+ ......                ....   ......+.+++.+++..+|..|.+..+...++|...
T Consensus       232 ~~~~~~~~~----------------~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         232 TPSLASPLS----------------PSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             CcccccccC----------------cccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            11 000000                0000   122357889999999999999999999888866554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=3.3e-25  Score=180.30  Aligned_cols=243  Identities=18%  Similarity=0.247  Sum_probs=153.0

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccC---------CCCeeeeeceecc
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSR---------DPHVVRLMDVKQG   75 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~---------h~~i~~~~~~~~~   75 (304)
                      +.....||.|+++.||.+.+..+|..+++|++....... .....+.+|.-....+..         |-.++..++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            455678999999999999999999999999988765211 122233333322222211         2234444444332


Q ss_pred             ccc---------CCce---EEEEEEeccCCCHHHHHHHhccCCCC---CChHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 021982           76 QNK---------EGRT---VLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKP  140 (304)
Q Consensus        76 ~~~---------~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~  140 (304)
                      ...         .+..   ..+++|+-+.++|.+.+.........   +.......+..|+++.+++||+.|++|+||+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~  173 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP  173 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence            211         1111   14778888888888876653332222   22333456668999999999999999999999


Q ss_pred             CCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCC-------CCCCCchhHHHHHHHHHHHhhcccc
Q 021982          141 HNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-------THYSTAVDMWSVACIFAELVTKTAL  213 (304)
Q Consensus       141 ~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~~Di~slG~il~~ll~g~~p  213 (304)
                      +|++++.+| .++|+||+.....+.....   ...+..|.|||.....       ..++.+.|.|+||+++|.|.+|..|
T Consensus       174 ~nfll~~~G-~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  174 ENFLLDQDG-GVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GGEEE-TTS--EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eeEEEcCCC-CEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999888 9999999998766543322   2335779999987542       2268899999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCC
Q 021982          214 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR  284 (304)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  284 (304)
                      |..........                               ..+.... ++|+.+++||+++|+.||.+|
T Consensus       250 f~~~~~~~~~~-------------------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPE-------------------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSG-------------------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCcccccc-------------------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            98664321110                               0222233 688999999999999999887

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=4.6e-25  Score=200.65  Aligned_cols=247  Identities=24%  Similarity=0.366  Sum_probs=176.3

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCc--hhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPP--TTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~--~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +|...+.||++.|=+|.++++.. | .+++|++-++........  +..++++ .... ++||.+++..+......    
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kA----   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKA----   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHH----
Confidence            67888999999999999998764 3 488998876553333222  2223333 3344 99999999988777666    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .|+|-+|...+|.+.+..    ...+..-+...++.|++.||+.+|+.||+|||||.+|||+..=+| +.|+||..-+.
T Consensus        96 -AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW-~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 -AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW-LYLTDFASFKP  169 (1431)
T ss_pred             -HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech-hhhhcccccCC
Confidence             789999999999999865    345788889999999999999999999999999999999997774 89999987533


Q ss_pred             cc--c-CCCccccc----cccccCCChhhhhCC----------CCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHH
Q 021982          163 FT--L-PIKKYTHE----ILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  224 (304)
Q Consensus       163 ~~--~-~~~~~~~~----~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~  224 (304)
                      .-  . ++..+...    ....+|.|||.|...          ..++++-||||+||+++|+++ |++||.... .-.+.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-L~aYr  248 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-LLAYR  248 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-HHhHh
Confidence            21  1 11221111    124679999999641          126788999999999999998 466664221 10000


Q ss_pred             HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCC-CCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP-NLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .-                        ..   ........ --+..++.||..|++.||.+|.|+++.|+-
T Consensus       249 ~~------------------------~~---~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  249 SG------------------------NA---DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cc------------------------Cc---cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            00                        00   00000000 123578999999999999999999999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-25  Score=193.29  Aligned_cols=243  Identities=27%  Similarity=0.408  Sum_probs=194.2

Q ss_pred             cccccceEEEEEEEc---cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982           12 VGEGTYGKVYRAREK---ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        12 lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      +|.|++|.|++++..   ..+..+++|+.++.............|-.++....+||.++++.-.++....     .+++.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-----l~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-----LYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-----hhHhh
Confidence            789999999988653   3356788888776554333334666788888888679999999998888777     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI  167 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~  167 (304)
                      ++..| .+...+..    ...+.+.........++-++.++|+.+++|+|+|++||+++.+| ++++.|||.++..-...
T Consensus        77 d~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             hhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhh
Confidence            99987 66665543    35577888888999999999999999999999999999999888 99999999987554332


Q ss_pred             CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCc
Q 021982          168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW  247 (304)
Q Consensus       168 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (304)
                      ..    +|+..|++||+..+   .....|.||+|+++++|+||..||..    +....+.+..-                
T Consensus       152 ~~----cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~----------------  204 (612)
T KOG0603|consen  152 IA----CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL----------------  204 (612)
T ss_pred             hc----ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc----------------
Confidence            22    88999999999872   57889999999999999999999998    33333332111                


Q ss_pred             ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-----HHHhcCCCcccccccc
Q 021982          248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKTR  303 (304)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~eil~~~~~~~~~~~~  303 (304)
                                  ..+..++..+++++..++..+|..|...     .|+++|+||..+++.+
T Consensus       205 ------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  205 ------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             ------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence                        1122577889999999999999999854     7999999999998764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=5.3e-24  Score=180.58  Aligned_cols=164  Identities=23%  Similarity=0.241  Sum_probs=122.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEcc-CCcEEEEEEeeecCC---CCCCCchhHHHHHHHHHccCCCCeee-eeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHED---DEGVPPTTLREVSILRMLSRDPHVVR-LMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~-~~~~~~~~   76 (304)
                      ++++|++.+.||+|+||+||++.++. ++..+++|++.....   .......+.+|+.+++.+ +|+|+++ +++.    
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~----   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT----   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc----
Confidence            57889999999999999999999876 677789987653211   111234578999999999 8999875 4432    


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC-CCCCeEEeCCCCeEEE
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL-KPHNLLMDRKTMTLKI  154 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl-~~~Nil~~~~~~~vkl  154 (304)
                      ..     .+++|||+.| +|. .+.       +..   ...++.+++.+|.+||+.|++|||| ||+||+++.++ .++|
T Consensus        91 ~~-----~~LVmE~~~G~~L~-~~~-------~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikL  153 (365)
T PRK09188         91 GK-----DGLVRGWTEGVPLH-LAR-------PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAV  153 (365)
T ss_pred             CC-----cEEEEEccCCCCHH-HhC-------ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEE
Confidence            22     6899999987 664 211       111   1467899999999999999999999 99999998766 8999


Q ss_pred             eeccceeecccCCCcc--------ccccccccCCChhhhhC
Q 021982          155 ADLGLARAFTLPIKKY--------THEILTLWYRAPEVLLG  187 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~  187 (304)
                      +|||++..........        ....+++.|++||.+..
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999998765432111        12344677889988853

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-23  Score=170.39  Aligned_cols=197  Identities=24%  Similarity=0.346  Sum_probs=146.3

Q ss_pred             cCCCCeeeeeceeccccc----------------------CCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHH
Q 021982           61 SRDPHVVRLMDVKQGQNK----------------------EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM  118 (304)
Q Consensus        61 ~~h~~i~~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~  118 (304)
                      .+||||+.+.+.|.++-.                      +..+.+|+||..+..+|.+++..     ...+.....-++
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHH
Confidence            579999999998765432                      23456999999999999999977     356777888899


Q ss_pred             HHHHHHHHHHHhcCccccCCCCCCeEEeCCC---CeEEEeeccceeeccc-----CCCc-cccccccccCCChhhhhCCC
Q 021982          119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTL-----PIKK-YTHEILTLWYRAPEVLLGST  189 (304)
Q Consensus       119 ~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~---~~vkl~dfg~~~~~~~-----~~~~-~~~~~~~~~~~~PE~~~~~~  189 (304)
                      .|+++|+.|||++|+.|+|+|.+||++.-++   ..+.++|||.+-.-..     +... .-..-|+..-++||+....+
T Consensus       348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999999999999999999994332   5689999998643322     1111 11223467789999886432


Q ss_pred             C-----CCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCC
Q 021982          190 H-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN  264 (304)
Q Consensus       190 ~-----~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (304)
                      .     .-.++|.|+.|.+.||+++...||-.......-...                          +....++.....
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--------------------------Yqe~qLPalp~~  481 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--------------------------YQESQLPALPSR  481 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh--------------------------hhhhhCCCCccc
Confidence            2     235799999999999999999999763322111100                          112334444557


Q ss_pred             CChhhHHHHHHhhcCCCCCCCCHH
Q 021982          265 LDKDGLDLLEQMLQYDPSKRISAK  288 (304)
Q Consensus       265 ~~~~l~~li~~~l~~dp~~Rps~~  288 (304)
                      +++.+++++..+|+.||++|+|++
T Consensus       482 vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  482 VPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CChHHHHHHHHHhcCCccccCCcc
Confidence            889999999999999999999865

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.90  E-value=7.2e-24  Score=192.50  Aligned_cols=225  Identities=30%  Similarity=0.464  Sum_probs=169.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|..++.+..|++|.||.++++.+.+++++| +.++.       .+.+.  ++... ..|.                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------lilRn--ilt~a-~npf------------------  133 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LILRN--ILTFA-GNPF------------------  133 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hhhhc--ccccc-CCcc------------------
Confidence            56889999999999999999999999999984 33211       00000  11111 2222                  


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                        +|     |+....++.    .++++.+        ++.+++|||+.||+|+|+||+|.+|..-| ++|++|||++...
T Consensus       134 --vv-----gDc~tllk~----~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  134 --VV-----GDCATLLKN----IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKG  193 (1205)
T ss_pred             --ee-----chhhhhccc----CCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhh
Confidence              22     444444433    1233332        27899999999999999999999999888 9999999997543


Q ss_pred             ccC---------------CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHH
Q 021982          164 TLP---------------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       164 ~~~---------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  228 (304)
                      -..               ......-+|+|.|.|||+..... |+...|.|++|+|+|+.+-|..||...+.++.+..++.
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence            111               01112337799999999999877 89999999999999999999999999999998888776


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC---CHHHHhcCCCcccccccc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI---SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~~~~~~  303 (304)
                      ....-.+..                         ..++++++++|..+|..+|..|.   .+-++.+|+||..++++.
T Consensus       273 d~i~wpE~d-------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~  325 (1205)
T KOG0606|consen  273 DDIEWPEED-------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS  325 (1205)
T ss_pred             hhccccccC-------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence            433322222                         25889999999999999999997   677999999999999874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=6.8e-24  Score=167.68  Aligned_cols=177  Identities=14%  Similarity=0.114  Sum_probs=130.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC-Cc------hhHHHHHHHHHccCCCCeeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV-PP------TTLREVSILRMLSRDPHVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~-~~------~~~~e~~~l~~l~~h~~i~~~~~~~~   74 (304)
                      |.++|++++.||.|+||.||.+.+  ++..+++|.+......... ..      .+.+|+..+.++ .|++|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeee
Confidence            568899999999999999999765  3667999998754332211 11      156888899999 9999999999876


Q ss_pred             ccccCC---ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC
Q 021982           75 GQNKEG---RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        75 ~~~~~~---~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~  150 (304)
                      ......   ....+++|||++| +|.+...        +++    ....+++.++..+|+.|++|||++|+||+++.++ 
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-
Confidence            543211   1236899999998 7766521        222    2456999999999999999999999999999665 


Q ss_pred             eEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHh
Q 021982          151 TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV  208 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll  208 (304)
                       ++|+|||...........            ........ +..++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~------------d~~vler~-y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK------------DRIDLERH-YGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH------------HHHHHHhH-hcccccccceeEeehHHH
Confidence             999999987544222111            11233334 558999999999988765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=2.1e-22  Score=157.44  Aligned_cols=141  Identities=17%  Similarity=0.136  Sum_probs=105.6

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC-------Cch-----------------hHHHHHHHHHccCCC
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV-------PPT-----------------TLREVSILRMLSRDP   64 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~-------~~~-----------------~~~e~~~l~~l~~h~   64 (304)
                      ...||+|++|.||.+.+. +|+.+++|+++........       ...                 ...|+..+..+ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence            468999999999999987 7999999999865321111       111                 23488889998 777


Q ss_pred             CeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHH-HhcCccccCCCCCC
Q 021982           65 HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGILHRDLKPHN  142 (304)
Q Consensus        65 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~i~h~dl~~~N  142 (304)
                      ++.....+. . ..     .++||||++| ++......    ..+++...+..++.|++.+|.++ |+.|++|+||||+|
T Consensus        80 ~v~~p~~~~-~-~~-----~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~N  148 (190)
T cd05147          80 GIPCPEPIL-L-KS-----HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYN  148 (190)
T ss_pred             CCCCCcEEE-e-cC-----CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence            664333221 1 11     3799999998 43332211    24688999999999999999999 79999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecc
Q 021982          143 LLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~  164 (304)
                      |+++ ++ .++|+|||++....
T Consensus       149 Ili~-~~-~v~LiDFG~a~~~~  168 (190)
T cd05147         149 LLYH-DG-KLYIIDVSQSVEHD  168 (190)
T ss_pred             EEEE-CC-cEEEEEccccccCC
Confidence            9998 45 79999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=3.3e-21  Score=149.31  Aligned_cols=187  Identities=16%  Similarity=0.050  Sum_probs=135.1

Q ss_pred             hhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC--CchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV--PPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .+...|++|+||+|+.+..  .+.+++.+.+.........  ...+.+|+++++++.++++++.++++    ..     .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~-----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG-----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC-----E
Confidence            4678899999999997754  4677777766654432211  12467899999999767889999886    22     6


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC-CCCCeEEeCCCCeEEEeeccceee
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL-KPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl-~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++|||+.| +|.+...          . ....++.|++.+|.++|++|++|+|| ||.||+++.++ .++|+|||++..
T Consensus        74 ~lvmeyI~G~~L~~~~~----------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPP----------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhhhh----------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCcee
Confidence            899999998 5543221          1 11357889999999999999999999 79999999777 899999999985


Q ss_pred             cccCCCcc-------------ccccccccCCChhhhhCCCCCC-CchhHHHHHHHHHHHhhccccCCC
Q 021982          163 FTLPIKKY-------------THEILTLWYRAPEVLLGSTHYS-TAVDMWSVACIFAELVTKTALFPG  216 (304)
Q Consensus       163 ~~~~~~~~-------------~~~~~~~~~~~PE~~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~  216 (304)
                      ........             .....++.++.|+...-....+ ...+.++.|+.+|.++|+..|.-.
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            54433210             0112267788887654332233 456777889999999999988543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=7.2e-21  Score=149.36  Aligned_cols=141  Identities=20%  Similarity=0.182  Sum_probs=106.9

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC------------------------CchhHHHHHHHHHccCCC
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV------------------------PPTTLREVSILRMLSRDP   64 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~h~   64 (304)
                      ...||+|++|.||++.+. +|+.|++|+++........                        ......|...+.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence            568999999999999987 7999999998865321100                        01124678888888 788


Q ss_pred             CeeeeeceecccccCCceEEEEEEeccCCC-HHH-HHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCC
Q 021982           65 HVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKK-YIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPH  141 (304)
Q Consensus        65 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~  141 (304)
                      ++.....+...  .     .++||||++|. +.. .+..     .+++......++.|++.++.++|+ .|++|+||||+
T Consensus        80 ~i~~p~~~~~~--~-----~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~  147 (190)
T cd05145          80 GVPVPEPILLK--K-----NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY  147 (190)
T ss_pred             CCCCceEEEec--C-----CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence            77444333221  1     37999999973 332 2322     357788999999999999999999 99999999999


Q ss_pred             CeEEeCCCCeEEEeeccceeeccc
Q 021982          142 NLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus       142 Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      ||+++ ++ .++|+|||++.....
T Consensus       148 NIll~-~~-~~~liDFG~a~~~~~  169 (190)
T cd05145         148 NILYH-DG-KPYIIDVSQAVELDH  169 (190)
T ss_pred             hEEEE-CC-CEEEEEcccceecCC
Confidence            99998 55 899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.8e-21  Score=177.48  Aligned_cols=194  Identities=26%  Similarity=0.342  Sum_probs=153.4

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHc--cCCCCeeeeeceecccccCCc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML--SRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l--~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.|.+-+.+|.|++|+||.|...+ |+.+|+|+=+....++-.     --.+++.+|  .--+.|..+...+...+.   
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~~~~~---  768 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHVFQNA---  768 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHccCCc---
Confidence            457888999999999999999877 899999986655544322     123344444  123455566555555555   


Q ss_pred             eEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC------CCCeEEE
Q 021982           82 TVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR------KTMTLKI  154 (304)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~------~~~~vkl  154 (304)
                        -++|+||.+ |+|.+++.    ..+.+++..+..++.|++..++.||..+|+||||||+|+++..      +..-++|
T Consensus       769 --S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 --SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             --ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence              689999999 69999986    4466899999999999999999999999999999999999942      3457999


Q ss_pred             eeccceeecccC--CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc
Q 021982          155 ADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL  213 (304)
Q Consensus       155 ~dfg~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p  213 (304)
                      +|||.+..+..-  ...+...+.+-.|-.+|+..|.+ +++..|.|+|+.+++.|+.|+.-
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHHH
Confidence            999999877532  23455566788899999888777 99999999999999999998743

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=2.5e-19  Score=141.32  Aligned_cols=141  Identities=18%  Similarity=0.212  Sum_probs=105.5

Q ss_pred             hhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc----CCCCeeeeeceecccccCCce
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS----RDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .-.+.||+|++|.||.  +..++.. +||++.....  .....+.+|+..++.+.    .||||+++++++......+..
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            3457899999999995  6666665 5888765322  23457889999999994    479999999999876532221


Q ss_pred             EEEEEEeccC---CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHH-HHHHhcCccccCCCCCCeEEeCC---CCeEEEe
Q 021982           83 VLYLVFEYMD---TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV-AFCHGHGILHRDLKPHNLLMDRK---TMTLKIA  155 (304)
Q Consensus        83 ~~~lv~e~~~---~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~i~h~dl~~~Nil~~~~---~~~vkl~  155 (304)
                       +.+|+||.+   ++|.++++.     ..+++.  ..++.+++.++ +|||+++|+|+||||+||+++..   +..++|+
T Consensus        80 -~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         80 -YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             -EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence             347899955   599999965     234444  35677888777 99999999999999999999743   2479999


Q ss_pred             eccce
Q 021982          156 DLGLA  160 (304)
Q Consensus       156 dfg~~  160 (304)
                      |++.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            94433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-19  Score=157.08  Aligned_cols=207  Identities=21%  Similarity=0.298  Sum_probs=150.7

Q ss_pred             HHccCCCCeeeeeceecccccCCceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCc-cc
Q 021982           58 RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI-LH  135 (304)
Q Consensus        58 ~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i-~h  135 (304)
                      +.+ .|.|+.+++|.+.+...     .++|.+||. |+|.+.+..   ..-.+++-....++++++.||.|+|+..+ +|
T Consensus         2 ~~l-~h~n~~~f~g~~~~~~~-----~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDGPE-----MIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             ccc-chhhhhhheeeEecCCc-----eEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            456 89999999999998866     899999998 599998876   23457778889999999999999998755 99


Q ss_pred             cCCCCCCeEEeCCCCeEEEeeccceeeccc--CCCccccccccccCCChhhhhCC---C---CCCCchhHHHHHHHHHHH
Q 021982          136 RDLKPHNLLMDRKTMTLKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLGS---T---HYSTAVDMWSVACIFAEL  207 (304)
Q Consensus       136 ~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~~---~---~~~~~~Di~slG~il~~l  207 (304)
                      +.++..|.+++ ..|.+|++|||+......  ............-|.|||.+...   .   ..+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999 567999999999865532  11111222236779999998763   1   147789999999999999


Q ss_pred             hhccccCCCCchHHHHHHHHHHhCC-CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC
Q 021982          208 VTKTALFPGDSELQQLLHIFRLLGT-PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS  286 (304)
Q Consensus       208 l~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  286 (304)
                      ++...||...........+...+.. .....-|                 ...... ...+++..+++.||..+|..||+
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP-----------------~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs  213 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRP-----------------SIELLN-ELPPELLLLVARCWEEIPEKRPS  213 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCCcCc-----------------chhhhh-hcchHHHHHHHHhcccChhhCcc
Confidence            9999999864332211222111111 0000000                 000000 45568999999999999999999


Q ss_pred             HHHHhc
Q 021982          287 AKKAME  292 (304)
Q Consensus       287 ~~eil~  292 (304)
                      ++++-.
T Consensus       214 ~~~i~~  219 (484)
T KOG1023|consen  214 IEQIRS  219 (484)
T ss_pred             HHHHHh
Confidence            998754

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.6e-19  Score=144.65  Aligned_cols=143  Identities=18%  Similarity=0.133  Sum_probs=107.4

Q ss_pred             hhhhhhcccccceEEEEEE-EccCCcEEEEEEeeecCCCCCC----------------------CchhHHHHHHHHHccC
Q 021982            6 FEKLEKVGEGTYGKVYRAR-EKATGKIVALKKTRLHEDDEGV----------------------PPTTLREVSILRMLSR   62 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~-~~~~~~~~~iK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~~   62 (304)
                      |.+.+.||.|++|.||.|. +..+|..|++|+++........                      ...+..|+..+.++ .
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~  108 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-Y  108 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-H
Confidence            8899999999999999998 6678999999998764321100                      01245788999998 4


Q ss_pred             C--CCeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC-ccccCC
Q 021982           63 D--PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-ILHRDL  138 (304)
Q Consensus        63 h--~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-i~h~dl  138 (304)
                      +  ..+++++++   . .     .++||||++| ++.....    ...++...++..++.|++.++.+||+.| ++|+||
T Consensus       109 ~~~i~~p~~~~~---~-~-----~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Di  175 (237)
T smart00090      109 EAGVPVPKPIAW---R-R-----NVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDL  175 (237)
T ss_pred             hcCCCCCeeeEe---c-C-----ceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCC
Confidence            4  233444432   1 1     4799999998 5544321    1234566677899999999999999999 999999


Q ss_pred             CCCCeEEeCCCCeEEEeeccceeecc
Q 021982          139 KPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus       139 ~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +|+||+++ ++ .++|+|||.+...+
T Consensus       176 kp~NIli~-~~-~i~LiDFg~a~~~~  199 (237)
T smart00090      176 SEYNILVH-DG-KVVIIDVSQSVELD  199 (237)
T ss_pred             ChhhEEEE-CC-CEEEEEChhhhccC
Confidence            99999999 55 89999999886433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=7.1e-20  Score=155.95  Aligned_cols=179  Identities=28%  Similarity=0.477  Sum_probs=134.0

Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      .++++.|++|.. +|.+++... ......+....+.++.|++.+++|   +|.+|+|++|.||+...++ .++|+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhhe
Confidence            347899999985 999999753 334556888999999999999999   9999999999999998776 8999999999


Q ss_pred             eecccCC------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc-cccCCCCchHHHHHHHHHHhCCC
Q 021982          161 RAFTLPI------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       161 ~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      +......      ...+...|+..|++||.+.++. ++.++||||||++|+|+++- ..++......+   .+..     
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~---d~r~-----  474 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIATLT---DIRD-----  474 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHhhh---hhhc-----
Confidence            8776543      3456668899999999999887 89999999999999999861 11111111111   1100     


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                            +.++..+..--+.-..|+..||.+.|.+||++.+.-.|+|.
T Consensus       475 ----------------------g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  475 ----------------------GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ----------------------CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                  01110000111344589999999999999988888888775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.5e-20  Score=169.73  Aligned_cols=265  Identities=22%  Similarity=0.343  Sum_probs=202.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCc-EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGK-IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~-~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ..|.+.+.||.|+++.+-.+....+.. .++.|.+...............|..+-+.+.+|+|++..++.......    
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~----   95 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS----   95 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc----
Confidence            468899999999999998887754433 455565555444444555666788888888569999999998877776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH-hcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                       .+++.++..| ++...+.  .......+.......+.|+..++.|+| ..+++|+|++|+|.+++..+..+++.|||++
T Consensus        96 -~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   96 -YLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             -cccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence             7899999776 6665552  122225677888999999999999999 9999999999999999966558999999999


Q ss_pred             eeccc-C--CCccccccc-cccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTL-P--IKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~-~--~~~~~~~~~-~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +.+.. .  ........| ++.|.+||.+.+..+..+..|+||.|+++..+++|..|+...........-...       
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~-------  245 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS-------  245 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc-------
Confidence            87655 2  233445567 999999999988666789999999999999999999999877654411110000       


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                          .            ....-......++....+++.+++..+|..|.+.+++..+||+..
T Consensus       246 ----~------------~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  246 ----N------------KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ----c------------ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                0            000012233467888899999999999999999999999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=7.1e-18  Score=134.97  Aligned_cols=136  Identities=22%  Similarity=0.267  Sum_probs=106.5

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC------CCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG------VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++.||+|++|.||++.+  .+..+++|..........      .......|+.++..+ .++++.....++.....    
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~----   73 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPEN----   73 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCC----
Confidence            36799999999999987  466788887653322111      112456788899998 88888776666555444    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.| +|.+.+...       .. ....++.+++.+|.++|+.|++|+|++|.||+++ ++ .++++|||.+.
T Consensus        74 -~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~  142 (211)
T PRK14879         74 -FIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAE  142 (211)
T ss_pred             -CEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCccc
Confidence             6899999987 888877541       12 7889999999999999999999999999999999 55 89999999885


Q ss_pred             e
Q 021982          162 A  162 (304)
Q Consensus       162 ~  162 (304)
                      .
T Consensus       143 ~  143 (211)
T PRK14879        143 F  143 (211)
T ss_pred             C
Confidence            4

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.5e-17  Score=131.65  Aligned_cols=138  Identities=25%  Similarity=0.323  Sum_probs=102.8

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC--------------------CCchhHHHHHHHHHccCCCC
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG--------------------VPPTTLREVSILRMLSRDPH   65 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~~h~~   65 (304)
                      |.+.+.||+|++|.||++.+. ++..+++|++........                    .......|...+..+ .+++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence            888999999999999999875 688999998775431110                    001245677888887 5653


Q ss_pred             --eeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           66 --VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        66 --i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                        ++..++.    ..     .+++|||+.| ++.....          ......++.+++.++.++|+.|++|+||+|.|
T Consensus        95 i~v~~~~~~----~~-----~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPIDW----NR-----HAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFN  155 (198)
T ss_pred             CCCCceeec----CC-----ceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCccc
Confidence              4444332    12     5899999998 5544321          13456788999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeeccc
Q 021982          143 LLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      |+++.++ .++|+|||.+...+.
T Consensus       156 ill~~~~-~~~liDfg~~~~~~~  177 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEcCCC-cEEEEECCccccCCC
Confidence            9999766 999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=3.6e-17  Score=129.65  Aligned_cols=131  Identities=22%  Similarity=0.286  Sum_probs=98.2

Q ss_pred             hcccccceEEEEEEEccCCcEEEEEEeeecCCCCC------CCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982           11 KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG------VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .||+|++|.||++.+  ++..+++|..........      ....+..|+++++.+ .++++.....+......     .
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~-----~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDN-----K   72 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCC-----C
Confidence            489999999999985  467788997553321111      124456799999998 67765444444444333     5


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++|||+.| ++.+.+...     .  .    .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||.+..
T Consensus        73 ~lv~e~~~g~~l~~~~~~~-----~--~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEG-----N--D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhc-----H--H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            899999987 887766431     0  0    7899999999999999999999999999999 55 899999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=1.4e-16  Score=124.92  Aligned_cols=140  Identities=22%  Similarity=0.257  Sum_probs=96.1

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchh----------------------HHHHHHHHHccCC-C
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----------------------LREVSILRMLSRD-P   64 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~~h-~   64 (304)
                      +.+.||+|++|.||.+.+. ++..+++|++.............                      ..|...+..+..+ .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 78899999887543221111111                      2445555555221 1


Q ss_pred             CeeeeeceecccccCCceEEEEEEeccCC-CHH-HHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCC
Q 021982           65 HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLK-KYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPH  141 (304)
Q Consensus        65 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~  141 (304)
                      .++++++..    .     .+++|||++| ++. ..+....      ...++..++.+++.++.++|+ .|++|+||+|+
T Consensus        80 ~~~~~~~~~----~-----~~lv~e~~~g~~~~~~~l~~~~------~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~  144 (187)
T cd05119          80 PVPKPIDLN----R-----HVLVMEFIGGDGIPAPRLKDVR------LLEDPEELYDQILELMRKLYREAGLVHGDLSEY  144 (187)
T ss_pred             CCCceEecC----C-----CEEEEEEeCCCCccChhhhhhh------hcccHHHHHHHHHHHHHHHhhccCcCcCCCChh
Confidence            233443321    1     5899999997 221 1222210      116788999999999999999 99999999999


Q ss_pred             CeEEeCCCCeEEEeeccceeeccc
Q 021982          142 NLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus       142 Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      ||+++ ++ .++++|||.+.....
T Consensus       145 Nili~-~~-~~~liDfg~a~~~~~  166 (187)
T cd05119         145 NILVD-DG-KVYIIDVPQAVEIDH  166 (187)
T ss_pred             hEEEE-CC-cEEEEECcccccccC
Confidence            99999 55 899999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=9.2e-17  Score=145.50  Aligned_cols=135  Identities=21%  Similarity=0.237  Sum_probs=103.1

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCC-----CCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDE-----GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      |...+.||+|+||.||++.+...  .+++|...... ...     .....+.+|+++++.+ .|++++....+...... 
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~-  410 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEE-  410 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCC-
Confidence            45678999999999999987543  34444322111 110     1123567899999999 89998877766655444 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++|||+.| +|.+++.            ....++.+++.+|.+||+.|++|+|+||+||+++ ++ .++|+|||
T Consensus       411 ----~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFG  472 (535)
T PRK09605        411 ----KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFG  472 (535)
T ss_pred             ----CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCc
Confidence                6899999987 8887764            2467899999999999999999999999999994 55 89999999


Q ss_pred             ceee
Q 021982          159 LARA  162 (304)
Q Consensus       159 ~~~~  162 (304)
                      ++..
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9854

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=2.4e-17  Score=142.99  Aligned_cols=257  Identities=21%  Similarity=0.238  Sum_probs=195.1

Q ss_pred             hhhhhhhhccc--ccceEEEEEEE--ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            4 DAFEKLEKVGE--GTYGKVYRARE--KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         4 ~~y~~~~~lg~--g~~g~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      ..+...+.+|.  |.+|.+|.+..  ..++..+++|.-+...........-.+++.-.+.+..|++.++....+..... 
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~-  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI-  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc-
Confidence            34677889999  99999999988  77888898887444433333344455677777777788999987666666665 


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHH----HHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK----GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~----~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                          .++-+|.++.++..+-..   .+..++...++..+.+..+    ||.++|+.+++|-|++|.||+...+....+++
T Consensus       193 ----lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  193 ----LFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             ----ceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence                899999999887777654   2334788899999999999    99999999999999999999999884599999


Q ss_pred             eccceeecccCCCccccc-----cccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC--chHHHHHHHHH
Q 021982          156 DLGLARAFTLPIKKYTHE-----ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD--SELQQLLHIFR  228 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~~-----~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~--~~~~~~~~~~~  228 (304)
                      |||+...+..+.-.....     .+...|++||...+.  ++..+|+|+||.++.+-.++..+....  ....+..... 
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-
Confidence            999998887654332222     668889999987654  689999999999999998886665433  2211111110 


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                                  .......+.+.++...+..|++.||..|++++.++++++...-
T Consensus       343 ----------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 ----------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ----------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                                        0011122567778889999999999999999999999987643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=9.2e-17  Score=129.57  Aligned_cols=212  Identities=15%  Similarity=0.224  Sum_probs=153.8

Q ss_pred             HHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 021982           54 VSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG  132 (304)
Q Consensus        54 ~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~  132 (304)
                      ...+..+ -|-||+++..|+.+...+......++.||++ |++.++|+..+.....+......+|+.||++||.|||+..
T Consensus       118 Fdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  118 FDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            3445566 7999999999999988866666889999998 6999999998888888999999999999999999999984


Q ss_pred             --ccccCCCCCCeEEeCCCCeEEEeeccceeeccc----CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHH
Q 021982          133 --ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL----PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE  206 (304)
Q Consensus       133 --i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~  206 (304)
                        +.|+++..+.|++..++ -+|++--........    .........+.++|.+||.-.-.. .+-++|||++|+...+
T Consensus       197 PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALE  274 (458)
T ss_pred             CccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc-cccchhhhhhhHHHHH
Confidence              99999999999999666 666653222111100    111122334578899998544333 6788999999999999


Q ss_pred             HhhccccCCCC-chHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhh-HHHHHHhhcCCCCCC
Q 021982          207 LVTKTALFPGD-SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDG-LDLLEQMLQYDPSKR  284 (304)
Q Consensus       207 ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~li~~~l~~dp~~R  284 (304)
                      |--+..--... +....-..                                .......+++.+ +.++.+|++..|..|
T Consensus       275 mailEiq~tnseS~~~~ee~--------------------------------ia~~i~~len~lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEEN--------------------------------IANVIIGLENGLQRGSITKCLEGEPNGR  322 (458)
T ss_pred             HHHheeccCCCcceeehhhh--------------------------------hhhheeeccCccccCcCcccccCCCCCC
Confidence            98765432221 11111111                                111112344444 479999999999999


Q ss_pred             CCHHHHhcCCCccccc
Q 021982          285 ISAKKAMEHPYFDDLD  300 (304)
Q Consensus       285 ps~~eil~~~~~~~~~  300 (304)
                      |++++++-||-+-++.
T Consensus       323 p~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  323 PDARLLLFHPLLFEVH  338 (458)
T ss_pred             cchhhhhcCceeeecc
Confidence            9999999999776654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=2.3e-15  Score=121.94  Aligned_cols=139  Identities=17%  Similarity=0.208  Sum_probs=101.7

Q ss_pred             hhcc-cccceEEEEEEEccCCcEEEEEEeeecCC-----------CCCCCchhHHHHHHHHHccCCCCe--eeeeceecc
Q 021982           10 EKVG-EGTYGKVYRAREKATGKIVALKKTRLHED-----------DEGVPPTTLREVSILRMLSRDPHV--VRLMDVKQG   75 (304)
Q Consensus        10 ~~lg-~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~h~~i--~~~~~~~~~   75 (304)
                      ..|| .|+.|+||.+...  +..+++|.+.....           .......+.+|+.++..+ .++++  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence            4577 8999999999764  67788987753210           112235677899999999 77775  666666443


Q ss_pred             cccCCceEEEEEEeccCC--CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEE
Q 021982           76 QNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK  153 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vk  153 (304)
                      ... .....++|+|++.|  +|.+++..     .++++.    .+.+++.++.+||+.|++|+||||.|||++.++ .++
T Consensus       114 ~~~-~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        114 RHG-LFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             ecC-cceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEE
Confidence            221 11124699999986  78777653     234443    357899999999999999999999999999776 899


Q ss_pred             Eeeccceee
Q 021982          154 IADLGLARA  162 (304)
Q Consensus       154 l~dfg~~~~  162 (304)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998854

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=3.6e-15  Score=112.68  Aligned_cols=131  Identities=26%  Similarity=0.351  Sum_probs=104.8

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC-CCeeeeeceecccccCCceEEEE
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD-PHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      +++.|++|.++.||++....  ..+++|.......    ...+..|...++.+..+ ..+++++.+....+.     .++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~-----~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGW-----SYL   70 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc-----cEE
Confidence            46789999999999998754  6788998754332    35678899999999433 588888887766544     799


Q ss_pred             EEeccCCC-HHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc---CccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           87 VFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---GILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        87 v~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ++||+.|. +...           +......++.+++.++..+|..   +++|+|++|.||+++..+ .++++|||.+.
T Consensus        71 v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~  137 (155)
T cd05120          71 LMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAG  137 (155)
T ss_pred             EEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEeccccc
Confidence            99999873 3221           5566778899999999999985   699999999999999755 89999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.62  E-value=1.8e-14  Score=126.71  Aligned_cols=169  Identities=20%  Similarity=0.328  Sum_probs=130.4

Q ss_pred             EEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCCCHHHHHHH
Q 021982           22 RAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRS  101 (304)
Q Consensus        22 ~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~  101 (304)
                      .+..+.++.++.+..+.....  .......+.++.++.+ +||+|+++++.+..+..     .|+|+|.+.. |..+++.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~-----~ylvTErV~P-l~~~lk~  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGT-----LYLVTERVRP-LETVLKE  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCc-----eEEEeecccc-HHHHHHH
Confidence            355667788888888876554  3455677888999999 99999999999998887     9999999986 4455554


Q ss_pred             hccCCCCCChHHHHHHHHHHHHHHHHHH-hcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCC
Q 021982          102 FRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR  180 (304)
Q Consensus       102 ~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~  180 (304)
                             +....+...+.||+.||.+|| +.+++|++|....++|+..| +.||++|.++.....-.........--.|.
T Consensus       101 -------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~  172 (690)
T KOG1243|consen  101 -------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFD  172 (690)
T ss_pred             -------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhccc
Confidence                   447788899999999999997 67899999999999999888 999999999865433222111222234466


Q ss_pred             ChhhhhCCCCCCCchhHHHHHHHHHHHhhc
Q 021982          181 APEVLLGSTHYSTAVDMWSVACIFAELVTK  210 (304)
Q Consensus       181 ~PE~~~~~~~~~~~~Di~slG~il~~ll~g  210 (304)
                      .|+....+.   -..|.|.||+++++++.|
T Consensus       173 ~P~~~~~s~---~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  173 DPEEIDPSE---WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ChhhcCccc---cchhhhhHHHHHHHHhCc
Confidence            776443322   456999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=7e-14  Score=108.48  Aligned_cols=142  Identities=15%  Similarity=0.199  Sum_probs=100.3

Q ss_pred             hhhcccccceEEEEEEEcc------CCcEEEEEEeeecCCC----------C----------CCCchhH----HHHHHHH
Q 021982            9 LEKVGEGTYGKVYRAREKA------TGKIVALKKTRLHEDD----------E----------GVPPTTL----REVSILR   58 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~----------~----------~~~~~~~----~e~~~l~   58 (304)
                      ...||.|..+.||.+....      .+..+++|+++.+...          +          .....+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998653      3578999988754210          0          0011222    6888888


Q ss_pred             HccCC-CCeeeeeceecccccCCceEEEEEEeccCCC-HH-HHHHHhccCCCCCChHHHHHHHHHHHHHHHHH-HhcCcc
Q 021982           59 MLSRD-PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LK-KYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC-HGHGIL  134 (304)
Q Consensus        59 ~l~~h-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~i~  134 (304)
                      ++... -+++.++++   ..      -++|||+++++ +. ..++.     ..++..+...+..+++.++..| |+.|++
T Consensus        82 rl~~~Gv~vP~pi~~---~~------~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~glV  147 (197)
T cd05146          82 RMQKAGIPCPEVVVL---KK------HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECNLV  147 (197)
T ss_pred             HHHHcCCCCCeEEEe---cC------CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence            88433 456666654   12      47999999873 22 12222     2345566778889999999998 899999


Q ss_pred             ccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982          135 HRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus       135 h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      ||||++.||+++ ++ .+.++|||.+.....+
T Consensus       148 HGDLs~~NIL~~-~~-~v~iIDF~qav~~~hp  177 (197)
T cd05146         148 HADLSEYNMLWH-DG-KVWFIDVSQSVEPTHP  177 (197)
T ss_pred             cCCCCHHHEEEE-CC-cEEEEECCCceeCCCC
Confidence            999999999998 45 7999999998765543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.50  E-value=1.2e-14  Score=133.40  Aligned_cols=264  Identities=24%  Similarity=0.323  Sum_probs=182.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-CCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +.+.+.+-+.+|.++.++.+.-..++.-..+|.......... .......+-+++-.. .+|.++   ..+....  ...
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~---~~~~s~~--~rs  877 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVV---RSFPSFP--CRS  877 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCcee---cccCCCC--CCC
Confidence            445667788899999999988777775455554332221111 111222222222111 233333   2222211  112


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...+++++.++ ++...+.+.    ...+.+-....+..+.+++++||...+.|+|++|.|++...++ ..++.||+...
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~  952 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLS  952 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCcccccc
Confidence            27899999986 777776552    3466666777888899999999999999999999999999777 89999997432


Q ss_pred             eccc---------------------C----------CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc
Q 021982          162 AFTL---------------------P----------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK  210 (304)
Q Consensus       162 ~~~~---------------------~----------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g  210 (304)
                      ..+.                     .          ........+++.|.+||...+.. ....+|.|++|+++++.++|
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence            2210                     0          01112235589999999998877 58889999999999999999


Q ss_pred             cccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHH--
Q 021982          211 TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK--  288 (304)
Q Consensus       211 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~--  288 (304)
                      ..||.........+.+.+.-                         ..+..-....+..+++++.+.+..+|.+|..+.  
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~-------------------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRD-------------------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred             CCCCCCcchhhhhhccccCC-------------------------CCCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence            99999999888776654421                         112222336788999999999999999999988  


Q ss_pred             -HHhcCCCccccccccC
Q 021982          289 -KAMEHPYFDDLDKTRL  304 (304)
Q Consensus       289 -eil~~~~~~~~~~~~~  304 (304)
                       ++-.|+||+.++++-|
T Consensus      1087 ~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1087 AEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             cccccCCccCCCCcccc
Confidence             9999999999987643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.44  E-value=2e-11  Score=102.53  Aligned_cols=256  Identities=14%  Similarity=0.106  Sum_probs=163.5

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc--CCceEEE
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK--EGRTVLY   85 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~--~~~~~~~   85 (304)
                      ....||+|+.+.+|.+-.-   ...+.|++......     ...+....|..-+.||-+-.-+.|-+..-.  +......
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa-----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA-----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCch-----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            4578999999999998432   23556877654322     111233344444466655443333221111  1122377


Q ss_pred             EEEeccCC--CHHHHH--HHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           86 LVFEYMDT--DLKKYI--RSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        86 lv~e~~~~--~l~~~l--~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ++|..++|  ..-.+.  ..+++......++.++++++.++.+...||..|.+-||++++|+||.+++ .|.|+|=....
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfq  165 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQ  165 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEccccee
Confidence            89999886  333333  23334445688999999999999999999999999999999999999777 89999877554


Q ss_pred             ecccCCCccccccccccCCChhhhhCC----CCCCCchhHHHHHHHHHHHhhc-cccCCCCc-------hHHHHHHHHHH
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTK-TALFPGDS-------ELQQLLHIFRL  229 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~il~~ll~g-~~p~~~~~-------~~~~~~~~~~~  229 (304)
                      .. ..........|.+.|.|||.-.-.    ..-+..+|.|.||+++++++.| +.||....       ..+...  ...
T Consensus       166 i~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I--a~g  242 (637)
T COG4248         166 IN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI--AHG  242 (637)
T ss_pred             ec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh--hcc
Confidence            33 444566677889999999965411    1246789999999999999987 99987532       111111  000


Q ss_pred             hCCCCCCCCccccccCCcccCCC--CCCCcccccCCCCChhhHHHHHHhhcC--CCCCCCCHHH
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQ--WNPQSLATAVPNLDKDGLDLLEQMLQY--DPSKRISAKK  289 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~--dp~~Rps~~e  289 (304)
                      .-.              +.....  ..+....-.+.-+++++..|..+|+..  .+.-|||++.
T Consensus       243 ~f~--------------ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFA--------------YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eee--------------echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            000              000000  000111112235789999999999985  4567999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.44  E-value=8.1e-13  Score=98.83  Aligned_cols=145  Identities=19%  Similarity=0.238  Sum_probs=105.3

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCC------CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED------DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .+..+.+|+.+.|+.+.+.  |+.++||.-.....      ..-...+...|+..+.++ .--.|....-++.+...   
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~---   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYG---   84 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCC---
Confidence            4567889999999999765  77888885332111      111223455677777777 44455555555555555   


Q ss_pred             eEEEEEEeccCC--CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeec
Q 021982           82 TVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~df  157 (304)
                        -.++|||++|  ++.+++.+.-.  .+....-...++.+|-..+.-||.++++||||+.+||++.+++  +.+.++||
T Consensus        85 --~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 --GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             --CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEee
Confidence              4799999998  88888887433  2333444489999999999999999999999999999998766  45599999


Q ss_pred             cceee
Q 021982          158 GLARA  162 (304)
Q Consensus       158 g~~~~  162 (304)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99854

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.43  E-value=2e-11  Score=104.88  Aligned_cols=218  Identities=18%  Similarity=0.207  Sum_probs=157.1

Q ss_pred             ceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCC--C
Q 021982           17 YGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--D   94 (304)
Q Consensus        17 ~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~--~   94 (304)
                      ..+.|++..+.+|..|++|-+....  .........-+++++.+ .|+|++++.+++.... -+..-+++|++|+.+  +
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHh-ccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence            3678999999999999999873322  11223445678999999 9999999999988322 222338899999985  6


Q ss_pred             HHHHH-HHhc----------cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           95 LKKYI-RSFR----------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        95 l~~~l-~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      |.+.- ....          ..+...++..+|.++.|++.||.++|+.|+...-|.|.+|+++++. +++|..+|.....
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVL  443 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeee
Confidence            66543 2111          2223467899999999999999999999999999999999999777 9999999987655


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc-CCCCchHHH-HHHHHHHhCCCCCCCCccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQ-LLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  241 (304)
                      ..+.            .+|  +.    -..+.|.=.||.+++.|.||..- +......+. ...+.              
T Consensus       444 ~~d~------------~~~--le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~--------------  491 (655)
T KOG3741|consen  444 QEDP------------TEP--LE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT--------------  491 (655)
T ss_pred             cCCC------------Ccc--hh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh--------------
Confidence            4432            111  21    23567899999999999999643 222222222 22222              


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                           +++|.+++++|.-.....+++ -++.+++.+
T Consensus       492 ---------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  492 ---------------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ---------------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                                 268889999999888888876 777777754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=1.1e-12  Score=101.05  Aligned_cols=127  Identities=17%  Similarity=0.190  Sum_probs=92.0

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      ++.|+.|.++.||.+...  +..+++|.......   .......|+..++.+.....+++++....  ..     .++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~-----~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ET-----GVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC-----CeEEE
Confidence            567899999999999865  67899998754322   12345688999998844333455555432  11     36999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCc-----cccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI-----LHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i-----~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      |+++| ++.+.         .   ......+.+++.+|..||+.++     +|+|++|.||+++ ++ .++++||+.+.
T Consensus        71 e~i~G~~l~~~---------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          71 EFIEGSELLTE---------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             EecCCCccccc---------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            99998 44321         0   1113456889999999999985     9999999999999 55 79999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=3.1e-12  Score=112.52  Aligned_cols=144  Identities=22%  Similarity=0.255  Sum_probs=92.8

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCC----------------------C--CC--------------chhH
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE----------------------G--VP--------------PTTL   51 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----------------------~--~~--------------~~~~   51 (304)
                      +.||+|++|.||+|+.+ +|+.|+||+.+......                      .  ..              -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999876 58899999875431000                      0  00              0123


Q ss_pred             HHHHHHHHcc---CCCCeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHH-HHH
Q 021982           52 REVSILRMLS---RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK-GVA  126 (304)
Q Consensus        52 ~e~~~l~~l~---~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~-~l~  126 (304)
                      .|+..+.++.   .+.+-+.+..++.+...    ..+++|||+.| ++.+.......   ..   ....++..++. .+.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~  271 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLN  271 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHH
Confidence            3444444431   12222333333332211    15899999998 77666543111   11   23446666665 478


Q ss_pred             HHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982          127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus       127 ~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      .+|..|++|+|++|.||+++.++ .++++|||++...+.
T Consensus       272 ql~~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~~  309 (437)
T TIGR01982       272 QVLRDGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHhCCceeCCCCcccEEECCCC-cEEEEeCCCeeECCH
Confidence            89999999999999999998777 899999999976653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3e-13  Score=117.84  Aligned_cols=252  Identities=18%  Similarity=0.184  Sum_probs=177.7

Q ss_pred             hhhhhhhhcccccceEEEEEEEc-cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREK-ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+|..+..||.|.++.++.+..+ -++..|++|.................|+.+...+..|.+.+.....+.....    
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----  340 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----  340 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----
Confidence            35778899999999999998765 5677888887765543333333445677777777778888877666555554    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++-.||+.+ ++......    ...+++...+.+..|++.++.++|+..++|.|++|+||++..++...+++||+..+
T Consensus       341 -~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  341 -GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             -ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence             5788999975 54433311    23578889999999999999999999999999999999998765688999999886


Q ss_pred             ecccCCCccccccccccCCC-hhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRA-PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~-PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .+.....   .....-++.| .|.+........+.|+++||..+.+..++...-........+                 
T Consensus       416 ~~~~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i-----------------  475 (524)
T KOG0601|consen  416 RLAFSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI-----------------  475 (524)
T ss_pred             ccceecc---cccccccccccchhhccccccccccccccccccccccccCcccCcccccceee-----------------
Confidence            4322111   1122334553 666666666889999999999999999876443222211100                 


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                    ........++.+..+..+.+.|+..|+..||++.++..|.=|..
T Consensus       476 --------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  476 --------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             --------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                          01112222344567788999999999999999999998876543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=3.5e-12  Score=95.86  Aligned_cols=132  Identities=21%  Similarity=0.268  Sum_probs=92.8

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCC-----CCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEG-----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..+++|+.+.++.+.+.  |..+++|.-....- ...     ...+-.+|+.++..+ ..-.+...+=+..+...     
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~-----   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDN-----   73 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCC-----
Confidence            46789999999999764  44566774332211 111     123445677888777 54455444444445555     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ..++|||..| .|.+.+...           ...++..+-.-+.-||..||+||||+++||++..+  .+.++|||++..
T Consensus        74 ~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            6799999999 666677652           14466777778889999999999999999999844  599999999853

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=5.2e-13  Score=118.90  Aligned_cols=150  Identities=19%  Similarity=0.249  Sum_probs=91.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC---------------------C-CC----------Cc--
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---------------------E-GV----------PP--   48 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---------------------~-~~----------~~--   48 (304)
                      +..|.. +.||+|++|.||.|+.+.+|+.|+||+.+..-..                     . ..          ..  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 8999999999999999888999999998743100                     0 00          01  


Q ss_pred             ----hhHHHHHHHHHcc---CCCCeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCC---CCCChHHHHHH
Q 021982           49 ----TTLREVSILRMLS---RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG---ENIPVNTVKSL  117 (304)
Q Consensus        49 ----~~~~e~~~l~~l~---~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~---~~~~~~~~~~~  117 (304)
                          .+..|+..+.++.   .+...+.+-.++.+-..    ..++||||+.| .+.+.-.. ...+   ..+....+..+
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~  272 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVF  272 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHH
Confidence                1223333333331   12333333333332211    15799999998 77653211 1111   11222223333


Q ss_pred             HHHHHHHHHHHHhcCccccCCCCCCeEEeCCC---CeEEEeeccceeeccc
Q 021982          118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTL  165 (304)
Q Consensus       118 ~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~---~~vkl~dfg~~~~~~~  165 (304)
                             +..+...|++|+|++|.||+++.++   ..++++|||.....+.
T Consensus       273 -------~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 -------FTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------HHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   3344569999999999999998665   3899999999876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=6e-13  Score=117.75  Aligned_cols=155  Identities=20%  Similarity=0.288  Sum_probs=112.4

Q ss_pred             HHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCc---------cccccccccCCChhhhhCCC
Q 021982          120 QLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK---------YTHEILTLWYRAPEVLLGST  189 (304)
Q Consensus       120 ~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~~  189 (304)
                      +++.|+.++|. .++||++|.|++|.++..+ ..|++.|+++.....+...         .........|.+||.+.+..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            34489999995 5899999999999999887 8999999998655442210         11112267899999998855


Q ss_pred             CCCCchhHHHHHHHHHHHhhcccc-CCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChh
Q 021982          190 HYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKD  268 (304)
Q Consensus       190 ~~~~~~Di~slG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (304)
                       .+.++|+||+|+++|.+..|+.+ +............... ..                       ........+++++
T Consensus       186 -~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-~~-----------------------~~~~~~s~~~p~e  240 (700)
T KOG2137|consen  186 -NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-LN-----------------------AGAFGYSNNLPSE  240 (700)
T ss_pred             -ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-cc-----------------------cccccccccCcHH
Confidence             89999999999999999955544 3333322222211111 00                       0011112478999


Q ss_pred             hHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          269 GLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       269 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      +++=+.+++..|+..||++.+++..|||++..
T Consensus       241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            99999999999999999999999999999853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.27  E-value=3.1e-11  Score=96.21  Aligned_cols=140  Identities=23%  Similarity=0.296  Sum_probs=103.8

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC----------------C----CCCCchhHHHHHHHHHccCC-C
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED----------------D----EGVPPTTLREVSILRMLSRD-P   64 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----------------~----~~~~~~~~~e~~~l~~l~~h-~   64 (304)
                      +.+...||-|..|.||.+.+. .|.++++|.-+.-..                .    ........+|..+|..|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            467789999999999999987 478899995432110                0    11123456788999999433 3


Q ss_pred             CeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCe
Q 021982           65 HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL  143 (304)
Q Consensus        65 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Ni  143 (304)
                      .+++.+++..         .++|||+.+| .|...         +++.+..-.++..|+..+..+...|++|||+++-||
T Consensus       172 ~VP~P~~~nR---------HaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIAWNR---------HAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCcccccc---------ceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheE
Confidence            6777776633         5899999999 33221         234566677788888888888899999999999999


Q ss_pred             EEeCCCCeEEEeeccceeeccc
Q 021982          144 LMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus       144 l~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      +++.+| .+.++||..+.....
T Consensus       234 lV~~dg-~~~vIDwPQ~v~~~h  254 (304)
T COG0478         234 LVTEDG-DIVVIDWPQAVPISH  254 (304)
T ss_pred             EEecCC-CEEEEeCcccccCCC
Confidence            999887 899999998765443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=3.1e-10  Score=93.08  Aligned_cols=139  Identities=20%  Similarity=0.226  Sum_probs=93.8

Q ss_pred             eEEEEEEEccCCcEEEEEEeeecCCCC---C-----CC-chhHHHHHHHHHccCCCCe--eeeeceecccccCCceEEEE
Q 021982           18 GKVYRAREKATGKIVALKKTRLHEDDE---G-----VP-PTTLREVSILRMLSRDPHV--VRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus        18 g~v~~~~~~~~~~~~~iK~~~~~~~~~---~-----~~-~~~~~e~~~l~~l~~h~~i--~~~~~~~~~~~~~~~~~~~l   86 (304)
                      ..|..+..  .|+.+.+|.........   .     .. ..+.+|...+..+ ...+|  +.++++............++
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEE
Confidence            33555543  46789999664322110   0     00 1366788888777 33333  33344543322222233689


Q ss_pred             EEeccCC--CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC------CCCeEEEeecc
Q 021982           87 VFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR------KTMTLKIADLG  158 (304)
Q Consensus        87 v~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~------~~~~vkl~dfg  158 (304)
                      |+|++++  +|.+++..+..  .+.+......++.+++..+..||..|++|+|+++.|||++.      ++..+.++||+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            9999997  68888765432  34566778899999999999999999999999999999985      23589999999


Q ss_pred             cee
Q 021982          159 LAR  161 (304)
Q Consensus       159 ~~~  161 (304)
                      .+.
T Consensus       191 r~~  193 (268)
T PRK15123        191 RAQ  193 (268)
T ss_pred             ccc
Confidence            874

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=1.1e-10  Score=90.43  Aligned_cols=129  Identities=24%  Similarity=0.297  Sum_probs=80.2

Q ss_pred             EEEEEEEccCCcEEEEEEeeecCCC----------CCC--------------CchhHHHHHHHHHccCC-CCeeeeecee
Q 021982           19 KVYRAREKATGKIVALKKTRLHEDD----------EGV--------------PPTTLREVSILRMLSRD-PHVVRLMDVK   73 (304)
Q Consensus        19 ~v~~~~~~~~~~~~~iK~~~~~~~~----------~~~--------------~~~~~~e~~~l~~l~~h-~~i~~~~~~~   73 (304)
                      .||.|... ++..+++|..+.....          ...              .....+|...|..+... -++++++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            37888764 4678999987654210          001              01345688899999433 2567776552


Q ss_pred             cccccCCceEEEEEEeccC--CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHH-HHhcCccccCCCCCCeEEeCCCC
Q 021982           74 QGQNKEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF-CHGHGILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~-Lh~~~i~h~dl~~~Nil~~~~~~  150 (304)
                         .      -++||||++  |.....+...     .++.+....++.+++..+.. +|+.|++|||+++.||+++.+  
T Consensus        80 ---~------~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--  143 (188)
T PF01163_consen   80 ---R------NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--  143 (188)
T ss_dssp             ---T------TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--
T ss_pred             ---C------CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--
Confidence               2      379999999  7333334331     22355677788888885544 679999999999999999944  


Q ss_pred             eEEEeeccceeecc
Q 021982          151 TLKIADLGLARAFT  164 (304)
Q Consensus       151 ~vkl~dfg~~~~~~  164 (304)
                      .+.++|||.+....
T Consensus       144 ~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CEEE--GTTEEETT
T ss_pred             eEEEEecCcceecC
Confidence            79999999987644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=5.2e-10  Score=90.05  Aligned_cols=144  Identities=19%  Similarity=0.278  Sum_probs=97.7

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC-CCeeeeeceecccccCCceEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD-PHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      .+.|+.|..+.+|++.... |..+++|........ .....+..|+.+++.+..+ ..+++++.+.......+  ..+++
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~--~~~~v   78 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG--TPFYV   78 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC--CceEE
Confidence            3578999999999998753 578999987544322 2345778899999998432 34566776655432111  15799


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh------------------------------------
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG------------------------------------  130 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~------------------------------------  130 (304)
                      ||++.| ++.+.+..     ..+++.....++.+++.+|..||+                                    
T Consensus        79 ~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          79 MERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            999988 44432210     235555666666666666666663                                    


Q ss_pred             --------------------cCccccCCCCCCeEEeCC-CCeEEEeecccee
Q 021982          131 --------------------HGILHRDLKPHNLLMDRK-TMTLKIADLGLAR  161 (304)
Q Consensus       131 --------------------~~i~h~dl~~~Nil~~~~-~~~vkl~dfg~~~  161 (304)
                                          ..++|+|+.|.||+++.+ +..+.++||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                                236999999999999973 3368999999874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK09902 hypothetical protein; Provisional

Probab=99.11  E-value=4.8e-09  Score=81.81  Aligned_cols=144  Identities=17%  Similarity=0.162  Sum_probs=102.7

Q ss_pred             ccccceEEEEEEEccCCcEEEEEEeeecCCC----CCCCchhHHHHHHHHHccCC-CCeeeeeceecccccCCceEEEEE
Q 021982           13 GEGTYGKVYRAREKATGKIVALKKTRLHEDD----EGVPPTTLREVSILRMLSRD-PHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        13 g~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      |+||-+.|+.....  |..+-+|.-...-..    ..-...+.+|...+..+... -.++++. ++......+....++|
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            45888889988755  335777854321110    22456788899988888322 1244444 4443444445568899


Q ss_pred             EeccCC--CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC-CeEEEeecccee
Q 021982           88 FEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-MTLKIADLGLAR  161 (304)
Q Consensus        88 ~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~-~~vkl~dfg~~~  161 (304)
                      +|-++|  +|.+++.....  .+.+......++.+++.++.-||+.|+.|+|+.+.||+++.++ ..+.++||.-+.
T Consensus       104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998885  88888765322  3567777889999999999999999999999999999998555 359999998764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=4.2e-09  Score=83.61  Aligned_cols=110  Identities=25%  Similarity=0.379  Sum_probs=82.8

Q ss_pred             CchhHHHHHHHHHccCCC--CeeeeeceecccccCCceEEEEEEeccCC--CHHHHHHHhccCCCCCChHHHHHHHHHHH
Q 021982           47 PPTTLREVSILRMLSRDP--HVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLC  122 (304)
Q Consensus        47 ~~~~~~e~~~l~~l~~h~--~i~~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~~i~  122 (304)
                      .....+|...+..+ ...  ..+.++++........ ...++|+|++++  +|.+++.....    .+......++.+++
T Consensus        55 ~~ra~~E~~~~~~L-~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   55 RSRAKREWRNLQRL-REAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALA  128 (206)
T ss_pred             chHHHHHHHHHHHH-HHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHH
Confidence            44667777777766 322  3455555554433323 447899999987  68888776333    56677889999999


Q ss_pred             HHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeeccceee
Q 021982          123 KGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARA  162 (304)
Q Consensus       123 ~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg~~~~  162 (304)
                      ..+.-||+.|++|+|+++.|||++.++  ..+.++||+.+..
T Consensus       129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  129 RLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999999998664  5799999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.96  E-value=3.6e-09  Score=83.68  Aligned_cols=140  Identities=19%  Similarity=0.236  Sum_probs=95.5

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCC----------------------chhHHHHHHHHHcc-CCCCe
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP----------------------PTTLREVSILRMLS-RDPHV   66 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~----------------------~~~~~e~~~l~~l~-~h~~i   66 (304)
                      .+|++|..+.||++.. .++..+++|+++.+.......                      ....+|+..|+++. .+-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            4678899999999875 457889999987654221110                      12235666666662 12334


Q ss_pred             eeeeceecccccCCceEEEEEEeccCCC--HHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCe
Q 021982           67 VRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNL  143 (304)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Ni  143 (304)
                      ++.+++..         -.++||+++..  -.-.|+.     -++.+.+...+..++++.+.-|.. .++||+||+.-||
T Consensus       133 P~Pi~~~~---------nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNi  198 (268)
T COG1718         133 PEPIAFRN---------NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNI  198 (268)
T ss_pred             CCceeecC---------CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhhe
Confidence            44444322         47999999853  1111111     233444688889999999999988 8999999999999


Q ss_pred             EEeCCCCeEEEeeccceeecccC
Q 021982          144 LMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus       144 l~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |++ ++ .+.++|++.++....+
T Consensus       199 L~~-~~-~p~iID~~QaV~~~hp  219 (268)
T COG1718         199 LVH-DG-EPYIIDVSQAVTIDHP  219 (268)
T ss_pred             EEE-CC-eEEEEECccccccCCC
Confidence            999 66 8999999999765543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.90  E-value=1.4e-08  Score=79.60  Aligned_cols=142  Identities=16%  Similarity=0.163  Sum_probs=81.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-CC------chhHHHHHHHHHcc--CCCCeeeeecee
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-VP------PTTLREVSILRMLS--RDPHVVRLMDVK   73 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~------~~~~~e~~~l~~l~--~h~~i~~~~~~~   73 (304)
                      -++|...+.+.......|.+..-  +|..+++|..+....... ..      ..+.+.+..+.++.  .......++...
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34566666666666666666643  467788886654221100 00      11222333333331  222222222222


Q ss_pred             cccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeE
Q 021982           74 QGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~v  152 (304)
                      ..-..+-....+++|||++| .+.+...        +++    .++..+.+++.-+|+.|++|||.+|.|+++..+  .+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GI  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cE
Confidence            21111112336789999999 5544321        222    355678888999999999999999999999944  59


Q ss_pred             EEeeccce
Q 021982          153 KIADLGLA  160 (304)
Q Consensus       153 kl~dfg~~  160 (304)
                      +++|++.-
T Consensus       174 ~iID~~~k  181 (229)
T PF06176_consen  174 RIIDTQGK  181 (229)
T ss_pred             EEEECccc
Confidence            99999865

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=9e-07  Score=66.54  Aligned_cols=130  Identities=21%  Similarity=0.234  Sum_probs=92.9

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      -++.+.|+.|.+|.||++.+.  |..+++|+-+.+    +....+..|++++..+....--++++.+..         .+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~---------~~   88 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE---------DF   88 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech---------hh
Confidence            467889999999999999886  557888875543    334678899999999865555666766633         24


Q ss_pred             EEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCC-CCCeEEeCCCCeEEEeeccceee
Q 021982           86 LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK-PHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~-~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +.|||..| +|.+.-..       .+    ..-+..++....-|-..||-|+.|+ |..+++..++ .+.|+||..++.
T Consensus        89 i~me~i~G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          89 IRMEYIDGRPLGKLEIG-------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcCcchhhhhhc-------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            56999999 66554321       12    2234456666777888899999975 5555555466 899999999863

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=2.1e-07  Score=82.97  Aligned_cols=142  Identities=20%  Similarity=0.245  Sum_probs=87.1

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCC---------------------C---CCCc--------------hhH
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---------------------E---GVPP--------------TTL   51 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---------------------~---~~~~--------------~~~   51 (304)
                      ..|++++-|.||.|+.++ |+.|+||+.+..-..                     .   -...              .+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578899999999999876 899999986543110                     0   0000              112


Q ss_pred             HHHHHHHHc----cCCCCeeeeeceecc-cccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHH-
Q 021982           52 REVSILRML----SRDPHVVRLMDVKQG-QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG-  124 (304)
Q Consensus        52 ~e~~~l~~l----~~h~~i~~~~~~~~~-~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~-  124 (304)
                      .|...+.++    .+.+.+ .+-.++.+ ...     -+++|||+.| .+.+....- .  ..++...+.   ..++.+ 
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~-----~VLtmE~i~Gi~i~d~~~l~-~--~g~d~k~ia---~~~~~~f  277 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTR-----RVLTMEWIDGIKISDIAALK-S--AGIDRKELA---ELLVRAF  277 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCC-----cEEEEEeeCCEecccHHHHH-h--cCCCHHHHH---HHHHHHH
Confidence            233333332    123333 33333322 222     5899999999 666553221 1  234433333   333332 


Q ss_pred             HHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeeccc
Q 021982          125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL  165 (304)
Q Consensus       125 l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~  165 (304)
                      +..+-..|++|+|.+|.||+++.++ .+.+.|||.....+.
T Consensus       278 ~~q~~~dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 LRQLLRDGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHhcCccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence            4555568999999999999999887 999999999866643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.57  E-value=2.5e-07  Score=87.34  Aligned_cols=204  Identities=21%  Similarity=0.286  Sum_probs=136.8

Q ss_pred             HHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH
Q 021982           51 LREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH  129 (304)
Q Consensus        51 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh  129 (304)
                      ..|+..+... .|+|+..+..|.......+ ....+..+++++ ++...+.+.    ..++....+.+..++..+|.++|
T Consensus       230 E~e~~~l~k~-~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  230 EIELESLSKI-AHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHhh-ccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence            3455667776 8999999998876655533 123355677776 777766552    56899999999999999999999


Q ss_pred             hcCccccCCCCC---CeEEeCCCCeEEEe--eccceeecccCCCccccccccccCCChhhhhCCC-CCCCchhHHHHHHH
Q 021982          130 GHGILHRDLKPH---NLLMDRKTMTLKIA--DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACI  203 (304)
Q Consensus       130 ~~~i~h~dl~~~---Nil~~~~~~~vkl~--dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~i  203 (304)
                      +....|.-+...   +--++..+ .+.++  ||+.+............ ..+..+.++|....+. ......|+|++|..
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~-~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSD-LLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             HhccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhh-cCccccccccccccccchhhhhhHHHHHHHH
Confidence            996666655555   33444444 56666  88887665544333222 2345566777665443 13445799999999


Q ss_pred             HHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC
Q 021982          204 FAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK  283 (304)
Q Consensus       204 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  283 (304)
                      +..+..|..+-........+.                                  ..   .....+.+++.+|+.-|+++
T Consensus       382 ~~~~~~~~~i~~~~~~~~~~l----------------------------------~~---~~~~~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAVPVSLL----------------------------------DV---LSTSELLDALPKCLDEDSEE  424 (1351)
T ss_pred             HhhhhhcCcccccccchhhhh----------------------------------cc---ccchhhhhhhhhhcchhhhh
Confidence            999988765433221111110                                  00   11126778999999999999


Q ss_pred             CCCHHHHhcCCCcccc
Q 021982          284 RISAKKAMEHPYFDDL  299 (304)
Q Consensus       284 Rps~~eil~~~~~~~~  299 (304)
                      |+++.+++.|+|.+.-
T Consensus       425 Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  425 RLSALELLTHPFLRFP  440 (1351)
T ss_pred             ccchhhhhhchhcccc
Confidence            9999999999998753

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=1.3e-06  Score=70.31  Aligned_cols=72  Identities=21%  Similarity=0.160  Sum_probs=50.1

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCC-eeeeeceecccccCCceEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH-VVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      ...+++|..+.||+.    .+..+++|......    ......+|.++++.+....- +++++++......     ..++
T Consensus         6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~-----~glv   72 (226)
T TIGR02172         6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR-----LGLI   72 (226)
T ss_pred             heeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe-----eeee
Confidence            357899999999984    24467888775322    23456789999998843332 5666766655444     5789


Q ss_pred             EeccCC
Q 021982           88 FEYMDT   93 (304)
Q Consensus        88 ~e~~~~   93 (304)
                      ||+++|
T Consensus        73 ~e~i~G   78 (226)
T TIGR02172        73 YELIVG   78 (226)
T ss_pred             eeecCC
Confidence            999998

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.39  E-value=6.9e-06  Score=67.13  Aligned_cols=74  Identities=23%  Similarity=0.224  Sum_probs=49.7

Q ss_pred             hcccccc-eEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEe
Q 021982           11 KVGEGTY-GKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE   89 (304)
Q Consensus        11 ~lg~g~~-g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   89 (304)
                      .|..|.. ..||.+...  +..+++|......     ......|+.+++.+..+--+++++++......     .+++||
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-----~~lv~e   72 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGR-----AWLLTS   72 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc-----cEEEEE
Confidence            4455555 778999653  3568888765332     34567899999988656556677776654432     589999


Q ss_pred             ccCC-CHH
Q 021982           90 YMDT-DLK   96 (304)
Q Consensus        90 ~~~~-~l~   96 (304)
                      ++.| ++.
T Consensus        73 ~i~G~~l~   80 (244)
T cd05150          73 AVPGVPAA   80 (244)
T ss_pred             eeCCccHh
Confidence            9988 443

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.33  E-value=2.4e-05  Score=61.23  Aligned_cols=131  Identities=22%  Similarity=0.317  Sum_probs=89.9

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecC--------------CCCCCCchhHHHHHHHHHcc-----CCCCeeee
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHE--------------DDEGVPPTTLREVSILRMLS-----RDPHVVRL   69 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~   69 (304)
                      ...||+|+.-.||.--   .+...+||+.....              ..........+|+.-...+.     .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4678999999888762   23446789887655              11122345566666665552     37889999


Q ss_pred             eceecccccCCceEEEEEEeccC---C----CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           70 MDVKQGQNKEGRTVLYLVFEYMD---T----DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      +|+.+.+.+     ..+|+|.+.   |    +|.+++..     ..+++    .+...+-....+|-+.+|+.+|++|.|
T Consensus        83 ~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~N  148 (199)
T PF10707_consen   83 YGFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-----GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHN  148 (199)
T ss_pred             eEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-----CCccH----HHHHHHHHHHHHHHHcCCeecCCCccc
Confidence            999988887     788888762   2    67777643     34554    344445556678899999999999999


Q ss_pred             eEEeCCC--C-eEEEee
Q 021982          143 LLMDRKT--M-TLKIAD  156 (304)
Q Consensus       143 il~~~~~--~-~vkl~d  156 (304)
                      |++...+  . .+.|+|
T Consensus       149 Iv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEEecCCCceEEEEEe
Confidence            9996443  3 566766

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.32  E-value=4.8e-06  Score=69.92  Aligned_cols=143  Identities=20%  Similarity=0.248  Sum_probs=100.9

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecC---CCCC---------------------CCchhHHHHHHHHHccCC
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE---DDEG---------------------VPPTTLREVSILRMLSRD   63 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~---------------------~~~~~~~e~~~l~~l~~h   63 (304)
                      +-.+|..|..+.||.+... +|..++||+++.+-   ++.+                     ......+|+..|+++ +.
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~  225 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NN  225 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-Hh
Confidence            4467889999999999765 57779999886542   1110                     001234677778888 55


Q ss_pred             CCeeeeeceecccccCCceEEEEEEeccCCC--HHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCC
Q 021982           64 PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKP  140 (304)
Q Consensus        64 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~  140 (304)
                      ..|+..--+....       .++||+++++.  ..-.|+     .-+++...+..+-.+++.-+.-|.+ +++||.||+-
T Consensus       226 aGIP~PePIlLk~-------hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE  293 (520)
T KOG2270|consen  226 AGIPCPEPILLKN-------HVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE  293 (520)
T ss_pred             cCCCCCCceeeec-------ceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence            5554433333322       47999999852  112222     2467888899999999999999975 6999999999


Q ss_pred             CCeEEeCCCCeEEEeeccceeecccC
Q 021982          141 HNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus       141 ~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      -|+|+. +| .+.++|.+.+.....+
T Consensus       294 fN~Lyh-dG-~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  294 FNLLYH-DG-KLYIIDVSQSVEHDHP  317 (520)
T ss_pred             hhheEE-CC-EEEEEEccccccCCCh
Confidence            999999 66 8999999988765544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.32  E-value=5.7e-06  Score=66.99  Aligned_cols=145  Identities=23%  Similarity=0.291  Sum_probs=79.8

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC-CeeeeeceecccccCCceEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP-HVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      ++.|+.|..+.+|.+...+  ..+++|.....    .....+..|..+++.+..+. .++.++.........+  ..+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~--~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG--FPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS--EEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc--cceEE
Confidence            4678999999999998765  47889986543    22346667888888884442 3566665433222222  26899


Q ss_pred             EeccCC-CHHH----------------HHHHhccC---CCCCChHH---------HHH------------HHHHHHH-HH
Q 021982           88 FEYMDT-DLKK----------------YIRSFRQT---GENIPVNT---------VKS------------LMYQLCK-GV  125 (304)
Q Consensus        88 ~e~~~~-~l~~----------------~l~~~~~~---~~~~~~~~---------~~~------------~~~~i~~-~l  125 (304)
                      |+++.| .+..                .+....+.   ..+.....         ...            ....+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            999988 5554                22222121   11111100         000            0111222 23


Q ss_pred             HHHHh-------cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          126 AFCHG-------HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       126 ~~Lh~-------~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..+++       ..++|+|+.|.||+++.++..+-|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            33332       3599999999999999444366899999774

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.17  E-value=3.1e-05  Score=60.34  Aligned_cols=100  Identities=19%  Similarity=0.199  Sum_probs=78.1

Q ss_pred             HHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCC-CHHHH---HHHhccCCCCCChHHHHHHHHHHHHHHH
Q 021982           51 LREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKY---IRSFRQTGENIPVNTVKSLMYQLCKGVA  126 (304)
Q Consensus        51 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~---l~~~~~~~~~~~~~~~~~~~~~i~~~l~  126 (304)
                      ..|.-+++.+...+++++++|.+.         .+++.|+.+. ++...   +..+    ..-++..+..++.+++..+.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~   73 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLE   73 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHH
Confidence            357888889966679999999874         3678899884 44321   1111    23588999999999999999


Q ss_pred             HHHh---cCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982          127 FCHG---HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus       127 ~Lh~---~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +|+.   ..+.-+|++++|+-++.++ ++|++|.+.+....
T Consensus        74 ~l~~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~~  113 (188)
T PF12260_consen   74 ELDHGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVED  113 (188)
T ss_pred             HHhcCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchhH
Confidence            9998   3588889999999999776 89999999876553

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.16  E-value=2e-05  Score=75.53  Aligned_cols=83  Identities=18%  Similarity=0.265  Sum_probs=54.9

Q ss_pred             hhhcccccceEEEEEEEccCC--cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCe--eeeeceecccccCCceEE
Q 021982            9 LEKVGEGTYGKVYRAREKATG--KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV--VRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i--~~~~~~~~~~~~~~~~~~   84 (304)
                      ++.++.|.+..+|.+.....+  ..+++|........ .....+.+|+.+++.+..|+++  ++++.++.+....+.  .
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~--~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT--A  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC--c
Confidence            567888999999998765433  46777865432211 1234677899999999546654  666666655432222  5


Q ss_pred             EEEEeccCCC
Q 021982           85 YLVFEYMDTD   94 (304)
Q Consensus        85 ~lv~e~~~~~   94 (304)
                      ++|||++.|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            7999999873

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.05  E-value=6.6e-05  Score=58.42  Aligned_cols=133  Identities=24%  Similarity=0.297  Sum_probs=88.8

Q ss_pred             hhhhhhhhcccccc-eEEEEEEEccCCcEEEEEEeee---cCCCC----------------CCCchhHHHHHHHHHcc--
Q 021982            4 DAFEKLEKVGEGTY-GKVYRAREKATGKIVALKKTRL---HEDDE----------------GVPPTTLREVSILRMLS--   61 (304)
Q Consensus         4 ~~y~~~~~lg~g~~-g~v~~~~~~~~~~~~~iK~~~~---~~~~~----------------~~~~~~~~e~~~l~~l~--   61 (304)
                      ..++.++.||.|.. |.||+++-.  |+.|++|.+..   .....                .....+..|-....+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            45778999999999 999999764  77999998332   11110                11223455555555552  


Q ss_pred             CCCCe--eeeeceecccc-------------cCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHH
Q 021982           62 RDPHV--VRLMDVKQGQN-------------KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA  126 (304)
Q Consensus        62 ~h~~i--~~~~~~~~~~~-------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~  126 (304)
                      ++.++  ++++||..-..             ........||.||....-            .++    ..-+.+|.+-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHH
Confidence            34455  89999874331             122334578888877632            122    224566777888


Q ss_pred             HHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982          127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus       127 ~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      .+|+.||+-+|+++.|..   +|   +|+|||.+
T Consensus       179 ~~~k~gI~~~Dv~~~ny~---~G---~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR---GG---KLVDFSSS  206 (207)
T ss_pred             HHHHCCeeeccCcccccc---CC---EEEecccC
Confidence            999999999999999987   34   89999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.02  E-value=7.4e-05  Score=60.70  Aligned_cols=74  Identities=18%  Similarity=0.258  Sum_probs=42.7

Q ss_pred             hhhcccccce-EEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC--CeeeeeceecccccCCceEEE
Q 021982            9 LEKVGEGTYG-KVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP--HVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         9 ~~~lg~g~~g-~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      ++.++.|+.. .||.+     +..+++|.....    .....+..|...++.+..+-  .++.+++.....  +.....+
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~--~~~~~~~   70 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG--EGYPWPW   70 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCc--cCCCcce
Confidence            3567767766 48887     235777864421    12346788999998884331  234444332221  1111247


Q ss_pred             EEEeccCC
Q 021982           86 LVFEYMDT   93 (304)
Q Consensus        86 lv~e~~~~   93 (304)
                      ++|+++.|
T Consensus        71 ~l~~~i~G   78 (235)
T cd05155          71 SVYRWLEG   78 (235)
T ss_pred             EEEEeecC
Confidence            88999887

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.01  E-value=0.00013  Score=59.14  Aligned_cols=73  Identities=18%  Similarity=0.259  Sum_probs=46.4

Q ss_pred             hhhcccccceEEEEEEEcc-CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      ++.|..|-...+|++.... .+..+++|......   ........|..+++.+..+.-.++++....   .      .++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~------~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ---N------GLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC---C------cEE
Confidence            4567888889999997543 24678889765321   112234478888888854544555544322   1      379


Q ss_pred             EeccCC
Q 021982           88 FEYMDT   93 (304)
Q Consensus        88 ~e~~~~   93 (304)
                      |||+.|
T Consensus        71 ~e~i~G   76 (235)
T cd05157          71 YEFIPG   76 (235)
T ss_pred             EEeeCC
Confidence            999887

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.98  E-value=1e-05  Score=66.86  Aligned_cols=138  Identities=18%  Similarity=0.291  Sum_probs=92.0

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC----------------CCCC----CCchhHHHHHHHHHccCCC-
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE----------------DDEG----VPPTTLREVSILRMLSRDP-   64 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~----~~~~~~~e~~~l~~l~~h~-   64 (304)
                      +.++.+||-|..+.+|.+-+.. |++.++|.-+.-.                ...+    ..-...+|+.-++.|-.|. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            6678899999999999998764 6778888433211                0011    1123346777777773332 


Q ss_pred             CeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCe
Q 021982           65 HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL  143 (304)
Q Consensus        65 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Ni  143 (304)
                      -+++.+++..         .++|||.+.| .|.+.-.          ....-.+...+...+--|-..|++|||++--||
T Consensus       173 pVPkpiD~~R---------H~Vvmelv~g~Pl~~v~~----------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNi  233 (465)
T KOG2268|consen  173 PVPKPIDHNR---------HCVVMELVDGYPLRQVRH----------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNI  233 (465)
T ss_pred             CCCCcccccc---------eeeHHHhhcccceeeeee----------cCChHHHHHHHHHHHHHHHHcCceecccchhee
Confidence            2445554422         5899999998 5543211          122334556666677788899999999999999


Q ss_pred             EEeCCCCeEEEeeccceeecc
Q 021982          144 LMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus       144 l~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++..++ .++++||.......
T Consensus       234 mv~dd~-~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  234 MVKDDD-KIVVIDFPQMVSTS  253 (465)
T ss_pred             EEecCC-CEEEeechHhhccC
Confidence            999766 89999998765443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.97  E-value=2.8e-06  Score=75.73  Aligned_cols=185  Identities=18%  Similarity=0.161  Sum_probs=125.5

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCC-eeeeeceecccccCCceEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH-VVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~~~~~~~~   84 (304)
                      |...+.++.++.+++++.+........ .+.+...       -...-++++|.++ +||| .+..++-+..+..     .
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~-----~  309 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDY-----L  309 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHc-cCCCCcccccccCCcccc-----c
Confidence            567788899999999999776543322 4444332       2344578899999 9999 4444444444443     7


Q ss_pred             EEEEeccCCC--HHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           85 YLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        85 ~lv~e~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++.++++++.  .....   ......+-..+.....+.-+.+++++|+.--+|+|    ||+... + ..+..+|+....
T Consensus       310 ~i~~~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~-~~~~~~~~v~~~  380 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E-EVKLLDFAVPPQ  380 (829)
T ss_pred             chhhhhhcCCccccccC---ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c-ccccccccCCcc
Confidence            8999999853  11111   01111233445566777778889999988778888    777763 4 789999998866


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCC
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP  215 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  215 (304)
                      +.... ......+++.+++||+...+. +....|.|++|.--.++--|-.|-.
T Consensus       381 L~~~~-~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  381 LTRTM-KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCccc-ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCC
Confidence            65543 334456789999999888776 7888999999976556665655533

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.92  E-value=0.0002  Score=64.13  Aligned_cols=142  Identities=21%  Similarity=0.218  Sum_probs=84.4

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCC---------------------CCC--------------chhHHHH
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE---------------------GVP--------------PTTLREV   54 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---------------------~~~--------------~~~~~e~   54 (304)
                      +.|+..+.|.|++++-+. |..|++|+=+..-...                     -..              -.+..|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            678999999999999886 8999999643221100                     000              0112233


Q ss_pred             HH----HHHccCCCC---eeeeeceecccccCCceEEEEEEeccCC-CH--HHHHHHhccCCCCCChHHHHHHHHHHHHH
Q 021982           55 SI----LRMLSRDPH---VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DL--KKYIRSFRQTGENIPVNTVKSLMYQLCKG  124 (304)
Q Consensus        55 ~~----l~~l~~h~~---i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l--~~~l~~~~~~~~~~~~~~~~~~~~~i~~~  124 (304)
                      +.    .+.+ .|-+   -+.+-.++++-..    .-+++|||++| .+  .+.+++     ..++...+..   .+.++
T Consensus       246 ~Nae~~~~~f-~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~---~l~~~  312 (538)
T KOG1235|consen  246 KNAERFRENF-KDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK-----RGISPHDILN---KLVEA  312 (538)
T ss_pred             HhHHHHHHHH-HhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHH---HHHHH
Confidence            22    2222 3333   1223333332211    15899999998 33  345554     2455554443   33333


Q ss_pred             H-HHHHhcCccccCCCCCCeEEeC---CCCeEEEeeccceeeccc
Q 021982          125 V-AFCHGHGILHRDLKPHNLLMDR---KTMTLKIADLGLARAFTL  165 (304)
Q Consensus       125 l-~~Lh~~~i~h~dl~~~Nil~~~---~~~~vkl~dfg~~~~~~~  165 (304)
                      . +-+=..|++|+|=.|.||++..   .+..+.+-|||+......
T Consensus       313 ~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  313 YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2 2334568999999999999994   346899999999865544

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.83  E-value=0.00059  Score=56.19  Aligned_cols=138  Identities=16%  Similarity=0.204  Sum_probs=78.0

Q ss_pred             hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEe
Q 021982           10 EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE   89 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   89 (304)
                      ..+..|-.+.+|++.  .++..+++|.........  ......|..+++.+..+.-.++++....         -++|+|
T Consensus         2 ~~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~---------~~~v~e   68 (256)
T TIGR02721         2 QTLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE---------HWLLVE   68 (256)
T ss_pred             CcCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC---------CEEEEE
Confidence            346678888999986  346678888754322111  1235678899998854433344444321         258899


Q ss_pred             ccCC-CHH--------------HHHHHhccCC---CCCChH-HHHHHHHHH---------HHHHHHHHh--------cCc
Q 021982           90 YMDT-DLK--------------KYIRSFRQTG---ENIPVN-TVKSLMYQL---------CKGVAFCHG--------HGI  133 (304)
Q Consensus        90 ~~~~-~l~--------------~~l~~~~~~~---~~~~~~-~~~~~~~~i---------~~~l~~Lh~--------~~i  133 (304)
                      |+.| .+.              +.+....+..   .+++.. .+.....++         ...+..+-+        ..+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            9887 321              2222222211   122211 111221111         122222222        248


Q ss_pred             cccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          134 LHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       134 ~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +|+|+.|.||+++.++  +.++||+.+..
T Consensus       149 ~H~Dl~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             ecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence            9999999999999654  78999998843

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.81  E-value=0.00036  Score=60.70  Aligned_cols=78  Identities=17%  Similarity=0.195  Sum_probs=52.4

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCC-----CCCCCchhHHHHHHHHHccCC--CCeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-----DEGVPPTTLREVSILRMLSRD--PHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.||.|....||.+....+++.++||.-.....     ......+...|...|+.+...  .++++++.+..  ..   
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~---  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--EL---  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CC---
Confidence            4678999999999999865445799997542211     112334566788888876433  45777776633  32   


Q ss_pred             eEEEEEEeccCC
Q 021982           82 TVLYLVFEYMDT   93 (304)
Q Consensus        82 ~~~~lv~e~~~~   93 (304)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              5799999865

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.81  E-value=0.00031  Score=59.18  Aligned_cols=145  Identities=16%  Similarity=0.158  Sum_probs=77.5

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC-Ceeeeeceecccc-cCCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP-HVVRLMDVKQGQN-KEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~-~~~~~~~~l   86 (304)
                      ++.+..|....+|.+...  +..+++|....     ........|+.++..+..+. .+++++....... .......++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            556777888899998643  34688898753     11234556777777773321 2444443211000 000112578


Q ss_pred             EEeccCC-CH-----------HHHHHHhccCCCCC--------ChHHHH------------HHHHHHHHHHHHHHh----
Q 021982           87 VFEYMDT-DL-----------KKYIRSFRQTGENI--------PVNTVK------------SLMYQLCKGVAFCHG----  130 (304)
Q Consensus        87 v~e~~~~-~l-----------~~~l~~~~~~~~~~--------~~~~~~------------~~~~~i~~~l~~Lh~----  130 (304)
                      ++++++| .+           ...+.........+        ......            .....+..++..+.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9999987 32           11111111100000        000000            011122333444443    


Q ss_pred             ---cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          131 ---HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       131 ---~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                         .+++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence               3799999999999999654 56899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.75  E-value=4.3e-05  Score=67.02  Aligned_cols=174  Identities=20%  Similarity=0.251  Sum_probs=109.3

Q ss_pred             chhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHH
Q 021982           48 PTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF  127 (304)
Q Consensus        48 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~  127 (304)
                      ..+....++++.+ .|+|....+++-.....    ...+|+|+++.++.+.+.........            +.     
T Consensus        27 ~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~----r~IVV~e~~~~Sled~~~~~~l~~~s------------~~-----   84 (725)
T KOG1093|consen   27 IQILGRFQYLKSL-QHDNLCQYLDFSRGKHE----RVIVVMEHYTMSLEDILKTGNLKDES------------LL-----   84 (725)
T ss_pred             HHHhhhhHHHHhh-cCccceeeEeeecCccc----eEEEEehhhccchHHHHHhcccchhh------------hc-----
Confidence            4556678888998 99999999987554332    27899999999999998774311111            00     


Q ss_pred             HHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHH
Q 021982          128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAEL  207 (304)
Q Consensus       128 Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~l  207 (304)
                            +|+ +.+.|        .+..+| -++   +..               |      ....+++|||++|.++.++
T Consensus        85 ------~~~-~~~~~--------~~~~td-~~~---t~~---------------~------~~~~pKsdVwsl~~i~~el  124 (725)
T KOG1093|consen   85 ------AHG-VLHLN--------IIYITD-HFL---TKY---------------P------SPIGPKSDVWSLGFIILEL  124 (725)
T ss_pred             ------ccc-cceeh--------hhhccc-ccc---ccC---------------C------CCCCcchhhhhHHHHHHHH
Confidence                  111 11112        233333 111   110               0      0123599999999999999


Q ss_pred             hhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          208 VTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       208 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                      .-|...+......+....+.+....+........                .......++.....+...|+...|..||..
T Consensus       125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~  188 (725)
T KOG1093|consen  125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAM----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLP  188 (725)
T ss_pred             HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHH----------------HHHHHHhhhHhHHHHhccCCccccccccch
Confidence            9998887776666665555543322211100000                001112466677889999999999999999


Q ss_pred             HHHhcCCCcccc
Q 021982          288 KKAMEHPYFDDL  299 (304)
Q Consensus       288 ~eil~~~~~~~~  299 (304)
                      .++..++-|.++
T Consensus       189 ~~~~k~~i~~ev  200 (725)
T KOG1093|consen  189 MELSKRCSFTEV  200 (725)
T ss_pred             hHHhcCccHHHH
Confidence            999999988764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.66  E-value=0.00083  Score=56.93  Aligned_cols=146  Identities=15%  Similarity=0.196  Sum_probs=76.1

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC-Ceeeeeceecccc-cCCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP-HVVRLMDVKQGQN-KEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~-~~~~~~~~l   86 (304)
                      ++.++.|....+|.+...  +..+++|......    .......+.+++..|..+. .+++++....... .......++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            456677777889998643  3357888764321    1234456677777773221 1334433211000 000123689


Q ss_pred             EEeccCC-CH-----------HHHHHHhccCCCCC--------ChH---HHH------------HHHHHHHHHHHHHHh-
Q 021982           87 VFEYMDT-DL-----------KKYIRSFRQTGENI--------PVN---TVK------------SLMYQLCKGVAFCHG-  130 (304)
Q Consensus        87 v~e~~~~-~l-----------~~~l~~~~~~~~~~--------~~~---~~~------------~~~~~i~~~l~~Lh~-  130 (304)
                      +++|++| .+           ...+.........+        ...   ...            .....+...++++.. 
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            9999877 21           11111111100000        000   000            011123334444432 


Q ss_pred             ------cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          131 ------HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       131 ------~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                            .+++|+|+++.||+++.++ .+.++||+.+.
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence                  5899999999999999765 67899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.57  E-value=0.00093  Score=56.46  Aligned_cols=73  Identities=18%  Similarity=0.181  Sum_probs=45.5

Q ss_pred             hhhcccccceEEEEEEEcc------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            9 LEKVGEGTYGKVYRAREKA------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++.|..|-...+|++....      .+..+++|......   ........|..+++.+..+.-.++++..+.  +     
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~-----   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP--N-----   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC--C-----
Confidence            3556778888999997543      25778899865432   123455678888888855444455555543  1     


Q ss_pred             EEEEEEeccCC
Q 021982           83 VLYLVFEYMDT   93 (304)
Q Consensus        83 ~~~lv~e~~~~   93 (304)
                        ..|++|+.|
T Consensus        73 --~~v~e~i~G   81 (302)
T cd05156          73 --GRIEEFIPS   81 (302)
T ss_pred             --CchhheeCC
Confidence              246777765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.55  E-value=0.00088  Score=57.30  Aligned_cols=142  Identities=17%  Similarity=0.197  Sum_probs=79.1

Q ss_pred             hhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            9 LEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      ++.|..|-...+|++...+.   +..+++|+......   ....-..|..+++.+..+.--+++++++.  +.       
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G-------   86 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG-------   86 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc-------
Confidence            45566677888999875432   23788897654321   23344578888888855554566666542  21       


Q ss_pred             EEEeccCC-CH--------------HHHHHHhccCCCC----C-ChHHHHHHHHHH----------------------HH
Q 021982           86 LVFEYMDT-DL--------------KKYIRSFRQTGEN----I-PVNTVKSLMYQL----------------------CK  123 (304)
Q Consensus        86 lv~e~~~~-~l--------------~~~l~~~~~~~~~----~-~~~~~~~~~~~i----------------------~~  123 (304)
                      ++.+|+.| ++              ...+........+    . ....+..+..++                      ..
T Consensus        87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~  166 (330)
T PLN02421         87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD  166 (330)
T ss_pred             EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence            46777655 22              1122222221111    1 122222222221                      11


Q ss_pred             HHHHHH----hc----CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          124 GVAFCH----GH----GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       124 ~l~~Lh----~~----~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      -+..+.    +.    -.+|+|+.+.||+++.++..++++||+++..
T Consensus       167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            122221    11    2799999999999986544899999999843

>PRK05231 homoserine kinase; Provisional

Probab=97.53  E-value=0.0035  Score=53.42  Aligned_cols=30  Identities=27%  Similarity=0.414  Sum_probs=25.3

Q ss_pred             cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          131 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       131 ~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .+++|+|+.|.||+++.+. ..-++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            3899999999999998543 55899999874

>PLN02236 choline kinase

Probab=97.47  E-value=0.0019  Score=55.64  Aligned_cols=142  Identities=17%  Similarity=0.209  Sum_probs=80.8

Q ss_pred             hhhcccccceEEEEEEEcc----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            9 LEKVGEGTYGKVYRAREKA----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +..|..|-...+|++....    .+..+++|......  . .......|..+++.+..+.--+++++.+..         
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~---------  108 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN---------  108 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C-eeechHHHHHHHHHHHHcCCCCceEEEECC---------
Confidence            4556678888899987532    23678899775432  1 222336788998888666556666666432         


Q ss_pred             EEEEeccCC-CHH--------------HHHHHhccCCCC-----CChHHHHHHHHHH-----------------HHHHHH
Q 021982           85 YLVFEYMDT-DLK--------------KYIRSFRQTGEN-----IPVNTVKSLMYQL-----------------CKGVAF  127 (304)
Q Consensus        85 ~lv~e~~~~-~l~--------------~~l~~~~~~~~~-----~~~~~~~~~~~~i-----------------~~~l~~  127 (304)
                      ..+.+|+.| ++.              ..+....+...+     ....++..+..++                 ...+..
T Consensus       109 g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        109 GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence            135666655 321              112222221111     1122232332211                 111222


Q ss_pred             HH--------hcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          128 CH--------GHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       128 Lh--------~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      |.        ...++|+|+++.||+++.++..+.++||.++..
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            21        125899999999999986544799999998853

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.41  E-value=0.0035  Score=53.57  Aligned_cols=76  Identities=18%  Similarity=0.196  Sum_probs=49.4

Q ss_pred             hcccccceEEEEEEEccCCcEEEEEEeee-----cCCCCCCCchhHHHHHHHHHccCC-C-CeeeeeceecccccCCceE
Q 021982           11 KVGEGTYGKVYRAREKATGKIVALKKTRL-----HEDDEGVPPTTLREVSILRMLSRD-P-HVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~~~e~~~l~~l~~h-~-~i~~~~~~~~~~~~~~~~~   83 (304)
                      .+|.|....||.+.+..+++.++||.-..     .........+..-|...|+...+. | .+++++.+  +...     
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~-----   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEM-----   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccc-----
Confidence            57999999999999865446799996442     122344455666788888776432 3 45666655  3332     


Q ss_pred             EEEEEeccCC
Q 021982           84 LYLVFEYMDT   93 (304)
Q Consensus        84 ~~lv~e~~~~   93 (304)
                      ..++||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            4689998853

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.34  E-value=0.0017  Score=56.12  Aligned_cols=77  Identities=16%  Similarity=0.217  Sum_probs=50.7

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEee----ecCCCCCCCchhHHHHHHHHHccCC-C-CeeeeeceecccccCCce
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTR----LHEDDEGVPPTTLREVSILRMLSRD-P-HVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~----~~~~~~~~~~~~~~e~~~l~~l~~h-~-~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.||.|.-.-||.+.+..++..++||.-.    ..........+..-|...|+...+. | ++++++.+-.  ..    
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~----  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VM----  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HH----
Confidence            567899999999999985445679999543    2223344455666788888876432 3 4666765533  32    


Q ss_pred             EEEEEEeccC
Q 021982           83 VLYLVFEYMD   92 (304)
Q Consensus        83 ~~~lv~e~~~   92 (304)
                       ..+|||+++
T Consensus       108 -~~~vMEdL~  116 (409)
T PRK12396        108 -NCCVMEDLS  116 (409)
T ss_pred             -hhHHHHhCc
Confidence             457888874

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.17  E-value=0.0021  Score=54.50  Aligned_cols=104  Identities=16%  Similarity=0.226  Sum_probs=72.4

Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ..+.|++|++.++++.-.        .....+++..++.+.+..+.-+.++ ..-|+++...||+++ +| +|.|+||.+
T Consensus       298 ~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEeee
Confidence            345788999988865322        2356788999999999999999876 799999999999999 77 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHH
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA  201 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG  201 (304)
                      ++.-..+ ....    -.++--|-.+.|..  +.+.+||-+=
T Consensus       368 sRl~~~q-~~is----y~rldhp~lF~G~d--d~QFeIYrlM  402 (488)
T COG5072         368 SRLSYSQ-GIIS----YNRLDHPDLFNGVD--DYQFEIYRLM  402 (488)
T ss_pred             eecccCC-ceee----ccccCchhhhcCcc--ceeeeHHHHH
Confidence            9732222 1111    12233444455433  5666666543

>PTZ00384 choline kinase; Provisional

Probab=97.15  E-value=0.0051  Score=53.56  Aligned_cols=73  Identities=15%  Similarity=0.249  Sum_probs=46.0

Q ss_pred             hhhcccccceEEEEEEEccC-CcE-----EEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            9 LEKVGEGTYGKVYRAREKAT-GKI-----VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~-~~~-----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++.|..|-...+|++..... +..     |.++..   .......-.-..|..+++.++.+.--+++++.+..       
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~---g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-------  124 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS---STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-------  124 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEec---cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC-------
Confidence            45666788889999975432 222     333332   12222233445789999999777777778777642       


Q ss_pred             EEEEEEeccCC
Q 021982           83 VLYLVFEYMDT   93 (304)
Q Consensus        83 ~~~lv~e~~~~   93 (304)
                        +++.||+.|
T Consensus       125 --g~l~efIeG  133 (383)
T PTZ00384        125 --FTIQEWVEG  133 (383)
T ss_pred             --EEEEEEecc
Confidence              488888876

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.94  E-value=0.014  Score=49.15  Aligned_cols=30  Identities=30%  Similarity=0.482  Sum_probs=26.6

Q ss_pred             CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          132 GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       132 ~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++|||+++.|++++.++ .+=+.||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            389999999999999887 599999999854

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.90  E-value=0.0001  Score=72.45  Aligned_cols=157  Identities=12%  Similarity=-0.002  Sum_probs=107.2

Q ss_pred             HHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc
Q 021982           53 EVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH  131 (304)
Q Consensus        53 e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~  131 (304)
                      |.+-.+.+ .|+++.....-.....   ....+..++++. |.+.+.+-+-.....++...-+.....+.+.+..-.|+.
T Consensus      1279 e~de~~~~-~h~~~~~~p~rI~ps~---s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1279 ERDELREA-KHYLTEVDPLRIPPSE---STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhh-hceeeecccccCCCCC---ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            33334445 6777765554332211   112467788887 488887766444444455444554445546666666654


Q ss_pred             -----CccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHH
Q 021982          132 -----GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAE  206 (304)
Q Consensus       132 -----~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~  206 (304)
                           --+|.++++-|-++..+- +|+++++|+.+..+......+...+++.|+.|+....-. ++.++|+|..|+-+|.
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHH
Confidence                 178999999999999555 899999999986566656666677788888998776655 6777999999999999


Q ss_pred             HhhccccCC
Q 021982          207 LVTKTALFP  215 (304)
Q Consensus       207 ll~g~~p~~  215 (304)
                      ..-|..+|.
T Consensus      1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred             HhcccHHHH
Confidence            887776654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.87  E-value=0.013  Score=48.82  Aligned_cols=30  Identities=27%  Similarity=0.463  Sum_probs=24.8

Q ss_pred             CccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          132 GILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       132 ~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .++|+|++|.||+++.++..+-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            489999999999999645346799999874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.41  E-value=0.033  Score=48.68  Aligned_cols=76  Identities=18%  Similarity=0.236  Sum_probs=50.2

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeee-----cCCCCCCCchhHHHHHHHHHccCC--CCeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRL-----HEDDEGVPPTTLREVSILRMLSRD--PHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~-----~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.+|.|....||.+.+.  +..++||.-..     .........+...|...|+.+.+.  ..+++++.+..+.     
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~-----  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM-----  109 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-----
Confidence            567889999999999873  44688996552     111112345555677777776322  4778888776633     


Q ss_pred             eEEEEEEeccCC
Q 021982           82 TVLYLVFEYMDT   93 (304)
Q Consensus        82 ~~~~lv~e~~~~   93 (304)
                        .+++||++++
T Consensus       110 --~vlvME~L~~  119 (418)
T PLN02756        110 --ALIGMRYLEP  119 (418)
T ss_pred             --CEEEEeecCC
Confidence              4678999865

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.35  E-value=0.062  Score=44.92  Aligned_cols=74  Identities=18%  Similarity=0.258  Sum_probs=46.7

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccCCceEEE
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      -.+.++.|....+|.+.  .++..+++|+-...     ....+..|+.-|+.|.  ..-.+++++++......     .+
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~f   88 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AF   88 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CE
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ce
Confidence            34567888899999986  56778999986621     2356788888888883  34467888888766554     58


Q ss_pred             EEEeccCC
Q 021982           86 LVFEYMDT   93 (304)
Q Consensus        86 lv~e~~~~   93 (304)
                      +++||++.
T Consensus        89 Llle~l~~   96 (288)
T PF03881_consen   89 LLLEFLEM   96 (288)
T ss_dssp             EEEE----
T ss_pred             EEEEeecC
Confidence            99999863

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK10593 hypothetical protein; Provisional

Probab=96.32  E-value=0.044  Score=46.15  Aligned_cols=108  Identities=18%  Similarity=0.216  Sum_probs=70.4

Q ss_pred             hhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC--CCeeeeeceecccccCCceEE
Q 021982            7 EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD--PHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .-.+.||.|..+.||.....+ + .+++|..+..    .....+..|...++.+..+  -.++++++++..+...+.  .
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~--~   88 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP--D   88 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC--e
Confidence            345679999999999996543 3 4677764321    1124778899999988554  367888877654322222  6


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH  131 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~  131 (304)
                      ++|||++.| ++.+.         ..+......+..+++.+|..||+.
T Consensus        89 ~LVmE~i~G~~~~~~---------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         89 VLLLERLRGVSVEAP---------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEEEeccCCEecCCC---------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            899999998 44320         123344555667777888888874

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.20  E-value=0.018  Score=49.81  Aligned_cols=60  Identities=22%  Similarity=0.288  Sum_probs=43.9

Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH-hcCccccCCCCCCeEEeCC
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRK  148 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~i~h~dl~~~Nil~~~~  148 (304)
                      ..++=+|..| ++..+++.     ...++.....++.-.++|+-.+- -.+++|.|+.|.||++-..
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            4566667777 77777765     33455667778888888866655 5689999999999999543

>PTZ00296 choline kinase; Provisional

Probab=95.24  E-value=0.38  Score=42.94  Aligned_cols=74  Identities=11%  Similarity=0.152  Sum_probs=44.2

Q ss_pred             hhhhcccccceEEEEEEEccC--------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            8 KLEKVGEGTYGKVYRAREKAT--------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      -++.|..|-.-.+|++.....        ++.|++|+.-....   ....-..|..+++.+..+.--+++++.+.  +  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lIdR~~E~~v~~~ls~~gi~P~l~~~f~--g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELYNPISEFEVYKTMSKYRIAPQLLNTFS--G--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---ceeCHHHHHHHHHHHHHCCCCCceEEEeC--C--
Confidence            355667777788898875421        45788887654321   22244568888887755444455665442  1  


Q ss_pred             CceEEEEEEeccCC
Q 021982           80 GRTVLYLVFEYMDT   93 (304)
Q Consensus        80 ~~~~~~lv~e~~~~   93 (304)
                           +.+.+|+.|
T Consensus       182 -----g~I~efi~g  190 (442)
T PTZ00296        182 -----GRIEEWLYG  190 (442)
T ss_pred             -----CEEEEeeCC
Confidence                 356777765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.19  E-value=0.3  Score=41.77  Aligned_cols=28  Identities=36%  Similarity=0.362  Sum_probs=23.4

Q ss_pred             cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          131 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       131 ~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .+++|+|+.+.||+++ +  .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            3689999999999995 3  47899999773

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.81  E-value=0.071  Score=45.18  Aligned_cols=29  Identities=24%  Similarity=0.512  Sum_probs=25.0

Q ss_pred             cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          131 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       131 ~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .+++|||+.+.||+++. + .+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            47899999999999986 4 68999999763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.63  E-value=0.054  Score=44.83  Aligned_cols=47  Identities=26%  Similarity=0.287  Sum_probs=34.5

Q ss_pred             HHHHHHHHHHHHHHHhc--CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          115 KSLMYQLCKGVAFCHGH--GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       115 ~~~~~~i~~~l~~Lh~~--~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ...+..+-.++.-.+..  -++|+|+.|+|++.+..+ .++|+||..|..
T Consensus       135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            33444444455444443  489999999999999757 899999999843

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.28  E-value=0.1  Score=41.48  Aligned_cols=31  Identities=32%  Similarity=0.490  Sum_probs=19.9

Q ss_pred             CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          132 GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       132 ~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      -++|+|+.+.||+++..+..++++||.++..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            5999999999999933334999999999854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.98  E-value=0.053  Score=41.98  Aligned_cols=29  Identities=28%  Similarity=0.374  Sum_probs=24.5

Q ss_pred             CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          132 GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       132 ~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      -.+|+|+.|.||++..++  ++++||+++..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            369999999999998554  88999999853

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.59  E-value=0.12  Score=43.76  Aligned_cols=29  Identities=17%  Similarity=0.192  Sum_probs=26.2

Q ss_pred             CccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          132 GILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       132 ~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      +++|+|+.+.|++++.++ .+.++||..++
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            799999999999998776 79999999874

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.93  E-value=0.089  Score=41.80  Aligned_cols=85  Identities=18%  Similarity=0.213  Sum_probs=55.5

Q ss_pred             hhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHH
Q 021982           49 TTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC  128 (304)
Q Consensus        49 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~L  128 (304)
                      -+..+..++.++   -.|+++.      +. +...+.++.|.|...--.+                ..++.-=+++|.-.
T Consensus       104 ~y~nky~v~Arm---hGilrL~------ND-n~~~yGvIlE~Cy~~~i~~----------------~N~i~agi~~L~~f  157 (308)
T PF07387_consen  104 LYFNKYRVFARM---HGILRLK------ND-NNYKYGVILERCYKIKINF----------------SNFITAGIKDLMDF  157 (308)
T ss_pred             hhhhhhhHHHHh---hheeEee------cC-CCceeEEEEeeccCcccch----------------hHHHHHhHHHHHHh
Confidence            445667777665   3566665      22 2223689999987511000                01111124567778


Q ss_pred             Hh--cCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982          129 HG--HGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus       129 h~--~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      |+  .+..|||-.|+||+-|+.| .+||.|-+..
T Consensus       158 H~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~L  190 (308)
T PF07387_consen  158 HSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVCL  190 (308)
T ss_pred             hccCCCeecCCCChhheeecCCC-CEEecChhhh
Confidence            84  4799999999999999888 8999997754

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	304
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-98
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-98
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-98
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-98
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-98
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-98
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-98
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-98
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-98
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-98
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-98
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-98
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-98
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-98
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-98
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-98
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-98
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-98
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-98
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-98
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-98
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-98
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-98
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-98
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-98
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-98
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-98
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-98
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-98
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-97
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-97
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-97
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-97
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-97
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-97
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-82
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-82
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-81
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-81
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-80
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-80
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-79
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-77
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-75
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-71
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-65
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-64
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-63
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-63
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-63
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-63
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-60
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-57
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-52
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-49
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-48
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-48
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-48
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-48
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-47
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-46
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-46
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-46
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-46
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-45
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-45
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-45
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-44
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-44
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-44
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-44
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-43
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-43
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-43
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-43
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-43
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-43
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-43
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-43
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-43
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-43
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-43
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-43
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-43
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-43
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-43
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-43
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-43
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-43
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-43
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-43
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-43
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-42
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-42
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-42
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-42
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-42
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-42
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-42
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-42
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-42
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-42
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-42
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-42
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-42
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-42
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-42
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-42
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-42
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-42
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-42
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-42
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-42
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-42
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-42
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-41
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-41
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-41
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-41
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-41
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-41
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-41
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-41
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-41
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-41
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-41
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-41
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-41
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-41
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-41
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-41
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-41
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-41
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-41
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-41
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-41
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-41
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-41
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-41
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-41
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-41
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-41
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-41
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-41
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-41
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-41
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-41
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-41
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-41
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-41
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-41
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-41
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-41
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-41
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-41
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-41
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-41
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-41
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-41
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-41
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-41
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-41
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-41
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-41
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-41
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-41
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-41
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-41
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-41
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-41
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-41
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-41
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-40
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-40
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-40
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-40
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-40
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-40
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-40
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-39
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-38
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-38
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-38
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-35
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-34
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-34
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-34
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-33
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-33
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-33
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-33
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-33
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-33
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-33
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-33
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-33
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-33
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-33
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-33
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-33
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-33
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-32
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-32
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-32
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-32
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-32
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-32
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-32
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-32
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-32
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-32
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-32
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-32
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-32
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-32
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-32
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-32
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-32
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-32
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-32
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-32
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-32
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-32
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-32
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-31
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-31
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-31
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-31
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-31
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-31
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-31
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-31
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-31
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-31
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-31
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-31
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-31
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-31
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-31
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-31
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-31
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-31
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-31
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-31
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-27
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-26
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-26
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-25
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-24
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-24
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-24
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-23
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-23
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-23
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-23
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-22
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-22
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-22
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-22
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-22
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-21
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-21
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-21
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-20
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-20
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-20
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-20
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-20
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-19
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-19
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-19
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-19
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-19
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-19
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-19
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		6e-19
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-19
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-19
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		8e-19
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-18
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-18
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-18
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-18
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-18
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-18
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-18
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-18
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-18
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-18
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-18
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-18
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-18
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-18
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-18
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-18
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-18
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-18
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-17
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-17
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-17
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-17
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-17
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-16
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-16
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-16
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-16
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-16
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-16
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-16
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-16
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-16
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-16
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		5e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-16
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-16
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-16
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-16
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-15
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-15
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-15
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-15
3soa_A	444	Full-Length Human Camkii Length = 444		1e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-14
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		7e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-14
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		8e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-12
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-06
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-06
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-06
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-06
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-06
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-06
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-06

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  355 bits (912), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  355 bits (912), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 61  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  355 bits (912), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  355 bits (912), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  355 bits (911), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 63  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 173
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  355 bits (911), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 69  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 120
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 179
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 239
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  355 bits (911), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 69  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 120
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 179
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 239
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  355 bits (910), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 66  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 117
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 176
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 236
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 237 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  355 bits (910), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 169/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++D DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 65  -PNIVKLLDVIHTENK-----LYLVFEHVDQDLKKFMDASALTG--IPLPLIKSYLFQLL 116
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  354 bits (909), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 229/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G++FCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  354 bits (908), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 63  -PNIVKLLDVIHTENK-----LYLVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLL 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  354 bits (908), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 65  -PNIVKLLDVIHTENK-----LYLVFEFLSMDLKKFMDASALTG--IPLPLIKSYLFQLL 116
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  353 bits (907), Expect = 5e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  353 bits (907), Expect = 5e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VAL K RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  353 bits (907), Expect = 5e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VAL K RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 61  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  353 bits (907), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  353 bits (907), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 61  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  353 bits (906), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  353 bits (906), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 63  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  353 bits (906), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 65  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 116
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  353 bits (906), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 64  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 234
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  353 bits (906), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 64  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 234
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  353 bits (906), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 63  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  353 bits (905), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 66  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 117
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 176
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 236
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 237 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  353 bits (905), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 168/299 (56%), Positives = 228/299 (76%), Gaps = 10/299 (3%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL +
Sbjct: 61  PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQ 113
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAPE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           +LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 244 LMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           + ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  353 bits (905), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 61  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 171
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  353 bits (905), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 65  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 116
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  353 bits (905), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 63  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 233
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  353 bits (905), Expect = 9e-98,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 64  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 116 QGLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 234
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  352 bits (904), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 167/297 (56%), Positives = 226/297 (76%), Gaps = 10/297 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  352 bits (903), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 168/300 (56%), Positives = 228/300 (76%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL 
Sbjct: 61  -PNIVKLLDVIHTENK-----LYLVFEHVHQDLKTFMDASALTG--IPLPLIKSYLFQLL 112
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  352 bits (903), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 167/300 (55%), Positives = 227/300 (75%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL 
Sbjct: 64  -PNIVKLLDVIHTENK-----LYLVFEFLSMDLKDFMDASALTG--IPLPLIKSYLFQLL 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 234
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  352 bits (903), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 167/300 (55%), Positives = 227/300 (75%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL 
Sbjct: 65  -PNIVKLLDVIHTENK-----LYLVFEFLSMDLKDFMDASALTG--IPLPLIKSYLFQLL 116
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  351 bits (900), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 167/300 (55%), Positives = 227/300 (75%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL 
Sbjct: 62  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKDFMDASALTG--IPLPLIKSYLFQLL 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 114 QGLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  351 bits (900), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 167/300 (55%), Positives = 227/300 (75%), Gaps = 10/300 (3%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L+ 
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLK ++ +   TG  IP+  +KS ++QL 
Sbjct: 65  -PNIVKLLDVIHTENK-----LYLVFEFLHQDLKTFMDASALTG--IPLPLIKSYLFQLL 116
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ Y HE++TLWYRAP
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 235
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  300 bits (768), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 151/301 (50%), Positives = 212/301 (70%), Gaps = 13/301 (4%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +M+ ++KLEKVGEGTYG VY+A++ + G+IVALK+ RL  +DEG+P T +RE+S+L+ L 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P++V L+DV   +       L LVFE+M+ DLKK +    +TG  +  + +K  +YQL
Sbjct: 78  H-PNIVSLIDVIHSER-----CLTLVFEFMEKDLKKVLDE-NKTG--LQDSQIKIYLYQL 128
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            +GVA CH H ILHRDLKP NLL++     LK+AD GLARAF +P++ YTHE++TLWYRA
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           P+VL+GS  YST+VD+WS+ CIFAE++T   LFPG ++  QL  IF +LGTPN + WP V
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 242 SSLMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
             L  W +  +  +  +  ++ +P   ++G+DLL  ML +DP+KRISA+ AM HPYF DL
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
Query: 300 D 300
           D
Sbjct: 308 D 308

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  300 bits (768), Expect = 6e-82,   Method: Compositional matrix adjust.
 Identities = 151/301 (50%), Positives = 212/301 (70%), Gaps = 13/301 (4%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +M+ ++KLEKVGEGTYG VY+A++ + G+IVALK+ RL  +DEG+P T +RE+S+L+ L 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P++V L+DV   +       L LVFE+M+ DLKK +    +TG  +  + +K  +YQL
Sbjct: 78  H-PNIVSLIDVIHSER-----CLTLVFEFMEKDLKKVLDE-NKTG--LQDSQIKIYLYQL 128
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            +GVA CH H ILHRDLKP NLL++     LK+AD GLARAF +P++ YTHE++TLWYRA
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           P+VL+GS  YST+VD+WS+ CIFAE++T   LFPG ++  QL  IF +LGTPN + WP V
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 242 SSLMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
             L  W +  +  +  +  ++ +P   ++G+DLL  ML +DP+KRISA+ AM HPYF DL
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
Query: 300 D 300
           D
Sbjct: 308 D 308

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  298 bits (763), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 151/297 (50%), Positives = 208/297 (70%), Gaps = 12/297 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +  LEK+GEGTYG VY+A+    G+  ALKK RL ++DEG+P TT+RE+SIL+ L +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V+L DV   + +     L LVFE++D DLKK +       E++   T KS + QL 
Sbjct: 59  HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESV---TAKSFLLQLL 110
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            G+A+CH   +LHRDLKP NLL++R+   LKIAD GLARAF +P++KYTHEI+TLWYRAP
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VL+GS  YST +D+WSV CIFAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
            L  +   +  + P    + +  LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  298 bits (762), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 150/297 (50%), Positives = 208/297 (70%), Gaps = 12/297 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +  LEK+GEGTYG VY+A+    G+  ALKK RL ++DEG+P TT+RE+SIL+ L +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V+L DV   + +     L LVFE++D DLKK +       E++   T KS + QL 
Sbjct: 59  HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESV---TAKSFLLQLL 110
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            G+A+CH   +LHRDLKP NLL++R+   LKIAD GLARAF +P++KYTHE++TLWYRAP
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VL+GS  YST +D+WSV CIFAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
            L  +   +  + P    + +  LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  296 bits (758), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 149/297 (50%), Positives = 207/297 (69%), Gaps = 12/297 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +  LEK+GEGTYG VY+A+    G+  ALKK RL ++DEG+P TT+RE+SIL+ L +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V+L DV   + +     L LVFE++D DLKK +       E++   T KS + QL 
Sbjct: 59  HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESV---TAKSFLLQLL 110
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            G+A+CH   +LHRDLKP NLL++R+   LKIAD GLARAF +P++KYTHE++TLWYRAP
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VL+GS  YST +D+WSV CIFAE+V    LFPG SE  QL+ IFR+LGTPN K WP V+
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
            L  +   +  + P    + +  LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  294 bits (753), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 148/299 (49%), Positives = 201/299 (67%), Gaps = 12/299 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M  +EKLEK+GEGTYG V++A+ + T +IVALK+ RL +DDEGVP + LRE+ +L+ L +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-K 59
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++VRL DV     K     L LVFE+ D DLKKY   F     ++    VKS ++QL 
Sbjct: 60  HKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKY---FDSCNGDLDPEIVKSFLFQLL 111
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           KG+ FCH   +LHRDLKP NLL++R    LK+AD GLARAF +P++ Y+ E++TLWYR P
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKT-ALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           +VL G+  YST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WP +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 242 SSLMNWHEYPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           + L ++  YP +    SL   VP L+  G DLL+ +L+ +P +RISA++A++HPYF D 
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 147/299 (49%), Positives = 201/299 (67%), Gaps = 12/299 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M  +EKLEK+GEGTYG V++A+ + T +IVALK+ RL +DDEGVP + LRE+ +L+ L +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-K 59
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++VRL DV     K     L LVFE+ D DLKKY   F     ++    VKS ++QL 
Sbjct: 60  HKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKY---FDSCNGDLDPEIVKSFLFQLL 111
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           KG+ FCH   +LHRDLKP NLL++R    LK+A+ GLARAF +P++ Y+ E++TLWYR P
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           +VL G+  YST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WP +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 242 SSLMNWHEYPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           + L ++  YP +    SL   VP L+  G DLL+ +L+ +P +RISA++A++HPYF D 
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  285 bits (730), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 150/306 (49%), Positives = 212/306 (69%), Gaps = 18/306 (5%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +D + ++ K+GEGTYG+VY+A +  T + VA+K+ RL  ++EGVP T +REVS+L+ L  
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +++ L  V    ++     L+L+FEY + DLKKY+        ++ +  +KS +YQL 
Sbjct: 93  R-NIIELKSVIHHNHR-----LHLIFEYAENDLKKYM----DKNPDVSMRVIKSFLYQLI 142
Query: 123 KGVAFCHGHGILHRDLKPHNLLMD----RKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            GV FCH    LHRDLKP NLL+      +T  LKI D GLARAF +PI+++THEI+TLW
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YR PE+LLGS HYST+VD+WS+ACI+AE++ KT LFPGDSE+ QL  IF +LG P++  W
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 239 PGVSSLMNWHE-YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           PGV++L +W + +P++  ++L   +   LD +GLDLL  ML+ DP KRISAK A+EHPYF
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322
Query: 297 --DDLD 300
             +D D
Sbjct: 323 SHNDFD 328

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  277 bits (708), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 140/296 (47%), Positives = 200/296 (67%), Gaps = 13/296 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ + KL+K+GEGTY  VY+ + K T  +VALK+ RL E +EG P T +REVS+L+ L +
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDL-K 58
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L D+   +       L LVFEY+D DLK+Y+      G  I ++ VK  ++QL 
Sbjct: 59  HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLL 110
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+A+CH   +LHRDLKP NLL++ +   LK+AD GLARA ++P K Y +E++TLWYR P
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           ++LLGST YST +DMW V CIF E+ T   LFPG +  +QL  IFR+LGTP E+ WPG+ 
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229
Query: 243 SLMNW--HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           S   +  + YP++  ++L +  P LD DG DLL ++LQ++   RISA+ AM+HP+F
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  265 bits (678), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 139/300 (46%), Positives = 200/300 (66%), Gaps = 18/300 (6%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F++LEK+G GTY  VY+   K TG  VALK+ +L + +EG P T +RE+S+++ L  + +
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIREISLMKELKHE-N 64
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQLCK 123
           +VRL DV   +NK     L LVFE+MD DLKKY+  R+   T   + +N VK   +QL +
Sbjct: 65  IVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+AFCH + ILHRDLKP NLL++++   LK+ D GLARAF +P+  ++ E++TLWYRAP+
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           VL+GS  YST++D+WS  CI AE++T   LFPG ++ +QL  IF ++GTPNE +WP V+ 
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 244 LMNWHEYPQWNP-----QSLA--TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           L  ++   Q  P     Q L   T  P LD + +D L  +LQ +P  R+SAK+A+ HP+F
Sbjct: 239 LPKYNPNIQQRPPRDLRQVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  243 bits (620), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 129/301 (42%), Positives = 194/301 (64%), Gaps = 9/301 (2%)
Query: 6   FEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--R 62
           +E + ++GEG YGKV++AR+ K  G+ VALK+ R+   +EG+P +T+REV++LR L    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+VVRL DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLL 130
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+ F H H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAP 188
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EVLL S+ Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 302
           +L     +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL++ 
Sbjct: 248 ALPR-QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306
Query: 303 R 303
           +
Sbjct: 307 K 307

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 129/301 (42%), Positives = 194/301 (64%), Gaps = 9/301 (2%)
Query: 6   FEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--R 62
           +E + ++GEG YGKV++AR+ K  G+ VALK+ R+   +EG+P +T+REV++LR L    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+VVRL DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLL 130
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+ F H H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAP 188
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EVLL S+ Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 302
           +L     +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL++ 
Sbjct: 248 ALPR-QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306
Query: 303 R 303
           +
Sbjct: 307 K 307

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  238 bits (608), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 130/298 (43%), Positives = 185/298 (62%), Gaps = 8/298 (2%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M    +E + ++G G YG VY+AR+  +G  VALK  R+   +EG+P +T+REV++LR L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 61  S--RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
                P+VVRLMDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLM 118
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            Q  +G+ F H + I+HRDLKP N+L+     T+K+AD GLAR ++  +  +   ++TLW
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMALFP-VVVTLW 176
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YRAPEVLL ST Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  W
Sbjct: 177 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           P   SL     +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y 
Sbjct: 236 PRDVSLPRG-AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  238 bits (606), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 130/298 (43%), Positives = 184/298 (61%), Gaps = 8/298 (2%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M    +E + ++G G YG VY+AR+  +G  VALK  R+   +EG+P +T+REV++LR L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 61  S--RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
                P+VVRLMDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLM 118
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            Q  +G+ F H + I+HRDLKP N+L+     T+K+AD GLAR ++  +      ++TLW
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LAPVVVTLW 176
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YRAPEVLL ST Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  W
Sbjct: 177 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           P   SL     +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y 
Sbjct: 236 PRDVSLPRG-AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  238 bits (606), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 127/294 (43%), Positives = 189/294 (64%), Gaps = 9/294 (3%)
Query: 6   FEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--R 62
           +E + ++GEG YGKV++AR+ K  G+ VALK+ R+   +EG+P +T+REV++LR L    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+VVRL DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLL 130
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+ F H H ++HRDLKP N+L+   +  +K+AD GLAR ++  +   T  ++TLWYRAP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAP 188
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EVLL S+ Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +L     +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF
Sbjct: 248 ALPR-QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 130/298 (43%), Positives = 184/298 (61%), Gaps = 8/298 (2%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M    +E + ++G G YG VY+AR+  +G  VALK  R+   +EG+P +T+REV++LR L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 61  S--RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
                P+VVRLMDV      +    + LVFE++D DL+ Y+      G  +P  T+K LM
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLM 118
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            Q  +G+ F H + I+HRDLKP N+L+     T+K+AD GLAR ++  +      ++TLW
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LDPVVVTLW 176
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YRAPEVLL ST Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  W
Sbjct: 177 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 235
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           P   SL     +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y 
Sbjct: 236 PRDVSLPRG-AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  227 bits (578), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 130/301 (43%), Positives = 183/301 (60%), Gaps = 11/301 (3%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG---VPPTTLREVSIL 57
           M    +E + ++G G YG VY+AR+  +G  VALK  R+     G   +P +T+REV++L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 58  RMLS--RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVK 115
           R L     P+VVRLMDV      +    + LVFE++D DL+ Y+      G  +P  T+K
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIK 123
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            LM Q  +G+ F H + I+HRDLKP N+L+     T+K+AD GLAR ++  +   T  ++
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LTPVVV 181
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           TLWYRAPEVLL ST Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E
Sbjct: 182 TLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
             WP   SL     +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y
Sbjct: 241 DDWPRDVSLPRG-AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 296 F 296
Sbjct: 300 L 300

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  219 bits (557), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 116/296 (39%), Positives = 181/296 (61%), Gaps = 13/296 (4%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL---HEDDEGVPPTTLREVSILRMLSR 62
           +EKL+ +GEG +  VY+AR+K T +IVA+KK +L    E  +G+  T LRE+ +L+ LS 
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+++ L+D    ++      + LVF++M+TDL+  I+        +  + +K+ M    
Sbjct: 72  -PNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTL 122
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+ + H H ILHRDLKP+NLL+D   + LK+AD GLA++F  P + Y H+++T WYRAP
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+L G+  Y   VDMW+V CI AEL+ +    PGDS+L QL  IF  LGTP E+ WP + 
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
           SL ++  +  +    L         D LDL++ +  ++P  RI+A +A++  YF +
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 106/301 (35%), Positives = 181/301 (60%), Gaps = 13/301 (4%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +M+ +EK+ K+GEG+YG V++ R + TG+IVA+KK    EDD  +    LRE+ +L+ L 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL- 59
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           + P++V L++V + + +     L+LVFEY D  +   +  +++    +P + VKS+ +Q 
Sbjct: 60  KHPNLVNLLEVFRRKRR-----LHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQT 111
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + V FCH H  +HRD+KP N+L+ + ++ +K+ D G AR  T P   Y  E+ T WYR+
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG--TPNEKVWP 239
           PE+L+G T Y   VD+W++ C+FAEL++   L+PG S++ QL  I + LG   P  +   
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230
Query: 240 GVSSLMNWHEYPQ-WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
             +   +  + P   + + L    PN+    L LL+  L  DP++R++ ++ + HPYF++
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290
Query: 299 L 299
           +
Sbjct: 291 I 291

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  190 bits (482), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 177/302 (58%), Gaps = 16/302 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EKL K+G+GT+G+V++AR + TG+ VALKK  +  + EG P T LRE+ IL++L  + +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE-N 78
Query: 66  VVRLMDV---KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           VV L+++   K       +  +YLVF++ + DL   + +         ++ +K +M  L 
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 135
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLW 178
            G+ + H + ILHRD+K  N+L+ R  + LK+AD GLARAF+L       +Y + ++TLW
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YR PE+LLG   Y   +D+W   CI AE+ T++ +  G++E  QL  I +L G+   +VW
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 239 PGVSS--LMNWHEYPQWNPQSLATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHP 294
           P V +  L    E  +   + +   +    +D   LDL++++L  DP++RI +  A+ H 
Sbjct: 255 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 295 YF 296
           +F
Sbjct: 315 FF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 177/302 (58%), Gaps = 16/302 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EKL K+G+GT+G+V++AR + TG+ VALKK  +  + EG P T LRE+ IL++L  + +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE-N 78
Query: 66  VVRLMDV---KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           VV L+++   K       +  +YLVF++ + DL   + +         ++ +K +M  L 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 135
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLW 178
            G+ + H + ILHRD+K  N+L+ R  + LK+AD GLARAF+L       +Y + ++TLW
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YR PE+LLG   Y   +D+W   CI AE+ T++ +  G++E  QL  I +L G+   +VW
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 239 PGVSS--LMNWHEYPQWNPQSLATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHP 294
           P V +  L    E  +   + +   +    +D   LDL++++L  DP++RI +  A+ H 
Sbjct: 255 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 295 YF 296
           +F
Sbjct: 315 FF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 177/302 (58%), Gaps = 16/302 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EKL K+G+GT+G+V++AR + TG+ VALKK  +  + EG P T LRE+ IL++L  + +
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE-N 77
Query: 66  VVRLMDV---KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           VV L+++   K       +  +YLVF++ + DL   + +         ++ +K +M  L 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 134
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLW 178
            G+ + H + ILHRD+K  N+L+ R  + LK+AD GLARAF+L       +Y + ++TLW
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLW 193
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YR PE+LLG   Y   +D+W   CI AE+ T++ +  G++E  QL  I +L G+   +VW
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 239 PGVSS--LMNWHEYPQWNPQSLATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHP 294
           P V +  L    E  +   + +   +    +D   LDL++++L  DP++RI +  A+ H 
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 295 YF 296
           +F
Sbjct: 314 FF 315

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 177/302 (58%), Gaps = 16/302 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +EKL K+G+GT+G+V++AR + TG+ VALKK  +  + EG P T LRE+ IL++L  + +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE-N 78
Query: 66  VVRLMDV---KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           VV L+++   K       +  +YLVF++ + DL   + +         ++ +K +M  L 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLL 135
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEILTLW 178
            G+ + H + ILHRD+K  N+L+ R  + LK+AD GLARAF+L       +Y + ++TLW
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YR PE+LLG   Y   +D+W   CI AE+ T++ +  G++E  QL  I +L G+   +VW
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254
Query: 239 PGVSS--LMNWHEYPQWNPQSLATAVPNLDKD--GLDLLEQMLQYDPSKRISAKKAMEHP 294
           P V +  L    E  +   + +   +    +D   LDL++++L  DP++RI +  A+ H 
Sbjct: 255 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 314
Query: 295 YF 296
           +F
Sbjct: 315 FF 316

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  187 bits (474), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 118/337 (35%), Positives = 188/337 (55%), Gaps = 55/337 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  +E ++K+G+G YG V+++ ++ TG++VA+KK      +      T RE+ IL  LS
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENI--PVNTVKSLMY 119
              ++V L++V +  N      +YLVF+YM+TDL   IR+      NI  PV+  + ++Y
Sbjct: 67  GHENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIRA------NILEPVHK-QYVVY 116
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI----- 174
           QL K + + H  G+LHRD+KP N+L++ +   +K+AD GL+R+F + I++ T+ I     
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSF-VNIRRVTNNIPLSIN 174
Query: 175 -----------------LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD 217
                             T WYRAPE+LLGST Y+  +DMWS+ CI  E++    +FPG 
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 218 SELQQLLHIFRLLGTP-NEKVWP--------GVSSLMNWHEYPQWNPQSLATAVPNL--- 265
           S + QL  I  ++  P NE V           + SL    E  Q N + + T   NL   
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294
Query: 266 -------DKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                  +++ LDLL+++LQ++P+KRISA  A++HP+
Sbjct: 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 102/297 (34%), Positives = 162/297 (54%), Gaps = 13/297 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +E L  VGEG+YG V + R K TG+IVA+KK    +DD+ V    +RE+ +L+ L R
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-R 82
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L++V + + +      YLVFE++D  +   +  F      +    V+  ++Q+ 
Sbjct: 83  HENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQII 134
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            G+ FCH H I+HRD+KP N+L+  ++  +K+ D G AR    P + Y  E+ T WYRAP
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT--PNEKVWPG 240
           E+L+G   Y  AVD+W++ C+  E+     LFPGDS++ QL HI   LG   P  +    
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 241 VSSLMNWHEYPQWNPQS-LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            + +      P+   +  L    P L +  +DL ++ L  DP KR    + + H +F
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 107/303 (35%), Positives = 164/303 (54%), Gaps = 14/303 (4%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V D +E +E +G G YG V  AR + TG+ VA+KK     D       TLRE+ IL+   
Sbjct: 52  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 111
Query: 62  RDPHVVRLMDVKQGQNKEGR-TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            D +++ + D+ +     G    +Y+V + M++DL + I S     + + +  V+  +YQ
Sbjct: 112 HD-NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQ 166
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILT 176
           L +G+ + H   ++HRDLKP NLL++ +   LKI D G+AR       ++    T  + T
Sbjct: 167 LLRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            WYRAPE++L    Y+ A+D+WSV CIF E++ +  LFPG + + QL  I  +LGTP+  
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285
Query: 237 VWPGVSS---LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           V   V +          P   P    T  P  D+  L LL +ML+++PS RISA  A+ H
Sbjct: 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345
Query: 294 PYF 296
           P+ 
Sbjct: 346 PFL 348

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  182 bits (463), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 107/303 (35%), Positives = 164/303 (54%), Gaps = 14/303 (4%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V D +E +E +G G YG V  AR + TG+ VA+KK     D       TLRE+ IL+   
Sbjct: 53  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 112
Query: 62  RDPHVVRLMDVKQGQNKEGR-TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            D +++ + D+ +     G    +Y+V + M++DL + I S     + + +  V+  +YQ
Sbjct: 113 HD-NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQ 167
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILT 176
           L +G+ + H   ++HRDLKP NLL++ +   LKI D G+AR       ++    T  + T
Sbjct: 168 LLRGLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            WYRAPE++L    Y+ A+D+WSV CIF E++ +  LFPG + + QL  I  +LGTP+  
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 286
Query: 237 VWPGVSS---LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           V   V +          P   P    T  P  D+  L LL +ML+++PS RISA  A+ H
Sbjct: 287 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 346
Query: 294 PYF 296
           P+ 
Sbjct: 347 PFL 349

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 109/299 (36%), Positives = 160/299 (53%), Gaps = 22/299 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +GEG YG V  A  K TG+IVA+KK     D       TLRE+ IL+    + +++ + +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHE-NIITIFN 76
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 131
           +++  + E    +Y++ E M TDL + I +   + ++I     +  +YQ  + V   HG 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLHGS 131
Query: 132 GILHRDLKPHNLLMDRKTMTLKIADLGLARAF----------TLPIKKYTHEILTLWYRA 181
            ++HRDLKP NLL++     LK+ D GLAR            T      T  + T WYRA
Sbjct: 132 NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+L S  YS A+D+WS  CI AEL  +  +FPG     QLL IF ++GTP+       
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 242 SSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  EY    P +    L    P ++  G+DLL++ML +DP+KRI+AK+A+EHPY 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  180 bits (457), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 109/299 (36%), Positives = 160/299 (53%), Gaps = 22/299 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +GEG YG V  A  K TG+IVA+KK     D       TLRE+ IL+    + +++ + +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHE-NIITIFN 76
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 131
           +++  + E    +Y++ E M TDL + I +   + ++I     +  +YQ  + V   HG 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLHGS 131
Query: 132 GILHRDLKPHNLLMDRKTMTLKIADLGLARAF----------TLPIKKYTHEILTLWYRA 181
            ++HRDLKP NLL++     LK+ D GLAR            T      T  + T WYRA
Sbjct: 132 NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+L S  YS A+D+WS  CI AEL  +  +FPG     QLL IF ++GTP+       
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 242 SSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  EY    P +    L    P ++  G+DLL++ML +DP+KRI+AK+A+EHPY 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 98/297 (32%), Positives = 172/297 (57%), Gaps = 11/297 (3%)
Query: 5   AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           A+   + +G G++G V++A+   + + VA+KK    +  +       RE+ I+R++ + P
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMRIV-KHP 92
Query: 65  HVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +VV L        +K+    L LV EY+   + +  R + +  + +P+  +K  MYQL +
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            +A+ H  GI HRD+KP NLL+D  +  LK+ D G A+   +  +     I + +YRAPE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSXICSRYYRAPE 211
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           ++ G+T+Y+T +D+WS  C+ AEL+    LFPG+S + QL+ I ++LGTP+ +    ++ 
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271
Query: 244 LMNWHEYPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
               H++PQ  P   +    P    D +DL+ ++L+Y PS R++A +A+ HP+FD+L
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 108/298 (36%), Positives = 162/298 (54%), Gaps = 22/298 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +GEG YG V  A  K TG+IVA+KK     D       TLRE+ IL+    + +++ + +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHE-NIITIFN 76
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH 131
           +++  + E    +Y++ E M TDL + I +   + ++I     +  +YQ  + V   HG 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLHGS 131
Query: 132 GILHRDLKPHNLLMDRKTMTLKIADLGLARAF-------TLPIKKYT---HEILTLWYRA 181
            ++HRDLKP NLL++     LK+ D GLAR         + P  + +     + T WYRA
Sbjct: 132 NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+L S  YS A+D+WS  CI AEL  +  +FPG     QLL IF ++GTP+       
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 242 SSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                  EY    P +    L    P ++  G+DLL++ML +DP+KRI+AK+A+EHPY
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  177 bits (448), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 107/300 (35%), Positives = 168/300 (56%), Gaps = 18/300 (6%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + +L+ +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEH-QTYCQRTLREIQIL-LRFRHEN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+ + D+ +    E    +Y+V + M+TDL K ++S + + ++I        +YQ+ +G+
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGL 157
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 158 KYIHSANVLHRDLKPSNLLIN-TTCDLKICDFGLAR-IADPEHDHTGFLTEXVATRWYRA 215
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 242 SSLMNWHEYPQWNPQSLATA----VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            + M    Y Q  P     A     P  D   LDLL++ML ++P+KRI+ ++A+ HPY +
Sbjct: 276 IN-MKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLE 334

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 82
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 137
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 138 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 195
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 84
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 139
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 140 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 197
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 316

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 90
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 145
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 146 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 203
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 263
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 264 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 322

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  173 bits (439), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 82
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 137
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 138 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 195
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 162/298 (54%), Gaps = 16/298 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LAFRHEN 84
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 139
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 140 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 197
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY 
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 157
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 158 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 215
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 82
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 137
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 138 KYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 195
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 82
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 137
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 138 KYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 195
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 114/347 (32%), Positives = 174/347 (50%), Gaps = 61/347 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G+YG VY A +K T K VA+KK     +D       LRE++IL  L  D +++RL D
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD-YIIRLYD 92
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRS-FRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +    +      LY+V E  D+DLKK  ++    T E+I     K+++Y L  G  F H 
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHI-----KTILYNLLLGENFIHE 147
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP----------------------IK 168
            GI+HRDLKP N L+++   ++K+ D GLAR                            K
Sbjct: 148 SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-----------TKTALFPGD 217
           + T  ++T WYRAPE++L   +Y+ ++D+WS  CIFAEL+            +  LFPG 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 218 SEL-----------------QQLLHIFRLLGTPNEKVWPGVSS---LMNWHEYPQWNPQS 257
           S                    QL  IF ++GTP E     ++    +     +P   P +
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
Query: 258 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 304
           L    P++  DG++LLE ML+++P+KRI+  +A++HPY  D+ K +L
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL 373

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 86
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 141
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 142 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLXEXVATRWYRA 199
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 87
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 142
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 143 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLXEXVATRWYRA 200
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 82
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 137
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 138 KYIHSANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVAD-PDHDHTGFLTEYVATRWYRA 195
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYXQRTLREIKIL-LRFRHEN 86
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 141
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 142 KYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 199
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 87
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 142
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 143 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 200
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 88
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 143
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 144 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 201
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 261
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 262 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 320

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 79
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 134
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 135 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 192
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 252
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 253 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 311

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 86
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 141
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 142 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 199
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 80
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 135
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 136 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 193
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 253
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 86
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 141
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 142 KYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 199
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 162/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 86
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K ++    + ++I        +YQ+ +G+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-----FLYQILRGL 141
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 142 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 199
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 162/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 80
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 135
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 136 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 193
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P ++    +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCI 253
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 103/299 (34%), Positives = 163/299 (54%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA++K    E  +     TLRE+ IL +  R  +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEH-QTYCQRTLREIKIL-LRFRHEN 86
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 141
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 142 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 199
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 103/325 (31%), Positives = 172/325 (52%), Gaps = 48/325 (14%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G++G V    +  +GK  ALKK  L +     P    RE+ I+++L    ++++L+D
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKV-LQD-----PRYKNRELDIMKVLDHV-NIIKLVD 67
Query: 72  V------------------------KQGQNKEGRTV---------LYLVFEYMDTDLKKY 98
                                      G N   ++V         L ++ EY+   L K 
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 99  IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           ++SF ++G +IP+N +   +YQL + V F H  GI HRD+KP NLL++ K  TLK+ D G
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
            A+   +P +     I + +YRAPE++LG+T Y+ ++D+WS+ C+F EL+    LF G++
Sbjct: 188 SAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGET 246
Query: 219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS----LATAVPNLDKDGLDLLE 274
            + QL+ I +++GTP ++    ++       +P    +     L    P+L    +DLLE
Sbjct: 247 SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL---AIDLLE 303
Query: 275 QMLQYDPSKRISAKKAMEHPYFDDL 299
           Q+L+Y+P  RI+  +AM HP+FD L
Sbjct: 304 QILRYEPDLRINPYEAMAHPFFDHL 328

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 108/304 (35%), Positives = 167/304 (54%), Gaps = 28/304 (9%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LAFRHEN 84
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        +YQ+ +G+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGL 139
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 140 KYIHSANVLHRDLKPSNLLLN-TTSDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 197
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN-EKVWPG 240
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+ E +  G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 241 VS--------SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
           ++        SL + ++ P WN        PN D   LDLL++ML ++P KRI  ++A+ 
Sbjct: 258 INLKARNYLLSLPHKNKVP-WN-----RLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311
Query: 293 HPYF 296
           HPY 
Sbjct: 312 HPYL 315

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  171 bits (432), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 16/299 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK    E  +     TLRE+ IL +  R  +
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKIL-LRFRHEN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +YLV   M  DL K +++   + ++I        +YQ+ +G+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY-----FLYQILRGL 157
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLWYRA 181
            + H   +LHRDLKP NLL++  T  LKI D GLAR    P   +T      + T WYRA
Sbjct: 158 KYIHSANVLHRDLKPSNLLLN-TTXDLKICDFGLARVAD-PDHDHTGFLTEYVATRWYRA 215
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 242 SSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 80
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 81  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 198
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHC-NIVRLRY 80
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 81  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 198
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 108
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 109 FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 168 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 226
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 227 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 286
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 287 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 337

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 108/305 (35%), Positives = 163/305 (53%), Gaps = 14/305 (4%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V   +  L+ VG G YG V  A +  TG  VA+KK       E       RE+ +L+ + 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM- 81
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           R  +V+ L+DV    +  +  T  YLV  +M TDL K ++      E +  + ++ L+YQ
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQ 136
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + KG+ + H  GI+HRDLKP NL ++ +   LKI D GLAR       +    ++T WYR
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQAD---SEMXGXVVTRWYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+L    Y+  VD+WSV CI AE++T   LF G   L QL  I ++ GTP  +    
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 241 VSS--LMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           + S    N+ +  P+   +  A+ + N     ++LLE+ML  D  +R++A +A+ HPYF+
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
Query: 298 DLDKT 302
            L  T
Sbjct: 313 SLHDT 317

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 93
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 94  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 153 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 211
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 212 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 271
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 272 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 322

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 85
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 86  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 145 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 203
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 204 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 263
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 264 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 314

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 116
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 117 FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 176 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 234
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 235 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 294
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 295 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 345

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 114
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 115 FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 232
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 92
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 93  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 152 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 210
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 270
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 271 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 321

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 80
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 81  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 198
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 159
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 160 FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 219 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 277
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 278 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 337
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 338 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 388

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 80
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 81  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 198
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 161/291 (55%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 118
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 119 FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 178 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 236
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 237 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 296
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 297 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 347

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 159/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHC-NIVRLRY 80
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 81  FFYSSGEKKD-EVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 198
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++       
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFA 258
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 81
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 82  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 141 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 199
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 200 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 259
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 260 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHC-NIVRLRY 80
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 81  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE++ G+T
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGAT 198
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++       
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFA 258
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 84
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 85  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 144 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 202
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 203 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 262
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 263 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 313

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 99
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 100 FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 159 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 217
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 218 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 277
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 278 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 328

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 88
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 89  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 148 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 206
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 207 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 266
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 267 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 317

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 92
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 93  FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 152 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 210
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 270
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 271 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 321

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 114
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 115 FFYSSGEKKD-EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 232
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 160/291 (54%), Gaps = 12/291 (4%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-- 69
           +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    ++VRL  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC-NIVRLRY 80
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G+ K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + +A+ H
Sbjct: 81  FFYSSGEKKD-VVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YRAPE++ G+T
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGAT 198
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++      +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 250 YPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  167 bits (422), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L + HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 76  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDH-----VQFLIYQ 129
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 185
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 246 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 295 YF 296
           YF
Sbjct: 303 YF 304

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++S + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++  +  LKI D GL R     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDS-ELKILDFGLCRHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 86  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 139
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++  +  LKI D GLAR     +  Y   + T WYR
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDS-ELKILDFGLARHTDDEMTGY---VATRWYR 195
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 255
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 256 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 295 YF 296
           YF
Sbjct: 313 YF 314

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 76  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 129
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 185
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 246 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 295 YF 296
           YF
Sbjct: 303 YF 304

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 82  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 135
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++  +  LKI D GLAR     +  Y   + T WYR
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDS-ELKILDFGLARHTDDEMTGY---VATRWYR 191
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 251
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 252 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 295 YF 296
           YF
Sbjct: 309 YF 310

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 87  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 140
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY---VATRWYR 196
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 257 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 295 YF 296
           YF
Sbjct: 314 YF 315

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 87  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 140
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY---VATRWYR 196
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 257 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 295 YF 296
           YF
Sbjct: 314 YF 315

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 86  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 139
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 195
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 255
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 256 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 295 YF 296
           YF
Sbjct: 313 YF 314

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 100 HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 153
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 209
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 269
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 270 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 326
Query: 295 YF 296
           YF
Sbjct: 327 YF 328

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 30  VPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 89
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 90  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 143
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 199
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 259
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 260 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 316
Query: 295 YF 296
           YF
Sbjct: 317 YF 318

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 87  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 140
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY---VATRWYR 196
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 257 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 295 YF 296
           YF
Sbjct: 314 YF 315

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 98
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 99  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 152
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 208
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 268
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 269 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 325
Query: 295 YF 296
           YF
Sbjct: 326 YF 327

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 116/359 (32%), Positives = 175/359 (48%), Gaps = 62/359 (17%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V D +E    +G G+YG VY A +K   K VA+KK     +D       LRE++IL  L 
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLK 85
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            D +++RL D+   ++      LY+V E  D+DLKK  ++     E      VK+++Y L
Sbjct: 86  SD-YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQ----HVKTILYNL 140
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----LPI---------- 167
             G  F H  GI+HRDLKP N L+++   ++KI D GLAR       + I          
Sbjct: 141 LLGEKFIHESGIIHRDLKPANCLLNQDC-SVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 168 -----------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-------- 208
                      K+ T  ++T WYRAPE++L   +Y+ ++D+WS  CIFAEL+        
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 209 ---TKTALFPGDSEL-----------------QQLLHIFRLLGTPNEKVWPGVSS---LM 245
               +  LFPG S                    QL  IF ++GTP E+    ++    + 
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIK 319
Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 304
               +P  +   L+    ++ K+G+DLLE ML+++  KRI+  KA+ HPY  D+ K  L
Sbjct: 320 YIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENL 378

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/312 (34%), Positives = 167/312 (53%), Gaps = 27/312 (8%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS- 61
           MD F+     G+GT+G V   +EK+TG  VA+KK  + +D    P    RE+ I++ L+ 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQD----PRFRNRELQIMQDLAV 75
Query: 62  -RDPHVVRLMDVKQGQNKEGRTVLYL--VFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
              P++V+L        +  R  +YL  V EY+   L +  R++ +     P   +K  +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 119 YQLCKGVAFCH--GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
           +QL + +   H     + HRD+KPHN+L++    TLK+ D G A+  + P +     I +
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICS 194
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            +YRAPE++ G+ HY+TAVD+WSV CIFAE++    +F GD+   QL  I R+LG P+ +
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254
Query: 237 VWPGVS------SLMNWHEYPQWN---PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
           V   ++       L N    P  N     SL  A     K+  DLL  +LQY P +R+  
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDA-----KEAYDLLSALLQYLPEERMKP 309
Query: 288 KKAMEHPYFDDL 299
            +A+ HPYFD+L
Sbjct: 310 YEALCHPYFDEL 321

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 87  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 140
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 196
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 257 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 295 YF 296
           YF
Sbjct: 314 YF 315

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 85  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 138
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 194
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 254
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 255 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 295 YF 296
           YF
Sbjct: 312 YF 313

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 85  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 138
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 194
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 254
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 255 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 295 YF 296
           YF
Sbjct: 312 YF 313

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 19  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 78
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 79  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 132
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 188
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 248
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 249 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 305
Query: 295 YF 296
           YF
Sbjct: 306 YF 307

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 82  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 135
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 191
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 251
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 252 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 295 YF 296
           YF
Sbjct: 309 YF 310

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 82  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 135
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 191
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 251
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 252 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 295 YF 296
           YF
Sbjct: 309 YF 310

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR       + T  + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD---DEMTGXVATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 100 HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 153
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 209
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 269
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 270 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 326
Query: 295 YF 296
           YF
Sbjct: 327 YF 328

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 18  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 77
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 78  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 131
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 187
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 247
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 248 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 304
Query: 295 YF 296
           YF
Sbjct: 305 YF 306

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 85  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 138
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++ +   LKI D GLAR     +  Y   + T WYR
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMTGY---VATRWYR 194
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 254
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 255 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 295 YF 296
           YF
Sbjct: 312 YF 313

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 102
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 103 HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 156
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 212
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 272
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 273 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 329
Query: 295 YF 296
           YF
Sbjct: 330 YF 331

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 156/299 (52%), Gaps = 14/299 (4%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  + +  +G  +A+KK             T RE+ +L+ + 
Sbjct: 49  VPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMK 108
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV     + E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 109 HE-NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 162
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 218
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV--- 237
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL GTP   V   
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISR 278
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P   +    +  PQ   ++ A      +   +DLLE+ML  D  KRI+A +A+ HPYF
Sbjct: 279 MPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 102
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 103 HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 156
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMXGY---VATRWYR 212
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 272
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 273 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 329
Query: 295 YF 296
           YF
Sbjct: 330 YF 331

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 76
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 77  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 130
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 246
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 247 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 303
Query: 295 YF 296
           YF
Sbjct: 304 YF 305

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 91
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 92  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 145
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 201
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 261
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 262 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 318
Query: 295 YF 296
           YF
Sbjct: 319 YF 320

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 76
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 77  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 130
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 246
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 247 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 303
Query: 295 YF 296
           YF
Sbjct: 304 YF 305

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 91
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 92  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 145
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 201
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 261
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 262 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 318
Query: 295 YF 296
           YF
Sbjct: 319 YF 320

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 86  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 139
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 195
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 255
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 256 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 295 YF 296
           YF
Sbjct: 313 YF 314

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++ +   LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 82  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 135
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 191
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 251
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 252 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 308
Query: 295 YF 296
           YF
Sbjct: 309 YF 310

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 86  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 139
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 195
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 255
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 256 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 312
Query: 295 YF 296
           YF
Sbjct: 313 YF 314

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 90
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 91  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 144
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++ +   LKI D GLAR     +  Y   + T WYR
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMTGY---VATRWYR 200
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 260
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 261 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 317
Query: 295 YF 296
           YF
Sbjct: 318 YF 319

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 90
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 91  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 144
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 200
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 260
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 261 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 317
Query: 295 YF 296
           YF
Sbjct: 318 YF 319

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMK 91
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 92  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 145
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 201
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 261
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 262 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 318
Query: 295 YF 296
           YF
Sbjct: 319 YF 320

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 76  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 129
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 185
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 246 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 295 YF 296
           YF
Sbjct: 303 YF 304

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 76  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 129
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  +   + T WYR
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMAGF---VATRWYR 185
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 246 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302
Query: 295 YF 296
           YF
Sbjct: 303 YF 304

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 98
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 99  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 152
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY---VATRWYR 208
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 268
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 269 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 325
Query: 295 YF 296
           YF
Sbjct: 326 YF 327

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  +   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMAGF---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  +G G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 25  VPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 85  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 138
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++ +   LKI D GLAR     +  Y   + T WYR
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMTGY---VATRWYR 194
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 254
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 255 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 311
Query: 295 YF 296
           YF
Sbjct: 312 YF 313

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  +   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMAGF---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDAGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDYGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 101/290 (34%), Positives = 150/290 (51%), Gaps = 15/290 (5%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           VG G YG V  A +K +G+ VA+KK       E       RE+ +L+ +  + +V+ L+D
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE-NVIGLLD 108
Query: 72  V-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           V     +       YLV  +M TDL+K +      G       ++ L+YQ+ KG+ + H 
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRDLKP NL ++     LKI D GLAR     +  Y   ++T WYRAPEV+L   H
Sbjct: 163 AGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMH 218
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV---SSLMNW 247
           Y+  VD+WSV CI AE++T   LF G   L QL  I ++ G P  +    +   ++    
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
              PQ   +      P       DLLE+ML+ D  KR++A +A+ HP+F+
Sbjct: 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  163 bits (413), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDRGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/290 (34%), Positives = 150/290 (51%), Gaps = 15/290 (5%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           VG G YG V  A +K +G+ VA+KK       E       RE+ +L+ +  + +V+ L+D
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE-NVIGLLD 90
Query: 72  V-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           V     +       YLV  +M TDL+K +      G       ++ L+YQ+ KG+ + H 
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRDLKP NL ++     LKI D GLAR     +  Y   ++T WYRAPEV+L   H
Sbjct: 145 AGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMH 200
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV---SSLMNW 247
           Y+  VD+WSV CI AE++T   LF G   L QL  I ++ G P  +    +   ++    
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
              PQ   +      P       DLLE+ML+ D  KR++A +A+ HP+F+
Sbjct: 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 159/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 100 HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 153
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR       +    + T WYR
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD---DEMXGXVATRWYR 209
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 269
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 270 ISSESARNYIQSLAQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 326
Query: 295 YF 296
           YF
Sbjct: 327 YF 328

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 108/302 (35%), Positives = 160/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDGGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 116/364 (31%), Positives = 179/364 (49%), Gaps = 77/364 (21%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKT-RLHEDDEGVPPTTLREVSILRML 60
           + D +E    +G G+YG V  A +K   ++VA+KK  R+ ED        LRE++IL  L
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-RILREIAILNRL 109
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT----VKS 116
           + D HVV+++D+   ++ E    LY+V E  D+D KK  R+        PV      +K+
Sbjct: 110 NHD-HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT--------PVYLTELHIKT 160
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--------TLPI- 167
           L+Y L  GV + H  GILHRDLKP N L++ +  ++K+ D GLAR           LPI 
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 168 ------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                             ++ T  ++T WYRAPE++L   +Y+ A+D+WS+ CIFAEL+ 
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 210 -----------KTALFPGDS--------------------ELQQLLHIFRLLGTPNEKVW 238
                      +  LFPG S                       QL  IF +LGTP+E+  
Sbjct: 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI 339
Query: 239 PGVS---SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
             +    +      +P+     LA   P    D + LL++ML ++P+KRI+  + + HP+
Sbjct: 340 EALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399
Query: 296 FDDL 299
           F ++
Sbjct: 400 FKEV 403

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 116/328 (35%), Positives = 174/328 (53%), Gaps = 41/328 (12%)
Query: 2   VMDAFE-KLEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILR 58
           V D FE +  KVG GTYG VY+A+ K        ALK+     +  G+  +  RE+++LR
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLR 73
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNT 113
            L + P+V+ L  V           ++L+F+Y + DL   I+  R +  N     +P   
Sbjct: 74  EL-KHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129
Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIKKY 170
           VKSL+YQ+  G+ + H + +LHRDLKP N+L+     +   +KIAD+G AR F  P+K  
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 171 TH---EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-------- 219
                 ++T WYRAPE+LLG+ HY+ A+D+W++ CIFAEL+T   +F    E        
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249
Query: 220 -LQQLLHIFRLLGTPNEKVW------PGVSSLMNWHEYPQWNPQSLATAVP----NLDKD 268
              QL  IF ++G P +K W      P  S+LM       +   SL   +       D  
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309
Query: 269 GLDLLEQMLQYDPSKRISAKKAMEHPYF 296
              LL+++L  DP KRI++++AM+ PYF
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 159/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI   GLAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILGFGLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 159/302 (52%), Gaps = 20/302 (6%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            + +V+ L+DV    ++ E    +YLV   M  DL   ++  + T ++     V+ L+YQ
Sbjct: 80  HE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-----VQFLIYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++     LKI D  LAR     +  Y   + T WYR
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFYLARHTDDEMTGY---VATRWYR 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 249
Query: 241 VSS------LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           +SS      + +  + P+ N    A      +   +DLLE+ML  D  KRI+A +A+ H 
Sbjct: 250 ISSESARNYIQSLTQMPKMN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 306
Query: 295 YF 296
           YF
Sbjct: 307 YF 308

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 158/296 (53%), Gaps = 16/296 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            + L  VG G YG V  A +    + VA+KK             T RE+ +L+ L  + +
Sbjct: 30  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE-N 88
Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           V+ L+DV     + E  + +YLV   M  DL   ++S   + E+     V+ L+YQL +G
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEH-----VQFLVYQLLRG 143
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + + H  GI+HRDLKP N+ ++  +  L+I D GLAR     +  Y   + T WYRAPE+
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVNEDS-ELRILDFGLARQADEEMTGY---VATRWYRAPEI 199
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +L   HY+  VD+WSV CI AEL+   ALFPG   + QL  I  ++GTP+ +V   +SS 
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS- 258
Query: 245 MNWHEYPQWNP----QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +   Y Q  P    + L++     +   +DLL +ML  D  +R+SA +A+ H YF
Sbjct: 259 EHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/296 (35%), Positives = 157/296 (53%), Gaps = 16/296 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            + L  VG G YG V  A +    + VA+KK             T RE+ +L+ L  + +
Sbjct: 30  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE-N 88
Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           V+ L+DV     + E  + +YLV   M  DL   ++    + E+     V+ L+YQL +G
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH-----VQFLVYQLLRG 143
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + + H  GI+HRDLKP N+ ++  +  L+I D GLAR     +  Y   + T WYRAPE+
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVNEDS-ELRILDFGLARQADEEMTGY---VATRWYRAPEI 199
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +L   HY+  VD+WSV CI AEL+   ALFPG   + QL  I  ++GTP+ +V   +SS 
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS- 258
Query: 245 MNWHEYPQWNP----QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +   Y Q  P    + L++     +   +DLL +ML  D  +R+SA +A+ H YF
Sbjct: 259 EHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 104/296 (35%), Positives = 157/296 (53%), Gaps = 16/296 (5%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            + L  VG G YG V  A +    + VA+KK             T RE+ +L+ L  + +
Sbjct: 22  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE-N 80
Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           V+ L+DV     + E  + +YLV   M  DL   ++    + E+     V+ L+YQL +G
Sbjct: 81  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEH-----VQFLVYQLLRG 135
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + + H  GI+HRDLKP N+ ++ +   L+I D GLAR     +  Y   + T WYRAPE+
Sbjct: 136 LKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLARQADEEMTGY---VATRWYRAPEI 191
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +L   HY+  VD+WSV CI AEL+   ALFPG   + QL  I  ++GTP+ +V   +SS 
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS- 250
Query: 245 MNWHEYPQWNP----QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +   Y Q  P    + L++     +   +DLL +ML  D  +R+SA +A+ H YF
Sbjct: 251 EHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  154 bits (388), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 164/311 (52%), Gaps = 34/311 (10%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L+ +G G  G V+ A +    K VA+KK  L  D + V    LRE+ I+R L  D +
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-TDPQSVK-HALREIKIIRRLDHD-N 69
Query: 66  VVRLMDV-----KQGQNKEGR----TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           +V++ ++      Q  +  G       +Y+V EYM+TDL   +       E+      + 
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-----ARL 124
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--- 173
            MYQL +G+ + H   +LHRDLKP NL ++ + + LKI D GLAR        Y+H+   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD---PHYSHKGHL 181
Query: 174 ---ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
              ++T WYR+P +LL   +Y+ A+DMW+  CIFAE++T   LF G  EL+Q+  I   +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 231 GTPNEKVWPGVSSLM-----NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI 285
              +E+    + S++     N    P    + L   +P + ++ +D LEQ+L + P  R+
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPH---KPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 286 SAKKAMEHPYF 296
           +A++A+ HPY 
Sbjct: 299 TAEEALSHPYM 309

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/309 (29%), Positives = 162/309 (52%), Gaps = 37/309 (11%)
Query: 4   DAFEKLEKVGEGTYGKVYRA-----REKATGKIVA-LKKTRLHEDDEGVPPTTLREVSIL 57
           D ++ + K+G G Y +V+ A      EK   KI+  +KK ++            RE+ IL
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK-----------REIKIL 85
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
             L   P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  
Sbjct: 86  ENLRGGPNIITLADIVK--DPVSRTPA-LVFEHVNNT------DFKQLYQTLTDYDIRFY 136
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           MY++ K + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + 
Sbjct: 137 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASR 195
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--- 233
           +++ PE+L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT    
Sbjct: 196 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 255
Query: 234 ------NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
                 N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A
Sbjct: 256 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315
Query: 288 KKAMEHPYF 296
           ++AMEHPYF
Sbjct: 316 REAMEHPYF 324

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLXGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 312 VDDALQHPYIN 322

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLXGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 312 VDDALQHPYIN 322

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 75  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM------ELDHERMSYLLYQ 127
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 128 MLXGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYR 185
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 186 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 305 VDDALQHPYIN 315

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 312 VDDALQHPYIN 322

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 120 HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 172
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 230
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 231 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 350 VDDALQHPYIN 360

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 21  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 80
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 81  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 133
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 134 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 191
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 192 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 310
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 311 VDDALQHPYIN 321

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 312 VDDALQHPYIN 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 312 VDDALQHPYIN 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 83  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 135
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 193
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 194 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 313 VDDALQHPYIN 323

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 83  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 135
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 193
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 194 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 313 VDDALQHPYIN 323

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 76  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 128
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 187 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 306 VDDALQHPYIN 316

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 76  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 128
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 187 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 306 VDDALQHPYIN 316

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 120 HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 172
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 230
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 231 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 350 VDDALQHPYIN 360

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 312 VDDALQHPYIN 322

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 156/311 (50%), Gaps = 25/311 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 75  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 127
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 185
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 186 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 237 VWPGVSSLMNWH------EYPQWNPQSLATAVPNLDK----DGLDLLEQMLQYDPSKRIS 286
           + P V + +          +P+  P SL  A    +K       DLL +ML  DP+KRIS
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 287 AKKAMEHPYFD 297
              A++HPY +
Sbjct: 305 VDDALQHPYIN 315

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGG 86
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 137
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 196
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 256
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 257 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 294 PYF 296
           PYF
Sbjct: 317 PYF 319

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 136
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 195
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 294 PYF 296
           PYF
Sbjct: 316 PYF 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 136
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 195
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 294 PYF 296
           PYF
Sbjct: 316 PYF 318

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 137
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 196
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 256
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 257 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 294 PYF 296
           PYF
Sbjct: 317 PYF 319

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 136
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 195
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 294 PYF 296
           PYF
Sbjct: 316 PYF 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 136
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 195
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 294 PYF 296
           PYF
Sbjct: 316 PYF 318

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 33  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLCGG 87
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 138
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 139 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 197
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 257
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 258 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 317
Query: 294 PYF 296
           PYF
Sbjct: 318 PYF 320

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 155/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T E++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPEVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 136
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 195
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 294 PYF 296
           PYF
Sbjct: 316 PYF 318

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 100/314 (31%), Positives = 152/314 (48%), Gaps = 33/314 (10%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  +++L+ +G G  G V  A +   G  VA+KK      ++       RE+ +L+ ++
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 79
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I         +    +  L+YQ
Sbjct: 80  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHM------ELDHERMSYLLYQ 132
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR  +      T  ++T +YR
Sbjct: 133 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTASTNFM-MTPYVVTRYYR 190
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP------- 233
           APEV+LG   Y   VD+WSV CI  ELV  + +F G   + Q   +   LGTP       
Sbjct: 191 APEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 249
Query: 234 ----------NEKVWPGVSSLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
                     N   +PG++    + E +P W   S +           DLL +ML  DP 
Sbjct: 250 LQPTVRNYVENRPAYPGIA----FEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPD 305
Query: 283 KRISAKKAMEHPYF 296
           KRIS  +A+ HPY 
Sbjct: 306 KRISVDEALRHPYI 319

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 99/302 (32%), Positives = 148/302 (49%), Gaps = 22/302 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK---------TRLHEDDEGVPPTTLREVSILRMLSR 62
           +  G+YG V  A   + G  VA+K+         T     D  +    LRE+ +L     
Sbjct: 30  ISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+++ L D+     +     LYLV E M TDL + I   R     I    ++  MY + 
Sbjct: 89  -PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV---ISPQHIQYFMYHIL 144
Query: 123 KGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            G+   H  G++HRDL P N+L+ D   +T  I D  LAR  T    K TH +   WYRA
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDIT--ICDFNLAREDTADANK-THYVTHRWYRA 201
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP--NEKVWP 239
           PE+++    ++  VDMWS  C+ AE+  + ALF G +   QL  I  ++GTP   + V  
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261
Query: 240 GVSSLMNWHEYPQWNPQSLA--TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
              S  ++      N  + A    VP  D   LDL+ +ML+++P +RIS ++A+ HPYF+
Sbjct: 262 SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321
Query: 298 DL 299
            L
Sbjct: 322 SL 323

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 99/302 (32%), Positives = 148/302 (49%), Gaps = 22/302 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK---------TRLHEDDEGVPPTTLREVSILRMLSR 62
           +  G+YG V  A   + G  VA+K+         T     D  +    LRE+ +L     
Sbjct: 30  ISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+++ L D+     +     LYLV E M TDL + I   R     I    ++  MY + 
Sbjct: 89  -PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV---ISPQHIQYFMYHIL 144
Query: 123 KGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            G+   H  G++HRDL P N+L+ D   +T  I D  LAR  T    K TH +   WYRA
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDIT--ICDFNLAREDTADANK-THYVTHRWYRA 201
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP--NEKVWP 239
           PE+++    ++  VDMWS  C+ AE+  + ALF G +   QL  I  ++GTP   + V  
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261
Query: 240 GVSSLMNWHEYPQWNPQSLA--TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
              S  ++      N  + A    VP  D   LDL+ +ML+++P +RIS ++A+ HPYF+
Sbjct: 262 SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321
Query: 298 DL 299
            L
Sbjct: 322 SL 323

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 156/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ ++++++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP+    +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 155/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 136
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 195
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT    V+    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 294 PYF 296
           PYF
Sbjct: 316 PYF 318

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 156/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ ++++++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP+    +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 98/310 (31%), Positives = 151/310 (48%), Gaps = 25/310 (8%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  +++L+ +G G  G V  A +   G  VA+KK      ++       RE+ +L+ ++
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I         +    +  L+YQ
Sbjct: 82  HK-NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTACTNFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+LG   Y+  VD+WSV CI  ELV    +F G   + Q   +   LGTP+ +    
Sbjct: 193 APEVILG-MGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 251
Query: 241 VS-SLMNWHE-------------YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
           +  ++ N+ E             +P W   S +           DLL +ML  DP KRIS
Sbjct: 252 LQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 311
Query: 287 AKKAMEHPYF 296
             +A+ HPY 
Sbjct: 312 VDEALRHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 155/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP+    +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 158/303 (52%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + VA+K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+L+D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 155/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP+    +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 154/303 (50%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + KVG G Y +V+        +     K  +            RE+ IL+ L   
Sbjct: 52  DDYEVVRKVGRGKYSEVFEGINVNNNE-----KCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D+ + Q+ +  +   L+FEY++         F+     +    ++  +Y+L K
Sbjct: 107 PNIVKLLDIVRDQHSKTPS---LIFEYVNN------TDFKVLYPTLTDYDIRYYIYELLK 157
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P K+Y   + + +++ PE
Sbjct: 158 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPE 216
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW---- 238
           +L+    Y  ++DMWS+ C+FA ++  K   F G     QL+ I ++LGT     +    
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKY 276
Query: 239 -----PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                P + +L+  H    W     A     +  + +D L+++L+YD  +R++A +AM H
Sbjct: 277 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 336
Query: 294 PYF 296
           PYF
Sbjct: 337 PYF 339

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  134 bits (338), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 155/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP+    +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  134 bits (338), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR           E++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MEPEVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  134 bits (337), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR           E++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MEPEVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRNYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  134 bits (336), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 154/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 83  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 135
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 193
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP     +K
Sbjct: 194 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 253 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 311 ISVDEALQHPYIN 323

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  133 bits (335), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 154/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP     +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 27  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 86
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 87  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 139
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 140 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 197
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 198 APEVILG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 256
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 257 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 314
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 315 ISVDEALQHPYIN 327

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 75
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 76  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 128
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYR 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP     +K
Sbjct: 187 APEVILG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 246 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 303
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 304 ISVDEALQHPYIN 316

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 159/306 (51%), Gaps = 31/306 (10%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A       I   ++  +            REV IL  L   
Sbjct: 38  DDYQLVRKLGRGKYSEVFEAI-----NITNNERVVVKILKPVKKKKIKREVKILENLRGG 92
Query: 64  PHVVRLMD-VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            ++++L+D VK   +K       LVFEY++         F+Q  + +    ++  MY+L 
Sbjct: 93  TNIIKLIDTVKDPVSKTPA----LVFEYINN------TDFKQLYQILTDFDIRFYMYELL 142
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           K + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ P
Sbjct: 143 KALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGP 201
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW--- 238
           E+L+    Y  ++DMWS+ C+ A ++  +   F G     QL+ I ++LGT  E+++   
Sbjct: 202 ELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYL 259
Query: 239 --------PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
                   P  + ++  H   +W     +     +  + LDLL+++L+YD  +R++AK+A
Sbjct: 260 KKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEA 319
Query: 291 MEHPYF 296
           MEHPYF
Sbjct: 320 MEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 159/306 (51%), Gaps = 31/306 (10%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A       I   ++  +            REV IL  L   
Sbjct: 43  DDYQLVRKLGRGKYSEVFEAI-----NITNNERVVVKILKPVKKKKIKREVKILENLRGG 97
Query: 64  PHVVRLMD-VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            ++++L+D VK   +K       LVFEY++         F+Q  + +    ++  MY+L 
Sbjct: 98  TNIIKLIDTVKDPVSKTPA----LVFEYINN------TDFKQLYQILTDFDIRFYMYELL 147
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           K + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ P
Sbjct: 148 KALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGP 206
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTPNEKVW--- 238
           E+L+    Y  ++DMWS+ C+ A ++  +   F G     QL+ I ++LGT  E+++   
Sbjct: 207 ELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYL 264
Query: 239 --------PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
                   P  + ++  H   +W     +     +  + LDLL+++L+YD  +R++AK+A
Sbjct: 265 KKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEA 324
Query: 291 MEHPYF 296
           MEHPYF
Sbjct: 325 MEHPYF 330

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 155/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ ++++++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV  I  E++    LFPG   + Q   +   LGTP+    +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 155/313 (49%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ ++++++
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 82  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQM------ELDHERMSYLLYQ 134
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR         T  ++T +YR
Sbjct: 135 MLVGIKHLHSAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSFM-MTPYVVTRYYR 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV  I  E++    LFPG   + Q   +   LGTP+    +K
Sbjct: 193 APEVILG-MGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 252 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 310 ISVDEALQHPYIN 322

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 29/313 (9%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ ++
Sbjct: 24  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 83
Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +Y+V E MD +L + I+        +    +  L+YQ
Sbjct: 84  HK-NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQ 136
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++ +   TLKI D GLAR            ++T +YR
Sbjct: 137 MLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMVPF-VVTRYYR 194
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN----EK 236
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP     +K
Sbjct: 195 APEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 253
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNL------------DKDGLDLLEQMLQYDPSKR 284
           + P V + +     P++   S     P++                 DLL +ML  D SKR
Sbjct: 254 LQPTVRTYV--ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 311
Query: 285 ISAKKAMEHPYFD 297
           IS  +A++HPY +
Sbjct: 312 ISVDEALQHPYIN 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLRQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 89
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 90  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 140
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 199
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 294 PYF 296
           PYF
Sbjct: 320 PYF 322

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 90
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 91  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 141
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 200
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 294 PYF 296
           PYF
Sbjct: 321 PYF 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 90
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 91  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 141
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 200
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 294 PYF 296
           PYF
Sbjct: 321 PYF 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 91
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 92  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 201
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 261
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 294 PYF 296
           PYF
Sbjct: 322 PYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  131 bits (329), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 157/303 (51%), Gaps = 25/303 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ + K+G G Y +V+ A      + V +K  +             RE+ IL  L   
Sbjct: 42  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 96
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L D+ +  +   RT   LVFE+++         F+Q  + +    ++  MY++ K
Sbjct: 97  PNIITLADIVK--DPVSRTPA-LVFEHVNN------TDFKQLYQTLTDYDIRFYMYEILK 147
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++ PE
Sbjct: 148 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPE 206
Query: 184 VLLGSTHYSTAVDMWSVACIFAELV-TKTALFPGDSELQQLLHIFRLLGTP--------- 233
           +L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT          
Sbjct: 207 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 266
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           N ++ P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AMEH
Sbjct: 267 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 326
Query: 294 PYF 296
           PYF
Sbjct: 327 PYF 329

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 147/299 (49%), Gaps = 44/299 (14%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +++++K+G G YG+V   R+K T    A+K  R            L EV++L++L   P+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PN 97
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKS--LMYQLC 122
           +++L D       E +   YLV E Y   +L      F +    +  N V +  ++ Q+ 
Sbjct: 98  IMKLYDFF-----EDKRNYYLVMECYKGGEL------FDEIIHRMKFNEVDAAVIIKQVL 146
Query: 123 KGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
            GV + H H I+HRDLKP NLL++   K   +KI D GL+  F    KK    + T +Y 
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYI 205
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEVL     Y    D+WS+  I   L+     F G ++ Q++L           KV  G
Sbjct: 206 APEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILR----------KVEKG 252
Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
             +     + P+W          N+ +   DL++QMLQ+D  +RISA++A+EHP+  ++
Sbjct: 253 KYTF----DSPEW---------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 88/328 (26%), Positives = 158/328 (48%), Gaps = 51/328 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L+ +G+G++G+V +A +    + VALK  R   +++        E+ IL  L +   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDK 155
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
              +  +   +N   R  + + FE +  +L + I+  +  G ++P+  V+   + + + +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCL 213
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHE-----ILTLWY 179
              H + I+H DLKP N+L+ ++  + +K+ D G +         Y H+     I + +Y
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--------CYEHQRVYTXIQSRFY 265
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           RAPEV+LG+  Y   +DMWS+ CI AEL+T   L PG+ E  QL  +  LLG P++K+  
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 240 GVSSLMNW---HEYPQWN-------------------------PQS--LATAVPNLDKD- 268
                 N+     YP++                          P+S     A+   D   
Sbjct: 325 ASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 269 GLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            LD L+Q L++DP+ R++  +A+ HP+ 
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 88/328 (26%), Positives = 158/328 (48%), Gaps = 51/328 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L+ +G+G++G+V +A +    + VALK  R   +++        E+ IL  L +   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDK 155
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
              +  +   +N   R  + + FE +  +L + I+  +  G ++P+  V+   + + + +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCL 213
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHE-----ILTLWY 179
              H + I+H DLKP N+L+ ++  + +K+ D G +         Y H+     I + +Y
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--------CYEHQRVYTXIQSRFY 265
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           RAPEV+LG+  Y   +DMWS+ CI AEL+T   L PG+ E  QL  +  LLG P++K+  
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 240 GVSSLMNW---HEYPQWN-------------------------PQS--LATAVPNLDKD- 268
                 N+     YP++                          P+S     A+   D   
Sbjct: 325 ASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 269 GLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            LD L+Q L++DP+ R++  +A+ HP+ 
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 155/323 (47%), Gaps = 41/323 (12%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L+ +G+G +G+V +A +    + VALK  R   +++        E+ IL  L +   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDK 155
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
              +  +   +N   R  + + FE +  +L + I+  +  G ++P+  V+   + + + +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCL 213
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
              H + I+H DLKP N+L+ ++  + +K+ D G   +     ++    I + +YRAPEV
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYXXIQSRFYRAPEV 270
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           +LG+  Y   +DMWS+ CI AEL+T   L PG+ E  QL  +  LLG P +K+       
Sbjct: 271 ILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRA 329
Query: 245 MNW---HEYPQWN-------------------------PQS--LATAVPNLDKD-GLDLL 273
            N+     YP++                          P+S     A+   D    LD L
Sbjct: 330 KNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389
Query: 274 EQMLQYDPSKRISAKKAMEHPYF 296
           +Q L++DP+ R++  +A+ HP+ 
Sbjct: 390 KQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 137/287 (47%), Gaps = 40/287 (13%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G+G++G+V + +++ T +  A+K             T LREV +L+ L   P++++L +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFE 88
Query: 72  VKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +      E  +  Y+V E Y   +L   I   ++  E+     +K    Q+  G+ + H 
Sbjct: 89  IL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 131 HGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H I+HRDLKP N+L++   K   +KI D GL+  F     K    I T +Y APEVL G+
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT 198
Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
             Y    D+WS   I   L++ T  F G +E   L           ++V  G  +     
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-----------KRVETGKYAF---- 241
Query: 249 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           + PQW           +  D  DL+ +ML + PS RI+A + +EHP+
Sbjct: 242 DLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 137/287 (47%), Gaps = 40/287 (13%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G+G++G+V + +++ T +  A+K             T LREV +L+ L   P++++L +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFE 88
Query: 72  VKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +      E  +  Y+V E Y   +L   I   ++  E+     +K    Q+  G+ + H 
Sbjct: 89  IL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 131 HGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H I+HRDLKP N+L++   K   +KI D GL+  F     K    I T +Y APEVL G+
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT 198
Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
             Y    D+WS   I   L++ T  F G +E   L           ++V  G  +     
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-----------KRVETGKYAF---- 241
Query: 249 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           + PQW           +  D  DL+ +ML + PS RI+A + +EHP+
Sbjct: 242 DLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 137/287 (47%), Gaps = 40/287 (13%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G+G++G+V + +++ T +  A+K             T LREV +L+ L   P++++L +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFE 88
Query: 72  VKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +      E  +  Y+V E Y   +L   I   ++  E+     +K    Q+  G+ + H 
Sbjct: 89  IL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 131 HGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H I+HRDLKP N+L++   K   +KI D GL+  F     K    I T +Y APEVL G+
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT 198
Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
             Y    D+WS   I   L++ T  F G +E   L           ++V  G  +     
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-----------KRVETGKYAF---- 241
Query: 249 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           + PQW           +  D  DL+ +ML + PS RI+A + +EHP+
Sbjct: 242 DLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/339 (27%), Positives = 158/339 (46%), Gaps = 58/339 (17%)
Query: 6   FEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRML-SRD 63
           +E ++ +GEG +GKV    + KA G+ VA+K  +   + +        E+ +L  L + D
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTD 72
Query: 64  PH-VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRS-----FRQTGENIPVNTVKSL 117
           P+   R + + +     G   + +VFE +      +I+      FR       ++ ++ +
Sbjct: 73  PNSTFRCVQMLEWFEHHGH--ICIVFELLGLSTYDFIKENGFLPFR-------LDHIRKM 123
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLM---------------DRKTMT---LKIADLGL 159
            YQ+CK V F H + + H DLKP N+L                D +T+    +K+ D G 
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 219
           A   T   + ++  + T  YRAPEV+L +  +S   D+WS+ CI  E      +FP    
Sbjct: 184 A---TYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 220 LQQLLHIFRLLG-TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN----------LDKD 268
            + L  + R+LG  P   +          H+   W+  S A    +          L +D
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 269 G-----LDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 302
                  DL+++ML+YDP+KRI+ ++A++HP+FD L K+
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/309 (29%), Positives = 152/309 (49%), Gaps = 49/309 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++    +G+G++G+V   ++K TG     K+++ ++ +   D E +    LREV +L+
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL----LREVQLLK 81
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSL 117
            L   P++++L +       E +   YLV E Y   +L   I S ++  E   V+  + +
Sbjct: 82  QLDH-PNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-I 131
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 175
           + Q+  G+ + H + I+HRDLKP NLL++ K+    ++I D GL+  F    KK   +I 
Sbjct: 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIG 190
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T +Y APEVL G+  Y    D+WS   I   L++    F G +E   L           +
Sbjct: 191 TAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-----------K 237
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           KV  G  +     E PQW   S +           DL+ +ML Y PS RISA+ A++H +
Sbjct: 238 KVEKGKYTF----ELPQWKKVSESAK---------DLIRKMLTYVPSMRISARDALDHEW 284
Query: 296 FDDLDKTRL 304
                K ++
Sbjct: 285 IQTYTKEQI 293

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/309 (29%), Positives = 152/309 (49%), Gaps = 49/309 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++    +G+G++G+V   ++K TG     K+++ ++ +   D E +    LREV +L+
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL----LREVQLLK 104
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSL 117
            L   P++++L +       E +   YLV E Y   +L   I S ++  E   V+  + +
Sbjct: 105 QLDH-PNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-I 154
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 175
           + Q+  G+ + H + I+HRDLKP NLL++ K+    ++I D GL+  F    KK   +I 
Sbjct: 155 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIG 213
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T +Y APEVL G+  Y    D+WS   I   L++    F G +E   L           +
Sbjct: 214 TAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-----------K 260
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           KV  G  +     E PQW   S +           DL+ +ML Y PS RISA+ A++H +
Sbjct: 261 KVEKGKYTF----ELPQWKKVSESAK---------DLIRKMLTYVPSMRISARDALDHEW 307
Query: 296 FDDLDKTRL 304
                K ++
Sbjct: 308 IQTYTKEQI 316

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/309 (29%), Positives = 152/309 (49%), Gaps = 49/309 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++    +G+G++G+V   ++K TG     K+++ ++ +   D E +    LREV +L+
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL----LREVQLLK 105
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSL 117
            L   P++++L +       E +   YLV E Y   +L   I S ++  E   V+  + +
Sbjct: 106 QLDH-PNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-I 155
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 175
           + Q+  G+ + H + I+HRDLKP NLL++ K+    ++I D GL+  F    KK   +I 
Sbjct: 156 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIG 214
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T +Y APEVL G+  Y    D+WS   I   L++    F G +E   L           +
Sbjct: 215 TAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-----------K 261
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           KV  G  +     E PQW   S +           DL+ +ML Y PS RISA+ A++H +
Sbjct: 262 KVEKGKYTF----ELPQWKKVSESAK---------DLIRKMLTYVPSMRISARDALDHEW 308
Query: 296 FDDLDKTRL 304
                K ++
Sbjct: 309 IQTYTKEQI 317

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 149/300 (49%), Gaps = 49/300 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++    +G+G++G+V   ++K TG     K+++ ++ +   D E +    LREV +L+
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL----LREVQLLK 87
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSL 117
            L   P++++L +       E +   YLV E Y   +L   I S ++  E   V+  + +
Sbjct: 88  QLDH-PNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAAR-I 137
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 175
           + Q+  G+ + H + I+HRDLKP NLL++ K+    ++I D GL+  F    KK   +I 
Sbjct: 138 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIG 196
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T +Y APEVL G+  Y    D+WS   I   L++    F G +E   L           +
Sbjct: 197 TAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-----------K 243
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           KV  G  +     E PQW   S +           DL+ +ML Y PS RISA+ A++H +
Sbjct: 244 KVEKGKYTF----ELPQWKKVSESAK---------DLIRKMLTYVPSMRISARDALDHEW 290

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 141/299 (47%), Gaps = 49/299 (16%)
Query: 12  VGEGTYGKVYRAREKATG-----KIVALKKTRLH-EDDEGVPPTTLREVSILRMLSRDPH 65
           +G G    V R   +ATG     KI+ +   RL  E  E V   T RE  ILR ++  PH
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMYQLCK 123
           ++ L+D     + E  + ++LVF     DL +    F    E + ++    +S+M  L +
Sbjct: 162 IITLID-----SYESSSFMFLVF-----DLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            V+F H + I+HRDLKP N+L+D   M ++++D G +     P +K      T  Y APE
Sbjct: 212 AVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFS-CHLEPGEKLRELCGTPGYLAPE 269
Query: 184 VL---LGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           +L   +  TH  Y   VD+W+   I   L+  +  F    ++  L  I        E  +
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM-------EGQY 322
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
              S        P+W+ +S             DL+ ++LQ DP  R++A++A++HP+F+
Sbjct: 323 QFSS--------PEWDDRSSTVK---------DLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/339 (26%), Positives = 157/339 (46%), Gaps = 58/339 (17%)
Query: 6   FEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRML-SRD 63
           +E ++ +GEG +GKV    + KA G+ VA+K  +   + +        E+ +L  L + D
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTD 72
Query: 64  PH-VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRS-----FRQTGENIPVNTVKSL 117
           P+   R + + +     G   + +VFE +      +I+      FR       ++ ++ +
Sbjct: 73  PNSTFRCVQMLEWFEHHGH--ICIVFELLGLSTYDFIKENGFLPFR-------LDHIRKM 123
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLM---------------DRKTMT---LKIADLGL 159
            YQ+CK V F H + + H DLKP N+L                D +T+    +K+ D G 
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 219
           A   T   + ++  +    YRAPEV+L +  +S   D+WS+ CI  E      +FP    
Sbjct: 184 A---TYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 220 LQQLLHIFRLLG-TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN----------LDKD 268
            + L  + R+LG  P   +          H+   W+  S A    +          L +D
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 269 G-----LDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 302
                  DL+++ML+YDP+KRI+ ++A++HP+FD L K+
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 91/312 (29%), Positives = 151/312 (48%), Gaps = 49/312 (15%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVS 55
           +  D ++    +G+G++G+V   ++K TG     K+++ ++ +   D E +    LREV 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL----LREVQ 78
Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTV 114
           +L+ L   P++ +L +       E +   YLV E Y   +L   I S ++  E   V+  
Sbjct: 79  LLKQLDH-PNIXKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAA 129
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTH 172
           + ++ Q+  G+ + H + I+HRDLKP NLL++ K+    ++I D GL+  F    KK   
Sbjct: 130 R-IIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKXKD 187
Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
           +I T +Y APEVL G+  Y    D+WS   I   L++    F G +E   L         
Sbjct: 188 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDIL--------- 236
Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
             +KV  G  +     E PQW   S +           DL+ + L Y PS RISA+ A++
Sbjct: 237 --KKVEKGKYTF----ELPQWKKVSESAK---------DLIRKXLTYVPSXRISARDALD 281
Query: 293 HPYFDDLDKTRL 304
           H +     K ++
Sbjct: 282 HEWIQTYTKEQI 293

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 95/326 (29%), Positives = 148/326 (45%), Gaps = 46/326 (14%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP---- 64
           + K+G G +  V+ A++      VA+K  R    D+        E+ +L+ ++       
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 65  ------HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
                 H+++L+D    +   G  V+ +VFE +  +L   I+ +   G  IP+  VK + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVV-MVFEVLGENLLALIKKYEHRG--IPLIYVKQIS 137
Query: 119 YQLCKGVAFCHGH-GILHRDLKPHNLLMD-----RKTMTLKIADLGLARAFTLPIKKYTH 172
            QL  G+ + H   GI+H D+KP N+LM+        + +KIADLG A  +    + YT+
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTN 194
Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHI 226
            I T  YR+PEVLLG+  +    D+WS AC+  EL+T   LF  D       +   +  I
Sbjct: 195 SIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 227 FRLLGT-PNEKVWPGVSS---------LMNWHEYPQWNPQSLATAVPNLDKDGL----DL 272
             LLG  P+  +  G  +         L N  +   W  + + T      KD      D 
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 273 LEQMLQYDPSKRISAKKAMEHPYFDD 298
           L  MLQ DP KR  A   + HP+  D
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 95/326 (29%), Positives = 148/326 (45%), Gaps = 46/326 (14%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP---- 64
           + K+G G +  V+ A++      VA+K  R    D+        E+ +L+ ++       
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 65  ------HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
                 H+++L+D    +   G  V+ +VFE +  +L   I+ +   G  IP+  VK + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVV-MVFEVLGENLLALIKKYEHRG--IPLIYVKQIS 137
Query: 119 YQLCKGVAFCHGH-GILHRDLKPHNLLMD-----RKTMTLKIADLGLARAFTLPIKKYTH 172
            QL  G+ + H   GI+H D+KP N+LM+        + +KIADLG A  +    + YT+
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTN 194
Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHI 226
            I T  YR+PEVLLG+  +    D+WS AC+  EL+T   LF  D       +   +  I
Sbjct: 195 SIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 227 FRLLGT-PNEKVWPGVSS---------LMNWHEYPQWNPQSLATAVPNLDKDGL----DL 272
             LLG  P+  +  G  +         L N  +   W  + + T      KD      D 
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 273 LEQMLQYDPSKRISAKKAMEHPYFDD 298
           L  MLQ DP KR  A   + HP+  D
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 148/333 (44%), Gaps = 48/333 (14%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           MD +E    +G+G++G+V +A ++   + VA+K   + ++ +        EV +L ++++
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNK 109
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
               ++   V   ++   R  L LVFE +  +L   +R+    G  + +N  +    Q+C
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKFAQQMC 167
Query: 123 KGVAFCHGH--GILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
             + F       I+H DLKP N+L+ + K   +KI D G +       ++    I + +Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG---QRIYQXIQSRFY 224
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           R+PEVLLG   Y  A+DMWS+ CI  E+ T   LF G +E+ Q+  I  +LG P   +  
Sbjct: 225 RSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
Query: 240 GVSSLMNWHEY---PQWNPQ---------------------SLATAVPNLDKDG------ 269
                  + E      WN +                      + T  P   + G      
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343
Query: 270 ------LDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  DL+ +ML YDP  RI    A++H +F
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 148/333 (44%), Gaps = 48/333 (14%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           MD +E    +G+G++G+V +A ++   + VA+K   + ++ +        EV +L ++++
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNK 109
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
               ++   V   ++   R  L LVFE +  +L   +R+    G  + +N  +    Q+C
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKFAQQMC 167
Query: 123 KGVAFCHGH--GILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
             + F       I+H DLKP N+L+ + K   +KI D G +       ++    I + +Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFY 224
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           R+PEVLLG   Y  A+DMWS+ CI  E+ T   LF G +E+ Q+  I  +LG P   +  
Sbjct: 225 RSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
Query: 240 GVSSLMNWHEY---PQWNPQ---------------------SLATAVPNLDKDG------ 269
                  + E      WN +                      + T  P   + G      
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343
Query: 270 ------LDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  DL+ +ML YDP  RI    A++H +F
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           ++ ++ +GEG++GKV  A    TG+ VALK    K     D +G      RE+S LR+L 
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLL- 70
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           R PH+++L DV + +++     + +V EY   +L  YI    +  E       +    Q+
Sbjct: 71  RHPHIIKLYDVIKSKDE-----IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQI 121
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              V +CH H I+HRDLKP NLL+D + + +KIAD GL+   T      T    +  Y A
Sbjct: 122 ISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 179
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+ G  +    VD+WS   I   ++ +    P D E   +L          + +  GV
Sbjct: 180 PEVISGKLYAGPEVDVWSCGVILYVMLCRR--LPFDDESIPVLF---------KNISNGV 228
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +L          P+ L+            L+++ML  +P  RIS  + M+  +F
Sbjct: 229 YTL----------PKFLSPGAAG-------LIKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           ++ ++ +GEG++GKV  A    TG+ VALK    K     D +G      RE+S LR+L 
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLL- 71
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           R PH+++L DV + +++     + +V EY   +L  YI    +  E       +    Q+
Sbjct: 72  RHPHIIKLYDVIKSKDE-----IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQI 122
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              V +CH H I+HRDLKP NLL+D + + +KIAD GL+   T      T    +  Y A
Sbjct: 123 ISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 180
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+ G  +    VD+WS   I   ++ +    P D E   +L          + +  GV
Sbjct: 181 PEVISGKLYAGPEVDVWSCGVILYVMLCRR--LPFDDESIPVLF---------KNISNGV 229
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +L          P+ L+            L+++ML  +P  RIS  + M+  +F
Sbjct: 230 YTL----------PKFLSPGAAG-------LIKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           ++ ++ +GEG++GKV  A    TG+ VALK    K     D +G      RE+S LR+L 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLL- 65
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           R PH+++L DV + +++     + +V EY   +L  YI    +  E       +    Q+
Sbjct: 66  RHPHIIKLYDVIKSKDE-----IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQI 116
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              V +CH H I+HRDLKP NLL+D + + +KIAD GL+   T      T    +  Y A
Sbjct: 117 ISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 174
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+ G  +    VD+WS   I   ++ +    P D E   +L          + +  GV
Sbjct: 175 PEVISGKLYAGPEVDVWSCGVILYVMLCRR--LPFDDESIPVLF---------KNISNGV 223
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +L          P+ L+            L+++ML  +P  RIS  + M+  +F
Sbjct: 224 YTL----------PKFLSPGAAG-------LIKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 148/333 (44%), Gaps = 48/333 (14%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           MD +E    +G+G++G+V +A ++   + VA+K   + ++ +        EV +L ++++
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFLNQAQIEVRLLELMNK 90
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
               ++   V   ++   R  L LVFE +  +L   +R+    G  + +N  +    Q+C
Sbjct: 91  HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKFAQQMC 148
Query: 123 KGVAFCHGH--GILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
             + F       I+H DLKP N+L+ + K   +KI D G +       ++    I + +Y
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFY 205
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           R+PEVLLG   Y  A+DMWS+ CI  E+ T   LF G +E+ Q+  I  +LG P   +  
Sbjct: 206 RSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 264
Query: 240 GVSSLMNWHEY---PQWNPQ---------------------SLATAVPNLDKDG------ 269
                  + E      WN +                      + T  P   + G      
Sbjct: 265 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 324
Query: 270 ------LDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  DL+ +ML YDP  RI    A++H +F
Sbjct: 325 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 357

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           ++ ++ +GEG++GKV  A    TG+ VALK    K     D +G      RE+S LR+L 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG---RIEREISYLRLL- 61
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           R PH+++L DV + +++     + +V EY   +L  YI    +  E       +    Q+
Sbjct: 62  RHPHIIKLYDVIKSKDE-----IIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQI 112
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              V +CH H I+HRDLKP NLL+D + + +KIAD GL+   T      T    +  Y A
Sbjct: 113 ISAVEYCHRHKIVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 170
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+ G  +    VD+WS   I   ++ +    P D E   +L          + +  GV
Sbjct: 171 PEVISGKLYAGPEVDVWSCGVILYVMLCRR--LPFDDESIPVLF---------KNISNGV 219
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +L          P+ L+            L+++ML  +P  RIS  + M+  +F
Sbjct: 220 YTL----------PKFLSPGAAG-------LIKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 143/301 (47%), Gaps = 49/301 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT-----LREVSILR 58
           D +++++K+G G YG+V   ++K TG   A+K  +       V  T+     L EV++L+
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK----KSSVTTTSNSGALLDEVAVLK 59
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSL 117
            L   P++++L +       E +   YLV E Y   +L   I   RQ    +    +   
Sbjct: 60  QLDH-PNIMKLYEFF-----EDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAVI--- 109
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 175
           M Q+  G  + H H I+HRDLKP NLL++ K+    +KI D GL+  F +   K    + 
Sbjct: 110 MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERLG 168
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T +Y APEVL     Y    D+WS   I   L+     F G ++ Q++L          +
Sbjct: 169 TAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTD-QEIL----------K 215
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           +V  G  S     + P W   S          +   L++ ML Y+PSKRISA++A+ HP+
Sbjct: 216 RVEKGKFSF----DPPDWTQVS---------DEAKQLVKLMLTYEPSKRISAEEALNHPW 262
Query: 296 F 296
Sbjct: 263 I 263

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 143/301 (47%), Gaps = 49/301 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT-----LREVSILR 58
           D +++++K+G G YG+V   ++K TG   A+K  +       V  T+     L EV++L+
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIK----KSSVTTTSNSGALLDEVAVLK 76
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFE-YMDTDLKKYIRSFRQTGENIPVNTVKSL 117
            L   P++++L +       E +   YLV E Y   +L   I   RQ    +    +   
Sbjct: 77  QLDH-PNIMKLYEFF-----EDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAVI--- 126
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL 175
           M Q+  G  + H H I+HRDLKP NLL++ K+    +KI D GL+  F +   K    + 
Sbjct: 127 MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERLG 185
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T +Y APEVL     Y    D+WS   I   L+     F G ++ Q++L          +
Sbjct: 186 TAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTD-QEIL----------K 232
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           +V  G  S     + P W           +  +   L++ ML Y+PSKRISA++A+ HP+
Sbjct: 233 RVEKGKFSF----DPPDWT---------QVSDEAKQLVKLMLTYEPSKRISAEEALNHPW 279
Query: 296 F 296
Sbjct: 280 I 280

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 53/300 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G++  VYRA    TG  VA+K   K  +++   G+      EV I   L + P ++ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK--AGMVQRVQNEVKIHCQL-KHPSILE 75
Query: 69  LMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           L +  +  N      +YLV E      M+  LK  ++ F +       N  +  M+Q+  
Sbjct: 76  LYNYFEDSN-----YVYLVLEMCHNGEMNRYLKNRVKPFSE-------NEARHFMHQIIT 123
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H HGILHRDL   NLL+ R  M +KIAD GLA    +P +K+     T  Y +PE
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTR-NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           +   S H     D+WS+ C+F  L+     F  D+          +  T N+ V      
Sbjct: 183 IATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDT----------VKNTLNKVVLAD--- 228
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 303
               +E P +           L  +  DL+ Q+L+ +P+ R+S    ++HP+      T+
Sbjct: 229 ----YEMPSF-----------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 56/296 (18%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           + +G GT+GKV   + + TG  VA+K   + ++   D  V     RE+  L++  R PH+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD--VVGKIRREIQNLKLF-RHPHI 78
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++L  V    +      +++V EY+   +L  YI    +  E       + L  Q+  GV
Sbjct: 79  IKLYQVISTPSD-----IFMVMEYVSGGELFDYICKNGRLDEK----ESRRLFQQILSGV 129
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYR 180
            +CH H ++HRDLKP N+L+D   M  KIAD GL+   +        E L     +  Y 
Sbjct: 130 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMS------DGEFLRXSCGSPNYA 182
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+ G  +    VD+WS   I   L+  T  F  D       H+  L     +K+  G
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-------HVPTLF----KKICDG 231
Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +           + PQ L  +V       + LL+ MLQ DP KR + K   EH +F
Sbjct: 232 IF----------YTPQYLNPSV-------ISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 145/304 (47%), Gaps = 51/304 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK--------KTRLHEDDEGVP---PTT 50
           + +++ K+ K+G G YG+V   +EK      A+K        K R  +D++ +       
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 51  LREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENI 109
             E+S+L+ L   P++++L DV      E +   YLV E+ +  +L + I +  +  E  
Sbjct: 94  YNEISLLKSLDH-PNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPI 167
             N    +M Q+  G+ + H H I+HRD+KP N+L++ K   + +KI D GL+  F+   
Sbjct: 148 AAN----IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
            K    + T +Y APEVL     Y+   D+WS   I   L+     F G ++ Q ++   
Sbjct: 204 -KLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDII--- 256
Query: 228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
                  +KV  G      + ++  W          N+  +  +L++ ML YD +KR +A
Sbjct: 257 -------KKVEKGKY----YFDFNDW---------KNISDEAKELIKLMLTYDYNKRCTA 296
Query: 288 KKAM 291
           ++A+
Sbjct: 297 EEAL 300

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 135/304 (44%), Gaps = 38/304 (12%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTL-REVSILRML 60
           D +E  E +G+G +  V R   + TG+  A+K   + +     G+    L RE SI  ML
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY 119
            + PH+V L++           +LY+VFE+MD  DL   I      G           M 
Sbjct: 84  -KHPHIVELLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTL 177
           Q+ + + +CH + I+HRD+KP N+L+  K  +  +K+ D G+A             + T 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            + APEV +    Y   VD+W    I   L++    F G  E      +F  +     K+
Sbjct: 198 HFMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKM 251
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            P            QW+         ++ +   DL+ +ML  DP++RI+  +A+ HP+  
Sbjct: 252 NP-----------RQWS---------HISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
Query: 298 DLDK 301
           + D+
Sbjct: 292 ERDR 295

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/218 (33%), Positives = 113/218 (51%), Gaps = 27/218 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL----REVSILRMLS 61
           L+ +G+G + KV  AR   TG+ VA+K   KT+L+       PT+L    REV I+++L+
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFREVRIMKILN 69
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             P++V+L +V      E    LYL+ EY    ++  Y+ +  +  E       +S   Q
Sbjct: 70  H-PNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQ 119
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +   V +CH   I+HRDLK  NLL+D   M +KIAD G +  FT+  K  T    +  Y 
Sbjct: 120 IVSAVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDTF-CGSPPYA 177
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           APE+  G  +    VD+WS+  I   LV+ +  F G +
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 143/294 (48%), Gaps = 41/294 (13%)
Query: 8   KLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           K E +G G +G+V++  E ATG  +A K  KTR  +D E V      E+S++  L    +
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK----NEISVMNQLDH-AN 147
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +++L D  + +N      + LV EY+D   + + R   ++     ++T+   M Q+C+G+
Sbjct: 148 LIQLYDAFESKND-----IVLVMEYVDGG-ELFDRIIDESYNLTELDTI-LFMKQICEGI 200
Query: 126 AFCHGHGILHRDLKPHNLL-MDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
              H   ILH DLKP N+L ++R    +KI D GLAR +  P +K      T  + APEV
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEV 259
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
            +     S   DMWSV  I   L++  + F GD++ + L +I                  
Sbjct: 260 -VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--------------- 303
Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
                  +W+ +       ++ ++  + + ++L  + S RISA +A++HP+  D
Sbjct: 304 -------RWDLED--EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 136/296 (45%), Gaps = 55/296 (18%)
Query: 10  EKVGEGTYGKV-----YRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLS 61
           E +GEG++GKV     Y+ ++K   K ++   LKK+ +H   E       RE+S L++L 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-------REISYLKLL- 66
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           R PH+++L DV         T + +V EY   +L  YI   ++  E+      +    Q+
Sbjct: 67  RHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTED----EGRRFFQQI 117
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              + +CH H I+HRDLKP NLL+D   + +KIAD GL+   T      T    +  Y A
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAA 175
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+ G  +    VD+WS  C     V      P D E             PN  ++  V
Sbjct: 176 PEVINGKLYAGPEVDVWS--CGIVLYVMLVGRLPFDDEF-----------IPN--LFKKV 220
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           +S +  +  P +           L      L+ +M+  DP +RI+ ++    P+F+
Sbjct: 221 NSCV--YVMPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 48/304 (15%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR----LHEDDEGVPPTTLREVSILR 58
           ++ FE  + +G+G++GKV+ A  K T +  A+K  +    L +DD      T+ E  +L 
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLS 73
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
           +    P +  +    Q +       L+ V EY++  DL  +I    Q+     ++     
Sbjct: 74  LAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHI----QSCHKFDLSRATFY 124
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
             ++  G+ F H  GI++RDLK  N+L+D K   +KIAD G+ +   L   K      T 
Sbjct: 125 AAEIILGLQFLHSKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APE+LLG   Y+ +VD WS   +  E++   + F G  E ++L H  R         
Sbjct: 184 DYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIR--------- 232
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYF 296
                  M+   YP+W           L+K+  DLL ++   +P KR+  +  + +HP F
Sbjct: 233 -------MDNPFYPRW-----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 274
Query: 297 DDLD 300
            +++
Sbjct: 275 REIN 278

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-HEDDEGVPPTTLREVSILRML 60
           V+D ++  E++G G +G V+R  E+ATG   A K     HE D+    T  +E+  + +L
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVL 211
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLM 118
            R P +V L D  +  N+     + +++E+M      +K      +  E+  V      M
Sbjct: 212 -RHPTLVNLHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAV----EYM 261
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
            Q+CKG+   H +  +H DLKP N++   +++  LK+ D GL  A   P +       T 
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTA 320
Query: 178 WYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            + APEV  G    Y T  DMWSV  +   L++  + F G+++ + L ++          
Sbjct: 321 EFAAPEVAEGKPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------- 371
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                           WN     +A   + +DG D + ++L  DP+ R++  +A+EHP+ 
Sbjct: 372 ---------------DWNMDD--SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 27/218 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL----REVSILRMLS 61
           L+ +G+G + KV  AR   TG+ VA+K   KT+L+       PT+L    REV I+++L+
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFREVRIMKILN 72
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             P++V+L +V      E    LYL+ EY    ++  Y+ +  +  E       +S   Q
Sbjct: 73  H-PNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQ 122
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +   V +CH   I+HRDLK  NLL+D   M +KIAD G +  FT+   K         Y 
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYA 180
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           APE+  G  +    VD+WS+  I   LV+ +  F G +
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-HEDDEGVPPTTLREVSILRML 60
           V+D ++  E++G G +G V+R  E+ATG   A K     HE D+    T  +E+  + +L
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVL 105
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLM 118
            R P +V L D  +  N+     + +++E+M      +K      +  E+  V      M
Sbjct: 106 -RHPTLVNLHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAV----EYM 155
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
            Q+CKG+   H +  +H DLKP N++   +++  LK+ D GL  A   P +       T 
Sbjct: 156 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTA 214
Query: 178 WYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            + APEV  G    Y T  DMWSV  +   L++  + F G+++ + L ++          
Sbjct: 215 EFAAPEVAEGKPVGYYT--DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------- 265
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                           WN     +A   + +DG D + ++L  DP+ R++  +A+EHP+ 
Sbjct: 266 ---------------DWNMDD--SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL----REVSILRMLSRDP 64
           +G+G + KV  AR   TG+ VA+K   KT+L+       PT+L    REV I+++L+  P
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLN-------PTSLQKLFREVRIMKILNH-P 74
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++V+L +V      E    LYLV EY    ++  Y+ +  +  E       ++   Q+  
Sbjct: 75  NIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVS 125
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            V +CH   I+HRDLK  NLL+D   M +KIAD G +  FT+  K  T    +  Y APE
Sbjct: 126 AVQYCHQKYIVHRDLKAENLLLD-GDMNIKIADFGFSNEFTVGNKLDTF-CGSPPYAAPE 183
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           +  G  +    VD+WS+  I   LV+ +  F G +
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G + KV  AR   TGK VA+K     + +        REV I+++L+  P++V+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH-PNIVK 77
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L +V      E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +
Sbjct: 78  LFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQY 128
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           CH   I+HRDLK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G
Sbjct: 129 CHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQG 186
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             +    VD+WS+  I   LV+ +  F G +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G + KV  AR   TGK VA+K     + +        REV I+++L+  P++V+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH-PNIVK 77
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L +V      E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +
Sbjct: 78  LFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQY 128
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           CH   I+HRDLK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G
Sbjct: 129 CHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQG 186
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             +    VD+WS+  I   LV+ +  F G +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 134/304 (44%), Gaps = 38/304 (12%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTL-REVSILRML 60
           D +E  E +G+G +  V R   + TG+  A+K   + +     G+    L RE SI  ML
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY 119
            + PH+V L++           +LY+VFE+MD  DL   I      G           M 
Sbjct: 86  -KHPHIVELLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 139
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTL 177
           Q+ + + +CH + I+HRD+KPH +L+  K  +  +K+   G+A             + T 
Sbjct: 140 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 199
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            + APEV +    Y   VD+W    I   L++    F G  E      +F  +     K+
Sbjct: 200 HFMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKM 253
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            P            QW+         ++ +   DL+ +ML  DP++RI+  +A+ HP+  
Sbjct: 254 NP-----------RQWS---------HISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293
Query: 298 DLDK 301
           + D+
Sbjct: 294 ERDR 297

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 136/293 (46%), Gaps = 41/293 (13%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + F+ LEK+GEG+YG VY+A  K TG+IVA+K+  +  D + +    ++E+SI++     
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQCD-S 83
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           PHVV+        +    T L++V EY        I   R   + +  + + +++    K
Sbjct: 84  PHVVKYYG-----SYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLK 136
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H    +HRD+K  N+L++ +    K+AD G+A   T  + K    I T ++ APE
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMAPE 195
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           V +    Y+   D+WS+     E+       P  +++  +  IF +   P          
Sbjct: 196 V-IQEIGYNCVADIWSLGITAIEMAEGK---PPYADIHPMRAIFMIPTNP---------- 241
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                      P +     P L  D   D ++Q L   P +R +A + ++HP+
Sbjct: 242 -----------PPTFRK--PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 56/296 (18%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           + +G GT+GKV     + TG  VA+K   + ++   D  V     RE+  L++  R PH+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLF-RHPHI 73
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++L  V         T  ++V EY+   +L  YI    +  E       + L  Q+   V
Sbjct: 74  IKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAV 124
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYR 180
            +CH H ++HRDLKP N+L+D   M  KIAD GL+   +        E L     +  Y 
Sbjct: 125 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMS------DGEFLRDSCGSPNYA 177
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+ G  +    VD+WS   I   L+  T   P D E     H+  L     +K+  G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT--LPFDDE-----HVPTLF----KKIRGG 226
Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           V  +      P++  +S+AT           LL  MLQ DP KR + K   EH +F
Sbjct: 227 VFYI------PEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 10/214 (4%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDP 64
           F   +K+G G + +VYRA     G  VALKK ++ +  D       ++E+ +L+ L+  P
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-P 92
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +V++        N+     L +V E  D  DL + I+ F++    IP  TV     QLC 
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            +   H   ++HRD+KP N+ +   T  +K+ DLGL R F+         + T +Y +PE
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFI-TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD 217
             +    Y+   D+WS+ C+  E+    + F GD
Sbjct: 207 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L  +G G+YG+  + R K+ GKI+  K+       E      + EV++LR L + P+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN 66
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VR  D    +     T LY+V EY +  DL   I    +  + +    V  +M QL   
Sbjct: 67  IVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 125 VAFCH-----GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           +  CH     GH +LHRDLKP N+ +D K   +K+ D GLAR            + T +Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
            +PE  +    Y+   D+WS+ C+  EL    AL P  +   Q
Sbjct: 183 MSPEQ-MNRMSYNEKSDIWSLGCLLYELC---ALMPPFTAFSQ 221

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 134/304 (44%), Gaps = 38/304 (12%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTL-REVSILRML 60
           D +E  E +G+G +  V R   + TG+  A+K   + +     G+    L RE SI  ML
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY 119
            + PH+V L++           +LY+VFE+MD  DL   I      G           M 
Sbjct: 84  -KHPHIVELLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTL 177
           Q+ + + +CH + I+HRD+KPH +L+  K  +  +K+   G+A             + T 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            + APEV +    Y   VD+W    I   L++    F G  E      +F  +     K+
Sbjct: 198 HFMAPEV-VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKM 251
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            P            QW+         ++ +   DL+ +ML  DP++RI+  +A+ HP+  
Sbjct: 252 NPR-----------QWS---------HISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
Query: 298 DLDK 301
           + D+
Sbjct: 292 ERDR 295

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 56/296 (18%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           + +G GT+GKV     + TG  VA+K   + ++   D  V     RE+  L++  R PH+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLF-RHPHI 73
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++L  V         T  ++V EY+   +L  YI    +  E       + L  Q+   V
Sbjct: 74  IKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAV 124
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWYR 180
            +CH H ++HRDLKP N+L+D   M  KIAD GL+   +        E L     +  Y 
Sbjct: 125 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMS------DGEFLRTSCGSPNYA 177
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+ G  +    VD+WS   I   L+  T   P D E     H+  L     +K+  G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT--LPFDDE-----HVPTLF----KKIRGG 226
Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           V  +      P++  +S+AT           LL  MLQ DP KR + K   EH +F
Sbjct: 227 VFYI------PEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L  +G G+YG+  + R K+ GKI+  K+       E      + EV++LR L + P+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN 66
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VR  D    +     T LY+V EY +  DL   I    +  + +    V  +M QL   
Sbjct: 67  IVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 125 VAFCH-----GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           +  CH     GH +LHRDLKP N+ +D K   +K+ D GLAR            + T +Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
            +PE  +    Y+   D+WS+ C+  EL    AL P  +   Q
Sbjct: 183 MSPEQ-MNRMSYNEKSDIWSLGCLLYELC---ALMPPFTAFSQ 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G + KV  AR   TGK VA++     + +        REV I+++L+  P++V+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH-PNIVK 77
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L +V      E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +
Sbjct: 78  LFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQY 128
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           CH   I+HRDLK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G
Sbjct: 129 CHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQG 186
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             +    VD+WS+  I   LV+ +  F G +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 133/304 (43%), Gaps = 58/304 (19%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSIL 57
             +D F+ +  +G+G +G VY AREK    I+ALK   K++L  + EGV     RE+ I 
Sbjct: 11  FTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQ 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVN 112
             L R P+++R+ +    + +     +YL+ E+     +  +L+K+ R   Q        
Sbjct: 69  SHL-RHPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRS------ 116
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH 172
              + M +L   + +CH   ++HRD+KP NLLM  K   LKIAD G   +   P  +   
Sbjct: 117 --ATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGW--SVHAPSLRRRX 171
Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LG 231
              TL Y  PE++ G TH    VD+W    +  E +     F   S  +    I  + L 
Sbjct: 172 MCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
            P                             P L     DL+ ++L+Y P +R+  K  M
Sbjct: 231 FP-----------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVM 261
Query: 292 EHPY 295
           EHP+
Sbjct: 262 EHPW 265

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G + KV  AR   TGK VA++     + +        REV I+++L+  P++V+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH-PNIVK 77
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L +V      E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +
Sbjct: 78  LFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQY 128
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           CH   I+HRDLK  NLL+D   M +KIAD G +  FT    K      +  Y APE+  G
Sbjct: 129 CHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFG-NKLDEFCGSPPYAAPELFQG 186
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             +    VD+WS+  I   LV+ +  F G +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 136/295 (46%), Gaps = 48/295 (16%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTR----LHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +G+G++GKV+ A  K T +  A+K  +    L +DD      T+ E  +L +    P + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLSLAWEHPFLT 81
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            +    Q +       L+ V EY++  DL  +I    Q+     ++       ++  G+ 
Sbjct: 82  HMFCTFQTKEN-----LFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQ 132
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
           F H  GI++RDLK  N+L+D K   +KIAD G+ +   L   K      T  Y APE+LL
Sbjct: 133 FLHSKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
           G   Y+ +VD WS   +  E++   + F G  E ++L H  R                M+
Sbjct: 192 GQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIR----------------MD 233
Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFDDLD 300
              YP+W           L+K+  DLL ++   +P KR+  +  + +HP F +++
Sbjct: 234 NPFYPRW-----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 13/211 (6%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G + KV  AR   TGK VA+K     + +        REV I+++L+  P++V+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH-PNIVK 77
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L +V      E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +
Sbjct: 78  LFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFRQIVSAVQY 128
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           CH   I+HRDLK  NLL+D   M +KIAD G +  FT    K         Y APE+  G
Sbjct: 129 CHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQG 186
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             +    VD+WS+  I   LV+ +  F G +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G + KV  AR   TGK VA+K     + +        REV I+++L+  P++V+
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH-PNIVK 70
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L +V      E    LYLV EY    ++  Y+ +     E       ++   Q+   V +
Sbjct: 71  LFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEK----EARAKFRQIVSAVQY 121
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           CH   I+HRDLK  NLL+D   M +KIAD G +  FT   K  T    +  Y APE+  G
Sbjct: 122 CHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQG 179
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             +    VD+WS+  I   LV+ +  F G +
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +E L  +G G+YG+  + R K+ GKI+  K+       E      + EV++LR L + P+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN 66
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VR  D    +     T LY+V EY +  DL   I    +  + +    V  +M QL   
Sbjct: 67  IVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 125 VAFCH-----GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           +  CH     GH +LHRDLKP N+ +D K   +K+ D GLAR            + T +Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
            +PE  +    Y+   D+WS+ C+  EL    AL P  +   Q
Sbjct: 183 MSPEQ-MNRMSYNEKSDIWSLGCLLYELC---ALMPPFTAFSQ 221

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/341 (24%), Positives = 151/341 (44%), Gaps = 66/341 (19%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           + + +E +  +GEGT+G+V +  + +  G  VALK  +   + E        E+++L  +
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIK---NVEKYKEAARLEINVLEKI 87
Query: 61  S-RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKY----IRSFRQTGEN----IPV 111
           + +DP            NK     ++  F+Y       +    + +F    +N     P+
Sbjct: 88  NEKDP-----------DNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 136
Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMTLK 153
           + V+ + +QLC+ V F H + + H DLKP N+L                     K+  ++
Sbjct: 137 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVR 196
Query: 154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL 213
           + D G A   T   + ++  + T  YRAPEV+L    +S   D+WS+ CI  E      L
Sbjct: 197 VVDFGSA---TFDHEHHSTIVSTRHYRAPEVIL-ELGWSQPCDVWSIGCIIFEYYVGFTL 252
Query: 214 FPGDSELQQLLHIFRLLG---------TPNEKVWPGVSSLMNWHE------YPQWNPQSL 258
           F      + L  + R+LG         T  +K +      ++W E      Y + N + L
Sbjct: 253 FQTHDNREHLAMMERILGPIPSRMIRKTRKQKYF--YRGRLDWDENTSAGRYVRENCKPL 310
Query: 259 A---TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
               T+         DL+E ML+Y+P+KR++  +A++HP+F
Sbjct: 311 RRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFF 351

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 152/337 (45%), Gaps = 52/337 (15%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKI-VALKKTRLHEDDEGVPPTTLR-EVSILRM 59
           + + +E +  +GEGT+GKV    + A GK  VALK  R    + G      R E+++L+ 
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKK 72
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +       + + V           + + FE +  +  ++++      +  P+  V+ + Y
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAY 130
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMTLKIADLGLAR 161
           QLC  + F H + + H DLKP N+L                     K  ++++AD G A 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             T   + +T  + T  YR PEV+L    ++   D+WS+ CI  E      LF      +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 222 QLLHIFRLLG---------TPNEK-------VWPGVSSLMNWHEYPQWNPQSLATAV--P 263
            L+ + ++LG         T  +K       VW   SS      Y + N + L + +   
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG---RYVKENCKPLKSYMLQD 303
Query: 264 NLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +L+   L DL+ +ML++DP++RI+  +A+ HP+F  L
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 152/337 (45%), Gaps = 52/337 (15%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKI-VALKKTRLHEDDEGVPPTTLR-EVSILRM 59
           + + +E +  +GEGT+GKV    + A GK  VALK  R    + G      R E+++L+ 
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKK 81
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +       + + V           + + FE +  +  ++++      +  P+  V+ + Y
Sbjct: 82  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAY 139
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMTLKIADLGLAR 161
           QLC  + F H + + H DLKP N+L                     K  ++++AD G A 
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 198
Query: 162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             T   + +T  + T  YR PEV+L    ++   D+WS+ CI  E      LF      +
Sbjct: 199 --TFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 255
Query: 222 QLLHIFRLLG---------TPNEK-------VWPGVSSLMNWHEYPQWNPQSLATAV--P 263
            L+ + ++LG         T  +K       VW   SS      Y + N + L + +   
Sbjct: 256 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR---YVKENCKPLKSYMLQD 312
Query: 264 NLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +L+   L DL+ +ML++DP++RI+  +A+ HP+F  L
Sbjct: 313 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 132/304 (43%), Gaps = 58/304 (19%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSIL 57
             +D F+    +G+G +G VY AREK    I+ALK   K++L  + EGV     RE+ I 
Sbjct: 12  FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQ 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY-----MDTDLKKYIRSFRQTGENIPVN 112
             L R P+++R+ +    + +     +YL+ E+     +  +L+K+ R   Q        
Sbjct: 70  SHL-RHPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRS------ 117
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH 172
              + M +L   + +CH   ++HRD+KP NLLM  K   LKIAD G   +   P  +   
Sbjct: 118 --ATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGW--SVHAPSLRRRX 172
Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LG 231
              TL Y  PE++ G TH    VD+W    +  E +     F   S  +    I  + L 
Sbjct: 173 MCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 231
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
            P                             P L     DL+ ++L+Y P +R+  K  M
Sbjct: 232 FP-----------------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVM 262
Query: 292 EHPY 295
           EHP+
Sbjct: 263 EHPW 266

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 152/337 (45%), Gaps = 52/337 (15%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKI-VALKKTRLHEDDEGVPPTTLR-EVSILRM 59
           + + +E +  +GEGT+GKV    + A GK  VALK  R    + G      R E+++L+ 
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKK 104
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +       + + V           + + FE +  +  ++++      +  P+  V+ + Y
Sbjct: 105 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAY 162
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMTLKIADLGLAR 161
           QLC  + F H + + H DLKP N+L                     K  ++++AD G A 
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 221
Query: 162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             T   + +T  + T  YR PEV+L    ++   D+WS+ CI  E      LF      +
Sbjct: 222 --TFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 278
Query: 222 QLLHIFRLLG---------TPNEK-------VWPGVSSLMNWHEYPQWNPQSLATAV--P 263
            L+ + ++LG         T  +K       VW   SS      Y + N + L + +   
Sbjct: 279 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG---RYVKENCKPLKSYMLQD 335
Query: 264 NLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +L+   L DL+ +ML++DP++RI+  +A+ HP+F  L
Sbjct: 336 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTELCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 80
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 81  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 131
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 132 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 188
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 189 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 241
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 242 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 50/299 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
            L R P+++RL            T +YL+ EY    ++ K ++   +  E        + 
Sbjct: 69  HL-RHPNILRLYGYFHDA-----TRVYLILEYAPRGEVYKELQKLSKFDEQ----RTATY 118
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTL 175
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T     
Sbjct: 176 DYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----- 229
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                    P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 230 ------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 69  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 119
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 176
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE + G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 177 YLPPEXIEGRXH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 229
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 230 -----------------------FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 89
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 90  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 140
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 197
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 198 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 250
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 296
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 251 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 64
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 65  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 115
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLD 172
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 173 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 225
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 226 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 62
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 63  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 113
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 213
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 214 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 69  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 119
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLD 176
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 177 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 229
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 230 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTDLCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRM 59
           V D ++ LE++G G +G V+R  EKATG++   K   T    D      T   E+SI+  
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY----TVKNEISIMNQ 104
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L   P ++ L D       E +  + L+ E++     +           +    V + M 
Sbjct: 105 LHH-PKLINLHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMR 156
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           Q C+G+   H H I+H D+KP N++ + +K  ++KI D GLA     P +       T  
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAE 215
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           + APE+ +         DMW++  +   L++  + F G+ +L+ L ++ R          
Sbjct: 216 FAAPEI-VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------- 265
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  +W    +++  + ++  P    +  D ++ +LQ +P KR++   A+EHP+ 
Sbjct: 266 -------DW----EFDEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q                P 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------------PS 211
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
            S      EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 212 DSX----QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G + KV  AR   TGK VA+K     + +        REV I ++L+  P++V+
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNH-PNIVK 77
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L +V      E    LYLV EY    ++  Y+ +  +  E       ++   Q+   V +
Sbjct: 78  LFEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEK----EARAKFRQIVSAVQY 128
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           CH   I+HRDLK  NLL+D     +KIAD G +  FT    K         Y APE+  G
Sbjct: 129 CHQKFIVHRDLKAENLLLD-ADXNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQG 186
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             +    VD+WS+  I   LV+ +  F G +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY  +  + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYC-SGGELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 69  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 119
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 176
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 177 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 229
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 230 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 67  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 174
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 175 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTXLCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 67  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 174
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 175 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 67
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 68  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 118
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 175
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 176 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 228
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 229 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 62
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 63  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 113
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 114 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 170
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 171 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 223
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 224 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 137/305 (44%), Gaps = 62/305 (20%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE   ++G G    VYR ++K T K  ALK  +   D + V      E+ +L  LS  
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSH- 107
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVF--EYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           P++++L ++ +    E   VL LV   E  D  ++K   S R   + +          Q+
Sbjct: 108 PNIIKLKEIFETPT-EISLVLELVTGGELFDRIVEKGYYSERDAADAVK---------QI 157
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL---- 175
            + VA+ H +GI+HRDLKP NLL         LKIAD GL+       K   H++L    
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS-------KIVEHQVLMKTV 210
Query: 176 --TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  Y APE+L G   Y   VDMWSV  I   L+     F  +   Q    +FR     
Sbjct: 211 CGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFR----- 261
Query: 234 NEKVWPGVSSLMNWHEY---PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
                     ++N   Y   P W+  SL         +  DL+ +++  DP KR++  +A
Sbjct: 262 ---------RILNCEYYFISPWWDEVSL---------NAKDLVRKLIVLDPKKRLTTFQA 303
Query: 291 MEHPY 295
           ++HP+
Sbjct: 304 LQHPW 308

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 40/297 (13%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR-EVSILRMLSR 62
           D F    K+G G +G V+   E+++G    +K   +++D   VP   +  E+ +L+ L  
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT--INKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P+++++ +V +  +      +Y+V E  +  +L + I S +  G+ +    V  LM Q+
Sbjct: 80  -PNIIKIFEVFEDYHN-----MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWY 179
              +A+ H   ++H+DLKP N+L    +    +KI D GLA  F    +  T+   T  Y
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALY 192
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV      +    D+WS   +   L+T    F G                       
Sbjct: 193 MAPEVFKRDVTFK--CDIWSAGVVMYFLLTGCLPFTG----------------------- 227
Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             +SL    +   +   + A     L    +DLL+QML  DP +R SA + + H +F
Sbjct: 228 --TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG YG+V  A  + T + VA+K   +    +  P    +E+ I  ML+ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINAMLNH 64
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 65  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 115
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 215
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 216 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 64
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 65  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 115
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SCHAPSSRRTTLSGTLD 172
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 173 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 225
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 226 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 130/299 (43%), Gaps = 35/299 (11%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           V D ++  ++V G G  GKV     + TG+  ALK   L++      P   +EV      
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK--LLYDS-----PKARQEVDHHWQA 78
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S  PH+V ++DV +  +  G+  L ++ E M+   + + R   +  +         +M  
Sbjct: 79  SGGPHIVCILDVYENMH-HGKRCLLIIMECMEGG-ELFSRIQERGDQAFTEREAAEIMRD 136
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +   + F H H I HRD+KP NLL     K   LK+ D G A+  T           T +
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPY 194
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  ++                + + 
Sbjct: 195 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT---------------GQAIS 238
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           PG+   +   +Y   NP+        + +D   L+  +L+ DP++R++  + M HP+ +
Sbjct: 239 PGMKRRIRLGQYGFPNPE-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 130/299 (43%), Gaps = 35/299 (11%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           V D ++  ++V G G  GKV     + TG+  ALK   L++      P   +EV      
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK--LLYDS-----PKARQEVDHHWQA 59
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S  PH+V ++DV +  +  G+  L ++ E M+   + + R   +  +         +M  
Sbjct: 60  SGGPHIVCILDVYENMH-HGKRCLLIIMECMEGG-ELFSRIQERGDQAFTEREAAEIMRD 117
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +   + F H H I HRD+KP NLL     K   LK+ D G A+  T           T +
Sbjct: 118 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPY 175
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  ++                + + 
Sbjct: 176 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT---------------GQAIS 219
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           PG+   +   +Y   NP+        + +D   L+  +L+ DP++R++  + M HP+ +
Sbjct: 220 PGMKRRIRLGQYGFPNPE-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 273

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 50/307 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-------HEDDEGVPPTTLREVSI 56
           + +E  E +G G    V R   K T K  A+K   +        E+ + +   TL+EV I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--V 114
           LR +S  P++++L D       E  T  +LVF     DL K    F    E + ++    
Sbjct: 64  LRKVSGHPNIIQLKD-----TYETNTFFFLVF-----DLMKKGELFDYLTEKVTLSEKET 113
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           + +M  L + +   H   I+HRDLKP N+L+D   M +K+ D G +     P +K     
Sbjct: 114 RKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVC 171
Query: 175 LTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
            T  Y APE++  S +     Y   VDMWS   I   L+  +  F      +Q+L + R+
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF---WHRKQML-MLRM 227
Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
           + + N +              P+W+  S             DL+ + L   P KR +A++
Sbjct: 228 IMSGNYQFGS-----------PEWDDYSDTVK---------DLVSRFLVVQPQKRYTAEE 267
Query: 290 AMEHPYF 296
           A+ HP+F
Sbjct: 268 ALAHPFF 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 89
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 90  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 140
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRDDLCGTLD 197
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 198 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 250
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 296
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 251 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 50/307 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-------HEDDEGVPPTTLREVSI 56
           + +E  E +G G    V R   K T K  A+K   +        E+ + +   TL+EV I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--V 114
           LR +S  P++++L D       E  T  +LVF     DL K    F    E + ++    
Sbjct: 77  LRKVSGHPNIIQLKD-----TYETNTFFFLVF-----DLMKKGELFDYLTEKVTLSEKET 126
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           + +M  L + +   H   I+HRDLKP N+L+D   M +K+ D G +     P +K     
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVC 184
Query: 175 LTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
            T  Y APE++  S +     Y   VDMWS   I   L+  +  F      +Q+L + R+
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF---WHRKQML-MLRM 240
Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
           + + N +              P+W+  S             DL+ + L   P KR +A++
Sbjct: 241 IMSGNYQFGS-----------PEWDDYSDTVK---------DLVSRFLVVQPQKRYTAEE 280
Query: 290 AMEHPYF 296
           A+ HP+F
Sbjct: 281 ALAHPFF 287

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 65
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 66  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 116
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRXXLCGTLD 173
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 174 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 226
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 227 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 67  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIA+ G   +   P  + T    TL 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGW--SVHAPSSRRTTLCGTLD 174
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 175 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 134/299 (44%), Gaps = 50/299 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 68
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
            L R P+++RL            T +YL+ EY    ++ K ++   +  E        + 
Sbjct: 69  HL-RHPNILRLYGYFHDA-----TRVYLILEYAPRGEVYKELQKLSKFDEQ----RTATY 118
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRXXLXGTL 175
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T     
Sbjct: 176 DYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----- 229
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                    P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 230 ------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 67  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRAALCGTLD 174
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 175 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 65
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 66  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 116
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIA+ G   +   P  + T    TL 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGW--SVHAPSSRRTTLCGTLD 173
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 174 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 226
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 227 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK    I+ALK   K +L  +  GV     REV I  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 60
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 61  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 111
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 112 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRTTLCGTLD 168
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 169 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 221
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 222 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 135/307 (43%), Gaps = 50/307 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-------HEDDEGVPPTTLREVSI 56
           + +E  E +G G    V R   K T K  A+K   +        E+ + +   TL+EV I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--V 114
           LR +S  P++++L D       E  T  +LVF     DL K    F    E + ++    
Sbjct: 77  LRKVSGHPNIIQLKD-----TYETNTFFFLVF-----DLMKKGELFDYLTEKVTLSEKET 126
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           + +M  L + +   H   I+HRDLKP N+L+D   M +K+ D G +     P +K     
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLRSVC 184
Query: 175 LTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
            T  Y APE++  S +     Y   VDMWS   I   L+  +  F      +Q+L + R+
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF---WHRKQML-MLRM 240
Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
           + + N +              P+W+  S             DL+ + L   P KR +A++
Sbjct: 241 IMSGNYQFGS-----------PEWDDYSDTVK---------DLVSRFLVVQPQKRYTAEE 280
Query: 290 AMEHPYF 296
           A+ HP+F
Sbjct: 281 ALAHPFF 287

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRAALCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRXXLCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 67  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRXXLCGTLD 174
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 175 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 143/303 (47%), Gaps = 52/303 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKK--TRLHEDDEGVPPTTLREVSI 56
           D ++  E++G+G +  V R  +  TG     KI+  KK   R H+  E       RE  I
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE-------REARI 56
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
            R+L + P++VRL D     ++EG    YLVF+ +   +L + I +     E    + ++
Sbjct: 57  CRLL-KHPNIVRLHD---SISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ 110
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
               Q+ + V  CH +GI+HRDLKP NLL+  K+    +K+AD GLA       + +   
Sbjct: 111 ----QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF 166
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  Y +PEVL     Y   VDMW+   I   L+     F  D +  +L          
Sbjct: 167 AGTPGYLSPEVLRKDP-YGKPVDMWACGVILYILLVGYPPF-WDEDQHRLY--------- 215
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            +++  G     +    P+W+     T  P    +  DL+ +ML  +P+KRI+A +A++H
Sbjct: 216 -QQIKAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPAKRITASEALKH 261
Query: 294 PYF 296
           P+ 
Sbjct: 262 PWI 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 64
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 65  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 115
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRDTLCGTLD 172
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 173 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 225
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 226 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 66
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 67  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRDDLCGTLD 174
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++  +    I R+  T      
Sbjct: 175 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 228 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 143/303 (47%), Gaps = 52/303 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKK--TRLHEDDEGVPPTTLREVSI 56
           D ++  E++G+G +  V R  +  TG     KI+  KK   R H+  E       RE  I
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE-------REARI 56
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
            R+L + P++VRL D     ++EG    YLVF+ +   +L + I +     E    + ++
Sbjct: 57  CRLL-KHPNIVRLHD---SISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ 110
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
               Q+ + V  CH +GI+HRDLKP NLL+  K+    +K+AD GLA       + +   
Sbjct: 111 ----QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGF 166
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  Y +PEVL     Y   VDMW+   I   L+     F  D +  +L          
Sbjct: 167 AGTPGYLSPEVLRKDP-YGKPVDMWACGVILYILLVGYPPF-WDEDQHRLY--------- 215
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            +++  G     +    P+W+     T  P    +  DL+ +ML  +P+KRI+A +A++H
Sbjct: 216 -QQIKAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPAKRITASEALKH 261
Query: 294 PYF 296
           P+ 
Sbjct: 262 PWI 264

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 137/302 (45%), Gaps = 42/302 (13%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSI 56
           MV D +E  E++G G +  V + R+K TGK  A   +KK RL     GV    + REV+I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           LR + R P+++ L D+      E +T + L+ E +       +  F    E++  +    
Sbjct: 62  LREI-RHPNIITLHDI-----FENKTDVVLILELVSGG---ELFDFLAEKESLTEDEATQ 112
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLKIADLGLARAFTLPIKKYTHE 173
            + Q+  GV + H   I H DLKP N+++  K +    +K+ D G+A        ++ + 
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNI 171
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  + APE+ +         DMWS+  I   L++  + F G+++ + L +I  +    
Sbjct: 172 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           +E+ +   S L                          D + ++L  DP +R++  +++EH
Sbjct: 231 DEEYFSNTSELAK------------------------DFIRRLLVKDPKRRMTIAQSLEH 266
Query: 294 PY 295
            +
Sbjct: 267 SW 268

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 132/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ FE    +G+G +G VY AREK +  I+ALK   K +L  +  GV     REV I  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQL--EKAGVEHQLRREVEIQS 63
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++  +     T  + +
Sbjct: 64  HL-RHPNILRLYGYFHDS-----TRVYLILEY--APLGTVYRELQKLSKFDEQRTA-TYI 114
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 115 TELANALSYCHSKKVIHRDIKPENLLLG-SAGELKIADFGW--SVHAPSSRRAALCGTLD 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F  ++       I R+  T      
Sbjct: 172 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT------ 224
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++PS+R   ++ +EHP+
Sbjct: 225 -----------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 51/284 (17%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE++  +G+G +G+V +AR     +  A+KK R  E+      T L EV +L  L+   +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNHQ-Y 63
Query: 66  VVRLMD--------VKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKS 116
           VVR           VK     + ++ L++  EY +   L   I S      N   +    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK----- 169
           L  Q+ + +++ H  GI+HRDLKP N+ +D ++  +KI D GLA+    +L I K     
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 170 -------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-------------- 208
                   T  I T  Y A EVL G+ HY+  +DM+S+  IF E++              
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 209 ---TKTALFP---GDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
              + +  FP    D++++    I RLL   +    PG  +L+N
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 51/284 (17%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE++  +G+G +G+V +AR     +  A+KK R  E+      T L EV +L  L+   +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNHQ-Y 63
Query: 66  VVRLMD--------VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           VVR           VK     + ++ L++  EY +   L   I S      N   +    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS---ENLNQQRDEYWR 120
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK----- 169
           L  Q+ + +++ H  GI+HRDLKP N+ +D ++  +KI D GLA+    +L I K     
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 170 -------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV-------------- 208
                   T  I T  Y A EVL G+ HY+  +DM+S+  IF E++              
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 209 ---TKTALFP---GDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
              + +  FP    D++++    I RLL   +    PG  +L+N
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 136/302 (45%), Gaps = 42/302 (13%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSI 56
           MV D +E  E++G G +  V + R+K TGK  A   +KK RL     GV    + REV+I
Sbjct: 23  MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           LR + R P+++ L D+      E +T + L+ E +       +  F    E++  +    
Sbjct: 83  LREI-RHPNIITLHDI-----FENKTDVVLILELVSGG---ELFDFLAEKESLTEDEATQ 133
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLKIADLGLARAFTLPIKKYTHE 173
            + Q+  GV + H   I H DLKP N+++  K +    +K+ D G+A        ++ + 
Sbjct: 134 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNI 192
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  + APE+ +         DMWS+  I   L++  + F G+++ + L +I  +    
Sbjct: 193 FGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 251
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           +E+ +   S L                          D + ++L  DP +R+   +++EH
Sbjct: 252 DEEYFSNTSELAK------------------------DFIRRLLVKDPKRRMXIAQSLEH 287
Query: 294 PY 295
            +
Sbjct: 288 SW 289

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 40/287 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++ ++ ++ +GEG  G+V  A  + T + VA+K   +    +  P    +E+ I +ML+ 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNH 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           + +VV+      G  +EG  + YL  EY     + + R     G  +P    +   +QL 
Sbjct: 64  E-NVVKFY----GHRREG-NIQYLFLEYCSGG-ELFDRIEPDIG--MPEPDAQRFFHQLM 114
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYR 180
            GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++     +  TL Y 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+L     ++  VD+WS   +       TA+  G+    Q          P++     
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVL------TAMLAGELPWDQ----------PSDSC--- 214
Query: 241 VSSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   EY  W   ++       +D   L LL ++L  +PS RI+
Sbjct: 215 -------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 254

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 36/297 (12%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           ++G G +  V +   K+TG+  A K  +     +      L E+++L +    P V+ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +V      E  + + L+ EY     + +     +  E +  N V  L+ Q+ +GV + H 
Sbjct: 96  EVY-----ENTSEIILILEYAAGG-EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 131 HGILHRDLKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLLG 187
           + I+H DLKP N+L+        +KI D G++R      +    EI+ T  Y APE+ L 
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEI-LN 206
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
               +TA DMW++  I   L+T T+ F G+   +  L+I ++    +E+ +  VS L   
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL--- 263
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 304
                                  D ++ +L  +P KR +A+  + H +    D   L
Sbjct: 264 ---------------------ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 13  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 65
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 66  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 123
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 124 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTEPCYTPY 182
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 183 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 226
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 227 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 277
Query: 295 YF 296
           + 
Sbjct: 278 WI 279

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ F+    +G+G +G VY ARE+ +  I+ALK   KT+L  +  GV     REV I  
Sbjct: 10  TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQL--EKAGVEHQLRREVEIQS 67
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++        T  + +
Sbjct: 68  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSRFDEQRTA-TYI 118
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  + T    TL 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLG-SNGELKIADFGW--SVHAPSSRRTTLCGTLD 175
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F   +  +    I R+  T      
Sbjct: 176 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT------ 228
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++ S+R++  + +EHP+
Sbjct: 229 -----------------------FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 67
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 68  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 125
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 184
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 185 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 228
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 229 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 279
Query: 295 YF 296
           + 
Sbjct: 280 WI 281

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 108/225 (48%), Gaps = 11/225 (4%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ + +L+K+GEG++GK    +    G+   +K+  +          + REV++L  + +
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-K 81
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P++V+  +     + E    LY+V +Y +  DL K I +  Q G     + +     Q+
Sbjct: 82  HPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQI 134
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           C  +   H   ILHRD+K  N+ +  K  T+++ D G+AR     ++     I T +Y +
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
           PE+   +  Y+   D+W++ C+  EL T    F   S    +L I
Sbjct: 194 PEI-CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 19  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 71
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 72  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 129
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 130 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 188
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 189 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 232
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 233 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 283
Query: 295 YF 296
           + 
Sbjct: 284 WI 285

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 21  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 73
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 74  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 131
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 132 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 190
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 191 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 234
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 235 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 285
Query: 295 YF 296
           + 
Sbjct: 286 WI 287

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 111
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 112 SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 169
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 228
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 229 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 272
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 273 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 323
Query: 295 YF 296
           + 
Sbjct: 324 WI 325

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 20  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDC----PKARREVELHWRA 72
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 73  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 130
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 131 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 189
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 190 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 233
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 234 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 284
Query: 295 YF 296
           + 
Sbjct: 285 WI 286

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 13  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 65
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 66  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 123
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 124 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 182
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 183 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 226
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 227 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 277
Query: 295 YF 296
           + 
Sbjct: 278 WI 279

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 14  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 66
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 67  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 124
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 125 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 183
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 184 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 227
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 228 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 278
Query: 295 YF 296
           + 
Sbjct: 279 WI 280

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 65  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 117
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 118 SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 175
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 176 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 234
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 235 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 278
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 279 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 329
Query: 295 YF 296
           + 
Sbjct: 330 WI 331

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 67
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 68  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 125
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 184
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 185 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---------------IS 228
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 229 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 279
Query: 295 YF 296
           + 
Sbjct: 280 WI 281

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 29  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 81
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 82  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 139
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 140 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 198
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 199 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 242
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 243 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 293
Query: 295 YF 296
           + 
Sbjct: 294 WI 295

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 135/301 (44%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D +E  E++G G +  V + R+K TGK  A   +KK RL     GV    + REV+IL
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R + R P+++ L D+      E +T + L+ E +       +  F    E++  +     
Sbjct: 70  REI-RHPNIITLHDIF-----ENKTDVVLILELVSGG---ELFDFLAEKESLTEDEATQF 120
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  K +    +K+ D G+A        ++ +  
Sbjct: 121 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIF 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F G+++ + L +I  +    +
Sbjct: 180 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 238
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           E+ +   S L                          D + ++L  DP +R+   +++EH 
Sbjct: 239 EEYFSNTSELAK------------------------DFIRRLLVKDPKRRMXIAQSLEHS 274
Query: 295 Y 295
           +
Sbjct: 275 W 275

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 44/292 (15%)
Query: 12  VGEGTYGKVYRAREKAT--GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +GEG+YGKV    +  T   + V + K +             +E+ +LR L R  +V++L
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQL 71
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
           +DV   + K+    +Y+V EY    +++ + S  +  +  PV        QL  G+ + H
Sbjct: 72  VDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLH 126
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARA---FTLPIKKYTHEILTLWYRAPEVLL 186
             GI+H+D+KP NLL+     TLKI+ LG+A A   F       T +  +  ++ PE+  
Sbjct: 127 SQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIAN 184
Query: 187 GSTHYST-AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
           G   +S   VD+WS       + T    F GD       +I++L     E +  G     
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-------NIYKLF----ENIGKG----- 228
Query: 246 NWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 296
                        + A+P      L DLL+ ML+Y+P+KR S ++  +H +F
Sbjct: 229 -------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + +   P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEIQH-PNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 68  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 118
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 177
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 178 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 228
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 229 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 295 Y 295
           +
Sbjct: 273 W 273

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + +   P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEIQH-PNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + +   P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEIQH-PNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 68  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 118
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 177
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 178 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 228
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 229 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 295 Y 295
           +
Sbjct: 273 W 273

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELVAGG---ELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 48/298 (16%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
            ++ F+    +G+G +G VY ARE+ +  I+ALK   KT+L  +  GV     REV I  
Sbjct: 10  TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQL--EKAGVEHQLRREVEIQS 67
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L R P+++RL            T +YL+ EY    L    R  ++        T  + +
Sbjct: 68  HL-RHPNILRLYGYFHDA-----TRVYLILEY--APLGTVYRELQKLSRFDEQRTA-TYI 118
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L   +++CH   ++HRD+KP NLL+      LKIAD G   +   P  +      TL 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLG-SNGELKIADFGW--SVHAPSSRRDTLCGTLD 175
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE++ G  H    VD+WS+  +  E +     F   +  +    I R+  T      
Sbjct: 176 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT------ 228
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-DLLEQMLQYDPSKRISAKKAMEHPY 295
                                   P+   +G  DL+ ++L+++ S+R++  + +EHP+
Sbjct: 229 -----------------------FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILILELVAGG---ELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPAFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 138/312 (44%), Gaps = 51/312 (16%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           +D FE +  +G+G++GKV  AR K TG + A   LKK  + +DD+     T+ E  IL +
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD--VECTMTEKRILSL 79
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
               P + +L    Q  ++     L+ V E+++  DL  +I+  R+  E       +   
Sbjct: 80  ARNHPFLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYA 130
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            ++   + F H  GI++RDLK  N+L+D +    K+AD G+ +              T  
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGICNGVTTATFCGTPD 189
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APE+ L    Y  AVD W++  +  E++   A F  ++E      I       N++V 
Sbjct: 190 YIAPEI-LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------NDEVV 242
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAME 292
                      YP W           L +D   +L+  +  +P+ R+ +         + 
Sbjct: 243 -----------YPTW-----------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280
Query: 293 HPYFDDLDKTRL 304
           HP+F ++D  +L
Sbjct: 281 HPFFKEIDWAQL 292

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 56/308 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTLR-EVSILRMLSRDPH 65
           +G G  G+V  A E+ T K VA+K     K  +    E  P   +  E+ IL+ L+  P 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PC 76
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++++ +    ++       Y+V E M+      K + + R     +   T K   YQ+  
Sbjct: 77  IIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLL 125
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
            V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   T  + TL    
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMRTLCGTP 180
Query: 179 -YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  + +   + +   
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
              P V     W E               + +  LDL++++L  DP  R + ++A+ HP+
Sbjct: 238 NFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 296 FDDLDKTR 303
             D D  R
Sbjct: 278 LQDEDMKR 285

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 56/308 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTLR-EVSILRMLSRDPH 65
           +G G  G+V  A E+ T K VA+K     K  +    E  P   +  E+ IL+ L+  P 
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PC 75
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++++ +    ++       Y+V E M+      K + + R     +   T K   YQ+  
Sbjct: 76  IIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLL 124
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
            V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   T  + TL    
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMRTLCGTP 179
Query: 179 -YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  + +   + +   
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQITSGKY 236
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
              P V     W E               + +  LDL++++L  DP  R + ++A+ HP+
Sbjct: 237 NFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKARFTTEEALRHPW 276
Query: 296 FDDLDKTR 303
             D D  R
Sbjct: 277 LQDEDMKR 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 56/308 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTLR-EVSILRMLSRDPH 65
           +G G  G+V  A E+ T K VA+K     K  +    E  P   +  E+ IL+ L+  P 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PC 76
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++++ +    ++       Y+V E M+      K + + R     +   T K   YQ+  
Sbjct: 77  IIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLL 125
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
            V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   T  + TL    
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMRTLCGTP 180
Query: 179 -YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  + +   + +   
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
              P V     W E               + +  LDL++++L  DP  R + ++A+ HP+
Sbjct: 238 NFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 296 FDDLDKTR 303
             D D  R
Sbjct: 278 LQDEDMKR 285

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 56/308 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTLR-EVSILRMLSRDPH 65
           +G G  G+V  A E+ T K VA+K     K  +    E  P   +  E+ IL+ L+  P 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PC 76
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++++ +    ++       Y+V E M+      K + + R     +   T K   YQ+  
Sbjct: 77  IIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLL 125
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
            V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   T  + TL    
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMRTLCGTP 180
Query: 179 -YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  + +   + +   
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
              P V     W E               + +  LDL++++L  DP  R + ++A+ HP+
Sbjct: 238 NFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 296 FDDLDKTR 303
             D D  R
Sbjct: 278 LQDEDMKR 285

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 56/308 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTLR-EVSILRMLSRDPH 65
           +G G  G+V  A E+ T K VA+K     K  +    E  P   +  E+ IL+ L+  P 
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PC 82
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++++ +    ++       Y+V E M+      K + + R     +   T K   YQ+  
Sbjct: 83  IIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLL 131
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
            V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   T  + TL    
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMRTLCGTP 186
Query: 179 -YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  + +   + +   
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQITSGKY 243
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
              P V     W E               + +  LDL++++L  DP  R + ++A+ HP+
Sbjct: 244 NFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKARFTTEEALRHPW 283
Query: 296 FDDLDKTR 303
             D D  R
Sbjct: 284 LQDEDMKR 291

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 96
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 97  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 147
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 148 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 260
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 96/366 (26%), Positives = 152/366 (41%), Gaps = 84/366 (22%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR--- 62
           +  + K+G G +  V+   +    + VA+K  +     +    T L E+ +L+ +     
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVK---SAQHYTETALDEIKLLKCVRESDP 89
Query: 63  -DPH---VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            DP+   VV+L+D  +     G  V  +VFE +   L K+I   +   + +PV  VKS++
Sbjct: 90  SDPNKDMVVQLIDDFKISGMNGIHVC-MVFEVLGHHLLKWI--IKSNYQGLPVRCVKSII 146
Query: 119 YQLCKGVAFCHGHG-ILHRDLKPHNLLM-------------------------------- 145
            Q+ +G+ + H    I+H D+KP N+LM                                
Sbjct: 147 RQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVST 206
Query: 146 --------------DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHY 191
                         +   + +KIADLG A       K +T +I T  YR+ EVL+G+  Y
Sbjct: 207 APAADLLVNPLDPRNADKIRVKIADLGNA---CWVHKHFTEDIQTRQYRSIEVLIGAG-Y 262
Query: 192 STAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIFRLLGT-PNEKVWPGVSSL 244
           ST  D+WS AC+  EL T   LF   S      +   + HI  LLG+ P      G  S 
Sbjct: 263 STPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSR 322
Query: 245 MNWH------EYPQWNPQSLATAV------PNLDKDGL-DLLEQMLQYDPSKRISAKKAM 291
             ++         +  P SL   +      P+ D     D L  ML+  P KR SA + +
Sbjct: 323 EFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECL 382
Query: 292 EHPYFD 297
            HP+ +
Sbjct: 383 RHPWLN 388

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 75
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 76  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 126
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 127 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 186 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 239
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 240 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 274

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 74
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 75  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 125
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 126 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 185 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 238
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 239 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 273

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 42/301 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V      E +T + L+ E +       +  F    E++        
Sbjct: 69  KEI-QHPNVITLHEVY-----ENKTDVILIGELV---AGGELFDFLAEKESLTEEEATEF 119
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMT--LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N +L+DR      +KI D GLA        ++ +  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L ++        
Sbjct: 179 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------- 229
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                   S +N+    ++   + A A         D + ++L  DP KR++ + +++HP
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 295 Y 295
           +
Sbjct: 274 W 274

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 95
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 96  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 146
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 147 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 259
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 260 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 294

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 98
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 99  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 149
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 150 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 262
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 98
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 99  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 149
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 150 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 262
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 80
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 81  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 132 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 191 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 244
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 245 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 279

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 73
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 74  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 124
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 125 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 184 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 237
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 238 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 272

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 76
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 77  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 127
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 128 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 187 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 240
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 241 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 275

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 125/299 (41%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 98
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y     L KYIR      E       +    ++   + + H
Sbjct: 99  FTFQDDEK-----LYFGLSYAKNGCLLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 149
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K  +    + T  Y +PE LL 
Sbjct: 150 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLT 207
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
               S + D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 262
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 99
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 100 FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 150
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 151 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 263
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 264 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 298

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 103
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 104 FCFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 154
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 155 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 214 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 267
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 268 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 95
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 96  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 146
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K  +    + T  Y +PE+L  
Sbjct: 147 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 259
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 260 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 96
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 97  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 147
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 148 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 260
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 99
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 100 FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 150
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K  +    + T  Y +PE+L  
Sbjct: 151 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 263
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 264 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 298

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 96
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 97  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 147
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 148 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 260
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 98
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 99  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 149
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 150 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 262
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 98
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 99  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 149
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 150 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 209 KSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR----- 262
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 130/306 (42%), Gaps = 56/306 (18%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           + D ++  + +G G + +V  A +K T K+VA+K     E  EG   +   E+++L  + 
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK-CIAKEALEGKEGSMENEIAVLHKI- 73
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVF------EYMDTDLKKYIRSFRQTGENIPVNTVK 115
           + P++V L D+ +         LYL+       E  D  ++K   + R            
Sbjct: 74  KHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASR-------- 120
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPIKKY 170
            L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P    
Sbjct: 121 -LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPGSVL 175
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           +    T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +  
Sbjct: 176 STACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234
Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
              +   W  +S                            D +  +++ DP KR + ++A
Sbjct: 235 YEFDSPYWDDISDSAK------------------------DFIRHLMEKDPEKRFTCEQA 270
Query: 291 MEHPYF 296
           ++HP+ 
Sbjct: 271 LQHPWI 276

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 98
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 99  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 149
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 150 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR----- 262
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 263 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 297

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 130/306 (42%), Gaps = 56/306 (18%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           + D ++  + +G G + +V  A +K T K+VA+K     E  EG   +   E+++L  + 
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK-CIAKEALEGKEGSMENEIAVLHKI- 73
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVF------EYMDTDLKKYIRSFRQTGENIPVNTVK 115
           + P++V L D+ +         LYL+       E  D  ++K   + R            
Sbjct: 74  KHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASR-------- 120
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPIKKY 170
            L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P    
Sbjct: 121 -LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPGSVL 175
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           +    T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +  
Sbjct: 176 STACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234
Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
              +   W  +S                            D +  +++ DP KR + ++A
Sbjct: 235 YEFDSPYWDDISDSAK------------------------DFIRHLMEKDPEKRFTCEQA 270
Query: 291 MEHPYF 296
           ++HP+ 
Sbjct: 271 LQHPWI 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 140/301 (46%), Gaps = 52/301 (17%)
Query: 6   FEKLEKVGEGTYGKVYR-----AREKATGKIVALKK--TRLHEDDEGVPPTTLREVSILR 58
           ++  E++G+G +  V R     A ++   KI+  KK   R H+  E       RE  I R
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE-------REARICR 76
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSL 117
           +L + P++VRL D     ++EG    YL+F+ +   +L + I +     E    + ++  
Sbjct: 77  LL-KHPNIVRLHD---SISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQ-- 128
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHEIL 175
             Q+ + V  CH  G++HRDLKP NLL+    K   +K+AD GLA       + +     
Sbjct: 129 --QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 186
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T  Y +PEVL     Y   VD+W+   I   L+     F  D +  +L           +
Sbjct: 187 TPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPF-WDEDQHRLY----------Q 234
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           ++  G     +    P+W+     T  P    +  DL+ +ML  +PSKRI+A +A++HP+
Sbjct: 235 QIKAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPSKRITAAEALKHPW 281
Query: 296 F 296
Sbjct: 282 I 282

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 130/306 (42%), Gaps = 56/306 (18%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           + D ++  + +G G + +V  A +K T K+VA+K     E  EG   +   E+++L  + 
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK-CIAKEALEGKEGSMENEIAVLHKI- 73
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVF------EYMDTDLKKYIRSFRQTGENIPVNTVK 115
           + P++V L D+ +         LYL+       E  D  ++K   + R            
Sbjct: 74  KHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASR-------- 120
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPIKKY 170
            L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P    
Sbjct: 121 -LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPGSVL 175
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           +    T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +  
Sbjct: 176 STACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234
Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
              +   W  +S                            D +  +++ DP KR + ++A
Sbjct: 235 YEFDSPYWDDISD------------------------SAKDFIRHLMEKDPEKRFTCEQA 270
Query: 291 MEHPYF 296
           ++HP+ 
Sbjct: 271 LQHPWI 276

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E  E +G G+Y    R   KAT    A+K     + D    PT   E+ IL    + 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PT--EEIEILLRYGQH 75
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNTVKSL 117
           P+++ L DV      +G+ V Y+V E M      D  L++   S R+           ++
Sbjct: 76  PNIITLKDVYD----DGKYV-YVVTELMKGGELLDKILRQKFFSEREA---------SAV 121
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTHEI 174
           ++ + K V + H  G++HRDLKP N+L   ++    +++I D G A+             
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APEV L    Y  A D+WS+  +   ++T    F    +            TP 
Sbjct: 182 YTANFVAPEV-LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----------DTPE 229
Query: 235 E---KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
           E   ++  G  SL   +    WN         ++     DL+ +ML  DP +R++A   +
Sbjct: 230 EILARIGSGKFSLSGGY----WN---------SVSDTAKDLVSKMLHVDPHQRLTAALVL 276
Query: 292 EHPYFDDLDK 301
            HP+    D+
Sbjct: 277 RHPWIVHWDQ 286

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 138/308 (44%), Gaps = 56/308 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTLR-EVSILRMLSRDPH 65
           +G G  G+V  A E+ T K VA++     K  +    E  P   +  E+ IL+ L+  P 
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH-PC 215
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++++ +    ++       Y+V E M+      K + + R     +   T K   YQ+  
Sbjct: 216 IIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLL 264
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
            V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   T  + TL    
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMRTLCGTP 319
Query: 179 -YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  + +   + +   
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQITSGKY 376
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
              P V     W E               + +  LDL++++L  DP  R + ++A+ HP+
Sbjct: 377 NFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKARFTTEEALRHPW 416
Query: 296 FDDLDKTR 303
             D D  R
Sbjct: 417 LQDEDMKR 424

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 138/308 (44%), Gaps = 56/308 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTLR-EVSILRMLSRDPH 65
           +G G  G+V  A E+ T K VA++     K  +    E  P   +  E+ IL+ L+  P 
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH-PC 201
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD--LKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++++ +    ++       Y+V E M+      K + + R     +   T K   YQ+  
Sbjct: 202 IIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQMLL 250
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW--- 178
            V + H +GI+HRDLKP N+L+  +     +KI D G ++     I   T  + TL    
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLMRTLCGTP 305
Query: 179 -YRAPEVL--LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            Y APEVL  +G+  Y+ AVD WS+  I   L    + +P  SE +  + +   + +   
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVI---LFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
              P V     W E               + +  LDL++++L  DP  R + ++A+ HP+
Sbjct: 363 NFIPEV-----WAE---------------VSEKALDLVKKLLVVDPKARFTTEEALRHPW 402
Query: 296 FDDLDKTR 303
             D D  R
Sbjct: 403 LQDEDMKR 410

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE++  +G+G +G+V +AR     +  A+KK R  E+      T L EV +L  L+   +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVXLLASLNHQ-Y 63
Query: 66  VVRLMD--------VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           VVR           VK     + ++ L++  EY +   L   I S      N   +    
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS---ENLNQQRDEYWR 120
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK----- 169
           L  Q+ + +++ H  GI+HR+LKP N+ +D ++  +KI D GLA+    +L I K     
Sbjct: 121 LFRQILEALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 170 -------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV 208
                   T  I T  Y A EVL G+ HY+  +D +S+  IF E +
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 130/299 (43%), Gaps = 62/299 (20%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL-------REVSILRMLSRDP 64
           +G G++G+V         KI   K TR+    + +P   +       +E+ I++ L   P
Sbjct: 34  IGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-P 83
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI---RSFRQTGENIPVNTVKSLMYQ 120
           +++RL      +  E  T +YLV E     +L + +   R FR++           +M  
Sbjct: 84  NIIRLY-----ETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-------DAARIMKD 131
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +   VA+CH   + HRDLKP N L   D     LK+ D GLA  F  P K    ++ T +
Sbjct: 132 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPY 190
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y +P+VL G   Y    D WS   +   L+     F   ++ + +L I     T  EK W
Sbjct: 191 YVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW 248
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
             VS            PQ+ +            L+ ++L   P +RI++ +A+EH +F+
Sbjct: 249 LNVS------------PQAES------------LIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 130/299 (43%), Gaps = 62/299 (20%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL-------REVSILRMLSRDP 64
           +G G++G+V         KI   K TR+    + +P   +       +E+ I++ L   P
Sbjct: 17  IGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-P 66
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI---RSFRQTGENIPVNTVKSLMYQ 120
           +++RL      +  E  T +YLV E     +L + +   R FR++           +M  
Sbjct: 67  NIIRLY-----ETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-------DAARIMKD 114
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +   VA+CH   + HRDLKP N L   D     LK+ D GLA  F  P K    ++ T +
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPY 173
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y +P+VL G   Y    D WS   +   L+     F   ++ + +L I     T  EK W
Sbjct: 174 YVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW 231
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
             VS            PQ+ +            L+ ++L   P +RI++ +A+EH +F+
Sbjct: 232 LNVS------------PQAES------------LIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 52/302 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKK--TRLHEDDEGVPPTTLREVSI 56
           D ++  E +G+G +  V R  +  TG     KI+  KK   R H+  E       RE  I
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE-------REARI 56
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
            R+L +  ++VRL D     ++EG    YLVF+ +   +L + I +     E    + ++
Sbjct: 57  CRLL-KHSNIVRLHD---SISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ 110
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
               Q+ + V  CH  G++HRDLKP NLL+  K     +K+AD GLA       + +   
Sbjct: 111 ----QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGF 166
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  Y +PEVL     Y   VD+W+   I   L+     F  D +  +L          
Sbjct: 167 AGTPGYLSPEVLRKEA-YGKPVDIWACGVILYILLVGYPPF-WDEDQHKLY--------- 215
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            +++  G     +    P+W+     T  P    +  +L+ QML  +P+KRI+A +A++H
Sbjct: 216 -QQIKAGAYDFPS----PEWD-----TVTP----EAKNLINQMLTINPAKRITAHEALKH 261
Query: 294 PY 295
           P+
Sbjct: 262 PW 263

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R +   P+++ L DV      E RT + L+ E +       +  F    E++      S 
Sbjct: 70  RQVLH-PNIITLHDVY-----ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSF 120
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  K +    +K+ D GLA      + ++ +  
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIF 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L +I  +    +
Sbjct: 180 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           E+ +   S L                          D + ++L  +  KR++ ++A+ HP
Sbjct: 239 EEFFSQTSELAK------------------------DFIRKLLVKETRKRLTIQEALRHP 274
Query: 295 YFDDLD 300
           +   +D
Sbjct: 275 WITPVD 280

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSIL 57
             +D FE    +G+G +G VY AREK +  IVALK   K+++  + EGV     RE+ I 
Sbjct: 20  FTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQI--EKEGVEHQLRREIEIQ 77
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
             L   P+++RL +    + +     +YL+ EY    +L K +    Q           +
Sbjct: 78  AHLHH-PNILRLYNYFYDRRR-----IYLILEYAPRGELYKEL----QKSCTFDEQRTAT 127
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
           +M +L   + +CHG  ++HRD+KP NLL+      LKIAD G   +   P  +      T
Sbjct: 128 IMEELADALMYCHGKKVIHRDIKPENLLLG-LKGELKIADFGW--SVHAPSLRRKTMCGT 184
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
           L Y  PE++ G  H +  VD+W +  +  EL+     F   S               NE 
Sbjct: 185 LDYLPPEMIEGRMH-NEKVDLWCIGVLCYELLVGNPPFESASH--------------NET 229
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
               V   + +       P S+ T          DL+ ++L+++PS+R+   +   HP+
Sbjct: 230 YRRIVKVDLKF-------PASVPTG-------AQDLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 131/303 (43%), Gaps = 54/303 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKK--TRLHEDDEGVPPTTLREVSI 56
           D ++  E++G+G +  V R  +K        KI+  KK   R H+  E       RE  I
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE-------REARI 83
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQ--TGENIPVNTV 114
            R+L + P++VRL D     ++EG       F Y+  DL      F      E       
Sbjct: 84  CRLL-KHPNIVRLHD---SISEEG-------FHYLVFDLVTGGELFEDIVAREYYSEADA 132
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTH 172
              ++Q+ + V   H H I+HRDLKP NLL+  K     +K+AD GLA       + +  
Sbjct: 133 SHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
              T  Y +PEVL     Y   VD+W+   I   L+     F  + +             
Sbjct: 193 FAGTPGYLSPEVLRKDP-YGKPVDIWACGVILYILLVGYPPFWDEDQ------------- 238
Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
              K++  + +       P+W+     T  P    +  +L+ QML  +P+KRI+A +A++
Sbjct: 239 --HKLYQQIKAGAYDFPSPEWD-----TVTP----EAKNLINQMLTINPAKRITADQALK 287
Query: 293 HPY 295
           HP+
Sbjct: 288 HPW 290

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 126/299 (42%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++     ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 96
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 97  FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 147
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 148 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L     EK +P        
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR----- 260
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
                                  DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 261 -----------------------DLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 295

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR---EVSILRMLSR 62
           +E  E++G G +G V R   + TG+ VA+K+ R     E  P    R   E+ I++ L+ 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNH 72
Query: 63  DPHVVRLMDVKQGQNKEGRTVL-YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            P+VV   +V  G  K     L  L  EY +  DL+KY+  F      +    +++L+  
Sbjct: 73  -PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSD 130
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL--KIADLGLARAFTLPIKKYTHEILTLW 178
           +   + + H + I+HRDLKP N+++      L  KI DLG A+      +  T  + TL 
Sbjct: 131 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQ 189
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           Y APE LL    Y+  VD WS   +  E +T
Sbjct: 190 YLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR---EVSILRMLSR 62
           +E  E++G G +G V R   + TG+ VA+K+ R     E  P    R   E+ I++ L+ 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERWCLEIQIMKKLNH 71
Query: 63  DPHVVRLMDVKQGQNKEGRTVL-YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            P+VV   +V  G  K     L  L  EY +  DL+KY+  F      +    +++L+  
Sbjct: 72  -PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSD 129
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL--KIADLGLARAFTLPIKKYTHEILTLW 178
           +   + + H + I+HRDLKP N+++      L  KI DLG A+      +  T  + TL 
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQ 188
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           Y APE LL    Y+  VD WS   +  E +T
Sbjct: 189 YLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 62/309 (20%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
           + D ++  + +G G + +V  A +K T K+VA+K   K  L    EG   +   E+++L 
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----EGKEGSMENEIAVLH 71
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVF------EYMDTDLKKYIRSFRQTGENIPVN 112
            + + P++V L D+ +         LYL+       E  D  ++K   + R         
Sbjct: 72  KI-KHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASR----- 120
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM-----DRKTMTLKIADLGLARAFTLPI 167
               L++Q+   V + H  GI+HRDLKP NLL      D K M   I+D GL++    P 
Sbjct: 121 ----LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM---ISDFGLSK-MEDPG 172
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
              +    T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I 
Sbjct: 173 SVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 231
Query: 228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
           +     +   W  +S                            D +  +++ DP KR + 
Sbjct: 232 KAEYEFDSPYWDDISDSAK------------------------DFIRHLMEKDPEKRFTC 267
Query: 288 KKAMEHPYF 296
           ++A++HP+ 
Sbjct: 268 EQALQHPWI 276

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 129/299 (43%), Gaps = 52/299 (17%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +GEG++  V  ARE AT +  A+K   + H   E   P   RE  ++  L   P  V+L 
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLY 101
Query: 71  DVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
              Q   K     LY    Y  + +L KYIR      E       +    ++   + + H
Sbjct: 102 FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 152
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLG 187
           G GI+HRDLKP N+L++ + M ++I D G A+  +   K+        T  Y +PE+L  
Sbjct: 153 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 188 STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNW 247
            +   ++ D+W++ CI  +LV     F   +E      I +L                  
Sbjct: 212 KSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----------------E 253
Query: 248 HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-------HPYFDDL 299
           +++P       A   P       DL+E++L  D +KR+  ++ ME       HP+F+ +
Sbjct: 254 YDFP-------AAFFPK----ARDLVEKLLVLDATKRLGCEE-MEGYGPLKAHPFFESV 300

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 129/308 (41%), Gaps = 53/308 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +   E +G G+Y +  R   KAT    A+K     + D         E+ IL    + 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQH 80
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNTVKSL 117
           P+++ L DV      +G+ V YLV E M      D  L++   S R+            +
Sbjct: 81  PNIITLKDVYD----DGKHV-YLVTELMRGGELLDKILRQKFFSERE---------ASFV 126
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           ++ + K V + H  G++HRDLKP N+L   ++     L+I D G A+             
Sbjct: 127 LHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACI-FAELVTKTALFPGDSELQQLLHIFRLLGTP 233
            T  + APEVL     Y    D+WS+  + +  L   T    G S+  +   I   +G+ 
Sbjct: 187 YTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSG 243
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
              +  G     NW+                + +   DL+ +ML  DP +R++AK+ ++H
Sbjct: 244 KFTLSGG-----NWN---------------TVSETAKDLVSKMLHVDPHQRLTAKQVLQH 283
Query: 294 PYFDDLDK 301
           P+    DK
Sbjct: 284 PWVTQKDK 291

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 130/311 (41%), Gaps = 59/311 (18%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +   E +G G+Y +  R   KAT    A+K     + D         E+ IL    + 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQH 80
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNTVKSL 117
           P+++ L DV      +G+ V YLV E M      D  L++   S R+            +
Sbjct: 81  PNIITLKDVYD----DGKHV-YLVTELMRGGELLDKILRQKFFSERE---------ASFV 126
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           ++ + K V + H  G++HRDLKP N+L   ++     L+I D G A+             
Sbjct: 127 LHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACI-FAELVTKTALFPGDSELQQLLHIFRLLGTP 233
            T  + APEVL     Y    D+WS+  + +  L   T    G S+            TP
Sbjct: 187 YTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD------------TP 233
Query: 234 NE---KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
            E   ++  G  +L   +    WN          + +   DL+ +ML  DP +R++AK+ 
Sbjct: 234 EEILTRIGSGKFTLSGGN----WN---------TVSETAKDLVSKMLHVDPHQRLTAKQV 280
Query: 291 MEHPYFDDLDK 301
           ++HP+    DK
Sbjct: 281 LQHPWVTQKDK 291

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 41/287 (14%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  AREK +G+ VA+K   L +           EV I+R       V    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
               G+       L+++ E++    L   +   R   E I      ++   + + +A+ H
Sbjct: 110 SYLVGEE------LWVLMEFLQGGALTDIVSQVRLNEEQI-----ATVCEAVLQALAYLH 158
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
             G++HRD+K  ++L+      +K++D G     +  + K    + T ++ APEV+   +
Sbjct: 159 AQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRS 216
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHE 249
            Y+T VD+WS+  +  E+V     +  DS +Q +    RL  +P  K       L N H+
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPPPK-------LKNSHK 266
Query: 250 YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                        P L     D LE+ML  DP +R +A++ ++HP+ 
Sbjct: 267 VS-----------PVLR----DFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 137/295 (46%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R  +++P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRE-NKNPN 78
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+     +    G+      + ++  + 
Sbjct: 79  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV--VTETCMDEGQ------IAAVCREC 125
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP  +     
Sbjct: 185 PEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ----- 237
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L+ D  KR SAK+ ++H + 
Sbjct: 238 ------------NPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 137/295 (46%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R  +++P+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRE-NKNPN 79
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+     +    G+      + ++  + 
Sbjct: 80  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV--VTETCMDEGQ------IAAVCREC 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 127 LQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 185
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP  +     
Sbjct: 186 PEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ----- 238
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L+ D  KR SAK+ ++H + 
Sbjct: 239 ------------NPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R  +++P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRE-NKNPN 78
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+     +    G+      + ++  + 
Sbjct: 79  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV--VTETCMDEGQ------IAAVCREC 125
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSEMVGTPYWMA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP  +     
Sbjct: 185 PEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ----- 237
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L  D  KR SAK+ ++H + 
Sbjct: 238 ------------NPEKLSAIF-------RDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 130/303 (42%), Gaps = 58/303 (19%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSR 62
           FE  E +G G + +V  A EKATGK+ A+K   K  L    +G   +   E+++LR +  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL----KGKESSIENEIAVLRKIKH 79
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVF------EYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           + ++V L D+ +  N      LYLV       E  D  ++K   + +            +
Sbjct: 80  E-NIVALEDIYESPNH-----LYLVMQLVSGGELFDRIVEKGFYTEKDAS---------T 124
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLL---MDRKTMTLKIADLGLARAFTLPIKKYTHE 173
           L+ Q+   V + H  GI+HRDLKP NLL    D ++  + I+D GL++         +  
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIM-ISDFGLSK-MEGKGDVMSTA 182
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  Y APEV L    YS AVD WS+  I   L+     F  +++ +    I +     
Sbjct: 183 CGTPGYVAPEV-LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEF 241
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           +   W  +S                            D +  +++ DP+KR + ++A  H
Sbjct: 242 DSPYWDDISD------------------------SAKDFIRNLMEKDPNKRYTCEQAARH 277
Query: 294 PYF 296
           P+ 
Sbjct: 278 PWI 280

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 55/304 (18%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++  E++G+G +  V R   K TG     KI+  KK    +  +       RE  I R
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----LEREARICR 83
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI--RSFRQTGENIPVNTVK 115
            L + P++VRL D  Q +     +  YLVF+ +   +L + I  R F    +        
Sbjct: 84  KL-QHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEAD------AS 131
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
             + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H 
Sbjct: 132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHG 189
Query: 174 IL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
              T  Y +PEVL     YS  VD+W+   I   L+     F  + +             
Sbjct: 190 FAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ------------- 235
Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
              +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++
Sbjct: 236 --HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALK 284
Query: 293 HPYF 296
            P+ 
Sbjct: 285 VPWI 288

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 54/305 (17%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR-EVSILRML 60
           +   F  +E +G G + +V+  +++ TGK+ ALK  +          ++L  E+++L+ +
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK---KSPAFRDSSLENEIAVLKKI 63
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVF------EYMDTDLKKYIRSFRQTGENIPVNTV 114
             + ++V L D+      E  T  YLV       E  D  L++ + + +           
Sbjct: 64  KHE-NIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------- 109
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNL--LMDRKTMTLKIADLGLARAFTLPIKKYTH 172
             ++ Q+   V + H +GI+HRDLKP NL  L   +   + I D GL++     I   + 
Sbjct: 110 -LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MST 166
Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
              T  Y APEV L    YS AVD WS+  I   L+     F  ++E +           
Sbjct: 167 ACGTPGYVAPEV-LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF--------- 216
Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
             EK+  G        E P W+         ++ +   D +  +L+ DP++R + +KA+ 
Sbjct: 217 --EKIKEGYYEF----ESPFWD---------DISESAKDFICHLLEKDPNERYTCEKALS 261
Query: 293 HPYFD 297
           HP+ D
Sbjct: 262 HPWID 266

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R +    +V+ L DV      E RT + L+ E +       +  F    E++      S 
Sbjct: 70  RQVLHH-NVITLHDVY-----ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSF 120
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  K +    +K+ D GLA      + ++ +  
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIF 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L +I  +    +
Sbjct: 180 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           E+ +   S L                          D + ++L  +  KR++ ++A+ HP
Sbjct: 239 EEFFSHTSELAK------------------------DFIRKLLVKETRKRLTIQEALRHP 274
Query: 295 YFDDLDKTR 303
           +   +D  +
Sbjct: 275 WITPVDNQQ 283

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R +    +V+ L DV      E RT + L+ E +       +  F    E++      S 
Sbjct: 70  RQVLHH-NVITLHDVY-----ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSF 120
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  K +    +K+ D GLA      + ++ +  
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIF 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L +I  +    +
Sbjct: 180 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           E+ +   S L                          D + ++L  +  KR++ ++A+ HP
Sbjct: 239 EEFFSQTSELAK------------------------DFIRKLLVKETRKRLTIQEALRHP 274
Query: 295 YFDDLDKTR 303
           +   +D  +
Sbjct: 275 WITPVDNQQ 283

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R +    +V+ L DV      E RT + L+ E +       +  F    E++      S 
Sbjct: 70  RQVLHH-NVITLHDVY-----ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSF 120
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  K +    +K+ D GLA      + ++ +  
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIF 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L +I  +    +
Sbjct: 180 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           E+ +   S L                          D + ++L  +  KR++ ++A+ HP
Sbjct: 239 EEFFSHTSELAK------------------------DFIRKLLVKETRKRLTIQEALRHP 274
Query: 295 YFDDLDKTR 303
           +   +D  +
Sbjct: 275 WITPVDNQQ 283

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 55/304 (18%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++  E++G+G +  V R   K TG     KI+  KK    +  +       RE  I R
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----LEREARICR 59
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI--RSFRQTGENIPVNTVK 115
            L + P++VRL D  Q +     +  YLVF+ +   +L + I  R F    +        
Sbjct: 60  KL-QHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEAD------AS 107
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
             + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H 
Sbjct: 108 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHG 165
Query: 174 IL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
              T  Y +PEVL     YS  VD+W+   I   L+     F  + +             
Sbjct: 166 FAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ------------- 211
Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
              +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++
Sbjct: 212 --HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALK 260
Query: 293 HPYF 296
            P+ 
Sbjct: 261 VPWI 264

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R  +++P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRE-NKNPN 78
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+     +    G+      + ++  + 
Sbjct: 79  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV--VTETCMDEGQ------IAAVCREC 125
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP  +     
Sbjct: 185 PEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ----- 237
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L  D  KR SAK+ ++H + 
Sbjct: 238 ------------NPEKLSAIF-------RDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R +    +V+ L DV      E RT + L+ E +       +  F    E++      S 
Sbjct: 70  RQVLHH-NVITLHDVY-----ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSF 120
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  K +    +K+ D GLA      + ++ +  
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIF 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L +I  +    +
Sbjct: 180 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           E+ +   S L                          D + ++L  +  KR++ ++A+ HP
Sbjct: 239 EEFFSQTSELAK------------------------DFIRKLLVKETRKRLTIQEALRHP 274
Query: 295 YFDDLDKTR 303
           +   +D  +
Sbjct: 275 WITPVDNQQ 283

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 55/304 (18%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++  E++G+G +  V R   K TG     KI+  KK    +  +       RE  I R
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----LEREARICR 60
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI--RSFRQTGENIPVNTVK 115
            L + P++VRL D  Q +     +  YLVF+ +   +L + I  R F    +        
Sbjct: 61  KL-QHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEAD------AS 108
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
             + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H 
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHG 166
Query: 174 IL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
              T  Y +PEVL     YS  VD+W+   I   L+     F  + +             
Sbjct: 167 FAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ------------- 212
Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
              +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++
Sbjct: 213 --HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALK 261
Query: 293 HPYF 296
            P+ 
Sbjct: 262 VPWI 265

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A   +KK +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R +    +V+ L DV      E RT + L+ E +       +  F    E++      S 
Sbjct: 70  RQVLHH-NVITLHDVY-----ENRTDVVLILELVSGG---ELFDFLAQKESLSEEEATSF 120
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT---LKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  K +    +K+ D GLA      + ++ +  
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIF 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE+ +         DMWS+  I   L++  + F GD++ + L +I  +    +
Sbjct: 180 GTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           E+ +   S L                          D + ++L  +  KR++ ++A+ HP
Sbjct: 239 EEFFSHTSELAK------------------------DFIRKLLVKETRKRLTIQEALRHP 274
Query: 295 YFDDLDKTR 303
           +   +D  +
Sbjct: 275 WITPVDNQQ 283

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 47/305 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E  E +G G+Y    R   KAT    A+K     + D    PT   E+ IL    + 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRD----PT--EEIEILLRYGQH 75
Query: 64  PHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P+++ L DV   G+     T L    E +D  L++   S R+           ++++ + 
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREA---------SAVLFTIT 126
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           K V + H  G++HRDLKP N+L   ++    +++I D G A+              T  +
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANF 186
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE---K 236
            APEV L    Y  A D+WS+  +    +T    F    +            TP E   +
Sbjct: 187 VAPEV-LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-----------DTPEEILAR 234
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +  G  SL   +    WN         ++     DL+ + L  DP +R++A   + HP+ 
Sbjct: 235 IGSGKFSLSGGY----WN---------SVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281
Query: 297 DDLDK 301
              D+
Sbjct: 282 VHWDQ 286

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 55/304 (18%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D ++  E++G+G +  V R   K TG     KI+  KK    +  +       RE  I R
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----LEREARICR 60
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI--RSFRQTGENIPVNTVK 115
            L + P++VRL D  Q +     +  YLVF+ +   +L + I  R F    +        
Sbjct: 61  KL-QHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEAD------AS 108
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
             + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GL  A  +   +  H 
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHG 166
Query: 174 IL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
              T  Y +PEVL     YS  VD+W+   I   L+     F  + +             
Sbjct: 167 FAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ------------- 212
Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
              +++  + +    +  P+W+     T  P    +   L++ ML  +P KRI+A +A++
Sbjct: 213 --HRLYAQIKAGAYDYPSPEWD-----TVTP----EAKSLIDSMLTVNPKKRITADQALK 261
Query: 293 HPYF 296
            P+ 
Sbjct: 262 VPWI 265

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 140/304 (46%), Gaps = 52/304 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGK-----IVALKK--TRLHEDDEGVPPTTLREVSI 56
           + ++  E++G+G +  V R  +   G+     I+  KK   R H+  E       RE  I
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-------REARI 63
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
            R+L + P++VRL D     ++EG    YL+F+ +   +L + I +     E    + ++
Sbjct: 64  CRLL-KHPNIVRLHD---SISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHE 173
               Q+ + V  CH  G++HR+LKP NLL+    K   +K+AD GLA       + +   
Sbjct: 118 ----QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  Y +PEVL     Y   VD+W+   I   L+     F  D +  +L          
Sbjct: 174 AGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPF-WDEDQHRLY--------- 222
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            +++  G     +    P+W+     T  P    +  DL+ +ML  +PSKRI+A +A++H
Sbjct: 223 -QQIKAGAYDFPS----PEWD-----TVTP----EAKDLINKMLTINPSKRITAAEALKH 268
Query: 294 PYFD 297
           P+  
Sbjct: 269 PWIS 272

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 135/292 (46%), Gaps = 48/292 (16%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           E +G G +G V+R  E ++ K    K  ++   D+ +     +E+SIL  ++R  +++ L
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILN-IARHRNILHL 66
Query: 70  MDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
                 ++ E    L ++FE++   D+ + I +   +   +    + S ++Q+C+ + F 
Sbjct: 67  -----HESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFL 118
Query: 129 HGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
           H H I H D++P N++   R++ T+KI + G AR    P   +      L + APE    
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF-----RLLFTAPEYYAP 172
Query: 188 STH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
             H     STA DMWS+  +   L++    F  ++  Q + +I     T +E+ +  +S 
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                                   + +D ++++L  +   R++A +A++HP+
Sbjct: 233 ------------------------EAMDFVDRLLVKERKSRMTASEALQHPW 260

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 137/295 (46%), Gaps = 47/295 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R  +++P+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRE-NKNPN 79
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+     +    G+      + ++  + 
Sbjct: 80  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV--VTETCMDEGQ------IAAVCREC 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HR++K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 127 LQALEFLHSNQVIHRNIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 185
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y   VD+WS+  +  E++     +  ++ L+  L++    GTP  +     
Sbjct: 186 PEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQ----- 238
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       NP+ L+           D L + L+ D  KR SAK+ ++H + 
Sbjct: 239 ------------NPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 141/309 (45%), Gaps = 53/309 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRARE---KATGKIVALK--KTRLHEDDEGVPPTTLREVSILR 58
           + FE L  +G+G YGKV++ R+     TGKI A+K  K  +   +      T  E +IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            + + P +V L+   Q   K     LYL+ EY+     +      + G  +  +T    +
Sbjct: 77  EV-KHPFIVDLIYAFQTGGK-----LYLILEYLSGG--ELFMQLEREGIFME-DTACFYL 127
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TL 177
            ++   +   H  GI++RDLKP N++++ +   +K+ D GL +  ++     TH    T+
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKE-SIHDGTVTHXFCGTI 185
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEK 236
            Y APE+L+ S H + AVD WS+  +  +++T    F G++  + +  I +  L  P   
Sbjct: 186 EYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--- 241
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAM 291
                                     P L ++  DLL+++L+ + + R+      A +  
Sbjct: 242 --------------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275
Query: 292 EHPYFDDLD 300
            HP+F  ++
Sbjct: 276 AHPFFRHIN 284

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 141/309 (45%), Gaps = 53/309 (17%)
Query: 4   DAFEKLEKVGEGTYGKVYRARE---KATGKIVALK--KTRLHEDDEGVPPTTLREVSILR 58
           + FE L  +G+G YGKV++ R+     TGKI A+K  K  +   +      T  E +IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            + + P +V L+   Q   K     LYL+ EY+     +      + G  +  +T    +
Sbjct: 77  EV-KHPFIVDLIYAFQTGGK-----LYLILEYLSGG--ELFMQLEREGIFME-DTACFYL 127
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TL 177
            ++   +   H  GI++RDLKP N++++ +   +K+ D GL +  ++     TH    T+
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKE-SIHDGTVTHTFCGTI 185
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEK 236
            Y APE+L+ S H + AVD WS+  +  +++T    F G++  + +  I +  L  P   
Sbjct: 186 EYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--- 241
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAM 291
                                     P L ++  DLL+++L+ + + R+      A +  
Sbjct: 242 --------------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275
Query: 292 EHPYFDDLD 300
            HP+F  ++
Sbjct: 276 AHPFFRHIN 284

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 45/261 (17%)
Query: 52  REVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYI--RSFRQTGENI 109
           REV +LR     P+V+R    ++      R   Y+  E     L++Y+  + F   G   
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKD-----RQFQYIAIELCAATLQEYVEQKDFAHLGLE- 119
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI----ADLGLARAFTL 165
           P+    +L+ Q   G+A  H   I+HRDLKPHN+L+       KI    +D GL +   +
Sbjct: 120 PI----TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 166 PIKKYTHEIL---TLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
               ++       T  + APE+L      + +  VD++S  C+F  ++++ +  P    L
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-HPFGKSL 234
Query: 221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD 280
           Q+  +I             G  SL   H  P+ +   +A           +L+E+M+  D
Sbjct: 235 QRQANILL-----------GACSLDCLH--PEKHEDVIAR----------ELIEKMIAMD 271
Query: 281 PSKRISAKKAMEHPYFDDLDK 301
           P KR SAK  ++HP+F  L+K
Sbjct: 272 PQKRPSAKHVLKHPFFWSLEK 292

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 19  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 75
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 76  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 127
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 128 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 184
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 185 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 70
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 71  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 122
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 123 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 179
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 180 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 102
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 103 NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 154
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 211
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 212 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 243

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 69
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 70  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 121
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 122 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 178
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 179 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 22  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 78
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 79  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 130
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 131 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 187
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 188 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 71
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 72  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 123
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 180
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 181 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 74
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 75  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 183
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 184 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 20  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 76
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 77  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 128
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 129 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 185
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 186 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 71
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 72  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 123
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 180
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 181 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 21  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 77
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 78  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 129
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 130 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTK--VLPQDKEXXKVKEPGESP 186
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 187 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 89
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 90  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 141
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 198
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 199 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 138/307 (44%), Gaps = 56/307 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G+ G V   +    G+ VA+K+  +   D       L E+ +L      P+V+R   
Sbjct: 41  LGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYY- 93
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAF 127
                ++     LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA 
Sbjct: 94  ----CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAH 148
Query: 128 CHGHGILHRDLKPHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL 175
            H   I+HRDLKP N+L+        D++T    + + I+D GL +        +   + 
Sbjct: 149 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 176 ----TLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
               T  +RAPE+L  ST    + ++D++S+ C+F  +++K     GD   ++       
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------- 261
Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
                  +  G+ SL    E    + +SL         +  DL+ QM+ +DP KR +A K
Sbjct: 262 -----SNIIRGIFSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMK 306
Query: 290 AMEHPYF 296
            + HP F
Sbjct: 307 VLRHPLF 313

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 89
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 90  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 141
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 198
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 199 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 138/307 (44%), Gaps = 56/307 (18%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G+ G V   +    G+ VA+K+  +   D       L E+ +L      P+V+R   
Sbjct: 41  LGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYY- 93
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAF 127
                ++     LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA 
Sbjct: 94  ----CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAH 148
Query: 128 CHGHGILHRDLKPHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL 175
            H   I+HRDLKP N+L+        D++T    + + I+D GL +        +   + 
Sbjct: 149 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 176 ----TLWYRAPEVLLGST--HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
               T  +RAPE+L  ST    + ++D++S+ C+F  +++K     GD   ++       
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------- 261
Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
                  +  G+ SL    E    + +SL         +  DL+ QM+ +DP KR +A K
Sbjct: 262 -----SNIIRGIFSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRPTAMK 306
Query: 290 AMEHPYF 296
            + HP F
Sbjct: 307 VLRHPLF 313

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 92/376 (24%), Positives = 154/376 (40%), Gaps = 102/376 (27%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML-SRDP 64
           +  + K+G G +  V+ + +    K VA+K  +     E    T L E+ +L+ + + DP
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDP 95
Query: 65  H------VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
           +      VV+L+D  +     G T + +VFE +   L K+I   +   + +P+  VK ++
Sbjct: 96  NDPNREMVVQLLDDFKISGVNG-THICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKII 152
Query: 119 YQLCKGVAFCHGHG-ILHRDLKPHNLLM-------------------------------- 145
            Q+ +G+ + H    I+H D+KP N+L+                                
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 146 ----------------DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
                           + + + +KIADLG A       K +T +I T  YR+ EVL+GS 
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLIGSG 269
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIFRLLG-TPNEKVWPG-- 240
            Y+T  D+WS AC+  EL T   LF   S      +   +  I  LLG  P + +  G  
Sbjct: 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328
Query: 241 -------------VSSLMNWH------EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDP 281
                        ++ L  W       E  +W+ +  A           D L  ML+  P
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT--------DFLLPMLELIP 380
Query: 282 SKRISAKKAMEHPYFD 297
            KR +A + + HP+ +
Sbjct: 381 EKRATAAECLRHPWLN 396

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 71
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 72  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 123
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEFFKVKEPGESP 180
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 181 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 12/220 (5%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
            +F++L ++G G+YG+V++ R K  G++ A+K++             L EV     + + 
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P  VRL      Q  E   +LYL  E     L+++  ++   G ++P   V   +     
Sbjct: 117 PCCVRLE-----QAWEEGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLL 168
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            +A  H  G++H D+KP N+ +  +    K+ D GL             E     Y APE
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRC-KLGDFGLLVELGTAGAGEVQEG-DPRYMAPE 226
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL 223
           +L GS  Y TA D++S+     E+     L  G    QQL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 92/376 (24%), Positives = 154/376 (40%), Gaps = 102/376 (27%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML-SRDP 64
           +  + K+G G +  V+ + +    K VA+K  +     E    T L E+ +L+ + + DP
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDP 79
Query: 65  H------VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
           +      VV+L+D  +     G T + +VFE +   L K+I   +   + +P+  VK ++
Sbjct: 80  NDPNREMVVQLLDDFKISGVNG-THICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKII 136
Query: 119 YQLCKGVAFCHGHG-ILHRDLKPHNLLM-------------------------------- 145
            Q+ +G+ + H    I+H D+KP N+L+                                
Sbjct: 137 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 196
Query: 146 ----------------DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGST 189
                           + + + +KIADLG A       K +T +I T  YR+ EVL+GS 
Sbjct: 197 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLIGSG 253
Query: 190 HYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIFRLLG-TPNEKVWPG-- 240
            Y+T  D+WS AC+  EL T   LF   S      +   +  I  LLG  P + +  G  
Sbjct: 254 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 312
Query: 241 -------------VSSLMNWH------EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDP 281
                        ++ L  W       E  +W+ +  A           D L  ML+  P
Sbjct: 313 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT--------DFLLPMLELIP 364
Query: 282 SKRISAKKAMEHPYFD 297
            KR +A + + HP+ +
Sbjct: 365 EKRATAAECLRHPWLN 380

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/307 (22%), Positives = 133/307 (43%), Gaps = 44/307 (14%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE +E VG GTYG+VY+ R   TG++ A+K   +  D+E       +E+++L+  S   +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 82
Query: 66  VVRLMDVKQGQNKEG-RTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +         +N  G    L+LV E+      TDL K  +     G  +    +  +  +
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICRE 137
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G++  H H ++HRD+K  N+L+  +   +K+ D G++      + +    I T ++ 
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 181 APEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
           APEV+    +    Y    D+WS+     E+       P   ++  +  +F +   P  +
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA---PPLCDMHPMRALFLIPRNPAPR 253
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +           +  +W+            K     +E  L  + S+R + ++ M+HP+ 
Sbjct: 254 L-----------KSKKWS------------KKFQSFIESCLVKNHSQRPATEQLMKHPFI 290
Query: 297 DDLDKTR 303
            D    R
Sbjct: 291 RDQPNER 297

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++ + ++ ++K+G G    VY A +      VA+K          +PP    E   L+  
Sbjct: 8   IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-------IPPREKEET--LKRF 58
Query: 61  SRDPH---------VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIP 110
            R+ H         +V ++DV +  +       YLV EY++   L +YI S       + 
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDD-----CYYLVMEYIEGPTLSEYIESHGP----LS 109
Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKK 169
           V+T  +   Q+  G+   H   I+HRD+KP N+L+D    TLKI D G+A+A +   + +
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQ 168
Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             H + T+ Y +PE   G        D++S+  +  E++     F G++
Sbjct: 169 TNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 60/311 (19%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G+ G V   +    G+ VA+K+  +   D       L E+ +L      P+V+R   
Sbjct: 23  LGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYY- 75
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAF 127
                ++     LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA 
Sbjct: 76  ----CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAH 130
Query: 128 CHGHGILHRDLKPHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL 175
            H   I+HRDLKP N+L+        D++T    + + I+D GL +        +   + 
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 176 ----TLWYRAPEVLLGSTHYST------AVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
               T  +RAPE+L  S +  T      ++D++S+ C+F  +++K     GD   ++   
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247
Query: 226 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI 285
                      +  G+ SL    E    + +SL         +  DL+ QM+ +DP KR 
Sbjct: 248 ---------SNIIRGIFSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRP 288
Query: 286 SAKKAMEHPYF 296
           +A K + HP F
Sbjct: 289 TAMKVLRHPLF 299

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E ++ +G G +G     R+K + ++VA+K     E  E +     RE+   R L R 
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIAANVKREIINHRSL-RH 74
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++VR  +V         T L +V EY    +L + I +  +  E+      +    QL 
Sbjct: 75  PNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSED----EARFFFQQLI 125
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            GV++CH   + HRDLK  N L+D      LKI D G +++  L  +  +  + T  Y A
Sbjct: 126 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKVWPG 240
           PEVLL   +     D+WS       ++     F    E +     I R+L          
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------- 234
Query: 241 VSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                           ++  A+P+   +  +   L+ ++   DP+KRIS  +   H +F
Sbjct: 235 ----------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 17/225 (7%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL----REVSILRM 59
           D +E  E +G G   +V+ AR+    + VA+K  R    D    P+      RE      
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAA 68
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L+  P +V + D  + +   G  + Y+V EY+D    + I      G   P   ++ ++ 
Sbjct: 69  LNH-PAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIA 123
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---LPIKKYTHEILT 176
             C+ + F H +GI+HRD+KP N+L+   T  +K+ D G+ARA       + +    I T
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILIS-ATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             Y +PE   G +      D++S+ C+  E++T    F GDS + 
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 34/298 (11%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK  +         P   REV +    
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQ-------DCPKARREVELHWRA 111
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +   
Sbjct: 112 SQCPHIVRIVDVYENLYA-GRKCLLIVXECLDGG-ELFSRIQDRGDQAFTEREASEIXKS 169
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T      T    T +
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPY 228
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV LG   Y  + D WS+  I   L+     F  +  L                + 
Sbjct: 229 YVAPEV-LGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL---------------AIS 272
Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           PG  + +   +Y   NP+        + ++   L+  +L+ +P++R +  +   HP+ 
Sbjct: 273 PGXKTRIRXGQYEFPNPE-----WSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 60/311 (19%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G+ G V   +    G+ VA+K+  +   D       L E+ +L      P+V+R   
Sbjct: 23  LGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYY- 75
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPV----NTVKSLMYQLCKGVAF 127
                ++     LY+  E  + +L+  + S   + EN+ +    N + SL+ Q+  GVA 
Sbjct: 76  ----CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAH 130
Query: 128 CHGHGILHRDLKPHNLLM--------DRKT----MTLKIADLGLARAFTLPIKKYTHEIL 175
            H   I+HRDLKP N+L+        D++T    + + I+D GL +        +   + 
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 176 ----TLWYRAPEVLLGSTHYST------AVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
               T  +RAPE+L  S +  T      ++D++S+ C+F  +++K     GD   ++   
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247
Query: 226 IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI 285
                      +  G+ SL    E    + +SL         +  DL+ QM+ +DP KR 
Sbjct: 248 ---------SNIIRGIFSL---DEMKCLHDRSLIA-------EATDLISQMIDHDPLKRP 288
Query: 286 SAKKAMEHPYF 296
           +A K + HP F
Sbjct: 289 TAMKVLRHPLF 299

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 74
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y+++  +      ++ +K L Y  Q+
Sbjct: 75  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHAER-----IDHIKLLQYTSQI 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTK--VLPQDKEXXKVKEPGESP 183
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 184 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 35/277 (12%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +GEG++    +   K + +  A+K        + +   T +E++ L++    P++V+L +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 72  VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           V   Q        +LV E ++  +L + I+  +   E         +M +L   V+  H 
Sbjct: 74  VFHDQ-----LHTFLVMELLNGGELFERIKKKKHFSET----EASYIMRKLVSAVSHMHD 124
Query: 131 HGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
            G++HRDLKP NLL   +   + +KI D G AR      +       TL Y APE LL  
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQ 183
Query: 189 THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH 248
             Y  + D+WS+  I   +++    F          H   L  T   ++   +       
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQS--------HDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 249 EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI 285
           E   W          N+ ++  DL++ +L  DP+KR+
Sbjct: 236 EGEAWK---------NVSQEAKDLIQGLLTVDPNKRL 263

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KLEK+G+G++G+V++  +  T K+VA+K   L E ++ +     +E+++L      P+
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCD-SPY 81
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN--TVKSLMYQLCK 123
           V +         K     L+++ EY+         S     E  P++   + +++ ++ K
Sbjct: 82  VTKYYGSYLKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILK 130
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    + T ++ APE
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 189
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           V+  S  Y +  D+WS+     EL       P  SEL  +  +F +              
Sbjct: 190 VIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI-------------- 231
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H + 
Sbjct: 232 -------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 140/310 (45%), Gaps = 45/310 (14%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKA---TGKIVALKKTRLHEDDEGVPPT--TLREVSIL 57
           ++ FE L+ +G G YGKV+  R+ +   TGK+ A+K  +     +    T  T  E  +L
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
             + + P +V L    Q + K     L+L+ +Y++      + +     E    + V+  
Sbjct: 113 EHIRQSPFLVTLHYAFQTETK-----LHLILDYINGG---ELFTHLSQRERFTEHEVQIY 164
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-T 176
           + ++   +   H  GI++RD+K  N+L+D     + + D GL++ F     +  ++   T
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGT 223
Query: 177 LWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           + Y AP+++ G  + +  AVD WS+  +  EL+T  + F  D E      I R +     
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----- 278
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKA 290
                   L +   YPQ    +LA           DL++++L  DP KR+      A + 
Sbjct: 279 --------LKSEPPYPQ-EMSALAK----------DLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 291 MEHPYFDDLD 300
            EH +F  ++
Sbjct: 320 KEHLFFQKIN 329

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KLEK+G+G++G+V++  +  T K+VA+K   L E ++ +     +E+++L      P+
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCD-SPY 66
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN--TVKSLMYQLCK 123
           V +         K     L+++ EY+         S     E  P++   + +++ ++ K
Sbjct: 67  VTKYYGSYLKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILK 115
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    + T ++ APE
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 174
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           V+  S  Y +  D+WS+     EL       P  SEL  +  +F +              
Sbjct: 175 VIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI-------------- 216
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H + 
Sbjct: 217 -------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L+++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 16  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 72
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ EY+    L+ Y++  ++      ++ +K L Y  Q+
Sbjct: 73  NIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQI 124
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HR+L   N+L++ +   +KI D GL +   LP  K  +++       
Sbjct: 125 CKGMEYLGTKRYIHRNLATRNILVENEN-RVKIGDFGLTKV--LPQDKEYYKVKEPGESP 181
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 182 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 39/286 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A EK TGK VA+KK  L +           EV I+R    D  V    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR--ELLFNEVVIMRDYHHDNVVDMYS 109
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
               G        L++V E+++      I +  +  E      + ++   + + +++ H 
Sbjct: 110 SYLVGDE------LWVVMEFLEGGALTDIVTHTRMNE----EQIATVCLSVLRALSYLHN 159
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRD+K  ++L+      +K++D G     +  + K    + T ++ APEV +    
Sbjct: 160 QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV-ISRLP 217
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           Y T VD+WS+  +  E++     +  +  LQ +  I   L  P  K    VSS++     
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSL-PPRVKDLHKVSSVLR---- 272
Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                 L+ ML  +PS+R +A++ + HP+ 
Sbjct: 273 --------------------GFLDLMLVREPSQRATAQELLGHPFL 298

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KLEK+G+G++G+V++  +  T K+VA+K   L E ++ +     +E+++L      P+
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCD-SPY 86
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN--TVKSLMYQLCK 123
           V +         K     L+++ EY+         S     E  P++   + +++ ++ K
Sbjct: 87  VTKYYGSYLKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILK 135
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    + T ++ APE
Sbjct: 136 GLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 194
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           V+  S  Y +  D+WS+     EL       P  SEL  +  +F +              
Sbjct: 195 VIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI-------------- 236
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H + 
Sbjct: 237 -------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 52/314 (16%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE ++ +G G +G V+ A+ K      A+K+ RL  + E      +REV  L  L   P 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALAKLEH-PG 64
Query: 66  VVRLMDV-------KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
           +VR  +        ++ Q    +  LY+  +    +  K   + R T E    +    + 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---------LPIKK 169
            Q+ + V F H  G++HRDLKP N+      + +K+ D GL  A            P+  
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 170 Y---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
           Y   T ++ T  Y +PE + G++ YS  VD++S+  I  EL     L+P  ++++++   
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERV--- 234
Query: 227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
            R L       +P + +     EY                     +++ ML   P +R  
Sbjct: 235 -RTLTDVRNLKFPPLFTQKYPCEYV--------------------MVQDMLSPSPMERPE 273
Query: 287 AKKAMEHPYFDDLD 300
           A   +E+  F+DLD
Sbjct: 274 AINIIENAVFEDLD 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KLEK+G+G++G+V++  +  T K+VA+K   L E ++ +     +E+++L      P+
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCD-SPY 66
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN--TVKSLMYQLCK 123
           V +         K     L+++ EY+         S     E  P++   + +++ ++ K
Sbjct: 67  VTKYYGSYLKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILK 115
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    + T ++ APE
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 174
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           V+  S  Y +  D+WS+     EL       P  SEL  +  +F +              
Sbjct: 175 VIKQSA-YDSKADIWSLGITAIELARGE---PPHSELHPMKVLFLI-------------- 216
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H + 
Sbjct: 217 -------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL----REVSILRM 59
           D +E  E +G G   +V+ AR+    + VA+K  R    D    P+      RE      
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAA 68
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L+  P +V + D  + +   G  + Y+V EY+D    + I      G   P   ++ ++ 
Sbjct: 69  LNH-PAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIA 123
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILT 176
             C+ + F H +GI+HRD+KP N+++   T  +K+ D G+ARA        T     I T
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
             Y +PE   G +      D++S+ C+  E++T    F GDS
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL----REVSILRM 59
           D +E  E +G G   +V+ AR+    + VA+K  R    D    P+      RE      
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAA 68
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L+  P +V + D  + +   G  + Y+V EY+D    + I      G   P   ++ ++ 
Sbjct: 69  LNH-PAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIA 123
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILT 176
             C+ + F H +GI+HRD+KP N+++   T  +K+ D G+ARA        T     I T
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             Y +PE   G +      D++S+ C+  E++T    F GDS + 
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E ++ +G G +G     R+K + ++VA+K     E  E +     RE+   R L R 
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIDENVKREIINHRSL-RH 73
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++VR  +V         T L +V EY    +L + I +  +  E+      +    QL 
Sbjct: 74  PNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSED----EARFFFQQLI 124
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            GV++CH   + HRDLK  N L+D      LKI D G +++  L  +  +  + T  Y A
Sbjct: 125 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIA 183
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKVWPG 240
           PEVLL   +     D+WS       ++     F    E +     I R+L          
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------- 233
Query: 241 VSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                           ++  A+P+   +  +   L+ ++   DP+KRIS  +   H +F
Sbjct: 234 ----------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 9   LEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           L ++G+G +G V   R    +  TG++VA+KK + H  +E +     RE+ IL+ L  D 
Sbjct: 18  LRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHD- 74
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY--QL 121
           ++V+   V       GR  L L+ E++    L++Y++  ++      ++ +K L Y  Q+
Sbjct: 75  NIVKYKGVCYSA---GRRNLKLIMEFLPYGSLREYLQKHKER-----IDHIKLLQYTSQI 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------ 175
           CKG+ +      +HRDL   N+L++ +   +KI D GL +   LP  K   ++       
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKV--LPQDKEXXKVKEPGESP 183
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             WY APE L  S  +S A D+WS   +  EL T
Sbjct: 184 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EYM   D+  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYMPGGDMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +K+AD G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/358 (24%), Positives = 149/358 (41%), Gaps = 79/358 (22%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHEDDEGVPPTT--LREVSILR 58
           + F+  +K+GEGT+  VY A  +      + +ALK          + PT+  +R  + L+
Sbjct: 21  NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKH---------LIPTSHPIRIAAELQ 71
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
            L+       +M VK    K    V+ +   Y++ +      SF     ++    V+  M
Sbjct: 72  CLTVAGGQDNVMGVKYCFRKNDHVVIAM--PYLEHE------SFLDILNSLSFQEVREYM 123
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA---FTLPIKKYTHE-- 173
             L K +   H  GI+HRD+KP N L +R+     + D GLA+      + + K+     
Sbjct: 124 LNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEA 183
Query: 174 -----------------------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT- 209
                                    T  +RAPEVL    + +TA+DMWS   IF  L++ 
Sbjct: 184 QQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243
Query: 210 KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS---SLMNWHEYPQWNPQSLA------- 259
           +   +    +L  L  I  + G+  E +    +   S++   E P  + + L        
Sbjct: 244 RYPFYKASDDLTALAQIMTIRGS-RETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMD 302
Query: 260 TAVPNLDKD-----------------GLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
           ++ P L  D                   DLL+++L  +P+ RI+A++A+ HP+F D+ 
Sbjct: 303 SSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EYM   D+  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYMPGGDMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +K+AD G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL----REVSILRM 59
           D +E  E +G G   +V+ AR+    + VA+K  R    D    P+      RE      
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAA 68
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L+  P +V + D  + +   G  + Y+V EY+D    + I      G   P   ++ ++ 
Sbjct: 69  LNH-PAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIA 123
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILT 176
             C+ + F H +GI+HRD+KP N+++   T  +K+ D G+ARA        T     I T
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             Y +PE   G +      D++S+ C+  E++T    F GDS + 
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 134/306 (43%), Gaps = 44/306 (14%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLS 61
           + +E + ++G+G +GKVY+A+ K TG + A K  +T+  E+ E      + E+ IL    
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY----IVEIEILATCD 66
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P++V+L+       K     L+++ E+        I      G   P   ++ +  Q+
Sbjct: 67  H-PYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEP--QIQVVCRQM 118
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H   I+HRDLK  N+LM  +   +++AD G++      ++K    I T ++ A
Sbjct: 119 LEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 182 PEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           PEV++  T     Y    D+WS+     E+     + P   EL  +  + ++  +     
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNPMRVLLKIAKS----- 229
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
                           +P +L T       +  D L+  L  +P  R SA + +EHP+  
Sbjct: 230 ----------------DPPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 272
Query: 298 DLDKTR 303
            +   +
Sbjct: 273 SITSNK 278

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 134/306 (43%), Gaps = 44/306 (14%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLS 61
           + +E + ++G+G +GKVY+A+ K TG + A K  +T+  E+ E      + E+ IL    
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY----IVEIEILATCD 74
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P++V+L+       K     L+++ E+        I      G   P   ++ +  Q+
Sbjct: 75  H-PYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEP--QIQVVCRQM 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H   I+HRDLK  N+LM  +   +++AD G++      ++K    I T ++ A
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 182 PEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           PEV++  T     Y    D+WS+     E+     + P   EL  +  + ++  +     
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNPMRVLLKIAKS----- 237
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
                           +P +L T       +  D L+  L  +P  R SA + +EHP+  
Sbjct: 238 ----------------DPPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280
Query: 298 DLDKTR 303
            +   +
Sbjct: 281 SITSNK 286

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 19/226 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL----REVSILRM 59
           D +E  E +G G   +V+ AR+    + VA+K  R    D    P+      RE      
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAA 85
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
           L+  P +V + D  + +   G  + Y+V EY+D   L+  + +    G   P   ++ ++
Sbjct: 86  LNH-PAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIE-VI 139
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---IL 175
              C+ + F H +GI+HRD+KP N+++   T  +K+ D G+ARA        T     I 
Sbjct: 140 ADACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
           T  Y +PE   G +      D++S+ C+  E++T    F GDS + 
Sbjct: 199 TAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 243

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 44/309 (14%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-TLREVSILRMLSR 62
           + F +   +G+G +G+V   + +ATGK+ A KK       +       L E  IL  ++ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
              VV L         E +  L LV   M+  DLK +I    Q G   P         ++
Sbjct: 244 R-FVVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEI 295
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           C G+   H   I++RDLKP N+L+D     ++I+DLGLA       +     + T+ Y A
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLA-VHVPEGQTIKGRVGTVGYMA 353
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV + +  Y+ + D W++ C+  E++       G S  QQ     R      E+V   V
Sbjct: 354 PEV-VKNERYTFSPDWWALGCLLYEMIA------GQSPFQQ-----RKKKIKREEVERLV 401
Query: 242 SSLMNWHEYPQ-WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPY 295
             +    EY + ++PQ+ +            L  Q+L  DP++R+     SA++  EHP 
Sbjct: 402 KEVP--EEYSERFSPQARS------------LCSQLLCKDPAERLGCRGGSAREVKEHPL 447
Query: 296 FDDLDKTRL 304
           F  L+  RL
Sbjct: 448 FKKLNFKRL 456

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 21/220 (9%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           F  L  +G+G++GKV  A  K T ++ A   LKK  + +DD+     T+ E  +L +L +
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDD--VECTMVEKRVLALLDK 78
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY-- 119
            P + +L    Q  ++     LY V EY++  DL  +I+   Q G+       +++ Y  
Sbjct: 79  PPFLTQLHSCFQTVDR-----LYFVMEYVNGGDLMYHIQ---QVGK---FKEPQAVFYAA 127
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++  G+ F H  GI++RDLK  N+++D +   +KIAD G+ +   +          T  Y
Sbjct: 128 EISIGLFFLHKRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMMDGVTTREFCGTPDY 186
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 219
            APE+ +    Y  +VD W+   +  E++     F G+ E
Sbjct: 187 IAPEI-IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 44/309 (14%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-TLREVSILRMLSR 62
           + F +   +G+G +G+V   + +ATGK+ A KK       +       L E  IL  ++ 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
              VV L         E +  L LV   M+  DLK +I    Q G   P         ++
Sbjct: 244 R-FVVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEI 295
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           C G+   H   I++RDLKP N+L+D     ++I+DLGLA       +     + T+ Y A
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLA-VHVPEGQTIKGRVGTVGYMA 353
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV + +  Y+ + D W++ C+  E++       G S  QQ     R      E+V   V
Sbjct: 354 PEV-VKNERYTFSPDWWALGCLLYEMIA------GQSPFQQ-----RKKKIKREEVERLV 401
Query: 242 SSLMNWHEYPQ-WNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPY 295
             +    EY + ++PQ+ +            L  Q+L  DP++R+     SA++  EHP 
Sbjct: 402 KEVP--EEYSERFSPQARS------------LCSQLLCKDPAERLGCRGGSAREVKEHPL 447
Query: 296 FDDLDKTRL 304
           F  L+  RL
Sbjct: 448 FKKLNFKRL 456

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 43/299 (14%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 66
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I +  +E + T  Y +P
Sbjct: 127 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDEMANEFVGTRSYMSP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG-TPNEKVWPGV 241
           E L G THYS   D+WS+     E+       P        + IF LL    NE      
Sbjct: 176 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPRPP-------MAIFELLDYIVNEP----- 222
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
                        P  L +AV +L+    D + + L  +P++R   K+ M H +    D
Sbjct: 223 -------------PPKLPSAVFSLEFQ--DFVNKCLIKNPAERADLKQLMVHAFIKRSD 266

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRD 63
           F+ L  +G G+Y KV   R K T +I A+K  K  L  DDE +      E  +    S  
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI-DWVQTEKHVFEQASNH 65
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P +V L    Q +++     L+ V EY++  DL  +++  R+    +P    +    ++ 
Sbjct: 66  PFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEIS 116
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             + + H  GI++RDLK  N+L+D +   +K+ D G+ +    P    +    T  Y AP
Sbjct: 117 LALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
           E+L G   Y  +VD W++  +  E++   + F
Sbjct: 176 EILRGED-YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRD 63
           F+ L  +G G+Y KV   R K T +I A+K  K  L  DDE +      E  +    S  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI-DWVQTEKHVFEQASNH 69
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P +V L    Q +++     L+ V EY++  DL  +++  R+    +P    +    ++ 
Sbjct: 70  PFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEIS 120
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             + + H  GI++RDLK  N+L+D +   +K+ D G+ +    P    +    T  Y AP
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
           E+L G   Y  +VD W++  +  E++   + F
Sbjct: 180 EILRGED-YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSIL 57
            +K+  +GEG +GKV    Y      TG++VA+K  +     EG  P       RE+ IL
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-----EGCGPQLRSGWQREIEIL 65
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R L  + H+V+     + Q   G   + LV EY+       + S R       V   + L
Sbjct: 66  RTLYHE-HIVKYKGCCEDQ---GEKSVQLVMEYVP------LGSLRDYLPRHCVGLAQLL 115
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----T 171
           ++  Q+C+G+A+ H    +HR L   N+L+D   + +KI D GLA+A     + Y     
Sbjct: 116 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVRED 174
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            +    WY APE L     Y  A D+WS      EL+T
Sbjct: 175 GDSPVFWY-APECLKECKFY-YASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSIL 57
            +K+  +GEG +GKV    Y      TG++VA+K  +     EG  P       RE+ IL
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-----EGCGPQLRSGWQREIEIL 64
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           R L  + H+V+     + Q   G   + LV EY+       + S R       V   + L
Sbjct: 65  RTLYHE-HIVKYKGCCEDQ---GEKSVQLVMEYVP------LGSLRDYLPRHCVGLAQLL 114
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----T 171
           ++  Q+C+G+A+ H    +HR L   N+L+D   + +KI D GLA+A     + Y     
Sbjct: 115 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVRED 173
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            +    WY APE L     Y  A D+WS      EL+T
Sbjct: 174 GDSPVFWY-APECLKECKFY-YASDVWSFGVTLYELLT 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 22/249 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 63
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 124 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDS--ELQQLLHIFRLL----GTPNE 235
           E L G THYS   D+WS+     E+ V +  + P D+  + +  + IF LL      P  
Sbjct: 173 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPP 231
Query: 236 KVWPGVSSL 244
           K+  GV SL
Sbjct: 232 KLPSGVFSL 240

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 128/303 (42%), Gaps = 49/303 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D  E + ++G G YG V + R   +G+I+A+K+ R           T+      R+L   
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----------ATVNSQEQKRLLMDL 100
Query: 64  PHVVRLMDVK------QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
              +R +D            +EG   +++  E MDT L K+ +     G+ IP + +  +
Sbjct: 101 DISMRTVDCPFTVTFYGALFREGD--VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 158
Query: 118 MYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
              + K +   H    ++HRD+KP N+L++     +K+ D G++      + K T +   
Sbjct: 159 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAK-TIDAGC 216
Query: 177 LWYRAPEVL---LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             Y APE +   L    YS   D+WS+     EL      FP DS            GTP
Sbjct: 217 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELA--ILRFPYDS-----------WGTP 263
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            ++       L    E P  +PQ  A        + +D   Q L+ +  +R +  + M+H
Sbjct: 264 FQQ-------LKQVVEEP--SPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQH 311
Query: 294 PYF 296
           P+F
Sbjct: 312 PFF 314

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRD 63
           F+ L  +G G+Y KV   R K T +I A+K  K  L  DDE +      E  +    S  
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT-EKHVFEQASNH 80
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P +V L    Q +++     L+ V EY++  DL  +++  R+    +P    +    ++ 
Sbjct: 81  PFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEIS 131
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             + + H  GI++RDLK  N+L+D +   +K+ D G+ +    P    +    T  Y AP
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
           E+L G   Y  +VD W++  +  E++   + F
Sbjct: 191 EILRGED-YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 125/299 (41%), Gaps = 46/299 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E ++ +G G +G     R+K   ++VA+K     E  E +     RE+   R L R 
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYI---ERGEKIDENVKREIINHRSL-RH 74
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++VR  +V         T L +V EY    +L + I +  +  E+      +    QL 
Sbjct: 75  PNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSED----EARFFFQQLI 125
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            GV++ H   + HRDLK  N L+D      LKIAD G ++A  L  +  +  + T  Y A
Sbjct: 126 SGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS-AVGTPAYIA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKVWPG 240
           PEVLL   +     D+WS       ++     F    E +     I R+L          
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------- 234
Query: 241 VSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                           ++  A+P+   +  +   L+ ++   DP+KRIS  +   H +F
Sbjct: 235 ----------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT--TLREVSILRMLSRDPHVV 67
           E +G G +GKVYRA     G  VA+K  R H+ DE +  T   +R+ + L  + + P+++
Sbjct: 13  EIIGIGGFGKVYRAF--WIGDEVAVKAAR-HDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
            L  V   +       L LV E+        + S    G+ IP + + +   Q+ +G+ +
Sbjct: 70  ALRGVCLKEPN-----LCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNY 120
Query: 128 CHGHGI---LHRDLKPHNLLM-------DRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
            H   I   +HRDLK  N+L+       D     LKI D GLAR +    K         
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA- 179
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG 216
            + APEV+  S  +S   D+WS   +  EL+T    F G
Sbjct: 180 -WMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 111/244 (45%), Gaps = 30/244 (12%)
Query: 9   LEKVGEGTYGKVYRAREKA----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           + ++G+G +G V   R       TG +VA+K+ +    D+       RE+ IL+ L  D 
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSD- 71
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLC 122
            +V+   V  G    GR  L LV EY+ +     +R F Q      ++  + L+Y  Q+C
Sbjct: 72  FIVKYRGVSYG---PGRQSLRLVMEYLPSGC---LRDFLQR-HRARLDASRLLLYSSQIC 124
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLW 178
           KG+ +      +HRDL   N+L++ +   +KIAD GLA+   L    Y      +    W
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APE L  +  +S   D+WS   +  EL T       D          R++G+  E+  
Sbjct: 184 Y-APESLSDNI-FSRQSDVWSFGVVLYELFTYC-----DKSCSPSAEFLRMMGS--ERDV 234
Query: 239 PGVS 242
           P +S
Sbjct: 235 PALS 238

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 37/298 (12%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 82
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
                  H I+HRD+KP N+L++ +   +K+ D G++      +      + T  Y +PE
Sbjct: 143 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMANSF--VGTRSYMSPE 192
Query: 184 VLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
            L G THYS   D+WS+     E+ V +  +  G   +     +  ++  P  K+  GV 
Sbjct: 193 RLQG-THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVF 251
Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
           SL    E+                    D + + L  +P++R   K+ M H +    D
Sbjct: 252 SL----EFQ-------------------DFVNKCLIKNPAERADLKQLMVHAFIKRSD 286

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/328 (22%), Positives = 134/328 (40%), Gaps = 64/328 (19%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR--DPHVVRL 69
           +G+G+YG V  A E  T  I A+K    ++  +  P    R  + +R++ +   P++ RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 70  MDVKQGQ------------------------NKEGRTVLYLVF-------EYMDTDLKKY 98
            +V + +                        +  G+  + +V        E  +  +   
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 99  IRSFRQTGENIPVNT-VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIAD 156
           I  FR++ + +     + ++M Q+   + + H  GI HRD+KP N L    K+  +K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 157 LGLARAF-TLPIKKY---THEILTLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKT 211
            GL++ F  L   +Y   T +  T ++ APEVL  +   Y    D WS   +   L+   
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 212 ALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLD 271
             FPG ++   +  +       N+K+           E P +N          L     D
Sbjct: 274 VPFPGVNDADTISQVL------NKKL---------CFENPNYNV---------LSPLARD 309
Query: 272 LLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           LL  +L  +  +R  A +A++HP+    
Sbjct: 310 LLSNLLNRNVDERFDAMRALQHPWISQF 337

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 125/299 (41%), Gaps = 46/299 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E ++ +G G +G     R+K + ++VA+K     E  E +     RE+   R L R 
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIDENVKREIINHRSL-RH 74
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++VR  +V         T L +V EY    +L + I +  +  E+      +    QL 
Sbjct: 75  PNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSED----EARFFFQQLI 125
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            GV++CH   + HRDLK  N L+D      LKI   G +++  L  +  +  + T  Y A
Sbjct: 126 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKS-TVGTPAYIA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKVWPG 240
           PEVLL   +     D+WS       ++     F    E +     I R+L          
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------- 234
Query: 241 VSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                           ++  A+P+   +  +   L+ ++   DP+KRIS  +   H +F
Sbjct: 235 ----------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 134/298 (44%), Gaps = 36/298 (12%)
Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            +++  +GEG +GKV    Y      TG+ VA+K  +       +     +E+ ILR L 
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLY 69
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY- 119
            +     ++  K    ++G   + L+ E++ +  LK+Y+   +       +N  + L Y 
Sbjct: 70  HE----NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYA 120
Query: 120 -QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEI 174
            Q+CKG+ +      +HRDL   N+L++ +   +KI D GL +A     +  T     + 
Sbjct: 121 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
              WY APE L+ S  Y  A D+WS      EL+T       DS+   +    +++G  +
Sbjct: 180 PVFWY-APECLMQSKFY-IASDVWSFGVTLHELLTYC-----DSDSSPMALFLKMIGPTH 232
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
            ++   V+ L+N  +  +  P       PN   +   L+ +  ++ PS R S +  +E
Sbjct: 233 GQM--TVTRLVNTLKEGKRLP-----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM- 70
           + EG +  VY A++  +G+  ALK  RL  ++E      ++EV  ++ LS  P++V+   
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 71  --DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
              + + ++  G+    L+ E     L ++++     G  +  +TV  + YQ C+ V   
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHM 152
Query: 129 HGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEI 174
           H     I+HRDLK  NLL+  +  T+K+ D G A   +              +++     
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 175 LTLWYRAPEVLLGSTHYSTA--VDMWSVACIFAELVTKTALFPGDSELQ 221
            T  YR PE++   +++      D+W++ CI   L  +   F   ++L+
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 134/298 (44%), Gaps = 36/298 (12%)
Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            +++  +GEG +GKV    Y      TG+ VA+K  +       +     +E+ ILR L 
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLY 81
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY- 119
            +     ++  K    ++G   + L+ E++ +  LK+Y+   +       +N  + L Y 
Sbjct: 82  HE----NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYA 132
Query: 120 -QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEI 174
            Q+CKG+ +      +HRDL   N+L++ +   +KI D GL +A     +  T     + 
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDS 191
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
              WY APE L+ S  Y  A D+WS      EL+T       DS+   +    +++G  +
Sbjct: 192 PVFWY-APECLMQSKFY-IASDVWSFGVTLHELLTYC-----DSDSSPMALFLKMIGPTH 244
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
            ++   V+ L+N  +  +  P       PN   +   L+ +  ++ PS R S +  +E
Sbjct: 245 GQM--TVTRLVNTLKEGKRLP-----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRD 63
           F+ L  +G G+Y KV   R K T +I A++  K  L  DDE +      E  +    S  
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT-EKHVFEQASNH 112
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P +V L    Q +++     L+ V EY++  DL  +++  R+    +P    +    ++ 
Sbjct: 113 PFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEIS 163
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             + + H  GI++RDLK  N+L+D +   +K+ D G+ +    P    +    T  Y AP
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
           E+L G   Y  +VD W++  +  E++   + F
Sbjct: 223 EILRGED-YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPH 65
           E++G G +G+V+  R +A   +VA+K  R     E +PP      L+E  IL+  S  P+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-----ETLPPDLKAKFLQEARILKQYSH-PN 173
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +VRL+ V   +       +Y+V E +      ++   R  G  + V T+  ++     G+
Sbjct: 174 IVRLIGVCTQKQP-----IYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI--LTLWYRAPE 183
            +      +HRDL   N L+  K + LKI+D G++R     +   +  +  + + + APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADGVXAASGGLRQVPVKWTAPE 285
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTA 212
             L    YS+  D+WS   +  E  +  A
Sbjct: 286 A-LNYGRYSSESDVWSFGILLWETFSLGA 313

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 16/234 (6%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 63
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 124 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNE 235
           E L G THYS   D+WS+     E+ V +  + P D++  +L+   ++ G   E
Sbjct: 173 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 9   LEKVGEGTYGKVYRAREKA----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           + ++G+G +G V   R       TG +VA+K+ +    D+       RE+ IL+ L  D 
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSD- 72
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLC 122
            +V+   V  G    GR  L LV EY+ +     +R F Q      ++  + L+Y  Q+C
Sbjct: 73  FIVKYRGVSYG---PGRQSLRLVMEYLPSGC---LRDFLQR-HRARLDASRLLLYSSQIC 125
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLW 178
           KG+ +      +HRDL   N+L++ +   +KIAD GLA+   L    Y      +    W
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           Y APE L  +  +S   D+WS   +  EL T
Sbjct: 185 Y-APESLSDNI-FSRQSDVWSFGVVLYELFT 213

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 135/316 (42%), Gaps = 35/316 (11%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 125
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 186 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 234
Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           E L G THYS   D+WS+     E+ V +  + P D++  +L+   ++ G   E      
Sbjct: 235 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 293
Query: 242 SSLMNWHEYPQWN-----------------PQSLATAVPNLDKDGLDLLEQMLQYDPSKR 284
           +       Y   +                 P  L +AV +L+    D + + L  +P++R
Sbjct: 294 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQ--DFVNKCLIKNPAER 351
Query: 285 ISAKKAMEHPYFDDLD 300
              K+ M H +    D
Sbjct: 352 ADLKQLMVHAFIKRSD 367

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 16/234 (6%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 63
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 124 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNE 235
           E L G THYS   D+WS+     E+ V +  + P D++  +L+   ++ G   E
Sbjct: 173 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 110/244 (45%), Gaps = 30/244 (12%)
Query: 9   LEKVGEGTYGKVYRAREKA----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           + ++G+G +G V   R       TG +VA+K+ +    D+       RE+ IL+ L  D 
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSD- 84
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLC 122
            +V+   V  G    GR  L LV EY+ +     +R F Q      ++  + L+Y  Q+C
Sbjct: 85  FIVKYRGVSYG---PGRQSLRLVMEYLPSGC---LRDFLQR-HRARLDASRLLLYSSQIC 137
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT----HEILTLW 178
           KG+ +      +HRDL   N+L++ +   +KIAD GLA+   L    Y      +    W
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APE L  +  +S   D+WS   +  EL T       D          R++G   E+  
Sbjct: 197 Y-APESLSDNI-FSRQSDVWSFGVVLYELFTYC-----DKSCSPSAEFLRMMGC--ERDV 247
Query: 239 PGVS 242
           P +S
Sbjct: 248 PALS 251

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 16/234 (6%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 63
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 124 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNE 235
           E L G THYS   D+WS+     E+ V +  + P D++  +L+   ++ G   E
Sbjct: 173 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 16/234 (6%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 63
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 124 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNE 235
           E L G THYS   D+WS+     E+ V +  + P D++  +L+   ++ G   E
Sbjct: 173 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           E +G+G +G+  +   + TG+++ +K+  L   DE    T L+EV ++R L   P+V++ 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEH-PNVLKF 72
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
           + V     +     L  + EY+    L+  I+S        P +   S    +  G+A+ 
Sbjct: 73  IGVLYKDKR-----LNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYL 124
Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-------------RAFTLPIKKYTHEIL 175
           H   I+HRDL  HN L+ R+   + +AD GLA             R+   P +K  + ++
Sbjct: 125 HSMNIIHRDLNSHNCLV-RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP 215
              ++ APE++ G + Y   VD++S   +  E++ +    P
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADP 223

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 25/248 (10%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP-PTTLREVSILRMLSRDP 64
           F  L ++G G++G VY AR+    ++VA+KK               ++EV  L+ L R P
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 114
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           + ++       ++       +LV EY        +   ++  + + +  V    +   +G
Sbjct: 115 NTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQG 166
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +A+ H H ++HRD+K  N+L+    + +K+ D G A +   P   +   + T ++ APEV
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA-SIMAPANXF---VGTPYWMAPEV 221
Query: 185 LLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +L      Y   VD+WS+     EL  +       + +  L HI +     NE   P + 
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NES--PALQ 274
Query: 243 SLMNWHEY 250
           S  +W EY
Sbjct: 275 S-GHWSEY 281

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 16/223 (7%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M  + +E ++ +G G +G+V   R K+T K+ A+K     E  +        E   +   
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +  P VV+L    Q         LY+V EYM   DL   + ++     ++P    +    
Sbjct: 131 ANSPWVVQLFYAFQDDR-----YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTA 180
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLW 178
           ++   +   H  G +HRD+KP N+L+D K+  LK+AD G         + +    + T  
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 179 YRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           Y +PEVL    G  +Y    D WSV     E++     F  DS
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML----- 60
           F+++E +G G +G+V++A+ +  GK   +++ + + +        L ++  + ++     
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 61  ----------SRDPHVVRLMDVKQGQN--KEGRTVLYLVFEYMDTD-LKKYIRSFRQTGE 107
                     S D       D +  +N  +     L++  E+ D   L+++I   R  GE
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GE 131
Query: 108 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI 167
            +       L  Q+ KGV + H   ++HRDLKP N+ +   T  +KI D GL  +     
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDG 190
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV 208
           K+ T    TL Y +PE  + S  Y   VD++++  I AEL+
Sbjct: 191 KR-TRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 16/223 (7%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M  + +E ++ +G G +G+V   R K+T K+ A+K     E  +        E   +   
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +  P VV+L    Q         LY+V EYM   DL   + ++     ++P    +    
Sbjct: 126 ANSPWVVQLFYAFQDDR-----YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTA 175
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLW 178
           ++   +   H  G +HRD+KP N+L+D K+  LK+AD G         + +    + T  
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 179 YRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           Y +PEVL    G  +Y    D WSV     E++     F  DS
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 46/299 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E ++ +G G +G     R+K + ++VA+K     E  E +     RE+   R L R 
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIDENVKREIINHRSL-RH 74
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++VR  +V         T L +V EY    +L + I +  +  E+      +    QL 
Sbjct: 75  PNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSED----EARFFFQQLI 125
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            GV++CH   + HRDLK  N L+D      LKI   G +++  L   +    + T  Y A
Sbjct: 126 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH-SQPKDTVGTPAYIA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH-IFRLLGTPNEKVWPG 240
           PEVLL   +     D+WS       ++     F    E +     I R+L          
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------- 234
Query: 241 VSSLMNWHEYPQWNPQSLATAVPN---LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                           ++  A+P+   +  +   L+ ++   DP+KRIS  +   H +F
Sbjct: 235 ----------------NVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---EGVPPTTLREVSILRM--- 59
           F+++E +G G +G+V++A+ +  GK   +K+ + + +    E      L  V+I+     
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 60  ---LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVK 115
                 DP         +  ++     L++  E+ D   L+++I   R  GE +      
Sbjct: 73  WDGFDYDPETS-----SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLAL 125
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            L  Q+ KGV + H   +++RDLKP N+ +   T  +KI D GL  +     K+   +  
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSK-G 183
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV 208
           TL Y +PE  + S  Y   VD++++  I AEL+
Sbjct: 184 TLRYMSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 37/297 (12%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D  E + ++G G YG V + R   +G+I+A+K+ R   + +      L ++ I       
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDC 65
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P  V          +EG   +++  E MDT L K+ +     G+ IP + +  +   + K
Sbjct: 66  PFTVTFYG---ALFREGD--VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 124 GVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            +   H    ++HRD+KP N+L++     +K+ D G++      + K   +     Y AP
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDI-DAGCKPYMAP 178
Query: 183 EVL---LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           E +   L    YS   D+WS+     EL      FP DS            GTP ++   
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELA--ILRFPYDS-----------WGTPFQQ--- 222
Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
               L    E P  +PQ  A        + +D   Q L+ +  +R +  + M+HP+F
Sbjct: 223 ----LKQVVEEP--SPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 16/223 (7%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M  + +E ++ +G G +G+V   R K+T K+ A+K     E  +        E   +   
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +  P VV+L    Q         LY+V EYM   DL   + ++     ++P    +    
Sbjct: 131 ANSPWVVQLFYAFQDDR-----YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTA 180
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEILTLW 178
           ++   +   H  G +HRD+KP N+L+D K+  LK+AD G         + +    + T  
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 179 YRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           Y +PEVL    G  +Y    D WSV     E++     F  DS
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 16/234 (6%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L   +  
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 90
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V          +    + ++    +D  LKK  R   Q    + +  +K L Y   K
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
                  H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y +P
Sbjct: 151 -------HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 199
Query: 183 EVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIFRLLGTPNE 235
           E L G THYS   D+WS+     E+ V +  + P D++  +L+   ++ G   E
Sbjct: 200 ERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 25/248 (10%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP-PTTLREVSILRMLSRDP 64
           F  L ++G G++G VY AR+    ++VA+KK               ++EV  L+ L R P
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 75
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           + ++       ++       +LV EY        +   ++  + + +  V    +   +G
Sbjct: 76  NTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQG 127
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +A+ H H ++HRD+K  N+L+    + +K+ D G A +   P   +   + T ++ APEV
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA-SIMAPANXF---VGTPYWMAPEV 182
Query: 185 LLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +L      Y   VD+WS+     EL  +       + +  L HI       NE   P + 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNES--PALQ 235
Query: 243 SLMNWHEY 250
           S  +W EY
Sbjct: 236 S-GHWSEY 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +K+AD G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL----REVSILRM 59
           D +E  E +G G   +V+ AR+    + VA+K  R    D    P+      RE      
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAA 68
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L+  P +V +    + +   G  + Y+V EY+D    + I      G   P   ++ ++ 
Sbjct: 69  LNH-PAIVAVYATGEAETPAG-PLPYIVMEYVDGVTLRDI--VHTEGPMTPKRAIE-VIA 123
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILT 176
             C+ + F H +GI+HRD+KP N+++   T  +K+ D G+ARA        T     I T
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             Y +PE   G +      D++S+ C+  E++T    F GDS + 
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPH 65
           E++G G +G+V+  R +A   +VA+K  R     E +PP      L+E  IL+  S  P+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-----ETLPPDLKAKFLQEARILKQYSH-PN 173
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +VRL+ V   +       +Y+V E +      ++   R  G  + V T+  ++     G+
Sbjct: 174 IVRLIGVCTQKQP-----IYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI--LTLWYRAPE 183
            +      +HRDL   N L+  K + LKI+D G++R     +   +  +  + + + APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTA 212
             L    YS+  D+WS   +  E  +  A
Sbjct: 286 A-LNYGRYSSESDVWSFGILLWETFSLGA 313

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRM 59
            +K+  +GEG +GKV    Y      TG++VA+K  +    D G    +   +E+ ILR 
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DAGPQHRSGWKQEIDILRT 89
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L  + H+++    K      G   L LV EY+       + S R       +   + L++
Sbjct: 90  LYHE-HIIK---YKGCCEDAGAASLQLVMEYVP------LGSLRDYLPRHSIGLAQLLLF 139
Query: 120 --QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THE 173
             Q+C+G+A+ H    +HRDL   N+L+D   + +KI D GLA+A     + Y      +
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEXYRVREDGD 198
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               WY APE L     Y  A D+WS      EL+T
Sbjct: 199 SPVFWY-APECLKEYKFY-YASDVWSFGVTLYELLT 232

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 6   FEKLEKVGEGTYGKVYRAREKA---TGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           FE L+ +G+G++GKV+  R+     +G + A   LKK  L   D      T  E  IL  
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDR---VRTKMERDILAD 86
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLM 118
           ++  P VV+L    Q + K     LYL+ +++   DL  + R  ++         VK  +
Sbjct: 87  VNH-PFVVKLHYAFQTEGK-----LYLILDFLRGGDL--FTRLSKEV--MFTEEDVKFYL 136
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            +L  G+   H  GI++RDLKP N+L+D +   +K+ D GL++      KK      T+ 
Sbjct: 137 AELALGLDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVE 195
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPN 234
           Y APEV+    H S + D WS   +  E++T +  F G    + +  I +  LG P 
Sbjct: 196 YMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ 251

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 9   LEKVGEGTYGKVYRAREKA----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           + ++G+G +G V   R       TG +VA+K+ +    D+       RE+ IL+ L  D 
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSD- 68
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY--QLC 122
            +V+   V  G    GR  L LV EY+ +     +R F Q      ++  + L+Y  Q+C
Sbjct: 69  FIVKYRGVSYG---PGRPELRLVMEYLPSGC---LRDFLQR-HRARLDASRLLLYSSQIC 121
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL----PIKKYTHEILTLW 178
           KG+ +      +HRDL   N+L++ +   +KIAD GLA+   L     + +   +    W
Sbjct: 122 KGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           Y APE  L    +S   D+WS   +  EL T
Sbjct: 181 Y-APES-LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 138/292 (47%), Gaps = 44/292 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KLE++G+G++G+V++  +  T ++VA+K   L E ++ +     +E+++L       +
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSS-Y 82
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN--TVKSLMYQLCK 123
           V +      G   +G + L+++ EY+            + G   P +   + +++ ++ K
Sbjct: 83  VTKYY----GSYLKG-SKLWIIMEYLGGG---SALDLLRAG---PFDEFQIATMLKEILK 131
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    + T ++ APE
Sbjct: 132 GLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 190
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           V+  S  Y +  D+WS+     EL       P +S++  +  +F +              
Sbjct: 191 VIQQSA-YDSKADIWSLGITAIELAKGE---PPNSDMHPMRVLFLI-------------- 232
Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                  P+ NP +L   V +  K   + ++  L  DPS R +AK+ ++H +
Sbjct: 233 -------PKNNPPTL---VGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKF 274

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 19  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 77
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+    G   +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 78  HVVRLL----GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 133
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HRDL   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 134 AEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 193 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 80
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+    G   +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 81  HVVRLL----GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HRDL   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 80
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+    G   +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 81  HVVRLL----GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HRDL   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 80
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+    G   +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 81  HVVRLL----GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HRDL   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 84  LYLVFEYMDTD-LKKYIRSFRQTGEN----IPVNTVKSLMYQLCKGVAFCHGH-GILHRD 137
           +Y+++EYM+ D + K+   F    +N    IP+  +K ++  +    ++ H    I HRD
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177
Query: 138 LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTA-VD 196
           +KP N+LMD K   +K++D G +    +  KK      T  +  PE     + Y+ A VD
Sbjct: 178 VKPSNILMD-KNGRVKLSDFGESEY--MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 197 MWSVA-CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNP 255
           +WS+  C++        + P   ++  L+ +F  + T N + +P      N   YP  N 
Sbjct: 235 IWSLGICLYVMFYN---VVPFSLKI-SLVELFNNIRTKNIE-YPLDR---NHFLYPLTNK 286
Query: 256 QSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
           +S  T   N L  + +D L+  L+ +P++RI+++ A++H +  D
Sbjct: 287 KS--TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 88
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 89  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 137
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 138 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 192
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 37/231 (16%)
Query: 12  VGEGTYGKVYRA----------REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +GEG +G+V  A          +E  T  +  LK     ED   +    + E+ +++M+ 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDL----VSEMEMMKMIG 98
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------EN 108
           +  +++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E 
Sbjct: 99  KHKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 109 IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-- 166
           +    + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR       
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDY 212
Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
            KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 21  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 79
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+ V      +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 80  HVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 135
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HRDL   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 136 AEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 195 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLS 61
           D +E + ++G+G +GKVY+A+ K T  + A K   T+  E+ E      + E+ IL    
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY----MVEIDILASCD 92
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P++V+L+D    +N     + +     +D  + +  R   ++        ++ +  Q 
Sbjct: 93  H-PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES-------QIQVVCKQT 144
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              + + H + I+HRDLK  N+L       +K+AD G++   T  I++    I T ++ A
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 203
Query: 182 PEVLLGSTH----YSTAVDMWSVACIFAELV 208
           PEV++  T     Y    D+WS+     E+ 
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D ++ ++ +G G +G     R+K T ++VA+K     E    +     RE+   R L R 
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSL-RH 75
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++VR  +V         T L ++ EY    +L + I +  +  E+      +    QL 
Sbjct: 76  PNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSED----EARFFFQQLL 126
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMT-LKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            GV++CH   I HRDLK  N L+D      LKI D G +++  L  +  +  + T  Y A
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIA 185
Query: 182 PEVLLGSTHYSTAVDMWSVA 201
           PEVLL   +     D+WS  
Sbjct: 186 PEVLLRQEYDGKIADVWSCG 205

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 116
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 117 QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 165
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 220
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 221 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 37/294 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L ++G G YG V +   K +G+I+A+K+ R    DE      L ++ ++   S  P++V+
Sbjct: 27  LGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN-IPVNTVKSLMYQLCKGVAF 127
                    +EG    ++  E M T   K+ +      ++ IP   +  +     K +  
Sbjct: 86  FYG---ALFREGDC--WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 128 CHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
              +  I+HRD+KP N+L+DR +  +K+ D G++      I K T +     Y APE + 
Sbjct: 141 LKENLKIIHRDIKPSNILLDR-SGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERID 198
Query: 187 GSTH---YSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPGVS 242
            S     Y    D+WS+     EL T    +P  +S   QL  + +  G P         
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP--------- 247
Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                   PQ +        P+     ++ +   L  D SKR   K+ ++HP+ 
Sbjct: 248 --------PQLSNSEEREFSPSF----INFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 124/303 (40%), Gaps = 40/303 (13%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-TLREVSILRMLSRDPHVVR 68
           E +GEG Y KV  A     GK  A+K   + E   G   +   REV  L     + +++ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVK---IIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L++       E  T  YLVFE +    +  +I+  +   E      V+ +   L     F
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAAL----DF 126
Query: 128 CHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTL-----PIK--KYTHEILTLW 178
            H  GI HRDLKP N+L +   K   +KI D  L     L     PI   + T    +  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 179 YRAPEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
           Y APEV+      +T Y    D+WS+  +   +++    F G            +     
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 246
Query: 235 EKVWPGVSSLMNWHEYP--QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
            K++  +      +E+P   W          ++  +  DL+ ++L  D  +R+SA + ++
Sbjct: 247 NKLFESIQE--GKYEFPDKDW---------AHISSEAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 293 HPY 295
           HP+
Sbjct: 296 HPW 298

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRM 59
            +K+  +GEG +GKV    Y      TG++VA+K  +    D G    +   +E+ ILR 
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DCGPQHRSGWKQEIDILRT 72
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L  + H+++     + Q   G   L LV EY+       + S R       +   + L++
Sbjct: 73  LYHE-HIIKYKGCCEDQ---GEKSLQLVMEYVP------LGSLRDYLPRHSIGLAQLLLF 122
Query: 120 --QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THE 173
             Q+C+G+A+ H    +HR+L   N+L+D   + +KI D GLA+A     + Y      +
Sbjct: 123 AQQICEGMAYLHAQHYIHRNLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               WY APE L     Y  A D+WS      EL+T
Sbjct: 182 SPVFWY-APECLKEYKFY-YASDVWSFGVTLYELLT 215

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLS 61
           D +E + ++G+G +GKVY+A+ K T  + A K   T+  E+ E      + E+ IL    
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY----MVEIDILASCD 92
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P++V+L+D    +N     + +     +D  + +  R   ++        ++ +  Q 
Sbjct: 93  H-PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES-------QIQVVCKQT 144
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              + + H + I+HRDLK  N+L       +K+AD G++   T  I++    I T ++ A
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMA 203
Query: 182 PEVLLGSTH----YSTAVDMWSVACIFAELV 208
           PEV++  T     Y    D+WS+     E+ 
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL 57
           M +  F  L  +G+G++GKV  +  K T ++ A   LKK  + +DD+     T+ E  +L
Sbjct: 17  MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVL 74
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
            +  + P + +L    Q  ++     LY V EY++  DL  +I+   +  E   V     
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA- 128
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
              ++  G+ F    GI++RDLK  N+++D +   +KIAD G+ +              T
Sbjct: 129 ---EIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKXFCGT 184
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 219
             Y APE+ +    Y  +VD W+   +  E++   A F G+ E
Sbjct: 185 PDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 58/307 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 89  KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 139
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K + ++ T+ Y  
Sbjct: 140 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMP 196
Query: 182 PEVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +  + S+  +           D+WS+ CI   +        G +  QQ+++    L 
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLH 250
Query: 232 T---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
               PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  
Sbjct: 251 AIIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIP 288
Query: 289 KAMEHPY 295
           + + HPY
Sbjct: 289 ELLAHPY 295

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 122/302 (40%), Gaps = 63/302 (20%)
Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK   + +D     P   REV +    
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD----CPKARREVELHWRA 67
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           S+ PH+VR++DV +     GR  L +V E +D   + + R   +  +         +M  
Sbjct: 68  SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGG-ELFSRIQDRGDQAFTEREASEIMKS 125
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + + + + H   I HRD+KP NLL    R    LK+ D G A+  T              
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------- 171
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
                       Y  + DMWS+  I   L+     F  +  L                + 
Sbjct: 172 ---------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AIS 207
Query: 239 PGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           PG+ + +   +Y    P+W+  S    +         L+  +L+ +P++R++  + M HP
Sbjct: 208 PGMKTRIRMGQYEFPNPEWSEVSEEVKM---------LIRNLLKTEPTQRMTITEFMNHP 258
Query: 295 YF 296
           + 
Sbjct: 259 WI 260

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 80
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+    G   +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 81  HVVRLL----GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HRDL   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEYSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 6   FEKLEKVGEGTYGKV----YRAREKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRM 59
            +K+  +GEG +GKV    Y      TG++VA+K  +    D G    +   +E+ ILR 
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DCGPQHRSGWKQEIDILRT 72
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L  + H+++     + Q   G   L LV EY+       + S R       +   + L++
Sbjct: 73  LYHE-HIIKYKGCCEDQ---GEKSLQLVMEYVP------LGSLRDYLPRHSIGLAQLLLF 122
Query: 120 --QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THE 173
             Q+C+G+A+ H    +HR+L   N+L+D   + +KI D GLA+A     + Y      +
Sbjct: 123 AQQICEGMAYLHSQHYIHRNLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGD 181
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               WY APE L     Y  A D+WS      EL+T
Sbjct: 182 SPVFWY-APECLKEYKFY-YASDVWSFGVTLYELLT 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLS 61
           D +E + ++G+G +GKVY+A+ K T  + A K   T+  E+ E      + E+ IL    
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY----MVEIDILASCD 92
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P++V+L+D    +N     + +     +D  + +  R   ++        ++ +  Q 
Sbjct: 93  H-PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTES-------QIQVVCKQT 144
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              + + H + I+HRDLK  N+L       +K+AD G++   T  I++    I T ++ A
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMA 203
Query: 182 PEVLLGSTH----YSTAVDMWSVACIFAELV 208
           PEV++  T     Y    D+WS+     E+ 
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEYSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEYSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE++  +G G++G+V   + K TG   A+K      D + V        TL E  I 
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIQ 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVLEYAPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +K+AD G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IKVADFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 58/307 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 117 KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 167
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K + ++ T+ Y  
Sbjct: 168 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMP 224
Query: 182 PEVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +  + S+  +           D+WS+ CI   +        G +  QQ+++    L 
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLH 278
Query: 232 T---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
               PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  
Sbjct: 279 AIIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIP 316
Query: 289 KAMEHPY 295
           + + HPY
Sbjct: 317 ELLAHPY 323

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 16/223 (7%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           M  + ++ ++ +G G +G+V   R KA+ K+ A+K     E  +        E   +   
Sbjct: 72  MKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 131
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +  P VV+L    Q         LY+V EYM   DL   + ++     ++P    K    
Sbjct: 132 ANSPWVVQLFCAFQDDK-----YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTA 181
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-RAFTLPIKKYTHEILTLW 178
           ++   +   H  G++HRD+KP N+L+D K   LK+AD G   +     +      + T  
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVHCDTAVGTPD 240
Query: 179 YRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           Y +PEVL    G  +Y    D WSV     E++     F  DS
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 283

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 31/228 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVAL------KKTRLHEDDEGVPPTTLREVSI 56
           +D FE+++ +G G++G+V   +   TG   A+      K  +L E +      TL E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH-----TLNEKRI 94
Query: 57  LRMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTV 114
           L+ ++  P +V+L    K   N      LY+V EY    ++  ++R   +  E       
Sbjct: 95  LQAVNF-PFLVKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFSE----PHA 143
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           +    Q+     + H   +++RDLKP NL++D++   +K+ D GLA+     +K  T  +
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGLAKR----VKGRTWXL 198
Query: 175 L-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 58/307 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 117 KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 167
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K + ++ T+ Y  
Sbjct: 168 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMP 224
Query: 182 PEVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +  + S+  +           D+WS+ CI   +        G +  QQ+++    L 
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLH 278
Query: 232 T---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
               PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  
Sbjct: 279 AIIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIP 316
Query: 289 KAMEHPY 295
           + + HPY
Sbjct: 317 ELLAHPY 323

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 58/307 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 73  KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 123
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K + ++ T+ Y  
Sbjct: 124 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMP 180
Query: 182 PEVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +  + S+  +           D+WS+ CI   +        G +  QQ+++    L 
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLH 234
Query: 232 T---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
               PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  
Sbjct: 235 AIIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIP 272
Query: 289 KAMEHPY 295
           + + HPY
Sbjct: 273 ELLAHPY 279

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   + K TG   A+K      D + V        TL E  IL
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 88
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 89  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFXE----PHAR 137
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 138 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 192
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 58/307 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 70  KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 120
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K + ++ T+ Y  
Sbjct: 121 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMP 177
Query: 182 PEVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +  + S+  +           D+WS+ CI   +        G +  QQ+++    L 
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLH 231
Query: 232 T---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
               PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  
Sbjct: 232 AIIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIP 269
Query: 289 KAMEHPY 295
           + + HPY
Sbjct: 270 ELLAHPY 276

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 103 IINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL--PIKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDXXKKT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 103 IINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL--PIKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDXXKKT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 58/307 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 69  KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 119
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K + ++ T+ Y  
Sbjct: 120 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMP 176
Query: 182 PEVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +  + S+  +           D+WS+ CI   +        G +  QQ+++    L 
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLH 230
Query: 232 T---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
               PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  
Sbjct: 231 AIIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIP 268
Query: 289 KAMEHPY 295
           + + HPY
Sbjct: 269 ELLAHPY 275

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 75
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 76  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 131
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 132 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 191 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 84
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 85  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 141 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 200 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL 57
           M +  F  L  +G+G++GKV  +  K T ++ A   LKK  + +DD+     T+ E  +L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVL 395
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
            +  + P + +L    Q  ++     LY V EY++  DL  +I+   +  E   V     
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA- 449
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
              ++  G+ F    GI++RDLK  N+++D +   +KIAD G+ +              T
Sbjct: 450 ---EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGT 505
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE 219
             Y APE+ +    Y  +VD W+   +  E++   A F G+ E
Sbjct: 506 PDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 90
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 91  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 146
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 206 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 31/228 (13%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVAL------KKTRLHEDDEGVPPTTLREVSI 56
           +D FE+++ +G G++G+V   +   TG   A+      K  +L E +      TL E  I
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH-----TLNEKRI 94
Query: 57  LRMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTV 114
           L+ ++  P +V+L    K   N      LY+V EY    ++  ++R   +  E       
Sbjct: 95  LQAVNF-PFLVKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFSE----PHA 143
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           +    Q+     + H   +++RDLKP NL++D++   +++ D GLA+     +K  T  +
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGLAKR----VKGRTWXL 198
Query: 175 L-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
             T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 129/306 (42%), Gaps = 56/306 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 89  KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 139
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT--HEILTLWYRAP 182
           V   H HGI+H DLKP N L+      LK+ D G+A              ++ T+ Y  P
Sbjct: 140 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPP 197
Query: 183 EVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
           E +  + S+  +           D+WS+ CI   +        G +  QQ+++    L  
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLHA 251
Query: 233 ---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
              PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  +
Sbjct: 252 IIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIPE 289
Query: 290 AMEHPY 295
            + HPY
Sbjct: 290 LLAHPY 295

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSIL 57
           + M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVL 59
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +  +R P +  L    Q  ++     L  V EY +         F            ++ 
Sbjct: 60  QN-TRHPFLTALKYAFQTHDR-----LCFVMEYANGG-----ELFFHLSRERVFTEERAR 108
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 168 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI---- 217
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 218 ---------LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 290 AMEHPYF 296
            MEH +F
Sbjct: 258 VMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSIL 57
           + M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVL 59
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +  +R P +  L    Q  ++     L  V EY +         F            ++ 
Sbjct: 60  QN-TRHPFLTALKYAFQTHDR-----LCFVMEYANGG-----ELFFHLSRERVFTEERAR 108
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 168 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI---- 217
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 218 ---------LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 290 AMEHPYF 296
            MEH +F
Sbjct: 258 VMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSIL 57
           + M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVL 59
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +  +R P +  L    Q  ++     L  V EY +         F            ++ 
Sbjct: 60  QN-TRHPFLTALKYAFQTHDR-----LCFVMEYANGG-----ELFFHLSRERVFTEERAR 108
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 168 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI---- 217
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 218 ---------LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 290 AMEHPYF 296
            MEH +F
Sbjct: 258 VMEHRFF 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 115/236 (48%), Gaps = 29/236 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 80
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 81  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 132
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAP 182
           AF      +HRDL+  N+L+   T++ KIAD GLAR   +   +YT        + + AP
Sbjct: 133 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAP 189
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 234
           E +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 190 EAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 244

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 80
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+    G   +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 81  HVVRLL----GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HR+L   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 137 AEIADGMAYLNAKKFVHRNLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 115/236 (48%), Gaps = 29/236 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 76
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 77  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 128
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAP 182
           AF      +HRDL+  N+L+   T++ KIAD GLAR   +   +YT        + + AP
Sbjct: 129 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAP 185
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 234
           E +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 186 EAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 115/236 (48%), Gaps = 29/236 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 70
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 71  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 122
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAP 182
           AF      +HRDL+  N+L+   T++ KIAD GLAR   +   +YT        + + AP
Sbjct: 123 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAP 179
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 234
           E +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 180 EAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 115/236 (48%), Gaps = 29/236 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 75
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 76  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 127
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAP 182
           AF      +HRDL+  N+L+   T++ KIAD GLAR   +   +YT        + + AP
Sbjct: 128 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAP 184
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 234
           E +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 185 EAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 239

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 22/228 (9%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE++ ++G G  G V + + + +G I+A K   L E    +    +RE+ +L   +  
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECN-S 73
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++V          +     + +  E+MD   L + ++  ++    IP   +  +   + 
Sbjct: 74  PYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVL 124
Query: 123 KGVAFC-HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYR 180
           +G+A+    H I+HRD+KP N+L++ +   +K+ D G++      I    +  + T  Y 
Sbjct: 125 RGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL---IDSMANSFVGTRSYM 180
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAEL-VTKTALFPGDSELQQLLHIF 227
           APE L G THYS   D+WS+     EL V +  + P D+  ++L  IF
Sbjct: 181 APERLQG-THYSVQSDIWSMGLSLVELAVGRYPIPPPDA--KELEAIF 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDP 64
           L ++G+G++G VY    +   K  A  +  +   +E          L E S+++  +   
Sbjct: 23  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH- 81
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIP------VNTVKSLM 118
           HVVRL+ V      +G+  L ++      DLK Y+RS R   EN P      +  +  + 
Sbjct: 82  HVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 137
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILT 176
            ++  G+A+ +    +HR+L   N ++     T+KI D G+ R    T   +K    +L 
Sbjct: 138 AEIADGMAYLNAKKFVHRNLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + + APE L     ++T+ DMWS   +  E+ +
Sbjct: 197 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS 228

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 92  IINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 147 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKT 205
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 206 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 251

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 83
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 84  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 140 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 199 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSIL 57
           + M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVL 64
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +  +R P +  L    Q  ++     L  V EY +         F            ++ 
Sbjct: 65  QN-TRHPFLTALKYAFQTHDR-----LCFVMEYANGG-----ELFFHLSRERVFTEERAR 113
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              
Sbjct: 114 FYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKXFCG 172
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 173 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI---- 222
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 223 ---------LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 262
Query: 290 AMEHPYF 296
            MEH +F
Sbjct: 263 VMEHRFF 269

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILR 58
           FE L+ +G+G++GKV+  + K +G        +  LKK  L   D      T  E  IL 
Sbjct: 27  FELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILV 82
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSL 117
            ++  P +V+L    Q + K     LYL+ +++   DL  + R  ++         VK  
Sbjct: 83  EVNH-PFIVKLHYAFQTEGK-----LYLILDFLRGGDL--FTRLSKEV--MFTEEDVKFY 132
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK      T+
Sbjct: 133 LAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTV 191
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEK 236
            Y APEV+    H  +A D WS   +  E++T T  F G    + +  I +  LG P + 
Sbjct: 192 EYMAPEVVNRRGHTQSA-DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP-QF 249
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPN 264
           + P   SL+      + NP +   A P+
Sbjct: 250 LSPEAQSLLRM--LFKRNPANRLGAGPD 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 126/259 (48%), Gaps = 33/259 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 65
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 66  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 117
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAP 182
           AF      +HRDL+  N+L+   T++ KIAD GLAR   +   +YT        + + AP
Sbjct: 118 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAP 174
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN--EK 236
           E +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++   N  E+
Sbjct: 175 EAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 233
Query: 237 VWPGVSSLMNWHEYPQWNP 255
           ++  +   + W E P+  P
Sbjct: 234 LYQLMR--LCWKERPEDRP 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSIL 57
           + M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVL 59
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +  +R P +  L    Q  ++     L  V EY +         F            ++ 
Sbjct: 60  QN-TRHPFLTALKYAFQTHDR-----LCFVMEYANGG-----ELFFHLSRERVFTEERAR 108
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 168 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI---- 217
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 218 ---------LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 290 AMEHPYF 296
            MEH +F
Sbjct: 258 VMEHRFF 264

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 95  IINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 150 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKT 208
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 209 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 254

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSIL 57
           + M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVL 62
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +  +R P +  L    Q  ++     L  V EY +         F            ++ 
Sbjct: 63  QN-TRHPFLTALKYAFQTHDR-----LCFVMEYANGG-----ELFFHLSRERVFTEERAR 111
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              
Sbjct: 112 FYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCG 170
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 171 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI---- 220
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 221 ---------LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 260
Query: 290 AMEHPYF 296
            MEH +F
Sbjct: 261 VMEHRFF 267

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 77
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+ V      +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 78  VRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 134 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 193 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 37/231 (16%)
Query: 12  VGEGTYGKVYRA----------REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +GEG +G+V  A          +E  T  +  LK     +D   +    + E+ +++M+ 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 144
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------EN 108
           +  +++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E 
Sbjct: 145 KHKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 109 IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-- 166
           +    + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR       
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDY 258
Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
            KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 81
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 82  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 137
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 138 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 197 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 226

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 90  IINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 145 DLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV-MKIADFGLARDINNIDYYKKT 203
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 204 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 249

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 55/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR---LHEDDEGVPPTTLREVSIL 57
           + M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R   +   DE     T+ E  +L
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVL 59
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +  +R P +  L    Q  ++     L  V EY +         F            ++ 
Sbjct: 60  QN-TRHPFLTALKYAFQTHDR-----LCFVMEYANGG-----ELFFHLSRERVFTEERAR 108
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 168 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELI---- 217
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 218 ---------LMEEIRFPR-----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 290 AMEHPYF 296
            MEH +F
Sbjct: 258 VMEHRFF 264

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 84
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 85  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 141 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 200 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 103 IIHLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 83
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 84  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 140 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 199 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----------KTRLHEDDEGVPPTTLREVS 55
           F+ L  +G G++G+V+  R +  G+  A+K          K   H +DE +  + +    
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVK 115
           I+RM           D +Q         ++++ +Y++      + S  +  +  P    K
Sbjct: 68  IIRMWGT------FQDAQQ---------IFMIMDYIEGGE---LFSLLRKSQRFPNPVAK 109
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               ++C  + + H   I++RDLKP N+L+D K   +KI D G A+     +   T+ + 
Sbjct: 110 FYAAEVCLALEYLHSKDIIYRDLKPENILLD-KNGHIKITDFGFAKY----VPDVTYXLC 164
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
            T  Y APEV + +  Y+ ++D WS   +  E++     F
Sbjct: 165 GTPDYIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILR 58
           FE L+ +G+G++GKV+  + K +G        +  LKK  L   D      T  E  IL 
Sbjct: 26  FELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILV 81
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSL 117
            ++  P +V+L    Q + K     LYL+ +++   DL  + R  ++         VK  
Sbjct: 82  EVNH-PFIVKLHYAFQTEGK-----LYLILDFLRGGDL--FTRLSKEV--MFTEEDVKFY 131
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK      T+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEK 236
            Y APEV+    H  +A D WS   +  E++T T  F G    + +  I +  LG P + 
Sbjct: 191 EYMAPEVVNRRGHTQSA-DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP-QF 248
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPN 264
           + P   SL+      + NP +   A P+
Sbjct: 249 LSPEAQSLLRM--LFKRNPANRLGAGPD 274

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILR 58
           FE L+ +G+G++GKV+  + K +G        +  LKK  L   D      T  E  IL 
Sbjct: 26  FELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILV 81
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSL 117
            ++  P +V+L    Q + K     LYL+ +++   DL  + R  ++         VK  
Sbjct: 82  EVNH-PFIVKLHYAFQTEGK-----LYLILDFLRGGDL--FTRLSKEV--MFTEEDVKFY 131
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + +L   +   H  GI++RDLKP N+L+D +   +K+ D GL++      KK      T+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL-LGTPNEK 236
            Y APEV+    H  +A D WS   +  E++T T  F G    + +  I +  LG P + 
Sbjct: 191 EYMAPEVVNRRGHTQSA-DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP-QF 248
Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPN 264
           + P   SL+      + NP +   A P+
Sbjct: 249 LSPEAQSLLRM--LFKRNPANRLGAGPD 274

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 78
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 79  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 130
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 131 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK------ 183
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 184 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 238
Query: 231 GTPN 234
              N
Sbjct: 239 RPDN 242

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 71
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 72  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 123
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 124 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK------ 176
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 177 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 231
Query: 231 GTPN 234
              N
Sbjct: 232 RPDN 235

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 58/307 (18%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L +   
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 117 KIIRLYDYEITDQ-----YIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 167
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K + ++  + Y  
Sbjct: 168 VHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMP 224
Query: 182 PEVL--LGSTHYS--------TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +  + S+  +           D+WS+ CI   +        G +  QQ+++    L 
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY------GKTPFQQIINQISKLH 278
Query: 232 T---PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
               PN ++           E+P          +P  +KD  D+L+  L+ DP +RIS  
Sbjct: 279 AIIDPNHEI-----------EFPD---------IP--EKDLQDVLKCCLKRDPKQRISIP 316
Query: 289 KAMEHPY 295
           + + HPY
Sbjct: 317 ELLAHPY 323

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 72
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 73  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 124
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 125 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK------ 177
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 178 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 232
Query: 231 GTPN 234
              N
Sbjct: 233 RPDN 236

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 70
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 71  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 122
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 123 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK------ 175
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 176 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 231 GTPN 234
              N
Sbjct: 231 RPDN 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           EK+G G++G V+RA  +  G  VA+K     +         LREV+I++ L R P++V  
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLF 99
Query: 70  MD-VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTG--ENIPVNTVKSLMYQLCKGVA 126
           M  V Q  N      L +V EY+        R   ++G  E +      S+ Y + KG+ 
Sbjct: 100 MGAVTQPPN------LSIVTEYLSRG--SLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 127 FCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           + H     I+HRDLK  NLL+D+K  T+K+ D GL+R              T  + APEV
Sbjct: 152 YLHNRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEV 210
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
           L        + D++S   I  EL T
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 76
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 77  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 128
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 129 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK------ 181
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 182 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 236
Query: 231 GTPN 234
              N
Sbjct: 237 RPDN 240

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 103 IITLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 81
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 82  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 130
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 131 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWTLC 185
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 186 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 231

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 79
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 80  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 131
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 132 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK------ 184
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 185 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 239
Query: 231 GTPN 234
              N
Sbjct: 240 RPDN 243

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 70
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 71  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 122
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 123 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIK------ 175
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 176 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 231 GTPN 234
              N
Sbjct: 231 RPDN 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 112
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+ V      +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 113 VRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 168
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 169 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 228 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 257

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 11  KVGEGTYGKV----YRAREKATG-KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++G G +G V    YR R+K     I  LK+     D E      +RE  I+  L  +P+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE----EMMREAQIMHQLD-NPY 71
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VRL+ V Q +       L LV E      L K++   R   E IPV+ V  L++Q+  G
Sbjct: 72  IVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMG 122
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRA 181
           + +      +HRDL   N+L+  +    KI+D GL++A       YT      W   + A
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYA-KISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE  +    +S+  D+WS      E ++
Sbjct: 182 PEC-INFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWTLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 103 IINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + ++IAD GLAR        KK 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MRIADFGLARDINNIDYYKKT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFAE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 116
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 117 QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 165
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGATWTLC 220
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 221 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLA 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFXE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLX 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFXE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVPGGEMFSHLRRIGRFXE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F KL+++G+G++G+VY+  +  T ++VA+K   L E ++ +     +E+++L      P+
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCD-SPY 78
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT----DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           + R         K     L+++ EY+      DL K           +    + +++ ++
Sbjct: 79  ITRYFGSYLKSTK-----LWIIMEYLGGGSALDLLK--------PGPLEETYIATILREI 125
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            KG+ + H    +HRD+K  N+L+  +   +K+AD G+A   T    K    + T ++ A
Sbjct: 126 LKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMA 184
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+  S  Y    D+WS+     EL       P +S+L  +  +F +            
Sbjct: 185 PEVIKQSA-YDFKADIWSLGITAIELAKGE---PPNSDLHPMRVLFLI------------ 228
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                    P+ +P +L        K   + +E  L  DP  R +AK+ ++H +
Sbjct: 229 ---------PKNSPPTLEG---QHSKPFKEFVEACLNKDPRFRPTAKELLKHKF 270

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 82
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 83  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 131
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D +   +++ D G A+     +K  T  + 
Sbjct: 132 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGY-IQVTDFGFAKR----VKGRTWXLC 186
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 187 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 11  KVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++GEG +GKV+ A       +    +VA+K   L E  E       RE  +L ML    H
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQ-H 104
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRS------FRQTGENIP-----VNT 113
           +VR   V      EGR +L +VFEYM   DL +++RS          GE++      +  
Sbjct: 105 IVRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYT 171
           + ++  Q+  G+ +  G   +HRDL   N L+  + + +KI D G++R    T   +   
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             +L + +  PE +L    ++T  D+WS   +  E+ T
Sbjct: 219 RTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFT 255

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFXE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 133/317 (41%), Gaps = 51/317 (16%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE--GVPPTTLREVSILR 58
           M  D F     +G G +G+V+  + KATGK+ A KK       +  G     + +  + +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
           + SR   +V L         E +T L LV   M+  D++ +I +  +  +N      +++
Sbjct: 242 VHSR--FIVSL-----AYAFETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAI 292
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  Q+  G+   H   I++RDLKP N+L+D     ++I+DLGLA        K      
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAG 351
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T  + APE+LLG   Y  +VD +++     E++                  FR  G   E
Sbjct: 352 TPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARG-------------PFRARG---E 394
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK---DGLDLLEQMLQYDPSKRI-----SA 287
           KV           E  +   + L  AV   DK      D  E +LQ DP KR+     S 
Sbjct: 395 KV-----------ENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 288 KKAMEHPYFDDLDKTRL 304
                HP F D+   +L
Sbjct: 444 DGLRTHPLFRDISWRQL 460

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 131/312 (41%), Gaps = 51/312 (16%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE--GVPPTTLREVSILR 58
           M  D F     +G G +G+V+  + KATGK+ A KK       +  G     + +  + +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
           + SR   +V L         E +T L LV   M+  D++ +I +  +  +N      +++
Sbjct: 242 VHSR--FIVSL-----AYAFETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAI 292
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  Q+  G+   H   I++RDLKP N+L+D     ++I+DLGLA        K      
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAG 351
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T  + APE+LLG   Y  +VD +++     E++                  FR  G   E
Sbjct: 352 TPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARG-------------PFRARG---E 394
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK---DGLDLLEQMLQYDPSKRI-----SA 287
           KV           E  +   + L  AV   DK      D  E +LQ DP KR+     S 
Sbjct: 395 KV-----------ENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 288 KKAMEHPYFDDL 299
                HP F D+
Sbjct: 444 DGLRTHPLFRDI 455

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 90
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 91  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFXE----PHAR 139
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 140 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 194
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 195 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 240

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFXE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 116
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 117 QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFXE----PHAR 165
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 220
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 221 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++ EY    +L++Y+R+ R  G            E +   
Sbjct: 103 IINLLG---ACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        K  
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKNT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 77
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R   EN PV    SL  M Q+   
Sbjct: 78  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N  +  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 134 IADGMAYLNANKFVHRDLAARNCXV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 193 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 131/312 (41%), Gaps = 51/312 (16%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE--GVPPTTLREVSILR 58
           M  D F     +G G +G+V+  + KATGK+ A KK       +  G     + +  + +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
           + SR   +V L         E +T L LV   M+  D++ +I +  +  +N      +++
Sbjct: 242 VHSR--FIVSL-----AYAFETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAI 292
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  Q+  G+   H   I++RDLKP N+L+D     ++I+DLGLA        K      
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAG 351
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T  + APE+LLG   Y  +VD +++     E++                  FR  G   E
Sbjct: 352 TPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARG-------------PFRARG---E 394
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK---DGLDLLEQMLQYDPSKRI-----SA 287
           KV           E  +   + L  AV   DK      D  E +LQ DP KR+     S 
Sbjct: 395 KV-----------ENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 288 KKAMEHPYFDDL 299
                HP F D+
Sbjct: 444 DGLRTHPLFRDI 455

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 131/312 (41%), Gaps = 51/312 (16%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE--GVPPTTLREVSILR 58
           M  D F     +G G +G+V+  + KATGK+ A KK       +  G     + +  + +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
           + SR   +V L         E +T L LV   M+  D++ +I +  +  +N      +++
Sbjct: 242 VHSR--FIVSL-----AYAFETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAI 292
Query: 118 MY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            Y  Q+  G+   H   I++RDLKP N+L+D     ++I+DLGLA        K      
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAG 351
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T  + APE+LLG   Y  +VD +++     E++                  FR  G   E
Sbjct: 352 TPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARG-------------PFRARG---E 394
Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDK---DGLDLLEQMLQYDPSKRI-----SA 287
           KV           E  +   + L  AV   DK      D  E +LQ DP KR+     S 
Sbjct: 395 KV-----------ENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443
Query: 288 KKAMEHPYFDDL 299
                HP F D+
Sbjct: 444 DGLRTHPLFRDI 455

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 42/293 (14%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           ++G G++  VY+  +  T   VA  + +  +  +        E   L+ L + P++VR  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGL-QHPNIVRFY 91
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
           D  +   K G+  + LV E   +  LK Y++ F+       +  ++S   Q+ KG+ F H
Sbjct: 92  DSWESTVK-GKKCIVLVTELXTSGTLKTYLKRFKVX----KIKVLRSWCRQILKGLQFLH 146
Query: 130 GHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVLL 186
                I+HRDLK  N+ +   T ++KI DLGLA   TL    +   ++ T  + APE   
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXAPEXY- 202
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
               Y  +VD+++      E  T    +   SE Q    I+R       +V  GV     
Sbjct: 203 -EEKYDESVDVYAFGXCXLEXATSEYPY---SECQNAAQIYR-------RVTSGV----- 246
Query: 247 WHEYPQWNPQSL-ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
                   P S    A+P +     +++E  ++ +  +R S K  + H +F +
Sbjct: 247 -------KPASFDKVAIPEVK----EIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFXE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 11  KVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++GEG +GKV+ A       +    +VA+K   L E  E       RE  +L ML    H
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQ-H 75
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRS------FRQTGENIP-----VNT 113
           +VR      G   EGR +L +VFEYM   DL +++RS          GE++      +  
Sbjct: 76  IVRFF----GVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 130
Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYT 171
           + ++  Q+  G+ +  G   +HRDL   N L+  + + +KI D G++R    T   +   
Sbjct: 131 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             +L + +  PE +L    ++T  D+WS   +  E+ T
Sbjct: 190 RTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFT 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 90
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R    N PV    SL  M Q+   
Sbjct: 91  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 206 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFXE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 11  KVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++GEG +GKV+ A       +    +VA+K   L E  E       RE  +L ML    H
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQ-H 81
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRS------FRQTGENIP-----VNT 113
           +VR      G   EGR +L +VFEYM   DL +++RS          GE++      +  
Sbjct: 82  IVRFF----GVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 136
Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYT 171
           + ++  Q+  G+ +  G   +HRDL   N L+  + + +KI D G++R    T   +   
Sbjct: 137 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             +L + +  PE +L    ++T  D+WS   +  E+ T
Sbjct: 196 RTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFT 232

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A  +++GK+VA+KK  L +           EV I+R    + +VV + 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHE-NVVEMY 94
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +     ++     L++V E+++      I +  +  E      + ++   + + ++  H 
Sbjct: 95  NSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHA 145
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRD+K  ++L+      +K++D G     +  + +    + T ++ APE L+    
Sbjct: 146 QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLP 203
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           Y   VD+WS+  +  E+V     +  +  L+ +  I        + + P    L N H+ 
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK- 252
Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       P+L       L+++L  DP++R +A + ++HP+ 
Sbjct: 253 ----------VSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRMLSRDPHVV 67
           EK+G G++G V+RA  +  G  VA+K   L E D         LREV+I++ L R P++V
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVAVKI--LMEQDFHAERVNEFLREVAIMKRL-RHPNIV 97
Query: 68  RLMD-VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTG--ENIPVNTVKSLMYQLCKG 124
             M  V Q  N      L +V EY+        R   ++G  E +      S+ Y + KG
Sbjct: 98  LFMGAVTQPPN------LSIVTEYLSRG--SLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 125 VAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           + + H     I+HR+LK  NLL+D+K  T+K+ D GL+R              T  + AP
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVT 209
           EVL        + D++S   I  EL T
Sbjct: 209 EVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A  +++GK+VA+KK  L +           EV I+R    + +VV + 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHE-NVVEMY 92
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +     ++     L++V E+++      I +  +  E      + ++   + + ++  H 
Sbjct: 93  NSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHA 143
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRD+K  ++L+      +K++D G     +  + +    + T ++ APE L+    
Sbjct: 144 QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLP 201
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           Y   VD+WS+  +  E+V     +  +  L+ +  I        + + P    L N H+ 
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK- 250
Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       P+L       L+++L  DP++R +A + ++HP+ 
Sbjct: 251 ----------VSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G+GTYG VY  R+ +    +A+K+  + E D         E+++ + L +  ++V+ + 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKE--IPERDSRYSQPLHEEIALHKHL-KHKNIVQYL- 85
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRS-FRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
              G   E   +   + +     L   +RS +    +N    T+     Q+ +G+ + H 
Sbjct: 86  ---GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN--EQTIGFYTKQILEGLKYLHD 140
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVL-LGS 188
           + I+HRD+K  N+L++  +  LKI+D G ++     I   T     TL Y APE++  G 
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGP 199
Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
             Y  A D+WS+ C   E+ T    F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A  +++GK+VA+KK  L +           EV I+R    + +VV + 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHE-NVVEMY 137
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +     ++     L++V E+++      I +  +  E      + ++   + + ++  H 
Sbjct: 138 NSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHA 188
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRD+K  ++L+      +K++D G     +  + +    + T ++ APE L+    
Sbjct: 189 QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLP 246
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           Y   VD+WS+  +  E+V     +  +  L+ +  I        + + P    L N H+ 
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK- 295
Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       P+L       L+++L  DP++R +A + ++HP+ 
Sbjct: 296 ----------VSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A  +++GK+VA+KK  L +           EV I+R    + +VV + 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHE-NVVEMY 87
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +     ++     L++V E+++      I +  +  E      + ++   + + ++  H 
Sbjct: 88  NSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHA 138
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRD+K  ++L+      +K++D G     +  + +    + T ++ APE L+    
Sbjct: 139 QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLP 196
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           Y   VD+WS+  +  E+V     +  +  L+ +  I        + + P    L N H+ 
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK- 245
Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       P+L       L+++L  DP++R +A + ++HP+ 
Sbjct: 246 ----------VSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A  +++GK+VA+KK  L +           EV I+R    + +VV + 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHE-NVVEMY 83
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +     ++     L++V E+++      I +  +  E      + ++   + + ++  H 
Sbjct: 84  NSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHA 134
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRD+K  ++L+      +K++D G     +  + +    + T ++ APE L+    
Sbjct: 135 QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLP 192
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           Y   VD+WS+  +  E+V     +  +  L+ +  I        + + P    L N H+ 
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK- 241
Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       P+L       L+++L  DP++R +A + ++HP+ 
Sbjct: 242 ----------VSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G+GTYG VY  R+ +    +A+K+  + E D         E+++ + L +  ++V+ + 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKE--IPERDSRYSQPLHEEIALHKHL-KHKNIVQYL- 71
Query: 72  VKQGQNKEGRTVLYLVFEYMDTDLKKYIRS-FRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
              G   E   +   + +     L   +RS +    +N    T+     Q+ +G+ + H 
Sbjct: 72  ---GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN--EQTIGFYTKQILEGLKYLHD 126
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAPEVL-LGS 188
           + I+HRD+K  N+L++  +  LKI+D G ++     I   T     TL Y APE++  G 
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGP 185
Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
             Y  A D+WS+ C   E+ T    F
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 115/236 (48%), Gaps = 29/236 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G +G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 66
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 67  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 118
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAP 182
           AF      +HR+L+  N+L+   T++ KIAD GLAR   +   +YT        + + AP
Sbjct: 119 AFIEERNYIHRNLRAANILVS-DTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAP 175
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLLGTPN 234
           E +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++   N
Sbjct: 176 EAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 230

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLSRDPHV 66
           ++G+G++G VY    K   K     +  +   +E          L E S+++  +   HV
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HV 80
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL--MYQL--- 121
           VRL+    G   +G+  L ++      DLK Y+RS R    N PV    SL  M Q+   
Sbjct: 81  VRLL----GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 136
Query: 122 -CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEILTLW 178
              G+A+ + +  +HRDL   N ++  +  T+KI D G+ R    T   +K    +L + 
Sbjct: 137 IADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           + +PE L     ++T  D+WS   +  E+ T
Sbjct: 196 WMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 225

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  ++      F  D  +Q
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQ 245

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+GEG+ G V  A  +++GK+VA+KK  L +           EV I+R    + +VV + 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE--LLFNEVVIMRDYQHE-NVVEMY 214
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
           +     ++     L++V E+++      I +  +  E      + ++   + + ++  H 
Sbjct: 215 NSYLVGDE-----LWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLQALSVLHA 265
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH 190
            G++HRD+K  ++L+      +K++D G     +  + +    + T ++ APE L+    
Sbjct: 266 QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLP 323
Query: 191 YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
           Y   VD+WS+  +  E+V     +  +  L+ +  I        + + P    L N H+ 
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPP---RLKNLHK- 372
Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       P+L       L+++L  DP++R +A + ++HP+ 
Sbjct: 373 ----------VSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++  Y    +L++Y+R+ R  G            E +   
Sbjct: 103 IINLLG---ACTQDGP--LYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P + +L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLTKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 37/297 (12%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D  E + ++G G YG V + R   +G+I A+K+ R   + +       R +  L +  R 
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQ----EQKRLLXDLDISXRT 89
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
                 +       +EG   +++  E  DT L K+ +     G+ IP + +  +   + K
Sbjct: 90  VDCPFTVTFYGALFREGD--VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 147
Query: 124 GVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            +   H    ++HRD+KP N+L++     +K  D G++      + K   +     Y AP
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKXCDFGISGYLVDDVAKDI-DAGCKPYXAP 205
Query: 183 EVL---LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           E +   L    YS   D+WS+     EL      FP DS            GTP ++   
Sbjct: 206 ERINPELNQKGYSVKSDIWSLGITXIELA--ILRFPYDS-----------WGTPFQQ--- 249
Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
               L    E P  +PQ  A        + +D   Q L+ +  +R +  +  +HP+F
Sbjct: 250 ----LKQVVEEP--SPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P + +L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLTKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFSE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            V+RL+D  +  +        L+ E M+   DL  +I       E +     +S  +Q+ 
Sbjct: 74  GVIRLLDWFERPDS-----FVLILERMEPVQDLFDFITERGALQEEL----ARSFFWQVL 124
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  P
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPP 182
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           E +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 11  KVGEGTYGKV----YRAREKATG-KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++G G +G V    YR R+K     I  LK+     D E +    +RE  I+  L  +P+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLD-NPY 397
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VRL+ V Q +       L LV E      L K++   R   E IPV+ V  L++Q+  G
Sbjct: 398 IVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMG 448
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRA 181
           + +      +HR+L   N+L+  +    KI+D GL++A       YT      W   + A
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYA-KISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE  +    +S+  D+WS      E ++
Sbjct: 508 PEC-INFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 132/307 (42%), Gaps = 54/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL 57
           + M+ FE L+ +G+GT+GKV   +EKATG+  A   LKK  +   DE     TL E  +L
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVL 205
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           +  SR P +  L    Q  ++     L  V EY +  +L  ++   R   E    +  + 
Sbjct: 206 QN-SRHPFLTALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSE----DRARF 255
Query: 117 LMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
              ++   + + H    +++RDLK  NL++D K   +KI D GL +              
Sbjct: 256 YGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCG 314
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 315 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI---- 364
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 365 ---------LMEEIRFPR-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 404
Query: 290 AMEHPYF 296
            M+H +F
Sbjct: 405 IMQHRFF 411

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 29/227 (12%)
Query: 12  VGEGTYGKVYRAR----EKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPH 65
           +GEG +G+V  A     +K   K       ++ +DD  E      + E+ +++M+ +  +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENIPVN 112
           ++ L+       ++G   LY++  Y    +L++Y+R+ R  G            E +   
Sbjct: 103 IINLLG---ACTQDGP--LYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP--IKKY 170
            + S  YQL +G+ +      +HRDL   N+L+    + +KIAD GLAR        KK 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKT 216
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 217 TNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 45/244 (18%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +E++G G  G+V+        K+   +LK+  +       P   L E ++++ L     +
Sbjct: 18  VERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQ-RL 70
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           VRL  V   +       +Y++ EYM+   L  ++++   +G  + +N +  +  Q+ +G+
Sbjct: 71  VRLYAVVTQEP------IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 122
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEI 174
           AF      +HRDL+  N+L+   T++ KIAD GLAR               PIK      
Sbjct: 123 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDAEXTAREGAKFPIK------ 175
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE---LQQLLHIFRLL 230
               + APE +   T ++   D+WS   +  E+VT   + +PG +    +Q L   +R++
Sbjct: 176 ----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 231 GTPN 234
              N
Sbjct: 231 RPDN 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 132/307 (42%), Gaps = 54/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL 57
           + M+ FE L+ +G+GT+GKV   +EKATG+  A   LKK  +   DE     TL E  +L
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVL 202
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           +  SR P +  L    Q  ++     L  V EY +  +L  ++   R   E    +  + 
Sbjct: 203 QN-SRHPFLTALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSE----DRARF 252
Query: 117 LMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
              ++   + + H    +++RDLK  NL++D K   +KI D GL +              
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCG 311
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 312 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI---- 361
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 362 ---------LMEEIRFPR-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 401
Query: 290 AMEHPYF 296
            M+H +F
Sbjct: 402 IMQHRFF 408

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 132/307 (42%), Gaps = 54/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL 57
           + M+ FE L+ +G+GT+GKV   +EKATG+  A   LKK  +   DE     TL E  +L
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVL 62
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           +  SR P +  L    Q  ++     L  V EY +  +L  ++   R   E    +  + 
Sbjct: 63  QN-SRHPFLTALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSE----DRARF 112
Query: 117 LMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
              ++   + + H    +++RDLK  NL++D K   +KI D GL +              
Sbjct: 113 YGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCG 171
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 172 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI---- 221
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 222 ---------LMEEIRFPR-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 261
Query: 290 AMEHPYF 296
            M+H +F
Sbjct: 262 IMQHRFF 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 132/307 (42%), Gaps = 54/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL 57
           + M+ FE L+ +G+GT+GKV   +EKATG+  A   LKK  +   DE     TL E  +L
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVL 63
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           +  SR P +  L    Q  ++     L  V EY +  +L  ++   R   E    +  + 
Sbjct: 64  QN-SRHPFLTALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSE----DRARF 113
Query: 117 LMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
              ++   + + H    +++RDLK  NL++D K   +KI D GL +              
Sbjct: 114 YGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCG 172
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 173 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI---- 222
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 223 ---------LMEEIRFPR-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 262
Query: 290 AMEHPYF 296
            M+H +F
Sbjct: 263 IMQHRFF 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 132/307 (42%), Gaps = 54/307 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSIL 57
           + M+ FE L+ +G+GT+GKV   +EKATG+  A   LKK  +   DE     TL E  +L
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA--HTLTENRVL 64
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           +  SR P +  L    Q  ++     L  V EY +  +L  ++   R   E    +  + 
Sbjct: 65  QN-SRHPFLTALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSE----DRARF 114
Query: 117 LMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
              ++   + + H    +++RDLK  NL++D K   +KI D GL +              
Sbjct: 115 YGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKXFCG 173
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN 234
           T  Y APEV L    Y  AVD W +  +  E++  +   +  D E      +F L+    
Sbjct: 174 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI---- 223
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                    LM    +P+            L  +   LL  +L+ DP +R+      AK+
Sbjct: 224 ---------LMEEIRFPR-----------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 263
Query: 290 AMEHPYF 296
            M+H +F
Sbjct: 264 IMQHRFF 270

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE+++ S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 20/226 (8%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           ++K+GEG +  V        G   ALK+   HE  +       RE  + R+ +  P+++R
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNH-PNILR 90
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
           L+     +         L+  +    L   I   +  G  +  + +  L+  +C+G+   
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 129 HGHGILHRDLKPHNL---------LMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           H  G  HRDLKP N+         LMD  +M      +  +R   L ++ +  +  T+ Y
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ-ALTLQDWAAQRCTISY 209
Query: 180 RAPEVLLGSTH--YSTAVDMWSVACI-----FAELVTKTALFPGDS 218
           RAPE+    +H       D+WS+ C+     F E         GDS
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D FE+++ +G G++G+V   +   TG   A+K      D + V        TL E  IL
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 96
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P + +L    K   N      LY+V EY    ++  ++R   +  E       +
Sbjct: 97  QAVNF-PFLTKLEFSFKDNSN------LYMVMEYAPGGEMFSHLRRIGRFXE----PHAR 145
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NL++D++   +K+ D G A+     +K  T  + 
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGY-IKVTDFGFAKR----VKGRTWXLC 200
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T  Y AP ++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAR--EKATG---KIVALKKTRLHEDDEGVPPTTLREVSIL 57
           + A   +E++GE  +GKVY+      A G   + VA+K   L +  EG      R  ++L
Sbjct: 8   LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAML 65
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYI--RS-FRQTGENIPVNT 113
           R   + P+VV L+ V           L ++F Y    DL +++  RS     G      T
Sbjct: 66  RARLQHPNVVCLLGVVTKDQP-----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 114 VKS---------LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT 164
           VKS         L+ Q+  G+ +   H ++H+DL   N+L+  K + +KI+DLGL R   
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVY 179
Query: 165 LP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDS 218
                K   + +L + + APE ++    +S   D+WS   +  E V    L P     + 
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWE-VFSYGLQPYCGYSNQ 237
Query: 219 ELQQLLHIFRLLGTPNE-KVWPGVSSLMNWHEYPQWNPQ 256
           ++ +++   ++L  P++   W     +  W+E+P   P+
Sbjct: 238 DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPR 276

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++ R  G            E +
Sbjct: 93  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDXX 206
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVA--LKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           L+++G G +G V   + K    +    +K+  + ED+        +E   +  LS  P +
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE------FFQEAQTMMKLSH-PKL 65
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+   V   +       +Y+V EY+    L  Y+RS    G+ +  + +  + Y +C+G+
Sbjct: 66  VKFYGVCSKEYP-----IYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGM 117
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
           AF   H  +HRDL   N L+DR  + +K++D G+ R + L   +Y   + T +   + AP
Sbjct: 118 AFLESHQFIHRDLAARNCLVDR-DLCVKVSDFGMTR-YVLD-DQYVSSVGTKFPVKWSAP 174
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVT 209
           EV      YS+  D+W+   +  E+ +
Sbjct: 175 EV-FHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAR--EKATG---KIVALKKTRLHEDDEGVPPTTLREVSIL 57
           + A   +E++GE  +GKVY+      A G   + VA+K   L +  EG      R  ++L
Sbjct: 25  LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAML 82
Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYI--RS-FRQTGENIPVNT 113
           R   + P+VV L+ V           L ++F Y    DL +++  RS     G      T
Sbjct: 83  RARLQHPNVVCLLGVVTKDQP-----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 114 VKS---------LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT 164
           VKS         L+ Q+  G+ +   H ++H+DL   N+L+  K + +KI+DLGL R   
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVY 196
Query: 165 LP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP----GDS 218
                K   + +L + + APE ++    +S   D+WS   +  E V    L P     + 
Sbjct: 197 AADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWE-VFSYGLQPYCGYSNQ 254
Query: 219 ELQQLLHIFRLLGTPNE-KVWPGVSSLMNWHEYPQWNPQ 256
           ++ +++   ++L  P++   W     +  W+E+P   P+
Sbjct: 255 DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPR 293

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT-----TLREVSIL 57
           +D F++++ +G G++G+V   + K +G   A+K      D + V        TL E  IL
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEHTLNEKRIL 95
Query: 58  RMLSRDPHVVRL-MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVK 115
           + ++  P +V+L    K   N      LY+V EY+   ++  ++R   +  E       +
Sbjct: 96  QAVNF-PFLVKLEFSFKDNSN------LYMVMEYVAGGEMFSHLRRIGRFSE----PHAR 144
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
               Q+     + H   +++RDLKP NLL+D++   +++ D G A+     +K  T  + 
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR----VKGRTWXLC 199
Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            T    APE++L S  Y+ AVD W++  +  E+      F  D  +Q
Sbjct: 200 GTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 136/313 (43%), Gaps = 54/313 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSIL 57
           + M+ F     +G G +G+VY  R+  TGK+ A+K   K R+           L E  +L
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET--LALNERIML 242
Query: 58  RMLSRD--PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
            ++S    P +V +       +K     L  + + M+  DL  ++       E      +
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEA----DM 293
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-E 173
           +    ++  G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  
Sbjct: 294 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHAS 349
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           + T  Y APEVL     Y ++ D +S+ C+  +L+       G S  +Q           
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ----------- 392
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SA 287
                       + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A
Sbjct: 393 --------HKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 443
Query: 288 KKAMEHPYFDDLD 300
           ++  E P+F  LD
Sbjct: 444 QEVKESPFFRSLD 456

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 136/313 (43%), Gaps = 54/313 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSIL 57
           + M+ F     +G G +G+VY  R+  TGK+ A+K   K R+           L E  +L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET--LALNERIML 243
Query: 58  RMLSRD--PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
            ++S    P +V +       +K     L  + + M+  DL  ++       E      +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEA----DM 294
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-E 173
           +    ++  G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHAS 350
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           + T  Y APEVL     Y ++ D +S+ C+  +L+       G S  +Q           
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ----------- 393
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SA 287
                       + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A
Sbjct: 394 --------HKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 288 KKAMEHPYFDDLD 300
           ++  E P+F  LD
Sbjct: 445 QEVKESPFFRSLD 457

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR--D 63
            E  E VG G +G V +A+ +A  K VA+K+     + +         +  LR LSR   
Sbjct: 11  IEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESERKAF-------IVELRQLSRVNH 61
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM---YQ 120
           P++V+L              + LV EY +      + +     E +P  T    M    Q
Sbjct: 62  PNIVKLYGA-------CLNPVCLVMEYAEGG---SLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 121 LCKGVAFCHG---HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
             +GVA+ H      ++HRDLKP NLL+      LKI D G A          T+   + 
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSA 168
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
            + APEV  GS +YS   D++S   I  E++T+   F
Sbjct: 169 AWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 134/319 (42%), Gaps = 59/319 (18%)
Query: 4   DAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-VPPTTLREVSILRMLS 61
           D ++  E V GEG + +V       T +  A+K   + E   G +     REV +L    
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI---RSFRQTGENIPVNTVKSL 117
              +V+ L++  + +++      YLVFE M    +  +I   R F +   ++ V  V S 
Sbjct: 69  GHRNVLELIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTL-----PIKKY 170
           +        F H  GI HRDLKP N+L +   +   +KI D GL     L     PI   
Sbjct: 124 L-------DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS-- 174
Query: 171 THEILTLW----YRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
           T E+LT      Y APEV+      ++ Y    D+WS+  I   L++    F G      
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD- 233
Query: 223 LLHIFRLLGTPNEKVWPGVSSLM------NWHEYPQWNPQSLATAVPNLDKDGLDLLEQM 276
                   G    +  P   +++        +E+P  +   ++ A         DL+ ++
Sbjct: 234 -------CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK-------DLISKL 279
Query: 277 LQYDPSKRISAKKAMEHPY 295
           L  D  +R+SA + ++HP+
Sbjct: 280 LVRDAKQRLSAAQVLQHPW 298

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 136/313 (43%), Gaps = 54/313 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSIL 57
           + M+ F     +G G +G+VY  R+  TGK+ A+K   K R+           L E  +L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET--LALNERIML 243
Query: 58  RMLSRD--PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
            ++S    P +V +       +K     L  + + M+  DL  ++       E      +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEA----DM 294
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-E 173
           +    ++  G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHAS 350
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           + T  Y APEVL     Y ++ D +S+ C+  +L+       G S  +Q           
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ----------- 393
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SA 287
                       + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A
Sbjct: 394 --------HKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 288 KKAMEHPYFDDLD 300
           ++  E P+F  LD
Sbjct: 445 QEVKESPFFRSLD 457

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 136/313 (43%), Gaps = 54/313 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSIL 57
           + M+ F     +G G +G+VY  R+  TGK+ A+K   K R+           L E  +L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET--LALNERIML 243
Query: 58  RMLSRD--PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
            ++S    P +V +       +K     L  + + M+  DL  ++       E      +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEA----DM 294
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-E 173
           +    ++  G+   H   +++RDLKP N+L+D     ++I+DLGLA  F+   KK  H  
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS---KKKPHAS 350
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           + T  Y APEVL     Y ++ D +S+ C+  +L+       G S  +Q           
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR------GHSPFRQ----------- 393
Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRI-----SA 287
                       + HE  +    ++A  +P+    +   LLE +LQ D ++R+      A
Sbjct: 394 --------HKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444
Query: 288 KKAMEHPYFDDLD 300
           ++  E P+F  LD
Sbjct: 445 QEVKESPFFRSLD 457

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR--D 63
            E  E VG G +G V +A+ +A  K VA+K+     + +         +  LR LSR   
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESERKAF-------IVELRQLSRVNH 60
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM---YQ 120
           P++V+L              + LV EY +      + +     E +P  T    M    Q
Sbjct: 61  PNIVKLYGA-------CLNPVCLVMEYAEGG---SLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 121 LCKGVAFCHG---HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
             +GVA+ H      ++HRDLKP NLL+      LKI D G A          T+   + 
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSA 167
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
            + APEV  GS +YS   D++S   I  E++T+   F
Sbjct: 168 AWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/343 (22%), Positives = 142/343 (41%), Gaps = 60/343 (17%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++ +AF  + K+G+GT+G+V   +     K  A+K  R   + +    +   E  IL+ +
Sbjct: 32  LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKI 88
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLY----LVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
            ++  +     VK      G+ + Y    L+FE +   L + I   R       +  +K 
Sbjct: 89  -QNDDINNNNIVKY----HGKFMYYDHMCLIFEPLGPSLYEIIT--RNNYNGFHIEDIKL 141
Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMD------------------------RKTMTL 152
              ++ K + +     + H DLKP N+L+D                         K+  +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 153 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           K+ D G A   T     +   I T  YRAPEV+L +  +  + DMWS  C+ AEL T + 
Sbjct: 202 KLIDFGCA---TFKSDYHGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 213 LFPGDSELQQLLHIFRLLG-TPNEKVWPGV----SSLMNWHEYPQWNPQSLAT--AVPNL 265
           LF     ++ L  +  ++   P   ++       S  +N  E     P++ ++  ++ ++
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 266 DKD-----------GLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
            K              D L  +LQ DP+ R S  + ++H + +
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 70  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 122
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 123 VRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 180
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 84
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++ R  G            E +
Sbjct: 85  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 198
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLL 224
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 257
Query: 225 HIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNPQSLATAVPNLDK 267
                +  P+         + + WH  P   P +    V +LD+
Sbjct: 258 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 300

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G + K Y   +  T ++ A K   K+ L +  +    +T  E++I + L  +PHVV 
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD-NPHVVG 90
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
                +  +      +Y+V E      ++ +    +  + +     +  M Q  +GV + 
Sbjct: 91  FHGFFEDDD-----FVYVVLEICR---RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H + ++HRDLK  NL ++   M +KI D GLA       ++      T  Y APEVL   
Sbjct: 143 HNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK 201
Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
            H S  VD+WS+ CI   L+     F
Sbjct: 202 GH-SFEVDIWSLGCILYTLLVGKPPF 226

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 77
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++ R  G            E +
Sbjct: 78  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 191
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLL 224
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 225 HIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNPQSLATAVPNLDK 267
                +  P+         + + WH  P   P +    V +LD+
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 293

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 85
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++ R  G            E +
Sbjct: 86  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 199
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLL 224
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 258
Query: 225 HIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNPQSLATAVPNLDK 267
                +  P+         + + WH  P   P +    V +LD+
Sbjct: 259 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 301

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 12  VGEGTYGKVYRA---REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +GEG +G V      +E  T   VA+K  +L    +      L E + ++  S  P+V+R
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH-PNVIR 100
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR-QTG-ENIPVNTVKSLMYQLCKGV 125
           L+ V    + +G     ++  +M   DL  Y+   R +TG ++IP+ T+   M  +  G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            +      LHRDL   N ++ R  MT+ +AD GL++      K Y+ +    +YR   + 
Sbjct: 161 EYLSNRNFLHRDLAARNCML-RDDMTVCVADFGLSK------KIYSGD----YYRQGRIA 209
Query: 186 -----------LGSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
                      L    Y++  D+W+      E+ T+    +PG
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 81
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++ R  G            E +
Sbjct: 82  HKNIINLLG---ACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 195
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLL 224
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 254
Query: 225 HIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNPQSLATAVPNLDK 267
                +  P+         + + WH  P   P +    V +LD+
Sbjct: 255 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 297

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++ R  G            E +
Sbjct: 93  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 206
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLL 224
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265
Query: 225 HIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNPQSLATAVPNLDK 267
                +  P+         + + WH  P   P +    V +LD+
Sbjct: 266 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 308

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++ R  G            E +
Sbjct: 93  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 206
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLL 224
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG    EL +LL
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 265
Query: 225 HIFRLLGTPNEKVWPGVSSLMN-WHEYPQWNPQSLATAVPNLDK 267
                +  P+         + + WH  P   P +    V +LD+
Sbjct: 266 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLDR 308

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 90  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 142
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 200
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 52  REVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPV 111
           +E++IL+ L   P+VV+L++V    N++    LY+VFE ++      + + +   E+   
Sbjct: 85  QEIAILKKLDH-PNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPTLKPLSED--- 137
Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 171
              +     L KG+ + H   I+HRD+KP NLL+      +KIAD G++  F       +
Sbjct: 138 -QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLS 195
Query: 172 HEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
           + + T  + APE L  +       A+D+W++                       L+ F  
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT--------------------LYCFVF 235
Query: 230 LGTP--NEKVWPGVSSLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
              P  +E++    S + +   E+P           P++ +D  DL+ +ML  +P  RI 
Sbjct: 236 GQCPFMDERIMCLHSKIKSQALEFPDQ---------PDIAEDLKDLITRMLDKNPESRIV 286
Query: 287 AKKAMEHPY 295
             +   HP+
Sbjct: 287 VPEIKLHPW 295

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 89  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 141
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 199
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 89  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 141
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 199
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 90  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 142
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 200
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 90  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 142
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 200
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 75  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 127
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 185
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 74  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 126
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 184
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 75  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 127
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 185
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 40/239 (16%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           ++ + ++++G G +G+V+        K VA+K  +        P + L E  I++ L  D
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTK-VAIKTLK---PGTMSPESFLEEAQIMKKLKHD 64
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN--IPVNTVKSLMYQL 121
             +V+L  V   +       +Y+V EYM+   K  +  F + GE   + +  +  +  Q+
Sbjct: 65  -KLVQLYAVVSEEP------IYIVTEYMN---KGSLLDFLKDGEGRALKLPNLVDMAAQV 114
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKY 170
             G+A+      +HRDL+  N+L+    +  KIAD GLAR               PIK  
Sbjct: 115 AAGMAYIERMNYIHRDLRSANILVG-NGLICKIADFGLARLIEDNEXTARQGAKFPIK-- 171
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFR 228
                   + APE  L    ++   D+WS   +  ELVTK  + +PG +  + L  + R
Sbjct: 172 --------WTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 221

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 129/307 (42%), Gaps = 50/307 (16%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
            D FE L  +G+G++GKV   ++  T K+ A+K   K +  E +E       +E+ I++ 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQG 71
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L   P +V L    Q +          +F  +D  L   +R   Q   +    TVK  + 
Sbjct: 72  LEH-PFLVNLWYSFQDEED--------MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK-KYTHEILTLW 178
           +L   + +     I+HRD+KP N+L+D     + I D  +A    LP + + T    T  
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAA--MLPRETQITTMAGTKP 179
Query: 179 YRAPEVLLG--STHYSTAVDMWSVACIFAELV--TKTALFPGDSELQQLLHIFRLLGTPN 234
           Y APE+        YS AVD WS+     EL+   +       +  ++++H F       
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239
Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH- 293
              W                            ++ + LL+++L+ +P +R S    +++ 
Sbjct: 240 PSAW---------------------------SQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272
Query: 294 PYFDDLD 300
           PY +D++
Sbjct: 273 PYMNDIN 279

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 133
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+             LY++ EY    +L++Y+++ R  G            E +
Sbjct: 134 HKNIINLLGACTQDGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 247
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 109 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 161
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 219
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 75  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 127
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 185
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G + K Y   +  T ++ A K   K+ L +  +    +T  E++I + L  +PHVV 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD-NPHVVG 106
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
                +  +      +Y+V E      ++ +    +  + +     +  M Q  +GV + 
Sbjct: 107 FHGFFEDDD-----FVYVVLEICR---RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H + ++HRDLK  NL ++   M +KI D GLA       ++      T  Y APEVL   
Sbjct: 159 HNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK 217
Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
            H S  VD+WS+ CI   L+     F
Sbjct: 218 GH-SFEVDIWSLGCILYTLLVGKPPF 242

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 96
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 97  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 149
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 150 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 207
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 251

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 116
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 117 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 169
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 227
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 72
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 73  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 125
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 126 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 183
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G + K Y   +  T ++ A K   K+ L +  +    +T  E++I + L  +PHVV 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD-NPHVVG 106
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
                +  +      +Y+V E      ++ +    +  + +     +  M Q  +GV + 
Sbjct: 107 FHGFFEDDD-----FVYVVLEICR---RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H + ++HRDLK  NL ++   M +KI D GLA       ++      T  Y APEVL   
Sbjct: 159 HNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKK 217
Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
            H S  VD+WS+ CI   L+     F
Sbjct: 218 GH-SFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 116
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 117 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 169
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 227
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 121
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 122 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 174
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 175 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 232
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 70  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 122
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 180
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 102 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 154
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 212
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 1   MVMDAFEK--LEKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSI 56
           MV+D  E   ++++G G +G V+      K    I  +K+  + EDD       + E  +
Sbjct: 22  MVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD------FIEEAEV 75
Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVK 115
           +  LS  P +V+L  V   Q       + LVFE+M+   L  Y+R+ R         T+ 
Sbjct: 76  MMKLSH-PKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGL---FAAETLL 126
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            +   +C+G+A+     ++HRDL   N L+  +   +K++D G+ R F L   +YT    
Sbjct: 127 GMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTG 183
Query: 176 TLW---YRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
           T +   + +PEV    + YS+  D+WS   +  E+ ++
Sbjct: 184 TKFPVKWASPEV-FSFSRYSSKSDVWSFGVLMWEVFSE 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G+G + K Y   +  T ++ A K   K+ L +  +    +T  E++I + L  +PHVV 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD-NPHVVG 106
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
                +  +      +Y+V E      ++ +    +  + +     +  M Q  +GV + 
Sbjct: 107 FHGFFEDDD-----FVYVVLEICR---RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS 188
           H + ++HRDLK  NL ++   M +KI D GLA       ++      T  Y APEVL   
Sbjct: 159 HNNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKK 217
Query: 189 THYSTAVDMWSVACIFAELVTKTALF 214
            H S  VD+WS+ CI   L+     F
Sbjct: 218 GH-SFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 103 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 155
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 213
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 12  VGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +G+G +G VY     ++A  +I    K+     +       LRE  ++R L+  P+V+ L
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-PNVLAL 87
Query: 70  MDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
           + +      EG  + +++  YM   DL ++IRS ++   N  V  + S   Q+ +G+ + 
Sbjct: 88  IGIML--PPEG--LPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL 140
Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----LPIKKYTHEILTLWYRAPEV 184
                +HRDL   N ++D ++ T+K+AD GLAR         ++++ H  L + + A E 
Sbjct: 141 AEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTA 212
            L +  ++T  D+WS   +  EL+T+ A
Sbjct: 200 -LQTYRFTTKSDVWSFGVLLWELLTRGA 226

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 70  GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 122
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 180
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 102 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 154
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 212
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 103 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 155
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 213
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 102 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 154
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 212
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 103 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 155
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 213
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 103 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 155
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 213
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLR---EVSILRMLSRD-P 64
           +G G +G VY     +    VA+K   K R+   D G  P   R   EV +L+ +S    
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI--SDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            V+RL+D  +   +    VL L       DL  +I       E +     +S  +Q+ + 
Sbjct: 102 GVIRLLDWFE---RPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEA 154
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  Y  PE 
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEW 212
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
           +    ++  +  +WS+  +  ++V     F  D E+
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 76
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM+   L  +++   +TG+ + +  +  +  Q+  G+A+  
Sbjct: 77  AVVSEEP------IYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 129 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 185
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 186 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 8   KLEK-VGEGTYGKVYRAREKATGKIVA--LKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           KLEK +G G +G+V+ A      K+    +K   +  +        L E ++++ L  D 
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE------AFLAEANVMKTLQHD- 237
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            +V+L  V        +  +Y++ E+M    L  +++S    G   P+  +     Q+ +
Sbjct: 238 KLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAE 289
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLPIKKYTHEILTLWYRAP 182
           G+AF      +HRDL+  N+L+   ++  KIAD GLAR     PIK          + AP
Sbjct: 290 GMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVGAKFPIK----------WTAP 338
Query: 183 EVL-LGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDS 218
           E +  GS  ++   D+WS   +  E+VT   + +PG S
Sbjct: 339 EAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMS 374

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 12  VGEGTYGKVYRAR---------EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +GEG +G+V  A           + T   V + K+   E D       + E+ +++M+ +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS---DLISEMEMMKMIGK 92
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG------------ENI 109
             +++ L+       ++G   LY++ EY    +L++Y+++    G            E +
Sbjct: 93  HKNIINLLG---ACTQDGP--LYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
               + S  YQ+ +G+ +      +HRDL   N+L+    + +KIAD GLAR        
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 206
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           KK T+  L + + APE L     Y+   D+WS   +  E+ T   + +PG
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 76
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM+   L  +++   +TG+ + +  +  +  Q+  G+A+  
Sbjct: 77  AVVSEEP------IYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLW 178
               +HRDL+  N+L+  + +  K+AD GLAR               PIK          
Sbjct: 129 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEWTARQGAKFPIK---------- 177
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
           + APE  L    ++   D+WS   +  EL TK  + +PG
Sbjct: 178 WTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 18  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 72
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+  
Sbjct: 73  AVVSEEP------IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE 124
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 125 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 181
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 182 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++  E L ++G GT G+V++ R + TG ++A+K+ R   + E      L ++ ++     
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHD 82
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+             T +++  E M T  +K  +  R  G  IP   +  +   + 
Sbjct: 83  CPYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKK--RMQGP-IPERILGKMTVAIV 134
Query: 123 KGVAFC-HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           K + +    HG++HRD+KP N+L+D +   +K+ D G++    +  K          Y A
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQ-IKLCDFGISGRL-VDDKAKDRSAGCAAYMA 192
Query: 182 PEVL----LGSTHYSTAVDMWSVACIFAELVTKTALFP 215
           PE +         Y    D+WS+     EL   T  FP
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELA--TGQFP 228

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +  +  +G G +G V+ A +K   K V    +KK ++ ED     P   +    + +LSR
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 63  DPH--VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             H  +++++D+ + Q         LV E   + L  +    R    + P+ +   +  Q
Sbjct: 86  VEHANIIKVLDIFENQG-----FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY--IFRQ 138
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L   V +     I+HRD+K  N+++  +  T+K+ D G A A+    K +     T+ Y 
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVI-AEDFTIKLIDFGSA-AYLERGKLFYTFCGTIEYC 196
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
           APEVL+G+ +    ++MWS+      LV +   F
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 245
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+  
Sbjct: 246 AVVSEEP------IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 298 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 355 YG-RFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 245
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+  
Sbjct: 246 AVVSEEP------IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 298 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 355 YG-RFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 133/319 (41%), Gaps = 59/319 (18%)
Query: 4   DAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-VPPTTLREVSILRMLS 61
           D ++  E V GEG + +V       T +  A+K   + E   G +     REV +L    
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYI---RSFRQTGENIPVNTVKSL 117
              +V+ L++  + +++      YLVFE M    +  +I   R F +   ++ V  V S 
Sbjct: 69  GHRNVLELIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMD--RKTMTLKIADLGLARAFTL-----PIKKY 170
           +        F H  GI HRDLKP N+L +   +   +KI D  L     L     PI   
Sbjct: 124 L-------DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS-- 174
Query: 171 THEILTLW----YRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
           T E+LT      Y APEV+      ++ Y    D+WS+  I   L++    F G      
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD- 233
Query: 223 LLHIFRLLGTPNEKVWPGVSSLM------NWHEYPQWNPQSLATAVPNLDKDGLDLLEQM 276
                   G    +  P   +++        +E+P  +   ++ A         DL+ ++
Sbjct: 234 -------CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK-------DLISKL 279
Query: 277 LQYDPSKRISAKKAMEHPY 295
           L  D  +R+SA + ++HP+
Sbjct: 280 LVRDAKQRLSAAQVLQHPW 298

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 245
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+  
Sbjct: 246 AVVSEEP------IYIVGEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 298 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 355 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G +GKVY+   +   K VALK+ R  E  +G+        ++     R PH+V L+ 
Sbjct: 47  IGHGVFGKVYKGVLRDGAK-VALKR-RTPESSQGIEEFETEIETL--SFCRHPHLVSLIG 102
Query: 72  VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK-SLMYQLCKGVA--- 126
               +N+     + L+++YM+  +LK+++      G ++P  ++      ++C G A   
Sbjct: 103 FCDERNE-----MILIYKYMENGNLKRHL-----YGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 127 -FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPE 183
            + H   I+HRD+K  N+L+D +    KI D G+++  T   + +   ++  TL Y  PE
Sbjct: 153 HYLHTRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPE 211
Query: 184 VLL------GSTHYSTAVDMWSVACIFAELV 208
             +       S  YS  V ++ V C  + +V
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 12  VGEGTYGKVYRAREKATG--KIVALKKTRL------HEDDEGVPPTTLREVSILRMLSRD 63
           +GEG +G+V +AR K  G     A+K+ +       H D  G       E+ +L  L   
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-------ELEVLCKLGHH 75
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFR------------QTGENIP 110
           P+++ L+        E R  LYL  EY    +L  ++R  R             T   + 
Sbjct: 76  PNIINLLGA-----CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 170
              +      + +G+ +      +HRDL   N+L+    +  KIAD GL+R   + +KK 
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKT 189
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              +   W       L  + Y+T  D+WS   +  E+V+
Sbjct: 190 MGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 110/266 (41%), Gaps = 27/266 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM------------ 118
           ++     K G  ++ +V      +L  Y+RS R   E +P  T + L             
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKTPEDLYKDFLTLEHLICY 153
Query: 119 -YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEI 174
            +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    +
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARL 212
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLL 230
              W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     +
Sbjct: 213 PLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 231 GTPNEKVWPGVSSLMN-WHEYPQWNP 255
             P+        ++++ WH  P   P
Sbjct: 271 RAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 12  VGEGTYGKVYRAREKATG--KIVALKKTRL------HEDDEGVPPTTLREVSILRMLSRD 63
           +GEG +G+V +AR K  G     A+K+ +       H D  G       E+ +L  L   
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-------ELEVLCKLGHH 85
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFR------------QTGENIP 110
           P+++ L+        E R  LYL  EY    +L  ++R  R             T   + 
Sbjct: 86  PNIINLLGA-----CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 170
              +      + +G+ +      +HRDL   N+L+    +  KIAD GL+R   + +KK 
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKT 199
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              +   W       L  + Y+T  D+WS   +  E+V+
Sbjct: 200 MGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMD 71
           +G G +GKVY+   +   K VALK+ R  E  +G+        ++     R PH+V L+ 
Sbjct: 47  IGHGVFGKVYKGVLRDGAK-VALKR-RTPESSQGIEEFETEIETL--SFCRHPHLVSLIG 102
Query: 72  VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK-SLMYQLCKGVA--- 126
               +N+     + L+++YM+  +LK+++      G ++P  ++      ++C G A   
Sbjct: 103 FCDERNE-----MILIYKYMENGNLKRHL-----YGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 127 -FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPE 183
            + H   I+HRD+K  N+L+D +    KI D G+++  T   + +   ++  TL Y  PE
Sbjct: 153 HYLHTRAIIHRDVKSINILLD-ENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPE 211
Query: 184 VLL------GSTHYSTAVDMWSVACIFAELV 208
             +       S  YS  V ++ V C  + +V
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 11  KVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           K+G+G +G+V+      T ++    LK   +       P   L+E  +++ L R   +V+
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKL-RHEKLVQ 326
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L  V   +       +Y+V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+
Sbjct: 327 LYAVVSEE------PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAY 378
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEV 184
                 +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE 
Sbjct: 379 VERMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEA 435
Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
            L    ++   D+WS   +  EL TK  + +PG
Sbjct: 436 AL-YGRFTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 80
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 81  GVCTREPP-----FYIIIEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 130
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 182
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 183 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 239 PEGCP-EKVYELMRAC--W----QWNP 258

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 132 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 49/264 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 73
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 74  GVCTREPP-----FYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 126
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 127 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTXTAHAGAKFPIK---------- 175
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 176 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEG 234
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNP 255
            P EKV+  + +   W    QWNP
Sbjct: 235 CP-EKVYELMRAC--W----QWNP 251

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 76
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 77  GVCTREPP-----FYIIIEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 126
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 127 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTXTAHAGAKFPIK------- 178
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 179 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 234
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 235 PEGCP-EKVYELMRAC--W----QWNP 254

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 9   LEKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++++G G +G V+      K    I  +++  + E+D       + E  ++  LS  P +
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVMMKLSH-PKL 64
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L  V   Q       + LVFE+M+   L  Y+R+ R         T+  +   +C+G+
Sbjct: 65  VQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGM 116
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
           A+     ++HRDL   N L+  +   +K++D G+ R F L   +YT    T +   + +P
Sbjct: 117 AYLEEASVIHRDLAARNCLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASP 173
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTK 210
           EV    + YS+  D+WS   +  E+ ++
Sbjct: 174 EV-FSFSRYSSKSDVWSFGVLMWEVFSE 200

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 49/264 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 75
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 76  GVCTREPP-----FYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 128
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 129 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 177
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 178 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNP 255
            P EKV+  + +   W    QWNP
Sbjct: 237 CP-EKVYELMRAC--W----QWNP 253

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVMEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 132 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 93
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 94  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 146
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 147 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 206 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 234

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 95
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 96  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 148
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----LPIKKYTHEILTLWYRAP 182
           F      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 149 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 208 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 236

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 49/264 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 75
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 76  GVCTREPP-----FYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 128
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 129 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 177
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 178 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNP 255
            P EKV+  + +   W    QWNP
Sbjct: 237 CP-EKVYELMRAC--W----QWNP 253

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 8   KLEK-VGEGTYGKVYRAREKATGKIVA--LKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           KLEK +G G +G+V+ A      K+    +K   +  +        L E ++++ L  D 
Sbjct: 18  KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE------AFLAEANVMKTLQHD- 70
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            +V+L  V        +  +Y++ E+M    L  +++S    G   P+  +     Q+ +
Sbjct: 71  KLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAE 122
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYR 180
           G+AF      +HRDL+  N+L+   ++  KIAD GLAR   +   +YT        + + 
Sbjct: 123 GMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWT 179
Query: 181 APEVL-LGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDS 218
           APE +  GS  ++   D+WS   +  E+VT   + +PG S
Sbjct: 180 APEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMS 217

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLW 178
               +HRDL+  N+L+  + +  K+AD GLAR               PIK          
Sbjct: 132 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEXTARQGAKFPIK---------- 180
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
           + APE  L    ++   D+WS   +  EL TK  + +PG
Sbjct: 181 WTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVCEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 132 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 88
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 89  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 138
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 139 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 190
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 191 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 246
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 247 PEGCP-EKVYELMRAC--W----QWNP 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 9   LEKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++++G G +G V+      K    I  +++  + E+D       + E  ++  LS  P +
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVMMKLSH-PKL 67
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L  V   Q       + LVFE+M+   L  Y+R+ R         T+  +   +C+G+
Sbjct: 68  VQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGM 119
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
           A+     ++HRDL   N L+  +   +K++D G+ R F L   +YT    T +   + +P
Sbjct: 120 AYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASP 176
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTK 210
           EV    + YS+  D+WS   +  E+ ++
Sbjct: 177 EV-FSFSRYSSKSDVWSFGVLMWEVFSE 203

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 80
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 81  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 130
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 182
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 183 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 239 PEGCP-EKVYELMRAC--W----QWNP 258

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 117/254 (46%), Gaps = 29/254 (11%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 73
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 74  GVCTREPP-----FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 126
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL-PIKKYTHEILTLWYRAPEVLLGS 188
               +HRDL   N L+    + +K+AD GL+R  T      +      + + APE  L  
Sbjct: 127 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPES-LAY 184
Query: 189 THYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLH----IFRLLGTPNEKVWPGV 241
             +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G P EKV+  +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCP-EKVYELM 243
Query: 242 SSLMNWHEYPQWNP 255
            +   W    QWNP
Sbjct: 244 RAC--W----QWNP 251

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 132 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 76
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 77  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 126
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 127 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAPAGAKFPIK------- 178
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 179 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 234
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 235 PEGCP-EKVYELMRAC--W----QWNP 254

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 95
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 96  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 148
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRA 181
           F      +HRDL   N ++D K  T+K+AD GLAR      F     K   ++   W   
Sbjct: 149 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
               L +  ++T  D+WS   +  EL+T+ A
Sbjct: 208 ES--LQTQKFTTKSDVWSFGVLLWELMTRGA 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 94
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 95  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 147
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRA 181
           F      +HRDL   N ++D K  T+K+AD GLAR      F     K   ++   W   
Sbjct: 148 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
               L +  ++T  D+WS   +  EL+T+ A
Sbjct: 207 ES--LQTQKFTTKSDVWSFGVLLWELMTRGA 235

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 80
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 81  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 130
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 182
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 183 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 239 PEGCP-EKVYELMRAC--W----QWNP 258

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 16  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 70
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 71  AVVSEEP------IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 122
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 123 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 179
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 180 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 77
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 78  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 127
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAPAGAKFPIK------- 179
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 180 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 236 PEGCP-EKVYELMRAC--W----QWNP 255

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 75
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 76  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 125
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 177
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 178 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 234 PEGCP-EKVYELMRAC--W----QWNP 253

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 12  VGEGTYGKVYRAREKATG--KIVALKKTRL------HEDDEGVPPTTLREVSILRMLSRD 63
           +GEG +G+V +AR K  G     A+K+ +       H D  G       E+ +L  L   
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-------ELEVLCKLGHH 82
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFR------------QTGENIP 110
           P+++ L+        E R  LYL  EY    +L  ++R  R             T   + 
Sbjct: 83  PNIINLLGA-----CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY 170
              +      + +G+ +      +HR+L   N+L+    +  KIAD GL+R   + +KK 
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVA-KIADFGLSRGQEVYVKKT 196
Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              +   W       L  + Y+T  D+WS   +  E+V+
Sbjct: 197 MGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 9   LEKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++++G G +G V+      K    I  +++  + E+D       + E  ++  LS  P +
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVMMKLSH-PKL 64
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L  V   Q       + LVFE+M+   L  Y+R+ R         T+  +   +C+G+
Sbjct: 65  VQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGM 116
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
           A+     ++HRDL   N L+  +   +K++D G+ R F L   +YT    T +   + +P
Sbjct: 117 AYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASP 173
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTK 210
           EV    + YS+  D+WS   +  E+ ++
Sbjct: 174 EV-FSFSRYSSKSDVWSFGVLMWEVFSE 200

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 99
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 100 SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 152
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRA 181
           F      +HRDL   N ++D K  T+K+AD GLAR      F     K   ++   W   
Sbjct: 153 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
               L +  ++T  D+WS   +  EL+T+ A
Sbjct: 212 ES--LQTQKFTTKSDVWSFGVLLWELMTRGA 240

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 114/263 (43%), Gaps = 24/263 (9%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN-------TVKSLM---YQ 120
           ++     K G  ++ +V      +L  Y+RS R   E +P         T++ L+   +Q
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEILTL 177
           + KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    +   
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNV-VKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLGTP 233
           W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     +  P
Sbjct: 212 WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAP 269
Query: 234 NEKVWPGVSSLMN-WHEYPQWNP 255
           +        ++++ WH  P   P
Sbjct: 270 DYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 113
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 114 SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 166
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 167 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 226 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 254

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 14  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 68
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 69  AVVSEEP------IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 120
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 121 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 177
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 178 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 94
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 95  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 147
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRA 181
           F      +HRDL   N ++D K  T+K+AD GLAR      F     K   ++   W   
Sbjct: 148 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
               L +  ++T  D+WS   +  EL+T+ A
Sbjct: 207 ES--LQTQKFTTKSDVWSFGVLLWELMTRGA 235

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 77
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 78  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 127
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 179
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 180 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 236 PEGCP-EKVYELMRAC--W----QWNP 255

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 80  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 129
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 181
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 182 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 238 PEGCP-EKVYELMRAC--W----QWNP 257

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 92
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 93  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 145
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRA 181
           F      +HRDL   N ++D K  T+K+AD GLAR      F     K   ++   W   
Sbjct: 146 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
               L +  ++T  D+WS   +  EL+T+ A
Sbjct: 205 ES--LQTQKFTTKSDVWSFGVLLWELMTRGA 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 92
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 93  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 145
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 146 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 205 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 233

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 86
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 87  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 139
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 140 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 199 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 227

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 112
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 113 SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 165
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 166 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 225 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 253

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 80
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 81  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 130
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTXTAHAGAKFPIK------- 182
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 183 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 239 PEGCP-EKVYELMRAC--W----QWNP 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 9   LEKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++++G G +G V+      K    I  +++  + E+D       + E  ++  LS  P +
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVMMKLSH-PKL 62
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L  V   Q       + LVFE+M+   L  Y+R+ R         T+  +   +C+G+
Sbjct: 63  VQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGM 114
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
           A+     ++HRDL   N L+  +   +K++D G+ R F L   +YT    T +   + +P
Sbjct: 115 AYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASP 171
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTK 210
           EV    + YS+  D+WS   +  E+ ++
Sbjct: 172 EV-FSFSRYSSKSDVWSFGVLMWEVFSE 198

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 93
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 94  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 146
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 147 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 206 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 234

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREK-ATGKIVALKKTRLHEDDEGVPPTTLREVSILRM 59
           +V   +E    +  G  G +Y A ++   G+ V LK   +H  D       + E   L  
Sbjct: 77  IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAE 135
Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           +   P +V++ +  +  ++ G  V Y+V EY+     K     R  G+ +PV    + + 
Sbjct: 136 VVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLL 189
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++   +++ H  G+++ DLKP N+++  +   LK+ DLG        I  + +   T  +
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSR----INSFGYLYGTPGF 243
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAEL 207
           +APE++   T  + A D+++V    A L
Sbjct: 244 QAPEIV--RTGPTVATDIYTVGRTLAAL 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 55/267 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 77
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 78  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 127
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 179
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 180 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNP 255
             G P EKV+  + +   W    QWNP
Sbjct: 236 PEGCP-EKVYELMRAC--W----QWNP 255

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 153
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 154 SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 206
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----AFTLPIKKYTHEILTLWYRA 181
           F      +HRDL   N ++D K  T+K+AD GLAR      F     K   ++   W   
Sbjct: 207 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
               L +  ++T  D+WS   +  EL+T+ A
Sbjct: 266 ES--LQTQKFTTKSDVWSFGVLLWELMTRGA 294

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 94
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 95  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 147
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 148 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 207 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 235

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 8   KLEK-VGEGTYGKVYRAREKATGKIVA--LKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           KLEK +G G +G+V+ A      K+    +K   +  +        L E ++++ L  D 
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE------AFLAEANVMKTLQHD- 243
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            +V+L  V        +  +Y++ E+M    L  +++S    G   P+  +     Q+ +
Sbjct: 244 KLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAE 295
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYR 180
           G+AF      +HRDL+  N+L+   ++  KIAD GLAR   +   +YT        + + 
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWT 352
Query: 181 APEVL-LGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDS 218
           APE +  GS  ++   D+WS   +  E+VT   + +PG S
Sbjct: 353 APEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMS 390

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 91
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 92  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 144
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 145 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 204 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 232

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 55/268 (20%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 75
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 76  GVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 125
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEIL 175
           +      +HRDL   N L+    + +K+AD GL+R  T            PIK       
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK------- 177
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFR 228
              + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R
Sbjct: 178 ---WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQ 256
             G P EKV+  + +   W    QWNP 
Sbjct: 234 PEGCP-EKVYELMRAC--W----QWNPS 254

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 114/263 (43%), Gaps = 24/263 (9%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN-------TVKSLM---YQ 120
           ++     K G  ++ +V      +L  Y+RS R   E +P         T++ L+   +Q
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHEILTL 177
           + KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    +   
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLGTP 233
           W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     +  P
Sbjct: 212 WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 269
Query: 234 NEKVWPGVSSLMN-WHEYPQWNP 255
           +        ++++ WH  P   P
Sbjct: 270 DYTTPEMYQTMLDCWHGEPSQRP 292

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 89
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 90  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 142
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 143 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 202 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 230

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 49/264 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 75
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 76  GVCTREPP-----FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 128
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 129 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 177
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 178 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNP 255
            P EKV+  + +   W    QWNP
Sbjct: 237 CP-EKVYELMRAC--W----QWNP 253

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 49/264 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 80
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 81  GVCTREPP-----FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 133
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 134 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 182
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 183 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 241
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNP 255
            P EKV+  + +   W    QWNP
Sbjct: 242 CP-EKVYELMRAC--W----QWNP 258

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 10  EKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           E +G G +G VY     +    KI    K+     D G     L E  I++  S  P+V+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 94
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
            L+ +      EG  ++  V  YM   DL+ +IR+      N  V  +     Q+ KG+ 
Sbjct: 95  SLLGI--CLRSEGSPLV--VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 147
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTHEILTLWYRAP 182
           +      +HRDL   N ++D K  T+K+AD GLAR         +   T   L + + A 
Sbjct: 148 YLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           E  L +  ++T  D+WS   +  EL+T+ A
Sbjct: 207 ES-LQTQKFTTKSDVWSFGVLLWELMTRGA 235

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVTEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 132 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + F    K+G G++G++Y      T + VA+K     E+ +   P  L E  I R+L 
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQ 60
Query: 62  RDPHV--VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
               +  VR   V+   N        LV + +   L+     F      + + TV  L  
Sbjct: 61  GGTGIPNVRWFGVEGDYN-------VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLAD 110
Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLM--DRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           Q+   V F H    LHRD+KP N LM   R+   + I D GLA+ +       TH+ +  
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQHIP- 166
Query: 178 WYRAPEVLLGSTHYST 193
            YR  + L G+  Y++
Sbjct: 167 -YRENKNLTGTARYAS 181

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE L+ +G G + +V   + K TG++ A+K     +  +    +  RE   + +    
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             + +L    Q +N      LYLV EY +  DL   +  F   GE IP    +  + ++ 
Sbjct: 121 RWITQLHFAFQDEN-----YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIV 172
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
             +   H  G +HRD+KP N+L+DR    +++AD G
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFG 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +V      +L  Y+RS R   E +P       +Y           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDAR 211
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 212 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 49/264 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 75
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 76  GVCTREPP-----FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 128
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 129 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 177
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 178 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNP 255
            P EKV+  + +   W    QWNP
Sbjct: 237 CP-EKVYELMRAC--W----QWNP 253

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ + R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKI-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 132 RMNYVHRDLRAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +V      +L  Y+RS R   E +P       +Y           
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDAR 248
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 249 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 306
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 307 MRAPDYTTPEMYQTMLDCWHGEPSQRP 333

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +V      +L  Y+RS R   E +P       +Y           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDXVRKGDAR 211
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 212 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +V      +L  Y+RS R   E +P       +Y           
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDAR 211
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 212 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 94
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y+V EYM   +L  Y+R   +  E +    +  +  Q+   + +  
Sbjct: 95  GVCTLEPP-----FYIVTEYMPYGNLLDYLRECNR--EEVTAVVLLYMATQISSAMEYLE 147
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 148 KKNFIHRDLAARNCLVGENHV-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 196
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG 216
           + APE L  +T +S   D+W+   +  E+ T   + +PG
Sbjct: 197 WTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPG 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +V      +L  Y+RS R   E +P       +Y           
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDAR 202
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 203 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 79
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 80  AVVSEEP------IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL   N+L+  + +  K+AD GLAR   +   +YT        + + APE  L
Sbjct: 132 RMNYVHRDLAAANILVG-ENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAAL 188
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 189 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 47/288 (16%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           F  L+ +G+G++GKV  AR KA     A+K    K  L + +E      + E ++L    
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK---HIMSERNVLLKNV 96
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           + P +V L    Q  +K     LY V +Y++  +L  +++  R   E       +    +
Sbjct: 97  KHPFLVGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEP----RARFYAAE 147
Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +   + + H   I++RDLKP N+L+D +   + + D GL +         +    T  Y 
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYL 206
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV L    Y   VD W +  +  E++     F   +  +   +I              
Sbjct: 207 APEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------------ 253
Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
                         P  L    PN+      LLE +LQ D +KR+ AK
Sbjct: 254 -------------KPLQLK---PNITNSARHLLEGLLQKDRTKRLGAK 285

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +V      +L  Y+RS R   E +P       +Y           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDAR 213
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 214 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 271
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 272 MRAPDYTTPEMYQTMLDCWHGEPSQRP 298

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 192 KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGNMSPEAFLQEAQVMKKL-RHEKLVQLY 246
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       +Y+V EYM    L  +++   + G+ + +  +  +  Q+  G+A+  
Sbjct: 247 AVVSEEP------IYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE 298
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI---LTLWYRAPEVLL 186
               +HRDL+  N+L+  + +  K+AD GL R   +   +YT        + + APE  L
Sbjct: 299 RMNYVHRDLRAANILVG-ENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAPEAAL 355
Query: 187 GSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
               ++   D+WS   +  EL TK  + +PG
Sbjct: 356 -YGRFTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 26/265 (9%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN---------TVKSLM--- 118
           ++     K G  ++ +V      +L  Y+RS R   E +P           T++ L+   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHEIL 175
           +Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    + 
Sbjct: 155 FQVAKGMEFLASRKXIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRLLG 231
             W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     + 
Sbjct: 214 LKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 232 TPNEKVWPGVSSLMN-WHEYPQWNP 255
            P+        ++++ WH  P   P
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRP 296

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 49/264 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G +G+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 73
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 74  GVCTREPP-----FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 126
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HRDL   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 127 KKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTXTAHAGAKFPIK---------- 175
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG--DSELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 176 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEG 234
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNP 255
            P EKV+  + +   W    QWNP
Sbjct: 235 CP-EKVYELMRAC--W----QWNP 251

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 80/358 (22%), Positives = 134/358 (37%), Gaps = 97/358 (27%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE ++ +G G +G V+ A+ K      A+K+ RL  + E      +REV  L  L   P 
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALAKLEH-PG 65
Query: 66  VVRLMD----------------------------------------------------VK 73
           +VR  +                                                    V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 74  QGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGI 133
           Q Q    +  LY+  +    +  K   + R + E+        +  Q+ + V F H  G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 134 LHRDLKPHNLLMDRKTMTLKIADLGLARAFT---------LPIKKY-TH--EILTLWYRA 181
           +HRDLKP N+      + +K+ D GL  A            P+  Y TH  ++ T  Y +
Sbjct: 186 MHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE + G+ +YS  VD++S+  I  EL+     F    E  +++   R L  P        
Sbjct: 245 PEQIHGN-NYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVRNLKFP-------- 292
Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
             L+   +YPQ +                 +++ ML   P++R  A   +E+  F++L
Sbjct: 293 --LLFTQKYPQEHM----------------MVQDMLSPSPTERPEATDIIENAIFENL 332

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G+G +G+V+      T + VA+K  +        P   L+E  +++ L R   +V+L 
Sbjct: 15  KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKL-RHEKLVQLY 69
Query: 71  DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +       + +V EYM    L  +++   +TG+ + +  +  +  Q+  G+A+  
Sbjct: 70  AVVSEEP------IXIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE 121
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-----------AFTLPIKKYTHEILTLW 178
               +HRDL+  N+L+  + +  K+AD GLAR               PIK          
Sbjct: 122 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEXTARQGAKFPIK---------- 170
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG 216
           + APE  L    ++   D+WS   +  EL TK  + +PG
Sbjct: 171 WTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 11  KVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++GEG +GKV+ A          KI+   KT L +  +       RE  +L  L  + H+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKT-LKDASDNARKDFHREAELLTNLQHE-HI 77
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTG-----ENIPVNTVKSLMY- 119
           V+      G   EG   L +VFEYM   DL K++R+           N P    +S M  
Sbjct: 78  VKFY----GVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTHEI 174
              Q+  G+ +      +HRDL   N L+  + + +KI D G++R    T   +   H +
Sbjct: 133 IAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           L + +  PE ++    ++T  D+WS+  +  E+ T
Sbjct: 192 LPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFT 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 39/242 (16%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM-LS 61
           +D  + LE +G G YG VY+       + VA+K               + E +I R+ L 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQ-----NFINEKNIYRVPLM 64
Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              ++ R +   +    +GR    LV EY  +  L KY+           V++ + L + 
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW----VSSCR-LAHS 119
Query: 121 LCKGVAFCHGH---------GILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----LP 166
           + +G+A+ H            I HRDL   N+L+ +   T  I+D GL+   T      P
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV-KNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 167 IKK---YTHEILTLWYRAPEVLLGSTHYSTA------VDMWSVACIFAELVTK-TALFPG 216
            ++      E+ T+ Y APEVL G+ +          VDM+++  I+ E+  + T LFPG
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 217 DS 218
           +S
Sbjct: 239 ES 240

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M   + L+ +G+G +G V     +  G  VA+K  +    ++      L E S++  L R
Sbjct: 11  MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQL-R 63
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             ++V+L+ V      E +  LY+V EYM    L  Y+RS  ++   +  + +      +
Sbjct: 64  HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDV 117
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEI 174
           C+ + +  G+  +HRDL   N+L+    +  K++D GL +  +       LP+K      
Sbjct: 118 CEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK------ 170
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               + APE L  +  +ST  D+WS   +  E+ +
Sbjct: 171 ----WTAPEALREAA-FSTKSDVWSFGILLWEIYS 200

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 103/234 (44%), Gaps = 37/234 (15%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILR 58
           +  E +  +GEG +G+V++AR           +VA+K  +  E    +     RE +++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMA 105
Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFR-------------- 103
               +P++V+L+    G    G+ +  L+FEYM   DL +++RS                
Sbjct: 106 EFD-NPNIVKLL----GVCAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 104 QTGENIPVNTVKSLMYQLC------KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL 157
           +   + P     S   QLC       G+A+      +HRDL   N L+  + M +KIAD 
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADF 218
Query: 158 GLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           GL+R        K   ++ + + +  PE +     Y+T  D+W+   +  E+ +
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFS 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 11  KVGEGTYGKVYRA--------REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++GEG +GKV+ A        ++K    + ALK   L    +       RE  +L  L  
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNLQH 76
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSF------------RQTGENI 109
           + H+V+   V    +      L +VFEYM   DL K++R+             RQ    +
Sbjct: 77  E-HIVKFYGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPI 167
            ++ +  +  Q+  G+ +      +HRDL   N L+    + +KI D G++R    T   
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYY 189
Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           +   H +L + +  PE ++    ++T  D+WS   I  E+ T
Sbjct: 190 RVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFT 230

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +       +L  Y+RS R   E +P       +Y           
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDAR 202
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 203 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M   + L+ +G+G +G V     +  G  VA+K  +    ++      L E S++  L R
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQL-R 72
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             ++V+L+    G   E +  LY+V EYM    L  Y+RS  ++   +  + +      +
Sbjct: 73  HSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDV 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEI 174
           C+ + +  G+  +HRDL   N+L+    +  K++D GL +  +       LP+K      
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK------ 179
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               + APE L     +ST  D+WS   +  E+ +
Sbjct: 180 ----WTAPEALR-EKKFSTKSDVWSFGILLWEIYS 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M   + L+ +G+G +G V     +  G  VA+K  +    ++      L E S++  L R
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQL-R 57
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             ++V+L+    G   E +  LY+V EYM    L  Y+RS  ++   +  + +      +
Sbjct: 58  HSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDV 111
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEI 174
           C+ + +  G+  +HRDL   N+L+    +  K++D GL +  +       LP+K      
Sbjct: 112 CEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK------ 164
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               + APE L     +ST  D+WS   +  E+ +
Sbjct: 165 ----WTAPEALR-EKKFSTKSDVWSFGILLWEIYS 194

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 47/231 (20%)
Query: 12  VGEGTYGKVYRA-----REKATGKIVALKKTRLHEDDEGVPPTTLR----EVSILRMLSR 62
           +GEG +GKV +A     + +A    VA+K  +     E   P+ LR    E ++L+ ++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-----ENASPSELRDLLSEFNVLKQVNH 85
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN------------- 108
            PHV++L       +++G   L L+ EY     L+ ++R  R+ G               
Sbjct: 86  -PHVIKLYGA---CSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 109 -------IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR 161
                  + +  + S  +Q+ +G+ +     ++HRDL   N+L+  +   +KI+D GL+R
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 162 AF---TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                   +K+    I   W  A E L     Y+T  D+WS   +  E+VT
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 35/257 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 321
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY---QLCKGVA 126
            V   +        Y++ E+M   +L  Y+R   +   N  V     L+Y   Q+   + 
Sbjct: 322 GVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSAME 371
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI-KKYTHEILTLWYRAPEVL 185
           +      +HR+L   N L+    + +K+AD GL+R  T      +      + + APE  
Sbjct: 372 YLEKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES- 429
Query: 186 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFRLLGTPNEKVW 238
           L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G P EKV+
Sbjct: 430 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-EKVY 488
Query: 239 PGVSSLMNWHEYPQWNP 255
             + +   W    QWNP
Sbjct: 489 ELMRAC--W----QWNP 499

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +       +L  Y+RS R   E +P       +Y           
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTLP--IKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR  +  P  ++K    
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDAR 202
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 203 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 107/267 (40%), Gaps = 28/267 (10%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV-SILRMLSRDPHVVRLM 70
           +G G +G+V  A      K    +   +    EG   +  R + S L++L    H + ++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY----------- 119
           ++     K G  ++ +       +L  Y+RS R   E +P       +Y           
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRN--EFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 120 ---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL---PIKKYTHE 173
              Q+ KG+ F      +HRDL   N+L+  K + +KI D GLAR        ++K    
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDAR 202
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPG---DSELQQLLHIFRL 229
           +   W  APE +     Y+   D+WS   +  E+ +  A  +PG   D E  + L     
Sbjct: 203 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 260
Query: 230 LGTPNEKVWPGVSSLMN-WHEYPQWNP 255
           +  P+        ++++ WH  P   P
Sbjct: 261 MRAPDYTTPEMYQTMLDCWHGEPSQRP 287

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 76
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 77  NPHVCRLLGICL------TSTVQLIMQLMPFGXLLDYVREHK---DNIGSQYLLNWCVQI 127
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + +
Sbjct: 128 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 187 MALESILHRI-YTHQSDVWSYGVTVWELMT 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGXLLD-----YVREHK---DNIGSQYLLNWCVQIA 127
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 187 ALESILHRI-YTHQSDVWSYGVTVWELMT 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 49/265 (18%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           K+G G YG+VY    K     VA+K   L ED   V    L+E ++++ + + P++V+L+
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEV-EEFLKEAAVMKEI-KHPNLVQLL 282
Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V   +        Y++ E+M   +L  Y+R   +  + +    +  +  Q+   + +  
Sbjct: 283 GVCTRE-----PPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE 335
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTHEILTLW 178
               +HR+L   N L+    + +K+AD GL+R  T            PIK          
Sbjct: 336 KKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK---------- 384
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGD--SELQQLLH----IFRLLG 231
           + APE  L    +S   D+W+   +  E+ T   + +PG   S++ +LL     + R  G
Sbjct: 385 WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443
Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQ 256
            P EKV+  + +   W    QWNP 
Sbjct: 444 CP-EKVYELMRAC--W----QWNPS 461

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 76  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 126
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + +
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 186 MALESILHRI-YTHQSDVWSYGVTVWELMT 214

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 2/115 (1%)
Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 173
            +S  +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT  
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDF 216
Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
             T  Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 77
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 78  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 128
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + +
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 188 MALESILHRI-YTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 76
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 77  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 127
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + +
Sbjct: 128 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 187 MALESILHRI-YTHQSDVWSYGVTVWELMT 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 79
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 80  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 130
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + +
Sbjct: 131 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 190 MALESILHRI-YTHQSDVWSYGVTVWELMT 218

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 78
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 79  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 129
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + +
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 189 MALESILHRI-YTHQSDVWSYGVTVWELMT 217

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M   + L+ +G+G +G V     +  G  VA+K  +    ++      L E S++  L R
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQL-R 244
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             ++V+L+    G   E +  LY+V EYM    L  Y+RS  ++   +  + +      +
Sbjct: 245 HSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDV 298
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEI 174
           C+ + +  G+  +HRDL   N+L+    +  K++D GL +  +       LP+K      
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKLPVK------ 351
Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               + APE L     +ST  D+WS   +  E+ +
Sbjct: 352 ----WTAPEALR-EKKFSTKSDVWSFGILLWEIYS 381

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 6/154 (3%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F +LEK+G G +G V++  ++  G I A+K+++            LREV    +L +  H
Sbjct: 11  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           VVR        +      + +  EY +   L   I    +         +K L+ Q+ +G
Sbjct: 71  VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           + + H   ++H D+KP N+ + R ++    ++ G
Sbjct: 126 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 159

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 182 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 235
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 236 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 271

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 127 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 186 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 239
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 240 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 275

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 6/154 (3%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F +LEK+G G +G V++  ++  G I A+K+++            LREV    +L +  H
Sbjct: 11  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           VVR        +      + +  EY +   L   I    +         +K L+ Q+ +G
Sbjct: 71  VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           + + H   ++H D+KP N+ + R ++    ++ G
Sbjct: 126 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 159

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 47/231 (20%)
Query: 12  VGEGTYGKVYRA-----REKATGKIVALKKTRLHEDDEGVPPTTLR----EVSILRMLSR 62
           +GEG +GKV +A     + +A    VA+K  +     E   P+ LR    E ++L+ ++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-----ENASPSELRDLLSEFNVLKQVNH 85
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN------------- 108
            PHV++L       +++G   L L+ EY     L+ ++R  R+ G               
Sbjct: 86  -PHVIKLYGA---CSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 109 -------IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR 161
                  + +  + S  +Q+ +G+ +     ++HRDL   N+L+  +   +KI+D GL+R
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 162 AF---TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                   +K+    I   W  A E L     Y+T  D+WS   +  E+VT
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 6/154 (3%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F +LEK+G G +G V++  ++  G I A+K+++            LREV    +L +  H
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           VVR        +      + +  EY +   L   I    +         +K L+ Q+ +G
Sbjct: 73  VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           + + H   ++H D+KP N+ + R ++    ++ G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 182 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 235
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 236 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 271

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 6/154 (3%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F +LEK+G G +G V++  ++  G I A+K+++            LREV    +L +  H
Sbjct: 9   FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 68
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           VVR        +      + +  EY +   L   I    +         +K L+ Q+ +G
Sbjct: 69  VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           + + H   ++H D+KP N+ + R ++    ++ G
Sbjct: 124 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 157

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 37/226 (16%)
Query: 12  VGEGTYGKVYRAREKATGKI-----VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +G G +GKV  A      K      VA+K  +  + D       + E+ ++  L    ++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENI 111
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ----------------TGENI 109
           V L+             +YL+FEY    DL  Y+RS R+                  E++
Sbjct: 112 VNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 110 PVNTVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 166
            V T + L+   YQ+ KG+ F      +HRDL   N+L+    + +KI D GLAR   + 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARD-IMS 224
Query: 167 IKKYT---HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              Y    +  L + + APE L     Y+   D+WS   +  E+ +
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTT---LREVSILRMLSRDP 64
           LEK+G+G++G V R    A +GK V++    L  D    P      +REV+ +  L    
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR- 75
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++RL  V      +  T L  +   +D  L+K+   F        + T+     Q+ +G
Sbjct: 76  NLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFL-------LGTLSRYAVQVAEG 127
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRA 181
           + +      +HRDL   NLL+  + + +KI D GL RA       Y    H  +   + A
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE L   T +S A D W       E+ T
Sbjct: 187 PESLKTRT-FSHASDTWMFGVTLWEMFT 213

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 19/224 (8%)
Query: 12  VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPP-----TTLREVSILRMLSRD--- 63
           +G+G +G V+ A  + T ++    K        G  P     T   EV++L  +      
Sbjct: 39  LGKGGFGTVF-AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P V+RL+D  + Q  EG  +L L       DL  YI      GE       +    Q+  
Sbjct: 98  PGVIRLLDWFETQ--EG-FMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA 150
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            +  CH  G++HRD+K  N+L+D +    K+ D G      L  + YT    T  Y  PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFDGTRVYSPPE 208
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-LQQLLHI 226
            +    +++    +WS+  +  ++V     F  D E L+  LH 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTT---LREVSILRMLSRDP 64
           LEK+G+G++G V R    A +GK V++    L  D    P      +REV+ +  L    
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR- 71
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++RL  V      +  T L  +   +D  L+K+   F        + T+     Q+ +G
Sbjct: 72  NLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFL-------LGTLSRYAVQVAEG 123
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRA 181
           + +      +HRDL   NLL+  + + +KI D GL RA       Y    H  +   + A
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE L   T +S A D W       E+ T
Sbjct: 183 PESLKTRT-FSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTT---LREVSILRMLSRDP 64
           LEK+G+G++G V R    A +GK V++    L  D    P      +REV+ +  L    
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR- 81
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++RL  V      +  T L  +   +D  L+K+   F        + T+     Q+ +G
Sbjct: 82  NLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFL-------LGTLSRYAVQVAEG 133
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRA 181
           + +      +HRDL   NLL+  + + +KI D GL RA       Y    H  +   + A
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE L   T +S A D W       E+ T
Sbjct: 193 PESLKTRT-FSHASDTWMFGVTLWEMFT 219

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 110/243 (45%), Gaps = 37/243 (15%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT-----LREVSILRMLSRD 63
           ++++G G +G+V+      + K VA+K  +        P T      L E ++++ L  D
Sbjct: 18  VKRLGAGQFGEVWMGYYNNSTK-VAVKTLK--------PGTMSVQAFLEEANLMKTLQHD 68
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +VRL  V   +       +Y++ EYM    L  +++S    G  + +  +     Q+ 
Sbjct: 69  -KLVRLYAVVTREEP-----IYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIA 120
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWY 179
           +G+A+      +HRDL+  N+L+    M  KIAD GLAR   +   +YT        + +
Sbjct: 121 EGMAYIERKNYIHRDLRAANVLVSESLMC-KIADFGLAR--VIEDNEYTAREGAKFPIKW 177
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSE------LQQLLHIFRLLGT 232
            APE  +    ++   D+WS   +  E+VT   + +PG +       L Q   + R+   
Sbjct: 178 TAPEA-INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENC 236
Query: 233 PNE 235
           P+E
Sbjct: 237 PDE 239

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 206 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 259
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 260 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 145 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 203
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 204 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 257
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 258 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 293

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 100
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 101 NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 152
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 153 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 212 ALESILHRI-YTHQSDVWSYGVTVWELMT 239

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 47/231 (20%)
Query: 12  VGEGTYGKVYRA-----REKATGKIVALKKTRLHEDDEGVPPTTLR----EVSILRMLSR 62
           +GEG +GKV +A     + +A    VA+K  +     E   P+ LR    E ++L+ ++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-----ENASPSELRDLLSEFNVLKQVNH 85
Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN------------- 108
            PHV++L       +++G   L L+ EY     L+ ++R  R+ G               
Sbjct: 86  -PHVIKLYGA---CSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 109 -------IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR 161
                  + +  + S  +Q+ +G+ +     ++HRDL   N+L+  +   +KI+D GL+R
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 162 AFTLP---IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                   +K+    I   W  A E L     Y+T  D+WS   +  E+VT
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTT---LREVSILRMLSRDP 64
           LEK+G+G++G V R    A +GK V++    L  D    P      +REV+ +  L    
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR- 75
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++RL  V      +  T L  +   +D  L+K+   F        + T+     Q+ +G
Sbjct: 76  NLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFL-------LGTLSRYAVQVAEG 127
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRA 181
           + +      +HRDL   NLL+  + + +KI D GL RA       Y    H  +   + A
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE L   T +S A D W       E+ T
Sbjct: 187 PESLKTRT-FSHASDTWMFGVTLWEMFT 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 77
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 129
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 189 ALESILHRI-YTHQSDVWSYGVTVWELMT 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 127
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 187 ALESILHRI-YTHQSDVWSYGVTVWELMT 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTT---LREVSILRMLSRDP 64
           LEK+G+G++G V R    A +GK V++    L  D    P      +REV+ +  L    
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR- 71
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++RL  V      +  T L  +   +D  L+K+   F        + T+     Q+ +G
Sbjct: 72  NLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFL-------LGTLSRYAVQVAEG 123
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT---HEILTLWYRA 181
           + +      +HRDL   NLL+  + + +KI D GL RA       Y    H  +   + A
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE L   T +S A D W       E+ T
Sbjct: 183 PESLKTRT-FSHASDTWMFGVTLWEMFT 209

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 78
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 130
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 190 ALESILHRI-YTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 81
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 82  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 133
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 134 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 193 ALESILHRI-YTHQSDVWSYGVTVWELMT 220

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 9   LEKVGEGTYGKVYRAR--EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           ++++G G +G V+      K    I  +++  + E+D       + E  ++  LS  P +
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVMMKLSH-PKL 65
Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L  V   Q       + LV E+M+   L  Y+R+ R         T+  +   +C+G+
Sbjct: 66  VQLYGVCLEQAP-----ICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGM 117
Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAP 182
           A+     ++HRDL   N L+  +   +K++D G+ R F L   +YT    T +   + +P
Sbjct: 118 AYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFPVKWASP 174
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTK 210
           EV    + YS+  D+WS   +  E+ ++
Sbjct: 175 EV-FSFSRYSSKSDVWSFGVLMWEVFSE 201

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 85
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 86  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 137
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 138 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 197 ALESILHRI-YTHQSDVWSYGVTVWELMT 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 78
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 130
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 190 ALESILHRI-YTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 78
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 130
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 190 ALESILHRI-YTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 82
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 134
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 194 ALESILHRI-YTHQSDVWSYGVTVWELMT 221

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 30/179 (16%)
Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           + Q+  G  + H + ++HRDLK  NL ++ + + +KI D GLA       ++      T 
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVL    H S  VD+WS+ CI   L+     F      +  L I +     NE  
Sbjct: 180 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----NEYS 233
Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            P              NP + +            L+++MLQ DP+ R +  + +   +F
Sbjct: 234 IPK-----------HINPVAAS------------LIQKMLQTDPTARPTINELLNDEFF 269

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 56/206 (27%)
Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 171
           +T+ +++ ++ +G+ + H +G +HRD+K  N+L+     +++IAD G++ AF       T
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS-AFLATGGDIT 178
Query: 172 HE------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
                   + T  + APEV+     Y    D+WS      EL T  A             
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA------------- 225
Query: 226 IFRLLGTPNEKVWPGVSSLMNWHEYP---------QWNPQSLATAVPNLD------KDGL 270
                                +H+YP         Q +P SL T V + +      K   
Sbjct: 226 --------------------PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR 265
Query: 271 DLLEQMLQYDPSKRISAKKAMEHPYF 296
            ++   LQ DP KR +A + + H +F
Sbjct: 266 KMISLCLQKDPEKRPTAAELLRHKFF 291

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 69
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 121
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 181 ALESILHRI-YTHQSDVWSYGVTVWELMT 208

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +VG G++G+V+R ++K TG   A+KK RL           + E+     LS  P +V L 
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------VFRVEELVACAGLS-SPRIVPLY 132
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
               G  +EG  V   +       L + I+   Q G  +P +     + Q  +G+ + H 
Sbjct: 133 ----GAVREGPWVNIFMELLEGGSLGQLIK---QMG-CLPEDRALYYLGQALEGLEYLHT 184
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY-------RAPE 183
             ILH D+K  N+L+        + D G   A  L        +LT  Y        APE
Sbjct: 185 RRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT 209
           V++G       VD+WS  C+   ++ 
Sbjct: 243 VVMGKP-CDAKVDIWSSCCMMLHMLN 267

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 127
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 187 ALESILHRI-YTHQSDVWSYGVTVWELMT 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 34/219 (15%)
Query: 12  VGEGTYGKVYRAR-EKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRMLSRDPHVVR 68
           +G+G +G V  A+ ++  G  V +    L  D          LRE + ++     PHV +
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAK 89
Query: 69  LMDVKQGQNKEGRT-VLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCK 123
           L+ V      +GR  +  ++  +M   DL  ++ + R  GEN   +P+ T+   M  +  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR-IGENPFNLPLQTLVRFMVDIAC 148
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR------------AFTLPIKKYT 171
           G+ +      +HRDL   N ++  + MT+ +AD GL+R            A  LP+K   
Sbjct: 149 GMEYLSSRNFIHRDLAARNCML-AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
            E            L    Y+   D+W+      E++T+
Sbjct: 208 LES-----------LADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           +VG G++G+V+R ++K TG   A+KK RL           + E+     LS  P +V L 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLS-SPRIVPLY 116
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
               G  +EG  V   +       L + I+   Q G  +P +     + Q  +G+ + H 
Sbjct: 117 ----GAVREGPWVNIFMELLEGGSLGQLIK---QMG-CLPEDRALYYLGQALEGLEYLHT 168
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY-------RAPE 183
             ILH D+K  N+L+        + D G   A  L        +LT  Y        APE
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT 209
           V++G       VD+WS  C+   ++ 
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLN 251

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 12  VGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A     GK        V + K+  H D++      + E+ I+  L +  
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQHE 102
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF------RQTGENIPVNTVKSLM 118
           ++V L+    G    G  VL +       DL  ++R        ++ G  + +  +    
Sbjct: 103 NIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEIL 175
            Q+ +G+AF      +HRD+   N+L+    +  KI D GLAR     +  I K    + 
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA-KIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             W  APE +     Y+   D+WS   +  E+ +
Sbjct: 218 VKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 32/220 (14%)
Query: 12  VGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A     GK        V + K+  H D++      + E+ I+  L +  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQHE 110
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN---------TVK 115
           ++V L+    G    G  VL +       DL  ++R  R  G     N         + +
Sbjct: 111 NIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 116 SLMY---QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKK 169
            L++   Q+ +G+AF      +HRD+   N+L+    +  KI D GLAR     +  I K
Sbjct: 167 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA-KIGDFGLARDIMNDSNYIVK 225
Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
               +   W  APE +     Y+   D+WS   +  E+ +
Sbjct: 226 GNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 56/206 (27%)
Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT 171
           +T+ +++ ++ +G+ + H +G +HRD+K  N+L+     +++IAD G++ AF       T
Sbjct: 116 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS-AFLATGGDIT 173
Query: 172 HE------ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
                   + T  + APEV+     Y    D+WS      EL T  A             
Sbjct: 174 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA------------- 220
Query: 226 IFRLLGTPNEKVWPGVSSLMNWHEYP---------QWNPQSLATAVPNLD------KDGL 270
                                +H+YP         Q +P SL T V + +      K   
Sbjct: 221 --------------------PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR 260
Query: 271 DLLEQMLQYDPSKRISAKKAMEHPYF 296
            ++   LQ DP KR +A + + H +F
Sbjct: 261 KMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 110/243 (45%), Gaps = 37/243 (15%)
Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT-----LREVSILRMLSRD 63
           ++K+G G +G+V+      + K VA+K  +        P T      L E ++++ L  D
Sbjct: 17  VKKLGAGQFGEVWMGYYNNSTK-VAVKTLK--------PGTMSVQAFLEEANLMKTLQHD 67
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +VRL  V   +       +Y++ E+M    L  +++S    G  + +  +     Q+ 
Sbjct: 68  -KLVRLYAVVTKEEP-----IYIITEFMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIA 119
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWY 179
           +G+A+      +HRDL+  N+L+    M  KIAD GLAR   +   +YT        + +
Sbjct: 120 EGMAYIERKNYIHRDLRAANVLVSESLMC-KIADFGLAR--VIEDNEYTAREGAKFPIKW 176
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGD------SELQQLLHIFRLLGT 232
            APE  +    ++   ++WS   +  E+VT   + +PG       S L Q   + R+   
Sbjct: 177 TAPEA-INFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENC 235
Query: 233 PNE 235
           P+E
Sbjct: 236 PDE 238

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIMELREATSPKANKEILDEAYVMASVD 109
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 110 NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 161
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 162 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 221 ALESILHRI-YTHQSDVWSYGVTVWELMT 248

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 12  VGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A     GK        V + K+  H D++      + E+ I+  L +  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQHE 110
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF------RQTGENIPVNTVKSLM 118
           ++V L+    G    G  VL +       DL  ++R        ++ G  + +  +    
Sbjct: 111 NIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEIL 175
            Q+ +G+AF      +HRD+   N+L+    +  KI D GLAR     +  I K    + 
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA-KIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             W  APE +     Y+   D+WS   +  E+ +
Sbjct: 226 VKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 22/228 (9%)
Query: 20  VYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSR--DPHVVRLMDVKQG 75
           VY A +    +IVALK     L  D    P    R     R   R  +PHVV + D  + 
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSD----PVFRTRXQREARTAGRLQEPHVVPIHDFGEI 105
Query: 76  QNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGIL 134
             +     LY+    ++  DL   +R  RQ G   P   V +++ Q+   +   H  G  
Sbjct: 106 DGQ-----LYVDXRLINGVDLAAXLR--RQ-GPLAPPRAV-AIVRQIGSALDAAHAAGAT 156
Query: 135 HRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHEILTLWYRAPEVLLGSTHYST 193
           HRD+KP N+L+        + D G+A A T   + +  + + TL+Y APE     +H + 
Sbjct: 157 HRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATY 214
Query: 194 AVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
             D++++ C+  E +T +  + GD       HI + +  P+  V PG+
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPS-TVRPGI 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 12  VGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A     GK        V + K+  H D++      + E+ I+  L +  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQHE 110
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS-------- 116
           ++V L+    G    G  VL +       DL  ++R   +  E  P   + +        
Sbjct: 111 NIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 117 --LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYT 171
                Q+ +G+AF      +HRD+   N+L+    +  KI D GLAR     +  I K  
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA-KIGDFGLARDIMNDSNYIVKGN 225
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             +   W  APE +     Y+   D+WS   +  E+ +
Sbjct: 226 ARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 12  VGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A     GK        V + K+  H D++      + E+ I+  L +  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQHE 110
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS-------- 116
           ++V L+    G    G  VL +       DL  ++R   +  E  P   + +        
Sbjct: 111 NIVNLL----GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 117 --LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYT 171
                Q+ +G+AF      +HRD+   N+L+    +  KI D GLAR     +  I K  
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA-KIGDFGLARDIMNDSNYIVKGN 225
Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             +   W  APE +     Y+   D+WS   +  E+ +
Sbjct: 226 ARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 72
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 124
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           +G+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 184 ALESILHRI-YTHQSDVWSYGVTVWELMT 211

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLM 70
           ++G G++G+V+R ++K TG   A+KK RL           + E+     LS  P +V L 
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------VFRVEELVACAGLS-SPRIVPLY 130
Query: 71  DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG 130
               G  +EG  V   +       L + I+   Q G  +P +     + Q  +G+ + H 
Sbjct: 131 ----GAVREGPWVNIFMELLEGGSLGQLIK---QMG-CLPEDRALYYLGQALEGLEYLHT 182
Query: 131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY-------RAPE 183
             ILH D+K  N+L+        + D G   A  L        +LT  Y        APE
Sbjct: 183 RRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT 209
           V++G       VD+WS  C+   ++ 
Sbjct: 241 VVMGKP-CDAKVDIWSSCCMMLHMLN 265

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 77
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 78  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 128
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D G A+      K+Y  E   + + +
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 188 MALESILHRI-YTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 77
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 78  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 128
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D G A+      K+Y  E   + + +
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 188 MALESILHRI-YTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 79
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 80  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 130
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D G A+      K+Y  E   + + +
Sbjct: 131 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 190 MALESILHRI-YTHQSDVWSYGVTVWELMT 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +  G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 82
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
            PHV RL+ +         + + L+ + M    L  Y+R  +   +NI    + +   Q+
Sbjct: 83  NPHVCRLLGICL------TSTVQLIMQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQI 133
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWY 179
            KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + +
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            A E +L    Y+   D+WS      EL+T
Sbjct: 193 MALESILHRI-YTHQSDVWSYGVTVWELMT 221

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 8   KLEKV-GEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           K+E+V G G +G+V   R K  GK    VA+K  ++    E      L E SI+      
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT-EKQRRDFLCEASIMGQFDH- 103
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P+VV L    +G    G+ V+ +V E+M+   L  ++R  +  G+   +  V  ++  + 
Sbjct: 104 PNVVHL----EGVVTRGKPVM-IVIEFMENGALDAFLR--KHDGQFTVIQLV-GMLRGIA 155
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYT---HEILTLW 178
            G+ +    G +HRDL   N+L++   +  K++D GL+R     P   YT    +I   W
Sbjct: 156 AGMRYLADMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW 214
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             APE +     +++A D+WS   +  E+++
Sbjct: 215 -TAPEAIQ-YRKFTSASDVWSYGIVMWEVMS 243

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 9   LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTT---LREVSILRMLSRDP 64
           LEK+G+G++G V R    A +GK V++    L  D    P      +REV+ +  L    
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR- 81
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++RL  V      +  T L  +   +D  L+K+   F        + T+     Q+ +G
Sbjct: 82  NLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFL-------LGTLSRYAVQVAEG 133
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-----YTHEILTLWY 179
           + +      +HRDL   NLL+  + + +KI D GL RA  LP          H  +   +
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRA--LPQNDDHXVMQEHRKVPFAW 190
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            APE L   T +S A D W       E+ T
Sbjct: 191 CAPESLKTRT-FSHASDTWMFGVTLWEMFT 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDPHVVRL 69
           ++G G++G+V+R  +K TG   A+KK RL            R   ++       P +V L
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLE---------VFRAEELMACAGLTSPRIVPL 131
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G  +EG  V   +       L + ++   + G  +P +     + Q  +G+ + H
Sbjct: 132 Y----GAVREGPWVNIFMELLEGGSLGQLVK---EQG-CLPEDRALYYLGQALEGLEYLH 183
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY-------RAP 182
              ILH D+K  N+L+        + D G   A  L       ++LT  Y        AP
Sbjct: 184 SRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKDLLTGDYIPGTETHMAP 241
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVT 209
           EV+LG +     VD+WS  C+   ++ 
Sbjct: 242 EVVLGRS-CDAKVDVWSSCCMMLHMLN 267

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKT-------RLHEDDEGVPPTTLREVSILRML-- 60
           +++G G++G VY+ +      +  L  T       +  +++ GV   T R V+IL  +  
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 76
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLM 118
           S  P +  +    +G +      LY      +T  ++KK I   RQT             
Sbjct: 77  STKPQLAIVTQWCEGSS------LYHHLHASETKFEMKKLIDIARQT------------- 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT-- 176
               +G+ + H   I+HRDLK +N+ +     T+KI D GLA   +     +  E L+  
Sbjct: 118 ---ARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATVKSRWSGSHQFEQLSGS 173
Query: 177 -LWYRAPEV--LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
            LW  APEV  +  S  YS   D+++   +  EL+T    +   +   Q++ +
Sbjct: 174 ILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 225

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 127
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D G A+      K+Y  E   + + + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 187 ALESILHRI-YTHQSDVWSYGVTVWELMT 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPH 65
           E +G+G +G+V+R +   E+   KI + ++ R    + E      LR  +IL  ++ D  
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD-- 105
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQL 121
                     ++    T L+LV +Y +   L  Y+  +  T E    + ++T   L +  
Sbjct: 106 ---------NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 156
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILT 176
            + V       I HRDLK  N+L+ +K  T  IADLGLA        T+ I    H + T
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGT 214
Query: 177 LWYRAPEVL---LGSTHYST--AVDMWSVACIFAELVTKTAL 213
             Y APEVL   +   H+ +    D++++  +F E+  + ++
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 9   LEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTT---LREVSILRMLSRDP 64
           LEK+G+G++G V R    A +GK V++    L  D    P      +REV+ +  L    
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR- 71
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +++RL  V      +  T L  +   +D  L+K+   F        + T+     Q+ +G
Sbjct: 72  NLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFL-------LGTLSRYAVQVAEG 123
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-----YTHEILTLWY 179
           + +      +HRDL   NLL+  + + +KI D GL RA  LP          H  +   +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRA--LPQNDDHXVMQEHRKVPFAW 180
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            APE L   T +S A D W       E+ T
Sbjct: 181 CAPESLKTRT-FSHASDTWMFGVTLWEMFT 209

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 77
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 129
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D G A+      K+Y  E   + + + 
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 189 ALESILHRI-YTHQSDVWSYGVTVWELMT 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +  G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 127
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 187 ALESILHRI-YTHQSDVWSYGVTVWELMT 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPH 65
           E +G+G +G+V+R +   E+   KI + ++ R    + E      LR  +IL  ++ D  
Sbjct: 9   ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD-- 66
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQL 121
                     ++    T L+LV +Y +   L  Y+  +  T E    + ++T   L +  
Sbjct: 67  ---------NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILT 176
            + V       I HRDLK  N+L+ +K  T  IADLGLA        T+ I    H + T
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGT 175
Query: 177 LWYRAPEVL---LGSTHYST--AVDMWSVACIFAELVTKTAL 213
             Y APEVL   +   H+ +    D++++  +F E+  + ++
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +  G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 82
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 134
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D GLA+      K+Y  E   + + + 
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 194 ALESILHRI-YTHQSDVWSYGVTVWELMT 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPH 65
           E +G+G +G+V+R +   E+   KI + ++ R    + E      LR  +IL  ++ D  
Sbjct: 15  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD-- 72
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQL 121
                     ++    T L+LV +Y +   L  Y+  +  T E    + ++T   L +  
Sbjct: 73  ---------NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 123
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILT 176
            + V       I HRDLK  N+L+ +K  T  IADLGLA        T+ I    H + T
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGT 181
Query: 177 LWYRAPEVL---LGSTHYST--AVDMWSVACIFAELVTKTAL 213
             Y APEVL   +   H+ +    D++++  +F E+  + ++
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPH 65
           E +G+G +G+V+R +   E+   KI + ++ R    + E      LR  +IL  ++ D  
Sbjct: 10  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD-- 67
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQL 121
                     ++    T L+LV +Y +   L  Y+  +  T E    + ++T   L +  
Sbjct: 68  ---------NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 118
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILT 176
            + V       I HRDLK  N+L+ +K  T  IADLGLA        T+ I    H + T
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGT 176
Query: 177 LWYRAPEVL---LGSTHYST--AVDMWSVACIFAELVTKTAL 213
             Y APEVL   +   H+ +    D++++  +F E+  + ++
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 218

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREV--SILRMLSRD 63
           F+K++ +G G +G VY+      G+ V +    + E  E   P   +E+      M S D
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVD 82
Query: 64  -PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            PHV RL+ +      +  T L      +D     Y+R  +   +NI    + +   Q+ 
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLD-----YVREHK---DNIGSQYLLNWCVQIA 134
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+ +    +KI D G A+      K+Y  E   + + + 
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           A E +L    Y+   D+WS      EL+T
Sbjct: 194 ALESILHRI-YTHQSDVWSYGVTVWELMT 221

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------T 176
            G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA     +K+   ++      T
Sbjct: 144 NGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARA----SEKFAQTVMXSRIVGT 198
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             Y APE L G    +   D++S   +  E++T
Sbjct: 199 TAYMAPEALRGEI--TPKSDIYSFGVVLLEIIT 229

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 104/253 (41%), Gaps = 49/253 (19%)
Query: 12  VGEGTYGKVYRA-------REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A        + A    V + K   H  +       + E+ +L  L    
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSYLGNHM 103
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM------ 118
           ++V L+    G    G   L +       DL  ++R  R+    I   T  ++M      
Sbjct: 104 NIVNLL----GACTIGGPTLVITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDDELA 157
Query: 119 ----------YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK 168
                     YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIK 212
Query: 169 KYTHEI------LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DS 218
             ++ +      L + + APE +     Y+   D+WS      EL +  ++ +PG   DS
Sbjct: 213 NDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 271
Query: 219 ELQQLL-HIFRLL 230
           +  +++   FR+L
Sbjct: 272 KFYKMIKEGFRML 284

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------T 176
            G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA     +K+   ++      T
Sbjct: 144 NGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARAS----EKFAQTVMXXRIVGT 198
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             Y APE L G    +   D++S   +  E++T
Sbjct: 199 TAYMAPEALRGEI--TPKSDIYSFGVVLLEIIT 229

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 16/216 (7%)
Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE L+ +G G +G+V   + K   K+ A+K     E  +       RE   + +      
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +  L    Q  N      LYLV +Y +  DL   +  F    + +P    +  + ++   
Sbjct: 136 ITTLHYAFQDDNN-----LYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIA 187
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-RAFTLPIKKYTHEILTLWYRAPE 183
           +   H    +HRD+KP N+LMD     +++AD G   +       + +  + T  Y +PE
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 184 VLL----GSTHYSTAVDMWSVA-CIFAELVTKTALF 214
           +L     G   Y    D WS+  C++  L  +T  +
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL------T 176
            G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA     +K+   ++      T
Sbjct: 138 NGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARA----SEKFAQXVMXXRIVGT 192
Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
             Y APE L G    +   D++S   +  E++T
Sbjct: 193 TAYMAPEALRGEI--TPKSDIYSFGVVLLEIIT 223

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPH 65
           E +G+G +G+V+R +   E+   KI + ++ R    + E      LR  +IL  ++ D  
Sbjct: 35  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD-- 92
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQL 121
                     ++    T L+LV +Y +   L  Y+  +  T E    + ++T   L +  
Sbjct: 93  ---------NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 143
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILT 176
            + V       I HRDLK  N+L+ +K  T  IADLGLA        T+ I    H + T
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGT 201
Query: 177 LWYRAPEVL---LGSTHYST--AVDMWSVACIFAELVTKTAL 213
             Y APEVL   +   H+ +    D++++  +F E+  + ++
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 243

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 174
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 167 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIKNDSNYVV 221
Query: 175 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 224
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 222 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280
Query: 225 HIFRLL 230
             FR+L
Sbjct: 281 EGFRML 286

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 174
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIKNDSNYVV 226
Query: 175 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 224
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 227 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 225 HIFRLL 230
             FR+L
Sbjct: 286 EGFRML 291

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTR-LHEDDEGVPPTTLREVSILRMLSRDPH 65
           E +G+G +G+V+R +   E+   KI + ++ R    + E      LR  +IL  ++ D  
Sbjct: 12  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD-- 69
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN---IPVNTVKSLMYQL 121
                     ++    T L+LV +Y +   L  Y+  +  T E    + ++T   L +  
Sbjct: 70  ---------NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 120
Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTLPIKKYTHEILT 176
            + V       I HRDLK  N+L+ +K  T  IADLGLA        T+ I    H + T
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAP-NHRVGT 178
Query: 177 LWYRAPEVL---LGSTHYST--AVDMWSVACIFAELVTKTAL 213
             Y APEVL   +   H+ +    D++++  +F E+  + ++
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI- 174
           S  YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK  ++ + 
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARH----IKNDSNYVV 226
Query: 175 -----LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSELQQLL- 224
                L + + APE +     Y+   D+WS      EL +  ++ +PG   DS+  +++ 
Sbjct: 227 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 225 HIFRLL 230
             FR+L
Sbjct: 286 EGFRML 291

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 104/253 (41%), Gaps = 49/253 (19%)
Query: 12  VGEGTYGKVYRA-------REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +G G +GKV  A        + A    V + K   H  +       + E+ +L  L    
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSYLGNHM 87
Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM------ 118
           ++V L+    G    G   L +       DL  ++R  R+    I   T  ++M      
Sbjct: 88  NIVNLL----GACTIGGPTLVITEYCCYGDLLNFLR--RKRDSFICSKTSPAIMEDDELA 141
Query: 119 ----------YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK 168
                     YQ+ KG+AF      +HRDL   N+L+    +T KI D GLAR     IK
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLAR----DIK 196
Query: 169 KYTHEI------LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DS 218
             ++ +      L + + APE +     Y+   D+WS      EL +  ++ +PG   DS
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 219 ELQQLL-HIFRLL 230
           +  +++   FR+L
Sbjct: 256 KFYKMIKEGFRML 268

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKT-------RLHEDDEGVPPTTLREVSILRML-- 60
           +++G G++G VY+ +      +  L  T       +  +++ GV   T R V+IL  +  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 88
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLM 118
           S  P +  +    +G      + LY      +T  ++KK I   RQT             
Sbjct: 89  STKPQLAIVTQWCEG------SSLYHHLHASETKFEMKKLIDIARQT------------- 129
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT-- 176
               +G+ + H   I+HRDLK +N+ +     T+KI D GLA   +     +  E L+  
Sbjct: 130 ---ARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 177 -LWYRAPEV--LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
            LW  APEV  +  S  YS   D+++   +  EL+T    +   +   Q++ +
Sbjct: 186 ILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 12  VGEGTYGKVYRAREKATGK------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +G G  G+V   R +  G+      I ALK               L E SI+      P+
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQFDH-PN 111
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++RL    +G    GR  + +V EYM+   L  ++R+    G+   +  +  ++  +  G
Sbjct: 112 IIRL----EGVVTRGRLAM-IVTEYMENGSLDTFLRT--HDGQ-FTIMQLVGMLRGVGAG 163
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRA 181
           + +    G +HRDL   N+L+D   +  K++D GL+R     P   YT     + + + A
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE +   T +S+A D+WS   +  E++ 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKT-------RLHEDDEGVPPTTLREVSILRML-- 60
           +++G G++G VY+ +      +  L  T       +  +++ GV   T R V+IL  +  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 88
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLM 118
           S  P +  +    +G      + LY      +T  ++KK I   RQT             
Sbjct: 89  STAPQLAIVTQWCEG------SSLYHHLHASETKFEMKKLIDIARQT------------- 129
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT-- 176
               +G+ + H   I+HRDLK +N+ +     T+KI D GLA   +     +  E L+  
Sbjct: 130 ---ARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 177 -LWYRAPEV--LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
            LW  APEV  +  S  YS   D+++   +  EL+T    +   +   Q++ +
Sbjct: 186 ILWM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 28/207 (13%)
Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDPHVVRL 69
           ++G G++G+V+R  +K TG   A+KK RL            R   ++       P +V L
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLE---------VFRAEELMACAGLTSPRIVPL 150
Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G  +EG  V   +       L + ++   + G  +P +     + Q  +G+ + H
Sbjct: 151 Y----GAVREGPWVNIFMELLEGGSLGQLVK---EQG-CLPEDRALYYLGQALEGLEYLH 202
Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY-------RAP 182
              ILH D+K  N+L+        + D G   A  L        +LT  Y        AP
Sbjct: 203 SRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKSLLTGDYIPGTETHMAP 260
Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVT 209
           EV+LG +     VD+WS  C+   ++ 
Sbjct: 261 EVVLGRS-CDAKVDVWSSCCMMLHMLN 286

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           +G G +G+V   R K  GK    VA+K  ++    E      L E SI+      P+++ 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIH 87
Query: 69  LMDVKQGQNKEGRTVLYLVFEYM-----DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           L    +G   + + V+ +V EYM     DT LKK    F        V  +  ++  +  
Sbjct: 88  L----EGVVTKSKPVM-IVTEYMENGSLDTFLKKNDGQFT-------VIQLVGMLRGISA 135
Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYR 180
           G+ +    G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + 
Sbjct: 136 GMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT 209
           APE  +    +++A D+WS   +  E+V+
Sbjct: 195 APEA-IAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA---FTLPIKKYTHEILTLWY 179
            G+ F H +  +HRD+K  N+L+D +  T KI+D GLARA   F   +   +  + T  Y
Sbjct: 135 NGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXX-SRIVGTTAY 192
Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            APE L G    +   D++S   +  E++T
Sbjct: 193 XAPEALRGEI--TPKSDIYSFGVVLLEIIT 220

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 110
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 111 L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GLAR     P   YT     + + + +PE 
Sbjct: 163 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 222 -IAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 107 ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-AFTL 165
           E I +  + S  +Q+ +G+ F      +HRDL   N+L+    + +KI D GLAR  +  
Sbjct: 194 EPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKN 252
Query: 166 P--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPG---DSE 219
           P  ++K    +   W  APE +     YST  D+WS   +  E+ +   + +PG   D +
Sbjct: 253 PDYVRKGDTRLPLKWM-APESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDED 310
Query: 220 LQQLLHIFRLLGTPNEKVWPGVSSLM--NWHEYPQWNPQ 256
               L     +  P E   P +  +M   WH  P+  P+
Sbjct: 311 FCSRLREGMRMRAP-EYSTPEIYQIMLDCWHRDPKERPR 348

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 42/245 (17%)
Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILR-ML 60
           +    + ++++G+G YG+V+  + +  G+ VA+K     E+      +  RE  I + +L
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-----ASWFRETEIYQTVL 87
Query: 61  SRDPHVVRLM--DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
            R  +++  +  D+K        T LYL+ +Y +   L  Y++S       +   ++  L
Sbjct: 88  MRHENILGFIAADIK---GTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKL 139
Query: 118 MYQLCKGVAFCHGH----------GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI 167
            Y    G+  CH H           I HRDLK  N+L+ +K  T  IADLGLA  F    
Sbjct: 140 AYSSVSGL--CHLHTEIFSTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVKFISDT 196
Query: 168 KKY----THEILTLWYRAPEVL---LGSTHYSTAV--DMWSVACIFAELVTKTALFPGDS 218
            +        + T  Y  PEVL   L   H+ + +  DM+S   I  E V +  +  G  
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIV 255
Query: 219 ELQQL 223
           E  QL
Sbjct: 256 EEYQL 260

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 110
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 111 L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 163 LSDMGFVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 222 -IAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRL--HEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 75
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 76  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 125
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 126 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 185 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 236

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 91
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 92  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 141
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 201 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 252

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 91
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 92  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 141
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 201 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 252

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 75
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 76  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 125
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 126 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 185 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 236

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 69
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 70  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 119
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 120 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 179 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 230

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 110
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 111 L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 163 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 222 -IAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 110
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 111 L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 163 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 222 -IAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 110
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 111 L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 163 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 222 -IAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 71
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 72  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 121
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 181 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 81
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 82  L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 134 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 193 -IAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 110
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 111 L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 163 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 222 -IAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRL--HEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 89
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 90  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 139
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 140 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 199 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 250

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 108
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 109 L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 161 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 219
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 220 -IAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 22/233 (9%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRL--HEDDEGVPPTTLREVSILRMLSRDPHVV 67
           +++G G +G V +   +    +  +    L    +D  +    L E ++++ L  +P++V
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 81
Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++ + + ++        LV E  +   L KY++  R   +      +  L++Q+  G+ 
Sbjct: 82  RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMK 131
Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---YRAPE 183
           +      +HRDL   N+L+  +    KI+D GL++A       Y  +    W   + APE
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 184 VLLGSTHYSTAVDMWSVACIFAELVT---KTALFPGDSELQQLLHIFRLLGTP 233
             +    +S+  D+WS   +  E  +   K       SE+  +L     +G P
Sbjct: 191 C-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 242

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 32/165 (19%)
Query: 6   FEKLEK---VGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           FE+LE    +G+G +G+VY  R       VA++   +  D+E       REV   R  +R
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQ-TR 87
Query: 63  DPHVVRLMDVKQGQNK--------EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTV 114
             +VV  M                +GRT+  +V               R     + VN  
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---------------RDAKIVLDVNKT 132
Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL 159
           + +  ++ KG+ + H  GILH+DLK  N+  D   +   I D GL
Sbjct: 133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVV--ITDFGL 175

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKT-------RLHEDDEGVPPTTLREVSILRML-- 60
           +++G G++G VY+ +      +  L  T       +  +++ GV   T R V+IL  +  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 72
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLM 118
           S  P +  +    +G +      LY     ++T  ++ K I   RQT +           
Sbjct: 73  STKPQLAIVTQWCEGSS------LYHHLHIIETKFEMIKLIDIARQTAQ----------- 115
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT-- 176
                G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+  
Sbjct: 116 -----GMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 177 -LWYRAPEV--LLGSTHYSTAVDMWSVACIFAELVT 209
            LW  APEV  +     YS   D+++   +  EL+T
Sbjct: 170 ILWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 15/216 (6%)
Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D F     +G G +GKVY+ R  A G +VA+K+ +  E  +G       EV ++ M +  
Sbjct: 38  DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLK-EERXQGGELQFQTEVEMISM-AVH 94
Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            +++RL            T   LV+ YM +  +   +R   ++   +     + +     
Sbjct: 95  RNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 149
Query: 123 KGVAFCHGH---GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLW 178
           +G+A+ H H    I+HRD+K  N+L+D +   + + D GLA+            +  T+ 
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF 214
           + APE  L +   S   D++    +  EL+T    F
Sbjct: 209 HIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKT-------RLHEDDEGVPPTTLREVSILRML-- 60
           +++G G++G VY+ +      +  L  T       +  +++ GV   T R V+IL  +  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 77
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLM 118
           S  P +  +    +G +      LY     ++T  ++ K I   RQT +           
Sbjct: 78  STKPQLAIVTQWCEGSS------LYHHLHIIETKFEMIKLIDIARQTAQ----------- 120
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT-- 176
                G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+  
Sbjct: 121 -----GMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 177 -LWYRAPEV--LLGSTHYSTAVDMWSVACIFAELVT 209
            LW  APEV  +     YS   D+++   +  EL+T
Sbjct: 175 ILWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 12  VGEGTYGKVYRAREKATGK------IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +G G  G+V   R +  G+      I ALK               L E SI+      P+
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQFDH-PN 111
Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++RL    +G    GR  + +V EYM+   L  ++R+    G+   +  +  ++  +  G
Sbjct: 112 IIRL----EGVVTRGRLAM-IVTEYMENGSLDTFLRT--HDGQ-FTIMQLVGMLRGVGAG 163
Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---LPIKKYTHEILTLWYRA 181
           + +    G +HRDL   N+L+D   +  K++D GL+R            T   + + + A
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTA 222
Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PE +   T +S+A D+WS   +  E++ 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 12  VGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           VG G +G+V   R K   K    VA+K  ++    E      L E SI+      P+++R
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDH-PNIIR 98
Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSF-RQTGENIPVNTVKSLMYQLCKGVAF 127
           L    +G   + + V+ +V EYM+      + SF R+      V  +  ++  +  G+ +
Sbjct: 99  L----EGVVTKSKPVM-IVTEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHE--ILTLWYRAPEV 184
               G +HRDL   N+L++   +  K++D GL+R     P   YT     + + + +PE 
Sbjct: 151 LSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 209
Query: 185 LLGSTHYSTAVDMWSVACIFAELVT 209
            +    +++A D+WS   +  E+++
Sbjct: 210 -IAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKT-------RLHEDDEGVPPTTLREVSILRML-- 60
           +++G G++G VY+ +      +  L  T       +  +++ GV   T R V+IL  +  
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGY 74
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLM 118
           S  P +  +    +G +      LY     ++T  ++ K I   RQT +           
Sbjct: 75  STKPQLAIVTQWCEGSS------LYHHLHIIETKFEMIKLIDIARQTAQ----------- 117
Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT-- 176
                G+ + H   I+HRDLK +N+ +  + +T+KI D GLA   +     +  E L+  
Sbjct: 118 -----GMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 177 -LWYRAPEV--LLGSTHYSTAVDMWSVACIFAELVT 209
            LW  APEV  +     YS   D+++   +  EL+T
Sbjct: 172 ILWM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 39/234 (16%)
Query: 5   AFEKLEKVGEGTYGKVYRAR---EKATGKIVALK-KTRLHEDDEGVPPTTLREVSILRML 60
           + + LE    G +G V++A+   +    KI  L+ K     + E      ++  ++L+ +
Sbjct: 16  SLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFI 75
Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY 119
           + +         K+G N E    L+L+  + D   L  Y++     G  I  N +  +  
Sbjct: 76  AAE---------KRGSNLE--VELWLITAFHDKGSLTDYLK-----GNIITWNELCHVAE 119
Query: 120 QLCKGVAF-------CHGHG----ILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--LP 166
            + +G+++       C G G    I HRD K  N+L+ +  +T  +AD GLA  F    P
Sbjct: 120 TMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLL-KSDLTAVLADFGLAVRFEPGKP 178
Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYST----AVDMWSVACIFAELVTKTALFPG 216
                 ++ T  Y APEVL G+ ++       +DM+++  +  ELV++     G
Sbjct: 179 PGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADG 232
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	304
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	0.0
3niz_A	311	Rhodanese family protein; structural genomics, str	0.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	0.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	0.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	0.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-180
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-180
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-179
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-178
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-178
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-177
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-175
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-165
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-151
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-149
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-145
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-135
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-132
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-129
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-113
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-88
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-88
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-85
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-85
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-69
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-66
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-66
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-65
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-62
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-61
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-60
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-60
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-59
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-59
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-59
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-58
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-57
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-57
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-56
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-56
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-56
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-55
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-55
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-54
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-54
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-54
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-53
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-53
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-53
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-53
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-52
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-52
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-52
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-52
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-51
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-51
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-51
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-51
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-50
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-50
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-50
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-50
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-50
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-50
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-49
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-49
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-49
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-49
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-49
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-49
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-48
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-48
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-48
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-48
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-48
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-48
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-48
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-48
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-48
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-47
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-47
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-47
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-46
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-45
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-45
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-45
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-45
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-45
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-44
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-44
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-44
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-44
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-43
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-43
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-42
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-39
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-39
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-38
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-37
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-36
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-34
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-34
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-32
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-30
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-30
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-30
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-29
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-29
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-29
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-28
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-28
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-28
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-28
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-27
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-27
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-27
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-27
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-27
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-26
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-26
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-25
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-18
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  507 bits (1307), Expect = 0.0
 Identities = 149/301 (49%), Positives = 208/301 (69%), Gaps = 13/301 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ ++KLEKVGEGTYG VY+A++   G+IVALK+ RL  +DEG+P T +RE+S+L+ L  
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-H 77

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V L+DV   +       L LVFE+M+ DLKK +   +     +  + +K  +YQL 
Sbjct: 78  HPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENKT---GLQDSQIKIYLYQLL 129

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +GVA CH H ILHRDLKP NLL++     LK+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VL+GS  YST+VD+WS+ CIFAE++T   LFPG ++  QL  IF +LGTPN + WP V 
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248

Query: 243 SLMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
            L  W +  +  +  +  ++ +P   ++G+DLL  ML +DP+KRISA+ AM HPYF DLD
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

Query: 301 K 301
            
Sbjct: 309 P 309

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  505 bits (1302), Expect = 0.0
 Identities = 150/299 (50%), Positives = 207/299 (69%), Gaps = 12/299 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +  LEK+GEGTYG VY+A+    G+  ALKK RL ++DEG+P TT+RE+SIL+ L +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V+L DV   + +     L LVFE++D DLKK +         +   T KS + QL 
Sbjct: 59  HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLL 110

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            G+A+CH   +LHRDLKP NLL++R+   LKIAD GLARAF +P++KYTHEI+TLWYRAP
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VL+GS  YST +D+WSV CIFAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
            L  +   +  + P    + +  LD+ G+DLL +ML+ DP++RI+AK+A+EH YF + +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  504 bits (1300), Expect = 0.0
 Identities = 147/301 (48%), Positives = 201/301 (66%), Gaps = 12/301 (3%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M  +EKLEK+GEGTYG V++A+ + T +IVALK+ RL +DDEGVP + LRE+ +L+ L +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-K 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++VRL DV     K     L LVFE+ D DLKKY  S      ++    VKS ++QL 
Sbjct: 60  HKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLL 111

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           KG+ FCH   +LHRDLKP NLL++R    LK+A+ GLARAF +P++ Y+ E++TLWYR P
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           +VL G+  YST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WP +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 242 SSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
           + L ++  YP +    SL   VP L+  G DLL+ +L+ +P +RISA++A++HPYF D  
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

Query: 301 K 301
            
Sbjct: 291 P 291

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  502 bits (1296), Expect = 0.0
 Identities = 129/303 (42%), Positives = 191/303 (63%), Gaps = 9/303 (2%)

Query: 3   MDAFEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
              +E + ++GEG YGKV++AR+ K  G+ VALK+ R+   +EG+P +T+REV++LR L 
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69

Query: 62  RDPH--VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
              H  VVRL DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMF 127

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           QL +G+ F H H ++HRDLKP N+L+      +K+AD GLAR ++  +   T  ++TLWY
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMA-LTSVVVTLWY 185

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           RAPEVLL S+ Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP
Sbjct: 186 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
              +L     +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL
Sbjct: 245 RDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

Query: 300 DKT 302
           ++ 
Sbjct: 304 ERC 306

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  499 bits (1287), Expect = e-180
 Identities = 149/304 (49%), Positives = 211/304 (69%), Gaps = 16/304 (5%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +D + ++ K+GEGTYG+VY+A +  T + VA+K+ RL  ++EGVP T +REVS+L+ L +
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-Q 91

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +++ L  V    ++     L+L+FEY + DLKKY+        ++ +  +KS +YQL 
Sbjct: 92  HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLI 142

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDR----KTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            GV FCH    LHRDLKP NLL+      +T  LKI D GLARAF +PI+++THEI+TLW
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           YR PE+LLGS HYST+VD+WS+ACI+AE++ KT LFPGDSE+ QL  IF +LG P++  W
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262

Query: 239 PGVSSLMNWHE-YPQWNPQSLATAVPN-LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           PGV++L +W + +P++  ++L   +   LD +GLDLL  ML+ DP KRISAK A+EHPYF
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

Query: 297 DDLD 300
              D
Sbjct: 323 SHND 326

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  498 bits (1285), Expect = e-180
 Identities = 129/303 (42%), Positives = 182/303 (60%), Gaps = 11/303 (3%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG---VPPTTLREVSILRM 59
              +E + ++G G YG VY+AR+  +G  VALK  R+     G   +P +T+REV++LR 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 60  LSRDPH--VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           L    H  VVRLMDV      +    + LVFE++D DL+ Y+      G  +P  T+K L
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 125

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
           M Q  +G+ F H + I+HRDLKP N+L+     T+K+AD GLAR ++  +   T  ++TL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMA-LTPVVVTL 183

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           WYRAPEVLL ST Y+T VDMWSV CIFAE+  +  LF G+SE  QL  IF L+G P E  
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           WP   SL     +P   P+ + + VP +++ G  LL +ML ++P KRISA +A++H Y  
Sbjct: 243 WPRDVSL-PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

Query: 298 DLD 300
             +
Sbjct: 302 KDE 304

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  497 bits (1281), Expect = e-179
 Identities = 116/300 (38%), Positives = 180/300 (60%), Gaps = 13/300 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLH---EDDEGVPPTTLREVSILRM 59
              +EKL+ +GEG +  VY+AR+K T +IVA+KK +L    E  +G+  T LRE+ +L+ 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
           L   P+++ L+D    ++      + LVF++M+TDL+  I+        +  + +K+ M 
Sbjct: 69  L-SHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYML 119

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
              +G+ + H H ILHRDLKP+NLL+D     LK+AD GLA++F  P + YTH+++T WY
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWY 178

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           RAPE+L G+  Y   VDMW+V CI AEL+ +    PGDS+L QL  IF  LGTP E+ WP
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
            + SL ++  +  +    L         D LDL++ +  ++P  RI+A +A++  YF + 
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  494 bits (1274), Expect = e-178
 Identities = 136/307 (44%), Positives = 200/307 (65%), Gaps = 16/307 (5%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
              F++LEK+G GTY  VY+   K TG  VALK+ +L + +EG P T +RE+S+++ L +
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIREISLMKEL-K 61

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQ 120
             ++VRL DV   +NK     L LVFE+MD DLKKY+  R+   T   + +N VK   +Q
Sbjct: 62  HENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L +G+AFCH + ILHRDLKP NLL++++   LK+ D GLARAF +P+  ++ E++TLWYR
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           AP+VL+GS  YST++D+WS  CI AE++T   LFPG ++ +QL  IF ++GTPNE +WP 
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235

Query: 241 VSSLMNWH-EYPQWNPQSLATAV-----PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           V+ L  ++    Q  P+ L   +       LD + +D L  +LQ +P  R+SAK+A+ HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 295 YFDDLDK 301
           +F +   
Sbjct: 296 WFAEYYH 302

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  493 bits (1272), Expect = e-178
 Identities = 106/303 (34%), Positives = 180/303 (59%), Gaps = 13/303 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +M+ +EK+ K+GEG+YG V++ R + TG+IVA+KK    EDD  +    LRE+ +L+ L 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL- 59

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           + P++V L++V + + +     L+LVFEY D  +   +  +++    +P + VKS+ +Q 
Sbjct: 60  KHPNLVNLLEVFRRKRR-----LHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQT 111

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + V FCH H  +HRD+KP N+L+ + +  +K+ D G AR  T P   Y  E+ T WYR+
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE+L+G T Y   VD+W++ C+FAEL++   L+PG S++ QL  I + LG    +     
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230

Query: 242 SSLMNWHEYPQWNPQ---SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
           S+   +      +P+    L    PN+    L LL+  L  DP++R++ ++ + HPYF++
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

Query: 299 LDK 301
           + +
Sbjct: 291 IRE 293

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  492 bits (1269), Expect = e-177
 Identities = 141/301 (46%), Positives = 201/301 (66%), Gaps = 13/301 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ + KL+K+GEGTY  VY+ + K T  +VALK+ RL E +EG P T +REVS+L+ L +
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDL-K 58

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L D+   +       L LVFEY+D DLK+Y+      G  I ++ VK  ++QL 
Sbjct: 59  HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLL 110

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+A+CH   +LHRDLKP NLL++ +   LK+AD GLARA ++P K Y +E++TLWYR P
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           ++LLGST YST +DMW V CIF E+ T   LFPG +  +QL  IFR+LGTP E+ WPG+ 
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229

Query: 243 SLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
           S   +    YP++  ++L +  P LD DG DLL ++LQ++   RISA+ AM+HP+F  L 
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289

Query: 301 K 301
           +
Sbjct: 290 E 290

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  487 bits (1257), Expect = e-175
 Identities = 101/301 (33%), Positives = 160/301 (53%), Gaps = 13/301 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +E L  VGEG+YG V + R K TG+IVA+KK    +DD+ V    +RE+ +L+ L R
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-R 82

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V L++V + + +      YLVFE++D  +   +  F      +    V+  ++Q+ 
Sbjct: 83  HENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQII 134

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            G+ FCH H I+HRD+KP N+L+ +    +K+ D G AR    P + Y  E+ T WYRAP
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+L+G   Y  AVD+W++ C+  E+     LFPGDS++ QL HI   LG    +     +
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 243 SLMNWH--EYPQWNP-QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
               +     P+    + L    P L +  +DL ++ L  DP KR    + + H +F   
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

Query: 300 D 300
            
Sbjct: 314 G 314

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  463 bits (1193), Expect = e-165
 Identities = 106/307 (34%), Positives = 178/307 (57%), Gaps = 16/307 (5%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +  +EKL K+G+GT+G+V++AR + TG+ VALKK  +  + EG P T LRE+ IL++L +
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-K 74

Query: 63  DPHVVRLMDV---KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
             +VV L+++   K       +  +YLVF++ + DL   + +         ++ +K +M 
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQ 131

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK----KYTHEIL 175
            L  G+ + H + ILHRD+K  N+L+ R  + LK+AD GLARAF+L       +YT+ ++
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           TLWYR PE+LLG   Y   +D+W   CI AE+ T++ +  G++E  QL  I +L G+   
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250

Query: 236 KVWPGVSSLMNWHEY--PQWNPQSLATAVPNL--DKDGLDLLEQMLQYDPSKRISAKKAM 291
           +VWP V +   + +    +   + +   +     D   LDL++++L  DP++RI +  A+
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 292 EHPYFDD 298
            H +F  
Sbjct: 311 NHDFFWS 317

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  429 bits (1105), Expect = e-151
 Identities = 98/300 (32%), Positives = 171/300 (57%), Gaps = 11/300 (3%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
              A+   + +G G++G V++A+   + + VA+KK    +  +       RE+ I+R++ 
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMRIV- 89

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           + P+VV L        +K+    L LV EY+   + +  R + +  + +P+  +K  MYQ
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L + +A+ H  GI HRD+KP NLL+D  +  LK+ D G A+      +     I + +YR
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNVSYICSRYYR 208

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++ G+T+Y+T +D+WS  C+ AEL+    LFPG+S + QL+ I ++LGTP+ +    
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268

Query: 241 VSSLMNWHEYPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           ++     H++PQ  P   +    P    D +DL+ ++L+Y PS R++A +A+ HP+FD+L
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  424 bits (1092), Expect = e-149
 Identities = 111/333 (33%), Positives = 170/333 (51%), Gaps = 41/333 (12%)

Query: 2   VMDAFEKL-EKVGEGTYGKVYRAREK--ATGKIVALKKTRLHEDDEGVPPTTLREVSILR 58
           V D FE    KVG GTYG VY+A+ K     K  ALK+        G+  +  RE+++LR
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLR 73

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGEN-----IPVNT 113
            L + P+V+ L  V           ++L+F+Y + DL   I+  R +  N     +P   
Sbjct: 74  EL-KHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KTMTLKIADLGLARAFTLPIKKY 170
           VKSL+YQ+  G+ + H + +LHRDLKP N+L+     +   +KIAD+G AR F  P+K  
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189

Query: 171 TH---EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-------- 219
                 ++T WYRAPE+LLG+ HY+ A+D+W++ CIFAEL+T   +F    E        
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249

Query: 220 -LQQLLHIFRLLGTPNEKVWPGVSSLMNWHE-YPQWNPQS---------LATAVPNLDKD 268
              QL  IF ++G P +K W  +  +         +   +         +       D  
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309

Query: 269 GLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
              LL+++L  DP KRI++++AM+ PYF +   
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  414 bits (1067), Expect = e-145
 Identities = 93/300 (31%), Positives = 160/300 (53%), Gaps = 10/300 (3%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
              ++   + +G G++G VY+A+   +G++VA+KK    +          RE+ I+R L 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKL- 104

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              ++VRL         K+    L LV +Y+   + +  R + +  + +PV  VK  MYQ
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L + +A+ H  GI HRD+KP NLL+D  T  LK+ D G A+      +     I + +YR
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYR 223

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++ G+T Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283

Query: 241 VSSLMNWHEYPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           ++      ++PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  386 bits (993), Expect = e-135
 Identities = 99/308 (32%), Positives = 157/308 (50%), Gaps = 17/308 (5%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
            MD F+     G+GT+G V   +EK+TG  VA+KK          P    RE+ I++ L+
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------PRFRNRELQIMQDLA 74

Query: 62  RDPH--VVRLMDV--KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
              H  +V+L       G+       L +V EY+   L +  R++ +     P   +K  
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 118 MYQLCKGVAFCH--GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
           ++QL + +   H     + HRD+KPHN+L++    TLK+ D G A+  + P +     I 
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYIC 193

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           + +YRAPE++ G+ HY+TAVD+WSV CIFAE++    +F GD+   QL  I R+LG P+ 
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253

Query: 236 KVWPGVSSLMNWHEYPQWNP----QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
           +V   ++      +             +       K+  DLL  +LQY P +R+   +A+
Sbjct: 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313

Query: 292 EHPYFDDL 299
            HPYFD+L
Sbjct: 314 CHPYFDEL 321

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  379 bits (975), Expect = e-132
 Identities = 98/334 (29%), Positives = 165/334 (49%), Gaps = 42/334 (12%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
               +   + +G G++G V    +  +GK  ALKK          P    RE+ I+++L 
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMKVL- 57

Query: 62  RDPHVVRLMDV---------------------------------KQGQNKEGRTVLYLVF 88
              ++++L+D                                      N      L ++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 89  EYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK 148
           EY+   L K ++SF ++G +IP+N +   +YQL + V F H  GI HRD+KP NLL++ K
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177

Query: 149 TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELV 208
             TLK+ D G A+    P +     I + +YRAPE++LG+T Y+ ++D+WS+ C+F EL+
Sbjct: 178 DNTLKLCDFGSAKKLI-PSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 209 TKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPN-LDK 267
               LF G++ + QL+ I +++GTP ++    ++       +P    +     +P     
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 268 DGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
             +DLLEQ+L+Y+P  RI+  +AM HP+FD L  
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  370 bits (951), Expect = e-129
 Identities = 83/311 (26%), Positives = 157/311 (50%), Gaps = 27/311 (8%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
             D ++ + K+G G Y +V+ A      + V +K  +  +  +       RE+ IL  L 
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLR 88

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEY-MDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             P+++ L D+ +           LVFE+  +TD K+  ++            ++  MY+
Sbjct: 89  GGPNIITLADIVKDPVSR---TPALVFEHVNNTDFKQLYQTL-------TDYDIRFYMYE 138

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + K + +CH  GI+HRD+KPHN+++D +   L++ D GLA  F  P ++Y   + + +++
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFK 197

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            PE+L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT +   + 
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257

Query: 240 GVSSLMNWHEY----PQWNPQSLATAVPN-----LDKDGLDLLEQMLQYDPSKRISAKKA 290
              ++     +     + + +     V +     +  + LD L+++L+YD   R++A++A
Sbjct: 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317

Query: 291 MEHPYFDDLDK 301
           MEHPYF  + K
Sbjct: 318 MEHPYFYTVVK 328

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  335 bits (860), Expect = e-113
 Identities = 110/360 (30%), Positives = 169/360 (46%), Gaps = 69/360 (19%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           + D +E    +G G+YG V  A +K   ++VA+KK     +D       LRE++IL  L 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL- 109

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
              HVV+++D+   ++ E    LY+V E  D+D KK  R+       +    +K+L+Y L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNL 165

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK------------ 169
             GV + H  GILHRDLKP N L++ +  ++K+ D GLAR    P               
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 170 ---------------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT--- 211
                           T  ++T WYRAPE++L   +Y+ A+D+WS+ CIFAEL+      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 212 --------ALFPGDS--------------------ELQQLLHIFRLLGTPNEKVWPGVSS 243
                    LFPG S                       QL  IF +LGTP+E+    +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

Query: 244 LMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
             +   Y    P+     LA   P    D + LL++ML ++P+KRI+  + + HP+F ++
Sbjct: 345 -EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  291 bits (747), Expect = 2e-98
 Identities = 92/312 (29%), Positives = 156/312 (50%), Gaps = 22/312 (7%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +   +  L+ +G G  G V+ A +    K VA+KK  +   D       LRE+ I+R L 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSVKHALREIKIIRRL- 65

Query: 62  RDPHVVRLMDVKQGQNKEGRTV---------LYLVFEYMDTDLKKYIRSFRQTGENIPVN 112
              ++V++ ++      +             +Y+V EYM+TDL   +       E+    
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA--- 122

Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-- 170
             +  MYQL +G+ + H   +LHRDLKP NL ++ + + LKI D GLAR           
Sbjct: 123 --RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

Query: 171 -THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
            +  ++T WYR+P +LL   +Y+ A+DMW+  CIFAE++T   LF G  EL+Q+  I   
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

Query: 230 LGTPNEKVWPGVSSLMNWH--EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
           +   +E+    + S++  +         + L   +P + ++ +D LEQ+L + P  R++A
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 288 KKAMEHPYFDDL 299
           ++A+ HPY    
Sbjct: 301 EEALSHPYMSIY 312

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  286 bits (735), Expect = 4e-96
 Identities = 108/322 (33%), Positives = 164/322 (50%), Gaps = 42/322 (13%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT----TLREVSIL 57
           +   F+    +GEG YG V  A  K TG+IVA+KK    +      P     TLRE+ IL
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-----PLFALRTLREIKIL 63

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           +   +  +++ + ++++  + E    +Y++ E M TDL + I +   + ++I     +  
Sbjct: 64  KHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYF 117

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY------- 170
           +YQ  + V   HG  ++HRDLKP NLL++     LK+ D GLAR                
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 171 ---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
                 + T WYRAPEV+L S  YS A+D+WS  CI AEL  +  +FPG     QLL IF
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236

Query: 228 RLLGTP----------NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQML 277
            ++GTP          + +    + SL      P +    L    P ++  G+DLL++ML
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSL------PMYPAAPLEKMFPRVNPKGIDLLQRML 290

Query: 278 QYDPSKRISAKKAMEHPYFDDL 299
            +DP+KRI+AK+A+EHPY    
Sbjct: 291 VFDPAKRITAKEALEHPYLQTY 312

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  285 bits (731), Expect = 2e-95
 Identities = 105/309 (33%), Positives = 161/309 (52%), Gaps = 24/309 (7%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT----TLREVSIL 57
           V   +  L  +GEG YG V  A +      VA+KK    E       T    TLRE+ IL
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-----QTYCQRTLREIKIL 79

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
               R  +++ + D+ +    E    +Y+V + M+TDL K +++   + ++I        
Sbjct: 80  LRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-----CYF 133

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY---THEI 174
           +YQ+ +G+ + H   +LHRDLKP NLL++  T  LKI D GLAR            T  +
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T WYRAPE++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

Query: 235 EKVWPGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
           ++    + + +    Y    P  N        PN D   LDLL++ML ++P KRI  ++A
Sbjct: 253 QEDLNCIIN-LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311

Query: 291 MEHPYFDDL 299
           + HPY +  
Sbjct: 312 LAHPYLEQY 320

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  283 bits (725), Expect = 2e-94
 Identities = 91/311 (29%), Positives = 141/311 (45%), Gaps = 20/311 (6%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPT---------TLR 52
           +   +     +  G+YG V    +   G  VA+K+      D                LR
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 53  EVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVN 112
           E+ +L      P+++ L D+     +     LYLV E M TDL + I   R         
Sbjct: 79  EIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ--- 134

Query: 113 TVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH 172
            ++  MY +  G+   H  G++HRDL P N+L+      + I D  LAR  T      TH
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDT-ADANKTH 192

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
            +   WYRAPE+++    ++  VDMWS  C+ AE+  + ALF G +   QL  I  ++GT
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252

Query: 233 PNEKVWPGVSSLMNW----HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
           P  +     SS        +       ++    VP  D   LDL+ +ML+++P +RIS +
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312

Query: 289 KAMEHPYFDDL 299
           +A+ HPYF+ L
Sbjct: 313 QALRHPYFESL 323

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  276 bits (709), Expect = 4e-92
 Identities = 108/303 (35%), Positives = 160/303 (52%), Gaps = 16/303 (5%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V   +  L+ VG G YG V  A +  TG  VA+KK       E       RE+ +L+ + 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM- 81

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           R  +V+ L+DV    +  +  T  YLV  +M TDL K ++  +   + I     + L+YQ
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI-----QFLVYQ 136

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + KG+ + H  GI+HRDLKP NL ++ +   LKI D GLAR     +   T  ++T WYR
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEM---TGYVVTRWYR 192

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+L    Y+  VD+WSV CI AE++T   LF G   L QL  I ++ GTP  +    
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252

Query: 241 VSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           + S      Y    P+   +  A+ + N     ++LLE+ML  D  +R++A +A+ HPYF
Sbjct: 253 LQS-DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

Query: 297 DDL 299
           + L
Sbjct: 312 ESL 314

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  276 bits (708), Expect = 6e-92
 Identities = 107/303 (35%), Positives = 159/303 (52%), Gaps = 16/303 (5%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM- 85

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +  +V+ L+DV    ++ E    +YLV   M  DL   ++  + T +++     + L+YQ
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-----QFLIYQ 140

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++ +   LKI D GLAR     +  Y   + T WYR
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY---VATRWYR 196

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 241 VSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +SS  +   Y     Q    + A      +   +DLLE+ML  D  KRI+A +A+ H YF
Sbjct: 257 ISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 297 DDL 299
              
Sbjct: 316 AQY 318

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  274 bits (703), Expect = 2e-91
 Identities = 101/303 (33%), Positives = 152/303 (50%), Gaps = 17/303 (5%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           +   +     VG G YG V  A +K +G+ VA+KK       E       RE+ +L+ + 
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM- 80

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +  +V+ L+DV     +       YLV  +M TDL+K +              ++ L+YQ
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL------KFSEEKIQYLVYQ 134

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + KG+ + H  G++HRDLKP NL ++ +   LKI D GLAR     +  Y   ++T WYR
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGY---VVTRWYR 190

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+L   HY+  VD+WSV CI AE++T   LF G   L QL  I ++ G P  +    
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 241 VSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           ++       Y    PQ   +      P       DLLE+ML+ D  KR++A +A+ HP+F
Sbjct: 251 LND-KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

Query: 297 DDL 299
           +  
Sbjct: 310 EPF 312

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  268 bits (688), Expect = 1e-88
 Identities = 108/343 (31%), Positives = 174/343 (50%), Gaps = 59/343 (17%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKK-TRLHEDDEGVPPT----TLREVSI 56
           V+  +E ++K+G+G YG V+++ ++ TG++VA+KK     ++      T    T RE+ I
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-----STDAQRTFREIMI 61

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           L  LS   ++V L++V +  N      +YLVF+YM+TDL   IR+      +      + 
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIRANILEPVHK-----QY 113

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY------ 170
           ++YQL K + + H  G+LHRD+KP N+L++     +K+AD GL+R+F    +        
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 171 ---------------THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP 215
                          T  + T WYRAPE+LLGST Y+  +DMWS+ CI  E++    +FP
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232

Query: 216 GDSELQQLLHIFRLLGTP---------NEKVWPGVSSL--------MNWHEYPQWNPQSL 258
           G S + QL  I  ++  P         +      + SL         N  +        L
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292

Query: 259 ATAVPNLDK--DGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
               P  D   + LDLL+++LQ++P+KRISA  A++HP+    
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  270 bits (691), Expect = 1e-88
 Identities = 110/353 (31%), Positives = 170/353 (48%), Gaps = 63/353 (17%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V D +     +G G+YG VY A +K T K VA+KK     +D       LRE++IL  L 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL- 82

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT--VKSLMY 119
           +  +++RL D+    +      LY+V E  D+DLKK  ++       I +    +K+++Y
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEEHIKTILY 136

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY--------- 170
            L  G  F H  GI+HRDLKP N L++ +  ++K+ D GLAR                  
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 171 -------------THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-------- 209
                        T  ++T WYRAPE++L   +Y+ ++D+WS  CIFAEL+         
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 210 ---KTALFPGDSELQ-----------------QLLHIFRLLGTPNEKVWPGVSSLMNW-- 247
              +  LFPG S                    QL  IF ++GTP E     ++       
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315

Query: 248 -HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
              +P   P +L    P++  DG++LLE ML+++P+KRI+  +A++HPY  D+
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  258 bits (662), Expect = 6e-85
 Identities = 91/313 (29%), Positives = 148/313 (47%), Gaps = 25/313 (7%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV- 81

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V    ++ E    +Y+V E MD +L + I+      E +       L+YQ
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-ELDHERM-----SYLLYQ 135

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++     TLKI D GLAR         T  ++T +YR
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAG-TSFMMTPYVVTRYYR 193

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+LG   Y   VD+WSV CI  E++    LFPG   + Q   +   LGTP  +    
Sbjct: 194 APEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 241 VSSL-------------MNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
           +                 ++ + +P     + +           DLL +ML  D SKRIS
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312

Query: 287 AKKAMEHPYFDDL 299
             +A++HPY +  
Sbjct: 313 VDEALQHPYINVW 325

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  261 bits (668), Expect = 8e-85
 Identities = 91/313 (29%), Positives = 146/313 (46%), Gaps = 25/313 (7%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV- 118

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V    +  E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 172

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++     TLKI D GLAR         T  ++T +YR
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAG-TSFMMTPYVVTRYYR 230

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+L    Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP  +    
Sbjct: 231 APEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

Query: 241 VSSL-------------MNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
           +                + + + +P     + +           DLL +ML  DP+KRIS
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349

Query: 287 AKKAMEHPYFDDL 299
              A++HPY +  
Sbjct: 350 VDDALQHPYINVW 362

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  215 bits (550), Expect = 8e-69
 Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 50/305 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L     
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 89  KIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 139

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAP 182
           V   H HGI+H DLKP N L+      LK+ D G+A            +    T+ Y  P
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

Query: 183 EVLLGSTH----------YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
           E +   +            S   D+WS+ CI   +      F         LH       
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------- 250

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
               + P        HE                +KD  D+L+  L+ DP +RIS  + + 
Sbjct: 251 --AIIDPN-------HEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

Query: 293 HPYFD 297
           HPY  
Sbjct: 293 HPYVQ 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  209 bits (535), Expect = 4e-66
 Identities = 72/305 (23%), Positives = 119/305 (39%), Gaps = 50/305 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L     
Sbjct: 11  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 70  KIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 120

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAP 182
           V   H HGI+H DLKP N L+      LK+ D G+A            +    T+ Y  P
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 183 EVLLGSTH----------YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
           E +   +            S   D+WS+ CI   +      F         LH    +  
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIID 235

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
           PN ++           E+P              +KD  D+L+  L+ DP +RIS  + + 
Sbjct: 236 PNHEI-----------EFPDI-----------PEKDLQDVLKCCLKRDPKQRISIPELLA 273

Query: 293 HPYFD 297
           HPY  
Sbjct: 274 HPYVQ 278

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  207 bits (530), Expect = 6e-66
 Identities = 70/314 (22%), Positives = 124/314 (39%), Gaps = 57/314 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           FE++  +G+G +G+V +AR     +  A+KK R  E+      T L EV +L  L    +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASL-NHQY 63

Query: 66  VVRLMDVKQGQN--------KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           VVR       +          + ++ L++  EY +   L   I S      N   +    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL- 175
           L  Q+ + +++ H  GI+HRDLKP N+ +D ++  +KI D GLA+     +     +   
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 176 -------------TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
                        T  Y A EVL G+ HY+  +DM+S+  IF E++       G   +  
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237

Query: 223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
           L  +  +              +                           ++  ++ +DP+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEK------------------------KIIRLLIDHDPN 273

Query: 283 KRISAKKAMEHPYF 296
           KR  A+  +   + 
Sbjct: 274 KRPGARTLLNSGWL 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  208 bits (532), Expect = 3e-65
 Identities = 72/306 (23%), Positives = 118/306 (38%), Gaps = 52/306 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDP 64
           +  L+++G G   KV++   +   +I A+K   L E D     +   E++ L  L     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
            ++RL D +          +Y+V E  + DL  +++  +    +I     KS    + + 
Sbjct: 117 KIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEA 167

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF---TLPIKKYTHEILTLWYRA 181
           V   H HGI+H DLKP N L+      LK+ D G+A      T  + K +  +  + Y  
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQ-VGAVNYMP 224

Query: 182 PEVLLGSTH----------YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
           PE +   +            S   D+WS+ CI   +      F         LH      
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------ 278

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
                + P        HE                +KD  D+L+  L+ DP +RIS  + +
Sbjct: 279 ---AIIDPN-------HEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPELL 319

Query: 292 EHPYFD 297
            HPY  
Sbjct: 320 AHPYVQ 325

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  201 bits (513), Expect = 6e-62
 Identities = 85/332 (25%), Positives = 150/332 (45%), Gaps = 59/332 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           +E L+ +G+G++G+V +A +    + VALK    + R H            E+ IL  L 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR-------QAAEEIRILEHLR 151

Query: 62  R-DP----HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           + D     +V+ +++    +N      + + FE +  +L + I+  +  G    +  V+ 
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNH-----ICMTFELLSMNLYELIKKNKFQG--FSLPLVRK 204

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
             + + + +   H + I+H DLKP N LL  +    +K+ D G +      +  Y   I 
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY---IQ 261

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           + +YRAPEV+LG   Y   +DMWS+ CI AEL+T   L PG+ E  QL  +  LLG P++
Sbjct: 262 SRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320

Query: 236 KV------------------WPGVSSLMNWHEY------------PQWNPQSLATAVPNL 265
           K+                  +  V++L +                     +    A+   
Sbjct: 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380

Query: 266 DKDGL-DLLEQMLQYDPSKRISAKKAMEHPYF 296
           D     D L+Q L++DP+ R++  +A+ HP+ 
Sbjct: 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  195 bits (498), Expect = 4e-61
 Identities = 70/294 (23%), Positives = 113/294 (38%), Gaps = 41/294 (13%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
             +F++L ++G G+YG+V++ R K  G++ A+K++             L EV     + +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P  VRL    +         LYL  E     L+++       G ++P   V   +    
Sbjct: 116 HPCCVRLEQAWEEGGI-----LYLQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTL 167

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
             +A  H  G++H D+KP N+ +       K+ D GL             E     Y AP
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAP 225

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+L GS  Y TA D++S+     E+     L  G    QQL       G    +   G+S
Sbjct: 226 ELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-----GYLPPEFTAGLS 278

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           S                        +   +L  ML+ DP  R +A+  +  P  
Sbjct: 279 S------------------------ELRSVLVMMLEPDPKLRATAEALLALPVL 308

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  195 bits (497), Expect = 4e-60
 Identities = 92/337 (27%), Positives = 144/337 (42%), Gaps = 68/337 (20%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP--- 64
           + K+G G +  V+ A++      VA+K  R    D+        E+ +L+ ++  D    
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 65  ------HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLM 118
                 H+++L+D    +   G  V+ +VFE +  +L   I+ +   G  IP+  VK + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVV-MVFEVLGENLLALIKKYEHRG--IPLIYVKQIS 137

Query: 119 YQLCKGVAFCHGH-GILHRDLKPHNLLMD-----RKTMTLKIADLGLARAFTLPIKKYTH 172
            QL  G+ + H   GI+H D+KP N+LM+        + +KIADLG A       + YT+
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTN 194

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHI 226
            I T  YR+PEVLLG+  +    D+WS AC+  EL+T   LF  D       +   +  I
Sbjct: 195 SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253

Query: 227 FRLLGTP-------------------------NEKVWPGVSSLMNWHEYPQWNPQSLATA 261
             LLG                             K WP    L   +++ +   + +   
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI--- 310

Query: 262 VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
                    D L  MLQ DP KR  A   + HP+  D
Sbjct: 311 --------SDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  193 bits (492), Expect = 4e-60
 Identities = 54/314 (17%), Positives = 107/314 (34%), Gaps = 37/314 (11%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRML 60
             +   + +G+G    V+R R K TG + A+K           +      +RE  +L+ L
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY 119
               ++V+L  +++           L+ E+     L   +         +P +    ++ 
Sbjct: 65  -NHKNIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLR 119

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDR---KTMTLKIADLGLARAFTLPIKKYTHEIL- 175
            +  G+     +GI+HR++KP N++           K+ D G AR           E   
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------DDEQFV 173

Query: 176 ----TLWYRAPEVLLGST-------HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 224
               T  Y  P++   +         Y   VD+WS+   F    T +  F      ++  
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 225 HIFR--LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
            +    + G P+  +     +     ++    P S  +    L      +L  +L+ D  
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS-CSLSRGLQVLLTPVLANILEADQE 292

Query: 283 KRISAKKAMEHPYF 296
           K     +       
Sbjct: 293 KCWGFDQFFAETSD 306

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  194 bits (495), Expect = 3e-59
 Identities = 75/307 (24%), Positives = 128/307 (41%), Gaps = 51/307 (16%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F   + +G G  G +   R     + VA+K  R+  +         REV +LR     P+
Sbjct: 26  FCPKDVLGHGAEGTIVY-RGMFDNRDVAVK--RILPECF---SFADREVQLLRESDEHPN 79

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYI--RSFRQTGENIPVNTVKSLMYQLCK 123
           V+R    ++ +        Y+  E     L++Y+  + F   G         +L+ Q   
Sbjct: 80  VIRYFCTEKDRQF-----QYIAIELCAATLQEYVEQKDFAHLGLEP-----ITLLQQTTS 129

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRK----TMTLKIADLGLARAFTLPIKKYTH---EILT 176
           G+A  H   I+HRDLKPHN+L+        +   I+D GL +   +    ++       T
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 177 LWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
             + APE+L        +  VD++S  C+F  ++++ +   G S  +Q      LLG  +
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---ANILLGACS 246

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                 +  L                   + D    +L+E+M+  DP KR SAK  ++HP
Sbjct: 247 ------LDCLHPE---------------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285

Query: 295 YFDDLDK 301
           +F  L+K
Sbjct: 286 FFWSLEK 292

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  189 bits (483), Expect = 4e-59
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 39/300 (13%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
            + +E L  +G G+YG+  + R K+ GKI+  K+       E      + EV++LR L +
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-K 63

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P++VR  D          T LY+V EY +  DL   I    +  + +    V  +M QL
Sbjct: 64  HPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 122 CKGVAFCH-----GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
              +  CH     GH +LHRDLKP N+ +D     +K+ D GLAR            + T
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            +Y +PE +     Y+   D+WS+ C+  EL      F   S+ +    I    G    +
Sbjct: 180 PYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF-RR 235

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           +    S  +N                        +++ +ML      R S ++ +E+P  
Sbjct: 236 IPYRYSDELN------------------------EIITRMLNLKDYHRPSVEEILENPLI 271

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  192 bits (490), Expect = 4e-59
 Identities = 91/339 (26%), Positives = 140/339 (41%), Gaps = 66/339 (19%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           +E    +G+G++G+V +A ++   + VA+K    K                EV +L +++
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-------QAQIEVRLLELMN 108

Query: 62  R-DP----HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           + D     ++V L      +N      L LVFE +  +L   +R+    G  + +N  + 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNH-----LCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRK 161

Query: 117 LMYQLCKGVAFCHGH--GILHRDLKPHN-LLMDRKTMTLKIADLGLARAFTLPIKKYTHE 173
              Q+C  + F       I+H DLKP N LL + K   +KI D G +      I +Y   
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY--- 218

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           I + +YR+PEVLLG   Y  A+DMWS+ CI  E+ T   LF G +E+ Q+  I  +LG P
Sbjct: 219 IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

Query: 234 N--------------------------------EKVWPGVSSLMN----WHEYPQWNPQS 257
                                            E   PG   L N        P      
Sbjct: 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337

Query: 258 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +           DL+ +ML YDP  RI    A++H +F
Sbjct: 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  189 bits (482), Expect = 7e-59
 Identities = 75/318 (23%), Positives = 126/318 (39%), Gaps = 54/318 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +  FE ++ +G G +G V+ A+ K      A+K+ RL   +       +REV  L  L  
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKL-E 61

Query: 63  DPHVVRLMDV-------KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
            P +VR  +        ++ Q    +  LY+  +     +LK ++   R T E    +  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVC 120

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---------- 164
             +  Q+ + V F H  G++HRDLKP N+        +K+ D GL  A            
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 165 --LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
                 ++T ++ T  Y +PE + G+  YS  VD++S+  I  EL+     F    E  +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLYP---FSTQMERVR 235

Query: 223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
            L   R L  P   ++                                 +++ ML   P 
Sbjct: 236 TLTDVRNLKFP--PLFTQKYPCEY------------------------VMVQDMLSPSPM 269

Query: 283 KRISAKKAMEHPYFDDLD 300
           +R  A   +E+  F+DLD
Sbjct: 270 ERPEAINIIENAVFEDLD 287

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  187 bits (476), Expect = 4e-58
 Identities = 61/303 (20%), Positives = 116/303 (38%), Gaps = 56/303 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F+++E +G G +G+V++A+ +  GK   +K+ + + +         REV  L  L    +
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKL-DHVN 65

Query: 66  VVRLMD-----------VKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNT 113
           +V                 +  ++     L++  E+ D   L+++I   ++ GE +    
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVL 123

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE 173
              L  Q+ KGV + H   +++RDLKP N+ +   T  +KI D GL  +     K+    
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRS- 181

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             TL Y +PE +     Y   VD++++  I AEL+         S+    L         
Sbjct: 182 KGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL--------R 232

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           +  +                                  LL+++L   P  R +  + +  
Sbjct: 233 DGIISDIFDKKEK------------------------TLLQKLLSKKPEDRPNTSEILRT 268

Query: 294 PYF 296
              
Sbjct: 269 LTV 271

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  190 bits (484), Expect = 1e-57
 Identities = 76/323 (23%), Positives = 133/323 (41%), Gaps = 58/323 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +     + +G G+ G V   +    G+ VA+K  R+  D        L E+ +L      
Sbjct: 15  NLVVSEKILGYGSSGTVV-FQGSFQGRPVAVK--RMLIDFC---DIALMEIKLLTESDDH 68

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT---VKSLMYQ 120
           P+V+R    +          LY+  E  + +L+  + S   + EN+ +       SL+ Q
Sbjct: 69  PNVIRYYCSETTDRF-----LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMT------------LKIADLGLARAFTLPIK 168
           +  GVA  H   I+HRDLKP N+L+   +              + I+D GL +       
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 169 KYTHEIL----TLWYRAPEVLLGSTH------YSTAVDMWSVACIFAELVTKTALFPGDS 218
            +   +     T  +RAPE+L  S +       + ++D++S+ C+F  +++K    P   
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK-GKHPFGD 242

Query: 219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 278
           +  +  +I R           G+ SL    +              +L  +  DL+ QM+ 
Sbjct: 243 KYSRESNIIR-----------GIFSLDEM-KCLHD---------RSLIAEATDLISQMID 281

Query: 279 YDPSKRISAKKAMEHPYFDDLDK 301
           +DP KR +A K + HP F    K
Sbjct: 282 HDPLKRPTAMKVLRHPLFWPKSK 304

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  188 bits (478), Expect = 2e-57
 Identities = 47/321 (14%), Positives = 86/321 (26%), Gaps = 48/321 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL-REVSILRMLS--- 61
            + +E +  G    V+  R+    +  ALK   +  ++       L         L    
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 62  -----------------RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQ 104
                                      +  GQ+        L+      DL+    +   
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 105 TGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR 161
                    +  +  L  QL +  A     G++H    P NL +      L + D+    
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-GRLMLGDVSALW 242

Query: 162 AFTLPIKKYTHEILTLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPGDSEL 220
                  +     + + Y   E L  ST  ++ A++ W +      +      F   +  
Sbjct: 243 KVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD 280
            +       L  P        S                      L      L+ + L +D
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGS-------------------CTPLPDFVKTLIGRFLNFD 340

Query: 281 PSKRISAKKAMEHPYFDDLDK 301
             +R+   +AME P F  L  
Sbjct: 341 RRRRLLPLEAMETPEFLQLQN 361

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  186 bits (473), Expect = 3e-57
 Identities = 59/302 (19%), Positives = 112/302 (37%), Gaps = 44/302 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  ++K+GEG +  V        G   ALK+   HE  +       RE  + R+    P+
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLF-NHPN 87

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++RL+     + +  +   +L+  +     L   I   +  G  +  + +  L+  +C+G
Sbjct: 88  ILRLVAYCL-RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--------- 175
           +   H  G  HRDLKP N+L+  +     + DLG      + ++  + + L         
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEG-SRQALTLQDWAAQR 204

Query: 176 -TLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
            T+ YRAPE+    +H       D+WS+ C+   ++     +    +    + +      
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL------ 258

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
                     ++ N    PQ    S              LL  M+  DP +R      + 
Sbjct: 259 ----------AVQNQLSIPQSPRHS---------SALWQLLNSMMTVDPHQRPHIPLLLS 299

Query: 293 HP 294
             
Sbjct: 300 QL 301

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  185 bits (472), Expect = 1e-56
 Identities = 63/342 (18%), Positives = 119/342 (34%), Gaps = 68/342 (19%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRMLS 61
           F  + K+G+GT+G+V   +     K  A+K      +          +   E  IL+ + 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR-------SAKIEADILKKIQ 89

Query: 62  RDP----HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
            D     ++V+        +      + L+FE +   L + I      G    +  +K  
Sbjct: 90  NDDINNNNIVKYHGKFMYYDH-----MCLIFEPLGPSLYEIITRNNYNG--FHIEDIKLY 142

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK-------- 169
             ++ K + +     + H DLKP N+L+D       +  +                    
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 170 --------YTHEILTLW-----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG 216
                   +  +          YRAPEV+L    +  + DMWS  C+ AEL T + LF  
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRT 261

Query: 217 DSELQQLLHIFRLLGTPNEKV---------------------WPGVSSLMNWHEYPQWNP 255
              ++ L  +  ++    + +                     WP  +S +      +   
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSI---NSIKHVK 318

Query: 256 QSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           + L        +   D L  +LQ DP+ R S  + ++H + +
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  184 bits (468), Expect = 3e-56
 Identities = 87/340 (25%), Positives = 144/340 (42%), Gaps = 62/340 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAR-EKATGKIVALK----KTRLHEDDEGVPPTTLREVSILRML 60
           +E ++ +GEG +GKV      KA G+ VA+K      R  E           E+ +L  L
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE-------AARSEIQVLEHL 68

Query: 61  SR-DP----HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVK 115
           +  DP      V++++  +         + +VFE +      +I+          ++ ++
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGH-----ICIVFELLGLSTYDFIKENGFLP--FRLDHIR 121

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHN-LLMDRKTMTLKIADLGLARAFTLP--IK---- 168
            + YQ+CK V F H + + H DLKP N L +           +       +   IK    
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 169 ---KYTHE-----ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL 220
               Y  E     + T  YRAPEV+L    +S   D+WS+ CI  E      +FP     
Sbjct: 182 GSATYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240

Query: 221 QQLLHIFRLLGTPNEKV----------------WPGVSSLMNWHEYPQWNPQSLATAVPN 264
           + L  + R+LG   + +                W   SS      Y     + L   + +
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAG---RYVSRACKPLKEFMLS 297

Query: 265 LDKDG---LDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
            D +     DL+++ML+YDP+KRI+ ++A++HP+FD L K
Sbjct: 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  183 bits (467), Expect = 6e-56
 Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 38/295 (12%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ + +L+K+GEG++GK    +    G+   +K+  +          + REV++L  + +
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-K 81

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P++V+  +  +         LY+V +Y +  DL K I    Q G     + +     Q+
Sbjct: 82  HPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQI 134

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           C  +   H   ILHRD+K  N+ +  K  T+++ D G+AR     ++     I T +Y +
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE+      Y+   D+W++ C+  EL T    F   S    +L I               
Sbjct: 194 PEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS------------- 239

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                   +P  +             D   L+ Q+ + +P  R S    +E  + 
Sbjct: 240 ------GSFPPVSLH--------YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  183 bits (466), Expect = 2e-55
 Identities = 54/311 (17%), Positives = 107/311 (34%), Gaps = 37/311 (11%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRML 60
             +   + +G+G    V+R R K TG + A+K           +      +RE  +L+ L
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY 119
               ++V+L  +++           L+ E+     L   +         +P +    ++ 
Sbjct: 65  -NHKNIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLR 119

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDR---KTMTLKIADLGLARAFTLPIKKYTHEIL- 175
            +  G+     +GI+HR++KP N++           K+ D G AR           E   
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------DDEQFV 173

Query: 176 ----TLWYRAPEVLLGST-------HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 224
               T  Y  P++   +         Y   VD+WS+   F    T +  F      ++  
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 225 HIFR--LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
            +    + G P+  +     +     ++    P S  +    L      +L  +L+ D  
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS-CSLSRGLQVLLTPVLANILEADQE 292

Query: 283 KRISAKKAMEH 293
           K     +    
Sbjct: 293 KCWGFDQFFAE 303

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  179 bits (457), Expect = 5e-55
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 36/296 (12%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLS 61
           +  F   +K+G G + +VYRA     G  VALKK ++ +  D       ++E+ +L+ L 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL- 89

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             P+V++        N+     L +V E  D  DL + I+ F++    IP  TV     Q
Sbjct: 90  NHPNVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           LC  +   H   ++HRD+KP N+ +   T  +K+ DLGL R F+         + T +Y 
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNEKVWP 239
           +PE +  +  Y+   D+WS+ C+  E+    + F GD   L  L            K+  
Sbjct: 204 SPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----------KIEQ 252

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                    +YP            +  ++   L+   +  DP KR       +   
Sbjct: 253 C--------DYPPLPS-------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  180 bits (459), Expect = 1e-54
 Identities = 82/346 (23%), Positives = 141/346 (40%), Gaps = 78/346 (22%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGK-IVALK----KTRLHEDDEGVPPTTLREVSILRML 60
           +E +  +GEGT+GKV    + A GK  VALK      +  E           E+++L+ +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE-------AARLEINVLKKI 73

Query: 61  SR-DP----HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVK 115
              D       V + D            + + FE +  +  ++++         P+  V+
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGH-----MCIAFELLGKNTFEFLKENNFQP--YPLPHVR 126

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLM------------------DRKTMTLKIADL 157
            + YQLC  + F H + + H DLKP N+L                     K  ++++AD 
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 158 GLARAFTLPIKKYTHE-----ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTA 212
           G A         + HE     + T  YR PEV+L    ++   D+WS+ CI  E      
Sbjct: 187 GSA--------TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFT 237

Query: 213 LFPGDSELQQLLHIFRLLGTPNEKV----------------WPGVSSLMNWHEYPQWNPQ 256
           LF      + L+ + ++LG     +                W   SS      Y + N +
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD---GRYVKENCK 294

Query: 257 SLATAVPNLDKD---GLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
            L + +     +     DL+ +ML++DP++RI+  +A+ HP+F  L
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  180 bits (457), Expect = 2e-54
 Identities = 68/345 (19%), Positives = 117/345 (33%), Gaps = 84/345 (24%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
           +   +     +G+G+YG V  A E  T  I A+K   K ++ + +         EV +++
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTV--- 114
            L   P++ RL +V + +       + LV E      L   +  F           V   
Sbjct: 84  KLH-HPNIARLYEVYEDEQY-----ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137

Query: 115 ---------------------------------KSLMYQLCKGVAFCHGHGILHRDLKPH 141
                                             ++M Q+   + + H  GI HRD+KP 
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197

Query: 142 NLLMD-RKTMTLKIADLGLARAFTLPIKKYTHEILTL----WYRAPEVLLGSTH-YSTAV 195
           N L    K+  +K+ D GL++ F        + + T     ++ APEVL  +   Y    
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257

Query: 196 DMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWPGVSSLMNWHEYP 251
           D WS   +   L+     FPG ++           L          +  +S         
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPGVNDAD----TISQVLNKKLCFENPNYNVLS--------- 304

Query: 252 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                              DLL  +L  +  +R  A +A++HP+ 
Sbjct: 305 ---------------PLARDLLSNLLNRNVDERFDAMRALQHPWI 334

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  186 bits (474), Expect = 2e-54
 Identities = 73/314 (23%), Positives = 129/314 (41%), Gaps = 29/314 (9%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
               +E  E++G G +G V R   + TG+ VA+K   +    ++ E        E+ I++
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW----CLEIQIMK 67

Query: 59  MLSRDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
            L   P+VV   +V  G  K     +  L  EY +  DL+KY+    +    +    +++
Sbjct: 68  KL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRT 125

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEI 174
           L+  +   + + H + I+HRDLKP N+++      +  KI DLG A+           E+
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD------QGEL 179

Query: 175 L-----TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
                 TL Y APE+L     Y+  VD WS   +  E +T    F  + +  Q     R 
Sbjct: 180 CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
               +  V+  ++  + +       P  L+  +    +     L+ ML +   +R +  +
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLP-TPNHLSGILAGKLE---RWLQCMLMWHQRQRGTDPQ 294

Query: 290 AMEHPYFDDLDKTR 303
                 F  LD   
Sbjct: 295 NPNVGCFQALDSIL 308

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  175 bits (447), Expect = 1e-53
 Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 58/309 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F +LEK+G G +G V++  ++  G I A+K+++            LREV    +L +  H
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           VVR        +      + +  EY +   L   I    +         +K L+ Q+ +G
Sbjct: 73  VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 125 VAFCHGHGILHRDLKPHNLLMDRK------------------TMTLKIADLGLARAFTLP 166
           + + H   ++H D+KP N+ + R                    +  KI DLG     + P
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187

Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
                 E     + A EVL  +  +    D++++A           L     +       
Sbjct: 188 ---QV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------- 236

Query: 227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                               WHE  Q     +      L ++  +LL+ M+  DP +R S
Sbjct: 237 --------------------WHEIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPS 273

Query: 287 AKKAMEHPY 295
           A   ++H  
Sbjct: 274 AMALVKHSV 282

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  181 bits (460), Expect = 1e-53
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 48/302 (15%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRL-HEDDEGVPPTTLREVSIL 57
           + + +++++K+G G YG+V   R+K T    A+K   KT +    +  +    L EV++L
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL----LEEVAVL 90

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           ++L   P++++L D  + +        YLV E     +L   I                 
Sbjct: 91  KLLDH-PNIMKLYDFFEDKRN-----YYLVMECYKGGELFDEI----IHRMKFNEVDAAV 140

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEI 174
           ++ Q+  GV + H H I+HRDLKP NLL++ K     +KI D GL+  F    KK    +
Sbjct: 141 IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERL 199

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T +Y APEVL     Y    D+WS+  I   L+     F G ++ + L  + +   T +
Sbjct: 200 GTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
              W  VS                            DL++QMLQ+D  +RISA++A+EHP
Sbjct: 258 SPEWKNVSE------------------------GAKDLIKQMLQFDSQRRISAQQALEHP 293

Query: 295 YF 296
           + 
Sbjct: 294 WI 295

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  179 bits (455), Expect = 2e-53
 Identities = 76/311 (24%), Positives = 131/311 (42%), Gaps = 46/311 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTL-REVSIL 57
           D +   + +G G  G+V  A E+ T K VA++     K  +    E  P   +  E+ IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           + L+  P ++++ +    ++       Y+V E M+  +L   +   ++  E     T K 
Sbjct: 195 KKLNH-PCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKRLKEA----TCKL 243

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEI 174
             YQ+   V + H +GI+HRDLKP N+L+  +     +KI D G ++             
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC 302

Query: 175 LTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
            T  Y APEVL+      Y+ AVD WS+  I    ++    F        L         
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-------- 354

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
             +++  G  +         W           + +  LDL++++L  DP  R + ++A+ 
Sbjct: 355 --DQITSGKYNF----IPEVW---------AEVSEKALDLVKKLLVVDPKARFTTEEALR 399

Query: 293 HPYFDDLDKTR 303
           HP+  D D  R
Sbjct: 400 HPWLQDEDMKR 410

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  179 bits (455), Expect = 7e-53
 Identities = 84/303 (27%), Positives = 138/303 (45%), Gaps = 49/303 (16%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLH--EDDEGVPPTTLREVSI 56
             D ++    +G+G++G+V   ++K TG+  A+K   K ++    D E +    LREV +
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL----LREVQL 79

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVK 115
           L+ L   P++++L +  + +        YLV E     +L   I     + +        
Sbjct: 80  LKQLDH-PNIMKLYEFFEDKGY-----FYLVGEVYTGGELFDEI----ISRKRFSEVDAA 129

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
            ++ Q+  G+ + H + I+HRDLKP NLL++ K+    ++I D GL+  F    KK   +
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDK 188

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           I T +Y APEVL G+  Y    D+WS   I   L++    F G +E   L  + +   T 
Sbjct: 189 IGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
               W  VS                            DL+ +ML Y PS RISA+ A++H
Sbjct: 247 ELPQWKKVSE------------------------SAKDLIRKMLTYVPSMRISARDALDH 282

Query: 294 PYF 296
            + 
Sbjct: 283 EWI 285

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  173 bits (442), Expect = 9e-53
 Identities = 81/321 (25%), Positives = 126/321 (39%), Gaps = 70/321 (21%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK-------KTRLHEDDEGVPPTTLREV 54
             + +E  E +G G    V R   K T K  A+K        +   E+ + +   TL+EV
Sbjct: 15  FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74

Query: 55  SILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTG 106
            ILR +S  P++++L D       E  T  +LVF+ M         T+      S ++T 
Sbjct: 75  DILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKET- 126

Query: 107 ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP 166
                   + +M  L + +   H   I+HRDLKP N+L+D   M +K+ D G +     P
Sbjct: 127 --------RKIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-P 176

Query: 167 IKKYTHEILTLWYRAPEVLLGS-----THYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            +K      T  Y APE++  S       Y   VDMWS   I   L+  +  F    ++ 
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236

Query: 222 QLLHIFR--LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQML 277
               + R  + G        W   S                            DL+ + L
Sbjct: 237 ----MLRMIMSGNYQFGSPEWDDYSD------------------------TVKDLVSRFL 268

Query: 278 QYDPSKRISAKKAMEHPYFDD 298
              P KR +A++A+ HP+F  
Sbjct: 269 VVQPQKRYTAEEALAHPFFQQ 289

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  178 bits (454), Expect = 1e-52
 Identities = 74/309 (23%), Positives = 136/309 (44%), Gaps = 51/309 (16%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTT-------- 50
           + +++ K+ K+G G YG+V   +EK      A+K   K++  +                 
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93

Query: 51  LREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENI 109
             E+S+L+ L   P++++L DV + +        YLV E+ +  +L + I +  +  E  
Sbjct: 94  YNEISLLKSLDH-PNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDEC- 146

Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--TLKIADLGLARAFTLPI 167
                 ++M Q+  G+ + H H I+HRD+KP N+L++ K     +KI D GL+  F+   
Sbjct: 147 ---DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KD 202

Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
            K    + T +Y APEVL     Y+   D+WS   I   L+     F G ++   +  + 
Sbjct: 203 YKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260

Query: 228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
           +     +   W  +S                         +  +L++ ML YD +KR +A
Sbjct: 261 KGKYYFDFNDWKNIS------------------------DEAKELIKLMLTYDYNKRCTA 296

Query: 288 KKAMEHPYF 296
           ++A+   + 
Sbjct: 297 EEALNSRWI 305

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  174 bits (444), Expect = 1e-52
 Identities = 78/308 (25%), Positives = 126/308 (40%), Gaps = 46/308 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRML 60
           D +E  E +G+G +  V R   + TG+  A+K     +             RE SI  ML
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY 119
              PH+V L++           +LY+VFE+MD  DL   I      G           M 
Sbjct: 84  KH-PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILTL 177
           Q+ + + +CH + I+HRD+KPH +L+  K  +  +K+   G+A             + T 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN- 234
            + APEV+     Y   VD+W    I   L++    F G  E      +F   + G    
Sbjct: 198 HFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKM 251

Query: 235 -EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
             + W  +S                        +   DL+ +ML  DP++RI+  +A+ H
Sbjct: 252 NPRQWSHIS------------------------ESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 294 PYFDDLDK 301
           P+  + D+
Sbjct: 288 PWLKERDR 295

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  177 bits (452), Expect = 2e-52
 Identities = 79/302 (26%), Positives = 138/302 (45%), Gaps = 48/302 (15%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRL-HEDDEGVPPTTLREVSIL 57
             + +  +  +G+G++G+V + +++ T +  A+K   K    ++D   +    LREV +L
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI----LREVELL 75

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           + L   P++++L ++ +  +       Y+V E     +L   I   ++  E+        
Sbjct: 76  KKLDH-PNIMKLFEILEDSSS-----FYIVGELYTGGELFDEIIKRKRFSEH----DAAR 125

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEI 174
           ++ Q+  G+ + H H I+HRDLKP N+L++ K     +KI D GL+  F     K    I
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI 184

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T +Y APEVL G+  Y    D+WS   I   L++ T  F G +E   L  +       +
Sbjct: 185 GTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
              W  +S                         D  DL+ +ML + PS RI+A + +EHP
Sbjct: 243 LPQWRTISD------------------------DAKDLIRKMLTFHPSLRITATQCLEHP 278

Query: 295 YF 296
           + 
Sbjct: 279 WI 280

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  172 bits (437), Expect = 3e-52
 Identities = 75/299 (25%), Positives = 129/299 (43%), Gaps = 44/299 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRML 60
           D F    K+G G +G V+   E+++G    +K   K R     E +      E+ +L+ L
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSL 77

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY 119
              P+++++ +V +  +      +Y+V E  +  +L + I S +  G+ +    V  LM 
Sbjct: 78  DH-PNIIKIFEVFEDYHN-----MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTL 177
           Q+   +A+ H   ++H+DLKP N+L    +    +KI D GLA  F    +  T+   T 
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTA 190

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEV       +   D+WS   +   L+T    F G S  +    +        +K 
Sbjct: 191 LYMAPEVFKRD--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQ-------QKA 237

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                +        +  P +            +DLL+QML  DP +R SA + + H +F
Sbjct: 238 TYKEPNY-----AVECRPLT---------PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  173 bits (441), Expect = 6e-52
 Identities = 83/318 (26%), Positives = 134/318 (42%), Gaps = 69/318 (21%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLH---EDDEGVPPTTLREVS 55
               ++  + +G G    V R   +ATG   A+K    T      E  E V   T RE  
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151

Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTGE 107
           ILR ++  PH++ L+D       E  + ++LVF+ M         T+      S ++T  
Sbjct: 152 ILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVAL--SEKET-- 202

Query: 108 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI 167
                  +S+M  L + V+F H + I+HRDLKP N+L+D   M ++++D G +     P 
Sbjct: 203 -------RSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLE-PG 253

Query: 168 KKYTHEILTLWYRAPEVLLGS-----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
           +K      T  Y APE+L  S       Y   VD+W+   I   L+  +  F    ++  
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL- 312

Query: 223 LLHIFR--LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQ 278
              + R  + G        W   SS                           DL+ ++LQ
Sbjct: 313 ---MLRMIMEGQYQFSSPEWDDRSS------------------------TVKDLISRLLQ 345

Query: 279 YDPSKRISAKKAMEHPYF 296
            DP  R++A++A++HP+F
Sbjct: 346 VDPEARLTAEQALQHPFF 363

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  170 bits (433), Expect = 1e-51
 Identities = 75/300 (25%), Positives = 134/300 (44%), Gaps = 52/300 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
           ++ FE    +G+G +G VY AREK +  I+ALK   K +L +   GV     REV I   
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSH 65

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L R P+++RL        +     +YL+ EY     + + ++   +  E        + +
Sbjct: 66  L-RHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQ----RTATYI 115

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--T 176
            +L   +++CH   ++HRD+KP NLL+      LKIAD G +       ++     L  T
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWS-VHAPSSRRTD---LCGT 170

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
           L Y  PE++ G   +   VD+WS+  +  E +     F  ++  +    I R+       
Sbjct: 171 LDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------ 223

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                        +P +           + +   DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 224 -----------FTFPDF-----------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  171 bits (436), Expect = 3e-51
 Identities = 84/307 (27%), Positives = 136/307 (44%), Gaps = 57/307 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRD 63
             K E +G G +G+V++  E ATG  +A K  KTR  +D E V      E+S++  L   
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV----KNEISVMNQLDH- 145

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVK 115
            ++++L D  + +N      + LV EY+D         D + Y  +              
Sbjct: 146 ANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIID-ESYNLTELD---------TI 190

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEI 174
             M Q+C+G+   H   ILH DLKP N+L  +R    +KI D GLAR +  P +K     
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNF 249

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APEV+      S   DMWSV  I   L++  + F GD++ + L +I        
Sbjct: 250 GTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           ++ +  +S                        ++  + + ++L  + S RISA +A++HP
Sbjct: 309 DEEFQDIS------------------------EEAKEFISKLLIKEKSWRISASEALKHP 344

Query: 295 YFDDLDK 301
           +  D   
Sbjct: 345 WLSDHKL 351

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  175 bits (446), Expect = 5e-51
 Identities = 76/301 (25%), Positives = 134/301 (44%), Gaps = 51/301 (16%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRM 59
           V+D ++  E++G G +G V+R  E+ATG   A K   T    D E V     +E+  + +
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV----RKEIQTMSV 210

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYI--RSFRQTGENIPVNTVKS 116
           L   P +V L D       E    + +++E+M   +L + +     + + E    +    
Sbjct: 211 LR-HPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMS-E----DEAVE 259

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            M Q+CKG+   H +  +H DLKP N++   +++  LK+ D GL      P +       
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTG 318

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN- 234
           T  + APEV  G        DMWSV  +   L++  + F G+++ + L ++       N 
Sbjct: 319 TAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNM 375

Query: 235 -EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            +  + G+S                        +DG D + ++L  DP+ R++  +A+EH
Sbjct: 376 DDSAFSGIS------------------------EDGKDFIRKLLLADPNTRMTIHQALEH 411

Query: 294 P 294
           P
Sbjct: 412 P 412

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  169 bits (431), Expect = 6e-51
 Identities = 77/313 (24%), Positives = 132/313 (42%), Gaps = 46/313 (14%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK-----KTRLHEDDEGVPPTTL-REVS 55
           + D +   + +G G  G+V  A E+ T K VA+K     K  +    E  P   +  E+ 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67

Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
           IL+ L+  P ++++ +    ++       Y+V E M+  +L   +   ++  E     T 
Sbjct: 68  ILKKLNH-PCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGNKRLKEA----TC 116

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTH 172
           K   YQ+   V + H +GI+HRDLKP N+L+  +     +KI D G ++           
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT 175

Query: 173 EILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
              T  Y APEVL+      Y+ AVD WS+  I    ++    F        L       
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK------ 229

Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
               +++  G  +         W           + +  LDL++++L  DP  R + ++A
Sbjct: 230 ----DQITSGKYNF----IPEVW---------AEVSEKALDLVKKLLVVDPKARFTTEEA 272

Query: 291 MEHPYFDDLDKTR 303
           + HP+  D D  R
Sbjct: 273 LRHPWLQDEDMKR 285

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  168 bits (427), Expect = 1e-50
 Identities = 80/302 (26%), Positives = 136/302 (45%), Gaps = 56/302 (18%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLH-EDDEGVPPTTLREVSILRM 59
           + +  +  +G+G++G+V + +++ T +  A+K   K     +D   +    LREV +L+ 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI----LREVELLKK 77

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L   P++++L ++ +  +       Y+V E     +L   I   ++  E    +    ++
Sbjct: 78  LDH-PNIMKLFEILEDSSS-----FYIVGELYTGGELFDEIIKRKRFSE----HDAARII 127

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGLARAFTLPIKKYTHEILT 176
            Q+  G+ + H H I+HRDLKP N+L++ K     +KI D GL+  F     K    I T
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGT 186

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN 234
            +Y APEVL G+  Y    D+WS   I   L++ T  F G +E      I +    G   
Sbjct: 187 AYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYA 240

Query: 235 --EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
                W  +S                         D  DL+ +ML + PS RI+A + +E
Sbjct: 241 FDLPQWRTIS------------------------DDAKDLIRKMLTFHPSLRITATQCLE 276

Query: 293 HP 294
           HP
Sbjct: 277 HP 278

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  167 bits (425), Expect = 2e-50
 Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 56/297 (18%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
             +G G++G+V  A +K T    A K   K  + ED +       +E+ I++ L   P++
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRF----KQEIEIMKSLDH-PNI 68

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +RL +  +         +YLV E     +L + +   R   E+        +M  +   V
Sbjct: 69  IRLYETFEDNTD-----IYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAV 119

Query: 126 AFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           A+CH   + HRDLKP N L    +    LK+ D GLA  F  P K    ++ T +Y +P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQ 178

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGTPN--EKVWP 239
           VL G   Y    D WS   +   L+     F   ++ +    +      GT    EK W 
Sbjct: 179 VLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIREGTFTFPEKDWL 232

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            VS                             L+ ++L   P +RI++ +A+EH +F
Sbjct: 233 NVS------------------------PQAESLIRRLLTKSPKQRITSLQALEHEWF 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  168 bits (428), Expect = 2e-50
 Identities = 74/306 (24%), Positives = 126/306 (41%), Gaps = 56/306 (18%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           +++G G +  V +   K+TG+  A K   K R  +D        L E+++L +    P V
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLELAKSCPRV 91

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           + L +V      E  + + L+ EY          L +         EN     V  L+ Q
Sbjct: 92  INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMV---SEN----DVIRLIKQ 139

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLW 178
           + +GV + H + I+H DLKP N+L+        +KI D G++R       +    + T  
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPE 198

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EK 236
           Y APE+L      +TA DMW++  I   L+T T+ F G+   +  L+I       +  E+
Sbjct: 199 YLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--SQVNVDYSEE 255

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +  VS                        +   D ++ +L  +P KR +A+  + H + 
Sbjct: 256 TFSSVS------------------------QLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

Query: 297 DDLDKT 302
              D  
Sbjct: 292 QQWDFE 297

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  169 bits (431), Expect = 3e-50
 Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 53/302 (17%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRM 59
           V D ++ LE++G G +G V+R  EKATG++   K   T    D   V      E+SI+  
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV----KNEISIMNQ 104

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNT 113
           L   P ++ L D       E +  + L+ E++      D    +           +    
Sbjct: 105 LHH-PKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAE 150

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTH 172
           V + M Q C+G+   H H I+H D+KP N++   +K  ++KI D GLA     P +    
Sbjct: 151 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKV 209

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
              T  + APE++          DMW++  +   L++  + F G+ +L+ L ++ R    
Sbjct: 210 TTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 268

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
            +E  +  VS                         +  D ++ +LQ +P KR++   A+E
Sbjct: 269 FDEDAFSSVS------------------------PEAKDFIKNLLQKEPRKRLTVHDALE 304

Query: 293 HP 294
           HP
Sbjct: 305 HP 306

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  166 bits (422), Expect = 5e-50
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 51/301 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
           ++ F+    +G+G++  VYRA    TG  VA+K   K  +++   G+      EV I   
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK--AGMVQRVQNEVKIHCQ 67

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L + P ++ L +  +  N      +YLV E     ++ +Y++      +    N  +  M
Sbjct: 68  L-KHPSILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFM 118

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEIL-- 175
           +Q+  G+ + H HGILHRDL   NLL+ R  M +KIAD GLA    +P  K YT   L  
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYT---LCG 174

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           T  Y +PE+   S H     D+WS+ C+F  L+     F     ++  L           
Sbjct: 175 TPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTL----------N 222

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
           KV      ++  +E P +           L  +  DL+ Q+L+ +P+ R+S    ++HP+
Sbjct: 223 KV------VLADYEMPSF-----------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

Query: 296 F 296
            
Sbjct: 266 M 266

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  167 bits (426), Expect = 6e-50
 Identities = 58/332 (17%), Positives = 128/332 (38%), Gaps = 57/332 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL-------- 51
           ++ +  +  + +G + K+    +    K  ALK   K+ L +  +               
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 52  ----REVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG 106
                E+ I+  + ++ + +    +    ++     +Y+++EYM+   + K+   F    
Sbjct: 88  DDFKNELQIITDI-KNEYCLTCEGIITNYDE-----VYIIYEYMENDSILKFDEYFFVLD 141

Query: 107 EN----IPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLAR 161
           +N    IP+  +K ++  +    ++ H    I HRD+KP N+LMD+    +K++D G + 
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGES- 199

Query: 162 AFTLPIKKYTHEIL------TLWYRAPEVLLGSTHYS-TAVDMWSVACIFAELVTKTALF 214
                  +Y  +        T  +  PE     + Y+   VD+WS+      +      F
Sbjct: 200 -------EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

Query: 215 PGDSELQQLLHIFRLLGTPNEKVWPGVSSL--MNWHEYPQWNPQSLATAVPNLDKDGLDL 272
                L +L             +            H       +    +   L  + +D 
Sbjct: 253 SLKISLVELF----------NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF 302

Query: 273 LEQMLQYDPSKRISAKKAMEHPYFDDLDKTRL 304
           L+  L+ +P++RI+++ A++H +  D +   L
Sbjct: 303 LKLFLRKNPAERITSEDALKHEWLADTNIEDL 334

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  165 bits (420), Expect = 1e-49
 Identities = 81/300 (27%), Positives = 135/300 (45%), Gaps = 52/300 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
           +D F+    +G+G +G VY AREK    I+ALK   K++L +  EGV     RE+ I   
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK--EGVEHQLRREIEIQSH 70

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L R P+++R+ +    + +     +YL+ E+    +L K ++   +  E        + M
Sbjct: 71  L-RHPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQ----RSATFM 120

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--T 176
            +L   + +CH   ++HRD+KP NLLM  K   LKIAD G +      +++ T   +  T
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWS-VHAPSLRRRT---MCGT 175

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
           L Y  PE++ G T +   VD+W    +  E +     F   S  +    I  +       
Sbjct: 176 LDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD------ 228

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                       ++P +           L     DL+ ++L+Y P +R+  K  MEHP+ 
Sbjct: 229 -----------LKFPPF-----------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  165 bits (420), Expect = 1e-49
 Identities = 72/308 (23%), Positives = 130/308 (42%), Gaps = 58/308 (18%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL-REVSIL 57
           V D +E  E++G G +  V + R+K TGK  A K   K RL     GV    + REV+IL
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPV 111
           R +   P+++ L D+      E +T + L+ E +      D   +K   +  +       
Sbjct: 63  REIRH-PNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE------- 109

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIK 168
                 + Q+  GV + H   I H DLKP N+++   +     +K+ D G+A        
Sbjct: 110 --ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGN 166

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           ++ +   T  + APE++          DMWS+  I   L++  + F G+++ + L +I  
Sbjct: 167 EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-- 223

Query: 229 LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                +  E+ +   S                        +   D + ++L  DP +R++
Sbjct: 224 SAVNYDFDEEYFSNTS------------------------ELAKDFIRRLLVKDPKRRMT 259

Query: 287 AKKAMEHP 294
             +++EH 
Sbjct: 260 IAQSLEHS 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  165 bits (419), Expect = 3e-49
 Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 54/296 (18%)

Query: 13  GEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           GEG+YGKV    +  T    A+K   K +L            +E+ +LR L R  +V++L
Sbjct: 14  GEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRL-RHKNVIQL 71

Query: 70  MDVKQGQNKEGRTVLYLVFEYM---DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           +DV   + K     +Y+V EY      ++   +   R      PV        QL  G+ 
Sbjct: 72  VDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKR-----FPVCQAHGYFCQLIDGLE 123

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRA 181
           + H  GI+H+D+KP NLL+     TLKI+ LG+A            +          ++ 
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAE---ALHPFAADDTCRTSQGSPAFQP 179

Query: 182 PEVLLGSTHYS-TAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           PE+  G   +S   VD+WS       + T    F GD       +I++L     E +  G
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-------NIYKLF----ENIGKG 228

Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  +  P                   DLL+ ML+Y+P+KR S ++  +H +F
Sbjct: 229 S------YAIPGD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  165 bits (420), Expect = 3e-49
 Identities = 77/308 (25%), Positives = 133/308 (43%), Gaps = 44/308 (14%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A K   K +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           R +    +V+ L DV      E RT + L+ E +   +L  ++       E        S
Sbjct: 70  RQVLH-HNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEE----EATS 119

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIKKYTHE 173
            + Q+  GV + H   I H DLKP N+++  K      +K+ D GLA        ++ + 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI 178

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
             T  + APE++          DMWS+  I   L++  + F GD++ + L +I  +    
Sbjct: 179 FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
           +E+ +   S                        +   D + ++L  +  KR++ ++A+ H
Sbjct: 238 DEEFFSHTS------------------------ELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 294 PYFDDLDK 301
           P+   +D 
Sbjct: 274 PWITPVDN 281

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  164 bits (418), Expect = 5e-49
 Identities = 66/311 (21%), Positives = 129/311 (41%), Gaps = 58/311 (18%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRM 59
           + + +   E +G G +G V+R  E ++ K    K  K +   D   V     +E+SIL +
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLV----KKEISILNI 57

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPVNT 113
             R  +++ L +       E    L ++FE++      +                +    
Sbjct: 58  A-RHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTS--------AFELNERE 103

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM-DRKTMTLKIADLGLARAFTLPIKKYTH 172
           + S ++Q+C+ + F H H I H D++P N++   R++ T+KI + G AR    P   +  
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRL 162

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
                 Y APEV       STA DMWS+  +   L++    F  ++  Q + +I  +   
Sbjct: 163 LFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--MNAE 219

Query: 233 PN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
               E+ +  +S                         + +D ++++L  +   R++A +A
Sbjct: 220 YTFDEEAFKEIS------------------------IEAMDFVDRLLVKERKSRMTASEA 255

Query: 291 MEHPYFDDLDK 301
           ++HP+     +
Sbjct: 256 LQHPWLKQKIE 266

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  165 bits (420), Expect = 6e-49
 Identities = 78/313 (24%), Positives = 134/313 (42%), Gaps = 54/313 (17%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A K   K +      GV    + REVSIL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPV 111
           R +   P+++ L DV      E RT + L+ E +      D   +K   S  +       
Sbjct: 70  RQVLH-PNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE------- 116

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPIK 168
               S + Q+  GV + H   I H DLKP N+++  K      +K+ D GLA        
Sbjct: 117 --ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGV 173

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           ++ +   T  + APE++          DMWS+  I   L++  + F GD++ + L +I  
Sbjct: 174 EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232

Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
           +    +E+ +   S                        +   D + ++L  +  KR++ +
Sbjct: 233 VSYDFDEEFFSQTS------------------------ELAKDFIRKLLVKETRKRLTIQ 268

Query: 289 KAMEHPYFDDLDK 301
           +A+ HP+   +D 
Sbjct: 269 EALRHPWITPVDT 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  163 bits (415), Expect = 7e-49
 Identities = 77/319 (24%), Positives = 129/319 (40%), Gaps = 69/319 (21%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRL-HEDDEGVPPTTLREVSIL 57
             D ++  E++G+G +  V R   K TG   A K     +L   D + +     RE  I 
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL----EREARIC 59

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENI 109
           R L   P++VRL D       +  +  YLVF+ +            + Y  S        
Sbjct: 60  RKLQH-PNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEADA---- 107

Query: 110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPI 167
                   + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GLA       
Sbjct: 108 -----SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DS 161

Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
           + +     T  Y +PEVL     YS  VD+W+   I   L+     F  + + +    ++
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LY 216

Query: 228 R--LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK 283
                G  +     W  V+                         +   L++ ML  +P K
Sbjct: 217 AQIKAGAYDYPSPEWDTVT------------------------PEAKSLIDSMLTVNPKK 252

Query: 284 RISAKKAMEHPYFDDLDKT 302
           RI+A +A++ P+  + ++ 
Sbjct: 253 RITADQALKVPWICNRERV 271

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  164 bits (417), Expect = 7e-49
 Identities = 74/313 (23%), Positives = 131/313 (41%), Gaps = 54/313 (17%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A K   K R      GV    + REVSIL
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSFRQTGENIPV 111
           + +   P+V+ L +V      E +T + L+ E +      D   +K   +  +       
Sbjct: 69  KEIQ-HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE------- 115

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADLGLARAFTLPIK 168
                 + Q+  GV + H   I H DLKP N+++   +     +KI D GLA        
Sbjct: 116 --ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGN 172

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
           ++ +   T  + APE++          DMWS+  I   L++  + F GD++ + L ++  
Sbjct: 173 EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231

Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
           +     ++ +   S                            D + ++L  DP KR++ +
Sbjct: 232 VNYEFEDEYFSNTS------------------------ALAKDFIRRLLVKDPKKRMTIQ 267

Query: 289 KAMEHPYFDDLDK 301
            +++HP+    D 
Sbjct: 268 DSLQHPWIKPKDT 280

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  164 bits (417), Expect = 8e-49
 Identities = 65/308 (21%), Positives = 123/308 (39%), Gaps = 53/308 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
                 + EG +  VY A++  +G+  ALK+   +E+++      ++EV  ++ LS  P+
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPN 87

Query: 66  VVRLMD---VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           +V+      + + ++  G+    L+ E     L ++++   ++   +  +TV  + YQ C
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146

Query: 123 KGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYT--------- 171
           + V   H     I+HRDLK  NLL+  +  T+K+ D G A   +                
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 172 HEIL---TLWYRAPEV--LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
            EI    T  YR PE+  L  +       D+W++ CI   L  +   F   ++L+ +   
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265

Query: 227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
           +                       P  + Q               L+  MLQ +P +R+S
Sbjct: 266 YS---------------------IPPHDTQY---------TVFHSLIRAMLQVNPEERLS 295

Query: 287 AKKAMEHP 294
             + +   
Sbjct: 296 IAEVVHQL 303

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  162 bits (413), Expect = 2e-48
 Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 52/298 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSR 62
           + +   +G+G + K +   +  T ++ A K   K+ L             E+SI R L  
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSL-A 73

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             HVV      +  +      +++V E      L +  +  +   E       +  + Q+
Sbjct: 74  HQHVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQI 124

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEIL--TLW 178
             G  + H + ++HRDLK  NL ++   + +KI D GLA        +K     L  T  
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKV---LCGTPN 180

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEVL    H S  VD+WS+ CI   L+     F   S L++             ++ 
Sbjct: 181 YIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETY----------LRI- 227

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  N +  P+            ++     L+++MLQ DP+ R +  + +   +F
Sbjct: 228 -----KKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFF 269

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  163 bits (415), Expect = 2e-48
 Identities = 75/362 (20%), Positives = 130/362 (35%), Gaps = 99/362 (27%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +  FE ++ +G G +G V+ A+ K      A+K+ RL   +       +REV  L  L  
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLE- 62

Query: 63  DPHVVRL----------------------------------------------------M 70
            P +VR                                                      
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 71  DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
            V Q Q    +  LY+  +     +LK ++   R + E+        +  Q+ + V F H
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREHGVCLHIFIQIAEAVEFLH 181

Query: 130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKKYTHEILTL 177
             G++HRDLKP N+        +K+ D GL  A                   +T ++ T 
Sbjct: 182 SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y +PE + G  +YS  VD++S+  I  EL+     F    E  +++   R         
Sbjct: 241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR------NLK 290

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           +P + +     +YPQ +                 +++ ML   P++R  A   +E+  F+
Sbjct: 291 FPLLFT----QKYPQEH----------------MMVQDMLSPSPTERPEATDIIENAIFE 330

Query: 298 DL 299
           +L
Sbjct: 331 NL 332

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  162 bits (412), Expect = 4e-48
 Identities = 64/298 (21%), Positives = 111/298 (37%), Gaps = 52/298 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL-REVSILRMLS 61
           ++    +G G +G VY     +    VA+K   K R+ +  E    T +  EV +L+ +S
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 62  -RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLM 118
                V+RL+D       E      L+ E  +   DL  +I       E       +S  
Sbjct: 105 SGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFF 155

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTDFDGTRV 213

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE +    ++  +  +WS+  +  ++V      P + + + +               
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVF---------- 261

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                      + Q            +  +   L+   L   PS R + ++   HP+ 
Sbjct: 262 -----------FRQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  162 bits (413), Expect = 4e-48
 Identities = 76/304 (25%), Positives = 115/304 (37%), Gaps = 68/304 (22%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           + +G G  GKV     + TG+  ALK                +EV      S  PH+V +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCI 87

Query: 70  MDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSF--RQTGENIPVNTVKSLMYQL 121
           +DV +  +   R +  ++ E M          ++  ++F  R+  E         +M  +
Sbjct: 88  LDVYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAE---------IMRDI 137

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEIL---- 175
              + F H H I HRD+KP NLL   K     LK+ D G A       K+ T   L    
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-------KETTQNALQTPC 190

Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLGT 232
            T +Y APEVL     Y  + DMWS+  I   L+     F  ++       + R   LG 
Sbjct: 191 YTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249

Query: 233 PN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
                  W  VS                         D   L+  +L+ DP++R++  + 
Sbjct: 250 YGFPNPEWSEVSE------------------------DAKQLIRLLLKTDPTERLTITQF 285

Query: 291 MEHP 294
           M HP
Sbjct: 286 MNHP 289

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  162 bits (411), Expect = 5e-48
 Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 54/300 (18%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHE-DDEGVPPTTLREVSILRMLS 61
           +     +G+G +G V+          VA+K   + R+          T   EV++L  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 62  RD---PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKS 116
                P V+RL+D       E +    LV E      DL  YI      GE       + 
Sbjct: 93  AGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRC 143

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
              Q+   +  CH  G++HRD+K  N+L+D +    K+ D G   A  L  + YT    T
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-AL-LHDEPYTDFDGT 201

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
             Y  PE +    +++    +WS+  +  ++V      P + + + L             
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD--IPFERDQEILEAELH-------- 251

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                        +P             +  D   L+ + L   PS R S ++ +  P+ 
Sbjct: 252 -------------FPAH-----------VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  162 bits (412), Expect = 5e-48
 Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 52/298 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSR 62
           + +   +G+G + K +   +  T ++ A K   K+ L             E+SI R L  
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSL-A 99

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             HVV      +  +      +++V E      L +  +  +   E       +  + Q+
Sbjct: 100 HQHVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQI 150

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP-IKKYTHEIL--TLW 178
             G  + H + ++HRDLK  NL ++   + +KI D GLA        +K     L  T  
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKV---LCGTPN 206

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEVL    H S  VD+WS+ CI   L+     F   S L++             ++ 
Sbjct: 207 YIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETY----------LRI- 253

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  N +  P+            ++     L+++MLQ DP+ R +  + +   +F
Sbjct: 254 -----KKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFF 295

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  165 bits (419), Expect = 6e-48
 Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 78/314 (24%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRL-HEDDEGVPPTTLREVSILRM 59
           + ++  E++G+G +  V R  +   G+  A       +L   D + +     RE  I R+
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL----EREARICRL 66

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPV 111
           L   P++VRL D    +        YL+F+ +            + Y  S          
Sbjct: 67  LKH-PNIVRLHDSISEEGH-----HYLIFDLVTGGELFEDIVAREYY--SEADA------ 112

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKK 169
                 + Q+ + V  CH  G++HR+LKP NLL+  K     +K+AD GLA       + 
Sbjct: 113 ---SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-----FPGDSELQQLL 224
           +     T  Y +PEVL     Y   VD+W+   I         L     F  + + +   
Sbjct: 170 WFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVI-----LYILLVGYPPFWDEDQHR--- 220

Query: 225 HIFR--LLGTP--NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD 280
            +++    G        W  V+                         +  DL+ +ML  +
Sbjct: 221 -LYQQIKAGAYDFPSPEWDTVT------------------------PEAKDLINKMLTIN 255

Query: 281 PSKRISAKKAMEHP 294
           PSKRI+A +A++HP
Sbjct: 256 PSKRITAAEALKHP 269

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  162 bits (411), Expect = 7e-48
 Identities = 67/290 (23%), Positives = 123/290 (42%), Gaps = 39/290 (13%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
           + +GEG++    +   K + +  A+K    R+  +       T +E++ L++    P++V
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-------TQKEITALKLCEGHPNIV 69

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           +L +V   Q        +LV E ++  +L + I+  +   E         +M +L   V+
Sbjct: 70  KLHEVFHDQLH-----TFLVMELLNGGELFERIKKKKHFSET----EASYIMRKLVSAVS 120

Query: 127 FCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
             H  G++HRDLKP NLL   +   + +KI D G AR      +       TL Y APE+
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           L  +  Y  + D+WS+  I   +++    F              ++    +K+  G  S 
Sbjct: 181 LNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----KKIKKGDFSF 235

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
               E   W          N+ ++  DL++ +L  DP+KR+       + 
Sbjct: 236 ----EGEAW---------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  162 bits (413), Expect = 8e-48
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 57/312 (18%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLH-EDDEGVPPTTLREVSIL 57
             D ++  E++G+G +  V R   K TG   A K     +L   D + +     RE  I 
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL----EREARIC 82

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           R L   P++VRL D       +  +  YLVF+ +   +L + I +     E         
Sbjct: 83  RKLQH-PNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASH 132

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHEI 174
            + Q+ + +A+CH +GI+HR+LKP NLL+  K     +K+AD GLA       + +    
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA 191

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-----FPGDSELQQLLHIFRL 229
            T  Y +PEVL     YS  VD+W+   I         L     F  + + +    I   
Sbjct: 192 GTPGYLSPEVLKKD-PYSKPVDIWACGVI-----LYILLVGYPPFWDEDQHRLYAQIKAG 245

Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
                   W  V+                         +   L++ ML  +P KRI+A +
Sbjct: 246 AYDYPSPEWDTVT------------------------PEAKSLIDSMLTVNPKKRITADQ 281

Query: 290 AMEHPYFDDLDK 301
           A++ P+  + ++
Sbjct: 282 ALKVPWICNRER 293

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  160 bits (408), Expect = 1e-47
 Identities = 69/317 (21%), Positives = 113/317 (35%), Gaps = 70/317 (22%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           + +GEG + +V       T +  A+K   K   H           REV +L       +V
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-----VFREVEMLYQCQGHRNV 73

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           + L++  + +++      YLVFE M    +  +I   R   E         ++  +   +
Sbjct: 74  LELIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNEL----EASVVVQDVASAL 124

Query: 126 AFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTL--PIKKYTHEIL-----T 176
            F H  GI HRDLKP N+L +       +KI D  L     L       +   L     +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 177 LWYRAPEVLLGSTH----YSTAVDMWSVACI-----------FAELVTKTALFPGDSELQ 221
             Y APEV+   +     Y    D+WS+  I                +      G++   
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244

Query: 222 QLLHIFR--LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQML 277
               +F     G     +K W  +S                  A     K   DL+ ++L
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISC----------------AA-----K---DLISKLL 280

Query: 278 QYDPSKRISAKKAMEHP 294
             D  +R+SA + ++HP
Sbjct: 281 VRDAKQRLSAAQVLQHP 297

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  162 bits (411), Expect = 2e-47
 Identities = 48/330 (14%), Positives = 109/330 (33%), Gaps = 72/330 (21%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLR-EVSILRMLS--- 61
             +   +G+        A ++ TG+   +      E         ++ EV  LR+L    
Sbjct: 75  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134

Query: 62  ------------------RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLK---KYIR 100
                             +DP   +++ V+  +        + ++  M ++L+   + + 
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194

Query: 101 SFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA 160
           S   T +++  +    L  Q+ + +A  H +G++H  L+P ++++D+    + +      
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEHL 253

Query: 161 RAFTLPIKKYTHEILTLWYRAPEVL----------LGSTHYSTAVDMWSVACIFAELVTK 210
                         ++  +  PE+              T  + + D W++  +   +   
Sbjct: 254 V----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 211 TALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL 270
                 D+ L     IFR                                +  N+ +   
Sbjct: 310 DLPITKDAALGGSEWIFR--------------------------------SCKNIPQPVR 337

Query: 271 DLLEQMLQYDPSKRISAKKAMEHPYFDDLD 300
            LLE  L+Y    R+   +AME P ++ L 
Sbjct: 338 ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  161 bits (409), Expect = 6e-47
 Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 58/306 (18%)

Query: 4   DAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           D ++   +V G G  GKV +   K T +  ALK  +             REV +    S+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQ 113

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSF--RQTGENIPVNTV 114
            PH+VR++DV +     GR  L +V E +           +  ++F  R+          
Sbjct: 114 CPHIVRIVDVYE-NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---------A 163

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTH 172
             +M  + + + + H   I HRD+KP NLL   K     LK+ D G A+  T      T 
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTT 222

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LL 230
              T +Y APEV LG   Y  + DMWS+  I   L+     F  +  L     +     +
Sbjct: 223 PCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281

Query: 231 GTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
           G        W  VS                        ++   L+  +L+ +P++R++  
Sbjct: 282 GQYEFPNPEWSEVS------------------------EEVKMLIRNLLKTEPTQRMTIT 317

Query: 289 KAMEHP 294
           + M HP
Sbjct: 318 EFMNHP 323

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  159 bits (405), Expect = 8e-47
 Identities = 74/318 (23%), Positives = 118/318 (37%), Gaps = 83/318 (26%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILR 58
             D +E  E +G G+Y    R   KAT    A+K   K++              E+ IL 
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILL 70

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIP 110
              + P+++ L DV      +    +Y+V E M            K +  S R+      
Sbjct: 71  RYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFF--SEREA----- 118

Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADLGLARAFTLPI 167
                ++++ + K V + H  G++HRDLKP N+L   ++    +++I D G A+      
Sbjct: 119 ----SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACI----------FAELVTKTALFPGD 217
                   T  + APEVL     Y  A D+WS+  +          FA     T     +
Sbjct: 175 GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP----E 229

Query: 218 SELQQLLH-IFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQM 276
             L ++    F L G      W  VS                            DL+ +M
Sbjct: 230 EILARIGSGKFSLSGGY----WNSVSD------------------------TAKDLVSKM 261

Query: 277 LQYDPSKRISAKKAMEHP 294
           L  DP +R++A   + HP
Sbjct: 262 LHVDPHQRLTAALVLRHP 279

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  155 bits (395), Expect = 2e-45
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 56/298 (18%)

Query: 8   KLEK-VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRD 63
            + + +GEG++GKV  A    T + VALK   +  L      +     RE+S L++L R 
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLL-RH 68

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           PH+++L DV         T + +V EY   +L  YI   ++  E+      +    Q+  
Sbjct: 69  PHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTED----EGRRFFQQIIC 119

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW----- 178
            + +CH H I+HRDLKP NLL+D   + +KIAD GL+   T          L        
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMT------DGNFLKTSCGSPN 172

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEV+ G  +    VD+WS   +   ++     F  +  +  L           +KV 
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLF----------KKVN 221

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             V      +  P +           L      L+ +M+  DP +RI+ ++    P+F
Sbjct: 222 SCV------YVMPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  155 bits (393), Expect = 2e-45
 Identities = 71/309 (22%), Positives = 121/309 (39%), Gaps = 68/309 (22%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRM 59
           +   F  +E +G G + +V+  +++ TGK+ ALK  K      D  +      E+++L+ 
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL----ENEIAVLKK 62

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPV 111
           +    ++V L D+ +          YLV + +          +   Y  + +        
Sbjct: 63  IKH-ENIVTLEDIYESTTH-----YYLVMQLVSGGELFDRILERGVY--TEKDA------ 108

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKK 169
                ++ Q+   V + H +GI+HRDLKP NLL         + I D GL++        
Sbjct: 109 ---SLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGI 163

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR- 228
            +    T  Y APEVL     YS AVD WS+  I   L+     F  ++E      +F  
Sbjct: 164 MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEK 218

Query: 229 -LLGTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI 285
              G        W  +S                        +   D +  +L+ DP++R 
Sbjct: 219 IKEGYYEFESPFWDDIS------------------------ESAKDFICHLLEKDPNERY 254

Query: 286 SAKKAMEHP 294
           + +KA+ HP
Sbjct: 255 TCEKALSHP 263

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  153 bits (389), Expect = 3e-45
 Identities = 85/293 (29%), Positives = 125/293 (42%), Gaps = 56/293 (19%)

Query: 13  GEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           G GT+GKV     + TG  VA+K   + ++      V     RE+  L++  R PH+++L
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLF-RHPHIIKL 76

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
             V         T  ++V EY+   +L  YI    +  E       + L  Q+   V +C
Sbjct: 77  YQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAVDYC 127

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW-----YRAPE 183
           H H ++HRDLKP N+L+D   M  KIAD GL+   +        E L        Y APE
Sbjct: 128 HRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMS------DGEFLRTSCGSPNYAAPE 180

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           V+ G  +    VD+WS   I   L+  T  F  +  +  L           +K+  GV  
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLF----------KKIRGGV-- 227

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                  P++           L++    LL  MLQ DP KR + K   EH +F
Sbjct: 228 ----FYIPEY-----------LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  152 bits (387), Expect = 6e-45
 Identities = 74/303 (24%), Positives = 123/303 (40%), Gaps = 52/303 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
           ++ ++ ++ +GEG YG+V  A  + T + VA+K     R  +  E +     +E+ I +M
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI----KKEICINKM 61

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L    +VV+    +         + YL  EY    +L   I       E       +   
Sbjct: 62  L-NHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFF 111

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +QL  GV + HG GI HRD+KP NLL+D +   LKI+D GLA   T+        +L   
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLA---TVFRYNNRERLLNKM 167

Query: 179 -----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
                Y APE+L     ++  VD+WS   +   ++     +   S+  Q           
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-------- 219

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                   + L  W +               +D   L LL ++L  +PS RI+     + 
Sbjct: 220 --DWKEKKTYLNPWKK---------------IDSAPLALLHKILVENPSARITIPDIKKD 262

Query: 294 PYF 296
            ++
Sbjct: 263 RWY 265

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  153 bits (389), Expect = 6e-45
 Identities = 72/316 (22%), Positives = 123/316 (38%), Gaps = 73/316 (23%)

Query: 13  GEGTYGKVYRAREKATGKIVALK---KTRL---------------------HEDDEGVPP 48
           G+G+YG V  A  +      A+K   K +L                          G   
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 49  TTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGE 107
              +E++IL+ L   P+VV+L++V    N+     LY+VFE ++   + +          
Sbjct: 82  QVYQEIAILKKL-DHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVPTLKP---- 133

Query: 108 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI 167
            +  +  +     L KG+ + H   I+HRD+KP NLL+  +   +KIAD G++  F    
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGS- 190

Query: 168 KKYTHEIL-----TLWYRAPEVLLGSTH-YS-TAVDMWSVACIFAELVTKTALFPGDSEL 220
                 +L     T  + APE L  +   +S  A+D+W++       V     F  +  +
Sbjct: 191 ----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-I 245

Query: 221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD 280
             L            K+           E+P           P++ +D  DL+ +ML  +
Sbjct: 246 MCLH----------SKIKSQA------LEFPDQ---------PDIAEDLKDLITRMLDKN 280

Query: 281 PSKRISAKKAMEHPYF 296
           P  RI   +   HP+ 
Sbjct: 281 PESRIVVPEIKLHPWV 296

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  153 bits (389), Expect = 2e-44
 Identities = 85/305 (27%), Positives = 124/305 (40%), Gaps = 64/305 (20%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FE   ++G G    VYR ++K T K  ALK  +   D + V      E+ +L  LS  
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLS-H 107

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD--------TDLKKYIRSFRQTGENIPVNTVK 115
           P++++L ++      E  T + LV E +          +   Y  S R            
Sbjct: 108 PNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYY--SERDA---------A 151

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFTLPIKKYTHE 173
             + Q+ + VA+ H +GI+HRDLKP NLL         LKIAD GL++            
Sbjct: 152 DAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTV 210

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LLG 231
             T  Y APE+L G   Y   VDMWSV  I   L+     F  +   Q    +FR  L  
Sbjct: 211 CGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNC 266

Query: 232 TPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
                   W  VS                         +  DL+ +++  DP KR++  +
Sbjct: 267 EYYFISPWWDEVS------------------------LNAKDLVRKLIVLDPKKRLTTFQ 302

Query: 290 AMEHP 294
           A++HP
Sbjct: 303 ALQHP 307

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  152 bits (385), Expect = 2e-44
 Identities = 68/306 (22%), Positives = 108/306 (35%), Gaps = 79/306 (25%)

Query: 4   DAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           D ++   +V G G  GKV +   K T +  ALK  +             REV +    S+
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-------REVELHWRASQ 69

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYM------DTDLKKYIRSF--RQTGENIPVNTV 114
            PH+VR++DV +     GR  L +V E +           +  ++F  R+          
Sbjct: 70  CPHIVRIVDVYE-NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---------A 119

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM--TLKIADLGLARAFTLPIKKYTH 172
             +M  + + + + H   I HRD+KP NLL   K     LK+ D G              
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------- 166

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR--LL 230
                   A E       Y  + DMWS+  I   L+     F  +  L     +     +
Sbjct: 167 --------AKETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216

Query: 231 GTPN--EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
           G        W  VS                        K    L+  +L+ +P++R++  
Sbjct: 217 GQYEFPNPEWSEVSE----------------EV-----K---MLIRNLLKTEPTQRMTIT 252

Query: 289 KAMEHP 294
           + M HP
Sbjct: 253 EFMNHP 258

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  154 bits (391), Expect = 3e-44
 Identities = 50/325 (15%), Positives = 103/325 (31%), Gaps = 63/325 (19%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLS--- 61
             +   +G+        A ++ TG+   +      E            EV  LR+L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 62  ------------------RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLK---KYIR 100
                             +DP   +++ V+  +        + ++  M ++L+   + + 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 101 SFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA 160
           S   T +++  +    L  Q+ + +A  H +G++H  L+P ++++D+    + +      
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEHL 258

Query: 161 RAFTLPIKKYTHE-ILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFP 215
                                A  +L    H     + A D W++      +        
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQ 275
            D+ L     IFR                       +  PQ +             LLE 
Sbjct: 319 DDAALGGSEWIFRS---------------------CKNIPQPVR-----------ALLEG 346

Query: 276 MLQYDPSKRISAKKAMEHPYFDDLD 300
            L+Y    R+   +AME P ++ L 
Sbjct: 347 FLRYPKEDRLLPLQAMETPEYEQLR 371

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  152 bits (386), Expect = 3e-44
 Identities = 60/304 (19%), Positives = 115/304 (37%), Gaps = 64/304 (21%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHED---DEGVPPTTLREVSILRM 59
           +  +  +G G +G V+ A +K   K V +K   K ++ ED   ++        E++IL  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSL 117
           +    ++++++D+      E +    LV E   +  DL  +I         +       +
Sbjct: 86  V-EHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYI 135

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
             QL   V +     I+HRD+K  N+++     T+K+ D G A            ++   
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLE------RGKLFYT 188

Query: 178 W-----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
           +     Y APEVL+G+ +    ++MWS+      LV +   F    E  +          
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--AAIHP--- 243

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
                             P             + K+ + L+  +LQ  P +R + +K + 
Sbjct: 244 ------------------PYL-----------VSKELMSLVSGLLQPVPERRTTLEKLVT 274

Query: 293 HPYF 296
            P+ 
Sbjct: 275 DPWV 278

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  152 bits (386), Expect = 4e-44
 Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 58/299 (19%)

Query: 8   KLEK-VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +L K +G+G + KV  AR   TG+ VA+K   KT+L+           REV I+++L   
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL---QKLFREVRIMKIL-NH 73

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++V+L +V      E    LYL+ EY    ++  Y+ +  +  E       +S   Q+ 
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIV 124

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TL 177
             V +CH   I+HRDLK  NLL+D   M +KIAD G +  FT          L       
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFT------VGGKLDAFCGAP 177

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APE+  G  +    VD+WS+  I   LV+ +  F G + L++L           E+V
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR----------ERV 226

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             G       +  P +           +  D  +LL++ L  +P KR + ++ M+  + 
Sbjct: 227 LRGK------YRIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  151 bits (384), Expect = 5e-44
 Identities = 74/303 (24%), Positives = 123/303 (40%), Gaps = 52/303 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
           ++ ++ ++ +GEG YG+V  A  + T + VA+K     R  +  E +     +E+ I +M
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI----KKEICINKM 61

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L    +VV+    +         + YL  EY    +L   I       E       +   
Sbjct: 62  L-NHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFF 111

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +QL  GV + HG GI HRD+KP NLL+D +   LKI+D GLA   T+        +L   
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLA---TVFRYNNRERLLNKM 167

Query: 179 -----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
                Y APE+L     ++  VD+WS   +   ++     +   S+  Q           
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-------- 219

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                   + L  W +               +D   L LL ++L  +PS RI+     + 
Sbjct: 220 --DWKEKKTYLNPWKK---------------IDSAPLALLHKILVENPSARITIPDIKKD 262

Query: 294 PYF 296
            ++
Sbjct: 263 RWY 265

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (377), Expect = 3e-43
 Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 38/292 (13%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
            ++G G++  VY+  +  T   VA  + +  +  +        E  +L+ L + P++VR 
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 90

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
            D  +   K  +  + LV E M +  LK Y++ F+     + +  ++S   Q+ KG+ F 
Sbjct: 91  YDSWESTVKGKKC-IVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFL 145

Query: 129 HGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
           H     I+HRDLK  N+ +   T ++KI DLGLA        K    I T  + APE+  
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-- 201

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
               Y  +VD+++      E+ T        SE Q    I+R       +V  GV     
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSE---YPYSECQNAAQIYR-------RVTSGV----- 246

Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
                   P S          +  +++E  ++ +  +R S K  + H +F +
Sbjct: 247 -------KPASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  150 bits (381), Expect = 8e-43
 Identities = 88/365 (24%), Positives = 144/365 (39%), Gaps = 86/365 (23%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DP--- 64
           + K+G G +  V+ + +    K VA+K  +     E    T L E+ +L+ +   DP   
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 65  ---HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
               VV+L+D  +     G  +  +VFE +   L K+I      G  +P+  VK ++ Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGTHIC-MVFEVLGHHLLKWIIKSNYQG--LPLPCVKKIIQQV 155

Query: 122 CKGVAFCHGH-GILHRDLKPHNLLM----------------------------------- 145
            +G+ + H    I+H D+KP N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 146 -------------DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYS 192
                        + + + +KIADLG A       K +T +I T  YR+ EVL+GS  Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYRSLEVLIGS-GYN 271

Query: 193 TAVDMWSVACIFAELVTKTALFPGDSELQ------QLLHIFRLLGTPNEKVWPGVS---- 242
           T  D+WS AC+  EL T   LF   S  +       +  I  LLG    K+         
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331

Query: 243 ------SLMNWHEYPQWNPQSLATAVPNLDKD----GLDLLEQMLQYDPSKRISAKKAME 292
                  L +  +   W    +        ++      D L  ML+  P KR +A + + 
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

Query: 293 HPYFD 297
           HP+ +
Sbjct: 392 HPWLN 396

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  151 bits (384), Expect = 1e-42
 Identities = 87/299 (29%), Positives = 131/299 (43%), Gaps = 57/299 (19%)

Query: 8   KLEK-VGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSRD 63
            L   +G GT+GKV   + + TG  VA+K   + ++      V     RE+  L++  R 
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLF-RH 75

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           PH+++L  V         + +++V EY+   +L  YI    +  E       + L  Q+ 
Sbjct: 76  PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESRRLFQQIL 126

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW---- 178
            GV +CH H ++HRDLKP N+L+D   M  KIAD GL+   +        E L       
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMS------DGEFLRTSCGSP 179

Query: 179 -YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEV+ G  +    VD+WS   I   L+  T  F  D  +  L           +K+
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLF----------KKI 228

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             G+         PQ+           L+   + LL+ MLQ DP KR + K   EH +F
Sbjct: 229 CDGIFYT------PQY-----------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  148 bits (375), Expect = 2e-42
 Identities = 58/304 (19%), Positives = 102/304 (33%), Gaps = 65/304 (21%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
                +VG G++G+V+R ++K TG   A+KK RL             E+     L   P 
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGL-SSPR 111

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +V L    +         + +  E ++   L + I+      E+         + Q  +G
Sbjct: 112 IVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEG 162

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-----TLWY 179
           + + H   ILH D+K  N+L+        + D G A          +         T  +
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV++G       VD+WS  C+   ++                      G       P
Sbjct: 223 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLN---------------------GCH-----P 255

Query: 240 GVSSLMNWHEYPQW--------NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
                  W +Y +          P  +    P+        +++ L+ +P  R SA +  
Sbjct: 256 -------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELR 308

Query: 292 EHPY 295
               
Sbjct: 309 RKVG 312

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  146 bits (371), Expect = 1e-41
 Identities = 74/304 (24%), Positives = 118/304 (38%), Gaps = 54/304 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
            D ++ ++ +G G +G     R+K T ++VA+K   +      DE V     RE+   R 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQ----REIINHRS 72

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L R P++VR  +V         T L ++ EY    +L + I +  +  E+      +   
Sbjct: 73  L-RHPNIVRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSED----EARFFF 122

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTLKIADLGLARAFTLPIKKYTHEILTL 177
            QL  GV++CH   I HRDLK  N L+D      LKI D G +++  L      H     
Sbjct: 123 QQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL------HSQPKS 176

Query: 178 W-----YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
                 Y APEVLL   +     D+WS       ++     F             R    
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP-------EEPRDYRK 229

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
             +++     S+      P     S          +   L+ ++   DP+ RIS  +   
Sbjct: 230 TIQRILSVKYSI------PDDIRIS---------PECCHLISRIFVADPATRISIPEIKT 274

Query: 293 HPYF 296
           H +F
Sbjct: 275 HSWF 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  142 bits (359), Expect = 1e-40
 Identities = 60/292 (20%), Positives = 106/292 (36%), Gaps = 51/292 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTL-----REVSILRML 60
            E  +++G+G +G V++ R      +VA+K   L + +             REV I+  L
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY 119
              P++V+L     G          +V E++   DL   +         I  +    LM 
Sbjct: 81  -NHPNIVKLY----GLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLML 129

Query: 120 QLCKGVAFCHGHG--ILHRDLKPHNLLMDRK----TMTLKIADLGLARAFTLPIKKYTHE 173
            +  G+ +       I+HRDL+  N+ +        +  K+AD GL++         +  
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV---HSVSGL 186

Query: 174 ILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
           +    + APE +      Y+   D +S A I   ++T    F   S  +    I  +   
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMI 242

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 284
             E + P           P+  P  L            +++E     DP KR
Sbjct: 243 REEGLRP---------TIPEDCPPRLR-----------NVIELCWSGDPKKR 274

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  140 bits (354), Expect = 9e-40
 Identities = 66/259 (25%), Positives = 103/259 (39%), Gaps = 34/259 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            E  E VG G +G V +A+ +   K VA+K+     + +      + E+  L  +   P+
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAF----IVELRQLSRV-NHPN 62

Query: 66  VVRLMDVKQGQNKEGRTV--LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           +V+L          G  +  + LV EY +   L   +                S   Q  
Sbjct: 63  IVKLY---------GACLNPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCS 112

Query: 123 KGVAFCHGH---GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           +GVA+ H      ++HRDLKP NLL+      LKI D G A          T+   +  +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAW 169

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT----PNE 235
            APEV  GS +YS   D++S   I  E++T+   F         +      GT      +
Sbjct: 170 MAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-K 227

Query: 236 KVWPGVSSLMN--WHEYPQ 252
            +   + SLM   W + P 
Sbjct: 228 NLPKPIESLMTRCWSKDPS 246

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  140 bits (354), Expect = 1e-39
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 32/230 (13%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           E +G+G +G+  +   + TG+++ +K+  L   DE    T L+EV ++R L   P+V++ 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCL-EHPNVLKF 72

Query: 70  MDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           + V  K  +       L  + EY+    L+  I+S        P +   S    +  G+A
Sbjct: 73  IGVLYKDKR-------LNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMA 122

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR-------------AFTLPIKKY-TH 172
           + H   I+HRDL  HN L+  +   + +AD GLAR             +   P +K    
Sbjct: 123 YLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ 222
            +   ++ APE++ G   Y   VD++S   +  E++ +    P       
Sbjct: 182 VVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (352), Expect = 1e-39
 Identities = 54/281 (19%), Positives = 112/281 (39%), Gaps = 41/281 (14%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
            +++G G++G VY+ +       VA+K   +             EV +LR   R  +++ 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILL 84

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
            M             L +V ++ +   L  ++ +   +     +  +  +  Q  +G+ +
Sbjct: 85  FMGYSTAPQ------LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDY 135

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR--AFTLPIKKYTHEILTLWYRAPEVL 185
            H   I+HRDLK +N+ +  +  T+KI D GLA   +      ++     ++ + APEV+
Sbjct: 136 LHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 186 LG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
               S  YS   D+++   +  EL+T    +   +   Q   I  ++G  +    P +S 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLS--PDLSK 249

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 284
           +          P+ +             L+ + L+    +R
Sbjct: 250 V------RSNCPKRMK-----------RLMAECLKKKRDER 273

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score =  140 bits (352), Expect = 2e-39
 Identities = 59/345 (17%), Positives = 110/345 (31%), Gaps = 82/345 (23%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV------PPTTLREVSIL 57
           +  ++ EK+GEG +G+V++         VA+K   +   D             L E+ I 
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 58  RMLS----------------RDPHVVR------------LMDVKQGQNKEGRTV-----L 84
           + LS                   H V+              +  +G   +         L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 85  YLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHGILHRDLKPH 141
           ++V E+     DL++                 KS+++QL   +A         HRDL   
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWG 191

Query: 142 NLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVA 201
           N+L+ + ++  K+      ++ T+P       I+               Y+ +       
Sbjct: 192 NVLLKKTSL-KKLHYTLNGKSSTIPSCGLQVSIID--------------YTLSRLERDGI 236

Query: 202 CIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN--WHEY--------P 251
            +F ++     LF GD + Q    I+RL+   N   W       N  W  Y         
Sbjct: 237 VVFCDVSMDEDLFTGDGDYQ--FDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM 294

Query: 252 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            +  +    A+  + +   +    ML +      SA   +     
Sbjct: 295 TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  137 bits (348), Expect = 8e-39
 Identities = 69/251 (27%), Positives = 108/251 (43%), Gaps = 20/251 (7%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           EK+G G++G V+RA     G  VA+K     +         LREV+I++ L R P++V  
Sbjct: 43  EKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLF 99

Query: 70  M-DVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           M  V Q  N      L +V EY+    L + +       E +      S+ Y + KG+ +
Sbjct: 100 MGAVTQPPN------LSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNY 152

Query: 128 CHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            H     I+HR+LK  NLL+D K  T+K+ D GL+R              T  + APEVL
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EKVWPGVSS 243
                 +   D++S   I  EL T    +   +  Q +  +            + P V++
Sbjct: 212 RDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270

Query: 244 LMN--WHEYPQ 252
           ++   W   P 
Sbjct: 271 IIEGCWTNEPW 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  136 bits (345), Expect = 9e-39
 Identities = 52/253 (20%), Positives = 96/253 (37%), Gaps = 23/253 (9%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L K+ E   G++++ R +  G  + +K  ++ +           E   LR+    P+V+ 
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLP 71

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           ++               L+  +M    L   +     T   +  +        + +G+AF
Sbjct: 72  VLGA---CQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAF 126

Query: 128 CHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            H     I    L   ++++D + MT +I+   +  +F  P + Y        + APE L
Sbjct: 127 LHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA-----WVAPEAL 180

Query: 186 LG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN--EKVWPGV 241
                     + DMWS A +  ELVT+   F   S ++  + +      P     + P V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240

Query: 242 SSLMN--WHEYPQ 252
           S LM    +E P 
Sbjct: 241 SKLMKICMNEDPA 253

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (342), Expect = 4e-38
 Identities = 60/299 (20%), Positives = 113/299 (37%), Gaps = 38/299 (12%)

Query: 8   KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVV 67
               +G+GTYG VY  R+ +    +A+K+    +     P     E+++ + L +  ++V
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP--LHEEIALHKHL-KHKNIV 82

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           + +             + +  E +    L   +RS     +     T+     Q+ +G+ 
Sbjct: 83  QYLGSFSENGF-----IKIFMEQVPGGSLSALLRSKWGPLK-DNEQTIGFYTKQILEGLK 136

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
           + H + I+HRD+K  N+L++  +  LKI+D G ++              TL Y APE++ 
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196

Query: 187 GSTH-YSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPGVSSL 244
                Y  A D+WS+ C   E+ T    F         +  +         KV P     
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV------GMFKVHP----- 245

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR 303
               E P            ++  +    + +  + DP KR  A   +   +     K +
Sbjct: 246 ----EIP-----------ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  133 bits (338), Expect = 9e-38
 Identities = 69/261 (26%), Positives = 106/261 (40%), Gaps = 35/261 (13%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRMLSRDPHVV 67
           E +G G +GKVYRA     G  VA+K  R   D++         +E  +  ML + P+++
Sbjct: 13  EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNII 69

Query: 68  RLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
            L  V  +  N      L LV E+     L + +      G+ IP + + +   Q+ +G+
Sbjct: 70  ALRGVCLKEPN------LCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118

Query: 126 AFCHGHG---ILHRDLKPHNLLMDRKT-------MTLKIADLGLARAFTLPIKKYTHEIL 175
            + H      I+HRDLK  N+L+ +K          LKI D GLAR +            
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAAG 176

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN- 234
              + APEV+  S  +S   D+WS   +  EL+T    F G   L     +         
Sbjct: 177 AYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235

Query: 235 -EKVWPGVSSLMN--WHEYPQ 252
                   + LM   W+  P 
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPH 256

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  134 bits (338), Expect = 3e-37
 Identities = 57/270 (21%), Positives = 101/270 (37%), Gaps = 39/270 (14%)

Query: 6   FEKL---EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           FE+L   E +G+G +G+VY  R       VA++   +  D+E       REV   R   R
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQT-R 87

Query: 63  DPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             +VV  M       +      L ++        L   +R        + VN  + +  +
Sbjct: 88  HENVVLFMGACMSPPH------LAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQE 138

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL--- 177
           + KG+ + H  GILH+DLK  N+  D     + I D GL     +       + L +   
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNG--KVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 178 WYR--APEVLLGST--------HYSTAVDMWSVACIFAELVTKTALFPGDSELQ---QLL 224
           W    APE++   +         +S   D++++  I+ EL  +   F          Q+ 
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256

Query: 225 HIFRLLGTPNEKVWPGVSSLMN--WHEYPQ 252
              +        +   +S ++   W    +
Sbjct: 257 TGMKPN-LSQIGMGKEISDILLFCWAFEQE 285

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  133 bits (336), Expect = 1e-36
 Identities = 44/320 (13%), Positives = 87/320 (27%), Gaps = 66/320 (20%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALK---KTRLHEDDEGVPPTTLREVS 55
                   +GEG + +VY A +         +   LK        E          + + 
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI-----GTQLME 119

Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQ-TGENIPVNT 113
            L+   +    ++       QN        LV E      L   I  ++    + +P   
Sbjct: 120 RLKPSMQ-HMFMKFYSAHLFQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT----------LKIADLGLARAF 163
           V S   ++   +   H   I+H D+KP N ++    +           L + DLG +   
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 164 TL--PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
            L      +T +  T  ++  E+L     ++  +D + VA     ++  T +   +    
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKN---- 288

Query: 222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDP 281
                                          WN                +    ML    
Sbjct: 289 ------------EGGECKPEGLFRRLPHLDMWN----------------EFFHVMLNIPD 320

Query: 282 SKRISAKKAMEHPYFDDLDK 301
              + +   +         +
Sbjct: 321 CHHLPSLDLLRQKLKKVFQQ 340

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  134 bits (340), Expect = 4e-36
 Identities = 76/316 (24%), Positives = 119/316 (37%), Gaps = 53/316 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
            D F     +G G +G+V+  + KATGK+ A   L K RL +         + E  IL  
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY--QGAMVEKKILAK 241

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           +     +V L    + +       L LV   M+  D++ +I +  +              
Sbjct: 242 VHS-RFIVSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----THE 173
            Q+  G+   H   I++RDLKP N+L+D     ++I+DLGLA        K      T  
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPG 354

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
                + APE+LLG   Y  +VD +++     E++     F    E  +   + +     
Sbjct: 355 -----FMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--VL 406

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAK 288
            + V            YP                   D  E +LQ DP KR+     S  
Sbjct: 407 EQAV-----------TYPDK-----------FSPASKDFCEALLQKDPEKRLGFRDGSCD 444

Query: 289 KAMEHPYFDDLDKTRL 304
               HP F D+   +L
Sbjct: 445 GLRTHPLFRDISWRQL 460

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  129 bits (327), Expect = 7e-36
 Identities = 67/312 (21%), Positives = 119/312 (38%), Gaps = 51/312 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
            D  E + ++G G YG V + R   +G+I+A+K+ R    +       L ++ I      
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVD 64

Query: 63  DPHVVRL--MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            P  V       ++G        +++  E MDT L K+ +     G+ IP + +  +   
Sbjct: 65  CPFTVTFYGALFREGD-------VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 117

Query: 121 LCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           + K +   H    ++HRD+KP N+L++     +K+ D G++      + K   +     Y
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDI-DAGCKPY 175

Query: 180 RAPEVLLGS---THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
            APE +        YS   D+WS+     EL      FP           F+ L    ++
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELA--ILRFP----YDSWGTPFQQL----KQ 225

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL-----DLLEQMLQYDPSKRISAKKAM 291
           V              +          P L  D       D   Q L+ +  +R +  + M
Sbjct: 226 V-------------VEEPS-------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

Query: 292 EHPYFDDLDKTR 303
           +HP+F   +   
Sbjct: 266 QHPFFTLHESKG 277

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 3e-35
 Identities = 68/306 (22%), Positives = 118/306 (38%), Gaps = 41/306 (13%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM-LSRDPH 65
           + ++++G+G YG+V+  + +  G+ VA+K     E+         RE  I +  L R  +
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEAS-----WFRETEIYQTVLMRHEN 92

Query: 66  VVRLM-DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++  +    +G      T LYL+ +Y +   L  Y++S       +   ++  L Y    
Sbjct: 93  ILGFIAADIKGTG--SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVS 145

Query: 124 GVAFCHGH--------GILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----T 171
           G+   H           I HRDLK  N+L+  K  T  IADLGLA  F     +      
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 172 HEILTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
             + T  Y  PEVL  S +          DM+S   I  E+  +        E Q   H 
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264

Query: 227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS 286
                   E +   V         P +  +  +       +    L+ +   ++P+ R++
Sbjct: 265 LVPSDPSYEDMREIVC---IKKLRPSFPNRWSSDECL---RQMGKLMTECWAHNPASRLT 318

Query: 287 AKKAME 292
           A +  +
Sbjct: 319 ALRVKK 324

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  127 bits (320), Expect = 9e-35
 Identities = 61/313 (19%), Positives = 113/313 (36%), Gaps = 55/313 (17%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM-LSRDPH 65
             LE VG+G YG+V+R   +  G+ VA+K     ++         RE  +    + R  +
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKS-----WFRETELYNTVMLRHEN 63

Query: 66  VVRLM-DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++  +      ++    T L+L+  Y +   L  Y++        +   +   ++  +  
Sbjct: 64  ILGFIASDMTSRHSS--TQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIAS 116

Query: 124 GVAFCHG--------HGILHRDLKPHNLLMDRKTMTLKIADLGLAR----AFTLPIKKYT 171
           G+A  H           I HRDLK  N+L+ +      IADLGLA     +         
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 172 HEILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI 226
             + T  Y APEVL  +           VD+W+   +  E+  +        + +     
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP---- 231

Query: 227 FRLLGTPNEKVWPGVSSLMNWHEY-------PQWNPQSLATAVPNLDKDGLDLLEQMLQY 279
                 P   V P   S  +  +        P    +  +            L+++    
Sbjct: 232 ------PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA---KLMKECWYQ 282

Query: 280 DPSKRISAKKAME 292
           +PS R++A +  +
Sbjct: 283 NPSARLTALRIKK 295

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  128 bits (322), Expect = 1e-34
 Identities = 65/314 (20%), Positives = 122/314 (38%), Gaps = 37/314 (11%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
            D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L     
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHE-CN 89

Query: 63  DPHVVRLMD--VKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMY 119
            P++V         G+       + +  E+MD   L + ++   +  E I    +  +  
Sbjct: 90  SPYIVGFYGAFYSDGE-------ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSI 138

Query: 120 QLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            + KG+ +    H I+HRD+KP N+L++ +   +K+ D G++      +   +  + T  
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMAN-SF-VGTRS 195

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT------KTALFPGDSELQQLLHIFRLLGT 232
           Y +PE L G+ HYS   D+WS+     E+               +      +        
Sbjct: 196 YMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL----------DLLEQMLQYDPS 282
           P  +      +       P      L   + N     L          D + + L  +P+
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 314

Query: 283 KRISAKKAMEHPYF 296
           +R   K+ M H + 
Sbjct: 315 ERADLKQLMVHAFI 328

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  131 bits (331), Expect = 1e-34
 Identities = 79/316 (25%), Positives = 128/316 (40%), Gaps = 56/316 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           M+ F     +G G +G+VY  R+  TGK+ A   L K R+           L E  +L +
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET--LALNERIMLSL 245

Query: 60  LSRDPH--VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
           +S      +V +       +K     L  + + M+  DL  ++       E         
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEA------DM 294

Query: 117 LMY--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
             Y  ++  G+   H   +++RDLKP N+L+D     ++I+DLGLA  F    KK  H  
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDF---SKKKPHAS 350

Query: 175 L-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
           + T  Y APEVL     Y ++ D +S+ C+  +L+   + F      +    I R+  T 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRM--TL 407

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAK 288
              V           E P                +   LLE +LQ D ++R+      A+
Sbjct: 408 TMAV-----------ELPDS-----------FSPELRSLLEGLLQRDVNRRLGCLGRGAQ 445

Query: 289 KAMEHPYFDDLDKTRL 304
           +  E P+F  LD   +
Sbjct: 446 EVKESPFFRSLDWQMV 461

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  130 bits (329), Expect = 2e-34
 Identities = 79/315 (25%), Positives = 128/315 (40%), Gaps = 54/315 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
            + F +   +G+G +G+V   + +ATGK+ A   L+K R+ +         L E  IL  
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE--AMALNEKQILEK 240

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           ++    VV L    + ++      L LV   M+  DLK +I    Q G   P        
Sbjct: 241 VNS-RFVVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYA 292

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEI 174
            ++C G+   H   I++RDLKP N+L+D     ++I+DLGLA              T   
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG- 350

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
               Y APEV+     Y+ + D W++ C+  E++   + F    +  +   + R      
Sbjct: 351 ----YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--LVKE 403

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKK 289
                         EY +                   L  Q+L  DP++R+     SA++
Sbjct: 404 VPE-----------EYSER-----------FSPQARSLCSQLLCKDPAERLGCRGGSARE 441

Query: 290 AMEHPYFDDLDKTRL 304
             EHP F  L+  RL
Sbjct: 442 VKEHPLFKKLNFKRL 456

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  125 bits (316), Expect = 7e-34
 Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 53/312 (16%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDPH 65
              E +G+G +G+V+R + +  G+ VA+K     E+         RE  I + +  R  +
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS-----WFREAEIYQTVMLRHEN 97

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           ++  +      N    T L+LV +Y +   L  Y+         + V  +  L      G
Sbjct: 98  ILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASG 151

Query: 125 VAFCHGH--------GILHRDLKPHNLLMDRKTMTLKIADLGLARAF----TLPIKKYTH 172
           +A  H           I HRDLK  N+L+  K  T  IADLGLA               H
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 173 EILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
            + T  Y APEVL  S            D++++  +F E+  + ++     + Q   +  
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 228 RLLGTPNEKVWPGVSSL-------MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD 280
                  E++   V            W        + +A            ++ +    +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA--LRVMA-----------KIMRECWYAN 317

Query: 281 PSKRISAKKAME 292
            + R++A +  +
Sbjct: 318 GAARLTALRIKK 329

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  123 bits (311), Expect = 2e-33
 Identities = 60/309 (19%), Positives = 116/309 (37%), Gaps = 46/309 (14%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           ++  E L ++G GT G+V++ R + TG ++A+K+ R    ++      L ++ ++     
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHD 82

Query: 63  DPHVVRLMD--VKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
            P++V+     +           +++  E M T  +K     ++    IP   +  +   
Sbjct: 83  CPYIVQCFGTFITNTD-------VFIAMELMGTCAEKLK---KRMQGPIPERILGKMTVA 132

Query: 121 LCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           + K + +    HG++HRD+KP N+L+D +   +K+ D G++        K         Y
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAK-DRSAGCAAY 190

Query: 180 RAPEVL----LGSTHYSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPN 234
            APE +         Y    D+WS+     EL T    +    ++ + L  +        
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-------- 242

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                            Q  P  L         D    ++  L  D  KR    K +EH 
Sbjct: 243 ----------------LQEEPPLLPGH-MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285

Query: 295 YFDDLDKTR 303
           +    +   
Sbjct: 286 FIKRYETLE 294

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (307), Expect = 6e-33
 Identities = 65/311 (20%), Positives = 126/311 (40%), Gaps = 52/311 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E  E +G G    V  A      + VA+K+  L +    +    L+E+  +      
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMS-QCHH 72

Query: 64  PHVVRLMD--VKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGEN-IPVNTVKS 116
           P++V      V + +       L+LV + +      D+ K+I +  +     +  +T+ +
Sbjct: 73  PNIVSYYTSFVVKDE-------LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--- 173
           ++ ++ +G+ + H +G +HRD+K  N+L+     +++IAD G++           ++   
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRK 184

Query: 174 --ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
             + T  + APEV+     Y    D+WS      EL T  A +     ++ L+       
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----- 239

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGL------DLLEQMLQYDPSKRI 285
                               Q +P SL T V + +           ++   LQ DP KR 
Sbjct: 240 -------------------LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

Query: 286 SAKKAMEHPYF 296
           +A + + H +F
Sbjct: 281 TAAELLRHKFF 291

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (307), Expect = 1e-32
 Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 46/310 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
             FE +E VG GTYG+VY+ R   TG++ A+K   +  D+E       +E+++L+  S  
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHH 80

Query: 64  PHVVRLMDV-KQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLM 118
            ++        +         L+LV E+      TDL K  +      E I       + 
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----IC 135

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            ++ +G++  H H ++HRD+K  N+L+      +K+ D G++      + +    I T +
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 179 YRAPEVLLGSTH----YSTAVDMWSVACIFA-ELVTKTALFPGDSELQQLLHIFRLLGTP 233
           + APEV+    +    Y    D+WS+  I A E+            ++ L  I       
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLI------- 246

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                            P+     L +      K     +E  L  + S+R + ++ M+H
Sbjct: 247 -----------------PRNPAPRLKS--KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287

Query: 294 PYFDDLDKTR 303
           P+  D    R
Sbjct: 288 PFIRDQPNER 297

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  121 bits (305), Expect = 1e-32
 Identities = 75/310 (24%), Positives = 131/310 (42%), Gaps = 54/310 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
            + F+  + +GEG++  V  ARE AT +  A+K   K  + ++++   P   RE  ++  
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV--PYVTRERDVMSR 86

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L   P  V+L    Q   K     LY    Y    +L KYIR              +   
Sbjct: 87  LD-HPFFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGS----FDETCTRFYT 136

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--T 176
            ++   + + HG GI+HRDLKP N+L++   M ++I D G A+  +   K+        T
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
             Y +PE+L   +    + D+W++ CI  +LV     F   +E      IF       +K
Sbjct: 196 AQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IF-------QK 243

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA------ 290
           +      +   +++P                   DL+E++L  D +KR+  ++       
Sbjct: 244 I------IKLEYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 286

Query: 291 MEHPYFDDLD 300
             HP+F+ + 
Sbjct: 287 KAHPFFESVT 296

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  121 bits (305), Expect = 2e-32
 Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 43/310 (13%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
            +  + L ++G G YG V +   K +G+I+A+K+ R    DE      L ++ ++   S 
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSD 79

Query: 63  DPHVVRL--MDVKQGQNKEGRTVLYLVFEYMDTDLKK-YIRSFRQTGENIPVNTVKSLMY 119
            P++V+      ++G         ++  E M T   K Y   +    + IP   +  +  
Sbjct: 80  CPYIVQFYGALFREGD-------CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITL 132

Query: 120 QLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
              K +        I+HRD+KP N+L+DR    +K+ D G++      I K T +     
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAK-TRDAGCRP 190

Query: 179 YRAPEVLLGSTH---YSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPN 234
           Y APE +  S     Y    D+WS+     EL T    +P  +S   QL  +        
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-------- 242

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNL-DKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                            + +P  L+ +         ++ +   L  D SKR   K+ ++H
Sbjct: 243 ----------------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286

Query: 294 PYFDDLDKTR 303
           P+    ++  
Sbjct: 287 PFILMYEERA 296

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (314), Expect = 3e-32
 Identities = 47/216 (21%), Positives = 89/216 (41%), Gaps = 20/216 (9%)

Query: 6   FEKLEKVGEGTYGKVYRAR-EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           +E    +  G  G +Y A      G+ V LK      D E      + E   L  +   P
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA-MAMAERQFLAEVV-HP 139

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            +V++ +  +  ++ G  V Y+V EY+    LK+         + +PV    + + ++  
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILP 193

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYRAP 182
            +++ H  G+++ DLKP N+++  +   LK+ DLG               +  T  ++AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRIN-----SFGYLYGTPGFQAP 246

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           E++      + A D+++V    A L        G  
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 7e-32
 Identities = 55/327 (16%), Positives = 110/327 (33%), Gaps = 48/327 (14%)

Query: 4   DAFEKLEKVGEG--TYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
             +E L  +G+G      V  AR K TG+ V +++  L      +      E+ + ++  
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF- 83

Query: 62  RDPHVVRLMD--VKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVK 115
             P++V      +   +       L++V  +M      DL           + +    + 
Sbjct: 84  NHPNIVPYRATFIADNE-------LWVVTSFMAYGSAKDLICTHF-----MDGMNELAIA 131

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK------ 169
            ++  + K + + H  G +HR +K  ++L+      + ++ L    +     ++      
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 170 -YTHEILTLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKT----------ALF--- 214
              + +  L + +PEVL  +   Y    D++SV     EL               L    
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

Query: 215 ----PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVP-NLDKDG 269
               P   +   +      +         G+S  +        N  S +           
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 270 LDLLEQMLQYDPSKRISAKKAMEHPYF 296
              +EQ LQ +P  R SA   + H +F
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFF 337

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (291), Expect = 1e-30
 Identities = 66/297 (22%), Positives = 126/297 (42%), Gaps = 51/297 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R  +++P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRE-NKNPN 78

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +V  +D     ++     L++V EY+     TD+   +         I       +  + 
Sbjct: 79  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDV---VTETCMDEGQIAA-----VCREC 125

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + + F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ A
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 182 PEVLLGSTHYSTAVDMWS--VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           PEV+     Y   VD+WS  +  I  E++     +  ++ L+ L  I             
Sbjct: 185 PEVVTRKA-YGPKVDIWSLGIMAI--EMIEGEPPYLNENPLRALYLI------------- 228

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                             L      L     D L + L+ D  KR SAK+ ++H + 
Sbjct: 229 -----------ATNGTPELQNP-EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  115 bits (291), Expect = 2e-30
 Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 47/295 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            +   K+GEG+ G V  AREK +G+ VA+K   L +           EV I+R   +  +
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRD-YQHFN 103

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           VV +        +     L+++ E++     TD+   +   R   E I       +   +
Sbjct: 104 VVEMYKSYLVGEE-----LWVLMEFLQGGALTDI---VSQVRLNEEQIAT-----VCEAV 150

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            + +A+ H  G++HRD+K  ++L+      +K++D G     +  + K    + T ++ A
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 209

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+  S  Y+T VD+WS+  +  E+V     +  DS +Q +  + R    P  K    V
Sbjct: 210 PEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNSHKV 267

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           S ++                         D LE+ML  DP +R +A++ ++HP+ 
Sbjct: 268 SPVLR------------------------DFLERMLVRDPQERATAQELLDHPFL 298

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  119 bits (300), Expect = 2e-30
 Identities = 71/307 (23%), Positives = 131/307 (42%), Gaps = 50/307 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           +  F  L  +G+G++GKV  +  K T ++ A   LKK  + +DD+     T+ E  +L +
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE--CTMVEKRVLAL 397

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
             + P + +L    Q  ++     LY V EY++  DL  +I+   +  E           
Sbjct: 398 PGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYA 448

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
            ++  G+ F    GI++RDLK  N+++D +   +KIAD G+ +              T  
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPD 507

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APE++     Y  +VD W+   +  E++   A F G+ E +    +F+ +      V 
Sbjct: 508 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSI--MEHNV- 559

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEH 293
                      YP+            + K+ + + + ++   P KR+       +   EH
Sbjct: 560 ----------AYPKS-----------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598

Query: 294 PYFDDLD 300
            +F  +D
Sbjct: 599 AFFRYID 605

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  115 bits (291), Expect = 4e-30
 Identities = 79/308 (25%), Positives = 138/308 (44%), Gaps = 56/308 (18%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           ++ F   + +G+G++GKV+ A  K T +  A   LKK  +  DD+     T+ E  +L +
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE--CTMVEKRVLSL 73

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
               P +  +    Q +       L+ V EY++  DL  +I+S  +       +      
Sbjct: 74  AWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYA 124

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----THE 173
            ++  G+ F H  GI++RDLK  N+L+D+    +KIAD G+ +   L   K      T +
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPD 183

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
                Y APE+LLG   Y+ +VD WS   +  E++   + F G  E +    +F  +   
Sbjct: 184 -----YIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSI--R 231

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-ME 292
            +              YP+W           L+K+  DLL ++   +P KR+  +    +
Sbjct: 232 MDNP-----------FYPRW-----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269

Query: 293 HPYFDDLD 300
           HP F +++
Sbjct: 270 HPLFREIN 277

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  113 bits (286), Expect = 7e-30
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 25/221 (11%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTL----REVSILRM 59
           ++ ++K+G G    VY A +      VA+K       E        TL    REV     
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-----EETLKRFEREVHNSSQ 67

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
           LS   ++V ++DV   +  +     YLV EY++   L +YI S       + V+T  +  
Sbjct: 68  LS-HQNIVSMIDV--DEEDD---CYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFT 117

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TL 177
            Q+  G+   H   I+HRD+KP N+L+D    TLKI D G+A+A +      T+ +L T+
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
            Y +PE   G        D++S+  +  E++     F G++
Sbjct: 177 QYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGET 216

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  114 bits (287), Expect = 7e-30
 Identities = 62/318 (19%), Positives = 119/318 (37%), Gaps = 59/318 (18%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
              + LE    G +G V++A+     + VA+K   + +           EV  L  + + 
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSW---QNEYEVYSLPGM-KH 77

Query: 64  PHVVRLM-DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            ++++ +   K+G +      L+L+  + +   L  +++        +  N +  +   +
Sbjct: 78  ENILQFIGAEKRGTS--VDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETM 130

Query: 122 CKGVAFCHGH----------GILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK 169
            +G+A+ H             I HRD+K  N+L+    +T  IAD GLA  F        
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGD 189

Query: 170 YTHEILTLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
              ++ T  Y APEVL G+ +        +DM+++  +  EL ++     G  +   L  
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML-- 247

Query: 226 IFRLLGTPNEKVWPGVSSLMNWHEY-----------PQWNPQSLATAVPNLDKDGLDLLE 274
                  P E+      SL +  E              W   +    +        + +E
Sbjct: 248 -------PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML-------CETIE 293

Query: 275 QMLQYDPSKRISAKKAME 292
           +   +D   R+SA    E
Sbjct: 294 ECWDHDAEARLSAGCVGE 311

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  113 bits (285), Expect = 2e-29
 Identities = 78/325 (24%), Positives = 119/325 (36%), Gaps = 60/325 (18%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM-LS 61
           +D  + LE +G G YG VY+       + VA+K               + E +I R+ L 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNF-----INEKNIYRVPLM 64

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              ++ R +   +    +GR    LV EY     L KY+             +   L + 
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHS 119

Query: 121 LCKGVAFCHG---------HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY- 170
           + +G+A+ H            I HRDL   N+L+     T  I+D GL+   T       
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRP 178

Query: 171 -------THEILTLWYRAPEVLLGS------THYSTAVDMWSVACIFAELVT-KTALFPG 216
                    E+ T+ Y APEVL G+            VDM+++  I+ E+    T LFPG
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 217 DS--ELQQLLHIFRLLGTPNEKVWPGVSSL-------MNWHEYPQWNPQSLATAVPNLDK 267
           +S  E Q             E +   VS           W E      +SL         
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLK-------- 289

Query: 268 DGLDLLEQMLQYDPSKRISAKKAME 292
              + +E     D   R++A+ A E
Sbjct: 290 ---ETIEDCWDQDAEARLTAQXAEE 311

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  113 bits (286), Expect = 2e-29
 Identities = 76/329 (23%), Positives = 129/329 (39%), Gaps = 83/329 (25%)

Query: 3   MDAFEKLEKVGEGTYGKVYRARE---KATGKIVA---LKKTRLHEDDEGVPPTTLREVSI 56
           ++ FE L+ +G G YGKV+  R+     TGK+ A   LKK  + +  +     T  E  +
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-HTRTERQV 111

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           L  + + P +V L    Q + K     L+L+ +Y+              GE         
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETK-----LHLILDYI------------NGGE--------- 145

Query: 117 LMYQLCK------------------GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           L   L +                   +   H  GI++RD+K  N+L+D     + + D G
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD-SNGHVVLTDFG 204

Query: 159 LARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTH-YSTAVDMWSVACIFAELVTKTALFPG 216
           L++ F     +  ++   T+ Y AP+++ G    +  AVD WS+  +  EL+T  + F  
Sbjct: 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264

Query: 217 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQM 276
           D E      I R +     +             YPQ            +     DL++++
Sbjct: 265 DGEKNSQAEISRRI--LKSEP-----------PYPQE-----------MSALAKDLIQRL 300

Query: 277 LQYDPSKRISAKKA-----MEHPYFDDLD 300
           L  DP KR+           EH +F  ++
Sbjct: 301 LMKDPKKRLGCGPRDADEIKEHLFFQKIN 329

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  114 bits (288), Expect = 2e-29
 Identities = 71/309 (22%), Positives = 129/309 (41%), Gaps = 54/309 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
            D FE L  +G+G++GKV   ++  T K+ A+K   K +  E +E       +E+ I++ 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQG 71

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L   P +V L    Q +       +++V + +   DL+ +++      E     TVK  +
Sbjct: 72  LEH-PFLVNLWYSFQDEED-----MFMVVDLLLGGDLRYHLQQNVHFKE----ETVKLFI 121

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--T 176
            +L   + +     I+HRD+KP N+L+D     + I D  +A       +  T   +  T
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITT---MAGT 177

Query: 177 LWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPG--DSELQQLLHIFRLLGT 232
             Y APE+        YS AVD WS+     EL+     +     +  ++++H F     
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---- 233

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-SAKKAM 291
               V            YP               ++ + LL+++L+ +P +R        
Sbjct: 234 -TTVV-----------TYP-----------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270

Query: 292 EHPYFDDLD 300
             PY +D++
Sbjct: 271 NFPYMNDIN 279

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (282), Expect = 2e-29
 Identities = 68/309 (22%), Positives = 130/309 (42%), Gaps = 50/309 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +E + ++G+G +GKVY+A+ K TG + A K      ++E      + E+ IL      
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILAT-CDH 75

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           P++V+L+       K     L+++ E+        +        +    +    ++ +  
Sbjct: 76  PYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI------MLELDRGLTEPQIQVVCR 124

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           Q+ + + F H   I+HRDLK  N+LM  +   +++AD G++      ++K    I T ++
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYW 183

Query: 180 RAPEVLLGST----HYSTAVDMWSVACIFA-ELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            APEV++  T     Y    D+WS+  I   E+          + ++ LL I        
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI-------- 234

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
                            + +P +L T       +  D L+  L  +P  R SA + +EHP
Sbjct: 235 ----------------AKSDPPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277

Query: 295 YFDDLDKTR 303
           +   +   +
Sbjct: 278 FVSSITSNK 286

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  112 bits (282), Expect = 3e-29
 Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 25/218 (11%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTL----REVSILRMLSR 62
              VG G  G VY A +    +IVALK     L  D     P       RE      L  
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-----PVFRTRMQREARTAGRLQ- 92

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           +PHVV + D   G   E    LY+    ++  DL   +R        +      +++ Q+
Sbjct: 93  EPHVVPIHDF--G---EIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQI 143

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TLWYR 180
              +   H  G  HRD+KP N+L+        + D G+A A T          + TL+Y 
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSA-DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           APE    S   +   D++++ C+  E +T +  + GD 
Sbjct: 203 APERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (280), Expect = 5e-29
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTL----REVSILRM 59
           +E  E +G G   +V+ AR+    + VA+K  +  L  D     P+      RE      
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-----PSFYLRFRREAQNAAA 68

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
           L+  P +V + D  + +   G    Y+V EY+D   L+  + +       +       ++
Sbjct: 69  LN-HPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVI 122

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH--EIL- 175
              C+ + F H +GI+HRD+KP N+++   T  +K+ D G+ARA        T    ++ 
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS 218
           T  Y +PE   G +      D++S+ C+  E++T    F GDS
Sbjct: 182 TAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  112 bits (282), Expect = 8e-29
 Identities = 80/315 (25%), Positives = 141/315 (44%), Gaps = 65/315 (20%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           +D FE +  +G+G++GKV  AR K TG + A   LKK  + +DD+     T+ E  IL +
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE--CTMTEKRILSL 79

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
               P + +L    Q  ++     L+ V E+++  DL  +I+  R+  E       ++  
Sbjct: 80  ARNHPFLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEA------RARF 128

Query: 119 Y--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----T 171
           Y  ++   + F H  GI++RDLK  N+L+D +    K+AD G+ +              T
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGT 187

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
            +     Y APE+L     Y  AVD W++  +  E++   A F  ++E      +F  + 
Sbjct: 188 PD-----YIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAI- 236

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA- 290
             N++V            YP W           L +D   +L+  +  +P+ R+ +    
Sbjct: 237 -LNDEV-----------VYPTW-----------LHEDATGILKSFMTKNPTMRLGSLTQG 273

Query: 291 -----MEHPYFDDLD 300
                + HP+F ++D
Sbjct: 274 GEHAILRHPFFKEID 288

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (278), Expect = 1e-28
 Identities = 72/305 (23%), Positives = 133/305 (43%), Gaps = 49/305 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + F+ LEK+GEG+YG VY+A  K TG+IVA+K+  +  D + +    ++E+SI++     
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQ-CDS 83

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           PHVV+               L++V EY      +D+ +         + +  + + +++ 
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRL------RNKTLTEDEIATILQ 132

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
              KG+ + H    +HRD+K  N+L++ +    K+AD G+A   T  + K    I T ++
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFW 191

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFA-ELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
            APEV+     Y+   D+WS+  I A E+      +     ++ +  I            
Sbjct: 192 MAPEVIQEIG-YNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI------------ 237

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
                       P   P +          +  D ++Q L   P +R +A + ++HP+   
Sbjct: 238 ------------PTNPPPTFRKP-ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

Query: 299 LDKTR 303
                
Sbjct: 285 AKGVS 289

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  111 bits (280), Expect = 1e-28
 Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 60/312 (19%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           +  F  L  +G+G++GKV  +  K T ++ A   LKK  + +DD+     T+ E  +L +
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE--CTMVEKRVLAL 76

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
             + P + +L    Q  ++     LY V EY++  DL  +I+   +  E           
Sbjct: 77  PGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYA 127

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----THE 173
            ++  G+ F    GI++RDLK  N+++D +   +KIAD G+ +              T +
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPD 186

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP 233
                Y APE++     Y  +VD W+   +  E++   A F G+ E +    I       
Sbjct: 187 -----YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------ 234

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAK 288
              V            YP+            + K+ + + + ++   P KR+       +
Sbjct: 235 EHNV-----------AYPKS-----------MSKEAVAICKGLMTKHPGKRLGCGPEGER 272

Query: 289 KAMEHPYFDDLD 300
              EH +F  +D
Sbjct: 273 DIKEHAFFRYID 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  109 bits (274), Expect = 3e-28
 Identities = 70/297 (23%), Positives = 130/297 (43%), Gaps = 48/297 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + F KLEK+G+G++G+V++  +  T K+VA+K   L E ++ +     +E+++L      
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQC-DS 79

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD----TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           P+V +         K     L+++ EY+      DL +           +    + +++ 
Sbjct: 80  PYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDLLE--------PGPLDETQIATILR 126

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           ++ KG+ + H    +HRD+K  N+L+      +K+AD G+A   T    K    + T ++
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV+  S  Y +  D+WS+     EL            ++ L  I             
Sbjct: 186 MAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI------------- 231

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                      P+ NP +L     N  K   + +E  L  +PS R +AK+ ++H + 
Sbjct: 232 -----------PKNNPPTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  109 bits (274), Expect = 7e-28
 Identities = 80/314 (25%), Positives = 134/314 (42%), Gaps = 65/314 (20%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           M+ F+ L+ +G+GT+GKV   REKATG+  A   L+K  +   DE     T+ E  +L+ 
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA--HTVTESRVLQ- 60

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
            +R P +  L    Q  ++     L  V EY +  +L  ++   R   E       ++  
Sbjct: 61  NTRHPFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEE------RARF 109

Query: 119 Y--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----T 171
           Y  ++   + + H   +++RD+K  NL++D K   +KI D GL +              T
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGT 168

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
            E     Y APEVL     Y  AVD W +  +  E++     F      +    +F L+ 
Sbjct: 169 PE-----YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELI- 217

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----S 286
              E++            +P+            L  +   LL  +L+ DP +R+      
Sbjct: 218 -LMEEI-----------RFPRT-----------LSPEAKSLLAGLLKKDPKQRLGGGPSD 254

Query: 287 AKKAMEHPYFDDLD 300
           AK+ MEH +F  ++
Sbjct: 255 AKEVMEHRFFLSIN 268

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  110 bits (276), Expect = 9e-28
 Identities = 68/316 (21%), Positives = 121/316 (38%), Gaps = 58/316 (18%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
            D FE L+ +G G + +V   + K TG++ A   + K  + +  E        E  +L +
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS--CFREERDVL-V 116

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTV 114
                 + +L    Q +N      LYLV EY       T L K+       GE IP    
Sbjct: 117 NGDRRWITQLHFAFQDENY-----LYLVMEYYVGGDLLTLLSKF-------GERIPAEMA 164

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           +  + ++   +   H  G +HRD+KP N+L+DR    +++AD G            +   
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLVA 223

Query: 175 L-TLWYRAPEVLLG------STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
           + T  Y +PE+L        +  Y    D W++     E+      F  DS  +     +
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE----TY 279

Query: 228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
                           ++++ E+              + ++  D ++++L   P  R+  
Sbjct: 280 G--------------KIVHYKEHLSLPLVD-----EGVPEEARDFIQRLLC-PPETRLGR 319

Query: 288 KKAME---HPYFDDLD 300
             A +   HP+F  LD
Sbjct: 320 GGAGDFRTHPFFFGLD 335

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  109 bits (275), Expect = 1e-27
 Identities = 62/314 (19%), Positives = 113/314 (35%), Gaps = 56/314 (17%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
            + FE L+ +G G +G+V   + K   K+ A   L K  + +  E        E  +L  
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA--CFREERDVLVN 130

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-----TDLKKYIRSFRQTGENIPVNTV 114
                 +  L    Q  N      LYLV +Y       T L K+           P    
Sbjct: 131 GDS-KWITTLHYAFQDDNN-----LYLVMDYYVGGDLLTLLSKFEDRL-------PEEMA 177

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI 174
           +  + ++   +   H    +HRD+KP N+LMD     +++AD G            +   
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVA 236

Query: 175 L-TLWYRAPEVLLGSTH----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL 229
           + T  Y +PE+L         Y    D WS+     E++     F  +S ++     +  
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGK 292

Query: 230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK 289
           +    E+            ++P          V ++ ++  DL+ +++      R+    
Sbjct: 293 IMNHKERF-----------QFPTQ--------VTDVSENAKDLIRRLIC-SREHRLGQNG 332

Query: 290 AME---HPYFDDLD 300
             +   HP+F  +D
Sbjct: 333 IEDFKKHPFFSGID 346

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  109 bits (275), Expect = 2e-27
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 52/308 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           M+ FE L+ +G+GT+GKV   +EKATG+  A   LKK  +   DE     TL E  +L  
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA--HTLTENRVL-Q 203

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
            SR P +  L    Q  ++     L  V EY +  +L  ++   R   E    +  +   
Sbjct: 204 NSRHPFLTALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSE----DRARFYG 254

Query: 119 YQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
            ++   + + H    +++RDLK  NL++D K   +KI D GL +              T 
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTP 313

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
            Y APEVL     Y  AVD W +  +  E++     F      +    +F L+       
Sbjct: 314 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI------- 361

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAME 292
                 LM    +P+            L  +   LL  +L+ DP +R+      AK+ M+
Sbjct: 362 ------LMEEIRFPRT-----------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404

Query: 293 HPYFDDLD 300
           H +F  + 
Sbjct: 405 HRFFAGIV 412

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  108 bits (272), Expect = 3e-27
 Identities = 70/313 (22%), Positives = 123/313 (39%), Gaps = 63/313 (20%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
              F  L+ +G+G++GKV  AR KA     A   L+K  + +  E      + E ++L  
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK--HIMSERNVLLK 94

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
             + P +V L    Q  +K     LY V +Y++  +L  +++  R   E       ++  
Sbjct: 95  NVKHPFLVGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEP------RARF 143

Query: 119 Y--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY-----T 171
           Y  ++   + + H   I++RDLKP N+L+D     + + D GL +              T
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGT 202

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG 231
            E     Y APEVL     Y   VD W +  +  E++     F   +  +    ++  + 
Sbjct: 203 PE-----YLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNI- 251

Query: 232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA- 290
             N+ +           +               +      LLE +LQ D +KR+ AK   
Sbjct: 252 -LNKPL-----------QLKPN-----------ITNSARHLLEGLLQKDRTKRLGAKDDF 288

Query: 291 ---MEHPYFDDLD 300
                H +F  ++
Sbjct: 289 MEIKSHVFFSLIN 301

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  107 bits (270), Expect = 3e-27
 Identities = 70/316 (22%), Positives = 131/316 (41%), Gaps = 58/316 (18%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           +  F+ L  +G G+Y KV   R K T +I A   +KK  +++D++        E  +   
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID--WVQTEKHVFEQ 65

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
            S  P +V L    Q +++     L+ V EY++  DL  +++  R+  E        +  
Sbjct: 66  ASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEE------HARF 114

Query: 119 Y--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL- 175
           Y  ++   + + H  GI++RDLK  N+L+D +   +K+ D G+ +    P    T     
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDT-TSTFCG 172

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL-----HIFRLL 230
           T  Y APE+L G   Y  +VD W++  +  E++   + F               ++F+++
Sbjct: 173 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
               +++             P+            L      +L+  L  DP +R+     
Sbjct: 232 --LEKQI-----------RIPRS-----------LSVKAASVLKSFLNKDPKERLGCHPQ 267

Query: 291 ------MEHPYFDDLD 300
                   HP+F ++D
Sbjct: 268 TGFADIQGHPFFRNVD 283

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  107 bits (269), Expect = 5e-27
 Identities = 73/313 (23%), Positives = 132/313 (42%), Gaps = 66/313 (21%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
           +D F++++ +G G++G+V   + K +G   A+K   K ++ +  +     TL E  IL+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQA 97

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
           +   P +V+L    +  +      LY+V EY+   ++  ++R   +  E        +  
Sbjct: 98  V-NFPFLVKLEFSFKDNSN-----LYMVMEYVAGGEMFSHLRRIGRFSEP------HARF 145

Query: 119 Y--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
           Y  Q+     + H   +++RDLKP NLL+D++   +++ D G A       K+      T
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFA-------KRVKGRTWT 197

Query: 177 L----WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT 232
           L       APE++L   + + AVD W++  +  E+      F  D  +Q    I+  +  
Sbjct: 198 LCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKI-- 250

Query: 233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-- 290
            + KV            +P            +   D  DLL  +LQ D +KR    K   
Sbjct: 251 VSGKV-----------RFP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGV 288

Query: 291 ---MEHPYFDDLD 300
                H +F   D
Sbjct: 289 NDIKNHKWFATTD 301

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  107 bits (269), Expect = 7e-27
 Identities = 70/316 (22%), Positives = 131/316 (41%), Gaps = 58/316 (18%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           +  F+ L  +G G+Y KV   R K T +I A   +KK  +++D++        E  +   
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID--WVQTEKHVFEQ 108

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
            S  P +V L    Q +++     L+ V EY++  DL  +++  R+  E        +  
Sbjct: 109 ASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEE------HARF 157

Query: 119 Y--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL- 175
           Y  ++   + + H  GI++RDLK  N+L+D +   +K+ D G+ +    P    T     
Sbjct: 158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDT-TSTFCG 215

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL-----HIFRLL 230
           T  Y APE+L G   Y  +VD W++  +  E++   + F               ++F+++
Sbjct: 216 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
               +++             P+            L      +L+  L  DP +R+     
Sbjct: 275 --LEKQI-----------RIPRS-----------LSVKAASVLKSFLNKDPKERLGCHPQ 310

Query: 291 ------MEHPYFDDLD 300
                   HP+F ++D
Sbjct: 311 TGFADIQGHPFFRNVD 326

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (265), Expect = 1e-26
 Identities = 64/308 (20%), Positives = 123/308 (39%), Gaps = 53/308 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-HEDDEGVPPTTLREVSILRMLSR 62
             F  L ++G G++G VY AR+    ++VA+KK     +         ++EV  L+ L R
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-R 112

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD---TDLKKYIRSFRQTGENIPVNTVKSLMY 119
            P+ ++       ++       +LV EY     +DL +         + +    + ++ +
Sbjct: 113 HPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEV------HKKPLQEVEIAAVTH 161

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
              +G+A+ H H ++HRD+K  N+L+      +K+ D G A          +  + T ++
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMA---PANSF-VGTPYW 216

Query: 180 RAPEVLLGST--HYSTAVDMWS--VACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
            APEV+L      Y   VD+WS  + CI  EL  +       + +  L HI         
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKPPLFNMNAMSALYHI--------- 265

Query: 236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                           Q    +L +   +  +   + ++  LQ  P  R +++  ++H +
Sbjct: 266 ---------------AQNESPALQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308

Query: 296 FDDLDKTR 303
                   
Sbjct: 309 VLRERPPT 316

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  104 bits (263), Expect = 2e-26
 Identities = 63/317 (19%), Positives = 133/317 (41%), Gaps = 74/317 (23%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRM 59
           +  F+ L  +G G++G+V+  R +  G+  A   LKK  +    +     T  E  +L +
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE--HTNDERLMLSI 62

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
           +   P ++R+    Q   +     ++++ +Y++  +L   +R  ++           +  
Sbjct: 63  V-THPFIIRMWGTFQDAQQ-----IFMIMDYIEGGELFSLLRKSQRFPNP------VAKF 110

Query: 119 Y--QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA-----RAFTL---PIK 168
           Y  ++C  + + H   I++RDLKP N+L+D+    +KI D G A       +TL   P  
Sbjct: 111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTP-- 167

Query: 169 KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR 228
               +     Y APEV+    + + ++D WS   +  E++     F   + ++     + 
Sbjct: 168 ----D-----YIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYE 213

Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
            +   N ++            +P +            ++D  DLL +++  D S+R+   
Sbjct: 214 KI--LNAEL-----------RFPPF-----------FNEDVKDLLSRLITRDLSQRLGNL 249

Query: 289 KA-----MEHPYFDDLD 300
           +        HP+F ++ 
Sbjct: 250 QNGTEDVKNHPWFKEVV 266

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  105 bits (263), Expect = 6e-26
 Identities = 70/309 (22%), Positives = 118/309 (38%), Gaps = 50/309 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRM 59
            + +E ++ +G G +G+V   R K+T K+ A+K   K  + +  +        E  I+  
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA--FFWEERDIMAF 125

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLM 118
            +  P VV+L    Q         LY+V EYM   DL   + ++      +P    +   
Sbjct: 126 ANS-PWVVQLFYAFQDDRY-----LYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYT 174

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL-TL 177
            ++   +   H  G +HRD+KP N+L+D+    LK+AD G                + T 
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 178 WYRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            Y +PEVL    G  +Y    D WSV     E++     F  DS +      +       
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYS------ 283

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME-- 292
                    +MN      + P        ++ K+  +L+   L  D   R+      E  
Sbjct: 284 --------KIMNHKNSLTF-PDD-----NDISKEAKNLICAFLT-DREVRLGRNGVEEIK 328

Query: 293 -HPYFDDLD 300
            H +F +  
Sbjct: 329 RHLFFKNDQ 337

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  103 bits (258), Expect = 7e-26
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 39/224 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM 59
              + L+++G+G +G V   R    +  TG++VA+KK  L    E       RE+ IL+ 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKS 67

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L +  ++V+   V       GR  L L+ EY+    L+ Y++  +   E I    +    
Sbjct: 68  L-QHDNIVKYKGVCY---SAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYT 120

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------L 165
            Q+CKG+ +      +HRDL   N+L++ +   +KI D GL +                 
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

Query: 166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PI          WY APE L  S  +S A D+WS   +  EL T
Sbjct: 180 PIF---------WY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 2e-25
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 39/224 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM 59
              + L+++G+G +G V   R    +  TG++VA+KK  L    E       RE+ IL+ 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKS 98

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L +  ++V+   V       GR  L L+ EY+    L+ Y++  +   E I    +    
Sbjct: 99  L-QHDNIVKYKGVCY---SAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYT 151

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------L 165
            Q+CKG+ +      +HRDL   N+L++ +   +KI D GL +                 
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

Query: 166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PI          WY APE L  S  +S A D+WS   +  EL T
Sbjct: 211 PIF---------WY-APESLTESK-FSVASDVWSFGVVLYELFT 243

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  101 bits (253), Expect = 5e-25
 Identities = 79/328 (24%), Positives = 134/328 (40%), Gaps = 89/328 (27%)

Query: 3   MDAFEKLEKVGEGTYGKVYRARE---KATGKIVA---LKKTRLHEDDEGVPPTTLREVSI 56
            + FE L  +G+G YGKV++ R+     TGKI A   LKK  +  + +     T  E +I
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-HTKAERNI 74

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           L  + + P +V L+   Q   K     LYL+ EY+              GE         
Sbjct: 75  LEEV-KHPFIVDLIYAFQTGGK-----LYLILEYL------------SGGE--------- 107

Query: 117 LMYQLCK------------------GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           L  QL +                   +   H  GI++RDLKP N++++     +K+ D G
Sbjct: 108 LFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN-HQGHVKLTDFG 166

Query: 159 LARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD 217
           L +         TH    T+ Y APE+L+ S  ++ AVD WS+  +  +++T    F G+
Sbjct: 167 LCKESIHDGTV-THTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGE 224

Query: 218 SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQML 277
           +  +        +     K+             P +           L ++  DLL+++L
Sbjct: 225 NRKK----TIDKI--LKCKL-----------NLPPY-----------LTQEARDLLKKLL 256

Query: 278 QYDPSKRISAKKA-----MEHPYFDDLD 300
           + + + R+ A          HP+F  ++
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHIN 284

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  101 bits (253), Expect = 7e-25
 Identities = 73/328 (22%), Positives = 126/328 (38%), Gaps = 91/328 (27%)

Query: 3   MDAFEKLEKVGEGTYGKVYRARE---KATGKIVA---LKKTRLHEDDEGVPPTTLREVSI 56
              FE L+ +G+G++GKV+  ++       ++ A   LKK  L   D      T  E  I
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV---RTKMERDI 79

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           L +    P +V+L    Q + K     LYL+ +++            + G+         
Sbjct: 80  L-VEVNHPFIVKLHYAFQTEGK-----LYLILDFL------------RGGD--------- 112

Query: 117 LMYQLCK------------------GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
           L  +L K                   +   H  GI++RDLKP N+L+D +   +K+ D G
Sbjct: 113 LFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFG 171

Query: 159 LARAFTLPIKKYTHEIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD 217
           L++      KK  +    T+ Y APEV+     ++ + D WS   +  E++T T  F G 
Sbjct: 172 LSKESIDHEKK-AYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGK 229

Query: 218 SELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQML 277
              +       ++     K+             PQ+           L  +   LL  + 
Sbjct: 230 DRKE----TMTMI--LKAKL-----------GMPQF-----------LSPEAQSLLRMLF 261

Query: 278 QYDPSKRISAKKA-----MEHPYFDDLD 300
           + +P+ R+ A          H +F  +D
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSFFSTID 289

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (250), Expect = 1e-24
 Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 45/249 (18%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTT-LREVSILR 58
              +++  +GEG +GKV   R       TG+ VA+K   L  +  G       +E+ ILR
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILR 78

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
            L    ++V+   +     ++G   + L+ E++ +  LK+Y+   +     I +      
Sbjct: 79  NL-YHENIVKYKGICT---EDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKY 131

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------- 164
             Q+CKG+ +      +HRDL   N+L++     +KI D GL +A               
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL 224
            P+          WY APE L+ S  +  A D+WS      EL+T       DS+   + 
Sbjct: 191 SPVF---------WY-APECLMQSK-FYIASDVWSFGVTLHELLTY-----CDSDSSPMA 234

Query: 225 HIFRLLGTP 233
              +++G  
Sbjct: 235 LFLKMIGPT 243

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  100 bits (251), Expect = 1e-24
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 39/224 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM 59
              + + ++G+G +G V   R       TG +VA+K+  L            RE+ IL+ 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKA 80

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L     +V+   V  G    GR  L LV EY+ +  L+ +++  R     +  + +    
Sbjct: 81  L-HSDFIVKYRGVSYGP---GRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYS 133

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------L 165
            Q+CKG+ +      +HRDL   N+L++ +   +KIAD GLA+                 
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQS 192

Query: 166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
           PI          WY APE L  +  +S   D+WS   +  EL T
Sbjct: 193 PIF---------WY-APESLSDNI-FSRQSDVWSFGVVLYELFT 225

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.3 bits (248), Expect = 2e-24
 Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 45/248 (18%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM 59
              +K+  +GEG +GKV           TG++VA+K  +     +       +E+ ILR 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ-HRSGWKQEIDILRT 89

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLM 118
           L    H+++     +     G   L LV EY+    L+ Y+        +I +  +    
Sbjct: 90  L-YHEHIIKYKGCCE---DAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFA 140

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------L 165
            Q+C+G+A+ H    +HRDL   N+L+D     +KI D GLA+A                
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDS 199

Query: 166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLH 225
           P+          WY APE L     +  A D+WS      EL+T       DS       
Sbjct: 200 PVF---------WY-APECLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTK 243

Query: 226 IFRLLGTP 233
              L+G  
Sbjct: 244 FLELIGIA 251

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 94.7 bits (236), Expect = 8e-23
 Identities = 39/216 (18%), Positives = 77/216 (35%), Gaps = 40/216 (18%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTR-----LHEDDEGVPPTTLREVSILR 58
           +     E +G+GT+ K+++   +  G    L +T      L +       +     S++ 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 59  MLSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
            L    H+V    V   G          LV E++    L  Y++  +     I +     
Sbjct: 68  KL-SHKHLVLNYGVCVCGDE------NILVQEFVKFGSLDTYLKKNKNC---INILWKLE 117

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-------TMTLKIADLGLARAFT----- 164
           +  QL   + F   + ++H ++   N+L+ R+          +K++D G++         
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177

Query: 165 -LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
              I          W   PE +    + + A D WS
Sbjct: 178 QERIP---------WV-PPECIENPKNLNLATDKWS 203

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 32/210 (15%)

Query: 9   LEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
              +G+G +G V  A+ K        VA+K  +            LRE + ++     PH
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPH 86

Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFR--QTGENIPVNTVKSLMYQL 121
           V +L+ V  + + K    +  ++  +M   DL  ++ + R  +   N+P+ T+   M  +
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKK 169
             G+ +      +HRDL   N ++  + MT+ +AD GL+R               LP+K 
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                   W  A E L  +  Y+   D+W+
Sbjct: 205 --------WL-ALESLADNL-YTVHSDVWA 224

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.8 bits (234), Expect = 3e-22
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 48/217 (22%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR---EKATGKI-VALKKTRLHEDDEGVPPTT----LREVS 55
             F+K++ +G G +G VY+     E    KI VA+K+ R     E   P      L E  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAY 69

Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
           ++  +  +PHV RL+ +           + L+ + M    L  Y+R  +   +NI    +
Sbjct: 70  VMASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHK---DNIGSQYL 119

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---------- 164
            +   Q+ KG+ +     ++HRDL   N+L+      +KI D GLA+             
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 165 --LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
             +PIK         W  A E +L    Y+   D+WS
Sbjct: 179 GKVPIK---------WM-ALESILHRI-YTHQSDVWS 204

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 59/259 (22%), Positives = 106/259 (40%), Gaps = 37/259 (14%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
             K+G G YG+VY    K     VA+K  +   +D       L+E ++++ + + P++V+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEI-KHPNLVQ 280

Query: 69  LMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           L+ V  +          Y++ E+M   +L  Y+R      + +    +  +  Q+   + 
Sbjct: 281 LLGVCTREPP------FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAME 332

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL----WYRAP 182
           +      +HR+L   N L+  +   +K+AD GL+R   +    YT          W  AP
Sbjct: 333 YLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWT-AP 388

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHI---FRLL---GTPNE 235
           E L  +  +S   D+W+   +  E+ T     +PG    Q    +   +R+    G P  
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-- 445

Query: 236 KVWPGVSSLMN--WHEYPQ 252
                V  LM   W   P 
Sbjct: 446 ---EKVYELMRACWQWNPS 461

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.4 bits (225), Expect = 3e-21
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 45/208 (21%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
             K+G G YG+VY    K     VA   LK+  +  ++       L+E ++++ + + P+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVMKEI-KHPN 70

Query: 66  VVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           +V+L+ V  ++          Y++ E+M   +L  Y+R      + +    +  +  Q+ 
Sbjct: 71  LVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQIS 121

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYT 171
             + +      +HRDL   N L+      +K+AD GL+R  T            PIK   
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 177

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                 W  APE L  +  +S   D+W+
Sbjct: 178 ------WT-APESLAYN-KFSIKSDVWA 197

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 37/210 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT-LREVSILRMLSR 62
           +     E++G G +G+V+  R +A   +VA+K     E          L+E  IL+    
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS--CRETLPPDLKAKFLQEARILKQY-S 170

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P++VRL+ V   +       +Y+V E +   D   ++R+    G  + V T+  ++   
Sbjct: 171 HPNIVRLIGVCTQKQP-----IYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDA 222

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------LPIKK 169
             G+ +      +HRDL   N L+  +   LKI+D G++R               +P+K 
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVK- 280

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                   W  APE L     YS+  D+WS
Sbjct: 281 --------WT-APEALN-YGRYSSESDVWS 300

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 89.6 bits (223), Expect = 4e-21
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 33/199 (16%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           L+ +G+G +G V        G  VA+K   +  D        L E S++  L R  ++V+
Sbjct: 26  LQTIGKGEFGDVMLG--DYRGNKVAVKC--IKNDAT--AQAFLAEASVMTQL-RHSNLVQ 78

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L+ V      E +  LY+V EYM    L  Y+RS       +  + +      +C+ + +
Sbjct: 79  LLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEY 132

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLWYR 180
             G+  +HRDL   N+L+  +    K++D GL +  +       LP+K         W  
Sbjct: 133 LEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDTGKLPVK---------WT- 181

Query: 181 APEVLLGSTHYSTAVDMWS 199
           APE L     +ST  D+WS
Sbjct: 182 APEALREKK-FSTKSDVWS 199

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.8 bits (223), Expect = 5e-21
 Identities = 36/278 (12%), Positives = 65/278 (23%), Gaps = 64/278 (23%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVV 67
           L   G     + ++A + A  + VAL          + V   TL     L  +   P V 
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVA 94

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           R++DV        R    +V E++    L++          +         M  L     
Sbjct: 95  RVLDVV-----HTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAAD 143

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL 186
             H  G+      P  + +      + +A                               
Sbjct: 144 AAHRAGVALSIDHPSRVRVSI-DGDVVLAYPA--------------------TMPDA--- 179

Query: 187 GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN 246
                +   D+  +      L+      P       L    R                  
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ------------- 221

Query: 247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR 284
                   P   A    ++      +  + +Q D   R
Sbjct: 222 --------PIEPADIDRDIPFQISAVAARSVQGDGGIR 251

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 89.6 bits (223), Expect = 5e-21
 Identities = 46/205 (22%), Positives = 92/205 (44%), Gaps = 39/205 (19%)

Query: 11  KVGEGTYGKVYRAREKATGKI--VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           ++G G +G V +   +    +  VA+K  +   +D  +    L E ++++ L  +P++VR
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 82

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           ++ + + ++        LV E  +   L KY++       ++    +  L++Q+  G+ +
Sbjct: 83  MIGICEAES------WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKY 132

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHEI 174
                 +HRDL   N+L+  +    KI+D GL++A                P+K      
Sbjct: 133 LEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVK------ 185

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWS 199
              WY APE +     +S+  D+WS
Sbjct: 186 ---WY-APECINYYK-FSSKSDVWS 205

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 89.6 bits (223), Expect = 5e-21
 Identities = 43/210 (20%), Positives = 85/210 (40%), Gaps = 46/210 (21%)

Query: 9   LEKVGEGTYGKVYRAREKATGKI---VALKKTRLHEDDEGVPPTT----LREVSILRMLS 61
              +GEG +G V++    +       VA+K  +          +     L+E   +R   
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-----NCTSDSVREKFLQEALTMRQF- 73

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             PH+V+L+ V           ++++ E     +L+ +++  + +   + + ++    YQ
Sbjct: 74  DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQ 124

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKK 169
           L   +A+      +HRD+   N+L+      +K+ D GL+R              LPIK 
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK- 182

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                   W  APE +     +++A D+W 
Sbjct: 183 --------WM-APESIN-FRRFTSASDVWM 202

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 91.3 bits (227), Expect = 6e-21
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 37/212 (17%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALK--KTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           L+ +G+G +G V     +  G  VA+K  K              L E S++  L R  ++
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF------LAEASVMTQL-RHSNL 248

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           V+L+ V      E +  LY+V EYM    L  Y+RS  +    +  + +      +C+ +
Sbjct: 249 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAM 302

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------LPIKKYTHEILTLW 178
            +  G+  +HRDL   N+L+       K++D GL +  +       LP+K         W
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKLPVK---------W 352

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
             APE L     +ST  D+WS   +  E+ + 
Sbjct: 353 T-APEALREKK-FSTKSDVWSFGILLWEIYSF 382

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 89.6 bits (223), Expect = 7e-21
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 31/209 (14%)

Query: 9   LEKVGEGTYGKVYRAREKATGKI---VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
            + +GEG +G V     K        VA+K  +L    +      L E + ++     P+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPN 97

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFR--QTGENIPVNTVKSLMYQLC 122
           V+RL+ V    + +G     ++  +M   DL  Y+   R     ++IP+ T+   M  + 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF------------TLPIKKY 170
            G+ +      LHRDL   N ++    MT+ +AD GL++               +P+K  
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 214

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                  W  A E L     Y++  D+W+
Sbjct: 215 -------WI-AIESLADRV-YTSKSDVWA 234

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 89.2 bits (222), Expect = 7e-21
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 41/206 (19%)

Query: 11  KVGEGTYGKVYRAREKATGKI--VALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVV 67
           ++G G +G V +   +   K   VA+K   L +  ++      +RE  I+  L  +P++V
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQL-DNPYIV 73

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           RL+ V Q +       L LV E      L K++       E IPV+ V  L++Q+  G+ 
Sbjct: 74  RLIGVCQAEA------LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMK 124

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHE 173
           +      +HRDL   N+L+  +    KI+D GL++A                P+K     
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK----- 178

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWS 199
               WY APE +     +S+  D+WS
Sbjct: 179 ----WY-APECINFRK-FSSRSDVWS 198

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 37/219 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           ++ +  +K+G G +G+V+ A      K VA+K  +            L E ++++ L + 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMK---PGSMSVEAFLAEANVMKTL-QH 242

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +V+L  V   +       +Y++ E+M    L  +++S    G   P+  +     Q+ 
Sbjct: 243 DKLVKLHAVVTKEP------IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIA 294

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYT 171
           +G+AF      +HRDL+  N+L+   ++  KIAD GLAR               PIK   
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIK--- 350

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
                 W  APE +   + ++   D+WS   +  E+VT 
Sbjct: 351 ------WT-APEAINFGS-FTIKSDVWSFGILLMEIVTY 381

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 41/206 (19%)

Query: 11  KVGEGTYGKVYRAREKATGKI--VALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVV 67
           ++G G +G V +   +   K   VA+K   L +  ++      +RE  I+  L  +P++V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQL-DNPYIV 399

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           RL+ V Q +       L LV E      L K++   R   E IPV+ V  L++Q+  G+ 
Sbjct: 400 RLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMK 450

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKKYTHE 173
           +      +HR+L   N+L+  +    KI+D GL++A                P+K     
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLK----- 504

Query: 174 ILTLWYRAPEVLLGSTHYSTAVDMWS 199
               WY APE +     +S+  D+WS
Sbjct: 505 ----WY-APECINFRK-FSSRSDVWS 524

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 88.0 bits (219), Expect = 2e-20
 Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 46/210 (21%)

Query: 9   LEKVGEGTYGKVYRAREKATGKI---VALKKTRLHEDDEGVPPTT----LREVSILRMLS 61
              +GEG +G+VY             VA+K  +     +          + E  I++ L 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-----KDCTLDNKEKFMSEAVIMKNL- 70

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             PH+V+L+ + + +        +++ E     +L  Y+   + +   + V T+     Q
Sbjct: 71  DHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQ 121

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKK 169
           +CK +A+      +HRD+   N+L+      +K+ D GL+R              LPIK 
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIK- 179

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                   W  +PE +     ++TA D+W 
Sbjct: 180 --------WM-SPESINFRR-FTTASDVWM 199

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 47/213 (22%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRML 60
           +  + +E++G G +G+V+        K VA   LK+  +  D        L E ++++ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA------FLAEANLMKQL 65

Query: 61  SRDPHVVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
            +   +VRL  V  ++         +Y++ EYM+   L  ++++    G  + +N +  +
Sbjct: 66  -QHQRLVRLYAVVTQEP--------IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDM 114

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LP 166
             Q+ +G+AF      +HRDL+  N+L+   T++ KIAD GLAR               P
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFP 173

Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           IK         W  APE +   T ++   D+WS
Sbjct: 174 IK---------WT-APEAINYGT-FTIKSDVWS 195

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 37/262 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           ++     K+G+G +G+V+      T + VA+K   L       P   L+E  +++ L R 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKT--LKPGTMS-PEAFLQEAQVMKKL-RH 321

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +V+L  V   +       +Y+V EYM    L  +++     G+ + +  +  +  Q+ 
Sbjct: 322 EKLVQLYAVVSEEP------IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIA 373

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL----W 178
            G+A+      +HRDL+  N+L+    +  K+AD GLAR   +   +YT          W
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARL--IEDNEYTARQGAKFPIKW 430

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHI---FRL---LG 231
             APE  L    ++   D+WS   +  EL TK  + +PG    + L  +   +R+     
Sbjct: 431 T-APEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488

Query: 232 TPNEKVWPGVSSLMN--WHEYP 251
            P       +  LM   W + P
Sbjct: 489 CP-----ESLHDLMCQCWRKEP 505

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 87.7 bits (218), Expect = 3e-20
 Identities = 53/216 (24%), Positives = 82/216 (37%), Gaps = 44/216 (20%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKI---VALKKTRLHEDDEGVPPTT---LREVSIL 57
                LEK+G+G++G V R    A       VA+K   L  D    P      +REV+ +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVNAM 75

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKS 116
             L    +++RL  V           + +V E      L   +R  +    +  + T+  
Sbjct: 76  HSL-DHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSR 125

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------ 164
              Q+ +G+ +      +HRDL   NLL+  +   +KI D GL RA              
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHR 184

Query: 165 -LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
            +P           W  APE L  +  +S A D W 
Sbjct: 185 KVPFA---------WC-APESLK-TRTFSHASDTWM 209

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.2 bits (219), Expect = 3e-20
 Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 48/217 (22%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRLHEDDEGVPPTT----LREVS 55
             F+K++ +G G +G VY+      G+     VA+K+ R     E   P      L E  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEILDEAY 69

Query: 56  ILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTV 114
           ++  +  +PHV RL+ +           + L+ + M    L  Y+R  +   +NI    +
Sbjct: 70  VMASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHK---DNIGSQYL 119

Query: 115 KSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---------- 164
            +   Q+ KG+ +     ++HRDL   N+L+      +KI D GLA+             
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 165 --LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
             +PIK         W  A E +L    Y+   D+WS
Sbjct: 179 GKVPIK---------WM-ALESILHRI-YTHQSDVWS 204

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 37/262 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           ++     K+G+G +G+V+      T + VA+K   L       P   L+E  +++ L R 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKT--LKPGTMS-PEAFLQEAQVMKKL-RH 238

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             +V+L  V   +       +Y+V EYM    L  +++     G+ + +  +  +  Q+ 
Sbjct: 239 EKLVQLYAVVSEEP------IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIA 290

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL----W 178
            G+A+      +HRDL+  N+L+    +  K+AD GLAR   +   +YT          W
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARL--IEDNEYTARQGAKFPIKW 347

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHI---FRL---LG 231
             APE  L    ++   D+WS   +  EL TK  + +PG    + L  +   +R+     
Sbjct: 348 T-APEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 405

Query: 232 TPNEKVWPGVSSLMN--WHEYP 251
            P       +  LM   W + P
Sbjct: 406 CP-----ESLHDLMCQCWRKEP 422

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 42/214 (19%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR---EKATGKI-VALKKTRLHED-DEGVPPTTLREVSILR 58
               KL+ +G G +G V++     E  + KI V +K   + +             +  + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIG 70

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
            L    H+VRL+ +  G +      L LV +Y+    L  ++R  R     +    + + 
Sbjct: 71  SL-DHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNW 120

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------------L 165
             Q+ KG+ +   HG++HR+L   N+L+      +++AD G+A                 
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

Query: 166 PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           PIK         W  A E +     Y+   D+WS
Sbjct: 180 PIK---------WM-ALESIH-FGKYTHQSDVWS 202

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 44/220 (20%), Positives = 88/220 (40%), Gaps = 46/220 (20%)

Query: 9   LEKVGEGTYGKVYRAREKATGKI---VALKKTRLHEDDEGVPPTT----LREVSILRMLS 61
              +GEG +G V++    +       VA+K  +          +     L+E   +R   
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREKFLQEALTMRQF- 448

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             PH+V+L+ V           ++++ E     +L+ +++  + +   + + ++    YQ
Sbjct: 449 DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQ 499

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKK 169
           L   +A+      +HRD+   N+L+      +K+ D GL+R              LPIK 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIK- 557

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
                   W  APE +     +++A D+W       E++ 
Sbjct: 558 --------WM-APESIN-FRRFTSASDVWMFGVCMWEILM 587

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 84.9 bits (211), Expect = 2e-19
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 47/208 (22%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++++G G +G V+        K VA   +++  + E+D       + E  ++  L   P 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED------FIEEAEVMMKL-SHPK 64

Query: 66  VVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           +V+L  V  +Q         + LV E+M+   L  Y+R+ R         T+  +   +C
Sbjct: 65  LVQLYGVCLEQAP-------ICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVC 114

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYT 171
           +G+A+     ++HRDL   N L+      +K++D G+ R               P+K   
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 170

Query: 172 HEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                 W  +PEV   S  YS+  D+WS
Sbjct: 171 ------WA-SPEVFSFSR-YSSKSDVWS 190

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 43/210 (20%)

Query: 9   LEKVGEGTYGKVYRAREKATGK---IVALKKTRLHED-DEGVPPTTLREVSILRMLSRDP 64
            + +G G  G+V   R +  G+    VA+K   L     E      L E SI+      P
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQF-DHP 110

Query: 65  HVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           +++RL  V  +G+      +  +V EYM+   L  ++R+         +  +  ++  + 
Sbjct: 111 NIIRLEGVVTRGR------LAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVG 161

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------LPIKK 169
            G+ +    G +HRDL   N+L+D   +  K++D GL+R                +PI+ 
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR- 219

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                   W  APE +     +S+A D+WS
Sbjct: 220 --------WT-APEAIA-FRTFSSASDVWS 239

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 84.6 bits (210), Expect = 4e-19
 Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 47/213 (22%)

Query: 9   LEKVGEGTYGKVYRAREKATGKI---VALKKTRLHED-DEGVPPTTLREVSILRMLSRDP 64
            E +G G +G VY              A+K   L+   D G     L E  I++     P
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDF-SHP 86

Query: 65  HVVRLMDV---KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +V+ L+ +    +G          +V  YM   DL+ +IR+      N  V  +     Q
Sbjct: 87  NVLSLLGICLRSEGS-------PLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQ 136

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR--------------AFTLP 166
           + KG+ +      +HRDL   N ++D +  T+K+AD GLAR                 LP
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195

Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           +K         W  A E L     ++T  D+WS
Sbjct: 196 VK---------WM-ALESLQTQK-FTTKSDVWS 217

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 83.8 bits (208), Expect = 5e-19
 Identities = 45/207 (21%), Positives = 87/207 (42%), Gaps = 45/207 (21%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           L+++G G +G V   + +     VA   +K+  + ED+       + E  ++  L     
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE------FIEEAKVMMNL-SHEK 80

Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +V+L  V  + +       ++++ EYM    L  Y+R  R          +  +   +C+
Sbjct: 81  LVQLYGVCTKQRP------IFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCE 131

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTH 172
            + +      LHRDL   N L++ +   +K++D GL+R               P++    
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVR---- 186

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWS 199
                W   PEVL+ S  +S+  D+W+
Sbjct: 187 -----WS-PPEVLMYSK-FSSKSDIWA 206

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 83.8 bits (208), Expect = 5e-19
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 45/207 (21%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVA---LKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           L+++G G +G V   + K     VA   +K+  + ED+        +E   +  L   P 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDE------FFQEAQTMMKL-SHPK 64

Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           +V+   V  +         +Y+V EY+    L  Y+RS  +    +  + +  + Y +C+
Sbjct: 65  LVKFYGVCSKEYP------IYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCE 115

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-----------LPIKKYTH 172
           G+AF   H  +HRDL   N L+D + + +K++D G+ R               P+K    
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK---- 170

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWS 199
                W  APEV      YS+  D+W+
Sbjct: 171 -----WS-APEVFHYFK-YSSKSDVWA 190

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 52/222 (23%), Positives = 86/222 (38%), Gaps = 52/222 (23%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
             ++GEG +GKV+ A            +VA+K   L +          RE  +L  L + 
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDPTLAARKDFQREAELLTNL-QH 76

Query: 64  PHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN--------- 112
            H+V+   V   G        L +VFEYM   DL K++R+       +            
Sbjct: 77  EHIVKFYGVCGDGDP------LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 113 TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----- 164
            +  ++    Q+  G+ +      +HRDL   N L+    + +KI D G++R        
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYY 189

Query: 165 -------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                  LPI+         W   PE ++    ++T  D+WS
Sbjct: 190 RVGGHTMLPIR---------WM-PPESIMYRK-FTTESDVWS 220

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 84.3 bits (209), Expect = 7e-19
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 47/217 (21%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHED-DEGVPPTTLREVSILRMLSR 62
             ++G+G++G VY    K   K      VA+K   ++E          L E S+++    
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNEASVMKEF-N 86

Query: 63  DPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL--- 117
             HVVRL+ V  QGQ         ++ E M   DLK Y+RS R    N PV    SL   
Sbjct: 87  CHHVVRLLGVVSQGQP------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 118 ---MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR------------A 162
                ++  G+A+ + +  +HRDL   N ++  +  T+KI D G+ R             
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGK 199

Query: 163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
             LP++         W  +PE L     ++T  D+WS
Sbjct: 200 GLLPVR---------WM-SPESLKDGV-FTTYSDVWS 225

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 54/225 (24%), Positives = 82/225 (36%), Gaps = 54/225 (24%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHED-DEGVPPTTLREVSILRMLSR 62
            + +G G +GKV  A      K      VA+K   L            + E+ +L  L  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGN 85

Query: 63  DPHVVRLMDV-KQGQNKEGRTVLYLVFEYM-DTDLKKYIRSFRQTGENIPVN-------- 112
             ++V L+     G          ++ EY    DL  ++R  R +      +        
Sbjct: 86  HMNIVNLLGACTIGGP------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 113 ---TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-- 164
               ++ L+   YQ+ KG+AF      +HRDL   N+L+       KI D GLAR     
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKND 198

Query: 165 ----------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                     LP+K         W  APE +     Y+   D+WS
Sbjct: 199 SNYVVKGNARLPVK---------WM-APESIFNCV-YTFESDVWS 232

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 52/222 (23%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALK--KTRLHEDDEGVPPTTLREVSILRMLS 61
            + +G G +GKV  A     GK      VA+K  K+  H D++      + E+ I+  L 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLG 107

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN------- 112
           +  ++V L+     G        + ++ EY    DL  ++R   +  E  P         
Sbjct: 108 QHENIVNLLGACTHGGP------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 113 TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----- 164
           + + L+    Q+ +G+AF      +HRD+   N+L+       KI D GLAR        
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNY 220

Query: 165 -------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                  LP+K         W  APE +     Y+   D+WS
Sbjct: 221 IVKGNARLPVK---------WM-APESIFDCV-YTVQSDVWS 251

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 82.7 bits (205), Expect = 2e-18
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 41/209 (19%)

Query: 10  EKVGEGTYGKVYRAREKATGK---IVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPH 65
             +G+G +G VY        +     A+K   L    +       LRE  ++R L   P+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAFLREGLLMRGL-NHPN 83

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           V+ L+    G       + +++  YM   DL ++IRS +    N  V  + S   Q+ +G
Sbjct: 84  VLALI----GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARG 136

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--------------LPIKKY 170
           + +      +HRDL   N ++D ++ T+K+AD GLAR                 LP+K  
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVK-- 193

Query: 171 THEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                  W  A E L     ++T  D+WS
Sbjct: 194 -------WT-ALESLQTYR-FTTKSDVWS 213

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 49/224 (21%)

Query: 9   LEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTT----LREVSILRMLS 61
            + VG G +G+V   R K   K    VA+K  +      G         L E SI+    
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-----VGYTEKQRRDFLGEASIMGQF- 103

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMY 119
             P+++RL  V  + +       + +V EYM+   L  ++R          V  +  ++ 
Sbjct: 104 DHPNIIRLEGVVTKSK------PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLR 154

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-------------LP 166
            +  G+ +    G +HRDL   N+L++   +  K++D GL R                +P
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
           I+         W  +PE +     +++A D+WS   +  E+++ 
Sbjct: 214 IR---------WT-SPEAIA-YRKFTSASDVWSYGIVLWEVMSY 246

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 56/213 (26%), Positives = 84/213 (39%), Gaps = 47/213 (22%)

Query: 9   LEKVGEGTYGKVYRAREKATGKI---VALKKTRLHED-DEGVPPTTLREVSILRMLSRDP 64
            E +G G +G VY              A+K   L+   D G     L E  I++     P
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDF-SHP 150

Query: 65  HVVRLMDV---KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +V+ L+ +    +G          +V  YM   DL+ +IR+      N  V  +     Q
Sbjct: 151 NVLSLLGICLRSEGS-------PLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQ 200

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--------------LP 166
           + KG+ F      +HRDL   N ++D +  T+K+AD GLAR                 LP
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259

Query: 167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           +K         W  A E L     ++T  D+WS
Sbjct: 260 VK---------WM-ALESLQTQK-FTTKSDVWS 281

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 50/230 (21%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKI----VALKKTRLHEDDEGVPPTT----LREVS 55
               + + +G G +G+VY+   K +       VA+K  +      G         L E  
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-----AGYTEKQRVDFLGEAG 98

Query: 56  ILRMLSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNT 113
           I+       +++RL  V  + +       + ++ EYM+   L K++R          V  
Sbjct: 99  IMGQF-SHHNIIRLEGVISKYK------PMMIITEYMENGALDKFLREKDGE---FSVLQ 148

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--------- 164
           +  ++  +  G+ +      +HRDL   N+L++   +  K++D GL+R            
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTT 207

Query: 165 ----LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK 210
               +PI+         W  APE +     +++A D+WS   +  E++T 
Sbjct: 208 SGGKIPIR---------WT-APEAIS-YRKFTSASDVWSFGIVMWEVMTY 246

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 82.4 bits (204), Expect = 3e-18
 Identities = 45/219 (20%), Positives = 73/219 (33%), Gaps = 51/219 (23%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTT----LREVSILRM 59
           +  +G G +G+VY  +            VA+K        E          L E  I+  
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELDFLMEALIISK 89

Query: 60  LSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
                ++VR + V  Q          +++ E M   DLK ++R  R          +  L
Sbjct: 90  F-NHQNIVRCIGVSLQSLP------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 118 ---MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLAR----------- 161
                 +  G  +   +  +HRD+   N L+         KI D G+AR           
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202

Query: 162 -AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
               LP+K         W   PE  +    +++  D WS
Sbjct: 203 GCAMLPVK---------WM-PPEAFMEGI-FTSKTDTWS 230

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 54/220 (24%)

Query: 10  EKVGEGTYGKVYRAREKATGK--IVALKKTRLHEDDEGVPPTT----LREVSILRMLSRD 63
           + +GEG +G+V +AR K  G     A+K+ +     E            E+ +L  L   
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRDFAGELEVLCKLGHH 85

Query: 64  PHVVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN-------- 112
           P+++ L+     +G        LYL  EY    +L  ++R  R    +            
Sbjct: 86  PNIINLLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138

Query: 113 -TVKSL---MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT---- 164
            + + L      + +G+ +      +HRDL   N+L+  +    KIAD GL+R       
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK 197

Query: 165 -----LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                LP++         W  A E L  S  Y+T  D+WS
Sbjct: 198 KTMGRLPVR---------WM-AIESLNYSV-YTTNSDVWS 226

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 81.6 bits (202), Expect = 4e-18
 Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 19/193 (9%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
            V + +    K+G G++G +Y   + A G+ VA+K     E  +   P    E  I +M+
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIYKMM 61

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
                +  +     G   +      +V E +   L+     F        + TV  L  Q
Sbjct: 62  QGGVGIPTIRW--CGAEGDYN---VMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQ 113

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTM--TLKIADLGLARAFTLPIKKYTHEILTLW 178
           +   + + H    +HRD+KP N LM        + I D GLA+ +    + + H    + 
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA-RTHQH----IP 168

Query: 179 YRAPEVLLGSTHY 191
           YR  + L G+  Y
Sbjct: 169 YRENKNLTGTARY 181

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 82.0 bits (203), Expect = 5e-18
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 51/221 (23%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
             ++GEG +GKV+ A            +VA+K   L E  E       RE  +L ML + 
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTML-QH 102

Query: 64  PHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN--------T 113
            H+VR   V  +G+       L +VFEYM   DL +++RS     + +            
Sbjct: 103 QHIVRFFGVCTEGRP------LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 114 VKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT------ 164
           +  L+    Q+  G+ +  G   +HRDL   N L+ +  + +KI D G++R         
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYR 215

Query: 165 ------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                 LPI+         W   PE +L    ++T  D+WS
Sbjct: 216 VGGRTMLPIR---------WM-PPESILYRK-FTTESDVWS 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.1 bits (203), Expect = 6e-18
 Identities = 45/219 (20%), Positives = 73/219 (33%), Gaps = 51/219 (23%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTT----LREVSILRM 59
           +  +G G +G+VY  +            VA+K        E          L E  I+  
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELDFLMEALIISK 130

Query: 60  LSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSL 117
                ++VR + V  Q          +++ E M   DLK ++R  R          +  L
Sbjct: 131 F-NHQNIVRCIGVSLQSLP------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 118 ---MYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLGLARAFT-------- 164
                 +  G  +   +  +HRD+   N L+         KI D G+AR           
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243

Query: 165 ----LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
               LP+K         W   PE  +    +++  D WS
Sbjct: 244 GCAMLPVK---------WM-PPEAFMEGI-FTSKTDTWS 271

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 81.2 bits (201), Expect = 8e-18
 Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 53/224 (23%)

Query: 9   LEKVGEGTYGKVYRAR-----EKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSR 62
            + +G G +G+V  A      + AT + VA+K   L E          + E+ IL  +  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGH 89

Query: 63  DPHVVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN------- 112
             +VV L+    K G        L ++ E+    +L  Y+RS R       V        
Sbjct: 90  HLNVVNLLGACTKPGGP------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 113 --TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT--- 164
             T++ L+   +Q+ KG+ F      +HRDL   N+L+  +   +KI D GLAR      
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202

Query: 165 ---------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                    LP+K         W  APE +     Y+   D+WS
Sbjct: 203 DYVRKGDARLPLK---------WM-APETIFDRV-YTIQSDVWS 235

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 30/213 (14%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
            K+G G++G++Y      T + VA+K     E+ +   P  L E  I R+L     +  +
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 70  MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH 129
                G   +      LV + +   L+     F      + + TV  L  Q+   V F H
Sbjct: 69  RW--FGVEGDYN---VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 130 GHGILHRDLKPHNLLMDRKTM--TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG 187
               LHRD+KP N LM        + I D GLA+ +      + H    + YR  + L G
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT-STHQH----IPYRENKNLTG 175

Query: 188 STHY-STAV----------DMWSVACIFAELVT 209
           +  Y S             D+ S+  +    + 
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLR 208

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 80.1 bits (198), Expect = 1e-17
 Identities = 42/222 (18%), Positives = 80/222 (36%), Gaps = 32/222 (14%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           +V   ++   ++GEG++G ++        + VA+K     E      P    E    ++L
Sbjct: 7   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRTYKLL 62

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +    +  +     GQ         LV + +   L+         G    V TV     Q
Sbjct: 63  AGCTGIPNVYY--FGQEGLHN---VLVIDLLGPSLEDL---LDLCGRKFSVKTVAMAAKQ 114

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTM----TLKIADLGLARAFTLPIKKYTHEILT 176
           +   V   H   +++RD+KP N L+ R        + + D G+ + +       T + + 
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY---RDPVTKQHIP 171

Query: 177 LWYRAPEVLLGSTHY-STAV----------DMWSVACIFAEL 207
             YR  + L G+  Y S             D+ ++  +F   
Sbjct: 172 --YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 211

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 54/225 (24%)

Query: 9   LEKVGEGTYGKVYRAR-------EKATGKIVALKKTRLHED-DEGVPPTTLREVSILRML 60
            + +GEG +G+V  A        +      VA+K   L  D  E      + E+ +++M+
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMI 131

Query: 61  SRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK--- 115
            +  +++ L+    Q         LY++ EY    +L++Y+++ R  G     N      
Sbjct: 132 GKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 116 ---------SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-- 164
                    S  YQ+ +G+ +      +HRDL   N+L+  +   +KIAD GLAR     
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHI 244

Query: 165 ----------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                     LP+K         W  APE L     Y+   D+WS
Sbjct: 245 DYYKKTTNGRLPVK---------WM-APEALFDRI-YTHQSDVWS 278

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 79.3 bits (196), Expect = 5e-17
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 54/225 (24%)

Query: 9   LEKVGEGTYGKVYRAR-------EKATGKIVALKKTRLHED-DEGVPPTTLREVSILRML 60
            + +GEG +G+V  A        +      VA+K   L +D  E      + E+ +++M+
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMI 97

Query: 61  SRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK--- 115
            +  +++ L+    Q         LY++ EY    +L++Y+R+ R  G     +  +   
Sbjct: 98  GKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 116 ---------SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-- 164
                    S  YQL +G+ +      +HRDL   N+L+  +   +KIAD GLAR     
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNI 210

Query: 165 ----------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                     LP+K         W  APE L     Y+   D+WS
Sbjct: 211 DYYKKTTNGRLPVK---------WM-APEALFDRV-YTHQSDVWS 244

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 78.0 bits (193), Expect = 8e-17
 Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 59/226 (26%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTT----LREVSILRM 59
           +E++GE  +GKVY+              VA+K  +     +            E  +   
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPLREEFRHEAMLRAR 68

Query: 60  LSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN----- 112
           L + P+VV L+ V  + Q       L ++F Y    DL +++       +    +     
Sbjct: 69  L-QHPNVVCLLGVVTKDQP------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 113 ----TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF-- 163
                    +    Q+  G+ +   H ++H+DL   N+L+  K + +KI+DLGL R    
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYA 180

Query: 164 ----------TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                      LPI+         W  APE ++    +S   D+WS
Sbjct: 181 ADYYKLLGNSLLPIR---------WM-APEAIMYGK-FSIDSDIWS 215

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.5 bits (194), Expect = 9e-17
 Identities = 61/231 (26%), Positives = 88/231 (38%), Gaps = 61/231 (26%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHED-DEGVPPTTLREVSILRMLSR 62
            + +G G +GKV  A      K      VA+K   L E  D       + E+ ++  L  
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM--LKEKADSSEREALMSELKMMTQLGS 107

Query: 63  DPHVVRLMDV--KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN------- 112
             ++V L+      G        +YL+FEY    DL  Y+RS R+      +        
Sbjct: 108 HENIVNLLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 113 ---------TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA 160
                    T + L+   YQ+ KG+ F      +HRDL   N+L+      +KI D GLA
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLA 219

Query: 161 RAFT------------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           R               LP+K         W  APE L     Y+   D+WS
Sbjct: 220 RDIMSDSNYVVRGNARLPVK---------WM-APESLFEGI-YTIKSDVWS 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 54/225 (24%)

Query: 9   LEKVGEGTYGKVYRAR-------EKATGKIVALKKTRLHED-DEGVPPTTLREVSILRML 60
            + +GEG +G+V  A        +      VA+K   L +D  E      + E+ +++M+
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMI 143

Query: 61  SRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVN------ 112
            +  +++ L+    Q         LY++ EY    +L++Y+R+ R  G     +      
Sbjct: 144 GKHKNIINLLGACTQDGP------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 113 ---TVKSLM---YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-- 164
              T K L+   YQL +G+ +      +HRDL   N+L+  +   +KIAD GLAR     
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNI 256

Query: 165 ----------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                     LP+K         W  APE L     Y+   D+WS
Sbjct: 257 DYYKKTTNGRLPVK---------WM-APEALFDRV-YTHQSDVWS 290

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 47/222 (21%), Positives = 83/222 (37%), Gaps = 32/222 (14%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           MV   F   +K+G G +G++   +   T + VA+K     E  +   P    E    + L
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQL 61

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
                + ++     G   +      +V E +   L+     F        + TV  +  Q
Sbjct: 62  GSGDGIPQVYY--FGPCGKYN---AMVLELLGPSLEDL---FDLCDRTFSLKTVLMIAIQ 113

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTM----TLKIADLGLARAFTLPIKKYTHEILT 176
           L   + + H   +++RD+KP N L+ R        + I D  LA+ +  P +   H I  
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP-ETKKH-IP- 170

Query: 177 LWYRAPEVLLGSTHY-STAV----------DMWSVACIFAEL 207
             YR  + L G+  Y S             D+ ++  +F   
Sbjct: 171 --YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 67/234 (28%)

Query: 9   LEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTT----LREVSILRM 59
           +  +GEG +G+V++AR           +VA+K  +     E           RE +++  
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----EEASADMQADFQREAALMAE 106

Query: 60  LSRDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK-- 115
              +P++V+L+ V   G+       + L+FEYM   DL +++RS          ++    
Sbjct: 107 F-DNPNIVKLLGVCAVGKP------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159

Query: 116 ------------------SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL 157
                              +  Q+  G+A+      +HRDL   N L+    M +KIAD 
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADF 218

Query: 158 GLARAF------------TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           GL+R               +PI+         W   PE +  +  Y+T  D+W+
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIR---------WM-PPESIFYNR-YTTESDVWA 261

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 32/174 (18%), Positives = 68/174 (39%), Gaps = 21/174 (12%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
           +K+G G +G +Y A      +  A    ++   +         E+   + +++   + + 
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN---GPLFSELKFYQRVAKKDCIKKW 99

Query: 70  MDVKQGQ-------------NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           ++ KQ                 +GR+  ++V E +  DL+K              +TV  
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQ 155

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAFTLPIKK 169
           L  ++   + + H +  +H D+K  NLL+  K    + +AD GL+  +      
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 70.3 bits (173), Expect = 4e-14
 Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 61/231 (26%)

Query: 9   LEKVGEGTYGKVYRAR-----EKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSR 62
            + +GEG +GKV +A       +A    VA+K   L E+         L E ++L+ +  
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSEFNVLKQV-N 84

Query: 63  DPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK----- 115
            PHV++L     Q         L L+ EY     L+ ++R  R+ G     +        
Sbjct: 85  HPHVIKLYGACSQDGP------LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 116 ---------------SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA 160
                          S  +Q+ +G+ +     ++HRDL   N+L+  +   +KI+D GL+
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA-EGRKMKISDFGLS 197

Query: 161 RAFT------------LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
           R               +P+K         W  A E L     Y+T  D+WS
Sbjct: 198 RDVYEEDSYVKRSQGRIPVK---------WM-AIESLFDHI-YTTQSDVWS 237

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.5 bits (165), Expect = 6e-13
 Identities = 28/168 (16%), Positives = 68/168 (40%), Gaps = 18/168 (10%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL 69
             +G+G +G +Y A    + + V      + + +         E+   +  ++   + + 
Sbjct: 41  LPIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99

Query: 70  MDVKQG-------------QNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKS 116
           +  ++               +K G++  +++ +   +DL+K    +    +     TV  
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKI---YEANAKRFSRKTVLQ 156

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAF 163
           L  ++   + + H H  +H D+K  NLL++ K    + + D GLA  +
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 65.3 bits (160), Expect = 2e-12
 Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 61/226 (26%)

Query: 11  KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT--LREVSILRMLSRDPHVVR 68
           K+GEG +G VY+         VA+KK     D           +E+ ++    +  ++V 
Sbjct: 38  KMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVE 94

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL------- 121
           L+    G + +G  +  LV+ YM                N       SL+ +L       
Sbjct: 95  LL----GFSSDGDDLC-LVYVYM---------------PN------GSLLDRLSCLDGTP 128

Query: 122 --------------CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI 167
                           G+ F H +  +HRD+K  N+L+D    T KI+D GLARA     
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARAS--EK 185

Query: 168 KKYTH---EIL-TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
              T     I+ T  Y APE L G    +   D++S   +  E++T
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIIT 229

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 64.1 bits (157), Expect = 6e-12
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 25/187 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F+    +G G +GKVY+   +  G  VALK  R   +          E+  L    R PH
Sbjct: 41  FDHKFLIGHGVFGKVYKGVLR-DGAKVALK--RRTPESSQGIEEFETEIETLSFC-RHPH 96

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC-- 122
           +V L+    G   E   ++ L+++YM+  +LK+++  +      + ++  + L  ++C  
Sbjct: 97  LVSLI----GFCDERNEMI-LIYKYMENGNLKRHL--YGSDLPTMSMSWEQRL--EICIG 147

Query: 123 --KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH---EIL-T 176
             +G+ + H   I+HRD+K  N+L+D      KI D G+++         TH    +  T
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKG--TELDQTHLSTVVKGT 204

Query: 177 LWYRAPE 183
           L Y  PE
Sbjct: 205 LGYIDPE 211

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.4 bits (144), Expect = 3e-10
 Identities = 21/174 (12%), Positives = 49/174 (28%), Gaps = 30/174 (17%)

Query: 10  EKVGEGTYGKVYRAREKATGKI--------VALKKTRLHEDDEGVPPTTLREVSILRMLS 61
                   G +Y A   +T            +LK        +        E +  +  +
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-------LDAKDGRLFNEQNFFQRAA 100

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLY-----------LVFEYMDTDLKKYIRSFRQTGENIP 110
           +   V +   +                        LV   +   L+  +         + 
Sbjct: 101 KPLQVNKWKKL-YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD--VSPKHVLS 157

Query: 111 VNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIADLGLARAF 163
             +V  +  +L   + F H +  +H ++   N+ +D +    + +A  G A  +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 22/189 (11%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSR 62
           D F     +G G +GKVY+ R    G +VA+K  RL E+   G       EV ++ M   
Sbjct: 30  DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVK--RLKEERTQGGELQFQTEVEMISMA-V 85

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQL 121
             +++RL    +G        L LV+ YM    +   +R   ++   +     + +    
Sbjct: 86  HRNLLRL----RGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140

Query: 122 CKGVAFCHGHG---ILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH---EIL 175
            +G+A+ H H    I+HRD+K  N+L+D +     + D GLA+       K TH    + 
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMD---YKDTHVTTAVR 196

Query: 176 -TLWYRAPE 183
            T+ + APE
Sbjct: 197 GTIGHIAPE 205

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.5 bits (118), Expect = 5e-07
 Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 24/106 (22%)

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT----------- 164
              +Q+ KG+ F      +HRDL   N+L+  +   +KI D GLAR              
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 255

Query: 165 -LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT 209
            LP+K         W  APE +     Y+   D+WS   +  E+ +
Sbjct: 256 RLPLK---------WM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.7 bits (95), Expect = 3e-04
 Identities = 24/107 (22%), Positives = 38/107 (35%), Gaps = 10/107 (9%)

Query: 8   KLEKV-GEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           KL K  G G +G+V  A     +K         K              + E+ IL  +  
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGEN 108
             +VV L+    G   +    L ++ E+    +L  Y+RS R     
Sbjct: 85  HLNVVNLL----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 2e-06
 Identities = 42/289 (14%), Positives = 82/289 (28%), Gaps = 68/289 (23%)

Query: 30  KIVALKKTRL-HEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF 88
           K +  +   L  E     P    R +SI+    RD  +    + K     +  T++    
Sbjct: 309 KYLDCRPQDLPREVLTTNP----RRLSIIAESIRD-GLATWDNWKHVNCDKLTTIIESSL 363

Query: 89  EYMD-TDLKKYIRS---FRQTGENIPVNTVKSLMYQLCKG-----VAFCHGHGILHRDLK 139
             ++  + +K       F     +IP   +  + + + K      V   H + ++ +   
Sbjct: 364 NVLEPAEYRKMFDRLSVFPP-SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-- 420

Query: 140 PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWS 199
                   K  T+ I  + L     L  +   H  +   Y  P+           +D + 
Sbjct: 421 -------PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY- 472

Query: 200 VACIF---------AELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEY 250
               +          E   +  LF        +   FR L    +K+          H+ 
Sbjct: 473 ---FYSHIGHHLKNIEHPERMTLFR------MVFLDFRFLE---QKI---------RHDS 511

Query: 251 PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
             WN               L+ L+Q+  Y     I           + +
Sbjct: 512 TAWNASG----------SILNTLQQLKFY--KPYICDNDPKYERLVNAI 548

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 6e-04
 Identities = 58/340 (17%), Positives = 101/340 (29%), Gaps = 75/340 (22%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           F  L    E     V +  E+          + +  +       T   +     L  D  
Sbjct: 68  FWTLLSKQEEM---VQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTV----KS-LMYQ 120
           V    +V        R   YL        L++ +   R   +N+ ++ V    K+ +   
Sbjct: 125 VFAKYNVS-------RLQPYL-------KLRQALLELRP-AKNVLIDGVLGSGKTWVALD 169

Query: 121 LCK--GVAFCHGHGI----LHRDLKPHNLLMDRKTMTLKIADLGLARA-FTLPIKKYTHE 173
           +C    V       I    L     P  +L   + +  +I     +R+  +  IK   H 
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 174 ILTLWYRAPEVLLGSTHYSTAV----DMWSVACI--FAE----LVTKT-------ALFPG 216
           I          LL S  Y   +    ++ +      F      L+T T        L   
Sbjct: 230 I----QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT-TRFKQVTDFLSAA 284

Query: 217 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNW---------HEYPQWNPQSLATAVPNLDK 267
            +    L H    L TP+E      S L+ +          E    NP+ L+  +    +
Sbjct: 285 TTTHISLDHHSMTL-TPDE----VKSLLLKYLDCRPQDLPREVLTTNPRRLSI-IAESIR 338

Query: 268 DGLDLLEQMLQYDPSKRISA-KKAMEH-------PYFDDL 299
           DGL   +     +  K  +  + ++           FD L
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	304
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.36
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.31
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.25
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.17
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.98
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.61
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.57
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.47
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.43
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.38
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.38
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.14
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.86
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.72
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.53
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.38
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.25
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.01
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.36

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-64  Score=419.56  Aligned_cols=262  Identities=27%  Similarity=0.457  Sum_probs=228.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.... ........+.+|+++++++ +||||+++++++++...   
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~---  106 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEK---  106 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE---
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCE---
Confidence            367999999999999999999999999999999997543 2233456788999999999 99999999999998776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...    ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus       107 --~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla  179 (311)
T 4aw0_A          107 --LYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTA  179 (311)
T ss_dssp             --EEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCc
Confidence              9999999986 999999763    4699999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .......  ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...-..      
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~------  252 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD------  252 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            8775432  2344568999999999998776 799999999999999999999999998888877777653111      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHH------HhcCCCccccccccC
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK------AMEHPYFDDLDKTRL  304 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e------il~~~~~~~~~~~~~  304 (304)
                                            ....+|+++++||.+||+.||.+|||++|      |++||||+++++++|
T Consensus       253 ----------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          253 ----------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             ----------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ----------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence                                  11258899999999999999999999998      589999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-64  Score=428.35  Aligned_cols=260  Identities=25%  Similarity=0.465  Sum_probs=221.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      |++|++++.||+|+||+||+++++.+|+.||||++............+.+|+.+++++ +||||+++++++.+...    
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~----   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGS----   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE----
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCE----
Confidence            5789999999999999999999999999999999987654444456788999999999 99999999999998776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||||+.| +|.+++..  .....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus        98 -~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~  173 (350)
T 4b9d_A           98 -LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIAR  173 (350)
T ss_dssp             -EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred             -EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccce
Confidence             9999999985 99999976  3345689999999999999999999999999999999999999887 89999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....+         
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------  243 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---------  243 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred             eecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence            7655433444567899999999998766 899999999999999999999999998888877777653211         


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                        .....+|+++.+||.+||+.||.+|||++|+|+||||++-
T Consensus       244 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          244 ------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             ------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                              1123689999999999999999999999999999999763

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-63  Score=418.52  Aligned_cols=256  Identities=22%  Similarity=0.434  Sum_probs=225.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|+++++||+|+||+||+|+++.+|+.||||++.....  .....+.+|+.+++.+ +||||+++++++.+.+.     
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~-----  145 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDE-----  145 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTE-----
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE-----
Confidence            569999999999999999999999999999999976543  2356788999999999 99999999999998877     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||+.| +|.+++..     ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~  219 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQ  219 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCcee
Confidence            9999999986 99998865     4699999999999999999999999999999999999999887 999999999988


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+........        
T Consensus       220 ~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--------  290 (346)
T 4fih_A          220 VSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--------  290 (346)
T ss_dssp             CCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC--------
T ss_pred             cCCCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--------
Confidence            776666667778999999999987766 89999999999999999999999998888777776655321111        


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                       .....+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       291 -----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          291 -----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence                             0112588999999999999999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-63  Score=409.96  Aligned_cols=255  Identities=31%  Similarity=0.494  Sum_probs=208.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||+||+++++.+|+.||+|++..... .......+.+|+++++++ +||||+++++++.+...    
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~----   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDE----   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE----
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCE----
Confidence            679999999999999999999999999999999976543 233445788999999999 99999999999988776    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +++||||++|+|.+.+...    .++++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus        88 -~~ivmEy~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  161 (275)
T 3hyh_A           88 -IIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNI  161 (275)
T ss_dssp             -EEEEEECCCEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC--
T ss_pred             -EEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCee
Confidence             9999999999999998762    5699999999999999999999999999999999999999777 999999999976


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      .... .......||+.|+|||++.+..+.+.++|||||||++|+|+||..||...+..+....+......          
T Consensus       162 ~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~----------  230 (275)
T 3hyh_A          162 MTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT----------  230 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------
T ss_pred             cCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            5543 33445688999999999988876678999999999999999999999988877776666543111          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                        ....+|+++.+||.+||+.||.+|||++|+++||||+.
T Consensus       231 ------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 ------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                              11258899999999999999999999999999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.8e-64  Score=415.95  Aligned_cols=260  Identities=26%  Similarity=0.398  Sum_probs=217.4

Q ss_pred             hhhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++............+..|+.+++++ +||||+++++++.+...  
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~--  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGK--  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTE--
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCE--
Confidence            67999999999999999999884   3577899999875543333344677899999999 99999999999998776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         +++||||+.| +|.+++...    ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus       101 ---~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A          101 ---LYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             ---EEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             ---EEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence               9999999986 999999763    4699999999999999999999999999999999999999887 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ++............+||+.|+|||++.+.. ++.++|||||||++|+|+||..||...+..+....+.+....       
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------  244 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG-------  244 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred             ceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-------
Confidence            987655555556678999999999998776 899999999999999999999999998888877777653111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCcccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~  303 (304)
                                           .+..+|+++.+||.+||+.||.+|||     ++|+++||||+++++++
T Consensus       245 ---------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          245 ---------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence                                 12258999999999999999999998     57999999999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-61  Score=419.30  Aligned_cols=257  Identities=22%  Similarity=0.431  Sum_probs=226.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|++++.||+|+||.||+|+++.+|+.||||++....  ......+.+|+.+++.+ +||||+++++++.+.+.    
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~----  222 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDE----  222 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTE----
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCE----
Confidence            356999999999999999999999999999999997543  23356788999999999 99999999999998776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +|+|||||.| +|.+++..     ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus       223 -~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~  295 (423)
T 4fie_A          223 -LWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCA  295 (423)
T ss_dssp             -EEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCE
T ss_pred             -EEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccce
Confidence             9999999986 99998865     4699999999999999999999999999999999999999887 99999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+........       
T Consensus       296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-------  367 (423)
T 4fie_A          296 QVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-------  367 (423)
T ss_dssp             ECCSSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------
T ss_pred             ECCCCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-------
Confidence            8776666667778999999999988766 89999999999999999999999998888777776655321111       


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                        .....+|+++.+||.+||..||.+|||++|+|+||||++.
T Consensus       368 ------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          368 ------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ------------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                              1123689999999999999999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-62  Score=420.13  Aligned_cols=293  Identities=36%  Similarity=0.649  Sum_probs=241.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      |.++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+++.+ +||||+++++++..... ..
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTT
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccccc
Confidence            35789999999999999999999999999999999975544333345677899999999 99999999998875432 12


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+|+||||++|+|.+++..    ..++++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus       131 ~~~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla  205 (398)
T 4b99_A          131 FKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMA  205 (398)
T ss_dssp             CCCEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeeccee
Confidence            233899999999999988854    35799999999999999999999999999999999999999877 9999999999


Q ss_pred             eecccC----CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLP----IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ......    .......+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+..+.+..+....+.+...
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            765432    2234456889999999999887778999999999999999999999999999999999999999888776


Q ss_pred             CCccccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .+........   ....+...+..+....+.+|+++.+||.+||..||.+|||++|+|+||||++..
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            6544332211   112233334445556778999999999999999999999999999999999763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.7e-61  Score=396.38  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=210.7

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |++.+.||+|+||+||+|.++.++..|++|++............+.+|+.+++++ +||||+++++++.+... +...++
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~-~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVK-GKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEET-TEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccC-CCcEEE
Confidence            3677789999999999999999999999999976554444456788999999999 99999999999875322 122379


Q ss_pred             EEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           86 LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +||||+.| +|.+++...    .++++..+..++.||+.||+|||++|  |+||||||+|||++..+..+||+|||+|+.
T Consensus       106 lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            99999985 999999763    46999999999999999999999998  999999999999985434899999999975


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...  .......||+.|+|||++.+ . ++.++|||||||++|+|+||..||...............-..          
T Consensus       182 ~~~--~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----------  247 (290)
T 3fpq_A          182 KRA--SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------  247 (290)
T ss_dssp             CCT--TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------
T ss_pred             CCC--CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----------
Confidence            433  23345678999999998864 3 899999999999999999999999876655444333221100          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                     ........++++.+||.+||+.||.+|||++|+|+||||++
T Consensus       248 ---------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 ---------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                           01112357889999999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.9e-60  Score=398.90  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=213.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|++.++||+|+||+||+++++.+|+.||||+++...       ...+|+.+++.+ +||||+++++++.+...     
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l-~HpnIV~l~~~~~~~~~-----  124 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGL-SSPRIVPLYGAVREGPW-----  124 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTC-CCTTBCCEEEEEEETTE-----
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhC-CCCCCCcEEEEEEECCE-----
Confidence            45788889999999999999999999999999997532       224799999999 99999999999988776     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||+.| +|.+++...    .++++.++..++.||+.||+|||++||+||||||+|||++.++..+||+|||++..
T Consensus       125 ~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          125 VNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            8999999986 999999763    46999999999999999999999999999999999999998775799999999987


Q ss_pred             cccCCCc-----cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          163 FTLPIKK-----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       163 ~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      .......     ....+||+.|+|||++.+.. ++.++|||||||++|+|+||..||...+..+....+....       
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-------  272 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-------  272 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-------
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-------
Confidence            6543211     12346899999999998876 8999999999999999999999998776655555554421       


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHH-------------hcCCCcccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-------------MEHPYFDDLDK  301 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei-------------l~~~~~~~~~~  301 (304)
                                        .......+.+|+++.+||.+||+.||.+|||+.|+             ++|||+.+...
T Consensus       273 ------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          273 ------------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             ------------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             ------------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence                              11122334789999999999999999999999998             68999988753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.4e-58  Score=391.78  Aligned_cols=283  Identities=26%  Similarity=0.443  Sum_probs=215.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      |.++|++.+.||+|+||+||+|+++   .+++.||+|.+....    ....+.+|+++++.+.+||||+++++++.+.+.
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            4578999999999999999999875   356789999875432    235677899999998789999999999998776


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           +++||||+.| +|.+.+.       .+++.++..++.||+.||+|||++||+||||||+|||++.+...+||+||
T Consensus        95 -----~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           95 -----VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             -----EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             -----EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence                 9999999985 9988873       48999999999999999999999999999999999999977459999999


Q ss_pred             cceeecccCC----------------------------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh
Q 021982          158 GLARAFTLPI----------------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT  209 (304)
Q Consensus       158 g~~~~~~~~~----------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~  209 (304)
                      |+|+......                            ......+||+.|+|||++.+...++.++||||+||++|+|++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            9997653321                            112344689999999999887778999999999999999999


Q ss_pred             ccccCCC-CchHHHHHHHHHHhCCCCCCCC--------------cc------ccccCCc-ccCC-----CCCCCcccccC
Q 021982          210 KTALFPG-DSELQQLLHIFRLLGTPNEKVW--------------PG------VSSLMNW-HEYP-----QWNPQSLATAV  262 (304)
Q Consensus       210 g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~--------------~~------~~~~~~~-~~~~-----~~~~~~~~~~~  262 (304)
                      |..||.. .+..+++..+....+.+....+              +.      ....... ...+     ...........
T Consensus       243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  322 (361)
T 4f9c_A          243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW  322 (361)
T ss_dssp             TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence            9999854 4556666666665543211000              00      0000000 0000     00001112234


Q ss_pred             CCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          263 PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ..+|+++.+||.+||..||.+|||++|+|+||||++++
T Consensus       323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            57899999999999999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-58  Score=386.09  Aligned_cols=264  Identities=26%  Similarity=0.428  Sum_probs=198.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC----
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE----   79 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~----   79 (304)
                      ++|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+++++++ +||||+++++++.+.+..    
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-HHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-HHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCcccccc
Confidence            5799999999999999999999999999999998765422 2235678899999999 999999999998765431    


Q ss_pred             ---CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           80 ---GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        80 ---~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                         ....++++|||+.| +|.+++..... .....+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~  160 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVG  160 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEc
Confidence               23347999999986 99999976322 12345567889999999999999999999999999999999887 99999


Q ss_pred             eccceeecccCCC------------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHH
Q 021982          156 DLGLARAFTLPIK------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL  223 (304)
Q Consensus       156 dfg~~~~~~~~~~------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~  223 (304)
                      |||+++.......            .....+||+.|+|||++.+.. ++.++|||||||++|+|++   ||......  .
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~~--~  234 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMER--V  234 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHHH--H
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccHH--H
Confidence            9999987654321            123346899999999998766 8999999999999999996   77654322  2


Q ss_pred             HHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          224 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ..+.......                        .+......++.+.+||.+||+.||.+|||+.|+++||||+++++
T Consensus       235 ~~~~~~~~~~------------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          235 RTLTDVRNLK------------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHHTTC------------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHHhcCC------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            2221111111                        01111235677889999999999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-57  Score=378.97  Aligned_cols=259  Identities=22%  Similarity=0.347  Sum_probs=212.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|.+.+.||+|+||+||++++.     .++..||||+++...  ......+.+|+++++++ +||||+++++++.+.+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCC
Confidence            467899999999999999999875     357789999986432  22345788999999999 9999999999999877


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhc---------cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFR---------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR  147 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~  147 (304)
                      .     +++||||+.+ +|.+++....         .....+++.++..++.||+.||.|||+++|+||||||+|||++.
T Consensus        89 ~-----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~  163 (299)
T 4asz_A           89 P-----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  163 (299)
T ss_dssp             S-----EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             E-----EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence            6     8999999985 9999997642         23457999999999999999999999999999999999999997


Q ss_pred             CCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHH
Q 021982          148 KTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLL  224 (304)
Q Consensus       148 ~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~  224 (304)
                      ++ .+||+|||+++.......  ......||+.|+|||++.+.. ++.++|||||||++|||+| |..||...+..+...
T Consensus       164 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  241 (299)
T 4asz_A          164 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  241 (299)
T ss_dssp             GG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             CC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            77 999999999976543322  222345799999999998876 8999999999999999998 899999988887777


Q ss_pred             HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .+......                           ..+..+|+++.+|+.+||+.||.+|||+.||+  +|++++.
T Consensus       242 ~i~~~~~~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~  288 (299)
T 4asz_A          242 CITQGRVL---------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA  288 (299)
T ss_dssp             HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred             HHHcCCCC---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence            66553211                           11236889999999999999999999999995  4776553

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-56  Score=373.38  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=202.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+++++.+.||+|+||+||+++++.   .++||+++...........+.+|+.+++++ +||||+++++++....     
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~-----  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTKDN-----  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS-----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEECCe-----
Confidence            3578889999999999999998653   589999876554444456788999999999 9999999999876432     


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||||+.| +|.+++...   ..++++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|.
T Consensus       106 -~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 -LAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             -CEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             -EEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCce
Confidence             6899999985 999998652   35799999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccC--CCccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLP--IKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~--~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      .....  ........||+.|+|||++.+.  ..++.++|||||||++|||+||..||...+...........-...    
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~----  256 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS----  256 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----
Confidence            65432  2234456789999999999753  347999999999999999999999998877665555444321111    


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                        .........+++++.+||.+||+.||.+|||+.||++
T Consensus       257 ------------------p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          257 ------------------PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             ------------------CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ------------------CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                              1112233468899999999999999999999998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.9e-56  Score=375.57  Aligned_cols=290  Identities=51%  Similarity=0.981  Sum_probs=243.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.+.. ++.+++|.+............+.+|+.+++.+ +||||+++++++.+...   
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~---   93 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERC---   93 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSC---
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCE---
Confidence            57899999999999999999999864 88999999876655444456788999999999 99999999999987776   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .++||||+.+++.+.+..   ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus        94 --~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~  167 (311)
T 3niz_A           94 --LTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLAR  167 (311)
T ss_dssp             --EEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             --EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCce
Confidence              899999999998888865   234689999999999999999999999999999999999999887 89999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||++.+...++.++||||||+++|+|++|..||......+....+....+.+....|+..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            87665555566678999999999987666899999999999999999999999999988889999998888888777665


Q ss_pred             cccCCccc--CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          242 SSLMNWHE--YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       242 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      .....+..  .............+.+++++.+||.+||+.||.+|||++|+++||||++++.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence            54333221  11222333445567889999999999999999999999999999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.6e-55  Score=368.11  Aligned_cols=287  Identities=51%  Similarity=0.962  Sum_probs=247.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||+||++.++.+++.+++|++............+.+|+.+++++ +||||+++++++.+...    
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----   75 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKK----   75 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE----
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCE----
Confidence            4789999999999999999999999999999999987665555556778999999999 99999999999987766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++||||+++++.+.+...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||.+..
T Consensus        76 -~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~  150 (292)
T 3o0g_A           76 -LTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARA  150 (292)
T ss_dssp             -EEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             -EEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccccee
Confidence             8999999999888877652   35799999999999999999999999999999999999999777 999999999988


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc-CCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ............+++.|+|||++.+...++.++||||||+++|+|++|..| |...+..+....+....+.+....|+..
T Consensus       151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             cCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence            766656666677899999999998776689999999999999999998777 5666777888888888898888888777


Q ss_pred             cccCCcccCCCCC-CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          242 SSLMNWHEYPQWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .....+....... ........+.+++.+.+||.+||+.||.+|||++|+++||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            6655544333322 223444566899999999999999999999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-56  Score=404.95  Aligned_cols=260  Identities=26%  Similarity=0.393  Sum_probs=214.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHH---HHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLRE---VSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e---~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++..... .........+|   +++++.+ +||||+++++.+++...
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence            5789999999999999999999999999999999975431 11122233344   4455556 89999999999998877


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           +|+||||+.| +|.+++...    ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus       267 -----lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DF  336 (689)
T 3v5w_A          267 -----LSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDL  336 (689)
T ss_dssp             -----EEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCC
T ss_pred             -----EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEeccc
Confidence                 9999999986 999999763    4699999999999999999999999999999999999999888 9999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH---HHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL---QQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~  234 (304)
                      |+|......  .....+||+.|+|||++.++..++.++|+|||||++|+|++|..||...+..   .....+...   . 
T Consensus       337 GlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---~-  410 (689)
T 3v5w_A          337 GLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---A-  410 (689)
T ss_dssp             TTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---C-
T ss_pred             ceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---C-
Confidence            999876543  2345689999999999976555899999999999999999999999765432   222222221   0 


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCcccccccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~  303 (304)
                                              ......+|+++.+||.+||+.||.+|++     ++||++||||++++++.
T Consensus       411 ------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          411 ------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence                                    0112368999999999999999999998     79999999999998864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.1e-56  Score=370.60  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=210.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      +++++++.||+|+||+||+|...     .++..||||.++... .......+.+|+.+++++ +||||+++++++.....
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCE
Confidence            56788899999999999999864     356789999987443 333456789999999999 99999999999988776


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccC------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM  145 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~  145 (304)
                           +++||||+.+ +|.++|......            ...+++.++..++.||+.||+|||+++++||||||+|||+
T Consensus       104 -----~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          104 -----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             -----CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -----EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence                 8999999985 999999764321            2468999999999999999999999999999999999999


Q ss_pred             eCCCCeEEEeeccceeecccC--CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHH
Q 021982          146 DRKTMTLKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQ  222 (304)
Q Consensus       146 ~~~~~~vkl~dfg~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~  222 (304)
                      +.++ .+||+|||+++.....  ........||+.|+|||++.+.. ++.++|||||||++|||+| |..||...+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9777 9999999999765432  22334557899999999998776 8999999999999999998 8999999888777


Q ss_pred             HHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ...+......                           ..+..+|+++.+|+.+||+.||.+|||+.||+++
T Consensus       257 ~~~i~~~~~~---------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRNRQVL---------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCC---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6665542211                           1223688999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1e-55  Score=373.35  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             hhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ++|.+.++||+|+||+||+++++     .++..||||+++...  ......+.+|+++++++ +||||+++++++.+...
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTML-QHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence            56788899999999999999875     357889999986432  22345788999999999 99999999999998776


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhcc-----------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEe
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQ-----------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD  146 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~  146 (304)
                           +++||||+.+ +|.+++.....           ...++++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus       118 -----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          118 -----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             -----EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             -----EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence                 8999999985 99999976432           224699999999999999999999999999999999999999


Q ss_pred             CCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHH
Q 021982          147 RKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQL  223 (304)
Q Consensus       147 ~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~  223 (304)
                      .++ .+||+|||+++......  .......||+.|+|||++.+.. ++.++|||||||++|||+| |..||...+..+..
T Consensus       193 ~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          193 QGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             TTT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             CCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            776 99999999997654322  2223456799999999998776 8999999999999999999 89999998887777


Q ss_pred             HHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          224 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..+......+                           .+..+++++.+|+.+||+.||.+|||+.||+++
T Consensus       271 ~~i~~g~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          271 DCITQGRELE---------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHcCCCCC---------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            6665532111                           123688999999999999999999999999873

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.3e-55  Score=365.51  Aligned_cols=287  Identities=52%  Similarity=0.958  Sum_probs=237.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||.||++.+ .+++.+++|++............+.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----   74 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKR----   74 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSC----
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCe----
Confidence            47899999999999999999998 5688999999876655555567788999999999 99999999999987766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .+++||++.++|.+.+...   ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||.+..
T Consensus        75 -~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  149 (288)
T 1ob3_A           75 -LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARA  149 (288)
T ss_dssp             -EEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHH
T ss_pred             -EEEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccc
Confidence             8999999999998888652   34689999999999999999999999999999999999999777 999999999977


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....|+...
T Consensus       150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence            65544445556779999999999876668999999999999999999999999999989888898888888777776554


Q ss_pred             ccCCcc-cCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ....+. ................+++++.+||.+||+.||.+|||+.|+++||||++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~n  288 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN  288 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC--
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcC
Confidence            433321 1112222234445567899999999999999999999999999999998754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.6e-56  Score=402.07  Aligned_cols=263  Identities=27%  Similarity=0.474  Sum_probs=225.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++++|++++.||+|+||.||+|.++.+|+.||+|++......  ....+.+|+++|+.+ +||||+++++++.+...   
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~---  228 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNE---  228 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSE---
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE---
Confidence            568999999999999999999999999999999998754321  235677899999999 99999999999998776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC-CCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~-~~~vkl~dfg~  159 (304)
                        ++++|||+.| +|.+++..   ....+++.++..++.||+.||.|||++||+||||||+|||++.+ ...+||+|||+
T Consensus       229 --~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          229 --MVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             --EEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             --EEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence              9999999986 99888853   23469999999999999999999999999999999999999854 24899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..+.........    
T Consensus       304 a~~~~~~-~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----  377 (573)
T 3uto_A          304 TAHLDPK-QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----  377 (573)
T ss_dssp             CEECCTT-SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS----
T ss_pred             eeEccCC-CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc----
Confidence            9877654 3344567899999999998876 799999999999999999999999999888887777653222211    


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                          .....+|+++.+||.+||+.||.+|||+.|+|+||||+..+.
T Consensus       378 --------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          378 --------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             --------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             --------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence                                123468999999999999999999999999999999997653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.6e-54  Score=364.00  Aligned_cols=291  Identities=46%  Similarity=0.859  Sum_probs=231.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.++.++..+++|.+.... .......+.+|+.+++.+ +||||+++++++.....    
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~----   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENK----   77 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTE----
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCe----
Confidence            468999999999999999999999999999999987654 233456788999999999 99999999999988766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccC--CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQT--GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                       .++||||+.|+|.+++......  ...+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.+
T Consensus        78 -~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~  155 (317)
T 2pmi_A           78 -LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLA  155 (317)
T ss_dssp             -EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSC
T ss_pred             -EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccc
Confidence             8999999999999998775432  24589999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....|+.
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            87765555555667899999999998765589999999999999999999999999999999999999888888888876


Q ss_pred             ccccCCcccCCC-CCCCc-----ccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMNWHEYPQ-WNPQS-----LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ......+..... .....     .......++.++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence            655443321111 11111     11223468899999999999999999999999999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-53  Score=360.54  Aligned_cols=293  Identities=44%  Similarity=0.783  Sum_probs=239.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC---CCCCCchhHHHHHHHHHcc--CCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED---DEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~   76 (304)
                      +.++|++++.||+|+||.||++.+..+++.|++|++.....   .........+|+.+++.+.  +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            56899999999999999999999999999999999876542   2223346677888877773  499999999999877


Q ss_pred             ccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           77 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      ........+++||+++++|.+++...  ....+++.+++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEee
Confidence            66555568999999999999998763  234599999999999999999999999999999999999999777 999999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ||.+...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....+.+...
T Consensus       164 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQ-MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCC-cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999765433 3334557799999999998776 7999999999999999999999999999999999999999888877


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .|+....... ..+............+.+++++.+||.+||+.||.+|||+.|+|+||||++.+
T Consensus       242 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          242 DWPRDVSLPR-GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TSCSSCSSCG-GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccchhhccc-cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            7765443322 12222233344455678999999999999999999999999999999999754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-54  Score=367.69  Aligned_cols=288  Identities=48%  Similarity=0.913  Sum_probs=235.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||.||++.+..++..+++|++....... ....+.+|+.+++.+ +||||+++++++.....    
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----   74 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDL-KHANIVTLHDIIHTEKS----   74 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSC----
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCE----
Confidence            478999999999999999999999999999999987544322 233455799999999 99999999999987776    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++||||++|+|.+++...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++..
T Consensus        75 -~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~  149 (324)
T 3mtl_A           75 -LTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARA  149 (324)
T ss_dssp             -EEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEEC
T ss_pred             -EEEEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCccccc
Confidence             8999999999999988763   34689999999999999999999999999999999999999877 899999999987


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....|+...
T Consensus       150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          150 KSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             C------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence            66555555566779999999999876668999999999999999999999999999999999999999998888777654


Q ss_pred             ccCCc--ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          243 SLMNW--HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       243 ~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .....  ...............+.+++++.+||.+||+.||.+|||++|+++||||.++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            33221  122222333344456688999999999999999999999999999999998854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.4e-54  Score=366.45  Aligned_cols=291  Identities=51%  Similarity=0.937  Sum_probs=234.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||.||++.+..+++.|++|++............+.+|+.+++.+ +||||+++++++.....   
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~---  107 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHR---  107 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTE---
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCE---
Confidence            46899999999999999999999999999999999987665555566788999999999 99999999999988776   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC----CeEEEeec
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----MTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~----~~vkl~df  157 (304)
                        .++||||+.|+|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++    ..+||+||
T Consensus       108 --~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          108 --LHLIFEYAENDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             --EEEEEECCSEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             --EEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence              8999999999999998763    4589999999999999999999999999999999999996332    36999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |++..............+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            99987765555556667799999999998766689999999999999999999999999999999999999988888877


Q ss_pred             CccccccCCcccCCCC-CCCcccc-cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          238 WPGVSSLMNWHEYPQW-NPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      |+.......+...... ....+.. ....+++++.+||.+||+.||.+|||++|+|+||||++.+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            7766655444322111 1111111 122478999999999999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-54  Score=368.38  Aligned_cols=258  Identities=22%  Similarity=0.365  Sum_probs=207.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC-----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG-----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||+||+|.+...+     +.|++|.+..... ......+.+|+.++.++.+||||+++++++....
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            467999999999999999999986543     5688998864322 2223568889999999955699999999886543


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL  144 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil  144 (304)
                      ..    +++|||||.+ +|.++|.....            ....+++.++..++.||+.||+|||+++++||||||+|||
T Consensus       142 ~~----~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          142 GP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  217 (353)
T ss_dssp             SC----CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             CE----EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence            21    7999999985 99999986432            1345899999999999999999999999999999999999


Q ss_pred             EeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHH
Q 021982          145 MDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQ  221 (304)
Q Consensus       145 ~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~  221 (304)
                      ++.++ .+||+|||+++.......  ......||+.|+|||++.+.. ++.++|||||||++|||+| |..||...+..+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99777 999999999986644322  233456799999999998876 8999999999999999998 899998766444


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ........-..                          ...+..+++++.++|.+||+.||.+|||+.||++|
T Consensus       296 ~~~~~i~~g~~--------------------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCC--------------------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            44333322111                          11123578999999999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.9e-53  Score=360.52  Aligned_cols=258  Identities=28%  Similarity=0.467  Sum_probs=222.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+..+|..|++|++............+.+|+.+++.+ +||||+++++++.....    
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~----   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKT----   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE----
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCE----
Confidence            5789999999999999999999999999999999986554444455678899999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++...    ..+++.+++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus        89 -~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  162 (328)
T 3fe3_A           89 -LYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSN  162 (328)
T ss_dssp             -EEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCG
T ss_pred             -EEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCce
Confidence             8999999975 999998763    4589999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ..... .......|++.|+|||++.+....+.++||||||+++|+|++|..||...+..+....+......         
T Consensus       163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------  232 (328)
T 3fe3_A          163 EFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---------  232 (328)
T ss_dssp             GGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred             ecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            65543 33455678999999999988775568999999999999999999999998877777666542111         


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                         ....+++++.+||++||+.||.+|||++|+++||||+...
T Consensus       233 -------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          233 -------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             -------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             -------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                               1125789999999999999999999999999999998653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-53  Score=360.77  Aligned_cols=288  Identities=40%  Similarity=0.767  Sum_probs=239.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC---CCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++++.||+|+||.||++.+..++..+++|.+......   ......+.+|+.+++.+ +||||+++++++..... 
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-   86 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN-   86 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC-
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCc-
Confidence            46899999999999999999999999999999998754322   22345778999999999 99999999999987766 


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                          .++||||+.++|.+.+..   ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||+
T Consensus        87 ----~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           87 ----ISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             ----CEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             ----eEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence                899999999998887754   234689999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +..............+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....|+
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            98776555555566789999999999776668999999999999999999999999999999999999998888888777


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......++.................++.++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence            7655544443333333333444567899999999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.3e-53  Score=359.93  Aligned_cols=262  Identities=27%  Similarity=0.380  Sum_probs=224.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      -+++|++++.||+|+||.||+++++.+++.|++|++..... .......+.+|+.+++.+ +||||+++++++.....  
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~--   79 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDR--   79 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSE--
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCE--
Confidence            36899999999999999999999999999999999875421 223345778899999999 99999999999988776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++||||+.| +|...+...    ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+
T Consensus        80 ---~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~  151 (337)
T 1o6l_A           80 ---LCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGL  151 (337)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             ---EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccc
Confidence               8999999986 998888653    4689999999999999999999999999999999999999887 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +..............|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+......       
T Consensus       152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------  223 (337)
T 1o6l_A          152 CKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------  223 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred             hhhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            976544444555667899999999987765 799999999999999999999999988777766665542110       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                           ....+++++.+||.+||+.||.+||     +++|+++||||..++++.
T Consensus       224 ---------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~  271 (337)
T 1o6l_A          224 ---------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ---------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence                                 1125889999999999999999999     999999999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-52  Score=361.25  Aligned_cols=264  Identities=26%  Similarity=0.427  Sum_probs=223.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC----CCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      +.++|++++.||+|+||.||++.++.+|..+++|.+........    ....+.+|+.+++.+ +||||+++++++.+..
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRT   88 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCC
Confidence            56789999999999999999999999999999999986543322    234678999999999 8999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC---eEE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLK  153 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~---~vk  153 (304)
                      .     .++||||+.| +|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.   .+|
T Consensus        89 ~-----~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           89 D-----VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             E-----EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             E-----EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEE
Confidence            6     8999999975 99998854    356999999999999999999999999999999999999986653   799


Q ss_pred             EeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |+|||++...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.......
T Consensus       160 l~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~  237 (361)
T 2yab_A          160 LIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF  237 (361)
T ss_dssp             ECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             EEecCCceEcCCC-CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            9999999876554 2334557899999999987765 7999999999999999999999999888877776665432111


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .                        ......+++.+.+||.+||..||.+|||+.|+++||||..+++
T Consensus       238 ~------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          238 D------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             C------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             C------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            1                        1122368899999999999999999999999999999997654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-52  Score=351.62  Aligned_cols=258  Identities=24%  Similarity=0.428  Sum_probs=222.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+..++..+++|.+......  ....+.+|+.+++.+ +||||+++++++.....    
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~----   91 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMREN-KNPNIVNYLDSYLVGDE----   91 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE----
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCE----
Confidence            56899999999999999999999999999999998765432  245678899999999 99999999999988776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.| +|.+++..     ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus        92 -~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~  164 (297)
T 3fxz_A           92 -LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCA  164 (297)
T ss_dssp             -EEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             -EEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCce
Confidence             8999999975 99998876     3689999999999999999999999999999999999999777 99999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+........       
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------  236 (297)
T 3fxz_A          165 QITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------  236 (297)
T ss_dssp             ECCSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-------
T ss_pred             ecCCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            7776655566667899999999998776 79999999999999999999999998887766665544321111       


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                        .....+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       237 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          237 ------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             ------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                              01125789999999999999999999999999999998753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-53  Score=376.80  Aligned_cols=294  Identities=37%  Similarity=0.661  Sum_probs=221.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.++.+++.|+||++............+.+|+.+++.+ +||||+++++++.....+..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccC
Confidence            45789999999999999999999999999999999865443333446778899999999 99999999999976554444


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..+++|||+++++|.+.+..    ...+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++.
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~  204 (458)
T 3rp9_A          130 DELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLAR  204 (458)
T ss_dssp             CCEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred             ceEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccch
Confidence            45899999999999888864    35699999999999999999999999999999999999999877 99999999998


Q ss_pred             ecccCC---------------------------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-----
Q 021982          162 AFTLPI---------------------------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-----  209 (304)
Q Consensus       162 ~~~~~~---------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-----  209 (304)
                      ......                           .......||+.|+|||++.....++.++|||||||++|+|++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            664321                           123445679999999988766668999999999999999998     


Q ss_pred             ------ccccCCCCc--------------------hHHHHHHHHHHhCCCCCCCCccccccCC---cccCCCCCCCcccc
Q 021982          210 ------KTALFPGDS--------------------ELQQLLHIFRLLGTPNEKVWPGVSSLMN---WHEYPQWNPQSLAT  260 (304)
Q Consensus       210 ------g~~p~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  260 (304)
                            |..+|...+                    ..++...+...++.+....+........   ...........+..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  566665433                    2466667777777766544332221100   11122223344556


Q ss_pred             cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          261 AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ..+..++++.+||++||..||.+|||++|+|+||||++++.
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            67788999999999999999999999999999999998854

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-53  Score=356.84  Aligned_cols=289  Identities=37%  Similarity=0.703  Sum_probs=223.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++++|++++.||+|++|.||++.+..++..+++|++............+.+|+.+++.+ +||||+++++++.....   
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~---   76 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRR---   76 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE---
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCe---
Confidence            57899999999999999999999999999999999876544433345677899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+++ ++.+++..    ...+++..+..++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||.+
T Consensus        77 --~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~  149 (311)
T 4agu_A           77 --LHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFA  149 (311)
T ss_dssp             --EEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCc
Confidence              8999999998 55555433    35689999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............+++.|+|||++.+...++.++||||||+++|+|++|..||......+....+....+.........
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          150 RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             EECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            87765555555667899999999998766689999999999999999999999999988888877777665543321111


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      +.....   ................+.++..+.+||.+||+.||.+|||++|+++||||+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            110000   0000001111223334678999999999999999999999999999999999854

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-52  Score=363.74  Aligned_cols=290  Identities=32%  Similarity=0.613  Sum_probs=234.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc----
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK----   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~----   78 (304)
                      .++|++++.||+|+||.||++.+..++..||+|++....      ....+|+.+++.+ +||||+++++++.....    
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTC-CCTTBCCEEEEEEEC------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHc-CCCCccchhheeeecCccccc
Confidence            578999999999999999999999999999999886432      2234799999999 99999999999865432    


Q ss_pred             -----------------------------CCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH
Q 021982           79 -----------------------------EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH  129 (304)
Q Consensus        79 -----------------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh  129 (304)
                                                   ......++||||+.|+|.+.+.........+++..++.++.||+.||.|||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                         223447899999999999999887777788999999999999999999999


Q ss_pred             hcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh
Q 021982          130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT  209 (304)
Q Consensus       130 ~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~  209 (304)
                      +.|++|+||||+||+++..+..+||+|||.+....... ......+++.|+|||++.+...++.++||||||+++|+|++
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            99999999999999998544499999999998765442 33445679999999999877668999999999999999999


Q ss_pred             ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccc-cCCCCChhhHHHHHHhhcCCCCCCCCHH
Q 021982          210 KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAK  288 (304)
Q Consensus       210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (304)
                      |..||...+..+....+....+.+....+...........++......+.. ....+++++.+||.+||+.||.+|||+.
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY  317 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            999999999999999999888877654433322211111222222222222 3346889999999999999999999999


Q ss_pred             HHhcCCCccccc
Q 021982          289 KAMEHPYFDDLD  300 (304)
Q Consensus       289 eil~~~~~~~~~  300 (304)
                      |+++||||+++.
T Consensus       318 e~l~hp~f~~~~  329 (383)
T 3eb0_A          318 EAMAHPFFDHLR  329 (383)
T ss_dssp             HHHTSGGGHHHH
T ss_pred             HHhcCHHHHHHH
Confidence            999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=364.74  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=219.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.|++|++.... ...........|..+++.+.+||||+++++++.+...   
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~---   98 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR---   98 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE---
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE---
Confidence            468999999999999999999999999999999987542 1222345677899999988689999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...    ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++
T Consensus        99 --~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a  171 (353)
T 3txo_A           99 --LFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMC  171 (353)
T ss_dssp             --EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccce
Confidence              8999999986 999888763    4599999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+......        
T Consensus       172 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------  242 (353)
T 3txo_A          172 KEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------  242 (353)
T ss_dssp             BCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred             eecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            76544444455567899999999998766 799999999999999999999999998888877777653111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH------HHHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~eil~~~~~~~~~~~~  303 (304)
                                          ....+++++.+||++||+.||.+||++      +|+++||||++++++.
T Consensus       243 --------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~  291 (353)
T 3txo_A          243 --------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ  291 (353)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence                                112578999999999999999999999      8999999999987653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.3e-53  Score=371.31  Aligned_cols=295  Identities=37%  Similarity=0.648  Sum_probs=231.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |.++|++++.||+|+||.||++.++.++..|+||++............+.+|+.+++.+ +||||+++++++........
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence            56889999999999999999999999999999999875443333446778999999999 99999999999987654333


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...++|||+++++|.+.+..    ...+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~  177 (432)
T 3n9x_A          103 DELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLAR  177 (432)
T ss_dssp             CCEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             CeEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcc
Confidence            44899999999999998864    35699999999999999999999999999999999999999777 99999999998


Q ss_pred             ecccCCC----------------------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc------
Q 021982          162 AFTLPIK----------------------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL------  213 (304)
Q Consensus       162 ~~~~~~~----------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p------  213 (304)
                      .......                      ......+|+.|+|||++.....++.++|||||||++|+|++|..|      
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            7654321                      235567799999999987666689999999999999999985443      


Q ss_pred             -----CCCCc-----------------hHHHHHHHHHHhCCCCCCCCccccccCC---cccCCCCCCCcccccCCCCChh
Q 021982          214 -----FPGDS-----------------ELQQLLHIFRLLGTPNEKVWPGVSSLMN---WHEYPQWNPQSLATAVPNLDKD  268 (304)
Q Consensus       214 -----~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  268 (304)
                           |...+                 ..++...+...++.+....+........   ...........+....+.++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence                 33222                 3566777777777776544332211100   0111222333444556789999


Q ss_pred             hHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          269 GLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       269 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      +.+||.+||+.||.+|||++|+|+||||+++++.
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            9999999999999999999999999999998654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-52  Score=364.96  Aligned_cols=290  Identities=36%  Similarity=0.653  Sum_probs=221.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.++.+++.|++|++..............+|+.+++.+.+||||+++++++...+.   
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND---   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---
Confidence            56889999999999999999999999999999999865443333445677899999999559999999999875432   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..+++||||++++|.+.+..     ..+++..+..++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++.
T Consensus        84 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  157 (388)
T 3oz6_A           84 RDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSR  157 (388)
T ss_dssp             SCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             CEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence            12899999999999988876     4689999999999999999999999999999999999999877 99999999997


Q ss_pred             ecccC---------------------CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH
Q 021982          162 AFTLP---------------------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL  220 (304)
Q Consensus       162 ~~~~~---------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  220 (304)
                      .....                     ........||+.|+|||++.+...++.++|||||||++|+|++|..||...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                     122334577999999999987666899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCccccccCCc------ccCCCCCCCccc-------------ccCCCCChhhHHHHHHhhcCCC
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSSLMNW------HEYPQWNPQSLA-------------TAVPNLDKDGLDLLEQMLQYDP  281 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~dp  281 (304)
                      .....+...++.+....+.........      ............             .....+++++.+||.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            999999888877664433221110000      000000000000             0122678999999999999999


Q ss_pred             CCCCCHHHHhcCCCccccc
Q 021982          282 SKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       282 ~~Rps~~eil~~~~~~~~~  300 (304)
                      .+|||++|+|+||||+.+.
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTC
T ss_pred             ccCCCHHHHhCCHHHHHhc
Confidence            9999999999999998763

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.1e-52  Score=360.70  Aligned_cols=262  Identities=24%  Similarity=0.393  Sum_probs=217.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.+++|++..... .......+..|..+++++.+||||+++++++.+...   
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~---  127 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR---  127 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE---
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE---
Confidence            5789999999999999999999999999999999986532 333456778899999888789999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|...+...    ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus       128 --~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla  200 (396)
T 4dc2_A          128 --LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMC  200 (396)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeeccee
Confidence              8999999986 998888763    4699999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---------HHHHHHHHHHhC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---------LQQLLHIFRLLG  231 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---------~~~~~~~~~~~~  231 (304)
                      ..............||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.....         ......+.... 
T Consensus       201 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-  278 (396)
T 4dc2_A          201 KEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-  278 (396)
T ss_dssp             BCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-
T ss_pred             eecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-
Confidence            76444444555668899999999998766 79999999999999999999999964321         11222222210 


Q ss_pred             CCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH------HHHhcCCCcccccccc
Q 021982          232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKTR  303 (304)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~eil~~~~~~~~~~~~  303 (304)
                                                 ......+++++.+||++||+.||.+||++      +|+++||||+.++++.
T Consensus       279 ---------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          279 ---------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             ---------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred             ---------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence                                       01123688999999999999999999985      7999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=368.04  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=223.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.++.++..+++|++............+.+|+.+++.+ +||||+++++++.+...   
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~---   84 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGH---   84 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSE---
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCE---
Confidence            45789999999999999999999999999999999876543333345678999999999 99999999999987776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~dfg  158 (304)
                        .++||||+.| +|.+.+...    ..+++..+..++.||+.||.|||++|++|+||||+||+++.+  +..+||+|||
T Consensus        85 --~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           85 --HYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             --EEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             --EEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence              8999999986 998888762    469999999999999999999999999999999999999842  3489999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++..............|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+........... 
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-  236 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE-  236 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT-
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc-
Confidence            9987766555556678899999999988765 79999999999999999999999998888777777765433222222 


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                             ...+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       237 -----------------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          237 -----------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             -----------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             -----------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                   23688999999999999999999999999999999754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-53  Score=362.91  Aligned_cols=289  Identities=37%  Similarity=0.632  Sum_probs=232.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||.||++.+..+|..|++|++............+.+|+.+++.+ +||||+++++++..... ..
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcccc
Confidence            45789999999999999999999999999999999865433333345677899999999 89999999999876532 12


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++|||+++++|.+++..     ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++
T Consensus       102 ~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a  175 (367)
T 1cm8_A          102 FTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA  175 (367)
T ss_dssp             CCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             CceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecc
Confidence            233699999998899998876     4689999999999999999999999999999999999999877 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+....+.+....+..
T Consensus       176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          176 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            875432   34456799999999998855689999999999999999999999999999999999988888776544333


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......   ...........+....+..++.+.+||.+||..||.+|||++|+|+||||+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            221100   011222233445556678899999999999999999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.7e-53  Score=373.61  Aligned_cols=288  Identities=33%  Similarity=0.575  Sum_probs=225.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||.||++.+..+++.|++|++............+.+|+.+++.+ +||||+++++++..... +.
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence            45789999999999999999999999999999999976543333456778899999999 99999999999876543 23


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++||||+++++.+.+..      .+++..++.++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++
T Consensus       139 ~~~~~lv~E~~~~~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a  211 (464)
T 3ttj_A          139 FQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA  211 (464)
T ss_dssp             CCEEEEEEECCSEEHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC
T ss_pred             CCeEEEEEeCCCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEee
Confidence            345899999999988777642      489999999999999999999999999999999999999877 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...++.+....+..
T Consensus       212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          212 RTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             -----C-CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eecCCC-cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            766543 3345567899999999998875 89999999999999999999999999999999999999888876544433


Q ss_pred             ccccCC-cc-cCCCCCCCcccccCCC------------CChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMN-WH-EYPQWNPQSLATAVPN------------LDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~-~~-~~~~~~~~~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ...... +. .........+....+.            .++++.+||.+||..||.+|||++|+|+||||+..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            211000 00 0001111111111111            15678999999999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.4e-52  Score=360.75  Aligned_cols=290  Identities=33%  Similarity=0.636  Sum_probs=233.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~   81 (304)
                      ..+|++++.||+|+||.||++.+..++. +++|++....      ....+|+++++.+ +||||+++++++..... ...
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~------~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT------TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc------chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCc
Confidence            3579999999999999999999987665 8888775432      1233799999999 99999999999876554 344


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..+++||||+.+++...+.........+++..++.++.||+.||.|||++|++||||||+||+++..+..+||+|||++.
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            55789999999988887776666667899999999999999999999999999999999999999434499999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ...... ......+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+.+..+.+....+...
T Consensus       191 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          191 ILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             ECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            764442 2334567999999999987766899999999999999999999999999999999999988887765443322


Q ss_pred             cccCCcccCCCCCCCcccc-cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .........+......+.. ..+.+++++.+||.+||+.||.+|||+.|+++||||+++..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            2111112222222222222 23458999999999999999999999999999999998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-51  Score=362.46  Aligned_cols=290  Identities=32%  Similarity=0.607  Sum_probs=234.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~~   82 (304)
                      .+|++++.||+|+||.||++.+..++..|+||++....      ....+|+++++.+ +||||+++++++..... ....
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcce
Confidence            36999999999999999999999999999999886432      2234799999999 99999999999865443 2334


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      ++++||||+.+++.+.+.........+++..++.++.||+.||.|||++||+|+||||+|||++.++..+||+|||++..
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            57899999999988888776666678999999999999999999999999999999999999997765899999999987


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+.+.++.+....+....
T Consensus       207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            65432 23345679999999999876568999999999999999999999999999999999998888877654443322


Q ss_pred             ccCCcccCCCCCCCcccc-cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          243 SLMNWHEYPQWNPQSLAT-AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .......+.......+.. ..+.+++++.+||.+||..||.+|||+.|+++||||+++..
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            111111111111112221 23467899999999999999999999999999999988743

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-52  Score=358.10  Aligned_cols=262  Identities=27%  Similarity=0.431  Sum_probs=223.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||+++++.+++.|++|++..... ..........|..++..+.+||||+++++++.+...   
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~---   92 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN---   92 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE---
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE---
Confidence            5789999999999999999999999999999999876421 122345667888888877699999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++...    ..+++.++..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++
T Consensus        93 --~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a  165 (345)
T 1xjd_A           93 --LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMC  165 (345)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhh
Confidence              8999999975 999998763    4589999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+......        
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------  236 (345)
T 1xjd_A          166 KENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--------  236 (345)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred             hhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence            76544444455667899999999998766 799999999999999999999999988877776666542110        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHH-HHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK-KAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-eil~~~~~~~~~~~~  303 (304)
                                          ....+++++.+||.+||+.||.+||++. ++++||||+.++++.
T Consensus       237 --------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~  280 (345)
T 1xjd_A          237 --------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  280 (345)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             --------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHH
Confidence                                1125789999999999999999999998 999999999988653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-52  Score=358.59  Aligned_cols=267  Identities=28%  Similarity=0.452  Sum_probs=222.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC---CCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE---DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      +.++|++.+.||+|+||.||++.++.+++.+++|++....   ........+.+|+.+++.+ +||||+++++++.....
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGM  100 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence            4578999999999999999999999999999999987532   2222346788999999999 99999999999988766


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEe
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIA  155 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~  155 (304)
                           .++||||+.| +|.+.+.........+++..++.++.||+.||.|||++|++|+||||+||+++.++  ..+||+
T Consensus       101 -----~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A          101 -----LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             -----EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             -----EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence                 8999999985 99888877666566799999999999999999999999999999999999998654  349999


Q ss_pred             eccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          156 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      |||++..............|++.|+|||++.+.. ++.++||||||+++|+|++|..||..... .....+.......  
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~--  251 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKM--  251 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCC--
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCC--
Confidence            9999987766544455567899999999998766 79999999999999999999999987543 3333333321110  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                            .......+++++.+||.+||+.||.+|||+.|+++||||++.+
T Consensus       252 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          252 ----------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             ----------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             ----------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                                  0111236889999999999999999999999999999998753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-51  Score=352.99  Aligned_cols=293  Identities=36%  Similarity=0.694  Sum_probs=236.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC---
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE---   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~---   79 (304)
                      .++|++++.||+|+||.||++.++.+++.+++|++............+.+|+.+++.+ +||||+++++++......   
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence            5789999999999999999999999999999999877666655666788999999999 899999999998765321   


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      .....++||||+++++.+.+...   ...+++.+++.++.|++.||.+||++|++|+||||+||+++.++ .+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchh
Confidence            12347999999999888887653   34699999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccC----CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLP----IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      +......    ........+++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+....+....
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9876422    223344567999999999987666899999999999999999999999999999999999988888877


Q ss_pred             CCCccccccCCcccCCCCC--CCccccc--CCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          236 KVWPGVSSLMNWHEYPQWN--PQSLATA--VPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ..|+...............  .......  ....++.+.+||.+||+.||.+|||++|+|+||||...+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            7776554332221111000  0000000  012367899999999999999999999999999998754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-50  Score=344.66  Aligned_cols=293  Identities=43%  Similarity=0.804  Sum_probs=239.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++++.||+|+||.||++.+. .+++.+++|++............+.+|+.+++.+.  +||||+++++++.....+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999995 67889999999876655555567778888877664  799999999998744333


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      .....+++||+++|+|.+++....  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.
T Consensus        90 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~  166 (326)
T 1blx_A           90 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGL  166 (326)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCS
T ss_pred             CCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCcc
Confidence            344589999999999999998732  34589999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+....+.+....|+
T Consensus       167 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          167 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCCGG-GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccCC-CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            9765433 2334456789999999998766 7999999999999999999999999999988888888888777666555


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ........ .+............+.++..+.+||.+||+.||.+|||+.|+++||||++++.
T Consensus       245 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          245 RDVALPRQ-AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             TTCSSCGG-GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccchh-hhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence            43222111 11111222344455689999999999999999999999999999999998864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.5e-52  Score=358.87  Aligned_cols=290  Identities=35%  Similarity=0.644  Sum_probs=235.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.+..++..|++|++.... .......+.+|+.+++.+ +||||+++++++.....+..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCcccc
Confidence            3578999999999999999999999999999999986432 222235677899999999 99999999999887654444


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...++++|+++|+|.+++..     ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.+.
T Consensus       103 ~~~~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~  176 (364)
T 3qyz_A          103 KDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLAR  176 (364)
T ss_dssp             CCEEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             ceEEEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceE
Confidence            44899999999999998875     4699999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          162 AFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       162 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ........   .....|++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+...++.+....+
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            76543221   234577999999999877666899999999999999999999999999988888888887777655433


Q ss_pred             ccccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ........   ...........+....+.+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            22111100   01111122223344556789999999999999999999999999999999976

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.5e-52  Score=356.21  Aligned_cols=262  Identities=24%  Similarity=0.396  Sum_probs=223.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.|++|++..... .......+..|..++..+.+||+|+++++++.....   
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~---   95 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR---   95 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE---
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE---
Confidence            4789999999999999999999999999999999876421 223345677888999887789999999999988766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++...    ..+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++
T Consensus        96 --~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a  168 (353)
T 2i0e_A           96 --LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMC  168 (353)
T ss_dssp             --EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcc
Confidence              8999999986 999998763    3589999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+......        
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------  239 (353)
T 2i0e_A          169 KENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------  239 (353)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred             cccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence            76444444455567899999999998766 799999999999999999999999988887777766652111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~  303 (304)
                                          ....+++++.+||.+||+.||.+||+     ++++++||||+.++++.
T Consensus       240 --------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          240 --------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence                                11268899999999999999999994     69999999999987653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-51  Score=349.44  Aligned_cols=258  Identities=24%  Similarity=0.436  Sum_probs=222.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.+++|++..... .......+.+|..+++.+ +||||+++++++.+...   
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~---   80 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQ---   80 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSE---
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCE---
Confidence            5789999999999999999999999999999999875421 122345677899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus        81 --~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           81 --IFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             --EEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             --EEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcc
Confidence              8999999986 999998762    4689999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+......        
T Consensus       154 ~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  221 (318)
T 1fot_A          154 KYVPDV---TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------  221 (318)
T ss_dssp             EECSSC---BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC--------
T ss_pred             eecCCc---cccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence            765432   23456799999999988765 799999999999999999999999988887777766652111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                          ..+.+++++.++|.+||+.||.+||     +++++++||||+++++++
T Consensus       222 --------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          222 --------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence                                1135789999999999999999999     999999999999987653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-51  Score=348.52  Aligned_cols=264  Identities=26%  Similarity=0.431  Sum_probs=221.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC----CCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|++........    ....+.+|+.+++.+ +||||+++++++....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKT   87 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCC
Confidence            46789999999999999999999999999999999886543322    234678999999999 9999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC---eEE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLK  153 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~---~vk  153 (304)
                      .     .++||||+.| +|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.   .+|
T Consensus        88 ~-----~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           88 D-----VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             E-----EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             E-----EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEE
Confidence            6     8999999975 99998854    356999999999999999999999999999999999999986552   799


Q ss_pred             EeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |+|||++....... ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+.......
T Consensus       159 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  236 (326)
T 2y0a_A          159 IIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  236 (326)
T ss_dssp             ECCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             EEECCCCeECCCCC-ccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence            99999998765432 334457899999999987665 7999999999999999999999999888777666655432111


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      .                        ......++..+.+||.+||+.||.+|||+.|+++||||...+.
T Consensus       237 ~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          237 E------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             C------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             C------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            1                        1122367899999999999999999999999999999987643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-51  Score=352.39  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=216.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.+++|++...... ......+..|..+++.+.+||||+++++++.....   
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~---   84 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR---   84 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE---
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE---
Confidence            57899999999999999999999999999999999865322 22234567889999887789999999999988766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus        85 --~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a  157 (345)
T 3a8x_A           85 --LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMC  157 (345)
T ss_dssp             --EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGC
T ss_pred             --EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEecccc
Confidence              8999999976 999888763    4589999999999999999999999999999999999999877 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc---------hHHHHHHHHHHhC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS---------ELQQLLHIFRLLG  231 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~---------~~~~~~~~~~~~~  231 (304)
                      ..............|++.|+|||++.+.. ++.++|+||||+++|+|++|..||....         .......+.... 
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-  235 (345)
T 3a8x_A          158 KEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-  235 (345)
T ss_dssp             BCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-
T ss_pred             ccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-
Confidence            76444444455567899999999998765 7999999999999999999999996521         112222222110 


Q ss_pred             CCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH------HHHhcCCCccccccc
Q 021982          232 TPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA------KKAMEHPYFDDLDKT  302 (304)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~eil~~~~~~~~~~~  302 (304)
                                                 ......++.++.+||.+||+.||.+||++      +|+++||||+.++++
T Consensus       236 ---------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          236 ---------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             ---------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence                                       01123688999999999999999999995      899999999998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-52  Score=361.44  Aligned_cols=289  Identities=37%  Similarity=0.597  Sum_probs=219.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||.||++.+..+|..|++|++............+.+|+.+++.+ +||||+++++++..... +.
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence            45789999999999999999999999999999999875433333345677899999999 89999999999875421 11


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++++|+++++|.+++..     ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus       106 ~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a  179 (367)
T 2fst_X          106 FNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA  179 (367)
T ss_dssp             CCCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC----
T ss_pred             CCeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccc
Confidence            223789999998888888754     4699999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+....+.+....+..
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            765432   33456799999999998755689999999999999999999999999999999999988888776544433


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......   ...........+....+..++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence            322100   011122233345555678899999999999999999999999999999999763

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-51  Score=352.76  Aligned_cols=294  Identities=32%  Similarity=0.541  Sum_probs=226.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc--CC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK--EG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~--~~   80 (304)
                      .++|++.+.||+|+||.||++.++.++..+++|++....   .......+++..++.+ +||||+++++++.....  ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccc
Confidence            578999999999999999999999999999999886432   2345667788888888 99999999999876443  23


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH--hcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--GHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      ....+++|||+.+++...+.........+++..+..++.|++.||.+||  +.|++|+||||+||+++..+..+||+|||
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A           98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            4457899999999998888776677778999999999999999999999  99999999999999999734499999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++....... ......+++.|+|||++.+...++.++||||||+++|+|++|..||...+.......+....+.+....+
T Consensus       178 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3e3p_A          178 SAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL  256 (360)
T ss_dssp             TCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence            998665432 3334567999999999987766899999999999999999999999999999999888888777665443


Q ss_pred             ccccccCCcccCCCCCCCc----ccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQS----LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ...................    +.......++++.+||.+||+.||.+|||+.|+|+||||+++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            3322111111111111111    11222346788999999999999999999999999999998743

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-51  Score=354.69  Aligned_cols=262  Identities=29%  Similarity=0.409  Sum_probs=221.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|++............+.+|+.+++.+ +||||+++++++.+...   
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~---  102 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF---  102 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCE---
Confidence            35689999999999999999999999999999999876544333345678899999999 99999999999988766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg  158 (304)
                        .++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++  ..+||+|||
T Consensus       103 --~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          103 --HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             --EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             --EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence              8999999986 89888754    35689999999999999999999999999999999999998653  369999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+........... 
T Consensus       177 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-  253 (362)
T 2bdw_A          177 LAIEVNDS-EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE-  253 (362)
T ss_dssp             TCBCCTTC-CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG-
T ss_pred             cceEecCC-cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc-
Confidence            99766543 2334557899999999998765 89999999999999999999999998887777666655322222111 


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                             ...+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       254 -----------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          254 -----------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             -----------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             -----------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                   12578999999999999999999999999999999753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-51  Score=358.23  Aligned_cols=265  Identities=25%  Similarity=0.373  Sum_probs=223.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.++..+++|++.... ........+.+|..+++.+ +||||+++++++.+...   
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~---  143 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRY---  143 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE---
Confidence            468999999999999999999999999999999987532 1223345678999999999 99999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++..     ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus       144 --~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a  215 (410)
T 3v8s_A          144 --LYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTC  215 (410)
T ss_dssp             --EEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEecccee
Confidence              8999999975 99998865     3589999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCCC---CCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTH---YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~---~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ........ ......||+.|+|||++.+...   ++.++||||||+++|+|++|..||...+..+....+........- 
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-  294 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF-  294 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC-
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC-
Confidence            87654322 2335578999999999986542   678999999999999999999999998888877777653211100 


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCcccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~~~~  303 (304)
                                             .....+|+++.+||.+||+.+|.+  ||+++||++||||++++++.
T Consensus       295 -----------------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          295 -----------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             -----------------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             -----------------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence                                   001258899999999999999988  99999999999999987653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.7e-51  Score=346.85  Aligned_cols=261  Identities=28%  Similarity=0.451  Sum_probs=211.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCC--CCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHED--DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ..++|++++.||+|+||.||++++.   .+++.+++|++.....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcC
Confidence            3578999999999999999999985   5788999999875432  222345677899999999 999999999999887


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      ..     .++||||+.| +|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+
T Consensus        94 ~~-----~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           94 GK-----LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             SC-----EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             CE-----EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEE
Confidence            76     8999999985 999988763    4589999999999999999999999999999999999999777 99999


Q ss_pred             eccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          156 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      |||++..............|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+......   
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~---  239 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN---  239 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---
Confidence            9999876544434444557899999999997765 799999999999999999999999988887777666553111   


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                               ..+.++.++.+||.+||+.||.+||     ++.|+++||||+.++++
T Consensus       240 -------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          240 -------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             -------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             -------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence                                     1135789999999999999999999     89999999999988654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-52  Score=352.24  Aligned_cols=260  Identities=24%  Similarity=0.432  Sum_probs=220.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|.+....   .....+.+|+.+++.+ +||||+++++++.+...   
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~---   75 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIA-RHRNILHLHESFESMEE---   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTE---
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCE---
Confidence            5789999999999999999999999999999999886432   1234577899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC-CCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~-~~~vkl~dfg~  159 (304)
                        .+++|||+.| +|.+++..   ...++++.+++.++.|++.||.|||++|++|+||||+||+++.+ +..+||+|||+
T Consensus        76 --~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~  150 (321)
T 1tki_A           76 --LVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             --EEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             --EEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence              8999999986 99888854   23468999999999999999999999999999999999999862 34899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.........    
T Consensus       151 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  224 (321)
T 1tki_A          151 ARQLKPG-DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----  224 (321)
T ss_dssp             CEECCTT-CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----
T ss_pred             CeECCCC-CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh----
Confidence            9876543 2334456799999999998765 789999999999999999999999998887777776653222111    


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                          ...+.+|+++.+||.+||..||.+|||+.|+++||||.+.
T Consensus       225 --------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          225 --------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             --------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             --------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                                1223688999999999999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9e-51  Score=339.33  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=214.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|++..... ......+.+|+++++.+ +||||+++++++.....   
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~---   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHN---   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE---
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhC-CCchHHhHHHheecCCe---
Confidence            56889999999999999999999999999999999876542 22346788999999999 99999999999987666   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~dfg  158 (304)
                        .++||||+.+ +|.+.+.........+++..++.++.|++.||.+||++|++|+||||+||+++.+  +..++|+|||
T Consensus        95 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           95 --MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             --EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             --EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence              8999999986 9999998766666789999999999999999999999999999999999999532  2479999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++...... .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||......+...........      
T Consensus       173 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------  243 (285)
T 3is5_A          173 LAELFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN------  243 (285)
T ss_dssp             CCCC-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------
T ss_pred             cceecCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc------
Confidence            99765443 22344567999999998854  3789999999999999999999999988776655544432111      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                         .......+++.+.+||.+||+.||.+|||+.|+++||||++
T Consensus       244 -------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 -------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                               11112247899999999999999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-51  Score=351.20  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=222.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.|++|++..... .......+.+|+.+++.+ +||||+++++++.+...   
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~---  115 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSN---  115 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE---
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCE---
Confidence            5789999999999999999999999999999999875431 223345778899999999 99999999999988766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus       116 --~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a  188 (350)
T 1rdq_E          116 --LYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccc
Confidence              8999999975 999998763    4589999999999999999999999999999999999999877 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+......        
T Consensus       189 ~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------  256 (350)
T 1rdq_E          189 KRVKGR---TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------  256 (350)
T ss_dssp             EECSSC---BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred             eeccCC---cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            876543   23457899999999998766 799999999999999999999999988887777766652111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                          ....+++++.++|.+||+.||.+||+     +++|++||||..+++.
T Consensus       257 --------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          257 --------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             --------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence                                11258899999999999999999998     9999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.8e-51  Score=350.79  Aligned_cols=288  Identities=35%  Similarity=0.663  Sum_probs=223.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||.||++.+..++..|++|++............+.+|+.+++.+ +||||+++++++.....    
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKR----   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE----
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCE----
Confidence            6899999999999999999999999999999999876544433344567899999999 89999999999987766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++||||+++++...+..   ....+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||.+..
T Consensus        99 -~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  173 (331)
T 4aaa_A           99 -WYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFART  173 (331)
T ss_dssp             -EEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC--
T ss_pred             -EEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCcee
Confidence             899999999854444332   234699999999999999999999999999999999999999777 999999999987


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.........+.
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            66555555566789999999999877568999999999999999999999999998888887777766554332111111


Q ss_pred             ccCCc--ccCC-CCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          243 SLMNW--HEYP-QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~--~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .....  ...+ ...........+.+++.+.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            00000  0000 0111223334567899999999999999999999999999999998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-51  Score=345.99  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=210.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC------------------------CCCCchhHHHHHHH
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD------------------------EGVPPTTLREVSIL   57 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------------------------~~~~~~~~~e~~~l   57 (304)
                      ..++|++.+.||+|+||.||++.+..+++.|++|++......                        ......+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            457899999999999999999999999999999998754321                        11245688999999


Q ss_pred             HHccCCCCeeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCcccc
Q 021982           58 RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHR  136 (304)
Q Consensus        58 ~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~  136 (304)
                      +.+ +||||+++++++.....   ...++||||+.+ +|.+.+     ...++++.+++.++.|++.||.|||++|++|+
T Consensus        91 ~~l-~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  161 (298)
T 2zv2_A           91 KKL-DHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHR  161 (298)
T ss_dssp             HTC-CCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HhC-CCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            999 99999999999876321   138999999986 665532     23579999999999999999999999999999


Q ss_pred             CCCCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCC--CCCchhHHHHHHHHHHHhhccccC
Q 021982          137 DLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALF  214 (304)
Q Consensus       137 dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~~Di~slG~il~~ll~g~~p~  214 (304)
                      ||||+||+++.++ .+||+|||++..............|++.|+|||++.+...  .+.++||||||+++|+|++|..||
T Consensus       162 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          162 DIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            9999999999777 8999999999877655444555678999999999876542  377899999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          215 PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                      ...........+.......                          ...+.+++++.++|.+||+.||.+|||+.|+++||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          241 MDERIMCLHSKIKSQALEF--------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             CCSSHHHHHHHHHHCCCCC--------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             CCccHHHHHHHHhcccCCC--------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            8877665555443321110                          01136889999999999999999999999999999


Q ss_pred             Cccc
Q 021982          295 YFDD  298 (304)
Q Consensus       295 ~~~~  298 (304)
                      ||++
T Consensus       295 ~~~~  298 (298)
T 2zv2_A          295 WVTR  298 (298)
T ss_dssp             HHHC
T ss_pred             cccC
Confidence            9963

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-52  Score=357.22  Aligned_cols=256  Identities=28%  Similarity=0.445  Sum_probs=214.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.+..++..|++|++.... ........+.+|+.+++.+ +||||+++++++.....   
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~---   83 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTD---   83 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE---
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCE---
Confidence            478999999999999999999999999999999987542 1223346788999999999 99999999999988776   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .++||||++|+|.+++...    ..+++.+++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++.
T Consensus        84 --~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~  156 (336)
T 3h4j_B           84 --IVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSN  156 (336)
T ss_dssp             --EEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTB
T ss_pred             --EEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccce
Confidence              8999999998999988763    4699999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ..... .......|++.|+|||++.+....+.++||||||+++|+|++|..||.........               .. 
T Consensus       157 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~-  219 (336)
T 3h4j_B          157 IMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KK-  219 (336)
T ss_dssp             TTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CC-
T ss_pred             eccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HH-
Confidence            65544 33345578999999999987764578999999999999999999999754321100               00 


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                  ...........+++++.+||++||+.||.+|||++|+++||||+.
T Consensus       220 ------------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          220 ------------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ------------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ------------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                        001111223468899999999999999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.8e-51  Score=338.89  Aligned_cols=264  Identities=28%  Similarity=0.412  Sum_probs=223.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.++.++..+++|++............+.+|+.+++.+ +||||+++++++.....   
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   79 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF---   79 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE---
Confidence            46889999999999999999999999999999999886554443445677899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg  158 (304)
                        .+++|||+.| +|.+.+...    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  ..++|+|||
T Consensus        80 --~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           80 --HYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             --EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             --EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence              8999999986 888888663    4589999999999999999999999999999999999998654  349999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .+...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+..........  
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  229 (284)
T 3kk8_A          154 LAIEVNDS-EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP--  229 (284)
T ss_dssp             TCEECCSS-CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             eeEEcccC-ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch--
Confidence            99776544 2334456799999999998766 7999999999999999999999999888777776665532222111  


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                            ....+++++.+||.+||+.||.+|||+.|+++||||.+...
T Consensus       230 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          230 ----------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             ----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             ----------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence                                  12368899999999999999999999999999999988643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-51  Score=356.22  Aligned_cols=288  Identities=35%  Similarity=0.603  Sum_probs=230.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC-C
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE-G   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-~   80 (304)
                      +.++|++.+.||+|+||.||++.++.++..|++|++............+.+|+.+++.+ +||||+++++++...... .
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCccc
Confidence            45789999999999999999999999999999999876544433346777899999999 899999999998876542 1


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....+++||++.++|.+.+.      ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||.+
T Consensus       119 ~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a  191 (371)
T 4exu_A          119 FYDFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA  191 (371)
T ss_dssp             CCCCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC
T ss_pred             ceeEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcc
Confidence            22248999999998877763      3599999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....+..
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          192 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            765433   23446699999999998755689999999999999999999999999999998888888777665433222


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......   ...........+....+.+++.+.+||.+||+.||.+|||+.|+++||||+.+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            111000   011122223334455667899999999999999999999999999999999763

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.3e-51  Score=347.74  Aligned_cols=267  Identities=25%  Similarity=0.411  Sum_probs=221.5

Q ss_pred             hhhhhhh-hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKL-EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|.+. +.||+|+||.||++.++.+++.+++|++............+.+|+.+++.+.+||||+++++++.....   
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~---  103 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE---  103 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE---
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe---
Confidence            4678887 899999999999999999999999999887655554556788999999999778999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC---CCCeEEEeec
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR---KTMTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~---~~~~vkl~df  157 (304)
                        .++||||+.| +|.+++..  .....+++.+++.++.|++.||.+||++|++|+||||+||+++.   ++ .+||+||
T Consensus       104 --~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~-~~kL~Df  178 (327)
T 3lm5_A          104 --IILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG-DIKIVDF  178 (327)
T ss_dssp             --EEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred             --EEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence              8999999986 88777643  23357999999999999999999999999999999999999986   44 8999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |++....... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.........  
T Consensus       179 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  254 (327)
T 3lm5_A          179 GMSRKIGHAC-ELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE--  254 (327)
T ss_dssp             GGCEEC----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             ccccccCCcc-ccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence            9998765442 233456799999999987765 799999999999999999999999998887777766554322221  


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                                            .....+++.+.++|.+||+.||.+|||++++++||||+..+++.
T Consensus       255 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          255 ----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             ----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                                  12236889999999999999999999999999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.6e-51  Score=363.10  Aligned_cols=261  Identities=27%  Similarity=0.376  Sum_probs=213.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .+++|++++.||+|+||.||++.++.++..|++|++.... ........+.+|+.+++.+ +||||+++++++.....  
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~--  222 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDR--  222 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTE--
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCE--
Confidence            3578999999999999999999999999999999987542 2233345667889999999 89999999999988776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                         +++||||+.| +|.+.+...    ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++ .+||+|||
T Consensus       223 ---~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG  294 (446)
T 4ejn_A          223 ---LCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFG  294 (446)
T ss_dssp             ---EEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCC
T ss_pred             ---EEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCC
Confidence               8999999986 898888653    468999999999999999999998 9999999999999999877 99999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++..............|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+......      
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------  367 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------  367 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC------
Confidence            9976544444555667899999999998766 899999999999999999999999988877776666542111      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                            ....+++++.+||.+||+.||.+||     |++|+++||||+.++++
T Consensus       368 ----------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          368 ----------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                                  1235889999999999999999999     99999999999998765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.2e-51  Score=352.67  Aligned_cols=262  Identities=25%  Similarity=0.411  Sum_probs=218.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      -.++|++++.||+|+||.||++.++.+++.|++|++.... ........+.+|+.+++.+ +||||+++++++.+...  
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~--   89 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEED--   89 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE--
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE--
Confidence            3688999999999999999999999999999999987543 2223346778899999999 99999999999998776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++||||+.| +|..++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||+
T Consensus        90 ---~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~  161 (384)
T 4fr4_A           90 ---MFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNI  161 (384)
T ss_dssp             ---EEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             ---EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccce
Confidence               8999999976 99888865    35699999999999999999999999999999999999999887 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHHHHHhCCCC
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFRLLGTPN  234 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~  234 (304)
                      +...... .......||+.|+|||++.+.  ..++.++||||||+++|+|++|..||.....   ......+....    
T Consensus       162 a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----  236 (384)
T 4fr4_A          162 AAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----  236 (384)
T ss_dssp             CEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----
T ss_pred             eeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----
Confidence            9876543 334556789999999998742  3378999999999999999999999975432   22222222210    


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-HHHHhcCCCcccccccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-AKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~eil~~~~~~~~~~~~  303 (304)
                                              ......+++.+.+||.+||+.||.+||+ ++++++||||++++++.
T Consensus       237 ------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~  282 (384)
T 4fr4_A          237 ------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA  282 (384)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred             ------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence                                    1112357899999999999999999998 99999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.8e-51  Score=351.66  Aligned_cols=261  Identities=25%  Similarity=0.366  Sum_probs=214.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHH-HHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSI-LRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~-l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++++.||+|+||.||+++++.++..|++|++..... .......+..|..+ ++.+ +||||+++++++.+...  
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~--  113 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK--  113 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSE--
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCE--
Confidence            5789999999999999999999999999999999976542 22233445556665 4556 99999999999988776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         +++||||+.| +|.+++...    ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+
T Consensus       114 ---~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~  185 (373)
T 2r5t_A          114 ---LYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGL  185 (373)
T ss_dssp             ---EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCB
T ss_pred             ---EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCcc
Confidence               8999999986 999888763    4589999999999999999999999999999999999999887 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +..............||+.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+.....        
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------  256 (373)
T 2r5t_A          186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------  256 (373)
T ss_dssp             CGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--------
T ss_pred             ccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--------
Confidence            976444444455667899999999998766 89999999999999999999999999888877777665211        


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH----HHHhcCCCcccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA----KKAMEHPYFDDLDKTR  303 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~~~~~~~~  303 (304)
                                          ...+.+++++.+||.+||+.||.+||++    .++++||||+.++++.
T Consensus       257 --------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          257 --------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             --------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence                                1123688999999999999999999987    6999999999988753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5e-51  Score=358.28  Aligned_cols=269  Identities=23%  Similarity=0.370  Sum_probs=225.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||+||+++++.+++.+++|++.... ........+.+|..++..+ +||||+++++++.+...   
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~---  148 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNN---  148 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSE---
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCE---
Confidence            578999999999999999999999999999999987532 1223345688999999999 99999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...   ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus       149 --~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          149 --LYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             --EEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence              8999999975 999998652   35699999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhh----CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ........ ......||+.|+|||++.    +...++.++||||||+++|+|++|..||...+..+....+.......  
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--  300 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--  300 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc--
Confidence            76654332 233457899999999997    23348999999999999999999999999988888777776432110  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCC--CCCHHHHhcCCCccccccccC
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSK--RISAKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~~~~~~  304 (304)
                                           .++.....+|+++.+||++||..+|++  ||+++|+++||||+.++++.+
T Consensus       301 ---------------------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          301 ---------------------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             ---------------------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             ---------------------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence                                 011112358999999999999988888  999999999999999988753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.9e-51  Score=346.11  Aligned_cols=261  Identities=28%  Similarity=0.464  Sum_probs=212.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||.||++.+..+++.+++|++...... .....+.+|+.+++.+ +||||+++++++.....   
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~---   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKML-NHENVVKFYGHRREGNI---   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCe---
Confidence            358899999999999999999999999999999998754332 2345788999999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++..    ...+++.+++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus        80 --~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a  152 (323)
T 3tki_A           80 --QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLA  152 (323)
T ss_dssp             --EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             --EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeecc
Confidence              8999999986 88777643    35699999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .......  .......|++.|+|||++.+....+.++||||||+++|+|++|..||..................      
T Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------  226 (323)
T 3tki_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------  226 (323)
T ss_dssp             EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT------
T ss_pred             ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc------
Confidence            7654322  22334577999999999988775688999999999999999999999876553222222211100      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         .......+++.+.+||.+||+.||.+|||+.|+++||||.+.
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          227 -------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             -------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                               001112578999999999999999999999999999999865

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-50  Score=343.22  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=222.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC----CCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|.+........    ....+.+|+.+++.+ +||||+++++++....
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRT   88 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence            46789999999999999999999999999999999886543322    234678999999999 9999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC---eEE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLK  153 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~---~vk  153 (304)
                      .     .+++|||+.+ +|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.   .++
T Consensus        89 ~-----~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           89 D-----VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             E-----EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             E-----EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEE
Confidence            6     8999999975 99998865    356899999999999999999999999999999999999986653   799


Q ss_pred             EeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |+|||++....... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+.......
T Consensus       160 l~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  237 (321)
T 2a2a_A          160 LIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF  237 (321)
T ss_dssp             ECCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             EccCccceecCccc-cccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence            99999998765442 334456799999999987765 7999999999999999999999999888777666554321111


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                              .......+++.+.+||.+||+.||.+|||+.|+++||||..++.
T Consensus       238 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          238 ------------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             ------------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             ------------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence                                    11122368899999999999999999999999999999998754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-50  Score=346.82  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=213.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.++.++..+++|++....      ....+|++++.++.+||||+++++++.+...   
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~---   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGKY---   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSE---
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCE---
Confidence            4578999999999999999999999999999999987542      2345788899888789999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC---CeEEEeec
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~---~~vkl~df  157 (304)
                        .++||||+.| +|.+.+..    ...+++.++..++.||+.||.|||++|++|+||||+||++..++   ..+||+||
T Consensus        91 --~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           91 --VYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             --EEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             --EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence              8999999986 99988865    34699999999999999999999999999999999999985443   25999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC---chHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD---SELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~  234 (304)
                      |++..............+++.|+|||++.+.. ++.++||||||+++|+|++|..||...   ...+....+........
T Consensus       165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  243 (342)
T 2qr7_A          165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS  243 (342)
T ss_dssp             TTCEECBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred             CCcccCcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence            99987765555555667899999999998755 788999999999999999999999763   33333443333211111


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                              ......+++++.+||++||..||.+|||+.++++||||.+.
T Consensus       244 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          244 ------------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             ------------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                                    11123689999999999999999999999999999999653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.2e-51  Score=342.78  Aligned_cols=265  Identities=22%  Similarity=0.388  Sum_probs=203.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||.||++.+..+++.+++|.+............+.++...++.+ +||||+++++++.....   
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~---   80 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGD---   80 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSS---
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCC---
Confidence            46899999999999999999999999999999999875433222222333344446666 99999999999987776   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||++|+|.+++.........+++..++.++.|++.||.+||++ |++|+||||+||+++.++ .++|+|||.+
T Consensus        81 --~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T 3fme_A           81 --VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGIS  157 (290)
T ss_dssp             --EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred             --EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence              899999999999999887767778899999999999999999999998 999999999999999777 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhh---CCCCCCCchhHHHHHHHHHHHhhccccCCCCc-hHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  236 (304)
                      ....... ......+++.|+|||++.   ....++.++||||||+++|+|++|..||.... ..............    
T Consensus       158 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----  232 (290)
T 3fme_A          158 GYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP----  232 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC----
T ss_pred             ccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC----
Confidence            7665432 223346789999999973   34447899999999999999999999998643 33333333321110    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                            ......+++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus       233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          233 ----------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             ----------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                                  001125789999999999999999999999999999998653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-50  Score=348.47  Aligned_cols=291  Identities=31%  Similarity=0.539  Sum_probs=226.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCC---------chhHHHHHHHHHccCCCCeeeeece
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP---------PTTLREVSILRMLSRDPHVVRLMDV   72 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~h~~i~~~~~~   72 (304)
                      +.++|++++.||+|+||.||++.+.. +..+++|.+..........         ..+.+|+.+++.+ +||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDI   97 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeee
Confidence            45789999999999999999999865 8899999987654443321         5678899999999 99999999999


Q ss_pred             ecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeE
Q 021982           73 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~v  152 (304)
                      +...........++||||+.|+|.+.+..   ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~  173 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DI  173 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CE
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CE
Confidence            87655544555899999999999888874   334789999999999999999999999999999999999999777 89


Q ss_pred             EEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCC
Q 021982          153 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      +|+|||.+...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.
T Consensus       174 kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999999754433 23344567899999999987556899999999999999999999999999988888888877766


Q ss_pred             CCCCCCcccccc----CCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          233 PNEKVWPGVSSL----MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       233 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      +....+......    ..................+..++.+.+||.+||+.||.+|||+.|+++||||+.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            543221111000    0001111122233444566889999999999999999999999999999999987

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-50  Score=352.72  Aligned_cols=290  Identities=20%  Similarity=0.252  Sum_probs=215.6

Q ss_pred             hhhhhhhhhcccc--cceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEG--TYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g--~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++++.||+|  +||.||++.++.++..|++|++............+.+|+.+++.+ +||||+++++++.....  
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~--  100 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNE--  100 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE--
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCE--
Confidence            4689999999999  999999999999999999999987654444456777899999999 99999999999988776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++||||+.+ +|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.
T Consensus       101 ---~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~  174 (389)
T 3gni_B          101 ---LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRS  174 (389)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGG
T ss_pred             ---EEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEccccc
Confidence               8999999985 999998763  235699999999999999999999999999999999999999777 999999998


Q ss_pred             eeecccCC-------CccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhC
Q 021982          160 ARAFTLPI-------KKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  231 (304)
Q Consensus       160 ~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  231 (304)
                      +.......       .......+++.|+|||++.+. ..++.++|||||||++|+|++|..||...+.............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            86543221       112223668889999999874 3489999999999999999999999987665544443332111


Q ss_pred             CCC--------CCCCccccccCC----------cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          232 TPN--------EKVWPGVSSLMN----------WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       232 ~~~--------~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ...        ............          ..................+++++.+||.+||+.||.+|||+.|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            100        000000000000          00000000111122345788999999999999999999999999999


Q ss_pred             CCcccccc
Q 021982          294 PYFDDLDK  301 (304)
Q Consensus       294 ~~~~~~~~  301 (304)
                      |||+.+.+
T Consensus       335 p~f~~~~~  342 (389)
T 3gni_B          335 SFFKQIKR  342 (389)
T ss_dssp             GGGGGC--
T ss_pred             HHHHHHhh
Confidence            99998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-51  Score=355.45  Aligned_cols=288  Identities=32%  Similarity=0.563  Sum_probs=216.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||.||++.+..++..+++|++............+.+|+.+++.+ +||||+++++++..... +.
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccccc
Confidence            45789999999999999999999999999999999876543333345677899999999 99999999999876542 22


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....++||||++++|.+.+..      .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus       102 ~~~~~lv~e~~~~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a  174 (371)
T 2xrw_A          102 FQDVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA  174 (371)
T ss_dssp             CCEEEEEEECCSEEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC-
T ss_pred             ccceEEEEEcCCCCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeecc
Confidence            334899999999998888752      589999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....+.+....+..
T Consensus       175 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          175 RTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccccc-cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            765443 2234457799999999998765 89999999999999999999999999998888888877666554332221


Q ss_pred             ccccCC-c-ccCCCCCCCcccccC-----C-------CCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMN-W-HEYPQWNPQSLATAV-----P-------NLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~-~-~~~~~~~~~~~~~~~-----~-------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ...... + ..........+....     +       ..++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            110000 0 000000000110000     1       125678999999999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.4e-50  Score=360.24  Aligned_cols=261  Identities=32%  Similarity=0.532  Sum_probs=218.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.++.++..+++|++............+.+|+.+++.+ +||||+++++++.....   
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~---  110 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRN---  110 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE---
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCE---
Confidence            45789999999999999999999999999999999987655555567888999999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg  158 (304)
                        .++||||+.| +|.+.+...    .++++..++.++.||+.||.|||++|++|+||||+||+++..+  ..+||+|||
T Consensus       111 --~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          111 --YYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             --EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             --EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence              8999999986 998888663    4589999999999999999999999999999999999997543  369999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++...... .......|++.|+|||++.+  .++.++||||||+++|+|++|..||...+..+....+........... 
T Consensus       185 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  260 (494)
T 3lij_A          185 LSAVFENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-  260 (494)
T ss_dssp             TCEECBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG-
T ss_pred             CCeECCCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh-
Confidence            99876544 33445678999999998864  379999999999999999999999999888887777766432222211 


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                             ...+|+.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       261 -----------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          261 -----------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -----------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -----------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                   23688999999999999999999999999999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=353.94  Aligned_cols=268  Identities=26%  Similarity=0.391  Sum_probs=222.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.|++|++.... ........+.+|..++..+ +||||+++++++.+...   
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~---  135 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENY---  135 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSE---
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCE---
Confidence            578999999999999999999999999999999987532 1122345678899999999 99999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...   +..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus       136 --~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla  209 (412)
T 2vd5_A          136 --LYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSC  209 (412)
T ss_dssp             --EEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhh
Confidence              8999999964 999998763   23689999999999999999999999999999999999999877 9999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhhC------CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLG------STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      ........ ......||+.|+|||++..      ...++.++|+||||+++|+|++|..||...+..+....+.......
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~  289 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL  289 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence            87654332 2234578999999999973      2347999999999999999999999999988887777766421110


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCC---CCHHHHhcCCCccccccccC
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKR---ISAKKAMEHPYFDDLDKTRL  304 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~eil~~~~~~~~~~~~~  304 (304)
                                             ........+|+++.+||++||+ +|.+|   |+++|+++||||+.++++.|
T Consensus       290 -----------------------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          290 -----------------------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             -----------------------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             -----------------------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                                   0111123689999999999999 99998   59999999999999988764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.4e-50  Score=345.84  Aligned_cols=291  Identities=36%  Similarity=0.661  Sum_probs=230.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.+..+++.+++|.+.... .......+.+|+.+++.+ +||||+++++++........
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence            5678999999999999999999999999999999985322 111234566899999999 99999999998876543333


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...+++||++.++|.+.+..     ..+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||++.
T Consensus        87 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~  160 (353)
T 2b9h_A           87 NEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLAR  160 (353)
T ss_dssp             CCEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             ceEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEeccccc
Confidence            44899999999999998876     4689999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCc----------cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhC
Q 021982          162 AFTLPIKK----------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLG  231 (304)
Q Consensus       162 ~~~~~~~~----------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  231 (304)
                      ........          .....|++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            76532211          22346689999999988766689999999999999999999999999988888888877776


Q ss_pred             CCCCCCCcc-cccc--CC-cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          232 TPNEKVWPG-VSSL--MN-WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       232 ~~~~~~~~~-~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .+....... ....  .. ...........+....+.+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            654321110 0000  00 001111222233444568999999999999999999999999999999998864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.9e-51  Score=344.79  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=189.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |.++|.+.+.||+|+||+||+++++  |+.||||++......   ......|+..+.++ +||||+++++++...+. ..
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~-~~   73 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER---SWFREAEIYQTVML-RHENILGFIAADNKDNG-TW   73 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH---HHHHHHHHHTSTTC-CCTTBCCEEEEEEEECS-SS
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh---hHHHHHHHHHHhcC-CCCCCCcEEEEEEecCC-Cc
Confidence            4578999999999999999999874  789999998643211   11222345555677 99999999999886543 22


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc--------CccccCCCCCCeEEeCCCCeE
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------GILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------~i~h~dl~~~Nil~~~~~~~v  152 (304)
                      ..+++||||+.+ +|.+++..     .+++++.+..++.|++.||.|||++        +|+||||||+|||++.++ .+
T Consensus        74 ~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~  147 (303)
T 3hmm_A           74 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TC  147 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CE
T ss_pred             eEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CE
Confidence            347999999985 99999975     4689999999999999999999987        999999999999999777 99


Q ss_pred             EEeeccceeecccCCCc----cccccccccCCChhhhhCCC-----CCCCchhHHHHHHHHHHHhhccccCCCCch----
Q 021982          153 KIADLGLARAFTLPIKK----YTHEILTLWYRAPEVLLGST-----HYSTAVDMWSVACIFAELVTKTALFPGDSE----  219 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~-----~~~~~~Di~slG~il~~ll~g~~p~~~~~~----  219 (304)
                      ||+|||++.........    .....||+.|+|||++.+..     .++.++|||||||++|||+||..||.....    
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            99999999876544322    22346899999999997642     256789999999999999999887643221    


Q ss_pred             ----------HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccc--cCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          220 ----------LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT--AVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       220 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                                .+........  ...+                    ..++.  .....+..+.+|+.+||+.||.+|||+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~--~~~r--------------------p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  285 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCE--QKLR--------------------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  285 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTT--SCCC--------------------CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCH
T ss_pred             chhcccccchHHHHHHHHhc--ccCC--------------------CCCCccccchHHHHHHHHHHHHHcccCHhHCcCH
Confidence                      1111111100  0000                    00000  011233568899999999999999999


Q ss_pred             HHHhcC
Q 021982          288 KKAMEH  293 (304)
Q Consensus       288 ~eil~~  293 (304)
                      .||++.
T Consensus       286 ~ei~~~  291 (303)
T 3hmm_A          286 LRIKKT  291 (303)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.5e-50  Score=333.75  Aligned_cols=258  Identities=27%  Similarity=0.419  Sum_probs=219.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|.+......  ....+.+|+.+++.+ +||||+++++++.....   
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~---   80 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTD---   80 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE---
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCe---
Confidence            567899999999999999999999999999999998764432  246788999999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE---eCCCCeEEEeec
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~---~~~~~~vkl~df  157 (304)
                        .++||||+.+ +|.+.+...    ..+++..++.++.|++.||.+||++|++|+||+|+||++   +.++ .++|+||
T Consensus        81 --~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Df  153 (277)
T 3f3z_A           81 --IYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDF  153 (277)
T ss_dssp             --EEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCC
T ss_pred             --EEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEec
Confidence              8999999986 998888663    458999999999999999999999999999999999999   5445 8999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |.+...... .......+++.|+|||.+.+.  ++.++||||||+++|+|++|..||...+..+....+.......... 
T Consensus       154 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  229 (277)
T 3f3z_A          154 GLAARFKPG-KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK-  229 (277)
T ss_dssp             TTCEECCTT-SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-
T ss_pred             ccceeccCc-cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-
Confidence            999876544 333455679999999988654  7999999999999999999999999988877777665532221111 


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                             ....+++.+.++|.+||+.||.+|||+.++++||||++.
T Consensus       230 -----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          230 -----------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             -----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             -----------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence                                   112578999999999999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=341.65  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=205.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||+||++.+..+++.|++|++...............|+..+..+.+||||+++++++.....    
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~----  131 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI----  131 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE----
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE----
Confidence            4789999999999999999999999999999998765433322233444566666665599999999999987766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++|||+++++|.+.+...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++..
T Consensus       132 -~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 -LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             -EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             -EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence             8999999999999988764   34699999999999999999999999999999999999999777 999999999877


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..... ......|++.|+|||++.+  .++.++||||||+++|+|++|..|+.........   ...   .         
T Consensus       207 ~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~~---~---------  268 (311)
T 3p1a_A          207 LGTAG-AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL---RQG---Y---------  268 (311)
T ss_dssp             CC-------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH---TTT---C---------
T ss_pred             cccCC-CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---hcc---C---------
Confidence            65432 2334467999999998876  3799999999999999999997776554332211   110   0         


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                    ........+++++.++|.+||+.||.+|||+.|+++||||++
T Consensus       269 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 --------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             --------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                          001122368899999999999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-50  Score=354.63  Aligned_cols=284  Identities=28%  Similarity=0.481  Sum_probs=224.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc-----CCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-----RDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~   76 (304)
                      +.++|++++.||+|+||.||++.+..++..|++|++....   .....+.+|+.+++.+.     +|+||+.+++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            4568999999999999999999999999999999986432   12245667888887772     567999999999877


Q ss_pred             ccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC-eEEEe
Q 021982           77 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM-TLKIA  155 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~-~vkl~  155 (304)
                      ..     .+++||+++++|.+++....  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++. .+||+
T Consensus       172 ~~-----~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          172 NH-----ICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             TE-----EEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             Ce-----EEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence            66     89999999999999998732  345899999999999999999999999999999999999997762 39999


Q ss_pred             eccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          156 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      |||++......   .....+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...++.+..
T Consensus       245 DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          245 DFGSSCYEHQR---VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ  320 (429)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecccceecCCc---ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            99999765432   33456799999999998776 799999999999999999999999999999999988888877665


Q ss_pred             CCCccccccCCcccCCCC------------------------------CCCcc-cccCCCCChhhHHHHHHhhcCCCCCC
Q 021982          236 KVWPGVSSLMNWHEYPQW------------------------------NPQSL-ATAVPNLDKDGLDLLEQMLQYDPSKR  284 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~R  284 (304)
                      ..+........+......                              ....+ .......++.+.+||++||+.||.+|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R  400 (429)
T 3kvw_A          321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR  400 (429)
T ss_dssp             HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence            432221111000000000                              00000 11122457889999999999999999


Q ss_pred             CCHHHHhcCCCcccc
Q 021982          285 ISAKKAMEHPYFDDL  299 (304)
Q Consensus       285 ps~~eil~~~~~~~~  299 (304)
                      ||+.|+|+||||++.
T Consensus       401 pta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          401 MTPGQALRHPWLRRR  415 (429)
T ss_dssp             CCHHHHHTSTTTC--
T ss_pred             CCHHHHhCChhhccC
Confidence            999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-50  Score=347.44  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=201.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.++.+++.|++|++.....   ....+.+|+.+++.+ +||||+++++++.....    
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~----   90 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSL-RHPNIVRFKEVILTPTH----   90 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE----
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCE----
Confidence            4789999999999999999999999999999999875432   235788999999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC-CeEEEeeccce
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-MTLKIADLGLA  160 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~-~~vkl~dfg~~  160 (304)
                       .++||||+.| +|.+++...    ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ ..+||+|||++
T Consensus        91 -~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           91 -LAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             -EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             -EEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence             8999999975 999988663    3599999999999999999999999999999999999998665 24999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......|++.|+|||++.+....+.++||||||+++|+|++|..||...............+.....     
T Consensus       166 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-----  239 (361)
T 3uc3_A          166 KSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-----  239 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-----
T ss_pred             cccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-----
Confidence            743332 22344568999999999988774455699999999999999999999876543322222222111100     


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                       .......+++++.+||.+||+.||.+|||+.|+++||||.+
T Consensus       240 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          240 -----------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             -----------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             -----------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence                             00011257899999999999999999999999999999954

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.4e-50  Score=338.48  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=216.5

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .|...+.||+|+||.||++.+..+|+.|++|++....  ......+.+|+.+++.+ +||||+++++++.....     .
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-----~  117 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEE-----L  117 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE-----E
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCE-----E
Confidence            3667789999999999999999899999999987543  23345678999999999 99999999999987766     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++||||+.| +|.+++..     ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++...
T Consensus       118 ~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~  191 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQI  191 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeec
Confidence            999999986 88887753     4689999999999999999999999999999999999999777 8999999999877


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      ...........|++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+........         
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  261 (321)
T 2c30_A          192 SKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL---------  261 (321)
T ss_dssp             CSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC---------
T ss_pred             ccCccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc---------
Confidence            65544555667899999999987765 79999999999999999999999988877666655543211110         


Q ss_pred             cCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                      .....+++.+.++|.+||+.||.+|||+.|+++||||....
T Consensus       262 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          262 ----------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             ----------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ----------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                            01124788999999999999999999999999999998653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.4e-50  Score=360.66  Aligned_cols=263  Identities=29%  Similarity=0.509  Sum_probs=221.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||+||++.++.++..|++|++............+.+|+.+++.+ +||||+++++++.....   
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~---   95 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS---   95 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCE---
Confidence            46789999999999999999999999999999999876544444456788999999999 99999999999988766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~dfg  158 (304)
                        .++||||+.| +|.+.+...    ..+++..++.++.||+.||.|||++|++|+||||+||+++..  +..+||+|||
T Consensus        96 --~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           96 --FYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             --EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             --EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence              8999999986 998888663    458999999999999999999999999999999999999643  2379999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++...... .......|++.|+|||++.+.  ++.++||||||+++|+|++|..||...+..+....+..........  
T Consensus       170 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  244 (486)
T 3mwu_A          170 LSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP--  244 (486)
T ss_dssp             CTTTBCCC-----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG--
T ss_pred             cCeECCCC-CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--
Confidence            99765443 233455789999999998763  7999999999999999999999999988887777766532222111  


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                            ....+|+++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       245 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          245 ----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             ----------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             ----------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                                  12258899999999999999999999999999999987643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.6e-50  Score=361.06  Aligned_cols=265  Identities=26%  Similarity=0.370  Sum_probs=222.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.|++|++..... .......+..|+.+++.+ +||||+++++++.....   
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~---  259 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTD---  259 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCE---
Confidence            4679999999999999999999999999999999875431 222345677899999999 99999999999988766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++.........+++..++.++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++
T Consensus       260 --l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla  336 (543)
T 3c4z_A          260 --LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLA  336 (543)
T ss_dssp             --EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeeccee
Confidence              8999999986 99999877554456799999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc----hHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS----ELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~  236 (304)
                      ..............||+.|+|||++.+.. ++.++|+|||||++|+|++|..||....    .......+.....     
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~-----  410 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV-----  410 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-----
T ss_pred             eeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-----
Confidence            87765544444558899999999998765 8999999999999999999999998653    2333333332110     


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCcccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~~  303 (304)
                                             .....+++++.+||.+||+.||.+||+     +++|++||||+.+++.+
T Consensus       411 -----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~  459 (543)
T 3c4z_A          411 -----------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ  459 (543)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred             -----------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence                                   112368899999999999999999996     58999999999987653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.2e-50  Score=335.01  Aligned_cols=260  Identities=24%  Similarity=0.356  Sum_probs=213.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+..++..+++|.+............+.+|+..+..+.+||||+++++++.....    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~----   85 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH----   85 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE----
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe----
Confidence            4789999999999999999999999999999999886655444456777899999988789999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC-------------
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-------------  148 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~-------------  148 (304)
                       .++||||+.| +|.+++.........+++.+++.++.||+.||.|||++|++|+||||+||+++.+             
T Consensus        86 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           86 -MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             -EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             -EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence             8999999976 9999998866655779999999999999999999999999999999999999843             


Q ss_pred             -----CCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHH
Q 021982          149 -----TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL  223 (304)
Q Consensus       149 -----~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~  223 (304)
                           ...++|+|||.+.......    ...+++.|+|||++.+...++.++||||||+++|+|++|..|+........ 
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-  239 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE-  239 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH-
T ss_pred             cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH-
Confidence                 2379999999998765432    234789999999998775577899999999999999999887765543222 


Q ss_pred             HHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          224 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                        +...                           ........+++++.++|.+||+.||.+|||+.|+++||||.+..+
T Consensus       240 --~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  288 (289)
T 1x8b_A          240 --IRQG---------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR  288 (289)
T ss_dssp             --HHTT---------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred             --HHcC---------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence              2111                           111222368899999999999999999999999999999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.6e-50  Score=370.77  Aligned_cols=262  Identities=24%  Similarity=0.395  Sum_probs=226.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||+++++.+++.||+|++.... ...........|..++..+.+||+|+.+++++.+...   
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~---  416 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR---  416 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE---
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE---
Confidence            467999999999999999999999999999999987542 1233456777899999888789999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus       417 --~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla  489 (674)
T 3pfq_A          417 --LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMC  489 (674)
T ss_dssp             --EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTC
T ss_pred             --EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeeccee
Confidence              8999999986 999988764    4599999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.....         
T Consensus       490 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  559 (674)
T 3pfq_A          490 KENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------  559 (674)
T ss_dssp             EECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------
T ss_pred             eccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            86544444555668899999999997766 89999999999999999999999999888877777654211         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH-----HHHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA-----KKAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~eil~~~~~~~~~~~~  303 (304)
                                         .....+++++.+||++||+.||.+||++     +||++||||+.+++++
T Consensus       560 -------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          560 -------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             -------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                               1123689999999999999999999998     9999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-50  Score=348.40  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=218.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.++.++..+++|.+......  ....+.+|+.+++.+ +||||+++++++.+...   
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~---  122 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQL-HHPKLINLHDAFEDKYE---  122 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSE---
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCE---
Confidence            457899999999999999999999999999999998753211  124677899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC-CCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~-~~~vkl~dfg~  159 (304)
                        .++||||+.| +|.+++..   ....+++.+++.++.||+.||.|||++|++|+||||+||+++.+ +..+||+|||+
T Consensus       123 --~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          123 --MVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             --EEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             --EEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence              8999999986 88887753   23468999999999999999999999999999999999999743 24799999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +....... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+........     
T Consensus       198 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-----  270 (387)
T 1kob_A          198 ATKLNPDE-IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-----  270 (387)
T ss_dssp             CEECCTTS-CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred             ceecCCCc-ceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            98765432 233456799999999988765 79999999999999999999999998887777666654321111     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         ......+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       271 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          271 -------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             -------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                               11223688999999999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.7e-50  Score=334.62  Aligned_cols=266  Identities=25%  Similarity=0.420  Sum_probs=219.5

Q ss_pred             CchhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC----CCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            1 MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         1 ~i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ++.++|++.+.||+|+||.||++.+..++..+++|.+........    ....+.+|+.+++.+ +||||+++++++...
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENK   80 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCC
Confidence            467899999999999999999999999999999999886543322    245678899999999 899999999999876


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC---CeE
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT---MTL  152 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~---~~v  152 (304)
                      ..     .+++||++.+ +|.+++...    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++   ..+
T Consensus        81 ~~-----~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~  151 (283)
T 3bhy_A           81 TD-----VVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI  151 (283)
T ss_dssp             SE-----EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCE
T ss_pred             Ce-----EEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCce
Confidence            65     8999999975 999998763    4689999999999999999999999999999999999998654   279


Q ss_pred             EEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCC
Q 021982          153 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      +|+|||.+....... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+......
T Consensus       152 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  229 (283)
T 3bhy_A          152 KLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD  229 (283)
T ss_dssp             EECCCTTCEECC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             EEEecccceeccCCC-cccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence            999999998765432 233446789999999987765 799999999999999999999999988777666555432111


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      .                        .......+++.+.++|.+||+.||.+|||+.++++||||+.+.+.
T Consensus       230 ~------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          230 F------------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             C------------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             C------------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            0                        111223678999999999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-50  Score=347.87  Aligned_cols=271  Identities=24%  Similarity=0.402  Sum_probs=217.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC---CCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE---DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      +.++|++++.||+|+||.||++.++.++..+++|++....   ........+.+|+.+++.+ +||||+++++++.+...
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCe
Confidence            4578999999999999999999999999999999987542   2333456788899999999 89999999999987765


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccC------------------------------------CCCCChHHHHHHHHHH
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQT------------------------------------GENIPVNTVKSLMYQL  121 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------------------------------~~~~~~~~~~~~~~~i  121 (304)
                           .++||||+.| +|.+++......                                    ...+++..++.++.|+
T Consensus       103 -----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A          103 -----ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             -----EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             -----EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence                 8999999975 998887532111                                    1224677889999999


Q ss_pred             HHHHHHHHhcCccccCCCCCCeEEeCCC-CeEEEeeccceeecccCCC----ccccccccccCCChhhhhCC-CCCCCch
Q 021982          122 CKGVAFCHGHGILHRDLKPHNLLMDRKT-MTLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGS-THYSTAV  195 (304)
Q Consensus       122 ~~~l~~Lh~~~i~h~dl~~~Nil~~~~~-~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~~  195 (304)
                      +.||.|||+.|++|+||||+||+++.++ ..+||+|||.+........    ......+++.|+|||++.+. ..++.++
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999999999999999999998554 3799999999986543221    23445679999999999753 4488999


Q ss_pred             hHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHH
Q 021982          196 DMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQ  275 (304)
Q Consensus       196 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  275 (304)
                      ||||||+++|+|++|..||...+..+....+..........                        ....+++++.+||.+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~  313 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP------------------------NYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG------------------------GGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc------------------------ccccCCHHHHHHHHH
Confidence            99999999999999999999988887777666532221111                        112478999999999


Q ss_pred             hhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          276 MLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       276 ~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      ||+.||.+|||+.++++||||++...+
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-50  Score=341.56  Aligned_cols=259  Identities=24%  Similarity=0.418  Sum_probs=192.3

Q ss_pred             hhhhhhh---hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKL---EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~---~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.   +.||+|+||.||++.++.+++.+++|++...     ......+|+.+++.+.+||||+++++++.+... 
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~-   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH-   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE-
Confidence            3566665   7899999999999999999999999998643     234677899999999569999999999987766 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEee
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIAD  156 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~d  156 (304)
                          .++||||+.| +|.+++..    ..++++.+++.++.|++.||.|||++|++|+||||+||+++.++  ..++|+|
T Consensus        81 ----~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  152 (325)
T 3kn6_A           81 ----TFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIID  152 (325)
T ss_dssp             ----EEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECC
T ss_pred             ----EEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEec
Confidence                8999999986 99998876    25699999999999999999999999999999999999997544  3799999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH-------HHHHHHHHH
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL-------QQLLHIFRL  229 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-------~~~~~~~~~  229 (304)
                      ||++..............+++.|+|||++.+.. ++.++||||||+++|+|++|..||......       +....+...
T Consensus       153 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             CTTCEECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cccceecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            999987666555556667799999999987766 899999999999999999999999865432       222222111


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ....                        .......+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       232 ~~~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          232 DFSF------------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             CCCC------------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             CCCC------------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            0000                        0011125889999999999999999999999999999998753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=348.81  Aligned_cols=288  Identities=35%  Similarity=0.602  Sum_probs=226.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC-C
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE-G   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-~   80 (304)
                      +.++|.+.+.||+|+||.||++.++.+|..|++|.+............+.+|+.+++.+ +||||+++++++...... .
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccc
Confidence            45789999999999999999999999999999999875443333345677899999999 899999999998765431 1


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....+++||++.++|.+.+.      ..+++..++.++.||+.||.+||++|++|+||||+||+++.++ .+||+|||.+
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~  173 (353)
T 3coi_A          101 FYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA  173 (353)
T ss_dssp             CCCCEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCT
T ss_pred             ceeEEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccc
Confidence            12258999999998776652      3589999999999999999999999999999999999999777 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+++.|+|||++.+...++.++||||||+++|+|++|..||...+..+....+....+.+....+..
T Consensus       174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            754432   23446689999999998755689999999999999999999999999888888888877766654432222


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......   ...........+....+.+++++.+||.+||+.||.+|||+.|+++||||....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            111000   001111222334445567899999999999999999999999999999998764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.4e-49  Score=338.89  Aligned_cols=284  Identities=28%  Similarity=0.577  Sum_probs=214.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+..++..+++|++...     ....+.+|+.+++.+..||||+++++++.....   .
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---R  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---C
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---C
Confidence            46899999999999999999999999999999998632     246788999999999559999999999886322   1


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..+++|||+.+ +|.+++.       .+++.+++.++.|++.||.|||++|++|+||||+||+++.++..++|+|||++.
T Consensus       107 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             ceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            27899999986 8877764       389999999999999999999999999999999999999777689999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC-chHHHHHHHHHHhCCCCC-----
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD-SELQQLLHIFRLLGTPNE-----  235 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~-----  235 (304)
                      ...... ......+++.|+|||.+.+...++.++||||||+++|+|++|..||... ...+....+....+....     
T Consensus       180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             EcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            765442 3344567899999999987566899999999999999999999998543 344444443333321100     


Q ss_pred             ----CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          236 ----KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       236 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                          ..-+.............+...........+++++.+||.+||+.||.+|||++|+|+||||+++.++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence                0000000000000000000000111123478999999999999999999999999999999998765

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=341.70  Aligned_cols=260  Identities=28%  Similarity=0.402  Sum_probs=200.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.+..+++.|++|++....    ....+.+|+.+++.+ +||||+++++++.....   
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~---  122 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTE---  122 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCe---
Confidence            4577999999999999999999999999999999987543    234567899999999 99999999999987665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC--CCCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~--~~~~vkl~dfg  158 (304)
                        .++||||+.+ +|.+++..    ...+++.+++.++.|++.||.|||+.|++|+||||+||+++.  ++..+||+|||
T Consensus       123 --~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          123 --ISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             --EEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             --EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence              8999999985 99888754    356899999999999999999999999999999999999975  23489999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH-HHHHHHHHhCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKV  237 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  237 (304)
                      ++...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||....... ....+.......    
T Consensus       197 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~----  270 (349)
T 2w4o_A          197 LSKIVEHQ-VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF----  270 (349)
T ss_dssp             -----------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC----
T ss_pred             cccccCcc-cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc----
Confidence            99765443 2233456799999999998765 7999999999999999999999998766554 333333211110    


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                          .......++.++.+||.+||+.||.+|||+.|+++||||.....
T Consensus       271 --------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          271 --------------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             --------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             --------------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence                                11122368899999999999999999999999999999987643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.8e-50  Score=344.15  Aligned_cols=282  Identities=24%  Similarity=0.370  Sum_probs=220.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc----CCCCeeeeeceecccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS----RDPHVVRLMDVKQGQN   77 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~   77 (304)
                      +.++|++++.||+|+||.||++.+..+++.|++|++....   ........|+.+++.+.    +||||+++++++....
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            5688999999999999999999999999999999986321   12245567899999984    3999999999998876


Q ss_pred             cCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC----------
Q 021982           78 KEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR----------  147 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~----------  147 (304)
                      .     .++|||+++++|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||+++.          
T Consensus       110 ~-----~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          110 H-----MCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             E-----EEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             e-----eEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            6     8999999988999999873  2346899999999999999999999999999999999999974          


Q ss_pred             --------------CCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc
Q 021982          148 --------------KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL  213 (304)
Q Consensus       148 --------------~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p  213 (304)
                                    .+..+||+|||++......   .....|++.|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCC
Confidence                          2348999999999765432   23456799999999998776 89999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCCCCCccccccCC--c-------ccCCCCCC---------CcccccCCCCChhhHHHHHH
Q 021982          214 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN--W-------HEYPQWNP---------QSLATAVPNLDKDGLDLLEQ  275 (304)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~  275 (304)
                      |...+..+....+.......+...+........  +       ...+....         ..........++.+.+||.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            999988888888777666554322111100000  0       00000000         00011112345778899999


Q ss_pred             hhcCCCCCCCCHHHHhcCCCcc
Q 021982          276 MLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       276 ~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      ||+.||.+|||+.|+|+||||+
T Consensus       339 ~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999995

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-50  Score=356.34  Aligned_cols=257  Identities=30%  Similarity=0.478  Sum_probs=220.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ..++|.+++.||+|+||.||++.+..+|..|++|++..... .......+.+|+.+++.+ +||||+++++++.....  
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~--   90 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSD--   90 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE--
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE--
Confidence            45789999999999999999999999999999999875421 223345788999999999 99999999999987766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++||||+.| +|.+++..    ...+++.+++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||+
T Consensus        91 ---~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~  162 (476)
T 2y94_A           91 ---IFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGL  162 (476)
T ss_dssp             ---EEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             ---EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccc
Confidence               8999999975 99888753    35699999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... .......|++.|+|||++.+....+.++||||||+++|+|++|..||...+.......+......       
T Consensus       163 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  234 (476)
T 2y94_A          163 SNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY-------  234 (476)
T ss_dssp             CEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC-------
T ss_pred             hhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC-------
Confidence            9876543 23445578999999999988765678999999999999999999999988877766666542111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                           ....+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       235 ---------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 ---------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ---------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                                 11257899999999999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.2e-50  Score=351.28  Aligned_cols=290  Identities=37%  Similarity=0.688  Sum_probs=214.4

Q ss_pred             chhhhhh-hhhcccccceEEEEEEEc--cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEK-LEKVGEGTYGKVYRAREK--ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~-~~~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      +.+.|++ .+.||+|+||.||++.++  .++..|++|.+....    ....+.+|+.+++.+ +||||+++++++.....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLREL-KHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCC
Confidence            3456776 457999999999999976  467889999986432    235678999999999 89999999999854221


Q ss_pred             CCceEEEEEEeccCCCHHHHHHHhccC-----CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE----eCCC
Q 021982           79 EGRTVLYLVFEYMDTDLKKYIRSFRQT-----GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM----DRKT  149 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~----~~~~  149 (304)
                         ...++||||+.++|.+.+......     ...+++..++.++.||+.||.|||++||+|+||||+||++    +.++
T Consensus        93 ---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           93 ---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             ---TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             ---CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence               128999999999999888654321     2358999999999999999999999999999999999999    4344


Q ss_pred             CeEEEeeccceeecccCC---CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch-------
Q 021982          150 MTLKIADLGLARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE-------  219 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-------  219 (304)
                       .+||+|||++.......   .......|++.|+|||++.+...++.++|||||||++|+|++|..||.....       
T Consensus       170 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          170 -RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             -CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             -cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence             89999999998765432   2234456799999999998766689999999999999999999999976543       


Q ss_pred             --HHHHHHHHHHhCCCCCCCCccccccCCcccCC----C--CCC----CcccccCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          220 --LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP----Q--WNP----QSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       220 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                        .+....+...++.+....|.............    .  ...    ..........++.+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              47788888889988888877665443321100    0  000    00111223457889999999999999999999


Q ss_pred             HHHhcCCCccccc
Q 021982          288 KKAMEHPYFDDLD  300 (304)
Q Consensus       288 ~eil~~~~~~~~~  300 (304)
                      +|+|+||||.+.+
T Consensus       329 ~e~L~hp~f~~~~  341 (405)
T 3rgf_A          329 EQAMQDPYFLEDP  341 (405)
T ss_dssp             HHHHTSGGGTSSS
T ss_pred             HHHhcChhhccCC
Confidence            9999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4e-50  Score=359.14  Aligned_cols=263  Identities=31%  Similarity=0.500  Sum_probs=222.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|++...... ......+.+|+.+++.+ +||||+++++++.....  
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~--  100 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGY--  100 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE--
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE--
Confidence            567899999999999999999999999999999998765432 33456788999999999 99999999999988766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC--CCCeEEEeec
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADL  157 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~--~~~~vkl~df  157 (304)
                         .++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.  .+..+||+||
T Consensus       101 ---~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A          101 ---FYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             ---EEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             ---EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence               8999999985 89888865    356999999999999999999999999999999999999952  2348999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |++...... .......|++.|+|||++.+ . ++.++||||||+++|+|++|..||...+..+....+.......... 
T Consensus       174 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  249 (484)
T 3nyv_A          174 GLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-T-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP-  249 (484)
T ss_dssp             THHHHBCCC-CSHHHHTTGGGTCCHHHHHT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-
T ss_pred             eeeEEcccc-cccccCCCCccccCceeecC-C-CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-
Confidence            999765543 23344568999999999876 3 7999999999999999999999999988888777766532222111 


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                             ....+|+++.+||.+||+.||.+|||+.|+|+||||+...+
T Consensus       250 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          250 -----------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             -----------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             -----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                                   11258899999999999999999999999999999987643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-49  Score=357.67  Aligned_cols=262  Identities=27%  Similarity=0.478  Sum_probs=218.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-----------CCCchhHHHHHHHHHccCCCCeeeee
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-----------GVPPTTLREVSILRMLSRDPHVVRLM   70 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~h~~i~~~~   70 (304)
                      +.++|++++.||+|+||.||++.++.++..+++|++.......           .....+.+|+.+++.+ +||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~  112 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLF  112 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            5688999999999999999999999999999999987654221           2345678899999999 999999999


Q ss_pred             ceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC
Q 021982           71 DVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT  149 (304)
Q Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~  149 (304)
                      +++.+...     .++||||+.| +|.+.+...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++
T Consensus       113 ~~~~~~~~-----~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          113 DVFEDKKY-----FYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EEEECSSE-----EEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT
T ss_pred             EEEEcCCE-----EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC
Confidence            99987766     8999999986 998888763    4599999999999999999999999999999999999998665


Q ss_pred             --CeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHH
Q 021982          150 --MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF  227 (304)
Q Consensus       150 --~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  227 (304)
                        ..+||+|||++...... .......|++.|+|||++.+  .++.++||||||+++|+|++|..||...+..+....+.
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  260 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE  260 (504)
T ss_dssp             CCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence              36999999999876554 23445578999999998864  37999999999999999999999999988887777766


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ........                        .....+|+++.+||++||+.||.+|||++|+|+||||++..
T Consensus       261 ~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          261 KGKYYFDF------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HCCCCCCH------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             cCCCCCCc------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            53211111                        11236899999999999999999999999999999998653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=342.72  Aligned_cols=292  Identities=31%  Similarity=0.584  Sum_probs=221.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---   78 (304)
                      +.++|++++.||+|++|.||++.+..+++.+++|.+....  ......+.+|+.+++.+ +||||+++++++.....   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccc
Confidence            5688999999999999999999999999999999886432  22345677899999999 99999999998754321   


Q ss_pred             ------CCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeE
Q 021982           79 ------EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        79 ------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~v  152 (304)
                            ......+++|||++|+|.+++..     .++++..++.++.|++.||++||++|++|+||||+||+++.++..+
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             C----CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence                  12234899999999999988753     5689999999999999999999999999999999999998665699


Q ss_pred             EEeeccceeecccCC---CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHH
Q 021982          153 KIADLGLARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       153 kl~dfg~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  229 (304)
                      ||+|||.+.......   .......+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999997654321   22234456889999999987556899999999999999999999999998888777777665


Q ss_pred             hCCCCCCCCccccccCCc--ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          230 LGTPNEKVWPGVSSLMNW--HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ........+.+.......  ...............+.++.++.+||.+||+.||.+|||+.|+++||||+..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            544332211111100000  000001112233344578999999999999999999999999999999998653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-50  Score=362.96  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=217.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.++.+++.|++|++..... .......+.+|+++++.+ +||||+++++++.+...   
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~---  258 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDA---  258 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCE---
Confidence            4679999999999999999999999999999999875421 222345677899999999 99999999999988766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...  ....+++..++.++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++
T Consensus       259 --l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla  333 (576)
T 2acx_A          259 --LCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLA  333 (576)
T ss_dssp             --EEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccc
Confidence              8999999975 999888753  234589999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHHHHHhCCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~  237 (304)
                      ....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.....   .............     
T Consensus       334 ~~~~~~~-~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-----  406 (576)
T 2acx_A          334 VHVPEGQ-TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE-----  406 (576)
T ss_dssp             EECCTTC-CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-----
T ss_pred             eecccCc-cccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-----
Confidence            8765442 233457899999999998765 79999999999999999999999987542   2222222221100     


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                            .....+|+++.+||.+||+.||.+||     +++|+++||||+++++++
T Consensus       407 ----------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~  455 (576)
T 2acx_A          407 ----------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR  455 (576)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred             ----------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence                                  01136889999999999999999999     899999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.6e-50  Score=332.34  Aligned_cols=265  Identities=28%  Similarity=0.431  Sum_probs=220.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.++.+++.+++|.+............+.+|+.+++.+ +||||+++++++.....   .
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---~   80 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTN---T   80 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGG---T
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCC---c
Confidence            5789999999999999999999999999999999986554444456778899999999 99999999998754321   1


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC-----ccccCCCCCCeEEeCCCCeEEEee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-----ILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-----i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      ..+++|||+.+ +|.+++.........+++..++.++.|++.||.+||+.|     ++|+||+|+||+++.++ .++|+|
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~d  159 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  159 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEec
Confidence            28999999986 999999887666677999999999999999999999999     99999999999999777 899999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ||.+..............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+......    
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----  234 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----  234 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----
T ss_pred             CchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc----
Confidence            999876654433333456789999999998766 799999999999999999999999988776665555442111    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                             .....+++++.++|.+||+.||.+|||+.|+++|+|+.+-.
T Consensus       235 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          235 -----------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             -----------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                                   11235789999999999999999999999999999998743

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=338.90  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=212.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC------CCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG------VPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      .++|++++.||+|+||.||++.++.++..|++|++........      ....+.+|+.+++.+ +||||+++++++...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeC
Confidence            4789999999999999999999999999999999886543222      456788899999999 999999999999877


Q ss_pred             ccCCceEEEEEEeccC-C-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEE
Q 021982           77 NKEGRTVLYLVFEYMD-T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI  154 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl  154 (304)
                      ..     .++|||++. | +|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||
T Consensus       102 ~~-----~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL  171 (335)
T 3dls_A          102 GF-----FQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKL  171 (335)
T ss_dssp             SE-----EEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEE
T ss_pred             CE-----EEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEE
Confidence            66     899999885 5 88888865    34699999999999999999999999999999999999999777 9999


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCC
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      +|||++....... ......|++.|+|||++.+....+.++||||||+++|+|++|..||......         .    
T Consensus       172 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~----  237 (335)
T 3dls_A          172 IDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------V----  237 (335)
T ss_dssp             CCCTTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------T----
T ss_pred             eecccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------H----
Confidence            9999998765542 3344567999999999988775588999999999999999999999753220         0    


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                           .........+++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       238 ---------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          238 ---------------------EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ---------------------TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ---------------------hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                                 00011122578999999999999999999999999999999763

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.6e-50  Score=333.08  Aligned_cols=257  Identities=28%  Similarity=0.479  Sum_probs=215.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ..++|++++.||+|++|.||++.+..++..+++|++.... ........+.+|+.+++.+ +||||+++++++.+...  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~--   83 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATR--   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE--
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCE--
Confidence            4689999999999999999999999999999999986532 1122345677899999999 89999999999987766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .+++|||+.+ +|.+.+...    ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus        84 ---~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~  155 (279)
T 3fdn_A           84 ---VYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGW  155 (279)
T ss_dssp             ---EEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCE
T ss_pred             ---EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccc
Confidence               8999999986 999988764    4589999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +......  ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+......       
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  225 (279)
T 3fdn_A          156 SVHAPSS--RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-------  225 (279)
T ss_dssp             ESCC----------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred             cccCCcc--cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC-------
Confidence            8654432  223456799999999987765 789999999999999999999999988877766665542111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                           ....+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       226 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          226 ---------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             ---------------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                                 1125789999999999999999999999999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.8e-49  Score=329.96  Aligned_cols=267  Identities=27%  Similarity=0.403  Sum_probs=219.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-------CCchhHHHHHHHHHccCCCCeeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-------VPPTTLREVSILRMLSRDPHVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   74 (304)
                      +.++|++.+.||+|++|.||++.++.+++.+++|++........       ....+.+|+.+++++.+||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            46789999999999999999999999999999999875532211       12356689999999955999999999998


Q ss_pred             ccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEE
Q 021982           75 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLK  153 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vk  153 (304)
                      ....     .++||||+.+ +|.+++...    ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++
T Consensus        95 ~~~~-----~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~k  164 (298)
T 1phk_A           95 TNTF-----FFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIK  164 (298)
T ss_dssp             CSSE-----EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEE
T ss_pred             cCCe-----EEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEE
Confidence            7665     8999999985 999998763    4689999999999999999999999999999999999999777 899


Q ss_pred             EeeccceeecccCCCccccccccccCCChhhhh-----CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHH
Q 021982          154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLL-----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  228 (304)
                      |+|||.+....... ......+++.|+|||++.     ....++.++||||||+++|+|++|..||...+.......+..
T Consensus       165 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          165 LTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             ECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EecccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            99999998765432 334456799999999986     233478999999999999999999999988877776666554


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                      ........                        ....++..+.++|.+||+.||.+|||+.|+++||||++...+.
T Consensus       244 ~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          244 GNYQFGSP------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             TCCCCCTT------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             CCcccCcc------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            32111111                        1125789999999999999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-49  Score=339.72  Aligned_cols=257  Identities=23%  Similarity=0.387  Sum_probs=215.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.+..++..|++|++...... ......+.+|+.+++.+ +||||+++++++.....    
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~----  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHT----  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE----
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCe----
Confidence            5689999999999999999999999999999998754322 12234677899999999 99999999999987765    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++||||+.|++.+.+...   ..++++.+++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus       129 -~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 -AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             -EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             -EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence             8999999999998888653   24789999999999999999999999999999999999999777 999999999976


Q ss_pred             cccCCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....    ....|++.|+|||++.+  ...++.++||||||+++|+|++|..||...+.......+.....+.       
T Consensus       204 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------  272 (348)
T 1u5q_A          204 MAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------  272 (348)
T ss_dssp             SSSB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred             cCCC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            5432    23467999999999863  3447899999999999999999999998887766665554421110       


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                         .....+++.+.+||.+||+.||.+|||++++++||||....
T Consensus       273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                               01125788999999999999999999999999999997643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3e-49  Score=332.78  Aligned_cols=264  Identities=24%  Similarity=0.414  Sum_probs=213.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||.||++.+..++..+++|.+....  ......+.+|+.+++.+ +||||+++++++.....   
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGK---   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-C---
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCe---
Confidence            3578999999999999999999999999999999886543  23356788899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus        91 --~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  164 (302)
T 2j7t_A           91 --LWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVS  164 (302)
T ss_dssp             --EEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHH
T ss_pred             --EEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCC
Confidence              8999999986 888887653   24689999999999999999999999999999999999999777 8999999987


Q ss_pred             eecccCCCccccccccccCCChhhhh----CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLL----GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ..............+++.|+|||.+.    ....++.++||||||+++|+|++|..||...+.......+.......   
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  241 (302)
T 2j7t_A          165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT---  241 (302)
T ss_dssp             HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---
T ss_pred             ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc---
Confidence            54333222233446789999999984    33447899999999999999999999999888776665554421110   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                            ......++..+.++|.+||+.||.+|||+.++++||||+.+...
T Consensus       242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence                                  00112578899999999999999999999999999999987643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-50  Score=333.76  Aligned_cols=260  Identities=29%  Similarity=0.490  Sum_probs=192.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.+..++..+++|.+..... .......+.+|+.+++.+ +||||+++++++.+...   
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   85 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNY---   85 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSE---
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCe---
Confidence            5789999999999999999999998999999999875431 222346788899999999 99999999999987665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++..   ...++++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus        86 --~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~  159 (278)
T 3cok_A           86 --VYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLA  159 (278)
T ss_dssp             --EEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred             --EEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence              8999999976 99888875   235689999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+..            
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            87665444444556799999999987765 78999999999999999999999976543222211100            


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                      ........++.++.++|.+||+.||.+|||+.++++||||.+...
T Consensus       227 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          227 ----------------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             ----------------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             ----------------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence                            000122357899999999999999999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.8e-49  Score=331.84  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=215.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.+..+++.+++|.+......  ....+.+|+.+++.+ +||||+++++++.....   
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   80 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKI-KHENIVTLEDIYESTTH---   80 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHC-CCTTBCCEEEEEECSSE---
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhC-CCCCeeehhhhcccCCE---
Confidence            568899999999999999999999999999999998754322  235678999999999 99999999999887765   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE---eCCCCeEEEeec
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~---~~~~~~vkl~df  157 (304)
                        .+++|||+.+ +|.+++...    ..+++..++.++.|++.||.+||+.|++|+||+|+||++   +.++ .++|+||
T Consensus        81 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Df  153 (304)
T 2jam_A           81 --YYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDF  153 (304)
T ss_dssp             --EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSC
T ss_pred             --EEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccC
Confidence              8999999975 999988663    468999999999999999999999999999999999999   4444 8999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |.+......  ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.........  
T Consensus       154 g~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--  228 (304)
T 2jam_A          154 GLSKMEQNG--IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES--  228 (304)
T ss_dssp             STTCCCCCB--TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT--
T ss_pred             CcceecCCC--ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence            998654332  233446799999999987765 799999999999999999999999988877766666543221111  


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                            .....+++++.++|.+||+.||.+|||+.|+++||||...
T Consensus       229 ----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          229 ----------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                                  1123688999999999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.3e-49  Score=339.00  Aligned_cols=261  Identities=28%  Similarity=0.479  Sum_probs=216.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC------CCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG------VPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      .++|++.+.||+|++|.||++.++.+|..|+||++........      ....+.+|+.+++.+.+||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            3679999999999999999999998999999999875432211      1235678999999987799999999998876


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      ..     .++||||+.| +|.+++...    ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+
T Consensus       173 ~~-----~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          173 SF-----MFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             SE-----EEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             CE-----EEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEE
Confidence            65     8999999986 999988753    4689999999999999999999999999999999999999777 99999


Q ss_pred             eccceeecccCCCccccccccccCCChhhhhCC-----CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHh
Q 021982          156 DLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-----THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  230 (304)
Q Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  230 (304)
                      |||++...... .......|++.|+|||++.+.     ..++.++||||||+++|+|++|..||...........+....
T Consensus       243 DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  321 (365)
T 2y7j_A          243 DFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ  321 (365)
T ss_dssp             CCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            99999876544 233456789999999998632     237889999999999999999999998887766666554422


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      .....                        .....++..+.++|.+||+.||.+|||+.++++||||+.
T Consensus       322 ~~~~~------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          322 YQFSS------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCCH------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCC------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            11111                        111257889999999999999999999999999999974

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.2e-50  Score=341.16  Aligned_cols=263  Identities=25%  Similarity=0.407  Sum_probs=205.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc----
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK----   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~----   78 (304)
                      .++|++++.||+|+||.||+++++.++..|++|++.... .......+.+|+.+++.+ +||||+++++++.....    
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhh
Confidence            578999999999999999999999999999999987544 223346788999999999 99999999998865432    


Q ss_pred             ------------------------------------------------CCceEEEEEEeccCC-CHHHHHHHhccCCCCC
Q 021982           79 ------------------------------------------------EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENI  109 (304)
Q Consensus        79 ------------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~  109 (304)
                                                                      ......+++|||+.| +|.+++..... ....
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~  161 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDR  161 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGS
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccch
Confidence                                                            112247999999986 99999876332 2345


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCC------------Cccccccccc
Q 021982          110 PVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI------------KKYTHEILTL  177 (304)
Q Consensus       110 ~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~------------~~~~~~~~~~  177 (304)
                      ++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.......            .......|++
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            6667899999999999999999999999999999999777 99999999998765542            2223446799


Q ss_pred             cCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCc
Q 021982          178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQS  257 (304)
Q Consensus       178 ~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (304)
                      .|+|||++.+.. ++.++||||||+++|+|++|..|+....  ........   .                        .
T Consensus       241 ~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~---~------------------------~  290 (332)
T 3qd2_B          241 LYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRN---L------------------------K  290 (332)
T ss_dssp             GGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHT---T------------------------C
T ss_pred             CccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhc---c------------------------C
Confidence            999999998776 7999999999999999999866542211  11111111   0                        0


Q ss_pred             ccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          258 LATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ........++.+.+||.+||+.||.+|||+.|+++||||+++
T Consensus       291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            111112456788999999999999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.6e-49  Score=329.96  Aligned_cols=264  Identities=28%  Similarity=0.509  Sum_probs=221.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|++|.||++.+..+++.+++|++............+.+|+++++++ +||||+++++++.....   
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~---   95 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS---   95 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE---
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCe---
Confidence            45789999999999999999999998999999999986655555567788999999999 99999999999887665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg  158 (304)
                        .++++|++.+ +|.+.+...    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++  ..++|+|||
T Consensus        96 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           96 --FYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             --EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             --EEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence              8999999975 898888653    3589999999999999999999999999999999999997543  379999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .+....... ......+++.|+|||.+.+.  ++.++||||||+++|+|++|..||...+..+....+........    
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  242 (287)
T 2wei_A          170 LSTCFQQNT-KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----  242 (287)
T ss_dssp             GGGTBCCCS-SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----
T ss_pred             cceeecCCC-ccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence            987654432 23344578999999988653  78999999999999999999999998887766665544211110    


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                          ......+++++.++|.+||+.||.+|||+.|+++||||++.+.+
T Consensus       243 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          243 --------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             --------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             --------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence                                01123688999999999999999999999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.4e-49  Score=334.51  Aligned_cols=264  Identities=23%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             hhhhhhh-hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKL-EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++. +.||+|+||.||++.+..++..|++|++....  ......+.+|+.+++++.+||||+++++++.....   
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~---   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR---   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE---
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE---
Confidence            4678885 78999999999999999999999999987543  23346788999999996589999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg  158 (304)
                        .++||||+.| +|.+++...    ..+++..++.++.|++.||.|||++|++|+||||+||+++.++  ..+||+|||
T Consensus        86 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           86 --FYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             --EEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence              8999999984 999998763    4689999999999999999999999999999999999998665  239999999


Q ss_pred             ceeecccCC-------CccccccccccCCChhhhhCC----CCCCCchhHHHHHHHHHHHhhccccCCCCch--------
Q 021982          159 LARAFTLPI-------KKYTHEILTLWYRAPEVLLGS----THYSTAVDMWSVACIFAELVTKTALFPGDSE--------  219 (304)
Q Consensus       159 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~--------  219 (304)
                      ++.......       .......|++.|+|||++.+.    ..++.++||||||+++|+|++|..||.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            987553221       112234579999999998741    2368899999999999999999999976532        


Q ss_pred             -------HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          220 -------LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       220 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                             ......+.......                        .......+++.+.+||.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~i~~~~~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKYEF------------------------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhHHHHHHHHHhccCccc------------------------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   11222222110000                        00111357899999999999999999999999999


Q ss_pred             CCCcccccc
Q 021982          293 HPYFDDLDK  301 (304)
Q Consensus       293 ~~~~~~~~~  301 (304)
                      ||||.....
T Consensus       296 hp~~~~~~~  304 (316)
T 2ac3_A          296 HPWVQGCAP  304 (316)
T ss_dssp             STTCC----
T ss_pred             ChhhcCCCC
Confidence            999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-49  Score=329.51  Aligned_cols=259  Identities=30%  Similarity=0.495  Sum_probs=219.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ..++|++.+.||+|++|.||++.+..++..+++|++..... .......+.+|+.+++.+ +||||+++++++.....  
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~--   88 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKR--   88 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE--
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCE--
Confidence            36889999999999999999999999999999999875421 222345778899999999 99999999999987665  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .+++|||+.+ +|.+++...    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        89 ---~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~  160 (284)
T 2vgo_A           89 ---IYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGW  160 (284)
T ss_dssp             ---EEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTT
T ss_pred             ---EEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccc
Confidence               8999999986 999998764    3589999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +......  ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.....        
T Consensus       161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------  229 (284)
T 2vgo_A          161 SVHAPSL--RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--------  229 (284)
T ss_dssp             CEECSSS--CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------
T ss_pred             cccCccc--ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc--------
Confidence            8765432  223456799999999988765 79999999999999999999999998877666555543110        


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                          ...+.++..+.++|.+||+.||.+|||+.++++||||+....+
T Consensus       230 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~  272 (284)
T 2vgo_A          230 --------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR  272 (284)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred             --------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence                                1113578999999999999999999999999999999876543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.9e-49  Score=330.24  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=218.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.+..++..+++|.+...... ......+.+|+.+++.+ +||||+++++++.....   
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~---   89 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDF---   89 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE---
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCE---
Confidence            56899999999999999999999999999999998754322 22335677899999999 99999999999987665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++...    ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus        90 --~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  162 (294)
T 2rku_A           90 --VFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  162 (294)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             --EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCc
Confidence              8999999985 888887653    4689999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+.....         
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  232 (294)
T 2rku_A          163 TKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------  232 (294)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------
T ss_pred             eecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---------
Confidence            87765544455567799999999987765 79999999999999999999999998877665554433110         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         .....+++.+.++|.+||+.||.+|||++|+++||||...
T Consensus       233 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          233 -------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence                               1112578899999999999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=329.96  Aligned_cols=259  Identities=26%  Similarity=0.448  Sum_probs=214.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+..++..+++|.+....    ....+.+|+.+++.+ +||||+++++++.....    
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   98 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTD----   98 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE----
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE----
Confidence            467999999999999999999999999999999987532    346788999999999 99999999999987665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        99 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~  173 (314)
T 3com_A           99 -LWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAG  173 (314)
T ss_dssp             -EEEEEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             -EEEEeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccch
Confidence             8999999987 999988642   35689999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.......        
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  244 (314)
T 3com_A          174 QLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT--------  244 (314)
T ss_dssp             ECBTTBSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             hhhhhccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc--------
Confidence            7765544455567799999999987765 7999999999999999999999998877665544433221100        


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                       ......++..+.++|.+||+.||.+|||+.++++||||.....
T Consensus       245 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          245 -----------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             -----------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             -----------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence                             0011246889999999999999999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-49  Score=334.03  Aligned_cols=268  Identities=24%  Similarity=0.417  Sum_probs=212.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC-
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG-   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~-   80 (304)
                      ..++|++++.||+|+||.||++.+..+++.+++|++.....   ....+.+|+.+++.+.+||||+++++++......+ 
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            35789999999999999999999999999999999875432   34678899999999978999999999987643211 


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ....++||||+.+ +|.+++....  ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcC
Confidence            2348999999986 9999998743  35689999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      +..............+++.|+|||++..    ...++.++||||||+++|+|++|..||...........+.......  
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  253 (326)
T 2x7f_A          176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR--  253 (326)
T ss_dssp             TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--
T ss_pred             ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc--
Confidence            8766544334445567999999999863    2347899999999999999999999998877665554443321100  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                              .....++..+.+||.+||..||.+|||+.++++||||.+...
T Consensus       254 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          254 ------------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             ------------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ------------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence                                    012357899999999999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.8e-49  Score=335.24  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=219.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.+..++..+++|.+...... ......+.+|+.+++.+ +||||+++++++.+...   
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~---  115 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDF---  115 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE---
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCe---
Confidence            46899999999999999999999999999999998754322 22335677899999999 99999999999987765   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++...    ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus       116 --~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~  188 (335)
T 2owb_A          116 --VFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  188 (335)
T ss_dssp             --EEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             --EEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCc
Confidence              8999999985 898887653    4689999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ..............+++.|+|||++.+.. ++.++||||||+++|+|++|..||......+....+......        
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------  259 (335)
T 2owb_A          189 TKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------  259 (335)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------
T ss_pred             eecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC--------
Confidence            87765544455567899999999998766 799999999999999999999999988776665555432110        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                          ....+++.+.+||.+||+.||.+|||+.|+++||||...
T Consensus       260 --------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          260 --------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             --------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence                                112578899999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=343.18  Aligned_cols=255  Identities=29%  Similarity=0.425  Sum_probs=208.7

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      .+.||+|+||.||++.+..++..+++|++.....  .....+.+|+.+++.+ +||||+++++++.....     .++||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~-----~~lv~  165 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQL-DHANLIQLYDAFESKND-----IVLVM  165 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE-----EEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE-----EEEEE
Confidence            5679999999999999999999999999875432  1235678899999999 99999999999987766     89999


Q ss_pred             eccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC-CCCeEEEeeccceeecccC
Q 021982           89 EYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-KTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~-~~~~vkl~dfg~~~~~~~~  166 (304)
                      ||+.+ +|.+++...   ...+++..++.++.||+.||.|||+.|++|+||||+||++.. ++..+||+|||++......
T Consensus       166 E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          166 EYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             ECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            99985 888888652   235899999999999999999999999999999999999942 3348999999999876544


Q ss_pred             CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCC
Q 021982          167 IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMN  246 (304)
Q Consensus       167 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (304)
                      . ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.........           
T Consensus       243 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-----------  309 (373)
T 2x4f_A          243 E-KLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-----------  309 (373)
T ss_dssp             C-BCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-----------
T ss_pred             c-ccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-----------
Confidence            2 334456899999999987665 799999999999999999999999998888777776653221111           


Q ss_pred             cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          247 WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                   .....+++++.+||.+||+.||.+|||+.|+++||||++.+
T Consensus       310 -------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 -------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             -------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             -------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                         12236889999999999999999999999999999998763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-49  Score=328.51  Aligned_cols=258  Identities=29%  Similarity=0.441  Sum_probs=210.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ..++|++.+.||+|++|.||++.++.+++.+++|.+.... ........+.+|+.+++.+ +||||+++++++.....  
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~--   85 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTD--   85 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE--
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCe--
Confidence            4578999999999999999999999899999999987543 1223445778899999999 99999999999887665  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .+++||++.+ +|.+++...    ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.
T Consensus        86 ---~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~  157 (276)
T 2h6d_A           86 ---FFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGL  157 (276)
T ss_dssp             ---EEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred             ---EEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeeccc
Confidence               8999999975 999998764    3589999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +....... ......+++.|+|||.+.+....+.++||||||+++|+|++|..||...........+......       
T Consensus       158 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  229 (276)
T 2h6d_A          158 SNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY-------  229 (276)
T ss_dssp             GGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred             ccccCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-------
Confidence            87654432 2334467899999999987664578999999999999999999999887776665554432111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                           ....++..+.++|.+||+.||.+|||+.++++||||++.
T Consensus       230 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          230 ---------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ---------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                                 112578899999999999999999999999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.7e-49  Score=344.15  Aligned_cols=262  Identities=28%  Similarity=0.412  Sum_probs=201.8

Q ss_pred             chhhhhhh-hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKL-EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|.+. +.||+|+||+||++.++.++..|++|++..       .....+|+.++.++.+||||+++++++..... +
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA-G  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-T
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc-C
Confidence            35677776 689999999999999999999999999862       24677889888666699999999999875221 1


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeec
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADL  157 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~df  157 (304)
                      ...+++||||+.| +|.+++...  ....+++.+++.++.||+.||.|||+.|++|+||||+||+++.+  +..+||+||
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence            2238999999986 999998762  23469999999999999999999999999999999999999863  348999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH----HHHHHHHHhCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ----QLLHIFRLLGTP  233 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~  233 (304)
                      |++...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.......    ....+.......
T Consensus       209 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          209 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TTCEECC------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccccccCCC-CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999765433 2334557799999999987665 8999999999999999999999997654321    112222110000


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .                        ......++.++.+||++||+.||.+|||+.|+++||||...
T Consensus       287 ~------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          287 P------------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             C------------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             C------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            0                        01123688999999999999999999999999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.6e-49  Score=327.41  Aligned_cols=262  Identities=29%  Similarity=0.457  Sum_probs=213.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|++|.||++.+..++..+++|.+...... .....+.+|+.+++.+ +||||+++++++.....    
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   79 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKML-NHENVVKFYGHRREGNI----   79 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE----
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCE----
Confidence            57899999999999999999999999999999998754332 2345778899999999 99999999999887665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++..    ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        80 -~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~  153 (276)
T 2yex_A           80 -QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLAT  153 (276)
T ss_dssp             -EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             -EEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCcc
Confidence             8999999986 88777643    35689999999999999999999999999999999999999777 89999999997


Q ss_pred             ecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH-HHHHHHHhCCCCCCCC
Q 021982          162 AFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ-LLHIFRLLGTPNEKVW  238 (304)
Q Consensus       162 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (304)
                      ......  .......+++.|+|||.+.+....+.++||||||+++|+|++|..||........ ...+... ..      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------  226 (276)
T 2yex_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT------  226 (276)
T ss_dssp             ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT------
T ss_pred             ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc------
Confidence            654322  2233456789999999998766457899999999999999999999987654322 2222110 00      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                         .......+++.+.++|.+||+.||.+|||+.|+++||||++...+
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          227 -------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             -------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             -------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence                               000112578999999999999999999999999999999987544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-49  Score=337.04  Aligned_cols=258  Identities=27%  Similarity=0.411  Sum_probs=204.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC--CCeeeeeceecccccC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD--PHVVRLMDVKQGQNKE   79 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~   79 (304)
                      ..++|++++.||+|+||.||++.+. ++..|++|.+............+.+|+.+++.+ .|  |||+++++++..... 
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~~~-   83 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQY-   83 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECSSE-
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeCCE-
Confidence            3567999999999999999999985 578899999886654444446678899999999 55  999999999987766 


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                          .++|||+.+++|.+++...    ..+++.++..++.|++.||.|||+.|++|+||||+||+++ ++ .+||+|||+
T Consensus        84 ----~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~  153 (343)
T 3dbq_A           84 ----IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGI  153 (343)
T ss_dssp             ----EEEEECCCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSS
T ss_pred             ----EEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeeccc
Confidence                8999998888999999762    4689999999999999999999999999999999999998 55 899999999


Q ss_pred             eeecccCCC--ccccccccccCCChhhhhC----------CCCCCCchhHHHHHHHHHHHhhccccCCCCchH-HHHHHH
Q 021982          160 ARAFTLPIK--KYTHEILTLWYRAPEVLLG----------STHYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHI  226 (304)
Q Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~----------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~  226 (304)
                      +........  ......|++.|+|||++.+          ...++.++||||||+++|+|++|..||...... .....+
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  233 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  233 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence            976654322  2234567999999999864          234788999999999999999999999865443 222222


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      .   .....                       .......+.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       234 ~---~~~~~-----------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          234 I---DPNHE-----------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             H---CTTSC-----------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             h---cCCcc-----------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            1   11111                       1112245678999999999999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.8e-49  Score=327.80  Aligned_cols=260  Identities=24%  Similarity=0.344  Sum_probs=211.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|++.+.||+|+||.||++.+..++..+++|.+............+.+|+.+++.+ +||||+++++++..... +...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~  103 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVK-GKKC  103 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESS-SCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccC-CCce
Confidence            358889999999999999999999999999999886554444456778899999999 99999999999876432 2334


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      .++||||+.+ +|.+++...    ..+++..++.++.|++.||.|||+.|  ++|+||||+||+++.++..++|+|||++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            7999999976 999998764    45899999999999999999999999  9999999999999844449999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......  ......+++.|+|||++.+.  ++.++||||||+++|+|++|..||..................        
T Consensus       180 ~~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------  247 (290)
T 1t4h_A          180 TLKRAS--FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--------  247 (290)
T ss_dssp             GGCCTT--SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--------
T ss_pred             cccccc--ccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--------
Confidence            654432  22344679999999988643  799999999999999999999999886655444433321100        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                       ........++++.++|.+||+.||.+|||+.++++||||++
T Consensus       248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                             11112256789999999999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-48  Score=328.99  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=218.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|++++.||+|+||.||++.+..++..+++|.+..... ......+.+|+.+++.+ +||||+++++++.....    
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTK----   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE----
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCe----
Confidence            4679999999999999999999999999999999875543 23456788999999999 99999999999987665    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++..     .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        95 -~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~  167 (303)
T 3a7i_A           95 -LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAG  167 (303)
T ss_dssp             -EEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             -EEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccce
Confidence             8999999986 89888753     5789999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      .............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.....          
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  236 (303)
T 3a7i_A          168 QLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----------  236 (303)
T ss_dssp             ECBTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----------
T ss_pred             ecCccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC----------
Confidence            7765544445567799999999997765 78999999999999999999999988776665544433110          


Q ss_pred             cccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                       ......++..+.++|.+||+.||.+|||+.++++||||...
T Consensus       237 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                             11123678999999999999999999999999999999764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.1e-49  Score=341.81  Aligned_cols=286  Identities=30%  Similarity=0.510  Sum_probs=218.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCC-----eeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH-----VVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-----i~~~~~~~~~~   76 (304)
                      +.++|++.+.||+|+||.||++.+..+++.|++|++....   ........|+.+++.+..|++     ++.+.+++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            4578999999999999999999999999999999986321   123455678888888855664     89999988877


Q ss_pred             ccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH--hcCccccCCCCCCeEEeC-CCCeEE
Q 021982           77 NKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--GHGILHRDLKPHNLLMDR-KTMTLK  153 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--~~~i~h~dl~~~Nil~~~-~~~~vk  153 (304)
                      ..     .++|||+++++|.+++....  ...+++..+..++.|++.||.|||  +.||+|+||||+||+++. ++..+|
T Consensus       129 ~~-----~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          129 NH-----LCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             TE-----EEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             Cc-----eEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence            66     89999999999999998732  245899999999999999999999  579999999999999963 234899


Q ss_pred             EeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |+|||++......   .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+....+.+
T Consensus       202 L~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  277 (382)
T 2vx3_A          202 IVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP  277 (382)
T ss_dssp             ECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EEeccCceecccc---cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999876533   33456799999999998776 8999999999999999999999999999988888888887766


Q ss_pred             CCCCCcccccc-------CC--c---------ccCCCCCCCccccc-----------CCC-------CChhhHHHHHHhh
Q 021982          234 NEKVWPGVSSL-------MN--W---------HEYPQWNPQSLATA-----------VPN-------LDKDGLDLLEQML  277 (304)
Q Consensus       234 ~~~~~~~~~~~-------~~--~---------~~~~~~~~~~~~~~-----------~~~-------~~~~l~~li~~~l  277 (304)
                      ....++.....       .+  +         ..........+...           ..+       .++++.+||.+||
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  357 (382)
T 2vx3_A          278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML  357 (382)
T ss_dssp             CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred             CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence            54332211100       00  0         00000000000000           000       0136899999999


Q ss_pred             cCCCCCCCCHHHHhcCCCcccccc
Q 021982          278 QYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       278 ~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      +.||.+|||++|+|+||||++...
T Consensus       358 ~~dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          358 DYDPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             CSCTTTSCCHHHHTTSGGGCC---
T ss_pred             CCChhhCCCHHHHhcCcccccCCC
Confidence            999999999999999999998643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-49  Score=339.33  Aligned_cols=286  Identities=28%  Similarity=0.493  Sum_probs=220.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEE-ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC------Ceeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP------HVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~------~i~~~~~~~~   74 (304)
                      +.++|++++.||+|+||.||++.+ +.++..+++|++....   .....+.+|+.+++.+ +|+      +++++++++.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccc
Confidence            567899999999999999999998 5678899999986321   1234567888888888 554      4899999988


Q ss_pred             ccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC------
Q 021982           75 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK------  148 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~------  148 (304)
                      ....     .++|||+++++|.+++...  ...++++..++.++.|++.||.|||++|++|+||||+||+++.+      
T Consensus        88 ~~~~-----~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           88 HHGH-----ICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             ETTE-----EEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             cCCc-----EEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence            7766     8999999988999999773  33468999999999999999999999999999999999999863      


Q ss_pred             ------------CCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCC
Q 021982          149 ------------TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG  216 (304)
Q Consensus       149 ------------~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  216 (304)
                                  +..++|+|||.+......   .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                        237999999999765432   23446799999999998765 79999999999999999999999999


Q ss_pred             CchHHHHHHHHHHhCCCCCCCCccccccCC-------cccCC---------CCCCCcccccCCCCChhhHHHHHHhhcCC
Q 021982          217 DSELQQLLHIFRLLGTPNEKVWPGVSSLMN-------WHEYP---------QWNPQSLATAVPNLDKDGLDLLEQMLQYD  280 (304)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~d  280 (304)
                      .+..+....+....+..+...+........       +....         ..............++++.+||.+||+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            888887777777666544322111110000       00000         00000001111234577899999999999


Q ss_pred             CCCCCCHHHHhcCCCccccccc
Q 021982          281 PSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       281 p~~Rps~~eil~~~~~~~~~~~  302 (304)
                      |.+|||+.|+++||||+.++++
T Consensus       317 P~~Rpt~~ell~hp~f~~~~~~  338 (339)
T 1z57_A          317 PAKRITLREALKHPFFDLLKKS  338 (339)
T ss_dssp             TTTSCCHHHHTTSGGGGGGGC-
T ss_pred             cccccCHHHHhcCHHHHHHhcc
Confidence            9999999999999999987653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-49  Score=334.69  Aligned_cols=275  Identities=21%  Similarity=0.319  Sum_probs=195.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.+..++..+++|.+...... .....+.+|+.+++.+ +||||+++++++.....    
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   87 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDE----   87 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCC-CCTTBCCEEEEEESSSC----
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCC----
Confidence            57899999999999999999999888999999988654322 2345677899999999 99999999999988776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhcc----CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQ----TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                       .+++|||+.| +|.+++.....    ....+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+||
T Consensus        88 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~df  165 (303)
T 2vwi_A           88 -LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADF  165 (303)
T ss_dssp             -EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred             -cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEec
Confidence             8999999975 99998876432    234689999999999999999999999999999999999999777 8999999


Q ss_pred             cceeecccCC-----CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCC
Q 021982          158 GLARAFTLPI-----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       158 g~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      |.+.......     .......+++.|+|||++.+...++.++||||||+++|+|++|..||..................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9986554321     11223467899999999876444789999999999999999999999887665544333221111


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                      ....                  ..........++.++.++|.+||+.||.+|||+.++++||||.+...+.
T Consensus       246 ~~~~------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          246 SLET------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             CTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             cccc------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence            0000                  0011223346889999999999999999999999999999999886543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-49  Score=348.14  Aligned_cols=265  Identities=26%  Similarity=0.427  Sum_probs=203.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC------CCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED------DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      +.++|++.+.||+|+||.||++.++.++..+++|++.....      .......+.+|+.+++++ +||||+++++++..
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec
Confidence            35789999999999999999999999999999999875431      222334678999999999 99999999999754


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeE
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTL  152 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~v  152 (304)
                      ..      .++||||+.+ +|.+++..    ...+++.+++.++.|++.||.|||++|++|+||||+||+++.++  ..+
T Consensus       212 ~~------~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~  281 (419)
T 3i6u_A          212 ED------YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI  281 (419)
T ss_dssp             SE------EEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred             Cc------eEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceE
Confidence            33      6899999986 88776643    45799999999999999999999999999999999999997543  359


Q ss_pred             EEeeccceeecccCCCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHh
Q 021982          153 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  230 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  230 (304)
                      ||+|||++...... .......|++.|+|||++.+  ...++.++||||||+++|+|++|..||................
T Consensus       282 kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~  360 (419)
T 3i6u_A          282 KITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  360 (419)
T ss_dssp             EECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred             EEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence            99999999766543 23344577999999999864  3447889999999999999999999998654432222222210


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ..                       .........+++.+.+||.+||+.||.+|||++|+++||||++.+.
T Consensus       361 ~~-----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  408 (419)
T 3i6u_A          361 KY-----------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  408 (419)
T ss_dssp             CC-----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred             CC-----------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence            00                       0111222368899999999999999999999999999999987653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=329.38  Aligned_cols=264  Identities=27%  Similarity=0.418  Sum_probs=216.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC--CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +.++|++.+.||+|+||.||++.+..++..+++|++....  ........+.+|+++++.+ +||||+++++++..... 
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-   80 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEK-   80 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCC-
Confidence            4678999999999999999999999999999999987542  1123346788999999999 99999999999853321 


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                        ...++||||+.+++.+.+...  ....+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.
T Consensus        81 --~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~  155 (305)
T 2wtk_C           81 --QKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGV  155 (305)
T ss_dssp             ---CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTT
T ss_pred             --CeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeecccc
Confidence              127999999999888888763  345799999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccC--CCccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLP--IKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +......  ........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...+..+....+.....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-----  230 (305)
T 2wtk_C          156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-----  230 (305)
T ss_dssp             CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----
T ss_pred             ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-----
Confidence            9876432  12223446799999999987643 247799999999999999999999998877666655544211     


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                             .....+++.+.++|.+||+.||.+|||+.|+++||||.+..
T Consensus       231 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          231 -----------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             -----------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             -----------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence                                   11125789999999999999999999999999999998753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-49  Score=338.23  Aligned_cols=262  Identities=27%  Similarity=0.433  Sum_probs=211.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCC--CCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHED--DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++++.||+|+||.||++++.   .+++.+++|++.....  .......+.+|+.+++.+..||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            378999999999999999999984   4788999999875321  12234566789999999977999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      .     .++||||+.+ +|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|
T Consensus       133 ~-----~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~D  202 (355)
T 1vzo_A          133 K-----LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTD  202 (355)
T ss_dssp             E-----EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred             e-----EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEee
Confidence            6     8999999986 999998763    3589999999999999999999999999999999999999777 999999


Q ss_pred             ccceeecccCC-CccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCCCch----HHHHHHHHHHh
Q 021982          157 LGLARAFTLPI-KKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPGDSE----LQQLLHIFRLL  230 (304)
Q Consensus       157 fg~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----~~~~~~~~~~~  230 (304)
                      ||++....... .......|++.|+|||++.+. ..++.++||||||+++|+|++|..||.....    ......+... 
T Consensus       203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-  281 (355)
T 1vzo_A          203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-  281 (355)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred             CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-
Confidence            99997654322 223345679999999999863 3378999999999999999999999975432    2222222211 


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                                 .......++..+.+||.+||..||.+||     |++|+++||||.+++++
T Consensus       282 ---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          282 ---------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             ---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence                                       0111236789999999999999999999     99999999999988654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-48  Score=339.68  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=205.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccC-CCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ++|++++.||+|+||.||++.+.. +..|++|++............+.+|+.+++.+.. ||||+++++++.....    
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~----  130 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY----  130 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE----
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE----
Confidence            469999999999999999999875 8889999988655444445677899999999943 6999999999887766    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +++|||+.+++|.+++...    ..+++.+++.++.||+.||.|||++||+|+||||+||+++ ++ .+||+|||++..
T Consensus       131 -~~lv~E~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~  203 (390)
T 2zmd_A          131 -IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQ  203 (390)
T ss_dssp             -EEEEEECCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSSCC
T ss_pred             -EEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCcccc
Confidence             8999997777999998763    3689999999999999999999999999999999999996 45 899999999976


Q ss_pred             cccCCC--ccccccccccCCChhhhhCC----------CCCCCchhHHHHHHHHHHHhhccccCCCCchH-HHHHHHHHH
Q 021982          163 FTLPIK--KYTHEILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAELVTKTALFPGDSEL-QQLLHIFRL  229 (304)
Q Consensus       163 ~~~~~~--~~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~  229 (304)
                      ......  ......|++.|+|||++.+.          ..++.++||||||+++|+|++|..||...... .....+.. 
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~-  282 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-  282 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC-
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC-
Confidence            654322  22345689999999999752          24788999999999999999999999875433 22322221 


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                        .....                       ......+.++.+||.+||+.||.+|||+.|+++||||...
T Consensus       283 --~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          283 --PNHEI-----------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             --TTSCC-----------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             --ccccC-----------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence              11100                       0112357889999999999999999999999999999753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.6e-49  Score=344.55  Aligned_cols=287  Identities=29%  Similarity=0.450  Sum_probs=215.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc-------CCCCeeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-------RDPHVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-------~h~~i~~~~~~~~   74 (304)
                      +.++|++++.||+|+||.||++.+..+++.|++|++....   .....+.+|+.+++.+.       +|+||+++++++.
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            4578999999999999999999999999999999986321   12346678999999883       2788999999987


Q ss_pred             ccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCC----
Q 021982           75 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKT----  149 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~----  149 (304)
                      ..... ....++|||++++++.+.+...  ....+++..++.++.||+.||.|||++ |++|+||||+|||++.++    
T Consensus       112 ~~~~~-~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          112 ISGVN-GTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEETT-EEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             ecCCC-CceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            43221 1238999999999988888763  335699999999999999999999998 999999999999998654    


Q ss_pred             --------------------------------------------CeEEEeeccceeecccCCCccccccccccCCChhhh
Q 021982          150 --------------------------------------------MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL  185 (304)
Q Consensus       150 --------------------------------------------~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~  185 (304)
                                                                  ..++|+|||.+......   .....+++.|+|||++
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence                                                        37999999999876543   3345679999999999


Q ss_pred             hCCCCCCCchhHHHHHHHHHHHhhccccCCCCc------hHHHHHHHHHHhCCCCCCCCccccccCCc-------ccCCC
Q 021982          186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHIFRLLGTPNEKVWPGVSSLMNW-------HEYPQ  252 (304)
Q Consensus       186 ~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~  252 (304)
                      .+.. ++.++|||||||++|+|++|..||...+      .......+....+.++...+........+       .....
T Consensus       266 ~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          266 IGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             cCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            8876 8999999999999999999999997654      44555566665555433211100000000       00000


Q ss_pred             CCCCcc-------cccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          253 WNPQSL-------ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       253 ~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ......       .......+..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000000       0011233467889999999999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-48  Score=331.79  Aligned_cols=265  Identities=27%  Similarity=0.435  Sum_probs=208.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC------CCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED------DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      +.++|++.+.||+|+||.||++.+..++..|++|++.....      .......+.+|+.+++.+ +||||+++++++..
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEES
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcC
Confidence            46889999999999999999999999999999999875421      222345678999999999 99999999999865


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeE
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTL  152 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~v  152 (304)
                      ..      .++||||+.+ +|.+++..    ...+++..++.++.||+.||.+||++|++|+||||+||+++.++  ..+
T Consensus        87 ~~------~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           87 ED------YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             SS------EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCE
T ss_pred             Cc------eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeE
Confidence            43      6899999986 88887753    35789999999999999999999999999999999999998654  259


Q ss_pred             EEeeccceeecccCCCccccccccccCCChhhhh--CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHh
Q 021982          153 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL  230 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  230 (304)
                      ||+|||++...... .......+++.|+|||++.  +...++.++||||||+++|+|++|..||................
T Consensus       157 kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  235 (322)
T 2ycf_A          157 KITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG  235 (322)
T ss_dssp             EECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred             EEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence            99999999776443 2223346799999999985  23447899999999999999999999997654432222221110


Q ss_pred             CCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ..                       .........+++.+.+||.+||+.||.+|||+.++++||||.+.+.
T Consensus       236 ~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          236 KY-----------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             CC-----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             cc-----------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence            00                       0011122368899999999999999999999999999999987643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-48  Score=336.86  Aligned_cols=286  Identities=21%  Similarity=0.341  Sum_probs=214.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||.||++.+..++..+++|.+.... .......+.+|+.+++.+ +||||+++++++.....   
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~---  105 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGE---  105 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTE---
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCE---
Confidence            4678999999999999999999999999999999987542 222235677899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                        .++||||+.| +|.+++...    ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||+
T Consensus       106 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  178 (360)
T 3eqc_A          106 --ISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGV  178 (360)
T ss_dssp             --EEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCC
T ss_pred             --EEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCC
Confidence              8999999986 999998764    3589999999999999999999996 999999999999999777 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +......  ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+.................+
T Consensus       179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          179 SGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             CHHHHHH--C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             Ccccccc--cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            8655332  223346799999999998765 8999999999999999999999998876655433221111110000000


Q ss_pred             cccc---cCCcccCCCCC-------------CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          240 GVSS---LMNWHEYPQWN-------------PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~---~~~~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      ....   ...........             ..........++.++.+||.+||+.||.+|||+.|+++||||+..+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence            0000   00000000000             000011123478899999999999999999999999999999987554

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.1e-48  Score=336.55  Aligned_cols=285  Identities=26%  Similarity=0.449  Sum_probs=219.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCC-cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCC------eeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATG-KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH------VVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~------i~~~~~~~~   74 (304)
                      +.++|++++.||+|+||.||++.+..++ ..|++|++....   .....+..|+.+++.+ .|++      ++.+.+++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeee
Confidence            5688999999999999999999998776 689999986321   1234567788898888 5554      888888887


Q ss_pred             ccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE---------
Q 021982           75 GQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---------  145 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~---------  145 (304)
                      ....     .+++||++++++.+.+...  ...++++.+++.++.||+.||.|||++|++|+||||+||++         
T Consensus        93 ~~~~-----~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           93 FHGH-----MCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             ETTE-----EEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eCCe-----EEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence            7665     8999999999998888763  33568999999999999999999999999999999999999         


Q ss_pred             ----------eCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCC
Q 021982          146 ----------DRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFP  215 (304)
Q Consensus       146 ----------~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  215 (304)
                                +.++ .+||+|||++......   .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||.
T Consensus       166 ~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          166 NEHKSCEEKSVKNT-SIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CCC-CCCEEEESCC-CEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccCCC-cEEEeecCcccccccc---ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCC
Confidence                      4344 8999999999765433   23446799999999998766 7999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCCCCCccccccCCcc----cCC------------CCCCCcccccCCCCChhhHHHHHHhhcC
Q 021982          216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWH----EYP------------QWNPQSLATAVPNLDKDGLDLLEQMLQY  279 (304)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~  279 (304)
                      ..+..+....+....+..+...+..........    ...            ..............+..+.+||.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            988888877777776655432211110000000    000            0000000011112345788999999999


Q ss_pred             CCCCCCCHHHHhcCCCccccccc
Q 021982          280 DPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       280 dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      ||.+|||+.|+++||||.+++.+
T Consensus       321 dP~~Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          321 DPAQRITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             STTTSCCHHHHTTSGGGGGCCHH
T ss_pred             ChhhCcCHHHHhcChhhcCCChh
Confidence            99999999999999999988643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=322.14  Aligned_cols=264  Identities=21%  Similarity=0.315  Sum_probs=207.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|.....||+|+||.||++.+..++..+++|.+....  ......+.+|+.+++.+ +||||+++++++.....     .
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----~   94 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGF-----I   94 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTE-----E
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCc-----E
Confidence            4555568999999999999999999999999987543  33456788999999999 99999999999987665     8


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      +++||++.+ +|.+++.... ....+++..++.++.|++.||.+||+.|++|+||+|+||+++..+..++|+|||.+...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999975 9999887632 23456789999999999999999999999999999999999974449999999999876


Q ss_pred             ccCCCccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...........+++.|+|||++.+.. .++.++||||||+++|+|++|..||..................          
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------  243 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV----------  243 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC----------
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc----------
Confidence            55433344556799999999987542 3688999999999999999999999765443322211111111          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                     .......+++++.++|.+||+.||.+|||+.++++||||+...++
T Consensus       244 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          244 ---------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             ---------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence                           011123688999999999999999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.6e-48  Score=324.38  Aligned_cols=253  Identities=28%  Similarity=0.345  Sum_probs=201.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.+  ++..+++|++............+.+|+.+++++ +||||+++++++.....    
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~----  108 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPN----  108 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTC----
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCc----
Confidence            57899999999999999999987  478899999876544433345678899999999 89999999999987776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                       .++||||+.+ +|.+++..... ...+++..++.++.|++.||+|||++|  ++|+||||+||+++.++ .+||+|||+
T Consensus       109 -~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~  185 (309)
T 3p86_A          109 -LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGL  185 (309)
T ss_dssp             -CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-
T ss_pred             -eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCC
Confidence             8999999986 99998875211 124899999999999999999999999  99999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +..............|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+......       
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------  257 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------  257 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred             CccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Confidence            976555444445567899999999998776 799999999999999999999999988877666554322111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         ......+++.+.++|.+||+.||.+|||+.++++
T Consensus       258 -------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          258 -------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                               1122368899999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.7e-50  Score=346.10  Aligned_cols=262  Identities=16%  Similarity=0.248  Sum_probs=199.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHcc--CCCCeeeee-------ce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLS--RDPHVVRLM-------DV   72 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~--~h~~i~~~~-------~~   72 (304)
                      .++|++.+.||+|+||.||++.+..++..|++|++..... .......+.+|+.+++.+.  +||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            3679999999999999999999988999999999986532 2333456778985444443  799999998       44


Q ss_pred             eccccc---------CCc---eEEEEEEeccCCCHHHHHHHhccCC---CCCChHHHHHHHHHHHHHHHHHHhcCccccC
Q 021982           73 KQGQNK---------EGR---TVLYLVFEYMDTDLKKYIRSFRQTG---ENIPVNTVKSLMYQLCKGVAFCHGHGILHRD  137 (304)
Q Consensus        73 ~~~~~~---------~~~---~~~~lv~e~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~d  137 (304)
                      +...+.         ++.   ...+++|||++|+|.+++.......   ..+++..++.++.||+.||+|||++|++|+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            433321         111   1268999999999999998753311   1234588889999999999999999999999


Q ss_pred             CCCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCC----------CCCCCchhHHHHHHHHHHH
Q 021982          138 LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAEL  207 (304)
Q Consensus       138 l~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~il~~l  207 (304)
                      |||+||+++.++ .+||+|||++...+.   ......| +.|+|||++.+.          ..++.++||||||+++|+|
T Consensus       232 ikp~NIll~~~~-~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          232 LRPVDIVLDQRG-GVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCC-CEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            999999999777 999999999976433   2334456 899999999876          2389999999999999999


Q ss_pred             hhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          208 VTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       208 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                      ++|..||...........                                .......+++++.+||.+||+.||.+|||+
T Consensus       307 ltg~~Pf~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          307 WCADLPITKDAALGGSEW--------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHSSCCC------CCSGG--------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHCCCCCcccccccchhh--------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            999999965442211110                                111124689999999999999999999999


Q ss_pred             HHHhcCCCcccccc
Q 021982          288 KKAMEHPYFDDLDK  301 (304)
Q Consensus       288 ~eil~~~~~~~~~~  301 (304)
                      .|+++||||+.+..
T Consensus       355 ~e~l~hp~f~~~~~  368 (377)
T 3byv_A          355 LQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHTSHHHHHHHH
T ss_pred             HHHhhChHHHHHHH
Confidence            99999999998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=329.49  Aligned_cols=281  Identities=20%  Similarity=0.287  Sum_probs=210.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.+..+++.|++|++...... .....+.+|+.+++.+ +||||+++++++.....   
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~---   81 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT---   81 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT---
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhc-CCCCcceEEEEeecCCC---
Confidence            457899999999999999999999999999999998754322 2245677899999999 89999999999876542   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE----eCCCCeEEEee
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM----DRKTMTLKIAD  156 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~----~~~~~~vkl~d  156 (304)
                      ...++||||+.+ +|.+++..... ...+++.+++.++.|++.||.|||++|++|+||||+||++    +.++ .+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEcc
Confidence            127999999975 99999876433 2348999999999999999999999999999999999998    5444 799999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhC-------CCCCCCchhHHHHHHHHHHHhhccccCCCCc----hHHHHHH
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLG-------STHYSTAVDMWSVACIFAELVTKTALFPGDS----ELQQLLH  225 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~----~~~~~~~  225 (304)
                      ||++....... ......+++.|+|||++..       ...++.++||||||+++|+|++|..||....    ..+....
T Consensus       160 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  238 (319)
T 4euu_A          160 FGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (319)
T ss_dssp             CTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred             CCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence            99998765543 3334567999999999862       3448999999999999999999999997433    2333333


Q ss_pred             HHHHhCCCCCCCCccccccCCc-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          226 IFRLLGTPNEKVWPGVSSLMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                      +...   .+...+......... ..+....+ ........++..+.++|++||+.||.+|||++|+++||
T Consensus       239 ~~~~---~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          239 IITG---KPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHH---CCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HhcC---CCcccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            3332   222222211111110 00000000 00111224556788999999999999999999999987

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.2e-49  Score=333.21  Aligned_cols=266  Identities=24%  Similarity=0.372  Sum_probs=212.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|++.+.||+|+||.||++.+..+++.|++|++....... .....+.+|+.+++.+ +||||+++++++......+
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCC
Confidence            5688999999999999999999999999999999987543221 2234567899999999 9999999999987765422


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                       ...++||||+.| +|.+++...    .++++.+++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||+
T Consensus        89 -~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  162 (311)
T 3ork_A           89 -PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGI  162 (311)
T ss_dssp             -EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSC
T ss_pred             -cccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccC
Confidence             235899999975 999998763    4689999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +........   ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||......+...........+   
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---  238 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---  238 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC---
Confidence            976544322   222345799999999998776 7999999999999999999999999888776655554421111   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                           .......+++++.++|.+||+.||.+||++.+++.|+|+...
T Consensus       239 ---------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          239 ---------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             ---------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                                 111233689999999999999999999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-48  Score=337.66  Aligned_cols=271  Identities=17%  Similarity=0.147  Sum_probs=194.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHcc-CCCCeeeeecee-------cc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLS-RDPHVVRLMDVK-------QG   75 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~-------~~   75 (304)
                      .|++.+.||+|+||.||++.+..++..|++|++..... .......+.+|+.+++.+. +||||++++..+       ..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            48999999999999999999999999999999986543 1122345567766666663 599988865333       22


Q ss_pred             ccc------------CCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHH------HHHHHHHHHHHHHHHhcCccccC
Q 021982           76 QNK------------EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTV------KSLMYQLCKGVAFCHGHGILHRD  137 (304)
Q Consensus        76 ~~~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~------~~~~~~i~~~l~~Lh~~~i~h~d  137 (304)
                      ...            ......++||||++|+|.+++.....   .+.+..+      ..++.||+.||+|||++|++|+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            111            00134799999999999999987533   3455555      67889999999999999999999


Q ss_pred             CCCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCC-CCCCCchhHHHHHHHHHHHhhccccCCC
Q 021982          138 LKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-THYSTAVDMWSVACIFAELVTKTALFPG  216 (304)
Q Consensus       138 l~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~  216 (304)
                      |||+|||++.++ .+||+|||++...+...   ....+++.|+|||++.+. ..++.++||||||+++|+|++|..||..
T Consensus       220 ikp~NIll~~~~-~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          220 FTPDNLFIMPDG-RLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             CSGGGEEECTTS-CEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CCHHHEEECCCC-CEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999999877 89999999998664322   134557999999999762 3379999999999999999999999976


Q ss_pred             CchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          217 DSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                      .....             ...+.....      .............+.+++.+.+||.+||+.||.+|||+.++++||||
T Consensus       296 ~~~~~-------------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          296 VTPGI-------------KGSWKRPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             CCTTC-------------TTCCCBCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             cCccc-------------ccchhhhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            54210             000000000      00000011111234789999999999999999999999999999999


Q ss_pred             ccccc
Q 021982          297 DDLDK  301 (304)
Q Consensus       297 ~~~~~  301 (304)
                      +++.+
T Consensus       357 ~~~~~  361 (371)
T 3q60_A          357 LQLQN  361 (371)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.9e-48  Score=323.18  Aligned_cols=262  Identities=24%  Similarity=0.407  Sum_probs=208.8

Q ss_pred             CchhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            1 MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         1 ~i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      ++.++|++++.||+|+||.||++.+..++..+++|.+....... .....+.+|+.+++.+ +||||+++++++..... 
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~-   85 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDC-   85 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSE-
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCe-
Confidence            35688999999999999999999999999999999986543322 2335677899999999 99999999999887766 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++||||+.| +|.+++...    .++++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||
T Consensus        86 ----~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg  156 (294)
T 4eqm_A           86 ----YYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFG  156 (294)
T ss_dssp             ----EEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCS
T ss_pred             ----EEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCC
Confidence                8999999986 999998764    4689999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          159 LARAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      .+....... .......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.............      
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~------  229 (294)
T 4eqm_A          157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV------  229 (294)
T ss_dssp             SSTTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC------
T ss_pred             CccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC------
Confidence            997654332 2223346799999999998876 79999999999999999999999998877665544432110      


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                       ........+.+++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus       230 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          230 -----------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             -----------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             -----------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence                             0111122346889999999999999999999555555555443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.1e-48  Score=327.78  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=212.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC----CCCchhHHHHHHHHHcc-CCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE----GVPPTTLREVSILRMLS-RDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~   76 (304)
                      +.++|++.+.||+|+||.||++.+..++..|++|.+.......    .....+..|+.+++.+. .||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            5678999999999999999999999999999999988654332    23467788999999994 369999999999877


Q ss_pred             ccCCceEEEEEEeccC--CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEE
Q 021982           77 NKEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI  154 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl  154 (304)
                      ..     .++++|++.  ++|.+++...    ..+++..++.++.|++.||.+||++|++|+||||+||+++.++..+||
T Consensus       121 ~~-----~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          121 DS-----FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             SE-----EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred             Cc-----EEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence            66     899999997  5899998763    468999999999999999999999999999999999999944449999


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCC
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      +|||++......  ......+++.|+|||++.+....+.++||||||+++|+|++|..||.....      +...  .  
T Consensus       192 ~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~--  259 (320)
T 3a99_A          192 IDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q--  259 (320)
T ss_dssp             CCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C--
T ss_pred             eeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c--
Confidence            999999876543  233456799999999998766557889999999999999999999976432      1110  0  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                              ......+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus       260 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          260 ------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                                    001135889999999999999999999999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.6e-48  Score=328.60  Aligned_cols=270  Identities=22%  Similarity=0.325  Sum_probs=195.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+.||+|+||.||++.+..++.   .+++|.+............+.+|+.+++++ +||||+++++++......
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC---
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccc
Confidence            5679999999999999999999877664   799999876544444456788999999999 999999999998876542


Q ss_pred             Cc-eEEEEEEeccCC-CHHHHHHHhccCC--CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           80 GR-TVLYLVFEYMDT-DLKKYIRSFRQTG--ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        80 ~~-~~~~lv~e~~~~-~l~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      +. ...+++|||+.+ +|.+++.......  ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .+||+
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl~  179 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVA  179 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEEC
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEEe
Confidence            21 224899999986 9999987654322  3589999999999999999999999999999999999999777 99999


Q ss_pred             eccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCC
Q 021982          156 DLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       156 dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      |||.+........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+..... 
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-  257 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-  257 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC-
Confidence            9999976544321  122334477899999998776 7999999999999999999 9999988877666655543211 


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-------HHHHhcCCCccccccc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-------AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~eil~~~~~~~~~~~  302 (304)
                                                ....+.+++++.++|.+||+.||.+|||       ++++++|||+....+.
T Consensus       258 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          258 --------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             --------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence                                      1112368899999999999999999999       8999999999886543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.5e-49  Score=336.47  Aligned_cols=278  Identities=19%  Similarity=0.351  Sum_probs=215.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCC---------------chhHHHHHHHHHccCCCCee
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP---------------PTTLREVSILRMLSRDPHVV   67 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~~h~~i~   67 (304)
                      .++|++++.||+|+||.||++.+  ++..|++|.+..........               ..+.+|+.+++.+ +||||+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence            47899999999999999999998  78999999987653222111               6788999999999 899999


Q ss_pred             eeeceecccccCCceEEEEEEeccCC-CHHHH------HHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCC
Q 021982           68 RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKY------IRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLK  139 (304)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~  139 (304)
                      ++++++.....     .++||||+.+ +|.++      +..  .....+++..++.++.|++.||.+||+ .|++|+||+
T Consensus       107 ~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~  179 (348)
T 2pml_X          107 TCEGIITNYDE-----VYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK  179 (348)
T ss_dssp             CCSEEEESSSE-----EEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred             eEEEEEeeCCe-----EEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence            99999988765     8999999987 88776      332  224679999999999999999999999 999999999


Q ss_pred             CCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCC-chhHHHHHHHHHHHhhccccCCCCc
Q 021982          140 PHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYST-AVDMWSVACIFAELVTKTALFPGDS  218 (304)
Q Consensus       140 ~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~  218 (304)
                      |+||+++.++ .++|+|||.+......  ......+++.|+|||++.+...++. ++||||||+++|+|++|..||....
T Consensus       180 p~Nil~~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          180 PSNILMDKNG-RVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGGEEECTTS-CEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hHhEEEcCCC-cEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999777 9999999999875443  3344567999999999987744555 9999999999999999999998877


Q ss_pred             h-HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          219 E-LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       219 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      . .+....+.......... ..        .................+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus       257 ~~~~~~~~i~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          257 SLVELFNNIRTKNIEYPLD-RN--------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             CSHHHHHHHTSCCCCCCCS-SS--------SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             cHHHHHHHHhccCcCCccc-hh--------hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            6 44444332211110000 00        00000011111222357899999999999999999999999999999999


Q ss_pred             ccccc
Q 021982          298 DLDKT  302 (304)
Q Consensus       298 ~~~~~  302 (304)
                      +.+.+
T Consensus       328 ~~~~~  332 (348)
T 2pml_X          328 DTNIE  332 (348)
T ss_dssp             TCCHH
T ss_pred             CCCHH
Confidence            98754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.9e-47  Score=320.56  Aligned_cols=266  Identities=29%  Similarity=0.434  Sum_probs=204.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---   78 (304)
                      +.++|++++.||+|+||.||++.+..++..+++|.+....   .....+.+|+.+++.+ +||||+++++++.....   
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhh
Confidence            3578999999999999999999999999999999986532   1235677899999999 99999999998765321   


Q ss_pred             -----CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeE
Q 021982           79 -----EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        79 -----~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~v  152 (304)
                           ......+++|||+.+ +|.+++...   ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~  155 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NV  155 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CE
Confidence                 223458999999975 999999752   24578899999999999999999999999999999999999777 89


Q ss_pred             EEeeccceeecccC--------------CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc
Q 021982          153 KIADLGLARAFTLP--------------IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS  218 (304)
Q Consensus       153 kl~dfg~~~~~~~~--------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~  218 (304)
                      +|+|||.+......              ........+++.|+|||++.+...++.++||||||+++|+|++   ||....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999998765422              1222344678999999999876568999999999999999998   555433


Q ss_pred             hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ................                       ........+..+.++|.+||+.||.+|||+.++++||||..
T Consensus       233 ~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEF-----------------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHHSTTCCC-----------------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             hHHHHHHhcccccccc-----------------------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            3222222221110000                       01112356788999999999999999999999999999987


Q ss_pred             ccc
Q 021982          299 LDK  301 (304)
Q Consensus       299 ~~~  301 (304)
                      ..+
T Consensus       290 ~~~  292 (303)
T 1zy4_A          290 KHQ  292 (303)
T ss_dssp             CCH
T ss_pred             CCh
Confidence            543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=323.38  Aligned_cols=262  Identities=21%  Similarity=0.369  Sum_probs=192.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.++.+++.+++|++............+.++..+++.+ +||||+++++++.....    
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~----   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTD----   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSE----
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc----
Confidence            4789999999999999999999999999999999875433222222333444556666 99999999999987765    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+++.+.......   ...+++..++.++.|++.||.+||++ |++|+||+|+||+++.++ .++|+|||.+.
T Consensus        99 -~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~  173 (318)
T 2dyl_A           99 -VFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISG  173 (318)
T ss_dssp             -EEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred             -EEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCch
Confidence             8999999966665554432   35689999999999999999999995 999999999999999777 89999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCc-hHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  236 (304)
                      ...... ......+++.|+|||++..    ...++.++||||||+++|+|++|..||.... ..+....+.......   
T Consensus       174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  249 (318)
T 2dyl_A          174 RLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL---  249 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC---
T ss_pred             hccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC---
Confidence            654432 2334467899999999852    3347899999999999999999999998743 334444443321110   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                            ......+++++.++|.+||+.||.+|||++++++||||+...
T Consensus       250 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          250 ----------------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             ----------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                                  001125789999999999999999999999999999998764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.9e-47  Score=320.88  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccC-CCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR-DPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||++.+.. +..+++|++............+.+|+.+++.+.. ||||+++++++.....   
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~---  102 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---  102 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE---
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE---
Confidence            4679999999999999999999864 8889999987655444445677889999999943 6999999999887765   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                        .+++||+.+++|.+++...    ..+++..++.++.|++.||.+||++|++|+||||+||+++ ++ .+||+|||.+.
T Consensus       103 --~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL~Dfg~~~  174 (313)
T 3cek_A          103 --IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIAN  174 (313)
T ss_dssp             --EEEEECCCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred             --EEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEEeeccccc
Confidence              8999997778999999763    4689999999999999999999999999999999999997 45 89999999997


Q ss_pred             ecccCCC--ccccccccccCCChhhhhCC----------CCCCCchhHHHHHHHHHHHhhccccCCCCchHH-HHHHHHH
Q 021982          162 AFTLPIK--KYTHEILTLWYRAPEVLLGS----------THYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFR  228 (304)
Q Consensus       162 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~  228 (304)
                      .......  ......+++.|+|||.+.+.          ..++.++||||||+++|+|++|..||....... .......
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            6644322  12334679999999998752          347889999999999999999999998754432 2222211


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                         ....                       .......+.++.++|.+||+.||.+|||+.|+++||||+..
T Consensus       255 ---~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          255 ---PNHE-----------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             ---TTSC-----------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             ---cccc-----------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence               1100                       01112457889999999999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-47  Score=326.99  Aligned_cols=269  Identities=23%  Similarity=0.386  Sum_probs=190.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHH-HHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVS-ILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||.||++.++.+++.|++|++....... ....+..|+. +++.+ +||||+++++++.....   
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~---   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGD---   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSE---
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCc---
Confidence            478999999999999999999999999999999987543221 1233445555 45555 99999999999987765   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhcc-CCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                        .++||||+.++|.+++..... ....+++..+..++.|++.||.+||+. |++|+||||+||+++.++ .+||+|||+
T Consensus        96 --~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~  172 (327)
T 3aln_A           96 --CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGI  172 (327)
T ss_dssp             --EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSS
T ss_pred             --eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCC
Confidence              899999999999888875332 246789999999999999999999999 999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhh---CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLL---GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +....... ......+++.|+|||++.   ....++.++||||||+++|+|++|..||.........  .    ......
T Consensus       173 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~~~  245 (327)
T 3aln_A          173 SGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--L----TQVVKG  245 (327)
T ss_dssp             SCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCS
T ss_pred             ceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--H----HHHhcC
Confidence            97654432 223346789999999984   2333789999999999999999999999765432110  0    000000


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                                      ............+++.+.+||.+||+.||.+|||+.++++||||....++
T Consensus       246 ----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          246 ----------------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             ----------------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             ----------------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence                            00001111224688999999999999999999999999999999876543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.5e-47  Score=322.04  Aligned_cols=253  Identities=18%  Similarity=0.236  Sum_probs=206.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.+..+++.|++|++....    ....+..|+.+++.+.+||||+++++++.....   
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY---   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE---
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc---
Confidence            5678999999999999999999999999999999887542    234688999999999899999999999888765   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCe-----EEEee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT-----LKIAD  156 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~-----vkl~d  156 (304)
                        .++|||+++++|.+++...   ...+++..++.++.|++.||+|||++|++|+||||+||+++.++ .     ++|+|
T Consensus        80 --~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~D  153 (330)
T 2izr_A           80 --NAMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIID  153 (330)
T ss_dssp             --EEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECC
T ss_pred             --cEEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEE
Confidence              8999999977999998763   35799999999999999999999999999999999999998766 5     99999


Q ss_pred             ccceeecccCCCc-------cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHH
Q 021982          157 LGLARAFTLPIKK-------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHI  226 (304)
Q Consensus       157 fg~~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~  226 (304)
                      ||++.........       .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.   .+....+
T Consensus       154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i  232 (330)
T 2izr_A          154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI  232 (330)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred             cccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence            9999876543221       24557799999999998766 79999999999999999999999987433   2333333


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ........                       ........+ ++.+++.+||+.||.+||++++|++
T Consensus       233 ~~~~~~~~-----------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          233 GDTKRATP-----------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHSC-----------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhhhccCC-----------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22111100                       000111344 9999999999999999999999887

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-46  Score=314.43  Aligned_cols=255  Identities=17%  Similarity=0.219  Sum_probs=209.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|++|.||++.+..+++.+++|++....    ....+.+|+.+++.+.+|++++++++++.....   
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~---   80 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH---   80 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE---
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce---
Confidence            5678999999999999999999999999999999886432    335688999999999889999999999877666   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC----CeEEEeec
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT----MTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~----~~vkl~df  157 (304)
                        .+++||+++++|.+++...   ..++++..++.++.|++.||.+||++|++|+||||+||+++.++    ..++|+||
T Consensus        81 --~~lv~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           81 --NVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             --EEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             --eEEEEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence              8999999977999999763   34699999999999999999999999999999999999998655    23999999


Q ss_pred             cceeecccCCC-------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc---hHHHHHHHH
Q 021982          158 GLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS---ELQQLLHIF  227 (304)
Q Consensus       158 g~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~---~~~~~~~~~  227 (304)
                      |.+........       ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||....   .......+.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            99987654322       234456799999999988766 7999999999999999999999998743   333333332


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ......                       ........+++++.+++.+||+.||.+|||+.+|++
T Consensus       235 ~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          235 EKKQST-----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHS-----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhccCc-----------------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            221110                       111222368899999999999999999999999976

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=329.30  Aligned_cols=260  Identities=20%  Similarity=0.301  Sum_probs=211.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEE-----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRARE-----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++++.||+|+||.||++.+     ..++..|++|.+.... .......+.+|+.+++.+ +||||+++++++....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence            57899999999999999999994     4567789999986322 122234577899999999 9999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc---CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--Ce
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ---TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MT  151 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~  151 (304)
                      .     .++||||+.| +|.+++.....   ....+++.+++.++.||+.||.|||++|++||||||+||+++.++  ..
T Consensus       148 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          148 P-----RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             S-----CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             C-----CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence            6     7999999975 99999987543   224589999999999999999999999999999999999998543  36


Q ss_pred             EEEeeccceeecccC--CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHH
Q 021982          152 LKIADLGLARAFTLP--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       152 vkl~dfg~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~  228 (304)
                      +||+|||++......  ........+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999755322  22233445688999999998766 8999999999999999998 9999998887776666554


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      ....                           .....+++.+.+||.+||+.||.+|||+.+|+++.++-
T Consensus       302 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          302 GGRM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2211                           11236789999999999999999999999999986553

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.1e-48  Score=333.72  Aligned_cols=288  Identities=30%  Similarity=0.479  Sum_probs=214.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc----------CCCCeeeeece
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS----------RDPHVVRLMDV   72 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~~i~~~~~~   72 (304)
                      .++|++++.||+|+||.||++.+..+++.+++|++....   .....+.+|+.+++++.          .||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            468999999999999999999999999999999986322   12345677888888873          17999999999


Q ss_pred             ecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc-CccccCCCCCCeEEeCC---
Q 021982           73 KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH-GILHRDLKPHNLLMDRK---  148 (304)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~Nil~~~~---  148 (304)
                      +...... ....+++||+++++|.+++....  ...+++..++.++.||+.||.|||++ |++|+||||+||+++.+   
T Consensus        95 ~~~~~~~-~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           95 FNHKGPN-GVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEETT-EEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             hhccCCC-CceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            8865422 22379999999889999998743  34589999999999999999999998 99999999999999532   


Q ss_pred             --CCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc------hH
Q 021982          149 --TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------EL  220 (304)
Q Consensus       149 --~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~------~~  220 (304)
                        ...+||+|||++......   .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+      ..
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence              237999999999776543   23446799999999998876 7999999999999999999999998654      44


Q ss_pred             HHHHHHHHHhCCCCCCCCccccc----------cCCcccCCCCCCCc----ccccCCCCChhhHHHHHHhhcCCCCCCCC
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSS----------LMNWHEYPQWNPQS----LATAVPNLDKDGLDLLEQMLQYDPSKRIS  286 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps  286 (304)
                      .....+...++..+...+.....          ..+......+....    .......++.++.+||.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            55556666555543321110000          00000000000000    00111244578899999999999999999


Q ss_pred             HHHHhcCCCccccc
Q 021982          287 AKKAMEHPYFDDLD  300 (304)
Q Consensus       287 ~~eil~~~~~~~~~  300 (304)
                      +.|+++||||++..
T Consensus       328 ~~ell~hp~f~~~~  341 (373)
T 1q8y_A          328 AGGLVNHPWLKDTL  341 (373)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhhChhhhccc
Confidence            99999999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.4e-47  Score=325.65  Aligned_cols=265  Identities=27%  Similarity=0.423  Sum_probs=184.5

Q ss_pred             chhhhhhhh-hcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLE-KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|++++ .||+|+||.||++.++.+++.|++|++...       .....++..+.+..+||||+++++++..... +
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~   97 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHH-G   97 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-T
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC-C
Confidence            568899966 599999999999999999999999998642       2334455544444499999999999876332 2


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeec
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADL  157 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~df  157 (304)
                      ....++||||+.| +|.+++...  ....+++.+++.++.|++.||.|||++|++|+||||+||+++.++  ..++|+||
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence            2347999999986 999999763  335799999999999999999999999999999999999998543  36999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |.+......  ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||....................   
T Consensus       176 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  249 (336)
T 3fhr_A          176 GFAKETTQN--ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---  249 (336)
T ss_dssp             TTCEEC------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccceecccc--ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc---
Confidence            999765533  233456699999999986655 78999999999999999999999976654432221111110000   


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                       ..........+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       250 -----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          250 -----------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -----------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                             000111123688999999999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.8e-47  Score=325.78  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=208.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .++|++.+.||+|+||.||++.+..       ++..+++|++.... .......+.+|+.+++.+.+||||+++++++..
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4689999999999999999998742       34579999886432 122234678899999999789999999999987


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      ...     +++||||+.+ +|.+++.....            ....+++.+++.++.||+.||.|||++|++|+||||+|
T Consensus       159 ~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          159 DGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             SSS-----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCC-----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            766     8999999986 99999987432            12458899999999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .+||+|||++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.....
T Consensus       234 Ill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          234 VLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             EEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999777 999999999986654322  223345578899999998766 8999999999999999999 9999988776


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .+....+.....                           ......+++++.++|.+||+.||.+|||+.|++++
T Consensus       312 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEGHR---------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555544433211                           11123688999999999999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=321.00  Aligned_cols=252  Identities=21%  Similarity=0.325  Sum_probs=206.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ..++|++.+.||+|+||.||++.+..++.   .+++|.+.... .......+.+|+.+++.+ +||||+++++++.....
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCc
Confidence            35789999999999999999999976554   49999986432 222235678899999999 99999999999987776


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++||||+.| +|.+++...   ...+++.+++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+||
T Consensus       125 -----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Df  195 (325)
T 3kul_A          125 -----AMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDF  195 (325)
T ss_dssp             -----CEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCC
T ss_pred             -----cEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCC
Confidence                 8999999976 999988642   34699999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCC
Q 021982          158 GLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       158 g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |++.........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......+
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  274 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP  274 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence            999876543222   22233467899999998766 7999999999999999999 999999888877776665432211


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                                 ....+++.+.++|.+||+.||.+|||+.++++
T Consensus       275 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          275 ---------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                       12368899999999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-46  Score=311.70  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=208.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+.. +..+++|++......   ...+.+|+.+++++ +||||+++++++.+...    
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~----   79 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAP----   79 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC---HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS----
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC---HHHHHHHHHHHHhC-CCCCEeeEEEEEecCCc----
Confidence            4789999999999999999999874 677999998754322   35688999999999 89999999999988776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||.+.
T Consensus        80 -~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~  154 (269)
T 4hcu_A           80 -ICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTR  154 (269)
T ss_dssp             -EEEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGG
T ss_pred             -eEEEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEeccccccc
Confidence             8999999986 899988652   34689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~------  227 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------  227 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred             cccccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC------
Confidence            554321 1222334577899999998766 7999999999999999999 999999888877766665432111      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                           ....+++.+.+++.+||+.||.+|||+.+++++
T Consensus       228 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          228 ---------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                 112478899999999999999999999999984

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-46  Score=309.03  Aligned_cols=250  Identities=21%  Similarity=0.331  Sum_probs=208.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      -.++|++++.||+|+||.||++.++ ++..+++|++......   ...+.+|+.+++.+ +||||+++++++.....   
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~---   77 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYP---   77 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS---
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhC-CCCCEeeEEEEEccCCc---
Confidence            3578999999999999999999876 4667999998754322   35688999999999 89999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.+ +|.+++....   ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||.+
T Consensus        78 --~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~  151 (268)
T 3sxs_A           78 --IYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMT  151 (268)
T ss_dssp             --EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCE
T ss_pred             --eEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccc
Confidence              8999999975 8999987642   3589999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ........ ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.......     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  225 (268)
T 3sxs_A          152 RYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY-----  225 (268)
T ss_dssp             EECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-----
T ss_pred             eecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC-----
Confidence            86654322 222334467899999998766 7899999999999999999 999999888777666654422111     


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                            .....++.+.+++.+||+.||.+|||+.+++++
T Consensus       226 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          226 ----------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  112468899999999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=316.35  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=201.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC----CCCchhHHHHHHHHHcc---CCCCeeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE----GVPPTTLREVSILRMLS---RDPHVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~---~h~~i~~~~~~~~   74 (304)
                      +.++|++.+.||+|+||.||++.+..++..+++|.+.......    .....+..|+.+++.+.   +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            4578999999999999999999999999999999987543221    23455667899888885   6999999999988


Q ss_pred             ccccCCceEEEEEEec-cC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeE
Q 021982           75 GQNKEGRTVLYLVFEY-MD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTL  152 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~v  152 (304)
                      ....     .++++|+ +. ++|.+++...    .++++..++.++.|++.||.+||++|++|+||+|+||+++.++..+
T Consensus       109 ~~~~-----~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          109 TQEG-----FMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred             cCCe-----EEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence            7766     7899998 55 4999998763    3589999999999999999999999999999999999999433499


Q ss_pred             EEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCC
Q 021982          153 KIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      +|+|||.+......  ......+++.|+|||++.+....+.++||||||+++|+|++|..||.....      +....  
T Consensus       180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~--  249 (312)
T 2iwi_A          180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE--  249 (312)
T ss_dssp             EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC--
T ss_pred             EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc--
Confidence            99999999876543  234456799999999998766456689999999999999999999975432      11100  


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                                ......++..+.++|.+||+.||.+|||+.|+++||||+...
T Consensus       250 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          250 --------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             --------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             --------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                                      001135789999999999999999999999999999998753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=323.97  Aligned_cols=257  Identities=24%  Similarity=0.394  Sum_probs=210.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccC-------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKAT-------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   74 (304)
                      ..++|++.+.||+|+||.||++.+...       +..+++|++.... .......+.+|+.+++.+.+||||+++++++.
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            357899999999999999999997543       3579999886432 22223567789999999988999999999998


Q ss_pred             ccccCCceEEEEEEeccCC-CHHHHHHHhccC------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCC
Q 021982           75 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPH  141 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~  141 (304)
                      ....     .++||||+.+ +|.+++......            ...+++.+++.++.|++.||.+||++|++|+||||+
T Consensus       146 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          146 QDGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             SSSS-----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             cCCc-----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            8776     8999999986 999999875421            246899999999999999999999999999999999


Q ss_pred             CeEEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCc
Q 021982          142 NLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDS  218 (304)
Q Consensus       142 Nil~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~  218 (304)
                      ||+++.++ .+||+|||++.......  .......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||....
T Consensus       221 NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          221 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999777 99999999997664432  2233345578899999998766 8999999999999999999 999999887


Q ss_pred             hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          219 ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..+....+......                           .....+++++.+||.+||+.||.+|||+.|++++
T Consensus       299 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTCCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76665555432111                           1123688999999999999999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-46  Score=326.32  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=207.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++.++..|++|.+.... .......+.+|+.+++.+ +||||+++++++.....    
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~----  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQP----  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSS----
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCC----
Confidence            468999999999999999999999899999999886432 112234677899999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++....   ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       187 -~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~  261 (377)
T 3cbl_A          187 -IYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSR  261 (377)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             -cEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence             8999999975 9999987632   3589999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCCcc--ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          162 AFTLPIKKY--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       162 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .........  ....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......      
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------  334 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------  334 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            654322111  1123467899999998765 7999999999999999998 99999988776665554432111      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       335 ---------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 ---------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                 112357899999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.8e-46  Score=312.52  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=210.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++.+.||+|++|.||++.++.++..+++|.+....   .....+.+|+.+++.+ +||||+++++++.....   
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~---   83 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP---   83 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS---
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCC---
Confidence            4578999999999999999999999999999999986432   2345778999999999 89999999999987776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++|||++.| +|.+++...  ....+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.+
T Consensus        84 --~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~  158 (288)
T 3kfa_A           84 --FYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLS  158 (288)
T ss_dssp             --EEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGG
T ss_pred             --EEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccc
Confidence              8999999985 999999763  335699999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ........ ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+.......+......      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------  231 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------  231 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC------
T ss_pred             eeccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC------
Confidence            76554332 223344578899999998766 7999999999999999999 99999887766555544432111      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           .....+++.+.+++.+||+.||.+|||+.++++
T Consensus       232 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          232 ---------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                                 112368899999999999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=314.86  Aligned_cols=252  Identities=25%  Similarity=0.424  Sum_probs=205.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.+..++..+++|.+...  .......+.+|+.+++.+ +||||+++++++.+...    
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~----   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKR----   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE----
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCe----
Confidence            47899999999999999999999999999999987532  222345678899999999 89999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++...   ...+++.+++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||.+.
T Consensus        82 -~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  156 (310)
T 3s95_A           82 -LNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLAR  156 (310)
T ss_dssp             -EEEEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCE
T ss_pred             -eEEEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccce
Confidence             8999999986 999998763   34689999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCCcc--------------ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH-----H
Q 021982          162 AFTLPIKKY--------------THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-----Q  222 (304)
Q Consensus       162 ~~~~~~~~~--------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~  222 (304)
                      .........              ....|++.|+|||++.+.. ++.++||||||+++|+|++|..|+.......     .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~  235 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN  235 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence            764332211              1346799999999998765 8999999999999999999999886532110     0


Q ss_pred             HHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ......                              ....+.+++.+.+++.+||+.||.+|||+.++++  |++.+
T Consensus       236 ~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          236 VRGFLD------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HHHHHH------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             hhcccc------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            000000                              0112468899999999999999999999999987  65544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.2e-46  Score=313.70  Aligned_cols=256  Identities=27%  Similarity=0.483  Sum_probs=197.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.+..++..+++|++..... .......+.+|+.+++.+ +||||+++++++.....   
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~---  106 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNE---  106 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE---
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCc---
Confidence            5789999999999999999999999999999999875332 222335677899999999 99999999999987766   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++||++.+ +|.+++.........+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus       107 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~  183 (310)
T 2wqm_A          107 --LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLG  183 (310)
T ss_dssp             --EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC---
T ss_pred             --EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccce
Confidence              8999999986 99999988766677899999999999999999999999999999999999999777 9999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch--HHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE--LQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  238 (304)
                      ..............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.....  ......+... ..+     
T Consensus       184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-----  256 (310)
T 2wqm_A          184 RFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYP-----  256 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSC-----
T ss_pred             eeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCC-----
Confidence            76655444444556799999999988765 79999999999999999999999975432  2222222111 000     


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          ......+++++.++|.+||+.||.+|||+.++++
T Consensus       257 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 --------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             --------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                0011357899999999999999999999999987

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.8e-46  Score=323.33  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             hhhhhhhhhcccccceEEEEEE-----EccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.     +..+++.|++|.+..... ......+.+|+.++..+.+||||+++++++....
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            5789999999999999999999     445668899999864321 1223467889999999988999999999987644


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC---------------------------------------------------
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT---------------------------------------------------  105 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------  105 (304)
                      ..    .+++|||+.+ +|.+++......                                                   
T Consensus       100 ~~----~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A          100 GP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             SC----CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             Cc----eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            32    6899999986 999999764321                                                   


Q ss_pred             -----------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCC--cccc
Q 021982          106 -----------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTH  172 (304)
Q Consensus       106 -----------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~--~~~~  172 (304)
                                 ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++........  ....
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence                       12289999999999999999999999999999999999999777 899999999976543322  2334


Q ss_pred             ccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCC
Q 021982          173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYP  251 (304)
Q Consensus       173 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (304)
                      ..+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...................                  
T Consensus       255 ~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------  315 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------  315 (359)
T ss_dssp             CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred             cCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence            45688999999998765 7999999999999999998 999998776544443333321111                  


Q ss_pred             CCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          252 QWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                              .....+++++.+++.+||+.||.+|||+.|+++|
T Consensus       316 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 --------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                    1123578999999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5e-46  Score=310.26  Aligned_cols=249  Identities=19%  Similarity=0.313  Sum_probs=204.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+. ++..+++|++......   ...+.+|+.+++.+ +||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~----   93 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRP----   93 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS----
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcC-CCCCEeeEEEEEecCCC----
Confidence            578999999999999999999887 4677999998754322   35688999999999 89999999999987776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++....   ..+++.+++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.+.
T Consensus        94 -~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~  168 (283)
T 3gen_A           94 -IFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSR  168 (283)
T ss_dssp             -EEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGG
T ss_pred             -eEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEccccccc
Confidence             8999999975 9999987532   3589999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.......      
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------  241 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------  241 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC------
T ss_pred             cccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC------
Confidence            553321 1122334477899999998766 7999999999999999998 999999888877776665432211      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                           .....++.+.++|.+||+.||.+|||+.++++|
T Consensus       242 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          242 ---------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ---------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                 112568899999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-46  Score=320.37  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++++.||+|+||.||++.+..     ++..+++|.+.... .......+.+|+.+++.+ +||||+++++++....
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEF-DNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCC
Confidence            5789999999999999999999873     44789999986432 222235678899999999 9999999999998766


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC--------------------CCCCChHHHHHHHHHHHHHHHHHHhcCcccc
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT--------------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHR  136 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~  136 (304)
                      .     .++||||+.+ +|.+++......                    ..++++.+++.++.||+.||.|||++|++|+
T Consensus       124 ~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          124 P-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             c-----eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            6     8999999986 999999874321                    2578999999999999999999999999999


Q ss_pred             CCCCCCeEEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-cccc
Q 021982          137 DLKPHNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTAL  213 (304)
Q Consensus       137 dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p  213 (304)
                      ||||+||+++.++ .+||+|||++.......  .......+++.|+|||++.+.. ++.++||||||+++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999777 99999999987654322  2223345688999999998766 8999999999999999999 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          214 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      |......+....+.....                           ......++..+.++|.+||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI---------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            998877666655443211                           1112368899999999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-46  Score=317.66  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+.     .++..+++|.+.... .......+.+|+.+++++.+||||+++++++....
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            467999999999999999999973     345689999987433 33345688899999999988999999999998876


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC-------------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT-------------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRD  137 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~d  137 (304)
                      .     .++||||+.+ +|.+++......                   ...+++..++.++.||+.||.+||++|++|+|
T Consensus       123 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          123 P-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             c-----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            6     8999999975 999999764321                   13479999999999999999999999999999


Q ss_pred             CCCCCeEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccC
Q 021982          138 LKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALF  214 (304)
Q Consensus       138 l~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~  214 (304)
                      |||+||+++.++ .++|+|||++........  ......+++.|+|||++.+.. ++.++||||||+++|+|+| |..||
T Consensus       198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999777 999999999976654322  123345578899999998766 7999999999999999998 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          215 PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..................                          ......+++++.+||.+||+.||.+|||+.+++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFK--------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCC--------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            877654444444332111                          01122578999999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.8e-46  Score=316.20  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=206.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEE--EEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIV--ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~--~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++.+.||+|+||.||++.++.++..+  ++|.+.... .......+.+|+.+++++.+||||+++++++.....  
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--  100 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--  100 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE--
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc--
Confidence            478999999999999999999998888755  888876432 233456788999999999889999999999987766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhc------------cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFR------------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR  147 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~  147 (304)
                         .+++|||+.+ +|.+++....            .....+++.+++.++.||+.||.+||++|++|+||||+||+++.
T Consensus       101 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          101 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             ---EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             ---eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence               8999999975 9999987643            23457999999999999999999999999999999999999997


Q ss_pred             CCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHH
Q 021982          148 KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  226 (304)
Q Consensus       148 ~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~  226 (304)
                      ++ .++|+|||++...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+
T Consensus       178 ~~-~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          178 NY-VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             GG-CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CC-eEEEcccCcCcccccc-ccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            77 8999999998743322 1223334578899999997765 7899999999999999998 99999888776655544


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .....                           ......+++.+.++|.+||+.||.+|||+.+++++
T Consensus       255 ~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          255 PQGYR---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGTCC---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCC---------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            32110                           01123578999999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-45  Score=314.21  Aligned_cols=251  Identities=20%  Similarity=0.273  Sum_probs=202.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcE----EEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKI----VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||++.+..++..    +++|.+... ........+.+|+.+++.+ +||||+++++++.... 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPGSS-   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECBSS-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCc-
Confidence            46899999999999999999999887775    666665433 2334456778999999999 9999999999986432 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++|+||+.+ +|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+||
T Consensus        89 -----~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Df  159 (325)
T 3kex_A           89 -----LQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADF  159 (325)
T ss_dssp             -----EEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred             -----cEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCC
Confidence                 7899999985 998888653   24689999999999999999999999999999999999999777 8999999


Q ss_pred             cceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......  
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--  236 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL--  236 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC--
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--
Confidence            99976644322  223345577999999998766 7999999999999999999 99999887766655544432111  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               .....++.++.+++.+||+.||.+|||+.+++++
T Consensus       237 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          237 -------------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -------------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -------------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     1112467889999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.9e-46  Score=316.16  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=207.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+.     .++..+++|.+.... .......+.+|+.+++.+ +||||+++++++....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCC
Confidence            578999999999999999999883     345789999886432 222335677899999999 9999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc--------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCcccc
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ--------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHR  136 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~  136 (304)
                      .     .+++|||+.+ +|.+++.....                    ....+++.+++.++.|++.||.|||++|++|+
T Consensus       100 ~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A          100 P-----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             c-----eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            6     8999999985 99999987543                    12348999999999999999999999999999


Q ss_pred             CCCCCCeEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-cccc
Q 021982          137 DLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTAL  213 (304)
Q Consensus       137 dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p  213 (304)
                      ||||+||+++.++ .++|+|||++........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999777 999999999986644322  122334578899999998765 7999999999999999999 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          214 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      |...........+.....                           ......+++.+.++|.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHR---------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             STTCCGGGHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCCc---------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            987776555444432110                           11123688999999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.9e-46  Score=306.82  Aligned_cols=249  Identities=28%  Similarity=0.413  Sum_probs=194.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC--CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD--EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++.+.||+|+||.||++.+.  +..+++|++......  ......+.+|+.+++.+ +||||+++++++.....  
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~--   80 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPN--   80 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCc--
Confidence            578999999999999999999875  788999988764332  23345778899999999 99999999999987766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC---ccccCCCCCCeEEeCC-------C
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG---ILHRDLKPHNLLMDRK-------T  149 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~---i~h~dl~~~Nil~~~~-------~  149 (304)
                         .+++|||+.+ +|.+++..     ..+++..++.++.|++.||.+||++|   ++|+||||+||+++.+       +
T Consensus        81 ---~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           81 ---LCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             ---CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             ---eEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence               8999999975 88887742     57999999999999999999999999   8899999999999852       3


Q ss_pred             CeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHH
Q 021982          150 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  229 (304)
                      ..++|+|||.+........  ....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+...........
T Consensus       153 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTTK--MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             CCEEECCCCC---------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             cceEEccCCcccccccccc--cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            4799999999976554322  2446799999999998766 799999999999999999999999988776655544331


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..                          .......+++.+.+++.+||+.||.+|||+.|++++
T Consensus       230 ~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 KL--------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CC--------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC--------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            11                          011123678999999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.3e-46  Score=315.07  Aligned_cols=261  Identities=20%  Similarity=0.313  Sum_probs=200.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc---CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA---TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|.+.+.||+|+||.||++.+..   ++..+++|.+............+.+|+.+++.+ +||||+++++++......
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecccc
Confidence            4789999999999999999998765   445799999876544443445678899999999 899999999998876654


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhc--cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFR--QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      +....+++|||+.+ +|.+++....  .....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~D  190 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVAD  190 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEECS
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEee
Confidence            44447999999986 9999986543  2335699999999999999999999999999999999999999777 899999


Q ss_pred             ccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCC
Q 021982          157 LGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       157 fg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      ||++.......  .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+...... 
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  268 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-  268 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC-
Confidence            99997654332  1122334578899999998765 7999999999999999999 88999887776655554432111 


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                                .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       269 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 --------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      1123688999999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-46  Score=317.10  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=212.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ..++|++.+.||+|+||.||++.+.     .++..+++|.+..... ......+.+|+.+++.+ +||||+++++++...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG  100 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccC
Confidence            4678999999999999999999876     3567899998864321 11233577899999999 999999999999877


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhcc------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT  149 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~  149 (304)
                      ..     .+++||++.+ +|.+++.....      ...++++..++.++.|++.||.+||++|++|+||||+||+++.++
T Consensus       101 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A          101 QP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SS-----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             Cc-----cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            66     7999999985 99999876432      124679999999999999999999999999999999999999777


Q ss_pred             CeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHH
Q 021982          150 MTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHI  226 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~  226 (304)
                       .++|+|||++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+
T Consensus       176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             -eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence             999999999976543321  122334578899999998766 7999999999999999999 89999888776666555


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC------CCccccc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH------PYFDDLD  300 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~------~~~~~~~  300 (304)
                      ....                           .......++..+.++|.+||+.||.+|||+.|++++      ++|++++
T Consensus       254 ~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          254 MEGG---------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             HTTC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             HcCC---------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            4321                           111123688999999999999999999999999987      6666554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=327.02  Aligned_cols=258  Identities=26%  Similarity=0.384  Sum_probs=195.7

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      +|.+.+.||+|+||+|+. ....+++.|+||.+...     ......+|+.+++.+.+||||+++++++.+...     .
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~-----~   93 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPE-----CFSFADREVQLLRESDEHPNVIRYFCTEKDRQF-----Q   93 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTT-----TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTE-----E
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCE-----E
Confidence            588999999999999764 34456889999988632     234567899999998789999999999887766     8


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC----CCeEEEeeccce
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK----TMTLKIADLGLA  160 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~----~~~vkl~dfg~~  160 (304)
                      ++|||+++|+|.+++...   ....++..++.++.||+.||.|||++|++|+||||+||+++.+    ...++|+|||++
T Consensus        94 ~lv~E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           94 YIAIELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEEECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEEECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            999999999999998753   2345666788999999999999999999999999999999532    236889999999


Q ss_pred             eecccCC---CccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          161 RAFTLPI---KKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       161 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      .......   .......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||............    ....
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~----~~~~  246 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----GACS  246 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT----TCCC
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh----ccCC
Confidence            8765432   22334567999999999875  2336889999999999999999 89999665443322211    1100


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ..                     ........+..+.+||.+||+.||.+|||+.++++||||..+.+
T Consensus       247 ~~---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          247 LD---------------------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             CT---------------------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             cc---------------------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            00                     00001123456889999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.9e-46  Score=311.26  Aligned_cols=257  Identities=24%  Similarity=0.379  Sum_probs=198.3

Q ss_pred             chhhhhhhhhcccccceEEEEEE----EccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      ..++|++++.||+|+||.||+++    +..++..+++|.+....  ......+.+|+.+++.+ +||||+++++++....
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            46889999999999999999998    56678899999886432  22235677899999999 9999999999886533


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      ..   ..++||||+.+ +|.+++....   ..+++.+++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|
T Consensus        85 ~~---~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~D  157 (295)
T 3ugc_A           85 RR---NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGD  157 (295)
T ss_dssp             HT---SCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC
T ss_pred             CC---ceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEcc
Confidence            21   16899999975 9999987632   3589999999999999999999999999999999999999777 999999


Q ss_pred             ccceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHH----------
Q 021982          157 LGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQL----------  223 (304)
Q Consensus       157 fg~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~----------  223 (304)
                      ||++........   ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+.........          
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             CCSCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             CcccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            999976644322   122334567799999998776 799999999999999999999998765332110          


Q ss_pred             --HHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          224 --LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       224 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                        .........                       .........+++++.++|.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IVFHLIELLKN-----------------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHT-----------------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhc-----------------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              011111000                       0011123368899999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-45  Score=312.12  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=208.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEE-----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRARE-----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+     ..++..+++|.+..... ......+.+|+.+++++.+||||+++++++....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            57899999999999999999985     34567899999874322 1223567889999999988999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccC--------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQT--------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      .     .+++|||+.+ +|.+++......              ..++++..++.++.|++.||.+||++|++|+||||+|
T Consensus       101 ~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A          101 P-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             S-----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             C-----cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            6     7999999986 999999874321              2358999999999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .++|+|||.+.........  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.....
T Consensus       176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999777 9999999999766544321  22344578899999988765 8999999999999999999 9999987665


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..............                          .....++..+.++|.+||+.||.+|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFRM--------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCCC--------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            44444443321111                          1113578999999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.3e-46  Score=328.23  Aligned_cols=264  Identities=26%  Similarity=0.380  Sum_probs=195.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.+.|.+.+.||+|+||+||.+ ...+|+.||+|.+....     ...+.+|+.+++.+.+||||+++++++.....   
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~---   83 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRF---   83 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE---
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe---
Confidence            3456777889999999999875 44568999999886432     23567899999877689999999999887665   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCC---CChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC----------
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGEN---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK----------  148 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~----------  148 (304)
                        .++|||+++|+|.+++.........   .++..++.++.||+.||.|||++|++|+||||+||+++.+          
T Consensus        84 --~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           84 --LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             --EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             --EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence              8999999999999999764332221   2445678899999999999999999999999999999743          


Q ss_pred             --CCeEEEeeccceeecccCCCc----cccccccccCCChhhhhC------CCCCCCchhHHHHHHHHHHHhh-ccccCC
Q 021982          149 --TMTLKIADLGLARAFTLPIKK----YTHEILTLWYRAPEVLLG------STHYSTAVDMWSVACIFAELVT-KTALFP  215 (304)
Q Consensus       149 --~~~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~il~~ll~-g~~p~~  215 (304)
                        +..+||+|||++.........    .....|++.|+|||++.+      ...++.++|||||||++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence              248999999999876554322    234567999999999975      2348999999999999999999 899997


Q ss_pred             CCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 021982          216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY  295 (304)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  295 (304)
                      ......  ..+..........                     .......+++++.+||.+||+.||.+|||+.++++|||
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~  298 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEM---------------------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL  298 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCC---------------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             CchhhH--HHHhcCCCCcccc---------------------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence            655433  2222211110000                     00001135678999999999999999999999999999


Q ss_pred             cccc
Q 021982          296 FDDL  299 (304)
Q Consensus       296 ~~~~  299 (304)
                      |...
T Consensus       299 f~~~  302 (434)
T 2rio_A          299 FWPK  302 (434)
T ss_dssp             GSCH
T ss_pred             cCCc
Confidence            9753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.2e-46  Score=309.60  Aligned_cols=255  Identities=21%  Similarity=0.329  Sum_probs=195.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++.+.||+|+||.||++.+..   .+++|++............+.+|+.+++.+ +||||++++++.....    
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~----   93 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTAPQ----   93 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS----
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeeccCCc----
Confidence            45789999999999999999997653   499999876655444456788999999999 9999999999754432    


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++..   ....+++.+++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||++
T Consensus        94 --~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  167 (289)
T 3og7_A           94 --LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLA  167 (289)
T ss_dssp             --CEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC--
T ss_pred             --cEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceec
Confidence              6899999986 88888753   235689999999999999999999999999999999999999877 9999999998


Q ss_pred             eecccC--CCccccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          161 RAFTLP--IKKYTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       161 ~~~~~~--~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ......  ........+++.|+|||.+..  ...++.++||||||+++|+|++|..||......+.............  
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--  245 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--  245 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC--
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc--
Confidence            755431  222334567999999999862  33378899999999999999999999988776665555544321111  


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          ........+++.+.+||.+||+.||.+|||+.++++
T Consensus       246 --------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 --------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                111222368899999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.6e-45  Score=305.96  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=206.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---   78 (304)
                      +.++|++++.||+|+||.||++.+..+++.+++|.+....      ..+.+|+.+++.+ +||||+++++++.....   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcc
Confidence            3578999999999999999999999899999999987432      4678999999999 99999999998765221   


Q ss_pred             --------CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC
Q 021982           79 --------EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT  149 (304)
Q Consensus        79 --------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~  149 (304)
                              ......+++|||+.+ +|.+++....  ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                    113347999999996 9999998743  35789999999999999999999999999999999999999777


Q ss_pred             CeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHH
Q 021982          150 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  229 (304)
                       .++|+|||.+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+....  .....+.. 
T Consensus       160 -~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~-  233 (284)
T 2a19_B          160 -QVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD-  233 (284)
T ss_dssp             -EEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT-
T ss_pred             -CEEECcchhheeccccc-cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc-
Confidence             99999999998765542 233446799999999998765 7999999999999999999998874321  11111111 


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                        ..                           ....++..+.++|.+||+.||.+|||+.|++++.+.-.
T Consensus       234 --~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 --GI---------------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             --TC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             --cc---------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence              00                           11257889999999999999999999999999876543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.6e-46  Score=316.29  Aligned_cols=261  Identities=20%  Similarity=0.299  Sum_probs=206.5

Q ss_pred             chhhhhhhhhcccccceEEEEEE-----EccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ..++|++++.||+|+||.||++.     +..++..+++|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKF-NHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCC
Confidence            46889999999999999999998     45667889999986332 222234677899999999 999999999999887


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCC---CCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--C
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTG---ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--M  150 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~  150 (304)
                      ..     .++||||+.+ +|.+++.......   ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++  .
T Consensus       106 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          106 LP-----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             SS-----CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             CC-----cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence            66     7999999965 9999998754322   4589999999999999999999999999999999999998432  3


Q ss_pred             eEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHH
Q 021982          151 TLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIF  227 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~  227 (304)
                      .++|+|||.+.......  .......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            79999999987553322  2223345688999999998765 7999999999999999998 999998887766655544


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                      .....                           .....+++.+.++|.+||+.||.+|||+.+++++.|+-
T Consensus       260 ~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          260 SGGRM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCC---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            32111                           11236889999999999999999999999999987754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.4e-46  Score=310.12  Aligned_cols=247  Identities=17%  Similarity=0.271  Sum_probs=199.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCC-------cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceec
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATG-------KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQ   74 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   74 (304)
                      ..++|++.+.||+|+||.||++.++.++       ..+++|.+....  ......+.+|+.+++.+ +||||+++++++.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   82 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKL-SHKHLVLNYGVCV   82 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTS-CCTTBCCEEEEEC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEE
Confidence            4678999999999999999999998776       469999886433  22345678899999999 8999999999998


Q ss_pred             ccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCe--
Q 021982           75 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMT--  151 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~--  151 (304)
                      ....     .++||||+.| +|.+++....   ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .  
T Consensus        83 ~~~~-----~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~~  153 (289)
T 4fvq_A           83 CGDE-----NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE-DRK  153 (289)
T ss_dssp             CTTC-----CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC-BGG
T ss_pred             eCCC-----CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC-ccc
Confidence            8766     7899999985 9999997632   3489999999999999999999999999999999999998776 4  


Q ss_pred             ------EEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc-CCCCchHHHHH
Q 021982          152 ------LKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLL  224 (304)
Q Consensus       152 ------vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p-~~~~~~~~~~~  224 (304)
                            ++|+|||.+......    ....+++.|+|||++.+...++.++||||||+++|+|++|..| +......... 
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-  228 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-  228 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-
T ss_pred             ccccceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-
Confidence                  999999998543321    2334688899999998755589999999999999999996554 4444443333 


Q ss_pred             HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ........                            .....++++.++|.+||+.||.+|||+.+++++
T Consensus       229 ~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          229 QFYEDRHQ----------------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHTTCC----------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHhhccCC----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22221110                            112467889999999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-45  Score=314.46  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEE----EEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIV----ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||++.+..++..+    ++|.+.... .......+.+|+.+++++ +||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC-
Confidence            578999999999999999999988777654    667665332 223446788999999999 9999999999988654 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .+++++++.+ +|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+||
T Consensus        91 -----~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Df  161 (327)
T 3poz_A           91 -----VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             -----EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             -----eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccC
Confidence                 5788888875 999988763   34689999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |++.........  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......  
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--  238 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--  238 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--
Confidence            999766543322  22334477899999998766 8999999999999999999 99999887665554444332111  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               .....++.++.+++.+||+.||.+|||+.+++++
T Consensus       239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 -------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                     1123578899999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.9e-46  Score=308.79  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=194.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ..++|++.+.||+|+||.||++.+..+   +..+++|.+.... .......+.+|+.+++.+ +||||+++++++... .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~   89 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQF-DHPHIVKLIGVITEN-P   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS-S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCccceEEEEEccC-c
Confidence            467899999999999999999998654   3468888876432 122234677899999999 999999999998543 2


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++||||+.+ +|.+++...   ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .+||+||
T Consensus        90 -----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Df  160 (281)
T 1mp8_A           90 -----VWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDF  160 (281)
T ss_dssp             -----CEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred             -----cEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECcc
Confidence                 6899999986 999998753   34689999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          158 GLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       158 g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      |++........ ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+.....    
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----  235 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----  235 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred             ccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----
Confidence            99976644322 122334577899999998665 7999999999999999996 9999988776665555443211    


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                             ....+.+++.+.+++.+||+.||.+|||+.++++
T Consensus       236 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          236 -----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                   1122368899999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.5e-46  Score=316.72  Aligned_cols=270  Identities=22%  Similarity=0.279  Sum_probs=205.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++.+.||+|+||.||++.+. ++..+++|.+....... ....+.+|+.+++.+ +||||+++++++.....   
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~---  101 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE---  101 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSC---
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhc-cCCCccceEEEEecCCc---
Confidence            4578999999999999999999854 57889999987544322 334688999999999 89999999999987776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc---CccccCCCCCCeEEeCCCCeEEEeec
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---GILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                        .++||||+.+ +|.+++........++++..++.++.|++.||.+||+.   |++|+||||+||+++.++ .++|+||
T Consensus       102 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Df  178 (326)
T 3uim_A          102 --RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF  178 (326)
T ss_dssp             --CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCC
T ss_pred             --eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccC
Confidence              7899999986 99999988666667799999999999999999999999   999999999999999777 9999999


Q ss_pred             cceeecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch----HHHHHHHHHHhCC
Q 021982          158 GLARAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE----LQQLLHIFRLLGT  232 (304)
Q Consensus       158 g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----~~~~~~~~~~~~~  232 (304)
                      |.+......... .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||.....    .............
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            999876543322 33345799999999997766 79999999999999999999999962211    0011111110000


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                        .......         .  ............+..+.+++.+||+.||.+|||+.|+++|-
T Consensus       258 --~~~~~~~---------~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          258 --EKKLEAL---------V--DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             --SCCSTTS---------S--CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             --chhhhhh---------c--ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence              0000000         0  00001111123446789999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-45  Score=304.55  Aligned_cols=249  Identities=20%  Similarity=0.322  Sum_probs=206.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.+. ++..+++|.+......   ...+.+|+.+++.+ +||||+++++++.....    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----   77 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAP----   77 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS----
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhC-CCCCEeeEEEEEccCCC----
Confidence            478999999999999999999986 4678999998754322   35788999999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++||++.+ +|.+++...   ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        78 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~  152 (267)
T 3t9t_A           78 -ICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTR  152 (267)
T ss_dssp             -CEEEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGG
T ss_pred             -eEEEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEccccccc
Confidence             8999999985 999998763   34689999999999999999999999999999999999999777 89999999987


Q ss_pred             ecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... .......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+.......      
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~------  225 (267)
T 3t9t_A          153 FVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------  225 (267)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred             ccccccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC------
Confidence            553221 1122334577899999998765 7999999999999999999 899999887776666554421111      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                           .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       226 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          226 ---------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                 112578899999999999999999999999973

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-45  Score=305.27  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=205.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.+.  +..+++|++............+.+|+.+++.+ +||||+++++++......   
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~---   82 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAP---   82 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSS---
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCC---
Confidence            578999999999999999999985  78899999886544444445688899999999 999999999998876211   


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ..+++|||+.+ +|.+++..  .....+++.+++.++.|++.||.|||++|  ++|+||||+||+++.++ .++++|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~  159 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADV  159 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGS
T ss_pred             CeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccc
Confidence            17899999985 99999976  33346899999999999999999999999  99999999999999777 899998888


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCC--CCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ......     ....+++.|+|||.+.+...  .+.++||||||+++|+|++|..||...+..+...........     
T Consensus       160 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  229 (271)
T 3kmu_A          160 KFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-----  229 (271)
T ss_dssp             CCTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             eeeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence            654222     23456899999999987542  233799999999999999999999988877766555432111     


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           ......+++.+.+++.+||+.||.+|||+.++++
T Consensus       230 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 ---------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 1122368899999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-45  Score=310.23  Aligned_cols=253  Identities=23%  Similarity=0.352  Sum_probs=198.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++.+.||+|+||.||++.+..+++.+++|++...... ......+.+|+.+++.+ +||||+++++++.....   
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~---  108 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQ---  108 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE---
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCe---
Confidence            57899999999999999999999999999999998754322 12235677899999999 99999999999987665   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++++|++.| +|.+++...    .++++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++
T Consensus       109 --~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~  181 (309)
T 2h34_A          109 --LYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIA  181 (309)
T ss_dssp             --EEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC-
T ss_pred             --EEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccC
Confidence              8999999986 999998763    4689999999999999999999999999999999999999777 9999999998


Q ss_pred             eecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          161 RAFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       161 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ....... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+....         
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  251 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI---------  251 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC---------
T ss_pred             ccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC---------
Confidence            7654432 2233456789999999987765 7899999999999999999999998876553333222110         


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-CHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-SAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~eil~  292 (304)
                                      .......+.+++++.++|.+||+.||.+|| |++++++
T Consensus       252 ----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ----------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ----------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ----------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                            011122347899999999999999999999 8888775

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.7e-45  Score=305.59  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=202.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC-----CCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG-----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ..++|++.+.||+|+||.||++.+..++..+++|.+........     ....+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCC
Confidence            35789999999999999999999999999999999876543322     225778899999999 999999999998654


Q ss_pred             ccCCceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCC---
Q 021982           77 NKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTM---  150 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~---  150 (304)
                      .       +++|||+. ++|.+.+..   ...++++..++.++.|++.||.+||++|  ++|+||||+||+++.++.   
T Consensus        96 ~-------~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           96 P-------RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             T-------EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             C-------eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCc
Confidence            3       58999998 499888764   3357999999999999999999999999  999999999999986651   


Q ss_pred             -eEEEeeccceeecccCCCccccccccccCCChhhhhC-CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH--HHHH
Q 021982          151 -TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ--LLHI  226 (304)
Q Consensus       151 -~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~  226 (304)
                       .++|+|||.+.....   ......+++.|+|||++.. ...++.++||||||+++|+|++|..||........  ....
T Consensus       166 ~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             CCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             eeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence             399999999964433   3344567999999999843 23368899999999999999999999986554332  2222


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ... .                         ........+++.+.++|.+||+.||.+|||+.++++
T Consensus       243 ~~~-~-------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          243 REE-G-------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHS-C-------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcc-C-------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            211 0                         011122368899999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.2e-45  Score=306.64  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=202.2

Q ss_pred             hhhhhhhh-hcccccceEEEEEEE--ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLE-KVGEGTYGKVYRARE--KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~-~lg~g~~g~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+ .||+|+||.||++.+  ..++..+++|++............+.+|+.+++.+ +||||+++++++.. .. 
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~-   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ES-   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SS-
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECC-CC-
Confidence            46788888 999999999999954  55678899999876544444456788999999999 99999999999833 33 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++||++.+ +|.+++...    ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||
T Consensus        92 ----~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           92 ----WMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             ----EEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             ----cEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCC
Confidence                7899999985 999998762    4589999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          159 LARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       159 ~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      ++.........   .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.....   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---  238 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---  238 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---
Confidence            99876543222   12233468899999998766 7899999999999999999 9999998877665555443211   


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                              ......+++.+.++|.+||+.||.+|||+.++++
T Consensus       239 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 ------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    1112368899999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.7e-45  Score=312.93  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=207.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-------cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-------ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .++|++.+.||+|+||.||++.+.       .++..+++|.+.... .......+.+|+.+++++.+||||+++++++..
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            578999999999999999999975       356789999886432 222235677899999999889999999999987


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhccC------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      ...     .++||||+.+ +|.+++......            ...+++..++.++.||+.||.+||++|++|+||||+|
T Consensus       113 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          113 DGP-----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             SSC-----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCc-----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            766     8999999986 999999864321            2348999999999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .+||+|||++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.....
T Consensus       188 Ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          188 VLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             EEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999777 899999999987654322  122334578899999998765 7999999999999999999 9999988877


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .+....+......                           .....++..+.++|.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 EELFKLLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6665555442111                           1123678999999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.3e-45  Score=328.52  Aligned_cols=250  Identities=22%  Similarity=0.359  Sum_probs=209.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++.++..|++|.+....   .....+.+|+.+++++ +||||+++++++.....    
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~----  290 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP----  290 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS----
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCc----
Confidence            467899999999999999999999989999999987532   2346788999999999 99999999999987766    


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+. |+|.+++...  ....+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       291 -~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  366 (495)
T 1opk_A          291 -FYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSR  366 (495)
T ss_dssp             -CEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEE
T ss_pred             -EEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccce
Confidence             899999998 4999999763  335689999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ....... ......+++.|+|||++.... ++.++||||||+++|+|++ |..||...+..+....+......       
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------  438 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------  438 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            6643321 122334467899999998766 7999999999999999999 99999887766555444332111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                          .....+++.+.+||.+||+.||.+|||+.+|++
T Consensus       439 --------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          439 --------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                112368899999999999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.6e-45  Score=304.34  Aligned_cols=254  Identities=19%  Similarity=0.238  Sum_probs=200.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|++|.||++.+..+++.+++|++....    ....+.+|+.+++.+ .|++++..+..+.....   
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~---   78 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGD---   78 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETT---
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHh-hcCCCCCccccccCCCC---
Confidence            4678999999999999999999999999999999886543    235688999999999 67665555555433222   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEe---CCCCeEEEeecc
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD---RKTMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~---~~~~~vkl~dfg  158 (304)
                       ..+++|||++++|.+++...   ..++++.+++.++.|++.||.|||++|++|+||||+||+++   .++ .+||+|||
T Consensus        79 -~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg  153 (296)
T 3uzp_A           79 -YNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFG  153 (296)
T ss_dssp             -EEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCT
T ss_pred             -ceEEEEEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCC
Confidence             27999999977999998742   34699999999999999999999999999999999999994   444 89999999


Q ss_pred             ceeecccCCC-------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHHHH
Q 021982          159 LARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFR  228 (304)
Q Consensus       159 ~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~  228 (304)
                      .+........       ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.....   ......+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            9987655432       123456799999999998766 79999999999999999999999976432   122222221


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .....                       ........+++++.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          233 KKMST-----------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHS-----------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cccCC-----------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            11000                       011112368899999999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.8e-46  Score=319.76  Aligned_cols=251  Identities=21%  Similarity=0.333  Sum_probs=195.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc---cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK---ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+.||+|+||.||+++++   .++..+++|.+.... .......+.+|+.+++++ +||||+++++++..... 
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKP-  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS-
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCc-
Confidence            468999999999999999999876   456779999986432 222335678899999999 99999999999987766 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++||||+.+ +|.+++..   ....+++.+++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||
T Consensus       121 ----~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  192 (373)
T 2qol_A          121 ----VMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFG  192 (373)
T ss_dssp             ----CEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             ----eEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCc
Confidence                8999999974 99999865   234689999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCCCcc---ccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          159 LARAFTLPIKKY---THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       159 ~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      ++..........   ....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......+ 
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-  270 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-  270 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            997665432211   1223367899999998766 8999999999999999998 999998887776665554322111 


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                                ....++..+.+++.+||+.||.+|||+.++++
T Consensus       271 --------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 --------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                      11257889999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=311.59  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=197.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEE----EEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIV----ALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||++.+..++..+    ++|.+... ........+.+|+.+++.+ +||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-
Confidence            578999999999999999999998877765    55555432 2333456788899999999 9999999999988654 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .+++++++.+ +|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+||
T Consensus        91 -----~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~Df  161 (327)
T 3lzb_A           91 -----VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             -----EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             -----ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccC
Confidence                 5788888875 999988763   34689999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          158 GLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       158 g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      |++.........  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......  
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--  238 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--  238 (327)
T ss_dssp             TC----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred             cceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            999766443222  22334477899999998766 7999999999999999999 99999887766655544332111  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               .....++.++.++|.+||+.||.+|||+.|+++
T Consensus       239 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 -------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     112357889999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.1e-45  Score=321.21  Aligned_cols=245  Identities=23%  Similarity=0.390  Sum_probs=203.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++  +..|++|+++...    ....+.+|+.+++++ +||||+++++++.....    
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~----  260 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKG----  260 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTS----
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCC----
Confidence            468999999999999999999876  6789999987432    456788999999999 99999999999766542    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..++||||+.+ +|.+++...  ....+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~  337 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTK  337 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCE
T ss_pred             ceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCcc
Confidence            18999999985 999999874  224579999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   ....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+......        
T Consensus       338 ~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------  405 (450)
T 1k9a_A          338 EASSTQ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------  405 (450)
T ss_dssp             ECC---------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC--------
T ss_pred             cccccc---cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            544321   2224578899999998766 8999999999999999998 99999887766655554432111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                         .....+++.+.++|.+||+.||.+|||+.++++
T Consensus       406 -------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          406 -------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                               112368899999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-44  Score=304.05  Aligned_cols=253  Identities=19%  Similarity=0.239  Sum_probs=196.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeecee-cccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVK-QGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-~~~~~~~   80 (304)
                      +.++|++.+.||+|+||.||++.+..+++.+++|++.....    ...+..|+.+++.+ .|++++..+..+ .....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~--   79 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY--   79 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTE--
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHh-cCCCCCCeeeeecCCCCc--
Confidence            46789999999999999999999999999999998665432    24678899999999 666665555554 33333  


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE---eCCCCeEEEeec
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM---DRKTMTLKIADL  157 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~---~~~~~~vkl~df  157 (304)
                         .+++||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||++   +.++ .+||+||
T Consensus        80 ---~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Df  152 (296)
T 4hgt_A           80 ---NVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDF  152 (296)
T ss_dssp             ---EEEEEECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCC
T ss_pred             ---eEEEEEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecC
Confidence               7999999988999998752   3469999999999999999999999999999999999999   5555 8999999


Q ss_pred             cceeecccCCC-------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchH---HHHHHHH
Q 021982          158 GLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSEL---QQLLHIF  227 (304)
Q Consensus       158 g~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~  227 (304)
                      |.+........       ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||......   .....+.
T Consensus       153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             ccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            99987654322       223456799999999998776 799999999999999999999999764321   1122111


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .....                       .........+++++.++|.+||+.||.+|||+.++++
T Consensus       232 ~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          232 EKKMS-----------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHH-----------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccccc-----------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11000                       0011122367899999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.5e-45  Score=305.27  Aligned_cols=257  Identities=24%  Similarity=0.409  Sum_probs=200.5

Q ss_pred             hhhhhhhhhcccccceEEEEEE----EccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||++.    +..++..+++|.+.... .......+.+|+.+++.+ +||||+++++++.....
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence            4679999999999999999998    56678999999987543 233446788999999999 99999999999886532


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                      .   ..+++|||+.+ +|.+++...   ...+++..++.++.|++.||++||++|++|+||||+||+++.++ .++|+||
T Consensus        98 ~---~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Df  170 (302)
T 4e5w_A           98 N---GIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDF  170 (302)
T ss_dssp             C---CEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred             c---eEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECcc
Confidence            1   27899999976 999998653   24689999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH-----------HH
Q 021982          158 GLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-----------QL  223 (304)
Q Consensus       158 g~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----------~~  223 (304)
                      |.+........   ......++..|+|||.+.+.. ++.++||||||+++|+|++|..|+.......           ..
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            99987655432   223345678899999998766 7899999999999999999998865432111           11


Q ss_pred             HHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          224 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .........                       .........+++.+.++|.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          250 TRLVNTLKE-----------------------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHT-----------------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhc-----------------------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            111111100                       0111123468899999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=324.22  Aligned_cols=280  Identities=20%  Similarity=0.293  Sum_probs=206.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++.+.||+|+||.||++.+..++..|++|++...... .....+.+|+.+++.+ +||||+++++++.....   
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~---   81 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT---   81 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT---
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCC---
Confidence            457899999999999999999999999999999998754322 2245667899999999 99999999999876542   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEE----eCCCCeEEEee
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLM----DRKTMTLKIAD  156 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~----~~~~~~vkl~d  156 (304)
                      ...++||||+.| +|.+++..... ...+++..++.++.|++.||.|||++|++|+||||+||++    +.++ .+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEec
Confidence            127999999975 99998866432 2348999999999999999999999999999999999998    5444 799999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhCC-------CCCCCchhHHHHHHHHHHHhhccccCCCCc----hHHHHHH
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGS-------THYSTAVDMWSVACIFAELVTKTALFPGDS----ELQQLLH  225 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~~Di~slG~il~~ll~g~~p~~~~~----~~~~~~~  225 (304)
                      ||++....... ......|++.|+|||++.+.       ..++.++||||||+++|+|++|..||....    ..+....
T Consensus       160 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  238 (396)
T 4eut_A          160 FGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (396)
T ss_dssp             GGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred             CCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence            99998765442 33445679999999998642       236789999999999999999999996432    2333333


Q ss_pred             HHHHhCCCCCCCCccccccCCc-ccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          226 IFRLLGTPNEKVWPGVSSLMNW-HEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      +..   ..+...+.......+. ..+....+ ........++..+.++|.+||+.||.+|||+.|++++
T Consensus       239 ~~~---~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          239 IIT---GKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHH---SCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             Hhc---CCCcccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            332   2222222222111110 00000000 0011112455678899999999999999999998653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.1e-46  Score=318.14  Aligned_cols=265  Identities=21%  Similarity=0.291  Sum_probs=203.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++ ++..+++|.+....  ......+.+|+.+++.+ +||||+++++++.....    
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----  109 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNE----  109 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTC----
T ss_pred             HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCe----
Confidence            478999999999999999999975 57889999876432  22345678899999999 99999999999987766    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++.........+++..++.++.|++.||.+||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       110 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  187 (321)
T 2qkw_B          110 -MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISK  187 (321)
T ss_dssp             -CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCE
T ss_pred             -EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccc
Confidence             8999999985 88888765444345689999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHH---HHHhCCCCCC
Q 021982          162 AFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHI---FRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~~  236 (304)
                      ......  .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||......+.....   .......   
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  263 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG---  263 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT---
T ss_pred             ccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc---
Confidence            654322  1223345799999999998766 799999999999999999999999754332111000   0000000   


Q ss_pred             CCccccccCCcccCCCCC-CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          237 VWPGVSSLMNWHEYPQWN-PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                  ...... ........+..+..+.+++.+||+.||.+|||+.|++++
T Consensus       264 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          264 ------------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             ------------CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                        000000 000111122455678999999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.9e-45  Score=312.66  Aligned_cols=256  Identities=20%  Similarity=0.323  Sum_probs=206.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc-----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||++.+..++.     .+++|.+.... .......+.+|+.+++.+.+||||+++++++....
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            4679999999999999999999876654     69999886432 11223567789999999978999999999998776


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc----------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEe
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ----------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD  146 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~  146 (304)
                      .     .++||||+.+ +|.+++.....          ....+++..++.++.|++.||.+||++|++|+||||+||+++
T Consensus       124 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          124 P-----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             S-----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             c-----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            6     8999999986 99999876432          134689999999999999999999999999999999999999


Q ss_pred             CCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHH
Q 021982          147 RKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQL  223 (304)
Q Consensus       147 ~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~  223 (304)
                      .++ .++|+|||++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.........
T Consensus       199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            777 999999999976544322  123344578899999998766 7999999999999999998 89999876655444


Q ss_pred             HHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          224 LHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ..........                          ......++.+.++|.+||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          277 YKLVKDGYQM--------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            4444321111                          111246889999999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-46  Score=339.48  Aligned_cols=289  Identities=25%  Similarity=0.361  Sum_probs=207.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~   81 (304)
                      .++|++.+.||+|+||.||++.+..++..|++|++.... .......+.+|+.+++.+ +||||+++++++..... ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCC
Confidence            478999999999999999999999999999999886432 122234677899999999 99999999998765221 112


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~dfg  158 (304)
                      ...++||||+.| +|.+++.... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++  ..++|+|||
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            236899999975 9999887632 234689999999999999999999999999999999999998655  249999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||........................
T Consensus       170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             ccccccccc-ccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            998765442 334457799999999987665 899999999999999999999999876543321111000000000000


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ........+..    ...........+++.+.++|.+||+.||.+|||+.++++||||+.++
T Consensus       248 ~~l~g~~~~~~----~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          248 DDLTGAVKFSS----VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCCSSSCCCCS----SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhcccccccc----ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            00000000000    00011112234678899999999999999999999999999998864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.2e-45  Score=303.02  Aligned_cols=249  Identities=23%  Similarity=0.393  Sum_probs=204.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||.||++.+. ++..+++|.+....   .....+.+|+++++.+ +||||+++++++....    
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~----   81 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQEP----   81 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS----
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhC-CCcCcceEEEEEcCCC----
Confidence            3578999999999999999999976 46679999886432   2246788999999999 9999999999986433    


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .+++|||+.+ +|.+++.....  ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus        82 --~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~  156 (279)
T 1qpc_A           82 --IYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLA  156 (279)
T ss_dssp             --CEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --cEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCccc
Confidence              6899999975 99998865321  3589999999999999999999999999999999999999776 8999999999


Q ss_pred             eecccCCCc-cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPIKK-YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ......... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~------  229 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------  229 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             ccccCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC------
Confidence            876543221 22334577899999998665 7899999999999999999 89999888777666555432111      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           .....+++.+.+++.+||+.||.+|||+.++++
T Consensus       230 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          230 ---------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                 112367899999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=309.15  Aligned_cols=252  Identities=20%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++.+.||+|+||.||++.++.++    ..+++|.+.... .......+.+|+.+++.+ +||||+++++++.....
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCC
Confidence            467889999999999999999886543    359999886432 222234677899999999 99999999999987766


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++|||++.+ +|.+++...   ...+++.+++.++.|++.||.+||++|++|+||||+||+++.++ .+||+||
T Consensus       121 -----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Df  191 (333)
T 1mqb_A          121 -----MMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDF  191 (333)
T ss_dssp             -----EEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             -----cEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCC
Confidence                 8999999986 999988752   34689999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCC
Q 021982          158 GLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       158 g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |.+.........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......+
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  270 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP  270 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence            999766543221   12223467899999998766 7999999999999999999 999998887766665554321111


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                                 ....++..+.++|.+||+.||.+|||+.+++++
T Consensus       271 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          271 ---------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       112578999999999999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.7e-45  Score=302.79  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=201.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ..++|++.+.||+|+||.||++.+...   +..+++|.+..... ......+.+|+.+++.+ +||||+++++++.... 
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-   86 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEEP-   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSSS-
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCC-
Confidence            357899999999999999999987543   34589998764321 12235677899999999 9999999999987543 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .+++||++.+ +|.+++...   ...+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+||
T Consensus        87 -----~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Df  157 (281)
T 3cc6_A           87 -----TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDF  157 (281)
T ss_dssp             -----CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCC
T ss_pred             -----CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCcc
Confidence                 5899999985 999998763   24689999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          158 GLARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       158 g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      |.+........ ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......+  
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~--  234 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP--  234 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC--
T ss_pred             CCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC--
Confidence            99876544321 223334578899999997665 7999999999999999998 999998776665555444321111  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               ....+++.+.++|.+||+.||.+|||+.|++++
T Consensus       235 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 -------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                     112578999999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4e-45  Score=309.45  Aligned_cols=259  Identities=23%  Similarity=0.370  Sum_probs=205.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEE-----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRARE-----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      ..++|++.+.||+|+||.||++.+     ..+++.+++|.+..... ......+.+|+.+++.+.+||||+++++++...
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            357899999999999999999985     34567899999864321 122346778999999997799999999998764


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccC------------CCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCe
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQT------------GENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNL  143 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Ni  143 (304)
                      ..    ..+++|||+.+ +|.+++......            ...+++..++.++.|++.||.+||+.|++|+||||+||
T Consensus       104 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          104 GG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             TS----CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             CC----ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            42    27899999986 999999764321            12388999999999999999999999999999999999


Q ss_pred             EEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchH
Q 021982          144 LMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL  220 (304)
Q Consensus       144 l~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~  220 (304)
                      +++.++ .++|+|||++........  ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......
T Consensus       180 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          180 LLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999777 899999999976543322  223345578899999998766 7999999999999999998 99999876644


Q ss_pred             HHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ............                          ......+++.+.++|.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCcc--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            433333322111                          01122578999999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=312.48  Aligned_cols=256  Identities=24%  Similarity=0.389  Sum_probs=187.9

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---CC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---EG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~   80 (304)
                      .+|++.+.||+|+||.||++.+..+++.|++|.+....  ......+.+|+.+++.+.+||||+++++++.....   ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            47999999999999999999999999999999886442  22234677899999999559999999999853322   33


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                      ....+++|||++|+|.+++..... ..++++.+++.++.||+.||.|||+.|  ++|+||||+||+++.++ .+||+|||
T Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCT
T ss_pred             CceEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCc
Confidence            445899999999999999876433 346999999999999999999999999  99999999999999777 89999999


Q ss_pred             ceeecccCCCc------------cccccccccCCChhhhh--CCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHH
Q 021982          159 LARAFTLPIKK------------YTHEILTLWYRAPEVLL--GSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL  224 (304)
Q Consensus       159 ~~~~~~~~~~~------------~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~  224 (304)
                      ++.........            .....+++.|+|||++.  ....++.++||||||+++|+|++|..||..........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  263 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN  263 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence            99766543211            11335789999999984  23347889999999999999999999997654322111


Q ss_pred             HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          225 HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..   .                           ........+..+.+||.+||+.||.+|||+.|++++
T Consensus       264 ~~---~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          264 GK---Y---------------------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -----C---------------------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             Cc---c---------------------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            10   0                           001122567889999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=312.66  Aligned_cols=257  Identities=12%  Similarity=0.100  Sum_probs=198.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc--------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeee-----
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA--------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRL-----   69 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~-----   69 (304)
                      .++|++.+.||+|+||.||++.+..        .+..+++|.+...       ..+.+|+.+++.+ +||||+++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRA-AKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHH-CCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHh-cccchhhhhhhhc
Confidence            4689999999999999999999987        4788999998743       4688999999999 89999884     


Q ss_pred             ----------eceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 021982           70 ----------MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLK  139 (304)
Q Consensus        70 ----------~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~  139 (304)
                                ++++....    ...++||||++++|.+++....  ...+++.+++.++.||+.||.|||++|++|+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik  186 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQD----KYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYVHGNVT  186 (352)
T ss_dssp             TCTTCSCCCCCEEEEETT----TEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred             cCCccCccchhhccccCC----cEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence                      34433311    2389999999779999998642  3569999999999999999999999999999999


Q ss_pred             CCCeEEeCCC-CeEEEeeccceeecccCCC-------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcc
Q 021982          140 PHNLLMDRKT-MTLKIADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT  211 (304)
Q Consensus       140 ~~Nil~~~~~-~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~  211 (304)
                      |+||+++.++ ..++|+|||++........       ......+++.|+|||++.+.. ++.++||||||+++|+|++|.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~  265 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCC
Confidence            9999999654 3799999999976643321       123346799999999988765 799999999999999999999


Q ss_pred             ccCCCCc-hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHH
Q 021982          212 ALFPGDS-ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA  290 (304)
Q Consensus       212 ~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei  290 (304)
                      .||.... ...........+.........                  .......+++.+.++|.+||+.||.+|||+.++
T Consensus       266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVG------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             CTTGGGTTCHHHHHHHHHHHHHSCCCEEC------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             CCcccCCcCHHHHHHHHHhccCChhhhhh------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence            9998764 333333222222111110000                  000112578999999999999999999999999


Q ss_pred             hc
Q 021982          291 ME  292 (304)
Q Consensus       291 l~  292 (304)
                      ++
T Consensus       328 ~~  329 (352)
T 2jii_A          328 RN  329 (352)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=311.93  Aligned_cols=259  Identities=22%  Similarity=0.395  Sum_probs=203.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++.+..+++.+++|.+....  ......+.+|+.+++.+ +||||+++++++..... ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLF-NHPNILRLVAYCLRERG-AKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEET-TEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccC-CCc
Confidence            367999999999999999999999999999999886532  22345677899999999 99999999999874322 223


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..++++||+.+ +|.+++........++++.+++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.+.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~  182 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcch
Confidence            37899999986 99999988766678899999999999999999999999999999999999999777 89999999886


Q ss_pred             ecccCCCc---------cccccccccCCChhhhhCCCC--CCCchhHHHHHHHHHHHhhccccCCCCchH--HHHHHHHH
Q 021982          162 AFTLPIKK---------YTHEILTLWYRAPEVLLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSEL--QQLLHIFR  228 (304)
Q Consensus       162 ~~~~~~~~---------~~~~~~~~~~~~PE~~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~  228 (304)
                      ........         .....+++.|+|||++.+...  ++.++||||||+++|+|++|..||......  ........
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            54321111         122345889999999875432  688999999999999999999998532111  01111111


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..                           .....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       263 ~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 QL---------------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cC---------------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            00                           001123678999999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-44  Score=311.12  Aligned_cols=259  Identities=15%  Similarity=0.179  Sum_probs=194.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-----CcEEEEEEeeecCCCCCCCchhHHHHHH---------------HHHccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-----GKIVALKKTRLHEDDEGVPPTTLREVSI---------------LRMLSR   62 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~---------------l~~l~~   62 (304)
                      .++|++++.||+|+||.||++.+..+     +..|++|++....      .....|+.+               ++.+ +
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~  106 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN------GPLFTELKFYQRAAKPEQIQKWIRTRKL-K  106 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC------HHHHHHHHHHHHHCCHHHHHHHHHHTTC-S
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc------hhHHHHHHHHHhhhhhHHHHHHHHHhhc-c
Confidence            35899999999999999999998765     5789999876432      233344444               4444 6


Q ss_pred             CCCeeeeeceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           63 DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        63 h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      ||||+++++++..... +....++||||++++|.+++...   ...+++.+++.++.||+.||.|||++|++|+||||+|
T Consensus       107 h~~iv~~~~~~~~~~~-~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~N  182 (364)
T 3op5_A          107 YLGVPKYWGSGLHDKN-GKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASN  182 (364)
T ss_dssp             CCCSCCEEEEEEEEET-TEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCeEEeeeeeccC-CcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHH
Confidence            9999999999877532 23347999999966999998762   3569999999999999999999999999999999999


Q ss_pred             eEEe--CCCCeEEEeeccceeecccCCCc-------cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc
Q 021982          143 LLMD--RKTMTLKIADLGLARAFTLPIKK-------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL  213 (304)
Q Consensus       143 il~~--~~~~~vkl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p  213 (304)
                      |+++  .++ .+||+|||++.........       .....||+.|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus       183 ill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~P  260 (364)
T 3op5_A          183 LLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLP  260 (364)
T ss_dssp             EEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            9998  555 8999999999776433211       12334799999999998776 89999999999999999999999


Q ss_pred             CCCCchHHHHH-HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          214 FPGDSELQQLL-HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       214 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      |.......... ...............                .  ......+++++.+++..||+.||.+||++.+|++
T Consensus       261 f~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~--~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          261 WEDNLKDPKYVRDSKIRYRENIASLMD----------------K--CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHCHHHHHH----------------H--HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccccCHHHHHHHHHHhhhhHHHHHH----------------H--hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            98543222211 111111000000000                0  0001367899999999999999999999999886

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=302.44  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=205.1

Q ss_pred             hhhhhhhh-hcccccceEEEEEEEc--cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLE-KVGEGTYGKVYRAREK--ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~-~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|.+.+ .||+|+||.||++.+.  .++..+++|.+.... .......+.+|+.+++.+ +||||+++++++.. .. 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~-   83 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EA-   83 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SS-
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC-CC-
Confidence            56788887 9999999999999864  457789999987542 222345677899999999 99999999999843 33 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++|||++.+ +|.+++..   ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||
T Consensus        84 ----~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg  155 (287)
T 1u59_A           84 ----LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFG  155 (287)
T ss_dssp             ----EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCT
T ss_pred             ----cEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECccc
Confidence                7999999986 99888853   235699999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          159 LARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       159 ~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      .+.........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+.....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---  231 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---  231 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---
Confidence            99876543221   22234478899999997665 7899999999999999998 9999988877666555443211   


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCC
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP  294 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  294 (304)
                                              ......+++.+.++|.+||+.||.+|||+.+++++.
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                                    112236889999999999999999999999999863

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.1e-45  Score=322.38  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++. +..|++|++....   .....+.+|+.+++.+ +||||+++++++... .    
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~----  256 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS---MSVEAFLAEANVMKTL-QHDKLVKLHAVVTKE-P----  256 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS---BCHHHHHHHHHHHTTC-CCTTBCCEEEEECSS-S----
T ss_pred             hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC---ccHHHHHHHHHHHhhC-CCCCEeeEEEEEeCC-c----
Confidence            4679999999999999999999864 6779999987532   2356788999999999 999999999998633 2    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++.....  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       257 -~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~  332 (454)
T 1qcf_A          257 -IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLAR  332 (454)
T ss_dssp             -CEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGG
T ss_pred             -cEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCce
Confidence             6899999975 99999975322  3578999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... .......+++.|+|||++.... ++.++||||||+++|+|++ |..||...+..+....+......+.     
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-----  406 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-----  406 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-----
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence            654321 1112233467899999998766 8999999999999999999 9999998888777766655322211     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                            ...+++++.++|.+||+.||.+|||+++|++
T Consensus       407 ----------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          407 ----------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                  1258899999999999999999999999976

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=312.11  Aligned_cols=263  Identities=15%  Similarity=0.112  Sum_probs=194.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc---CCcEEEEEEeeecCCC---------CCCCchhHHHHHHHHHccCCCCeeeee
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA---TGKIVALKKTRLHEDD---------EGVPPTTLREVSILRMLSRDPHVVRLM   70 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~h~~i~~~~   70 (304)
                      .++|++.+.||+|+||.||++.+..   ++..+++|........         ......+.+|+..++.+ +||||++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~  114 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY  114 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence            4689999999999999999999987   7788999988754211         00123455677788888 999999999


Q ss_pred             ceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC-
Q 021982           71 DVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-  149 (304)
Q Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~-  149 (304)
                      +++..... +....++||||++++|.+++...    ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++ 
T Consensus       115 ~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          115 GSGLTEFK-GRSYRFMVMERLGIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEEESS-SCEEEEEEEECEEEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             cccccccC-CCcEEEEEEeccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            99887431 22348999999966999988653    2689999999999999999999999999999999999998554 


Q ss_pred             CeEEEeeccceeecccCCC-------ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCC-chHH
Q 021982          150 MTLKIADLGLARAFTLPIK-------KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGD-SELQ  221 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~-~~~~  221 (304)
                      ..+||+|||++........       ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||... ....
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence            3899999999977643221       113446799999999998775 799999999999999999999999542 2222


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccC--CCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAV--PNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ..............                    .......  ..+++++.++|.+||+.||.+|||+++|++
T Consensus       269 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          269 AVQTAKTNLLDELP--------------------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHTTT--------------------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhccccc--------------------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22222211111100                    0011111  158899999999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.9e-45  Score=312.31  Aligned_cols=258  Identities=21%  Similarity=0.300  Sum_probs=194.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||++++.  ++.|++|++......   ......|+.+++.+ +||||+++++++...... ..
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~-~~   95 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ---SWQNEYEVYSLPGM-KHENILQFIGAEKRGTSV-DV   95 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH---HHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSS-SE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH---HHHHHHHHHHHhcC-CCCCchhhcceeccCCCC-Cc
Confidence            357999999999999999999876  788999998654211   23445578888898 999999999998875432 23


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc----------CccccCCCCCCeEEeCCCCe
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH----------GILHRDLKPHNLLMDRKTMT  151 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~----------~i~h~dl~~~Nil~~~~~~~  151 (304)
                      .+++||||+.+ +|.+++..     ..+++..++.++.|++.||.|||+.          |++|+||||+||+++.++ .
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~  169 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-T  169 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-C
T ss_pred             eEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-e
Confidence            37999999986 99999976     4599999999999999999999999          999999999999999777 9


Q ss_pred             EEEeeccceeecccCCC--ccccccccccCCChhhhhCCC----CCCCchhHHHHHHHHHHHhhccccCCCCchHH----
Q 021982          152 LKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGST----HYSTAVDMWSVACIFAELVTKTALFPGDSELQ----  221 (304)
Q Consensus       152 vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~----~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----  221 (304)
                      +||+|||++........  ......|++.|+|||++.+..    .++.++||||||+++|+|++|..||.......    
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            99999999977654332  223356799999999997642    24567899999999999999999997543210    


Q ss_pred             --------HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccc--cCCCCChhhHHHHHHhhcCCCCCCCCHHHHh
Q 021982          222 --------QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT--AVPNLDKDGLDLLEQMLQYDPSKRISAKKAM  291 (304)
Q Consensus       222 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  291 (304)
                              ....+.........                   ......  .....+.++.+||.+||+.||.+|||+.|++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell  310 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVVVHKKK-------------------RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG  310 (322)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCC-------------------CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhhhccCCchhhhhhhhhcccC-------------------CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence                    00011110000000                   000000  0012335589999999999999999999998


Q ss_pred             c
Q 021982          292 E  292 (304)
Q Consensus       292 ~  292 (304)
                      +
T Consensus       311 ~  311 (322)
T 3soc_A          311 E  311 (322)
T ss_dssp             H
T ss_pred             H
Confidence            7

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.8e-45  Score=308.88  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=202.8

Q ss_pred             hhhhhhhhhcccccceEEEEEE----EccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||+++    +..++..+++|.+....  ......+.+|+.+++.+ +||||+++++++.....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence            4689999999999999999999    46678899999986432  12234578899999999 99999999998764322


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                         ...++||||+.+ +|.+++.....   .+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+||
T Consensus        99 ---~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Df  171 (327)
T 3lxl_A           99 ---QSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADF  171 (327)
T ss_dssp             ---CEEEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCG
T ss_pred             ---ceEEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEccc
Confidence               237899999965 99999876432   589999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHH----------
Q 021982          158 GLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLL----------  224 (304)
Q Consensus       158 g~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~----------  224 (304)
                      |.+........   ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||..........          
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL  250 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence            99987654322   223345678899999998766 7899999999999999999999987654322111          


Q ss_pred             -HHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          225 -HIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                       ........                       .........+++.+.++|.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          251 SRLLELLEE-----------------------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHT-----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhhc-----------------------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             11110000                       01111234688999999999999999999999999764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-44  Score=304.32  Aligned_cols=246  Identities=26%  Similarity=0.408  Sum_probs=190.3

Q ss_pred             chhhhhhh-hhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKL-EKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|.++ +.||+|+||.||++.+..++..|++|.+..       .....+|+.++.++.+||||+++++++..... +
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~   86 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA-G   86 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-T
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC-C
Confidence            56788887 779999999999999999999999999863       34677899988665599999999999876221 1


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeec
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADL  157 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~df  157 (304)
                      ....++||||+.| +|.+++..  .....+++..++.++.|++.||.|||++|++|+||||+||+++.+  +..++|+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            2238999999986 99999987  333579999999999999999999999999999999999999973  348999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |++.....                       ..++.++||||||+++|+|++|..||................       
T Consensus       165 g~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~-------  214 (299)
T 3m2w_A          165 GFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------  214 (299)
T ss_dssp             TTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS-------
T ss_pred             cccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH-------
Confidence            99854321                       126789999999999999999999997655432111000000       


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                                   ..............+++++.++|.+||+.||.+|||+.|+++||||.+..
T Consensus       215 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          215 -------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             -------------CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             -------------hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                         00000001111246899999999999999999999999999999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.2e-44  Score=318.71  Aligned_cols=254  Identities=21%  Similarity=0.266  Sum_probs=202.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||++.+..++..|+||++.....    ...+..|+.+++.+..++++..+..+......   
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~---   77 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDY---   77 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE---
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE---
Confidence            56899999999999999999999999999999998765432    34678999999999555666666666555444   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEe---CCCCeEEEeecc
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMD---RKTMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~---~~~~~vkl~dfg  158 (304)
                        .++||||++++|.+++...   ...+++.+++.++.||+.||.|||++||+|+||||+|||++   .++ .+||+|||
T Consensus        78 --~~lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFG  151 (483)
T 3sv0_A           78 --NVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFG  151 (483)
T ss_dssp             --EEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCT
T ss_pred             --EEEEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCC
Confidence              7999999988999998753   34699999999999999999999999999999999999994   445 89999999


Q ss_pred             ceeecccCCCc-------cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHHHH
Q 021982          159 LARAFTLPIKK-------YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHIFR  228 (304)
Q Consensus       159 ~~~~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~  228 (304)
                      ++.........       .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||.....   .+.+..+..
T Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             cceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            99876543221       22456799999999998776 79999999999999999999999987543   233332222


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ....                       .........++.++.+||.+||+.||.+||++.+|++
T Consensus       231 ~~~~-----------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          231 KKVA-----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHH-----------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccc-----------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1100                       0111112368899999999999999999999998876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-44  Score=300.69  Aligned_cols=245  Identities=23%  Similarity=0.389  Sum_probs=195.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|++|.||++.+.  +..+++|.+...    .....+.+|+.+++.+ +||||+++++++.....    
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~----   88 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKG----   88 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC------
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch----hHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCC----
Confidence            578999999999999999999875  788999988643    2346788999999999 99999999998655432    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..+++|||+.+ +|.+++.....  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~  165 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTK  165 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC--
T ss_pred             ceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeeccccc
Confidence            17899999986 99999976422  3478999999999999999999999999999999999999777 99999999987


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+....          
T Consensus       166 ~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----------  231 (278)
T 1byg_A          166 EASSTQ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------  231 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------
T ss_pred             cccccc---cCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------
Confidence            554332   2234578899999998765 7999999999999999998 999998776655444432211          


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                       .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       232 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 -----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                             01112368899999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-44  Score=319.91  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=203.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++. +..+++|++.....   ....+.+|+.+++.+ +||||+++++++.. ..    
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~----  252 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EP----  252 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS----
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-Cc----
Confidence            4679999999999999999999875 45699999875332   235788999999999 99999999999876 22    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++....  ...+++.+++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       253 -~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~  328 (452)
T 1fmk_A          253 -IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLAR  328 (452)
T ss_dssp             -CEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC
T ss_pred             -eEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccce
Confidence             6899999985 9999996532  24589999999999999999999999999999999999999777 89999999997


Q ss_pred             ecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ....... ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......+      
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------  401 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------  401 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            6543221 122334577899999998765 7999999999999999999 999999888777666554422111      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC--CCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH--PYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~--~~~~~  298 (304)
                                           ....+++.+.++|.+||+.||.+|||+++|++.  .+|..
T Consensus       402 ---------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          402 ---------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ---------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                                 123688999999999999999999999999873  45543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=303.36  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=205.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.+..   .+++|++............+.+|+.+++.+ +||||+++++++.....    
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~----  103 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPH----  103 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSC----
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCc----
Confidence            4789999999999999999998864   489999887666666667888999999999 99999999999988776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.| +|.+++..   ....+++..++.++.|++.||.+||+.|++|+||+|+||+++ ++ .++|+|||++.
T Consensus       104 -~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~  177 (319)
T 2y4i_B          104 -LAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFS  177 (319)
T ss_dssp             -EEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC
T ss_pred             -eEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCcc
Confidence             8999999985 99888754   234689999999999999999999999999999999999998 55 89999999976


Q ss_pred             ecccC-----CCccccccccccCCChhhhhC--------CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHH
Q 021982          162 AFTLP-----IKKYTHEILTLWYRAPEVLLG--------STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFR  228 (304)
Q Consensus       162 ~~~~~-----~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  228 (304)
                      .....     ........|++.|+|||++.+        ...++.++||||||+++|+|++|..||...........+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  257 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT  257 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            54321     122333457899999999875        23478899999999999999999999998877666555443


Q ss_pred             HhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ......                          ....++.++.+++.+||+.||.+|||+.++++  .|+++
T Consensus       258 ~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l  300 (319)
T 2y4i_B          258 GMKPNL--------------------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKL  300 (319)
T ss_dssp             TCCCCC--------------------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred             CCCCCC--------------------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence            211110                          11257889999999999999999999999997  44443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-45  Score=323.72  Aligned_cols=258  Identities=17%  Similarity=0.208  Sum_probs=195.1

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCC-CCeeeeece----------
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRD-PHVVRLMDV----------   72 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~----------   72 (304)
                      .|+..+.||+|+||.||++.+..+|..|+||++.... ........+.+|+.+++.+ .| ++...+..+          
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhhc
Confidence            4778889999999999999999999999999887433 2333466788899999988 55 322111111          


Q ss_pred             -----------ecccccCCceEEEEEEeccCCCHHHHHHHh---ccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC
Q 021982           73 -----------KQGQNKEGRTVLYLVFEYMDTDLKKYIRSF---RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL  138 (304)
Q Consensus        73 -----------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl  138 (304)
                                 +...........+++|+.+.++|.++++..   .....++++..++.++.|++.||.|||++||+||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                       111110011226889999999999888643   233446788899999999999999999999999999


Q ss_pred             CCCCeEEeCCCCeEEEeeccceeecccCCCccccccccccCCChhhhh---------CCCCCCCchhHHHHHHHHHHHhh
Q 021982          139 KPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL---------GSTHYSTAVDMWSVACIFAELVT  209 (304)
Q Consensus       139 ~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~---------~~~~~~~~~Di~slG~il~~ll~  209 (304)
                      ||+|||++.++ .+||+|||++...+..   .....| +.|+|||++.         ....++.++||||||+++|+|++
T Consensus       238 Kp~NILl~~~~-~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          238 RPVDIVLDQRG-GVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CGGGEEECTTC-CEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCC-eEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999887 8999999998765543   334466 9999999994         33337889999999999999999


Q ss_pred             ccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHH
Q 021982          210 KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK  289 (304)
Q Consensus       210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  289 (304)
                      |..||...+.......                                .......+|+.+.+||.+||+.||.+|||+.+
T Consensus       313 g~~Pf~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEW--------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             SSCCCCTTGGGSCSGG--------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCcchhhhHHH--------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999976553211110                                00111267899999999999999999999999


Q ss_pred             HhcCCCccccc
Q 021982          290 AMEHPYFDDLD  300 (304)
Q Consensus       290 il~~~~~~~~~  300 (304)
                      +++||||+.+.
T Consensus       361 ~l~~~~~~~~~  371 (413)
T 3dzo_A          361 AMETPEYEQLR  371 (413)
T ss_dssp             HTTSHHHHHHH
T ss_pred             HHhCHHHHHHH
Confidence            99999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-44  Score=301.11  Aligned_cols=247  Identities=28%  Similarity=0.349  Sum_probs=191.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.+.  ++.+++|.+...    .....+.+|+.+++++ +||||+++++++.+.      
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~------   73 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRV-NHPNIVKLYGACLNP------   73 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTTT------
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC------
Confidence            468999999999999999999875  678999987532    2345678899999999 999999999987732      


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh---cCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG---HGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                       .++||||+.| +|.+++.... ....+++..++.++.|++.||.|||+   +|++|+||||+||+++.++..+||+|||
T Consensus        74 -~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           74 -VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             -TEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             -cEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence             5899999975 9999987532 12347889999999999999999999   8999999999999999777568999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .+......   .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||.................       
T Consensus       152 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------  220 (307)
T 2eva_A          152 TACDIQTH---MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-------  220 (307)
T ss_dssp             C---------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-------
T ss_pred             cccccccc---cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-------
Confidence            99765432   22345799999999998765 89999999999999999999999976433221111111100       


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                        ........+++.+.+++.+||+.||.+|||+.+++++
T Consensus       221 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          221 ------------------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             ------------------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                              0111223688999999999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.4e-45  Score=305.41  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=194.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHH--ccCCCCeeeeeceecccccC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM--LSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +.++|++++.||+|+||.||++.+  ++..|++|++....     ......|.+++..  + +||||+++++++......
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVML-RHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETT
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCC
Confidence            578999999999999999999987  58889999986432     2345567777776  6 899999999987654322


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH--------hcCccccCCCCCCeEEeCCCC
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--------GHGILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~i~h~dl~~~Nil~~~~~~  150 (304)
                       ....+++|||+.+ +|.+++..     ..+++..++.++.|++.||.|||        +.|++|+||||+||+++.++ 
T Consensus        78 -~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-  150 (301)
T 3q4u_A           78 -STQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-  150 (301)
T ss_dssp             -EEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-
T ss_pred             -CceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-
Confidence             2337899999986 99999843     47999999999999999999999        99999999999999999777 


Q ss_pred             eEEEeeccceeecccCCCc----cccccccccCCChhhhhCCCC-----CCCchhHHHHHHHHHHHhhc----------c
Q 021982          151 TLKIADLGLARAFTLPIKK----YTHEILTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTK----------T  211 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~il~~ll~g----------~  211 (304)
                      .+||+|||++.........    .....|++.|+|||++.+...     ++.++||||||+++|+|++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            9999999999766543322    223367999999999987632     34689999999999999999          7


Q ss_pred             ccCCCCc----hHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          212 ALFPGDS----ELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       212 ~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                      .||....    .................  .                  .........++.+.+|+.+||+.||.+|||+
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  290 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPN--I------------------PNRWFSDPTLTSLAKLMKECWYQNPSARLTA  290 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCC--C------------------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCC--C------------------ChhhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence            7775432    12222222111000000  0                  0000111355779999999999999999999


Q ss_pred             HHHhc
Q 021982          288 KKAME  292 (304)
Q Consensus       288 ~eil~  292 (304)
                      .++++
T Consensus       291 ~~i~~  295 (301)
T 3q4u_A          291 LRIKK  295 (301)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-44  Score=307.14  Aligned_cols=260  Identities=24%  Similarity=0.376  Sum_probs=200.8

Q ss_pred             chhhh-hhhhhcccccceEEEEEEE----ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccc
Q 021982            2 VMDAF-EKLEKVGEGTYGKVYRARE----KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y-~~~~~lg~g~~g~v~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   76 (304)
                      +.++| ++++.||+|+||.||++..    ..++..+++|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecC
Confidence            45666 9999999999999988754    4467889999987432 112234678899999999 899999999998864


Q ss_pred             ccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEe
Q 021982           77 NKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIA  155 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~  155 (304)
                      ..   ..+++||||+.+ +|.+++..     ..+++.+++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+
T Consensus       106 ~~---~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~  176 (318)
T 3lxp_A          106 GA---ASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIG  176 (318)
T ss_dssp             TT---TEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             CC---ceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEEC
Confidence            32   137899999986 99998855     3589999999999999999999999999999999999999777 89999


Q ss_pred             eccceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH-----------
Q 021982          156 DLGLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-----------  221 (304)
Q Consensus       156 dfg~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----------  221 (304)
                      |||.+........   ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||.......           
T Consensus       177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  255 (318)
T 3lxp_A          177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM  255 (318)
T ss_dssp             CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred             CccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence            9999987655432   122334578899999998766 7899999999999999999999987654321           


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ...........                       .........++.++.+||.+||+.||.+|||+.|+++  +|+.
T Consensus       256 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~  307 (318)
T 3lxp_A          256 TVLRLTELLER-----------------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKT  307 (318)
T ss_dssp             HHHHHHHHHHT-----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             hHHHHHHHHhc-----------------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHH
Confidence            11111111100                       0011122368899999999999999999999999986  4443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=299.99  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=195.5

Q ss_pred             hhhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      |++.+.||+|+||.||++.+..++.   .+++|.+.... .......+.+|+.+++.+ +||||+++++++......   
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~---   97 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGL---   97 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC---
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCC---
Confidence            5566899999999999999765544   68889876322 112235677899999999 999999999998765541   


Q ss_pred             EEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++++|++. ++|.+++..   ....+++.+++.++.|++.||++||++|++|+||||+||+++.++ .++|+|||.+.
T Consensus        98 -~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~  172 (298)
T 3pls_A           98 -PHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLAR  172 (298)
T ss_dssp             -CEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSC
T ss_pred             -cEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcc
Confidence             489999996 499998865   235689999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccC----CCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc-CCCCchHHHHHHHHHHhCCCCCC
Q 021982          162 AFTLP----IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       162 ~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      .....    ........+++.|+|||.+.+.. ++.++||||||+++|+|++|..| |...+..+....+......    
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----  247 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL----  247 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC----
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC----
Confidence            55332    12233345588999999997765 79999999999999999996555 5554444444433322111    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                             .....+++.+.+++.+||+.||.+|||+.++++
T Consensus       248 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 -----------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                   112357889999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.5e-44  Score=300.23  Aligned_cols=257  Identities=24%  Similarity=0.329  Sum_probs=198.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-CCc--EEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-TGK--IVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~--~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||++.+.. ++.  .+++|.+..... .......+.+|+.+++.+ +||||+++++++.... 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-
Confidence            5789999999999999999998643 333  589998875432 222345778899999999 9999999999988654 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++++|++.+ +|.+++....   ..+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+||
T Consensus        95 -----~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           95 -----MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             -----CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -----ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccc
Confidence                 5899999985 9999887642   3589999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCC
Q 021982          158 GLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       158 g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |.+.........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+...... 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-  243 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-  243 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC-
Confidence            999776543221   12334577899999998765 7899999999999999999 99999988776666555432111 


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                               ......++..+.++|.+||+.||.+|||+.++++  +|.++
T Consensus       244 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          244 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             -------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence                                     1112368899999999999999999999999998  55544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.9e-44  Score=300.38  Aligned_cols=251  Identities=23%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCC---cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATG---KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .+|++.+.||+|+||.||++.+..++   ..+++|.+.... .......+.+|+.+++++ +||||+++++++...... 
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS-  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC-
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCc-
Confidence            35889999999999999999975433   357888775322 222235677899999999 999999999986543321 


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .+++|||+.+ +|.+++..   ....+++..++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||.
T Consensus       102 ---~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          102 ---PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             ---CEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             ---eEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcccc
Confidence               7899999987 99999864   235689999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCC----CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCC
Q 021982          160 ARAFTLPI----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       160 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      +.......    .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......  
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--  251 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--  251 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC--
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC--
Confidence            97654322    1223334578899999998766 7999999999999999999 56667666655554444332111  


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               .....+++.+.+++.+||+.||.+|||+.++++
T Consensus       252 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          252 -------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     112257889999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.6e-44  Score=301.83  Aligned_cols=262  Identities=24%  Similarity=0.318  Sum_probs=200.0

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC--CCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED--DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      |...+.||+|+||.||++.+  ++..+++|.+.....  .......+.+|+.+++.+ +||||+++++++.....     
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-----  104 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDD-----  104 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS-----
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCc-----
Confidence            45558999999999999986  478899998875432  222345678899999999 99999999999987766     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .+++|||+.+ +|.+++.... ...++++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+..
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  182 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARA  182 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence            8999999975 9999887543 235789999999999999999999999999999999999999777 999999999976


Q ss_pred             cccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .......  .....|++.|+|||.+.+.  ++.++||||||+++|+|++|..||...........+.......... +..
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  259 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT-IED  259 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC-HHH
T ss_pred             cccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh-hhh
Confidence            5543221  2334679999999988653  6899999999999999999999998765433222222221111100 000


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .            ............+..+.+++.+||+.||.+|||+.++++
T Consensus       260 ~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          260 Y------------IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             H------------SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             h------------ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            0            000111112234567899999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-43  Score=325.29  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=198.9

Q ss_pred             hhcccccceEEEEEEE--ccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRARE--KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      +.||+|+||.||++.+  +.++..++||+++...........+.+|+++++.+ +||||+++++++....      .++|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~------~~lv  447 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAES------WMLV  447 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEESSS------EEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC------EEEE
Confidence            4799999999999965  45567899999876554444456788999999999 9999999999986432      6899


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.+ +|.+++..    ...+++.+++.++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++......
T Consensus       448 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  522 (635)
T ss_dssp             EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC-
T ss_pred             EEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccC
Confidence            999986 99999865    24689999999999999999999999999999999999999777 9999999999766433


Q ss_pred             CC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          167 IK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       167 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ..   ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+......          
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----------  591 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----------  591 (635)
T ss_dssp             ------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred             ccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            21   122334478899999998766 7999999999999999998 99999988887766665543211          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                       .....+++++.+||.+||+.||.+|||+.+|++
T Consensus       592 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                             112368899999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.7e-44  Score=321.37  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=207.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||.||++.++. +..|+||++.....   ....+.+|+.+++.+ +||||+++++++... .    
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~----  335 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE-P----  335 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-S----
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhC-CCCCEeeEEEEEeec-c----
Confidence            4679999999999999999999875 45699999875332   235788999999999 999999999998763 2    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++....  ...+++.+++.++.||+.||.|||++|++|+||||+|||++.++ .+||+|||++.
T Consensus       336 -~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  411 (535)
T 2h8h_A          336 -IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLAR  411 (535)
T ss_dssp             -CEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTT
T ss_pred             -ceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccce
Confidence             6899999986 9999996532  24589999999999999999999999999999999999999777 89999999997


Q ss_pred             ecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... .......++..|+|||++.... ++.++||||||+++|+|++ |..||......+....+......+      
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------  484 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------  484 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC------
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            554321 1112234467899999998765 8999999999999999999 899999888777666554322111      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC--CCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH--PYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~--~~~~~  298 (304)
                                           ....++..+.+||.+||+.||.+|||+++|++.  .+|..
T Consensus       485 ---------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          485 ---------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ---------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                                 123688999999999999999999999999874  45543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-44  Score=309.21  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=188.7

Q ss_pred             hhhhhhhcccccceEEEEEEEccCC---cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATG---KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .|++.+.||+|+||.||++.+..++   ..+++|.+... ........+.+|+.+++++ +||||+++++++......  
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~--  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS--  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC--
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC--
Confidence            4677899999999999999875433   35788877532 2222345678899999999 999999999986543321  


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.+ +|.+++..   ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++
T Consensus       166 --~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a  239 (373)
T 3c1x_A          166 --PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLA  239 (373)
T ss_dssp             --CEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred             --eEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccc
Confidence              6899999986 99999864   234688999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCC----ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          161 RAFTLPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       161 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ........    ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+......   
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~---  315 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---  315 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC---
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC---
Confidence            76543211    122334577899999998766 7999999999999999999 67788766554444433321110   


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                              .....+++.+.+++.+||+.||.+|||+.+++++
T Consensus       316 ------------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          316 ------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    1123578999999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=300.09  Aligned_cols=256  Identities=24%  Similarity=0.383  Sum_probs=199.7

Q ss_pred             hhhhhhhhhcccccceEEEEEE----EccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAR----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||++.    +..++..+++|.+...  .......+.+|+.+++.+ +||||+++++++.....
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCC
Confidence            5679999999999999999998    4567889999998643  222345678999999999 99999999998775442


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                      .   ..++|||++.+ +|.+++...   ...+++.+++.++.|++.||.+||++|++|+||||+||+++.++ .++|+||
T Consensus       117 ~---~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          117 R---NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             C---ceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecC
Confidence            1   27899999986 999998763   24689999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHH------------
Q 021982          158 GLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQ------------  222 (304)
Q Consensus       158 g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~------------  222 (304)
                      |.+.........   .....++..|+|||.+.+.. ++.++||||||+++|+|++|..|+........            
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence            999876544321   12234567899999998766 78999999999999999999999875422110            


Q ss_pred             HHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ...+...+..                       .........+++++.++|.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          269 VFHLIELLKN-----------------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHT-----------------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhc-----------------------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0011111100                       0001112368899999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=320.95  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             hhhhh-hcccccceEEEEEEEcc--CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            6 FEKLE-KVGEGTYGKVYRAREKA--TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         6 y~~~~-~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +.+.+ .||+|+||.||++.++.  ++..|+||+++... .......+.+|+++++.+ +||||+++++++... .    
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~----  409 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE-A----  409 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEESS-S----
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEeccC-C----
Confidence            34444 79999999999998753  45679999987542 233456788999999999 999999999998753 2    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++..   ....+++.+++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus       410 -~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~  484 (613)
T 2ozo_A          410 -LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSK  484 (613)
T ss_dssp             -EEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTT
T ss_pred             -eEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcc
Confidence             7999999986 89988854   245699999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+.....      
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------  557 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------  557 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            65433211   12223467899999998765 8999999999999999998 9999998887776665544211      


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                           ......+++++.++|.+||+.||.+|||+.+|++
T Consensus       558 ---------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 ---------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ---------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 1122368899999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=300.77  Aligned_cols=260  Identities=24%  Similarity=0.355  Sum_probs=191.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHH--HHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSIL--RMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l--~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++++.||+|+||.||++.+  ++..|++|++....     ......+..++  ..+ +||||+++++.+......+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTS
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhc-cCcchhhheecccccccCC
Confidence            57899999999999999999976  57899999987432     22333444443  346 9999999998776655555


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc---------CccccCCCCCCeEEeCCCC
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH---------GILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---------~i~h~dl~~~Nil~~~~~~  150 (304)
                      ...+++||||+.+ +|.+++..     ...++..++.++.|++.||.|||+.         |++|+||||+||+++.++ 
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-  157 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-  157 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-
T ss_pred             CceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-
Confidence            5568999999975 99999966     3458899999999999999999999         999999999999999777 


Q ss_pred             eEEEeeccceeecccCC--------CccccccccccCCChhhhhCC------CCCCCchhHHHHHHHHHHHhhccccCCC
Q 021982          151 TLKIADLGLARAFTLPI--------KKYTHEILTLWYRAPEVLLGS------THYSTAVDMWSVACIFAELVTKTALFPG  216 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~------~~~~~~~Di~slG~il~~ll~g~~p~~~  216 (304)
                      .+||+|||++.......        .......|++.|+|||++.+.      ..++.++||||||+++|+|++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            99999999998764321        122234679999999999763      2256789999999999999999877643


Q ss_pred             CchH-----------------HHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCccccc---CCCCChhhHHHHHHh
Q 021982          217 DSEL-----------------QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATA---VPNLDKDGLDLLEQM  276 (304)
Q Consensus       217 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~  276 (304)
                      ....                 .........  ..                    ....+...   ...+++.+.+||.+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--------------------~~~~~~~~~~~~~~~~~~l~~li~~c  295 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSR--EK--------------------QRPKFPEAWKENSLAVRSLKETIEDC  295 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTT--SC--------------------CCCCCCTTCCCCSHHHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcc--cc--------------------cCCCCCcccccccchHHHHHHHHHHH
Confidence            2210                 011111000  00                    00000000   112445799999999


Q ss_pred             hcCCCCCCCCHHHHhc------CCCccc
Q 021982          277 LQYDPSKRISAKKAME------HPYFDD  298 (304)
Q Consensus       277 l~~dp~~Rps~~eil~------~~~~~~  298 (304)
                      |+.||.+|||+.|+++      ++|-++
T Consensus       296 l~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          296 WDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             SCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             hcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            9999999999999954      566554

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=302.69  Aligned_cols=257  Identities=24%  Similarity=0.375  Sum_probs=189.1

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHc-cCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML-SRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|++++.||+|+||.||++.++  +..+++|++....     ......|.+++... .+||||+++++++...... 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~-  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS-  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG-
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC-
Confidence            5688999999999999999999875  7899999986432     12334455554433 2899999999998766321 


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc--------CccccCCCCCCeEEeCCCCe
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------GILHRDLKPHNLLMDRKTMT  151 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------~i~h~dl~~~Nil~~~~~~~  151 (304)
                      ....++||||+.+ +|.+++..     ..+++..++.++.|++.||.|||+.        |++|+||||+||+++.++ .
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~  180 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-T  180 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-C
T ss_pred             CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-C
Confidence            1238999999986 99999965     3689999999999999999999998        999999999999999777 9


Q ss_pred             EEEeeccceeecccCCCcc----ccccccccCCChhhhhCCCCCCCc------hhHHHHHHHHHHHhhc----------c
Q 021982          152 LKIADLGLARAFTLPIKKY----THEILTLWYRAPEVLLGSTHYSTA------VDMWSVACIFAELVTK----------T  211 (304)
Q Consensus       152 vkl~dfg~~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~------~Di~slG~il~~ll~g----------~  211 (304)
                      +||+|||++..........    ....|++.|+|||++.+.. .+..      +||||||+++|+|++|          .
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            9999999997664432221    2346799999999998765 3443      9999999999999999          5


Q ss_pred             ccCCCCch----HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          212 ALFPGDSE----LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       212 ~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                      .||.....    ........... . .....+                  .......+++++.++|.+||+.||.+|||+
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  319 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIK-K-LRPSFP------------------NRWSSDECLRQMGKLMTECWAHNPASRLTA  319 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTS-C-CCCCCC------------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhh-c-cCcccc------------------ccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence            56543221    11222111100 0 000000                  000012456779999999999999999999


Q ss_pred             HHHhcC
Q 021982          288 KKAMEH  293 (304)
Q Consensus       288 ~eil~~  293 (304)
                      .+++++
T Consensus       320 ~ell~~  325 (337)
T 3mdy_A          320 LRVKKT  325 (337)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999984

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.8e-43  Score=300.90  Aligned_cols=245  Identities=17%  Similarity=0.201  Sum_probs=193.6

Q ss_pred             hhhhhhhhhcccccceEEEEE-----EEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccC---CCCeeeeeceec
Q 021982            3 MDAFEKLEKVGEGTYGKVYRA-----REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR---DPHVVRLMDVKQ   74 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~-----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---h~~i~~~~~~~~   74 (304)
                      .++|++.+.||+|+||.||++     .+..+++.+++|.+...     ....+..|..+++.+ .   |+||+.+++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERL-KPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHS-CGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHh-hhhhhhhhhhhheeee
Confidence            357999999999999999999     46677889999998642     234677888888888 5   899999999998


Q ss_pred             ccccCCceEEEEEEeccCC-CHHHHHHHhcc-CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC-----
Q 021982           75 GQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ-TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-----  147 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~-----  147 (304)
                      ..+.     .++||||+.| +|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.     
T Consensus       138 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          138 FQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             CSSC-----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred             cCCC-----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence            8777     8999999985 99999986544 3457999999999999999999999999999999999999986     


Q ss_pred             ------CCCeEEEeeccceeeccc--CCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch
Q 021982          148 ------KTMTLKIADLGLARAFTL--PIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE  219 (304)
Q Consensus       148 ------~~~~vkl~dfg~~~~~~~--~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~  219 (304)
                            ++ .+||+|||++.....  .........||+.|+|||++.+.. ++.++||||||+++|+|++|..||.....
T Consensus       213 ~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          213 DDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             ------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             cccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                  45 899999999976542  223345567899999999998876 89999999999999999999999865432


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      ....      .                        ...+..  ...++.+.+++..||+.+|.+|++..+.+.
T Consensus       291 ~~~~------~------------------------~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          291 GECK------P------------------------EGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             TEEE------E------------------------CSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             Ccee------e------------------------chhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            1000      0                        000000  023567889999999999999976544444

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.8e-42  Score=295.17  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=196.3

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHH--ccCCCCeeeeeceecccccC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRM--LSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~--l~~h~~i~~~~~~~~~~~~~   79 (304)
                      +.++|++.+.||+|+||.||++.+.  ++.|++|.+....     ...+..|.++++.  + +||||+++++++......
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHHHSCC-CCTTBCCEEEEEECCCSS
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh-----HHHHHHHHHHHHHhhc-CCCcEEEEEeeecccCCc
Confidence            4578999999999999999999874  8899999986432     2456778888887  5 899999999998876521


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH--------hcCccccCCCCCCeEEeCCCC
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH--------GHGILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~i~h~dl~~~Nil~~~~~~  150 (304)
                      . ...+++|||+.+ +|.+++..     ..+++.+++.++.|++.||.+||        +.|++|+||||+||+++.++ 
T Consensus       112 ~-~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-  184 (342)
T 1b6c_B          112 W-TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-  184 (342)
T ss_dssp             C-CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-
T ss_pred             c-ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-
Confidence            1 127999999986 99999975     36899999999999999999999        89999999999999999777 


Q ss_pred             eEEEeeccceeecccCCC----ccccccccccCCChhhhhCCCC-----CCCchhHHHHHHHHHHHhhc----------c
Q 021982          151 TLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTK----------T  211 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~il~~ll~g----------~  211 (304)
                      .+||+|||++........    ......+++.|+|||++.+...     ++.++||||||+++|+|++|          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            999999999987655432    1234467999999999976532     23689999999999999999          6


Q ss_pred             ccCCCCch----HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCH
Q 021982          212 ALFPGDSE----LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA  287 (304)
Q Consensus       212 ~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (304)
                      .||.....    ..........  .......+                .  .......+..+.+|+.+||+.||.+|||+
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~----------------~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~  324 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCE--QKLRPNIP----------------N--RWQSCEALRVMAKIMRECWYANGAARLTA  324 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTT--SCCCCCCC----------------G--GGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             cCccccCcCcccHHHHHHHHHH--HHhCCCCc----------------c--cccchhHHHHHHHHHHHHhccChhhCCCH
Confidence            78765421    1222211110  00000000                0  00011344678999999999999999999


Q ss_pred             HHHhcC
Q 021982          288 KKAMEH  293 (304)
Q Consensus       288 ~eil~~  293 (304)
                      .+++++
T Consensus       325 ~~i~~~  330 (342)
T 1b6c_B          325 LRIKKT  330 (342)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.8e-42  Score=316.44  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=201.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC---CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+.||+|+||.||++.+..+   +..+++|.+.... .......+.+|+.+++.+ +||||+++++++.+. . 
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~-  464 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQF-DHPHIVKLIGVITEN-P-  464 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-S-
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-c-
Confidence            46799999999999999999998654   3468888775432 122235678899999999 999999999998543 2 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .++||||+.+ +|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||
T Consensus       465 ----~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG  536 (656)
T 2j0j_A          465 ----VWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFG  536 (656)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             ----eEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecC
Confidence                6899999985 999998752   34689999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ++........ ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+......    
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----  611 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----  611 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9976543321 122334578899999998765 8999999999999999997 99999988877776666543211    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                             ...+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       612 -----------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                   112368899999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.8e-43  Score=299.86  Aligned_cols=256  Identities=19%  Similarity=0.256  Sum_probs=187.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC------CCCCchhHHHHHHHHHcc--------CCCC--
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD------EGVPPTTLREVSILRMLS--------RDPH--   65 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~--------~h~~--   65 (304)
                      ..++|++++.||+|+||.||++++  ++..||+|++......      ......+.+|+.+++.+.        .|||  
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999988  5789999999876432      222356788999999884        2545  


Q ss_pred             ---------------eeeeeceecccccC--------CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHH
Q 021982           66 ---------------VVRLMDVKQGQNKE--------GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQL  121 (304)
Q Consensus        66 ---------------i~~~~~~~~~~~~~--------~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i  121 (304)
                                     |+++++++......        .....++||||+.+ ++.+.+..     ..+++..++.++.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL  170 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence                           44555554431100        12238999999975 55555422     468999999999999


Q ss_pred             HHHHHHHH-hcCccccCCCCCCeEEeCCC-------------------CeEEEeeccceeecccCCCccccccccccCCC
Q 021982          122 CKGVAFCH-GHGILHRDLKPHNLLMDRKT-------------------MTLKIADLGLARAFTLPIKKYTHEILTLWYRA  181 (304)
Q Consensus       122 ~~~l~~Lh-~~~i~h~dl~~~Nil~~~~~-------------------~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~  181 (304)
                      +.||.||| +.||+||||||+|||++.++                   ..+||+|||++......     ...||+.|+|
T Consensus       171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999999 99999999999999999664                   28999999999876543     3477999999


Q ss_pred             hhhhhCCCCCCCchhHHHHHHH-HHHHhhccccCCCCchHH-HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCccc
Q 021982          182 PEVLLGSTHYSTAVDMWSVACI-FAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLA  259 (304)
Q Consensus       182 PE~~~~~~~~~~~~Di~slG~i-l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (304)
                      ||++.+..  +.++||||||++ .+++++|..||....... ....+........                     ....
T Consensus       246 PE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~  302 (336)
T 2vuw_A          246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT---------------------KCNT  302 (336)
T ss_dssp             SGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS---------------------CCCS
T ss_pred             hhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc---------------------ccch
Confidence            99998654  789999998777 777888998885422111 1122221111100                     0011


Q ss_pred             ccCCCCChhhHHHHHHhhcCCCCCCCCHHHHh-cCCCcc
Q 021982          260 TAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM-EHPYFD  297 (304)
Q Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil-~~~~~~  297 (304)
                      ...+.+++++.+||++||+.|     |++|+| +||||+
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            112257789999999999977     999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.1e-41  Score=280.03  Aligned_cols=228  Identities=16%  Similarity=0.097  Sum_probs=181.5

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|++.+.||+|+||.||++.+..+++.|++|++...... ......+.+|+.++..+ +||||+++++++...+.  
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~--  105 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAG--  105 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE--
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCc--
Confidence            557899999999999999999999999999999998754332 12235678899999999 99999999999988766  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++||||+.| +|.++++.      .....++..++.|++.||+|||++|++|+||||+||+++.++ .++|++++ 
T Consensus       106 ---~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~-  174 (286)
T 3uqc_A          106 ---GLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA-  174 (286)
T ss_dssp             ---EEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC-
T ss_pred             ---EEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc-
Confidence               8999999986 99998843      246667899999999999999999999999999999999777 89988443 


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                                         |++|        ++.++||||||+++|+|++|..||...+..+......            
T Consensus       175 -------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------  215 (286)
T 3uqc_A          175 -------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------  215 (286)
T ss_dssp             -------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------
T ss_pred             -------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------
Confidence                               2222        6889999999999999999999998654321000000            


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                               ..............+.+++++.++|.+||+.||.+| |+.|+++
T Consensus       216 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          216 ---------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             ---------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             ---------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                     000001111223345789999999999999999999 9999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.8e-43  Score=323.56  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEcc-CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKA-TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +.++|++++.||+|+||.||++.+.. +++.|++|++.... .......+..|+.+++.+ +||||+++++++......+
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCC
Confidence            45789999999999999999999976 68899999876432 112234567899999999 9999999999998876655


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ....++||||+.| +|.+.+..      ++++.+++.++.||+.||.|||++||+|+||||+||+++. + .+||+|||+
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~-~~kl~DFG~  227 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-E-QLKLIDLGA  227 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-S-CEEECCCTT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-C-cEEEEeccc
Confidence            5557999999986 87765532      6899999999999999999999999999999999999985 4 899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +......    ....||+.|+|||++.+.  .+.++||||||+++|+|++|..||.......           ..     
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~-----  285 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP-----  285 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC-----
T ss_pred             chhcccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc-----------cc-----
Confidence            9876543    344679999999998765  3889999999999999999988876421100           00     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                      ..  ......++.+.++|.+||+.||.+||+..+.+.|+|+.-
T Consensus       286 ----------------~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 ----------------ED--DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ----------------TT--CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----------------cc--ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                            00  000124578899999999999999999999998888754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.6e-33  Score=254.84  Aligned_cols=188  Identities=15%  Similarity=0.095  Sum_probs=133.2

Q ss_pred             hcccccceEEEEEEEccCCcEEEEEEeeecCCCCC--------CCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982           11 KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG--------VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      ..+.|+.|....++....|..+++|.+..+.....        ....+.+|+++|+++..|+||++++++++++..    
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~----  316 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS----  316 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE----
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE----
Confidence            34567777777777777789999999876532221        123578899999999889999999999998887    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +|+||||+.| +|.+.+..    ..++++.   .++.||+.||+|+|++||+||||||+|||++.++ .+||+|||+++
T Consensus       317 -~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr  387 (569)
T 4azs_A          317 -GWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIV  387 (569)
T ss_dssp             -EEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEE
T ss_pred             -EEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCe
Confidence             9999999998 99999975    2456554   5789999999999999999999999999999887 99999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL  213 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p  213 (304)
                      .............||+.|++||++.+.  ....+|+||+|++++.+.++..+
T Consensus       388 ~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          388 TTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             eCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence            776665566667889999999998764  56789999999999888766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.2e-27  Score=213.56  Aligned_cols=184  Identities=19%  Similarity=0.254  Sum_probs=136.6

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC------CCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG------VPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..+.||+|+||.||++.  ..+..+++|..........      ....+.+|+++++++ +||||+++..+......   
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTT---
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCc---
Confidence            45689999999999994  3467888887654221111      123468899999999 99999955555444444   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++||||+.| +|.+++..            +..++.|++.+|.|||++||+|+||||+||+++.   .+||+|||++
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla  476 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLG  476 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTC
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccC
Confidence              5899999985 99888754            5689999999999999999999999999999996   8999999999


Q ss_pred             eecccCCCc-------cccccccccCCChhhhhC--CCCCCCchhHHHHHHHHHHHhhccccCC
Q 021982          161 RAFTLPIKK-------YTHEILTLWYRAPEVLLG--STHYSTAVDMWSVACIFAELVTKTALFP  215 (304)
Q Consensus       161 ~~~~~~~~~-------~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~  215 (304)
                      .........       .....||+.|+|||++..  .. ++...|+|+..+-..+-+.++.+|.
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~-Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEG-YKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHH-HHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHhccccC
Confidence            876543221       124567999999999976  33 6778899999998888877766653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.2e-24  Score=177.77  Aligned_cols=144  Identities=18%  Similarity=0.155  Sum_probs=110.1

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC----------------CCchhHHHHHHHHHccCCCCeeee
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG----------------VPPTTLREVSILRMLSRDPHVVRL   69 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~~h~~i~~~   69 (304)
                      |.+.+.||+|++|.||++.+ .++..+++|+++.......                ....+.+|+.+++.+ +  | +++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v  166 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAV  166 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSS
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCc
Confidence            33459999999999999999 7789999999875432111                123467899999999 4  4 555


Q ss_pred             eceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC
Q 021982           70 MDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK  148 (304)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~  148 (304)
                      .+++.. ..     .++||||+.| +|.+ +          .......++.|++.||.+||+.|++|+||||+||+++ +
T Consensus       167 ~~~~~~-~~-----~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          167 PKVYAW-EG-----NAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CCEEEE-ET-----TEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T
T ss_pred             CeEEec-cc-----eEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C
Confidence            555433 22     5899999986 7765 3          1234567999999999999999999999999999999 6


Q ss_pred             CCeEEEeeccceeecccCCCccccccccccCCChhhhh
Q 021982          149 TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL  186 (304)
Q Consensus       149 ~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~  186 (304)
                      + .++|+|||++..             +..+.+||.+.
T Consensus       229 ~-~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 E-GIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             T-EEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             C-cEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            6 999999999864             23357888774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.9e-21  Score=159.17  Aligned_cols=138  Identities=19%  Similarity=0.190  Sum_probs=104.7

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcE--EEEEEeeecCCCCCC----------------------CchhHHHHHHHHHcc
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKI--VALKKTRLHEDDEGV----------------------PPTTLREVSILRMLS   61 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~--~~iK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~   61 (304)
                      |.+.+.||+|+||.||++.+..+|..  +++|+++........                      ...+.+|+..++.+ 
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  127 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA-  127 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence            56788999999999999998777888  999987654211100                      01467899999999 


Q ss_pred             CCCCe--eeeeceecccccCCceEEEEEEeccCC------CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH-hcC
Q 021982           62 RDPHV--VRLMDVKQGQNKEGRTVLYLVFEYMDT------DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH-GHG  132 (304)
Q Consensus        62 ~h~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~  132 (304)
                      .|+++  +.+++.    ..     .++||||+++      +|.+....       .++..+..++.|++.+|.+|| +.|
T Consensus       128 ~~~~i~~p~~~~~----~~-----~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g  191 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MK-----NVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE  191 (258)
T ss_dssp             HHTTCCCCCEEEE----ET-----TEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred             HhCCCCCCeEEEc----CC-----CEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence            66654  333332    12     5899999952      56554322       345678899999999999999 999


Q ss_pred             ccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982          133 ILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus       133 i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      ++|+||||+|||++.   .++|+|||++...
T Consensus       192 ivHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            999999999999985   7999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=1.5e-18  Score=147.76  Aligned_cols=142  Identities=18%  Similarity=0.242  Sum_probs=96.0

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCC----------c--h--------hHHHHHHHHHccCCCC
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVP----------P--T--------TLREVSILRMLSRDPH   65 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~----------~--~--------~~~e~~~l~~l~~h~~   65 (304)
                      |.+..+||+|++|.||.|.+. +|+.+|||+++.........          .  .        ..+|...+.++ .+..
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g  174 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG  174 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence            889999999999999999985 58899999876432111000          0  0        12244444444 2222


Q ss_pred             eeeeeceecccccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeE
Q 021982           66 VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL  144 (304)
Q Consensus        66 i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil  144 (304)
                      +... ..+....      .++||||++| ++...          ...+....++.|++.++.+||+.|++||||||.|||
T Consensus       175 v~vp-~p~~~~~------~~LVME~i~G~~L~~l----------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FPVP-EPIAQSR------HTIVMSLVDALPMRQV----------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNIL  237 (397)
T ss_dssp             CSCC-CEEEEET------TEEEEECCSCEEGGGC----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             CCCC-eeeeccC------ceEEEEecCCccHhhh----------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence            2111 1111111      3699999998 54322          223345678999999999999999999999999999


Q ss_pred             EeCCCC---------eEEEeeccceeecccC
Q 021982          145 MDRKTM---------TLKIADLGLARAFTLP  166 (304)
Q Consensus       145 ~~~~~~---------~vkl~dfg~~~~~~~~  166 (304)
                      ++.++.         .+.|+||+.+.....+
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp  268 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSMDHP  268 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred             EeCCCCcccccccccceEEEEeCCcccCCCC
Confidence            986541         3899999998765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=1.3e-12  Score=106.92  Aligned_cols=139  Identities=14%  Similarity=0.147  Sum_probs=107.0

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|++...++.|+.+.||.+...  +..+++|........  ....+..|+.+++.+..+..+++++++......     
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-----   84 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-----   84 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-----
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc-----
Confidence            56888888899999999999743  578999988653211  234688999999999667778888888776544     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh--------------------------------
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG--------------------------------  130 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~--------------------------------  130 (304)
                      .+++||++.| ++.+..         .+......++.+++.+|..||+                                
T Consensus        85 ~~lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             eEEEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            7999999999 765541         1223345788999999999998                                


Q ss_pred             ---------------------------cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          131 ---------------------------HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       131 ---------------------------~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                                                 ..++|||++|.||+++.++ .+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                       4589999999999998543 56799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=8.9e-11  Score=95.69  Aligned_cols=132  Identities=13%  Similarity=0.127  Sum_probs=90.3

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCC-eeeeeceecccccCCceEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH-VVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~~~~~~~~   84 (304)
                      |.+....+.|..+.||.+.. .+|..+++|.....     ....+..|+.+++.+..+.- +++++++....+.     .
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~-----~   90 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-----D   90 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-----E
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC-----C
Confidence            44333334566699999964 34667999986532     23567889999999855422 5667777665443     7


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-------------------------------  132 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-------------------------------  132 (304)
                      +++||++.| ++ . .    .   ...   ...++.+++.+|..||+..                               
T Consensus        91 ~~v~e~i~G~~l-~-~----~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (264)
T 1nd4_A           91 WLLLGEVPGQDL-L-S----S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL  158 (264)
T ss_dssp             EEEEECCSSEET-T-T----S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred             EEEEEecCCccc-C-c----C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence            899999998 54 2 1    0   111   2356667777777777643                               


Q ss_pred             ---------------------------ccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          133 ---------------------------ILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       133 ---------------------------i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                                                 ++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                       99999999999998543 56699999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=3.9e-10  Score=96.44  Aligned_cols=144  Identities=15%  Similarity=0.246  Sum_probs=101.9

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEee--ecCCCCCCCchhHHHHHHHHHccC-CCCeeeeeceecccccCCceEE
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTR--LHEDDEGVPPTTLREVSILRMLSR-DPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~--~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .++.|+.|.++.+|.+...  +..+++|...  .... ......+..|+.+++.+.. +..+++++.++.+....+.  .
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~--~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR--A  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS--C
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC--e
Confidence            3567899999999999764  4578888765  3221 1123577889999999943 3457788877765532222  5


Q ss_pred             EEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh---------------------------------
Q 021982           85 YLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG---------------------------------  130 (304)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---------------------------------  130 (304)
                      ++|||++.| .+.+.      .-..+++.+...++.+++.+|..||+                                 
T Consensus       117 ~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             EEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             EEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            799999998 43221      11246788888999999999999997                                 


Q ss_pred             -------------------------cCccccCCCCCCeEEeCCCC-eEEEeeccceee
Q 021982          131 -------------------------HGILHRDLKPHNLLMDRKTM-TLKIADLGLARA  162 (304)
Q Consensus       131 -------------------------~~i~h~dl~~~Nil~~~~~~-~vkl~dfg~~~~  162 (304)
                                               ..++|||+++.||+++.++. .+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     35899999999999997652 468999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=8.5e-11  Score=98.21  Aligned_cols=188  Identities=16%  Similarity=0.184  Sum_probs=116.9

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCC--eeeeeceecccccCCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH--VVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~--i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      ++.++.|....+|.+.     ..+++|.....    .....+..|...++.+..+..  ++.++.......  .....++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceE
Confidence            4567889999999873     45888975422    123467789999988844433  334433322211  1112478


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-----------------------------------  130 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-----------------------------------  130 (304)
                      ||+++.| ++.+...      ..++..+...++.+++..+..||+                                   
T Consensus        94 vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             EEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             EEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            8999998 5543322      246777788888888888888886                                   


Q ss_pred             -----------------------cCccccCCCCCCeEEeCC-CCeEEEeeccceeecccCCCccccccccccCCChhhhh
Q 021982          131 -----------------------HGILHRDLKPHNLLMDRK-TMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLL  186 (304)
Q Consensus       131 -----------------------~~i~h~dl~~~Nil~~~~-~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~  186 (304)
                                             ..++|+|++|.||+++.+ +..+.++||+.+...... ...........-.+|+...
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHH
Confidence                                   136999999999999974 436889999998653221 1111000000002333221


Q ss_pred             C---C-CC---------CCCchhHHHHHHHHHHHhhccccC
Q 021982          187 G---S-TH---------YSTAVDMWSVACIFAELVTKTALF  214 (304)
Q Consensus       187 ~---~-~~---------~~~~~Di~slG~il~~ll~g~~p~  214 (304)
                      .   . ..         .....+.|++|.+++.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1   0 00         112368999999999999998775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=2.2e-07  Score=75.95  Aligned_cols=132  Identities=16%  Similarity=0.163  Sum_probs=92.0

Q ss_pred             cccccce-EEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEec
Q 021982           12 VGEGTYG-KVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEY   90 (304)
Q Consensus        12 lg~g~~g-~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   90 (304)
                      +..|..+ .||.+....++..+++|.-...     ....+..|...++.+..+--+++++.+..+.+.     .+++||+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~-----~~lvme~  101 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD-----AWLLTTA  101 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE-----EEEEEEC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe-----EEEEEEe
Confidence            3345544 6899888777788999986532     234577899999988655456777777766554     7899999


Q ss_pred             cCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 021982           91 MDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH--------------------------------------  131 (304)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------------------------------------  131 (304)
                      +.| ++.+....        .......+..++...|..||+.                                      
T Consensus       102 l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A          102 IPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             CCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             eCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            998 66554432        2233344556666666666641                                      


Q ss_pred             --------------------CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          132 --------------------GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       132 --------------------~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                                          .++|||+.+.||+++.++ .+-|+||+.+..
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~  223 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI  223 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence                                168999999999999554 567999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=5.2e-07  Score=75.20  Aligned_cols=135  Identities=17%  Similarity=0.204  Sum_probs=86.7

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC--CeeeeeceecccccCCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP--HVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      ++.++.|....+|.+     +..+++|.....    .....+..|..+++.+..+-  .+++++.+....  .+  ..++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~--~g--~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS--DG--NPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT--TS--CEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC--CC--ceEE
Confidence            355778888899998     466888874311    12346778999999994432  245555554321  11  1579


Q ss_pred             EEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 021982           87 VFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGH----------------------------------  131 (304)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~----------------------------------  131 (304)
                      +|+++.| ++.+..-      ..++..+...++.++...|..||+.                                  
T Consensus        91 v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             EEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            9999998 5544211      1234444445555555555555542                                  


Q ss_pred             --------------------------CccccCCCCCCeEEeC---CCCeEEEeeccceee
Q 021982          132 --------------------------GILHRDLKPHNLLMDR---KTMTLKIADLGLARA  162 (304)
Q Consensus       132 --------------------------~i~h~dl~~~Nil~~~---~~~~vkl~dfg~~~~  162 (304)
                                                .++|+|++|.||+++.   ++..+.|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                      3589999999999986   353468999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.31  E-value=1.1e-05  Score=62.43  Aligned_cols=135  Identities=14%  Similarity=0.063  Sum_probs=89.9

Q ss_pred             CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCcccc
Q 021982           94 DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH  172 (304)
Q Consensus        94 ~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~  172 (304)
                      +|.+.|+.+.   .|++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+| +|-+.+ ..+.           
T Consensus        34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            6888888754   489999999999999999887732 2212333557889999888 666664 1110           


Q ss_pred             ccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCC
Q 021982          173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQ  252 (304)
Q Consensus       173 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (304)
                       .....+.|||...  ...+.+.=|||||+++|.-+--..|-.                                     
T Consensus        98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~-------------------------------------  137 (229)
T 2yle_A           98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKEN-------------------------------------  137 (229)
T ss_dssp             ----------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTT-------------------------------------
T ss_pred             -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcc-------------------------------------
Confidence             0122466887653  235788899999999999875332211                                     


Q ss_pred             CCCCcccccCCCCChhhHHHHHHhhcCC-------------------------CCCCCCHHHHhc
Q 021982          253 WNPQSLATAVPNLDKDGLDLLEQMLQYD-------------------------PSKRISAKKAME  292 (304)
Q Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~d-------------------------p~~Rps~~eil~  292 (304)
                              ..+.+|+.|.+||..|.+-+                         +..|+|+++|++
T Consensus       138 --------eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          138 --------EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             --------EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             --------cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence                    12369999999999998662                         467889998875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.25  E-value=5.9e-06  Score=71.40  Aligned_cols=78  Identities=15%  Similarity=0.160  Sum_probs=48.7

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCC-----CCCCCchhHHHHHHHHHccCC-C-CeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-----DEGVPPTTLREVSILRMLSRD-P-HVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~h-~-~i~~~~~~~~~~~~~~~   81 (304)
                      .+.+|.|..+.||.+....++..+++|.......     ..........|..+++.+... + .+++++.+  +...   
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~---  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM---  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT---
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc---
Confidence            5678999999999997665677899997653211     112334567788898887443 3 34455543  2222   


Q ss_pred             eEEEEEEeccCC
Q 021982           82 TVLYLVFEYMDT   93 (304)
Q Consensus        82 ~~~~lv~e~~~~   93 (304)
                        .++|||+++|
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              4799999976

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=3.4e-06  Score=71.79  Aligned_cols=83  Identities=11%  Similarity=0.131  Sum_probs=52.1

Q ss_pred             hhhc-ccccceEEEEEEEc--c----CCcEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCC--CCeeeeeceeccccc
Q 021982            9 LEKV-GEGTYGKVYRAREK--A----TGKIVALKKTRLHED-DEGVPPTTLREVSILRMLSRD--PHVVRLMDVKQGQNK   78 (304)
Q Consensus         9 ~~~l-g~g~~g~v~~~~~~--~----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~   78 (304)
                      .+.| +.|....+|.+...  .    ++..+++|....... .......+..|+.+++.+..+  -.+++++.+..+...
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3566 78888999988653  1    156788887653320 010125677899998888544  346677776554321


Q ss_pred             CCceEEEEEEeccCC
Q 021982           79 EGRTVLYLVFEYMDT   93 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~   93 (304)
                      .+.  .+++||++.|
T Consensus       105 ~g~--~~~v~e~l~G  117 (357)
T 3ats_A          105 LGT--PFFLMDYVEG  117 (357)
T ss_dssp             TSS--CEEEEECCCC
T ss_pred             cCC--ceEEEEecCC
Confidence            111  4789999987

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.08  E-value=2.3e-05  Score=64.92  Aligned_cols=69  Identities=14%  Similarity=0.084  Sum_probs=43.8

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      ++.|+.|....+|.+      ..+++|.......   .......|+.+++.+..+.-.++++....+.       -++++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~-------~~~v~   86 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVDPAT-------GVMVT   86 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTTT-------CCEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEECCC-------CEEEE
Confidence            677888999999999      4588898764311   1233456888887775443335666543322       25889


Q ss_pred             ecc-CC
Q 021982           89 EYM-DT   93 (304)
Q Consensus        89 e~~-~~   93 (304)
                      ||+ +|
T Consensus        87 e~i~~g   92 (301)
T 3dxq_A           87 RYIAGA   92 (301)
T ss_dssp             ECCTTC
T ss_pred             eecCCC
Confidence            999 66

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.98  E-value=3.7e-05  Score=64.76  Aligned_cols=30  Identities=20%  Similarity=0.334  Sum_probs=26.5

Q ss_pred             cCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982          131 HGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus       131 ~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ..++|||+++.||+++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            5799999999999997666 79999999874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.61  E-value=0.0002  Score=62.20  Aligned_cols=78  Identities=10%  Similarity=0.034  Sum_probs=45.2

Q ss_pred             hcCccccCCCCCCeEEeCCCCeEEEeeccceeecccCCCccccccc--cccCCChhhhhCCC--CCCCchhHHHHHHHHH
Q 021982          130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL--TLWYRAPEVLLGST--HYSTAVDMWSVACIFA  205 (304)
Q Consensus       130 ~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~--~~~~~~PE~~~~~~--~~~~~~Di~slG~il~  205 (304)
                      ...++|||++|.||+++.++  +.++||+.+..-... ........  ...|++|+......  .......+.++...+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            45799999999999998554  999999988643211 11111110  12345554432111  0112344557777777


Q ss_pred             HHhhc
Q 021982          206 ELVTK  210 (304)
Q Consensus       206 ~ll~g  210 (304)
                      ..+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.57  E-value=0.00046  Score=57.31  Aligned_cols=73  Identities=16%  Similarity=0.233  Sum_probs=53.4

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCC--CCeeeeeceecccccCCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD--PHVVRLMDVKQGQNKEGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~~~~~~l   86 (304)
                      .+.|+.|....+|.+..  ++..+++|.....     ....+..|...++.+...  ..+++++.+......     .++
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~-----~~l  108 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH-----SFL  108 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE-----EEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc-----eEE
Confidence            45688899999999975  3667889987632     134577888888888543  567777777655433     799


Q ss_pred             EEeccCC
Q 021982           87 VFEYMDT   93 (304)
Q Consensus        87 v~e~~~~   93 (304)
                      +||++.|
T Consensus       109 vme~l~G  115 (312)
T 3jr1_A          109 LLEALNK  115 (312)
T ss_dssp             EEECCCC
T ss_pred             EEEeccC
Confidence            9999986

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.53  E-value=0.00062  Score=58.12  Aligned_cols=142  Identities=14%  Similarity=0.121  Sum_probs=82.3

Q ss_pred             hhhcccccceEEEEEEEcc-------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKA-------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++.|..|-...+|++....       .+..+++|....   .........+|..+++.+..+.-.+++++.+.+      
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------
Confidence            4567778888899998642       346799998532   112234556799998888655555667665442      


Q ss_pred             eEEEEEEeccCC-CH--------------HHHHHHhccCCCC----CC--hHHHHHHHHHHHH-----------------
Q 021982           82 TVLYLVFEYMDT-DL--------------KKYIRSFRQTGEN----IP--VNTVKSLMYQLCK-----------------  123 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l--------------~~~l~~~~~~~~~----~~--~~~~~~~~~~i~~-----------------  123 (304)
                         .+|+||+.| ++              .+.+........+    ..  +.++..+..++..                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               278999876 32              1222322222211    11  2445555544422                 


Q ss_pred             --HHHHHH----h----cCccccCCCCCCeEEeCC---CCeEEEeeccceee
Q 021982          124 --GVAFCH----G----HGILHRDLKPHNLLMDRK---TMTLKIADLGLARA  162 (304)
Q Consensus       124 --~l~~Lh----~----~~i~h~dl~~~Nil~~~~---~~~vkl~dfg~~~~  162 (304)
                        .+..|.    +    ..++|+|+.+.||+++.+   ...+.++||.++..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              223332    2    259999999999999876   23799999999854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.47  E-value=0.0011  Score=57.81  Aligned_cols=72  Identities=17%  Similarity=0.182  Sum_probs=47.7

Q ss_pred             hhhcccccceEEEEEEEcc-------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKA-------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++.|+.|....+|++....       .+..+++|+....    .....+..|..+++.+..+.-.+++++.+.+      
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG------  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC------
Confidence            4567888889999998643       2567899987421    1114556788988888555444666655431      


Q ss_pred             eEEEEEEeccCC
Q 021982           82 TVLYLVFEYMDT   93 (304)
Q Consensus        82 ~~~~lv~e~~~~   93 (304)
                         .+++||+.|
T Consensus       148 ---g~v~e~l~G  156 (429)
T 1nw1_A          148 ---GRLEEYIPS  156 (429)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---CEEEEEeCC
Confidence               278888875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.43  E-value=0.00087  Score=56.19  Aligned_cols=32  Identities=25%  Similarity=0.326  Sum_probs=26.7

Q ss_pred             cCccccCCCCCCeEEeCC---CCeEEEeeccceee
Q 021982          131 HGILHRDLKPHNLLMDRK---TMTLKIADLGLARA  162 (304)
Q Consensus       131 ~~i~h~dl~~~Nil~~~~---~~~vkl~dfg~~~~  162 (304)
                      ..++|||+.+.||+++.+   +..+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999864   13799999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.38  E-value=0.0037  Score=54.76  Aligned_cols=73  Identities=12%  Similarity=0.089  Sum_probs=46.7

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      ++.|+.|....+|++.....+..+++|+.....   ........|..+++.+..+.-.+++++.+.  +       ..++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~-------G~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFFT--N-------GRIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T-------EEEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C-------eEEE
Confidence            456778888999999875444778899774321   112223589999999955544466776652  1       2489


Q ss_pred             eccCC
Q 021982           89 EYMDT   93 (304)
Q Consensus        89 e~~~~   93 (304)
                      ||+.|
T Consensus       181 e~I~G  185 (458)
T 2qg7_A          181 EFMDG  185 (458)
T ss_dssp             ECCCS
T ss_pred             EeeCC
Confidence            99876

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.38  E-value=0.00074  Score=56.26  Aligned_cols=147  Identities=13%  Similarity=0.112  Sum_probs=74.9

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC-Ceeeeeceeccccc-CCceEEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP-HVVRLMDVKQGQNK-EGRTVLYL   86 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~~-~~~~~~~l   86 (304)
                      ++.|+.|....+|.+...+ + .+++|.....    .....+..|..+++.+..+. .+++++........ ......++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            3456678888899987542 3 6888987642    12345667888887774332 13333321100000 00012588


Q ss_pred             EEeccCC-CH-----------HHHHHHhcc---C-CCC----CChHHHHH---------------HHHHHHHHHHHHHh-
Q 021982           87 VFEYMDT-DL-----------KKYIRSFRQ---T-GEN----IPVNTVKS---------------LMYQLCKGVAFCHG-  130 (304)
Q Consensus        87 v~e~~~~-~l-----------~~~l~~~~~---~-~~~----~~~~~~~~---------------~~~~i~~~l~~Lh~-  130 (304)
                      +++++.| .+           ...+.....   . ..+    ........               +...+...+..+.+ 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            9999987 31           111111111   0 001    01000000               00113344555543 


Q ss_pred             ------cCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          131 ------HGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       131 ------~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                            .+++|+|+.+.||+++.++ .+.++||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                  3699999999999998553 457999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.30  E-value=0.004  Score=50.98  Aligned_cols=76  Identities=17%  Similarity=0.154  Sum_probs=50.8

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC--CeeeeeceecccccCCceE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP--HVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~i~~~~~~~~~~~~~~~~~   83 (304)
                      ..-++.+|.|..+.||++... +|+.+++|+.....  ......+..|+..|+.+....  -+++++.+   ..      
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~------   84 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DD------   84 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET------
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec---cC------
Confidence            345677899999999999864 57889999765332  222345778999999884432  23444433   12      


Q ss_pred             EEEEEeccCC
Q 021982           84 LYLVFEYMDT   93 (304)
Q Consensus        84 ~~lv~e~~~~   93 (304)
                      .+++||++.+
T Consensus        85 ~~lv~e~l~~   94 (288)
T 3f7w_A           85 RTLAMEWVDE   94 (288)
T ss_dssp             TEEEEECCCC
T ss_pred             ceEEEEeecc
Confidence            3688999864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.25  E-value=0.0012  Score=56.24  Aligned_cols=73  Identities=14%  Similarity=0.154  Sum_probs=42.6

Q ss_pred             hhhcccccceEEEEEEEccC--------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            9 LEKVGEGTYGKVYRAREKAT--------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ++.++.|....+|.+.....        +..+++|+.....   ........|..+++.+..+.-.+++++..   ..  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF---NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec---CC--
Confidence            45677888889999976531        2578888765321   11123457888888885443345565443   11  


Q ss_pred             ceEEEEEEeccCC
Q 021982           81 RTVLYLVFEYMDT   93 (304)
Q Consensus        81 ~~~~~lv~e~~~~   93 (304)
                          +++++|+.|
T Consensus       110 ----~~v~e~i~G  118 (369)
T 3c5i_A          110 ----GRIEEWLYG  118 (369)
T ss_dssp             ----EEEEECCCS
T ss_pred             ----cEEEEEecC
Confidence                578999876

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.86  E-value=0.0063  Score=52.70  Aligned_cols=73  Identities=12%  Similarity=0.093  Sum_probs=47.9

Q ss_pred             hhhcccccceEEEEEEEccC-------CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKAT-------GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++.+..|-...+|++.....       +..+++|.....   ........+|..+++.+..+.-.+++++.+.       
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~---t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~-------  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH---VGKFYDSKVELDVFRYLSNINIAPNIIADFP-------  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC---C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET-------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC---cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC-------
Confidence            45677888899999986521       467889986432   1223344678888888855554566665322       


Q ss_pred             eEEEEEEeccCC
Q 021982           82 TVLYLVFEYMDT   93 (304)
Q Consensus        82 ~~~~lv~e~~~~   93 (304)
                        -+.|++|+.|
T Consensus       145 --~~~I~efI~G  154 (424)
T 3mes_A          145 --EGRIEEFIDG  154 (424)
T ss_dssp             --TEEEEECCCS
T ss_pred             --CCEEEEEeCC
Confidence              1578999987

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.72  E-value=0.0049  Score=51.35  Aligned_cols=76  Identities=14%  Similarity=0.162  Sum_probs=43.5

Q ss_pred             hcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC-Ceeeeeceeccccc--CCceEEEEE
Q 021982           11 KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP-HVVRLMDVKQGQNK--EGRTVLYLV   87 (304)
Q Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~~--~~~~~~~lv   87 (304)
                      .++ |....+|.+... +|..+++|.......   ....+..|..+++.+..+. .+++++..  +...  ......+++
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEE
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEE
Confidence            455 777889988543 355789998763211   2345667888888774332 23444433  1110  001125789


Q ss_pred             EeccCC
Q 021982           88 FEYMDT   93 (304)
Q Consensus        88 ~e~~~~   93 (304)
                      +++++|
T Consensus       106 ~~~i~G  111 (328)
T 1zyl_A          106 FPSVGG  111 (328)
T ss_dssp             EECCCC
T ss_pred             EEecCC
Confidence            999987

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.53  E-value=0.024  Score=47.51  Aligned_cols=30  Identities=20%  Similarity=0.308  Sum_probs=26.4

Q ss_pred             CccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          132 GILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       132 ~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++|+|+.+.||+++.++ .+.++||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            599999999999998666 799999988754

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.38  E-value=0.024  Score=48.75  Aligned_cols=31  Identities=19%  Similarity=0.269  Sum_probs=25.2

Q ss_pred             ccccCCCCCCeEEeC-----CCCeEEEeeccceeec
Q 021982          133 ILHRDLKPHNLLMDR-----KTMTLKIADLGLARAF  163 (304)
Q Consensus       133 i~h~dl~~~Nil~~~-----~~~~vkl~dfg~~~~~  163 (304)
                      ++|+|+.+.||++..     ++..+.++||.++..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            689999999999942     3347999999998653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.25  E-value=0.092  Score=46.03  Aligned_cols=63  Identities=17%  Similarity=0.147  Sum_probs=16.9

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEE------EEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceec
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVAL------KKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQ   74 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~i------K~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   74 (304)
                      +.+.||   ||.||++.......+|++      |..............+.++..+.+.+ .|||+++.+.+..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEE
Confidence            345666   999999988765567777      65543333333445667788888888 8999998888654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.01  E-value=0.71  Score=35.60  Aligned_cols=90  Identities=12%  Similarity=0.186  Sum_probs=60.8

Q ss_pred             HHHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccC-C-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHH
Q 021982           52 REVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCH  129 (304)
Q Consensus        52 ~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh  129 (304)
                      .|+..|..  .+|+++.. .+-..++.     +.+.++.-+ + +... ++       .++....++++.+|+....+++
T Consensus        35 ~el~LL~~--~~~~Fl~~-~I~e~eD~-----v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~   98 (215)
T 4ann_A           35 HLMYLLEQ--HSPYFIDA-ELTELRDS-----FQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNR   98 (215)
T ss_dssp             GGGGGGGS--CCTTBCCE-EEEECSSE-----EEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGG
T ss_pred             HHHHHHhc--cCCcccce-EEEEcccE-----EEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhc
Confidence            34455543  68988877 45444443     556666554 2 3322 22       3788889999999998774443


Q ss_pred             hcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982          130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus       130 ~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .=+|--+.|+||+++.++ .+++.-.|.-
T Consensus        99 --~r~tf~L~P~NL~f~~~~-~p~i~~RGik  126 (215)
T 4ann_A           99 --TRYTFVLAPDELFFTRDG-LPIAKTRGLQ  126 (215)
T ss_dssp             --SSEECCCSGGGEEECTTS-CEEESCCEET
T ss_pred             --CceEEEEecceEEEcCCC-CEEEEEccCc
Confidence              336778999999999877 8999877754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.36  E-value=1.5  Score=33.85  Aligned_cols=88  Identities=18%  Similarity=0.252  Sum_probs=59.0

Q ss_pred             HHHHHHHccCCCCeeeeeceecccccCCceEEEEEEeccC-C-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHH-HHH
Q 021982           53 EVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-T-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA-FCH  129 (304)
Q Consensus        53 e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~-~Lh  129 (304)
                      ++..+..  .+|++  -..+-.+++.     +.+.++.-. + +.. .++       .++....++++.+|+.... ++ 
T Consensus        41 e~~lL~~--~~~~f--~~~I~~~eD~-----~~i~y~~~~~~~~f~-~i~-------~~~~~eKlrll~nl~~L~~~~~-  102 (219)
T 4ano_A           41 ELEVLKE--VDPCI--VRDIDVSEDE-----VKVVIKPPSSFLTFA-AIR-------KTTLLSRIRAAIHLVSKVKHHS-  102 (219)
T ss_dssp             GGGGGGG--SCSSS--EEEEEECSSE-----EEEEEECCTTCEEHH-HHH-------TSCHHHHHHHHHHHHHHHSSCC-
T ss_pred             HHHHHhc--cCCCC--CeEEEEeCCE-----EEEEEEcCcccCcHH-HHH-------hcCHHHHHHHHHHHHHHHHHhh-
Confidence            3444443  68888  3333344444     566666653 3 444 333       3788899999998888665 34 


Q ss_pred             hcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982          130 GHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus       130 ~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                       ..-+|--+.|+||+++.++ .+++.-.|.-
T Consensus       103 -~~r~tf~l~P~NL~f~~~~-~p~i~hRGi~  131 (219)
T 4ano_A          103 -ARRLIFIVCPENLMFNRAL-EPFFLHVGVK  131 (219)
T ss_dssp             -SSSEECCCCGGGEEECTTC-CEEESCCEET
T ss_pred             -hCceeEEEeCceEEEeCCC-cEEEEEcCCc
Confidence             3457778999999999777 8999987764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	304
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-88
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-83
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-82
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-80
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-79
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-78
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-77
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-76
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-74
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-73
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-71
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-70
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-70
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-68
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-68
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-67
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-66
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-66
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-66
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-65
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-65
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-63
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-62
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-62
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-61
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-61
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-61
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-58
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-56
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-52
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-52
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-50
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-49
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-44
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-41
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-39
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (672), Expect = 5e-88
 Identities = 167/300 (55%), Positives = 225/300 (75%), Gaps = 10/300 (3%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ F+K+EK+GEGTYG VY+AR K TG++VALKK RL  + EGVP T +RE+S+L+ L  
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-N 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P++V+L+DV   +NK     LYLVFE++  DLKK++         IP+  +KS ++QL 
Sbjct: 60  HPNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLL 112

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+AFCH H +LHRDLKP NLL++ +   +K+AD GLARAF +P++ YTHE++TLWYRAP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E+LLG  +YSTAVD+WS+ CIFAE+VT+ ALFPGDSE+ QL  IFR LGTP+E VWPGV+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK 301
           S+ ++   +P+W  Q  +  VP LD+DG  LL QML YDP+KRISAK A+ HP+F D+ K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 9e-83
 Identities = 116/296 (39%), Positives = 179/296 (60%), Gaps = 13/296 (4%)

Query: 7   EKLEKVGEGTYGKVYRAREKATGKIVALKKTRL---HEDDEGVPPTTLREVSILRMLSRD 63
           EKL+ +GEG +  VY+AR+K T +IVA+KK +L    E  +G+  T LRE+ +L+ L   
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SH 59

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P+++ L+D    ++      + LVF++M+TDL+  I+        +  + +K+ M    +
Sbjct: 60  PNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQ 111

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
           G+ + H H ILHRDLKP+NLL+D     LK+AD GLA++F  P + YTH+++T WYRAPE
Sbjct: 112 GLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           +L G+  Y   VDMW+V CI AEL+ +    PGDS+L QL  IF  LGTP E+ WP + S
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           L ++  +  +    L         D LDL++ +  ++P  RI+A +A++  YF + 
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (641), Expect = 1e-82
 Identities = 93/296 (31%), Positives = 161/296 (54%), Gaps = 10/296 (3%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +   + +G G++G VY+A+   +G++VA+KK    +  +       RE+ I+R L    +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMRKL-DHCN 74

Query: 66  VVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +VRL         K+    L LV +Y+   + +  R + +  + +PV  VK  MYQL + 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +A+ H  GI HRD+KP NLL+D  T  LK+ D G A+         ++ I + +YRAPE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
           + G+T Y++++D+WS  C+ AEL+    +FPGDS + QL+ I ++LGTP  +    ++  
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 245 MNWHEYPQWNPQSLATAV-PNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
               ++PQ           P    + + L  ++L+Y P+ R++  +A  H +FD+L
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  244 bits (622), Expect = 1e-80
 Identities = 150/297 (50%), Positives = 206/297 (69%), Gaps = 12/297 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M+ +  LEK+GEGTYG VY+A+    G+  ALKK RL ++DEG+P TT+RE+SIL+ L +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-K 58

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++V+L DV   + +     L LVFE++D DLKK +         +   T KS + QL 
Sbjct: 59  HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLL 110

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
            G+A+CH   +LHRDLKP NLL++R+   LKIAD GLARAF +P++KYTHEI+TLWYRAP
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +VL+GS  YST +D+WSV CIFAE+V  T LFPG SE  QL+ IFR+LGTPN K WP V+
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
            L  +   +  + P    + +  LD+ G+DLL +ML+ DP++RI+AK+A+EH YF +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 2e-79
 Identities = 129/301 (42%), Positives = 191/301 (63%), Gaps = 9/301 (2%)

Query: 6   FEKLEKVGEGTYGKVYRARE-KATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--R 62
           +E + ++GEG YGKV++AR+ K  G+ VALK+ R+   +EG+P +T+REV++LR L    
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            P+VVRL DV      +  T L LVFE++D DL  Y+    + G  +P  T+K +M+QL 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLL 126

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           +G+ F H H ++HRDLKP N+L+      +K+AD GLAR ++      T  ++TLWYRAP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYS-FQMALTSVVVTLWYRAP 184

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           EVLL S  Y+T VD+WSV CIFAE+  +  LF G S++ QL  I  ++G P E+ WP   
Sbjct: 185 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT 302
           +L     +   + Q +   V ++D+ G DLL + L ++P+KRISA  A+ HPYF DL++ 
Sbjct: 244 ALPRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302

Query: 303 R 303
           +
Sbjct: 303 K 303

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (606), Expect = 4e-78
 Identities = 146/299 (48%), Positives = 200/299 (66%), Gaps = 12/299 (4%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M  +EKLEK+GEGTYG V++A+ + T +IVALK+ RL +DDEGVP + LRE+ +L+ L +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-K 59

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
             ++VRL DV     K       LVFE+ D DLKKY  S      ++    VKS ++QL 
Sbjct: 60  HKNIVRLHDVLHSDKKL-----TLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLL 111

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAP 182
           KG+ FCH   +LHRDLKP NLL++R    LK+A+ GLARAF +P++ Y+ E++TLWYR P
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           +VL G+  YST++DMWS  CIFAEL      LFPG+    QL  IFRLLGTP E+ WP +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 242 SSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           + L ++  YP +    SL   VP L+  G DLL+ +L+ +P +RISA++A++HPYF D 
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 1e-77
 Identities = 107/305 (35%), Positives = 174/305 (57%), Gaps = 16/305 (5%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           +  +EKL K+G+GT+G+V++AR + TG+ VALKK  +  + EG P T LRE+ IL++L +
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-K 67

Query: 63  DPHVVRLMDV---KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
             +VV L+++   K       +  +YLVF++ + DL   + +         ++ +K +M 
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQ 124

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP----IKKYTHEIL 175
            L  G+ + H + ILHRD+K  N+L+ R    LK+AD GLARAF+L       +YT+ ++
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 176 TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE 235
           TLWYR PE+LLG   Y   +D+W   CI AE+ T++ +  G++E  QL  I +L G+   
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 236 KVWPGVSSLMNWHEY----PQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
           +VWP V +   + +      Q             D   LDL++++L  DP++RI +  A+
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

Query: 292 EHPYF 296
            H +F
Sbjct: 304 NHDFF 308

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (599), Expect = 2e-76
 Identities = 101/300 (33%), Positives = 158/300 (52%), Gaps = 14/300 (4%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           +  L  +GEG YG V  A +      VA+KK     + +     TLRE+ IL    R  +
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRF-RHEN 67

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           ++ + D+ +    E    +YLV   M  DL K +++     +++  + +   +YQ+ +G+
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGL 122

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP---IKKYTHEILTLWYRAP 182
            + H   +LHRDLKP NLL++  T  LKI D GLAR            T  + T WYRAP
Sbjct: 123 KYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E++L S  Y+ ++D+WSV CI AE+++   +FPG   L QL HI  +LG+P+++    + 
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 243 SLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           +L   +     P  N        PN D   LDLL++ML ++P KRI  ++A+ HPY +  
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  229 bits (585), Expect = 1e-74
 Identities = 84/310 (27%), Positives = 158/310 (50%), Gaps = 27/310 (8%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
            D ++ + K+G G Y +V+ A      + V +K  +  +  +       RE+ IL  L  
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRG 88

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P+++ L D+ +           LVFE+++ TD K+  ++            ++  MY++
Sbjct: 89  GPNIITLADIVKDPVSR---TPALVFEHVNNTDFKQLYQTL-------TDYDIRFYMYEI 138

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
            K + +CH  GI+HRD+KPHN+++D +   L++ D GLA  +  P ++Y   + + +++ 
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKG 197

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVW-- 238
           PE+L+    Y  ++DMWS+ C+ A ++  K   F G     QL+ I ++LGT +   +  
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 239 -------PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAM 291
                  P  + ++  H   +W     +     +  + LD L+++L+YD   R++A++AM
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

Query: 292 EHPYFDDLDK 301
           EHPYF  + K
Sbjct: 318 EHPYFYTVVK 327

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (581), Expect = 1e-73
 Identities = 108/305 (35%), Positives = 162/305 (53%), Gaps = 14/305 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V   +  L+ VG G YG V  A +  TG  VA+KK       E       RE+ +L+ + 
Sbjct: 16  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM- 74

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           R  +V+ L+DV    +  +  T  YLV  +M TDL K ++      E +  + ++ L+YQ
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQ 129

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + KG+ + H  GI+HRDLKP NL ++ +   LKI D GLAR       + T  ++T WYR
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQAD---SEMTGYVVTRWYR 185

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+L    Y+  VD+WSV CI AE++T   LF G   L QL  I ++ GTP  +    
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 241 VSSLMNWH---EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           + S    +     P+   +  A+ + N     ++LLE+ML  D  +R++A +A+ HPYF+
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 298 DLDKT 302
            L  T
Sbjct: 306 SLHDT 310

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  221 bits (564), Expect = 5e-71
 Identities = 73/302 (24%), Positives = 136/302 (45%), Gaps = 39/302 (12%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+D ++  E++G G +G V+R  E+ATG   A K   +    E    T  +E+  + +L 
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKETVRKEIQTMSVL- 80

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           R P +V L D  +  N+     + +++E+M   +L + +         +  +     M Q
Sbjct: 81  RHPTLVNLHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQ 132

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
           +CKG+   H +  +H DLKP N++   +++  LK+ D GL      P +       T  +
Sbjct: 133 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEF 191

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APEV  G        DMWSV  +   L++  + F G+++ + L ++       ++  + 
Sbjct: 192 AAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL 299
           G+S                        +DG D + ++L  DP+ R++  +A+EHP+    
Sbjct: 251 GIS------------------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286

Query: 300 DK 301
           + 
Sbjct: 287 NA 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 3e-70
 Identities = 70/316 (22%), Positives = 129/316 (40%), Gaps = 33/316 (10%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D FEK+ ++G G  G V++   K +G ++A K   L E    +    +RE+ +L      
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHEC-NS 63

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++V          +     + +  E+MD   L + ++   +    IP   +  +   + 
Sbjct: 64  PYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVI 114

Query: 123 KGVAFCH-GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           KG+ +    H I+HRD+KP N+L++ +   +K+ D G++    L        + T  Y +
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQ--LIDSMANSFVGTRSYMS 171

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPG-DSELQQLLHIFRLLGTPNEKVWPG 240
           PE L G+ HYS   D+WS+     E+       P  D++  +L+   ++ G   E     
Sbjct: 172 PERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230

Query: 241 VSSLMNWHEY-----PQWNPQSLATAVPN----------LDKDGLDLLEQMLQYDPSKRI 285
            +       Y     P      L   + N             +  D + + L  +P++R 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290

Query: 286 SAKKAMEHPYFDDLDK 301
             K+ M H +    D 
Sbjct: 291 DLKQLMVHAFIKRSDA 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 4e-70
 Identities = 105/302 (34%), Positives = 153/302 (50%), Gaps = 14/302 (4%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V + ++ L  VG G YG V  A +  TG  VA+KK             T RE+ +L+ + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM- 74

Query: 62  RDPHVVRLMDV-KQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           +  +V+ L+DV    ++ E    +YLV   M  DL   ++      + +  + V+ L+YQ
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQ 129

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           + +G+ + H   I+HRDLKP NL ++      KI D GLAR     +  Y     T WYR
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMTGYVA---TRWYR 185

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE++L   HY+  VD+WSV CI AEL+T   LFPG   + QL  I RL+GTP  ++   
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 241 VSSL---MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
           +SS           Q    + A      +   +DLLE+ML  D  KRI+A +A+ H YF 
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

Query: 298 DL 299
             
Sbjct: 306 QY 307

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  215 bits (549), Expect = 1e-68
 Identities = 74/297 (24%), Positives = 134/297 (45%), Gaps = 39/297 (13%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V D ++ LE++G G +G V+R  EKATG++   K   ++        T   E+SI+  L 
Sbjct: 27  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQL- 83

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             P ++ L D  + + +     + L+ E++   +L   I         +    V + M Q
Sbjct: 84  HHPKLINLHDAFEDKYE-----MVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQ 135

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMD-RKTMTLKIADLGLARAFTLPIKKYTHEILTLWY 179
            C+G+   H H I+H D+KP N++ + +K  ++KI D GLA     P +       T  +
Sbjct: 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEF 194

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            APE++          DMW++  +   L++  + F G+ +L+ L ++ R     +E  + 
Sbjct: 195 AAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
            VS                         +  D ++ +LQ +P KR++   A+EHP+ 
Sbjct: 254 SVS------------------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 3e-68
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 39/298 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +E L  +G G+YG+  + R K+ GKI+  K+       E      + EV++LR L + 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KH 62

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P++VR  D    +       LY+V EY +  DL   I    +  + +    V  +M QL 
Sbjct: 63  PNIVRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 123 KGVAFCH-----GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTL 177
             +  CH     GH +LHRDLKP N+ +D K   +K+ D GLAR            + T 
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           +Y +PE +     Y+   D+WS+ C+  EL      F   S+ +    I           
Sbjct: 179 YYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--------- 228

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPY 295
                    +   P                +  +++ +ML      R S ++ +E+P 
Sbjct: 229 -------GKFRRIP-----------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 8e-67
 Identities = 63/297 (21%), Positives = 123/297 (41%), Gaps = 40/297 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           D +E + ++G+G +GKVY+A+ K T  + A K   +    E      + E+ IL      
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEELEDYMVEIDILASC-DH 68

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+D    +N      L+++ E+        +    +    +  + ++ +  Q   
Sbjct: 69  PNIVKLLDAFYYENN-----LWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLD 121

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + + H + I+HRDLK  N+L       +K+AD G++   T  I++    I T ++ APE
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 184 VLLGST----HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
           V++  T     Y    D+WS+     E+          + ++ LL I +    P     P
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--SEPPTLAQP 238

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                       +  D L++ L+ +   R +  + ++HP+ 
Sbjct: 239 -----------------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  207 bits (527), Expect = 2e-66
 Identities = 78/306 (25%), Positives = 123/306 (40%), Gaps = 48/306 (15%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-------HEDDEGVPPTTLREVSI 56
           + +E  E +G G    V R   K T K  A+K   +        E+ + +   TL+EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVK 115
           LR +S  P++++L D  +          +LVF+ M   +L  Y+         +     +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTF-----FFLVFDLMKKGELFDYLTE----KVTLSEKETR 113

Query: 116 SLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL 175
            +M  L + +   H   I+HRDLKP N+L+D   M +K+ D G +     P +K      
Sbjct: 114 KIMRALLEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLD-PGEKLREVCG 171

Query: 176 TLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL 230
           T  Y APE++  S +     Y   VDMWS   I   L+  +  F    ++  L  I    
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231

Query: 231 GTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA 290
                  W   S                            DL+ + L   P KR +A++A
Sbjct: 232 YQFGSPEWDDYS------------------------DTVKDLVSRFLVVQPQKRYTAEEA 267

Query: 291 MEHPYF 296
           + HP+F
Sbjct: 268 LAHPFF 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 3e-66
 Identities = 65/295 (22%), Positives = 130/295 (44%), Gaps = 40/295 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +   E +G G +G V+R  E ++ K    K  ++   D+       +E+SIL +  R 
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIA-RH 60

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            +++ L +  +   +     L ++FE++   D+ + I     +   +    + S ++Q+C
Sbjct: 61  RNILHLHESFESMEE-----LVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVC 112

Query: 123 KGVAFCHGHGILHRDLKPHN-LLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           + + F H H I H D++P N +   R++ T+KI + G AR                 Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT-APEYYA 171

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV       STA DMWS+  +   L++    F  ++  Q + +I     T +E+ +  +
Sbjct: 172 PEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
           S                         + +D ++++L  +   R++A +A++HP+ 
Sbjct: 231 S------------------------IEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 3e-66
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 38/296 (12%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + ++ ++ +GEG YG+V  A  + T + VA+K   + +     P    +E+ I +ML   
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKML-NH 62

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
            +VV+    ++  N       YL  EY        +    +    +P    +   +QL  
Sbjct: 63  ENVVKFYGHRREGNI-----QYLFLEYCSGGE---LFDRIEPDIGMPEPDAQRFFHQLMA 114

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRA 181
           GV + HG GI HRD+KP NLL+D +   LKI+D GLA  F    ++        TL Y A
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE+L     ++  VD+WS   +   ++     +   S+  Q    ++   T         
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------- 225

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
                      W           +D   L LL ++L  +PS RI+     +  +++
Sbjct: 226 --------LNPW---------KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-65
 Identities = 65/291 (22%), Positives = 128/291 (43%), Gaps = 39/291 (13%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           + + EK+G+G  G VY A + ATG+ VA+++  L +  +      + E+ ++R   ++P+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPN 78

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +V  +D     ++     L++V EY+       + +     E      + ++  +  + +
Sbjct: 79  IVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQAL 129

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVL 185
            F H + ++HRD+K  N+L+     ++K+ D G     T    K +  + T ++ APEV+
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 186 LGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSLM 245
                Y   VD+WS+  +  E++     +  ++ L+ L  I    GTP  +    +S   
Sbjct: 189 TRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS--- 243

Query: 246 NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                    D L + L  D  KR SAK+ ++H + 
Sbjct: 244 ---------------------AIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-65
 Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 44/296 (14%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLS 61
           ++ FE    +G+G +G VY AREK +  I+ALK     + +  GV     REV I   L 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL- 63

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           R P+++RL        +     +YL+ EY     + + ++               + + +
Sbjct: 64  RHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLS----KFDEQRTATYITE 114

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L   +++CH   ++HRD+KP NLL+      LKIAD G +     P  + T    TL Y 
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVH--APSSRRTTLCGTLDYL 171

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
            PE++ G   +   VD+WS+  +  E +     F  ++  +    I R+  T        
Sbjct: 172 PPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------ 224

Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                                   + +   DL+ ++L+++PS+R   ++ +EHP+ 
Sbjct: 225 ----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (511), Expect = 1e-63
 Identities = 60/294 (20%), Positives = 118/294 (40%), Gaps = 43/294 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLH-EDDEGVPPTTLREVSILRMLSRDP 64
           F  L ++G G++G VY AR+    ++VA+KK     +         ++EV  L+ L R P
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 75

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           + ++       ++       +LV EY        +   ++    +    + ++ +   +G
Sbjct: 76  NTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQG 127

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEV 184
           +A+ H H ++HRD+K  N+L+      +K+ D G A             + T ++ APEV
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMA----PANSFVGTPYWMAPEV 182

Query: 185 LLGSTH--YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           +L      Y   VD+WS+     EL  +       + +  L HI +              
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 228

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
                +E P            +  +   + ++  LQ  P  R +++  ++H + 
Sbjct: 229 -----NESPALQS-------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-63
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 36/304 (11%)

Query: 2   VMDAFEKLEKV-GEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           ++D ++   +V G G  GKV +   K T +  ALK  +             REV +    
Sbjct: 9   IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRA 61

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMY 119
           S+ PH+VR++DV +     GR  L +V E +D  +L   I+   +  +         +M 
Sbjct: 62  SQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMK 118

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHEILTL 177
            + + + + H   I HRD+KP NLL         LK+ D G A+  T      T    T 
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTP 177

Query: 178 WYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV 237
           +Y APEVL     Y  + DMWS+  I   L+     F  +  L     +   +       
Sbjct: 178 YYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------- 229

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD 297
                  M  +E+P             + ++   L+  +L+ +P++R++  + M HP+  
Sbjct: 230 ------RMGQYEFPNPEW-------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276

Query: 298 DLDK 301
              K
Sbjct: 277 QSTK 280

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (505), Expect = 3e-62
 Identities = 94/313 (30%), Positives = 148/313 (47%), Gaps = 25/313 (7%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           V+  ++ L+ +G G  G V  A +    + VA+KK      ++       RE+ +++ + 
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV- 73

Query: 62  RDPHVVRLMDVKQGQNK-EGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              +++ L++V   Q   E    +YLV E MD +L + I+        +    +  L+YQ
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQ 127

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+   H  GI+HRDLKP N+++     TLKI D GLAR         T  ++T +YR
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAG-TSFMMTPYVVTRYYR 185

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APEV+LG   Y   VD+WSV CI  E+V    LFPG   + Q   +   LGTP  +    
Sbjct: 186 APEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 241 VSSLMNWH--EYPQWNPQSLATAVPN------------LDKDGLDLLEQMLQYDPSKRIS 286
           +   +  +    P++   +     P+                  DLL +ML  DP+KRIS
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 287 AKKAMEHPYFDDL 299
              A++HPY +  
Sbjct: 305 VDDALQHPYINVW 317

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (501), Expect = 4e-62
 Identities = 72/298 (24%), Positives = 127/298 (42%), Gaps = 40/298 (13%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS 61
           + D ++  + +G G + +V  A +K T K+VA+K     +  EG   +   E+++L  + 
Sbjct: 7   IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHKI- 64

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
           + P++V L D+ +         LYL+ + +   +L   I                 L++Q
Sbjct: 65  KHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQ 115

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +   V + H  GI+HRDLKP NLL     +   + I+D GL++    P    +    T  
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTPG 174

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y APEVL     YS AVD WS+  I   L+     F  +++ +    I +     +   W
Sbjct: 175 YVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             +S                            D +  +++ DP KR + ++A++HP+ 
Sbjct: 234 DDIS------------------------DSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 5e-62
 Identities = 63/295 (21%), Positives = 121/295 (41%), Gaps = 39/295 (13%)

Query: 6   FEKLE-KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP 64
           F K + ++G G++  VY+  +  T   VA  + +  +  +        E  +L+ L + P
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHP 68

Query: 65  HVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           ++VR  D  +   K  +  + LV E M +  LK Y++ F+     + +  ++S   Q+ K
Sbjct: 69  NIVRFYDSWESTVKGKKC-IVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILK 123

Query: 124 GVAFCH--GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           G+ F H     I+HRDLK  N+ +   T ++KI DLGLA             I T  + A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAVIGTPEFMA 181

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE+      Y  +VD+++      E+ T    +       Q+                  
Sbjct: 182 PEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--------------- 224

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF 296
             + +  +   ++             +  +++E  ++ +  +R S K  + H +F
Sbjct: 225 --VTSGVKPASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 6e-61
 Identities = 78/311 (25%), Positives = 125/311 (40%), Gaps = 50/311 (16%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRL-HEDDEGVPPTTLREVSILRMLSR 62
           + F+  + +GEG++  V  ARE AT +  A+K     H   E   P   RE  ++  L  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 66

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P  V+L    Q   K     LY    Y    +L KYIR              +    ++
Sbjct: 67  HPFFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEI 117

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWY 179
              + + HG GI+HRDLKP N+L++   M ++I D G A+  +   K  +    + T  Y
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 180 RAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP 239
            +PE+L        + D+W++ CI  +LV     F   +E      I +L     EK +P
Sbjct: 177 VSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235

Query: 240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA------MEH 293
                                          DL+E++L  D +KR+  ++         H
Sbjct: 236 ----------------------------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267

Query: 294 PYFDDLDKTRL 304
           P+F+ +    L
Sbjct: 268 PFFESVTWENL 278

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 7e-61
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 42/305 (13%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLS 61
           ++ F   + +G+G++GKV+ A  K T +  A+K  +      +     T+ E  +L +  
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
             P +  +    Q +       L+ V EY++  DL  +I+S  +      ++       +
Sbjct: 61  EHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAE 111

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           +  G+ F H  GI++RDLK  N+L+D K   +KIAD G+ +   L   K      T  Y 
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 170

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           APE+LLG   Y+ +VD WS   +  E++   + F G  E +    I              
Sbjct: 171 APEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------------- 215

Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA-MEHPYFDDL 299
               M+   YP+W           L+K+  DLL ++   +P KR+  +    +HP F ++
Sbjct: 216 ---RMDNPFYPRW-----------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

Query: 300 DKTRL 304
           +   L
Sbjct: 262 NWEEL 266

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 9e-61
 Identities = 72/310 (23%), Positives = 132/310 (42%), Gaps = 42/310 (13%)

Query: 2   VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTL-REVSIL 57
           V D ++  E++G G +  V + REK+TG   A K   K R      GV    + REVSIL
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSL 117
           + + + P+V+ L +V + +       + L+ E +       +  F    E++        
Sbjct: 68  KEI-QHPNVITLHEVYENKTD-----VILILELVA---GGELFDFLAEKESLTEEEATEF 118

Query: 118 MYQLCKGVAFCHGHGILHRDLKPHNLLMDRK---TMTLKIADLGLARAFTLPIKKYTHEI 174
           + Q+  GV + H   I H DLKP N+++  +      +KI D GLA        ++ +  
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIF 177

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  + APE++          DMWS+  I   L++  + F GD++ + L ++  +     
Sbjct: 178 GTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
           ++ +   S                            D + ++L  DP KR++ + +++HP
Sbjct: 237 DEYFSNTS------------------------ALAKDFIRRLLVKDPKKRMTIQDSLQHP 272

Query: 295 YFDDLDKTRL 304
           +    D  + 
Sbjct: 273 WIKPKDTQQA 282

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  188 bits (477), Expect = 6e-58
 Identities = 74/313 (23%), Positives = 131/313 (41%), Gaps = 46/313 (14%)

Query: 1   MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRM 59
           + M+ F     +G G +G+VY  R+  TGK+ A+K         +      L E  +L +
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 60  LSRD--PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
           +S    P +V +       +K     L  + + M+  DL  ++       E      ++ 
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSE----ADMRF 111

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILT 176
              ++  G+   H   +++RDLKP N+L+D +   ++I+DLGLA  F+   KK    + T
Sbjct: 112 YAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS--KKKPHASVGT 168

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
             Y APEVL     Y ++ D +S+ C+  +L+   + F      +    I R+  T   +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMAVE 227

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAM 291
           +    S                         +   LLE +LQ D ++R+      A++  
Sbjct: 228 LPDSFS------------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263

Query: 292 EHPYFDDLDKTRL 304
           E P+F  LD   +
Sbjct: 264 ESPFFRSLDWQMV 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-56
 Identities = 62/301 (20%), Positives = 108/301 (35%), Gaps = 52/301 (17%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTT----LREVSILRMLS 61
           ++    +G G +G VY     +    VA+K        +            EV +L+ +S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 62  RD-PHVVRLMDVKQGQNKEGRTVLYLVFEYMD--TDLKKYIRSFRQTGENIPVNTVKSLM 118
                V+RL+D  +  +        L+ E  +   DL  +I         +     +S  
Sbjct: 66  SGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGA----LQEELARSFF 116

Query: 119 YQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLW 178
           +Q+ + V  CH  G+LHRD+K  N+L+D     LK+ D G      L    YT    T  
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTDFDGTRV 174

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y  PE +    ++  +  +WS+  +  ++V     F  D E+ +    FR          
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------- 224

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD 298
                                     +  +   L+   L   PS R + ++   HP+  D
Sbjct: 225 ------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

Query: 299 L 299
           +
Sbjct: 261 V 261

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 3e-54
 Identities = 51/295 (17%), Positives = 108/295 (36%), Gaps = 41/295 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
                 +++G G++G VY+ +       VA+K   +             EV +LR   R 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RH 63

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
            +++  M             L +V ++ + + L  ++           +  +  +  Q  
Sbjct: 64  VNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTA 114

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL--PIKKYTHEILTLWYR 180
           +G+ + H   I+HRDLK +N+ +    +T+KI D GLA   +      ++     ++ + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 181 APEVLLG--STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           APEV+       YS   D+++   +  EL+T    +   +   Q++ +            
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR--------- 224

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                         +    L+    N  K    L+ + L+    +R    + +  
Sbjct: 225 -------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  174 bits (441), Expect = 1e-53
 Identities = 69/296 (23%), Positives = 113/296 (38%), Gaps = 37/296 (12%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLH-EDDEGVPPTTLREVSILRMLSR 62
           D +E  E +G G   +V+ AR+    + VA+K  R     D        RE      L  
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-N 65

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
            P +V + D  + +   G  + Y+V EY+D   L+  + +       +       ++   
Sbjct: 66  HPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADA 120

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLW 178
           C+ + F H +GI+HRD+KP N+++   T  +K+ D G+ARA        T     I T  
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW 238
           Y +PE   G        D++S+ C+  E++T    F GDS +       R    P     
Sbjct: 180 YLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHP 294
            G+S                         D   ++ + L  +P  R      M   
Sbjct: 239 EGLS------------------------ADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 2e-52
 Identities = 72/308 (23%), Positives = 119/308 (38%), Gaps = 45/308 (14%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLS 61
           M+ F+ L+ +G+GT+GKV   REKATG+  A+K  R      +     T+ E  +L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
           R P +  L    Q  ++     L  V EY +      +               +    ++
Sbjct: 63  RHPFLTALKYAFQTHDR-----LCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEI 114

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
              + + H   +++RD+K  NL++D K   +KI D GL +              T  Y A
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEVL  +  Y  AVD W +  +  E++     F      +    I        E  +P  
Sbjct: 174 PEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFP-- 225

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYF 296
                                  L  +   LL  +L+ DP +R+      AK+ MEH +F
Sbjct: 226 ---------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

Query: 297 DDLDKTRL 304
             ++   +
Sbjct: 265 LSINWQDV 272

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  173 bits (439), Expect = 2e-52
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 40/326 (12%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS---- 61
           +  + K+G G +  V+ A++      VA+K  R    D+        E+ +L+ ++    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 71

Query: 62  ------RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVK 115
                    H+++L+D    +   G   +++V  +            +     IP+  VK
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNG---VHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 116 SLMYQLCKGVAFCH-GHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKKYTH 172
            +  QL  G+ + H   GI+H D+KP N+LM+       +  + +A         + YT+
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 173 EILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------ELQQLLHI 226
            I T  YR+PEVLLG+  +    D+WS AC+  EL+T   LF  D       +   +  I
Sbjct: 189 SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 227 FRLLGTPNEKVWPGVSS----------LMNWHEYPQWNPQSLATA----VPNLDKDGLDL 272
             LLG     +                L N  +   W  + + T       +  K+  D 
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 273 LEQMLQYDPSKRISAKKAMEHPYFDD 298
           L  MLQ DP KR  A   + HP+  D
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKD 333

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  170 bits (432), Expect = 9e-52
 Identities = 62/308 (20%), Positives = 124/308 (40%), Gaps = 48/308 (15%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLS 61
           +  F+ L  +G G++G+V+  R +  G+  A+K  +            T  E  +L ++ 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV- 61

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P ++R+    Q   +     ++++ +Y++      + S  +  +  P    K    ++
Sbjct: 62  THPFIIRMWGTFQDAQQ-----IFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEV 113

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           C  + + H   I++RDLKP N+L+D+    +KI D G A+                 Y A
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYTLCGTP---DYIA 169

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV+     Y+ ++D WS   +  E++     F   + ++    I        E  +P  
Sbjct: 170 PEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----AELRFP-- 221

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 296
                                P  ++D  DLL +++  D S+R+       +    HP+F
Sbjct: 222 ---------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

Query: 297 DDLDKTRL 304
            ++   +L
Sbjct: 261 KEVVWEKL 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 6e-50
 Identities = 69/315 (21%), Positives = 128/315 (40%), Gaps = 47/315 (14%)

Query: 3   MDAFEKLEKVGEGTYGKVYRARE---KATGKIVALKKTRLHE--DDEGVPPTTLREVSIL 57
           ++ FE L+ +G G YGKV+  R+     TGK+ A+K  +             T  E  +L
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 58  RMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKS 116
             + + P +V L    Q + K     L+L+ +Y++  +L  ++    +       + V+ 
Sbjct: 83  EHIRQSPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRER----FTEHEVQI 133

Query: 117 LMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEIL- 175
            + ++   +   H  GI++RD+K  N+L+D     + + D GL++ F     +  ++   
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCG 192

Query: 176 -TLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
              +     V  G + +  AVD WS+  +  EL+T  + F  D E      I R +    
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKK 289
                 +S                            DL++++L  DP KR+      A +
Sbjct: 253 PPYPQEMS------------------------ALAKDLIQRLLMKDPKKRLGCGPRDADE 288

Query: 290 AMEHPYFDDLDKTRL 304
             EH +F  ++   L
Sbjct: 289 IKEHLFFQKINWDDL 303

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-49
 Identities = 56/292 (19%), Positives = 111/292 (38%), Gaps = 45/292 (15%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSR 62
           M   + L+ +G+G +G V     +  G  VA+K  +     +      L E S++  L R
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQL-R 58

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             ++V+L+ V      E +  LY+V EYM    L  Y+R   +    +  + +      +
Sbjct: 59  HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDV 112

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
           C+ + +  G+  +HRDL   N+L+  +    K++D GL +  +          L + + A
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS---STQDTGKLPVKWTA 168

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE L     +ST  D+WS   +  E+ +   +      L+ ++                 
Sbjct: 169 PEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------------- 212

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
             +   ++                     ++++     D + R S  +  E 
Sbjct: 213 --VEKGYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 3e-49
 Identities = 63/308 (20%), Positives = 114/308 (37%), Gaps = 48/308 (15%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLS 61
           +D F++++ +G G++G+V   + K +G   A+K     +         TL E  IL+ + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV- 98

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
             P +V+L    +  +     + Y+    M + L++  R              +    Q+
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--------FSEPHARFYAAQI 150

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRA 181
                + H   +++RDLKP NLL+D++   +++ D G A+                   A
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTWTLCGTP---EALA 206

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PE++L    Y+ AVD W++  +  E+      F  D  +Q    I               
Sbjct: 207 PEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------------- 252

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYF 296
                   +P            +   D  DLL  +LQ D +KR             H +F
Sbjct: 253 ----GKVRFP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

Query: 297 DDLDKTRL 304
              D   +
Sbjct: 298 ATTDWIAI 305

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 5e-49
 Identities = 62/318 (19%), Positives = 107/318 (33%), Gaps = 62/318 (19%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKI-----VALKKTRLHEDDEGVPPTTLREVSILR 58
           +  E  + +G G +GKV  A      K      VA+K  +  + D       + E+ ++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 95

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN--------- 108
            L    ++V L+             +YL+FEY    DL  Y+RS R+             
Sbjct: 96  QLGSHENIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 109 ----------IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG 158
                     +    +    YQ+ KG+ F      +HRDL   N+L+      +KI D G
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFG 209

Query: 159 LARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFP 215
           LAR            +  L + + APE L     Y+   D+WS   +  E+ +     +P
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQ 275
           G         + +                    + P +  + +             +++ 
Sbjct: 269 GIPVDANFYKLIQNGFKM---------------DQPFYATEEIY-----------IIMQS 302

Query: 276 MLQYDPSKRISAKKAMEH 293
              +D  KR S       
Sbjct: 303 CWAFDSRKRPSFPNLTSF 320

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-46
 Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 45/301 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           ++     K+G+G +G+V+      T + VA+K  +            L+E  +++ L R 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---EAFLQEAQVMKKL-RH 71

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
             +V+L  V   +       +Y+V EYM            +TG+ + +  +  +  Q+  
Sbjct: 72  EKLVQLYAVVSEEP------IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIAS 124

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL-PIKKYTHEILTLWYRAP 182
           G+A+      +HRDL+  N+L+    +  K+AD GLAR                + + AP
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           E  L    ++   D+WS   +  EL T     +PG    + L  + R    P        
Sbjct: 184 EAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP------ 236

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK--KAMEHPYFDDL 299
                                P   +   DL+ Q  + +P +R + +  +A    YF   
Sbjct: 237 ---------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

Query: 300 D 300
           +
Sbjct: 276 E 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 5e-46
 Identities = 47/305 (15%), Positives = 93/305 (30%), Gaps = 45/305 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           + +    K+G G++G +Y   + A G+ VA+K   +      +      E  I +M+   
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMMQGG 62

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
             +  +       +        +V E +   L+     F        + TV  L  Q+  
Sbjct: 63  VGIPTIRWCGAEGDY-----NVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMIS 114

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKI--ADLGLARAFT-------LPIKKYTHEI 174
            + + H    +HRD+KP N LM        +   D GLA+ +        +P ++  +  
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  Y +    LG    S   D+ S+  +       +  + G     +     R      
Sbjct: 175 GTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------ 227

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA---KKAM 291
                         E     P  +         +    L          +      ++  
Sbjct: 228 ------------ISEKKMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

Query: 292 EHPYF 296
            + + 
Sbjct: 274 RNLFH 278

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-46
 Identities = 62/306 (20%), Positives = 113/306 (36%), Gaps = 50/306 (16%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGKI--VALKKTRLHEDDEGVPPTTLREVSILRML 60
            +  +  + +GEG +G+V +AR K  G     A+K+ + +   +        E+ +L  L
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVLCKL 67

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIR------------SFRQTGE 107
              P+++ L+   + +       LYL  EY    +L  ++R                T  
Sbjct: 68  GHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122

Query: 108 NIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPI 167
            +    +      + +G+ +      +HRDL   N+L+       KIAD GL+R   + +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYV 181

Query: 168 KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIF 227
           KK     L + + A E L  S  Y+T  D+WS   +  E+V+            +L    
Sbjct: 182 KKTMG-RLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK- 238

Query: 228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISA 287
                           L   +   +           N D +  DL+ Q  +  P +R S 
Sbjct: 239 ----------------LPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSF 273

Query: 288 KKAMEH 293
            + +  
Sbjct: 274 AQILVS 279

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 7e-46
 Identities = 55/300 (18%), Positives = 116/300 (38%), Gaps = 48/300 (16%)

Query: 11  KVGEGTYGKVYRA--REKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           ++G G +G V +   + K   K VA+K  +   +D  +    L E ++++ L  +P++VR
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 72

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFC 128
           ++ + + ++        LV E  +      +  + Q   ++    +  L++Q+  G+ + 
Sbjct: 73  MIGICEAES------WMLVMEMAELGP---LNKYLQQNRHVKDKNIIELVHQVSMGMKYL 123

Query: 129 HGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLWYRAPEVL 185
                +HRDL   N+L+  +    KI+D GL++A       Y   TH    + + APE +
Sbjct: 124 EESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 186 LGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL 244
                +S+  D+WS   +  E  +     + G    +    + +                
Sbjct: 183 NYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------------- 225

Query: 245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK---KAMEHPYFDDLDK 301
               E                 ++  DL+     YD   R         + + Y+D +++
Sbjct: 226 ---GERMGCP--------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  153 bits (386), Expect = 3e-45
 Identities = 42/298 (14%), Positives = 87/298 (29%), Gaps = 44/298 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
           ++   ++GEG++G ++        + VA+K      D   +      E    ++L+    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGCTG 62

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGV 125
           +  +    Q           LV + +   L+  +      G    V TV     Q+   V
Sbjct: 63  IPNVYYFGQEGLH-----NVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARV 114

Query: 126 AFCHGHGILHRDLKPHNLLMDRKTM----TLKIADLGLARAFTLPIKK-------YTHEI 174
              H   +++RD+KP N L+ R        + + D G+ + +  P+ K         +  
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            T  Y +    LG    S   D+ ++  +F   +  +  + G           R+     
Sbjct: 175 GTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK- 232

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
                                  L        ++    +                   
Sbjct: 233 -------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 6e-45
 Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 50/302 (16%)

Query: 11  KVGEGTYGKVYRAREKATGK--IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVR 68
           ++G G +G V +   +   K   VA+K  +    ++      +RE  I+  L  +P++VR
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQL-DNPYIVR 73

Query: 69  LMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAF 127
           L+ V Q +       L LV E      L K++   R   E IPV+ V  L++Q+  G+ +
Sbjct: 74  LIGVCQAEA------LMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKY 124

Query: 128 CHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE---ILTLWYRAPEV 184
                 +HRDL   N+L+  +    KI+D GL++A       YT        L + APE 
Sbjct: 125 LEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 185 LLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
           +     +S+  D+WS      E ++     +      + +  I +               
Sbjct: 184 INFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------------- 227

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK---KAMEHPYFDDLD 300
                +  +          P    +   L+     Y    R       + M   Y+    
Sbjct: 228 ----GKRMECP--------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

Query: 301 KT 302
           K 
Sbjct: 276 KV 277

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-44
 Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 29/298 (9%)

Query: 9   LEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS-RDPHVV 67
            E +G+G +G+V+R +    G+ VA+K     E+         RE  I + +  R  +++
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENIL 60

Query: 68  RLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGE---NIPVNTVKSLMYQLCK 123
             +      N    T L+LV +Y +   L  Y+  +  T E    + ++T   L +   +
Sbjct: 61  GFIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 119

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY----THEILTLWY 179
            V       I HRDLK  N+L+ +   T  IADLGLA               H + T  Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 180 RAPEVLLGSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN 234
            APEVL  S +          D++++  +F E+  + ++     + Q   +         
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
           E++   V         P               +    ++ +    + + R++A +  +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQS------CEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 6e-44
 Identities = 56/296 (18%), Positives = 111/296 (37%), Gaps = 43/296 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
           +  + +E++G G +G+V+          VA+K  +        P   L E ++++ L + 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMKQL-QH 67

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
             +VRL  V   +       +Y++ EYM+            +G  + +N +  +  Q+ +
Sbjct: 68  QRLVRLYAVVTQEP------IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAE 120

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL-PIKKYTHEILTLWYRAP 182
           G+AF      +HRDL+  N+L+   T++ KIAD GLAR                + + AP
Sbjct: 121 GMAFIEERNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E +     ++   D+WS   +  E+VT   +        +++                  
Sbjct: 180 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---------------- 222

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYF 296
            L   +   +           N  ++   L+    +  P  R +          +F
Sbjct: 223 -LERGYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 9e-44
 Identities = 52/292 (17%), Positives = 105/292 (35%), Gaps = 43/292 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
                ++++G G +G V+          VA+K  R     E      + E  ++  L   
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKL-SH 59

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           P +V+L  V   Q       + LVFE+M+   L  Y+R+ R         T+  +   +C
Sbjct: 60  PKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVC 111

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEI-LTLWYRA 181
           +G+A+     ++HRDL   N L+      +K++D G+ R         +      + + +
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170

Query: 182 PEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGV 241
           PEV   S  YS+  D+WS   +  E+ ++  +   +    +++                 
Sbjct: 171 PEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------- 216

Query: 242 SSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                   +  + P                ++    +  P  R +  + +  
Sbjct: 217 ------TGFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 6e-43
 Identities = 61/296 (20%), Positives = 104/296 (35%), Gaps = 45/296 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLH-EDDEGVPPTTLREVSILRMLS 61
              LEK+G+G++G V R    A       VA+K  +             +REV+ +  L 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL- 68

Query: 62  RDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQL 121
              +++RL  V           + +V E     L   +   R+   +  + T+     Q+
Sbjct: 69  DHRNLIRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQV 120

Query: 122 CKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY---THEILTLW 178
            +G+ +      +HRDL   NLL+  +   +KI D GL RA       Y    H  +   
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 179 YRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKV 237
           + APE L     +S A D W       E+ T     + G +  Q L  I +         
Sbjct: 180 WCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------- 229

Query: 238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                        P+           +  +D  +++ Q   + P  R +     + 
Sbjct: 230 --------EGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 8e-43
 Identities = 49/291 (16%), Positives = 103/291 (35%), Gaps = 45/291 (15%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPH 65
              L+++G G +G V   + +     VA+K  +     E      + E  ++  L     
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNL-SHEK 60

Query: 66  VVRLMDVKQGQNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKG 124
           +V+L  V   Q       ++++ EYM    L  Y+R  R          +  +   +C+ 
Sbjct: 61  LVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEA 112

Query: 125 VAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT-LPIKKYTHEILTLWYRAPE 183
           + +      LHRDL   N L++ +   +K++D GL+R                + +  PE
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           VL+ S  +S+  D+W+   +  E+ +   + +   +  +   HI + L      +     
Sbjct: 172 VLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS--- 227

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                                   +    ++         +R + K  + +
Sbjct: 228 ------------------------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (362), Expect = 9e-42
 Identities = 53/289 (18%), Positives = 102/289 (35%), Gaps = 37/289 (12%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRD 63
                  K+G G YG+VY    K     VA+K  +   +D       L+E ++++ + + 
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEI-KH 72

Query: 64  PHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCK 123
           P++V+L+ V   +        Y++ E+M               E +    +  +  Q+  
Sbjct: 73  PNLVQLLGVCTREPP-----FYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISS 126

Query: 124 GVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPE 183
            + +      +HRDL   N L+  +   +K+AD GL+R  T                   
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185

Query: 184 VLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS 243
             L    +S   D+W+   +  E+ T         +L Q+  +                 
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------- 235

Query: 244 LMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
                E P+  P+ +            +L+    Q++PS R S  +  +
Sbjct: 236 -----ERPEGCPEKVY-----------ELMRACWQWNPSDRPSFAEIHQ 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-41
 Identities = 59/312 (18%), Positives = 109/312 (34%), Gaps = 57/312 (18%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILR 58
           +     + +G G +GKV  A      +      VA+K  +            + E+ +L 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLS 81

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN--------- 108
            L    ++V L+               ++ EY    DL  ++R  R +            
Sbjct: 82  YLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 109 -----IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF 163
                + +  + S  YQ+ KG+AF      +HRDL   N+L+       KI D GLAR  
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDI 195

Query: 164 TLPIKKY--THEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSEL 220
                     +  L + + APE +     Y+   D+WS      EL +  ++ +PG    
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 221 QQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYD 280
            +   + +                     +   +P        +   +  D+++     D
Sbjct: 255 SKFYKMIK-------------------EGFRMLSP-------EHAPAEMYDIMKTCWDAD 288

Query: 281 PSKRISAKKAME 292
           P KR + K+ ++
Sbjct: 289 PLKRPTFKQIVQ 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 3e-41
 Identities = 58/293 (19%), Positives = 106/293 (36%), Gaps = 42/293 (14%)

Query: 6   FEKLEKVGEGTYGKVYRAREKATGKIVALK---KTRLHEDDEGVPPTTLREVSILRMLSR 62
           F+K++ +G G +G VY+      G+ V +    K              L E  ++  +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69

Query: 63  DPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLC 122
           +PHV RL+ +           + L+ + M       +   R+  +NI    + +   Q+ 
Sbjct: 70  NPHVCRLLGICLTST------VQLITQLMPFG--CLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 123 KGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE--ILTLWYR 180
           KG+ +     ++HRDL   N+L+      +KI D GLA+      K+Y  E   + + + 
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
           A E +L    Y+   D+WS      EL+T  +         ++  I              
Sbjct: 181 ALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------------- 225

Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
              L      PQ          P    D   ++ +    D   R   ++ +  
Sbjct: 226 ---LEKGERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 8e-41
 Identities = 61/318 (19%), Positives = 116/318 (36%), Gaps = 65/318 (20%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILR 58
           +  E +  +GEG +G+V++AR           +VA+K  +  E    +     RE +++ 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMA 71

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN--------- 108
               +P++V+L+ V           + L+FEYM   DL +++RS                
Sbjct: 72  EF-DNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 109 -----------IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL 157
                      +       +  Q+  G+A+      +HRDL   N L+    M +KIAD 
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADF 184

Query: 158 GLARAF--TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-F 214
           GL+R        K   ++ + + +  PE +     Y+T  D+W+   +  E+ +     +
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 215 PGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLE 274
            G +  + + ++                   N    P+  P  L            +L+ 
Sbjct: 244 YGMAHEEVIYYVRD----------------GNILACPENCPLELY-----------NLMR 276

Query: 275 QMLQYDPSKRISAKKAME 292
                 P+ R S      
Sbjct: 277 LCWSKLPADRPSFCSIHR 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-40
 Identities = 64/312 (20%), Positives = 121/312 (38%), Gaps = 56/312 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATGK-------IVALKKTRLHEDDEGVPPTTLREVSI 56
           D     + +GEG +G+V  A      K        VA+K  +    ++ +    + E+ +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 71

Query: 57  LRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTG--------- 106
           ++M+ +  +++ L+             LY++ EY    +L++Y+++ R  G         
Sbjct: 72  MKMIGKHKNIINLLGACTQDGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 107 ---ENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF 163
              E +    + S  YQ+ +G+ +      +HRDL   N+L+      +KIAD GLAR  
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDI 185

Query: 164 --TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ 221
                 KK T+  L + + APE L     Y+   D+WS   +  E+ T          ++
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244

Query: 222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDP 281
           +L  +                 L   H   +           N   +   ++       P
Sbjct: 245 ELFKL-----------------LKEGHRMDKP---------SNCTNELYMMMRDCWHAVP 278

Query: 282 SKRISAKKAMEH 293
           S+R + K+ +E 
Sbjct: 279 SQRPTFKQLVED 290

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (353), Expect = 3e-40
 Identities = 53/300 (17%), Positives = 107/300 (35%), Gaps = 47/300 (15%)

Query: 3   MDAFEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRM 59
           +   +  + +G G +G+V     K  GK    VA+K  +    ++      L E SI+  
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQ 83

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
               P+V+ L  V           + ++ E+M+          RQ      V  +  ++ 
Sbjct: 84  F-DHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSF--LRQNDGQFTVIQLVGMLR 135

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTH-----EI 174
            +  G+ +      +HRDL   N+L++   +  K++D GL+R         T+       
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 175 LTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP 233
           + + + APE +     +++A D+WS   +  E+++     +   +    +  I +    P
Sbjct: 195 IPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253

Query: 234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
                            P   P +L             L+    Q D + R    + +  
Sbjct: 254 ----------------PPMDCPSALH-----------QLMLDCWQKDRNHRPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-40
 Identities = 48/293 (16%), Positives = 98/293 (33%), Gaps = 40/293 (13%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKAT---GKIVALKKTRLHEDDEGVPPTTLREVSILRML 60
           +  E    +GEG +G V++    +       VA+K  + +   + V    L+E   +R  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65

Query: 61  SRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQ 120
              PH+V+L+ V           ++++ E       +     R+    + + ++    YQ
Sbjct: 66  -DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQ 116

Query: 121 LCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHEILTLWYR 180
           L   +A+      +HRD+   N+L+      +K+ D GL+R           +       
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175

Query: 181 APEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG 240
                +    +++A D+W       E++          +   ++                
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--------------- 220

Query: 241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
              + N    P           PN       L+ +   YDPS+R    +    
Sbjct: 221 --RIENGERLPMP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 3e-39
 Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 43/291 (14%)

Query: 10  EKVGEGTYGKVYRAR---EKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV 66
           E +G G +G VY              A+K       D G     L E  I++     P+V
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDF-SHPNV 90

Query: 67  VRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVA 126
           + L+ +             +V  YM     +          N  V  +     Q+ KG+ 
Sbjct: 91  LSLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMK 144

Query: 127 FCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKYTHE----ILTLWYRAP 182
           F      +HRDL   N ++D K  T+K+AD GLAR          H      L + + A 
Sbjct: 145 FLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 183 EVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS 242
           E L     ++T  D+WS   +  EL+T+ A    D     +             +  G  
Sbjct: 204 ESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----------VYLLQGRR 252

Query: 243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH 293
            L      P++ P  L            +++ +        R S  + +  
Sbjct: 253 LL-----QPEYCPDPLY-----------EVMLKCWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 9e-39
 Identities = 61/311 (19%), Positives = 110/311 (35%), Gaps = 54/311 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAR-----EKATGKIVALKKTRLHEDDEGVPPTTLREVSILR 58
           D  +  + +G G +G+V  A      + AT + VA+K  +            + E+ IL 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILI 71

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGEN--------- 108
            +    +VV L+             L ++ E+    +L  Y+RS R              
Sbjct: 72  HIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127

Query: 109 ---IPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTL 165
              + +  +    +Q+ KG+ F      +HRDL   N+L+  K   +KI D GLAR    
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYK 186

Query: 166 P--IKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQ 222
                +     L L + APE +     Y+   D+WS   +  E+ +  A  +PG    ++
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 223 LLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPS 282
                +                      P +    +              +      +PS
Sbjct: 246 FCRRLKEGTRM---------------RAPDYTTPEMY-----------QTMLDCWHGEPS 279

Query: 283 KRISAKKAMEH 293
           +R +  + +EH
Sbjct: 280 QRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-37
 Identities = 69/318 (21%), Positives = 116/318 (36%), Gaps = 57/318 (17%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILR 58
           +      ++G+G++G VY    K          VA+K               L E S+++
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMK 78

Query: 59  MLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPV------ 111
                 HVVRL+ V             ++ E M   DLK Y+RS R    N PV      
Sbjct: 79  EF-NCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 112 NTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF--TLPIKK 169
           + +  +  ++  G+A+ + +  +HRDL   N ++     T+KI D G+ R    T   +K
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRK 191

Query: 170 YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFR 228
               +L + + +PE L     ++T  D+WS   +  E+ T     + G S  Q L  +  
Sbjct: 192 GGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

Query: 229 LLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK 288
                                        L     N      +L+    QY+P  R S  
Sbjct: 251 ---------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 283

Query: 289 KAME------HPYFDDLD 300
           + +        P F ++ 
Sbjct: 284 EIISSIKEEMEPGFREVS 301

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-37
 Identities = 47/296 (15%), Positives = 104/296 (35%), Gaps = 44/296 (14%)

Query: 4   DAFEKLEKVGEGTYGKVYRAREKATG----KIVALKKTRLHEDDEGVPPTTLREVSILRM 59
               + + +G G +G+VY+   K +       VA+K  +     E      L E  I+  
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 65

Query: 60  LSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMY 119
                +++RL  V           + ++ EYM+          R+      V  +  ++ 
Sbjct: 66  F-SHHNIIRLEGVISKYKP-----MMIITEYMENGALDKF--LREKDGEFSVLQLVGMLR 117

Query: 120 QLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY---THEILT 176
            +  G+ +      +HRDL   N+L++   +  K++D GL+R      +     +   + 
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 177 LWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK 236
           + + APE +     +++A D+WS   +  E++T       +    +++            
Sbjct: 177 IRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---------- 225

Query: 237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME 292
                  + +    P            +       L+ Q  Q + ++R      + 
Sbjct: 226 -------INDGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.5 bits (203), Expect = 1e-19
 Identities = 27/211 (12%), Positives = 60/211 (28%), Gaps = 51/211 (24%)

Query: 10  EKVGEGTYGKVYRAREKATGKIVALKKTRL----------------HEDDEGVPPTTLRE 53
           + +GEG    V+    +       +K  ++                         +   E
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 54  VSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNT 113
              L+ L +   V ++   +            ++ E +D      +R             
Sbjct: 65  FRALQKL-QGLAVPKVYAWEGN---------AVLMELIDAKELYRVRVENP--------- 105

Query: 114 VKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLPIKKY--- 170
              ++  + + VA  +  GI+H DL  +N+L+      + I D   +        +    
Sbjct: 106 -DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILE 162

Query: 171 -THEILTLWYRAPEVLLGSTHYSTAVDMWSV 200
                +  ++           Y T  D+ S 
Sbjct: 163 RDVRNIITYFS--------RTYRTEKDINSA 185

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	304
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.28
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.88
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.29
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.42
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.7

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-62  Score=406.23  Aligned_cols=290  Identities=58%  Similarity=1.081  Sum_probs=249.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||+||+|++..+++.||+|++............+.+|+++++++ +||||+++++++.+...    
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~----   75 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENK----   75 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE----
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccc----
Confidence            5899999999999999999999999999999999976655555667888999999999 99999999999998877    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       +++||||+++++.+.+..  .....+++.++..++.||+.||+|||++||+||||||+||+++.++ .+||+|||.+..
T Consensus        76 -~~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~  151 (298)
T d1gz8a_          76 -LYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARA  151 (298)
T ss_dssp             -EEEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHH
T ss_pred             -eeEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCccee
Confidence             999999999988777765  3345799999999999999999999999999999999999999777 999999999988


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............|++.|+|||++.....++.++||||||+++|+|++|..||...+..+....+....+.+.+..++...
T Consensus       152 ~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             HCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccc
Confidence            77666666677889999999999888778999999999999999999999999999999999999998888888777665


Q ss_pred             ccCCcc-cCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          243 SLMNWH-EYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                      ...... ..............+.+|+++.+||.+||..||.+|||++|+++||||+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            554432 22233334455566789999999999999999999999999999999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-61  Score=399.90  Aligned_cols=256  Identities=24%  Similarity=0.432  Sum_probs=222.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++......  ....+.+|+.+++.+ +||||+++++++.+.+.     
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~-----   91 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMREN-KNPNIVNYLDSYLVGDE-----   91 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE-----
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCE-----
Confidence            5799999999999999999999999999999998765432  245788999999999 99999999999998776     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||+.| +|.+++..     ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus        92 ~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~  165 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  165 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhhee
Confidence            8999999986 88887654     4699999999999999999999999999999999999999877 999999999988


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+........        
T Consensus       166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--------  236 (293)
T d1yhwa1         166 ITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--------  236 (293)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------
T ss_pred             eccccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            766555566678899999999998765 79999999999999999999999998887777666655321111        


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                       .....+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       237 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         237 -----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             -----------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                             1112588999999999999999999999999999999753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-62  Score=399.32  Aligned_cols=261  Identities=28%  Similarity=0.437  Sum_probs=211.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||+||+++++.+|+.||+|.+......+.....+.+|+++++++ +||||+++++++.+....   
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~---   78 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNT---   78 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC-------
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCC---
Confidence            4789999999999999999999999999999999876654444455688899999999 999999999988653221   


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC-----ccccCCCCCCeEEeCCCCeEEEee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG-----ILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-----i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      .+++||||++| +|.+++.........+++..++.++.||+.||+|||++|     |+||||||+|||++.++ .+||+|
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            27999999986 999999876666678999999999999999999999976     99999999999999877 999999


Q ss_pred             ccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          157 LGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ||++..............||+.|+|||++.+.. ++.++|||||||++|+|+||..||...+..+....+.....     
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-----  231 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----  231 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            999987766555555678899999999997766 89999999999999999999999998887777666654211     


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  296 (304)
                                            ......+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus       232 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 ----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                  11123688999999999999999999999999999995

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=397.75  Aligned_cols=260  Identities=28%  Similarity=0.465  Sum_probs=214.8

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...... .....+.+|+++++++ +||||+++++++.+.+.    
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~----   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKML-NHENVVKFYGHRREGNI----   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTC-CCTTBCCEEEEEEETTE----
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCce----
Confidence            47899999999999999999999999999999998765432 2345788999999999 99999999999998776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||||+.| +|.+++..    ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        78 -~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~  151 (271)
T d1nvra_          78 -QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLAT  151 (271)
T ss_dssp             -EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             -eEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhhe
Confidence             8999999986 88887743    35799999999999999999999999999999999999999777 89999999998


Q ss_pred             ecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ......  .......||+.|+|||++.+...++.++|||||||++|+|++|..||..................       
T Consensus       152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------  224 (271)
T d1nvra_         152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------  224 (271)
T ss_dssp             ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-------
T ss_pred             eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------
Confidence            765432  23445678999999999988775678899999999999999999999776544333222221111       


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                        .......+|+++.+||.+||+.||.+|||++|+++||||++-
T Consensus       225 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         225 ------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             ------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence                              111123578999999999999999999999999999999853

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-61  Score=395.25  Aligned_cols=254  Identities=28%  Similarity=0.487  Sum_probs=220.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.... ........+.+|+++++++ +||||+++++++.+...   
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~---   80 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATR---   80 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE---
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCE---
Confidence            578999999999999999999999999999999987543 2233446778899999999 99999999999998776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...    .++++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        81 --~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          81 --VYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             --EEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeeccccee
Confidence              8999999985 999988763    4699999999999999999999999999999999999999877 8999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.+....        
T Consensus       154 ~~~~~~--~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------  222 (263)
T d2j4za1         154 VHAPSS--RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------  222 (263)
T ss_dssp             SCCCCC--CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------
T ss_pred             eecCCC--cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            765443  334557899999999998866 799999999999999999999999988877776665442110        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                          ....+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       223 --------------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         223 --------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             --------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                                11258899999999999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-61  Score=399.20  Aligned_cols=262  Identities=27%  Similarity=0.462  Sum_probs=223.0

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      .++|++++.||+|+||+||+|+++.+++.||||++.... ........+.+|+++++++ +||||+++++++.+.+.   
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~---   82 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEK---   82 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSE---
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCE---
Confidence            468999999999999999999999999999999987543 2233456788999999999 99999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...    ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus        83 --~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a  155 (288)
T d1uu3a_          83 --LYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTA  155 (288)
T ss_dssp             --EEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --EEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccc
Confidence              8999999986 999988764    4699999999999999999999999999999999999999777 8999999999


Q ss_pred             eecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          161 RAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       161 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.+....      
T Consensus       156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~------  228 (288)
T d1uu3a_         156 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD------  228 (288)
T ss_dssp             EECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC------
T ss_pred             eecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC------
Confidence            8765332  2234457899999999998876 799999999999999999999999988887777666542110      


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHH------HhcCCCccccccccC
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK------AMEHPYFDDLDKTRL  304 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e------il~~~~~~~~~~~~~  304 (304)
                                            ....+|+++.+||.+||+.||.+|||++|      |++||||+++++++|
T Consensus       229 ----------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         229 ----------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             ----------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ----------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence                                  11258899999999999999999999998      589999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=397.73  Aligned_cols=283  Identities=40%  Similarity=0.772  Sum_probs=240.2

Q ss_pred             hhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC---CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEE
Q 021982            8 KLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD---EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVL   84 (304)
Q Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   84 (304)
                      .++.||+|+||+||+|+++.+|+.||||++......   +.....+.+|+++++++ +||||+++++++...+.     .
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~-----~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN-----I   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC-----C
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCc-----e
Confidence            357899999999999999999999999998754322   22346788999999999 99999999999998877     8


Q ss_pred             EEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           85 YLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      ++||||+.|++...+.   .....+++.++..++.||+.||+|||++|++||||||+||+++.++ .+||+|||.+....
T Consensus        76 ~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             eehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccC
Confidence            9999999986555443   3346799999999999999999999999999999999999999777 99999999998776


Q ss_pred             cCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccccc
Q 021982          165 LPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSSL  244 (304)
Q Consensus       165 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (304)
                      ..........||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+....+.+....++.....
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            66555566678999999999987766899999999999999999999999999999999999999999888888776665


Q ss_pred             CCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          245 MNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      .............+....+.+++++.+||.+||+.||++|||++|+|+||||++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            55554444444455556678999999999999999999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=395.20  Aligned_cols=258  Identities=23%  Similarity=0.397  Sum_probs=220.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      +.|++++.||+|+||+||+|+++.++..||+|++....  ......+.+|+++++++ +||||+++++++.+.+.     
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~-----   83 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENN-----   83 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTE-----
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCe-----
Confidence            46999999999999999999999999999999987543  33456788999999999 99999999999998776     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||+.| +|.+++...   ..++++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~  159 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAK  159 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhc
Confidence            8999999986 888887653   24699999999999999999999999999999999999999887 899999999977


Q ss_pred             cccCCCccccccccccCCChhhhhC----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLG----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ............||+.|+|||++..    ...++.++|||||||++|+|+||..||...+..+....+.......     
T Consensus       160 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-----  234 (288)
T d2jfla1         160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-----  234 (288)
T ss_dssp             CHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-----
T ss_pred             cCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            6554444455678999999999853    3337899999999999999999999999888777766665431110     


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                          ......+|+++.+||.+||+.||.+|||++|+++||||+.
T Consensus       235 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 --------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             --------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             --------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                0112358899999999999999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-59  Score=391.25  Aligned_cols=294  Identities=43%  Similarity=0.801  Sum_probs=243.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-CcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc--CCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-GKIVALKKTRLHEDDEGVPPTTLREVSILRMLS--RDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++++.||+|+||+||+|++..+ ++.||||++..............+|+++++.+.  +||||+++++++.....+
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999655 567899999877666666667778888877663  799999999998766555


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      .....++++|++++++......  .....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhh
Confidence            5556899999999876665554  3446789999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+....+.+....|+
T Consensus       163 ~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         163 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCCCGG-GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhccc-ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            8765433 3445567899999999998776 8999999999999999999999999999999999999988888776665


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                      ......... ...............+++.+.+||.+||+.||.+|||++|+|+||||+++++-
T Consensus       241 ~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         241 RDVALPRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             TTCSSCGGG-SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccchhhh-hccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            543332221 12222333445566899999999999999999999999999999999999764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-60  Score=395.65  Aligned_cols=260  Identities=26%  Similarity=0.430  Sum_probs=206.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |.++|++++.||+|+||+||+|+++.+++.||+|++....... ....+.+|+.+++++ +||||+++++++.+...   
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~---   81 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKI-KHPNIVALDDIYESGGH---   81 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTC-CCTTBCCEEEEEECSSE---
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE---
Confidence            6788999999999999999999999999999999987654332 235677899999999 99999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC--CCCeEEEeecc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR--KTMTLKIADLG  158 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~--~~~~vkl~dfg  158 (304)
                        +++||||+.| +|.+++..    ...+++.++..++.||+.||+|||++|++||||||+||++..  ++..+||+|||
T Consensus        82 --~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          82 --LYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             --EEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             --EEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence              8999999985 99999865    357999999999999999999999999999999999999953  23489999999


Q ss_pred             ceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          159 LARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      ++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+.........   
T Consensus       156 ~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  230 (307)
T d1a06a_         156 LSKMEDPG-SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS---  230 (307)
T ss_dssp             ------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT---
T ss_pred             eeEEccCC-CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC---
Confidence            99766544 3334567899999999998776 799999999999999999999999988887777766653222111   


Q ss_pred             ccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          239 PGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                           ...+.+|+++.+||.+||+.||.+|||++|+++||||+.
T Consensus       231 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         231 ---------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             ---------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ---------------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                                 122368999999999999999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-59  Score=389.77  Aligned_cols=285  Identities=53%  Similarity=0.966  Sum_probs=241.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||+||+|+++ +++.||||++......+.....+.+|+++++++ +||||+++++++...+.    
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~----   74 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKR----   74 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSC----
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCc----
Confidence            579999999999999999999986 678999999987665566677899999999999 99999999999998887    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .++++|++.+++...+..   ....+++.++..++.||+.||+|||+.||+|+||||+||+++.++ .+|++|||.+..
T Consensus        75 -~~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~  149 (286)
T d1ob3a_          75 -LVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARA  149 (286)
T ss_dssp             -EEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHH
T ss_pred             -eeEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEeccccccee
Confidence             899999999976666543   346799999999999999999999999999999999999999887 999999999987


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ............+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....+.+....|+...
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence            76655555556679999999999887778999999999999999999999999999999999999988888887777665


Q ss_pred             ccCCccc-CCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          243 SLMNWHE-YPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       243 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ....... .............+.+++++.+||++||+.||++|||++|+|+||||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            5444322 2233344455667789999999999999999999999999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-60  Score=397.57  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=227.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +++|++++.||+|+||.||+|+++.+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++.+...   
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~---   79 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDR---   79 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSE---
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccc---
Confidence            688999999999999999999999999999999997543 1233456788999999999 99999999999998877   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| +|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        80 --~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a  152 (337)
T d1o6la_          80 --LCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             --cccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccc
Confidence              9999999996 898888763    4689999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+......        
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~--------  223 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--------  223 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred             cccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC--------
Confidence            87665555566678999999999998876 799999999999999999999999998887777666552111        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                          .+..+|+++.+||++||+.||.+|++     ++|+++||||++++++
T Consensus       224 --------------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         224 --------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             --------------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence                                12368999999999999999999994     9999999999988654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-59  Score=390.26  Aligned_cols=266  Identities=26%  Similarity=0.423  Sum_probs=223.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCC----CCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEG----VPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      |.++|++++.||+|+||+||+|+++.+|+.||+|++........    ....+.+|+.+++++ +||||+++++++.+..
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~   86 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKT   86 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence            45789999999999999999999999999999999976543322    234678899999999 9999999999999877


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC---eEE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM---TLK  153 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~---~vk  153 (304)
                      .     +++||||+.| +|.+++...    ..+++..++.++.|++.||+|||++|++||||||+||+++.++.   .+|
T Consensus        87 ~-----~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          87 D-----VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             E-----EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             E-----EEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceE
Confidence            6     8999999985 999998763    46999999999999999999999999999999999999986652   599


Q ss_pred             EeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCC
Q 021982          154 IADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      ++|||++....... ......+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.......
T Consensus       158 l~DfG~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~  235 (293)
T d1jksa_         158 IIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  235 (293)
T ss_dssp             ECCCTTCEECTTSC-BCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             ecchhhhhhcCCCc-cccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            99999998765543 334457799999999998765 7999999999999999999999999888877776665431111


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccccc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  303 (304)
                                              .....+.+|+++.+||++||+.||.+|||++|+++||||+..+++.
T Consensus       236 ------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         236 ------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             ------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             ------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence                                    1112246899999999999999999999999999999999876653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-59  Score=398.86  Aligned_cols=263  Identities=27%  Similarity=0.474  Sum_probs=223.7

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |+++|++++.||+|+||.||+|+++.+|+.||+|++.....  .....+.+|+++++++ +||||+++++++.+.+.   
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~---   97 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNE---   97 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTE---
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE---
Confidence            56899999999999999999999999999999999865432  2235677899999999 99999999999998776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC-CCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK-TMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~-~~~vkl~dfg~  159 (304)
                        +++||||+.| +|.+++..   ...++++.++..++.||+.||.|||++|++||||||+|||++.+ +..+||+|||+
T Consensus        98 --~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          98 --MVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             --EEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             --EEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence              9999999986 99888753   23469999999999999999999999999999999999999643 24899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.........    
T Consensus       173 a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----  246 (350)
T d1koaa2         173 TAHLDPK-QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----  246 (350)
T ss_dssp             CEECCTT-SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC----
T ss_pred             heecccc-cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence            9876554 3334567899999999998876 789999999999999999999999988888877777654222211    


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                          ...+.+|+++.+||.+||+.||.+|||++|+|+||||+..+.
T Consensus       247 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         247 --------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             --------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             --------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                                122368899999999999999999999999999999987653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-59  Score=390.59  Aligned_cols=258  Identities=24%  Similarity=0.440  Sum_probs=223.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++.... ........+.+|+.+++++ +||||+++++++.+...   
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~---   78 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQ---   78 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSE---
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCe---
Confidence            578999999999999999999999999999999987542 2233456788999999999 99999999999998776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        +++||||+.| ++...+..    ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        79 --~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a  151 (316)
T d1fota_          79 --IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFA  151 (316)
T ss_dssp             --EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             --eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccc
Confidence              9999999986 77777765    34588999999999999999999999999999999999999877 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....         
T Consensus       152 ~~~~~~---~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------  218 (316)
T d1fota_         152 KYVPDV---TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------  218 (316)
T ss_dssp             EECSSC---BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------
T ss_pred             eEeccc---cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC---------
Confidence            876543   23457899999999998766 79999999999999999999999999888877777665311         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                         ...+.+|+++.++|.+||..||.+|+     |++++++||||+++++++
T Consensus       219 -------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~  267 (316)
T d1fota_         219 -------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  267 (316)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence                               11236889999999999999999996     999999999999987654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-59  Score=381.61  Aligned_cols=257  Identities=25%  Similarity=0.348  Sum_probs=209.8

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      |++.+.||+|+||+||+|.++.++..|++|.+............+.+|+++++++ +||||+++++++.+... +...++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~-~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVK-GKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESS-SCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccc-cCCEEE
Confidence            3677789999999999999999999999999876554444455788999999999 99999999999875432 223479


Q ss_pred             EEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcC--ccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           86 LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHG--ILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +||||++| +|.+++...    ..+++.++..++.||+.||+|||+++  |+||||||+|||++.++..+||+|||++..
T Consensus        89 ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            99999986 999998763    46899999999999999999999998  999999999999975444899999999975


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ....  ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||..................          
T Consensus       165 ~~~~--~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~----------  230 (270)
T d1t4ha_         165 KRAS--FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------  230 (270)
T ss_dssp             CCTT--SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------
T ss_pred             ccCC--ccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC----------
Confidence            4332  2335578999999998865 3 799999999999999999999999876655444333221000          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFD  297 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  297 (304)
                                     ........++++.+||.+||+.||++|||++|+|+||||+
T Consensus       231 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 ---------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ---------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ---------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                           0111235788999999999999999999999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.3e-59  Score=396.10  Aligned_cols=261  Identities=28%  Similarity=0.463  Sum_probs=221.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +.++|++++.||+|+||.||+|.++.+|+.||+|++......  ....+.+|+.+++++ +||||+++++++.+...   
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~---  100 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQL-HHPKLINLHDAFEDKYE---  100 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSE---
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE---
Confidence            467899999999999999999999999999999998754321  134667899999999 99999999999998776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC-CCCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR-KTMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~-~~~~vkl~dfg~  159 (304)
                        +++||||++| +|.+.+..   ...++++.+++.++.||+.||+|||++||+||||||+|||++. ++..+||+|||+
T Consensus       101 --~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         101 --MVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             --EEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             --EEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence              8999999986 88776543   3457999999999999999999999999999999999999973 234899999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... .......+++.|+|||++.+.. ++.++|||||||++|+|+||..||...+..+....+.........    
T Consensus       176 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~----  249 (352)
T d1koba_         176 ATKLNPD-EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----  249 (352)
T ss_dssp             CEECCTT-SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS----
T ss_pred             ceecCCC-CceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence            9877654 3344557799999999998766 899999999999999999999999998888877777654322222    


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                          ...+.+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       250 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         250 --------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             --------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             --------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                                1223689999999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.5e-58  Score=376.81  Aligned_cols=261  Identities=28%  Similarity=0.412  Sum_probs=222.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC-------CchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV-------PPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.........       ...+.+|+.+++.+..||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999999999999999998865433322       12467899999999559999999999998


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEE
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI  154 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl  154 (304)
                      .+.     +++||||+.| +|.+++...    .++++.++..++.||+.||+|||++|++||||||+||+++.++ .+||
T Consensus        82 ~~~-----~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          82 NTF-----FFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             SSE-----EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEE
T ss_pred             Ccc-----eEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEE
Confidence            777     9999999985 999999763    4699999999999999999999999999999999999999777 9999


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhC-----CCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHH
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLG-----STHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRL  229 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  229 (304)
                      +|||++....... ......||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||...+.......+...
T Consensus       152 ~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         152 TDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             CCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ccchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            9999998776543 3445678999999999863     333688999999999999999999999998887777766653


Q ss_pred             hCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          230 LGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                      ......                        ...+++|+++.+||.+||+.||.+|||++|+++||||++
T Consensus       231 ~~~~~~------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         231 NYQFGS------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CCCCCT------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCCCC------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            221111                        112368999999999999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-59  Score=395.16  Aligned_cols=286  Identities=23%  Similarity=0.363  Sum_probs=215.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ..++|++++.||+|+||+||+|+++.+|..||+|++.... .......+.+|+.+++.+ +||||+++++++.+...   
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~---   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGE---   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSE---
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE---
Confidence            4678999999999999999999999999999999987543 223345778899999999 99999999999998876   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                        +++||||+.| +|.+++...    ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        79 --~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGl  151 (322)
T d1s9ja_          79 --ISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGV  151 (322)
T ss_dssp             --EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCC
T ss_pred             --EEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCC
Confidence              8999999996 999998763    459999999999999999999997 5999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHh-CCCCCC--
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLL-GTPNEK--  236 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--  236 (304)
                      |......  ......||+.|+|||++.+.. ++.++||||+||++|+|++|..||...+..+......... +.....  
T Consensus       152 a~~~~~~--~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         152 SGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             CHHHHHH--TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             ccccCCC--ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence            9866432  223457899999999999876 8999999999999999999999998765433222111111 110000  


Q ss_pred             --CCccccccCCcc-cCCCCC----------CCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          237 --VWPGVSSLMNWH-EYPQWN----------PQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       237 --~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                        ............ ......          ..........+|.++.+||.+||..||.+|||++|+|+||||+..+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence              000000000000 000000          000000112468899999999999999999999999999999887654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-58  Score=392.54  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=223.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecC-CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHE-DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      +++|++++.||+|+||.||+|+++.+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++.....   
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~---  115 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSN---  115 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE---
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccc---
Confidence            588999999999999999999999999999999987543 2233446788999999999 99999999999988776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                        .++|||++.| ++...+...    ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus       116 --~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a  188 (350)
T d1rdqe_         116 --LYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             --EEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             --cccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceee
Confidence              8999999986 888888663    4699999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....||+.|+|||++.+.. ++.++|||||||++|+|+||..||...+.......+......        
T Consensus       189 ~~~~~~---~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------  256 (350)
T d1rdqe_         189 KRVKGR---TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------  256 (350)
T ss_dssp             EECSSC---BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred             eecccc---cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC--------
Confidence            876543   23457899999999998766 799999999999999999999999988887777776653211        


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCccccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~  302 (304)
                                          ....+|+++.+||++||..||.+|+     |++++++||||+++++.
T Consensus       257 --------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         257 --------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             --------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             --------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence                                1236899999999999999999995     99999999999998764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-58  Score=385.87  Aligned_cols=254  Identities=23%  Similarity=0.378  Sum_probs=213.5

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCC-CCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDD-EGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +.|+.++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++++ +||||+++++++.+...    
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~----   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHT----   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE----
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCE----
Confidence            3599999999999999999999999999999998754432 22234678899999999 99999999999988776    


Q ss_pred             EEEEEEeccCCC-HHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDTD-LKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||||+.|+ +..++..    ..++++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        90 -~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~  163 (309)
T d1u5ra_          90 -AWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSAS  163 (309)
T ss_dssp             -EEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCB
T ss_pred             -EEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeeccccc
Confidence             89999999974 4333332    35799999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      .....    ....||+.|+|||++.+.  ..++.++|||||||++|+|++|..||...+..+....+........     
T Consensus       164 ~~~~~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-----  234 (309)
T d1u5ra_         164 IMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-----  234 (309)
T ss_dssp             SSSSB----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----
T ss_pred             ccCCC----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            65432    345789999999998653  3478999999999999999999999998888777766655321111     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                           ....+|+++.+||.+||+.||.+|||++|+|+||||..
T Consensus       235 ---------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         235 ---------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ---------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ---------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                                 11257899999999999999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=388.17  Aligned_cols=260  Identities=28%  Similarity=0.435  Sum_probs=222.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHHHHHHH-HccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLREVSILR-MLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~-~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +++|++++.||+|+||+||+|+++.+++.||+|++..... .......+..|..++. .+ +||||+++++++.+.+.  
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~--   77 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKEN--   77 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSE--
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCc--
Confidence            4789999999999999999999999999999999975431 2223345566666665 56 99999999999998877  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         +++||||+.| +|.+++...    ..+++.++..++.||+.||+|||++|++||||||+|||++.++ ++||+|||.
T Consensus        78 ---~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~  149 (320)
T d1xjda_          78 ---LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGM  149 (320)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             ---eeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccch
Confidence               9999999986 999998763    4589999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +..............||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....        
T Consensus       150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------  220 (320)
T d1xjda_         150 CKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------  220 (320)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             hhhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            987766666666678899999999998876 79999999999999999999999998888777766654211        


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHH-HHhcCCCccccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAK-KAMEHPYFDDLDKT  302 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-eil~~~~~~~~~~~  302 (304)
                                          .....+|+++.+||++||+.||.+|||+. |+++||||++++++
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~  264 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  264 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence                                11136899999999999999999999996 89999999988654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=387.15  Aligned_cols=288  Identities=32%  Similarity=0.612  Sum_probs=235.2

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CCceE
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EGRTV   83 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~~~~   83 (304)
                      +|+.++.||+|+||+||+|+++.+|+.||||++....      ....+|+++++++ +||||+++++++..... ....+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceE
Confidence            5899999999999999999999999999999987542      2334799999999 99999999999865443 33455


Q ss_pred             EEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeec
Q 021982           84 LYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAF  163 (304)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~  163 (304)
                      +++||||+++++...+.........+++.+++.++.||+.||+|||++||+||||||+|||++.++..+||+|||++...
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            89999999998877777666666789999999999999999999999999999999999999987768999999999876


Q ss_pred             ccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCccccc
Q 021982          164 TLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPGVSS  243 (304)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (304)
                      .... ......|++.|+|||.+.+...++.++|||||||++|+|++|..||...+..+.+..+.+.++.+....+.....
T Consensus       174 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         174 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            5443 334457899999999988776689999999999999999999999999999999999888887776544433322


Q ss_pred             cCCcccCCCCCCCcc-cccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          244 LMNWHEYPQWNPQSL-ATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       244 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ............... ....+.+++++.+||.+||..||.+|||+.|+|+||||+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            222112222112211 223457899999999999999999999999999999999873

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-58  Score=392.54  Aligned_cols=262  Identities=26%  Similarity=0.379  Sum_probs=213.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCC-CCCCCchhHHH---HHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHED-DEGVPPTTLRE---VSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e---~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      +++|++++.||+|+||.||+|+++.+|+.||+|++..... .......+.+|   +++++.+ +||||+++++++.+.+.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCE
Confidence            6889999999999999999999999999999999864321 11112233344   5556666 79999999999988776


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           +++||||+.| +|.+++...    ..+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+||
T Consensus        82 -----~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DF  151 (364)
T d1omwa3          82 -----LSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDL  151 (364)
T ss_dssp             -----EEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCC
T ss_pred             -----EEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeee
Confidence                 8999999985 999998763    4589999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |++......  ......||+.|+|||++.+...++.++|||||||++|+|+||..||...+..+...........     
T Consensus       152 Gla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-----  224 (364)
T d1omwa3         152 GLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----  224 (364)
T ss_dssp             TTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-----
T ss_pred             ceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----
Confidence            999876543  3345578999999999976666899999999999999999999999876543332222211111     


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCC-----HHHHhcCCCccccccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRIS-----AKKAMEHPYFDDLDKT  302 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~~~~~  302 (304)
                                          .......+|+++.+||.+||+.||.+|||     ++|+++||||++++++
T Consensus       225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence                                11122368999999999999999999999     7999999999998764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=376.03  Aligned_cols=288  Identities=50%  Similarity=0.950  Sum_probs=242.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+++.+ +||||+++++++.+...    
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~----   75 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKK----   75 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE----
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccc----
Confidence            5799999999999999999999999999999999987665555567888999999999 99999999999998887    


Q ss_pred             EEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           83 VLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                       .+++++++.|.....+..   ....+++..++.++.|++.||+|||++||+|+||||+||+++.++ .+||+|||.+..
T Consensus        76 -~~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~  150 (292)
T d1unla_          76 -LTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARA  150 (292)
T ss_dssp             -EEEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             -eeEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhc
Confidence             899999999844333332   235789999999999999999999999999999999999999777 899999999988


Q ss_pred             cccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccC-CCCchHHHHHHHHHHhCCCCCCCCccc
Q 021982          163 FTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTPNEKVWPGV  241 (304)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (304)
                      ............+++.|+|||.+.+...++.++|||||||++|+|++|..|| ...+..+....+......+....++..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             ccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence            7766555555667899999999988776899999999999999999999985 455566777788888888877777666


Q ss_pred             cccCCcccCCCC-CCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          242 SSLMNWHEYPQW-NPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ............ .........+.+++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            555444333322 22234555678899999999999999999999999999999998763

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-58  Score=389.63  Aligned_cols=289  Identities=37%  Similarity=0.632  Sum_probs=233.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      +.++|++++.||+|+||+||+|.++.+|+.||||++............+.+|+++++.+ +||||+++++++..... ..
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccc
Confidence            46889999999999999999999999999999999875444433445778899999999 99999999999886653 23


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++||||+++++....+.     ..+++..++.++.||+.||+|||++||+|+||||+|||++.++ .+|++|||.+
T Consensus        95 ~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a  168 (346)
T d1cm8a_          95 FTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA  168 (346)
T ss_dssp             CCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             cceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccce
Confidence            334799999998788777654     4699999999999999999999999999999999999999777 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ......   .....+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+.........+.+....+..
T Consensus       169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         169 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            876543   34557799999999998877689999999999999999999999999999888888888777765443322


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......   ...........+......+++++.+||.+||..||.+|||++|+|+||||+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            211100   111222334445556678999999999999999999999999999999999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=387.23  Aligned_cols=259  Identities=24%  Similarity=0.441  Sum_probs=221.9

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |.++|++++.||+|+||+||+|.++.+++.||+|+++....+   ...+.+|+++++++ +||||+++++++.+...   
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~---   75 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIA-RHRNILHLHESFESMEE---   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHS-CCTTBCCEEEEEEETTE---
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE---
Confidence            689999999999999999999999999999999998754322   24577899999999 99999999999998776   


Q ss_pred             eEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC-CeEEEeeccc
Q 021982           82 TVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT-MTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~-~~vkl~dfg~  159 (304)
                        +++||||++| +|.+++..   ...++++.+++.++.||+.||+|||++||+||||||+|||++.++ ..++|+|||+
T Consensus        76 --~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          76 --LVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             --EEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             --EEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccch
Confidence              9999999996 99988854   234699999999999999999999999999999999999997543 4799999999


Q ss_pred             eeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          160 ARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      +...... .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+....+.+......     
T Consensus       151 ~~~~~~~-~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----  223 (321)
T d1tkia_         151 ARQLKPG-DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-----  223 (321)
T ss_dssp             CEECCTT-CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----
T ss_pred             hhccccC-CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            9876543 2334456799999999988776 89999999999999999999999999988888777766322211     


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  298 (304)
                                         ....+.+|+++.+||.+||..||.+|||++|+++||||++
T Consensus       224 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         224 -------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                               1122368999999999999999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-57  Score=373.00  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=212.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC----CCCchhHHHHHHHHHcc-CCCCeeeeeceeccc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE----GVPPTTLREVSILRMLS-RDPHVVRLMDVKQGQ   76 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~   76 (304)
                      +.++|++.+.||+|+||+||+|++..+|..||||++.......    .....+.+|+.+++++. .||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            4578999999999999999999999999999999987643221    22355778999999994 389999999999887


Q ss_pred             ccCCceEEEEEEeccCC--CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEE
Q 021982           77 NKEGRTVLYLVFEYMDT--DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKI  154 (304)
Q Consensus        77 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl  154 (304)
                      +.     .++|||++.+  ++.+++...    ..+++.+++.++.||+.||+|||++|++||||||+||+++.++..+||
T Consensus        82 ~~-----~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          82 DS-----FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             SE-----EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             Ce-----EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEE
Confidence            76     8999999974  777777653    469999999999999999999999999999999999999976559999


Q ss_pred             eeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCC
Q 021982          155 ADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      +|||++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+.      +....    
T Consensus       153 ~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~----  220 (273)
T d1xwsa_         153 IDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ----  220 (273)
T ss_dssp             CCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC----
T ss_pred             Cccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhcc----
Confidence            999999765443  334567899999999998776567889999999999999999999976432      11110    


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                              ......+|+++.+||++||+.||.+|||++|+++||||+++
T Consensus       221 ------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         221 ------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             ------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ------------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                                    01123689999999999999999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=379.96  Aligned_cols=290  Identities=35%  Similarity=0.634  Sum_probs=228.8

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |.++|++++.||+|+||+||+|.++.+|+.||||++.... .......+.+|+.+++++ +||||+++++++........
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeecccccc
Confidence            4578999999999999999999999999999999986432 222234677899999999 99999999999887665444


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      ...+++++.++|+|.+++..     ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~  157 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLAR  157 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             ceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCcee
Confidence            45677777777799999875     4699999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCC
Q 021982          162 AFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVW  238 (304)
Q Consensus       162 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (304)
                      .......   ......|++.|+|||++.....++.++||||+||++|+|++|..||...+..+........+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            6644322   2344567999999999876666899999999999999999999999998887777777666655543221


Q ss_pred             ccccccC---CcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          239 PGVSSLM---NWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       239 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      .......   .................+.+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            1110000   001112222233445567899999999999999999999999999999999865

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=370.20  Aligned_cols=292  Identities=36%  Similarity=0.697  Sum_probs=227.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc---C
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK---E   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~   79 (304)
                      .++|++++.||+|+||+||+|+++.+|+.||||++......+.....+.+|+++++.+ +||||+++++++.....   .
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence            4789999999999999999999999999999999887766666667888999999999 99999999998865432   1


Q ss_pred             CceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           80 GRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                      ....++++||++.+.+.....   .....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+|++|||+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             cCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecce
Confidence            122378999999986655443   3345789999999999999999999999999999999999999887 999999999


Q ss_pred             eeecccCC----CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLPI----KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      +.......    .......||+.|+|||++.+...++.++|||||||++|+|++|..||...+.......+....+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97664321    22233467999999999988766899999999999999999999999999998888888888887776


Q ss_pred             CCCccccccCCcccCCCCCC--Ccccc--cCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          236 KVWPGVSSLMNWHEYPQWNP--QSLAT--AVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ..+.................  .....  .....++++.+||.+||+.||++|||++|+|+||||.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            65544433222211111100  00000  011346788999999999999999999999999999863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=379.16  Aligned_cols=266  Identities=27%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             chhhhhhhh-hcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLE-KVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      |.++|.++. .||+|+||+||+|++..+++.||||++..       .....+|+.++.++.+||||+++++++.+... .
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA-G   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-T
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-C
Confidence            578999886 59999999999999999999999999863       35677899987766589999999999876322 1


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC--CeEEEeec
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT--MTLKIADL  157 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~--~~vkl~df  157 (304)
                      ...+++|||||+| +|.+++..  .....+++.+++.++.||+.||+|||++|++||||||+||+++.++  ..+||+||
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence            2338999999985 99999975  3335799999999999999999999999999999999999998532  47999999


Q ss_pred             cceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          158 GLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      |++...... .......||+.|+|||++.+.. ++.++|||||||++|+|+||..||...+.......+...+..... .
T Consensus       159 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~  235 (335)
T d2ozaa1         159 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-E  235 (335)
T ss_dssp             TTCEECCCC-CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-S
T ss_pred             ceeeeccCC-CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-C
Confidence            999876554 3345567899999999987765 899999999999999999999999776554443333221111000 0


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                         ........+|+++.+||++||+.||.+|||+.|+++||||.+.
T Consensus       236 -------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         236 -------------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -------------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             -------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence                               0001112588999999999999999999999999999999653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.4e-55  Score=371.80  Aligned_cols=284  Identities=28%  Similarity=0.573  Sum_probs=218.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||+||+|+++.+++.||||+++..     ....+.+|+++++.+..||||+++++++......   
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~---  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSR---  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC---
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC---
Confidence            36799999999999999999999999999999998632     2457789999999996699999999998754321   


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                      .+++||||+++ +|...       ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++..++|+|||.+.
T Consensus       106 ~~~~v~e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence            28899999997 65433       24699999999999999999999999999999999999999777689999999998


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc-hHHHHHHHHHHhCCCCC-----
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS-ELQQLLHIFRLLGTPNE-----  235 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~-----  235 (304)
                      ...... ......+|+.|+|||.+.+...++.++||||+||++|+|++|..||.... ..+....+...++.+..     
T Consensus       179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            765542 34455679999999999887768999999999999999999999997654 33444444443332111     


Q ss_pred             ----CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccccc
Q 021982          236 ----KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDKT  302 (304)
Q Consensus       236 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  302 (304)
                          ...+.........................+|+++.+||++||..||.+|||++|+|+||||.++.++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                0011111100000000000111112234578999999999999999999999999999999998774

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=361.41  Aligned_cols=255  Identities=20%  Similarity=0.300  Sum_probs=205.7

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||+||+++.+   ..||||+++...........+.+|+.+++++ +||||+++++++....     
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~-----   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTAPQ-----   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS-----
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEeccE-----
Confidence            467999999999999999999754   3599999987666665667888999999999 9999999999875432     


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||||+.| +|.+++...   ..++++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        78 -~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 -LAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             -CEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             -EEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEcccccee
Confidence             6899999985 999988652   34699999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCC--CccccccccccCCChhhhhCC--CCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCC
Q 021982          162 AFTLPI--KKYTHEILTLWYRAPEVLLGS--THYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKV  237 (304)
Q Consensus       162 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (304)
                      ......  .......||+.|+|||++.+.  ..++.++|||||||++|||+||..||...+...........-..+    
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----  228 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----  228 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----
Confidence            654322  233445779999999998753  237899999999999999999999998877665555444332111    


Q ss_pred             CccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          238 WPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                        ........++|+++.+||.+||+.||.+|||+.||+++
T Consensus       229 ------------------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 ------------------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ------------------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                              11222334688999999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-55  Score=363.09  Aligned_cols=256  Identities=21%  Similarity=0.348  Sum_probs=210.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||+||+|.++.++..||||+++.+.   .....+.+|+++++++ +||||+++++++.+.+.    
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~----   87 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP----   87 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhC-CCCCEecCCccEeeCCe----
Confidence            467899999999999999999999999999999986432   2346788999999999 99999999999988776    


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .+++|||+.+ +|.+++..  .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        88 -~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~  163 (287)
T d1opja_          88 -FYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR  163 (287)
T ss_dssp             -CEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTT
T ss_pred             -eEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEcccccee
Confidence             8999999985 99998876  3346799999999999999999999999999999999999999777 99999999998


Q ss_pred             ecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ....... ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...............-.         
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---------  233 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------  233 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---------
T ss_pred             ecCCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC---------
Confidence            6654332 233345688999999998776 79999999999999999997777655444443333332110         


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                                       .......+|+++.+||.+||+.||.+|||++||++  +|+.+
T Consensus       234 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 -----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             -----------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                             01122368899999999999999999999999976  44443

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=376.43  Aligned_cols=289  Identities=36%  Similarity=0.591  Sum_probs=228.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC-C
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE-G   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-~   80 (304)
                      +.++|++++.||+|+||+||+|++..+|+.||||++............+.+|+++++++ +|||++++++++...... .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence            35789999999999999999999999999999999876544433445678899999999 999999999998755432 2


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ....+++++..+|+|.+++..     ..+++.+++.++.||+.||+|||++||+||||||+||+++.++ .+|++|||.+
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a  168 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA  168 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC---
T ss_pred             CceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchh
Confidence            222455555555699988743     4699999999999999999999999999999999999999887 9999999999


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .....   ......|++.|+|||.+.+...++.++|||||||++|+|++|..||...+.......+......+.......
T Consensus       169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            75543   234456789999999988877789999999999999999999999999998888888888776654332211


Q ss_pred             ccccCC---cccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCccccc
Q 021982          241 VSSLMN---WHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLD  300 (304)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  300 (304)
                      ......   ...........+......+++++.+||++||..||.+|||++|+|+||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            111000   111122233344455668999999999999999999999999999999999763

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=375.96  Aligned_cols=288  Identities=32%  Similarity=0.553  Sum_probs=219.0

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc-CC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK-EG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~   80 (304)
                      |+++|++++.||+|+||+||+|.++.+|..||||++............+.+|+.+++++ +||||+++++++..... +.
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeccccccc
Confidence            56889999999999999999999999999999999986654444445678999999999 99999999999876543 23


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccce
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLA  160 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~  160 (304)
                      ...+++||||+.+++.+.+.      ..+++..++.++.||+.||+|||++||+|+||||+||+++.++ .++++|||.+
T Consensus        94 ~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~  166 (355)
T d2b1pa1          94 FQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA  166 (355)
T ss_dssp             CCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred             CceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhh
Confidence            44589999999998776653      3689999999999999999999999999999999999999877 8999999998


Q ss_pred             eecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          161 RAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... .......+|+.|+|||++.+.. ++.++||||+||++++|++|..||...+.......+......+....+..
T Consensus       167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hccccc-cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            765543 3344556799999999998765 89999999999999999999999999998888888888777655443322


Q ss_pred             ccccCC-c-ccCCCCCCC------------cccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccc
Q 021982          241 VSSLMN-W-HEYPQWNPQ------------SLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDL  299 (304)
Q Consensus       241 ~~~~~~-~-~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  299 (304)
                      ...... . .........            .........|+++.+||++||..||.+||||+|+|+||||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            211100 0 000000000            0011112346788999999999999999999999999999863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=350.10  Aligned_cols=248  Identities=19%  Similarity=0.305  Sum_probs=210.6

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||+|+||+||+++++ ++..||||+++.....   ...+.+|+++++++ +||||+++++++.+.+.     
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~-----   73 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRP-----   73 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTC-CCTTBCCEEEEECCSSS-----
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhc-CCCceeeEEEEEeeCCc-----
Confidence            67999999999999999999985 5778999998864432   35788999999999 99999999999988776     


Q ss_pred             EEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      +++||||+. |++.+++...   ...+++..+..++.|+++||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~  149 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  149 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCB
T ss_pred             eEEEEEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhhee
Confidence            899999998 5888876543   24689999999999999999999999999999999999999777 899999999976


Q ss_pred             cccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... ......+++.|+|||.+.+.. ++.++||||||+++|||+| |..||...+..+....+......+       
T Consensus       150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------  221 (258)
T d1k2pa_         150 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------  221 (258)
T ss_dssp             CSSSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-------
T ss_pred             ccCCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence            654322 233456789999999998776 7999999999999999998 899999988887776665432111       


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                          .....++++.+||.+||+.||.+|||+++|++|
T Consensus       222 --------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         222 --------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             --------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                112578899999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=358.57  Aligned_cols=251  Identities=22%  Similarity=0.370  Sum_probs=202.4

Q ss_pred             hhcccccceEEEEEEEcc--CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEEEE
Q 021982           10 EKVGEGTYGKVYRAREKA--TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLYLV   87 (304)
Q Consensus        10 ~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   87 (304)
                      ++||+|+||+||+|.++.  +++.||||+++....+......+.+|+.+++++ +||||+++++++..+ .     .++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~-----~~lv   85 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-S-----WMLV   85 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-S-----EEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-C-----EEEE
Confidence            469999999999998653  456899999876544444456788999999999 999999999998643 2     6899


Q ss_pred             EeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecccC
Q 021982           88 FEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFTLP  166 (304)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~  166 (304)
                      |||+.+ +|.+++..    ..++++.+++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++......
T Consensus        86 mE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          86 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  160 (277)
T ss_dssp             EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence            999985 99998875    35699999999999999999999999999999999999999777 9999999999876543


Q ss_pred             CCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcccc
Q 021982          167 IKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPGVS  242 (304)
Q Consensus       167 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (304)
                      ...   .....|++.|+|||++.+.. ++.++||||||+++|||+| |..||...+..+....+.+....          
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----------  229 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----------  229 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred             ccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            222   22345689999999998776 7999999999999999998 89999988877666555432111          


Q ss_pred             ccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHH---hcCCCccccc
Q 021982          243 SLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA---MEHPYFDDLD  300 (304)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei---l~~~~~~~~~  300 (304)
                                       .....+|+++.+||.+||+.||.+|||+++|   |+|+|++-++
T Consensus       230 -----------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~  273 (277)
T d1xbba_         230 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  273 (277)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             -----------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence                             1123688999999999999999999999998   5677766544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-55  Score=358.14  Aligned_cols=254  Identities=23%  Similarity=0.420  Sum_probs=207.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++++.||+|+||.||+|.++ ++..||||++....   .....+.+|+++++++ +||||+++++++.+..     
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-----   81 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQEP-----   81 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-----
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhC-CCCCEeEEEeeeccCC-----
Confidence            468999999999999999999986 46789999986433   2345789999999999 9999999999876533     


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ +|.+++....  ..++++.++..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.
T Consensus        82 -~~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~  157 (272)
T d1qpca_          82 -IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLAR  157 (272)
T ss_dssp             -CEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             -eEEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceE
Confidence             6899999985 8888765432  24589999999999999999999999999999999999999777 99999999998


Q ss_pred             ecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcccc-CCCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTAL-FPGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... .......+++.|+|||++.+.. ++.++||||||+++|+|+||..| +...+..+....+.......      
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~------  230 (272)
T d1qpca_         158 LIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV------  230 (272)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------
T ss_pred             EccCCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence            765432 2234456789999999998766 79999999999999999996554 55555555555544321111      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc--CCCccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYFDD  298 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~--~~~~~~  298 (304)
                                           ....+++++.+||.+||+.||++|||+++|++  ++||..
T Consensus       231 ---------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 ---------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                                 12368899999999999999999999999998  788864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-54  Score=357.53  Aligned_cols=262  Identities=25%  Similarity=0.379  Sum_probs=208.2

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCC-CCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDE-GVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      |.++|++.+.||+|+||+||+|++..+++.||+|+++.....+ .....+.+|+.+++.+ +||||+++++++......+
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSS
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCC
Confidence            5688999999999999999999999999999999987654322 2334678899999999 9999999999988765432


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                       ...++||||+.| +|.+++...    .++++.+++.++.||+.||+|||++|++||||||+||+++.++ .++++|||.
T Consensus        84 -~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~  157 (277)
T d1o6ya_          84 -PLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGI  157 (277)
T ss_dssp             -EEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTT
T ss_pred             -ceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhh
Confidence             237899999996 888887663    4699999999999999999999999999999999999999777 899999999


Q ss_pred             eeecccCC---CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          160 ARAFTLPI---KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       160 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      +.......   .......||+.|+|||++.+.. ++.++|||||||++|+|+||..||...+..+........-..+   
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~---  233 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---  233 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC---
Confidence            86553322   2334457899999999998765 8999999999999999999999999888777666655432111   


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-CHHHHhcCCCc
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-SAKKAMEHPYF  296 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~eil~~~~~  296 (304)
                                           .....+.+|+++.++|.+||+.||.+|| |+++++ |+|.
T Consensus       234 ---------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~  272 (277)
T d1o6ya_         234 ---------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLV  272 (277)
T ss_dssp             ---------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred             ---------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence                                 1122347899999999999999999999 556554 5554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=351.60  Aligned_cols=248  Identities=21%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceE
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTV   83 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   83 (304)
                      ++|++++.||+|+||+||++.+++ +..||||++....   .....+.+|+++++++ +||||+++++++...+.     
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~-----   74 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA---MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAP-----   74 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS---SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS-----
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc---CcHHHHHHHHHHHHhc-CCCCcccccceeccCCc-----
Confidence            579999999999999999999864 6779999987533   2336788999999999 99999999999988776     


Q ss_pred             EEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982           84 LYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .++||||+.+ +|.+++...   ...+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|||++..
T Consensus        75 ~~lv~E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~  150 (263)
T d1sm2a_          75 ICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRF  150 (263)
T ss_dssp             CEEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC----
T ss_pred             eEEEEEecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchhee
Confidence            8999999985 899887652   35689999999999999999999999999999999999999777 999999999976


Q ss_pred             cccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc-cccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          163 FTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       163 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      ...... ......|++.|+|||++.+.. ++.++||||||+++|||+|+ ..||...+..+....+.......       
T Consensus       151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------  222 (263)
T d1sm2a_         151 VLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------  222 (263)
T ss_dssp             --------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-------
T ss_pred             ccCCCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-------
Confidence            654322 223456789999999998776 89999999999999999995 55666666666665554432111       


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                          ....+++++.+||.+||+.||.+|||++||++|
T Consensus       223 --------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         223 --------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                112578999999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=361.61  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=206.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCc-----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGK-----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      ++|++++.||+|+||+||+|++...++     .|++|.+.... .......+.+|+.++.++.+||||+++++++.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            679999999999999999999876543     58888776433 333456788999999998789999999999998877


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhcc-------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCC
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQ-------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDL  138 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl  138 (304)
                           +++||||+.+ +|.+++.....                   ....+++..++.++.||+.||+|||++||+||||
T Consensus       116 -----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         116 -----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             -----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             -----EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence                 8999999985 99999976432                   1245899999999999999999999999999999


Q ss_pred             CCCCeEEeCCCCeEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCC
Q 021982          139 KPHNLLMDRKTMTLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFP  215 (304)
Q Consensus       139 ~~~Nil~~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~  215 (304)
                      ||+||+++.++ .+||+|||+++........  .....||+.|+|||++.+.. ++.++|||||||++|+|+| |..||.
T Consensus       191 Kp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         191 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             chhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999777 9999999999766544332  23456699999999998776 8999999999999999998 899998


Q ss_pred             CCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          216 GDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ..+..+....+...-..                          ......+|+++.+||.+||+.||.+|||++||++|
T Consensus       269 ~~~~~~~~~~~~~~~~~--------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFK--------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCC--------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77665555554432111                          11123688999999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=362.29  Aligned_cols=267  Identities=27%  Similarity=0.436  Sum_probs=216.2

Q ss_pred             hhhhhhhhhcccccceEEEEEEE---ccCCcEEEEEEeeecC--CCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRARE---KATGKIVALKKTRLHE--DDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~---~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      +++|++++.||+|+||+||+|++   +.+|+.||+|++....  .+......+.+|+++++++..||||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            37899999999999999999987   4468899999986543  122334677889999999955589999999998887


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEee
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIAD  156 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~d  156 (304)
                      .     .++++||+.+ +|.+++...    ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|
T Consensus       103 ~-----~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~D  172 (322)
T d1vzoa_         103 K-----LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTD  172 (322)
T ss_dssp             E-----EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred             c-----eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEee
Confidence            7     8999999986 999988764    3578999999999999999999999999999999999999887 999999


Q ss_pred             ccceeecccC-CCccccccccccCCChhhhhCCC-CCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCCCC
Q 021982          157 LGLARAFTLP-IKKYTHEILTLWYRAPEVLLGST-HYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGTPN  234 (304)
Q Consensus       157 fg~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (304)
                      ||++...... ........|++.|++||.+.+.. .++.++|||||||+||+|++|..||...+..+....+........
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~  252 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE  252 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence            9999766433 23344567799999999997654 378899999999999999999999977654443333333211110


Q ss_pred             CCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCC-----CHHHHhcCCCcccccccc
Q 021982          235 EKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRI-----SAKKAMEHPYFDDLDKTR  303 (304)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~~~~  303 (304)
                                              ......+|+++.+||.+||+.||.+||     |++|+++||||++++++.
T Consensus       253 ------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~  302 (322)
T d1vzoa_         253 ------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD  302 (322)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence                                    111236899999999999999999999     589999999999987653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=354.86  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=206.5

Q ss_pred             hhhhhhhh-cccccceEEEEEEEccC--CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            4 DAFEKLEK-VGEGTYGKVYRAREKAT--GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         4 ~~y~~~~~-lg~g~~g~v~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      ++|.+.+. ||+|+||+||+|.++.+  +..||||++.... .......+.+|+++++++ +||||+++++++..+.   
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~---   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAEA---   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESSS---
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCe---
Confidence            56777774 99999999999987643  4479999986432 222345788999999999 9999999999986532   


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccc
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGL  159 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~  159 (304)
                         .++||||+++ +|.+++..   ....+++.++..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+
T Consensus        83 ---~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGl  155 (285)
T d1u59a_          83 ---LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGL  155 (285)
T ss_dssp             ---EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             ---EEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchh
Confidence               7899999996 99888743   235799999999999999999999999999999999999999777 999999999


Q ss_pred             eeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          160 ARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       160 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      +.........   .....+++.|+|||++.+.. ++.++||||||+++|||+| |..||...+..+....+......   
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---  231 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---  231 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---
T ss_pred             hhcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            9876543221   22345689999999998776 8999999999999999998 89999988877666655432111   


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHH---hcCCCcc
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKA---MEHPYFD  297 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei---l~~~~~~  297 (304)
                                              ...+.+|+++.+||.+||+.||.+|||+.+|   |+|+|++
T Consensus       232 ------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         232 ------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                                    1223688999999999999999999999988   5677764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-53  Score=355.30  Aligned_cols=252  Identities=20%  Similarity=0.327  Sum_probs=196.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCc---EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGK---IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++.+.||+|+||+||+|.++.+++   .+++|.+.... .......+.+|+++++++ +||||+++++++..... 
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~-  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTP-  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS-
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE-
Confidence            4678899999999999999999976654   47777765332 222335688999999999 99999999999987776 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          +++||||+.+ +|.+++..   ....+++.++..++.||+.||+|||++|++||||||+|||++.++ .+||+|||
T Consensus       102 ----~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG  173 (299)
T d1jpaa_         102 ----VMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFG  173 (299)
T ss_dssp             ----CEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             ----EEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcc
Confidence                8999999986 88887764   234689999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCCCc-----cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCC
Q 021982          159 LARAFTLPIKK-----YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       159 ~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      ++.........     .....+++.|+|||.+.+.. ++.++|||||||++|||+| |..||...+..+....+......
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~  252 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL  252 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99866543221     12234588999999998766 8999999999999999998 89999988887766665543221


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      +                           ....+++++.+||.+||+.||.+|||+.||+++
T Consensus       253 ~---------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         253 P---------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             C---------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             C---------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            1                           123688999999999999999999999998874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=349.57  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=203.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .++|++.+.||+|+||+||+|.++++ ..||||++.....   ....+.+|+.+++++ +||||+++++++.+..     
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~-----   85 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKL-RHEKLVQLYAVVSEEP-----   85 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-----
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhc-ccCCEeEEEEEEecCC-----
Confidence            47899999999999999999998764 5699999864432   236789999999999 9999999999986433     


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       .++||||+.+ ++..++....  ...+++.+++.++.||+.||+|||++|++|+||||+|||++.++ .+||+|||++.
T Consensus        86 -~~lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~  161 (285)
T d1fmka3          86 -IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLAR  161 (285)
T ss_dssp             -CEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC
T ss_pred             -eEEEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhh
Confidence             6899999995 7887776532  24699999999999999999999999999999999999999777 99999999997


Q ss_pred             ecccCC-CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccC-CCCchHHHHHHHHHHhCCCCCCCCc
Q 021982          162 AFTLPI-KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       162 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~  239 (304)
                      ...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+ ......+....+......+      
T Consensus       162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~------  234 (285)
T d1fmka3         162 LIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------  234 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------
T ss_pred             hccCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence            654332 2233456789999999998766 799999999999999999975555 5555555555544322111      


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc--CCCccccc
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME--HPYFDDLD  300 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~--~~~~~~~~  300 (304)
                                           ..+.+++++.+||.+||+.||++|||+++|++  ++||....
T Consensus       235 ---------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         235 ---------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                                 22368899999999999999999999999998  88997653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=345.25  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=195.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC---cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG---KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      .++|++++.||+|+||.||+|.+..++   ..+++|.+.... .......+.+|+.+++++ +||||+++++++.+. . 
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~-   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQF-DHPHIVKLIGVITEN-P-   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS-S-
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-e-
Confidence            578999999999999999999986543   357777765332 222345678999999999 999999999998643 2 


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          +++||||+.+ ++.+++..   ...++++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||
T Consensus        82 ----~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG  153 (273)
T d1mp8a_          82 ----VWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFG  153 (273)
T ss_dssp             ----CEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC--
T ss_pred             ----EEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccch
Confidence                7899999986 88877654   235789999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCCC-ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCC
Q 021982          159 LARAFTLPIK-KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEK  236 (304)
Q Consensus       159 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (304)
                      ++........ ......+++.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+......    
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~----  228 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----  228 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----
T ss_pred             hheeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9986654322 233446689999999998766 7999999999999999998 89999888877766665442111    


Q ss_pred             CCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          237 VWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                             ...+++|+++.+||.+||+.||.+|||+.||+++
T Consensus       229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   1234689999999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=348.47  Aligned_cols=250  Identities=23%  Similarity=0.352  Sum_probs=199.8

Q ss_pred             hhhhhhhhcccccceEEEEEEEccCCc----EEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccC
Q 021982            4 DAFEKLEKVGEGTYGKVYRAREKATGK----IVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         4 ~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      ++|++++.||+|+||+||+|.+..+|+    .|++|.+.... .......+.+|+.+++++ +||||+++++++.+..  
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~--   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST--   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESSS--
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC--
Confidence            469999999999999999999987775    47778775432 233456788999999999 9999999999998654  


Q ss_pred             CceEEEEEEeccC-CCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecc
Q 021982           80 GRTVLYLVFEYMD-TDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLG  158 (304)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg  158 (304)
                          .+++++++. |+|.+.+..   ....+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||
T Consensus        85 ----~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFG  156 (317)
T d1xkka_          85 ----VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFG  156 (317)
T ss_dssp             ----EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCS
T ss_pred             ----eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccc
Confidence                466777776 588887765   245789999999999999999999999999999999999999777 99999999


Q ss_pred             ceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCC
Q 021982          159 LARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNE  235 (304)
Q Consensus       159 ~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (304)
                      ++.........  .....||+.|+|||++.+.. ++.++||||||+++|+|+| |..||...+..+....+.+....+  
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--  233 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--  233 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC--
T ss_pred             cceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            99876543332  22335689999999998776 8999999999999999998 788998877666555554432111  


Q ss_pred             CCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          236 KVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                               ..+.+++++.+|+.+||+.||.+|||+.||++|
T Consensus       234 -------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         234 -------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             -------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                     123688999999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=340.65  Aligned_cols=251  Identities=20%  Similarity=0.322  Sum_probs=194.3

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC----cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG----KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .+.|+..+.||+|+||.||+|.++.++    ..||||++..... ......+.+|+++++++ +||||+++++++.....
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCc
Confidence            356889999999999999999987654    3689998864322 22234678999999999 99999999999988776


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .+++|||+.+ ++.+.+..   ....+++.++..++.|++.||+|||+++|+||||||+|||++.++ .+||+||
T Consensus        84 -----~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DF  154 (283)
T d1mqba_          84 -----MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDF  154 (283)
T ss_dssp             -----EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             -----eEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEccc
Confidence                 8999999987 77776654   235799999999999999999999999999999999999999777 9999999


Q ss_pred             cceeecccCCC---ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccC-CCCchHHHHHHHHHHhCCC
Q 021982          158 GLARAFTLPIK---KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALF-PGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       158 g~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~  233 (304)
                      |++........   ......||+.|+|||++.+.. ++.++||||||+++|||++|..|+ ...+..+....+......+
T Consensus       155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~  233 (283)
T d1mqba_         155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP  233 (283)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             chhhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC
Confidence            99976644322   222345689999999998776 899999999999999999965554 4445544444443321111


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                                 ....++..+.+||.+||+.||.+|||+.||++
T Consensus       234 ---------------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         234 ---------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                       12257899999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=337.45  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=196.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-C--cEEEEEEeeecCC-CCCCCchhHHHHHHHHHccCCCCeeeeeceeccccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-G--KIVALKKTRLHED-DEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNK   78 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-~--~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   78 (304)
                      .++|++++.||+|+||.||+|+.... +  ..||||++..... .......+.+|+.+++++ +||||+++++++.+.. 
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~~-   84 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-   84 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeecc-
Confidence            35799999999999999999986533 2  3688998875443 223345788999999999 9999999999997643 


Q ss_pred             CCceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeec
Q 021982           79 EGRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADL  157 (304)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~df  157 (304)
                           .++||||+.+ ++.+.+....   .++++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+||
T Consensus        85 -----~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~Df  155 (273)
T d1u46a_          85 -----MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDF  155 (273)
T ss_dssp             -----CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -----hheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccc
Confidence                 6899999985 8888776532   3699999999999999999999999999999999999999877 9999999


Q ss_pred             cceeecccCCCc---cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCC
Q 021982          158 GLARAFTLPIKK---YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTP  233 (304)
Q Consensus       158 g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  233 (304)
                      |++.........   .....+++.|+|||.+.+.. ++.++||||||+++|||+| |..||...+..+....+.+.-.. 
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-  233 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-  233 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC-
Confidence            999876543221   22334578899999998766 8999999999999999998 89999988888777766542111 


Q ss_pred             CCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          234 NEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                                               ......+|+++.+||.+||+.||++|||+.||++
T Consensus       234 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     1122368899999999999999999999999974

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=342.71  Aligned_cols=258  Identities=22%  Similarity=0.361  Sum_probs=196.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccC-----CcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKAT-----GKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++++.||+|+||.||+|.+...     ++.||+|.+...... .....+..|...+.++.+|+||+.+++++....
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            47899999999999999999997543     357999988643322 123456677888888878999999999876544


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeE
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLL  144 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil  144 (304)
                      ..    ++++|||+.+ +|.+++.....            ....+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus        91 ~~----~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          91 GP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             SC----CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             Ce----EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence            32    7899999985 99999976432            1245899999999999999999999999999999999999


Q ss_pred             EeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc-cccCCCCchHH
Q 021982          145 MDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQ  221 (304)
Q Consensus       145 ~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~  221 (304)
                      ++.++ .+||+|||++........  ......||+.|+|||++.+.. ++.++|||||||++|+|+|| ..||......+
T Consensus       167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99777 999999999976544322  233456799999999998766 89999999999999999987 55787665544


Q ss_pred             HHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          222 QLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      ........-..                          ......+++++.++|.+||+.||.+|||++||++|
T Consensus       245 ~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCC--------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44444332111                          11123588999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=336.48  Aligned_cols=252  Identities=23%  Similarity=0.391  Sum_probs=200.6

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      +++|++++.||+|+||.||++.++  |..||||+++.+    .....+.+|+++++++ +||||+++++++.+....   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~---   75 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGG---   75 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--C---
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH----HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCc---
Confidence            578999999999999999999985  678999998643    3346788999999999 999999999988654321   


Q ss_pred             EEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeecccee
Q 021982           83 VLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLAR  161 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~  161 (304)
                       +++||||+.+ +|.+++.....  ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++ .+|++|||.+.
T Consensus        76 -~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~  151 (262)
T d1byga_          76 -LYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTK  151 (262)
T ss_dssp             -CEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC--
T ss_pred             -EEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccce
Confidence             7999999985 99999876322  3589999999999999999999999999999999999999877 89999999997


Q ss_pred             ecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCchHHHHHHHHHHhCCCCCCCCcc
Q 021982          162 AFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSELQQLLHIFRLLGTPNEKVWPG  240 (304)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (304)
                      .....   .....+++.|+|||.+.+.. ++.++||||||+++|||+| |..||...+..+....+.+..          
T Consensus       152 ~~~~~---~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~----------  217 (262)
T d1byga_         152 EASST---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------  217 (262)
T ss_dssp             -------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------
T ss_pred             ecCCC---CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------
Confidence            64432   23345688999999998766 8999999999999999998 688888776666555543321          


Q ss_pred             ccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcCCCcccccc
Q 021982          241 VSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEHPYFDDLDK  301 (304)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  301 (304)
                                       .......+++++.+||.+||+.||.+|||+.++++  +++.+.+
T Consensus       218 -----------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~--~L~~i~~  259 (262)
T d1byga_         218 -----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE--QLEHIKT  259 (262)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH--HHHHHHh
Confidence                             11223368899999999999999999999999988  4555543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=340.49  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=205.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcE--EEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKI--VALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      .++|++.+.||+|+||+||+|.++.++..  ++||.+.... .......+.+|+.++.++.+||||+++++++...+.  
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~--   85 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--   85 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE--
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe--
Confidence            36899999999999999999999888775  5566654332 223456789999999998679999999999998776  


Q ss_pred             ceEEEEEEeccCC-CHHHHHHHh------------ccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeC
Q 021982           81 RTVLYLVFEYMDT-DLKKYIRSF------------RQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDR  147 (304)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~  147 (304)
                         +++||||+.+ +|.+++...            ......+++..+..++.||+.||.|||+++++||||||+|||++.
T Consensus        86 ---~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          86 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             ---EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             ---eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence               8999999995 999998653            233467999999999999999999999999999999999999998


Q ss_pred             CCCeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcc-ccCCCCchHHHHHHH
Q 021982          148 KTMTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT-ALFPGDSELQQLLHI  226 (304)
Q Consensus       148 ~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~-~p~~~~~~~~~~~~~  226 (304)
                      ++ .+||+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|. .||...+..+....+
T Consensus       163 ~~-~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         163 NY-VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             GG-CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CC-ceEEcccccccccccccc-ccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            77 999999999976544322 23446789999999998776 799999999999999999975 567777766665554


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                      .....                           ......+++++.+||.+||+.||++|||+.||+++
T Consensus       240 ~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 PQGYR---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGTCC---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCC---------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33211                           11123688999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-51  Score=338.91  Aligned_cols=254  Identities=22%  Similarity=0.366  Sum_probs=206.4

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++++.||+|+||+||+|++++     ++..||||.+.... .......+.+|+++++++ +||||+++++++....
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEF-DNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCC
Confidence            3689999999999999999999753     45689999886432 222345688999999999 9999999999998877


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc--------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCcccc
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ--------------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHR  136 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~  136 (304)
                      .     .+++||++.+ +|.+++.....                    ....+++..+..++.|++.||+|||+++++||
T Consensus        90 ~-----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr  164 (301)
T d1lufa_          90 P-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  164 (301)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             c-----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence            6     8999999985 99998865321                    12358899999999999999999999999999


Q ss_pred             CCCCCCeEEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhcc-cc
Q 021982          137 DLKPHNLLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKT-AL  213 (304)
Q Consensus       137 dl~~~Nil~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~-~p  213 (304)
                      ||||+|||++.++ .+||+|||++.......  .......+++.|+|||.+.+.. ++.++||||||+++|||++|. .|
T Consensus       165 DlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         165 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             EEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCC
Confidence            9999999999777 89999999997654332  2223456689999999998776 899999999999999999995 57


Q ss_pred             CCCCchHHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          214 FPGDSELQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      |...+..+....+.....                           ......+++++.+||.+||+.||.+|||+.||++
T Consensus       243 ~~~~~~~e~~~~v~~~~~---------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDGNI---------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTTSCHHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCC---------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888777776665543211                           1122368899999999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=336.94  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=203.1

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCC-------cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATG-------KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQG   75 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   75 (304)
                      .++|++++.||+|+||.||+|++..++       ..||+|++...... .....+..|...+.++.+||||+++++++.+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-HHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            578999999999999999999876544       36899988643322 2235677788888888789999999999998


Q ss_pred             cccCCceEEEEEEeccCC-CHHHHHHHhcc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           76 QNKEGRTVLYLVFEYMDT-DLKKYIRSFRQ------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      ...     .++||||+.+ +|.+++.....            ....+++.+++.++.||+.||+|||++|++||||||+|
T Consensus        91 ~~~-----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          91 DGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             SSS-----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCe-----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            776     8999999985 99999976432            22468999999999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCCC--ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPIK--KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      ||++.++ .+||+|||.+........  ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+.
T Consensus       166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            9999887 899999999987654322  233346689999999998766 8999999999999999998 6888887777


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .+....+......                           .....+++++.+||.+||+.||.+|||+.||++
T Consensus       244 ~~~~~~i~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTTCCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            6655544332111                           112368899999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=336.12  Aligned_cols=263  Identities=24%  Similarity=0.355  Sum_probs=213.9

Q ss_pred             hhhhhhhhhcccccceEEEEEEEcc-----CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKA-----TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++++.||+|+||+||+|.++.     ++..||||++.... .......+.+|+++++++ +||||+++++++....
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCC
Confidence            4789999999999999999998863     34679999886432 222234578999999999 8999999999998777


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhc------cCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFR------QTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~  150 (304)
                      .     .++||||+.+ +|.+++....      .....+++..+..++.|++.||.|||+++++||||||+|||++.++ 
T Consensus        97 ~-----~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-  170 (308)
T d1p4oa_          97 P-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-  170 (308)
T ss_dssp             S-----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-
T ss_pred             c-----eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-
Confidence            6     8999999985 8988876432      1223578899999999999999999999999999999999999777 


Q ss_pred             eEEEeeccceeecccCCCc--cccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhc-cccCCCCchHHHHHHHH
Q 021982          151 TLKIADLGLARAFTLPIKK--YTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTK-TALFPGDSELQQLLHIF  227 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~~~~~~~  227 (304)
                      .+||+|||++.........  .....+++.|+|||.+.+.. ++.++||||||+++|+|+|| ..||...+..+....+.
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999766443222  23335689999999998776 78999999999999999998 57888887777776655


Q ss_pred             HHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc------CCCcccccc
Q 021982          228 RLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME------HPYFDDLDK  301 (304)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~------~~~~~~~~~  301 (304)
                      +...                           ......+++.+.++|.+||+.||.+|||+++|++      +|+|++++.
T Consensus       250 ~~~~---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~  302 (308)
T d1p4oa_         250 EGGL---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF  302 (308)
T ss_dssp             TTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred             hCCC---------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCC
Confidence            4211                           1122368899999999999999999999999998      788887653

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-49  Score=331.95  Aligned_cols=263  Identities=17%  Similarity=0.224  Sum_probs=201.6

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      |.++|++++.||+|+||.||+|++..+|+.||||++....    ....+..|+++++.+..|++|+.+.+++.....   
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~---   77 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY---   77 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE---
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCE---
Confidence            4678999999999999999999999999999999877543    234678899999999444455555555555554   


Q ss_pred             eEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC--CCeEEEeeccc
Q 021982           82 TVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK--TMTLKIADLGL  159 (304)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~--~~~vkl~dfg~  159 (304)
                        .++|||++++++.+.+..   ....+++.++..++.|++.||+|||++||+||||||+||+++..  +..++++|||+
T Consensus        78 --~~ivme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~  152 (299)
T d1ckia_          78 --NVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  152 (299)
T ss_dssp             --EEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred             --EEEEEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence              889999999988777654   33579999999999999999999999999999999999998643  34799999999


Q ss_pred             eeecccCC-------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHHHHHHHHHHhCC
Q 021982          160 ARAFTLPI-------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQQLLHIFRLLGT  232 (304)
Q Consensus       160 ~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  232 (304)
                      +.......       .......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||......+...........
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             ceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            98765432       1233456899999999998766 899999999999999999999999876654433322221100


Q ss_pred             CCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHH---HhcCCCcc
Q 021982          233 PNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKK---AMEHPYFD  297 (304)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e---il~~~~~~  297 (304)
                      ..                    .........++|+++.++|..||+.||.+||++.+   +|+|+|.+
T Consensus       232 ~~--------------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         232 KM--------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HH--------------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cC--------------------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            00                    00111223478999999999999999999999874   56676543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=331.99  Aligned_cols=256  Identities=23%  Similarity=0.339  Sum_probs=206.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEc-----cCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccc
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREK-----ATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQN   77 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   77 (304)
                      .++|++.+.||+|+||.||+|++.     .++..||||+++.... ......+.+|+.+++.+.+||||+++++++....
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            478999999999999999999863     3456899999875432 2234467889999999977999999999998877


Q ss_pred             cCCceEEEEEEeccCC-CHHHHHHHhcc--------------CCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCC
Q 021982           78 KEGRTVLYLVFEYMDT-DLKKYIRSFRQ--------------TGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHN  142 (304)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~N  142 (304)
                      .     .+++|||+.+ +|.+++.....              ....+++..+..++.||+.||+|||++|++||||||+|
T Consensus       101 ~-----~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_         101 P-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             S-----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             E-----EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            6     8999999986 99999876432              22468999999999999999999999999999999999


Q ss_pred             eEEeCCCCeEEEeeccceeecccCC--CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhh-ccccCCCCch
Q 021982          143 LLMDRKTMTLKIADLGLARAFTLPI--KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVT-KTALFPGDSE  219 (304)
Q Consensus       143 il~~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~  219 (304)
                      |+++.++ .++++|||.+.......  .......+++.|+|||.+.+.. ++.++||||||+++|+|+| |..||...+.
T Consensus       176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999777 99999999998765432  2233456799999999998766 8999999999999999999 5666666555


Q ss_pred             HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          220 LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .+.+..+...-..+                          ......++++.+||.+||+.||.+|||++||++
T Consensus       254 ~~~~~~~i~~~~~~--------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         254 DSKFYKMIKEGFRM--------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SHHHHHHHHHTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCC--------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            55554444321111                          111257899999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.3e-48  Score=321.43  Aligned_cols=256  Identities=17%  Similarity=0.223  Sum_probs=206.1

Q ss_pred             CchhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCC
Q 021982            1 MVMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEG   80 (304)
Q Consensus         1 ~i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   80 (304)
                      +|.++|++++.||+|+||+||+|++..+|+.||+|++....    ....+.+|+..++.+.+|+|++.+++++.....  
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~--   75 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH--   75 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE--
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc--
Confidence            36789999999999999999999999999999999876432    234678899999999667999999999887666  


Q ss_pred             ceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCC----CCeEEEee
Q 021982           81 RTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRK----TMTLKIAD  156 (304)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~----~~~vkl~d  156 (304)
                         .++|||+++++|.+++...   ...+++.++..++.|++.||++||++|++||||||+||+++..    ...++|+|
T Consensus        76 ---~~~vme~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D  149 (293)
T d1csna_          76 ---NVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD  149 (293)
T ss_dssp             ---EEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             ---cEEEEEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence               8999999999999887653   3468999999999999999999999999999999999999742    23799999


Q ss_pred             ccceeecccCC-------CccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCch---HHHHHHH
Q 021982          157 LGLARAFTLPI-------KKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSE---LQQLLHI  226 (304)
Q Consensus       157 fg~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~  226 (304)
                      ||+++......       .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.....   ......+
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            99998764321       1233456899999999998766 89999999999999999999999975432   2333222


Q ss_pred             HHHhCCCCCCCCccccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhc
Q 021982          227 FRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAME  292 (304)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  292 (304)
                      .......                       ......+.+|+++.+++..|++.+|.+||+.+.+.+
T Consensus       229 ~~~~~~~-----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         229 GEKKQST-----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHS-----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhccCCC-----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2211100                       111223468899999999999999999998776654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=326.25  Aligned_cols=247  Identities=24%  Similarity=0.304  Sum_probs=192.0

Q ss_pred             hhhcccccceEEEEEEEccCC---cEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCceEEE
Q 021982            9 LEKVGEGTYGKVYRAREKATG---KIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRTVLY   85 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   85 (304)
                      .+.||+|+||+||+|.+..++   ..|+||.+... ........+.+|+++++++ +||||+++++++.....    ..+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~----~~~  105 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG----SPL  105 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTT----EEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCC----ceE
Confidence            467999999999999986543   35889988632 2233346788999999999 99999999998765432    179


Q ss_pred             EEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCCCeEEEeeccceeecc
Q 021982           86 LVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKTMTLKIADLGLARAFT  164 (304)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~~~  164 (304)
                      +||||+++ +|.+++..   .....++..+..++.|++.||.|||+.+++||||||+|||++.++ .+||+|||++....
T Consensus       106 lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMY  181 (311)
T ss_dssp             EEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTT
T ss_pred             EEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhcc
Confidence            99999996 88887754   334677889999999999999999999999999999999999776 99999999998664


Q ss_pred             cCCC----ccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCchHH-HHHHHHHHhCCCCCCCCc
Q 021982          165 LPIK----KYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDSELQ-QLLHIFRLLGTPNEKVWP  239 (304)
Q Consensus       165 ~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (304)
                      ....    ......|++.|+|||.+.+.. ++.++||||||+++|||+||..||....... ....+.....        
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~--------  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC--------
T ss_pred             ccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            4322    122345689999999988776 7999999999999999999888876554333 2222222111        


Q ss_pred             cccccCCcccCCCCCCCcccccCCCCChhhHHHHHHhhcCCCCCCCCHHHHhcC
Q 021982          240 GVSSLMNWHEYPQWNPQSLATAVPNLDKDGLDLLEQMLQYDPSKRISAKKAMEH  293 (304)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  293 (304)
                                         ......+++++.+||.+||+.||++|||+.||++|
T Consensus       253 -------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         253 -------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                               11123578999999999999999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=319.68  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=188.4

Q ss_pred             chhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHH--HHHHHHccCCCCeeeeeceecccccC
Q 021982            2 VMDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLRE--VSILRMLSRDPHVVRLMDVKQGQNKE   79 (304)
Q Consensus         2 i~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e--~~~l~~l~~h~~i~~~~~~~~~~~~~   79 (304)
                      |..+|.+.+.||+|+||.||++++  +|..||||+++...     ......|  +..+..+ +||||+++++++......
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGT   72 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSS
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCc
Confidence            457899999999999999999986  47899999986432     1233334  4444566 899999999998876532


Q ss_pred             CceEEEEEEeccCC-CHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh--------cCccccCCCCCCeEEeCCCC
Q 021982           80 GRTVLYLVFEYMDT-DLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG--------HGILHRDLKPHNLLMDRKTM  150 (304)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~--------~~i~h~dl~~~Nil~~~~~~  150 (304)
                       ...+++||||+++ +|.+++..     ..+++..++.++.|++.||.|||+        +||+|+||||+|||++.++ 
T Consensus        73 -~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-  145 (303)
T d1vjya_          73 -WTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-  145 (303)
T ss_dssp             -SEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-
T ss_pred             -ceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-
Confidence             2347999999985 99999976     468999999999999999999996        5999999999999999777 


Q ss_pred             eEEEeeccceeecccCCC----ccccccccccCCChhhhhCCCC-----CCCchhHHHHHHHHHHHhhccccCCCCch--
Q 021982          151 TLKIADLGLARAFTLPIK----KYTHEILTLWYRAPEVLLGSTH-----YSTAVDMWSVACIFAELVTKTALFPGDSE--  219 (304)
Q Consensus       151 ~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~il~~ll~g~~p~~~~~~--  219 (304)
                      .+||+|||++........    ......||+.|+|||++.+...     ++.++||||||+++|+|+||..||.....  
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            999999999987654432    2234567999999999875421     46689999999999999999888743221  


Q ss_pred             ------------HHHHHHHHHHhCCCCCCCCccccccCCcccCCCCCCCcccc--cCCCCChhhHHHHHHhhcCCCCCCC
Q 021982          220 ------------LQQLLHIFRLLGTPNEKVWPGVSSLMNWHEYPQWNPQSLAT--AVPNLDKDGLDLLEQMLQYDPSKRI  285 (304)
Q Consensus       220 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rp  285 (304)
                                  ..........  ..                    ....+..  ........+.+|+.+||+.||.+||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~--~~--------------------~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  283 (303)
T d1vjya_         226 LPYYDLVPSDPSVEEMRKVVCE--QK--------------------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARL  283 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTT--SC--------------------CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC
T ss_pred             cchhhcccccchHHHHHHHHhc--cc--------------------cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc
Confidence                        1111111100  00                    0000000  0112334588999999999999999


Q ss_pred             CHHHHhc
Q 021982          286 SAKKAME  292 (304)
Q Consensus       286 s~~eil~  292 (304)
                      |+.||++
T Consensus       284 s~~ei~~  290 (303)
T d1vjya_         284 TALRIKK  290 (303)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.7e-47  Score=324.70  Aligned_cols=283  Identities=29%  Similarity=0.448  Sum_probs=201.9

Q ss_pred             hhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHcc----------CCCCeeeeeceec
Q 021982            5 AFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLS----------RDPHVVRLMDVKQ   74 (304)
Q Consensus         5 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~~i~~~~~~~~   74 (304)
                      +|++++.||+|+||+||+|+++.+|+.||||+++....   ......+|+++++.+.          .|+||+++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            69999999999999999999999999999999874321   1245667888888772          2578999998876


Q ss_pred             ccccCCceEEEEEEecc--CCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHh-cCccccCCCCCCeEEeCCCC-
Q 021982           75 GQNKEGRTVLYLVFEYM--DTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHG-HGILHRDLKPHNLLMDRKTM-  150 (304)
Q Consensus        75 ~~~~~~~~~~~lv~e~~--~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~Nil~~~~~~-  150 (304)
                      .....   ..+++++++  .+........  .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++. 
T Consensus        91 ~~~~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          91 HKGPN---GVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEETT---EEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             ecccc---ceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            54321   134444444  3444444443  444678999999999999999999998 89999999999999986542 


Q ss_pred             ----eEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHHHHHhhccccCCCCc------hH
Q 021982          151 ----TLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIFAELVTKTALFPGDS------EL  220 (304)
Q Consensus       151 ----~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~------~~  220 (304)
                          .++++|||.+......   .....+++.|+|||++.+.. ++.++|+||+|+++++|++|+.||....      ..
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cccceeeEeecccccccccc---cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence                5999999999765432   24456799999999998776 7999999999999999999999997543      23


Q ss_pred             HHHHHHHHHhCCCCCCCCccccccCCc-------ccCCCCCCCc-------ccccCCCCChhhHHHHHHhhcCCCCCCCC
Q 021982          221 QQLLHIFRLLGTPNEKVWPGVSSLMNW-------HEYPQWNPQS-------LATAVPNLDKDGLDLLEQMLQYDPSKRIS  286 (304)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps  286 (304)
                      +........++......+........+       ..........       ........++++.+||.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            445555555555433221110000000       0000000000       00111234577899999999999999999


Q ss_pred             HHHHhcCCCcccc
Q 021982          287 AKKAMEHPYFDDL  299 (304)
Q Consensus       287 ~~eil~~~~~~~~  299 (304)
                      ++|+|+||||++.
T Consensus       322 a~e~L~Hp~f~~~  334 (362)
T d1q8ya_         322 AGGLVNHPWLKDT  334 (362)
T ss_dssp             HHHHHTCGGGTTC
T ss_pred             HHHHhcCcccCCC
Confidence            9999999999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=2.3e-24  Score=166.73  Aligned_cols=172  Identities=16%  Similarity=0.107  Sum_probs=117.6

Q ss_pred             hhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCC----------------CchhHHHHHHHHHccCCCCeeee
Q 021982            6 FEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGV----------------PPTTLREVSILRMLSRDPHVVRL   69 (304)
Q Consensus         6 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~----------------~~~~~~e~~~l~~l~~h~~i~~~   69 (304)
                      +.+.+.||+|+||+||+|.+. +|+.||||+++........                ......|...+.++ .|++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            456889999999999999985 5889999987643211100                01223467778888 88888887


Q ss_pred             eceecccccCCceEEEEEEeccCCCHHHHHHHhccCCCCCChHHHHHHHHHHHHHHHHHHhcCccccCCCCCCeEEeCCC
Q 021982           70 MDVKQGQNKEGRTVLYLVFEYMDTDLKKYIRSFRQTGENIPVNTVKSLMYQLCKGVAFCHGHGILHRDLKPHNLLMDRKT  149 (304)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~Nil~~~~~  149 (304)
                      ++...         .+++||++++...          ..++......++.|++.++.+||++|++|+||||+|||++. +
T Consensus        80 ~~~~~---------~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~  139 (191)
T d1zara2          80 YAWEG---------NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-E  139 (191)
T ss_dssp             EEEET---------TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-T
T ss_pred             EEecC---------CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-C
Confidence            75521         2699999997311          12566777889999999999999999999999999999994 4


Q ss_pred             CeEEEeeccceeecccCCCccccccccccCCChhhhhCCCCCCCchhHHHHHHHH
Q 021982          150 MTLKIADLGLARAFTLPIKKYTHEILTLWYRAPEVLLGSTHYSTAVDMWSVACIF  204 (304)
Q Consensus       150 ~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~il  204 (304)
                       .++|+|||.+.....+....... .+.. .-.+.+. . .++.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~~~l~-rd~~-~~~~~f~-r-~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWREILE-RDVR-NIITYFS-R-TYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHHHHH-HHHH-HHHHHHH-H-HHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHHHHH-HHHH-HHHHHHc-C-CCCCcccHHHHHHHH
Confidence             68999999997654332211000 0000 0012221 2 267889999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=6.7e-08  Score=76.68  Aligned_cols=85  Identities=14%  Similarity=0.132  Sum_probs=57.5

Q ss_pred             hhhhhhhhhcccccceEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCce
Q 021982            3 MDAFEKLEKVGEGTYGKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGRT   82 (304)
Q Consensus         3 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   82 (304)
                      .+.|+.++..+.++.+.||.+.  .++..+++|........  ....+..|...++.+..+--+++++.+....+.    
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~----   84 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW----   84 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE----
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc----
Confidence            3566666665556667899885  34666788876543322  234577899998888555556777777665544    


Q ss_pred             EEEEEEeccCC-CHH
Q 021982           83 VLYLVFEYMDT-DLK   96 (304)
Q Consensus        83 ~~~lv~e~~~~-~l~   96 (304)
                       .++||+++.| ++.
T Consensus        85 -~~lv~~~l~G~~~~   98 (263)
T d1j7la_          85 -SNLLMSEADGVLCS   98 (263)
T ss_dssp             -EEEEEECCSSEEHH
T ss_pred             -eEEEEEeccccccc
Confidence             7899999988 543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.28  E-value=3.1e-06  Score=70.97  Aligned_cols=78  Identities=15%  Similarity=0.140  Sum_probs=49.0

Q ss_pred             hhhcccccceEEEEEEEccCCcEEEEEEeeec-----CCCCCCCchhHHHHHHHHHccCC--CCeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKATGKIVALKKTRLH-----EDDEGVPPTTLREVSILRMLSRD--PHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~~   81 (304)
                      .+.+|.|....||.+.+..+++.+++|.....     ........+...|...++.+..+  ..+++++.+.  ...   
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~---  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM---  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT---
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCC---
Confidence            45789999999999998777888999965431     11222334566788888877544  3455565543  222   


Q ss_pred             eEEEEEEeccCC
Q 021982           82 TVLYLVFEYMDT   93 (304)
Q Consensus        82 ~~~~lv~e~~~~   93 (304)
                        .+++||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3689999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.88  E-value=9.1e-05  Score=57.64  Aligned_cols=72  Identities=14%  Similarity=0.145  Sum_probs=46.0

Q ss_pred             hcccccc-eEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCC-CeeeeeceecccccCCceEEEEEE
Q 021982           11 KVGEGTY-GKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDP-HVVRLMDVKQGQNKEGRTVLYLVF   88 (304)
Q Consensus        11 ~lg~g~~-g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~~~~~~~~~lv~   88 (304)
                      .+..|.. +.||.+... ++..+++|.....     ....+..|...++.+..+. .+++++.+..+.+.     .+++|
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~-----~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-----DWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-----EEEEE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccc-----eEEEE
Confidence            3444443 678988754 3556888875432     2345778888888875432 25566666555443     78999


Q ss_pred             eccCC
Q 021982           89 EYMDT   93 (304)
Q Consensus        89 e~~~~   93 (304)
                      +++.|
T Consensus        86 ~~i~G   90 (255)
T d1nd4a_          86 GEVPG   90 (255)
T ss_dssp             ECCSS
T ss_pred             Eeeec
Confidence            99976

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.29  E-value=0.00043  Score=57.56  Aligned_cols=72  Identities=17%  Similarity=0.182  Sum_probs=49.4

Q ss_pred             hhhcccccceEEEEEEEcc-------CCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCeeeeeceecccccCCc
Q 021982            9 LEKVGEGTYGKVYRAREKA-------TGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHVVRLMDVKQGQNKEGR   81 (304)
Q Consensus         9 ~~~lg~g~~g~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   81 (304)
                      ++.|+.|-.-.+|++....       .+..+++++.-..    .......+|..+++.++.+.-.+++++++.+      
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------
Confidence            4567888889999998653       2356777776421    1233456789999988666666778777642      


Q ss_pred             eEEEEEEeccCC
Q 021982           82 TVLYLVFEYMDT   93 (304)
Q Consensus        82 ~~~~lv~e~~~~   93 (304)
                         ..|+||+.|
T Consensus       117 ---g~I~efi~g  125 (395)
T d1nw1a_         117 ---GRLEEYIPS  125 (395)
T ss_dssp             ---EEEECCCCE
T ss_pred             ---ceEEEEecc
Confidence               478888865

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.42  E-value=0.0067  Score=48.63  Aligned_cols=71  Identities=15%  Similarity=0.164  Sum_probs=39.6

Q ss_pred             eEEEEEEEccCCcEEEEEEeeecCCCCCCCchhHHHHHHHHHccCCCCe--eeeeceecccccCCceEEEEEEeccCC
Q 021982           18 GKVYRAREKATGKIVALKKTRLHEDDEGVPPTTLREVSILRMLSRDPHV--VRLMDVKQGQNKEGRTVLYLVFEYMDT   93 (304)
Q Consensus        18 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~   93 (304)
                      -.||.+... +|..+++|+.+....   ....+..|...+..|..+ .+  +..+..............+.++++..|
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW---TADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            468998764 577899998764322   235577788888877422 22  222211111111122346788888765

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.70  E-value=0.0049  Score=49.15  Aligned_cols=31  Identities=23%  Similarity=0.318  Sum_probs=26.3

Q ss_pred             cCccccCCCCCCeEEeCCCCeEEEeeccceee
Q 021982          131 HGILHRDLKPHNLLMDRKTMTLKIADLGLARA  162 (304)
Q Consensus       131 ~~i~h~dl~~~Nil~~~~~~~vkl~dfg~~~~  162 (304)
                      .|++|+|+.++||+++.+. ..-++||+.++.
T Consensus       183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             cccccCCcchhhhhccccc-ceeEeccccccc
Confidence            3799999999999999665 568999998853